Citrus Sinensis ID: 012203

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------47
Protein Sequence
MAAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVAQVFTTVDGSISISRVDAVPGEKWSSIIQLKLEEQEEPLGPRCSASTARGTIQLVLVSVNH
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccEEccEEcccccccEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccccccEEEEccccEEEccccEEcccccccccccccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccHHHHHHHHHHcccccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHccccccccHHHHHHcccccccccHHHHHHHHHccccccccccccHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccHccccccccccccccccccccccccHHccccccHHHHHHEEHHHEccccccEEEEEEEEcccccEEEEHEHcHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEcccccccEEEccccccccccHHHHHcccccccccccHHHHHHcEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccHHHHccccHHHHHHHHccccccHHHcccHHHHHHcHHHHccHHccccccHHHHHHHHcccHccccccEEEEEccccccccccccccccccccEEEEEEccccccccccccccEEEEccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEEEEEcc
Coil and Loop (DISEMBL)
maavgqsnsssepsrqpckcyrvrSLAETILDTNQISNLRERFVLGqqlgwgqfgvirvcsdkftgeVFACKSIAKdrlvtidderSVKLEIEIMTRlsghpnvvdlkavyedeDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGvvhrdlkpenillatkassspikladfglatyiepgqsllgtvgspfyiapevlaggynqaadVWSAGVILYILLsgmppfwgntksrIFDAvrtadlrfpsnpwdhisdSAKDLVMGMlstdpsqrltarqvldhswmgdgiqdpeklsgnkiedckewdlgsgsfstqiiprnqdisfgtgspvfsddespaftcrtsfssflqepststgfsfcspgdsdasefmsplpsmpsfsffspgsvaqvFTTVdgsisisrvdavpgekWSSIIQLKLeeqeeplgprcsastargTIQLVLVSVNH
Flexible Loop (DISEMBL)
maavgqsnsssepsrqpcKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFAcksiakdrlvtiddersVKLEIEimtrlsghpnvvdLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTadlrfpsnpwdHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVAQVFTTVDGSISisrvdavpgeKWSSIIQLKLeeqeeplgprcsastargtiQLVLVSVNH
Low Complexity Region (SEG)
MAAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFCSPGDSDAsefmsplpsmpsfsffspgsVAQVFTTVDGSISISRVDAVPGEKWSSIIQLKLEEQEEPLGPRCSASTARGTIQLVLVSVNH
Disordered region (IsUnstruct)
*****************CKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS*****LV****************VLDHSWM***************EDCKEWDLGSGSFSTQIIP*****************************************************************FFSPGSVAQVFTTVDGSISISRVDAVPGEKWSSIIQLK*******************TIQLVLV****
Disordered Region (DISOPRED)
**********************************QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP**************DL**GS**************************************************************SPLPSM***********AQVFTTVDGSISISRVDAVPG****SIIQLKLEE******************QLVLVSV**
Disordered Region (DISEMBL)
*******************CYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVAQVFTTVDGSISISRVDAVPGEKWSSIIQLKLEEQ*********ASTARGTIQLVLVSVNH
Disordered Region (DISPRO)
******************************LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFCSPGDSDASEFMSPLPSMPSFSFFSP*************************************************TARGTIQLVLVSVNH
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVAQVFTTVDGSISISRVDAVPGEKWSSIIQLKLEEQEEPLGPRCSASTARGTIQLVLVSVNH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	468	2.2.26 [Sep-21-2011]
Q9FMP5	528	Calcium-dependent protein	no	no	0.585	0.518	0.507	7e-81
P28582	532	Calcium-dependent protein	N/A	no	0.628	0.552	0.484	2e-80
Q3E9C0	523	Calcium-dependent protein	no	no	0.585	0.523	0.503	2e-80
Q9C6P3	521	Calcium-dependent protein	no	no	0.626	0.562	0.493	2e-79
Q9SJ61	520	Calcium-dependent protein	no	no	0.619	0.557	0.491	3e-79
Q06850	610	Calcium-dependent protein	no	no	0.600	0.460	0.521	3e-79
Q9ZSA2	531	Calcium-dependent protein	no	no	0.581	0.512	0.509	5e-79
A5A7I7	557	Calcium-dependent protein	N/A	no	0.583	0.490	0.509	6e-79
Q38870	646	Calcium-dependent protein	no	no	0.638	0.462	0.478	6e-79
Q8RWL2	534	Calcium-dependent protein	no	no	0.557	0.488	0.517	7e-79

>sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1

 Score =  301 bits (771), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 139/274 (50%), Positives = 189/274 (68%)

Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           + +++  + LG++LG GQFGV  +C+ K TG  FACK+IAK +LV  +D   V+ E++IM
Sbjct: 66  MEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIM 125

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
             L+G PN+V+LK  YED+  VHLVMELCAGGELF R+   G +SE  A  L   ++Q+V
Sbjct: 126 HHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQIV 185

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
             CH +GV+HRDLKPEN LL  K  +SP+K  DFGL+ + +PG+     VGS +YIAPEV
Sbjct: 186 HTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEV 245

Query: 216 LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
           L   Y   AD+WS GV+LYILL G+PPFW  +++ IF+A+    + F S+PW  IS  AK
Sbjct: 246 LKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQAK 305

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           DLV  ML++DP QRLTA QVL+H W+ +  + P+
Sbjct: 306 DLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPD 339

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2

 Score =  300 bits (768), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 144/297 (48%), Positives = 201/297 (67%), Gaps = 3/297 (1%)

Query: 14  SRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKS 73
           S +P + +R  S   TIL      ++R ++ LG++LG GQFG +  C++  +G+++ACKS
Sbjct: 55  SLKPRQVHRPES--NTIL-GKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKS 111

Query: 74  IAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL 133
           I K +LV+ +D+  +K EI+I+  LSG PN+V+ K V+ED   VHLVMELCAGGELF R+
Sbjct: 112 ILKRKLVSKNDKEDIKREIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRI 171

Query: 134 EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT 193
              G +SE  A  +  Q++ VV  CH +GV+HRDLKPEN LL++K   + +K  DFGL+ 
Sbjct: 172 IAQGHYSERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSV 231

Query: 194 YIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFD 253
           +IE G+     VGS +Y+APEVL   Y +  D+WSAGVILYILLSG+PPFW   +  IFD
Sbjct: 232 FIEEGKVYRNIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFD 291

Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           A+    + F S PW  +S+SAKDLV  ML+ DP +R+T+ QVLDH WM +G +  +K
Sbjct: 292 AILEGVIDFESEPWPSVSNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGGEASDK 348

May play a role in signal transduction pathways that involve calcium as a second messenger.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1

 Score =  299 bits (766), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 138/274 (50%), Positives = 191/274 (69%)

Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           + +++  + LG++LG GQFGV  +C+ K TG  FACK+IAK +LV  +D   V+ E++IM
Sbjct: 61  MEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRREVQIM 120

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
             L+G PN+V+LK  YED+  VHLVMELCAGGELF R+   G +SE  A  L   ++Q++
Sbjct: 121 HHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQII 180

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
             CH +GV+HRDLKPEN LL +K  +SP+K  DFGL+ + +PG+     VGS +YIAPEV
Sbjct: 181 HTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEV 240

Query: 216 LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
           L   Y   AD+WS GV+LYILL G+PPFW  +++ IF+A+ +  + F S+PW  IS  AK
Sbjct: 241 LRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVISPQAK 300

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           DLV  ML++DP QRLTA QVL+H W+ +  + P+
Sbjct: 301 DLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPD 334

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1

 Score =  296 bits (759), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 147/298 (49%), Positives = 200/298 (67%), Gaps = 5/298 (1%)

Query: 13  PSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACK 72
           P R P K     S A  IL+     +++  + L ++LG GQFGV  +C++K TG+ FACK
Sbjct: 48  PWRNPAK----HSGAAAILE-KPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACK 102

Query: 73  SIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR 132
           SI+K +LVT  D+  ++ EI+IM  LSG PN+V+ K  YEDE  V+LVMELCAGGELF R
Sbjct: 103 SISKKKLVTKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDR 162

Query: 133 LEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA 192
           +   G +SE  A  +  Q++ VV  CH +GV+HRDLKPEN LL++K   + IK  DFGL+
Sbjct: 163 ILAKGHYSERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLS 222

Query: 193 TYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIF 252
            +IE G+     VGS +Y+APEVL   Y +  D+WSAG+ILYILLSG+PPFW  T+  IF
Sbjct: 223 VFIEEGRVYKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIF 282

Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           DA+   ++ F S PW  IS+SAKDLV  ML+ DP +R++A +VL H W+ +G +  +K
Sbjct: 283 DAILEGEIDFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDK 340

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SJ61|CDPKP_ARATH Calcium-dependent protein kinase 25 OS=Arabidopsis thaliana GN=CPK25 PE=2 SV=1

 Score =  296 bits (757), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 146/297 (49%), Positives = 193/297 (64%), Gaps = 7/297 (2%)

Query: 19  KCYRVRSL------AETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACK 72
           K + VR L      AE++L T +  +L+E + LG +LG GQFG   VC +K TGE +ACK
Sbjct: 103 KAHNVRRLMSAGLQAESVLKT-KTGHLKEYYNLGSKLGHGQFGTTFVCVEKGTGEEYACK 161

Query: 73  SIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR 132
           SI K +L   +D   V+ EIEIM  L G PNV+ +K  YED   VH+VMELC GGELF R
Sbjct: 162 SIPKRKLENEEDVEDVRREIEIMKHLLGQPNVISIKGAYEDSVAVHMVMELCRGGELFDR 221

Query: 133 LEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA 192
           + + G +SE +A  L   ++ VV  CH +GV+HRDLKPEN L       SP+K  DFGL+
Sbjct: 222 IVERGHYSERKAAHLAKVILGVVQTCHSLGVMHRDLKPENFLFVNDDEDSPLKAIDFGLS 281

Query: 193 TYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIF 252
            +++PG++    VGSP+YIAPEVL   Y   AD+WSAGV++Y+LLSG  PFWG T+  IF
Sbjct: 282 MFLKPGENFTDVVGSPYYIAPEVLNKNYGPEADIWSAGVMIYVLLSGSAPFWGETEEEIF 341

Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           + V   +L   S+PW  +S+SAKDL+  ML  +P QRLTA+QVL H W+ D    P+
Sbjct: 342 NEVLEGELDLTSDPWPQVSESAKDLIRKMLERNPIQRLTAQQVLCHPWIRDEGNAPD 398

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06850|CDPK1_ARATH Calcium-dependent protein kinase 1 OS=Arabidopsis thaliana GN=CPK1 PE=1 SV=1

 Score =  295 bits (756), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 148/284 (52%), Positives = 192/284 (67%), Gaps = 3/284 (1%)

Query: 28  ETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS 87
           E++L   +  N +E + LG++LG GQFG   +C +K TG+ FACKSIAK +L+T +D   
Sbjct: 136 ESVL-QRKTENFKEFYSLGRKLGQGQFGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVED 194

Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL 147
           V+ EI+IM  L+GHPNV+ +K  YED   VHLVME CAGGELF R+ + G ++E +A  L
Sbjct: 195 VRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAEL 254

Query: 148 FMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS 207
              ++ VV  CH +GV+HRDLKPEN L  +K   S +K  DFGL+ + +P       VGS
Sbjct: 255 TRTIVGVVEACHSLGVMHRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGS 314

Query: 208 PFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
           P+Y+APEVL   Y   ADVWSAGVI+YILLSG+PPFW  T+  IF+ V   DL F S+PW
Sbjct: 315 PYYVAPEVLRKRYGPEADVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPW 374

Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG-DGIQDPEK 310
             IS+SAKDLV  ML  DP +RLTA QVL H W+  DG+  P+K
Sbjct: 375 PSISESAKDLVRKMLVRDPKKRLTAHQVLCHPWVQVDGVA-PDK 417

May play a role in signal transduction pathways that involve calcium as a second messenger. Phosphorylates the Ca(2+)-ATPase ACA2 resulting in the inhibition of its calcium activation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZSA2|CDPKL_ARATH Calcium-dependent protein kinase 21 OS=Arabidopsis thaliana GN=CPK21 PE=1 SV=1

 Score =  295 bits (755), Expect = 5e-79,   Method: Compositional matrix adjust.
 Identities = 139/273 (50%), Positives = 188/273 (68%), Gaps = 1/273 (0%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           ++R+ + LG++LG GQFG+  +C +  TG  +ACKSI K +L++  D+  VK EI+IM  
Sbjct: 75  DIRKFYSLGKELGRGQFGITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKREIQIMQY 134

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
           LSG PN+V++K  YED   +HLVMELCAGGELF R+   G +SE  A  +   ++ VV  
Sbjct: 135 LSGQPNIVEIKGAYEDRQSIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSIVNVVQI 194

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
           CH +GVVHRDLKPEN LL++K  ++ +K  DFGL+ +IE G+     VGS +Y+APEVL 
Sbjct: 195 CHFMGVVHRDLKPENFLLSSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR 254

Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y +  D+WSAGVILYILLSG+PPFW   +  IFD V   ++ F S PW  IS+SAKDL
Sbjct: 255 RSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSISESAKDL 314

Query: 278 VMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           V  ML+ DP +R+TA QVL+H W+  G + P+K
Sbjct: 315 VRKMLTKDPKRRITAAQVLEHPWIKGG-EAPDK 346

May play a role in signal transduction pathways that involve calcium as a second messenger. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A5A7I7|CDPK4_SOLTU Calcium-dependent protein kinase 4 OS=Solanum tuberosum GN=CPK4 PE=2 SV=1

 Score =  295 bits (755), Expect = 6e-79,   Method: Compositional matrix adjust.
 Identities = 139/273 (50%), Positives = 188/273 (68%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           N+R+ + LG++LG GQFG   +C++  TG  +ACKSI+K +L++ +D   V+ EI+IM  
Sbjct: 89  NIRDLYTLGRKLGQGQFGTTYLCTENSTGAEYACKSISKRKLISKEDVEDVRREIQIMHH 148

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
           LSGH N+V +K  YED  YVH+VME+C+GGELF R+ + G +SE +A  L   ++ VV  
Sbjct: 149 LSGHRNIVTIKGAYEDPLYVHIVMEICSGGELFDRIIQRGHYSERKAAELTKIIVGVVEA 208

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
           CH +GV+HRDLKPEN LL  K +   +K  DFGL+ + +PGQ     VGSP+Y+APEVL 
Sbjct: 209 CHSLGVMHRDLKPENFLLVNKDNDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 268

Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y   ADVW+AGVILYILLSG+PPFW  T+  IFDAV    + F S+PW  IS+SAKDL
Sbjct: 269 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISESAKDL 328

Query: 278 VMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           +  ML   PS+RLTA +VL H W+ +    P++
Sbjct: 329 IRKMLCMQPSERLTAHEVLCHPWICENGVAPDR 361

Regulates the production of reactive oxygen species (ROS) by NADPH oxidase.

Solanum tuberosum (taxid: 4113)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38870|CDPK2_ARATH Calcium-dependent protein kinase 2 OS=Arabidopsis thaliana GN=CPK2 PE=1 SV=1

 Score =  295 bits (754), Expect = 6e-79,   Method: Compositional matrix adjust.
 Identities = 146/305 (47%), Positives = 198/305 (64%), Gaps = 6/305 (1%)

Query: 7   SNSSSEPSRQPCKCYRVRSLAETILDTNQI-----SNLRERFVLGQQLGWGQFGVIRVCS 61
           S +  E   +P K   +R ++   L T  +      N +E + LG++LG GQFG   +C 
Sbjct: 145 SETKPETKAEPQKPKHMRRVSSAGLRTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCL 204

Query: 62  DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM 121
           +K TG  +ACKSI+K +L+T +D   V+ EI+IM  L+GHPNV+ +K  YED   VHLVM
Sbjct: 205 EKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVM 264

Query: 122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
           ELC+GGELF R+ + G ++E +A  L   ++ V+  CH +GV+HRDLKPEN L  ++   
Sbjct: 265 ELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENFLFVSREED 324

Query: 182 SPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 241
           S +K  DFGL+ + +P +     VGSP+Y+APEVL   Y   +DVWSAGVI+YILLSG+P
Sbjct: 325 SLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIVYILLSGVP 384

Query: 242 PFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           PFW  T+  IF+ V   DL F S+PW  IS+SAKDLV  ML  DP +RLTA QVL H W+
Sbjct: 385 PFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAHQVLCHPWV 444

Query: 302 G-DGI 305
             DG+
Sbjct: 445 QIDGV 449

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWL2|CDPKT_ARATH Calcium-dependent protein kinase 29 OS=Arabidopsis thaliana GN=CPK29 PE=2 SV=2

 Score =  295 bits (754), Expect = 7e-79,   Method: Compositional matrix adjust.
 Identities = 135/261 (51%), Positives = 180/261 (68%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + L ++LG GQFG+   C+DK  G  +ACKSI+K +L+   D   V+ E+ I+  L+G P
Sbjct: 85  YDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDIEDVRREVMILQHLTGQP 144

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N+V+ +  YED+D +HLVMELC+GGELF R+ K G +SE EA  +F Q++ VV  CH +G
Sbjct: 145 NIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAANIFRQIVNVVHVCHFMG 204

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQ 222
           VVHRDLKPEN LL +    SPIK  DFGL+ +IE G+     VGS +Y+APEVL   Y +
Sbjct: 205 VVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLHRNYGK 264

Query: 223 AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGML 282
             DVWSAGV+LYILLSG+PPFWG T+  IF+A+    L   ++PW  IS+SAKDL+  ML
Sbjct: 265 EIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETSPWPTISESAKDLIRKML 324

Query: 283 STDPSQRLTARQVLDHSWMGD 303
             DP +R+TA + L+H WM D
Sbjct: 325 IRDPKKRITAAEALEHPWMTD 345

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	468
224136890	526	predicted protein [Populus trichocarpa]	0.908	0.807	0.754	0.0
224120124	512	predicted protein [Populus trichocarpa]	0.903	0.826	0.745	0.0
255539573	530	calcium-dependent protein kinase, putati	0.925	0.816	0.714	1e-173
225455487	520	PREDICTED: calcium-dependent protein kin	0.873	0.786	0.730	1e-171
356559884	518	PREDICTED: calcium-dependent protein kin	0.908	0.820	0.715	1e-169
357444093	508	Calcium-dependent protein kinase [Medica	0.869	0.801	0.690	1e-161
21064945	511	CDPK-like protein [Solanum tuberosum]	0.886	0.812	0.665	1e-160
45331386	465	CDPK-related protein kinase [Vigna radia	0.905	0.911	0.678	1e-159
449452378	526	PREDICTED: calcium-dependent protein kin	0.901	0.802	0.646	1e-158
225426761	523	PREDICTED: calcium-dependent protein kin	0.856	0.766	0.691	1e-157

>gi|224136890|ref|XP_002322441.1| predicted protein [Populus trichocarpa] gi|222869437|gb|EEF06568.1| predicted protein [Populus trichocarpa]

 Score =  658 bits (1697), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/431 (75%), Positives = 369/431 (85%), Gaps = 6/431 (1%)

Query: 3   AVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSD 62
           AV +SNSS E  +QPC CYRV SL ETILDT+QISNL++R+VLG+QLGWGQFGVIRVC+D
Sbjct: 2   AVAKSNSSRESLKQPCNCYRVSSLTETILDTHQISNLKDRYVLGEQLGWGQFGVIRVCTD 61

Query: 63  KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           K + EV ACKSI+KDRLVT+DD RSVKLEIEIMTRLSGH NVVDLKAVYEDEDYVHLVME
Sbjct: 62  KLSREVLACKSISKDRLVTLDDARSVKLEIEIMTRLSGHANVVDLKAVYEDEDYVHLVME 121

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
           LCAGGELFH+LEK GRFSEAEARVLF  LMQVVLYCHE GVVHRDLKPENILLATK+SSS
Sbjct: 122 LCAGGELFHQLEKHGRFSEAEARVLFRHLMQVVLYCHENGVVHRDLKPENILLATKSSSS 181

Query: 183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP 242
           PIKLADFGLATY++PGQSL GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP
Sbjct: 182 PIKLADFGLATYVKPGQSLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP 241

Query: 243 FWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           FWG TKSRIFDAVR ADLRFPS+PWDHI++SAK+LV GML TDPSQR T++QVLD+SWM 
Sbjct: 242 FWGKTKSRIFDAVRAADLRFPSDPWDHITESAKELVRGMLCTDPSQRFTSQQVLDNSWMK 301

Query: 303 DGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTS 362
                PE+ S  + + C+EWDLG  S S  ++ R+QD+SFGTGSP+ +D +SP FTCR+S
Sbjct: 302 HDGPYPEESSQREKQICEEWDLGGSSLSI-LMARDQDVSFGTGSPIINDVQSPTFTCRSS 360

Query: 363 FSSFLQEPST----STGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSV-AQVFTTVDGS 417
           FSSFL EPST    S GFSF S  DS+A EF+SP+ SMPSF+F SPG V  Q  +T++ S
Sbjct: 361 FSSFLGEPSTPSFVSGGFSFRSSDDSNALEFISPVSSMPSFAFSSPGPVIEQGSSTLEFS 420

Query: 418 ISISRVDAVPG 428
            +ISR+D+V G
Sbjct: 421 SNISRIDSVCG 431

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224120124|ref|XP_002318248.1| predicted protein [Populus trichocarpa] gi|222858921|gb|EEE96468.1| predicted protein [Populus trichocarpa]

 Score =  648 bits (1671), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/429 (74%), Positives = 365/429 (85%), Gaps = 6/429 (1%)

Query: 3   AVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSD 62
           AVG+SNSS EP +QPC CYRV SL E+ILDT+Q SNL++R+VLG+QLGWGQFGVIRVC+D
Sbjct: 2   AVGKSNSSHEPLKQPCNCYRVSSLIESILDTDQTSNLKDRYVLGEQLGWGQFGVIRVCTD 61

Query: 63  KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           K TGEV ACKSI+KDRLVT DD RSVKLEIEIMTRLSGH NVVDLKAVYEDE+YVHLVME
Sbjct: 62  KLTGEVLACKSISKDRLVTSDDARSVKLEIEIMTRLSGHDNVVDLKAVYEDENYVHLVME 121

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
           LCAGGELF +LEK GRFSEAEAR LF  LMQVV YCHE GVVHRDLKPENILLA+K+SSS
Sbjct: 122 LCAGGELFQQLEKHGRFSEAEARDLFKHLMQVVQYCHENGVVHRDLKPENILLASKSSSS 181

Query: 183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP 242
           PIKLADFGLATY++PGQSL GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP
Sbjct: 182 PIKLADFGLATYVKPGQSLRGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP 241

Query: 243 FWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           FWG TKSRIFDAVR ADLRFPSNPWDHI+ SAK+LV GML TDPSQR TA+QVLD+SWM 
Sbjct: 242 FWGKTKSRIFDAVRAADLRFPSNPWDHITQSAKELVRGMLCTDPSQRFTAQQVLDNSWMK 301

Query: 303 DGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTS 362
             +  PE+ S  + + C+EW LG GSFST ++ R+QD+SFGTGSP+F D +S  F CR+S
Sbjct: 302 YDLPYPEEPSQREKQSCQEWGLGGGSFST-LMARDQDVSFGTGSPIFHDVQSSTFKCRSS 360

Query: 363 FSSFLQEPSTST----GFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVAQV-FTTVDGS 417
           FSSFL EPST      GFSF +  DS+A EFMSP+ SMPSF+F S G V ++  +T++ S
Sbjct: 361 FSSFLAEPSTPIFAPGGFSFHNGDDSNALEFMSPVSSMPSFAFSSAGPVIELGSSTLELS 420

Query: 418 ISISRVDAV 426
            +ISR+D++
Sbjct: 421 SNISRIDSM 429

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255539573|ref|XP_002510851.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223549966|gb|EEF51453.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 320/448 (71%), Positives = 363/448 (81%), Gaps = 15/448 (3%)

Query: 3   AVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSD 62
           AV + NSS    +QPC CY + SL +TILDTNQ SNL++R++LG+QLGWGQFGVIRVC+D
Sbjct: 2   AVAKCNSSYNLLKQPCTCYTISSLTQTILDTNQTSNLKDRYLLGEQLGWGQFGVIRVCTD 61

Query: 63  KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           KF+G++FACKSIAKDRLVT DD RSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY+HLVME
Sbjct: 62  KFSGDLFACKSIAKDRLVTSDDARSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYIHLVME 121

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
           LCAGGELFH+LEK GRFSE EARVLF  +MQVVLYCHEIGVVHRDLKPENILLATKASSS
Sbjct: 122 LCAGGELFHQLEKHGRFSETEARVLFRHMMQVVLYCHEIGVVHRDLKPENILLATKASSS 181

Query: 183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP 242
            IKLADFGLATYI+PGQSL GTVGSPFYIAPEVLAGGYNQAAD+WSAGVILYILLSGMPP
Sbjct: 182 QIKLADFGLATYIKPGQSLHGTVGSPFYIAPEVLAGGYNQAADIWSAGVILYILLSGMPP 241

Query: 243 FWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           FWG TKS+IFDAVR ADLRFPSNPWD +++SAK+LV GML TDPS RLTA+QVLDHSWM 
Sbjct: 242 FWGKTKSQIFDAVRAADLRFPSNPWDRVTESAKELVRGMLCTDPSLRLTAQQVLDHSWMK 301

Query: 303 DGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTS 362
           D  Q  E     + + C  WDLG GSFST ++ +NQ+ISFG GSP+  D ESP F CR+S
Sbjct: 302 DDGQCSEAPDQCQKKSCGGWDLGGGSFST-LMAQNQNISFGAGSPIICDVESPTFKCRSS 360

Query: 363 FSSFLQEPST----STGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVAQVFTTVDGSI 418
           FSSFL E ST    S  FSF +  DS+A EF SP+ S+PSF+FFSPG V     T  GS 
Sbjct: 361 FSSFLVETSTPCFVSGLFSFRNSDDSNALEFSSPISSIPSFAFFSPGPV-----TEQGSC 415

Query: 419 SISRVDAVPGEKWSSIIQLKLEEQEEPL 446
           ++     +P +K SSII +  E   E +
Sbjct: 416 TLD----LPNKK-SSIIPIHGEVSLEKM 438

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455487|ref|XP_002280303.1| PREDICTED: calcium-dependent protein kinase 25-like [Vitis vinifera]

 Score =  607 bits (1565), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 303/415 (73%), Positives = 342/415 (82%), Gaps = 6/415 (1%)

Query: 20  CYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL 79
           CY+V SL ETILDT+Q SNL++RFVLG+QLGWGQFGVIR CSDK  GEV ACKSIAKDRL
Sbjct: 19  CYKVESLKETILDTDQTSNLKDRFVLGEQLGWGQFGVIRACSDKLAGEVLACKSIAKDRL 78

Query: 80  VTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRF 139
           VT DD RSVKLEIEIMT+LSGHPNVVDLKAVYE+EDYVHLVMELCAGGELFH+LEK GRF
Sbjct: 79  VTQDDVRSVKLEIEIMTKLSGHPNVVDLKAVYEEEDYVHLVMELCAGGELFHQLEKHGRF 138

Query: 140 SEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ 199
           SEAEARVLF  LM+VV+YCH+ G+VHRDLKPENILLATKASSSPIKLADFGLATYI+PGQ
Sbjct: 139 SEAEARVLFRHLMEVVMYCHDKGIVHRDLKPENILLATKASSSPIKLADFGLATYIKPGQ 198

Query: 200 SLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD 259
           SL GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWG TKSRIFDAVR AD
Sbjct: 199 SLYGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSRIFDAVRAAD 258

Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDC 319
           LRFPS+PWD +S SA++L+ GML  DPSQRLTA++VLDHSW+ D  Q  E+   ++ +  
Sbjct: 259 LRFPSDPWDQLSGSAEELIRGMLCRDPSQRLTAQEVLDHSWIRDHAQSSEEPREHENQSY 318

Query: 320 KEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPST----STG 375
           +    G  SFST  + RNQDISFGTG  V  D +SP FTCR+SF+SF  EPST    S G
Sbjct: 319 EHLGEGGSSFST-FMTRNQDISFGTGPRVICDAQSPQFTCRSSFTSFGLEPSTPCFASGG 377

Query: 376 FSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVA-QVFTTVDGSISISRVDAVPGE 429
           FSF S  + +  EF SP+PSMPSF+FFSP  +  Q   T+D S +IS V+A+  E
Sbjct: 378 FSFGSTDEPNTLEFSSPVPSMPSFAFFSPCPITVQESYTLDLSANISTVNAIQKE 432

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356559884|ref|XP_003548226.1| PREDICTED: calcium-dependent protein kinase 32-like [Glycine max]

 Score =  602 bits (1553), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 309/432 (71%), Positives = 350/432 (81%), Gaps = 7/432 (1%)

Query: 3   AVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSD 62
           AV  SNSS+EP      CY+V  L ETILD + ISNL++R++LG+QLGWGQFGVIR CSD
Sbjct: 2   AVANSNSSNEPCASY-NCYKVAGLTETILDISHISNLKDRYILGEQLGWGQFGVIRTCSD 60

Query: 63  KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           K TGEV ACKSIAKDRLVT DD +SVKLEIEIM RLSGHPNVVDLKAVYE+E +VHLVME
Sbjct: 61  KLTGEVLACKSIAKDRLVTSDDLKSVKLEIEIMARLSGHPNVVDLKAVYEEEGFVHLVME 120

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
           LCAGGELFHRLEK G FSE++ARVLF  LMQVVLYCHE GVVHRDLKPENILLAT++SSS
Sbjct: 121 LCAGGELFHRLEKHGWFSESDARVLFRHLMQVVLYCHENGVVHRDLKPENILLATRSSSS 180

Query: 183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP 242
           PIKLADFGLATYI+PGQSL G VGSPFYIAPEVLAG YNQAADVWSAGVILYILLSGMPP
Sbjct: 181 PIKLADFGLATYIKPGQSLHGLVGSPFYIAPEVLAGAYNQAADVWSAGVILYILLSGMPP 240

Query: 243 FWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           FWG TKSRIF+AV+ A L+FPS PWD IS+SAKDL+ GMLSTDPS+RLTAR+VLDH WM 
Sbjct: 241 FWGKTKSRIFEAVKAASLKFPSEPWDRISESAKDLIRGMLSTDPSRRLTAREVLDHYWME 300

Query: 303 DGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTS 362
               +PE+LS  KI +C+EW+ G  SFS  ++ R+QDISFG  SP   D +SP FTCR+S
Sbjct: 301 CNQTNPEQLSECKIRNCEEWNAGGSSFSASLMSRSQDISFGASSPT-CDAQSPTFTCRSS 359

Query: 363 FSSFLQEPST----STGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVA-QVFTTVDGS 417
           FSSFL EP T    S GFSF S GDS   EF SP+PSM SFSF SP SV  Q    ++ S
Sbjct: 360 FSSFLVEPVTPCLVSGGFSFKSAGDSPDLEFCSPVPSMLSFSFLSPSSVVEQKSCKLECS 419

Query: 418 ISISRVDAVPGE 429
            +++ V+A+ GE
Sbjct: 420 ANMADVNAIAGE 431

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357444093|ref|XP_003592324.1| Calcium-dependent protein kinase [Medicago truncatula] gi|355481372|gb|AES62575.1| Calcium-dependent protein kinase [Medicago truncatula]

 Score =  575 bits (1483), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 286/414 (69%), Positives = 329/414 (79%), Gaps = 7/414 (1%)

Query: 19  KCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDR 78
            CY+V S+ ETIL+  Q SNL++R+VLG+QLGWGQFGVIR CSD+ TGEV ACKSIAKDR
Sbjct: 17  NCYKVASMTETILNAKQTSNLKDRYVLGEQLGWGQFGVIRTCSDRTTGEVLACKSIAKDR 76

Query: 79  LVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR 138
           LVT DD +SVKLEIEIM +LSGHPNVVDLKAVYE+ED+VHLVMELCAGGELFH LEK GR
Sbjct: 77  LVTSDDMQSVKLEIEIMAKLSGHPNVVDLKAVYEEEDFVHLVMELCAGGELFHLLEKHGR 136

Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
           FSE+E RVLF  LMQ+VLYCHE G+VHRDLKPENILLATK+ SSPIKLADFGLATYI+PG
Sbjct: 137 FSESEGRVLFRHLMQMVLYCHENGIVHRDLKPENILLATKSFSSPIKLADFGLATYIKPG 196

Query: 199 QSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA 258
           QSL G VGSPFYIAPEVLAG YNQAAD+WSAGVILYILLSGMPPFWG TKSRIF+AV+ A
Sbjct: 197 QSLHGLVGSPFYIAPEVLAGAYNQAADIWSAGVILYILLSGMPPFWGKTKSRIFEAVKAA 256

Query: 259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIED 318
           DLRFPS PWD IS SAKDL+  ML  + SQRLTA++VLDH WM     + E+LS +KIE 
Sbjct: 257 DLRFPSEPWDRISKSAKDLIRRMLCIEHSQRLTAQEVLDHCWMESDPTNLEQLSEHKIES 316

Query: 319 CKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEP----STST 374
             EW +G GSFS   + RN+DISFG GSP   D +SP FTC++SFSS   EP    S S 
Sbjct: 317 SGEWHVGGGSFSASFMSRNEDISFGAGSPT-CDAQSPTFTCKSSFSSIFVEPVTPISVSG 375

Query: 375 GFSF-CSPGDSDASEFMSPLPSMPSFSFFSPGSVAQVFTTV-DGSISISRVDAV 426
           GFSF  S G S   EF +P+ SMPSF+F  P SV +  + + + S + S V+A+
Sbjct: 376 GFSFRSSGGGSIGLEFSTPVSSMPSFAFLGPSSVVEQNSLIFEFSSNTSEVNAI 429

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|21064945|gb|AAM29184.1| CDPK-like protein [Solanum tuberosum]

 Score =  571 bits (1472), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 284/427 (66%), Positives = 335/427 (78%), Gaps = 12/427 (2%)

Query: 3   AVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSD 62
           AV +SNS++E S     CY+V +L+ TILD +  +NL +R++LG+QLGWGQFG+IR CSD
Sbjct: 2   AVAKSNSNTESSFYTSCCYKVANLSGTILDASHTANLHDRYILGEQLGWGQFGIIRTCSD 61

Query: 63  KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           KFTGEV ACKS+AK+RLVT +D RSVKLEIEIMTRLSGHPNVVDLKAVYE+ED VHLVME
Sbjct: 62  KFTGEVLACKSVAKNRLVTQEDVRSVKLEIEIMTRLSGHPNVVDLKAVYEEEDCVHLVME 121

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
           LCAGGELFH+LE+ GRFSEAEARVLF  LM+VV+YCH  G+VHRDLKPENILLATK SSS
Sbjct: 122 LCAGGELFHQLERHGRFSEAEARVLFHDLMEVVMYCHHKGIVHRDLKPENILLATKGSSS 181

Query: 183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP 242
           PIKLADFGLATYI+PGQSL GTVGSPFYIAPEVLAGGYN+AAD+WS GVILYILLSG+PP
Sbjct: 182 PIKLADFGLATYIKPGQSLHGTVGSPFYIAPEVLAGGYNEAADIWSTGVILYILLSGIPP 241

Query: 243 FWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           FWG TKS+IFDAVR ADLRFPS+ WD IS SAK+L+ GML TDPSQRLT +Q+LDH+W+ 
Sbjct: 242 FWGKTKSKIFDAVRAADLRFPSDRWDTISSSAKELIKGMLCTDPSQRLTPQQILDHAWVR 301

Query: 303 DGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTS 362
           D       +S +  E C +     GS  + ++ RNQDISFGTGS V  D +SP FTC++S
Sbjct: 302 D-------ISPHFNEPCLKVHSDEGSCCSSLMTRNQDISFGTGSAVLIDAQSPKFTCKSS 354

Query: 363 FSSFLQEPST----STGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVA-QVFTTVDGS 417
           FS+ L E ST    S  FSF S   S+  +F SP+ ++PSF+FF    V  Q    VD S
Sbjct: 355 FSTLLTEQSTTSYGSAVFSFSSTNGSNGHDFASPVLTLPSFTFFGSSLVVDQGSYEVDLS 414

Query: 418 ISISRVD 424
           +  S VD
Sbjct: 415 VRASDVD 421

Source: Solanum tuberosum

Species: Solanum tuberosum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|45331386|gb|AAS57948.1| CDPK-related protein kinase [Vigna radiata]

 Score =  567 bits (1462), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 293/432 (67%), Positives = 339/432 (78%), Gaps = 8/432 (1%)

Query: 3   AVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSD 62
           AV +S+S+SEP      CY V +L ETIL+T+Q+SNL++R+VLG+QLGWGQFGV + CSD
Sbjct: 2   AVARSDSNSEPCTS-YNCYNVAALTETILETSQVSNLKDRYVLGEQLGWGQFGV-QDCSD 59

Query: 63  KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           K TGEV ACKSIAKDRLVT DD RSVKLEIEIM RLSGHPNVVDLKAVYE+E +VHLVME
Sbjct: 60  KLTGEVLACKSIAKDRLVTSDDLRSVKLEIEIMARLSGHPNVVDLKAVYEEEGFVHLVME 119

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
           LCAGGELFHRLEK G FSE+EARV+F  LMQVVLYCHE  VVHRDL PENILLAT++SSS
Sbjct: 120 LCAGGELFHRLEKHGWFSESEARVIFRHLMQVVLYCHENRVVHRDLNPENILLATRSSSS 179

Query: 183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP 242
           PIKLADFGLATYI+PGQSL G VGSPFYIAPEVLAG YNQAADVWSAGVILYILLSG PP
Sbjct: 180 PIKLADFGLATYIKPGQSLHGLVGSPFYIAPEVLAGAYNQAADVWSAGVILYILLSGTPP 239

Query: 243 FWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           FWG TKSRIF+AV+ A L+FP  PWD IS+SAKDL+ GML TDPS+RLTA++VLDH WM 
Sbjct: 240 FWGKTKSRIFEAVKAASLKFPLEPWDRISESAKDLIKGMLCTDPSRRLTAQEVLDHCWME 299

Query: 303 DGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTS 362
               + E+L  N+I+ CK+WD+G  SFS    P  + ++F   + +      P FTCR+S
Sbjct: 300 SNQTNQEQLGENQIQSCKQWDVGGSSFSASFSPGIRTLAFSL-ALLHVMLNRPTFTCRSS 358

Query: 363 FSSFLQEPST----STGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVAQVFTTVDG-S 417
           FSSFL+EP T    S GFSF S GDS   EF SP+PSM SFSF SP  V +  +   G S
Sbjct: 359 FSSFLEEPVTPCVLSAGFSFKSVGDSSGLEFSSPIPSMLSFSFLSPSPVVEHKSCKLGCS 418

Query: 418 ISISRVDAVPGE 429
            ++S VDA+ GE
Sbjct: 419 ANMSDVDAIAGE 430

Source: Vigna radiata

Species: Vigna radiata

Genus: Vigna

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452378|ref|XP_004143936.1| PREDICTED: calcium-dependent protein kinase 25-like [Cucumis sativus] gi|449495864|ref|XP_004159967.1| PREDICTED: calcium-dependent protein kinase 25-like [Cucumis sativus]

 Score =  563 bits (1451), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 280/433 (64%), Positives = 339/433 (78%), Gaps = 11/433 (2%)

Query: 19  KCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDR 78
            C++V SL+ETIL+T Q+ NL++R+VLG++LGWGQFGVIR CSD+ TGE+ ACKSIAKDR
Sbjct: 19  NCFKVSSLSETILETTQVGNLKDRYVLGERLGWGQFGVIRSCSDRMTGEMLACKSIAKDR 78

Query: 79  LVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR 138
           L+T+DD RSVKLEIEIM+RLSGHPNVV+LKAVYE+E+ VHL+MELCAGGELFH+LEK GR
Sbjct: 79  LMTVDDVRSVKLEIEIMSRLSGHPNVVNLKAVYEEEECVHLLMELCAGGELFHQLEKHGR 138

Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
           FSE++ARV+F  L+QVV YCHE GVVHRDLKPENILLAT +SSSPIKLADFGLATYI+PG
Sbjct: 139 FSESDARVVFKHLIQVVKYCHENGVVHRDLKPENILLATTSSSSPIKLADFGLATYIKPG 198

Query: 199 QSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA 258
           Q+L GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWG TKSRIF+AVR A
Sbjct: 199 QNLHGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGKTKSRIFEAVRAA 258

Query: 259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIED 318
           +LRFPSN WDH+S SAKDL+  ML  DPS+RLTA++VL HSWM D  Q  ++       D
Sbjct: 259 ELRFPSNLWDHVSTSAKDLISRMLCMDPSKRLTAKEVLGHSWMKDAAQASQEQEKQDARD 318

Query: 319 CKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDE---SPAFTCRTSFSSFLQE-----P 370
           C+  ++G  S     I RN+D SF  G+PV  +D+   SP FTC++SFSSFL +      
Sbjct: 319 CRRVEMGMSSSPAPFIVRNRDFSFSDGTPVICEDQMGHSPVFTCKSSFSSFLLDNVGTPS 378

Query: 371 STSTGFSFCSPGDSD-ASEFMSPLPSMPSFSFFSPGS--VAQVFTTVDGSISISRVDAVP 427
           S   GFSF S  + D A+EF SP+P +PSF+FFSP S  V QV +++    ++S  + + 
Sbjct: 379 SVPGGFSFSSCVELDTATEFSSPIPKLPSFTFFSPCSSTVDQVNSSMRFKANLSLSETLH 438

Query: 428 GEKWSSIIQLKLE 440
            E     + L LE
Sbjct: 439 EEPIKRKLSLLLE 451

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225426761|ref|XP_002275946.1| PREDICTED: calcium-dependent protein kinase 34 [Vitis vinifera] gi|297742607|emb|CBI34756.3| unnamed protein product [Vitis vinifera]

 Score =  561 bits (1447), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 285/412 (69%), Positives = 322/412 (78%), Gaps = 11/412 (2%)

Query: 4   VGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDK 63
           + Q   SSE S   C CY+   L E IL+  Q+SNL++R+VLG+QLG GQFGVIR CSDK
Sbjct: 3   IAQIGKSSELSTWSCNCYKTTGLTEPILELTQVSNLKDRYVLGEQLGCGQFGVIRACSDK 62

Query: 64  FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL 123
            TGE+ ACKSIAK+RL T DD  SVKLEIEIMTRLSGHPNVVDLKAVYE+EDYVHLVMEL
Sbjct: 63  LTGEMLACKSIAKERLTTSDDVCSVKLEIEIMTRLSGHPNVVDLKAVYEEEDYVHLVMEL 122

Query: 124 CAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP 183
           CAGGELFHRLEK G FSE EAR +F  LMQVV+YCH+ GVVHRDLKPENILLATK+SSSP
Sbjct: 123 CAGGELFHRLEKQGMFSECEARDIFRHLMQVVMYCHDKGVVHRDLKPENILLATKSSSSP 182

Query: 184 IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPF 243
           IKLADFGLATYI+PGQSL GTVGSPFYIAPEVLAGGYNQAADVWS GVILYILLSGMPPF
Sbjct: 183 IKLADFGLATYIKPGQSLHGTVGSPFYIAPEVLAGGYNQAADVWSTGVILYILLSGMPPF 242

Query: 244 WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           WG TKSRIFDAVR ADL FP NPWD+IS SAK+L+ GML  DPS+RLTA QVL HSWM D
Sbjct: 243 WGKTKSRIFDAVRAADLWFPPNPWDYISASAKELITGMLCVDPSKRLTAAQVLAHSWMKD 302

Query: 304 GIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDE---SPAFTCR 360
            ++  ++    K     + +LG  SFST +I RNQD SF   SP+ SD +   SPAFTCR
Sbjct: 303 FVESSQEPYKRKDPRSGQLELGGSSFSTPLIARNQDYSFSYESPITSDGQMGTSPAFTCR 362

Query: 361 TSFSSFLQEPST------STGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGS 406
           +SFS+FL + +          FS C   +S A EF SP+PS+PSF+FFSP S
Sbjct: 363 SSFSTFLVDNNAPCSVSGGFSFSSCC--ESAAREFPSPVPSLPSFTFFSPSS 412

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	468
TAIR|locus:2034720	522	PEPKR1 "phosphoenolpyruvate ca	0.758	0.680	0.667	2.1e-125
TAIR|locus:2175503	610	CPK1 "calcium dependent protei	0.643	0.493	0.493	5.1e-74
TAIR|locus:2138897	531	CPK21 "calcium-dependent prote	0.628	0.553	0.493	1.1e-73
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.653	0.585	0.464	1.4e-73
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.585	0.518	0.507	2.2e-73
TAIR|locus:2015846	521	CPK33 "calcium-dependent prote	0.645	0.579	0.478	3.6e-73
TAIR|locus:2075885	646	CPK2 "calmodulin-domain protei	0.638	0.462	0.486	7.5e-73
TAIR|locus:2039215	520	CPK25 "calcium-dependent prote	0.602	0.542	0.501	9.6e-73
TAIR|locus:2827528	544	CPK6 "calcium dependent protei	0.634	0.545	0.483	1.2e-72
TAIR|locus:2092399	541	CPK9 "calmodulin-domain protei	0.651	0.563	0.470	2e-72

TAIR|locus:2034720 PEPKR1 "phosphoenolpyruvate carboxylase-related kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1232 (438.7 bits), Expect = 2.1e-125, P = 2.1e-125
 Identities = 241/361 (66%), Positives = 285/361 (78%)

Query:    18 CKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD 77
             C CY+V SL ETIL+   +SNL++R+VLG+QLGWGQFGVIRVCSDK TGE  ACKSI+KD
Sbjct:    19 CNCYKVASLTETILNPVNVSNLKDRYVLGEQLGWGQFGVIRVCSDKLTGERLACKSISKD 78

Query:    78 RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
             RLVT DD +S+KLEI IM +L+GHPNVV+LKAVYE++D VHLVMELCAGGELFH+LEK+G
Sbjct:    79 RLVTQDDMKSIKLEIAIMAKLAGHPNVVNLKAVYEEKDSVHLVMELCAGGELFHKLEKYG 138

Query:   138 RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
             R+SE  ARVLF  LMQVV +CH+ G+VHRDLKPENIL+AT +SSSPIKLADFGLATYI+P
Sbjct:   139 RYSEVRARVLFKHLMQVVKFCHDSGIVHRDLKPENILMATMSSSSPIKLADFGLATYIKP 198

Query:   198 GQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT 257
             G+ L GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSG PPFWG TKS+IFDAVR 
Sbjct:   199 GEKLSGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGAPPFWGKTKSKIFDAVRA 258

Query:   258 ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIE 317
             ADLRF + PWD+I+  AKDL+ GML  DPSQRL+A +VL HSWM    +  ++       
Sbjct:   259 ADLRFSAEPWDNITSYAKDLIRGMLCVDPSQRLSADEVLAHSWMEQLSESGQEQYDQDGF 318

Query:   318 DCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPST--STG 375
              C+  + G  SFSTQ + R QD SF  G    S D    F  ++SFS+FL   +T  ++G
Sbjct:   319 GCEGLENGGCSFSTQCVSREQDYSFSVGQLEQSTDND--F--KSSFSTFLPADNTLPNSG 374

Query:   376 F 376
             F
Sbjct:   375 F 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 747 (268.0 bits), Expect = 5.1e-74, P = 5.1e-74
 Identities = 152/308 (49%), Positives = 200/308 (64%)

Query:     9 SSSEPSRQPCKCYRVRSLAETILDTNQI-----SNLRERFVLGQQLGWGQFGVIRVCSDK 63
             S  +P  +P K   ++ ++   L T  +      N +E + LG++LG GQFG   +C +K
Sbjct:   111 SKPDPPAKPKKPKHMKRVSSAGLRTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCVEK 170

Query:    64 FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL 123
              TG+ FACKSIAK +L+T +D   V+ EI+IM  L+GHPNV+ +K  YED   VHLVME 
Sbjct:   171 TTGKEFACKSIAKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMEC 230

Query:   124 CAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP 183
             CAGGELF R+ + G ++E +A  L   ++ VV  CH +GV+HRDLKPEN L  +K   S 
Sbjct:   231 CAGGELFDRIIQRGHYTERKAAELTRTIVGVVEACHSLGVMHRDLKPENFLFVSKHEDSL 290

Query:   184 IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPF 243
             +K  DFGL+ + +P       VGSP+Y+APEVL   Y   ADVWSAGVI+YILLSG+PPF
Sbjct:   291 LKTIDFGLSMFFKPDDVFTDVVGSPYYVAPEVLRKRYGPEADVWSAGVIVYILLSGVPPF 350

Query:   244 WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG- 302
             W  T+  IF+ V   DL F S+PW  IS+SAKDLV  ML  DP +RLTA QVL H W+  
Sbjct:   351 WAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKKRLTAHQVLCHPWVQV 410

Query:   303 DGIQDPEK 310
             DG+  P+K
Sbjct:   411 DGVA-PDK 417

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016020 "membrane" evidence=NAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005777 "peroxisome" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 744 (267.0 bits), Expect = 1.1e-73, P = 1.1e-73
 Identities = 148/300 (49%), Positives = 198/300 (66%)

Query:    11 SEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFA 70
             S PS  P     VR   +TIL      ++R+ + LG++LG GQFG+  +C +  TG  +A
Sbjct:    53 STPSSNPVS---VRD-PDTILG-KPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGNTYA 107

Query:    71 CKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELF 130
             CKSI K +L++  D+  VK EI+IM  LSG PN+V++K  YED   +HLVMELCAGGELF
Sbjct:   108 CKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGGELF 167

Query:   131 HRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
              R+   G +SE  A  +   ++ VV  CH +GVVHRDLKPEN LL++K  ++ +K  DFG
Sbjct:   168 DRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKATDFG 227

Query:   191 LATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSR 250
             L+ +IE G+     VGS +Y+APEVL   Y +  D+WSAGVILYILLSG+PPFW   +  
Sbjct:   228 LSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKG 287

Query:   251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
             IFD V   ++ F S PW  IS+SAKDLV  ML+ DP +R+TA QVL+H W+  G + P+K
Sbjct:   288 IFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQVLEHPWIKGG-EAPDK 346

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0019903 "protein phosphatase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 743 (266.6 bits), Expect = 1.4e-73, P = 1.4e-73
 Identities = 143/308 (46%), Positives = 200/308 (64%)

Query:     2 AAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS 61
             AA     +S  P   P    +   +   +     + +++  + LG++LG GQFGV  +C+
Sbjct:    29 AAEASVRASKHPPASPPPATKQGPIGPVL--GRPMEDVKSSYTLGKELGRGQFGVTHLCT 86

Query:    62 DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM 121
              K TG  FACK+IAK +LV  +D   V+ E++IM  L+G PN+V+LK  YED+  VHLVM
Sbjct:    87 QKATGLQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVM 146

Query:   122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
             ELCAGGELF R+   G +SE  A  L   ++Q++  CH +GV+HRDLKPEN LL +K  +
Sbjct:   147 ELCAGGELFDRIIAKGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDEN 206

Query:   182 SPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 241
             SP+K  DFGL+ + +PG+     VGS +YIAPEVL   Y   AD+WS GV+LYILL G+P
Sbjct:   207 SPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVP 266

Query:   242 PFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             PFW  +++ IF+A+ +  + F S+PW  IS  AKDLV  ML++DP QRLTA QVL+H W+
Sbjct:   267 PFWAESENGIFNAILSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWI 326

Query:   302 GDGIQDPE 309
              +  + P+
Sbjct:   327 KEDGEAPD 334

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
 Identities = 139/274 (50%), Positives = 189/274 (68%)

Query:    36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
             + +++  + LG++LG GQFGV  +C+ K TG  FACK+IAK +LV  +D   V+ E++IM
Sbjct:    66 MEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIM 125

Query:    96 TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
               L+G PN+V+LK  YED+  VHLVMELCAGGELF R+   G +SE  A  L   ++Q+V
Sbjct:   126 HHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQIV 185

Query:   156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
               CH +GV+HRDLKPEN LL  K  +SP+K  DFGL+ + +PG+     VGS +YIAPEV
Sbjct:   186 HTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEV 245

Query:   216 LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
             L   Y   AD+WS GV+LYILL G+PPFW  +++ IF+A+    + F S+PW  IS  AK
Sbjct:   246 LKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQAK 305

Query:   276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             DLV  ML++DP QRLTA QVL+H W+ +  + P+
Sbjct:   306 DLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPD 339

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 739 (265.2 bits), Expect = 3.6e-73, P = 3.6e-73
 Identities = 147/307 (47%), Positives = 202/307 (65%)

Query:     4 VGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDK 63
             +    +   P R P K     S A  IL+     +++  + L ++LG GQFGV  +C++K
Sbjct:    39 ISTGTNQPPPWRNPAK----HSGAAAILE-KPYEDVKLFYTLSKELGRGQFGVTYLCTEK 93

Query:    64 FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL 123
              TG+ FACKSI+K +LVT  D+  ++ EI+IM  LSG PN+V+ K  YEDE  V+LVMEL
Sbjct:    94 STGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMEL 153

Query:   124 CAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP 183
             CAGGELF R+   G +SE  A  +  Q++ VV  CH +GV+HRDLKPEN LL++K   + 
Sbjct:   154 CAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSKDEKAL 213

Query:   184 IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPF 243
             IK  DFGL+ +IE G+     VGS +Y+APEVL   Y +  D+WSAG+ILYILLSG+PPF
Sbjct:   214 IKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLSGVPPF 273

Query:   244 WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
             W  T+  IFDA+   ++ F S PW  IS+SAKDLV  ML+ DP +R++A +VL H W+ +
Sbjct:   274 WAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLKHPWLRE 333

Query:   304 GIQDPEK 310
             G +  +K
Sbjct:   334 GGEASDK 340

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 736 (264.1 bits), Expect = 7.5e-73, P = 7.5e-73
 Identities = 149/306 (48%), Positives = 202/306 (66%)

Query:     9 SSSEPSRQPCKCYRVRSLA---ETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
             + +EP + P    RV S     E++L   +  N +E + LG++LG GQFG   +C +K T
Sbjct:   151 TKAEPQK-PKHMRRVSSAGLRTESVLQ-RKTENFKEFYSLGRKLGQGQFGTTFLCLEKGT 208

Query:    66 GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA 125
             G  +ACKSI+K +L+T +D   V+ EI+IM  L+GHPNV+ +K  YED   VHLVMELC+
Sbjct:   209 GNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCS 268

Query:   126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK 185
             GGELF R+ + G ++E +A  L   ++ V+  CH +GV+HRDLKPEN L  ++   S +K
Sbjct:   269 GGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENFLFVSREEDSLLK 328

Query:   186 LADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWG 245
               DFGL+ + +P +     VGSP+Y+APEVL   Y   +DVWSAGVI+YILLSG+PPFW 
Sbjct:   329 TIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIVYILLSGVPPFWA 388

Query:   246 NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG-DG 304
              T+  IF+ V   DL F S+PW  IS+SAKDLV  ML  DP +RLTA QVL H W+  DG
Sbjct:   389 ETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAHQVLCHPWVQIDG 448

Query:   305 IQDPEK 310
             +  P+K
Sbjct:   449 VA-PDK 453

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;NAS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

TAIR|locus:2039215 CPK25 "calcium-dependent protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
 Identities = 142/283 (50%), Positives = 188/283 (66%)

Query:    27 AETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER 86
             AE++L T +  +L+E + LG +LG GQFG   VC +K TGE +ACKSI K +L   +D  
Sbjct:   117 AESVLKT-KTGHLKEYYNLGSKLGHGQFGTTFVCVEKGTGEEYACKSIPKRKLENEEDVE 175

Query:    87 SVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV 146
              V+ EIEIM  L G PNV+ +K  YED   VH+VMELC GGELF R+ + G +SE +A  
Sbjct:   176 DVRREIEIMKHLLGQPNVISIKGAYEDSVAVHMVMELCRGGELFDRIVERGHYSERKAAH 235

Query:   147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG 206
             L   ++ VV  CH +GV+HRDLKPEN L       SP+K  DFGL+ +++PG++    VG
Sbjct:   236 LAKVILGVVQTCHSLGVMHRDLKPENFLFVNDDEDSPLKAIDFGLSMFLKPGENFTDVVG 295

Query:   207 SPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP 266
             SP+YIAPEVL   Y   AD+WSAGV++Y+LLSG  PFWG T+  IF+ V   +L   S+P
Sbjct:   296 SPYYIAPEVLNKNYGPEADIWSAGVMIYVLLSGSAPFWGETEEEIFNEVLEGELDLTSDP 355

Query:   267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             W  +S+SAKDL+  ML  +P QRLTA+QVL H W+ D    P+
Sbjct:   356 WPQVSESAKDLIRKMLERNPIQRLTAQQVLCHPWIRDEGNAPD 398

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2827528 CPK6 "calcium dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 734 (263.4 bits), Expect = 1.2e-72, P = 1.2e-72
 Identities = 144/298 (48%), Positives = 197/298 (66%)

Query:    13 PSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACK 72
             P ++P     V + +  +L  ++  N+R+ + L ++LG GQFG   +C+D  TG  +ACK
Sbjct:    56 PVKEPIMRRNVDNQSYYVLG-HKTPNIRDLYTLSRKLGQGQFGTTYLCTDIATGVDYACK 114

Query:    73 SIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR 132
             SI+K +L++ +D   V+ EI+IM  L+GH N+V +K  YED  YVH+VMELCAGGELF R
Sbjct:   115 SISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVMELCAGGELFDR 174

Query:   133 LEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA 192
             +   G +SE +A  L   ++ VV  CH +GV+HRDLKPEN LL  K     +K  DFGL+
Sbjct:   175 IIHRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 234

Query:   193 TYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIF 252
              + +PGQ     VGSP+Y+APEVL   Y   ADVW+AGVILYILLSG+PPFW  T+  IF
Sbjct:   235 VFFKPGQIFKDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIF 294

Query:   253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
             DAV    + F ++PW  ISDSAKDL+  ML + PS+RLTA +VL H W+ +    P++
Sbjct:   295 DAVLKGYIDFDTDPWPVISDSAKDLIRKMLCSSPSERLTAHEVLRHPWICENGVAPDR 352

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=RCA;IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006820 "anion transport" evidence=RCA

GO:0006862 "nucleotide transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0015696 "ammonium transport" evidence=RCA

GO:0015802 "basic amino acid transport" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0043269 "regulation of ion transport" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 732 (262.7 bits), Expect = 2.0e-72, P = 2.0e-72
 Identities = 146/310 (47%), Positives = 202/310 (65%)

Query:     5 GQSNSSSEPSRQ----PCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVC 60
             G  NS   P R     P    +  + + +IL+ N   +++  + LG++LG GQFGV  +C
Sbjct:    50 GSVNSQPPPWRAAAAAPGLSPKTTTKSNSILE-NAFEDVKLFYTLGKELGRGQFGVTYLC 108

Query:    61 SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV 120
             ++  TG+ +ACKSI+K +LVT  D+  ++ EI+IM  LSG PN+V+ K  YEDE  V+LV
Sbjct:   109 TENSTGKKYACKSISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLV 168

Query:   121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS 180
             MELCAGGELF R+   G ++E  A  +  Q++ VV  CH +GV+HRDLKPEN LL++K  
Sbjct:   169 MELCAGGELFDRIIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDE 228

Query:   181 SSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGM 240
              + IK  DFGL+ +IE G+     VGS +Y+APEVL   Y +  D+WSAG+ILYILLSG+
Sbjct:   229 KALIKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGV 288

Query:   241 PPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
             PPFW  T+  IFDA+    + F S PW  IS SAKDLV  ML+ DP +R++A  VL H W
Sbjct:   289 PPFWAETEKGIFDAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPW 348

Query:   301 MGDGIQDPEK 310
             + +G +  +K
Sbjct:   349 LREGGEASDK 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=TAS

GO:0005886 "plasma membrane" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XV.3174.1 hypothetical protein (528 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	468
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-104
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-88
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-74
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-64
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-63
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-60
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-59
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-58
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-57
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-57
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-56
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-56
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-55
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-51
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-51
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-51
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-50
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-49
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-47
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-47
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-46
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-46
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-45
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-45
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-45
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-44
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-44
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-44
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-41
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-40
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-40
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-40
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-39
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-39
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-38
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-38
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-38
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-38
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-37
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-37
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-37
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-37
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-37
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-37
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-37
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-37
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-36
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-36
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-36
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-35
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-35
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-35
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-35
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-35
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-35
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-34
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-34
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-34
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-34
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-34
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-34
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-34
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-34
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-34
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-34
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-33
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-33
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-33
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-33
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-33
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-33
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-32
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-32
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-32
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-32
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-32
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-31
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-31
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-31
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-31
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-31
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-31
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-30
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-30
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-30
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-30
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-30
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-30
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-30
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-30
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-29
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-29
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-29
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-29
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-29
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-29
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-29
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-29
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-29
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-29
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-29
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-29
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-29
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-28
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-28
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-28
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-28
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-28
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-28
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-27
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-27
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-27
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-27
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-27
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-26
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-26
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-26
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-26
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-26
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-26
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-26
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-26
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-25
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-25
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-25
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-25
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-25
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-25
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-25
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-25
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-25
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-25
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-25
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-24
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-24
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-24
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-24
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-23
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-23
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-23
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-23
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-23
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-23
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-22
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-22
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-22
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-22
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-21
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-21
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-21
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-21
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-20
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-20
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-20
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-20
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-18
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-18
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-17
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-16
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-14
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.002
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.003
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  309 bits (794), Expect = e-104
 Identities = 121/261 (46%), Positives = 162/261 (62%), Gaps = 9/261 (3%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + + ++LG G FG + +  DK TG++ A K I K ++    D   +  EI+I+ +L  HP
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N+V L  V+EDED ++LVME C GG+LF  L+K GR SE EAR    Q++  + Y H  G
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYN 221
           +VHRDLKPENILL        +KLADFGLA  ++PG+ L   VG+P Y+APEVL G GY 
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 222 QAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           +A D+WS GVILY LL+G PPF G +    +F  +      FP   WD IS  AKDL+  
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLIRK 233

Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           +L  DP +RLTA + L H + 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  269 bits (691), Expect = 3e-88
 Identities = 112/265 (42%), Positives = 158/265 (59%), Gaps = 11/265 (4%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + L ++LG G FG +     K TG++ A K + K        +++ + EI I+ RLS HP
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLS-HP 58

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N+V L   +ED+D+++LVME C GG+LF  L + G  SE EA+ + +Q+++ + Y H  G
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAGG-- 219
           ++HRDLKPENILL        +K+ADFGLA  +    S L T VG+P+Y+APEVL GG  
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 220 YNQAADVWSAGVILYILLSGMPPFWG---NTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           Y    DVWS GVILY LL+G PPF G     + ++   +    L F    W   S+ AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
           L+   L+ DPS+R TA ++L H W 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  234 bits (599), Expect = 1e-74
 Identities = 100/258 (38%), Positives = 152/258 (58%), Gaps = 13/258 (5%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K TG+++A K + K +++   +      E  I++R++ HP +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++ E+ ++LV+E   GGELF  L K GRFSE  AR    +++  + Y H +G+++RDL
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119

Query: 169 KPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAADV 226
           KPENILL    +   IKL DFGLA  +    S   T  G+P Y+APEVL G GY +A D 
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS GV+LY +L+G PPF+   +  I++ +    LRFP    + +S  A+DL+ G+L  DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232

Query: 287 SQRLT---ARQVLDHSWM 301
           ++RL    A ++  H + 
Sbjct: 233 TKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  206 bits (527), Expect = 2e-64
 Identities = 97/254 (38%), Positives = 140/254 (55%), Gaps = 44/254 (17%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  DK TG+  A K I   +  +      +  EIEI+ +L+ HPN+V L 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLN-HPNIVKLY 57

Query: 109 AVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
            V+EDE++++LVME C GG L   L E  G+ SE E   + +Q+++ + Y H  G++HRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 168 LKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL--AGGYNQAA 224
           LKPENILL   + +  +KLADFGL+  +   +SLL T VG+P Y+APEVL   G Y++ +
Sbjct: 118 LKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 225 DVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
           D+WS GVILY L                                      KDL+  ML  
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 285 DPSQRLTARQVLDH 298
           DP +R +A+++L+H
Sbjct: 201 DPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  205 bits (525), Expect = 5e-63
 Identities = 96/271 (35%), Positives = 148/271 (54%), Gaps = 24/271 (8%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F   + LG G FG + +   K +G+ +A K ++K ++V +     V  E  I+  +  HP
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HP 61

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL---YCH 159
            +V+L   ++D+  ++LVME   GGELF  L K GRF E  AR       QVVL   Y H
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY---AAQVVLALEYLH 118

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPFYIAPEV-LA 217
            + +V+RDLKPEN+LL +      IK+ DFG A  ++    +L GT   P Y+APE+ L+
Sbjct: 119 SLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVKGRTYTLCGT---PEYLAPEIILS 172

Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
            GY +A D W+ G+++Y +L+G PPF+ +   +I++ +    +RFPS      S  AKDL
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDL 228

Query: 278 VMGMLSTDPSQRL-----TARQVLDHSWMGD 303
           +  +L  D ++RL         + +H W   
Sbjct: 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  197 bits (503), Expect = 4e-60
 Identities = 88/262 (33%), Positives = 140/262 (53%), Gaps = 19/262 (7%)

Query: 52  GQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY 111
           G +G + +   K TG+++A K I K  ++  +    V  E +I+++    P VV L   +
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSF 62

Query: 112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPE 171
           + +  ++LVME   GG+L   LE  G   E  AR+   +++  + Y H  G++HRDLKP+
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPD 122

Query: 172 NILLATKASSSPIKLADFGLATYIEPGQSL---------LGTVGSPFYIAPEVLAG-GYN 221
           NIL+    S+  +KL DFGL+      + +            VG+P YIAPEV+ G G++
Sbjct: 123 NILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179

Query: 222 QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
           +  D WS G ILY  L G+PPF G T   IF  +    + +P +    +SD A DL+  +
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLISKL 237

Query: 282 LSTDPSQRLTAR---QVLDHSW 300
           L  DP +RL A+   ++ +H +
Sbjct: 238 LVPDPEKRLGAKSIEEIKNHPF 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  194 bits (496), Expect = 4e-59
 Identities = 90/273 (32%), Positives = 143/273 (52%), Gaps = 26/273 (9%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEIMTRLS 99
            +  G+ LG G FG + +  DK TGE+ A KS+    L    +E    L  EI I++ L 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALEREIRILSSLQ 57

Query: 100 GHPNVV-----DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
            HPN+V     +     E+++ +++ +E  +GG L   L+KFG+  E   R    Q+++ 
Sbjct: 58  -HPNIVRYYGSERD---EEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEG 113

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYI 211
           + Y H  G+VHRD+K  NIL+    S   +KLADFG A  +   ++  GT    G+P+++
Sbjct: 114 LAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 212 APEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW--D 268
           APEV+    Y +AAD+WS G  +  + +G PP W    + +  A           P   +
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP-WSELGNPM--AALYKIGSSGEPPEIPE 227

Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           H+S+ AKD +   L  DP +R TA ++L H ++
Sbjct: 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  193 bits (493), Expect = 2e-58
 Identities = 85/272 (31%), Positives = 138/272 (50%), Gaps = 29/272 (10%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F  G+ +G G F  + +  +K T + +A K + K +L+     + VK+E E++TRL+GHP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            ++ L   ++DE+ ++ V+E    GEL   + K+G   E   R    +++  + Y H  G
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA--------------------TYIEPGQSLL 202
           ++HRDLKPENILL        IK+ DFG A                    + IE  +   
Sbjct: 123 IIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 203 GT-VGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL 260
            + VG+  Y++PE+L      +++D+W+ G I+Y +L+G PPF G+ +   F  +   + 
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239

Query: 261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTA 292
            FP N        AKDL+  +L  DP  RL  
Sbjct: 240 SFPPN----FPPDAKDLIEKLLVLDPQDRLGV 267

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  190 bits (486), Expect = 1e-57
 Identities = 91/263 (34%), Positives = 145/263 (55%), Gaps = 12/263 (4%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            + LG  +G G FGV+    +  TG+  A K I+ +++   +  +S+  EI+++  L  H
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLK-H 58

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           PN+V      E  D +++++E    G L   ++KFG F E+   V   Q++Q + Y HE 
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPEVLAG-G 219
           GV+HRD+K  NIL  TK     +KLADFG+AT + +  +     VG+P+++APEV+   G
Sbjct: 119 GVIHRDIKAANILT-TKDGV--VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 220 YNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            + A+D+WS G  +  LL+G PP++  N  + +F  V+      P      IS   KD +
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG----ISPELKDFL 231

Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
           M     DP+ R TA+Q+L H W+
Sbjct: 232 MQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  189 bits (482), Expect = 5e-57
 Identities = 88/267 (32%), Positives = 135/267 (50%), Gaps = 22/267 (8%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K     FA K + K  +V    +  +  E EI+   + HP +V L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++D+ Y++++ME C GGEL+  L   G F E  AR     ++    Y H  G+++RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 169 KPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVW 227
           KPEN+LL +      +KL DFG A  ++ GQ      G+P Y+APE++   GY+ + D W
Sbjct: 120 KPENLLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 228 SAGVILYILLSGMPPFWGN------TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
           S G++LY LL+G PPF  +        + I        L FP+    +I  +AKDL+  +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKG--NGKLEFPN----YIDKAAKDLIKQL 230

Query: 282 LSTDPSQRL-----TARQVLDHSWMGD 303
           L  +P +RL       + +  H W   
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFNG 257

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  189 bits (481), Expect = 7e-56
 Identities = 95/296 (32%), Positives = 147/296 (49%), Gaps = 45/296 (15%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + F + + +G G FG + +  DK TG+V+A K + K  ++  +    V+ E +I+   + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-AD 59

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P +V L   ++DE++++LVME   GG+L + L +   F E  AR    +L+  +   H+
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT-YIEPGQSLLG---------------- 203
           +G +HRD+KP+NIL+    +   IKLADFGL     +                       
Sbjct: 120 LGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 204 -------------TVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGN--- 246
                        TVG+P YIAPEVL G  Y    D WS GVILY +L G PPF+ +   
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 247 -TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT-ARQVLDHSW 300
            T ++I +   +  LRFP +P   +S  A DL+  +L  DP  RL    ++  H +
Sbjct: 237 ETYNKIINWKES--LRFPPDP--PVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  185 bits (473), Expect = 8e-56
 Identities = 73/262 (27%), Positives = 133/262 (50%), Gaps = 14/262 (5%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           ++ + +Q+G G FG + +   K  G+++  K I    +   + E ++  E++I+ +L+ H
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLN-H 58

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLY 157
           PN++     +E++  + +VME   GG+L  +++K  +    F E +    F+QL   + Y
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVL 216
            H   ++HRD+KP+NI L +      +KL DFG++             VG+P+Y++PE+ 
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175

Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               YN  +D+WS G +LY L +   PF G     +   +      +P  P    S   +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPPIP-SQYSSELR 232

Query: 276 DLVMGMLSTDPSQRLTARQVLD 297
           +LV  +L  DP +R +  Q+L 
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  184 bits (469), Expect = 4e-55
 Identities = 85/265 (32%), Positives = 143/265 (53%), Gaps = 14/265 (5%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F L + +G G FG + +   + T ++FA K + K + V     R+V  E  I+  L+ HP
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HP 60

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V+L   ++DE+ ++LV++L  GG+L + L +  +FSE + +    +++  + Y H  G
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYN 221
           ++HRD+KP+NILL  +     + + DF +AT + P      T G+P Y+APEVL   GY+
Sbjct: 121 IIHRDIKPDNILLDEQGH---VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177

Query: 222 QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR---TADLRFPSNPWDHISDSAKDLV 278
            A D WS GV  Y  L G  P+ G++++          TAD+ +P+      S  A D +
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA----TWSTEAIDAI 233

Query: 279 MGMLSTDPSQRL--TARQVLDHSWM 301
             +L  DP +RL    + + +H + 
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 2e-51
 Identities = 90/290 (31%), Positives = 141/290 (48%), Gaps = 49/290 (16%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE-------RSVKLEIEIMTRLS 99
           ++LG G +GV+    DK TGE+ A K I  D     ++E       R    EI ++  L 
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN----EEEGIPSTALR----EISLLKELK 56

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYC 158
            HPN+V L  V   E  ++LV E C   +L   L+K     S    + +  QL++ + YC
Sbjct: 57  -HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA 217
           H   ++HRDLKP+NIL+        +KLADFGLA     P ++    V + +Y APE+L 
Sbjct: 115 HSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL 171

Query: 218 G--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT---------ADL-- 260
           G   Y+ A D+WS G I   +++G P F G+++     +IF  + T           L  
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231

Query: 261 ------RFPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                 +FP    + +         DL+  ML  +P++R++A++ L H +
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  178 bits (450), Expect = 3e-51
 Identities = 104/385 (27%), Positives = 169/385 (43%), Gaps = 31/385 (8%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + + ++LG G FG + +  D+   ++ A K +AK       +      EI+I+  L+  P
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLMQVVLYCH 159
           N+V L   ++DE  ++LVME   GG L   L+K GR    SE+EA  +  Q++  + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-------VGSPFYIA 212
             G++HRD+KPENILL        +KL DFGLA  +    S           VG+P Y+A
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 213 PEVLAGG----YNQAADVWSAGVILYILLSGMPPF----WGNTKSRIFDAVRTADLRFPS 264
           PEVL G      + ++D+WS G+ LY LL+G+PPF      +  S+    +        +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 265 NPWD-----HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG-IQDPEKLSGNKIED 318
           +P        IS +A DL+  +L+ DP  RL++   L H  +    +++ +     K +D
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296

Query: 319 CKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSF 378
                L        +I     ++         D                   ++S+    
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKE--LAPNGVSSSPHNSSSLLLS 354

Query: 379 CSPGDSDASEFMSPLPSMPSFSFFS 403
            +     +   +S   S  S S  S
Sbjct: 355 TASSKRSSLPKISARSSPSSLSSSS 379

Length = 384

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  175 bits (444), Expect = 8e-51
 Identities = 94/250 (37%), Positives = 146/250 (58%), Gaps = 13/250 (5%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F +G+ LG G FG +R+   K TGE +A K + K  ++ +   + V  E  I+  LS HP
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HP 78

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V++   ++DE+ V+ ++E   GGELF  L K GRF    A+    +L+    Y H   
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPEVL-AGGY 220
           +++RDLKPEN+LL  K     +K+ DFG A  + +   +L GT   P Y+APEV+ + G+
Sbjct: 139 IIYRDLKPENLLLDNKGH---VKVTDFGFAKKVPDRTFTLCGT---PEYLAPEVIQSKGH 192

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
            +A D W+ GV+LY  ++G PPF+ +T  RI++ +    L+FP+  W      A+DLV G
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKG 248

Query: 281 MLSTDPSQRL 290
           +L TD ++RL
Sbjct: 249 LLQTDHTKRL 258

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  172 bits (438), Expect = 2e-50
 Identities = 86/259 (33%), Positives = 138/259 (53%), Gaps = 18/259 (6%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG + +  D+ +   +A K +A   ++ +  E+ V  E  ++  +S HP ++ L 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLF 67

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
               D+ +++++ME   GGELF  L   GRFS +       +++  + Y H   +V+RDL
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127

Query: 169 KPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADV 226
           KPENILL  +     IKL DFG A    +   +L GT   P Y+APEV+   G+N+A D 
Sbjct: 128 KPENILLDKEGH---IKLTDFGFAKKLRDRTWTLCGT---PEYLAPEVIQSKGHNKAVDW 181

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W+ G+++Y +L G PPF+ +    I++ +    L FP     H+   AKDL+  +L  D 
Sbjct: 182 WALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDR 237

Query: 287 SQRL-----TARQVLDHSW 300
           ++RL      A  V +H W
Sbjct: 238 TRRLGNMKNGADDVKNHRW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  169 bits (430), Expect = 3e-49
 Identities = 91/285 (31%), Positives = 137/285 (48%), Gaps = 44/285 (15%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           ++G G +GV+    DK TGE+ A K I          + +++ EI+++  L+ HPN++ L
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELN-HPNIIKL 63

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGR-----FSEAEARVLFMQLMQVVLYCHEIG 162
             V+  +  ++LV E          L K  +       E+  +    QL+Q + +CH  G
Sbjct: 64  LDVFRHKGDLYLVFEFMD-----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVL--AGG 219
           ++HRDLKPEN+L+ T      +KLADFGLA ++  P +     V + +Y APE+L    G
Sbjct: 119 ILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTAD---------------L 260
           Y+   D+WS G I   LLS  P F G ++     +IF  + T D                
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 261 RFPSN---PWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDH 298
            FP     P   +    S  A DL+  ML  DP +R+TA Q L H
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  166 bits (422), Expect = 5e-48
 Identities = 87/293 (29%), Positives = 136/293 (46%), Gaps = 43/293 (14%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD--ERSVKLEIEIMTRLS 99
           R+ +  ++G G  G++    D+ TGE  A K +A   L  ++         EI+ +    
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA---LRRLEGGIPNQALREIKALQACQ 57

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            HP VV L  V+       LVME       E+    E+     EA+ +     L++ V Y
Sbjct: 58  -HPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEER--PLPEAQVKSYMRMLLKGVAY 114

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEV 215
            H  G++HRDLKP N+L+   ++   +K+ADFGLA      +  L +  V + +Y APE+
Sbjct: 115 MHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171

Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTAD---------- 259
           L G   Y+   D+W+ G I   LL+G P F G       + +F  + T +          
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231

Query: 260 -----LRFPSN---PWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                + FP +   P + I    S  A DL+ G+L  DPS+RL+A + L H +
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  163 bits (416), Expect = 2e-47
 Identities = 80/264 (30%), Positives = 134/264 (50%), Gaps = 18/264 (6%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F + +++G G FG +     K TG+  A K I   +L + + +  +  EI+I+ +   HP
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCK-HP 57

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGG---ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
           N+V     Y  +D + +VME C+GG   +L          +E++   +  +L++ + Y H
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLH 115

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG- 218
             G++HRD+K  NILL +      +KL DFGL+  +   ++    VG+P+++APEV+ G 
Sbjct: 116 SNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDA-VRTADLRFPSNPWDH-ISDSAKD 276
            Y+  AD+WS G+    L  G PP+   ++     A  + A    P        SD  KD
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229

Query: 277 LVMGMLSTDPSQRLTARQVLDHSW 300
            +   L  +P +R TA Q+L H +
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  164 bits (418), Expect = 3e-47
 Identities = 88/293 (30%), Positives = 141/293 (48%), Gaps = 43/293 (14%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD--ERSVKLEIEIMTRLS 99
           R+  G++LG G + V+    DK TG + A K I         D    +   EI+++  L 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----KFGRFSEAEARVLFMQLMQV 154
            HPN++ L  V+  +  ++LV E          LE     K    + A+ +   +  ++ 
Sbjct: 61  -HPNIIGLLDVFGHKSNINLVFEFMETD-----LEKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + Y H   ++HRDLKP N+L+A+      +KLADFGLA ++  P + +   V + +Y AP
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171

Query: 214 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------ADLR 261
           E+L G   Y    D+WS G I   LL  +P   G++      +IF+A+ T        + 
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231

Query: 262 ----------FPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                     FP  P   I    SD A DL+  +L+ +P++R+TARQ L+H +
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  160 bits (407), Expect = 3e-46
 Identities = 78/256 (30%), Positives = 131/256 (51%), Gaps = 10/256 (3%)

Query: 52  GQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY 111
           G FG + +   + TG+ FA K + K  ++  +   +VK E  IM      P V  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPE 171
           + +DY++LVME   GG+    ++  G   E  A+    +++  V   H+ G++HRD+KPE
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 172 NILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAG 230
           N+L+        +KL DFGL+      +  +GT   P Y+APE + G G ++ +D WS G
Sbjct: 127 NLLIDQTGH---LKLTDFGLSRNGLENKKFVGT---PDYLAPETILGVGDDKMSDWWSLG 180

Query: 231 VILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
            +++  L G PPF   T   +FD + +  + +P    +  S  A DL+  +L  DP++RL
Sbjct: 181 CVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRL 240

Query: 291 TA---RQVLDHSWMGD 303
            A   +++  H +   
Sbjct: 241 GANGYQEIKSHPFFKS 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  161 bits (410), Expect = 6e-46
 Identities = 80/244 (32%), Positives = 135/244 (55%), Gaps = 9/244 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K T E++A K + KD ++  DD      E  ++     HP +  L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
           + ++ +D +  VME   GG+L   +++ GRF E  AR    +++  + + HE G+++RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADV 226
           K +N+LL ++     IK+ADFG+    I  G +     G+P YIAPE+L+   Y  A D 
Sbjct: 123 KLDNVLLDSEGH---IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W+ GV+LY +L+G  PF G+ +  +F ++   ++R+P      +S  AK ++   L+ +P
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTKNP 235

Query: 287 SQRL 290
            +RL
Sbjct: 236 EKRL 239

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  159 bits (404), Expect = 4e-45
 Identities = 103/357 (28%), Positives = 162/357 (45%), Gaps = 43/357 (12%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG+ +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALK 61

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   FSE  AR    +++  + Y H   VV+RDL
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 122 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     ++F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 234

Query: 287 SQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGS 346
            QRL           G G +D +++  ++      W               QD+      
Sbjct: 235 KQRL-----------GGGPEDAKEIMEHRFFASINW---------------QDVVQKKLE 268

Query: 347 PVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFCSPGDSDASEFMSP--LPSMPSFSF 401
           P F     P  T  T  + +  E  T+   +   P   D+   +     P  P FS+
Sbjct: 269 PPF----KPQVTSETD-TRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSY 320

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  159 bits (405), Expect = 5e-45
 Identities = 94/265 (35%), Positives = 146/265 (55%), Gaps = 15/265 (5%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F +  Q+G G +G + +   K TGE+ A K + K  L  +++ R V  E +I+T  +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSE 61

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L   ++D++Y++L ME   GG+    L   G  SE  AR    ++ + V   HE+G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTVGSPFYIAPEVLAG-GY 220
            +HRDLKPEN L+    +S  IKL DFGL+   +    S+   VGSP Y+APEVL G GY
Sbjct: 122 YIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTYANSV---VGSPDYMAPEVLRGKGY 175

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR--TADLRFPS--NPWDHISDSAKD 276
           +   D WS G +LY  L G PPF G+T +  ++ ++     L+ P   +P  ++SD A D
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235

Query: 277 LVMGMLSTDPSQRLTA-RQVLDHSW 300
           L+  ++  DPS+R  +   + +H +
Sbjct: 236 LITKLI-NDPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  158 bits (402), Expect = 6e-45
 Identities = 96/289 (33%), Positives = 154/289 (53%), Gaps = 22/289 (7%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +     + T  ++A K+I K  +V+  +      E  ++ +++  P +V LK
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  + ++LV+    GGELFH L++ GRF  + AR    +L+  +   H+  V++RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 169 KPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAADV 226
           KPENILL  +     I L DFGL            T  G+P Y+APE+L G GY +A D 
Sbjct: 120 KPENILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W+ GV+LY +L+G+PPF+    + ++  +    LRFP    D     AKDL++G+LS DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232

Query: 287 SQRL---TARQVLDHSWMGD---------GIQDPEKLSGNKIEDCKEWD 323
           ++RL    A+++ +H +            GIQ P K + +   D   +D
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFD 281

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  156 bits (397), Expect = 1e-44
 Identities = 86/271 (31%), Positives = 133/271 (49%), Gaps = 20/271 (7%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIA--KDRLVTIDDERSVKLEIEIMTRLS 99
           R+  G ++G G FG +    +  TGE+ A K I    +   TI   + +  E++++  L 
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI---KEIADEMKVLELLK 57

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            HPN+V    V    + V++ ME C+GG L   LE      E   RV  +QL++ + Y H
Sbjct: 58  -HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-----GQSLLGTVGSPFYIAPE 214
             G+VHRD+KP NI L     +  IKL DFG A  ++      G+ +    G+P Y+APE
Sbjct: 117 SHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 215 VLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP-WDH 269
           V+ G    G+ +AAD+WS G ++  + +G  P W    +             P  P    
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
           +S   KD +   L +DP +R TA ++L H +
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  157 bits (400), Expect = 2e-44
 Identities = 97/288 (33%), Positives = 145/288 (50%), Gaps = 45/288 (15%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            F   + LG G  G + +   K TG++FA K + K  ++  +  + V  E EI+  L  H
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-H 60

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEK--FGRFSEAEARVLFMQLMQVVL--- 156
           P +  L A ++ E Y+ LVM+ C GGELF  L++      SE  AR  F    +V+L   
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR--FY-AAEVLLALE 117

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG------QSLLGT------ 204
           Y H +G+V+RDLKPENILL     S  I L+DF L+   +            G+      
Sbjct: 118 YLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 205 ------------------VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG 245
                             VG+  YIAPEV++G G+  A D W+ G++LY +L G  PF G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234

Query: 246 NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTAR 293
           + +   F  +   ++ FP +P   +S SA+DL+  +L  DPS+RL ++
Sbjct: 235 SNRDETFSNILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSK 280

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  154 bits (393), Expect = 9e-44
 Identities = 88/289 (30%), Positives = 143/289 (49%), Gaps = 36/289 (12%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + + +QLG G FG + +  +K TGE+ A K + K +  + ++  +++ E++ + +L+ HP
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLR-EVKSLRKLNEHP 58

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFH--RLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           N+V LK V+ + D ++ V E    G L+   +  K   FSE+  R +  Q++Q + + H+
Sbjct: 59  NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL--AG 218
            G  HRDLKPEN+L++       +K+ADFGLA  I         V + +Y APE+L  + 
Sbjct: 118 HGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDAVRTA---D 259
            Y+   D+W+ G I+  L +  P F G+                TK    +  + A    
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234

Query: 260 LRFP---SNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            RFP         +    S  A DL+  ML  DP +R TA Q L H + 
Sbjct: 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  152 bits (385), Expect = 6e-43
 Identities = 94/259 (36%), Positives = 144/259 (55%), Gaps = 14/259 (5%)

Query: 46  GQQLGWGQFGVIRVCSDKFTGEVFACK--SIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           G+ LG G FG +    +   G+ FA K  S+A D     +  + ++ EI ++++L  HPN
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPN 63

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGV 163
           +V       +ED +++ +EL  GG L   L+K+G F E   R+   Q++  + Y H+   
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA--GGYN 221
           VHRD+K  NIL+ T      +KLADFG+A  +          GSP+++APEV+A  GGY 
Sbjct: 124 VHRDIKGANILVDTNGV---VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 222 QAADVWSAGVILYILLSGMPPFWGNTK--SRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
            AAD+WS G  +  + +G PP W   +  + +F   R+ +L  P  P DH+SD AKD ++
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEGVAAVFKIGRSKEL--PPIP-DHLSDEAKDFIL 236

Query: 280 GMLSTDPSQRLTARQVLDH 298
             L  DPS R TA ++L+H
Sbjct: 237 KCLQRDPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  148 bits (375), Expect = 2e-41
 Identities = 74/264 (28%), Positives = 127/264 (48%), Gaps = 12/264 (4%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
               + LG G  GV+     K TG+++A K I  D     +  + +  E++ + R    P
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTL-RSCESP 59

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI- 161
            VV     +  E  + +V+E   GG L   L+K G+  E     +  Q+++ + Y H   
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAGG- 219
            ++HRD+KP N+L+ +K     +K+ADFG++  +E       T VG+  Y++PE + G  
Sbjct: 120 HIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW--DHISDSAKDL 277
           Y+ AAD+WS G+ L     G  PF    +   F+ ++ A    P      +  S   +D 
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-AICDGPPPSLPAEEFSPEFRDF 235

Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +   L  DP +R +A ++L H ++
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  148 bits (376), Expect = 3e-41
 Identities = 82/266 (30%), Positives = 134/266 (50%), Gaps = 14/266 (5%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE +   +++G G  G +   +D+ TG+  A K +     +   ++  +  EI IM +  
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM----RLRKQNKELIINEILIM-KDC 72

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAE-ARVLFMQLMQVVLY 157
            HPN+VD    Y   D + +VME   GG L   +   F R +E + A V   +++Q + Y
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVC-REVLQGLEY 131

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
            H   V+HRD+K +NILL+   S   +KLADFG A  +   +S   + VG+P+++APEV+
Sbjct: 132 LHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               Y    D+WS G++   +  G PP+      R    + T  +    NP +  S   K
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP-EKWSPEFK 247

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           D +   L  DP +R +A ++L H ++
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  145 bits (369), Expect = 2e-40
 Identities = 86/292 (29%), Positives = 134/292 (45%), Gaps = 50/292 (17%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--RSVKLEIEIMTRLSGHPNVV 105
           Q+G G +G +    +K TGE+ A K I   R+    +    +   EI+++ +L  HPN+V
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLR-HPNIV 61

Query: 106 DLKAVYEDEDY--VHLVMELC----AGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            LK +   +    +++V E       G  L        +F+E++ +    QL++ + Y H
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEVLA 217
             G++HRD+K  NIL+        +KLADFGLA       S   T  V + +Y  PE+L 
Sbjct: 118 SNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT-ADLRFP--SNPWD 268
           G   Y    D+WS G IL  L  G P F G+T+     +IF+   +  D  +P  S    
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234

Query: 269 --------------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                                I  SA DL+  +L+ DP +R++A Q L H +
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  146 bits (370), Expect = 4e-40
 Identities = 87/253 (34%), Positives = 135/253 (53%), Gaps = 10/253 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K T E FA K++ KD ++  DD     +E  ++     HP +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++ ++++  VME   GG+L   ++  GRF EA AR    +++  + + H+ G+++RDL
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAADV 226
           K +N+LL        IK+ADFG+      G+    T  G+P YIAPE+L G  YN++ D 
Sbjct: 123 KLDNVLLDKDGH---IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS GV+LY +L G  PF G  +  +FD++      FP   W  IS  AKD +  +   DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFERDP 235

Query: 287 SQRLTAR-QVLDH 298
           ++RL     +  H
Sbjct: 236 TKRLGVDGDIRQH 248

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  146 bits (369), Expect = 4e-40
 Identities = 108/362 (29%), Positives = 164/362 (45%), Gaps = 44/362 (12%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ +V  D+      E  ++   S HP +  LK
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRD 167
             ++  D +  VME   GGELF  L +   FSE  AR    +++  + Y H E  VV+RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 168 LKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAAD 225
           LK EN++L        IK+ DFGL    I+ G ++    G+P Y+APEVL    Y +A D
Sbjct: 122 LKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  GV++Y ++ G  PF+     ++F+ +   ++RFP      +S  AK L+ G+L  D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLSGLLKKD 234

Query: 286 PSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTG 345
           P QRL           G G  D +++  +K      W               QD+     
Sbjct: 235 PKQRL-----------GGGPDDAKEIMQHKFFAGIVW---------------QDVYEKKL 268

Query: 346 SPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFCSPGDSDASEFMSPL--PSMPSFSFFS 403
            P F     P  T  T  + +  E  T+   +   P   D+ E +     P  P FS+ +
Sbjct: 269 VPPF----KPQVTSETD-TRYFDEEFTAQMITITPPDQDDSMETVDNERRPHFPQFSYSA 323

Query: 404 PG 405
             
Sbjct: 324 SA 325

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  142 bits (361), Expect = 2e-39
 Identities = 76/268 (28%), Positives = 125/268 (46%), Gaps = 31/268 (11%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +R    K  G++   K I    +   + ++ V  E+ I+  L  HPN+V   
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELK-HPNIVR-- 63

Query: 109 AVYEDEDY------VHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYC 158
             Y D         +++VME C GG+L   ++K         E     +  QL+  +  C
Sbjct: 64  --YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 159 HEIG-----VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIA 212
           H        V+HRDLKP NI L    +   +KL DFGLA  +    S   T VG+P+Y++
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNN---VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 213 PEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI- 270
           PE L    Y++ +D+WS G ++Y L +  PPF    + ++   ++    R       +  
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR----RIPYRY 234

Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDH 298
           S    +++  ML+ DP +R +  ++L  
Sbjct: 235 SSELNEVIKSMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  143 bits (363), Expect = 4e-39
 Identities = 79/247 (31%), Positives = 133/247 (53%), Gaps = 9/247 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG + +   K  G+ +A K + K  ++   +++ +  E  ++ +   HP +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D ++ V++   GGELF  L++   F E  AR    ++   + Y H + +++RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVL-AGGYNQAADV 226
           KPENILL ++     + L DFGL    IE  ++     G+P Y+APEVL    Y++  D 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  G +LY +L G+PPF+    + ++D +    LR   N    IS SA+ L+ G+L  D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN----ISVSARHLLEGLLQKDR 235

Query: 287 SQRLTAR 293
           ++RL A+
Sbjct: 236 TKRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  141 bits (357), Expect = 1e-38
 Identities = 83/248 (33%), Positives = 132/248 (53%), Gaps = 7/248 (2%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  K TG+++ACK + K RL     E+    E +I+ ++S    +V L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLA 59

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
             +E +D + LVM L  GG+L + +   G   F EA A     Q++  + + H+  +V+R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAAD 225
           DLKPEN+LL    +   ++++D GLA  ++ G+ + G  G+P Y+APEVL G  Y+ + D
Sbjct: 120 DLKPENVLLDDHGN---VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            ++ G  LY +++G  PF    +    + ++   L       D  S  AKDL   +L  D
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236

Query: 286 PSQRLTAR 293
           P +RL  R
Sbjct: 237 PEKRLGCR 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 1e-38
 Identities = 92/291 (31%), Positives = 140/291 (48%), Gaps = 53/291 (18%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +R+   K TG ++A K + K  ++  +    V+ E +I+   + +P VV L 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++DE+Y++L+ME   GG++   L K   F+E E R    + +  +   H++G +HRD+
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127

Query: 169 KPENILLATKASSSPIKLADFGLATYIE---------------PGQSLL----------- 202
           KP+N+LL  K     IKL+DFGL T ++               P   L            
Sbjct: 128 KPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184

Query: 203 -------------GTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGNTK 248
                         TVG+P YIAPEV L  GYN+  D WS GVI+Y +L G PPF  +  
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244

Query: 249 S----RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
                +I +   T  L+FP      +S  AKDL+  +   +  +RL    V
Sbjct: 245 QETYRKIINWKET--LQFPDE--VPLSPEAKDLIKRLC-CEAERRLGNNGV 290

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  142 bits (359), Expect = 1e-38
 Identities = 86/259 (33%), Positives = 136/259 (52%), Gaps = 15/259 (5%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 122 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 234

Query: 287 SQRL-----TARQVLDHSW 300
            QRL      A++V++H +
Sbjct: 235 KQRLGGGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 1e-38
 Identities = 87/285 (30%), Positives = 130/285 (45%), Gaps = 43/285 (15%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +GV+  C +K TGE+ A K   K+     D +++   E++++ +L  H N+V+LK
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLR-HENIVNLK 66

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
             +  +  ++LV E      L   LE   G       R    QL+Q + YCH   ++HRD
Sbjct: 67  EAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125

Query: 168 LKPENILLATKASSSPIKLADFGLATYIE--PGQSLLGTVGSPFYIAPEVLAGG--YNQA 223
           +KPENIL+   + S  +KL DFG A  +   P   L   V + +Y APE+L G   Y + 
Sbjct: 126 IKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 224 ADVWSAGVILYILLSGMPPFWGNTK----SRIFDAV---------------RTADLRFPS 264
            DVW+ G I+  LL G P F G++       I   +               R A + FP 
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP- 241

Query: 265 NPWDHI-----------SDSAKDLVMGMLSTDPSQRLTARQVLDH 298
                            S  A D +   L  DP +RLT  ++L H
Sbjct: 242 -EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  139 bits (353), Expect = 1e-37
 Identities = 74/244 (30%), Positives = 134/244 (54%), Gaps = 9/244 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K T E++A K + KD ++  DD     +E  ++      P +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
           + ++  D ++ VME   GG+L + +++ G+F E  A     ++   + + H  G+++RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 169 KPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K +N++L    +   IK+ADFG+    I  G++     G+P YIAPE++A   Y ++ D 
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W+ GV+LY +L+G PPF G  +  +F ++   ++ +P +    +S  A  +  G+L+  P
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLLTKHP 240

Query: 287 SQRL 290
           ++RL
Sbjct: 241 AKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  138 bits (349), Expect = 3e-37
 Identities = 78/246 (31%), Positives = 132/246 (53%), Gaps = 9/246 (3%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G ++A K + KD ++  DD      E  I++    HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L   ++  D +  VME   GG+L   ++K  RF EA AR    ++   +++ H+ G+++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 167 DLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAGG-YNQAA 224
           DLK +N+LL  +      KLADFG+    I  G++     G+P YIAPE+L    Y  + 
Sbjct: 121 DLKLDNVLLDHEGHC---KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177

Query: 225 DVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
           D W+ GV+LY +L G  PF    +  +F+A+   ++ +P+  W  +S  A D++   ++ 
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTK 233

Query: 285 DPSQRL 290
           +P+ RL
Sbjct: 234 NPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  137 bits (348), Expect = 4e-37
 Identities = 88/269 (32%), Positives = 136/269 (50%), Gaps = 25/269 (9%)

Query: 52  GQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY 111
           G +G + +   K T + FA K I K  L+  +  + V +E +I+T  + +P VV +   +
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSF 70

Query: 112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPE 171
           E + ++ +VME   GG+    L+  G      AR+ F + +  + Y H  G+VHRDLKP+
Sbjct: 71  ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPD 130

Query: 172 NILLATKASSSPIKLADFGL--------ATYIEPGQSLLGT--------VGSPFYIAPEV 215
           N+L+    S   IKL DFGL         T +  G     T         G+P YIAPEV
Sbjct: 131 NLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV 187

Query: 216 -LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
            L  GY +  D W+ G+ILY  L G  PF+G+T   +F  V + D+ +P    + +   A
Sbjct: 188 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD-EALPADA 246

Query: 275 KDLVMGMLSTDPSQRL---TARQVLDHSW 300
           +DL+  +L  +P +RL    A +V  H +
Sbjct: 247 QDLISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  138 bits (348), Expect = 5e-37
 Identities = 76/244 (31%), Positives = 132/244 (54%), Gaps = 9/244 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K T EV+A K + KD ++  DD      E  I+   + HP +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++ +D +  VME   GG+L  ++++  +F E  +R    ++   +++ H  GV++RDL
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADV 226
           K +NILL  +      KLADFG+    I  G +     G+P YIAPE+L    Y  + D 
Sbjct: 123 KLDNILLDAEGH---CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W+ GV++Y +++G PPF  + +  +F+++   D+ +P   W  +S  A  ++   ++ +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--W--LSKEAVSILKAFMTKNP 235

Query: 287 SQRL 290
           ++RL
Sbjct: 236 NKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 5e-37
 Identities = 80/262 (30%), Positives = 128/262 (48%), Gaps = 11/262 (4%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F L + +G G FG +    DK T +V A K I  +     D+   ++ EI+ +++   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRS 58

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P +      +     + ++ME C GG     L K G+  E     +  +++  + Y HE
Sbjct: 59  -PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-G 218
            G +HRD+K  NILL+ +     +KLADFG++  +    S   T VG+PF++APEV+   
Sbjct: 117 EGKIHRDIKAANILLSEEGD---VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
           GY++ AD+WS G+    L  G PP       R+           PS   +  S   KD V
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL--FLIPKNNPPSLEGNKFSKPFKDFV 231

Query: 279 MGMLSTDPSQRLTARQVLDHSW 300
              L+ DP +R +A+++L H +
Sbjct: 232 SLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  137 bits (347), Expect = 6e-37
 Identities = 79/247 (31%), Positives = 133/247 (53%), Gaps = 9/247 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG + +   K   + +A K + K  ++   +E+ +  E  ++ +   HP +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D ++ V++   GGELF+ L++   F E  AR    ++   + Y H + +V+RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVL-AGGYNQAADV 226
           KPENILL ++     I L DFGL    IE   +     G+P Y+APEVL    Y++  D 
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  G +LY +L G+PPF+    + ++D +    L+   N    I++SA+ L+ G+L  D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQKDR 235

Query: 287 SQRLTAR 293
           ++RL A+
Sbjct: 236 TKRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  136 bits (345), Expect = 7e-37
 Identities = 81/278 (29%), Positives = 142/278 (51%), Gaps = 29/278 (10%)

Query: 43  FVLGQQLGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRL 98
           F L + LG G +G   ++R       G+++A K + K  +V         + E +++  +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
              P +V L   ++ +  +HL+++   GGELF  L +   F+E+E RV   +++  + + 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-----SLLGTVGSPFYIAP 213
           H++G+++RD+K ENILL    S   + L DFGL+      +     S  GT+    Y+AP
Sbjct: 122 HQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE---YMAP 175

Query: 214 EVLAG---GYNQAADVWSAGVILYILLSGMPPFW----GNTKSRIFDAVRTADLRFPSNP 266
           EV+ G   G+++A D WS GV+ + LL+G  PF      N++S I   +  +   FP   
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT- 234

Query: 267 WDHISDSAKDLVMGMLSTDPSQRL---TARQVLDHSWM 301
              +S  A+D +  +L  DP +RL    A ++ +H + 
Sbjct: 235 ---MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  137 bits (347), Expect = 8e-37
 Identities = 84/264 (31%), Positives = 138/264 (52%), Gaps = 19/264 (7%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG ++V  +K TG+++A K + K  L+  +     + E +I++  S  P +  L+
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI-SNSPWIPQLQ 67

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
             ++D+D ++LVME   GG+L   L ++  +F E  A+    +L+  +   H++G VHRD
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127

Query: 168 LKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEVLA-------G 218
           +KPEN+L+     +  IKLADFG A  +   + +     VG+P YIAPEVL        G
Sbjct: 128 IKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD--LRFPSNPWDHISDSAKD 276
            Y    D WS GVI Y ++ G  PF   T ++ ++ +      L+FP +P   +S    D
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP--KVSSDFLD 242

Query: 277 LVMGMLSTDPSQRLTARQVLDHSW 300
           L+  +L     +RL    +  H +
Sbjct: 243 LIQSLL-CGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  135 bits (341), Expect = 6e-36
 Identities = 85/252 (33%), Positives = 134/252 (53%), Gaps = 12/252 (4%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRLSGHP 102
           VLG+  G+G+   +R  +   TG++FA K + K  +V    D    K E  I+  +  HP
Sbjct: 3   VLGKG-GYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +VDL   ++    ++L++E  +GGELF  LE+ G F E  A     ++   + + H+ G
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTVGSPFYIAPEVLA-GGY 220
           +++RDLKPENILL  +     +KL DFGL    I  G       G+  Y+APE+L   G+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
            +A D WS G ++Y +L+G PPF    + +  D +    L  P     +++  A+DL+  
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKK 233

Query: 281 MLSTDPSQRLTA 292
           +L  +PS RL A
Sbjct: 234 LLKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  135 bits (340), Expect = 7e-36
 Identities = 82/260 (31%), Positives = 137/260 (52%), Gaps = 15/260 (5%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K +G+ +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++ +D +  VME   GGELF  L +   FSE   R    +++  + Y H   +V+RDL
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I    ++    G+P Y+APEVL    Y +A D 
Sbjct: 122 KLENLMLDKDGH---IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     ++F+ +   D++FP      +S  AK L+ G+L  DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT----LSADAKSLLSGLLIKDP 234

Query: 287 SQRL-----TARQVLDHSWM 301
           ++RL      A++++ HS+ 
Sbjct: 235 NKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 9e-36
 Identities = 77/259 (29%), Positives = 130/259 (50%), Gaps = 15/259 (5%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS-VKLEIEIMT--RLSGHPNVV 105
           +G G +G +       TG V A K I  D   T DD+ S ++ E+ +++  R S  PN+ 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLD---TPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
                Y     + ++ME   GG +   L K G  +E    V+  +++  + Y H++GV+H
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAGG--YNQ 222
           RD+K  NIL+     +  +KL DFG+A  +    S   T VG+P+++APEV+  G  Y+ 
Sbjct: 125 RDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 223 AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGML 282
            AD+WS G+ +Y + +G PP+      R    +     + P    +  S   ++ V   L
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMMLI--PKSKPPRLEDNGYSKLLREFVAACL 239

Query: 283 STDPSQRLTARQVLDHSWM 301
             +P +RL+A ++L   W+
Sbjct: 240 DEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  134 bits (338), Expect = 1e-35
 Identities = 74/244 (30%), Positives = 135/244 (55%), Gaps = 9/244 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K T E++A K + KD ++  DD     +E  ++      P +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
           + ++  D ++ VME   GG+L + +++ G+F E +A     ++   + + H  G+++RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 169 KPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K +N++L    S   IK+ADFG+   ++  G +     G+P YIAPE++A   Y ++ D 
Sbjct: 128 KLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W+ GV+LY +L+G PPF G  +  +F ++   ++ +P +    +S  A  +  G+++  P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLMTKHP 240

Query: 287 SQRL 290
           S+RL
Sbjct: 241 SKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  134 bits (338), Expect = 1e-35
 Identities = 90/271 (33%), Positives = 139/271 (51%), Gaps = 35/271 (12%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVD 106
           LG G FG + +   K TGE++A K++ K  ++  D+  S+  E  I    +   HP +V+
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEAR------VLFMQLMQVVLYCHE 160
           L A ++ ED+V  VME  AGG+L   +     FSE  A       VL +Q      Y HE
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQ------YLHE 119

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG- 218
             +V+RDLK +N+LL T+     +K+ADFGL    +  G       G+P ++APEVL   
Sbjct: 120 NKIVYRDLKLDNLLLDTEGF---VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y +A D W  GV++Y +L G  PF G+ +  +FD++   ++R+P      +S  A  ++
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIM 232

Query: 279 MGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             +L  +P +RL           G G +D E
Sbjct: 233 RRLLRRNPERRL-----------GSGEKDAE 252

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  133 bits (336), Expect = 2e-35
 Identities = 79/249 (31%), Positives = 133/249 (53%), Gaps = 9/249 (3%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K T + FA K++ KD ++  DD     +E  +++    HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L   ++ ++ +  VME   GG+L   ++   +F    A     +++  + + H  G+V+R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAA 224
           DLK +NILL T      IK+ADFG+      G +   T  G+P YIAPE+L G  YN + 
Sbjct: 121 DLKLDNILLDTDGH---IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177

Query: 225 DVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
           D WS GV+LY +L G  PF G+ +  +F ++R  +  +P   W  ++  AKD+++ +   
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLFVR 233

Query: 285 DPSQRLTAR 293
           +P +RL  +
Sbjct: 234 EPERRLGVK 242

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  133 bits (336), Expect = 2e-35
 Identities = 76/247 (30%), Positives = 132/247 (53%), Gaps = 9/247 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG + +   K  G  +A K + K  ++   ++  +  E  ++ +   HP +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  + ++ V++   GGELF  L++   F E  AR    ++   + Y H + +++RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADV 226
           KPENILL ++     + L DFGL    +EP ++     G+P Y+APEVL    Y++  D 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  G +LY +L G+PPF+    S+++D +    L+ P       + +A DL++G+L  D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK----TVAACDLLVGLLHKDQ 235

Query: 287 SQRLTAR 293
            +RL A+
Sbjct: 236 RRRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  132 bits (334), Expect = 3e-35
 Identities = 88/292 (30%), Positives = 142/292 (48%), Gaps = 58/292 (19%)

Query: 52  GQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER------SVKLEIEIMTRLSGHPNVV 105
           G +GV+    DK TGE+ A K +       ++ E+      S++ EI I+ +L  HPN+V
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKL------KMEKEKEGFPITSLR-EINILLKLQ-HPNIV 67

Query: 106 DLK--AVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIG 162
            +K   V  + D +++VME     +L   +E     F ++E + L +QL+  V + H+  
Sbjct: 68  TVKEVVVGSNLDKIYMVME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAGG-- 219
           ++HRDLK  N+LL  +     +K+ DFGLA  Y  P +     V + +Y APE+L G   
Sbjct: 127 ILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183

Query: 220 YNQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAVRTAD---------------- 259
           Y+ A D+WS G I   LL+  P F G    +  ++IF  + T                  
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243

Query: 260 ---------LR--FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                    LR  FP+     +SD+  DL+  +L+ DP++R++A   L H +
Sbjct: 244 TFTKYPYNQLRKKFPALS---LSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (335), Expect = 4e-35
 Identities = 83/249 (33%), Positives = 130/249 (52%), Gaps = 11/249 (4%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR--LSGHPNVVD 106
           +G G FG +     K T  ++A K ++K  +V   +      E  I+ R  L   P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           LK  ++ +  ++LV +  +GGELF  L+K GRFSE  A+    +L+  + + H+  +V+R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL--AGGYNQA 223
           DLKPENILL    ++  I L DFGL+           T  G+  Y+APEVL    GY + 
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Query: 224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS 283
            D WS GV+++ +  G  PF+     +++  +    +RFP N    +SD  +  V G+L+
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV---LSDEGRQFVKGLLN 234

Query: 284 TDPSQRLTA 292
            +P  RL A
Sbjct: 235 RNPQHRLGA 243

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  132 bits (332), Expect = 1e-34
 Identities = 88/272 (32%), Positives = 136/272 (50%), Gaps = 21/272 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVF---ACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           E F   + LG G FG  RV    +  E F   A K   K +++       V  E +I+  
Sbjct: 30  EDFNFIRTLGTGSFG--RVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY 87

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
           ++ HP  V+L   ++DE Y++LV+E   GGE F  L +  RF          Q++ +  Y
Sbjct: 88  IN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
              + +V+RDLKPEN+LL        IK+ DFG A  ++     L   G+P YIAPE+L 
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGF---IKMTDFGFAKVVDTRTYTL--CGTPEYIAPEILL 201

Query: 218 G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
             G+ +AAD W+ G+ +Y +L G PPF+ N    I+  +    + FP      + ++ K 
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKH 257

Query: 277 LVMGMLSTDPSQRL-----TARQVLDHSWMGD 303
           L+  +LS D ++R       A+ V +H W G+
Sbjct: 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289

Length = 340

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  131 bits (333), Expect = 1e-34
 Identities = 95/312 (30%), Positives = 148/312 (47%), Gaps = 57/312 (18%)

Query: 42  RFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVK--L-EIEIMT 96
           R+ L + +G G +GV  VCS  DK TG   A K I+       DD    K  L EI+++ 
Sbjct: 1   RYELLKPIGSGAYGV--VCSAVDKRTGRKVAIKKISN----VFDDLIDAKRILREIKLLR 54

Query: 97  RLSGHPNVVDLKAVYEDEDY-----VHLVMELCAGGELFHRLEKFGRF-SEAEARVLFMQ 150
            L  H N++ L  +           V++V EL    +L H++ K  +  ++   +    Q
Sbjct: 55  HL-RHENIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVIKSPQPLTDDHIQYFLYQ 111

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT----VG 206
           +++ + Y H   V+HRDLKP NIL+    S+  +K+ DFGLA  ++P +   G     V 
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 207 SPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT--- 257
           + +Y APE+L  +  Y +A D+WS G I   LL+  P F G       + I + + T   
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228

Query: 258 ADLRFPSN----------------PWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLD 297
            DL+F ++                P   +    S  A DL+  ML  DP +R+TA + L 
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288

Query: 298 HSWMGDGIQDPE 309
           H ++   + DPE
Sbjct: 289 HPYL-AQLHDPE 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  129 bits (327), Expect = 1e-34
 Identities = 85/274 (31%), Positives = 137/274 (50%), Gaps = 35/274 (12%)

Query: 46  GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER---SVKLEIEIMTRLSGHP 102
           GQQLG G F       D  TG + A K +   R  + + E    +++ EI +M RL+ HP
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HP 63

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           +++ +     ++ + +L +E  AGG + H L K+G F EA       QL++ + Y HE  
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEP---------GQSLLGTVGSPFYIAP 213
           ++HRD+K  N+L+   ++   +++ADFG A  +           GQ LLGT+    ++AP
Sbjct: 124 IIHRDVKGANLLI--DSTGQRLRIADFGAAARLAAKGTGAGEFQGQ-LLGTIA---FMAP 177

Query: 214 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKS--------RIFDAVRTADLRFPS 264
           EVL G  Y ++ DVWS G ++  + +  PP W   K         +I  A        PS
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIFKIASATTA-----PS 231

Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
            P +H+S   +D+ +  L   P  R  +R++L H
Sbjct: 232 IP-EHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  131 bits (330), Expect = 1e-34
 Identities = 77/244 (31%), Positives = 130/244 (53%), Gaps = 9/244 (3%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K  GE FA K++ KD ++  DD     +E  ++     +P +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++ ++++  VME   GG+L   ++  GRF    A     +++  + + H  G+++RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAADV 226
           K +N++L        IK+ADFG+      G +   T  G+P YIAPE+L G  Y  + D 
Sbjct: 123 KLDNVMLDRDGH---IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS GV+LY +L G  PF G+ +  +F+++R     +P   W  I+  +KD++  +   DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFERDP 235

Query: 287 SQRL 290
           ++RL
Sbjct: 236 TRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  131 bits (330), Expect = 1e-34
 Identities = 82/277 (29%), Positives = 148/277 (53%), Gaps = 18/277 (6%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-VVDL 107
           LG G FG + +   K T E++A K + KD ++  DD     +E  ++  LSG P  +  L
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPPFLTQL 66

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
            + ++  D ++ VME   GG+L +++++ GRF E  A     ++   + + H  G+++RD
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126

Query: 168 LKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAAD 225
           LK +N++L    S   IK+ADFG+    +  G +     G+P YIAPE++A   Y ++ D
Sbjct: 127 LKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV+LY +L+G  PF G  +  +F ++   ++ +P +    +S  A  +  G+++  
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKH 239

Query: 286 PSQRLTA-----RQVLDHSWMGDGIQDPEKLSGNKIE 317
           P +RL       R + +H++      D EKL   +++
Sbjct: 240 PGKRLGCGPEGERDIKEHAFF--RYIDWEKLERKEVQ 274

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  130 bits (328), Expect = 4e-34
 Identities = 85/316 (26%), Positives = 148/316 (46%), Gaps = 58/316 (18%)

Query: 38  NLRERFV-LGQQLGWGQFGVIRVCSDKFTGEVFACK-----SIAKDRLVTIDDERSVKL- 90
           ++ ER++  G  LG G +G +    D  TG++ A K      I+ D            + 
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 91  -----EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEAR 145
                E++IM  +  H N++ L  VY + D+++LVM++ A  +L   +++  R +E++ +
Sbjct: 65  FTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVK 122

Query: 146 VLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT------------ 193
            + +Q++  +   H+   +HRDL P NI + +K      K+ADFGLA             
Sbjct: 123 CILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLS 179

Query: 194 ---YIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK 248
               ++  + +   V + +Y APE+L G   Y+ A D+WS G I   LL+G P F G  +
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239

Query: 249 ----SRIFDAVRTAD-----------LRFP---SNPWD------HISDSAKDLVMGMLST 284
                RIF+ + T +           L        P D      + SD A DL+  +L  
Sbjct: 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299

Query: 285 DPSQRLTARQVLDHSW 300
           +P +R++A++ L H +
Sbjct: 300 NPLERISAKEALKHEY 315

Length = 335

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  129 bits (326), Expect = 5e-34
 Identities = 90/290 (31%), Positives = 143/290 (49%), Gaps = 50/290 (17%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER------SVKLEIEIMTRLSGHP 102
           +G G +G++    D  +GE+ A K       V +D+ER      S++ EI ++  L  HP
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKK------VRMDNERDGIPISSLR-EITLLLNLR-HP 66

Query: 103 NVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCH 159
           N+V+LK V   +  D + LVME C   +L   L+     FSE++ + L +QL++ + Y H
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAG 218
           E  ++HRDLK  N+LL  K     +K+ADFGLA TY  P + +   V + +Y APE+L G
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182

Query: 219 G--YNQAADVWSAGVILYILLSGMPPFWGNTK---------------SRIFDAVR----T 257
              Y  A D+W+ G IL  LL+  P   G ++                 I+         
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242

Query: 258 ADLRFPSNPWDH-------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                P  P+++       +S++   L+  +L  DP +R TA + L+ S+
Sbjct: 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  131 bits (330), Expect = 5e-34
 Identities = 91/313 (29%), Positives = 137/313 (43%), Gaps = 67/313 (21%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           FV  + +G G FG + +     T  ++A K++ K  ++  +    VK E +I+   + + 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNE 61

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            VV L   ++D+D ++ VM+   GG++   L + G F E  AR    +L   +   H++G
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLAT---------YIEPGQ-------------- 199
            +HRD+KP+NIL+        IKL DFGL T         Y + G               
Sbjct: 122 FIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 200 ------------------------SLLGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILY 234
                                   SL   VG+P YIAPEVL   GY Q  D WS GVILY
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSL---VGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 235 ILLSGMPPFWGN----TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
            +L G PPF  +    T+ ++ +   T  L  P      +S  A DL++  L      RL
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINWETT--LHIP--SQAKLSREASDLIL-RLCCGAEDRL 290

Query: 291 ---TARQVLDHSW 300
               A ++  H +
Sbjct: 291 GKNGADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 6e-34
 Identities = 77/266 (28%), Positives = 133/266 (50%), Gaps = 21/266 (7%)

Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--TIDDERSVKLEIEIMTRLSGHP 102
            G+ LG G FG + +C D  TG   A K +  D     T  +  +++ EI+++  L  H 
Sbjct: 6   RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HE 64

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V       D++ + + ME   GG +  +L+ +G  +E   R    Q+++ V Y H   
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM 124

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEP----GQSLLGTVGSPFYIAPEVLAG 218
           +VHRD+K  NIL   + S+  +KL DFG +  ++     G  +    G+P++++PEV++G
Sbjct: 125 IVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 219 -GYNQAADVWSAGVILYILLSGMPPFWGNTK--SRIFDAVRTADLRFPSNPW--DHISDS 273
            GY + ADVWS G  +  +L+  PP W   +  + IF          P+NP    H+S  
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPQLPSHVSPD 235

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHS 299
           A++ +      +  +R +A ++L H 
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  127 bits (320), Expect = 8e-34
 Identities = 73/259 (28%), Positives = 126/259 (48%), Gaps = 22/259 (8%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG++ +C  K   ++   K I  +++ T D+  + + E +++  LS HPN+++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYY 65

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
             + ++  + +VME   GG L   ++K       E      F+Q++  + + H   ++HR
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAAD 225
           DLK +NILL        +K+ DFG++  +         VG+P YI+PE+  G  YNQ +D
Sbjct: 126 DLKTQNILLDKHKMV--VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSD 183

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-----RFPSNPW-DHISDSAKDLVM 279
           +W+ G +LY L S           R F+A     L          P  D  S   + L++
Sbjct: 184 IWALGCVLYELAS---------LKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234

Query: 280 GMLSTDPSQRLTARQVLDH 298
            ML+ DPS+R    Q++  
Sbjct: 235 SMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  127 bits (321), Expect = 1e-33
 Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 21/268 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID-DERSVKLEIEIMTRLS 99
           E F + ++LG G +G +     K TG+V A K      +V ++ D + +  EI I+ +  
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIK------VVPVEEDLQEIIKEISIL-KQC 55

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYC 158
             P +V     Y     + +VME C  G +   ++   +  +E E   +  Q ++ + Y 
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV-GSPFYIAPEVLA 217
           H    +HRD+K  NILL  +      KLADFG++  +    +   TV G+PF++APEV+ 
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172

Query: 218 G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP---SNPWDHISDS 273
             GYN  AD+WS G+    +  G PP+      R    +     + P   S+P +  S  
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDP-EKWSPE 228

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             D V   L  DP +R +A Q+L H ++
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  127 bits (320), Expect = 1e-33
 Identities = 78/273 (28%), Positives = 133/273 (48%), Gaps = 34/273 (12%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSI-------AKDRLVTIDDERSVKLEIEIM 95
           F + +++G GQF V+        G V A K +       AK R      +  +K EI+++
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR------QDCLK-EIDLL 56

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQL 151
            +L  HPNV+   A + + + +++V+EL   G+L   ++ F +      E      F+QL
Sbjct: 57  KQLD-HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP----GQSLLGTVGS 207
              + + H   ++HRD+KP N+ +        +KL D GL  +         SL   VG+
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSL---VGT 169

Query: 208 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKS--RIFDAVRTADLRFPS 264
           P+Y++PE +   GYN  +D+WS G +LY + +   PF+G+  +   +   +   D  +P 
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPP 227

Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
            P DH S+  +DLV   ++ DP +R     VL 
Sbjct: 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  127 bits (321), Expect = 3e-33
 Identities = 83/252 (32%), Positives = 133/252 (52%), Gaps = 20/252 (7%)

Query: 49  LGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVV 105
           LG G FG   ++R  +    G+++A K + K  L   D  R+ K+E +I+  +  HP +V
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEV-NHPFIV 61

Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
            L   ++ E  ++L+++   GG+LF RL K   F+E + +    +L   + + H +G+++
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121

Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQ----SLLGTVGSPFYIAPEVL-AGGY 220
           RDLKPENILL        IKL DFGL+      +    S  GTV    Y+APEV+   G+
Sbjct: 122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE---YMAPEVVNRRGH 175

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
            Q+AD WS GV+++ +L+G  PF G  +      +  A L  P      +S  A+ L+  
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQSLLRA 231

Query: 281 MLSTDPSQRLTA 292
           +   +P+ RL A
Sbjct: 232 LFKRNPANRLGA 243

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 5e-33
 Identities = 82/274 (29%), Positives = 129/274 (47%), Gaps = 30/274 (10%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           +E + L Q++G G +G +    D  TGE+ A K I    L   DD   ++ EI ++    
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECR 58

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGG---ELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
            HPN+V     Y   D + +VME C GG   +++      G  SE +   +  + ++ + 
Sbjct: 59  -HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLA 115

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG----QSLLGTVGSPFYIA 212
           Y HE G +HRD+K  NILL        +KLADFG++  +       +S +GT   P+++A
Sbjct: 116 YLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGT---PYWMA 169

Query: 213 PEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS---- 264
           PEV A    GGY+   D+W+ G+    L    PP +     R    +  ++   P     
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229

Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
             W   S    D +   L+ DP +R TA ++L H
Sbjct: 230 EKW---SPVFHDFIKKCLTKDPKKRPTATKLLQH 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  127 bits (319), Expect = 6e-33
 Identities = 93/344 (27%), Positives = 157/344 (45%), Gaps = 32/344 (9%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG + +   K  G+ +A K + K  ++   +++ +  E  ++ +   HP +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  + ++ V++   GGELF  L++   F E  AR    ++   + Y H I +V+RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVL-AGGYNQAADV 226
           KPENILL    S   + L DFGL    I    +     G+P Y+APEV+    Y+   D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  G +LY +L G+PPF+    + ++D +    L  P       S +A  ++  +L  D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNI----LHKPLVLRPGASLTAWSILEELLEKDR 235

Query: 287 SQRLTAR----QVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISF 342
            +RL A+    ++ +H +        E LS   +E  K     + +        N D   
Sbjct: 236 QRRLGAKEDFLEIQEHPFF-------ESLSWTDLEQKKIPPPFNPNVEGPDDISNFD--- 285

Query: 343 GTGSPVFSDDESPAFTCRTS-----FSSFLQEPSTSTGFSFCSP 381
                VF+++  P   C +S      +S L+      GFS+  P
Sbjct: 286 ----AVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 7e-33
 Identities = 90/295 (30%), Positives = 134/295 (45%), Gaps = 62/295 (21%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +R+   K TG+++A K++ K  +   D    VK E +++   S  P VV L 
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVSLY 67

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++D  Y++L+ME   GG+L   L K+  FSE   R    + +  +   H++G +HRD+
Sbjct: 68  YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127

Query: 169 KPENILLATKASSSPIKLADFGLAT----------YIEPGQS------------------ 200
           KP+NIL+        IKL+DFGL+T          Y +  Q                   
Sbjct: 128 KPDNILIDRGGH---IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184

Query: 201 --------------------LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSG 239
                                  TVG+P YIAPE+    GY Q  D WS G I++  L G
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244

Query: 240 MPPFWG----NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
            PPF       T  +I +   T  L FP +   H+S  A+DL+  ++ T+   RL
Sbjct: 245 WPPFCSENSHETYRKIINWRET--LYFPDDI--HLSVEAEDLIRRLI-TNAENRL 294

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  125 bits (315), Expect = 1e-32
 Identities = 80/267 (29%), Positives = 144/267 (53%), Gaps = 32/267 (11%)

Query: 43  FVLGQQLGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLV----TIDDERSVKLEIEIM 95
           F L + LG G +G   ++R  S   +G+++A K + K  +V    T +  R+   E +++
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT---ERQVL 58

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
             +   P +V L   ++ +  +HL+++   GGELF  L +  RF E E ++   +++  +
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL-----ATYIEPGQSLLGTVGSPFY 210
            + H++G+++RD+K ENILL    S+  + L DFGL        +E   S  GT+    Y
Sbjct: 119 EHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE---Y 172

Query: 211 IAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFW----GNTKSRIFDAVRTADLRFP 263
           +AP+++ G   G+++A D WS GV++Y LL+G  PF      N+++ I   +  ++  +P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 232

Query: 264 SNPWDHISDSAKDLVMGMLSTDPSQRL 290
                 +S  AKD++  +L  DP +RL
Sbjct: 233 QE----MSALAKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  123 bits (312), Expect = 2e-32
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 41/275 (14%)

Query: 43  FVLGQQLGWGQFGVI-----RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
             LG++LG G FG +     +   +    +V A K++ +    + ++      E  IM +
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEG--ASEEEREEFLEEASIMKK 57

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL- 156
           LS HPN+V L  V    + +++V E   GG+L   L K G       ++    L+Q+ L 
Sbjct: 58  LS-HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE------KLTLKDLLQMALQ 110

Query: 157 ------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG---QSLLGTVGS 207
                 Y      VHRDL   N L+     +  +K++DFGL+  I      +   G    
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167

Query: 208 PFYIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTAD-LRFPS 264
             ++APE L  G +   +DVWS GV+L+ + + G  P+ G +   + + +     L  P 
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPE 227

Query: 265 NPWDHISDSAKDLVMGMLS---TDPSQRLTARQVL 296
           N  D +     +L   ML     DP  R T  +++
Sbjct: 228 NCPDEL----YEL---MLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  124 bits (313), Expect = 2e-32
 Identities = 88/294 (29%), Positives = 140/294 (47%), Gaps = 55/294 (18%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK----LEIEIMTRLSGHPN 103
           ++G G +GV+  C ++ TG++ A K     + V  +D+  +K     EI ++ +L  HPN
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPN 61

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIG 162
           +V+L  V+  +  +HLV E C    + + LEK  R   E   + +  Q +Q V +CH+  
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLAGG-- 219
            +HRD+KPENIL+ TK     IKL DFG A  +  PG      V + +Y APE+L G   
Sbjct: 121 CIHRDVKPENILI-TKQGQ--IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTK------------------SRIF--------- 252
           Y    DVW+ G +   LL+G P + G +                    +IF         
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237

Query: 253 -----DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                +     + +FP     +IS  A   + G L  DP++RL+  ++L+H + 
Sbjct: 238 SIPEPETREPLESKFP-----NISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  126 bits (318), Expect = 2e-32
 Identities = 95/277 (34%), Positives = 142/277 (51%), Gaps = 36/277 (12%)

Query: 34  NQISNLR---ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
            +I+ LR   E F + + +G G FG +++   K + +V+A K ++K  ++   D      
Sbjct: 33  EKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL------EKFGRFSEAEA 144
           E +IM   +    +V L   ++D+ Y+++VME   GG+L + +      EK+ RF  AE 
Sbjct: 93  ERDIMAH-ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEV 151

Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLG 203
            VL +  +      H +G +HRD+KP+N+LL     S  +KLADFG    ++  G     
Sbjct: 152 -VLALDAI------HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCD 201

Query: 204 T-VGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFD 253
           T VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+ +    T S+I D
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261

Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
                 L FP +    IS  AKDL+   L TD   RL
Sbjct: 262 --HKNSLTFPDDI--EISKQAKDLICAFL-TDREVRL 293

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  123 bits (311), Expect = 3e-32
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 34/271 (12%)

Query: 44  VLGQQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            LG++LG G FG +                A K++ +D   +         E  IM +L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLF-MQL---MQV 154
            HPNVV L  V  +E+ +++VME   GG+L   L K   + S ++  + F +Q+   M+ 
Sbjct: 60  -HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSD-LLSFALQIARGME- 116

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG-SP-FYIA 212
             Y      +HRDL   N L+        +K++DFGL+  +          G  P  ++A
Sbjct: 117 --YLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLPIRWMA 171

Query: 213 PEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTAD-LRFPSNPWDH 269
           PE L  G +   +DVWS GV+L+ + + G  P+ G +   + + ++    L  P N    
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPN---- 227

Query: 270 ISDSAKDLVMGMLS---TDPSQRLTARQVLD 297
                 +L   ML     DP  R T  ++++
Sbjct: 228 ---CPPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 6e-32
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 7/248 (2%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  + TG+++ACK + K R+     E     E +I+ +++    VV L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLA 66

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF--MQLMQVVLYCHEIGVVHR 166
             YE +D + LV+ L  GG+L   +   G     E R +F   ++   +   H   +V+R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAAD 225
           DLKPENILL        I+++D GLA  I  G+++ G VG+  Y+APEV+    Y  + D
Sbjct: 127 DLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPD 183

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  G ++Y ++ G  PF    +    + V            +  S++A+ +   +L+ D
Sbjct: 184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKD 243

Query: 286 PSQRLTAR 293
           P  RL  R
Sbjct: 244 PGFRLGCR 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  124 bits (313), Expect = 7e-32
 Identities = 98/301 (32%), Positives = 146/301 (48%), Gaps = 51/301 (16%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD--RLVTIDDERSVKLEIEIMTRL 98
            ++ + Q+LG G +G++    D+ T EV A K I  D  R  T D +R+ + EI  +  L
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNAT-DAQRTFR-EIMFLQEL 63

Query: 99  SGHPNVVDLKAVYE---DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
             HPN+V L  V +   D+D ++LV E     +L H + +     +   R +  QL++ +
Sbjct: 64  GDHPNIVKLLNVIKAENDKD-IYLVFE-YMETDL-HAVIRANILEDVHKRYIMYQLLKAL 120

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-----TYIEPGQSLLGT--VGSP 208
            Y H   V+HRDLKP NILL +      +KLADFGLA         P   +L T  V + 
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCR---VKLADFGLARSLSELEENPENPVL-TDYVATR 176

Query: 209 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAV---RTAD 259
           +Y APE+L G   Y +  D+WS G IL  +L G P F G    N   +I + +      D
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 260 L-------------RFPSNPWDHI-------SDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
           +               PS P   +       SD A DL+  +L  +P++RLTA + L+H 
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296

Query: 300 W 300
           +
Sbjct: 297 Y 297

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  122 bits (308), Expect = 1e-31
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 41/285 (14%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           ++G G F  +     + TG+ +A K + K    +++   +++ EI+ + RLS HPN++ L
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRL 63

Query: 108 KAVYEDEDY--VHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLMQVVLYCHEIG 162
             V  D     + LV EL     L+  ++  GR     E   +    QL++ + + H  G
Sbjct: 64  IEVLFDRKTGRLALVFEL-MDMNLYELIK--GRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL--AGGY 220
           + HRD+KPENIL+        +KLADFG    I         + + +Y APE L   G Y
Sbjct: 121 IFHRDIKPENILIKDDI----LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT--ADLRFPSNPWDHI---- 270
               D+W+ G + + +LS  P F G  +    ++I D + T  A++        H+    
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236

Query: 271 ---------------SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                          S    DL+  +L+ DP +R+TA+Q L H +
Sbjct: 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  121 bits (306), Expect = 1e-31
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 43/276 (15%)

Query: 44  VLGQQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            LG++LG G FG +                A K++ +D   +         E  IM +L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLD 59

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC- 158
            HPN+V L  V  +E+ + +VME   GG+L   L K         R   + L  ++ +  
Sbjct: 60  -HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK--------NRPKELSLSDLLSFAL 110

Query: 159 ---------HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG-SP 208
                         +HRDL   N L+        +K++DFGL+  +          G  P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLP 167

Query: 209 -FYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTAD-LRFPS 264
             ++APE L  G +   +DVWS GV+L+ + + G  P+ G + + + + ++    L  P 
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP 227

Query: 265 NPWDHISDSAKDLVMGMLS---TDPSQRLTARQVLD 297
           N          +L   ML     DP  R T  ++++
Sbjct: 228 N-------CPPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  122 bits (306), Expect = 2e-31
 Identities = 82/258 (31%), Positives = 129/258 (50%), Gaps = 12/258 (4%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  + TG+++ACK + K R+     E     E +I+ +++    VV L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLA 66

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF--MQLMQVVLYCHEIGVVHR 166
             YE +D + LV+ L  GG+L   +   G     E R +F   ++   +   H+  +V+R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAAD 225
           DLKPENILL        I+++D GLA ++  GQ++ G VG+  Y+APEV+    Y  + D
Sbjct: 127 DLKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ G +LY +++G  PF    K    + V            +  S  A+ L   +L  D
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKD 243

Query: 286 PSQRL-----TARQVLDH 298
           P +RL      AR+V +H
Sbjct: 244 PKERLGCQGGGAREVKEH 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  121 bits (304), Expect = 3e-31
 Identities = 79/260 (30%), Positives = 122/260 (46%), Gaps = 25/260 (9%)

Query: 47  QQLGWGQFG-VIRVCSDKFTGEVFACKSI----------AKDRLVTIDDERSVKLEIEIM 95
           + LG G FG V +V        + A K I           ++R  +I D  S   E+ I+
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS---EVTII 62

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAG---GELFHRL-EKFGRFSEAEARVLFMQL 151
                HPN+V     + + D +++VM+L  G   GE F+ L EK  RF+E     +F+Q+
Sbjct: 63  KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 152 MQVVLYCH-EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFY 210
           +  + Y H E  +VHRDL P NI+L        + + DFGLA   +P   L   VG+  Y
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGED---DKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
             PE++    Y + ADVW+ G ILY + +  PPF+      +  A +  +  +   P   
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--ATKIVEAVYEPLPEGM 237

Query: 270 ISDSAKDLVMGMLSTDPSQR 289
            S+   D++   L+ D   R
Sbjct: 238 YSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  120 bits (304), Expect = 3e-31
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 24/270 (8%)

Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRLSGHPN 103
           L + +G G   V+         E  A K I  ++  T +D+ R    E++ M+    HPN
Sbjct: 5   LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK---EVQAMS-QCNHPN 60

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLE---KFGRFSEAEARVLFMQLMQVVLYCHE 160
           VV     +   D + LVM   +GG L   ++     G   EA    +  ++++ + Y H 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT----VGSPFYIAPEV 215
            G +HRD+K  NILL    S   +K+ADFG++  + + G          VG+P ++APEV
Sbjct: 121 NGQIHRDIKAGNILLGEDGS---VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 216 LA--GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD----H 269
           +    GY+  AD+WS G+    L +G  P+      ++   + T     PS         
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQNDPPSLETGADYKK 235

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            S S + ++   L  DPS+R TA ++L H 
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  121 bits (304), Expect = 4e-31
 Identities = 81/249 (32%), Positives = 125/249 (50%), Gaps = 7/249 (2%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  + TG+++ACK + K R+     E     E +I+ +++    VV+L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLA 66

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF--MQLMQVVLYCHEIGVVHR 166
             YE +D + LV+ +  GG+L   +   G     E R LF   +++  +   H    V+R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAAD 225
           DLKPENILL        I+++D GLA  I  G+S+ G VG+  Y+APEVL    Y  + D
Sbjct: 127 DLKPENILLDDYGH---IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  G ++Y ++ G  PF G  +    + V    L          S+ AK +   +L+ D
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD 243

Query: 286 PSQRLTARQ 294
           P QRL  ++
Sbjct: 244 PKQRLGCQE 252

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  121 bits (304), Expect = 4e-31
 Identities = 83/301 (27%), Positives = 128/301 (42%), Gaps = 62/301 (20%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK----LEIEIMTRL 98
           F   ++LG G +  +    ++ TGE+ A K I       +D E         EI +M  L
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI------HLDAEEGTPSTAIREISLMKEL 55

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-------GRFSEAEARVLFMQL 151
             H N+V L  V   E+ + LV E          L+K+       G       +    QL
Sbjct: 56  K-HENIVRLHDVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQL 109

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFY 210
           ++ + +CHE  V+HRDLKP+N+L+  +     +KLADFGLA     P  +    V + +Y
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWY 166

Query: 211 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTADLRFPS 264
            AP+VL G   Y+ + D+WS G I+  +++G P F G        +IF  + T       
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT----E 222

Query: 265 NPWDHISDSAK-------------------------DLVMGMLSTDPSQRLTARQVLDHS 299
           + W  IS   +                         DL+  +L  +P  R++A   L H 
Sbjct: 223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282

Query: 300 W 300
           W
Sbjct: 283 W 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  120 bits (303), Expect = 1e-30
 Identities = 102/362 (28%), Positives = 168/362 (46%), Gaps = 54/362 (14%)

Query: 43  FVLGQQLGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRL 98
           F L + LG G +G   ++R  +   TG+++A K + K  LV         + E  ++  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
              P +V L   ++ E  +HL+++  +GGE+F  L +   FSE E R    +++  + + 
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI--EPGQSLLGTVGSPFYIAPEVL 216
           H++G+V+RD+K ENILL    S   + L DFGL+     E  +      G+  Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 217 AG--GYNQAADVWSAGVILYILLSGMPPFW----GNTKSRIFDAVRTADLRFPSNPWDHI 270
            G  G+ +A D WS G++++ LL+G  PF      NT+S +   +   D  FPS     I
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS----FI 234

Query: 271 SDSAKDLVMGMLSTDPSQRL-----TARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLG 325
              A+DL+  +L  DP +RL      A ++ +H +      D E L+  K+         
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG--LDWEALALRKVN-------- 284

Query: 326 SGSFSTQIIPRNQ-DIS-----FGTGSPVFSDDESPAFTCRTSFSSFLQEPSTSTGFSFC 379
              F   I  RN+ D+      F    PV+S   +P                   G+SF 
Sbjct: 285 -PPFRPSI--RNELDVGNFAEEFTNLEPVYSPAGTPPSG-----------ARVFQGYSFV 330

Query: 380 SP 381
           +P
Sbjct: 331 AP 332

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  119 bits (299), Expect = 2e-30
 Identities = 77/269 (28%), Positives = 137/269 (50%), Gaps = 23/269 (8%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +     K TG+++ACK + K RL     E+   LE EI+ +++  P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF--MQLMQVVLYCHEIGVVHR 166
             +E + ++ LVM L  GG+L + +   G       RV+    Q+   +L+ H + +V+R
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA-GGYNQAAD 225
           D+KPEN+LL  + +    +L+D GLA  ++ G+++    G+  Y+APE+L    Y+   D
Sbjct: 120 DMKPENVLLDDQGNC---RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVD 176

Query: 226 VWSAGVILYILLSGMPPFWGN----TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
            ++ G  +Y +++G  PF  +     K  +       +++F      + ++ +KD+    
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH---QNFTEESKDICRLF 233

Query: 282 LSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           L+  P  RL +R+  D         DP K
Sbjct: 234 LAKKPEDRLGSREKND---------DPRK 253

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  120 bits (303), Expect = 2e-30
 Identities = 86/286 (30%), Positives = 133/286 (46%), Gaps = 46/286 (16%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +R+   K TG ++A K + K  ++  +    ++ E +I+    G   VV + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMF 67

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++D+  ++L+ME   GG++   L K    SE   +    + +  +   H++G +HRD+
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127

Query: 169 KPENILLATKASSSPIKLADFGLATYIEPG------------------------------ 198
           KP+N+LL  K     +KL+DFGL T ++                                
Sbjct: 128 KPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 199 ------QSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRI 251
                 Q    TVG+P YIAPEV +  GYN+  D WS GVI+Y +L G PPF   T    
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 252 FDAVRT--ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
           +  V      L FP  P   IS+ AKDL++    TD   R+ +  V
Sbjct: 245 YRKVMNWKETLVFP--PEVPISEKAKDLIL-RFCTDSENRIGSNGV 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 2e-30
 Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 22/267 (8%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK---LEIEIMTRLSGHPNV 104
           +LG G FG +     K TG   A K I       I+ E  ++   +EI+I++    HPN+
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKII------QIESEEELEDFMVEIDILSECK-HPNI 64

Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGV 163
           V L   Y  E+ + +++E C GG L   + +  R  +E + R +  Q+++ + + H   V
Sbjct: 65  VGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKV 124

Query: 164 VHRDLKPENILLATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFYIAPEVLA----- 217
           +HRDLK  NILL        +KLADFG+ A      Q     +G+P+++APEV+A     
Sbjct: 125 IHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181

Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
              Y+  AD+WS G+ L  L    PP       R+   +  ++      P    S S  D
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQP-SKWSSSFND 240

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +   L  DP  R TA ++L H ++ D
Sbjct: 241 FLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  119 bits (299), Expect = 2e-30
 Identities = 95/301 (31%), Positives = 139/301 (46%), Gaps = 59/301 (19%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER------SVKLEIEIMTRLSGH 101
           Q+G G +G +    DK TGE+ A K       V +D+E+      +++ EI+I+ +L+ H
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKK------VRLDNEKEGFPITAIR-EIKILRQLN-H 65

Query: 102 PNVVDLKAVYEDEDYV----------HLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQ 150
            N+V+LK +  D+             +LV E     +L   LE     FSE   +    Q
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEY-MDHDLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSP 208
           L++ + YCH+   +HRD+K  NILL  K     IKLADFGLA      +S   T  V + 
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKVITL 181

Query: 209 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK-------SRI-------- 251
           +Y  PE+L G   Y  A DVWS G IL  L +  P F  N +       SR+        
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241

Query: 252 ---------FDAVRTADL--RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                    F+ ++      R     +  I   A DL+  ML+ DPS+R TA + L+  W
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301

Query: 301 M 301
           +
Sbjct: 302 L 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  117 bits (294), Expect = 4e-30
 Identities = 72/264 (27%), Positives = 140/264 (53%), Gaps = 13/264 (4%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           +   + +G G +G + +   +  G+ +  K +   R  +  + ++ + E +++++L  HP
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLK-HP 59

Query: 103 NVVDLKAVYEDED-YVHLVMELCAGGELFHRL-EKFGRF-SEAEARVLFMQLMQVVLYCH 159
           N+V  +  +E ED  +++VM  C GG+L+H+L E+ G+   E +    F+Q+   + Y H
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG 218
           E  ++HRDLK +N+ L     ++ IK+ D G+A  +E    +  T +G+P+Y++PE+ + 
Sbjct: 120 EKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 219 G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             YN  +DVW+ G  +Y + +    F  N K       R  + + P  P D+ S    +L
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAF--NAKDMNSLVYRIIEGKLPPMPKDY-SPELGEL 233

Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +  MLS  P +R + + +L   ++
Sbjct: 234 IATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  117 bits (295), Expect = 4e-30
 Identities = 78/276 (28%), Positives = 135/276 (48%), Gaps = 25/276 (9%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL------EIEIM 95
           +++ G  +G G FG + +  +  +GE+ A K +    +     +R   +      EI ++
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
             L  H N+V       D D++++ +E   GG +   L  +G F E   R    Q+++ +
Sbjct: 61  KELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGL 119

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV--------GS 207
            Y H  G++HRD+K  NIL+  K     IK++DFG++  +E   SL            GS
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKLE-ANSLSTKTNGARPSLQGS 175

Query: 208 PFYIAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSR-IFDAVRTADLRFPSN 265
            F++APEV+    Y + AD+WS G ++  +L+G  PF   T+ + IF   +  +   P  
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF---KIGENASPEI 232

Query: 266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  +IS  A D +      D ++R TA ++L H ++
Sbjct: 233 P-SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  117 bits (294), Expect = 5e-30
 Identities = 72/265 (27%), Positives = 142/265 (53%), Gaps = 14/265 (5%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           ++V  +++G G FG   +   K  G+ +  K I   ++   + E S K E+ +++ +  H
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK-EVAVLSNMK-H 58

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQVVLYCH 159
           PN+V  +  +E+   +++VM+ C GG+L+ ++  ++   F E +    F+Q+   + + H
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG 218
           +  ++HRD+K +NI L TK  +  IKL DFG+A  +     L  T +G+P+Y++PE+   
Sbjct: 119 DRKILHRDIKSQNIFL-TKDGT--IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175

Query: 219 G-YNQAADVWSAGVILYILLSGMPPF-WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
             YN  +D+W+ G +LY + +    F  GN K+ +   +R +   +P     H S   ++
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS---YPPVS-SHYSYDLRN 231

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
           LV  +   +P  R +   +L+ +++
Sbjct: 232 LVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  119 bits (299), Expect = 8e-30
 Identities = 96/277 (34%), Positives = 145/277 (52%), Gaps = 36/277 (12%)

Query: 34  NQISNLR---ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           N+I +LR   E + + + +G G FG +++   K T +V+A K ++K  ++   D      
Sbjct: 33  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL------EKFGRFSEAEA 144
           E +IM   +  P VV L   ++D+ Y+++VME   GG+L + +      EK+ RF  AE 
Sbjct: 93  ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 151

Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLG 203
            VL +  +      H +G +HRD+KP+N+LL     S  +KLADFG    + + G     
Sbjct: 152 -VLALDAI------HSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVRCD 201

Query: 204 T-VGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFD 253
           T VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+ +    T S+I +
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261

Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
                 L FP +  + IS  AK+L+   L TD   RL
Sbjct: 262 --HKNSLTFPDD--NDISKEAKNLICAFL-TDREVRL 293

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  117 bits (296), Expect = 8e-30
 Identities = 81/265 (30%), Positives = 124/265 (46%), Gaps = 19/265 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + F   +++G G FG +    D  T EV A K ++     + +  + +  E+  + +L  
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR- 73

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAG--GELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
           HPN ++ K  Y  E    LVME C G   ++    +K     E E   +    +Q + Y 
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK--PLQEVEIAAICHGALQGLAYL 131

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV-LA 217
           H    +HRD+K  NILL    +   +KLADFG A+ + P  S +GT   P+++APEV LA
Sbjct: 132 HSHERIHRDIKAGNILLTEPGT---VKLADFGSASLVSPANSFVGT---PYWMAPEVILA 185

Query: 218 ---GGYNQAADVWSAGVILYILLSGMPP-FWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
              G Y+   DVWS G+    L    PP F  N  S ++   +       SN W   SD 
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDY 242

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDH 298
            ++ V   L   P  R ++ ++L H
Sbjct: 243 FRNFVDSCLQKIPQDRPSSEELLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  117 bits (294), Expect = 1e-29
 Identities = 83/291 (28%), Positives = 132/291 (45%), Gaps = 50/291 (17%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTRLSGHPN 103
           +++G G +G +    ++ T E+ A K +  D     DDE    S   EI ++  L  H N
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALREICLLKELK-HKN 60

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYC 158
           +V L  V   +  + LV E C        L+K+     G       +    QL++ + +C
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLA 217
           H   V+HRDLKP+N+L+        +KLADFGLA  +  P +     V + +Y  P+VL 
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172

Query: 218 G--GYNQAADVWSAGVILYILL-SGMPPFWGNTKS----RIFDAVRTA------------ 258
           G   Y+ + D+WSAG I   L  +G P F GN       RIF  + T             
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 259 -DLRFPSNP----WDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
               +P  P      ++    + + +DL+  +L  +P QR++A + L H +
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  117 bits (294), Expect = 1e-29
 Identities = 89/291 (30%), Positives = 144/291 (49%), Gaps = 50/291 (17%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--RSVKL-EIEIMTRLSGHPN 103
           +++G G +GV+    DK TGE+ A K I   RL T +DE   S  + EI ++  L+ HPN
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKI---RLET-EDEGVPSTAIREISLLKELN-HPN 59

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF----GRFSEAEARV-LFM-QLMQVVLY 157
           +V L  V   E+ ++LV E      L   L+K+             +  ++ QL+Q + Y
Sbjct: 60  IVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVL 216
           CH   V+HRDLKP+N+L+  + +   +KLADFGLA  +  P ++    V + +Y APE+L
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGA---LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Query: 217 AGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTAD----------- 259
            G   Y+   D+WS G I   +++  P F G+++     RIF  + T D           
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231

Query: 260 ------LRFPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                  ++       +     +   DL+  ML  DP++R++A+  L H +
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  116 bits (293), Expect = 1e-29
 Identities = 89/289 (30%), Positives = 142/289 (49%), Gaps = 50/289 (17%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTRLSGHPN 103
           +++G G +GV+    +K TGEV A K I   RL T + E    +   EI ++  L+ HPN
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKI---RLDT-ETEGVPSTAIREISLLKELN-HPN 60

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF------GRFSEAEARVLFMQLMQVVLY 157
           +V L  V   E+ ++LV E      L   L+KF              +    QL+Q + +
Sbjct: 61  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVL 216
           CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y APE+L
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Query: 217 AGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTAD----------- 259
            G   Y+ A D+WS G I   +++    F G+++     RIF  + T D           
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 260 ------LRFPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDH 298
                  ++    +  +     +  +DL+  ML  DP++R++A+  L H
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  116 bits (291), Expect = 1e-29
 Identities = 74/269 (27%), Positives = 125/269 (46%), Gaps = 21/269 (7%)

Query: 46  GQQLGWGQFGVIRVCSDKFTGEVFACKSIA---KDRLVTIDDERSVKLEIEIMTRLSGHP 102
           G+ LG G +G +  C     G++ A K +     + L    +   ++ E++++  L  H 
Sbjct: 5   GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HV 62

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N+V       D++ + + ME   GG +   L +FG   E        Q++  V Y H   
Sbjct: 63  NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYI-------EPGQSLLGTVGSPFYIAPEV 215
           VVHRD+K  N++L     +  IKL DFG A  +            L    G+P+++APEV
Sbjct: 123 VVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 216 L-AGGYNQAADVWSAGVILYILLSGMPPFWGNTK--SRIFDAVRTADLRFPSNPWDHISD 272
           +   GY + +D+WS G  ++ + +G PP   +    + +F  +       P  P D  S 
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMF-YIGAHRGLMPRLP-DSFSA 236

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           +A D V   L+ D  +R +A Q+L H ++
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 2e-29
 Identities = 84/292 (28%), Positives = 128/292 (43%), Gaps = 44/292 (15%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTRL- 98
           +    ++G G +G +    D  TG   A K +     V + +E    S   EI ++ +L 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR----VPLSEEGIPLSTLREIALLKQLE 56

Query: 99  -SGHPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQ 150
              HPN+V L  V      + E  + LV E     +L   L K  +        + L  Q
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFY 210
           L++ V + H   +VHRDLKP+NIL+    S   +K+ADFGLA       +L   V + +Y
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWY 172

Query: 211 IAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT-ADLRFPS 264
            APEVL    Y    D+WS G I   L    P F G ++     +IFD +   ++  +P 
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232

Query: 265 N---PWD---------------HISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
           N   P                  I +   DL+  ML+ +P +R++A + L H
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 3e-29
 Identities = 84/280 (30%), Positives = 132/280 (47%), Gaps = 31/280 (11%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
             F L + +G G +G +     K TG++ A K +     +  D+E  +K E  I+ + S 
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61

Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGG---ELFHRLEKFG-RFSEAEARVLFMQ 150
           HPN+      +       ++D + LVMELC GG   +L   L K G R  E     +  +
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPF 209
            ++ + Y HE  V+HRD+K +NILL   A    +KL DFG++  ++       T +G+P+
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 210 YIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSR-IFDAVRTA--DL 260
           ++APEV+A        Y+  +DVWS G+    L  G PP       R +F   R     L
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238

Query: 261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
           + P N W   S    D +   L  +  QR    ++L+H +
Sbjct: 239 KSPEN-W---SKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  117 bits (294), Expect = 3e-29
 Identities = 82/270 (30%), Positives = 129/270 (47%), Gaps = 45/270 (16%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +R+   K TG V+A K + K  ++  +    ++ E +I+   +    VV + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMF 67

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++D+  ++L+ME   GG++   L K    +E E +    + +  +   H++G +HRD+
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127

Query: 169 KPENILLATKASSSPIKLADFGLATYIEPG------------------------------ 198
           KP+N+LL +K     +KL+DFGL T ++                                
Sbjct: 128 KPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 199 ------QSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRI 251
                 Q    TVG+P YIAPEV +  GYN+  D WS GVI+Y +L G PPF   T    
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 252 FDAVRT--ADLRFPSNPWDHISDSAKDLVM 279
           +  V      L FP  P   IS+ AKDL++
Sbjct: 245 YKKVMNWKETLIFP--PEVPISEKAKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  115 bits (288), Expect = 4e-29
 Identities = 85/270 (31%), Positives = 133/270 (49%), Gaps = 15/270 (5%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           N +E F L Q++G G +G +    +  TGE+ A K I   +L   +D   V+ EI IM +
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-IMMK 61

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
              H N+V     Y   D + + ME C GG L       G  SE++   +  + +Q + Y
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
            H  G +HRD+K  NILL        +KLADFG++  I    +   + +G+P+++APEV 
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGH---VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178

Query: 217 A----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI-- 270
           A    GGYNQ  D+W+ G+    L    PP +     R    +  ++ + P    D +  
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKLKDKMKW 237

Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
           S+S    V   L+ +P +R TA ++L H +
Sbjct: 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  114 bits (286), Expect = 4e-29
 Identities = 78/257 (30%), Positives = 125/257 (48%), Gaps = 17/257 (6%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-VTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +G G FG   +     + + +A K I   RL  +       + E  ++ ++  HPN+V  
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEI---RLPKSSSAVEDSRKEAVLLAKMK-HPNIVAF 63

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRL-EKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVH 165
           K  +E + ++++VME C GG+L  ++  + G+ F E      F+Q+   V + HE  V+H
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123

Query: 166 RDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPEVLAG-GYNQA 223
           RD+K +NI L        +KL DFG A  +  PG      VG+P+Y+ PE+     YN  
Sbjct: 124 RDIKSKNIFLTQNGK---VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK 180

Query: 224 ADVWSAGVILYILLSGMPPFWGNT-KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGML 282
           +D+WS G ILY L +   PF  N+ K+ I    + +    PS    H S   + L+  M 
Sbjct: 181 SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPS----HYSYELRSLIKQMF 236

Query: 283 STDPSQRLTARQVLDHS 299
             +P  R +A  +L   
Sbjct: 237 KRNPRSRPSATTILSRG 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  115 bits (288), Expect = 5e-29
 Identities = 77/259 (29%), Positives = 121/259 (46%), Gaps = 29/259 (11%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  + TG+++ACK + K R+     E     E  I+ +++    VV L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLA 66

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC-----HEIGV 163
             YE +D + LV+ +  GG+L   +   G     E R +F       L C         +
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA---AELCCGLEDLQRERI 123

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQ 222
           V+RDLKPENILL  +     I+++D GLA  I  G+++ G VG+  Y+APEV+    Y  
Sbjct: 124 VYRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180

Query: 223 AADVWSAGVILYILLSGMPPF--------WGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
           + D W  G ++Y ++ G  PF              R+ +       +F        S+ A
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF--------SEDA 232

Query: 275 KDLVMGMLSTDPSQRLTAR 293
           K +   +L+ +P +RL  R
Sbjct: 233 KSICRMLLTKNPKERLGCR 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  114 bits (287), Expect = 5e-29
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 24/270 (8%)

Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIA--KDRLVTIDDERSVKLEIEIMTRLSGHP 102
           LG+ LG G FG + +C D  TG   A K +    +   T  +  +++ EI+++  L  H 
Sbjct: 6   LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HE 64

Query: 103 NVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            +V       D  E  + + ME   GG +  +L+ +G  +E   R    Q+++ V Y H 
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFG----LATYIEPGQSLLGTVGSPFYIAPEVL 216
             +VHRD+K  NIL   + S   +KL DFG    L T    G  +    G+P++++PEV+
Sbjct: 125 NMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSR--IFDAVRTADLRFPSNPW--DHIS 271
           +G GY + AD+WS G  +  +L+  PP W   ++   IF          P+NP    H+S
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPVLPPHVS 235

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           D  +D +  +   +   R +A ++L H+++
Sbjct: 236 DHCRDFLKRIF-VEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  116 bits (293), Expect = 5e-29
 Identities = 85/290 (29%), Positives = 137/290 (47%), Gaps = 48/290 (16%)

Query: 49  LGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +G G +G  +VCS  D  TG   A K +++     I  +R+ + E+ ++ +   H NV+ 
Sbjct: 23  VGSGAYG--QVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLL-KHMDHENVIG 78

Query: 107 LKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           L  V+      ED   V+LV  L  G +L + + K  + S+   + L  Q+++ + Y H 
Sbjct: 79  LLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA--G 218
            G++HRDLKP NI +        +K+ DFGLA + +    + G V + +Y APE++    
Sbjct: 137 AGIIHRDLKPSNIAV---NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 191

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF------------ 262
            YNQ  D+WS G I+  LL+G   F G+       RI + V T D               
Sbjct: 192 HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY 251

Query: 263 -------PSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                  P   +  +    +  A DL+  ML  DP +R+TA + L H ++
Sbjct: 252 IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  115 bits (289), Expect = 5e-29
 Identities = 88/290 (30%), Positives = 146/290 (50%), Gaps = 51/290 (17%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD---ERSVKLEIEIMTRLSGHPN 103
           +++G G +GV+    +K TG++ A K I   RL + ++     +++ EI ++  L  HPN
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIR-EISLLKELQ-HPN 60

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF------GRFSEAE-ARVLFMQLMQVVL 156
           +V L+ V   E  ++L+ E      L   L+K+      G++ +AE  +    Q++Q +L
Sbjct: 61  IVCLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEV 215
           +CH   V+HRDLKP+N+L+  K     IKLADFGLA     P +     V + +Y APEV
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172

Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTAD---------- 259
           L G   Y+   D+WS G I   + +  P F G+++     RIF  + T            
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232

Query: 260 ----LRFP-------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
                 FP        +   ++ +   DL+  ML  DP++R++A++ L+H
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  114 bits (286), Expect = 6e-29
 Identities = 74/267 (27%), Positives = 135/267 (50%), Gaps = 22/267 (8%)

Query: 42  RFVLGQQLGWGQFG-VIRV--CSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
            F + ++LG G +G V +V   SD    + +A K +    +   + E +V  EI I+  +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSD---NQFYALKEVDLGSMSQKEREDAVN-EIRILASV 56

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQV 154
           + HPN++  K  + D + + +VME    G+L   + K  +      E E   +F+QL++ 
Sbjct: 57  N-HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAP 213
           +   HE  ++HRDLK  NILL    ++  +K+ D G++  ++  +++  T +G+P Y+AP
Sbjct: 116 LQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLK--KNMAKTQIGTPHYMAP 170

Query: 214 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           EV  G  Y+  +D+WS G +LY + +  PPF   +   +   V+    ++P  P  + S 
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIPPIY-SQ 227

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHS 299
             ++ +  ML   P  R    ++L   
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  115 bits (288), Expect = 1e-28
 Identities = 71/253 (28%), Positives = 129/253 (50%), Gaps = 18/253 (7%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +  + +   K T  ++A K + K+ +   +D   V+ E  +  + S HP +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
           + ++ E  +  V+E   GG+L   +++  +  E  AR    ++   + Y HE G+++RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADV 226
           K +N+LL ++     IKL D+G+    + PG +     G+P YIAPE+L G  Y  + D 
Sbjct: 123 KLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 227 WSAGVILYILLSGMPPF---------WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
           W+ GV+++ +++G  PF           NT+  +F  +    +R P +    +S  A  +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASV 235

Query: 278 VMGMLSTDPSQRL 290
           +   L+ DP +RL
Sbjct: 236 LKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  113 bits (285), Expect = 2e-28
 Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 57/291 (19%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK----LEIEIMTRLSGHPNV 104
           +G G +G++  C  K TG++ A K     + +  +D++ VK     EI ++ +L  H N+
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLR-HENL 62

Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIG 162
           V+L  V+  +  ++LV E      +   LEK+  G       + LF Q+++ + +CH   
Sbjct: 63  VNLIEVFRRKKRLYLVFEF-VDHTVLDDLEKYPNGLDESRVRKYLF-QILRGIEFCHSHN 120

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAGG-- 219
           ++HRD+KPENIL+   + S  +KL DFG A T   PG+     V + +Y APE+L G   
Sbjct: 121 IIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNT------------------------KSRIFDAV 255
           Y +A D+W+ G ++  +L+G P F G++                        K+ +F  +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 256 RTADL--------RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
           R  ++        RFP      +S    DL    L  DP  R ++ Q+L H
Sbjct: 238 RLPEVKEIEPLEKRFPK-----LSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  114 bits (286), Expect = 2e-28
 Identities = 94/296 (31%), Positives = 141/296 (47%), Gaps = 49/296 (16%)

Query: 41  ERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
            R+V  Q +G G FG+  VCS  D+ TG+  A K I K     +  +R+ + E++++  L
Sbjct: 10  NRYVDLQPVGMGAFGL--VCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66

Query: 99  SGHPNVVDLKAVY----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
             H N++ L  ++    ED   ++ V EL   G   HRL       +   +    Q+++ 
Sbjct: 67  R-HENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H  GVVHRDLKP NIL+        +K+ DFGLA   +P   + G V + +Y APE
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCD---LKICDFGLARIQDP--QMTGYVSTRYYRAPE 175

Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAVRTA---------- 258
           ++     Y+   D+WSAG I   +L G P F G    N  S I D + T           
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235

Query: 259 --DLRF----------P-SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              LRF          P S  + +   SA DL+  ML  DP +R++A + L H ++
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  112 bits (282), Expect = 2e-28
 Identities = 81/265 (30%), Positives = 136/265 (51%), Gaps = 22/265 (8%)

Query: 46  GQQLGWGQFGVIRVCSDKFTGEVFACKSIA--KDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           G+ LG G FG + +C D  TG   A K +    +   T  +  +++ EI+++  L  H  
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HER 65

Query: 104 VVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           +V       D  E  + + ME   GG +  +L+ +G  +E+  R    Q+++ + Y H  
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFG----LATYIEPGQSLLGTVGSPFYIAPEVLA 217
            +VHRD+K  NIL   + S+  +KL DFG    L T    G  +    G+P++++PEV++
Sbjct: 126 MIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 218 G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSR--IFD-AVRTADLRFPSNPWDHISDS 273
           G GY + ADVWS G  +  +L+  PP W   ++   IF  A +  + + PS    HIS+ 
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEAMAAIFKIATQPTNPQLPS----HISEH 237

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDH 298
           A+D + G +  +   R +A ++L H
Sbjct: 238 ARDFL-GCIFVEARHRPSAEELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  112 bits (281), Expect = 4e-28
 Identities = 68/253 (26%), Positives = 127/253 (50%), Gaps = 10/253 (3%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F + +++G GQF  +   +    G   A K +    L+          EI+++ +L+ HP
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 62

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYC 158
           NV+   A + +++ +++V+EL   G+L   ++ F +      E      F+QL   + + 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPE-VL 216
           H   V+HRD+KP N+ +    ++  +KL D GL  +     +   + VG+P+Y++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 217 AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
             GYN  +D+WS G +LY + +   PF+G+  +      +     +P  P DH S+  + 
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239

Query: 277 LVMGMLSTDPSQR 289
           LV   ++ DP +R
Sbjct: 240 LVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  112 bits (281), Expect = 5e-28
 Identities = 73/252 (28%), Positives = 128/252 (50%), Gaps = 12/252 (4%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-VVDL 107
           LG G FG +  C  + TG+++ACK + K RL          +E  I+ ++  H   +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRL----EKFGRFSEAEARVLFMQLMQVVLYCHEIGV 163
              ++ +  + LVM +  GG+L + +    E+   F E  A     Q++  + + H+  +
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-LLGTVGSPFYIAPEVLAG-GYN 221
           ++RDLKPEN+LL    +   ++++D GLA  ++ GQS   G  G+P ++APE+L G  Y+
Sbjct: 119 IYRDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 222 QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
            + D ++ GV LY +++   PF    +      ++   L       D  S ++K     +
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 282 LSTDPSQRLTAR 293
           L+ DP +RL  R
Sbjct: 236 LAKDPEKRLGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  112 bits (282), Expect = 6e-28
 Identities = 81/268 (30%), Positives = 126/268 (47%), Gaps = 19/268 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E FV   ++G G FG +   ++  T EV A K ++     T +  + +  E++ + +L  
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK- 79

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAG--GELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
           HPN ++ K  Y  E    LVME C G   +L    +K     E E   +    +Q + Y 
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYL 137

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL-- 216
           H   ++HRD+K  NILL        +KLADFG A+   P  S +GT   P+++APEV+  
Sbjct: 138 HSHNMIHRDIKAGNILLTEPGQ---VKLADFGSASKSSPANSFVGT---PYWMAPEVILA 191

Query: 217 --AGGYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDS 273
              G Y+   DVWS G+    L    PP +  N  S ++   +       SN W   +DS
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDS 248

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            +  V   L   P +R  + ++L H ++
Sbjct: 249 FRGFVDYCLQKIPQERPASAELLRHDFV 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  113 bits (283), Expect = 1e-27
 Identities = 89/259 (34%), Positives = 134/259 (51%), Gaps = 33/259 (12%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +++   K + +V+A K ++K  ++   D      E +IM   +  P VV L 
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLF 109

Query: 109 AVYEDEDYVHLVMELCAGGELFHRL------EKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
             ++D+ Y+++VME   GG+L + +      EK+ +F  AE  VL +  +      H +G
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV-VLALDAI------HSMG 162

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT-VGSPFYIAPEVLA--- 217
           ++HRD+KP+N+LL        +KLADFG    + E G     T VG+P YI+PEVL    
Sbjct: 163 LIHRDVKPDNMLLDKHGH---LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 218 --GGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFDAVRTADLRFPSNPWDHIS 271
             G Y +  D WS GV L+ +L G  PF+ +    T S+I D      L FP +    IS
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD--HKNSLNFPEDV--EIS 275

Query: 272 DSAKDLVMGMLSTDPSQRL 290
             AK+L+   L TD   RL
Sbjct: 276 KHAKNLICAFL-TDREVRL 293

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 1e-27
 Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 28/269 (10%)

Query: 48  QLGWGQFGVIR--VCSDKFTGEVF-ACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPN 103
           +LG G FG +       K       A K++ +D     ++ER   L E  +M +L GHPN
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED---ASEEERKDFLKEARVMKKL-GHPN 57

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEK--FGRFSEAEARVLFMQLMQVVL----- 156
           VV L  V  +E+ ++LV+E   GG+L   L K      S  ++ +    L+   +     
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 157 --YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI--- 211
             Y      VHRDL   N L+        +K++DFGL+  +          G    I   
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 212 APEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
           APE L  G +   +DVWS GV+L+ + + G  P+ G +   + + +R    R    P ++
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYR-LPKP-EY 231

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
             D   +L++     DP  R T  ++++ 
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  111 bits (279), Expect = 1e-27
 Identities = 79/259 (30%), Positives = 121/259 (46%), Gaps = 19/259 (7%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G FG +    D  T EV A K ++     + +  + +  E++ + R+  HPN ++
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIE 89

Query: 107 LKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            K  Y  E    LVME C G   +L    +K     E E   +    +Q + Y H   ++
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL----AGGY 220
           HRD+K  NILL        +KLADFG A+   P  S +GT   P+++APEV+     G Y
Sbjct: 148 HRDIKAGNILLTEPGQ---VKLADFGSASIASPANSFVGT---PYWMAPEVILAMDEGQY 201

Query: 221 NQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +   DVWS G+    L    PP +  N  S ++   +       SN W   SD  ++ V 
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNFVD 258

Query: 280 GMLSTDPSQRLTARQVLDH 298
             L   P  R T+ ++L H
Sbjct: 259 SCLQKIPQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  110 bits (276), Expect = 2e-27
 Identities = 71/220 (32%), Positives = 112/220 (50%), Gaps = 29/220 (13%)

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLF 148
           EI I++ L  HPN++     + D++ + + ME   GG L+ ++  +K   F E       
Sbjct: 49  EIVILSLLQ-HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL 107

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA----TYIEPGQSLLGT 204
            Q++  V Y H+ G++HRD+K  NI L TKA    IKL DFG++    +     ++++GT
Sbjct: 108 FQIVSAVSYIHKAGILHRDIKTLNIFL-TKAGL--IKLGDFGISKILGSEYSMAETVVGT 164

Query: 205 VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL--R 261
              P+Y++PE+  G  YN  +D+W+ G +LY LL         T  R FDA    +L  +
Sbjct: 165 ---PYYMSPELCQGVKYNFKSDIWALGCVLYELL---------TLKRTFDATNPLNLVVK 212

Query: 262 FPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLD 297
                +  +    S     LV  +L  DP +R TA +VLD
Sbjct: 213 IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  110 bits (277), Expect = 2e-27
 Identities = 73/278 (26%), Positives = 136/278 (48%), Gaps = 25/278 (8%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIA-KDRLVTIDDER------SVKLEIEI 94
           ++V G+ +G G +G + +  +  TGE+ A K +     +    D R      +++ EIE 
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           +  L  H N+V        E+Y+ + +E   GG +   L  +GRF E   R    Q+++ 
Sbjct: 62  LKDLD-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY---IEPGQSLLGTVGSPFYI 211
           + Y H  G++HRDLK +N+L+         K++DFG++     I      +   GS F++
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGIC---KISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 212 APEVL---AGGYNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADLRFP 263
           APEV+   + GY+   D+WS G ++  + +G  P W + ++     ++ +      +  P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPI--P 234

Query: 264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            +   ++S  A D +    + +P  R TAR++L H ++
Sbjct: 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  110 bits (277), Expect = 2e-27
 Identities = 88/281 (31%), Positives = 134/281 (47%), Gaps = 32/281 (11%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E+ V   +LG G  G +  C  K TG +FA K+I  D     D ++ +  E+EI  +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEIN-KSCK 57

Query: 101 HPNVVDLKAVYEDE--DYVHLVMELCAGGEL---FHR-LEKFGRFSEAEARVLFMQLMQV 154
            P +V     + DE    + + ME C GG L   + +  ++ GR  E   +VL  ++ + 
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE---KVL-GKIAES 113

Query: 155 VL----YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPF 209
           VL    Y H   ++HRD+KP NILL  K     +KL DFG++   E   SL GT  G+ F
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSG--ELVNSLAGTFTGTSF 168

Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFD------AVRTADLRF 262
           Y+APE + G  Y+  +DVWS G+ L  +     PF    +  +         V   +   
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228

Query: 263 PSNPWDHI--SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              P + I  S+  KD +   L  DP++R T   +L+H W+
Sbjct: 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  108 bits (272), Expect = 4e-27
 Identities = 75/260 (28%), Positives = 132/260 (50%), Gaps = 13/260 (5%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           R+ + +++G G FG I +   K   E    K I   ++   + E S K E+ ++ ++  H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK-EVILLAKMK-H 58

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQVVLYCH 159
           PN+V   A +++   + +VME C GG+L  R+  ++   FSE +    F+Q+   + + H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG 218
           +  ++HRD+K +NI L+     +  KL DFG+A  +     L  T VG+P+Y++PE+   
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 219 G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF-PSNPWDHISDSAKD 276
             YN   D+WS G +LY L +   PF GN   ++   ++     F P +P  + S   + 
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQGYFAPISP--NFSRDLRS 232

Query: 277 LVMGMLSTDPSQRLTARQVL 296
           L+  +    P  R +   +L
Sbjct: 233 LISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  110 bits (276), Expect = 5e-27
 Identities = 69/254 (27%), Positives = 128/254 (50%), Gaps = 16/254 (6%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +  + +   K   +++A K + K+ +   +D   V+ E  +  + S +P +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
           + ++    + LV+E   GG+L   +++  +  E  AR    ++   + + HE G+++RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADV 226
           K +N+LL        IKL D+G+    + PG +     G+P YIAPE+L G  Y  + D 
Sbjct: 123 KLDNVLLDADGH---IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 227 WSAGVILYILLSGMPPF-------WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           W+ GV+++ +++G  PF         NT+  +F  +    +R P      +S  A  ++ 
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF----LSVKASHVLK 235

Query: 280 GMLSTDPSQRLTAR 293
           G L+ DP +RL  +
Sbjct: 236 GFLNKDPKERLGCQ 249

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  109 bits (273), Expect = 7e-27
 Identities = 76/265 (28%), Positives = 133/265 (50%), Gaps = 19/265 (7%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEIMTR 97
           R       ++G G  G++ + +DK TG   A K     ++     +R   L  E+ IM R
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK-----KMDLRKQQRRELLFNEVVIM-R 71

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
              HPN+V++ + Y   D + +VME   GG L   +    R +E +   + + +++ + +
Sbjct: 72  DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSF 130

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE---PGQSLLGTVGSPFYIAPE 214
            H  GV+HRD+K ++ILL    S   +KL+DFG    +    P +  L  VG+P+++APE
Sbjct: 131 LHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPE 185

Query: 215 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V++   Y    D+WS G+++  ++ G PP++     +    +R        N    +S  
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSPR 244

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDH 298
            +  +  ML  DP+QR TA ++L+H
Sbjct: 245 LRSFLDRMLVRDPAQRATAAELLNH 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  109 bits (274), Expect = 1e-26
 Identities = 88/316 (27%), Positives = 144/316 (45%), Gaps = 60/316 (18%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK---LEIE 93
            +L  R++  + LG G  G++    D         K +A  ++V + D +SVK    EI+
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSD-----CDKRVAVKKIV-LTDPQSVKHALREIK 54

Query: 94  IMTRL--------------SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRF 139
           I+ RL              SG     D+ ++ E  + V++V E     +L + LE+ G  
Sbjct: 55  IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE-LNSVYIVQE-YMETDLANVLEQ-GPL 111

Query: 140 SEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ 199
           SE  AR+   QL++ + Y H   V+HRDLKP N+ + T+     +K+ DFGLA  ++P  
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE--DLVLKIGDFGLARIVDPHY 169

Query: 200 SLLG----TVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTK----S 249
           S  G     + + +Y +P +L     Y +A D+W+AG I   +L+G P F G  +     
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229

Query: 250 RIFDAV---RTADLR-----FPSNPWDH--------------ISDSAKDLVMGMLSTDPS 287
            I ++V   R  D        PS   +               ++  A D +  +L+ +P 
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289

Query: 288 QRLTARQVLDHSWMGD 303
            RLTA + L H +M  
Sbjct: 290 DRLTAEEALMHPYMSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  108 bits (272), Expect = 1e-26
 Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 19/262 (7%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G FG +    D    EV A K ++     + +  + +  E+  + +L  HPN + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79

Query: 107 LKAVYEDEDYVHLVMELCAG--GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            +  Y  E    LVME C G   +L    +K     E E   +    +Q + Y H   ++
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL----AGGY 220
           HRD+K  NILL+       +KL DFG A+ + P    +GT   P+++APEV+     G Y
Sbjct: 138 HRDVKAGNILLSEPGL---VKLGDFGSASIMAPANXFVGT---PYWMAPEVILAMDEGQY 191

Query: 221 NQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +   DVWS G+    L    PP +  N  S ++   +       S  W   S+  ++ V 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVD 248

Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
             L   P  R T+  +L H ++
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 1e-26
 Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 21/255 (8%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-VVDL 107
           +G G FG + V   K TG+V+A K + K  ++   +    + E +++  ++G    + +L
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL--VNGDRRWITNL 66

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
              ++DE+ ++LVM+   GG+L   L KF  R  E  AR    +++  +   H++G VHR
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPG---QSLLGTVGSPFYIAPEVL------A 217
           D+KP+N+LL        I+LADFG    +      QS +  VG+P YI+PE+L       
Sbjct: 127 DIKPDNVLLDKNGH---IRLADFGSCLRLLADGTVQSNVA-VGTPDYISPEILQAMEDGK 182

Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD--LRFPSNPWDHISDSAK 275
           G Y    D WS GV +Y +L G  PF+  +    +  +       +FP +  D +S+ AK
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD-VSEEAK 241

Query: 276 DLVMGMLSTDPSQRL 290
           DL+  ++ + P  RL
Sbjct: 242 DLIRRLICS-PETRL 255

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  108 bits (270), Expect = 2e-26
 Identities = 84/271 (30%), Positives = 133/271 (49%), Gaps = 28/271 (10%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH---PNVV 105
           +G G FG +  C    TG+++A K + K R+     E ++ L   IM  L      P +V
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLALNERIMLSLVSTGDCPFIV 60

Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
            +   +   D +  +++L  GG+L + L + G FSEAE R    +++  + + H   VV+
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 166 RDLKPENILLATKASSSPIKLADFGLA---TYIEPGQSLLGTVGSPFYIAPEVLAGG--Y 220
           RDLKP NILL        ++++D GLA   +  +P  S    VG+  Y+APEVL  G  Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAY 173

Query: 221 NQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
           + +AD +S G +L+ LL G  PF  +    K  I     T  +  P    D  S   + L
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSL 229

Query: 278 VMGMLSTDPSQRL-----TARQVLDHSWMGD 303
           + G+L  D ++RL      A++V +H +   
Sbjct: 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  108 bits (272), Expect = 2e-26
 Identities = 73/253 (28%), Positives = 129/253 (50%), Gaps = 18/253 (7%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +  + +   K T  ++A K I K+ +   +D   V+ E  +    S HP +V L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
           + ++ E  +  V+E  +GG+L   +++  +  E  AR    ++   + + HE G+++RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADV 226
           K +N+LL    +   IKL D+G+    I PG +     G+P YIAPE+L G  Y  + D 
Sbjct: 123 KLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 227 WSAGVILYILLSGMPPF---------WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
           W+ GV+++ +++G  PF           NT+  +F  +    +R P +    +S  A  +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKASSV 235

Query: 278 VMGMLSTDPSQRL 290
           + G L+ DP +RL
Sbjct: 236 LKGFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (267), Expect = 3e-26
 Identities = 77/263 (29%), Positives = 134/263 (50%), Gaps = 16/263 (6%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK--LEIEIMTRLS 99
           R++L Q+LG G FG + +  DK        K + +  +  ++   +V+   E +++++L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVV 155
            HP +V   A + + D   ++ E C G +L  +LE+        SE +    F+QL+  V
Sbjct: 61  -HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPE 214
            Y H+  ++HRDLK +NI L     ++ +K+ DFG++  +     L  T  G+P+Y++PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175

Query: 215 VLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
            L   GY+  +D+WS G ILY +      F G     +   +R  +   PS P +  S  
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--VLRIVEGPTPSLP-ETYSRQ 232

Query: 274 AKDLVMGMLSTDPSQRLTARQVL 296
              ++  ML+ DPS R +A ++L
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  107 bits (269), Expect = 5e-26
 Identities = 76/256 (29%), Positives = 131/256 (51%), Gaps = 18/256 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + F + + +G G FG + V   K T  ++A K + K  ++   +    + E  ++  ++G
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL--VNG 58

Query: 101 HPN-VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYC 158
               +  L   ++DE+Y++LVM+   GG+L   L KF  R  E  AR    +++  +   
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEVL 216
           H++  VHRD+KP+N+LL        I+LADFG    +    ++  +  VG+P YI+PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 217 A------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR--FPSNPWD 268
                  G Y    D WS GV +Y +L G  PF+  +    +  +   + R  FPS+  D
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235

Query: 269 HISDSAKDLVMGMLST 284
            +S+ AKDL+  ++ +
Sbjct: 236 -VSEEAKDLIQRLICS 250

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  105 bits (264), Expect = 6e-26
 Identities = 66/253 (26%), Positives = 127/253 (50%), Gaps = 10/253 (3%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F + +++G GQF  +   +     +  A K +    ++     +    EI+++ +L+ HP
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HP 62

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYC 158
           NV+     + +++ +++V+EL   G+L   ++ F +      E      F+QL   V + 
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPE-VL 216
           H   V+HRD+KP N+ +    ++  +KL D GL  +     +   + VG+P+Y++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 217 AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
             GYN  +D+WS G +LY + +   PF+G+  +      +     +P  P +H S+  ++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239

Query: 277 LVMGMLSTDPSQR 289
           LV   +  DP QR
Sbjct: 240 LVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  105 bits (263), Expect = 9e-26
 Identities = 81/272 (29%), Positives = 129/272 (47%), Gaps = 19/272 (6%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           N +  + L Q++G G +G +    +  TGE+ A K I   +L   DD   ++ EI  M +
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEI-FMVK 61

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
              H N+V     Y   + + + ME C GG L       G  SE +   +  + +Q + Y
Sbjct: 62  ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
            H  G +HRD+K  NILL        +KLADFG+A  I    +   + +G+P+++APEV 
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178

Query: 217 A----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP----SNPWD 268
           A    GGYNQ  D+W+ G+    L    PP +     R    +  ++ + P       W 
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW- 237

Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
             S +  + V   L+ +P +R TA ++L H +
Sbjct: 238 --SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 9e-26
 Identities = 80/266 (30%), Positives = 128/266 (48%), Gaps = 22/266 (8%)

Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGHPN 103
           LG+ LG G FG + +C D  TG   A K +  D       +    LE EI + +   H  
Sbjct: 6   LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65

Query: 104 VVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           +V       D  E  + + +E   GG +  +L+ +G  +E   R    Q++Q V Y H  
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIE----PGQSLLGTVGSPFYIAPEVLA 217
            +VHRD+K  NIL   + S+  +KL DFG +  I+     G  +    G+P++++PEV++
Sbjct: 126 MIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 218 G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSR--IFDAVRTADLRFPSNPW--DHISD 272
           G GY + ADVWS    +  +L+  PP W   ++   IF          P+ P   D +SD
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP-WAEYEAMAAIFKIATQ-----PTKPMLPDGVSD 236

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDH 298
           + +D  +  +  +  +R TA  +L H
Sbjct: 237 ACRDF-LKQIFVEEKRRPTAEFLLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  105 bits (264), Expect = 1e-25
 Identities = 76/268 (28%), Positives = 131/268 (48%), Gaps = 11/268 (4%)

Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           I + ++++   +++G G  G +    D  TG+  A K I    L     +  +  EI +M
Sbjct: 14  IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVM 70

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
             L  +PN+V+    +   D + +VME  AGG L   + +     EA+   +  + +Q +
Sbjct: 71  KELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQAL 128

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPE 214
            + H   V+HRD+K +N+LL    S   +KL DFG    I P QS   T VG+P+++APE
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 215 VLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+    Y    D+WS G++   ++ G PP+      R    + T       NP + +S  
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPI 244

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            +D +   L  D  +R +A+++L H ++
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  106 bits (267), Expect = 1e-25
 Identities = 87/305 (28%), Positives = 136/305 (44%), Gaps = 52/305 (17%)

Query: 39  LRERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           +  R+   + +G G +GV  VCS  D  +G+  A K I     V    +R+++ E++I+ 
Sbjct: 3   VGSRYKPIENIGSGAYGV--VCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKIL- 58

Query: 97  RLSGHPNVVDLKAVY----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           R   H N++ ++ +      D   V++VM+L    +L H +      +E   R    QL+
Sbjct: 59  RHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYFLYQLL 117

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-----TYIEPGQSLLGTVGS 207
           + + Y H   V+HRDLKP N+L+        +++ DFG+A     +  E    +   V +
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCE---LRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 208 PFYIAPEVL--AGGYNQAADVWSAGVI-------------------LYILLS--GMPPFW 244
            +Y APE+L     Y  A D+WS G I                   L ++LS  G P   
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-- 232

Query: 245 GNTKSRI-FDAVRTADLRFPSN---PWDHI----SDSAKDLVMGMLSTDPSQRLTARQVL 296
               +RI  D VR      P     PW  I    S  A DL+  ML  DP +R+T  Q L
Sbjct: 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292

Query: 297 DHSWM 301
            H ++
Sbjct: 293 QHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  106 bits (266), Expect = 3e-25
 Identities = 89/297 (29%), Positives = 126/297 (42%), Gaps = 54/297 (18%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           FV  + LG G FG + +     T  ++A K++ K  ++  +    VK E +I+   + + 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNE 61

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            VV L   ++D+D ++ VM+   GG++   L + G F E  AR    +L   V   H++G
Sbjct: 62  WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG 121

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLAT---------YIEPGQSLL----------- 202
            +HRD+KP+NIL+        IKL DFGL T         Y + G  +            
Sbjct: 122 FIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 203 ----------------------------GTVGSPFYIAPEV-LAGGYNQAADVWSAGVIL 233
                                         VG+P YIAPEV L  GY Q  D WS GVIL
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 234 YILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
           Y +L G PPF   T       V          P   +S  A DL++  L   P  RL
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLII-KLCRGPEDRL 294

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  104 bits (260), Expect = 4e-25
 Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 41/290 (14%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTRLSGHPN 103
           +++G G +GV+    D+ T E  A K I  ++    +DE    +   EI ++  +  H N
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQ----EDEGVPSTAIREISLLKEMQ-HGN 62

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE--ARVLFMQLMQVVLYCHEI 161
           +V L+ V   E  ++LV E     +L   ++    F++     +    Q+++ + YCH  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
            V+HRDLKP+N+L+  + ++  +KLADFGLA  +  P ++    V + +Y APE+L G  
Sbjct: 122 RVLHRDLKPQNLLIDRRTNA--LKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179

Query: 220 -YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLR------------- 261
            Y+   D+WS G I   +++  P F G+++     +IF  + T +               
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239

Query: 262 -FPSNPWDHI-------SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            FP  P   +         +  DL+  ML  DPS+R+TAR  L+H +  D
Sbjct: 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289

Length = 294

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 5e-25
 Identities = 85/306 (27%), Positives = 136/306 (44%), Gaps = 54/306 (17%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIA--KDRLVTIDDERSVKLEIE 93
           ++  R+     +G G +G+  VCS   K TG   A K I+  + +       R    EI+
Sbjct: 2   DVGPRYQNLSYIGEGAYGM--VCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIK 55

Query: 94  IMTRLSGHPNVVDLKAVYEDEDY-----VHLVMELCAGGELFHRLEKFGRFSEAEARVLF 148
           I+ R   H N++ +  +     +     V++V EL       ++L K    S    +   
Sbjct: 56  ILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHLSNDHIQYFL 112

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP----GQSLLGT 204
            Q+++ + Y H   V+HRDLKP N+LL T      +K+ DFGLA   +P       L   
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLTEY 169

Query: 205 VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAVRT- 257
           V + +Y APE++  + GY +A D+WS G IL  +LS  P F G    +  + I   + T 
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229

Query: 258 --ADLR----------------FPSNPWD----HISDSAKDLVMGMLSTDPSQRLTARQV 295
              DL                  P  PW+    +    A DL+  ML+ +P +R+T  + 
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289

Query: 296 LDHSWM 301
           L H ++
Sbjct: 290 LAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  103 bits (259), Expect = 5e-25
 Identities = 75/260 (28%), Positives = 131/260 (50%), Gaps = 19/260 (7%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           ++G G  G++ + ++K TG+  A K +   +       R +     ++ R   H NVVD+
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDM 84

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
              Y   D + +VME   GG L   +    R +E +   + + +++ + Y H  GV+HRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 168 LKPENILLATKASSSPIKLADFGLATYIE---PGQSLLGTVGSPFYIAPEVLAG-GYNQA 223
           +K ++ILL    S   IKL+DFG    +    P +  L  VG+P+++APEV++   Y   
Sbjct: 144 IKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPEVISRLPYGTE 198

Query: 224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD--HISDSAKDLVMGM 281
            D+WS G+++  ++ G PP++         A+R      P    D   +S   +  +  M
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255

Query: 282 LSTDPSQRLTARQVLDHSWM 301
           L  +PSQR TA+++L H ++
Sbjct: 256 LVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  103 bits (258), Expect = 6e-25
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 22/265 (8%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH---PNVV 105
           +G G FG +  C    TG+++A K + K R + +    ++ L   IM  L      P +V
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
            +   +   D +  +++L  GG+L + L + G FSE E R    +++  + + H   VV+
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQA 223
           RDLKP NILL        ++++D GLA      +    +VG+  Y+APEVL  G  Y+ +
Sbjct: 121 RDLKPANILLDEHGH---VRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGTAYDSS 176

Query: 224 ADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           AD +S G +L+ LL G  PF  +    K  I     T ++  P    D  S   K L+ G
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP----DSFSPELKSLLEG 232

Query: 281 MLSTDPSQRL-----TARQVLDHSW 300
           +L  D S+RL      A++V +H +
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  103 bits (260), Expect = 7e-25
 Identities = 77/305 (25%), Positives = 122/305 (40%), Gaps = 64/305 (20%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERSVKLEIEIMTRLSGHPN 103
            ++G G FG +     K T ++ A K +  +       I   R    EI+I+  L  H N
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLK-HEN 72

Query: 104 VVDLKAV--------YEDEDYVHLVMELCAGGELFHRL-----EKFGRFSEAEARVLFMQ 150
           VV+L  +           +   +LV E C      H L      K  +F+ +E + +   
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCE-----HDLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-----TYIEPGQSLLGTV 205
           L+  + Y H   ++HRD+K  NIL+ TK     +KLADFGLA     +           V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILI-TKDGI--LKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 206 GSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK--------------- 248
            + +Y  PE+L G   Y    D+W AG I+  + +  P   GNT+               
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244

Query: 249 SRIFDAVRTADL----RFPSNPWDHI---------SDSAKDLVMGMLSTDPSQRLTARQV 295
             ++  V   +L      P      +            A DL+  +L  DP++R+ A   
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304

Query: 296 LDHSW 300
           L+H +
Sbjct: 305 LNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  104 bits (260), Expect = 9e-25
 Identities = 85/282 (30%), Positives = 139/282 (49%), Gaps = 29/282 (10%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F + + +G G FG + V   K   +VFA K + K  ++   +    + E +++     
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GD 59

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCH 159
           +  +  L   ++DE+ ++LVM+   GG+L   L KF  R  E  AR    +++  +   H
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFG-LATYIEPG--QSLLGTVGSPFYIAPEVL 216
           ++  VHRD+KP+NIL+        I+LADFG     +E G  QS +  VG+P YI+PE+L
Sbjct: 120 QLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEIL 175

Query: 217 ------AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR--FPSNPWD 268
                  G Y    D WS GV +Y +L G  PF+  +    +  +     R  FP+   D
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235

Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
            +S+ AKDL+         +RL   +  +H    +GI+D ++
Sbjct: 236 -VSEDAKDLI---------RRLICSR--EHRLGQNGIEDFKQ 265

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  103 bits (258), Expect = 9e-25
 Identities = 73/282 (25%), Positives = 142/282 (50%), Gaps = 18/282 (6%)

Query: 24  RSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID 83
           ++    ++D     +L E ++   ++G G  G++ +  +K +G   A K +   +     
Sbjct: 7   KAALRMVVDQGDPRSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----Q 59

Query: 84  DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE 143
             R +     ++ R   H NVV++   Y   + + ++ME   GG L   + +  R +E +
Sbjct: 60  QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQ 118

Query: 144 ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE---PGQS 200
              +   ++Q + Y H  GV+HRD+K ++ILL        +KL+DFG    I    P + 
Sbjct: 119 IATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPKRK 175

Query: 201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD 259
            L  VG+P+++APEV++   Y    D+WS G+++  ++ G PP++ ++  +    +R + 
Sbjct: 176 SL--VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP 233

Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                N    IS   +D +  ML+ +P +R TA+++LDH ++
Sbjct: 234 PPKLKN-AHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (258), Expect = 9e-25
 Identities = 76/271 (28%), Positives = 132/271 (48%), Gaps = 17/271 (6%)

Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL---EI 92
           + + ++++   +++G G  G +    D  TG+  A K +       +  +   +L   EI
Sbjct: 14  VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM------NLQQQPKKELIINEI 67

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
            +M R + HPN+V+    Y   D + +VME  AGG L   + +     E +   +  + +
Sbjct: 68  LVM-RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 125

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYI 211
           Q + + H   V+HRD+K +NILL    S   +KL DFG    I P QS   T VG+P+++
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 212 APEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           APEV+    Y    D+WS G++   ++ G PP+      R    + T       NP + +
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKL 241

Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           S   +D +   L  D  +R +A+++L H ++
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)

Query: 62  DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY-EDEDY-VHL 119
           +   G+ +A K    D+       +S   EI ++  L  H NVV L  V+ E  D  V+L
Sbjct: 23  NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSVYL 81

Query: 120 VMELCAGGEL----FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL 175
           + +           FHR  K      +  + L  Q++  V Y H   V+HRDLKP NIL+
Sbjct: 82  LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV 141

Query: 176 ATKASSS-PIKLADFGLA-TYIEPGQSLL---GTVGSPFYIAPEVLAGG--YNQAADVWS 228
             +      +K+ D GLA  +  P + L      V + +Y APE+L G   Y +A D+W+
Sbjct: 142 MGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201

Query: 229 AGVILYILLSGMPPFWG----NTKS---------RIFDAVRTAD---------------- 259
            G I   LL+  P F G      KS         RIF+ + T                  
Sbjct: 202 IGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL 261

Query: 260 ------LRFPSN---PWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                   +PSN    W            DL+  +L  DP++R+TA + L+H +
Sbjct: 262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  103 bits (259), Expect = 1e-24
 Identities = 88/293 (30%), Positives = 131/293 (44%), Gaps = 51/293 (17%)

Query: 49  LGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +G G +G+  VCS  +  T E  A K IA      ID +R+++ EI+++ R   H NV+ 
Sbjct: 13  IGRGAYGI--VCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLL-RHLDHENVIA 68

Query: 107 LKAV--------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
           +K +        + D   V++V EL    +L   +      S+   +    QL++ + Y 
Sbjct: 69  IKDIMPPPHREAFND---VYIVYEL-MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVL- 216
           H   V+HRDLKP N+LL        +K+ DFGLA T  E G  +   V + +Y APE+L 
Sbjct: 125 HSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 217 -AGGYNQAADVWSAGVILYILLSGMPPFWG-------NTKSRIFDAVRTADLRFPSNP-- 266
               Y  A DVWS G I   LL   P F G          + +  +    DL F  N   
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241

Query: 267 ------------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                             + H +  A DL+  ML  DPS+R+T  + L H ++
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  102 bits (254), Expect = 3e-24
 Identities = 75/268 (27%), Positives = 131/268 (48%), Gaps = 11/268 (4%)

Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           + + ++++   +++G G  G +    D  TG+  A K +    L     +  +  EI +M
Sbjct: 14  VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVM 70

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
            R + +PN+V+    Y   D + +VME  AGG L   + +     E +   +  + +Q +
Sbjct: 71  -RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQAL 128

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPE 214
            + H   V+HRD+K +NILL    S   +KL DFG    I P QS   T VG+P+++APE
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 215 VLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+    Y    D+WS G++   ++ G PP+      R    + T       NP + +S  
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAV 244

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            +D +   L  D  +R +A+++L H ++
Sbjct: 245 FRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  103 bits (258), Expect = 3e-24
 Identities = 78/256 (30%), Positives = 115/256 (44%), Gaps = 53/256 (20%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           FV  + LG G FG + +     T  ++A K++ K  ++  +    VK E +I+   + + 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNE 61

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            VV L   ++D+D ++ VM+   GG++   L +   F E  AR    +L   +   H++G
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLAT---------YIEPGQSL------------ 201
            +HRD+KP+NIL+        IKL DFGL T         Y + G  +            
Sbjct: 122 FIHRDIKPDNILIDLDGH---IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 202 ----------LGT-----------------VGSPFYIAPEV-LAGGYNQAADVWSAGVIL 233
                     L T                 VG+P YIAPEV L  GY Q  D WS GVIL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 234 YILLSGMPPFWGNTKS 249
           + +L G PPF   T +
Sbjct: 239 FEMLVGQPPFLAPTPT 254

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (252), Expect = 3e-24
 Identities = 76/269 (28%), Positives = 131/269 (48%), Gaps = 33/269 (12%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--RSVKLEIEIMTRLSGHPNVV 105
           +LG G  GV+     + TG++ A K+I     + I++   + +  E++I+ +    P +V
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTI----RLEINEAIQKQILRELDILHK-CNSPYIV 62

Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYCHE 160
                + +   + + ME   GG L    +K      GR  E     + + +++ + Y HE
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSL----DKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 161 -IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG 218
              ++HRD+KP NIL+ ++     IKL DFG++  +    SL  T VG+  Y+APE + G
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV--NSLAKTFVGTSSYMAPERIQG 173

Query: 219 G-YNQAADVWSAGVILYILLSG-MP-PFWGNTKSRIFD----AVRTADLRFPSNPWDHIS 271
             Y+  +D+WS G+ L  L +G  P P   +    IF+     V     R PS  +   S
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF---S 230

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
              +D V   L  DP +R + +++L+H +
Sbjct: 231 PDFQDFVNLCLIKDPRERPSYKELLEHPF 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  101 bits (252), Expect = 6e-24
 Identities = 76/265 (28%), Positives = 131/265 (49%), Gaps = 22/265 (8%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    +K TG + A K I       ++D     +EIEI+   + HP +V L
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YMVEIEILATCN-HPYIVKL 74

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
              +  +  + +++E C GG +   + +  R  +E + +V+  Q+++ + Y H + ++HR
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134

Query: 167 DLKPENILLATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFYIAPEVLA------GG 219
           DLK  N+LL        IKLADFG+ A  ++  Q     +G+P+++APEV+         
Sbjct: 135 DLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD---LRFPSNPWDHISDSAKD 276
           Y+  AD+WS G+ L  +    PP       R+   +  ++   L  PS  W   S   +D
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-W---SMEFRD 247

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
            +   L   P  R +A Q+L+H ++
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  105 bits (262), Expect = 6e-24
 Identities = 85/292 (29%), Positives = 139/292 (47%), Gaps = 36/292 (12%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S L E  V+ +++G G+FG + +   K T E F  K+I+   L   +  + V +E+ +M 
Sbjct: 10  SRLNEYEVI-KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMR 67

Query: 97  RLSGHPNVVDL--KAVYEDEDYVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQ 150
            L  H N+V    + + +    ++++ME C  G+L   ++K    FG+  E     +  Q
Sbjct: 68  ELK-HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126

Query: 151 LMQVVLYCHEIG-------VVHRDLKPENILLAT-------------KASSSPI-KLADF 189
           L+  + YCH +        V+HRDLKP+NI L+T               +  PI K+ DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186

Query: 190 GLATYIEPGQSLLGTVGSPFYIAPEVL---AGGYNQAADVWSAGVILYILLSGMPPFWGN 246
           GL+  I         VG+P+Y +PE+L      Y+  +D+W+ G I+Y L SG  PF   
Sbjct: 187 GLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--- 243

Query: 247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
            K+  F  + +   R P  P    S     L+  +L+    +R +A Q L +
Sbjct: 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295

Length = 1021

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 65/258 (25%), Positives = 121/258 (46%), Gaps = 12/258 (4%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F +  ++G G FGV+     K    V+A K I   ++   + E ++  E  ++ +L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLD-SS 59

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHE 160
            ++     + D+  +++VME    G+L   L+        E +    F+Q++  + + H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAGG 219
             ++HRD+K  N+ L    +   +K+ D G+A  +    +   T VG+P+Y++PE+    
Sbjct: 120 KKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 220 -YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            YN+ +DVW+ GV+LY   +G  PF  N +  +   ++     FP     +    A  L+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALI--LKIIRGVFPPVSQMYSQQLA-QLI 233

Query: 279 MGMLSTDPSQRLTARQVL 296
              L+ D  QR    Q+L
Sbjct: 234 DQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  100 bits (249), Expect = 1e-23
 Identities = 73/268 (27%), Positives = 130/268 (48%), Gaps = 11/268 (4%)

Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           + + ++++   +++G G  G +    D  TG+  A + +    L     +  +  EI +M
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM 71

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
            R + +PN+V+    Y   D + +VME  AGG L   + +     E +   +  + +Q +
Sbjct: 72  -RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQAL 129

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG-TVGSPFYIAPE 214
            + H   V+HRD+K +NILL    S   +KL DFG    I P QS     VG+P+++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 215 VLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+    Y    D+WS G++   ++ G PP+      R    + T       NP + +S  
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAI 245

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            +D +   L  D  +R +A+++L H ++
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  100 bits (251), Expect = 2e-23
 Identities = 79/303 (26%), Positives = 138/303 (45%), Gaps = 51/303 (16%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFT----GEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           R+ L ++LG G +G+  VCS +       E  A K I       I  +R+++ E++++  
Sbjct: 1   RYELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRH 57

Query: 98  LSGHPNVV---DLKAVYEDE-DYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLM 152
             GH N+    D+  V+    + ++L  EL       H++ + G   ++A  +    Q++
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQIL 115

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-----LLGTVGS 207
             + Y H   V+HRDLKP N+L+    +   +K+ DFGLA             +   V +
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 208 PFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAVRTAD-- 259
            +Y APE++     Y +A DVWS G IL  LL   P F G    +  ++I   + T D  
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232

Query: 260 --LRFPS-NPWDHI------------------SDSAKDLVMGMLSTDPSQRLTARQVLDH 298
              R  S    ++I                  +  A DL+  +L+ DP++R++  + L+H
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292

Query: 299 SWM 301
            ++
Sbjct: 293 PYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 81/265 (30%), Positives = 127/265 (47%), Gaps = 22/265 (8%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    +K TG + A K I       ++D     +EI+I+     HPN+V L
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED---YMVEIDILASCD-HPNIVKL 67

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
              +  E+ + +++E CAGG +   + +  R  +E + RV+  Q ++ + Y HE  ++HR
Sbjct: 68  LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127

Query: 167 DLKPENILLATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFYIAPEVLA------GG 219
           DLK  NIL         IKLADFG+ A      Q     +G+P+++APEV+         
Sbjct: 128 DLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD---LRFPSNPWDHISDSAKD 276
           Y+  ADVWS G+ L  +    PP       R+   +  ++   L  PS  W   S   KD
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR-W---SSEFKD 240

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
            +   L  +   R T  Q+L H ++
Sbjct: 241 FLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 86/323 (26%), Positives = 128/323 (39%), Gaps = 74/323 (22%)

Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSI----AKDRLVTIDDERSVKLE 91
            S LR  + +  +LG G FG +       TG V A K I     KD    I   R    E
Sbjct: 4   CSKLR-DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALR----E 57

Query: 92  IEIMTRLSGHPNVVDL-KAVYEDED-------YVHLVM-----ELCAGGELFHRLEKFGR 138
           I+I+ +L  HPNVV L     E  D        V++V      +L     L        +
Sbjct: 58  IKILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG---LLEN-PSV-K 111

Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEP 197
            +E++ +   +QL++ + Y HE  ++HRD+K  NIL+  +     +K+ADFGLA  Y  P
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFGLARPYDGP 168

Query: 198 GQSL-----------LGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFW 244
             +               V + +Y  PE+L G   Y  A D+W  G +   + +  P   
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228

Query: 245 GNTK----SRIFDAVRT----------------ADLRFPSNP-------WDHISDSAKDL 277
           G +       IF    T                    F + P            +   DL
Sbjct: 229 GKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL-DL 287

Query: 278 VMGMLSTDPSQRLTARQVLDHSW 300
           +  +LS DP +RLTA   L+H +
Sbjct: 288 LSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 98.1 bits (244), Expect = 6e-23
 Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 38/282 (13%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +GV+  C  K T E+ A K   KD     + + +   E++ M R     N+V+LK
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELK-MLRTLKQENIVELK 66

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-ARVLFMQLMQVVLYCHEIGVVHRD 167
             +     ++LV E      +   LE+       E  R    QL++ + +CH+  +VHRD
Sbjct: 67  EAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRD 125

Query: 168 LKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEVLAGG-YNQAA 224
           +KPEN+L+   + +  +KL DFG A  +  G +   T  V + +Y +PE+L G  Y +A 
Sbjct: 126 IKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182

Query: 225 DVWSAGVILYILLSGMPPFWGNTK-------------------SRIFDAVRTADLRFPS- 264
           D+WS G IL  L  G P F G ++                      +   R   LRFP+ 
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242

Query: 265 -NPWDH-------ISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
            +P          +S    DL+  +L  +P+ R    Q L+H
Sbjct: 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 98.2 bits (244), Expect = 6e-23
 Identities = 71/283 (25%), Positives = 138/283 (48%), Gaps = 18/283 (6%)

Query: 24  RSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID 83
           R+  + ++D        + F+   ++G G  G++ + + K +G++ A K +   +     
Sbjct: 6   RAALQMVVDPGDPRTYLDNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----Q 58

Query: 84  DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE 143
             R +     ++ R   H NVV++   Y   D + +VME   GG L   +    R +E +
Sbjct: 59  QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQ 117

Query: 144 ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE---PGQS 200
              + + +++ +   H  GV+HRD+K ++ILL        +KL+DFG    +    P + 
Sbjct: 118 IAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRK 174

Query: 201 LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD 259
            L  VG+P+++APE+++   Y    D+WS G+++  ++ G PP++     +    +R  +
Sbjct: 175 SL--VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-N 231

Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           L         +S S K  +  +L  DP+QR TA ++L H ++ 
Sbjct: 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 97.0 bits (241), Expect = 1e-22
 Identities = 81/280 (28%), Positives = 126/280 (45%), Gaps = 42/280 (15%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + +G G +G +    +K  G   A K +  D +  ID+E  ++ E  I+  LS HPNVV 
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEE--IEAEYNILKALSDHPNVVK 79

Query: 107 LKAVYEDEDYVH-----LVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLY 157
              +Y  +D  +     LV+ELC GG +   ++ F     R  E     +  + +  + +
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
            H    +HRD+K  NILL T+     +KL DFG++  +   +    T VG+PF++APEV+
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 217 A------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP---- 266
           A        Y+   DVWS G+    L  G PP       R       A  + P NP    
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-------ALFKIPRNPPPTL 249

Query: 267 -----WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                W   S+   D +   L+ D  +R T   +L H ++
Sbjct: 250 HQPELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 96.7 bits (240), Expect = 2e-22
 Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 20/267 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G FG +    D  T +V A K I  D     D+   ++ EI ++++   
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 61

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P V      Y     + ++ME   GG     L + G F E +   +  ++++ + Y H 
Sbjct: 62  -PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL-AG 218
              +HRD+K  N+LL+ +     +KLADFG+A  +   Q    T VG+PF++APEV+   
Sbjct: 120 EKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP----WDHISDSA 274
            Y+  AD+WS G+    L  G PP       R+           P N         S   
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNNPPTLTGEFSKPF 229

Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWM 301
           K+ +   L+ DPS R TA+++L H ++
Sbjct: 230 KEFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 92/298 (30%), Positives = 141/298 (47%), Gaps = 55/298 (18%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--RSVKL-EIEIMTRLSGHPN 103
           +++G G +G +    DK TG++ A K   K RL  +D+E      L EI ++  LS    
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALK---KTRL-EMDEEGIPPTALREISLLQMLSESIY 62

Query: 104 VVDLKAVYEDED-----YVHLVMELCAGGELFHRLEKF--------GRFSEAEARVLFM- 149
           +V L  V   E+      ++LV E      L   L+KF        GR   A+    FM 
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSP 208
           QL++ V +CH+ GV+HRDLKP+N+L+        +K+AD GL   +  P +S    + + 
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL 175

Query: 209 FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSR----IFDAVRT----- 257
           +Y APEVL G   Y+   D+WS G I   +    P F G+++ +    IF  + T     
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235

Query: 258 ----ADLR----FP-------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
               + LR    FP       S     +S    DL+  ML  DP++R++A+  L H +
Sbjct: 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 76/263 (28%), Positives = 121/263 (46%), Gaps = 12/263 (4%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G FG +    D  T EV A K I  D     D+   ++ EI ++++   
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 61

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P +      Y     + ++ME   GG     L K G   E     +  ++++ + Y H 
Sbjct: 62  -PYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHS 119

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-G 218
              +HRD+K  N+LL+ +     +KLADFG+A  +   Q    T VG+PF++APEV+   
Sbjct: 120 ERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y+  AD+WS G+    L  G PP       R+   +       P       S   K+ V
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFKEFV 233

Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
              L+ DP  R TA+++L H ++
Sbjct: 234 EACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 98.9 bits (246), Expect = 3e-22
 Identities = 78/248 (31%), Positives = 123/248 (49%), Gaps = 22/248 (8%)

Query: 66  GEVFACKSIAKDRLVTIDDERSV---KLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           G     K +AK   V ++DER     + E+  +     H  +V     ++ +D + L+ME
Sbjct: 89  GSDPKEKVVAK--FVMLNDERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLLLIME 145

Query: 123 LCAGGELF----HRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
             +GG+L      RL++   F E E  +LF Q++  +   H   ++HRDLK  NI L   
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM-- 203

Query: 179 ASSSPIKLADFGLATYIEPGQSL-LGT--VGSPFYIAPEVLAGG-YNQAADVWSAGVILY 234
             +  IKL DFG +       SL + +   G+P+Y+APE+     Y++ AD+WS GVILY
Sbjct: 204 -PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILY 262

Query: 235 ILLSGMPPFWGNTKSRIFDAVRTADLR-FPSNPWDHISDSAKDLVMGMLSTDPSQRLTAR 293
            LL+   PF G ++  I   V       FP      +S   K L+  +LS +P+ R T +
Sbjct: 263 ELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP----VSSGMKALLDPLLSKNPALRPTTQ 318

Query: 294 QVLDHSWM 301
           Q+L   ++
Sbjct: 319 QLLHTEFL 326

Length = 478

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 94.8 bits (235), Expect = 6e-22
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 12/263 (4%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G FG +    D  T +V A K I  D     D+   ++ EI ++++   
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 61

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P V      Y  +  + ++ME   GG     LE  G   E +   +  ++++ + Y H 
Sbjct: 62  -PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS 119

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-G 218
              +HRD+K  N+LL+       +KLADFG+A  +   Q    T VG+PF++APEV+   
Sbjct: 120 EKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y+  AD+WS G+    L  G PP       ++   +   +   P     + S   K+ V
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFV 233

Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
              L+ +PS R TA+++L H ++
Sbjct: 234 EACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 94.5 bits (235), Expect = 7e-22
 Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 32/274 (11%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEI 94
               ER VLG+    G +G++    D  T    A K I +      D      L  EI +
Sbjct: 8   DENGERVVLGK----GTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIAL 58

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM--QL 151
            + L  H N+V       +  +  + ME   GG L   L  K+G   + E  ++F   Q+
Sbjct: 59  HSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG----LATYIEPGQSLLGTVGS 207
           ++ + Y H+  +VHRD+K +N+L+ T   S  +K++DFG    LA      ++  GT+  
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINPCTETFTGTLQ- 174

Query: 208 PFYIAPEVL---AGGYNQAADVWSAGVILYILLSGMPPFW--GNTKSRIFDAVRTADLRF 262
             Y+APEV+     GY   AD+WS G  +  + +G PPF   G  ++ +F          
Sbjct: 175 --YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--H 230

Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
           P  P + +S  AK+ ++     DP +R +A  +L
Sbjct: 231 PEIP-ESLSAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 94.6 bits (235), Expect = 9e-22
 Identities = 85/289 (29%), Positives = 130/289 (44%), Gaps = 42/289 (14%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD--ERSVKLEIEIMTRLSG--HPN 103
           ++G G +G +    D  +G   A KS+   R+ T +D    S   E+ ++ RL    HPN
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSV---RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 104 VVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVL 156
           +V L  V      + E  V LV E     +L   L+K           + L  Q ++ + 
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV- 215
           + H   +VHRDLKPENIL+    S   +KLADFGLA       +L   V + +Y APEV 
Sbjct: 123 FLHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179

Query: 216 LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVR-------TADLRFPS 264
           L   Y    D+WS G I   +    P F GN+++    +IFD +          D+  P 
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239

Query: 265 NPWD------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             +              I +S   L++ ML+ +P +R++A + L H + 
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 29/290 (10%)

Query: 31  LDTNQISNLRER---FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS 87
           LD   +S LR+    F L + +G G +G +       TG++ A K +     VT D+E  
Sbjct: 3   LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEE 58

Query: 88  VKLEIEIMTRLSGHPNVVDL------KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSE 141
           +KLEI ++ + S H N+         K+    +D + LVME C  G +   ++     + 
Sbjct: 59  IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118

Query: 142 AEARVLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ 199
            E  + ++  ++++ + + H   V+HRD+K +N+LL   A    +KL DFG++  ++   
Sbjct: 119 KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTV 175

Query: 200 SLLGT-VGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSR-I 251
               T +G+P+++APEV+A        Y+  +D+WS G+    +  G PP       R +
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235

Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           F   R    +  S  W   S    D + G L  +   R +  Q+L H ++
Sbjct: 236 FLIPRNPPPKLKSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 75/238 (31%), Positives = 115/238 (48%), Gaps = 34/238 (14%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + +G G +G +   ++K  G + A K +  D +  +D+E  ++ E  I+  L  HPNVV 
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEE--IEAEYNILQSLPNHPNVVK 83

Query: 107 LKAVYEDEDY-----VHLVMELCAGG---ELFHRLEKFG-RFSEAEARVLFMQLMQVVLY 157
              ++   D      + LV+ELC GG   EL   L   G R  EA    +    +  + +
Sbjct: 84  FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
            H   ++HRD+K  NILL T+     +KL DFG++  +   +    T VG+PF++APEV+
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 217 A------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFD--AVRTADLRFPSNP 266
           A        Y+   DVWS G+    L  G PP        +FD   V+T   + P NP
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPP--------LFDMHPVKTL-FKIPRNP 249

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 92.1 bits (228), Expect = 5e-21
 Identities = 72/275 (26%), Positives = 130/275 (47%), Gaps = 26/275 (9%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F L + +G G +G +       TG++ A K +     VT D+E  +K EI ++ + S H 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 103 NVVDLKAVYED------EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQV 154
           N+      +        +D + LVME C  G +   ++     +  E  + ++  ++++ 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAP 213
           + + H+  V+HRD+K +N+LL   A    +KL DFG++  ++       T +G+P+++AP
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Query: 214 EVLA------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSR-IFDAVRTADLRFPSNP 266
           EV+A        Y+  +D+WS G+    +  G PP       R +F   R    R  S  
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           W   S   +  +   L  + SQR T  Q++ H ++
Sbjct: 241 W---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 93.0 bits (231), Expect = 7e-21
 Identities = 91/317 (28%), Positives = 141/317 (44%), Gaps = 56/317 (17%)

Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
             +  L ER+   +Q+G G +G   VCS  DK TGE  A K +++     I  +R+ + E
Sbjct: 8   KTVWELPERYTSLKQVGSGAYG--SVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-E 64

Query: 92  IEIMTRLSGHPNVVDLKAV------YEDEDYVHLVMELCAGGELFHRLEKF--GRFSEAE 143
           + ++  +  H NV+ L  V       ++    +LVM       +   L+K      SE +
Sbjct: 65  LTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHPLSEDK 118

Query: 144 ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG 203
            + L  Q++  + Y H  G++HRDLKP N  LA       +K+ DFGLA + +    + G
Sbjct: 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGN--LAVNEDCE-LKILDFGLARHAD--AEMTG 173

Query: 204 TVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGN--------------- 246
            V + +Y APEV+     YNQ  D+WS G I+  +L+G   F G                
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233

Query: 247 -------------TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTAR 293
                         KS I    +     F S  +   S  A DL+  ML  D  +RLTA 
Sbjct: 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTAT 292

Query: 294 QVLDHSWMGDGIQDPEK 310
           + L+H +  D  +D ++
Sbjct: 293 EALEHPYF-DSFRDADE 308

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 91.7 bits (228), Expect = 8e-21
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 21/217 (9%)

Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           RE   LG+ +G GQFG       +   ++K    V  CK+                 E  
Sbjct: 5   REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-----SVREKFLQEAY 59

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-MQLM 152
           IM +   HP++V L  V  + + V +VMEL   GEL   L+      +  + +L+  QL 
Sbjct: 60  IMRQFD-HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLS 117

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-Y 210
             + Y      VHRD+   N+L+++      +KL DFGL+ Y+E       + G  P  +
Sbjct: 118 TALAYLESKRFVHRDIAARNVLVSSPDC---VKLGDFGLSRYLEDESYYKASKGKLPIKW 174

Query: 211 IAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWG 245
           +APE +    +  A+DVW  GV ++ IL+ G+ PF G
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 45/304 (14%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D    +  A K +++     I   R+ + E+ ++  +  
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMK- 72

Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + S+   + L  QL++ 
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H  G++HRDLKP N+ +        +++ DFGLA   +    + G V + +Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCE---LRILDFGLAR--QADDEMTGYVATRWYRAPE 185

Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF------ 262
           ++     YNQ  D+WS G I+  LL G   F GN       RI + V T           
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 263 ----------PSNPWDHISDS-------AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI 305
                     P  P   +          A DL+  ML  D  +R++A + L H +     
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ-Y 304

Query: 306 QDPE 309
            DPE
Sbjct: 305 HDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 76/273 (27%), Positives = 121/273 (44%), Gaps = 33/273 (12%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE F L ++LG G FG   V    +   V  A K +  D L+   D    + E++ + RL
Sbjct: 5   REEFTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRL 59

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--------Q 150
             H +++ L AV    + V+++ EL   G L   L         E +VL +        Q
Sbjct: 60  R-HKHLISLFAVCSVGEPVYIITELMEKGSLLAFL------RSPEGQVLPVASLIDMACQ 112

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF- 209
           + + + Y  E   +HRDL   NIL+         K+ADFGLA  I+    L      P+ 
Sbjct: 113 VAEGMAYLEEQNSIHRDLAARNILVGEDLVC---KVADFGLARLIKEDVYLSSDKKIPYK 169

Query: 210 YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
           + APE  + G ++  +DVWS G++LY + + G  P+ G     ++D + TA  R P    
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-TAGYRMPCPA- 227

Query: 268 DHISDSAKDLVMGMLSTDPSQR---LTARQVLD 297
                    +++   + +P  R      R+ LD
Sbjct: 228 -KCPQEIYKIMLECWAAEPEDRPSFKALREELD 259

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 41/265 (15%)

Query: 52  GQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM--TRLSGHPNVVDLKA 109
           G+FG + V   K T ++F  K I                 IE M    +  +PN + L  
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAKNFN----------AIEPMVHQLMKDNPNFIKLYY 76

Query: 110 VYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLK 169
                    L+M+    G+LF  L+K G+ SEAE + +  QL++ +   H+  ++H D+K
Sbjct: 77  SVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136

Query: 170 PENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGSPFYIAPEVLAG-GYNQAADV 226
            EN+L   +A    I L D+GL   I  G      GT+    Y +PE + G  Y+ + D 
Sbjct: 137 LENVLY-DRAKDR-IYLCDYGLCKII--GTPSCYDGTLD---YFSPEKIKGHNYDVSFDW 189

Query: 227 WSAGVILYILLSGMPPFWGNT---------KSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
           W+ GV+ Y LL+G  PF  +            R         L F  N    +S +A D 
Sbjct: 190 WAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-----KLPFIKN----VSKNANDF 240

Query: 278 VMGMLSTDPSQRLTA-RQVLDHSWM 301
           V  ML  + + RLT   +++ H ++
Sbjct: 241 VQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 83/315 (26%), Positives = 139/315 (44%), Gaps = 51/315 (16%)

Query: 33  TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI 92
              I  + +R+   +Q+G G +G +    D+ TG   A K + +     +  +R+ + E+
Sbjct: 7   NKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-EL 65

Query: 93  EIMTRLSGHPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV 146
            ++  +  H NV+ L  V+      +     +LVM     G    +L K  + SE   + 
Sbjct: 66  RLLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF 122

Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG 206
           L  Q+++ + Y H  G++HRDLKP N+ +        +K+ DFGLA   +    + G V 
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFGLARQTD--SEMTGYVV 177

Query: 207 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGN--------------TKSR 250
           + +Y APEV+     Y Q  D+WS G I+  +L+G P F G+              T S+
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237

Query: 251 IF-------DA---------VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQ 294
            F       DA          R  D R   +   + +  A +++  ML  D   R+TA +
Sbjct: 238 EFVQKLQSEDAKNYVKKLPRFRKKDFR---SLLPNANPLAVNVLEKMLVLDAESRITAAE 294

Query: 295 VLDHSWMGDGIQDPE 309
            L H +  +   DPE
Sbjct: 295 ALAHPYF-EEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 26/269 (9%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--RSVKLEIEIMTRLSGHPNVV 105
           +LG G +G +     + TG   A K I   RL  +D+     + +E++I+ +    P +V
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI---RL-ELDESKFNQIIMELDILHKAVS-PYIV 62

Query: 106 DLKAVYEDEDYVHLVMELCAGG---ELFHRLEKFGRFSEAE-ARVLFMQLMQVVLYCHEI 161
           D    +  E  V++ ME    G   +L+          E    R+ +  +  +     E 
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAGG- 219
            ++HRD+KP N+L+        +KL DFG++  +    SL  T +G   Y+APE +  G 
Sbjct: 123 NIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLV--ASLAKTNIGCQSYMAPERIKSGG 177

Query: 220 ------YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT-ADLRFPSNPWDHISD 272
                 Y   +DVWS G+ +  +  G  P+   T + IF  +    D   P+ P    SD
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP-SGYSD 236

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            A+D V   L+  P++R T  Q+L+H W+
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 37/233 (15%)

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYCH 159
           H N+V L  +   +  + LV E     +L   ++  G         LF+ QL++ + YCH
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLAG 218
           +  V+HRDLKP+N+L++ +     +KLADFGLA     P ++    V + +Y  P+VL G
Sbjct: 121 QRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177

Query: 219 G--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIF-----------------DA 254
              Y+ + D+W  G I Y + +G P F G+T       +IF                   
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237

Query: 255 VRTADLRFPS-----NPWDHISD--SAKDLVMGMLSTDPSQRLTARQVLDHSW 300
            +     F       N    +      ++L +  L  +P +R++A + + H +
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 47  QQLGWGQFGVIRVCSDKF----TGEVFACKSIAKDRLVTIDDERS-VKLEIEIMTRLSGH 101
           +QLG G FG + +C        TGE  A KS+        +  RS  + EIEI+  L  H
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLD-H 65

Query: 102 PNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-MQLMQVVLYC 158
            N+V  K V E      + L+ME    G L   L++       +  +LF  Q+ + + Y 
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP-----FYIAP 213
                +HRDL   NIL+    S   +K++DFGLA  +   +     V  P     F+ AP
Sbjct: 126 GSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYY-YVKEPGESPIFWYAP 181

Query: 214 EVLAGG-YNQAADVWSAGVILYILLS 238
           E L    ++ A+DVWS GV LY L +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 81/294 (27%), Positives = 126/294 (42%), Gaps = 45/294 (15%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLS 99
           E +V   +LG G +  +     K T  + A K I   RL   +      + E+ ++  L 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLK 61

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYC 158
            H N+V L  +   E  + LV E     +L   L+  G         +FM QL++ + YC
Sbjct: 62  -HANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA 217
           H+  ++HRDLKP+N+L+  K     +KLADFGLA     P ++    V + +Y  P+VL 
Sbjct: 120 HKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNT---------------------------- 247
           G   Y+   D+W  G ILY + +G P F G+T                            
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236

Query: 248 -KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
            +S +F   R   L    N    +     DL+  +L  +   R++A   L HS+
Sbjct: 237 FRSYLFPQYRAQPLI---NHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 91.3 bits (226), Expect = 7e-20
 Identities = 91/319 (28%), Positives = 141/319 (44%), Gaps = 59/319 (18%)

Query: 32  DTNQISNLRERFVLGQQLGWGQFGVI--RVCSDKFTGEVFACKSIAKDRLVTIDDERSVK 89
           D N+  N  + + LG  +G G FGV+   +C D  T E  A K +       + D +   
Sbjct: 59  DINRSPN--KSYKLGNIIGNGSFGVVYEAICID--TSEKVAIKKV-------LQDPQYKN 107

Query: 90  LEIEIMTRLSGHPNVVDLKAVY--------EDEDYVHLVMELCAGGELFHRLEK-FGRFS 140
            E+ IM  L+ H N++ LK  Y        E   ++++VME     +  H+  K + R +
Sbjct: 108 RELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNN 164

Query: 141 EAEARVLF----MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            A    L      QL + + Y H   + HRDLKP+N+L+     +  +KL DFG A  + 
Sbjct: 165 HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLL 222

Query: 197 PGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SR 250
            GQ  +  + S FY APE++ G   Y    D+WS G I+  ++ G P F G +      R
Sbjct: 223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR 282

Query: 251 IFDAVRT-------------ADLRFPS-NPWD-------HISDSAKDLVMGMLSTDPSQR 289
           I   + T             AD++FP   P D          D A + +   L  +P +R
Sbjct: 283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342

Query: 290 LTARQVLDHSWMGDGIQDP 308
           L   + L   +  D ++DP
Sbjct: 343 LNPIEALADPFF-DDLRDP 360

Length = 440

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 87/302 (28%), Positives = 138/302 (45%), Gaps = 53/302 (17%)

Query: 42  RFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R+ + + +G G +GV  VCS  D  TGE  A K I  D    + D   +  EI+++ RL 
Sbjct: 1   RYKIQEVIGKGSYGV--VCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLL-RLL 56

Query: 100 GHPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLM 152
            HP++V++K +       E +D +++V EL    +L H++ K       E    F+ QL+
Sbjct: 57  RHPDIVEIKHIMLPPSRREFKD-IYVVFEL-MESDL-HQVIKANDDLTPEHHQFFLYQLL 113

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA--TYIEPGQSLLGT--VGSP 208
           + + Y H   V HRDLKP+NIL     +   +K+ DFGLA   + +   ++  T  V + 
Sbjct: 114 RALKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 209 FYIAPEVLA---GGYNQAADVWSAGVILYILLSGMPPFWG-------------------- 245
           +Y APE+       Y  A D+WS G I   +L+G P F G                    
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230

Query: 246 ------NTKSRIF-DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
                 N K+R +  ++R       S  + +    A  L+  +L+ DP  R TA + L  
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290

Query: 299 SW 300
            +
Sbjct: 291 PY 292

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 88.6 bits (219), Expect = 3e-19
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 45/296 (15%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  H NV+ L 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK-HENVIGLL 82

Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ + Y H   
Sbjct: 83  DVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GY 220
           ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE++     Y
Sbjct: 141 IIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHY 195

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTK-------------------SRI-FDAVRTADL 260
           NQ  D+WS G I+  LL+G   F G                       +I  ++ R    
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255

Query: 261 RFPSNPWDHISD-------SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
                P  + ++        A DL+  ML  D  +R+TA Q L H++      DP+
Sbjct: 256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ-YHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 9e-19
 Identities = 62/192 (32%), Positives = 105/192 (54%), Gaps = 20/192 (10%)

Query: 117 VHLVMELCAGGELFHRLE---KFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN 172
           + LV++    G+L   ++   K  R F E EA +LF+Q++  V + H   ++HRD+K  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 173 ILLATKASSSPIKLADFGLATYI------EPGQSLLGTVGSPFYIAPEVL-AGGYNQAAD 225
           ILL    S+  +KL DFG +         + G++  GT   P+Y+APE+     Y++ AD
Sbjct: 174 ILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGT---PYYVAPEIWRRKPYSKKAD 227

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
           ++S GV+LY LL+   PF G     +    +T   R+   P   IS   +++V  +LS+D
Sbjct: 228 MFSLGVLLYELLTLKRPFDGENMEEVMH--KTLAGRYDPLP-PSISPEMQEIVTALLSSD 284

Query: 286 PSQRLTARQVLD 297
           P +R ++ ++L+
Sbjct: 285 PKRRPSSSKLLN 296

Length = 496

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 72/210 (34%), Positives = 100/210 (47%), Gaps = 31/210 (14%)

Query: 47  QQLGWGQFGVIRVCS-DKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           QQLG G FG + +C  D     TGEV A K +      T +  R  + EIEI+  L  H 
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HD 65

Query: 103 NVVDLKAV-YE-DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYCH 159
           N+V  K V Y      + LVME    G L   L+K     +    +L+  Q+ + + Y  
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYI----------EPGQSLLGTVGSPF 209
               VHRDL   NIL+    S + +K+ DFGL   +          EPG+S +      F
Sbjct: 126 SKRYVHRDLATRNILVE---SENRVKIGDFGLTKVLPQDKEYYKVREPGESPI------F 176

Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLS 238
           + APE L    ++ A+DVWS GV+LY L +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 32/248 (12%)

Query: 70  ACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE 128
           A K++ K      D E+   L E  +M+  + HPN+V L  V    +  +++MEL  GG+
Sbjct: 30  AVKTLRKG---ATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYIIMELMEGGD 85

Query: 129 LFHRLEKFGRFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASS 181
           L   L            +   +L+ + L       Y  ++  +HRDL   N L++ K   
Sbjct: 86  LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYD 145

Query: 182 SP--IKLADFGLAT-------YIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGV 231
           +   +K+ DFGLA        Y + G+ LL       ++APE L  G +   +DVWS GV
Sbjct: 146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR----WMAPESLLDGKFTTQSDVWSFGV 201

Query: 232 ILY-ILLSGMPPFWGNTKSRIFDAVRTAD-LRFPSNPWDHISDSAKDLVMGMLSTDPSQR 289
           +++ IL  G  P+       +   V     L+ P N  D I      L+    + DPS+R
Sbjct: 202 LMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKI----YQLMTNCWAQDPSER 257

Query: 290 LTARQVLD 297
            T  ++ +
Sbjct: 258 PTFDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 63/264 (23%), Positives = 119/264 (45%), Gaps = 23/264 (8%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G  G +       T  + A K I  D  +T++ ++ +  E+EI+ +    P ++ 
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDS-PYIIG 63

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
               +  E+ + +  E   GG L    + + +  E     + + +++ + Y   + ++HR
Sbjct: 64  FYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHR 119

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAA 224
           D+KP N+L+ T+     +KL DFG++T +    S+  T VG+  Y+APE ++G  Y   +
Sbjct: 120 DVKPSNMLVNTRGQ---VKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 225 DVWSAGVILYILLSGM---PPFWGNTKS----RIFDAVRTADLRFPSNPWDHISDSAKDL 277
           DVWS G+    L  G    P    N  S    ++   +   D   P  P    S+     
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--VDEDPPVLPVGQFSEKFVHF 232

Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +   +   P +R     ++DH ++
Sbjct: 233 ITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 85/289 (29%), Positives = 128/289 (44%), Gaps = 47/289 (16%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL----EIEIMTRLSG--H 101
           ++G G +G +    D   G  F    +A  R+     E  + L    E+ ++  L    H
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 102 PNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQ 153
           PNVV L  V      + E  + LV E     +L   L+K    G  +E   + +  QL++
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTET-IKDMMFQLLR 121

Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            + + H   VVHRDLKP+NIL+    SS  IKLADFGLA       +L   V + +Y AP
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 214 EV-LAGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAV------------- 255
           EV L   Y    D+WS G I   +    P F G++      +I D +             
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 256 --RTADLRFPSNPWDH----ISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
             R A     + P +     I +  KDL++  L+ +P++R++A   L H
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 66/258 (25%)

Query: 94  IMTRLSGHPNVVDLKAVY------EDEDYVHLVME-----LCAGGELFHRLEKFGRFSEA 142
           ++ +L  H N++ L  V+      E+   V+LVME     LC   ++        R S  
Sbjct: 67  VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC---QVIQMDLDHERMS-- 121

Query: 143 EARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL 202
               L  Q++  + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S +
Sbjct: 122 ---YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFM 173

Query: 203 GT--VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGN------------- 246
            T  V + +Y APEV+ G GY +  D+WS G I+  ++ G   F G              
Sbjct: 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233

Query: 247 -TKSRIF-----DAVRT-----------------ADLRFP--SNPWDHISDS-AKDLVMG 280
            T S  F       VR                   D+ FP  S   + +  S A+DL+  
Sbjct: 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSK 293

Query: 281 MLSTDPSQRLTARQVLDH 298
           ML  DP +R++    L H
Sbjct: 294 MLVIDPEKRISVDDALQH 311

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 13/212 (6%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLS 99
           E ++   +LG G +  +     K T  + A K I   RL   +      + E+ ++  L 
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 62

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYC 158
            H N+V L  +   E  + LV E     +L   L+  G         LF+ QL++ + YC
Sbjct: 63  -HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA 217
           H   V+HRDLKP+N+L+  +     +KLADFGLA     P ++    V + +Y  P++L 
Sbjct: 121 HRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNT 247
           G   Y+   D+W  G I Y + +G P F G+T
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.9 bits (210), Expect = 2e-17
 Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 23/235 (9%)

Query: 78  RLVTIDDERSVK---LEIEIMTRLSGHPNVVDL--KAVYEDEDYVHLVMELCAGGELFHR 132
           R    ++E        E  +  RL  HPN+V L           +  V E   G  L   
Sbjct: 12  RTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPP-GLLFAVFEYVPGRTLREV 69

Query: 133 LEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA 192
           L   G     E   L +Q++  +   H  G+VHRDLKP+NI+++        K+ DFG+ 
Sbjct: 70  LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129

Query: 193 TYIEPG------QSLLGT---VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPP 242
           T + PG       +L  T   +G+P Y APE L G      +D+++ G+I    L+G   
Sbjct: 130 TLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188

Query: 243 FWGNTKSRI-FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQR-LTARQV 295
             G + + I +  +   D+  P     H       ++   L+ DP QR  +A  +
Sbjct: 189 VQGASVAEILYQQLSPVDVSLPPWIAGH---PLGQVLRKALNKDPRQRAASAPAL 240

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 81.7 bits (201), Expect = 3e-17
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 44/292 (15%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG--HPNV 104
           ++LG G +  +     K  G++ A K I   RL   ++E +    I   + L G  H N+
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVI---RLQ--EEEGTPFTAIREASLLKGLKHANI 65

Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGV 163
           V L  +   ++ + LV E     +L   ++K  G       ++   QL++ + Y H+  +
Sbjct: 66  VLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLAGG--Y 220
           +HRDLKP+N+L+   + +  +KLADFGLA     P  +    V + +Y  P+VL G   Y
Sbjct: 125 LHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 221 NQAADVWSAGVILYILLSGMPPFWG-----NTKSRIFDAVRTAD---------------L 260
           +   D+W  G I   ++ G+  F G     +   RIF  + T +                
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241

Query: 261 RFP-------SNPWDHIS--DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           RF           W+ +S  + A+DL   +L   P  RL+A+  L H +  D
Sbjct: 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 18/220 (8%)

Query: 45  LGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
             ++LG GQFGV+     K+ G++  A K I +  +     E     E ++M +LS HPN
Sbjct: 8   FLKELGSGQFGVVH--LGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPN 60

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           +V L  V   +  + +V E  A G L + L E+ G+        +   + + + Y    G
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---APEVLA-G 218
            +HRDL   N L+        +K++DFGLA Y+   Q    + G+ F +    PEV    
Sbjct: 121 FIHRDLAARNCLVGEDNV---VKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYS 176

Query: 219 GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT 257
            ++  +DVWS GV+++ + S G  P+   + S + ++V  
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 31/206 (15%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
            LG  +G G+FG   V    + G+  A K + KD         +   E  +MT L  HPN
Sbjct: 9   KLGATIGKGEFG--DVMLGDYRGQKVAVKCL-KDDSTAAQ---AFLAEASVMTTLR-HPN 61

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL------- 156
           +V L  V    + +++V E  A G L   L   GR     A +   Q +   L       
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGME 116

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---AP 213
           Y  E   VHRDL   N+L++    +   K++DFGLA     GQ           +   AP
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVA---KVSDFGLAKEASQGQD-----SGKLPVKWTAP 168

Query: 214 EVLAGG-YNQAADVWSAGVILYILLS 238
           E L    ++  +DVWS G++L+ + S
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 80/301 (26%), Positives = 125/301 (41%), Gaps = 55/301 (18%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAK--DRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           + +G+G FGV+   +D   G+  A K +      LV+    + V  E++++     H NV
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC---KRVFRELKMLCFFK-HDNV 61

Query: 105 VDLKAVYE--DEDYVHLVMELCAGGELFHR-LEKF----GRFSEAEARVLFMQLMQVVLY 157
           +    + +    D      E+    EL    L K        S    +V   Q+++ + Y
Sbjct: 62  LSALDILQPPHIDPFE---EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEV 215
            H  G++HRD+KP N+L+    S+  +K+ DFGLA   EP +S   T  V + +Y APE+
Sbjct: 119 LHSAGILHRDIKPGNLLVN---SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175

Query: 216 LAGG--YNQAADVWSAGVILYILLS---------------------GMPPFWGNTKSRIF 252
           L G   Y  A D+WS G I   LL                      G P       +   
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-- 233

Query: 253 DAVRTADLRFPSNP---------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           +  R   LR P  P             +  A  L+  ML  DP +R++A   L H ++ +
Sbjct: 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293

Query: 304 G 304
           G
Sbjct: 294 G 294

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 13/212 (6%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLS 99
           E ++  ++LG G +  +     K T  + A K I   RL   +      + E+ ++  L 
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 62

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYC 158
            H N+V L  +   +  + LV E     +L   ++  G   S    ++   Q+++ + YC
Sbjct: 63  -HANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA 217
           H   V+HRDLKP+N+L+  +     +KLADFGLA     P ++    V + +Y  P+VL 
Sbjct: 121 HRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177

Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNT 247
           G   Y+   D+W  G I + + SG P F G+T
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 70/255 (27%), Positives = 112/255 (43%), Gaps = 28/255 (10%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G FG +     K   EV A K+      +  D +R    E EI+ +   HPN+V 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEV-AVKTCRST--LPPDLKRKFLQEAEILKQYD-HPNIVK 56

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL-------YCH 159
           L  V   +  +++VMEL  GG L   L K       + R+   +L+Q+ L       Y  
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFLRK------KKNRLTVKKLLQMSLDAAAGMEYLE 110

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGSPF-YIAPEVL 216
               +HRDL   N L+        +K++DFG++   E G   +  G    P  + APE L
Sbjct: 111 SKNCIHRDLAARNCLVGENNV---LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167

Query: 217 -AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
             G Y   +DVWS G++L+   S G  P+ G +  +  + + +   R P        +  
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMP--APQLCPEEI 224

Query: 275 KDLVMGMLSTDPSQR 289
             L++   + DP  R
Sbjct: 225 YRLMLQCWAYDPENR 239

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 79/308 (25%), Positives = 131/308 (42%), Gaps = 57/308 (18%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D   G   A K +++        +R+ + E+ ++ +   
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-EL-VLLKCVN 78

Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLM 152
           H N++ L  V+      E+   V+LVMEL      ++ H      R S      L  Q++
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQML 133

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
             + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + +Y A
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190

Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SRIF 252
           PEV+ G GY +  D+WS G I+  L+ G   F G                      +R+ 
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250

Query: 253 DAVRTADLRFPSNP----------WDHISDS---------AKDLVMGMLSTDPSQRLTAR 293
             VR      P  P          W   S+S         A+DL+  ML  DP +R++  
Sbjct: 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310

Query: 294 QVLDHSWM 301
           + L H ++
Sbjct: 311 EALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 31/236 (13%)

Query: 62  DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM 121
           D  T + F  K + K    +       +  + I+      PN+V L      ED V LV+
Sbjct: 14  DTRTQQTFILKGLRKSSEYS-------RERLTIIPH--CVPNMVCLHKYIVSEDSVFLVL 64

Query: 122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
           +   GG+L+  + KF    E   +    +++  +   H  G+V RDL P NILL  +   
Sbjct: 65  QHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH- 123

Query: 182 SPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQ---AADVWSAGVILYILLS 238
             I+L  F   + +E   S  G      Y APEV  GG ++   A D WS G IL+ LL+
Sbjct: 124 --IQLTYFSRWSEVED--SCDGEAVENMYCAPEV--GGISEETEACDWWSLGAILFELLT 177

Query: 239 GMPPFWGNTKSRIFDA--VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTA 292
           G       T      +       L  P    + +S+ A+ L+  +L  +P++RL A
Sbjct: 178 GK------TLVECHPSGINTHTTLNIP----EWVSEEARSLLQQLLQFNPTERLGA 223

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 78/260 (30%), Positives = 118/260 (45%), Gaps = 22/260 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A K++   +  T+  E  ++ E +IM +L
Sbjct: 5   RESLKLERKLGAGQFG--EVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQ-EAQIMKKL 58

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFM-QLMQVVL 156
             H  +V L AV  +E+ +++V E  + G L   L    G+       V    Q+ + + 
Sbjct: 59  R-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---AP 213
           Y      +HRDL   NIL+         K+ADFGLA  IE  +      G+ F I   AP
Sbjct: 118 YLESRNYIHRDLAARNILVGENLV---CKIADFGLARLIEDDE-YTAREGAKFPIKWTAP 173

Query: 214 E-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           E    G +   +DVWS G++L  I+  G  P+ G T   + + V     R P  P  +  
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPP--NCP 230

Query: 272 DSAKDLVMGMLSTDPSQRLT 291
           +   DL++     DP +R T
Sbjct: 231 EELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 70/253 (27%), Positives = 114/253 (45%), Gaps = 41/253 (16%)

Query: 65  TGEVFACKSIAKDRLVTIDDE--RSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           TG ++A K I  +     +D   R +  EIEI+ R   HPNVV    +++    + +++E
Sbjct: 98  TGRLYALKVIYGNH----EDTVRRQICREIEIL-RDVNHPNVVKCHDMFDHNGEIQVLLE 152

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
              GG L    E      E     +  Q++  + Y H   +VHRD+KP N+L+    S+ 
Sbjct: 153 FMDGGSL----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAK 205

Query: 183 PIKLADFG----LATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQ------AADVWSAGVI 232
            +K+ADFG    LA  ++P  S +GT+    Y++PE +    N       A D+WS GV 
Sbjct: 206 NVKIADFGVSRILAQTMDPCNSSVGTIA---YMSPERINTDLNHGAYDGYAGDIWSLGVS 262

Query: 233 LYILLSGMPPF-------WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
           +     G  PF       W +    +  A+  +    P       S   +  +   L  +
Sbjct: 263 ILEFYLGRFPFGVGRQGDWAS----LMCAICMSQ---PPEAPATASREFRHFISCCLQRE 315

Query: 286 PSQRLTARQVLDH 298
           P++R +A Q+L H
Sbjct: 316 PAKRWSAMQLLQH 328

Length = 353

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 79/291 (27%), Positives = 125/291 (42%), Gaps = 48/291 (16%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE-IEIMTRLSG--HPN 103
           ++LG G +  +     +  G++ A K I      ++  E  V    I   + L G  H N
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVI------SMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGV 163
           +V L  +   ++ +  V E        + ++  G       R+   QL++ + Y H   +
Sbjct: 65  IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLAGG--Y 220
           +HRDLKP+N+L++       +KLADFGLA     P Q+    V + +Y  P+VL G   Y
Sbjct: 125 LHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFD---------AVRTADL-----RFPS-N 265
           + A D+W AG I   +L G P F G   S +F+          V T D      + P+  
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGV--SDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239

Query: 266 P--------------WDHISD--SAKDLVMGMLSTDPSQRLTARQVLDHSW 300
           P              W  +S    A+DL   ML   P  R++A+  L H +
Sbjct: 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.2 bits (190), Expect = 8e-16
 Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 47  QQLGWGQFG-VIRVCSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + LG G FG V   C D     TGE+ A K++ ++      +    K EI I+  L  H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLY-HE 66

Query: 103 NVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           N+V  K    +     + L+ME    G L   L K  + + A+  +   Q+ + + Y H 
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHS 125

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---GSP-FYIAPEVL 216
              +HRDL   N+LL    +   +K+ DFGLA  +  G           SP F+ A E L
Sbjct: 126 QHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 217 A-GGYNQAADVWSAGVILYILLS 238
               ++ A+DVWS GV LY LL+
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 22/283 (7%)

Query: 29  TILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSV 88
           TI      ++L +   LG+ +G G  G +     K TG V A K +   R    ++ + +
Sbjct: 4   TIDGQKYPADLNDLENLGE-IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKEENKRI 60

Query: 89  KLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL---CAGGELFHRLEKFGRFSEAEAR 145
            ++++++ +    P +V     +  +  V + MEL   C   +L  R++      E    
Sbjct: 61  LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-KLLKRIQGP--IPEDILG 117

Query: 146 VLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
            + + +++ + Y  E  GV+HRD+KP NILL    +S  +KL DFG++  +   ++   +
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGRLVDSKAKTRS 174

Query: 205 VGSPFYIAPEVL-----AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-RTA 258
            G   Y+APE +        Y+  ADVWS G+ L  L +G  P+        F+ + +  
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKIL 232

Query: 259 DLRFPSNPWD-HISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
               PS P +   S      V   L+ D  +R   R++L H +
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 79.0 bits (195), Expect = 2e-15
 Identities = 72/292 (24%), Positives = 122/292 (41%), Gaps = 46/292 (15%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL---EIEIMTR 97
           +R+ + + +G G  G + +  D       A K I +D     ++    K    E +I   
Sbjct: 2   QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED---LSENPLLKKRFLREAKIAAD 58

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL----EKFGRFSEAEARV------- 146
           L  HP +V + ++  D D V+  M    G  L   L    +K     E   +        
Sbjct: 59  LI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-- 204
           +F ++   + Y H  GV+HRDLKP+NILL        + + D+G A + +  +  L    
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 205 -----------------VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN 246
                            VG+P Y+APE L G   +++ D+++ GVILY +L+   P+   
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234

Query: 247 TKSRIFDAVRTADLRFPSN--PWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
              +I        +  P    P+  I      + M  L+ DP++R ++ Q L
Sbjct: 235 KGRKISYRDV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 18/220 (8%)

Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           L Q++G GQFG++ +       +V A K+I +  +     E     E ++M +LS HP +
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAM----SEEDFIEEAQVMMKLS-HPKL 61

Query: 105 VDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           V L  V  +   + LV E    G L  + R ++ G+FS+     + + + + + Y     
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-G 218
           V+HRDL   N L+     +  +K++DFG+  ++   Q    T G+ F   + +PEV +  
Sbjct: 121 VIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPEVFSFS 176

Query: 219 GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT 257
            Y+  +DVWS GV+++ + S G  P+   + S + + +  
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)

Query: 48  QLGWGQFGVIR--VCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           +LG G FG +   V   K   EV  A K++ ++ +     ++    E  +M +L  HP +
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQLD-HPCI 58

Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
           V L  V + E  + LVMEL   G L   L+K      ++ + L  Q+   + Y      V
Sbjct: 59  VRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGS-PF-YIAPEVLA-GG 219
           HRDL   N+LL  +      K++DFG++  +  G       T G  P  + APE +  G 
Sbjct: 118 HRDLAARNVLLVNRHQ---AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 220 YNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
           ++  +DVWS GV L+   S G  P+     + +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 76.8 bits (189), Expect = 7e-15
 Identities = 47/152 (30%), Positives = 80/152 (52%), Gaps = 4/152 (2%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E FV+ + +  G FG + +   K   +++A K + K  ++  +    V+ E + +  LS 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSK 62

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P +V L    +  + V+LVME   GG++   L  +G F E  A     ++   + Y H 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLA 192
            G++HRDLKP+N+L+   ++   IKL DFGL+
Sbjct: 123 HGIIHRDLKPDNMLI---SNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 75.5 bits (185), Expect = 7e-15
 Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 57/300 (19%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G  G++    D       A K +++        +R+ + E+ +M +   H N++ L 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVNHKNIISLL 82

Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            V+      E+   V+LVMEL     L   ++            L  Q++  + + H  G
Sbjct: 83  NVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG 139

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEVLAG-G 219
           ++HRDLKP NI++    S   +K+ DFGLA     G S + T  V + +Y APEV+ G G
Sbjct: 140 IIHRDLKPSNIVV---KSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 220 YNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTKSRIFDAV- 255
           Y +  D+WS G I+       IL  G                  P F    +  + + V 
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 256 ---RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              + A L FP    D +           +  A+DL+  ML  DP++R++  + L H ++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.4 bits (183), Expect = 8e-15
 Identities = 65/268 (24%), Positives = 121/268 (45%), Gaps = 25/268 (9%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G +GV+       TG + A K I     V   +++ + ++++I  R    P  V  
Sbjct: 8   ELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRSVDCPYTVTF 65

Query: 108 -KAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEA-RVLFMQLMQVVLYCHE-IG 162
             A++ + D V + ME+      + + ++   G     +    + + +++ + Y H  + 
Sbjct: 66  YGALFREGD-VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV--GSPFYIAPEVL---- 216
           V+HRD+KP N+L+        +KL DFG++ Y+    S+  T+  G   Y+APE +    
Sbjct: 125 VIHRDVKPSNVLINRNGQ---VKLCDFGISGYLV--DSVAKTIDAGCKPYMAPERINPEL 179

Query: 217 -AGGYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
              GY+  +DVWS G+ +  L +G  P+  W     ++   V       P  P +  S  
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---PQLPAEKFSPE 236

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            +D V   L  +  +R    ++L H + 
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 22/177 (12%)

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  IM +   HPN++ L+ V      V ++ E    G L    +KF R  E + +    Q
Sbjct: 55  EASIMGQFD-HPNIIRLEGVVTKSRPVMIITEYMENGSL----DKFLR--ENDGKFTVGQ 107

Query: 151 LMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG 203
           L+ ++        Y  E+  VHRDL   NIL+    S+   K++DFGL+  +E  ++   
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYT 164

Query: 204 TVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           T G    I   APE +A   +  A+DVWS G++++ ++S G  P+W  +   +  AV
Sbjct: 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 30/213 (14%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ++  LG+ +G G+FG   V   ++TG+  A K+I  D  VT    ++   E  +MT+L  
Sbjct: 6   QKLTLGEIIGEGEFGA--VLQGEYTGQKVAVKNIKCD--VT---AQAFLEETAVMTKLH- 57

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL---- 156
           H N+V L  V      +++VMEL + G L + L   GR       V  +QL+Q  L    
Sbjct: 58  HKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRAL-----VSVIQLLQFSLDVAE 111

Query: 157 ---YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF-YIA 212
              Y     +VHRDL   NIL++    +   K++DFGLA     G   +     P  + A
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVA---KVSDFGLARV---GSMGVDNSKLPVKWTA 165

Query: 213 PEVLAGG-YNQAADVWSAGVILYILLS-GMPPF 243
           PE L    ++  +DVWS GV+L+ + S G  P+
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 5   RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 60

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 61  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---APE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F I   APE
Sbjct: 120 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 175

Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 176 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 216

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 33/198 (16%)

Query: 91  EIEIMTRLSGHPNVVDLKAVY--EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE----- 143
           EI ++  L  HPNV+ L+ V+    +  V L+ +  A  +L+H + KF R S+A      
Sbjct: 48  EIALLRELK-HPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHII-KFHRASKANKKPVQ 104

Query: 144 -----ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLA----T 193
                 + L  Q++  + Y H   V+HRDLKP NIL+  +      +K+AD G A    +
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 194 YIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRI 251
            ++P   L   V + +Y APE+L G   Y +A D+W+ G I   LL+  P F        
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-------- 216

Query: 252 FDAVRTADLRFPSNPWDH 269
               R  D++  SNP+ H
Sbjct: 217 --HCRQEDIK-TSNPYHH 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 71/286 (24%), Positives = 127/286 (44%), Gaps = 44/286 (15%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK---LEIEIMTRLSGHPNVV 105
           +G G FG +     K +G + A K     R+ +  DE+  K   ++++++ R S  P +V
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVK-----RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66

Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFS-EAEARVLFMQLMQVVLYC------ 158
                   E    + MEL     +   L+KF ++  E    V+  +++  +         
Sbjct: 67  KFYGALFREGDCWICMEL-----MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121

Query: 159 ---HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAP 213
               E+ ++HRD+KP NILL    +   IKL DFG++  +    S+  T   G   Y+AP
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGN---IKLCDFGISGQLV--DSIAKTRDAGCRPYMAP 176

Query: 214 EVLA----GGYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTA----DLRFP 263
           E +      GY+  +DVWS G+ LY + +G  P+  W +    +FD +            
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGDPPILS 232

Query: 264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           ++     S S  + +   L  D S+R   +++L+H ++ D  +   
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNV 278

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 78/267 (29%), Positives = 117/267 (43%), Gaps = 36/267 (13%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    L ++LG GQFG +       T  V A K++      T+D +  +  E +IM +L 
Sbjct: 5   RTSIQLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPG---TMDPKDFLA-EAQIMKKLR 59

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM-----QV 154
            HP ++ L AV   E+ +++V EL   G L   L+          R L +  +     QV
Sbjct: 60  -HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG------GAGRALKLPQLIDMAAQV 112

Query: 155 ---VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
              + Y      +HRDL   N+L+     ++  K+ADFGLA  I+         G+ F I
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDI-YEAREGAKFPI 168

Query: 212 ---APEVLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
              APE  A  YN+    +DVWS G++L  I+  G  P+ G T + +   V     R P 
Sbjct: 169 KWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPC 225

Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLT 291
            P         D+++     DP  R T
Sbjct: 226 PP--GCPKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 30/226 (13%)

Query: 47  QQLGWGQFGVI-RVCSDKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           ++LG G FGV+ R       G+V   A K +  D+L  I D+     E  IM  L  H N
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK--EAAIMHSLD-HEN 57

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           ++ L  V      + +V EL   G L  RL  +  G F  +      +Q+   + Y    
Sbjct: 58  LIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLAT--------YI-EPGQSLLGTVGSPF-YI 211
             +HRDL   NILLA+      +K+ DFGL          Y+ E    +      PF + 
Sbjct: 117 RFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKV------PFAWC 167

Query: 212 APEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           APE L    ++ A+DVW  GV L+ + + G  P+ G + S+I   +
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 47  QQLGWGQFGVIRVC-----SDKFTGEVFACKSIA-KDRLVTIDDERSVKLEIEIMTRLSG 100
           + LG G FG + +C      D  TGE  A KS+  +     I D   +K EIEI+  L  
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLY- 64

Query: 101 HPNVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLY 157
           H N+V  K +  ++  + + L+ME    G L   L +   + +  +     +Q+ + + Y
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ---SLLGTVGSP-FYIAP 213
                 VHRDL   N+L+    S   +K+ DFGL   IE  +   ++   + SP F+ AP
Sbjct: 125 LGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 214 EVL-AGGYNQAADVWSAGVILYILLS 238
           E L    +  A+DVWS GV LY LL+
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 33/198 (16%)

Query: 91  EIEIMTRLSGHPNVVDLKAVY--EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE----- 143
           EI ++  L  HPNV+ L+ V+    +  V L+ +  A  +L+H + KF R S+A      
Sbjct: 48  EIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHII-KFHRASKANKKPMQ 104

Query: 144 -----ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLA----T 193
                 + L  Q++  + Y H   V+HRDLKP NIL+  +      +K+AD G A    +
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 194 YIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRI 251
            ++P   L   V + +Y APE+L G   Y +A D+W+ G I   LL+  P F        
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-------- 216

Query: 252 FDAVRTADLRFPSNPWDH 269
               R  D++  SNP+ H
Sbjct: 217 --HCRQEDIK-TSNPFHH 231

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 43/249 (17%)

Query: 52  GQFGVIRVCS-DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS----------- 99
           G FG I +C+    T E  A + +          ER +   ++  +R +           
Sbjct: 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG 218

Query: 100 --GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEA----------EARVL 147
              H N++ ++ +   E   +++ +     +    L  F  + EA          + R +
Sbjct: 219 RLNHENILKIEEILRSEANTYMITQ-----KYDFDLYSF-MYDEAFDWKDRPLLKQTRAI 272

Query: 148 FMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTV 205
             QL+  V Y H+  ++HRD+K ENI L        I L DFG A   E  +     G V
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK---IVLGDFGTAMPFEKEREAFDYGWV 329

Query: 206 GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKS------RIFDAVRT 257
           G+    +PE+LAG GY +  D+WS G+IL  +LS    P             +I D++  
Sbjct: 330 GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSV 389

Query: 258 ADLRFPSNP 266
            D  FP  P
Sbjct: 390 CDEEFPDPP 398

Length = 501

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 36/272 (13%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK----LEIEIMTRLSGHP 102
             LG G  G +       TG V A K       V I  + SV+     E++IM      P
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKV------VHIGAKSSVRKQILRELQIMHECRS-P 63

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV-----LY 157
            +V     + +E+ + + ME    G L    +K G        +L    + VV     LY
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV---EILGKIAVAVVEGLTYLY 120

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
            +   ++HRD+KP NIL+    S   IKL DFG++   E   S+  T VG+  Y++PE +
Sbjct: 121 -NVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSG--ELINSIADTFVGTSTYMSPERI 174

Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSR--------IFDAV-RTADLRFPSNP 266
            GG Y   +DVWS G+ +  L  G  PF  +            I D + +      P  P
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234

Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
                +  +D V   L  DP++R T +Q+   
Sbjct: 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 74/286 (25%), Positives = 117/286 (40%), Gaps = 47/286 (16%)

Query: 40  RERFVLGQQLGWGQFG-VIRVCSDKF-TGEVF---ACKSIAKDRLVTIDDERSVKLEIEI 94
           RE+  L ++LG G FG V    +     GE     A K++ ++   ++ +      E  +
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASV 62

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM----- 149
           M   + H +VV L  V        +VMEL A G+L   L    R  EAE           
Sbjct: 63  MKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQ 119

Query: 150 QLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT-------YI 195
           + +Q+         Y      VHRDL   N ++A       +K+ DFG+         Y 
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYR 176

Query: 196 EPGQSLLGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
           + G+ LL     P  ++APE L  G +   +DVWS GV+L+ +      P+ G +   + 
Sbjct: 177 KGGKGLL-----PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231

Query: 253 DAVRTAD-LRFPSNPWDHISDSAKDLVMGML-STDPSQRLTARQVL 296
             V     L  P N  D + +     +M M    +P  R T  +++
Sbjct: 232 KFVIDGGHLDLPENCPDKLLE-----LMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 16/215 (7%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG GQFGV+ +   +   +V A K+I +  +     E     E ++M +LS HP +V 
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKV-AIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQ 63

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V   +  +++V E    G L + L ++ G+ S+     +   + + + Y      +H
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---APEVLA-GGYN 221
           RDL   N L++   S+  +K++DFG+  Y+   +    + G+ F +    PEV     Y+
Sbjct: 124 RDLAARNCLVS---STGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYS 179

Query: 222 QAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAV 255
             +DVWS GV+++ +   G  PF   +   + + +
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 31/228 (13%)

Query: 49  LGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +G G FG VIR    K   ++ A   + K+   + +D R    E+E++ +L  HPN+++L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEK---------FGRFSEAEARVLFMQLMQVVL-- 156
               E+  Y+++ +E    G L   L K         F +     + +   QL+Q     
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 157 -----YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA----TYIEPGQSLLGTVGS 207
                Y  E   +HRDL   N+L+    +S   K+ADFGL+     Y++     L     
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLAS---KIADFGLSRGEEVYVKKTMGRLPVR-- 183

Query: 208 PFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD 253
             ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T + +++
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 29/229 (12%)

Query: 49  LGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +G G FG V++    K    + A     K+   + DD R    E+E++ +L  HPN+++L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEK---------FGRFSEAEARVLFMQLMQV---- 154
               E   Y++L +E    G L   L K         F   +   + +   QL+      
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 155 ---VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA----TYIEPGQSLLGTVGS 207
              + Y  +   +HRDL   NIL+     +   K+ADFGL+     Y+   +  +G +  
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRGQEVYV---KKTMGRLPV 175

Query: 208 PFYIAPEVLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
            +     +    Y   +DVWS GV+L+ ++S G  P+ G T + +++ +
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 17/226 (7%)

Query: 49  LGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVV 105
           +G G+FG   VCS   K  G+     +I   +    + +R   L E  IM +   HPN++
Sbjct: 12  IGAGEFG--EVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNII 68

Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            L+ V      V +V E    G L   L K  G+F+  +   +   +   + Y  ++G V
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128

Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPFYI---APEVLA-GG 219
           HRDL   NIL+    S+   K++DFGL+  +E   ++   T G    I   APE +A   
Sbjct: 129 HRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 220 YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPS 264
           +  A+DVWS G++++ ++S G  P+W  +   +  A+     R P+
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPA 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 71/263 (26%)

Query: 94  IMTRLSGHPNVVDLKAVY------EDEDYVHLVMELCAGG-------ELFHRLEKFGRFS 140
           ++ +   H N++ L  V+      E+   V++VMEL           EL H    +    
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY---- 130

Query: 141 EAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS 200
                 L  Q++  + + H  G++HRDLKP NI++    S   +K+ DFGLA     G S
Sbjct: 131 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR--TAGTS 179

Query: 201 LLGT--VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK--------- 248
            + T  V + +Y APEV+ G GY +  D+WS G I+  ++ G   F G            
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

Query: 249 ----------SRIFDAVRT-----------------ADLRFPSNPWDH---ISDSAKDLV 278
                      ++   VRT                  D+ FP++  +H    +  A+DL+
Sbjct: 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS-EHNKLKASQARDLL 298

Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
             ML  D S+R++  + L H ++
Sbjct: 299 SKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 27/229 (11%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + +     + +V A K++    +      ++   E  +M  L 
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSV----QAFLEEANLMKTLQ 59

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-------MQLM 152
            H  +V L AV   E+ ++++ E  A G L   L+     S+   +VL         Q+ 
Sbjct: 60  -HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIA 113

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI- 211
           + + Y      +HRDL+  N+L++    S   K+ADFGLA  IE  +      G+ F I 
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIK 169

Query: 212 --APEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVR 256
             APE +  G +   +DVWS G++LY I+  G  P+ G + S +  A++
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 21/231 (9%)

Query: 49  LGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVV 105
           +G G+FG   VC    K  G+     +I   +    + +R   L E  IM +   HPN++
Sbjct: 12  IGAGEFG--EVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNII 68

Query: 106 DLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGV 163
            L+ V      V ++ E    G L  F R    G+F+  +   +   +   + Y  E+  
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNY 127

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYI---APEVLA 217
           VHRDL   NIL+    S+   K++DFGL+ ++E   S      ++G    I   APE +A
Sbjct: 128 VHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 218 -GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP 266
              +  A+DVWS G++++ ++S G  P+W  +   + +A+   D R P   
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPPPM 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 36/229 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVC------------SDKFTGE--VFACKSIAKDRLVTIDDE 85
           R++  L ++LG GQFG + +C            + +F G+  + A K +  D  VT    
Sbjct: 4   RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTAR 61

Query: 86  RSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL---EKFGRFSEA 142
                EI+IM+RL  +PN++ L  V   +D + ++ E    G+L   L   E    F+ A
Sbjct: 62  NDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120

Query: 143 E-------ARVLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT 193
                   A +L+M  Q+   + Y   +  VHRDL   N L+    +   IK+ADFG++ 
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSR 177

Query: 194 YIEPGQ--SLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS 238
            +  G    + G    P  ++A E +L G +  A+DVW+ GV L+ + +
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 23/221 (10%)

Query: 40  RERFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTID-DERSVKL-EIEIMT 96
           R     G+ LG G FG V+   +   +      K   K    T    ER   + E++IM+
Sbjct: 34  RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLF-MQLMQV 154
            L  H N+V+L         + ++ E C  G+L + L +    F   E  + F  Q+ + 
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-------TYIEPGQSLLGTVGS 207
           + +      +HRDL   N+LL        +K+ DFGLA        Y+  G + L     
Sbjct: 154 MAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARL----- 205

Query: 208 PF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG 245
           P  ++APE +    Y   +DVWS G++L+ + S G  P+ G
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 79/265 (29%), Positives = 123/265 (46%), Gaps = 33/265 (12%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + + +     +V A K++      T+  E  ++ E +IM +L 
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPG---TMSPESFLE-EAQIMKKLR 59

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--------QL 151
            H  +V L AV  +E  +++V E  + G L   L+      + E R L +        Q+
Sbjct: 60  -HDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK------DGEGRALKLPNLVDMAAQV 111

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
              + Y   +  +HRDL+  NIL+         K+ADFGLA  IE  +      G+ F I
Sbjct: 112 AAGMAYIERMNYIHRDLRSANILVGDGLVC---KIADFGLARLIEDNE-YTARQGAKFPI 167

Query: 212 ---APE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP 266
              APE  L G +   +DVWS G++L  L++ G  P+ G     + + V     R P  P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPC-P 225

Query: 267 WDHISDSAKDLVMGMLSTDPSQRLT 291
            D    S  +L++     DP +R T
Sbjct: 226 QD-CPISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 66/254 (25%), Positives = 111/254 (43%), Gaps = 60/254 (23%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVF------ACKSIAKDRLVTIDDERSVKL------EIEI 94
           ++LG G FG +      + GE+       +  S+A   + T+ +    K+      E E+
Sbjct: 11  EELGEGAFGKV------YKGELTGPNERLSATSVA---IKTLKENAEPKVQQEFRQEAEL 61

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--------EKFGRFSEAEARV 146
           M+ L  HPN+V L  V   E    ++ E  A G+L   L               E     
Sbjct: 62  MSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 147 L----FMQL-MQVV-----LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT--- 193
           L    F+ + +Q+      L  H    VHRDL   N L+    +   +K++DFGL+    
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHF--VHRDLAARNCLVGEGLT---VKISDFGLSRDIY 175

Query: 194 ----YIEPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGN 246
               Y    +SLL     P  ++ PE +L G +   +D+WS GV+L+ + S G+ P++G 
Sbjct: 176 SADYYRVQSKSLL-----PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230

Query: 247 TKSRIFDAVRTADL 260
           +   + + +R+  L
Sbjct: 231 SNQEVIEMIRSRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 67/242 (27%), Positives = 101/242 (41%), Gaps = 38/242 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---------DDERSVKL 90
           R+   L + LG G FG +      + G        A +  V +          DE    +
Sbjct: 5   RDSITLLRALGHGAFGEV------YEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM 58

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  IM++ + H N+V L  V  +     +++EL AGG+L   L +  R        L M+
Sbjct: 59  EALIMSKFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMK 116

Query: 151 -LMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT-------YI 195
            L+           Y  E   +HRD+   N LL  K      K+ADFG+A        Y 
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176

Query: 196 EPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD 253
           + G+++L     P    PE  L G +    DVWS GV+L+ + S G  P+ G T   + +
Sbjct: 177 KGGRAMLPIKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232

Query: 254 AV 255
            V
Sbjct: 233 FV 234

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 31/200 (15%)

Query: 54  FGVIRVCSDKFTGEVF-ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV-- 110
           + VI+  +    G VF A K    D +V    ++   L   ++ +   HP+V+ +K    
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLV 127

Query: 111 -----------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
                      Y  + Y +L                       +A ++  Q+++ + Y H
Sbjct: 128 SGAITCMVLPHYSSDLYTYLTKRS-------------RPLPIDQALIIEKQILEGLRYLH 174

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA-G 218
              ++HRD+K ENI +        + + D G A +     + LG  G+    APEVLA  
Sbjct: 175 AQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231

Query: 219 GYNQAADVWSAGVILYILLS 238
            YN  AD+WSAG++L+ +L+
Sbjct: 232 KYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 35/229 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDR-LVTIDDERS------- 87
           R+R    ++LG GQFG + +C     +KF  + F+         LV +   R        
Sbjct: 4   RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR 63

Query: 88  ---VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL---FHRLEKFGRFSE 141
              +K EI+IM+RL   PN++ L AV    D + ++ E    G+L     R E      +
Sbjct: 64  NDFLK-EIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 142 AEAR------VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT 193
           A+        ++FM  Q+   + Y   +  VHRDL   N L+    +   IK+ADFG++ 
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT---IKIADFGMSR 178

Query: 194 YIEPGQ--SLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS 238
            +  G    + G    P  +++ E +L G +  A+DVW+ GV L+ +L+
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 77/259 (29%), Positives = 119/259 (45%), Gaps = 21/259 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 5   RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 59

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM-QLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V    Q+   + Y
Sbjct: 60  -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 117

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 118 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 173

Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 230

Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 231 SLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 45/264 (17%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK---------LEIEIMTR 97
           +++G G FG           EVF+ +  A +  V +   R             E  I+ +
Sbjct: 1   ERIGRGNFG-----------EVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQ 49

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV-- 155
            S HPN+V L  V   +  +++VMEL  GG+    L   G       R+   +L+Q+V  
Sbjct: 50  YS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVEN 102

Query: 156 -----LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG--QSLLGTVGSP 208
                 Y      +HRDL   N L+  K   + +K++DFG++   E G   S  G    P
Sbjct: 103 AAAGMEYLESKHCIHRDLAARNCLVTEK---NVLKISDFGMSREEEDGVYASTGGMKQIP 159

Query: 209 F-YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSN 265
             + APE L  G Y+  +DVWS G++L+   S G  P+   +  +  +A+    +R P  
Sbjct: 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLP-- 216

Query: 266 PWDHISDSAKDLVMGMLSTDPSQR 289
             +   D+   L+      DP QR
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 18/223 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
            +     ++LG GQFGV++    K+ G+   A K I +  +     E     E ++M +L
Sbjct: 3   PKDLTFLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKL 56

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLY 157
           S H  +V L  V   +  +++V E  + G L + L + G RF  ++   +   + + + Y
Sbjct: 57  S-HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
                 +HRDL   N L+  +     +K++DFGL+ Y+   +    +VGS F   +  PE
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGC---VKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE 171

Query: 215 VLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           VL    ++  +DVW+ GV+++ + S G  P+     S   + V
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 67/237 (28%), Positives = 109/237 (45%), Gaps = 34/237 (14%)

Query: 83  DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHR----LEKF 136
           DD R    E+E++ +L  HPN+++L    E   Y++L +E    G L  F R    LE  
Sbjct: 49  DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 108

Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKL 186
             F+ A +    +   Q++ +  ++            +HRDL   NIL+     +   K+
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA---KI 165

Query: 187 ADFGLATYIEPGQSLL--GTVGS-PF-YIAPEVLAGG-YNQAADVWSAGVILYILLS-GM 240
           ADFGL+     GQ +    T+G  P  ++A E L    Y   +DVWS GV+L+ ++S G 
Sbjct: 166 ADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 221

Query: 241 PPFWGNTKSRIFDAVRTA-DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
            P+ G T + +++ +     L  P N      D   DL+       P +R +  Q+L
Sbjct: 222 TPYCGMTCAELYEKLPQGYRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 48  QLGWGQFGVIR--VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI----EIMTRLSGH 101
           +LG G FG ++  +   K + +  A K +  D     +++ ++K E+     +M +L  +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-----NNDPALKDELLREANVMQQLD-N 55

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           P +V +  + E E ++ LVMEL   G L   L+K    +E     L  Q+   + Y  E 
Sbjct: 56  PYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS---PF-YIAPEVLA 217
             VHRDL   N+LL T+  +   K++DFGL+  +   ++          P  + APE + 
Sbjct: 115 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171

Query: 218 -GGYNQAADVWSAGVILYILLS-GMPPFWG 245
              ++  +DVWS GV+++   S G  P+ G
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 73/305 (23%), Positives = 117/305 (38%), Gaps = 73/305 (23%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI------EIMTRLS-- 99
           +LG G  GV+     + +G + A K I               LEI      +I+  L   
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLI--------------HLEIKPAIRNQIIRELKVL 53

Query: 100 ---GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEA-EARVLFMQLMQVV 155
                P +V     +  +  + + ME   GG L   L+K GR  E    ++    L  + 
Sbjct: 54  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLT 113

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ---SLLGT-VGSPFYI 211
               +  ++HRD+KP NIL+    S   IKL DFG++     GQ   S+  + VG+  Y+
Sbjct: 114 YLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYM 165

Query: 212 APEVLAGG-YNQAADVWSAGVILYILLSGM---PPFWGNTKSRIF----------DAVRT 257
           +PE L G  Y   +D+WS G+ L  +  G    PP        +F          ++ R 
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225

Query: 258 ADLRFPSN---------------------PWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
                P +                     P    SD  +D V   L  +P +R   +++ 
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285

Query: 297 DHSWM 301
            H ++
Sbjct: 286 KHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 19/95 (20%)

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           QL+  + Y H  G++HRD+K EN+L+        I L DFG A +        G+  +PF
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFAR------GSWSTPF 318

Query: 210 YI---------APEVLAGG-YNQAADVWSAGVILY 234
           +          APEVLAG  Y  + D+WSAG++++
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 18/215 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + +       +V A KS+ +  +       +   E  +M +L 
Sbjct: 5   RETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQ 59

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HP +V L AV   E  ++++ E    G L   L+          +++ M  Q+ + + +
Sbjct: 60  -HPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---APE 214
                 +HRDL+  NIL++        K+ADFGLA  IE  +      G+ F I   APE
Sbjct: 118 IERKNYIHRDLRAANILVSETLCC---KIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 173

Query: 215 VLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNT 247
            +  G +   +DVWS G++L  I+  G  P+ G T
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 52/293 (17%)

Query: 40  RERFVLGQQLGWGQFG-VIR---VCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEI 94
           R+R  LG+ LG G FG V++   V  D        A K +  D   T  D   +  E+E+
Sbjct: 11  RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEM 68

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHR-------LEKFGRFSEAEAR 145
           M  +  H N+++L  V   E  +++V+E  A G L  F R                 E  
Sbjct: 69  MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 146 VLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT----- 193
           +    L+           +      +HRDL   N+L+        +K+ADFGLA      
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHI 185

Query: 194 --YIEPGQSLLGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTK 248
             Y +     L     P  ++APE L    Y   +DVWS GV+L+ I   G  P+ G   
Sbjct: 186 DYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240

Query: 249 SRIFDAVRTAD-LRFPSNPWDHISDSAKDLVMGMLS---TDPSQRLTARQVLD 297
             +F  ++    +  P N         ++L   M       PSQR T +Q+++
Sbjct: 241 EELFKLLKEGYRMEKPQN-------CTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 20/216 (9%)

Query: 49  LGWGQFGVIR--VCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEIMTRLSGHPNV 104
           LG G FG +      DK    V  CK         +  E  +K   E  I+ +   HPN+
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKE-------DLPQELKIKFLSEARILKQYD-HPNI 54

Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-MQLMQVVLYCHEIGV 163
           V L  V      +++VMEL  GG+    L K     + +  V F +     + Y      
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPF-YIAPEVLA-GGY 220
           +HRDL   N L+     ++ +K++DFG++   + G  S  G    P  + APE L  G Y
Sbjct: 115 IHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 221 NQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           +  +DVWS G++L+   S G+ P+ G T  +  + V
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 52/294 (17%)

Query: 40  RERFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTI------DDERSVKL-- 90
           R+R VLG+ LG G FG V+R        E +       D+ VT+      D+     L  
Sbjct: 11  RDRLVLGKPLGEGCFGQVVR-------AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD 63

Query: 91  ---EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEK-------FGR 138
              E+E+M  +  H N+++L  V   E  +++++E  A G L  F R  +       F  
Sbjct: 64  LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123

Query: 139 FSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGL 191
               E ++ F  L+           Y      +HRDL   N+L+      + +K+ADFGL
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGL 180

Query: 192 ATYIEPGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGN 246
           A  +        T        ++APE L    Y   +DVWS G++++ I   G  P+ G 
Sbjct: 181 ARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240

Query: 247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS---TDPSQRLTARQVLD 297
               +F  +R        +  D  S+   +L M M       P+QR T +Q+++
Sbjct: 241 PVEELFKLLREG------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 65/255 (25%), Positives = 115/255 (45%), Gaps = 26/255 (10%)

Query: 24  RSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID 83
           +   ET   ++  S +R ++ +   L  G  G + VC+    G+    K I K     + 
Sbjct: 75  QEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVK----AVT 128

Query: 84  DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL--CAGGELFHRLEKFGRFSE 141
             ++   EI+I+  +S H  +++L   Y  +  V +VM    C   +LF  +++ G    
Sbjct: 129 GGKTPGREIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPL 184

Query: 142 AEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---G 198
            +A  +  +L++ + Y H  G++HRD+K ENI L    ++    L DFG A  ++     
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV---LGDFGAACKLDAHPDT 241

Query: 199 QSLLGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWG---NTKSR---- 250
               G  G+    +PE+LA   Y    D+WSAG++L+ +       +G    + S     
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301

Query: 251 IFDAVRTADLRFPSN 265
           I   ++   L FP N
Sbjct: 302 IIRCMQVHPLEFPQN 316

Length = 392

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 79/320 (24%), Positives = 130/320 (40%), Gaps = 66/320 (20%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM--TRL 98
           +RF +   LG G FG +    D+   E  A K +      T    R  K+EI+ M   R 
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT----RDAKIEIQFMEKVRQ 184

Query: 99  SGHPNVVDLKAV--YEDEDYVHLVMELCAGGE-LFHRLEKFGRFSEAEARVLFMQLMQVV 155
           +   +   L  +  Y   +  H+ + +   G  L   + K G FS      +  Q    +
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244

Query: 156 LYCH-EIGVVHRDLKPENILLATKASS-----------SPIKLADFGLATYIEPGQSLLG 203
            Y H E+ ++H DLKPENIL+ T  +             P ++    L    +   S   
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA 304

Query: 204 TVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSG----------------------M 240
            V +  Y +PEV+ G G+  + D+WS G I+Y L +G                      +
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364

Query: 241 PPFW----GNTKSR-IFDAVRTADLRFPSNPWDHISDSAK--------------DLVMGM 281
           P  W    G  ++R ++++     LR  ++P  H++  A+              DL+ G+
Sbjct: 365 PSEWAGRCGTEEARLLYNSA--GQLRPCTDP-KHLARIARARPVREVIRDDLLCDLIYGL 421

Query: 282 LSTDPSQRLTARQVLDHSWM 301
           L  D  +RL ARQ+  H ++
Sbjct: 422 LHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 18/223 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T +V A K++      T+  E  ++ E +IM +L 
Sbjct: 5   RESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPG---TMMPEAFLQ-EAQIMKKLR 59

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E    G L   L E  G++ +    V +  Q+   + Y
Sbjct: 60  -HDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  +HRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 118 IERMNYIHRDLRAANILVGDNLVC---KIADFGLARLIEDNE-YTARQGAKFPIKWTAPE 173

Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
             L G +   +DVWS G++L  L++ G  P+ G     + + V
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G + A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 68

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQ---SLLGT-VGSPFYIAPEVLAGG-YN 221
           D+KP NIL+ ++     IKL DFG++     GQ   S+  + VG+  Y++PE L G  Y+
Sbjct: 129 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 222 QAADVWSAGVILYILLSGMPP 242
             +D+WS G+ L  +  G  P
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 30/95 (31%), Positives = 57/95 (60%), Gaps = 2/95 (2%)

Query: 205 VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP 263
           +G+P Y+APE+L G  +  A D W+ GV L+  L+G+PPF   T  ++F  +   D+ +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
               + +S +A++ +  +L+ DP++R   +++  H
Sbjct: 601 EGE-EKLSVNAQNAIEILLTMDPTKRAGLKELKQH 634

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVVDL 107
           +G G+FG +     K  G      +I   +    + +R   L E  IM + S H N++ L
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRL 71

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           + V        ++ E    G L   L +  G FS  +   +   +   + Y  ++  VHR
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR 131

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIE--PGQSLLGTVGS-PF-YIAPEVLA-GGYN 221
           DL   NIL+    S+   K++DFGL+  +E  P  +   + G  P  + APE +A   + 
Sbjct: 132 DLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 222 QAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
            A+DVWS G++++ ++S G  P+W  +   +  A+     R P+ P D
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPA-PMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 42/289 (14%)

Query: 40  RERFVLGQQLGWGQFGVIRVCS---------DKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           R+R VLG+ LG G FG + +           ++ T    A K +  D   T  D   +  
Sbjct: 17  RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTK--VAVKMLKSD--ATEKDLSDLIS 72

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE---------------- 134
           E+E+M  +  H N+++L      +  +++++E  + G L   L                 
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 135 KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY 194
              + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARD 189

Query: 195 IEPGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKS 249
           I        T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G    
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249

Query: 250 RIFDAVRTAD-LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
            +F  ++    +  PSN  + +    +D    +    PSQR T +Q+++
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAV----PSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKD---RLVTIDDERSVKLEI----EIMTRLSG 100
           +LG G FG ++         V+  +    D   +++  ++E+SV+ E+    EIM +L  
Sbjct: 2   ELGSGNFGCVK-------KGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD- 53

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVL-- 156
           +P +V +  V E E  + LVME+ +GG L     KF  G+  E     +   + QV +  
Sbjct: 54  NPYIVRMIGVCEAEALM-LVMEMASGGPL----NKFLSGKKDEITVSNVVELMHQVSMGM 108

Query: 157 -YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG--TVGS-PF-YI 211
            Y      VHRDL   N+LL  +  +   K++DFGL+  +    S     + G  P  + 
Sbjct: 109 KYLEGKNFVHRDLAARNVLLVNQHYA---KISDFGLSKALGADDSYYKARSAGKWPLKWY 165

Query: 212 APE-VLAGGYNQAADVWSAGVILYILLS-GMPPF 243
           APE +    ++  +DVWS G+ ++   S G  P+
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 69/291 (23%), Positives = 116/291 (39%), Gaps = 51/291 (17%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---------DDERSVKL 90
           R+  VL ++LG G FG  +V    F GE +  +      LV +         D  +  + 
Sbjct: 4   RDTIVLKRELGEGAFG--KV----FLGECYHLEPENDKELVAVKTLKETASNDARKDFER 57

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-------FSEAE 143
           E E++T    H N+V    V  + D   +V E    G+L   L   G             
Sbjct: 58  EAELLTNF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116

Query: 144 ARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT--- 193
             +   QL+Q+ +       Y      VHRDL   N L+        +K+ DFG++    
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV---VKIGDFGMSRDVY 173

Query: 194 ----YIEPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGN 246
               Y   G ++L     P  ++ PE ++   +   +DVWS GV+L+ I   G  P++G 
Sbjct: 174 TTDYYRVGGHTML-----PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228

Query: 247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           +   + + +    L     P         D+++G    DP QR+  + + +
Sbjct: 229 SNEEVIECITQGRLLQR--PRT-CPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 17/201 (8%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+     K +G + A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 68

Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L++  R  E     + + +++ + Y  E   ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 128

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQ---SLLGT-VGSPFYIAPEVLAGG-YN 221
           D+KP NIL+ ++     IKL DFG++     GQ   S+  + VG+  Y++PE L G  Y+
Sbjct: 129 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 222 QAADVWSAGVILYILLSGMPP 242
             +D+WS G+ L  L  G  P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 65/260 (25%), Positives = 117/260 (45%), Gaps = 23/260 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCS-DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG + + + +K T    A K++    +          L    + + 
Sbjct: 5   RESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSV-----EAFLAEANVMKT 57

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVL 156
             H  +V L AV   E  ++++ E  A G L  F + ++  +    +      Q+ + + 
Sbjct: 58  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---AP 213
           +  +   +HRDL+  NIL++        K+ADFGLA  IE  +      G+ F I   AP
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVC---KIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172

Query: 214 EVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           E +  G +   +DVWS G++L  +++ G  P+ G +   +  A+     R P    ++  
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRP--ENCP 229

Query: 272 DSAKDLVMGMLSTDPSQRLT 291
           +   +++M      P +R T
Sbjct: 230 EELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 36/286 (12%)

Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 14  RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 72

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE---------KFGRFSEAEA 144
           +M  +  H N+++L      +  +++++E  + G L   L           +      + 
Sbjct: 73  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132

Query: 145 RVLF-------MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           ++ F        Q+ + + Y      +HRDL   N+L+     ++ +K+ADFGLA  +  
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNN 189

Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249

Query: 253 DAVRTAD-LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
             ++    +  P+N  + +    +D    +    PS R T +Q+++
Sbjct: 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAI----PSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 40/288 (13%)

Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R R  LG+ LG G FG       I +  DK    V     + KD   T  D   +  E+E
Sbjct: 11  RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEME 69

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE---------KFGRFSEAEA 144
           +M  +  H N+++L      +  +++++E  + G L   L           F      E 
Sbjct: 70  MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129

Query: 145 RVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           ++ F  L+           Y      +HRDL   N+L+      + +K+ADFGLA  +  
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHN 186

Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +F
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLS---TDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 247 KLLKEG------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 41/232 (17%)

Query: 40  RERFVLGQQLGWGQFGVIRVC---------------SDKFTGEV-FACKSIAKDRLVT-- 81
           R+     ++LG GQFG + +C               +D     V  A K +  D      
Sbjct: 4   RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63

Query: 82  IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSE 141
            D  +    E++I++RLS  PN+  L  V   +  + ++ME    G+L   L+K    + 
Sbjct: 64  EDFLK----EVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 142 AEAR---------VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
             A          +L+M  Q+   + Y   +  VHRDL   N L+     +  IK+ADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG---KNYTIKIADFG 175

Query: 191 LAT--YIEPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS 238
           ++   Y      + G    P  ++A E VL G +   +DVW+ GV L+ +L+
Sbjct: 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 20/210 (9%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            +   L Q +G G+FG + +    + G   A K I  D        ++   E  +MT+L 
Sbjct: 5   MKELKLLQTIGKGEFGDVML--GDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR 57

Query: 100 GHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL--FMQLMQVVL 156
            H N+V L  V  E++  +++V E  A G L   L   GR       +L   + + + + 
Sbjct: 58  -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF-YIAPEV 215
           Y      VHRDL   N+L++    +   K++DFGL       Q    T   P  + APE 
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVA---KVSDFGLTKEASSTQD---TGKLPVKWTAPEA 170

Query: 216 L-AGGYNQAADVWSAGVILYILLS-GMPPF 243
           L    ++  +DVWS G++L+ + S G  P+
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 47/297 (15%)

Query: 54  FGVIRVCSDKFTGEVFAC-KSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE 112
           F ++   +    G  FAC  +   + +V    +R        + R   HP+++ LK  + 
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFT 153

Query: 113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN 172
              +  L++      +L+  L      +  +   +   +++ + Y HE  ++HRD+K EN
Sbjct: 154 YNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212

Query: 173 ILLATKASSSPIKLADFGLATY-IEPGQS-LLGTVGSPFYIAPEVLA-GGYNQAADVWSA 229
           I +        + L DFG A + ++   +   G  G+    APE+LA   Y  A D+WSA
Sbjct: 213 IFINHPGD---VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269

Query: 230 GVILYILLSGMPPFW------GNTKSR-----IFDAVRTADLRFPSNP------------ 266
           G++L+ + +     +      G+  S      I     T    FP +             
Sbjct: 270 GIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLA 329

Query: 267 ------------WDHISDSAKD---LVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
                       W ++ +   D   L+  ML+ D   R +A  +LD +   D I DP
Sbjct: 330 KKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD-IPDP 385

Length = 391

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 46/253 (18%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-- 99
             VLG+ LG G+FG +           F  K  A    V +   +      E+   LS  
Sbjct: 1   NLVLGKTLGEGEFGKV------VKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF 54

Query: 100 ------GHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEK------FGRFSEAEAR 145
                  HP+V+ L      +  + L++E    G L  F R  +       G      + 
Sbjct: 55  NLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSS 114

Query: 146 VLF----------------MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF 189
            L                  Q+ + + Y  E+ +VHRDL   N+L+   A    +K++DF
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDF 171

Query: 190 GLATYIEPGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFW 244
           GL+  +    S +          ++A E L    Y   +DVWS GV+L+ +++ G  P+ 
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231

Query: 245 GNTKSRIFDAVRT 257
           G    R+F+ ++T
Sbjct: 232 GIAPERLFNLLKT 244

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 68/270 (25%), Positives = 108/270 (40%), Gaps = 30/270 (11%)

Query: 43  FVLGQQLGWGQFGVI---RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
             LG+ LG G+FG +   ++  D  +    A K++  D     + E  +  E   M    
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFD 59

Query: 100 GHPNVVDLKAV-YEDEDYVHL-----VMELCAGGEL-----FHRLEKFGRFSEAEARVLF 148
            HPNV+ L  V +E      +     ++     G+L     + RL         +  + F
Sbjct: 60  -HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 149 M-QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS 207
           M  +   + Y      +HRDL   N +L    +   + +ADFGL+  I  G        +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---VCVADFGLSKKIYSGDYYRQGRIA 175

Query: 208 PF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTAD-LR 261
                +IA E LA   Y   +DVW+ GV ++ I   G  P+ G     I+D +R  + L+
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235

Query: 262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLT 291
            P    +   D   DL+      DP  R T
Sbjct: 236 QP----EDCLDELYDLMYSCWRADPKDRPT 261

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 41/236 (17%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACK---SIAKDR--LVTID--------DER 86
           R   +  ++LG GQFG + +C      ++   +   ++ K R  LV +         + R
Sbjct: 4   RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR 63

Query: 87  SVKL-EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL------FHRLEKFGRF 139
           +  L E++I++RL   PN++ L  V  DED + ++ E    G+L       H  +K    
Sbjct: 64  NDFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122

Query: 140 SEAEAR------VLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKL 186
           ++A         + +  L+ V L       Y   +  VHRDL   N L+    +   IK+
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT---IKI 179

Query: 187 ADFGLATYIEPGQ--SLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS 238
           ADFG++  +  G    + G    P  ++A E +L G +  A+DVW+ GV L+ +L 
Sbjct: 180 ADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 8/94 (8%)

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS--PF-YIAP 213
           Y  E  +VHRDL   N+L+ T      +K+ DFGLA  ++  +      G   P  ++A 
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 214 E-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG 245
           E +L   Y   +DVWS GV ++ L++ G  P+ G
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 67/269 (24%), Positives = 115/269 (42%), Gaps = 32/269 (11%)

Query: 43  FVLGQQLGWGQFGVIR---VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           F LG+ LG G+FG +R   + S+  + +  A K +  D   + D E  ++ E   M    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 100 GHPNV-----VDLKAVYEDEDYVHLV-MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
            HPNV     V L++  +    + +V +     G+L H      R  E    +    L++
Sbjct: 60  -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFLLMSRIGEEPFTLPLQTLVR 117

Query: 154 VVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG 206
            ++       Y      +HRDL   N +L    +   + +ADFGL+  I  G        
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT---VCVADFGLSKKIYSGDYYRQGCA 174

Query: 207 SPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTAD-L 260
           S     ++A E LA   Y   +DVW+ GV ++ I+  G  P+ G   S I++ +   + L
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234

Query: 261 RFPSNPWDHISDSAKDLVMGMLSTDPSQR 289
           + P +  + +     +L+    S +P  R
Sbjct: 235 KQPPDCLEDVY----ELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 27/199 (13%)

Query: 68  VFACKSIAKDRLVTI--------DDERSVKLEIEI-MTRLSGHPNVVDLKAVYEDEDYVH 118
           V   K    + LV +          E    L+ EI  +R   HPN++     +  +  ++
Sbjct: 16  VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELY 75

Query: 119 LVMELCAGG---ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL 175
           +V  L A G   +L       G   E     +   ++  + Y H  G +HR +K  +ILL
Sbjct: 76  VVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL 134

Query: 176 ATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYI-------APEVLAG---GYNQAA 224
              +    + L+    + + I+ G+        P          +PEVL     GYN+ +
Sbjct: 135 ---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS 191

Query: 225 DVWSAGVILYILLSGMPPF 243
           D++S G+    L +G  PF
Sbjct: 192 DIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 60/294 (20%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---------TIDDERSVKL 90
           R   VL ++LG G FG +      F  E +   S  KD+++         T+   +  + 
Sbjct: 4   RRDIVLKRELGEGAFGKV------FLAECYNL-SPTKDKMLVAVKALKDPTLAARKDFQR 56

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL--- 147
           E E++T L  H ++V    V  D D + +V E    G+L     KF R    +A +L   
Sbjct: 57  EAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDL----NKFLRAHGPDAMILVDG 111

Query: 148 ----------FMQLMQV-------VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                       Q++ +       ++Y      VHRDL   N L+    ++  +K+ DFG
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFG 168

Query: 191 LAT-------YIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMP 241
           ++        Y   G ++L     P    PE ++   +   +DVWS GVIL+ I   G  
Sbjct: 169 MSRDVYSTDYYRVGGHTMLPIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Query: 242 PFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
           P++  + + + + +     R    P         D+++G    +P QRL  +++
Sbjct: 225 PWFQLSNTEVIECITQG--RVLERP-RVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 12/152 (7%)

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL--FMQLMQVVLYC 158
           H  +V L  +      + LV +L   G L   + +  R S    R+L   +Q+ + + Y 
Sbjct: 68  HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYL 125

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG--QSLLGTVGSPF-YIAPE- 214
            E  +VHR+L   NILL    S S +++ADFG+A  + P   +       +P  ++A E 
Sbjct: 126 EEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 215 VLAGGYNQAADVWSAGVILYILLS-GMPPFWG 245
           +L G Y   +DVWS GV ++ ++S G  P+ G
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 34/196 (17%)

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL------EKFGRFSEAEA 144
           E  +M  L  HPN+V L  V   E  V ++ E    G+L   L         G  S+ + 
Sbjct: 57  EASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 145 RV-----------LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT 193
            V           + +Q+   + Y      VH+DL   NIL+  +     +K++D GL+ 
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH---VKISDLGLSR 172

Query: 194 YIEPG-------QSLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFW 244
            I          +SLL     P    PE ++ G ++  +D+WS GV+L+ + S G+ P++
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMP----PEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228

Query: 245 GNTKSRIFDAVRTADL 260
           G +   + + VR   L
Sbjct: 229 GFSNQEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 18/190 (9%)

Query: 117 VHLVMELCAGGELF-HRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL 175
           V LV +L   G L  +  E   R    +     +Q+ + + Y  E+ +VHRDL   N+L+
Sbjct: 83  VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142

Query: 176 ATKASSSPIKLADFGLATYIEPGQSLL----GTVGSPFYIAPEVLAGGYNQAADVWSAGV 231
               S + +K+ DFGLA  ++  ++      G V   +     +L   +   +DVWS GV
Sbjct: 143 ---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199

Query: 232 ILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS---TDPS 287
            ++ L++ G  P+ G     I D +   + R P  P         D+ M M+     D  
Sbjct: 200 TVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQPP-----ICTIDVYMIMVKCWMIDSE 253

Query: 288 QRLTARQVLD 297
            R   R+++D
Sbjct: 254 CRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 23/208 (11%)

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL---- 156
           H N+V L+ V    + + +V E  + G L   L K       E +++  QLM ++     
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH------EGQLVAGQLMGMLPGLAS 118

Query: 157 ---YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT--YIEPGQSLLGTVGSPFYI 211
              Y  E+G VH+ L    +L+    S    K++ F        E   + +       + 
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175

Query: 212 APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
           APE +    ++ A+DVWS G++++ ++S G  P+W  +   +  AV     R P     +
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLP--APRN 232

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLD 297
             +    L++     +  +R    Q+  
Sbjct: 233 CPNLLHQLMLDCWQKERGERPRFSQIHS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 48/252 (19%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDR------LVTIDDERSVKLEIE 93
           RE+  + ++LG G FG++      + G     K + KD       + T+++  S++  IE
Sbjct: 5   REKITMSRELGQGSFGMV------YEG---IAKGVVKDEPETRVAIKTVNEAASMRERIE 55

Query: 94  ------IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL 147
                 +M   + H +VV L  V        ++MEL   G+L   L       E      
Sbjct: 56  FLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 148 FMQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLAT---- 193
              L +++    EI            VHRDL   N ++A   +   +K+ DFG+      
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYE 171

Query: 194 ---YIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTK 248
              Y + G+ LL       +++PE L  G +   +DVWS GV+L+ I      P+ G + 
Sbjct: 172 TDYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227

Query: 249 SRIFDAVRTADL 260
            ++   V    L
Sbjct: 228 EQVLRFVMEGGL 239

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 22/153 (14%)

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLA--TYIEPGQSLLGTVGSPF-YIAPE-VLAGG 219
           +HRDL   NILL+     + +K+ DFGLA   Y +P     G    P  ++APE +    
Sbjct: 195 IHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251

Query: 220 YNQAADVWSAGVILYILLS-GMPPFWG-----NTKSRIFDAVRTADLRFPSNPWDHISDS 273
           Y   +DVWS GV+L+ + S G  P+ G         R+ +  R   +R P    ++ +  
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---MRAP----EYATPE 304

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
              +++     +P  R T  ++++   +GD +Q
Sbjct: 305 IYSIMLDCWHNNPEDRPTFSELVEI--LGDLLQ 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 69/250 (27%), Positives = 108/250 (43%), Gaps = 33/250 (13%)

Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS----- 99
           LG+ LG G+FG +        G++    SI K  + T+      + E+E     +     
Sbjct: 3   LGKTLGEGEFGSV------MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKE 56

Query: 100 -GHPNVVDLKAV----YEDEDYVH--LVMELCAGGEL-----FHRLEKFGRFSEAEARVL 147
             HPNV+ L  V     E E Y    +++     G+L     + RL    ++   +  V 
Sbjct: 57  FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK 116

Query: 148 FM-QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL-LGTV 205
           FM  +   + Y      +HRDL   N +L    +   + +ADFGL+  I  G     G +
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVADFGLSKKIYNGDYYRQGRI 173

Query: 206 GS-PF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTAD-L 260
              P  +IA E LA   Y   +DVWS GV ++ I   G  P+ G   S I+D +R  + L
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233

Query: 261 RFPSNPWDHI 270
           + P +  D +
Sbjct: 234 KQPPDCLDGL 243

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 22/153 (14%)

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLA--TYIEPGQSLLGTVGSPF-YIAPEVLAGG- 219
           +HRDL   NILL+     + +K+ DFGLA   Y +P     G    P  ++APE +    
Sbjct: 201 IHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 220 YNQAADVWSAGVILYILLS-GMPPFWG-----NTKSRIFDAVRTADLRFPSNPWDHISDS 273
           Y   +DVWS GV+L+ + S G  P+ G         R+ +  R   +R P    D+ +  
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---MRAP----DYTTPE 310

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
               ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 311 MYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 43/223 (19%)

Query: 40  RERFVLGQQLGWGQFGVIR--VCSDKFTGEVFACKSIAKDRLV--TIDDERSVKLEIE-- 93
           RE+  L ++LG G FG++      D   GE       A+ R+   T+++  S++  IE  
Sbjct: 5   REKITLLRELGQGSFGMVYEGNARDIIKGE-------AETRVAVKTVNESASLRERIEFL 57

Query: 94  ----IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
               +M   + H +VV L  V        +VMEL A G+L   L      +E        
Sbjct: 58  NEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 150 QLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLAT------ 193
            L +++    EI            VHRDL   N ++A   +   +K+ DFG+        
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETD 173

Query: 194 -YIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY 234
            Y + G+ LL        +APE L  G +  ++D+WS GV+L+
Sbjct: 174 YYRKGGKGLLPVRW----MAPESLKDGVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 36/156 (23%)

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           +K+  E  D+VH+V ++ AG E                           L  H   VVH+
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEF--------------------------LSSHH--VVHK 148

Query: 167 DLKPENILLATKASSSPIKLADFGL--ATYIEPGQSLLGTVGSPF-YIAPE-VLAGGYNQ 222
           DL   N+L+  K +   +K++D GL    Y      L+G    P  +++PE ++ G ++ 
Sbjct: 149 DLATRNVLVFDKLN---VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI 205

Query: 223 AADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT 257
            +D+WS GV+L+ + S G+ P+ G +   + + +R 
Sbjct: 206 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 28/236 (11%)

Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSV---KLEIEIMTRLSGHPNV 104
            LG G+FG + +   K   E      +    L    DE      + E+++  +LS H NV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNV 70

Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM---QVVLYCHEI 161
           V L  +  + +  ++++E    G+L    ++F R ++++   L    +   Q V  C +I
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDL----KQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 162 G----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIEPGQSLLGTVGSPF 209
                       VHRDL   N L++   S   +K++   L+   Y      L   +    
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVS---SQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183

Query: 210 YIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFP 263
           ++APE V    ++  +DVWS GV+++ +   G  PF+G +   + + ++   L  P
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 22/154 (14%)

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLA--TYIEPGQSLLGTVGSPF-YIAPE-VLAGG 219
           +HRDL   NILL+    ++ +K+ DFGLA   Y +P     G+   P  ++APE +    
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 220 YNQAADVWSAGVILYILLS-GMPPFWG-----NTKSRIFDAVRTADLRFPSNPWDHISDS 273
           Y   +DVWS GV+L+ + S G  P+ G         R+ D  R   +R P    ++ +  
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR---MRAP----ENATPE 305

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD 307
              +++     DP +R T   +++   +GD +Q+
Sbjct: 306 IYRIMLACWQGDPKERPTFSALVE--ILGDLLQE 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 57/226 (25%), Positives = 87/226 (38%), Gaps = 41/226 (18%)

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHR--------------------LEKFGR 138
           HPN+V L  V      + L+ E  A G+L  F R                          
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL------A 192
            S  E   +  Q+   + Y  E   VHRDL   N L+        +K+ADFGL      A
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLSRNIYSA 183

Query: 193 TYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSR 250
            Y +  ++    +    ++ PE +    Y   +DVW+ GV+L+ + S GM P++G     
Sbjct: 184 DYYKASENDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240

Query: 251 IFDAVRTAD-LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
           +   VR  + L  P N          +L+    S  PS R +   +
Sbjct: 241 VIYYVRDGNVLSCPDN----CPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 18/143 (12%)

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLA-------TYIEPGQSLLGTVGSPFYIAPE-V 215
           VHRDL   N+LLA       +K+ DFGLA        Y+  G + L       ++APE +
Sbjct: 259 VHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESI 311

Query: 216 LAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
               Y   +DVWS G++L+ + S G  P+ G      F     +  R  + P DH +   
Sbjct: 312 FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKP-DHATQEV 369

Query: 275 KDLVMGMLSTDPSQRLTARQVLD 297
            D+++   +++P +R +   + D
Sbjct: 370 YDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 54/213 (25%)

Query: 40  RERFVLGQQLGWGQFG------------------VIRVCSDKFTGEVF-------ACKSI 74
           ++ FVLG++LG G FG                  V++  ++    E++       AC + 
Sbjct: 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNS 190

Query: 75  AKDRLVTIDDERSVKLEIE--IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR 132
             D +    +  S K E E  ++ R  G   + DL      +++ + V        L  +
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQ---SKEFPYNVEPY-----LLGK 242

Query: 133 LEKFGRFSEAEARVLFMQLMQVVLYC----HEIGVVHRDLKPENILLATKASSSPIKLAD 188
           ++   +  E E +++   +M+ +L+     H  G+VHRD+KP+NI+ +  + S   K+ D
Sbjct: 243 VQDLPKGLERENKII-QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--FKIID 299

Query: 189 FGLAT-------YIEPGQSLLGTVGSPFYIAPE 214
            G A        YI P + LL     P Y APE
Sbjct: 300 LGAAADLRVGINYI-PKEFLL----DPRYAAPE 327

Length = 566

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 9/123 (7%)

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP 208
           +Q+ + ++Y  E  +VHRDL   N+L+    S + +K+ DFGLA  +E  +      G  
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGGK 172

Query: 209 F---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
               ++A E +    +   +DVWS GV ++ L++ G  P+ G     I D +   + R P
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLP 231

Query: 264 SNP 266
             P
Sbjct: 232 QPP 234

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 53/240 (22%), Positives = 102/240 (42%), Gaps = 32/240 (13%)

Query: 40  RERFVLGQQLGWGQFGVI------RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R   VL ++LG G FG +       +C ++   ++       KD   + +  +    E E
Sbjct: 4   RHNIVLKRELGEGAFGKVFLAECYNLCPEQ--DKILVAVKTLKD--ASDNARKDFHREAE 59

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-------------RFS 140
           ++T L  H ++V    V  + D + +V E    G+L   L   G               +
Sbjct: 60  LLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118

Query: 141 EAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA--TYIEPG 198
           +++   +  Q+   ++Y      VHRDL   N L+     +  +K+ DFG++   Y    
Sbjct: 119 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDY 175

Query: 199 QSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAV 255
             + G    P  ++ PE ++   +   +DVWS GV+L+ I   G  P++  + + + + +
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 17/156 (10%)

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL----GT 204
           +Q+ + + Y  E  +VHRDL   N+L+ T      +K+ DFGLA  +   +       G 
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGADEKEYHAEGGK 172

Query: 205 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
           V   +     +L   Y   +DVWS GV ++ L++ G  P+ G   S I   +   + R P
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP 231

Query: 264 SNPWDHISDSAKDLVMGMLS---TDPSQRLTARQVL 296
             P   I     D+ M M+     D   R   R+++
Sbjct: 232 QPPICTI-----DVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 21/215 (9%)

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFM 149
             +M++LS H ++V L  V   ++ + +V E    G L  F   EK    S      +  
Sbjct: 52  ASLMSQLS-HKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNN-VSLHWKLDVAK 108

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLA---TKASSSP-IKLADFGLATYIEPGQSLLGTV 205
           QL   + Y  +  +VH ++  +NIL+A         P IKL+D G+   +   +  +   
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER- 167

Query: 206 GSPFYIAPEVLAGGY---NQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLR 261
             P +IAPE +  G      AAD WS G  L  I  +G  P    + S      +    R
Sbjct: 168 -IP-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-R 224

Query: 262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
            P      ++    +L+    + DP++R + R +L
Sbjct: 225 LPMPDCAELA----NLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 59/287 (20%), Positives = 115/287 (40%), Gaps = 47/287 (16%)

Query: 40  RERFVLGQQLGWGQFGVIRV--CSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           R   VL  +LG G FG + +  C +    +     ++   +  +    +  + E E++T 
Sbjct: 4   RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV 63

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL---------- 147
           L  H ++V    V  +   + +V E    G+L     +F R    +A++L          
Sbjct: 64  LQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDL----NRFLRSHGPDAKILAGGEDVAPGQ 118

Query: 148 --FMQLMQV-------VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT----- 193
               Q++ +       ++Y   +  VHRDL   N L+        +K+ DFG++      
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV---VKIGDFGMSRDIYST 175

Query: 194 --YIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKS 249
             Y   G+++L     P    PE +L   +   +D+WS GV+L+ I   G  P++  + +
Sbjct: 176 DYYRVGGRTMLPIRWMP----PESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231

Query: 250 RIFDAVRTA-DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
              + +    +L  P             ++ G    +P QR+  + +
Sbjct: 232 EAIECITQGRELERPRT----CPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG--QSLLGTVG 206
           +Q+   + Y H+ GV+H+D+   N ++        +K+ D  L+  + P     L     
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKITDNALSRDLFPMDYHCLGDNEN 180

Query: 207 SPF-YIAPEVLAGG-YNQAADVWSAGVILYIL--LSGMP 241
            P  ++A E L    Y+ A+DVWS GV+L+ L  L   P
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 19/185 (10%)

Query: 70  ACKSIAKDRLVTIDDERSVK--LEIEIMTRLSGHPNVVDLKAV-YEDEDYVHLVMELCAG 126
           A KS+ +     I D   V+  L+  I+ +   HPNV+ L  +    E    +V+     
Sbjct: 27  AVKSLNR-----ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81

Query: 127 GELFHRLEKFGRFSEAEARVLF-MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK 185
           G+L + +         +  + F +Q+ + + Y      VHRDL   N +L    +   +K
Sbjct: 82  GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT---VK 138

Query: 186 LADFGLA--TYIEPGQSLLGTVGSPF---YIAPEVL-AGGYNQAADVWSAGVILYILLS- 238
           +ADFGLA   Y +   S+    G+     ++A E L    +   +DVWS GV+L+ L++ 
Sbjct: 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198

Query: 239 GMPPF 243
           G PP+
Sbjct: 199 GAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 31/89 (34%), Positives = 43/89 (48%), Gaps = 19/89 (21%)

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLA-------TYIEPGQSLLGTVGSPF-YIAPE- 214
           VHRDL   N+L+        +K+ DFGLA        YI  G + L     P  ++APE 
Sbjct: 261 VHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISKGSTFL-----PLKWMAPES 312

Query: 215 VLAGGYNQAADVWSAGVILY--ILLSGMP 241
           +    Y   +DVWS G++L+    L G P
Sbjct: 313 IFNNLYTTLSDVWSFGILLWEIFTLGGTP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 33/112 (29%), Positives = 47/112 (41%), Gaps = 17/112 (15%)

Query: 133 LEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL 191
           LE  GR  +E E   + +Q +  +   H      R  K  NILL          L   G 
Sbjct: 7   LEVRGRPLNEEEIWAVCLQCLGALRELH------RQAKSGNILLTW-----DGLLKLDGS 55

Query: 192 ATYIEPGQSLLGTVGSPFYIAPEVL-AGGYNQAADVWSAGVILYILLSGMPP 242
             +  P QS       P+++APEV+    Y + AD++S G+ LY  L    P
Sbjct: 56  VAFKTPEQSR----PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 24/166 (14%)

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           +++L  HPN+V  +A +  ++ + +V    A G     +     F +  + +    ++Q 
Sbjct: 52  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMSELAIAYILQG 109

Query: 155 VL----YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA---TYIEPGQSLLGTVGS 207
           VL    Y H +G VHR +K  +IL++        K+   GL    + I  GQ L      
Sbjct: 110 VLKALDYIHHMGYVHRSVKASHILISVDG-----KVYLSGLRSNLSMINHGQRLRVVHDF 164

Query: 208 PFY-------IAPEVLA---GGYNQAADVWSAGVILYILLSGMPPF 243
           P Y       ++PEVL     GY+  +D++S G+    L +G  PF
Sbjct: 165 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 55/180 (30%), Positives = 77/180 (42%), Gaps = 32/180 (17%)

Query: 132 RLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA---SSSP-IKLA 187
           R EK GR   A    +  QL   + Y  +  +VH ++  +NILLA       +SP IKL+
Sbjct: 108 RKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLS 166

Query: 188 DFGLATYIEPGQSLLG-----TVGSPFYIAPEVLAGGYN--QAADVWSAG-VILYILLSG 239
           D        PG S         V    +IAPE + GG +   AAD WS G  +L I   G
Sbjct: 167 D--------PGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218

Query: 240 MPPFWGNT---KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
             P    T   K R ++  +   L  PS            L+   L+ +P+QR + R +L
Sbjct: 219 EVPLKERTPSEKERFYE--KKHRLPEPSCK------ELATLISQCLTYEPTQRPSFRTIL 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 60/286 (20%)

Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT-----RLSGH 101
           +++G G FG +        GEV +  + A+  +  +    SV+ +++ +      R   H
Sbjct: 1   KEIGNGWFGKV------ILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQH 54

Query: 102 PNVVD-LKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQV---V 155
            N++  L    E   Y+ LVME C  G+L  + R  +       +   L     ++   +
Sbjct: 55  SNLLQCLGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGL 113

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-------TYIEPGQSLLGTVGSP 208
           L+ H+   +H DL   N LL    +   +K+ D+GL+        Y+ P Q  +     P
Sbjct: 114 LHLHKNNFIHSDLALRNCLLTADLT---VKIGDYGLSHNKYKEDYYVTPDQLWV-----P 165

Query: 209 F-YIAPE--------VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD-AVRT 257
             +IAPE        +L     + ++VWS GV ++ L   G  P+   +  ++    VR 
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225

Query: 258 ADLRFP--------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
             L+ P        S+ W          VM      P QR +A +V
Sbjct: 226 QQLKLPKPRLKLPLSDRWYE--------VMQFCWLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 28/203 (13%)

Query: 84  DERSVKLEIE-IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--GRFS 140
           +E    L+ E +++    HPN++    V+    ++ ++    A G     L+ +     S
Sbjct: 40  EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS 99

Query: 141 EAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS 200
           EA    +    ++ + Y H+ G +HR++K  +IL++     S   L+   L + +  GQ 
Sbjct: 100 EALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSH--LYSLVRNGQK 157

Query: 201 LLGTVGSPFY-------IAPEVLA---GGYNQAADVWSAGVILYILLSGMPPFWGNTKSR 250
                  P +       ++PE+L     GYN  +D++S G+    L +G  PF       
Sbjct: 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF------- 210

Query: 251 IFDAVRTADLR-----FPSNPWD 268
             D +RT  L       P +P D
Sbjct: 211 -QDMLRTQMLLQKLKGPPYSPLD 232

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 9e-04
 Identities = 40/139 (28%), Positives = 62/139 (44%), Gaps = 10/139 (7%)

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGSPF-YIAPE-VLAGG 219
           +HRDL   NILL     +   K+ DFGLA  I    + +  G    P  ++APE +    
Sbjct: 236 IHRDLAARNILLTHGRIT---KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV 292

Query: 220 YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
           Y   +DVWS G++L+ + S G  P+ G      F  +     R  S   +       D++
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP--ECAPSEMYDIM 350

Query: 279 MGMLSTDPSQRLTARQVLD 297
                 DP +R T +Q++ 
Sbjct: 351 KSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 24/60 (40%), Positives = 32/60 (53%), Gaps = 5/60 (8%)

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG--SPFYIAPEVL 216
           H IG+VHRD+KPEN+L+        +K+ DFG A  +  G +     G   P Y  PE L
Sbjct: 326 HRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGSPF-YIAPE-VLAGG 219
           +HRD+   N+LL         K+ DFGLA  I    + +  G    P  ++APE +    
Sbjct: 234 IHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCV 290

Query: 220 YNQAADVWSAGVILYILLS-GMPPFWG 245
           Y   +DVWS G++L+ + S G  P+ G
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 40.0 bits (94), Expect = 0.002
 Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 32/187 (17%)

Query: 31  LDTNQISNLRERFV---LGQQLGWGQFGVIRVCSDKFTGEVF---------ACKSIAKDR 78
            D   +  L +R +   +G ++G G+   + V  D    +V          + + + ++R
Sbjct: 78  YDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNR 137

Query: 79  LVTIDDER---------SVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL 129
               D E          + + E E + RL  +P  V +        +  +VME   G EL
Sbjct: 138 DYLADKEHGSWLYVSRLAAEREFEALQRL--YPEGVKVPKPIAWNRHA-VVMEYIEGVEL 194

Query: 130 FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF 189
           + RL    R        +  ++++ V   +  G+VH DL   NIL+        I + D+
Sbjct: 195 Y-RL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD---IVVIDW 246

Query: 190 GLATYIE 196
             A  I 
Sbjct: 247 PQAVPIS 253

Length = 304

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 12/101 (11%)

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLA---TKASSSP--IKLADFGLATYIEPGQSLLGT 204
           QL   + +  + G+ H ++  +N+LL     + + +P  IKL+D G++  + P + LL  
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER 167

Query: 205 VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSG--MP 241
           +  P ++ PE +      + AAD WS G  L+ + SG   P
Sbjct: 168 I--P-WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 15/38 (39%), Positives = 23/38 (60%), Gaps = 3/38 (7%)

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY 194
           Y HE G+ H D+KPENI++        I   D+G+A++
Sbjct: 141 YIHEHGISHGDIKPENIMVDGNNRGYII---DYGIASH 175

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	468
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
smart00090	237	RIO RIO-like kinase.	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.66
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
KOG1243	690	consensus Protein kinase [General function predict	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.09
COG4248	637	Uncharacterized protein with protein kinase and he	99.04
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.9
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.8
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.74
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.57
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.52
PRK09902	216	hypothetical protein; Provisional	98.48
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.39
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.28
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.26
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.17
PLN02876	822	acyl-CoA dehydrogenase	98.13
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.06
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.04
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.02
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.87
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.82
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.7
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.61
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.5
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.49
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.4
PRK05231	319	homoserine kinase; Provisional	97.3
KOG2270	520	consensus Serine/threonine protein kinase involved	97.28
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.26
PLN02236	344	choline kinase	96.95
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.92
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.81
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.78
PLN02756	418	S-methyl-5-thioribose kinase	96.69
PRK10593	297	hypothetical protein; Provisional	96.51
PRK12396	409	5-methylribose kinase; Reviewed	96.43
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.24
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.18
PTZ00384	383	choline kinase; Provisional	96.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.1
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.02
PRK11768	325	serine/threonine protein kinase; Provisional	95.7
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.67
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.4
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.32
PRK06148	1013	hypothetical protein; Provisional	95.28
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.64
COG2334	331	Putative homoserine kinase type II (protein kinase	94.22
PTZ00296	442	choline kinase; Provisional	93.81

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-62  Score=481.26  Aligned_cols=268  Identities=37%  Similarity=0.667  Sum_probs=248.9

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh----hhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI----DDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~----~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      +.+++.|.+.+.||+|+||.|-+|..+.||+.||||++++......    .....+.+|++||++|. |||||+++++|+
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~  246 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE  246 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence            4588999999999999999999999999999999999998765442    23456789999999996 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      ..+..||||||+.||+|++.+-.++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+..+-.+||+|||+|
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999988777778999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC----CCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGNTKSR-IFDAVRTADLRFPSNPW  267 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~~~sDiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~  267 (468)
                      +....+..+.+.||||.|.|||++.++    +..++|+|||||+||.+|+|.+||.+..... +.++|..+.+.+....|
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            999888889999999999999999863    4569999999999999999999998877666 89999999999999999


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..+++++++||++||..||++|||++|+|+||||+...
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            99999999999999999999999999999999998654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-59  Score=457.33  Aligned_cols=268  Identities=37%  Similarity=0.661  Sum_probs=244.1

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||+||.++.+++++.||+|+++|..+....+.+....|..||.+++ ||+||+++..|++.+.+||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence            467999999999999999999999999999999999998888888899999999999986 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee-cCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~-~~~  198 (468)
                      |+||+.||+|+.+|++.+.|++..++.|+.+|+.||.|||++|||||||||+|||||.+|+   |+|+|||+++.. ..+
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH---i~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH---IKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc---EEEeccccchhcccCC
Confidence            9999999999999999999999999999999999999999999999999999999987665   999999999854 444


Q ss_pred             CccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ....++|||+.|||||++.+ +|+..+||||||+++|||++|.+||.+.+..++++.|.......+.   ..++.+++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardl  256 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDL  256 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHH
Confidence            56677899999999999987 4999999999999999999999999999999999999998855443   4589999999


Q ss_pred             HHHccccCCCCCC----CHHHHHhCcCCCCCCCCCccccCCcc
Q 012203          278 VMGMLSTDPSQRL----TARQVLDHSWMGDGIQDPEKLSGNKI  316 (468)
Q Consensus       278 i~~~L~~dP~~Rp----t~~eiL~h~~~~~~~~~~~~~~~~~~  316 (468)
                      ++++|.+||++|+    .+.+|.+||||....  ++.+..++.
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in--W~~l~~k~l  297 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN--WEKLLAKKL  297 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCC--HHHHHhcCC
Confidence            9999999999996    689999999998744  344443333

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-58  Score=471.22  Aligned_cols=257  Identities=38%  Similarity=0.638  Sum_probs=245.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+..+......+.+.+||+|.++|+ |||||+++++|++.+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            67999999999999999999999999999999999998888888999999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-C
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-Q  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~  199 (468)
                      +|+|..++|..++++++.++|.+++.+++||+.||.|||+++|||||||..|+||+.+.+   |||+|||||..+... +
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~---VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN---VKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc---EEecccceeeeecCccc
Confidence            999999999999999999999999999999999999999999999999999999998776   999999999998744 6


Q ss_pred             ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ...+.||||.|+|||++.. +++..+||||+||++|.||.|++||...+..+.++.|...++.+|.    .++.++++||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            7789999999999999986 5999999999999999999999999999999999999999999995    7999999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+||++||.+|||+++||.|+||+.+.
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            999999999999999999999996654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-56  Score=425.25  Aligned_cols=268  Identities=33%  Similarity=0.626  Sum_probs=247.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.++|++++.||.|+||.|.+++++.+|..||+|++.+..+....+.+...+|..+|+.+. ||+++++++.|.+.+.+|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEE
Confidence            3457999999999999999999999999999999999999988888999999999999997 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||||++||.|+.++++.++|++..++.|+.||+.||+|||+++|++|||||||||||++|.   +||+|||+|+.....
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~---iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH---IKITDFGFAKRVSGR  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc---EEEEeccceEEecCc
Confidence            99999999999999999999999999999999999999999999999999999999997666   999999999998653


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                        ..+.||||.|+|||++..+ |+.++|+|+|||++|||+.|.+||...+..++++.|..++..||    ..++.++++|
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP----~~fs~~~kdL  271 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP----SYFSSDAKDL  271 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC----cccCHHHHHH
Confidence              6688999999999999875 99999999999999999999999999999999999999999999    4789999999


Q ss_pred             HHHccccCCCCCC-----CHHHHHhCcCCCCCCCCCccccCCcccc
Q 012203          278 VMGMLSTDPSQRL-----TARQVLDHSWMGDGIQDPEKLSGNKIED  318 (468)
Q Consensus       278 i~~~L~~dP~~Rp-----t~~eiL~h~~~~~~~~~~~~~~~~~~~~  318 (468)
                      |+++|+.|-.+|.     ...+|.+||||+...  ++....++++.
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~--W~~i~~r~ie~  315 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD--WEAILQRKIEP  315 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCccccccc--HHHHhhccccC
Confidence            9999999999994     478999999998643  44444444443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-55  Score=444.33  Aligned_cols=262  Identities=34%  Similarity=0.640  Sum_probs=244.7

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..--.+|..++.||.|+|++|++|+++.+++.||||++.|+.+......+-+..|.++|.+|.+||.|++|+..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34445799999999999999999999999999999999999988888888999999999999889999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+|+||+++|+|.++|++.+.|++..++.|+.+|+.||+|||++|||||||||+|||||.|++   +||+|||.|+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh---ikITDFGsAK~l~  225 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH---IKITDFGSAKILS  225 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc---EEEeeccccccCC
Confidence            9999999999999999999999999999999999999999999999999999999999998776   9999999998875


Q ss_pred             CCCcc--------------ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 012203          197 PGQSL--------------LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR  261 (468)
Q Consensus       197 ~~~~~--------------~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  261 (468)
                      +....              .+++||..|.+||+|..+ .+..+|||+||||||.|+.|.+||.+.+.-.+++.|...++.
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~  305 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE  305 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence            43211              347999999999999986 789999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ||.    .+++.+++||+++|..||.+|+|+++|.+||||....
T Consensus       306 fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  306 FPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             CCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence            994    7889999999999999999999999999999998754

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.6e-55  Score=441.51  Aligned_cols=264  Identities=34%  Similarity=0.578  Sum_probs=237.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.++|+++++||+|+||.||+|+.+.||+.||+|++.|..+...++...++.|..+|... ++|+||+++..|++.+++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeE
Confidence            456799999999999999999999999999999999999888888899999999999985 6999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-  197 (468)
                      |||||++||++..+|.+.+.|++..++.|+.+++.|++.||+.|+|||||||+|+|||..|+   |||+||||+..+.. 
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH---iKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH---IKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC---Eeeccccccchhhhh
Confidence            99999999999999999999999999999999999999999999999999999999987665   99999999853311 


Q ss_pred             ---------------------C--C------------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHH
Q 012203          198 ---------------------G--Q------------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSA  229 (468)
Q Consensus       198 ---------------------~--~------------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSl  229 (468)
                                           .  .                        .....+|||.|||||++.+. |+..+|+|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0  0                        01134899999999999885 9999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHHhCcCCCCCCC
Q 012203          230 GVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSWMGDGIQ  306 (468)
Q Consensus       230 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~eiL~h~~~~~~~~  306 (468)
                      |||+||||.|.+||.+.+..+.++.|.+-...+....-..++++++|||.+||. ||++|+.   ++||.+||||+....
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence            999999999999999999999999999887444433346788999999999999 9999985   999999999988654


Q ss_pred             C
Q 012203          307 D  307 (468)
Q Consensus       307 ~  307 (468)
                      +
T Consensus       454 ~  454 (550)
T KOG0605|consen  454 D  454 (550)
T ss_pred             c
Confidence            3

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-54  Score=422.69  Aligned_cols=265  Identities=36%  Similarity=0.656  Sum_probs=242.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ....+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .....+.+..|+.||+.|+ |||||.+++++++++++
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeE
Confidence            456789999999999999999999999999999999998876 5566778899999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC---CCEEEeecCceee
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS---SPIKLADFGLATY  194 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~---~~ikL~DFGla~~  194 (468)
                      |||||||.||+|.++|++++.+++..++.++.||+.||++||+++||||||||.||||+.....   -.+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999876222   4689999999999


Q ss_pred             ecCCCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          195 IEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      +.++....+.||+|.|||||+++. .|+.|+|+||+|+|+|+|++|++||...+..+++..++.+....+..+ ..++..
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~  243 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNP  243 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCc
Confidence            999888899999999999999965 699999999999999999999999999999999998887765544332 456777


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..+|+...|+.||..|.+..+.+.|+++....
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            88999999999999999999999999997654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-56  Score=415.69  Aligned_cols=266  Identities=40%  Similarity=0.779  Sum_probs=251.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.+.|++.+.||+|.|+.||.|.++.+|+.+|+|+++...+.. .+.+.+.+|++|-+.|+ |||||++++.+.+....
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence            46778999999999999999999999999999999998877644 47788999999999997 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||+|++.|++|+.-|-.+.-++|..+-.+++||++||.|+|.+||+|||+||+|+|+.+......+||+|||+|..+..
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999999999988776666789999999999999999999999999999999999999988888999999999999998


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      +....+..|||.|||||++... |+..+|||+.|||||.|+.|++||++.+...+++.|.++...++...|+.+++++++
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence            8888899999999999999875 999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      |+++||..||.+|+|+.|+|+|||+++..
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcchH
Confidence            99999999999999999999999998743

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-54  Score=424.23  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=228.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE-EEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY-VHL  119 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~-~~l  119 (468)
                      .+.+.++.||+|+.|+||+|+|+.|++.+|+|.|...  ......+++.+|++++++. +|||||.+|+.|..+.. ++|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence            4577788999999999999999999999999999544  3556678899999999999 59999999999999994 999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||.||+|+++++..++++|.....++.+|++||.|||+ ++||||||||+||||+.++.   |||||||.++.+.+.
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe---VKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE---VKICDFGVSGILVNS  232 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC---EEeccccccHHhhhh
Confidence            99999999999999999999999999999999999999996 89999999999999987766   999999999988765


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcc-CCCCCCCCCCCC
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN-----TKSRIFDAVRTAD-LRFPSNPWDHIS  271 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~~~~~~s  271 (468)
                       ...+++||..|||||.+.+. |+.++||||||+.++|+.+|+.||...     ...+++..|.... .++|.   ..++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~---~~fS  308 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE---GEFS  308 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc---ccCC
Confidence             56789999999999999996 999999999999999999999999764     4556667776643 23332   2599


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      +++++||..||++||.+|++++|+++|||+++...
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            99999999999999999999999999999987543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-54  Score=450.32  Aligned_cols=320  Identities=30%  Similarity=0.483  Sum_probs=267.1

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.++|+++++||+|+||+|+++..+.+++.||||+++|+.+...++.+..+.|.+|+....+||++++++..|+.++++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            34679999999999999999999999999999999999999999999999999999998878999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-C
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-P  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~  197 (468)
                      +||||+.||++..+. ..+.|++..++.|+..|+.||.|||++||||||||.+|||||.+|.   +||+|||+++.-- .
T Consensus       446 fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh---~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH---VKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc---EEecccccccccCCC
Confidence            999999999955444 4478999999999999999999999999999999999999987665   9999999998744 5


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      +....++||||.|||||++.+. |+..+|||+|||+|||||.|..||.+.+.+++++.|...+..+|    ..++.++.+
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP----~~ls~ea~~  597 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSKEAIA  597 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CcccHHHHH
Confidence            6677889999999999999986 99999999999999999999999999999999999999999888    579999999


Q ss_pred             HHHHccccCCCCCCC-----HHHHHhCcCCCCCCCCCccccCCcccccccccCCCCCCccccccCCccCccCCCCCCCCC
Q 012203          277 LVMGMLSTDPSQRLT-----ARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSD  351 (468)
Q Consensus       277 li~~~L~~dP~~Rpt-----~~eiL~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  351 (468)
                      +++++|.+||++|+.     +++|..||||+...  +..+..+++++...-     ....+---.|.+-.|....|..++
T Consensus       598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~--w~~L~~r~i~PPf~P-----~i~~~~D~snFd~eFt~e~p~Lt~  670 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID--WDDLLNRRIKPPFVP-----TIKGPEDVSNFDEEFTSEKPALTP  670 (694)
T ss_pred             HHHHHhccCcccccCCCCCCchhhhhCCccccCC--HHHHhhccCCCCCCc-----ccCChhhhcccchhhhcCCCccCC
Confidence            999999999999996     58999999998754  455555555442110     001111123455555555554432


Q ss_pred             CCCCcccccCCCcccccCCCCCCcccccCC
Q 012203          352 DESPAFTCRTSFSSFLQEPSTSTGFSFCSP  381 (468)
Q Consensus       352 ~~~p~~~~~~~~~~~~~~~~~~~gfs~~~~  381 (468)
                       ..+..-++       .+...|.||||.++
T Consensus       671 -~~~~~l~~-------~~q~~F~~Fs~~~~  692 (694)
T KOG0694|consen  671 -SDPRPLTE-------EEQEAFRDFSFVAE  692 (694)
T ss_pred             -CCccccch-------hhHHHhcCccccCC
Confidence             11111111       23566899999665

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-53  Score=439.31  Aligned_cols=259  Identities=39%  Similarity=0.671  Sum_probs=243.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      +-|++++.||.|+-|.|.+|++..||+.+|||++.+...........+.+||-||+-|. |||+++++++|+++.++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence            45999999999999999999999999999999999875445556678999999999885 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      .||++||.|++++-+.+++++.+++++++||+.|+.|||..+|+||||||+|+|||.+++   |||+|||+|..-.++..
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCCcc
Confidence            999999999999999999999999999999999999999999999999999999998776   99999999999888888


Q ss_pred             cccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      +.+.||+|.|.|||++.|. | +.++||||.|||||.||+|++||++.+...++..++.+.+.+|    ..++.++++||
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLL  243 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLL  243 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHH
Confidence            8999999999999999995 5 7799999999999999999999999999999999999999998    57999999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                      .+||..||.+|+|.+||++|||+......
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcCCCC
Confidence            99999999999999999999999875543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=429.32  Aligned_cols=260  Identities=42%  Similarity=0.753  Sum_probs=238.0

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI--DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~--~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ....++|++++.||+|+||+|++|.+..+|+.||+|++.++.....  .....+.+|+.++++++.||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            4567899999999999999999999999999999998877633212  23557778999999997799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec-CCCCCEEEeecCcee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK-ASSSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~-~~~~~ikL~DFGla~  193 (468)
                      ..+|+|||||.||+|++++.+.+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ ++   +||+|||++.
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~---~Kl~DFG~s~  169 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN---LKLSDFGLSA  169 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC---EEEecccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999987 44   9999999999


Q ss_pred             ee-cCCCccccCCCCCCCcChhhhcC-C-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          194 YI-EPGQSLLGTVGSPFYIAPEVLAG-G-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       194 ~~-~~~~~~~~~~GT~~Y~APE~l~~-~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      .. ..+....+.||||.|+|||++.+ . | +.++||||+||+||.|++|+.||...+...++..|..+.+.+|.    .
T Consensus       170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~  245 (370)
T KOG0583|consen  170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----Y  245 (370)
T ss_pred             ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----C
Confidence            88 46667789999999999999988 3 5 57999999999999999999999999999999999999888884    4


Q ss_pred             C-CHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          270 I-SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       270 ~-s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      + +.++++|+.+||..||.+|+|+.+|++||||+.
T Consensus       246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            4 999999999999999999999999999999987

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-52  Score=424.34  Aligned_cols=271  Identities=52%  Similarity=0.923  Sum_probs=254.3

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ....+...|++.+.||+|.||+||+|+++.+|+.+|+|++.+.......+...+.+|+.||+++.+|||||.++++|++.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            45678889999999999999999999999999999999999987766666788999999999998899999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC-CCCEEEeecCcee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS-SSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~-~~~ikL~DFGla~  193 (468)
                      +.+++|||+|.||+|++.+.+. .+++..+..++.|++.+++|||+.||+||||||+|+|+..... .+.+|++|||++.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999999876 4999999999999999999999999999999999999987654 3479999999999


Q ss_pred             eecCCCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ....+......+|||.|+|||++.. .|+..+||||+||++|.|++|.+||++.+.......+..+++.|...+|..++.
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            9988778889999999999999995 699999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      .++++|.+||..||.+|+|+.++|+|||++....
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence            9999999999999999999999999999987533

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-53  Score=399.56  Aligned_cols=268  Identities=38%  Similarity=0.678  Sum_probs=246.3

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC--h---hhHHHHHHHHHHHHHhcCCCCceeee
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT--I---DDERSVKLEIEIMTRLSGHPNVVDLK  108 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~--~---~~~~~~~~Ei~iL~~L~~HpnIv~l~  108 (468)
                      ..-+.+.+.|.-.+.||.|..++|..|.++.+|+.+|+|+|.......  .   .-.+.-..|+.||+++.+||+|++++
T Consensus        10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            344567788999999999999999999999999999999996543211  1   11234567999999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       109 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      ++|+.+..+++|+|+|+.|.|+++|...-.+++.+.+.+++|+++|++|||.++|+||||||+|||++.+.+   |||+|
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~---i~isD  166 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN---IKISD  166 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc---eEEec
Confidence            999999999999999999999999999888999999999999999999999999999999999999998777   99999


Q ss_pred             cCceeeecCCCccccCCCCCCCcChhhhcC-------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 012203          189 FGLATYIEPGQSLLGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR  261 (468)
Q Consensus       189 FGla~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  261 (468)
                      ||++..+.+++.....||||+|+|||.+..       +|+..+|+|++|||+|.|+.|.+|||.....-+++.|..+++.
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence            999999999999999999999999999863       4888999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       262 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      |.++.|.+++...+|||.+||+.||.+|+|++|+|.||||.+.
T Consensus       247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            9999999999999999999999999999999999999999553

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-51  Score=403.73  Aligned_cols=260  Identities=35%  Similarity=0.573  Sum_probs=236.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      +.|++++.||.|..|+||+|+.+.++..+|+|++.++.+...+...+++.|.+||+.+ +||.++.||..|+.+++.|++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence            4688999999999999999999999999999999999888878888999999999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-
Q 012203          121 MELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-  197 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-  197 (468)
                      ||||+||+|..++++.  +.|+++.++.|+.+++.||+|||-.|||+|||||+||||.++|+   |.|+||.|+..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH---IMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH---IMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc---EEeeeccccccCCCC
Confidence            9999999999999775  56999999999999999999999999999999999999986655   99999998743210 


Q ss_pred             --------------------------------C-C-----------------------ccccCCCCCCCcChhhhcCC-C
Q 012203          198 --------------------------------G-Q-----------------------SLLGTVGSPFYIAPEVLAGG-Y  220 (468)
Q Consensus       198 --------------------------------~-~-----------------------~~~~~~GT~~Y~APE~l~~~-~  220 (468)
                                                      . .                       ....++||-+|+|||++.|. .
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                       01134799999999999985 9


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC----HHHHH
Q 012203          221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT----ARQVL  296 (468)
Q Consensus       221 ~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt----~~eiL  296 (468)
                      +.++|||+|||++|||++|..||.+.+..+.+.+|......||..+  .++..++|||+++|.+||.+|+.    ++||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999999999999999875  78899999999999999999998    99999


Q ss_pred             hCcCCCCCCC
Q 012203          297 DHSWMGDGIQ  306 (468)
Q Consensus       297 ~h~~~~~~~~  306 (468)
                      +||||+...+
T Consensus       391 ~HpFF~gVnW  400 (459)
T KOG0610|consen  391 RHPFFEGVNW  400 (459)
T ss_pred             cCccccCCCh
Confidence            9999987554

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-49  Score=401.00  Aligned_cols=250  Identities=34%  Similarity=0.622  Sum_probs=223.2

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+..|+++++++. ||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765444445567788999999996 99999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CCCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~  205 (468)
                      |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++... ........+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---EEEeeCCCCcccccCCCccccee
Confidence            999999998889999999999999999999999999999999999999987554   9999999987632 223344568


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|||||||++|||++|+.||...+.......+......++    ..+++++.+||.+||.+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            99999999999875 89999999999999999999999999888888888877766665    46899999999999999


Q ss_pred             CCCCCC-----CHHHHHhCcCCCCC
Q 012203          285 DPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       285 dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      ||++||     ++.++++|+||...
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-51  Score=398.60  Aligned_cols=262  Identities=37%  Similarity=0.667  Sum_probs=247.1

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ...+++.||++.+.||+|.||+|-+|.+...|+.||||.|.++.+....+.-.+.+||+||..| +||||+++|++|++.
T Consensus        47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENk  125 (668)
T KOG0611|consen   47 HKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENK  125 (668)
T ss_pred             cccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCC
Confidence            3467899999999999999999999999999999999999999988888888999999999999 599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+.|||||..+|+|++++...+.+++.+++.+++||..|+.|||+++++|||||.+|||+|.|++   +||+|||++..
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N---iKIADFGLSNl  202 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN---IKIADFGLSNL  202 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC---eeeeccchhhh
Confidence            999999999999999999999999999999999999999999999999999999999999998887   99999999999


Q ss_pred             ecCCCccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          195 IEPGQSLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      +..+....++||+|.|.+||+++|. | ++.+|-|||||+||.|+.|.+||++.+...+.++|..+.++-|..     +.
T Consensus       203 y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-----PS  277 (668)
T KOG0611|consen  203 YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-----PS  277 (668)
T ss_pred             hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-----Cc
Confidence            9988999999999999999999985 4 789999999999999999999999999999999999998877754     45


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+.-||+.||..||++|.|+.+|..|=|+.-+.
T Consensus       278 dA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy  310 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATIEDIASHWWVNWGY  310 (668)
T ss_pred             hHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence            789999999999999999999999999886544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-50  Score=386.26  Aligned_cols=257  Identities=31%  Similarity=0.604  Sum_probs=218.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|+.+.++|+|+||+||+|+++.||+.||||++..... ...-.+...+||++|++|+ |+|+|.++++|.....++||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence            568889999999999999999999999999999965431 2223456778999999997 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~  198 (468)
                      +|||+. ++.+-+++. ..++.+.++.|++|++.|+.|+|++++|||||||+||||+.++.   +||||||+|+.+. ++
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv---vKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV---VKLCDFGFARTLSAPG  155 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc---EEeccchhhHhhcCCc
Confidence            999965 555556554 56999999999999999999999999999999999999987665   9999999999887 66


Q ss_pred             CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----------------
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD-----------------  259 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------------  259 (468)
                      .....++.|.+|+|||.+.|.  |+..+|||++||++.||++|.+.|.+...-+.+-.|...-                 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            666778999999999999984  9999999999999999999999999887666555443321                 


Q ss_pred             --CCCCCC--------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          260 --LRFPSN--------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       260 --~~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                        .++|..        ....++.-+.||+++||+.||++|++.+|+|.|+||..
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence              112221        13456778999999999999999999999999999943

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-50  Score=410.46  Aligned_cols=255  Identities=33%  Similarity=0.613  Sum_probs=234.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|.+.+.||+|+||.||+|+.|.+.+.||+|.+.|... ...+.+.+.+|++|+++|+ ||||+.++++|+...++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence            578999999999999999999999999999999998764 4456788999999999997 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      .|||.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++..+.   +|+||||+|+.+..+..
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~---~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT---LKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc---eeechhhhhhhcccCce
Confidence            999976 99999999999999999999999999999999999999999999999986555   99999999998776544


Q ss_pred             c-ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          201 L-LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       201 ~-~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      . ....|||.|||||+..+. |+..+|+||||||+|||+.|++||......++.+.|...+..+|.    .++.++..|+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence            3 456799999999999986 999999999999999999999999999888999999888777774    7899999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +.+|.+||.+|+|+.+++.|||.+...
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhh
Confidence            999999999999999999999987643

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.7e-48  Score=398.75  Aligned_cols=260  Identities=30%  Similarity=0.501  Sum_probs=222.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++.++. ||||+++++.+++.+.+|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEE
Confidence            47999999999999999999999999999999998764444445567888999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      ||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.   +||+|||+++.+.... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~---vkL~DFGla~~~~~~~~  156 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC---EEEeeccCccccccccc
Confidence            999999999999998889999999999999999999999999999999999999986554   9999999987543210 


Q ss_pred             -----------------------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCC
Q 012203          200 -----------------------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPF  243 (468)
Q Consensus       200 -----------------------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf  243 (468)
                                                         .....+||+.|+|||++.+. ++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                               01245899999999999775 899999999999999999999999


Q ss_pred             CCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCC---CCCCHHHHHhCcCCCCCC
Q 012203          244 WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPS---QRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~---~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+.+..+.+..+..........+...++++++++|.+|+. +|.   .||+++||++||||+...
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence            9888888888877643332222234688999999999775 444   458999999999997643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.1e-49  Score=397.34  Aligned_cols=255  Identities=36%  Similarity=0.683  Sum_probs=229.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+++.+|+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEE
Confidence            367999999999999999999999999999999998764444445567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... 
T Consensus        96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH---VKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC---EEEeeccCceEcCCC-
Confidence            9999999999999998889999999999999999999999999999999999999987655   999999999876533 


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                       ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.++.+......++    ..++..+++||
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  246 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLV  246 (329)
T ss_pred             -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHH
Confidence             2356899999999999875 89999999999999999999999998888888888877766555    35788999999


Q ss_pred             HHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      .+||++||.+|++     ++++++||||.+.
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            9999999999997     7999999999763

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-50  Score=375.14  Aligned_cols=255  Identities=35%  Similarity=0.663  Sum_probs=239.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|-||.||+|+.+.++-.||+|++.|+++.......++.+|++|-..|+ ||||+++|++|.++...||+
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence            56999999999999999999999999999999999988777777789999999999997 99999999999999999999


Q ss_pred             EeccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLE--KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~--~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||.++|+|+..|.  ...+|++..+..|++|++.||.|+|.+++|||||||+|+|++.++.   +||+|||.+...+ .
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~---lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAP-S  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC---eeccCCCceeecC-C
Confidence            99999999999998  6678999999999999999999999999999999999999976665   9999999998765 4


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ....+.|||..|.+||+..+. ++..+|+|++|++.||++.|.+||...+..+.++.|.+.+..+|    ..++.++.|+
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl  252 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL  252 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence            556789999999999999985 99999999999999999999999999999999999999999998    5799999999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      |.+||.++|.+|.+..|+++|||+...
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999998653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-49  Score=401.38  Aligned_cols=280  Identities=30%  Similarity=0.454  Sum_probs=237.7

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--D  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~  115 (468)
                      .-.+.|+.+++||+|.||.||+|++..+|+.||+|.+..+.. .........+||.||++|. ||||++|.+...+.  .
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCc
Confidence            344568899999999999999999999999999999987753 3344567788999999995 99999999999876  7


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .+|||+|||+ -+|.-++... -+|++.+++.|++||+.||+|||.+||+|||||.+|||||.++.   +||+|||||+.
T Consensus       192 siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~---LKiaDFGLAr~  267 (560)
T KOG0600|consen  192 SIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV---LKIADFGLARF  267 (560)
T ss_pred             eEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC---EEeccccceee
Confidence            8999999995 5898888763 46999999999999999999999999999999999999987666   99999999998


Q ss_pred             ecCCC--ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC---
Q 012203          195 IEPGQ--SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW---  267 (468)
Q Consensus       195 ~~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---  267 (468)
                      +....  .....+-|.+|+|||.+.|.  |+.++|+||.||||.||+.|++.|.+.+..+.++.|.+.........|   
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            76544  45567889999999999985  999999999999999999999999999998888888654433332223   


Q ss_pred             ----------------------CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCCCCccccCCccccccccc
Q 012203          268 ----------------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWD  323 (468)
Q Consensus       268 ----------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~~~~~~~~~~~~~~~~~  323 (468)
                                            ..++..+.+|+..||..||++|.|+.++|+|+||.......+.......+.+++++
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~  425 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELD  425 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHH
Confidence                                  24678899999999999999999999999999996665555555555556665554

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-49  Score=390.17  Aligned_cols=253  Identities=33%  Similarity=0.609  Sum_probs=227.3

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.............+.+|+++++++. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEE
Confidence            47999999999999999999999999999999997654434445567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~---~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH---IKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEEEecCcchhccCC--
Confidence            999999999999998889999999999999999999999999999999999999986554   999999999876432  


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+..+.+......++    ..++..+++||+
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  230 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIK  230 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHH
Confidence            2346799999999999875 89999999999999999999999999888888888887776665    356889999999


Q ss_pred             HccccCCCCCCC-----HHHHHhCcCCCC
Q 012203          280 GMLSTDPSQRLT-----ARQVLDHSWMGD  303 (468)
Q Consensus       280 ~~L~~dP~~Rpt-----~~eiL~h~~~~~  303 (468)
                      +||+.||.+|++     ++|+++|+||..
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            999999999995     999999999965

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.2e-48  Score=399.44  Aligned_cols=260  Identities=32%  Similarity=0.477  Sum_probs=221.0

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+++++++. ||||+++++++.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999998765555556678899999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC--
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--  199 (468)
                      ||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++..+....  
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~---~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG---HIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC---CEEEeeCcCCccccccccc
Confidence            9999999999999888899999999999999999999999999999999999998655   49999999975331000  


Q ss_pred             ----------------------------------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHH
Q 012203          200 ----------------------------------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVI  232 (468)
Q Consensus       200 ----------------------------------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvi  232 (468)
                                                                    .....+||+.|+|||++.+. ++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          01235799999999999764 8999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc--cCCCCCCCHHHHHhCcCCCCCC
Q 012203          233 LYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS--TDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       233 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~--~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +|||++|+.||...+..+....+...........+..+++++.+||.+||.  .++.+|++++++++||||.+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            999999999998877766665555433333333345789999999999654  4555599999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-48  Score=391.53  Aligned_cols=251  Identities=32%  Similarity=0.596  Sum_probs=222.6

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+..|+++++.+.+||||+++++++++.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998765444455667788999999887799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~  205 (468)
                      |+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... .......+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH---IKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc---EEecccCCCeecCcCCCccccee
Confidence            999999988888999999999999999999999999999999999999987654   99999999875322 22334567


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|+|||||++|+|++|+.||...+.......+......++    ..+++++.+||++||++
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence            99999999999875 89999999999999999999999998888888888777665554    46889999999999999


Q ss_pred             CCCCCCCH-----HHHHhCcCCCCC
Q 012203          285 DPSQRLTA-----RQVLDHSWMGDG  304 (468)
Q Consensus       285 dP~~Rpt~-----~eiL~h~~~~~~  304 (468)
                      ||++||++     .++++||||+..
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999     999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-50  Score=399.74  Aligned_cols=264  Identities=32%  Similarity=0.507  Sum_probs=226.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-E
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-Y  116 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-~  116 (468)
                      .+-+||.++++||.|.||.||+|+.+.+|+.||||.++++- ..+++. .-.+|+..|++|..||||+++++++.+++ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            35678999999999999999999999999999999997763 344433 34569999999966999999999999888 9


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      +|+||||| ..+|+++++.+ +.|++..++.|+.||++||+|+|++|+.|||+||||||+..+.   .|||+|||+|+.+
T Consensus        85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~---~iKiaDFGLARev  160 (538)
T KOG0661|consen   85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND---VIKIADFGLAREV  160 (538)
T ss_pred             EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc---eeEeccccccccc
Confidence            99999999 67999999765 4599999999999999999999999999999999999998544   4999999999999


Q ss_pred             cCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----------------
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT----------------  257 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----------------  257 (468)
                      ........++.|.+|+|||++..  .|+.+.|||++|||++|+.+-++.|.+.+..+.+-.|..                
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            88888888999999999999865  399999999999999999999999988776555444432                


Q ss_pred             ---ccCCCCCCC-------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          258 ---ADLRFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       258 ---~~~~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                         ..+++|...       ....+.++.+||.+||..||++||||+|+|+||||+.....
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence               233343322       23478899999999999999999999999999999875543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-48  Score=390.51  Aligned_cols=251  Identities=30%  Similarity=0.544  Sum_probs=219.2

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+|+.||+|++.+..............|..++..+.+||||+++++++.+++.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999998754333334556777888888776799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~  205 (468)
                      |+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++.... .......+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH---IKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEeCccCCCeecccCCCceeccC
Confidence            999999988888999999999999999999999999999999999999987554   99999999875322 22334568


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..++.+.+......++    ..++.+++++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence            99999999999875 89999999999999999999999999888888888776655444    35789999999999999


Q ss_pred             CCCCCCCH-HHHHhCcCCCCC
Q 012203          285 DPSQRLTA-RQVLDHSWMGDG  304 (468)
Q Consensus       285 dP~~Rpt~-~eiL~h~~~~~~  304 (468)
                      ||++|+++ +++++||||...
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCC
Confidence            99999997 589999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-48  Score=392.39  Aligned_cols=250  Identities=32%  Similarity=0.602  Sum_probs=221.9

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+++++++. ||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765444455677888999999996 99999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~  205 (468)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++.... .......+
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH---IKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc---EEEecCcCCccCCCccccccccc
Confidence            999999988888999999999999999999999999999999999999986655   99999999876432 22334568


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+..+.+......++    ..++.++.+||.+||++
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence            99999999999864 89999999999999999999999998888787777776666555    46889999999999999


Q ss_pred             CCCCCC-----CHHHHHhCcCCCCC
Q 012203          285 DPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       285 dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      ||++|+     ++.|+++|+||...
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999997     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.5e-48  Score=389.32  Aligned_cols=256  Identities=30%  Similarity=0.568  Sum_probs=226.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+..|++++..+..|++|+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            48999999999999999999999999999999987654444556678889999999975567999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CCCc
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQS  200 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~  200 (468)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH---IKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC---EEEeecCcceecCCCCCc
Confidence            99999999999998888999999999999999999999999999999999999987554   9999999987532 2233


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+......++    ..++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            4456899999999999875 89999999999999999999999999888888888877666555    468899999999


Q ss_pred             HccccCCCCCCCH-----HHHHhCcCCCCC
Q 012203          280 GMLSTDPSQRLTA-----RQVLDHSWMGDG  304 (468)
Q Consensus       280 ~~L~~dP~~Rpt~-----~eiL~h~~~~~~  304 (468)
                      +||.+||.+|++.     +++++||||...
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999976     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=396.07  Aligned_cols=270  Identities=35%  Similarity=0.626  Sum_probs=232.8

Q ss_pred             CccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh-----------hhHHHHHHHHHHHHHhcC
Q 012203           32 DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI-----------DDERSVKLEIEIMTRLSG  100 (468)
Q Consensus        32 ~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~-----------~~~~~~~~Ei~iL~~L~~  100 (468)
                      ...+-...-+.|++++.||+|.||+|.+|++..+++.||||++.|..+...           ...+.+.+||.||++|. 
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-  166 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-  166 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-
Confidence            344445566789999999999999999999999999999999987644221           12458899999999997 


Q ss_pred             CCCceeeeEEEEeC--CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec
Q 012203          101 HPNVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK  178 (468)
Q Consensus       101 HpnIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~  178 (468)
                      |||||+|+++..+.  +.+|||+|||..|.+...-.....+++.+++.|+++++.||+|||.+|||||||||+|+||+.+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence            99999999999754  6899999999999886443332238999999999999999999999999999999999999876


Q ss_pred             CCCCCEEEeecCceeeecCC------CccccCCCCCCCcChhhhcCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 012203          179 ASSSPIKLADFGLATYIEPG------QSLLGTVGSPFYIAPEVLAGG-----YNQAADVWSAGVILYILLSGMPPFWGNT  247 (468)
Q Consensus       179 ~~~~~ikL~DFGla~~~~~~------~~~~~~~GT~~Y~APE~l~~~-----~~~~sDiwSlGvil~elltG~~Pf~~~~  247 (468)
                      +   ++||+|||.+.....+      ..+...+|||.|+|||...++     .+.+.||||+||+||.|+.|+.||.+..
T Consensus       247 g---~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  247 G---TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             C---cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            5   4999999999877332      223457999999999998762     3678999999999999999999999999


Q ss_pred             hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                      ..++++.|.+..+.||..+  .+.++++|||++||++||++|++..+|..|||.......
T Consensus       324 ~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  324 ELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             HHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence            9999999999999999874  789999999999999999999999999999999876543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-50  Score=386.38  Aligned_cols=258  Identities=34%  Similarity=0.625  Sum_probs=241.5

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      -++|..++.||+|.||+|-+|+.+.+++.||+|+++|+-+...+....-..|-++|+..+ ||.+..+...|+.++++|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEE
Confidence            456888999999999999999999999999999999998887777777888999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee-ecCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY-IEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~-~~~~  198 (468)
                      ||||..||.|+-+|.+.+-|++..++.|...|+.||.|||+++|++||||.+|+|+|++++   |||+|||+++. +..+
T Consensus       246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH---IKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH---IKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc---eEeeecccchhccccc
Confidence            9999999999999999889999999999999999999999999999999999999998776   99999999986 3455


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ....++||||.|+|||++... |+..+|||.+||++|||++|++||...+...+++.|...+++||    ..++++++.|
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----r~ls~eAktL  398 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----RTLSPEAKTL  398 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC----ccCCHHHHHH
Confidence            677899999999999999874 99999999999999999999999999999999999999999999    5799999999


Q ss_pred             HHHccccCCCCCCC-----HHHHHhCcCCCCCC
Q 012203          278 VMGMLSTDPSQRLT-----ARQVLDHSWMGDGI  305 (468)
Q Consensus       278 i~~~L~~dP~~Rpt-----~~eiL~h~~~~~~~  305 (468)
                      +..+|.+||.+|+.     +.||..|+||....
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            99999999999984     89999999998754

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.8e-48  Score=390.37  Aligned_cols=251  Identities=30%  Similarity=0.557  Sum_probs=222.9

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+..|.+++..+.+||||+++++++++.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999998765444455667778999998876799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~  205 (468)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... .......+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH---CKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEeecccceecccCCccccccc
Confidence            999999988889999999999999999999999999999999999999987654   99999999876432 22334567


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+.++.+......++    ..++.++.++|.+||++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence            99999999999874 89999999999999999999999999988888888887766555    35789999999999999


Q ss_pred             CCCCCC-------CHHHHHhCcCCCCC
Q 012203          285 DPSQRL-------TARQVLDHSWMGDG  304 (468)
Q Consensus       285 dP~~Rp-------t~~eiL~h~~~~~~  304 (468)
                      ||++|+       +++++++||||...
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            999999       99999999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-48  Score=396.10  Aligned_cols=259  Identities=32%  Similarity=0.570  Sum_probs=224.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.+. ||||++++++|.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence            47999999999999999999999999999999998754433445567888999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      ||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..+.... 
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEeecccceecccccc
Confidence            999999999999998888999999999999999999999999999999999999987655   9999999987643211 


Q ss_pred             --------------------------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCC
Q 012203          200 --------------------------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGM  240 (468)
Q Consensus       200 --------------------------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~  240 (468)
                                                            .....+||+.|+|||++.+. ++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                  11135799999999998764 899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHHhCcCCCCC
Q 012203          241 PPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSWMGDG  304 (468)
Q Consensus       241 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~eiL~h~~~~~~  304 (468)
                      .||...+..+....+......+.......+++++++||++||. +|.+|++   ++|+++||||+..
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999888877777776544333333334689999999999997 9999998   9999999999764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=392.01  Aligned_cols=258  Identities=33%  Similarity=0.591  Sum_probs=216.7

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--EE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED--YV  117 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~--~~  117 (468)
                      ..+|..++.||+|+||.||++.++.+|+.+|+|.+.....   ...+.+.+|+.+|.+|+ |||||++++......  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeee
Confidence            3458889999999999999999999999999999877622   12677999999999997 999999999854444  79


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEee-cCCCCCEEEeecCceeee
Q 012203          118 HLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLAT-KASSSPIKLADFGLATYI  195 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~-~~~~~~ikL~DFGla~~~  195 (468)
                      +|+|||++||+|.+++.+.+ .++++.++.+.+||++||+|||++||+||||||+|||++. ++.   +||+|||+++..
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~---~KlaDFG~a~~~  168 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD---VKLADFGLAKKL  168 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe---EEeccCcccccc
Confidence            99999999999999999987 7999999999999999999999999999999999999987 344   999999999877


Q ss_pred             cC----CCccccCCCCCCCcChhhhcCCC--CCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccCCCCCCCCC
Q 012203          196 EP----GQSLLGTVGSPFYIAPEVLAGGY--NQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       196 ~~----~~~~~~~~GT~~Y~APE~l~~~~--~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ..    ........|||.|||||++..+.  ..++|||||||++.||+||+.||... ......-.+.... ..| ....
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip~  246 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIPD  246 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCCc
Confidence            63    22234578999999999999553  34999999999999999999999763 3333233333222 122 2335


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      .++.++++||.+||.+||++||||+++|+|||.++...
T Consensus       247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            79999999999999999999999999999999977553

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6e-48  Score=388.24  Aligned_cols=256  Identities=29%  Similarity=0.549  Sum_probs=227.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||+|+||.||+|+++.+++.||+|++.+..............|..++..+..|++|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48999999999999999999999999999999987654444445567778888888877999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCc
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQS  200 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~  200 (468)
                      ||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc---EEEccCCCceecCCCCCc
Confidence            99999999999988888999999999999999999999999999999999999987655   99999999976432 223


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ....+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+...+.+.+......+|    ..++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence            3456899999999999875 89999999999999999999999999888888888887766655    468899999999


Q ss_pred             HccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          280 GMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       280 ~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      +||++||.+|++     ..++++|+||+..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999997     4899999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-48  Score=394.02  Aligned_cols=257  Identities=36%  Similarity=0.640  Sum_probs=226.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+..|++++..+. ||||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence            47999999999999999999999999999999998765444455677889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~---~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH---IKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEeecCCCCccCcccCc
Confidence            999999999999998888999999999999999999999999999999999999987655   9999999998765432 


Q ss_pred             -----------------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 012203          200 -----------------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS  249 (468)
Q Consensus       200 -----------------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~  249 (468)
                                                   ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                         22345799999999999875 899999999999999999999999988877


Q ss_pred             HHHHHHHh--ccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC-HHHHHhCcCCCCC
Q 012203          250 RIFDAVRT--ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT-ARQVLDHSWMGDG  304 (468)
Q Consensus       250 ~~~~~i~~--~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-~~eiL~h~~~~~~  304 (468)
                      .....+..  ....++..  ..+++++.+||.+||. ||.+|++ ++++++||||.+.
T Consensus       237 ~~~~~i~~~~~~~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         237 ETYNKIINWKESLRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHHhccCCcccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            77777766  33344432  3589999999999997 9999999 9999999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.8e-48  Score=388.82  Aligned_cols=251  Identities=31%  Similarity=0.582  Sum_probs=222.5

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998764434445567778999998876799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~  205 (468)
                      |+|..++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++..... .......+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~---~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc---EEEeeCCCCeecCcCCCcccccc
Confidence            999999998889999999999999999999999999999999999999987655   99999999876432 23344568


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..++.+.+......++    ..++.++.++|++||++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence            99999999999875 89999999999999999999999999988888888877665554    35889999999999999


Q ss_pred             CCCCCCCH------HHHHhCcCCCCC
Q 012203          285 DPSQRLTA------RQVLDHSWMGDG  304 (468)
Q Consensus       285 dP~~Rpt~------~eiL~h~~~~~~  304 (468)
                      ||.+|+++      +++++||||...
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            99999998      999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.7e-48  Score=390.51  Aligned_cols=259  Identities=31%  Similarity=0.525  Sum_probs=222.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+..|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEE
Confidence            46999999999999999999999999999999998764434445567888999999885 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..+....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH---IKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC---EEeccCCCCeECCCCC
Confidence            9999999999999876 67999999999999999999999999999999999999986655   9999999998765433


Q ss_pred             cc--ccCCCCCCCcChhhhcC-------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          200 SL--LGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       200 ~~--~~~~GT~~Y~APE~l~~-------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      ..  ....||+.|+|||++..       .++.++|||||||++|+|++|+.||...+....+..+..............+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            22  23579999999999862       3788999999999999999999999888877777776654322221122468


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +.++.+||++||. ||.+|||++++++||||...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999999998 99999999999999999763

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-48  Score=387.02  Aligned_cols=248  Identities=35%  Similarity=0.646  Sum_probs=220.4

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE  128 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  128 (468)
                      ||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++++. ||||+++++++.+.+.+|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            699999999999999999999999997654444455667888999999995 9999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCCCC
Q 012203          129 LFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTVGS  207 (468)
Q Consensus       129 L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~GT  207 (468)
                      |.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.... .......+||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc---EEEEECcccccCccCCCccccccCC
Confidence            9999988889999999999999999999999999999999999999986654   99999999875432 2233456899


Q ss_pred             CCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCC
Q 012203          208 PFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP  286 (468)
Q Consensus       208 ~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP  286 (468)
                      +.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+..+.+......++    ..+++++.++|.+||.+||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence            999999999875 89999999999999999999999998888888888777666555    4688999999999999999


Q ss_pred             CCCC---CHHHHHhCcCCCCC
Q 012203          287 SQRL---TARQVLDHSWMGDG  304 (468)
Q Consensus       287 ~~Rp---t~~eiL~h~~~~~~  304 (468)
                      .+||   ++.++++||||.+.
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCC
Confidence            9997   58999999999764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-48  Score=396.40  Aligned_cols=259  Identities=32%  Similarity=0.539  Sum_probs=220.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|.+++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+++++++. ||||++++++|.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEE
Confidence            47999999999999999999999999999999997654434445667889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.   +||+|||+++.+.... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~---~kl~DfGla~~~~~~~~  156 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH---IKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC---EEEeecccccccccccc
Confidence            999999999999988888999999999999999999999999999999999999986554   9999999986432100 


Q ss_pred             -----------------------------------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHH
Q 012203          200 -----------------------------------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGV  231 (468)
Q Consensus       200 -----------------------------------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGv  231 (468)
                                                                     .....+||+.|+|||++.+. ++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                                                           00125799999999999775 899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCC---CCHHHHHhCcCCCCC
Q 012203          232 ILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQR---LTARQVLDHSWMGDG  304 (468)
Q Consensus       232 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---pt~~eiL~h~~~~~~  304 (468)
                      ++|||++|++||...+..+.+..+......+.......++.++++||.+||. +|.+|   +++.|++.||||+..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999999998888777777766533222222234688999999999998 77765   599999999999763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.4e-48  Score=388.55  Aligned_cols=250  Identities=31%  Similarity=0.598  Sum_probs=216.0

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHH-HHHhcCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~i-L~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|..+ ++.+. ||||+++++.+.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            469999999999999999999999999977543333344455566554 56674 9999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccC
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT  204 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~  204 (468)
                      ||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... .......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc---EEEeccCCCcccccCCCccccc
Confidence            9999999998888999999999999999999999999999999999999987654   99999999875432 2233456


Q ss_pred             CCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          205 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..++.+.+.......+    ..++..+.++|++||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            899999999999875 89999999999999999999999999888888888876655544    4578999999999999


Q ss_pred             cCCCCCCCH----HHHHhCcCCCCC
Q 012203          284 TDPSQRLTA----RQVLDHSWMGDG  304 (468)
Q Consensus       284 ~dP~~Rpt~----~eiL~h~~~~~~  304 (468)
                      +||.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999999987    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.4e-48  Score=381.44  Aligned_cols=259  Identities=30%  Similarity=0.467  Sum_probs=218.9

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++++. |+||+++++++.+++.+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence            889999999999999999999999999999998765433344456778999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          123 LCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       123 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |+++|+|..++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~---~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH---IRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---EEEeeCCCcEEcCCCCe
Confidence            99999999888543  35899999999999999999999999999999999999986554   99999999988765555


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.........+.+..............++.++.+|++
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            5567899999999999875 899999999999999999999999876543332222222122222233568999999999


Q ss_pred             HccccCCCCCCC-----HHHHHhCcCCCCCC
Q 012203          280 GMLSTDPSQRLT-----ARQVLDHSWMGDGI  305 (468)
Q Consensus       280 ~~L~~dP~~Rpt-----~~eiL~h~~~~~~~  305 (468)
                      +||+.||++||+     ++++++||||.+..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999997     89999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-50  Score=379.96  Aligned_cols=244  Identities=30%  Similarity=0.591  Sum_probs=215.5

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE-EEEeC-CEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA-VYEDE-DYVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~-~~~~~-~~~~l  119 (468)
                      .|+|+++||+|+||.||++.+..+|+.+|.|.+....+ .....+....|+.+|++|. |||||++++ .|.++ ..++|
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhHH
Confidence            49999999999999999999999999999999986654 4455677888999999995 999999998 45444 45999


Q ss_pred             EEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--cC--cEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          120 VMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHE--IG--VVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~--~g--IiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      |||||.+|+|.++++..    +.++|..++.++.|++.||.++|.  ..  |+||||||.||+|+.++.   +||+|||+
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv---vKLGDfGL  174 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV---VKLGDFGL  174 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc---eeeccchh
Confidence            99999999999999653    569999999999999999999998  44  999999999999997665   99999999


Q ss_pred             eeeecCCC-ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          192 ATYIEPGQ-SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       192 a~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ++.+.... ...+.+|||.||+||++.+ +|+.++||||+||++|||+.-++||.+.+..++.+.|.+++..  ..+-..
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~--~~p~~~  252 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP--PLPDEH  252 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--CCcHHH
Confidence            99887654 3457899999999999987 5999999999999999999999999999999999999998653  223357


Q ss_pred             CCHHHHHHHHHccccCCCCCCCH
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTA  292 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~  292 (468)
                      +|..+..+|..|+..||++||+.
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc
Confidence            89999999999999999999984

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-48  Score=389.68  Aligned_cols=258  Identities=33%  Similarity=0.552  Sum_probs=226.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+..|++++.++. ||||+++++++.+.+.+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEE
Confidence            46999999999999999999999999999999998765444445667889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.....  .
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH---IKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC---EEEEeCcCCccccc--c
Confidence            999999999999998888999999999999999999999999999999999999986554   99999999986543  3


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC----CCCCCHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP----WDHISDSAK  275 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~----~~~~s~~l~  275 (468)
                      ....+||+.|+|||++.+. ++.++|||||||++|||++|+.||...+..+....+......+....    ...+++++.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            3456899999999999875 89999999999999999999999998888887777665432222111    125789999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ++|.+||..+|.+||+++++++||||.+.
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-47  Score=386.76  Aligned_cols=250  Identities=34%  Similarity=0.619  Sum_probs=221.9

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+++++.+|+.||+|++.+...........+.+|+++++++. ||||++++++|...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999999999999999998764444445567778999999996 99999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~  205 (468)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... .......+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC---EEecccHHhccccCCCCcccccc
Confidence            999999988888999999999999999999999999999999999999986554   99999999876432 22334568


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+.......+......++    ..+++++.++|.+||.+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            99999999999764 89999999999999999999999998888888888777766655    46889999999999999


Q ss_pred             CCCCCC-----CHHHHHhCcCCCCC
Q 012203          285 DPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       285 dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      ||++|+     ++.++++|+||...
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999998     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-47  Score=387.46  Aligned_cols=256  Identities=30%  Similarity=0.527  Sum_probs=216.7

Q ss_pred             CeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCC-ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~-~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      +|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .......+..|+++++++++||||+++++++.+++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999999874   47899999999764322 2233456788999999997799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~---~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH---VVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC---EEEeeCcCCccccc
Confidence            999999999999999988888999999999999999999999999999999999999987654   99999999986543


Q ss_pred             CC--ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhccCCCCCCCCCC
Q 012203          198 GQ--SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNT----KSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       198 ~~--~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ..  .....+||+.|+|||++.+.  ++.++|||||||++|||++|+.||....    ...+...+......++    ..
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----CC
Confidence            22  23356899999999999763  7889999999999999999999996432    3334444444433333    46


Q ss_pred             CCHHHHHHHHHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      ++..+.+++.+||..||++||     +++++++||||++.
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            889999999999999999999     88999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-47  Score=391.85  Aligned_cols=265  Identities=27%  Similarity=0.470  Sum_probs=226.2

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .+....++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~  115 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDD  115 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC
Confidence            34455678999999999999999999999999999999997654444445566888999999985 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~---~kL~DFG~a~~  191 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH---LKLADFGTCMK  191 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC---EEEEeccccee
Confidence            999999999999999999976 46899999999999999999999999999999999999986655   99999999987


Q ss_pred             ecCCCc--cccCCCCCCCcChhhhcCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          195 IEPGQS--LLGTVGSPFYIAPEVLAGG-----YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       195 ~~~~~~--~~~~~GT~~Y~APE~l~~~-----~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      ......  ..+.+||+.|+|||++.+.     ++.++|||||||++|+|++|+.||...+....+..+......+.....
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  271 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED  271 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence            653322  2356899999999998642     788999999999999999999999988888888877765433333333


Q ss_pred             CCCCHHHHHHHHHccccCCCC--CCCHHHHHhCcCCCCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQ--RLTARQVLDHSWMGDG  304 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~--Rpt~~eiL~h~~~~~~  304 (468)
                      ..++..+++++.+||..++.+  |+++.|+++||||+..
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            468999999999999866544  8899999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.8e-47  Score=383.90  Aligned_cols=251  Identities=34%  Similarity=0.587  Sum_probs=218.5

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||+||+|+++.+++.||+|++.+..............|..++..+.+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998764433444556667888887666799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-CccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~  205 (468)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... ......+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH---IKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC---EEEccCcCCeECCCCCCcccccc
Confidence            999999988889999999999999999999999999999999999999986654   999999999865332 2334568


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..++...+......++    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            99999999999875 89999999999999999999999999888888887766544444    46789999999999999


Q ss_pred             CCCCCCCH-HHHHhCcCCCCC
Q 012203          285 DPSQRLTA-RQVLDHSWMGDG  304 (468)
Q Consensus       285 dP~~Rpt~-~eiL~h~~~~~~  304 (468)
                      ||++||++ +++++|+||...
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CHHHcCCChHHHHcCcccCCC
Confidence            99999986 589999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-48  Score=390.99  Aligned_cols=255  Identities=33%  Similarity=0.580  Sum_probs=226.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCC-cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTG-EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      .++|++.+.||+|+||.||+|.++.++ ..||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEE
Confidence            456999999999999999999976554 789999997765444445667889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... 
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~---ikL~DFG~a~~~~~-  183 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF---IKMTDFGFAKVVDT-  183 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC---EEEecCCCCeecCC-
Confidence            99999999999999998889999999999999999999999999999999999999986554   99999999987643 


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                       .....+||+.|+|||++.+. ++.++|||||||++|||++|+.||...+.....+.+......+|    ..+++.+.++
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  258 (340)
T PTZ00426        184 -RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHL  258 (340)
T ss_pred             -CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence             23456899999999999875 89999999999999999999999999888888888877766555    4678999999


Q ss_pred             HHHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      |++||+.||.+|+     +++++++||||.+.
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999996     89999999999763

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.2e-47  Score=390.74  Aligned_cols=266  Identities=28%  Similarity=0.469  Sum_probs=227.8

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ....-.++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.+. ||||+++++++.+.
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~  115 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDD  115 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence            33445578999999999999999999999999999999997654433444556788999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~---~kL~DfG~~~~  191 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMK  191 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC---EEEEeccceee
Confidence            999999999999999999876 46899999999999999999999999999999999999987655   99999999987


Q ss_pred             ecCCC--ccccCCCCCCCcChhhhcC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          195 IEPGQ--SLLGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       195 ~~~~~--~~~~~~GT~~Y~APE~l~~-----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      .....  .....+||+.|+|||++.+     .++.++|||||||++|||++|+.||.+.+....+..+............
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD  271 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence            65432  2235689999999999864     2788999999999999999999999998888888887665433322223


Q ss_pred             CCCCHHHHHHHHHccccCCCC--CCCHHHHHhCcCCCCCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQ--RLTARQVLDHSWMGDGI  305 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~--Rpt~~eiL~h~~~~~~~  305 (468)
                      ..++.++++||++||..+|.+  |++++|+++||||++..
T Consensus       272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            468999999999999999988  99999999999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-49  Score=376.90  Aligned_cols=262  Identities=39%  Similarity=0.715  Sum_probs=238.3

Q ss_pred             ccccCCeEEE-eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--
Q 012203           37 SNLRERFVLG-QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--  113 (468)
Q Consensus        37 ~~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--  113 (468)
                      ..+.++|.+- +.||-|-.|.|..|.++.||+.+|+|++...        ...++|+++--...+|||||.++++|++  
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            3477889885 6899999999999999999999999987533        4567788888778899999999999864  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          114 --EDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       114 --~~~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                        ...+.+|||.++||+|++.++.++.  |+|.++..|++||..|+.|||+.+|.||||||+|+|.+....+..+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence              4678999999999999999988766  999999999999999999999999999999999999998888889999999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhccCCCCC
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNT----KSRIFDAVRTADLRFPS  264 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~  264 (468)
                      |+|+.........+.|-||+|.|||++.. +|+..+|+||+||++|.|++|.+||+.+.    ...+..+|..+.+.||.
T Consensus       209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            99999877777888999999999999986 59999999999999999999999997654    34678899999999999


Q ss_pred             CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       265 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ..|..+|+.++|+|+++|..+|.+|+|++++++|||+.+...
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            999999999999999999999999999999999999977543

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-49  Score=376.71  Aligned_cols=266  Identities=37%  Similarity=0.669  Sum_probs=238.0

Q ss_pred             ccCCeEE-EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           39 LRERFVL-GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        39 l~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      +.+-|++ .+.||+|+|+.|-.|....+|+.||||+|.|.   ......++.+|++++.++++|+||++++++|+++..+
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            4445665 46899999999999999999999999999886   3345678899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||||.+.||.|...|.++..|++.++.++.++|+.||.+||.+||.||||||+|||...-+.-..||||||.+...+.-
T Consensus       152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999998766667899999999765432


Q ss_pred             C--------CccccCCCCCCCcChhhhc---C---CCCCcchHHHHHHHHHHHHhCCCCCCCCC---------------h
Q 012203          198 G--------QSLLGTVGSPFYIAPEVLA---G---GYNQAADVWSAGVILYILLSGMPPFWGNT---------------K  248 (468)
Q Consensus       198 ~--------~~~~~~~GT~~Y~APE~l~---~---~~~~~sDiwSlGvil~elltG~~Pf~~~~---------------~  248 (468)
                      .        ....+.+|+..|||||+..   +   .|+.++|.||||||+|.||.|++||.++.               .
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence            1        2344678999999999864   2   38999999999999999999999996543               3


Q ss_pred             HHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                      ..+++.|+.+.+.||...|..++.+++|+|..+|..|+.+|.++.++++|||++....+
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            67899999999999999999999999999999999999999999999999999876543

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.2e-47  Score=383.12  Aligned_cols=254  Identities=34%  Similarity=0.568  Sum_probs=221.2

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEEeCCEEEEE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      |++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|++++..++  +||||+++++++.+.+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            788999999999999999999999999999998764433444566777777664332  499999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~  199 (468)
                      |||++|++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... ..
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~---~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF---VKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc---EEeCcccCCccCCCCCC
Confidence            999999999988865 57999999999999999999999999999999999999987655   99999999875432 22


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+..+.+......++    ..+++.+.++|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  232 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISIM  232 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Confidence            33456899999999999875 89999999999999999999999999888888888877766655    46789999999


Q ss_pred             HHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      .+||++||.+||     +++++++|+||++.
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999999999     79999999999764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=399.38  Aligned_cols=256  Identities=29%  Similarity=0.478  Sum_probs=226.2

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      =...|...++||+|+.|.||.|+...+++.||||.+.+..   ....+-+.+|+.+|+.++ |+|||++++.|...+.+|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhcccceeE
Confidence            3456888999999999999999999999999999998764   344577889999999997 999999999999899999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||++||+|.+++... .++|.++..++++++.||+|||.+||+|||||.+|||++.++.   +||+|||++..+...
T Consensus       347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~---vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS---VKLTDFGFCAQISEE  422 (550)
T ss_pred             EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc---EEEeeeeeeeccccc
Confidence            999999999999999774 5999999999999999999999999999999999999988776   999999999887765


Q ss_pred             C-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      . ...+.+|||+|||||+...+ |+.+.||||||++++||+-|.+||...+.-..+..|..... .....+..++..+++
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P~lk~~~klS~~~kd  501 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PKLKNPEKLSPELKD  501 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-CCcCCccccCHHHHH
Confidence            5 45678999999999999875 99999999999999999999999987666655555544322 222234789999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      |+.+||+.|+++|+++.|+|+||||+.
T Consensus       502 FL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            999999999999999999999999954

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-47  Score=394.43  Aligned_cols=258  Identities=34%  Similarity=0.516  Sum_probs=222.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+++++++. ||||+++++.|.+++.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence            6999999999999999999999999999999998764444455677889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC---
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG---  198 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~---  198 (468)
                      |||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..+...   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~---~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEEeECCCCccccccccc
Confidence            99999999999988888999999999999999999999999999999999999986554   999999997532100   


Q ss_pred             ---------------------------------------------CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHH
Q 012203          199 ---------------------------------------------QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVI  232 (468)
Q Consensus       199 ---------------------------------------------~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvi  232 (468)
                                                                   ....+.+||+.|+|||++.+. ++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         001235799999999999764 9999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHHhCcCCCCC
Q 012203          233 LYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSWMGDG  304 (468)
Q Consensus       233 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~eiL~h~~~~~~  304 (468)
                      +|||++|++||...+..+....+..............+++++.++|.+|+ .||.+|++   ++++++||||+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999999988777766666654443333344678999999999987 59999997   9999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.2e-47  Score=381.46  Aligned_cols=252  Identities=31%  Similarity=0.551  Sum_probs=219.1

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+++.||+|++.+..............|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998764333334556677888888765799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~  205 (468)
                      |+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++..... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH---IKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---EEEccCCcceECCCCCCceeeec
Confidence            999999988888999999999999999999999999999999999999987654   99999999876432 22334568


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+..+.+......++    ..++.++.++|.+||++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            99999999999875 89999999999999999999999998888888887776654444    35788999999999999


Q ss_pred             CCCCCCCHH-HHHhCcCCCCCC
Q 012203          285 DPSQRLTAR-QVLDHSWMGDGI  305 (468)
Q Consensus       285 dP~~Rpt~~-eiL~h~~~~~~~  305 (468)
                      ||++|+++. ++++||||....
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCCC
Confidence            999999996 899999997743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.8e-48  Score=394.97  Aligned_cols=259  Identities=32%  Similarity=0.506  Sum_probs=222.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .+|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+++|+++. ||||+++++.|.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEE
Confidence            36999999999999999999999999999999997654333344567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC--
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG--  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~--  198 (468)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..+...  
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~---ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC---EEEEeCCCCcccccccc
Confidence            999999999999998888999999999999999999999999999999999999986554   999999997532100  


Q ss_pred             ------------------------------------------CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHH
Q 012203          199 ------------------------------------------QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYI  235 (468)
Q Consensus       199 ------------------------------------------~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~e  235 (468)
                                                                ......+||+.|+|||++.+. ++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                      001235799999999999875 8999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHHhCcCCCCC
Q 012203          236 LLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL---TARQVLDHSWMGDG  304 (468)
Q Consensus       236 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---t~~eiL~h~~~~~~  304 (468)
                      |++|+.||.+.+..+....+...........+..++.++.++|.+|+ .+|.+|+   ++.++++||||+..
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999999988877766666554444444444678999999999977 5999999   99999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.2e-47  Score=388.39  Aligned_cols=273  Identities=28%  Similarity=0.463  Sum_probs=229.7

Q ss_pred             hhhcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceee
Q 012203           28 ETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL  107 (468)
Q Consensus        28 ~~i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l  107 (468)
                      .++-...++....++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.+. ||||+++
T Consensus        30 ~~~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~  108 (371)
T cd05622          30 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQL  108 (371)
T ss_pred             hHhhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeE
Confidence            334344455566689999999999999999999999999999999997654434444566788999999885 9999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       108 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      ++.+.+.+.+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~---ikL~  184 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLA  184 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC---EEEE
Confidence            9999999999999999999999999876 46899999999999999999999999999999999999986554   9999


Q ss_pred             ecCceeeecCCCc--cccCCCCCCCcChhhhcCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 012203          188 DFGLATYIEPGQS--LLGTVGSPFYIAPEVLAGG-----YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       188 DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~-----~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                      |||++........  ....+||+.|+|||++.+.     ++.++|||||||++|||++|+.||...+....+..+.....
T Consensus       185 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~  264 (371)
T cd05622         185 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN  264 (371)
T ss_pred             eCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999987654322  2356899999999998642     78899999999999999999999999888888888776543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCC--CCCHHHHHhCcCCCCCC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQ--RLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~eiL~h~~~~~~~  305 (468)
                      .++......++..++++|.+||..++.+  |++++++++|+||++..
T Consensus       265 ~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         265 SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            3333333578999999999999854443  78999999999997744

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.5e-47  Score=380.22  Aligned_cols=256  Identities=29%  Similarity=0.559  Sum_probs=225.8

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+..|+.+++.+.+|++|+++++++++.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999999999999999999987644444455677789999988876788999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-Cc
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QS  200 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~  200 (468)
                      ||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~---ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEeccccccccCCCCcc
Confidence            99999999999998889999999999999999999999999999999999999987654   999999998764322 22


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+.....+.+......++    ..++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  233 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence            3456799999999999875 89999999999999999999999999888888888887766555    467899999999


Q ss_pred             HccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          280 GMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       280 ~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      +||++||.+|++     .+++++|+||...
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            999999999997     5799999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.2e-48  Score=361.14  Aligned_cols=259  Identities=30%  Similarity=0.498  Sum_probs=223.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .+|..++.||+|.||+||+|++..+|+.||||.|+.... ...-.....+||+.|+.++ |+||+.++++|-+.+.+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence            578899999999999999999999999999999987643 2233456788999999997 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      +||++ .+|+.+++.. ..++...++.|+.++++||+|||++.|+||||||.|+|++.++.   +||+|||+|+.+....
T Consensus        80 fEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~---lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ---LKIADFGLARFFGSPN  155 (318)
T ss_pred             EEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc---EEeecccchhccCCCC
Confidence            99995 5999999765 45899999999999999999999999999999999999987665   9999999999886543


Q ss_pred             ccc-cCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC---------
Q 012203          200 SLL-GTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW---------  267 (468)
Q Consensus       200 ~~~-~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---------  267 (468)
                      ... ..+-|.+|+|||.+.|.  |+..+|+||.|||+.||+.|.+-|.+.+.-+.+..|...-.....+.|         
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            332 33789999999999984  999999999999999999999999998887777777554333222222         


Q ss_pred             ---------------CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          268 ---------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       268 ---------------~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                     ...++++.||+.+||.+||.+|+++.|+|+|+||++..
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                           23567889999999999999999999999999998743

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-47  Score=387.53  Aligned_cols=251  Identities=33%  Similarity=0.577  Sum_probs=218.8

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      ||+|+||+||+|+++.+|+.||+|++.+..............|..++.++.  +||||+++++++++.+.+|+||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997654433334445566777777664  699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~  205 (468)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH---IALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEecCCcCcCCCCCCCCccCcc
Confidence            999999998889999999999999999999999999999999999999987654   99999999876432 23344578


Q ss_pred             CCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          206 GSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       206 GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|+.||...+..+.++.+......++.   ..+++++.++|++||.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence            9999999999875  3789999999999999999999999998888888888777766654   3578999999999999


Q ss_pred             cCCCCCC----CHHHHHhCcCCCCCC
Q 012203          284 TDPSQRL----TARQVLDHSWMGDGI  305 (468)
Q Consensus       284 ~dP~~Rp----t~~eiL~h~~~~~~~  305 (468)
                      +||.+||    ++.++++||||....
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCCC
Confidence            9999998    799999999997643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=378.79  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=226.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .+.|++.+.||.|..++||+|+...+++.||||+++.++.  .++.+.+.+|+..|..+. ||||++++..|..+..+|+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeEE
Confidence            4569999999999999999999999999999999998864  344789999999999885 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||.||.+|++.++++..  ..+.|..+..+++++++||.|||.+|-||||||+.||||+.+|.   |||+|||.+..+..
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~---VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT---VKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc---EEEcCceeeeeecc
Confidence            99999999999999775  34999999999999999999999999999999999999988776   99999998766543


Q ss_pred             CC-c----cccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC------CC
Q 012203          198 GQ-S----LLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR------FP  263 (468)
Q Consensus       198 ~~-~----~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------~~  263 (468)
                      .. .    ..+.+|||+|||||++..   +|+.|+||||||++..||.+|..||....+.+++-.-.++.+.      ++
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence            21 1    156699999999999764   5999999999999999999999999888877766555444442      23


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+....++..++++|..||++||.+|||+.++|+|+||++..
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            333456788999999999999999999999999999998743

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.4e-47  Score=381.42  Aligned_cols=250  Identities=30%  Similarity=0.578  Sum_probs=214.7

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHH-HHHHhcCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE-IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~-iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+..|+. +++.+ +||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999999999999999998754333333445555655 56667 49999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccC
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT  204 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~  204 (468)
                      |++|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEccCCCCccCCCCCCccccc
Confidence            9999999988888999999999999999999999999999999999999987655   99999999875322 2233456


Q ss_pred             CCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          205 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      +||+.|+|||++.+. ++.++|||||||++|||++|+.||...+...+.+.+......++    ...+..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence            899999999999875 89999999999999999999999999888888888776655544    3578899999999999


Q ss_pred             cCCCCCCCH----HHHHhCcCCCCC
Q 012203          284 TDPSQRLTA----RQVLDHSWMGDG  304 (468)
Q Consensus       284 ~dP~~Rpt~----~eiL~h~~~~~~  304 (468)
                      +||.+|+++    .++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            999999875    599999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.8e-47  Score=382.02  Aligned_cols=250  Identities=29%  Similarity=0.550  Sum_probs=215.7

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHH-HHHhcCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~i-L~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|..+ ++.+ +||||++++++++..+.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence            469999999999999999999999999977644333444556666655 5556 59999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccC
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT  204 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~  204 (468)
                      ||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~---~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH---VVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEEeecCCcccCCCCCCCcccc
Confidence            9999999998889999999999999999999999999999999999999987654   99999999875432 2233456


Q ss_pred             CCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          205 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..++++.+.......+    ...+..+.++|++||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence            899999999999875 89999999999999999999999999888888887776654443    3578899999999999


Q ss_pred             cCCCCCCCH----HHHHhCcCCCCC
Q 012203          284 TDPSQRLTA----RQVLDHSWMGDG  304 (468)
Q Consensus       284 ~dP~~Rpt~----~eiL~h~~~~~~  304 (468)
                      +||.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            999999976    599999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.3e-47  Score=379.76  Aligned_cols=250  Identities=33%  Similarity=0.558  Sum_probs=218.2

Q ss_pred             eEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCC-ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           47 QQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~-~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      +.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+++|+++. ||||++++++|..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence            68999999999999874   47899999999765332 2233456778999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCcc
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSL  201 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~  201 (468)
                      |++|++|.+++.+.+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH---VKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEeeCcCCeecccCCCcc
Confidence            9999999999998888999999999999999999999999999999999999986654   99999999876433 2233


Q ss_pred             ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHH
Q 012203          202 LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG  280 (468)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  280 (468)
                      ...+||+.|+|||++.+. ++.++|||||||++|||++|+.||...+.......+......++    ..+++.+.++|++
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  233 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKK  233 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            456899999999999875 88999999999999999999999998888888888777665554    4678999999999


Q ss_pred             ccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          281 MLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       281 ~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      ||++||++||     +++++++||||...
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.4e-47  Score=373.11  Aligned_cols=254  Identities=30%  Similarity=0.499  Sum_probs=212.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|+||+||+|+++.+++.||+|++.....  ......+.+|+++++++. ||||+++++++.+.+..++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence            569999999999999999999999999999999975432  222346778999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEECcCcceeeccCCC
Confidence            999975 9999887654 4789999999999999999999999999999999999986655   9999999998654322


Q ss_pred             -ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---------------
Q 012203          200 -SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR---------------  261 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------  261 (468)
                       ......||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+....+......               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             2345678999999999875  3899999999999999999999999887766665554332111               


Q ss_pred             ----CCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          262 ----FPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       262 ----~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                          ++.       .....++.++++||++||++||.+|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                110       0113567899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.9e-47  Score=382.31  Aligned_cols=251  Identities=29%  Similarity=0.550  Sum_probs=216.4

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++.++.+||||++++++|.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765444455667889999999997799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee-cCCCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~-~~~~~~~~~~  205 (468)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.. .........+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEECcCccccccccCCCcccccc
Confidence            999999988889999999999999999999999999999999999999986554   999999998753 2233345678


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN---------TKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ||+.|+|||++.+. ++.++|+|||||++|+|++|+.||...         ......+.+......+|    ..++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            99999999999875 899999999999999999999999532         12234455555555544    46789999


Q ss_pred             HHHHHccccCCCCCCC------HHHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRLT------ARQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt------~~eiL~h~~~~~~  304 (468)
                      ++|++||.+||.+|++      ++++++||||...
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999997      7899999999653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.1e-47  Score=372.03  Aligned_cols=256  Identities=29%  Similarity=0.486  Sum_probs=213.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++..... .......+.+|+++++++. ||||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEE
Confidence            479999999999999999999999999999999976532 2233466788999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||++++.+..+......+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV---LKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEEeeccCccccccccc
Confidence            999998877766655567999999999999999999999999999999999999986554   9999999998765332 


Q ss_pred             -ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----------------
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-----------------  260 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  260 (468)
                       ......||+.|+|||++.+. ++.++|+|||||++|+|++|++||.+.+..+....+.....                 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             22345799999999999774 89999999999999999999999987665444333322111                 


Q ss_pred             --CCCCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 --RFPSN---------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 --~~~~~---------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                        .++..         .+..++.++.+||++||++||++|||++|+|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              11100         112478889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-47  Score=383.68  Aligned_cols=250  Identities=34%  Similarity=0.615  Sum_probs=221.8

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+..|+++++++. ||||+++++++.+++.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765444445567788999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT  204 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~  204 (468)
                      |+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.   +||+|||+++.... .......
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC---EEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 79999999999999987654   99999999876432 2333456


Q ss_pred             CCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          205 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+.....+.+......++    ..+++++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            899999999999764 89999999999999999999999998888888888777766665    4688999999999999


Q ss_pred             cCCCCCC-----CHHHHHhCcCCCCC
Q 012203          284 TDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       284 ~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      +||++|+     ++.++++|+||.+.
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.7e-47  Score=388.28  Aligned_cols=259  Identities=31%  Similarity=0.540  Sum_probs=222.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++.++. ||||+++++.+++.+.+|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            46999999999999999999999999999999997654434445667888999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~---vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC---EEEeeccCCcccccccc
Confidence            999999999999998888999999999999999999999999999999999999986554   9999999987543210 


Q ss_pred             -----------------------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCC
Q 012203          200 -----------------------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPF  243 (468)
Q Consensus       200 -----------------------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf  243 (468)
                                                         .....+||+.|+|||++.+. ++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               01245799999999999875 899999999999999999999999


Q ss_pred             CCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHHhCcCCCCC
Q 012203          244 WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL---TARQVLDHSWMGDG  304 (468)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---t~~eiL~h~~~~~~  304 (468)
                      ...+.......+..............+++++++||.+|+. ||.+|+   +++++++||||.+.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            9888888877776543322222224588999999999874 999998   48999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.8e-46  Score=377.05  Aligned_cols=252  Identities=27%  Similarity=0.517  Sum_probs=216.9

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++.++.+||||+++++++++.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998765444455667889999999997799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CCCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~  205 (468)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH---IKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC---EEEeccccceeccCCCCceeccc
Confidence            999999988888999999999999999999999999999999999999987655   9999999997632 233345678


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN-------TKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...       ......+.+......+|    ..++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            99999999999875 899999999999999999999999532       22334445544444444    4688999999


Q ss_pred             HHHccccCCCCCCC------HHHHHhCcCCCCCC
Q 012203          278 VMGMLSTDPSQRLT------ARQVLDHSWMGDGI  305 (468)
Q Consensus       278 i~~~L~~dP~~Rpt------~~eiL~h~~~~~~~  305 (468)
                      |++||.+||++|++      ++++++|+||....
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            99999999999998      57999999997643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.9e-46  Score=377.63  Aligned_cols=249  Identities=31%  Similarity=0.591  Sum_probs=213.7

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHH-HHHHhcCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE-IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~-iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+..|.. +++.+ +||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999998654333333344555554 45666 59999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CCccccC
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT  204 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~  204 (468)
                      ||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.... .......
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~---~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEEccCCCCcccccCCCCcccc
Confidence            9999999998888999999999999999999999999999999999999986554   99999999976432 2233456


Q ss_pred             CCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          205 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|++||...+..+.++.+......++    ..++..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcc
Confidence            899999999999875 89999999999999999999999999888888887766554433    4688999999999999


Q ss_pred             cCCCCCCCHH----HHHhCcCCCC
Q 012203          284 TDPSQRLTAR----QVLDHSWMGD  303 (468)
Q Consensus       284 ~dP~~Rpt~~----eiL~h~~~~~  303 (468)
                      +||.+|+++.    ++++|+||..
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCC
Confidence            9999999865    8999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.6e-46  Score=376.13  Aligned_cols=260  Identities=27%  Similarity=0.501  Sum_probs=220.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+..|+.++..+. |+||+++++++++.+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            47999999999999999999999999999999997643333344556788999999885 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC---EEEEeccceeeccCCC
Confidence            999999999999987 467999999999999999999999999999999999999986554   9999999998765433


Q ss_pred             cc--ccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC-CCCCCC
Q 012203          200 SL--LGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS-NPWDHI  270 (468)
Q Consensus       200 ~~--~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  270 (468)
                      ..  ...+||+.|+|||++.+      .++.++|||||||++|+|++|+.||...+..+.+..+......++. ..+..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            22  23579999999999874      3788999999999999999999999988877777777655433321 223567


Q ss_pred             CHHHHHHHHHccccCCCC--CCCHHHHHhCcCCCCC
Q 012203          271 SDSAKDLVMGMLSTDPSQ--RLTARQVLDHSWMGDG  304 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~--Rpt~~eiL~h~~~~~~  304 (468)
                      +++++++|.+||..++.+  |++++++++|+||+..
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            899999999999976655  5689999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-46  Score=378.74  Aligned_cols=251  Identities=28%  Similarity=0.533  Sum_probs=215.7

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++.++.+||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765444455667888999998887799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CCCccccCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~  205 (468)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~---~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC---EEEeeCCccccccCCCCcccccc
Confidence            999999988889999999999999999999999999999999999999987655   9999999987643 223334568


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN---------TKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||...         ....+.+.+......+|    ..++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            99999999999875 899999999999999999999999521         12234444555555544    46789999


Q ss_pred             HHHHHccccCCCCCCC------HHHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRLT------ARQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt------~~eiL~h~~~~~~  304 (468)
                      ++|++||.+||++|++      ++++++||||+..
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-48  Score=379.56  Aligned_cols=320  Identities=29%  Similarity=0.479  Sum_probs=264.3

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .+|..+..||+|+||+|.+|..+.+.+.||||+++++-+...++.+--..|-++|.....-|.+++++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            35899999999999999999999999999999999998888888888888999998666688999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee-cCCC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~-~~~~  199 (468)
                      |||+.||+|.-.|+..++|.+..+..|+..|+-||-+||++|||+||||..||||+.+++   |||+|||+++.- -.+.
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH---iKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc---eEeeecccccccccCCc
Confidence            999999999999999999999999999999999999999999999999999999987665   999999999863 3455


Q ss_pred             ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ...++||||.|+|||++.. .|+..+||||+||+||||+.|.+||.+.+.+++++.|......+|    ..++.++.++.
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkEAv~ic  581 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKEAVAIC  581 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHHHHHHH
Confidence            6678999999999999876 599999999999999999999999999999999999999988888    57999999999


Q ss_pred             HHccccCCCCCCC-----HHHHHhCcCCCCCCCCCccccCCcccccccccCCCCCCccccccCCccCccCCCCCCCCCCC
Q 012203          279 MGMLSTDPSQRLT-----ARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDISFGTGSPVFSDDE  353 (468)
Q Consensus       279 ~~~L~~dP~~Rpt-----~~eiL~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  353 (468)
                      +.+|.+.|.+|+.     -.+|..||||+...  ++......+++...-..     ...-...|.+-.|....|.     
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD--Wek~E~~eiqPPfkPk~-----k~~r~~eNFD~~Ft~~~~~-----  649 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRID--WEKLERREIQPPFKPKI-----KCGRDAENFDKFFTREPTD-----  649 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhcc--HHHHhhccCCCCCCCcc-----ccCCchhhhhHHHhcCCCC-----
Confidence            9999999999995     47899999998754  44444444443111000     0000112344445444432     


Q ss_pred             CCcccccCCCcccccCCCCCCcccccCCC
Q 012203          354 SPAFTCRTSFSSFLQEPSTSTGFSFCSPG  382 (468)
Q Consensus       354 ~p~~~~~~~~~~~~~~~~~~~gfs~~~~~  382 (468)
                         .|.++...-..-+.+.+.||||.++.
T Consensus       650 ---lTPpD~~v~~nldq~eF~gFsfvNpe  675 (683)
T KOG0696|consen  650 ---LTPPDKLVMMNLDQSEFEGFSFVNPE  675 (683)
T ss_pred             ---CCCchHHHHhcCchhhcCceeeeChh
Confidence               23333222222346779999997653

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.1e-46  Score=370.94  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=209.3

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.....  ......+.+|+++++++. ||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEE
Confidence            3679999999999999999999999999999999975432  222345678999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||+. ++|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~  156 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVP  156 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECCCCcceeccCC
Confidence            999995 6888777654 56899999999999999999999999999999999999986554   999999998764322


Q ss_pred             -CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCC-------------
Q 012203          199 -QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLR-------------  261 (468)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~-------------  261 (468)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+... .+..+.+......             
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             23345678999999999875  378899999999999999999999976432 2222222111000             


Q ss_pred             -CCCC--------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 -FPSN--------------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 -~~~~--------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                       +...              .....++.+++|+.+||+.||++|||++|+++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence             0000              0012457899999999999999999999999999997743

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=373.10  Aligned_cols=259  Identities=29%  Similarity=0.532  Sum_probs=219.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..+. |+||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence            47999999999999999999999999999999997654334445566888999999985 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH---IRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC---EEEEECCceeecCCCC
Confidence            999999999999976 457999999999999999999999999999999999999976554   9999999997765433


Q ss_pred             cc--ccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCCCCC
Q 012203          200 SL--LGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL--RFPSNPWDH  269 (468)
Q Consensus       200 ~~--~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~  269 (468)
                      ..  ...+||+.|+|||++.+      .++.++|||||||++|+|++|+.||......+.+..+.....  .++.. ...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~  235 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD-VTD  235 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCc-cCC
Confidence            22  23479999999999862      378899999999999999999999988887777777655433  23322 245


Q ss_pred             CCHHHHHHHHHccccCCCC--CCCHHHHHhCcCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQ--RLTARQVLDHSWMGDG  304 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~--Rpt~~eiL~h~~~~~~  304 (468)
                      +++.++++|++||..++++  |++++++++||||.+.
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            8999999999998765544  7899999999999663

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=382.95  Aligned_cols=260  Identities=37%  Similarity=0.686  Sum_probs=239.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +..-|.+.+.||+|-|++|-+|++..+|+.||||++.|.++... ....+.+|++.|+-++ |||||++|++......+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhc-CcCeeeeeehhcccceEE
Confidence            55669999999999999999999999999999999999876543 3456778999998875 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||+|+-.||+|+++|.++ ..+.|+.++.|+.||+.|+.|+|+.+++||||||+||.+.+.  -+-|||+|||++..+.+
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK--lGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK--LGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee--cCceEeeeccccccCCC
Confidence            999999999999999776 459999999999999999999999999999999999998753  35699999999999999


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~-~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ++...+.||+..|-|||++.|. |+ +++||||||||||.|++|++||+..+..+.+..|...++..|    ..++.+++
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~eCr  247 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSKECR  247 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhHHHH
Confidence            9999999999999999999986 75 589999999999999999999999999999999999999888    58999999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      +||..||+.||.+|.+.++|..|+|++....
T Consensus       248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  248 DLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            9999999999999999999999999987653

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-46  Score=377.72  Aligned_cols=249  Identities=31%  Similarity=0.564  Sum_probs=218.4

Q ss_pred             eEEeecCCeEEEEEEE---cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 012203           47 QQLGWGQFGVIRVCSD---KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL  123 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~---~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~  123 (468)
                      +.||+|+||.||++++   +.+|+.||+|++.+... .......+..|+++++++. ||||+++++++.+++.+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence            5799999999999987   35789999999976543 2233456778999999995 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-Cccc
Q 012203          124 CAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLL  202 (468)
Q Consensus       124 ~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~  202 (468)
                      ++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... ....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc---EEEeeccCCcccCCCCCcee
Confidence            999999999988888999999999999999999999999999999999999986654   999999999865443 2344


Q ss_pred             cCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHc
Q 012203          203 GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM  281 (468)
Q Consensus       203 ~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~  281 (468)
                      ..+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+....+......++    ..+++.+.++|++|
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~  232 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL  232 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence            56899999999999874 88999999999999999999999998888888888777666555    36789999999999


Q ss_pred             cccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          282 LSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       282 L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      |++||++||+     ++++++|+||...
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=362.73  Aligned_cols=260  Identities=31%  Similarity=0.457  Sum_probs=219.3

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDYV  117 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~~~~  117 (468)
                      -+.|+.++.|++|.||.||.|+++.|++.||+|.++-+.- ....--.-.+||.+|.+++ |||||.+.++...  -+.+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcC-CCCeeeeEEEEecccccee
Confidence            3458999999999999999999999999999999976642 1122234567999999997 9999999999864  4579


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |||||||+ -+|..++..-+ +|...+++.++.|++.||+|||.+.|+||||||+|+|+...|.   +||+|||+|+.+.
T Consensus       153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~---lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI---LKIADFGLAREYG  228 (419)
T ss_pred             eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc---EEecccchhhhhc
Confidence            99999995 59999997654 8999999999999999999999999999999999999976554   9999999999886


Q ss_pred             CC-CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC------------
Q 012203          197 PG-QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR------------  261 (468)
Q Consensus       197 ~~-~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------  261 (468)
                      .. ......+-|.+|+|||.+.|.  |+.+.|+||+|||+.||+++++.|.+...-+.++.|.+....            
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            54 334556789999999999985  999999999999999999999999999888777777543221            


Q ss_pred             -------CCCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 -------FPSNP---------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 -------~~~~~---------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                             ++..+         +..+++...+|++.+|.+||.+|.|+.|.|+|.||.+..
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                   11111         112568899999999999999999999999999998854

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=366.56  Aligned_cols=266  Identities=30%  Similarity=0.523  Sum_probs=227.5

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-  113 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-  113 (468)
                      +.-.+..+|...+.||.|+||.|+.|.++.+|+.||+|.+... +......++..+|+.+|+.++ |+||+.+++++.. 
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPP   93 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccc
Confidence            4455777888899999999999999999999999999998632 234456778889999999997 9999999999965 


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          114 ----EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       114 ----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                          -+.+|+|+|+| +.+|.++++....+++..++.++.||++||+|+|+.+|+||||||.|+|++.+..   +||+||
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~---lKI~DF  169 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD---LKICDF  169 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC---EEeccc
Confidence                46799999999 7799999998777999999999999999999999999999999999999998776   899999


Q ss_pred             CceeeecC---CCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----
Q 012203          190 GLATYIEP---GQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD-----  259 (468)
Q Consensus       190 Gla~~~~~---~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----  259 (468)
                      |+|+....   ...+..++.|.+|.|||++..  .|+.+.||||+|||+.||++|++.|.+.+..+.++.|...-     
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            99998864   445577899999999999865  49999999999999999999999998887766555543211     


Q ss_pred             ------------------CCCCCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          260 ------------------LRFPSNP----WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       260 ------------------~~~~~~~----~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                        ...|..+    +...++.+.+|+.+||..||.+|+|++|+|.|||+.....
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence                              1122221    4578899999999999999999999999999999977543

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-46  Score=365.59  Aligned_cols=259  Identities=30%  Similarity=0.488  Sum_probs=218.5

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++.+.+.+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence            4899999999999999999999999999999997654433333455778999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||++||+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH---IRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC---EEEeeCCCceecCCCC
Confidence            999999999888653  45899999999999999999999999999999999999976544   9999999998865544


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      .....+|++.|+|||++.+. ++.++||||+||++|+|++|+.||.+.......+.+...-...+......++..+.+|+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            44566899999999999765 88999999999999999999999987665443333322212222223356889999999


Q ss_pred             HHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      .+||..||++||     +++++++|+||...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999999999     89999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.6e-46  Score=372.79  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=210.9

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-----CE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE-----DY  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~-----~~  116 (468)
                      +|++.+.||+|+||.||+|+++.+|+.||+|++..... .......+.+|++++++++ ||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence            69999999999999999999999999999999865321 2234456888999999996 99999999988543     35


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||| +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++...
T Consensus        79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---EEEccCccccccc
Confidence            89999999 5799999988888999999999999999999999999999999999999986554   9999999997643


Q ss_pred             CCC----ccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----------
Q 012203          197 PGQ----SLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA-----------  258 (468)
Q Consensus       197 ~~~----~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------  258 (468)
                      ...    .....+||+.|+|||++.+   .++.++|||||||++|+|++|++||.+.+.....+.+...           
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221    1234579999999999865   4889999999999999999999999776644333222110           


Q ss_pred             ----------------cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          259 ----------------DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       259 ----------------~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                      ........+..+++.+.+++.+||+.||++|||++|+++||||++..
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                            00000111235678899999999999999999999999999997644

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-45  Score=371.28  Aligned_cols=260  Identities=28%  Similarity=0.478  Sum_probs=220.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+..|+.++..+. |+||+++++.+++.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence            47999999999999999999999999999999997643333334456788999999885 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~---~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC---EEEeecchheecccCC
Confidence            999999999999977 467999999999999999999999999999999999999986554   9999999997654332


Q ss_pred             c--cccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC-CCCCCC
Q 012203          200 S--LLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS-NPWDHI  270 (468)
Q Consensus       200 ~--~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  270 (468)
                      .  ....+||+.|+|||++.+      .++.++|||||||++|||++|+.||...+..+.+..+......++. .....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence            2  234579999999999862      3788999999999999999999999988888888777665433221 123568


Q ss_pred             CHHHHHHHHHccccCCCC--CCCHHHHHhCcCCCCC
Q 012203          271 SDSAKDLVMGMLSTDPSQ--RLTARQVLDHSWMGDG  304 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~--Rpt~~eiL~h~~~~~~  304 (468)
                      ++++++|+++||..++++  |++++|+++||||...
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            999999999999765554  6899999999999764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-47  Score=377.32  Aligned_cols=257  Identities=28%  Similarity=0.475  Sum_probs=225.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      ...|...+.||+|+||.||+|.+..+++.||+|++..+.  ..+....+++|+.+|..+. ++||.++|+.|.....+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHH
Confidence            345777899999999999999999999999999998874  3456678899999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      +||||.||++.+.++..+.+.+..+..++++++.||.|||..+.+|||||+.|||+..++.   +||+|||++..+....
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~---vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD---VKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc---EEEEecceeeeeechh
Confidence            9999999999999998777799999999999999999999999999999999999987765   9999999998876543


Q ss_pred             c-cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 S-LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~-~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      . ..+++|||.|||||++.+ +|+.|+||||||++.+||++|.+|+....+...+-.|-+   ..|...-..+++.+++|
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---~~PP~L~~~~S~~~kEF  242 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SAPPRLDGDFSPPFKEF  242 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---CCCCccccccCHHHHHH
Confidence            3 378899999999999997 599999999999999999999999977666443333322   23333335789999999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +..||.+||+.||+|.++|+|.|++...
T Consensus       243 V~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  243 VEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            9999999999999999999999998743

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.1e-45  Score=371.20  Aligned_cols=259  Identities=24%  Similarity=0.377  Sum_probs=219.1

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||.||+++++.+|..+|+|++....  .......+.+|+++|+++. ||||+++++++.+++.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence            478999999999999999999999999999999987642  2334567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||++|++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.   +||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc---EEEccCccccccccc
Confidence            999999999999999888899999999999999999999986 6999999999999987655   999999999765432


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----------------
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-----------------  260 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  260 (468)
                       ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..++...+.....                 
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             23456799999999999875 89999999999999999999999977665544333221100                 


Q ss_pred             ---------------------------CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 ---------------------------RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 ---------------------------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                                 ..+......+++++++||.+||++||++|||++|+++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                       001111234788999999999999999999999999999997643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=413.21  Aligned_cols=268  Identities=31%  Similarity=0.540  Sum_probs=237.8

Q ss_pred             CccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           32 DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        32 ~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      ...++.--.++|.+++.||+|+||.|.+++++.+++.||+|+++|-......+..-|..|..+|..- +.+=|++++..|
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAF  144 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAF  144 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHh
Confidence            3445556678899999999999999999999999999999999885554455567788999999765 588999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      ++++++|+||||++||+|..++.+.+++++..+++|+..|+.||.-||+.|+|||||||+|||||..|+   |||+|||.
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH---ikLADFGs  221 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH---IKLADFGS  221 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc---Eeeccchh
Confidence            999999999999999999999999999999999999999999999999999999999999999987665   99999999


Q ss_pred             eeeecCCCcc--ccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--cCC
Q 012203          192 ATYIEPGQSL--LGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA--DLR  261 (468)
Q Consensus       192 a~~~~~~~~~--~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~  261 (468)
                      +..+..+...  ...+|||.|++||++..      .|+..+||||+||++|||++|..||+.....+.+..|.+.  .+.
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence            9887744332  34689999999999952      3899999999999999999999999999999999999876  667


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHHhCcCCCCCCC
Q 012203          262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSWMGDGIQ  306 (468)
Q Consensus       262 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~eiL~h~~~~~~~~  306 (468)
                      ||..  ..+|+++++||.++|. +|+.|+.   ++++.+||||.+..+
T Consensus       302 FP~~--~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  302 FPDE--TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             CCcc--cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence            7733  4699999999999997 7899998   999999999987554

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-45  Score=362.79  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=209.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcC-CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEE-----
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYE-----  112 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~-----  112 (468)
                      ++|++.+.||+|+||.||+|++.. +|+.||+|++...... ........+|+.+++++.  +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999854 4788999998764322 222345567888877764  4999999999985     


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      ....+++||||+. ++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~---~kl~Dfg  155 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFG  155 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC---EEEcccc
Confidence            3457999999995 6999998764  35899999999999999999999999999999999999987654   9999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-----CCC
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR-----FPS  264 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~  264 (468)
                      ++.............||+.|+|||++.+. ++.++|||||||++|||++|++||.+.+..+.+..+......     ++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            99877655445567899999999999764 899999999999999999999999988776666655432110     000


Q ss_pred             ------------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          265 ------------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       265 ------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                                        .....+++.+++|+.+||+.||++|||+.|+|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              0013567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=374.57  Aligned_cols=248  Identities=28%  Similarity=0.439  Sum_probs=214.2

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcE-EEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-EEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-YVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~-vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-~~~l  119 (468)
                      ...+.+.||.|+||+||.+.++  |+. ||+|++......... ...+.+|+.+|.+|+ |||||++++++.+.. .++|
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEE
Confidence            3455666999999999999886  555 999999876543333 678999999999996 999999999998887 7999


Q ss_pred             EEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC-cEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          120 VMELCAGGELFHRLEK--FGRFSEAEARVLFMQLMQVVLYCHEIG-VVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~g-IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ||||+++|+|.+++.+  .+.++...+..++.||++||.|||+++ ||||||||+||||+.+.  .++||+|||+++...
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREKV  195 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceeec
Confidence            9999999999999988  578999999999999999999999999 99999999999998765  259999999998876


Q ss_pred             CC-CccccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PG-QSLLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~-~~~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .. .......||+.|||||++.+.   |+.|+|||||||++|||+||+.||.+....+....+.....+.+..  ..+++
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~  273 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECPP  273 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCH
Confidence            54 334447899999999999953   9999999999999999999999999888766666665554443322  34899


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+..++.+||..||.+||++.+++.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999999875

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-45  Score=363.24  Aligned_cols=251  Identities=29%  Similarity=0.490  Sum_probs=208.8

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE  128 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  128 (468)
                      ||+|+||+||+|.++.+|+.||+|.+.+...........+..|+++++++. ||||+++++++..++.+|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            699999999999999999999999997765433344566788999999995 9999999999999999999999999999


Q ss_pred             HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc-ccc
Q 012203          129 LFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-LLG  203 (468)
Q Consensus       129 L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~  203 (468)
                      |..++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++........ ...
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCccceecCCCCccccc
Confidence            9888743    346899999999999999999999999999999999999976554   99999999987654332 334


Q ss_pred             CCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcc
Q 012203          204 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGML  282 (468)
Q Consensus       204 ~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L  282 (468)
                      ..||+.|+|||++.+. ++.++|+|||||++|+|++|+.||...........+.......+......++..+.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            6799999999999875 899999999999999999999999765432222222211111222223568999999999999


Q ss_pred             ccCCCCCC-----CHHHHHhCcCCCC
Q 012203          283 STDPSQRL-----TARQVLDHSWMGD  303 (468)
Q Consensus       283 ~~dP~~Rp-----t~~eiL~h~~~~~  303 (468)
                      +.||++||     +++++++||||++
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            99999999     8899999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.6e-45  Score=358.80  Aligned_cols=255  Identities=30%  Similarity=0.469  Sum_probs=208.7

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEEe-----C
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYED-----E  114 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~~-----~  114 (468)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+...... ........+|++++++++  +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            599999999999999999999999999999998764321 122234566788877764  59999999999864     3


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      ..+++||||+. ++|.+++.+.  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~---~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLA  155 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECccCcc
Confidence            56899999996 5898888764  34899999999999999999999999999999999999986655   999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----CCC---
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-----RFP---  263 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~~---  263 (468)
                      .............||+.|+|||++.+. ++.++|||||||++|+|++|++||......+....+.....     .++   
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            876654444556789999999999764 89999999999999999999999987776655544432110     000   


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          264 ---------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       264 ---------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                                     ......+++.+.++|.+||++||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                           00123567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.5e-45  Score=383.26  Aligned_cols=258  Identities=28%  Similarity=0.456  Sum_probs=210.8

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--  114 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--  114 (468)
                      ....++|++++.||+|+||+||+|.+..+++.||||++....       ....+|+.+|++++ ||||++++++|...  
T Consensus        62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECF  133 (440)
T ss_pred             cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccc
Confidence            345678999999999999999999999999999999886432       23356999999996 99999999887432  


Q ss_pred             ------CEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCE
Q 012203          115 ------DYVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       115 ------~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~i  184 (468)
                            ..+++||||+++ +|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++  ..+
T Consensus       134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~--~~v  210 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT--HTL  210 (440)
T ss_pred             ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC--Cce
Confidence                  357899999964 77776643    45699999999999999999999999999999999999997543  349


Q ss_pred             EEeecCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----
Q 012203          185 KLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA----  258 (468)
Q Consensus       185 kL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----  258 (468)
                      ||+|||+++.+.........+||+.|+|||++.+  .|+.++|||||||++|||++|++||.+.+..+.+..+...    
T Consensus       211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             eeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999999988766555566789999999999875  4899999999999999999999999887765554444321    


Q ss_pred             -------------cCCCCCCC--------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          259 -------------DLRFPSNP--------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       259 -------------~~~~~~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                   ...++...        ....++++.+||.+||++||.+|||+.|+|+||||.+..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                         11112110        124678999999999999999999999999999997643

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.4e-45  Score=358.86  Aligned_cols=259  Identities=32%  Similarity=0.502  Sum_probs=215.6

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|++.+.||+|+||.||++.++.+++.||+|.+.+...........+..|+.+++++. |+||+++++.+.+.+.+|+||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence            3788899999999999999999999999999987764433334456778999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||++|++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~---~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH---IRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---EEEeeccceeecCCCc
Confidence            999999999988553  35899999999999999999999999999999999999986554   9999999998765444


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ......|++.|+|||++.+. ++.++|+|||||++|+|++|+.||...................+......+++++.+|+
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            44556899999999999875 89999999999999999999999976543211111111111111122356888999999


Q ss_pred             HHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      .+||+.||++|||     ++|+++||||.+.
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999     9999999999663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.7e-45  Score=384.21  Aligned_cols=263  Identities=27%  Similarity=0.391  Sum_probs=210.7

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc-----CCCCceeeeEE
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-----GHPNVVDLKAV  110 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-----~HpnIv~l~~~  110 (468)
                      +....++|++++.||+|+||+||+|.+..+++.||||++....    ........|++++++++     +|.++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3445688999999999999999999999999999999986431    22344566888887775     24458899999


Q ss_pred             EEeC-CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCC--------
Q 012203          111 YEDE-DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKAS--------  180 (468)
Q Consensus       111 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~--------  180 (468)
                      |..+ .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.        
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence            8754 5899999998 88999999888899999999999999999999998 59999999999999986542        


Q ss_pred             -----CCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 012203          181 -----SSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDA  254 (468)
Q Consensus       181 -----~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~  254 (468)
                           ...+||+|||++....  ......+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.+..+.+..
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             ccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                 1249999999886432  233457899999999999875 99999999999999999999999988776655554


Q ss_pred             HHhccCCCCCCC------------------------------------C--CCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 012203          255 VRTADLRFPSNP------------------------------------W--DHISDSAKDLVMGMLSTDPSQRLTARQVL  296 (468)
Q Consensus       255 i~~~~~~~~~~~------------------------------------~--~~~s~~l~~li~~~L~~dP~~Rpt~~eiL  296 (468)
                      +......+|...                                    +  ....+.+.+||.+||++||++|||++|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            433222111000                                    0  01135678999999999999999999999


Q ss_pred             hCcCCCCCC
Q 012203          297 DHSWMGDGI  305 (468)
Q Consensus       297 ~h~~~~~~~  305 (468)
                      +||||.+..
T Consensus       437 ~Hp~~~~~~  445 (467)
T PTZ00284        437 THPYVLKYY  445 (467)
T ss_pred             cCccccccC
Confidence            999997644

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-44  Score=375.09  Aligned_cols=253  Identities=24%  Similarity=0.392  Sum_probs=207.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|....         ..+.+|+++|++|. ||||++++++|..+...+
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeE
Confidence            45689999999999999999999999999999996532         34578999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +|||++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus       160 lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~---vkL~DFG~a~~~~~~  235 (391)
T PHA03212        160 LILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAACFPVDI  235 (391)
T ss_pred             EEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC---EEEEeCCcccccccc
Confidence            999999 5799999988788999999999999999999999999999999999999986654   999999999753321


Q ss_pred             --CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcc---------
Q 012203          199 --QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT-------KSRIFDAVRTAD---------  259 (468)
Q Consensus       199 --~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~---------  259 (468)
                        ......+||+.|+|||++.+. ++.++|||||||++|||++|+.||....       ....+..+....         
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence              223456899999999999875 8999999999999999999998875432       111111111100         


Q ss_pred             -----------------CCCCCC--CC---CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          260 -----------------LRFPSN--PW---DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       260 -----------------~~~~~~--~~---~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                       ...+..  .|   ..++.++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                             000000  01   13567899999999999999999999999999997643

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-46  Score=377.49  Aligned_cols=255  Identities=31%  Similarity=0.551  Sum_probs=232.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE-EEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY-VHL  119 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~-~~l  119 (468)
                      +.|.+++++|+|+||.+++++++.+++.|++|.|....... ...+...+|+.++++++ |||||.+++.|.+++. ++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence            56999999999999999999999999999999998877543 34457788999999997 9999999999998888 999


Q ss_pred             EEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||+||+||+|.+.|.+.+  .|+++.+..++.|++.|+.|||+++|+|||||+.|||+++++.   |||+|||+|+.+.+
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~---VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK---VKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc---eeecchhhhhhcCC
Confidence            999999999999997654  5999999999999999999999999999999999999998766   99999999999988


Q ss_pred             CC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .. ...+.+|||.||.||++.+. |+.|+|||||||++|||++-+++|.+.+...+...|.+.......   ..++.+++
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~  235 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR  235 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence            76 66788999999999999985 999999999999999999999999999999999999888733222   57899999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .+|+.||.++|..||++.++|.+|.+..
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            9999999999999999999999988753

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-44  Score=355.88  Aligned_cols=248  Identities=28%  Similarity=0.509  Sum_probs=208.1

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE  128 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  128 (468)
                      ||+|+||.||+++++.+|+.||+|.+.+..............|+++++++. ||||++++++++++..+|+||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            699999999999999999999999997654433334455667999999995 9999999999999999999999999999


Q ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCC
Q 012203          129 LFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG  206 (468)
Q Consensus       129 L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~G  206 (468)
                      |..++....  .+++..+..++.|++.||+|||++||+||||||+||+++.++.   ++|+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN---CRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC---EEEeeceeeeecCCCceeeccCC
Confidence            998886543  4888999999999999999999999999999999999986554   99999999987765544455679


Q ss_pred             CCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHc
Q 012203          207 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM  281 (468)
Q Consensus       207 T~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~  281 (468)
                      ++.|+|||++.+. ++.++|+|||||++|+|++|+.||.....    .++..........++   ...+++++++|+.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence            9999999999775 89999999999999999999999976432    222232222222222   246889999999999


Q ss_pred             cccCCCCCCCH----HHHHhCcCCCC
Q 012203          282 LSTDPSQRLTA----RQVLDHSWMGD  303 (468)
Q Consensus       282 L~~dP~~Rpt~----~eiL~h~~~~~  303 (468)
                      |++||.+||++    ++++.|+||+.
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcC
Confidence            99999999999    77889999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-44  Score=360.82  Aligned_cols=258  Identities=26%  Similarity=0.469  Sum_probs=213.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|.+.+.||+|+||.||+|+++.+++.||+|.+.....  ......+.+|+++++++. ||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence            579999999999999999999999999999999876532  222345678999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECccccceecCCCc
Confidence            999965 8888886643 4889999999999999999999999999999999999986554   9999999997654322


Q ss_pred             -ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----------------
Q 012203          200 -SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD-----------------  259 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------------  259 (468)
                       ......+|+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+....+....                 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             2334578999999999865  37899999999999999999999998877655554443211                 


Q ss_pred             --CCCCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          260 --LRFPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       260 --~~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                        ..++.       .....+++++++||.+||..||.+|||+.|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence              11111       01135788999999999999999999999999999997643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.6e-44  Score=355.13  Aligned_cols=260  Identities=32%  Similarity=0.504  Sum_probs=219.8

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|+..+.||+|+||+||++.+..+++.+|+|++.+...........+.+|+++|++++ |+||+.+++.+.+++..++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEE
Confidence            3788899999999999999999999999999997765443444456778999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||+++++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~---~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH---IRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC---EEEecCCcceecCCCC
Confidence            999999999888653  36999999999999999999999999999999999999986554   9999999998765444


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ......|++.|+|||++.+. ++.++|+|||||++|+|++|..||...........+..............++.++.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            44556899999999999764 89999999999999999999999987665444333333222222233356889999999


Q ss_pred             HHccccCCCCCCC-----HHHHHhCcCCCCCC
Q 012203          279 MGMLSTDPSQRLT-----ARQVLDHSWMGDGI  305 (468)
Q Consensus       279 ~~~L~~dP~~Rpt-----~~eiL~h~~~~~~~  305 (468)
                      .+||+.||++||+     +.++++|+||++..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            9999999999999     88999999997753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.9e-45  Score=352.52  Aligned_cols=254  Identities=38%  Similarity=0.665  Sum_probs=213.2

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |++++.||+|+||+||+++++.+++.||+|++...... ........+|+.+++++. ||||+++++++.+.+..++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence            89999999999999999999999999999999876432 122223456999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee-cCCCcc
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSL  201 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~-~~~~~~  201 (468)
                      |+++++|.+++...+.+++..+..++.|++.||.+||++||+|+||||+||+++.++.   ++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~---~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE---VKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE---EEESSGTTTEESTSTTSEB
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence            9999999999998889999999999999999999999999999999999999986555   999999999864 333445


Q ss_pred             ccCCCCCCCcChhhhc-C-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          202 LGTVGSPFYIAPEVLA-G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSR---IFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       202 ~~~~GT~~Y~APE~l~-~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      ....+++.|+|||++. + .++.++|+||||+++|+|++|..||.......   ....................+..+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            5678999999999998 4 48999999999999999999999998873333   33322222222221111223479999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +|.+||+.||++||++.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-44  Score=369.71  Aligned_cols=259  Identities=26%  Similarity=0.432  Sum_probs=210.6

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE---  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~---  114 (468)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++++. ||||+++++++...   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence            356889999999999999999999999999999999976532 3344567788999999995 99999999998644   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                         ..+|+||||+.+ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~---~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEecCCC
Confidence               357999999964 67776643  5889999999999999999999999999999999999987654   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT-------------  257 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-------------  257 (468)
                      +.............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+....+..+..             
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            9876544444567899999999999874 89999999999999999999999987654433222111             


Q ss_pred             ---------ccCCCCCC----------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          258 ---------ADLRFPSN----------------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       258 ---------~~~~~~~~----------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                               ....++..                .....++.+++||.+||+.||++|||++|+|+||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence                     11111100                011246789999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.1e-45  Score=370.95  Aligned_cols=255  Identities=24%  Similarity=0.388  Sum_probs=209.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++....  .......+.+|+++++++. |+||+++++++.+++.+++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEE
Confidence            456888999999999999999999999999999986542  2334567889999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||||+++|+|...    ....+..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..+....
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTM  222 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---EEEcccccceeccccc
Confidence            9999999998643    34567888899999999999999999999999999999987654   9999999998765332


Q ss_pred             -ccccCCCCCCCcChhhhcC-----C-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          200 -SLLGTVGSPFYIAPEVLAG-----G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~-----~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                       ......||+.|+|||++..     . .+.++|||||||++|||++|+.||......+....+.......+......++.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence             2345689999999999853     2 35689999999999999999999975443333332222222222223357889


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ++++||.+||..||++|||+.|+++|+||...
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            99999999999999999999999999999774

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-45  Score=360.02  Aligned_cols=257  Identities=30%  Similarity=0.534  Sum_probs=218.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE----  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~----  114 (468)
                      ..-.|...+.+|.|+||.||.|....+++.||||.+..+.-.       -.+|+++|+++. |||||++..+|...    
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~-HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLD-HPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcC-CcCeeeEEEEEEecCCCc
Confidence            444688999999999999999999999999999988665322       235899999885 99999999998532    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          115 -DYVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       115 -~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                       -++.+||||++. +|.+.++.    +.+++.-.++.|.+||++||.|||+.||+||||||.|||+|.+  .+.+|||||
T Consensus        94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~--tg~LKicDF  170 (364)
T KOG0658|consen   94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD--TGVLKICDF  170 (364)
T ss_pred             hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC--CCeEEeccC
Confidence             246689999964 99999975    4678999999999999999999999999999999999999854  567999999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-------
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-------  260 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------  260 (468)
                      |.|+.+..++...++..|..|+|||.+.|.  |+.+.||||.|||+.||+-|++-|.+.+..+.+..|.+.-.       
T Consensus       171 GSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  171 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             CcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999999999888899999999999999984  99999999999999999999999999887776666543211       


Q ss_pred             ----------CCC---CCC-----CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          261 ----------RFP---SNP-----WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       261 ----------~~~---~~~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                .+|   ..+     ....++++.+|+.++|+++|.+|.++.|++.||||.+...
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                      111   111     2457899999999999999999999999999999976543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3e-44  Score=363.36  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=216.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|+||.||++.++.+++.+|+|++....  .......+.+|+++++++. ||||++++++|.+++.++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEE
Confidence            3578999999999999999999999999999999987642  2334567889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||++|++|.+++.+.+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.   +||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~~~~~~~  156 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID  156 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC---EEEeeCCcchhhhh
Confidence            9999999999999999888899999999999999999999985 7999999999999986554   99999999876532


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------------
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA------------------  258 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------  258 (468)
                      . ......||+.|+|||++.+. ++.++|+|||||++|+|++|+.||.......+...+...                  
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence            2 23345799999999999875 889999999999999999999999765543332211100                  


Q ss_pred             ------------------------cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          259 ------------------------DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       259 ------------------------~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                              ....+......++.++++|+.+||++||++|||+.|++.|+||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                    00000011123678899999999999999999999999999997643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=374.76  Aligned_cols=258  Identities=37%  Similarity=0.623  Sum_probs=235.1

Q ss_pred             eEE--EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           43 FVL--GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        43 y~i--~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      |+|  .+.||+|.||+||-++++.+|+.||||+|.|.++.. .....+++|+.||+++. ||.||.+--.|+..+.+++|
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVV  641 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVV  641 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEE
Confidence            444  478999999999999999999999999999988754 44588999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l-~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||.+.|.-|+-+| ...+++++...+.++.||+.||+|||.++|+|+||||+|||+.....--.+||||||+|+.+....
T Consensus       642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            9999654444444 345789999999999999999999999999999999999999887766679999999999998888


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ...+.+|||.|+|||+++++ |+..-|+||.|||+|.-+.|..||..  .+++-++|++..+.+|.++|..++.++.|||
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlI  799 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLI  799 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence            88889999999999999875 99999999999999999999999954  4678899999999999999999999999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +.+|+..-.+|.+.++.|.|+|+++.
T Consensus       800 n~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  800 NNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHHHhcchHhhccchhhhcc
Confidence            99999999999999999999999763

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-46  Score=368.58  Aligned_cols=260  Identities=34%  Similarity=0.563  Sum_probs=229.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      +.|+.-+.||+||||.||-|+.+.||+.||+|.+.|+++..........+|..||.++. .++||.+-..|+..+.+|+|
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence            45888889999999999999999999999999999988766666677888999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |..|.||+|.-+|-+.+  .|++..++.|+.+|+.||++||+.+|++||+||+|||||..|+   |.|+|+|||..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh---vRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH---VRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC---eEeeccceEEecCCC
Confidence            99999999988886655  6999999999999999999999999999999999999986655   999999999999999


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      +...+.+||.+|||||+++++ |+...|||||||++|||+.|+.||.......-.+.+......-+..+.+.++++++++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            988889999999999999986 9999999999999999999999997644332222333333333333346899999999


Q ss_pred             HHHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      ...+|.+||.+|+     +++++.+||||++.
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            9999999999998     47899999999873

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.1e-44  Score=352.90  Aligned_cols=255  Identities=35%  Similarity=0.656  Sum_probs=226.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|.+.+.||+|++|.||++.+..+++.+|+|++.+...........+.+|+++++++. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence            46999999999999999999999999999999997765444455677889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||+|.|||++.++.   +||+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~---~kl~dfg~~~~~~~~--  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVKGR--  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC---EEEeeCCCccccCCC--
Confidence            999999999999998889999999999999999999999999999999999999986654   999999999876544  


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ....+|++.|+|||.+.+. ++.++|+||||+++|+|++|+.||...+.....+.+......++    ..++..++++|+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~  230 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIR  230 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHH
Confidence            3456799999999998764 78899999999999999999999988777777777766555554    356899999999


Q ss_pred             HccccCCCCCC-----CHHHHHhCcCCCCCC
Q 012203          280 GMLSTDPSQRL-----TARQVLDHSWMGDGI  305 (468)
Q Consensus       280 ~~L~~dP~~Rp-----t~~eiL~h~~~~~~~  305 (468)
                      +||..||.+|+     +++|+++||||....
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999999     999999999996643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.4e-44  Score=364.33  Aligned_cols=258  Identities=25%  Similarity=0.420  Sum_probs=212.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE---  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~---  114 (468)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+.+++.+. ||||+++++++...   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeecccccc
Confidence            356789999999999999999999999999999999876432 2334567788999999995 99999999988543   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                         ..+|+||||++ ++|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~  172 (364)
T cd07875          99 EEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL  172 (364)
T ss_pred             cccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc---EEEEeCCC
Confidence               46899999995 578777754  5889999999999999999999999999999999999987654   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL----------  260 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------  260 (468)
                      ++............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+.....          
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            9876554445567899999999999875 89999999999999999999999988776555544432100          


Q ss_pred             ------------CCC----------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          261 ------------RFP----------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       261 ------------~~~----------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                                  .+.                .......+..+++||.+||+.||.+|||+.|+|+||||..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                        000                0011123567899999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.3e-44  Score=367.28  Aligned_cols=258  Identities=27%  Similarity=0.472  Sum_probs=215.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-----E
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-----Y  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-----~  116 (468)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+++++.++ ||||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence            4788999999999999999999999999999986532 23334567889999999996 999999999998776     8


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~a~~~~  154 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV---LKICDFGLARVEE  154 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC---EEeccccceeecc
Confidence            999999995 689998888788999999999999999999999999999999999999986554   9999999998754


Q ss_pred             CCC--ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--------------
Q 012203          197 PGQ--SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA--------------  258 (468)
Q Consensus       197 ~~~--~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------  258 (468)
                      ...  ......+|+.|+|||++.+.  ++.++|||||||++|||++|+.||.+.+..+..+.+...              
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  23345789999999999873  789999999999999999999999887766555544321              


Q ss_pred             ---------cCCCCC-----CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          259 ---------DLRFPS-----NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       259 ---------~~~~~~-----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                               ....+.     ......++++.+||.+||+.||++|||+.|+++||||....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                     111110     11234678999999999999999999999999999997743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=344.56  Aligned_cols=255  Identities=27%  Similarity=0.476  Sum_probs=217.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC--hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT--IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~--~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +.|.+.+.||+|++|.||.|.+..+++.+|+|.+.......  ......+.+|+++++++. ||||+++++++++++.++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEE
Confidence            46999999999999999999999999999999987653322  123457888999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.   ++|+|||++......
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~---~~l~dfg~~~~~~~~  157 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecccceecccc
Confidence            99999999999999998888999999999999999999999999999999999999986554   999999999865432


Q ss_pred             Ccc----ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          199 QSL----LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       199 ~~~----~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ...    ....|++.|+|||++.+. ++.++||||||+++|+|++|+.||...+.......+........  ....++..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  235 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--LPSHVSPD  235 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC--CCccCCHH
Confidence            211    345688999999999875 88999999999999999999999977655544444433322211  22468899


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +.++|.+||.+||++|||+.++++|+||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=353.49  Aligned_cols=260  Identities=28%  Similarity=0.453  Sum_probs=218.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCC---
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-VVDLKAVYEDED---  115 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn-Iv~l~~~~~~~~---  115 (468)
                      ...|..+++||+|+||+||+|+.+.+|+.||+|.+..+... ...-....+|+.+|++|+ |+| ||.+++++..++   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeeccccc
Confidence            34477778899999999999999999999999999776431 112345678999999997 999 999999998877   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          116 ---YVHLVMELCAGGELFHRLEKFG----RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       116 ---~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                         .+++|+||+ .-+|..++....    .++...++.+++||+.||+|||+++|+||||||.||||+.++.   +||+|
T Consensus        88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~---lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV---LKLAD  163 (323)
T ss_pred             ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc---Eeeec
Confidence               899999998 569999998765    4777899999999999999999999999999999999987555   99999


Q ss_pred             cCceeeec-CCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 012203          189 FGLATYIE-PGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN  265 (468)
Q Consensus       189 FGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  265 (468)
                      ||+|+... +.+.....++|.+|+|||++.+.  |+...||||+|||++||+++++.|.+....+.+..|..........
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99998765 44456677899999999999985  9999999999999999999999999988776666664332211111


Q ss_pred             CC--------------------------CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          266 PW--------------------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       266 ~~--------------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .|                          ...+....+++.+||+++|.+|.+++.+|.|+||....
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            11                          12335789999999999999999999999999997754

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.9e-45  Score=376.81  Aligned_cols=258  Identities=31%  Similarity=0.468  Sum_probs=217.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-----CCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-----PNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-----pnIv~l~~~~~~~  114 (468)
                      .-+|.|.+.||+|.||+|-+|.+..|++.||||+++.+.    ...++-..|+.||.+|..|     -|+|+++++|...
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            338999999999999999999999999999999997653    3456677799999999733     3899999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +++|||+|++ +.+|+++|+.+  ..|+...++.++.||+.||.+||++||||+|||||||||..-+ ...|||+|||.|
T Consensus       261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~-r~~vKVIDFGSS  338 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK-RSRIKVIDFGSS  338 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-cCceeEEecccc
Confidence            9999999999 67999999876  4589999999999999999999999999999999999997544 347999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC----------
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR----------  261 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------  261 (468)
                      .....  ...+++.+..|+|||++.|. |+.+.||||||||++||++|.+.|.+.+..+.+..|......          
T Consensus       339 c~~~q--~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  339 CFESQ--RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cccCC--cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            87553  34488999999999999984 999999999999999999999999988887777665421100          


Q ss_pred             -----CCC-------------------------------------C--CC----C-CCCHHHHHHHHHccccCCCCCCCH
Q 012203          262 -----FPS-------------------------------------N--PW----D-HISDSAKDLVMGMLSTDPSQRLTA  292 (468)
Q Consensus       262 -----~~~-------------------------------------~--~~----~-~~s~~l~~li~~~L~~dP~~Rpt~  292 (468)
                           |..                                     .  .+    . .-...+.|||++||..||.+|+|+
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                 000                                     0  00    0 112357999999999999999999


Q ss_pred             HHHHhCcCCCCCC
Q 012203          293 RQVLDHSWMGDGI  305 (468)
Q Consensus       293 ~eiL~h~~~~~~~  305 (468)
                      .++|+|||+....
T Consensus       497 ~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  497 AQALNHPFLTGTS  509 (586)
T ss_pred             HHHhcCccccccc
Confidence            9999999998543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.8e-44  Score=362.75  Aligned_cols=259  Identities=26%  Similarity=0.420  Sum_probs=211.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE---  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~---  114 (468)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.+. ||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence            356789999999999999999999999999999999876432 3344567778999999996 99999999998643   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                         ..+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~---~kl~Dfg~  165 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL  165 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC---EEEeeCcc
Confidence               357999999965 67777754  5889999999999999999999999999999999999987654   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD-----------  259 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------  259 (468)
                      ++............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+....           
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            9876554445567899999999999875 8999999999999999999999998766544333221100           


Q ss_pred             -----------C-----CCC-----------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          260 -----------L-----RFP-----------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       260 -----------~-----~~~-----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                 .     .++           .......+..+++||.+||..||++|||+.|+|+||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                       0     000           00112345688999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-43  Score=376.39  Aligned_cols=256  Identities=28%  Similarity=0.405  Sum_probs=220.4

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCC-CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFT-GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ....|.+.+.||+|++|.||+|.+..+ ++.||+|.+...   .......+.+|+.+|+++. ||||+++++++..++.+
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEE
Confidence            345599999999999999999999877 788999977543   3344456788999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          118 HLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      ||||||++||+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~---~kL~DFgla~  217 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI---IKLGDFGFSK  217 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc---EEEEeCcCce
Confidence            999999999999988754    346899999999999999999999999999999999999986554   9999999998


Q ss_pred             eecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          194 YIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       194 ~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      .+.....   ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..++...+........   ...
T Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~  294 (478)
T PTZ00267        218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCP  294 (478)
T ss_pred             ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---Ccc
Confidence            7654322   3456799999999999875 89999999999999999999999998888887777766544311   246


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ++.++.++|.+||.+||++||++.+++.|+|++..
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            78999999999999999999999999999998653

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.5e-44  Score=378.70  Aligned_cols=264  Identities=25%  Similarity=0.427  Sum_probs=225.1

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ..+.....++|++.+.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.++..+. |+||+++++.+.
T Consensus        24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~  101 (496)
T PTZ00283         24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFA  101 (496)
T ss_pred             cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeeccee
Confidence            34556677899999999999999999999999999999999977644 3445567888999999995 999999988875


Q ss_pred             eCC--------EEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC
Q 012203          113 DED--------YVHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS  180 (468)
Q Consensus       113 ~~~--------~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~  180 (468)
                      ..+        .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC
Confidence            332        478999999999999998653    46899999999999999999999999999999999999987654


Q ss_pred             CCCEEEeecCceeeecCC---CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 012203          181 SSPIKLADFGLATYIEPG---QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR  256 (468)
Q Consensus       181 ~~~ikL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  256 (468)
                         +||+|||+++.+...   ......+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+..+.++.+.
T Consensus       182 ---vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~  258 (496)
T PTZ00283        182 ---VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL  258 (496)
T ss_pred             ---EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence               999999999875432   223456899999999999875 8999999999999999999999999888877777766


Q ss_pred             hccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       257 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ......   ....+++++.+++.+||..||.+||++.++++|||++..
T Consensus       259 ~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        259 AGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             cCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            554321   124688999999999999999999999999999998653

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-45  Score=374.56  Aligned_cols=261  Identities=39%  Similarity=0.640  Sum_probs=241.7

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      .+-...|.+.+.||+|.|++|.++++..++..||+|+|.+..+... ..+.+.+|+++|+.|. |||||+++.+.+....
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLN-HPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcC-Ccceeeeeeeeeecce
Confidence            3445669999999999999999999999999999999999876443 3455889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||+.+|.+++++.++++..+.+++.++.|+..|++|||+++|+|||||.+||||+.+.+   +||+|||++..+.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn---ikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN---IKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc---eeeeccccceeec
Confidence            9999999999999999999999999999999999999999999999999999999999998887   9999999999999


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .+....+.||++.|.|||++.+. | ++++|+||+|+++|.|+.|.+||.+.+..++.+....+.++.|.    .++.++
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dc  282 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDC  282 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechh
Confidence            88899999999999999999985 4 78999999999999999999999999998888888888888774    678899


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      +++|+++|..+|.+|++++++.+|.|+.....
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence            99999999999999999999999999976543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-43  Score=351.51  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=213.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|+||.||+|.++.+++.||+|.+.....  ......+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence            569999999999999999999999999999999875432  222345678999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-  198 (468)
                      |||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... 
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPT  158 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc---EEECcCcchhccCCCC
Confidence            99996 5898888664 46899999999999999999999999999999999999987654   999999999764432 


Q ss_pred             CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----------------
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL----------------  260 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  260 (468)
                      .......+++.|+|||++.+.  ++.++|||||||++|+|++|++||...+..+....+.....                
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            223345678999999998763  78899999999999999999999988776655544432111                


Q ss_pred             ---CCCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 ---RFPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 ---~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                         .++.       .....+++.+++||.+||+.||.+|||++|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence               0110       01135788999999999999999999999999999996644

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-43  Score=358.88  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEE-----cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSD-----KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      +++|++.+.||+|+||.||+|.+     +.+++.||+|++....  .......+.+|+.++.++.+||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            46799999999999999999975     2446789999987542  2334567889999999996699999999988754


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHc---------------------------------------------------------
Q 012203          115 -DYVHLVMELCAGGELFHRLEKF---------------------------------------------------------  136 (468)
Q Consensus       115 -~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------------  136 (468)
                       +.+++||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999998653                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCC
Q 012203          137 -----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSP  208 (468)
Q Consensus       137 -----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~  208 (468)
                           ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.......   .....+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~---~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc---EEEeecccccccccCcchhcccCCCCCc
Confidence                 23778888999999999999999999999999999999986554   99999999986543221   12234667


Q ss_pred             CCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccC
Q 012203          209 FYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSR-IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD  285 (468)
Q Consensus       209 ~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  285 (468)
                      .|+|||++.+. ++.++|||||||++|||++ |..||.+....+ ....+..... ..  ....+++.+.+++.+||+.|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-MR--APENATPEIYRIMLACWQGD  317 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-CC--CCCCCCHHHHHHHHHHccCC
Confidence            89999998765 8999999999999999997 999998755433 3333333221 11  12467889999999999999


Q ss_pred             CCCCCCHHHHHh
Q 012203          286 PSQRLTARQVLD  297 (468)
Q Consensus       286 P~~Rpt~~eiL~  297 (468)
                      |++|||+.|+++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-44  Score=362.07  Aligned_cols=259  Identities=27%  Similarity=0.470  Sum_probs=212.8

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE---  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~---  114 (468)
                      .+.++|++.+.||.|+||+||+|.+..+++.||+|++.+... .......+.+|+++|+++. ||||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence            467899999999999999999999999999999999876422 2233456778999999996 99999999988543   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                         ..+|++||++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~---~kl~Dfg~  164 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE---LRILDFGL  164 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC---EEEcCCcc
Confidence               4579999998 8899887754 57999999999999999999999999999999999999987655   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL---------  260 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------  260 (468)
                      +.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+.....         
T Consensus       165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            987543  2345689999999999876  388999999999999999999999987665544443322110         


Q ss_pred             --------------CCCCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 --------------RFPSN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 --------------~~~~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                    ..+..    .+...++.+.+||.+||+.||++|||+.|+++||||.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                          00100    1124567789999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=352.00  Aligned_cols=257  Identities=36%  Similarity=0.600  Sum_probs=223.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+.+...........+..|+++++++. ||||+++++.+.+.+..|+|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEE
Confidence            47999999999999999999999999999999998765544345667889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||+.|++|.+++.+.  ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.   ++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH---IMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC---EEEeecchhhccccc
Confidence            9999999999999764  56899999999999999999999999999999999999987554   999999998654321


Q ss_pred             C------------------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 012203          199 Q------------------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT  247 (468)
Q Consensus       199 ~------------------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~  247 (468)
                      .                              ......||..|+|||++.+. ++.++||||||+++|+|++|+.||.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1                              11134689999999999875 8899999999999999999999998888


Q ss_pred             hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC----HHHHHhCcCCCC
Q 012203          248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT----ARQVLDHSWMGD  303 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt----~~eiL~h~~~~~  303 (468)
                      ....+..+......++..  ..+++.+.++|.+||..||++||+    ++|+++|+||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            777776666555554433  347899999999999999999999    999999999975

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.2e-43  Score=350.56  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=215.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||++.+..+++.+|+|.+..+.  .......+.+|++++++++ ||||+++++.+.+++.+++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEE
Confidence            46999999999999999999999999999999987542  2334566888999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||++|++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.   +||+|||++...... 
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~-  153 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS-  153 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc---EEEccCCCccccccc-
Confidence            9999999999999988889999999999999999999997 58999999999999987554   999999998765432 


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-----------------
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR-----------------  261 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  261 (468)
                      .....+|++.|+|||.+.+. ++.++|+|||||++|+|++|+.||...+.......+......                 
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            23456889999999998765 889999999999999999999999765544333222211100                 


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          262 -----------------FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       262 -----------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                       .+..+...++.++.+++.+||..||++|||+.++++||||...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                             0111122467889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.8e-43  Score=343.45  Aligned_cols=256  Identities=30%  Similarity=0.545  Sum_probs=213.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++..... .....+.+.+|+++++++. ||||+++++++...+.+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence            479999999999999999999999999999999875432 1223356778999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||++++.|..++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.   ++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc---EEECccccceecCCCcc
Confidence            999999999888877778999999999999999999999999999999999999986554   9999999998765433 


Q ss_pred             ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----------------
Q 012203          200 SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-----------------  260 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  260 (468)
                      ......++..|+|||++.+.  ++.++|+||||+++|+|++|+.||.+.+..+....+.....                 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            23345688999999998763  78899999999999999999999987665444333322100                 


Q ss_pred             --CCCC--------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 --RFPS--------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 --~~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                        ..+.        ..+..++..+.+|+.+||+.||++||++.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              0010        0123568889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2e-43  Score=353.27  Aligned_cols=249  Identities=28%  Similarity=0.471  Sum_probs=194.6

Q ss_pred             EeEEeecCCeEEEEEEEc--CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEEEEEE
Q 012203           46 GQQLGWGQFGVIRVCSDK--FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDYVHLVM  121 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~--~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~~~~~lV~  121 (468)
                      +++||+|+||+||+|+++  .+++.||+|.+.....     ...+.+|+++|+++. ||||+++++++..  +..+|++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999976  4678999999865432     245678999999996 9999999999854  56789999


Q ss_pred             eccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec-CCCCCEEEeecCc
Q 012203          122 ELCAGGELFHRLEKF---------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK-ASSSPIKLADFGL  191 (468)
Q Consensus       122 E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~-~~~~~ikL~DFGl  191 (468)
                      ||+ +++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||++.+ ...+.+||+|||+
T Consensus        80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            998 56888887532         248999999999999999999999999999999999999654 2345699999999


Q ss_pred             eeeecCCC----ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 012203          192 ATYIEPGQ----SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS---------RIFDAVR  256 (468)
Q Consensus       192 a~~~~~~~----~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~  256 (468)
                      +.......    .....+||+.|+|||++.+.  ++.++||||+||++|+|++|++||......         ..++.+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            98764321    23456889999999998763  789999999999999999999999643321         1111111


Q ss_pred             hccC-----------CCC-----------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          257 TADL-----------RFP-----------------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       257 ~~~~-----------~~~-----------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ....           ..+                       .......+..+.+||++||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1000           000                       00011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-43  Score=363.52  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=207.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEc--CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDK--FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~--~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .+..+|++++.||+|+||.||+|...  .+++.||+|.+...        ....+|+++|+++. ||||+++++++...+
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            35668999999999999999999764  35688999987653        23457999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+|||++ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   ++|+|||++...
T Consensus       160 ~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~---~~l~DfG~a~~~  235 (392)
T PHA03207        160 TVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN---AVLGDFGAACKL  235 (392)
T ss_pred             EEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC---EEEccCcccccc
Confidence            999999999 4689999987788999999999999999999999999999999999999986554   999999999766


Q ss_pred             cCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHh----ccCCCCC
Q 012203          196 EPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS---RIFDAVRT----ADLRFPS  264 (468)
Q Consensus       196 ~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~----~~~~~~~  264 (468)
                      .....   .....||+.|+|||++.+. ++.++|||||||++|||++|+.||.+....   ..+..+..    ....++.
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            54322   2346799999999999875 899999999999999999999999765421   11111111    1111111


Q ss_pred             C-----------------------C---CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          265 N-----------------------P---WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       265 ~-----------------------~---~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .                       .   ...++.++.++|++||..||++|||+.|+|.||||+...
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            0                       0   023567899999999999999999999999999997654

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-43  Score=340.19  Aligned_cols=252  Identities=30%  Similarity=0.532  Sum_probs=217.1

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||.|++|.||+|.+..+|+.||+|++.+...........+..|..++....+|+||+++++++..++.+|+||||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999999999999999997654333333445566666665555799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCC
Q 012203          127 GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG  206 (468)
Q Consensus       127 gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~G  206 (468)
                      ++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.   ++|+|||++.....   .....|
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH---LKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---EEEeecccceeccc---cccCCC
Confidence            999999988888999999999999999999999999999999999999986554   99999999876443   234568


Q ss_pred             CCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccC
Q 012203          207 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD  285 (468)
Q Consensus       207 T~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  285 (468)
                      ++.|+|||.+.+. ++.++|+||||+++|+|++|..||...+.......+......++......+++.+.+++.+||+.|
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            8999999998875 789999999999999999999999888888888877777666665555578999999999999999


Q ss_pred             CCCCCC---HHHHHhCcCCCCC
Q 012203          286 PSQRLT---ARQVLDHSWMGDG  304 (468)
Q Consensus       286 P~~Rpt---~~eiL~h~~~~~~  304 (468)
                      |++||+   ++|+++||||++.
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcC
Confidence            999995   5799999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-42  Score=334.73  Aligned_cols=252  Identities=24%  Similarity=0.419  Sum_probs=218.6

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|.+.+.||+|++|.||+|.++.+++.|++|.+..... .......+.+|++++++++ ||||+++++.+.+.+..|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence            48899999999999999999999999999999876543 2445667889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||++|++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~---~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC---EEEcccccceeccCcc
Confidence            999999999999774  56899999999999999999999999999999999999987554   9999999998765433


Q ss_pred             c-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 S-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      . .....|++.|+|||++.+. ++.++|+|||||++|+|++|+.||...+.......+........   ...++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence            2 2345789999999998875 88999999999999999999999988877666666554433211   13678899999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +.+||+.+|++||++.+++.|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.8e-43  Score=341.88  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=213.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE---  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~---  114 (468)
                      ...+.|++.+.||+|+||.||+|.++.+++.||+|++....    .....+.+|+.+++++.+||||+++++++...   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            45678999999999999999999999999999999986542    23456788999999996799999999998653   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                         ..+|+||||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.   ++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~---~~l~Df  155 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDF  155 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC---EEEccC
Confidence               5689999999999999999763  45899999999999999999999999999999999999987654   999999


Q ss_pred             CceeeecCC-CccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 012203          190 GLATYIEPG-QSLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       190 Gla~~~~~~-~~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      |++...... .......|++.|+|||++.+      .++.++|+|||||++|+|++|..||...........+....  .
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~  233 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A  233 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--C
Confidence            999875432 22334679999999999852      37889999999999999999999997665544443333222  2


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +......++..+.+|+.+||..||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            222234678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.5e-43  Score=343.33  Aligned_cols=254  Identities=32%  Similarity=0.500  Sum_probs=213.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.+. ||||+++++.+...+.+|+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence            357899999999999999999999999999999986542   233456788999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---~~l~dfg~~~~~~~~~  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH---VKLADFGVSAQITATI  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECcceeeeEccCcc
Confidence            9999999999999998889999999999999999999999999999999999999986554   9999999987654322


Q ss_pred             -ccccCCCCCCCcChhhhc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC-CCCCCCHH
Q 012203          200 -SLLGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN-PWDHISDS  273 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~  273 (468)
                       ......|++.|+|||++.    +.++.++|+|||||++|+|++|..||...................+.. ....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence             223457999999999974    248889999999999999999999997655444333333332222211 11257789


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      +.++|.+||..||++||+++++++|||
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.8e-43  Score=347.30  Aligned_cols=258  Identities=33%  Similarity=0.554  Sum_probs=223.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      +.|++.+.||+|+||.||++.++.+++.|++|.+.+...........+.+|+++++.+. ||||+++++.+..++.+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEE
Confidence            46999999999999999999999999999999987664333344567888999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||+++...... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~---~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC---EEEeeCCCccccCcCcc
Confidence            999999999999988888999999999999999999999999999999999999976554   9999999986421100 


Q ss_pred             ---------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 012203          200 ---------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       200 ---------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                                     ......|+..|+|||.+.+. ++.++|+|||||++|+|++|..||.+.+..+....+.......+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                           01124678899999998764 89999999999999999999999998888888887777665555


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHHhCcCCCC
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSWMGD  303 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~eiL~h~~~~~  303 (468)
                      ... ..++.++.++|++||++||++||+   +.++++||||..
T Consensus       237 ~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         237 EGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             Ccc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            543 268899999999999999999998   799999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.9e-42  Score=334.59  Aligned_cols=252  Identities=24%  Similarity=0.519  Sum_probs=214.8

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CCEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-EDYVHLV  120 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-~~~~~lV  120 (468)
                      +|++.+.||+|++|.||++.++.+++.||+|.+..... .....+.+.+|++++++++ |+|++++++.+.. +..+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence            59999999999999999999999999999999876432 2334567888999999996 9999999998864 4578999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||+++++|.+++...  ..+++.+++.++.|++.||.+||++||+||||||+||+++.++.   ++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~---~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI---IKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc---EEEecccceEEeccc
Confidence            9999999999999763  45899999999999999999999999999999999999986554   999999999876432


Q ss_pred             C-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      . ......|++.|+|||++.+. ++.++|+||||+++|+|++|+.||...+.......+......  . ....+++.+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--P-MPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--C-CccccCHHHHH
Confidence            2 23345789999999998875 889999999999999999999999887766665555544331  1 22468899999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ++.+||+.||++||++.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.2e-43  Score=341.68  Aligned_cols=255  Identities=30%  Similarity=0.463  Sum_probs=212.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+.+|+.+++++. ||||+++++++...+.++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEE
Confidence            3457999999999999999999999999999999986542   233456788999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++|+|||++......
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~---~~l~dfg~~~~~~~~  159 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD---VKLADFGVAAKITAT  159 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC---EEECcCccceeeccc
Confidence            99999999999999988888999999999999999999999999999999999999976554   999999999876432


Q ss_pred             C-ccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC-CCCCCCH
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN-PWDHISD  272 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~  272 (468)
                      . ......|++.|+|||.+.+    .++.++|+|||||++|+|++|+.||......+....+.......+.. ....++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            2 2234578999999999842    37889999999999999999999996554433322222222222111 1135788


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      .+.++|++||..||++|||++++++|+|
T Consensus       240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         240 TFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-43  Score=341.33  Aligned_cols=252  Identities=34%  Similarity=0.583  Sum_probs=220.0

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+++++++. ||||+++++.+++.+.+++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence            4899999999999999999999999999999998765444455678899999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCcc
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL  201 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~  201 (468)
                      ||+.|++|..++.....+++..+..++.||++||.|||++|++|+||||+||+++.++.   ++|+|||++.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH---VHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC---EEEeecccccccCCCccc
Confidence            99999999999988778999999999999999999999999999999999999987655   999999999877655444


Q ss_pred             ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          202 LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ....|+..|+|||++.+. ++.++|+||||+++|+|++|..||.....   ..+...........+    ..++..+.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  232 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----ATWSTEAIDA  232 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc----ccCcHHHHHH
Confidence            567789999999998865 79999999999999999999999987663   333333222222222    4678999999


Q ss_pred             HHHccccCCCCCCCH--HHHHhCcCC
Q 012203          278 VMGMLSTDPSQRLTA--RQVLDHSWM  301 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~--~eiL~h~~~  301 (468)
                      |.+||..||.+||++  +|+++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.5e-43  Score=342.07  Aligned_cols=254  Identities=30%  Similarity=0.479  Sum_probs=208.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||+|++|.||+|+++.+++.||+|++..... .......+.+|+.+++++. ||||+++++++.+++.+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence            48999999999999999999999999999999875432 2223456788999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          122 ELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       122 E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||++ ++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+||+++.++.   ++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc---EEECcccceeecCCC
Confidence            9996 6898888653   46899999999999999999999999999999999999987655   999999999765432


Q ss_pred             C-ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---------------
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL---------------  260 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------  260 (468)
                      . ......+++.|+|||++.+.  ++.++|+|||||++|+|++|++||.+.+.......+.....               
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2 22344678999999998753  78899999999999999999999987654332222111000               


Q ss_pred             ----------CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 ----------RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 ----------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                                .........+++++.++|++||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      00011124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.2e-43  Score=386.03  Aligned_cols=265  Identities=28%  Similarity=0.494  Sum_probs=219.9

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-  113 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-  113 (468)
                      ....+.++|++++.||+|+||+||+|+++.+++.+|+|++..... .......+..|+.+|++|. |||||+++++|.+ 
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de   84 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNK   84 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEec
Confidence            345567899999999999999999999999999999999976543 3344567889999999996 9999999999854 


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc-------CcEecccCCCcEEEeecC--
Q 012203          114 -EDYVHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEI-------GVVHRDLKPENILLATKA--  179 (468)
Q Consensus       114 -~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~-------gIiHrDIKp~NILl~~~~--  179 (468)
                       ...+||||||+++|+|.++|...    +.+++..++.|+.||+.||.|||+.       +|+||||||+||||+...  
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             46799999999999999999653    5699999999999999999999984       499999999999997531  


Q ss_pred             ------------CCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCC
Q 012203          180 ------------SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFW  244 (468)
Q Consensus       180 ------------~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~  244 (468)
                                  ....+||+|||++..+.........+||+.|+|||++.+   .++.++||||||||||+|++|+.||.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                        123589999999987654444456689999999999864   37899999999999999999999997


Q ss_pred             CCChH-HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          245 GNTKS-RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       245 ~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..... .+...+... .   ..+....+.++.+||..||..+|.+||++.|+|.|+|+....
T Consensus       245 ~~~~~~qli~~lk~~-p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        245 KANNFSQLISELKRG-P---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             cCCcHHHHHHHHhcC-C---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            65443 333333322 2   222346789999999999999999999999999999997654

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.5e-42  Score=336.46  Aligned_cols=255  Identities=28%  Similarity=0.461  Sum_probs=216.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|+||+|.+..+++.+++|++......  .....+.+|+++++++. |+||+++++.+...+.+++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence            4799999999999999999999889999999999765432  25678899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          121 MELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||+++|++|.+++...   ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++..+..
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~---~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS---VKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC---EEEcccchHHHhcc
Confidence            9999999999999764   45899999999999999999999999999999999999986554   99999999876554


Q ss_pred             CCc-----cccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-CCCC-CCC
Q 012203          198 GQS-----LLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR-FPSN-PWD  268 (468)
Q Consensus       198 ~~~-----~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~-~~~  268 (468)
                      ...     .....|++.|+|||++...  ++.++|+|||||++|+|++|+.||...+..+.+..+...... ++.. .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            322     1345789999999998764  788999999999999999999999877665555554443221 2111 124


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .++..+.+++.+||..||++||+++++++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-44  Score=343.79  Aligned_cols=259  Identities=28%  Similarity=0.533  Sum_probs=235.3

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|.+++.||+|+|++|.+++++.|.+.||+|+++|+.+...++.+-++.|..+..+.++||.+|-++.+|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            35799999999999999999999999999999999999887788888999999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee-ecCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY-IEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~-~~~~  198 (468)
                      |.||++||+|.-.+++.++++++.++.|...|..||.|||++|||+||||..|+|+|.+++   |||+|+|+++. +.++
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh---ikltdygmcke~l~~g  405 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc---eeecccchhhcCCCCC
Confidence            9999999999999999899999999999999999999999999999999999999987665   99999999986 5567


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHHhccCCCCCCCCCC
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG--------NTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ....++||||.|+|||++.+. |+..+|||+|||+++||+.|+.||..        ++.+-+++.|....++.|    ..
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip----rs  481 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP----RS  481 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc----ce
Confidence            778899999999999999996 99999999999999999999999952        233446677777777777    46


Q ss_pred             CCHHHHHHHHHccccCCCCCCC------HHHHHhCcCCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLT------ARQVLDHSWMGDGI  305 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt------~~eiL~h~~~~~~~  305 (468)
                      ++-.+..+++..|.+||.+|+.      ..++..|+||+...
T Consensus       482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            7778899999999999999984      78999999998543

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-42  Score=336.92  Aligned_cols=253  Identities=28%  Similarity=0.505  Sum_probs=213.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh------hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI------DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~------~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+........      .....+.+|+.+++++. ||||+++++++.+.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            47888999999999999999998999999999876543221      12356788999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.   ++|+|||+++..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~---~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC---EEecccCCCccc
Confidence            99999999999999999998888999999999999999999999999999999999999976554   999999998876


Q ss_pred             cCCC-------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          196 EPGQ-------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       196 ~~~~-------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      ....       ......|++.|+|||.+.+. ++.++|+|||||++|+|++|+.||...+.......+...  ..+ ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-~~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN--ASP-EIP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc--CCC-cCC
Confidence            5221       11234688999999998765 888999999999999999999999876554443333322  111 122


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ..++..+.++|++||+.||.+||++.++++|+||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            4678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-42  Score=340.63  Aligned_cols=252  Identities=24%  Similarity=0.420  Sum_probs=210.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.++.  .......+.+|+++++++. ||||+++++.+...+..++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEE
Confidence            46889999999999999999999999999999987652  2334567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |||+++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.   ++|+|||++...... .
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~---~~l~dfg~~~~~~~~-~  149 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLVNS-I  149 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC---EEEeeCCcceecccc-c
Confidence            999999998654    35789999999999999999999999999999999999987655   999999999876433 2


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhccCCCCCCCCCCCCH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK-------SRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ....+||+.|+|||++.+. ++.++|+|||||++|+|++|+.||.....       ......+....  .+.......+.
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  227 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSE  227 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCH
Confidence            3456899999999999875 89999999999999999999999965321       12222222221  12222345788


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++.+++.+||+.||++||+++|+++||||+...
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.2e-42  Score=340.21  Aligned_cols=266  Identities=25%  Similarity=0.437  Sum_probs=219.6

Q ss_pred             hhcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeee
Q 012203           29 TILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK  108 (468)
Q Consensus        29 ~i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~  108 (468)
                      .++....+....++|.+.+.||+|+||.||++.++.+++.+|+|++....    .....+..|+.+++++.+||||++++
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~   85 (291)
T cd06639          10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFY   85 (291)
T ss_pred             hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            45666777788999999999999999999999999999999999986532    22356778999999996799999999


Q ss_pred             EEEEeC-----CEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          109 AVYEDE-----DYVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       109 ~~~~~~-----~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      +++...     +.+++||||++|++|.++++.    ...+++..++.++.|++.||+|||++||+||||||+||+++.++
T Consensus        86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~  165 (291)
T cd06639          86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC
Confidence            998654     468999999999999998853    35689999999999999999999999999999999999998755


Q ss_pred             CCCCEEEeecCceeeecCCC-ccccCCCCCCCcChhhhcCC------CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 012203          180 SSSPIKLADFGLATYIEPGQ-SLLGTVGSPFYIAPEVLAGG------YNQAADVWSAGVILYILLSGMPPFWGNTKSRIF  252 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~------~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~  252 (468)
                      .   +||+|||++....... ......|+..|+|||++...      ++.++|+|||||++|+|++|+.||.........
T Consensus       166 ~---~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~  242 (291)
T cd06639         166 G---VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL  242 (291)
T ss_pred             C---EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence            4   9999999988654322 22345789999999998542      578999999999999999999999877655544


Q ss_pred             HHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      ..+........ .....++..+.++|.+||+.||++||++.++++||||+
T Consensus       243 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         243 FKIPRNPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHhcCCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            44433322111 11235678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=339.92  Aligned_cols=257  Identities=29%  Similarity=0.495  Sum_probs=220.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||+|.+..+++.||+|++....  .......+.+|+++++++. |+||+++++.+.++..+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence            47899999999999999999999999999999987653  2344567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-C
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-Q  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~  199 (468)
                      +||+++++|.+++... ++++..+..++.|++.||.|||+++++||||+|+||+++.++.   ++|+|||++...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD---VKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEcccccceeeccccc
Confidence            9999999999999875 7899999999999999999999999999999999999987655   999999999887644 2


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ......|++.|+|||++.+. ++.++|+|||||++|+|++|+.||...+.......+......  ......++.++.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--CCcccccCHHHHHHH
Confidence            33456789999999999875 899999999999999999999999876655555544443221  111123788999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      .+||..||++|||++++++|+||+....
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            9999999999999999999999977543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.7e-43  Score=344.43  Aligned_cols=254  Identities=28%  Similarity=0.495  Sum_probs=207.2

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||+|++|.||+|+++.+|+.||+|.+..... .......+.+|+++++++. ||||+++++++.+.+.+++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence            58999999999999999999999999999999876432 2222356778999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          122 ELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      ||+. ++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++....... 
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~---~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc---EEECccchhhccCCCCC
Confidence            9996 588887765 467999999999999999999999999999999999999987654   9999999998654322 


Q ss_pred             ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhccC----------------
Q 012203          200 SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFW-GNTKSRIFDAVRTADL----------------  260 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~----------------  260 (468)
                      ......+++.|+|||++.+.  ++.++|||||||++|+|++|..||. +.+..+.++.+.....                
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            22345788999999998763  7899999999999999999988864 4444444433321100                


Q ss_pred             -CCCC--------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 -RFPS--------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 -~~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                       .++.        .....+++++.++|++||+.||.+|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             0000        0113578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.9e-42  Score=331.81  Aligned_cols=252  Identities=28%  Similarity=0.485  Sum_probs=220.6

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||.|+||.||.+++..+++.+++|.+..... .......+.+|+++++++. |+||+++++++.+.+.++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence            59999999999999999999999999999999876543 2344567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||+++++|.+++.+.  ..+++..+..++.|++.+|.|||+.|++||||||+||+++.++.   +||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~---~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL---IKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC---EEECcCcceEEccccc
Confidence            999999999999775  45899999999999999999999999999999999999987654   9999999998764433


Q ss_pred             -ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                       ......|++.|+|||++.+. ++.++|+||||+++|+|++|..||...+..+....+........   ...++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---VSVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence             23456789999999998774 78899999999999999999999988887777777765543322   15678999999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +.+||.+||++||++.++++|+|+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-42  Score=342.99  Aligned_cols=261  Identities=30%  Similarity=0.470  Sum_probs=216.0

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC--ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      +|++.+.||.|++|.||+|.++.+|+.||+|.+......  .......+..|++++++++ |+||+++++++.+.+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            589999999999999999999999999999999766432  1223355678999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||+ +++|.+++.... .+++..+..++.||++||.|||++||+||||||+|||++.++.   ++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~---~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC---EEEccceeeeeccCC
Confidence            99999 999999998766 7999999999999999999999999999999999999987654   999999999876543


Q ss_pred             C-ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC------------
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP------------  263 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------  263 (468)
                      . ......+++.|+|||.+.+  .++.++|+|||||++|+|++|.+||.+.+..+.+..+........            
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            2 2334467889999999865  378899999999999999999988877665554444432110000            


Q ss_pred             ------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          264 ------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       264 ------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                                  ...+...+..+.++|.+||.+||++|||++|+++|+||++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence                        00123457889999999999999999999999999999886643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-42  Score=342.31  Aligned_cols=260  Identities=27%  Similarity=0.460  Sum_probs=218.6

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      +.....+|++.+.||+|++|.||++.++.+++.|++|.+.....   .....+.+|+.+++.+. ||||+++++.+....
T Consensus        15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~   90 (296)
T cd06654          15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGD   90 (296)
T ss_pred             cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCC
Confidence            34566799999999999999999999999999999999876532   23466888999999985 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      ..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   ++|+|||++...
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~---~kl~dfg~~~~~  166 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQI  166 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC---EEECccccchhc
Confidence            99999999999999999865 46899999999999999999999999999999999999986554   999999998765


Q ss_pred             cCCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          196 EPGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       196 ~~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ..... .....|++.|+|||.+.+. ++.++|+|||||++|+|++|+.||...........+..... .+......++..
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  245 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAI  245 (296)
T ss_pred             cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCHH
Confidence            43322 2345789999999998875 78999999999999999999999987665443333322211 111222468889


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +.+++.+||.+||++|||+.++++|+||...
T Consensus       246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=8.3e-43  Score=342.27  Aligned_cols=251  Identities=34%  Similarity=0.563  Sum_probs=211.5

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE  128 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  128 (468)
                      ||+|+||+||+|.++.+|+.||+|++.+...........+..|++++++++ ||||+++++.++..+.+|+||||++|++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            689999999999999999999999997654433344556678999999996 9999999999999999999999999999


Q ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCC
Q 012203          129 LFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG  206 (468)
Q Consensus       129 L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~G  206 (468)
                      |.+++.+.+  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.   ++|+|||++.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN---VRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEccCcchhhhccCCccccccC
Confidence            999997765  6999999999999999999999999999999999999986554   99999999877654444445678


Q ss_pred             CCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccC
Q 012203          207 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD  285 (468)
Q Consensus       207 T~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  285 (468)
                      +..|+|||++.+. ++.++|+|||||++|+|++|+.||...........+.......+......+++.+.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            8899999998765 888999999999999999999999765542222233222222233333567999999999999999


Q ss_pred             CCCCC-----CHHHHHhCcCCCC
Q 012203          286 PSQRL-----TARQVLDHSWMGD  303 (468)
Q Consensus       286 P~~Rp-----t~~eiL~h~~~~~  303 (468)
                      |.+||     ++.++++||||..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhc
Confidence            99999     8999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.7e-42  Score=332.02  Aligned_cols=253  Identities=27%  Similarity=0.501  Sum_probs=219.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+..... .......+.+|+++++++. ||||+++++.+...+.+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence            58999999999999999999999999999999987643 3344677889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||++|++|.+++...  ..+++..+..++.|++.+|.|||++|++||||||+||+++.++  ..+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEccCCCceecCCCc
Confidence            999999999999764  3489999999999999999999999999999999999997543  347999999998876554


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ......|++.|+|||.+.+. ++.++|+||||+++|+|++|+.||...+.......+......   .....++..+.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHHHHH
Confidence            44556789999999999875 788999999999999999999999887766666555543322   11246789999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .+||..||++|||+.|++.|||+
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-42  Score=336.72  Aligned_cols=248  Identities=35%  Similarity=0.664  Sum_probs=216.3

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE  128 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  128 (468)
                      ||.|++|.||+|++..+++.+|+|++.+...........+.+|+++++++. ||||+++++.+.+.+.+++||||++|++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            689999999999999999999999998765544455678999999999995 9999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCC
Q 012203          129 LFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP  208 (468)
Q Consensus       129 L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~  208 (468)
                      |.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||++.............|++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC---EEEeeCCcccccCcccccccccCCc
Confidence            9999988888999999999999999999999999999999999999987654   9999999998776544344567899


Q ss_pred             CCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHh--ccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          209 FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT--KSRIFDAVRT--ADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       209 ~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      .|+|||.+.+. ++.++|+||||+++|+|++|..||....  ..+....+..  ....++    ...++++.++|.+||.
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~  232 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIKQLLR  232 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHHHHcc
Confidence            99999998764 8999999999999999999999998776  5555555553  222222    3458899999999999


Q ss_pred             cCCCCCCC-----HHHHHhCcCCCCC
Q 012203          284 TDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       284 ~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      .||++|++     ++|+++||||.+.
T Consensus       233 ~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         233 RNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CChhhCcCCcccCHHHHhcChhhhCC
Confidence            99999999     9999999999753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=333.61  Aligned_cols=254  Identities=31%  Similarity=0.519  Sum_probs=216.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++....   ......+.+|+++++++. ||||+++++.+.+.+.+|+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence            467999999999999999999999899999999997653   235678889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.   +||+|||++......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD---VKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC---EEECccccchhhhhh
Confidence            99999999999999776 78999999999999999999999999999999999999986555   999999998765432


Q ss_pred             C-ccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC-CCCCCCCH
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS-NPWDHISD  272 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~  272 (468)
                      . ......++..|+|||++.+    .++.++|+|||||++|+|++|+.||...........+.......+. .....++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence            2 2334578999999999864    3788999999999999999999999877665555444444222211 11235678


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      ++.+++.+||..||.+|||+.++++|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-42  Score=336.31  Aligned_cols=254  Identities=28%  Similarity=0.480  Sum_probs=212.7

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC---ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~---~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +|++.+.||.|+||.||+|.+. +|+.+|+|.+......   .......+.+|+++++++. |+||+++++++.+.+.++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            4888999999999999999874 7899999998754321   1223456888999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-  197 (468)
                      +||||++|++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.   ++|+|||++..... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI---IKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe---EEeccchhhHhhhhc
Confidence            99999999999999988888999999999999999999999999999999999999986554   99999999875421 


Q ss_pred             ------CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          198 ------GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       198 ------~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                            ........|++.|+|||++.+. ++.++|+|||||++|+|++|+.||...+.......+.......+. ....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR-LPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC-CCCCC
Confidence                  1122345789999999999875 889999999999999999999999776654443333333222222 22468


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +.++.++|++||.+||++||++.++++||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.9e-42  Score=339.17  Aligned_cols=261  Identities=27%  Similarity=0.433  Sum_probs=213.0

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ...+....++|++.+.||+|+||.||+|.++.+++.+|+|++....    .....+.+|+.+++++.+||||+++++++.
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            3556678899999999999999999999999999999999876432    123567789999999967999999999873


Q ss_pred             -----eCCEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCC
Q 012203          113 -----DEDYVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP  183 (468)
Q Consensus       113 -----~~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~  183 (468)
                           ..+.+++||||++|++|.+++..    ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.   
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC---
Confidence                 45679999999999999988753    346889999999999999999999999999999999999987554   


Q ss_pred             EEEeecCceeeecCCC-ccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 012203          184 IKLADFGLATYIEPGQ-SLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR  256 (468)
Q Consensus       184 ikL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  256 (468)
                      ++|+|||++....... ......|++.|+|||++..      .++.++|||||||++|+|++|+.||...........+.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~  242 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP  242 (286)
T ss_pred             EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence            9999999998765332 2234579999999999852      37889999999999999999999997765443333222


Q ss_pred             hccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       257 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .... ........++..+.+++.+||+.||++|||+.|+++|+||
T Consensus       243 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         243 RNPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            2111 1111113467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-43  Score=356.60  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=201.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .+|++++.||+|+||.||+|+++.+++.||+|+..+..         ...|+.+++++. ||||+++++++.+.+..++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence            46999999999999999999999999999999864432         245899999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ---VCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEecCccccccccCc
Confidence            99995 688888755 466999999999999999999999999999999999999986554   9999999997654444


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC-Ch----------HHHHHHHHhcc---CCCCC
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN-TK----------SRIFDAVRTAD---LRFPS  264 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~-~~----------~~~~~~i~~~~---~~~~~  264 (468)
                      ...+..||+.|+|||++.+. ++.++|||||||++|||+++..|+... ..          ..+.+.+....   ..++.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            44567899999999999775 899999999999999999865554322 11          11111111111   01110


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          265 --------------------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       265 --------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                                                .....++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                      001245677889999999999999999999999999975

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-42  Score=342.13  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=216.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||.||++.+..+|+.||+|.+....  .......+.+|+++++++. ||||+++++.+..++.+|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEE
Confidence            46899999999999999999999999999999986542  3344567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          121 MELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |||++|++|..++...   ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.   +||+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC---EEEeecCCccccc
Confidence            9999999999988763   379999999999999999999997 59999999999999987544   9999999997654


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-------CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-------~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      .. ......|++.|+|||++.+.       ++.++|+|||||++|+|++|+.||...........+.......+......
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            32 23345688999999998542       47899999999999999999999976655555444433222222222346


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++.++.++|.+||+.||++||+++++++||||....
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            899999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-42  Score=343.38  Aligned_cols=262  Identities=27%  Similarity=0.453  Sum_probs=219.6

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ......+|++.+.||+|++|.||++.++.+++.||+|.+.....   ...+.+.+|+.+++.+. ||||+++++++...+
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~   89 (297)
T cd06656          14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGD   89 (297)
T ss_pred             cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            45677899999999999999999999999999999999875432   33466788999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.   ++|+|||++...
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~---~~l~Dfg~~~~~  165 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQI  165 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEECcCccceEc
Confidence            99999999999999999866 56899999999999999999999999999999999999986554   999999999876


Q ss_pred             cCCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          196 EPGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       196 ~~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ..... .....|++.|+|||.+.+. ++.++|+|||||++|+|++|+.||...+.......+.... ..+......++..
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  244 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAV  244 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHH
Confidence            54322 2345789999999999875 8899999999999999999999997765433322222111 1111223567889


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      +.+++.+||..||++||++.++++||||+....
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            999999999999999999999999999976553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.9e-42  Score=341.85  Aligned_cols=262  Identities=27%  Similarity=0.467  Sum_probs=221.4

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      +......+|++.+.||.|++|.||++.+..+|+.|++|.+....   ......+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   88 (296)
T cd06655          13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVG   88 (296)
T ss_pred             hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecC
Confidence            33445678999999999999999999999999999999987543   233567888999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+|+|+||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++..
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~---~kl~dfg~~~~  164 (296)
T cd06655          89 DELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS---VKLTDFGFCAQ  164 (296)
T ss_pred             ceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEccCccchh
Confidence            999999999999999998876 46899999999999999999999999999999999999986554   99999999876


Q ss_pred             ecCCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          195 IEPGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       195 ~~~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ...... .....|++.|+|||.+.+. ++.++|+|||||++|+|++|+.||...+.......+..... ........++.
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  243 (296)
T cd06655         165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSP  243 (296)
T ss_pred             cccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCH
Confidence            544322 2345789999999998765 88999999999999999999999987766554444433322 11222356889


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+.++|.+||..||.+||++.++++||||+...
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            999999999999999999999999999997644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.2e-42  Score=340.68  Aligned_cols=258  Identities=27%  Similarity=0.454  Sum_probs=216.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .+.|++++.||.|+||.||++++..+++.+++|++...   .......+.+|+++++++. ||||+++++.+..++.+|+
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEEE
Confidence            46799999999999999999999999999999998754   3445667888999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||++|++|..++.+ ...+++..+..++.|++.+|.|||++|++||||||+||+++.++.   +||+|||++......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~dfg~~~~~~~~  163 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKT  163 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC---EEEccCccceecccc
Confidence            9999999999888754 456899999999999999999999999999999999999976554   999999998764322


Q ss_pred             -CccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          199 -QSLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                       .......+++.|+|||++.+      .++.++|+|||||++|+|++|.+||...+.......+....... ......++
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  242 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSKWS  242 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCcccC
Confidence             12234578899999999852      26789999999999999999999998776655555544332211 11124678


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .++.++|.+||..||++||+++++++||||....
T Consensus       243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            8999999999999999999999999999996544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=365.20  Aligned_cols=252  Identities=26%  Similarity=0.455  Sum_probs=215.0

Q ss_pred             EEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCC
Q 012203           48 QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGG  127 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg  127 (468)
                      .||+|.||+||.|+++.+...+|||.|..+   .....+.+..||.+-++|+ |.|||+++|.+.+++++-|.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            699999999999999999999999998755   2345677889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHH-cCCC--CHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc-ccc
Q 012203          128 ELFHRLEK-FGRF--SEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-LLG  203 (468)
Q Consensus       128 sL~~~l~~-~~~l--~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~  203 (468)
                      +|.++++. .+++  .|.+.-.|.+||++||.|||++.|+|||||-+||||+.  -++.+||+|||-++.+..-.. .-+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--ySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--YSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--ccceEEecccccchhhccCCccccc
Confidence            99999965 5777  88999999999999999999999999999999999975  356799999999988765433 346


Q ss_pred             CCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHH
Q 012203          204 TVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG  280 (468)
Q Consensus       204 ~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  280 (468)
                      +.||..|||||++..   +|+.++|||||||++.||.||++||......+. ...+-+.+....+....++.+++.||.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            789999999999975   499999999999999999999999976443221 1122233333333346788999999999


Q ss_pred             ccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          281 MLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       281 ~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      |+.+||.+||+++++|..||++....
T Consensus       815 cFepd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             HcCCCcccCccHHHhccCcccccCCC
Confidence            99999999999999999999987643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.2e-42  Score=341.74  Aligned_cols=241  Identities=17%  Similarity=0.178  Sum_probs=207.5

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----CCEEEEEEe
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED----EDYVHLVME  122 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~----~~~~~lV~E  122 (468)
                      ..||+|+++.||+|..  +|+.||+|.+.+.........+.+.+|+.+|++++ ||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            4799999999999987  68999999997764333333567889999999996 9999999999976    457899999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCcc
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL  201 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~  201 (468)
                      |++||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++.   +||+|||+++.....  .
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~---~kl~dfg~~~~~~~~--~  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK---LKIICHGLEKILSSP--P  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc---EEEcccchHhhhccc--c
Confidence            999999999999888899999999999999999999984 9999999999999987654   999999998765432  2


Q ss_pred             ccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          202 LGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       202 ~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ....|++.|+|||++.+   .++.++|||||||++|||++|+.||...+..++...+.....+++..  ..+++++++++
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence            34578999999999975   48999999999999999999999999888888887776554443322  36789999999


Q ss_pred             HHccccCCCCCCCHHHHHh
Q 012203          279 MGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+||+.||++|||++|+++
T Consensus       256 ~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHhcCCcccCcCHHHHHH
Confidence            9999999999999999985

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-42  Score=340.72  Aligned_cols=256  Identities=28%  Similarity=0.490  Sum_probs=213.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|++|.||+|.++.+++.||+|++.+..... ...+.+.+|+++++++. ||||+++++++.+.+..|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEE
Confidence            47999999999999999999999899999999987653322 33456788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||++++.|..+......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.   ++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~---~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc---EEEEeeeeeeeccCCcc
Confidence            999999999888877667999999999999999999999999999999999999987554   9999999998765432 


Q ss_pred             ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----------------
Q 012203          200 SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-----------------  260 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  260 (468)
                      ......++..|+|||++.+.  ++.++||||||+++|+|++|++||......+....+.....                 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            22345688999999998753  78899999999999999999999976654433333221100                 


Q ss_pred             --CCCC--------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 --RFPS--------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 --~~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                        ..+.        ..+..++..+.+++.+||..||++||++.+++.|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              0110        0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-42  Score=338.40  Aligned_cols=252  Identities=30%  Similarity=0.489  Sum_probs=208.1

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CEEEEE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DYVHLV  120 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~~~lV  120 (468)
                      |++.+.||+|+||.||+|.++.+++.||+|++.+... . ........|+.++.++.+||||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            7889999999999999999999999999999876432 1 12233456899999997799999999999987  899999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||++ ++|.+.+.. ...+++..++.++.|++.||+|||++|++||||||+||+++.    +.+||+|||++.......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCC
Confidence            99996 588888765 356899999999999999999999999999999999999986    449999999998775544


Q ss_pred             ccccCCCCCCCcChhhhcC-C-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc------------------
Q 012203          200 SLLGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD------------------  259 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------  259 (468)
                      ......+++.|+|||++.. + ++.++|+|||||++|||++|..||.+.+..+....+....                  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            4445678999999998754 3 6889999999999999999999998877655544443211                  


Q ss_pred             CCCCCCC-------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          260 LRFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       260 ~~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ..++...       ...++.++.++|.+||.+||++||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1111100       12468899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=341.00  Aligned_cols=256  Identities=30%  Similarity=0.482  Sum_probs=217.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||++.+..+++.+|+|++...   .......+..|+++++++. ||||+++++.+.++..+|+|
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEEE
Confidence            5699999999999999999999889999999998654   3445567888999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   ++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~---~~l~d~g~~~~~~~~~  157 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTL  157 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC---EEEccCccchhhcccc
Confidence            9999999999999764 46999999999999999999999999999999999999986554   9999999986643221


Q ss_pred             -ccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          200 -SLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                       ......|++.|+|||++..      .++.++|+|||||++|+|++|+.||......+....+........ .....++.
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWSS  236 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCCH
Confidence             2234578999999999852      267799999999999999999999988776665555544332111 11246788


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ++.++|.+||+.||.+||++.++++|+||.+.
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            99999999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.5e-42  Score=331.43  Aligned_cols=252  Identities=24%  Similarity=0.527  Sum_probs=217.8

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||+|+||.||++++..+|+.||+|.+..... .......+.+|+.+++++. ||||+++++++++.+..++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence            59999999999999999999999999999999876533 2334567889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||+++++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.   ++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~---~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---IKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEEeeccceeecCcch
Confidence            9999999999997643  5789999999999999999999999999999999999976554   9999999998765432


Q ss_pred             c-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 S-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      . .....|++.|+|||++.+. ++.++|+|||||++|+|++|+.||...+..+....+........   ...++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence            2 2234688999999998775 78899999999999999999999988777777766655543211   24678899999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      |.+||+.+|++||++.++++|+||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=334.94  Aligned_cols=256  Identities=28%  Similarity=0.473  Sum_probs=212.7

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED--  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~--  115 (468)
                      ...++|++.+.||.|++|.||+|.++.+++.+++|++....    .....+.+|+.+++++.+|+||+++++++.+..  
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            45689999999999999999999999899999999987653    234678899999999977999999999997644  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          116 ----YVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       116 ----~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                          .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.   ++|+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~---~~l~  155 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLV  155 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe---EEEC
Confidence                58999999999999998865    357899999999999999999999999999999999999987654   9999


Q ss_pred             ecCceeeecCCC-ccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 012203          188 DFGLATYIEPGQ-SLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       188 DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                      |||++....... ......|++.|+|||++..      .++.++|||||||++|+|++|+.||...........+.....
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            999987654322 2234578999999999853      267899999999999999999999976554444444433322


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .. ......+++.++++|++||..||++|||+.|+++|||+
T Consensus       236 ~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 PT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            11 11113477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-42  Score=335.29  Aligned_cols=258  Identities=28%  Similarity=0.480  Sum_probs=214.0

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC---hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~---~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +|+..+.||+|++|.||++.++.+++.+|+|++.......   ......+..|+.++++++ |+||+++++++.+.+.++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence            4788899999999999999999999999999997643221   123467889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++  ..+||+|||++......
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG--QRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEcccccccccccc
Confidence            9999999999999998888899999999999999999999999999999999999997543  24899999998776532


Q ss_pred             C-----ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-CCCCCCCCCCCC
Q 012203          199 Q-----SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD-LRFPSNPWDHIS  271 (468)
Q Consensus       199 ~-----~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s  271 (468)
                      .     ......|+..|+|||++.+. ++.++|+||||+++|+|++|..||...........+.... ..........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            1     11234688999999998764 8899999999999999999999996544333333332211 111122224678


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      +++.+++.+||..||++||++.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.3e-42  Score=337.83  Aligned_cols=255  Identities=29%  Similarity=0.454  Sum_probs=214.7

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |++.+.||.|+||.||++.+..++..+++|.+...   .......+.+|+++++.+. ||||+++++.+...+..++|||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEEEE
Confidence            78889999999999999999999999999998654   2344567888999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-Cc
Q 012203          123 LCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QS  200 (468)
Q Consensus       123 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~  200 (468)
                      |+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.   +||+|||++...... ..
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~---~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC---EEEccccccccccccccc
Confidence            9999999988765 457999999999999999999999999999999999999986554   999999998765322 22


Q ss_pred             cccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          201 LLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .....|++.|+|||++..      .++.++|+|||||++|+|++|++||...+..+....+........ .....++.++
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  238 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSEF  238 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccccCHHH
Confidence            334578999999999842      267899999999999999999999987766555555443322111 1124678999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .++|.+||.+||.+||++.++++||||....
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            9999999999999999999999999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7e-42  Score=330.62  Aligned_cols=252  Identities=29%  Similarity=0.533  Sum_probs=217.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE--eCCEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE--DEDYVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~--~~~~~~l  119 (468)
                      +|++.+.||.|+||.||+|.+..+|+.+|+|++..... .....+.+..|++++++++ ||||+++++.+.  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence            58999999999999999999999999999999876543 3444567888999999996 999999999875  4567899


Q ss_pred             EEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          120 VMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCH-----EIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH-----~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      +|||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+++|+||||+||+++.++.   +||+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~---~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN---VKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC---EEEeccc
Confidence            9999999999999976    357899999999999999999999     889999999999999986554   9999999


Q ss_pred             ceeeecCCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          191 LATYIEPGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       191 la~~~~~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ++........ .....|++.|+|||++.+. ++.++|+||||+++|+|++|+.||...+...+.+.+.......   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---Ccc
Confidence            9988765443 3456789999999999775 7889999999999999999999998887777666666554321   124


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .++..+.+++.+||..+|++||+++++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.2e-42  Score=339.36  Aligned_cols=252  Identities=30%  Similarity=0.468  Sum_probs=203.5

Q ss_pred             EEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHh--cCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           48 QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL--SGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L--~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      .||+|+||.||++.+..+++.+|+|.+.+.............+|..+++.+  .+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999999999999999999776443222233344454444433  259999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCC
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV  205 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~  205 (468)
                      |++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.   ++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~---~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC---EEEccCCcceeccccC-ccCcC
Confidence            9999999988888999999999999999999999999999999999999986554   9999999987654322 23457


Q ss_pred             CCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          206 GSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       206 GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      ||+.|+|||++.+  .++.++|+||+||++|+|++|..||......... .+.......+......++.++.++|.+||.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            9999999999864  3789999999999999999999999754322211 122222222222335688999999999999


Q ss_pred             cCCCCCC-----CHHHHHhCcCCCCC
Q 012203          284 TDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       284 ~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      .||.+|+     +++++++||||+..
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCC
Confidence            9999999     69999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=362.80  Aligned_cols=256  Identities=32%  Similarity=0.579  Sum_probs=237.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .+++++..||-|+||.|=++..+.....+|+|+++|.++....+.+.+..|.+||..++ .|+||++|..|.++.++||+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence            34677889999999999999887666669999999999988888899999999999997 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      ||-|-||.|+..|++++.|.+.+++.|+.++++|++|||++|||+|||||+|.+++.++-   +||.|||+|+.+..+..
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy---~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY---LKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc---eEEeehhhHHHhccCCc
Confidence            999999999999999999999999999999999999999999999999999999987655   99999999999999999


Q ss_pred             cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCCCCCCCHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL--RFPSNPWDHISDSAKDL  277 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~l~~l  277 (468)
                      ..++||||.|.|||++.+ +.+.++|.|+||+++|||++|.+||.+.++...++.|.++--  .+|    ..++..+.+|
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P----r~I~k~a~~L  651 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP----RRITKTATDL  651 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc----cccchhHHHH
Confidence            999999999999999876 599999999999999999999999999999999999987643  344    5899999999


Q ss_pred             HHHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      |+++...+|.+|+.     +.||.+|.||..-
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence            99999999999996     8999999999653

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-42  Score=338.33  Aligned_cols=259  Identities=25%  Similarity=0.447  Sum_probs=213.2

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE-  112 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~-  112 (468)
                      .++....+.|++.+.||.|+||.||+|.++.+++.+|+|++....    .....+..|+.+++++.+||||+++++++. 
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            334445678999999999999999999999999999999986542    234568889999999977999999999985 


Q ss_pred             -----eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEE
Q 012203          113 -----DEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       113 -----~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                           ..+.+|++|||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.   ++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~---~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE---VK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EE
Confidence                 356899999999999999999763  45888889999999999999999999999999999999986554   99


Q ss_pred             EeecCceeeecCC-CccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 012203          186 LADFGLATYIEPG-QSLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA  258 (468)
Q Consensus       186 L~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  258 (468)
                      |+|||++...... .......|++.|+|||++..      .++.++|+|||||++|+|++|+.||...........+...
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  241 (282)
T cd06636         162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  241 (282)
T ss_pred             EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC
Confidence            9999998765422 22334678999999999752      3788999999999999999999999766544333333222


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       259 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .  .+......++.++.++|.+||+.||.+|||+.|+++||||
T Consensus       242 ~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         242 P--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             C--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            1  1222234688999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.2e-42  Score=337.83  Aligned_cols=258  Identities=28%  Similarity=0.426  Sum_probs=208.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE----
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY----  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~----  116 (468)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++++.+||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            469999999999999999999999999999999866532 222345678899999999768999999999987665    


Q ss_pred             -EEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          117 -VHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       117 -~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                       .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++.+  .+.+||+|||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg  156 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLG  156 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeecc
Confidence             8999999975 898888643     357999999999999999999999999999999999999862  2349999999


Q ss_pred             ceeeecCC-CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC------
Q 012203          191 LATYIEPG-QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR------  261 (468)
Q Consensus       191 la~~~~~~-~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------  261 (468)
                      ++...... .......+++.|+|||++.+.  ++.++|+||||+++|+|++|..||.+.+.......+......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            99865432 122234678899999998653  789999999999999999999999876654433333221000      


Q ss_pred             -----------CC-------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          262 -----------FP-------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       262 -----------~~-------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                                 ++       ......++.++.++|.+||.+||.+||++.|++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                       00       011135788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.1e-42  Score=337.38  Aligned_cols=255  Identities=33%  Similarity=0.516  Sum_probs=213.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||.|++|.||+|.++.+|+.||+|++...... ......+.+|+.+++++. ||||+++++++.+.+.+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence            589999999999999999999999999999999765432 233567889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          122 ELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      ||+ +++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||++....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~---~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV---LKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc---EEEeeeeecccccCCCC
Confidence            999 99999998653 56899999999999999999999999999999999999987554   9999999998765432 


Q ss_pred             -ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----------------
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD-----------------  259 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------------  259 (468)
                       ......|+..|+|||++.+.  ++.++|||||||++|+|++|.+||.+.+....+..+...-                 
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             23345789999999998653  6889999999999999999999987766555444433210                 


Q ss_pred             --CCCCCC-------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          260 --LRFPSN-------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       260 --~~~~~~-------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                        ..++..       .....+..+.++|++||.+||.+|||++++++||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              011111       1134678999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3e-42  Score=337.46  Aligned_cols=250  Identities=27%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             ccCCeEEEeEE--eecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           39 LRERFVLGQQL--GWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        39 l~~~y~i~~~L--G~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +.+.|++.+.+  |+|+||.||++.++.+++.+|+|++.+.....        .|+.....+.+||||+++++.|...+.
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            44567777666  99999999999999999999999987653211        122233333469999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||++|++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++  ..++|+|||++....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~~l~dfg~~~~~~  161 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIG  161 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--CeEEEecCccceecC
Confidence            999999999999999998878899999999999999999999999999999999999998765  149999999998764


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccCCCCCCCCCCCCHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRI-FDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      ..   ....|++.|+|||++.+. ++.++|+|||||++|+|++|+.||........ ...+.... ..+...+..++..+
T Consensus       162 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (267)
T PHA03390        162 TP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA  237 (267)
T ss_pred             CC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence            32   235689999999999864 88999999999999999999999975543322 11111111 22223335789999


Q ss_pred             HHHHHHccccCCCCCCC-HHHHHhCcCCC
Q 012203          275 KDLVMGMLSTDPSQRLT-ARQVLDHSWMG  302 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt-~~eiL~h~~~~  302 (468)
                      .++|.+||+.||.+|++ ++++|+||||+
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            99999999999999996 69999999996

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.7e-42  Score=347.51  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=204.5

Q ss_pred             EEeEEeec--CCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           45 LGQQLGWG--QFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        45 i~~~LG~G--~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      +++.||+|  +|++||++.++.+|+.||+|++..... .......+.+|+++++.+. ||||+++++++..++..|+|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence            46789999  678999999999999999999976532 2334567788999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CC
Q 012203          123 LCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQ  199 (468)
Q Consensus       123 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~  199 (468)
                      |+++|+|.+++..+  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.   ++++||+....... +.
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~---~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc---EEEcccchhhccccccc
Confidence            99999999999653  45899999999999999999999999999999999999987654   99999986543321 11


Q ss_pred             -------ccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-------
Q 012203          200 -------SLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF-------  262 (468)
Q Consensus       200 -------~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------  262 (468)
                             ......++..|+|||++.+   .++.++|||||||++|+|++|+.||...................       
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   0112356788999999975   38899999999999999999999997655443332222211100       


Q ss_pred             C-----------------------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          263 P-----------------------------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       263 ~-----------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +                                   ......+++.+.+||.+||+.||++|||++|+++||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence            0                                   00112356789999999999999999999999999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.4e-42  Score=341.04  Aligned_cols=260  Identities=33%  Similarity=0.500  Sum_probs=212.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DYV  117 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~~  117 (468)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|.+...... ......+.+|+.++++++ |+||+++++++.+.  +.+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence            45699999999999999999999999999999998754321 122234567999999996 99999999999755  578


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++||||+. ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~kL~dfg~~~~~~  159 (309)
T cd07845          84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYG  159 (309)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECccceeeecC
Confidence            99999996 588888875 366899999999999999999999999999999999999986554   9999999998765


Q ss_pred             CCC-ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-------------
Q 012203          197 PGQ-SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-------------  260 (468)
Q Consensus       197 ~~~-~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------------  260 (468)
                      ... ......+++.|+|||++.+  .++.++|+|||||++|+|++|++||...+..+.+..+.....             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            432 2233456888999999875  378999999999999999999999988887776666544211             


Q ss_pred             ------CCCCCC-------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 ------RFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 ------~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                            ..+...       ....++.+.++|++||+.||++|||++|++.||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                  011110       123578899999999999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-41  Score=330.96  Aligned_cols=255  Identities=28%  Similarity=0.507  Sum_probs=211.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC--ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~~~  116 (468)
                      +.|++.+.||+|+||.||++.++.+|+.||+|.+......  .......+.+|+.+++++. ||||+++++++.+  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            4699999999999999999999999999999988653221  2234567888999999996 9999999999876  357


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++++|||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~l~Dfg~~~~~~  157 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC---EEECcCccccccc
Confidence            8899999999999999988888999999999999999999999999999999999999986554   9999999987653


Q ss_pred             CC----CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          197 PG----QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       197 ~~----~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ..    .......|+..|+|||++.+. ++.++|+|||||++|+|++|+.||...........+..... .+. ....++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~~~  235 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-NPV-LPPHVS  235 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC-CCC-CchhhC
Confidence            21    122345689999999998764 88999999999999999999999977654444433332211 111 124677


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      ..+.++|.+||. +|++||+++|++.|||+.
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            889999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.7e-42  Score=348.98  Aligned_cols=260  Identities=26%  Similarity=0.445  Sum_probs=212.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE----  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~----  114 (468)
                      +.++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++++. ||||++++++|...    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCcc
Confidence            56889999999999999999999999999999999865422 3334456778999999995 99999999998644    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 --DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 --~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                        ..+|+||||+. ++|.+.+...  +++..+..++.|++.||+|||++||+||||||+||+++.++.   +||+|||++
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~---~kL~Dfg~~  165 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLA  165 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEccCccc
Confidence              35799999995 5888888653  899999999999999999999999999999999999987655   999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC----------
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR----------  261 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------  261 (468)
                      .............|++.|+|||++.+. ++.++|||||||++|+|++|+.||...+....+..+......          
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            876654444556789999999999875 899999999999999999999999876654443333211000          


Q ss_pred             --------------------------CCCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          262 --------------------------FPSN---PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       262 --------------------------~~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                                ++..   .....++.+.++|.+||+.||.+|||+.|+|+||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                                      0000   01234667899999999999999999999999999976543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1e-41  Score=332.29  Aligned_cols=254  Identities=29%  Similarity=0.521  Sum_probs=209.8

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC--ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDYV  117 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~~~~  117 (468)
                      .|++.+.||+|+||.||+|.+..+++.|++|.+......  .......+.+|+.++++++ ||||+++++++.+  .+.+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence            588999999999999999999999999999998754321  2233457888999999996 9999999999875  4678


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +++|||+++++|.+++.+.+.+++...+.++.|++.||.|||+++|+||||||+||+++.++.   +||+|||++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~---~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEccCCCcccccc
Confidence            999999999999999988888999999999999999999999999999999999999986554   99999999876542


Q ss_pred             C----CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          198 G----QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       198 ~----~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .    .......++..|+|||.+.+. ++.++|+|||||++|+|++|+.||...........+...... + .....+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~-~~~~~~~~  236 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-P-QLPSHISE  236 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-C-CCchhcCH
Confidence            1    112235688999999999875 889999999999999999999999776554444333322111 1 11235778


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      .+++++ +||..||++||+++|+++||||+
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            899999 57778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.5e-42  Score=331.37  Aligned_cols=251  Identities=29%  Similarity=0.460  Sum_probs=212.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.+....     ....+.+|+++++++ +||||+++++.+.+...+|++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence            57999999999999999999999889999999986542     257888999999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      +||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.   ++|+|||++.......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~---~~l~dfg~~~~~~~~~  153 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTM  153 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc---EEEcccccchhcccCc
Confidence            999999999999976 356899999999999999999999999999999999999987554   9999999998765433


Q ss_pred             -ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                       ......|+..|+|||++.+. ++.++|||||||++|+|++|+.||...........+...... .......++..+.++
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF  232 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence             22345688999999998775 889999999999999999999999776554433333222111 111123577899999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      |.+||+.||++|||+.|++.||||
T Consensus       233 i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.5e-42  Score=334.99  Aligned_cols=256  Identities=24%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||++.++.+|+.||+|++.....  ......+..|+.++.+..+||||+++++++..++.+|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            469999999999999999999999999999999876532  223345566777655555799999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          121 MELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      |||++ |+|.+++..    ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.   +||+|||++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~---~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ---VKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC---EEEeeccccccc
Confidence            99995 688877754    24689999999999999999999997 9999999999999987554   999999999876


Q ss_pred             cCCCccccCCCCCCCcChhhhcC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCC-h-HHHHHHHHhccCCCCCCCCC
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGNT-K-SRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~-----~~~~~sDiwSlGvil~elltG~~Pf~~~~-~-~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ..........|+..|+|||++.+     .++.++|+|||||++|+|++|+.||.... . ..+...+.......+   ..
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  231 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP---AE  231 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC---cc
Confidence            54333334578999999998864     36889999999999999999999996432 2 222222222222222   24


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .++.++.++|.+||..+|++||+++++++|+||....
T Consensus       232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            5789999999999999999999999999999997754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.1e-42  Score=335.70  Aligned_cols=254  Identities=33%  Similarity=0.658  Sum_probs=223.3

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|.+.+.||.|++|.||++.++.+|+.||+|++.+...........+..|+++++++.+||||+++++++.+.+.+++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998765545555677889999999996699999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~---~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEecCCccccccCCccc
Confidence            999999999999999888999999999999999999999999999999999999986554   9999999987654322 


Q ss_pred             --------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 012203          200 --------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA  258 (468)
Q Consensus       200 --------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  258 (468)
                                          ......|+..|+|||++.+. ++.++|+||||+++++|++|+.||........++.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                11234678999999998765 788999999999999999999999887766666666655


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCH----HHHHhCcCC
Q 012203          259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTA----RQVLDHSWM  301 (468)
Q Consensus       259 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~eiL~h~~~  301 (468)
                      ...++    ..+++.+.++|.+||+.||.+||++    +++++||||
T Consensus       238 ~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44444    4668999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-41  Score=328.86  Aligned_cols=254  Identities=33%  Similarity=0.527  Sum_probs=214.6

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+...... ......+.+|+++++++. |+||+++++.+.+.+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence            699999999999999999999989999999999766432 346678999999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc-
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-  200 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-  200 (468)
                      ||+++++|.+++.+...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.   +||+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV---IKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEcccccccccCCCCCc
Confidence            99999999999988777999999999999999999999999999999999999987554   99999999987654322 


Q ss_pred             ----cccCCCCCCCcChhhhcCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCCCCCCCCCCCC
Q 012203          201 ----LLGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       201 ----~~~~~GT~~Y~APE~l~~~----~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                          .....+++.|+|||++.+.    ++.++||||||+++|+|++|+.||..... ......+.. ........+..++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence                2235788999999998753    68899999999999999999999965532 222222222 2222222234568


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ..+.++|.+||+.||.+|||+.+++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=335.77  Aligned_cols=258  Identities=27%  Similarity=0.525  Sum_probs=217.3

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEEeCCEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++++.  +|||++++++++.+...+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4788899999999999999999999999999987542  2334567888999999996  59999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++   .++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG---NVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC---CEEEccCCceeecCCCc
Confidence            9999999999999866 4789999999999999999999999999999999999998654   49999999998765432


Q ss_pred             -ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                       ......|++.|+|||.+.++  ++.++|+|||||++|+|++|..||...........+...  ..+......++.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence             23345789999999998753  688999999999999999999999876655444333222  2222222347889999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                      ++.+||..||++||++.++++|+||++....
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence            9999999999999999999999999776543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-41  Score=332.74  Aligned_cols=256  Identities=27%  Similarity=0.505  Sum_probs=212.9

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC-------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-------IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~-------~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.+.......       ....+.+..|+.+++++. ||||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            5889999999999999999999999999999886432111       112346788999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+++||||++|++|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.   ++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~---~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI---CKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe---EEEeecccccc
Confidence            999999999999999999998888999999999999999999999999999999999999986554   99999999976


Q ss_pred             ecCCC---ccccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--cCCCCCCC
Q 012203          195 IEPGQ---SLLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA--DLRFPSNP  266 (468)
Q Consensus       195 ~~~~~---~~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~  266 (468)
                      .....   ......|+..|+|||++...   ++.++|+||||+++|+|++|..||...........+...  ...++...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            54321   12345688999999998752   788999999999999999999999655544333332222  22233333


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ...++.++.+++.+||.+||++||++++++.|||+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            45678999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-41  Score=327.74  Aligned_cols=254  Identities=33%  Similarity=0.554  Sum_probs=216.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC--CChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~--~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      +|+..+.||+|++|+||+|.++.+++.|++|.+.....  ......+.+.+|+++++++. |+||+++++++.+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence            57888999999999999999998999999999876432  12334567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      +|||++|++|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.   +||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~---~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV---VKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEccCccceeccccc
Confidence            9999999999999988888999999999999999999999999999999999999986554   9999999998765544


Q ss_pred             ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ......|++.|+|||.+...  ++.++|+|||||++|+|++|+.||...........+.... ..+ .....+++.+.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELP-PIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCC-CcCCCcCHHHHHH
Confidence            34566789999999998653  7889999999999999999999997766444433333211 111 1224678999999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +.+||+.||++||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=365.54  Aligned_cols=251  Identities=31%  Similarity=0.454  Sum_probs=212.1

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE-EE---eC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV-YE---DE  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~-~~---~~  114 (468)
                      -..+++|.+.|.+|||+.||+|++...|..||+|++-..   .....+.+++||++|++|++|+|||.|++. ..   .+
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            345689999999999999999999887799999998654   456678899999999999999999999993 21   11


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCEEEe
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                         -.++|.||||+||.|-+++..+  .+|++.++++|+.++++|+.+||...  |||||||-|||||..+++   +|||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~---~KLC  188 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN---YKLC  188 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC---EEeC
Confidence               3588999999999999999753  56999999999999999999999997  999999999999987665   9999


Q ss_pred             ecCceeeecCCC-cc---------ccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 012203          188 DFGLATYIEPGQ-SL---------LGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFD  253 (468)
Q Consensus       188 DFGla~~~~~~~-~~---------~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~  253 (468)
                      |||.+...-... ..         ....-|+.|+|||++.-    ..+.|+|||+|||+||-|++...||.....    -
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----l  264 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----L  264 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----e
Confidence            999986432211 11         12357999999999852    389999999999999999999999976544    3


Q ss_pred             HHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       254 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .|.++.+.+|..  ..+++.+++||..||+.||++||++-|++.+-+.
T Consensus       265 aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  265 AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            456777888865  5899999999999999999999999999976554

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-41  Score=330.65  Aligned_cols=252  Identities=26%  Similarity=0.500  Sum_probs=212.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||+|+++.+++.||+|.+.............+.+|+++++++. ||||+++++++.+.+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            57999999999999999999999999999999987654444555667888999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          121 MELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~---~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC---EEECccccceecc
Confidence            999999999988853    244889999999999999999999999999999999999986554   9999999998765


Q ss_pred             CCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK--SRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .... .....|++.|+|||.+.+. ++.++|+||||+++|+|++|+.||.....  ....+.+...  .++......++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcCH
Confidence            3322 2345789999999998764 88999999999999999999999965432  3444444332  233333356788


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .+.+++.+||..+|++||++.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.9e-42  Score=335.94  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=212.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCC-----cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTG-----EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ++|++.+.||+|+||.||+|.+...+     +.||+|.+....  .......+.+|+++++++. ||||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence            46899999999999999999986555     789999986542  2334567889999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          116 YVHLVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      ..+++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            999999999999999999764                4578889999999999999999999999999999999998655


Q ss_pred             CCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 012203          180 SSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA  254 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~  254 (468)
                      .   ++|+|||++.......   ......+++.|+|||.+.+ .++.++|||||||++|||++ |..||.+....++...
T Consensus       162 ~---~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         162 T---VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             c---EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            4   9999999998654322   1233467889999999876 48999999999999999998 9999998888888777


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.......   ....+++++.+|+.+||+.||.+||+++|++++
T Consensus       239 i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            76554322   125789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.1e-42  Score=341.57  Aligned_cols=249  Identities=28%  Similarity=0.471  Sum_probs=192.8

Q ss_pred             EeEEeecCCeEEEEEEEcC--CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE--eCCEEEEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKF--TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE--DEDYVHLVM  121 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~--~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~--~~~~~~lV~  121 (468)
                      ..+||+|+||.||+|+++.  +++.||+|.+.....     ...+.+|+++++++. ||||+++++++.  .+..+++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence            4689999999999999764  568999999865422     245678999999996 999999999984  456889999


Q ss_pred             eccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC-CCCCEEEeecCc
Q 012203          122 ELCAGGELFHRLEKF---------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGL  191 (468)
Q Consensus       122 E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~-~~~~ikL~DFGl  191 (468)
                      ||+. ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+..++ ..+.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            9985 5888877532         2488999999999999999999999999999999999996442 345699999999


Q ss_pred             eeeecCCC----ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 012203          192 ATYIEPGQ----SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS---------RIFDAVR  256 (468)
Q Consensus       192 a~~~~~~~----~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~  256 (468)
                      ++......    ......||+.|+|||++.+.  ++.++|||||||++|||++|++||......         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            98765332    22345789999999998763  789999999999999999999999653321         1111110


Q ss_pred             hccC--------------CCC--------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          257 TADL--------------RFP--------------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       257 ~~~~--------------~~~--------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ....              .++                    .......+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000              000                    00011235578899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-41  Score=337.91  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=203.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcC----------------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKF----------------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN  103 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn  103 (468)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|++++.+++ |||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence            4689999999999999999998642                34579999987642  3344567889999999996 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcE
Q 012203          104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-------------------RFSEAEARVLFMQLMQVVLYCHEIGVV  164 (468)
Q Consensus       104 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------------~l~~~~~~~i~~qil~aL~~LH~~gIi  164 (468)
                      |+++++++.+.+..++||||+++|+|.+++....                   .+++..+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999986532                   357788899999999999999999999


Q ss_pred             ecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh--
Q 012203          165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS--  238 (468)
Q Consensus       165 HrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt--  238 (468)
                      ||||||+|||++.++.   +||+|||+++.......   .....++..|+|||++.++ ++.++|||||||++|+|++  
T Consensus       161 H~dlkp~Nill~~~~~---~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLVGENLT---IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEEcCCcc---EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            9999999999986554   99999999987644322   1223567889999998764 8999999999999999986  


Q ss_pred             CCCCCCCCChHHHHHHHHhc----cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          239 GMPPFWGNTKSRIFDAVRTA----DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       239 G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +..||...+..+....+...    ...........++..+.+++.+||+.||++|||+.+|.+
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            66888776665555443221    111111112467889999999999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-41  Score=332.48  Aligned_cols=249  Identities=20%  Similarity=0.340  Sum_probs=208.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      .++|++.+.||+|+||.||+|.++   ..+..||+|.+....  .......+.+|+.+++++. ||||+++++++..++.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCC
Confidence            456999999999999999999875   346789999987652  2334567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .++||||+++|+|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+|||++.++.   ++++|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~---~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV---CKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc---EEECCCcccccc
Confidence            99999999999999999774 57899999999999999999999999999999999999986554   999999987654


Q ss_pred             cCCCcc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          196 EPGQSL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       196 ~~~~~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ......  ....+++.|+|||++.+. ++.++|||||||++|||++ |..||+.....+..+.+.... ..+  ....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~  234 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-RLP--APRNCP  234 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CCC--CCCCCC
Confidence            322111  123456789999998764 8999999999999999775 999999888877777765542 222  235688


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..+.+++.+||+.+|++||++++|++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-42  Score=359.12  Aligned_cols=250  Identities=27%  Similarity=0.402  Sum_probs=204.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....         ..+.+|+++|++|. |||||++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence            4579999999999999999999999999999996422         23567999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||++ .++|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++.....
T Consensus       238 v~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~---vkL~DFGla~~~~~~  313 (461)
T PHA03211        238 VLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGS  313 (461)
T ss_pred             EEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC---EEEcccCCceecccc
Confidence            99999 56888888664 46999999999999999999999999999999999999986554   999999999876432


Q ss_pred             Cc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhccCC---CC
Q 012203          199 QS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT--------KSRIFDAVRTADLR---FP  263 (468)
Q Consensus       199 ~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~---~~  263 (468)
                      ..   ....+||+.|+|||++.+. ++.++|||||||++|||++|..|+....        ...+.+.+......   ++
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            21   2345799999999999875 8999999999999999999887654321        23344444332211   11


Q ss_pred             ------------------------CCCCC---CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          264 ------------------------SNPWD---HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       264 ------------------------~~~~~---~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                                              ...|.   .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    11121   45668999999999999999999999999999964

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.5e-42  Score=352.51  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=204.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCC-----CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFT-----GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      -.++|++.+.||+|+||.||+|++...     ++.||+|++....  .......+.+|+++++.+.+||||+++++++.+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            345799999999999999999986543     4579999997653  233456788999999999569999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc---------------------------------------------------------
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF---------------------------------------------------------  136 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------------  136 (468)
                      .+.+++|||||++|+|.+++.+.                                                         
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            99999999999999999998642                                                         


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCcc--
Q 012203          137 -------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL--  201 (468)
Q Consensus       137 -------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--  201 (468)
                                   .++++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++........  
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~---~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR---VAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC---eEEEeeceeeeeccCCcceee
Confidence                         2477888999999999999999999999999999999998654   4999999999876433221  


Q ss_pred             -ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          202 -LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       202 -~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                       ....+++.|+|||++.+. ++.++|||||||++|+|++ |+.||...........+.........  ...+++++.+++
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li  348 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIM  348 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHH
Confidence             122356679999998764 8999999999999999997 99999776554433333333322222  235689999999


Q ss_pred             HHccccCCCCCCCHHHHHh
Q 012203          279 MGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+||+.||.+|||+.++++
T Consensus       349 ~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         349 KMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-42  Score=335.66  Aligned_cols=256  Identities=31%  Similarity=0.541  Sum_probs=212.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|++|.||+|.++.+++.||+|++..... .......+.+|+++++++. |+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEE
Confidence            479999999999999999999999999999999876432 2233467889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||++++.+..++.+...+++..+..++.||+.||.|||++|++||||+|+||+++.++.   +||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~---~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV---LKLCDFGFARALRARPA  155 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEEeeecccccCCCcc
Confidence            999998777777776677999999999999999999999999999999999999987554   9999999998765443 


Q ss_pred             -ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----------------
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL----------------  260 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  260 (468)
                       ......+++.|+|||++.+.  ++.++|+||||+++|+|++|++||.+....+....+.....                
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             23346788999999998764  78899999999999999999999977655443332221100                


Q ss_pred             ---CCCC---------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 ---RFPS---------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 ---~~~~---------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                         .++.         .....++.++.+||++||..||++||+++++++|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence               0000         0112348899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-41  Score=328.77  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=218.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||+|.++.+|+.|++|++......  .....+.+|++++.+++ |+||+++++++...+.+++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEE
Confidence            3689999999999999999999999999999998765321  44677889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.   ++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~---~~l~df~~~~~~~~~~  154 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTL  154 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC---EEEccCccceecccCC
Confidence            9999999999999888889999999999999999999999 99999999999999987555   9999999998765443


Q ss_pred             ccc-cCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          200 SLL-GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       200 ~~~-~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      ... ...++..|+|||.+.+. ++.++|+||||+++|+|++|+.||...   ...+....+.....  +......++..+
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  232 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--PSLPAEEFSPEF  232 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--CCCCcccCCHHH
Confidence            332 45788999999998875 788999999999999999999999776   33444444443222  111112278999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .++|++||..+|++||++.++++|||++.
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-41  Score=334.44  Aligned_cols=250  Identities=31%  Similarity=0.494  Sum_probs=204.0

Q ss_pred             EEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHh--cCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           48 QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL--SGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L--~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      .||+|+||.||+|.+..+++.||+|++.+..............|..+++.+  .+||+|+.+++.+.+.+.+++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999999999999999999876443222222334444443333  259999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCC
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV  205 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~  205 (468)
                      |++|..++.+.+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.   ++|+|||++...... .....+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~---~kl~dfg~~~~~~~~-~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKK-KPHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC---EEEccCcCccccCcc-CCcCcC
Confidence            9999999988888999999999999999999999999999999999999986554   999999998765432 223457


Q ss_pred             CCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHH
Q 012203          206 GSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG  280 (468)
Q Consensus       206 GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  280 (468)
                      |++.|+|||++.+  .++.++|+||+||++|+|++|+.||....   ..............++    ..++..+.+++.+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~  232 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEG  232 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC----CcCCHHHHHHHHH
Confidence            9999999999975  37899999999999999999999997653   2222222222222222    4578999999999


Q ss_pred             ccccCCCCCC-----CHHHHHhCcCCCCCC
Q 012203          281 MLSTDPSQRL-----TARQVLDHSWMGDGI  305 (468)
Q Consensus       281 ~L~~dP~~Rp-----t~~eiL~h~~~~~~~  305 (468)
                      ||..||.+|+     ++.++++||||+...
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            9999999999     999999999997744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-41  Score=326.40  Aligned_cols=248  Identities=28%  Similarity=0.487  Sum_probs=213.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||.|+||.||++.++.+++.+|+|.+....  .....+.+.+|+.+++++. ||||+++++.+++++.+|+||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            5899999999999999999999999999999986543  2334567888999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.   ++|+|||++.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK---VKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc---EEEcccCcceeecccc
Confidence            999999999988653  45899999999999999999999999999999999999976554   9999999998764322


Q ss_pred             -ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                       ......|++.|+|||++.+. ++.++|+||||+++|+|++|..||...+.......+........   ...++..+.++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHH
Confidence             22345789999999999875 89999999999999999999999988877776666655443321   14678899999


Q ss_pred             HHHccccCCCCCCCHHHHHhC
Q 012203          278 VMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      |.+||..||++||++.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.8e-42  Score=351.08  Aligned_cols=251  Identities=23%  Similarity=0.400  Sum_probs=204.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEE-----cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSD-----KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .++|++.+.||+|+||.||+|++     ..++..||+|++....  .....+.+.+|+.+|+.+.+||||+++++++.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            45799999999999999999974     3467789999986542  2234567888999999996699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC---------------------------------------------------------
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG---------------------------------------------------------  137 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------------  137 (468)
                      +..++|||||+||+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999986432                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          138 ------------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       138 ------------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                                        .+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~---~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR---ITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC---cEEEecCccceeccCcc
Confidence                              367888899999999999999999999999999999998644   49999999998765332


Q ss_pred             cc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChH-HHHHHHHhccCCCCCCCCCCCCHH
Q 012203          200 SL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKS-RIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       200 ~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ..   ....++..|+|||++.+. ++.++|||||||++|||++ |..||...... ...+.+... ....  .....+.+
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~  345 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-YRML--SPECAPSE  345 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-ccCC--CCCCCCHH
Confidence            21   123356679999999875 8999999999999999998 89999776543 333333332 2221  12456889


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.+|+.+||+.||++||++.|+++.
T Consensus       346 l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         346 MYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=363.69  Aligned_cols=258  Identities=28%  Similarity=0.452  Sum_probs=223.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      +-|+|+..||.|+||.||+|.++.++-..|.|+|...   .......+.-||+||..+. ||+||+|++.|..++.+||+
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceEEE
Confidence            4578888999999999999999999999999998654   4456677888999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~  198 (468)
                      .|||.||-++.++-.- ..+.+..+..+++|++.||.|||+++|||||||..|||++-+|.   |+|+|||.+.... ..
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKNKSTR  184 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---EeeecccccccchhHH
Confidence            9999999999988554 46999999999999999999999999999999999999998887   9999999875533 22


Q ss_pred             CccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          199 QSLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      +...+++|||+|||||+...      .|+.++||||||++|.||..+.+|-...+...++-.|.+..+.-. .....++.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL-lqPS~Ws~  263 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-LQPSHWSR  263 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-cCcchhhh
Confidence            34567899999999999864      399999999999999999999999988777776666655443211 12357889


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      .+.||+++||.+||..||++.++|+|||+.+...
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            9999999999999999999999999999986543

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-41  Score=336.42  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=206.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC---
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED---  115 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~---  115 (468)
                      .-++|++.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|++++++++ ||||+++++++...+   
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPY   87 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEecccccc
Confidence            34579999999999999999999999999999999865432 1222345567999999996 999999999986543   


Q ss_pred             -----EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          116 -----YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       116 -----~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                           ..++||||+. ++|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.   +||+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~df  163 (310)
T cd07865          88 NRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI---LKLADF  163 (310)
T ss_pred             cCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc---EEECcC
Confidence                 4699999995 5888888664 36899999999999999999999999999999999999986554   999999


Q ss_pred             CceeeecCCCc-----cccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 012203          190 GLATYIEPGQS-----LLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       190 Gla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      |++........     .....++..|+|||++.+.  ++.++|+||||+++|+|++|+.||.+.+.......+......+
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99976643221     1245678899999998764  6889999999999999999999998877655544443321111


Q ss_pred             C-------------------CCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          263 P-------------------SNP---------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       263 ~-------------------~~~---------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +                   ...         ....+..+.++|.+||..||.+|||++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            1                   100         01235678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=333.62  Aligned_cols=254  Identities=28%  Similarity=0.509  Sum_probs=204.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||+|.++.+++.||+|.+.....  ......+.+|+++++++. ||||+++++++.+++..++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence            679999999999999999999998999999999876432  112234667999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-  198 (468)
                      |||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++...... 
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~~~  157 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPS  157 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC---EEECccccccccCCCC
Confidence            999974 999988764 46899999999999999999999999999999999999987655   999999998754321 


Q ss_pred             CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccC---------------
Q 012203          199 QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDAVRTADL---------------  260 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~---------------  260 (468)
                      .......+++.|+|||++.+  .++.++||||+|+++|+|++|+.||.... ..+....+.....               
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            12223457889999999875  37889999999999999999999997654 2222222211000               


Q ss_pred             ----CCCC-------CCCCCCC--HHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 ----RFPS-------NPWDHIS--DSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 ----~~~~-------~~~~~~s--~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                          .++.       .....++  .++.+++.+||..||++|||+.+++.|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                0000       0012334  788999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-41  Score=329.33  Aligned_cols=249  Identities=35%  Similarity=0.622  Sum_probs=218.2

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE  128 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  128 (468)
                      ||.|+||.||++++..+|+.+++|++.............+.+|+++++++. ||||+++++.+...+..|++|||++|++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999999899999999997765444455678889999999996 9999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC---------
Q 012203          129 LFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ---------  199 (468)
Q Consensus       129 L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---------  199 (468)
                      |.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.   ++|+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC---EEEEecccchhcccCcccccccccc
Confidence            9999998888999999999999999999999999999999999999987655   9999999987644321         


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ......+++.|+|||++.+. ++.++|+||||+++|+|++|+.||......+....+......++..  ..++..+.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence            12335688899999998765 7889999999999999999999998888888887777755555432  23589999999


Q ss_pred             HHccccCCCCCCCH---HHHHhCcCCCC
Q 012203          279 MGMLSTDPSQRLTA---RQVLDHSWMGD  303 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~---~eiL~h~~~~~  303 (468)
                      .+||+.+|++|||+   .++++||||++
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            99999999999999   99999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.3e-42  Score=332.93  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=213.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.+.....  ......+.+|+++++++. ||||+++++.+..++.++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEE
Confidence            368888999999999999999999999999999876532  244567888999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~---~~l~d~g~~~~~~~~  154 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLVNS  154 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC---EEEeecccchhhHHH
Confidence            9999999999999876 789999999999999999999999 99999999999999987554   999999998765432


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT-----KSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .. ....++..|+|||.+.+. ++.++|+||||+++|+|++|+.||....     ..+..+.+....  .+..+...++.
T Consensus       155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  231 (265)
T cd06605         155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--PPRLPSGKFSP  231 (265)
T ss_pred             Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence            22 226789999999999775 8999999999999999999999996542     222222222221  12222223888


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ++.++|.+||..||++|||+.+++.||||+.
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            9999999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-41  Score=334.50  Aligned_cols=254  Identities=32%  Similarity=0.517  Sum_probs=208.0

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|++.+.||.|++|.||+|+++.+|+.||+|.+..+.. .......+.+|++++++++ ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence            48999999999999999999999999999999875532 2223457888999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||+. ++|..++...  ..+++..++.++.|++.||+|||++|++||||+|+||+++.++.   +||+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~---~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEeeccchhhcccCc
Confidence            9995 6898888653  56899999999999999999999999999999999999987655   9999999987654322


Q ss_pred             -ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-cC---------------
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA-DL---------------  260 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~---------------  260 (468)
                       ......+++.|+|||++.+.  ++.++|+|||||++|+|++|+.||...+.......+... ..               
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             22334678899999988763  688999999999999999999999776554333222211 10               


Q ss_pred             --CCCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 --RFPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 --~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                        .++.       .....++.+++++|.+||+.||++|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              0110       0113467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-41  Score=338.60  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=205.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEE--EEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v--avK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ++|++.+.||+|+||+||+|.++.++..+  ++|.+...  ........+.+|++++.++.+||||+++++++.+++.+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            46899999999999999999998777654  66665432  234455678889999999966999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          119 LVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      +||||+++++|.+++.+.+                .+++..++.++.|++.||+|||++||+||||||+|||++.++.  
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--  162 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--  162 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--
Confidence            9999999999999997543                4789999999999999999999999999999999999986554  


Q ss_pred             CEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 012203          183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                       +||+|||++.............++..|+|||++.+. ++.++|||||||++|+|++ |..||...+..+..+.+.... 
T Consensus       163 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-  240 (303)
T cd05088         163 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  240 (303)
T ss_pred             -EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence             999999998643221111122346679999998765 7899999999999999998 999998877777666554321 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                        ....+..++.++.+++.+||+.||++||++++++.+
T Consensus       241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              111224578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.7e-42  Score=337.48  Aligned_cols=255  Identities=31%  Similarity=0.490  Sum_probs=210.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~~~  118 (468)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.+...... ......+.+|++++++++ ||||+++++++...  +.+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            4699999999999999999999999999999999765332 222345678999999996 99999999999877  8999


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||++ ++|.+++.... .+++..++.++.||+.||.|||++|++||||||+|||++.++.   +||+|||++.....
T Consensus        83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~---~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc---EEEeecCceeeccC
Confidence            9999996 59999887644 5899999999999999999999999999999999999987654   99999999987654


Q ss_pred             C-CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-----------CC
Q 012203          198 G-QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR-----------FP  263 (468)
Q Consensus       198 ~-~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------~~  263 (468)
                      . .......+++.|+|||++.+.  ++.++|+||||+++|+|++|.+||...........+......           ++
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 233345688999999998763  688999999999999999999999877665554443321100           00


Q ss_pred             ---------------CCCCCC--CCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          264 ---------------SNPWDH--ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       264 ---------------~~~~~~--~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                                     ...+..  +++.+.++|++||+.||++|||+.|+++|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                           000111  58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-41  Score=334.83  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=214.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||+||++.+..+|+.||+|++....  .......+.+|+++++.+. ||||+++++.+...+.+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence            57899999999999999999999999999999987542  2334567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+++++|.+++.+.+.+++..+..++.+++.||.|||+ .+++||||||+||+++.++   .++|+|||++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG---QIKLCDFGVSGELINS-  157 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC---cEEEccCCcccchhhh-
Confidence            9999999999999888889999999999999999999997 5899999999999997654   4999999998754322 


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhccCCCCCCCC
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS-----------RIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~  267 (468)
                      ......|+..|+|||++.+. ++.++|+|||||++|+|++|+.||......           +....+....  .+....
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  235 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLPS  235 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--CCCCCc
Confidence            22345789999999998764 889999999999999999999999764431           2222222211  111112


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..++.++.+|+.+||++||++|||+.|+++|+||.+..
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            34788999999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.4e-41  Score=331.45  Aligned_cols=258  Identities=27%  Similarity=0.495  Sum_probs=218.4

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ...+|...+.||+|++|.||++.++.+++.+++|.+...   .....+.+.+|+.+++++. ||||+++++++...+..+
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~   92 (285)
T cd06648          17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELW   92 (285)
T ss_pred             chHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEE
Confidence            344566678999999999999999989999999988543   2234456788999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +++||++|++|.+++.. +++++..+..++.|++.||+|||++||+||||+|+||+++.++.   ++|+|||++......
T Consensus        93 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~d~g~~~~~~~~  168 (285)
T cd06648          93 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR---VKLSDFGFCAQVSKE  168 (285)
T ss_pred             EEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc---EEEcccccchhhccC
Confidence            99999999999999987 67999999999999999999999999999999999999986554   999999988754332


Q ss_pred             C-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      . ......|++.|+|||.+.+. ++.++|+|||||++|+|++|+.||...+.......+......... ....++..+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~  247 (285)
T cd06648         169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRS  247 (285)
T ss_pred             CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHHH
Confidence            1 22345789999999999875 889999999999999999999999887776666666554322221 12347889999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++.+||..||++||++.++++|+||....
T Consensus       248 li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         248 FLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHHHHcccChhhCcCHHHHccCcccccCC
Confidence            99999999999999999999999997754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=344.82  Aligned_cols=252  Identities=29%  Similarity=0.487  Sum_probs=215.9

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      -|.++.+||+|+||.||+|.++.+|+.+|||.+..+     .+.+++..||.||+++. .|++|++|+.|..+..+||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEeeh
Confidence            478889999999999999999999999999988654     46788999999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          122 ELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||..|++.++++. ++.+++.++..+++..+.||+|||...-||||||..|||++.++.   .||+|||.|..+.... 
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~---AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI---AKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch---hhhhhccccchhhhhHH
Confidence            99999999999965 467999999999999999999999999999999999999987665   8999999998765332 


Q ss_pred             ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSR-IFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ...+.+|||.|||||++.. +|+.++||||||++..||..|++||..-.... ++-.-.+....|.  ....++.++.||
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~--KPE~WS~~F~DF  262 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK--KPEEWSSEFNDF  262 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC--ChHhhhhHHHHH
Confidence            3457899999999999987 79999999999999999999999996543322 1111111112222  124678999999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +++||.++|++|.|+.++++|+|+++.
T Consensus       263 i~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  263 IRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            999999999999999999999999874

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.2e-42  Score=336.54  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=207.7

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|...+.||+|+||.||++.+..+++.+|+|.+.+...  ......+.+|+.++.++.+||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            45667889999999999999999999999999876532  2445678889999999977999999999999999999999


Q ss_pred             eccCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          122 ELCAGGELFHRLE-----KFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       122 E~~~ggsL~~~l~-----~~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      ||+. ++|.++..     ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.   +||+|||++...
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN---IKLCDFGISGQL  158 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc---EEEeecchhHHh
Confidence            9985 46555432     236799999999999999999999975 9999999999999986554   999999999765


Q ss_pred             cCCCccccCCCCCCCcChhhhcCC----CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---c-cCCCCCCCC
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT---A-DLRFPSNPW  267 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~----~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~-~~~~~~~~~  267 (468)
                      ..........|++.|+|||++.+.    ++.++|||||||++|+|++|+.||....  ...+.+..   . ....+...+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEE  236 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcCCCcCC
Confidence            544334455789999999998753    7889999999999999999999996543  22222221   1 122222223


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ..++.++.+|+.+||++||++|||++++++||||+..
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            4588999999999999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-41  Score=332.42  Aligned_cols=249  Identities=24%  Similarity=0.418  Sum_probs=211.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .++|.+.+.||+|+||.||+|.+..     +++.||+|++....  ..+....+.+|+++|+++. ||||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence            3568999999999999999998753     46889999987542  2334578899999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG--------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS  180 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~--------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~  180 (468)
                      ...++||||++|++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997643              3788899999999999999999999999999999999987654


Q ss_pred             CCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 012203          181 SSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV  255 (468)
Q Consensus       181 ~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i  255 (468)
                         +||+|||++........   .....+++.|+|||++.+. ++.++|||||||++|+|++ |..||...+..+..+.+
T Consensus       161 ---~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         161 ---VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             ---EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence               99999999976543221   1233567889999998865 8999999999999999998 99999888888888777


Q ss_pred             HhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          256 RTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       256 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .......+   ...++..+.+++.+||++||++||+++|+++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            75544332   2468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-41  Score=332.76  Aligned_cols=257  Identities=29%  Similarity=0.480  Sum_probs=218.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      ...|+..+.||.|+||.||+|.++.+++.||+|++....  .......+.+|+.+++++. ||||+++++.+.+++.+|+
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence            346888899999999999999999999999999987653  2344567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||||++|++|.+++.. +++++..+..++.|++.||+|||+++++|+||+|+||+++.++.   ++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~---~~l~dfg~~~~~~~~~  155 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC---EEEcccccceeccCCc
Confidence            9999999999999875 57899999999999999999999999999999999999986554   9999999997765432


Q ss_pred             c-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 S-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      . .....++..|+|||++.+. ++.++|+|||||++|+|++|..||...........+....   +......++..+.++
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l  232 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEF  232 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHH
Confidence            1 2234688899999998764 8899999999999999999999998777665554443322   122234678899999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      +.+||..||++||++.+++.|+|+.....
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         233 IDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            99999999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-42  Score=350.35  Aligned_cols=254  Identities=27%  Similarity=0.443  Sum_probs=207.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      ...|+++++||+||.+.||++..- +.+.||+|.+..... .......+.+|+..|.+|++|.+|++|+++-..++++||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            456999999999999999999875 456777776654432 344568899999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKFGRF-SEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l-~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||= ..+|.++|++.... +...++.|+.|++.|+.++|+.||||-||||.|+|+.    .+.+||+|||.|..+...
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCcc
Confidence            99984 67999999886543 3358899999999999999999999999999999997    455999999999988765


Q ss_pred             Cc---cccCCCCCCCcChhhhcC------------CCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccC--
Q 012203          199 QS---LLGTVGSPFYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDAVRTADL--  260 (468)
Q Consensus       199 ~~---~~~~~GT~~Y~APE~l~~------------~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~--  260 (468)
                      ..   ..+.+||+.||+||.+..            +.+.++||||||||||+|+.|++||.... ...-+..|.....  
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            43   245799999999999852            15679999999999999999999995422 2233344444332  


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .||..+   -..++.++++.||..||++||++.++|+|||++-
T Consensus       593 efp~~~---~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  593 EFPDIP---ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cccCCC---CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            444321   1234999999999999999999999999999865

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.2e-42  Score=338.51  Aligned_cols=258  Identities=28%  Similarity=0.492  Sum_probs=215.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .+.|.....||.|+||.||++.+..+++.||||.+...   .......+.+|+.+++++. ||||+++++.+...+..++
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEEE
Confidence            34455567899999999999999999999999998653   2334567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.   ++|+|||++.......
T Consensus        97 v~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kL~dfg~~~~~~~~~  172 (292)
T cd06658          97 VMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR---IKLSDFGFCAQVSKEV  172 (292)
T ss_pred             EEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---EEEccCcchhhccccc
Confidence            9999999999998854 56899999999999999999999999999999999999986654   9999999987653322


Q ss_pred             -ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                       ......|++.|+|||++.+. ++.++|+||||+++|||++|+.||...........+...... .......++..+.++
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  251 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSSVLRGF  251 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-ccccccccCHHHHHH
Confidence             22345789999999998764 889999999999999999999999887766655555433211 111123578899999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      +.+||..||.+|||++++++|+||.....
T Consensus       252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         252 LDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HHHHccCChhHCcCHHHHhhChhhhccCC
Confidence            99999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=341.33  Aligned_cols=260  Identities=28%  Similarity=0.472  Sum_probs=209.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE----  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~----  114 (468)
                      +.++|++.+.||+|++|.||+|.++.+|+.||+|.+....  .......+..|+.++++++ ||||+++++++...    
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES   79 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence            5678999999999999999999999999999999986432  2233456778999999996 99999999987544    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 -DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                       ...|+||||+. ++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~---~kl~dfg~~~  154 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLAR  154 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC---EEECccccee
Confidence             36899999995 588887754 57999999999999999999999999999999999999986555   9999999998


Q ss_pred             eecCCCc----cccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-------
Q 012203          194 YIEPGQS----LLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-------  260 (468)
Q Consensus       194 ~~~~~~~----~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------  260 (468)
                      .......    .....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+.......+.....       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            7543221    233578999999998754  488999999999999999999999977654433322211000       


Q ss_pred             -------------CCC---CC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          261 -------------RFP---SN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       261 -------------~~~---~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                   ..+   ..    .....+.++.+++.+||+.||++|||+.|+++||||.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                         000   00    01245788999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.2e-41  Score=325.64  Aligned_cols=253  Identities=27%  Similarity=0.528  Sum_probs=214.9

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|.+.+.||+|+||.||++.++.+|+.+|+|.+..... .....+.+.+|++++++++ |+||+++++.+.+.+..++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence            58999999999999999999999999999999976543 2234567788999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          122 ELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||+++++|.+++.+..  .+++..+..++.|++.||.|||+++++|+||||+||+++.++.  .+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM--VAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC--eEEecccccchhccCCc
Confidence            9999999999997643  4789999999999999999999999999999999999976533  37999999987765432


Q ss_pred             c-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 S-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      . .....|++.|+|||++.+. ++.++|+||||+++|+|++|..||...+..+....+.......   ....++..+.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHHH
Confidence            2 2234689999999998764 8899999999999999999999998776666555544332211   124678899999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +.+||..+|++|||++|+++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.9e-41  Score=332.30  Aligned_cols=260  Identities=29%  Similarity=0.469  Sum_probs=210.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||+|.++.+|+.||+|.+..... .......+.+|+++++++. ||||+++++++.+.+.+|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence            579999999999999999999999999999999866532 2223456788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||++ ++|.+.+.....  +++..++.++.||+.||+|||++|++||||||+||+++.++  ..+||+|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~--~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC--CEEEEcccccccccCCC
Confidence            99995 588888765443  57888899999999999999999999999999999998543  24899999999765432


Q ss_pred             C-ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--------------
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR--------------  261 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------  261 (468)
                      . ......+++.|+|||++.+.  ++.++|||||||++|+|++|++||...+..+....+......              
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            2 22345678999999998763  788999999999999999999999876654444333211000              


Q ss_pred             ----C---CCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 ----F---PSN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 ----~---~~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                          +   +..    ....+++++.+++.+||+.||++||++.++++|+||.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                0   000    1135688999999999999999999999999999997643

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.4e-41  Score=326.36  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=205.3

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      ......||+|+||.||+|.++.++..|++|.+...   .....+.+.+|+.++++++ |+||+++++++...+..++|||
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEe
Confidence            34446899999999999999999999999998754   2345567889999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          123 LCAGGELFHRLEKF-GRF--SEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       123 ~~~ggsL~~~l~~~-~~l--~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |+++++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++.+  .+.++|+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~--~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC--CCeEEEecchhheecccCC
Confidence            99999999999764 445  788899999999999999999999999999999999753  2359999999987654322


Q ss_pred             -ccccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                       ......|++.|+|||++.+.   ++.++|+||||+++|+|++|+.||............ .............+++++.
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  242 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAK  242 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHH
Confidence             22345689999999998652   788999999999999999999999754332211111 1111111112246788999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +++.+||+.+|.+|||+.|++.||||
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.8e-41  Score=330.57  Aligned_cols=253  Identities=30%  Similarity=0.523  Sum_probs=208.5

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||.|++|.||+|+++.+|+.||+|++.....  ......+.+|+++++++. ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence            48999999999999999999999999999999976532  223456678999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          122 ELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       122 E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~---~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc---EEEeecchhhhhcCC
Confidence            99975 888888654   35899999999999999999999999999999999999986554   999999999765432


Q ss_pred             C-ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---------------
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL---------------  260 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------  260 (468)
                      . ......+++.|++||++.+.  ++.++|+|||||++|+|++|+.||.+.+..+....+.....               
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            1 22345678999999998763  68899999999999999999999987766555444332110               


Q ss_pred             ---CCCCC-------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 ---RFPSN-------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 ---~~~~~-------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                         .++..       ....++..+.+++.+||+.||++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence               00000       012457789999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=357.89  Aligned_cols=256  Identities=36%  Similarity=0.564  Sum_probs=221.6

Q ss_pred             hcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           30 ILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        30 i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      ++.......+.+.|.+...+|.|+|+.|..|.+..+++.+++|++.+..       ....+|+.++.+..+||||+++++
T Consensus       311 il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~  383 (612)
T KOG0603|consen  311 VLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHD  383 (612)
T ss_pred             HhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecc
Confidence            3333444558899999999999999999999999999999999998762       223457888888889999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          110 VYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       110 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                      .+.+..+.|+|||++.|+.|.+.+...+.+. .++..|+++|+.|+.|||++|++||||||+|||++  ++.++++|+||
T Consensus       384 v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyF  460 (612)
T KOG0603|consen  384 VYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYF  460 (612)
T ss_pred             eecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEe
Confidence            9999999999999999999999998766665 78888999999999999999999999999999996  34556999999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccCCCCCCCC
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKS-RIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~  267 (468)
                      |.++.....  ..+.|-|..|.|||++.. +|+.++||||||++||+||+|+.||...... ++...+..+.+.      
T Consensus       461 G~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------  532 (612)
T KOG0603|consen  461 GFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------  532 (612)
T ss_pred             chhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------
Confidence            999987654  445677889999999986 4999999999999999999999999877665 555555554433      


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ..+|+.+++||++||+.||.+|+++.+++.|+|+.+
T Consensus       533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             cccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence            579999999999999999999999999999999933

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.9e-41  Score=329.70  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=211.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ++.|.+.+.||+|++|.||+|.+..     ++..|++|.+....  .......+..|+.+++++. |+||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence            4679999999999999999999987     77899999886542  2333456888999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG-------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      +..++||||++|++|.+++...+       .+++..+..++.||+.||.|||+++++||||||+||+++.++....+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653       48899999999999999999999999999999999999876655669999


Q ss_pred             ecCceeeecCCCcc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 012203          188 DFGLATYIEPGQSL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       188 DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      |||+++........   ....+++.|+|||++.+. ++.++|||||||++|+|++ |+.||...+..+..+.+..... .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR-L  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C
Confidence            99999876332211   122335679999998764 8999999999999999997 9999988877777666544321 1


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                        .....++..+.+++.+||+.||++||++.++++|
T Consensus       241 --~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 --DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              1124678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-41  Score=341.70  Aligned_cols=260  Identities=30%  Similarity=0.455  Sum_probs=213.1

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE----  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~----  114 (468)
                      +.++|.+.+.||+|+||+||+|++..+|+.||+|.+..... .......+..|+.+++++. ||||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence            56789999999999999999999999999999999875422 2233456778999999995 99999999988644    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 -DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                       ..+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.   +||+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~---~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEECcCcccc
Confidence             35899999994 799999988888999999999999999999999999999999999999986554   9999999998


Q ss_pred             eecCC-CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----------
Q 012203          194 YIEPG-QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL----------  260 (468)
Q Consensus       194 ~~~~~-~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------  260 (468)
                      ..... .......++..|+|||.+.+  .++.++|+|||||++|+|++|++||.+.+.......+.....          
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            76543 22344578999999999864  388999999999999999999999977654433332221100          


Q ss_pred             -------------CCC----CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          261 -------------RFP----SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       261 -------------~~~----~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                   ..+    ......+++++.++|++||+.||++|||++++++||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                         000    00124678899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.9e-41  Score=328.45  Aligned_cols=251  Identities=27%  Similarity=0.522  Sum_probs=210.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||++.++.+++.+|+|.+.+...........+.+|+.+++++. ||||+++++++.+++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence            46889999999999999999999999999999887654434445567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          121 MELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |||++|++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEECcchhhhccc
Confidence            999999999998864    345899999999999999999999999999999999999986554   9999999987664


Q ss_pred             CCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK--SRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ... ......|++.|+|||++.+. ++.++|+||||+++|+|++|..||.+...  ....+.+...  .++...+..+++
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence            332 22345789999999999764 88899999999999999999999976543  2333333322  233334456889


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+.+++.+||..||++|||+.+|++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5e-41  Score=329.40  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=208.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      ..++|++.+.||+|++|+||+|.++.     ++..||+|.+....  .......+.+|+.+++++. ||||+++++++.+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence            56789999999999999999998752     35789999986542  2234556889999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCC
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFG----------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP  183 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~  183 (468)
                      .+..++||||+++++|.+++.+..          .+++..+..++.|++.||.|||++|++||||||+||+++.++.   
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~---  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC---
Confidence            999999999999999999997532          2567788999999999999999999999999999999986554   


Q ss_pred             EEEeecCceeeecCCCcc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 012203          184 IKLADFGLATYIEPGQSL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA  258 (468)
Q Consensus       184 ikL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~  258 (468)
                      ++|+|||++.........   ....+++.|+|||++.+. ++.++|+|||||++|||++ |..||.+.+..+..+.+...
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998765432211   123457789999998865 8999999999999999999 79999888877777766554


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       259 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .....   ...+++.+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43221   24678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.7e-41  Score=337.47  Aligned_cols=256  Identities=27%  Similarity=0.496  Sum_probs=215.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ..|.....||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.+. ||||+++++.+..++..|+|
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEE
Confidence            34555668999999999999999999999999986542   223456788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++....... 
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~---~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc---EEEeechhHhhcccccc
Confidence            999999999987755 56899999999999999999999999999999999999987655   9999999987554322 


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ......|++.|+|||++.+. ++.++|+|||||++|+|++|+.||......+....+....... ...+..++..+.++|
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~i  251 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNAHKISPVLRDFL  251 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-ccccCCCCHHHHHHH
Confidence            22346789999999999864 8999999999999999999999998777666665554432221 222356788999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+||+.||.+||+++++++|+||.+..
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         252 ERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhChhhccCC
Confidence            999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.9e-40  Score=318.53  Aligned_cols=253  Identities=33%  Similarity=0.576  Sum_probs=216.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DYVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~~~l  119 (468)
                      +|.+.+.||+|++|.||+|.++.+++.+++|++..... .....+.+.+|+++++++. ||||+++++.+.+.  +.+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence            48899999999999999999999999999999876543 2345678889999999996 99999999999988  89999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ++||+++++|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~  155 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC---EEEcccccEEeccccc
Confidence            9999999999999988888999999999999999999999999999999999999987554   9999999998876554


Q ss_pred             c---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          200 S---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       200 ~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .   .....++..|+|||.+.+. ++.++|+||||+++|+|++|..||.... .......+...  .........++..+
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  233 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHH
Confidence            3   3456789999999999876 8999999999999999999999997765 22222222211  11111224668999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .++|.+||..||++||++.++++||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.2e-41  Score=330.57  Aligned_cols=255  Identities=28%  Similarity=0.477  Sum_probs=203.1

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.....  ......+.+|+++++++. |+||+++++++.+.+..|+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEE
Confidence            3679999999999999999999999999999999876532  122345678999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-
Q 012203          120 VMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-  197 (468)
                      ||||+. ++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||+++.... 
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~Dfg~~~~~~~~  156 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIP  156 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc---EEEeccccccccCCC
Confidence            999995 677776654 356788899999999999999999999999999999999986554   99999999876432 


Q ss_pred             CCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHh-ccC-------------
Q 012203          198 GQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKS-RIFDAVRT-ADL-------------  260 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~-~~~-------------  260 (468)
                      ........+++.|+|||++.+  .++.++|+|||||++|+|++|+.||...... +.+..+.. ...             
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            222334568999999999875  3788999999999999999999999754431 22211111 000             


Q ss_pred             C-----C----CC---CCCC--CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 R-----F----PS---NPWD--HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 ~-----~----~~---~~~~--~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .     +    +.   ..+.  ..+..+.+++.+||..||++|||++|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0     0    00   0011  135689999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=350.07  Aligned_cols=242  Identities=26%  Similarity=0.406  Sum_probs=209.2

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      +++++.||+|.||.||+|..+ ....||+|.++...+    ....+.+|+++|++|+ |+|||++++++..++.+|||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEEEE
Confidence            555789999999999999986 345899999976533    2356779999999997 9999999999999889999999


Q ss_pred             ccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          123 LCAGGELFHRLEK--FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       123 ~~~ggsL~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |++.|+|.++|+.  ...+.......++.||++|++||+++++|||||-..||||+.+.   .+||+|||+|+....+..
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~---~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL---VVKISDFGLARLIGDDEY  358 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc---eEEEcccccccccCCCce
Confidence            9999999999987  46699999999999999999999999999999999999997655   499999999996554443


Q ss_pred             cccC--CCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          201 LLGT--VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       201 ~~~~--~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      ....  --...|.|||.+.. .++.|+|||||||+||||+| |+.||.+++..++++.+.++ .++|..  ..+|+++.+
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-yRlp~P--~~CP~~vY~  435 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-YRLPRP--EGCPDEVYE  435 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-CcCCCC--CCCCHHHHH
Confidence            2221  22345999999986 59999999999999999998 99999999999999998877 445543  579999999


Q ss_pred             HHHHccccCCCCCCCHHHHH
Q 012203          277 LVMGMLSTDPSQRLTARQVL  296 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL  296 (468)
                      +++.||..+|++|||++.+.
T Consensus       436 lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  436 LMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHhhCCcccCCCHHHHH
Confidence            99999999999999998765

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.2e-41  Score=329.51  Aligned_cols=255  Identities=28%  Similarity=0.463  Sum_probs=216.3

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      +-|++.+.||.|+||.||+|.+..+++.+|+|++....  .......+.+|+.+++++. ||||+++++.+.+++.+|+|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence            44788899999999999999999899999999986543  2234567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||+++++|.+++.. ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++.   ++|+|||++....... 
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~---~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC---EEEeecccceecccchh
Confidence            999999999999875 56899999999999999999999999999999999999986554   9999999987764332 


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ......|+..|+|||.+.+. ++.++|+|||||++|+|++|..||...........+.....   ......++.++.+++
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i  233 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFV  233 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHH
Confidence            12345688999999998764 78899999999999999999999987766555555433321   112246788999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+||+.+|.+||++.++++||||.+..
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         234 EACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhhhh
Confidence            999999999999999999999997754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.5e-41  Score=330.47  Aligned_cols=248  Identities=22%  Similarity=0.390  Sum_probs=209.5

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      +..|.+.+.||+|+||.||++.+.     .++..+|+|.+...   .......+.+|+++++++. ||||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence            456999999999999999999863     34567899988654   3344567889999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG-------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~-------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~  181 (468)
                      +.+++||||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+|||++.++. 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~-  158 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-  158 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence            99999999999999999997643             3899999999999999999999999999999999999986554 


Q ss_pred             CCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 012203          182 SPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR  256 (468)
Q Consensus       182 ~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~  256 (468)
                        +||+|||++........   .....+++.|+|||++.+. ++.++|+|||||++|+|++ |..||......+....+.
T Consensus       159 --~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         159 --VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             --EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence              99999999986543221   1233457789999999865 8999999999999999998 999998888777777776


Q ss_pred             hccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       257 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .......   ...++.++.+++.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6543211   2467889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-40  Score=327.92  Aligned_cols=258  Identities=30%  Similarity=0.483  Sum_probs=210.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~~~~~  118 (468)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+....  .......+.+|+++++++. ||||++++++|.+  .+.+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEE
Confidence            47999999999999999999999999999999987653  2244567889999999996 9999999999864  44799


Q ss_pred             EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          119 LVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.   ++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~---~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe---EEEeecccccc
Confidence            99999999999888753    345899999999999999999999999999999999999986554   99999999876


Q ss_pred             ecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhccC-CCCCCCC
Q 012203          195 IEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT-----KSRIFDAVRTADL-RFPSNPW  267 (468)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~-~~~~~~~  267 (468)
                      ..... .....++..|+|||.+.+. ++.++|+|||||++|+|++|+.||....     ..+....+..... ..+....
T Consensus       155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            54322 2245678899999998764 8999999999999999999999997652     2333333333211 1111111


Q ss_pred             --CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          268 --DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       268 --~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                        ..+++.+.++|.+||..||++|||+.|++.|+||+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence              23567899999999999999999999999999996644

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-40  Score=319.56  Aligned_cols=252  Identities=28%  Similarity=0.536  Sum_probs=219.3

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||.|++|.||++.+..+++.|++|++..... .......+..|++++++++ |||++++.+.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence            58999999999999999999998999999999976543 2345667889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          122 ELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       122 E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||+++++|.+++...    ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.   ++|+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~---~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc---EEECCccceeeccc
Confidence            999999999999764    67999999999999999999999999999999999999986554   99999999987654


Q ss_pred             CC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .. ......|++.|+|||.+.+. ++.++|+||+|+++|+|++|+.||...+..+....+........   ...++..+.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence            33 23345789999999998765 88999999999999999999999988777776666654432211   136789999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +++.+||..||++|||+.++++||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7e-41  Score=332.40  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=206.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCc--EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGE--VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~--~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ++|++.+.||+|+||.||+|.++.++.  .+++|.+...  ......+.+.+|++++.++.+||||+++++++.+.+.+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            679999999999999999999987765  4688877532  233445678889999999966999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          119 LVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      ++|||+++++|.+++.+..                .+++..++.++.|++.||+|||++||+||||||+|||++.++.  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--  157 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--  157 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--
Confidence            9999999999999997642                4788999999999999999999999999999999999986554  


Q ss_pred             CEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 012203          183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                       +||+|||++..............+..|+|||++.+. ++.++|||||||++|||++ |..||......+..+.+.... 
T Consensus       158 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-  235 (297)
T cd05089         158 -SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  235 (297)
T ss_pred             -EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-
Confidence             999999998643221111122335579999998765 8999999999999999997 999998888877777665432 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+  ....++..+.+|+.+||+.||.+||+++++++.
T Consensus       236 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RME--KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111  224688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-40  Score=322.17  Aligned_cols=251  Identities=28%  Similarity=0.558  Sum_probs=211.3

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|.+.............+.+|+++++++. |+||+++++.+.+.+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence            57999999999999999999999999999999987654444445678889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          121 MELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |||+++++|..++...    ..+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~---~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV---VKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc---EEEeccceeeecc
Confidence            9999999999998642    45899999999999999999999999999999999999987655   9999999988654


Q ss_pred             CCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT--KSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ... ......|++.|+|||++.+. ++.++|+|||||++|+|++|+.||....  ..+..+.+....  ++..+...++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhhcCH
Confidence            332 22345789999999998765 8999999999999999999999996543  223444443332  22223346788


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9e-41  Score=333.14  Aligned_cols=257  Identities=29%  Similarity=0.474  Sum_probs=215.4

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|+||.||++.+..+|+.||+|.+.............+.+|+++++++. ||||+++++++.+.+..|
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeEE
Confidence            4567999999999999999999999999999999987654444455567889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.   ++|+|||++.....
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~---~kL~dfg~~~~~~~  167 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT---VKLADFGSASLVSP  167 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC---EEEeecCcceecCC
Confidence            9999996 577777654 456899999999999999999999999999999999999986554   99999999976543


Q ss_pred             CCccccCCCCCCCcChhhhc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      .   ....|++.|+|||++.    +.++.++||||||+++|+|++|+.||...+.......+....  .+......+++.
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  242 (307)
T cd06607         168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLSSNDWSDY  242 (307)
T ss_pred             C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--CCCCCchhhCHH
Confidence            2   3457889999999874    237889999999999999999999998776555444333221  122222457889


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +.++|.+||..||++||++.+++.|+|+....
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            99999999999999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3e-41  Score=340.95  Aligned_cols=261  Identities=27%  Similarity=0.459  Sum_probs=213.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE----eC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE----DE  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~----~~  114 (468)
                      +.++|++.+.||.|++|.||+|.++.+|+.||+|++..... .......+.+|+.+|+++. ||||+++++++.    ..
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence            45789999999999999999999999999999999876532 2234566778999999996 999999999886    34


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      ..+++||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++..
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~dfg~~~~  156 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE---LRIGDFGMARG  156 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEeccccccee
Confidence            57899999995 699999987788999999999999999999999999999999999999987655   99999999977


Q ss_pred             ecCCC-----ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-------
Q 012203          195 IEPGQ-----SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-------  260 (468)
Q Consensus       195 ~~~~~-----~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------  260 (468)
                      .....     ......|+..|+|||++.+  .++.++|||||||++|+|++|+.||.+.+.......+.....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            64322     1234578999999999865  388999999999999999999999977665433332221100       


Q ss_pred             -------------CCC---CCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 -------------RFP---SNP----WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 -------------~~~---~~~----~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                   .++   ...    ....+.++.++|++||+.||++||++.+++.||||.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence                         011   111    235688999999999999999999999999999997644

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-41  Score=327.48  Aligned_cols=253  Identities=31%  Similarity=0.492  Sum_probs=211.1

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CEEEEE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DYVHLV  120 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~~~lV  120 (468)
                      |++.+.||.|++|.||+|.+..+|+.+|+|++.... ........+.+|+++++++. |||++++++++.+.  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence            788999999999999999999999999999998764 22333456788999999996 99999999999988  899999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||++ ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.   +||+|||++.......
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~---~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRN  154 (287)
T ss_pred             ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC---EEEccccceeeccCCC
Confidence            99996 4899888765 57999999999999999999999999999999999999987655   9999999998765443


Q ss_pred             --ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC---------
Q 012203          200 --SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP---------  266 (468)
Q Consensus       200 --~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------  266 (468)
                        ......++..|+|||.+.+  .++.++||||||+++|+|++|+.||...+.......+...........         
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              2334567889999998765  378999999999999999999999988776655555443211111000         


Q ss_pred             -----------------CCC-CCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          267 -----------------WDH-ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       267 -----------------~~~-~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                                       ... ++..+.+++.+||..||.+||++.++++|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                             012 38889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.2e-40  Score=316.72  Aligned_cols=251  Identities=31%  Similarity=0.531  Sum_probs=214.8

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|.+.+.||+|++|.||++.+..+++.+++|++.....   .....+.+|+++++++. |+||+++++.+..++..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence            48899999999999999999998999999999976532   35678889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          122 ELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       122 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      ||++|++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.   ++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe---EEEeecccccccccccc
Confidence            999999999999876 57999999999999999999999999999999999999986554   99999999987765443


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      .....|+..|+|||.+.+. ++.++|+||||+++|+|++|+.||...+.......+........ .....++..+.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHHHHH
Confidence            4456789999999999865 78899999999999999999999987654444444333222111 111234889999999


Q ss_pred             HccccCCCCCCCHHHHHhCcC
Q 012203          280 GMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       280 ~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      +||+.||++|||+.|+++|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=330.10  Aligned_cols=253  Identities=31%  Similarity=0.512  Sum_probs=208.1

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |++.+.||.|++|.||+|.++.+|+.||+|++..+.. .......+.+|+++++++. ||||+++++++.+.+..|++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence            6788999999999999999999999999999876532 2223356778999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          123 LCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |+ +++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.++.   ++|+|||++....... 
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA---LKLADFGLARAFGVPVR  154 (283)
T ss_pred             cc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc---EEEeecccccccCCCcc
Confidence            99 469999998765  6899999999999999999999999999999999999987554   9999999997654322 


Q ss_pred             ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----------------
Q 012203          200 SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-----------------  260 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  260 (468)
                      ......+++.|+|||++.+.  ++.++|+||||+++|+|++|++||...+.......+.....                 
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            22334678899999988653  68899999999999999999999987665433332221100                 


Q ss_pred             -CCC-------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 -RFP-------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 -~~~-------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                       .++       ......++..+.++|.+||+.||.+|||++|+++|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence             000       11124577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.5e-42  Score=334.52  Aligned_cols=256  Identities=29%  Similarity=0.460  Sum_probs=214.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+++++++. ||||+++++.+..++.+|+
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEE
Confidence            345777889999999999999999899999999987553  2234567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.   ++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~---~~l~dfg~~~~~~~~~  155 (277)
T cd06642          80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC---EEEccccccccccCcc
Confidence            9999999999998865 56899999999999999999999999999999999999986554   9999999997655332


Q ss_pred             c-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 S-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      . .....|+..|+|||.+.+. ++.++|+|||||++|+|++|+.||...........+....   +......++.++.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l  232 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFKEF  232 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC---CCCCCcccCHHHHHH
Confidence            1 2234688999999999875 8889999999999999999999997665555444333222   111224578899999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      |.+||+.+|++||++.++++|+|+....
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            9999999999999999999999986543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-41  Score=334.43  Aligned_cols=258  Identities=28%  Similarity=0.462  Sum_probs=204.7

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcC--CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKF--TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DYV  117 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~--~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~~  117 (468)
                      +|++.+.||+|++|.||+|.++.  +++.||+|.+.............+.+|+.+++++. ||||+++++++.+.  +.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            58999999999999999999988  89999999998753222233456778999999996 99999999999988  889


Q ss_pred             EEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC-CCCEEEeecCc
Q 012203          118 HLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS-SSPIKLADFGL  191 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~-~~~ikL~DFGl  191 (468)
                      ++||||++ ++|.+.+...     ..+++..++.++.|++.||.|||+++|+||||||+||+++.++. .+.+||+|||+
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            99999996 4777776432     26899999999999999999999999999999999999987222 45599999999


Q ss_pred             eeeecCCCc----cccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHH
Q 012203          192 ATYIEPGQS----LLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSR---------IFDAVR  256 (468)
Q Consensus       192 a~~~~~~~~----~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~---------~~~~i~  256 (468)
                      +........    ....++++.|+|||++.+.  ++.++|+|||||++|+|++|++||.......         ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            987543221    2345789999999988763  7899999999999999999999997654321         011100


Q ss_pred             h------------------------c--cCCCCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          257 T------------------------A--DLRFPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       257 ~------------------------~--~~~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .                        .  ...++.       ..+...+..+.+++.+||+.||++|||+.|+++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            0                        0  000110       0012567789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=322.31  Aligned_cols=254  Identities=28%  Similarity=0.492  Sum_probs=212.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC--CChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~--~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~  116 (468)
                      ..|++.+.||+|++|.||+|.++.+++.||+|.+.....  ........+.+|++++++++ ||||+++++++.+.  +.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            579999999999999999999999999999998854321  12334567889999999996 99999999998764  56


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++++|||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~  157 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEECccccccccc
Confidence            8999999999999999988788999999999999999999999999999999999999986554   9999999998654


Q ss_pred             CC----CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          197 PG----QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       197 ~~----~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ..    .......|+..|+|||++.+. ++.++|+|||||++|+|++|+.||...........+.....  +......++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~  235 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS  235 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence            21    122345789999999999875 88999999999999999999999987655544443332221  122235788


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +.+.+++.+||+ +|.+||++.+++.|||.
T Consensus       236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=317.89  Aligned_cols=252  Identities=34%  Similarity=0.594  Sum_probs=217.2

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||+|++|.||++.++.+++.|++|.+...... ......+.+|+++++++. |||++++++++.+.+.++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence            589999999999999999999999999999999876432 345678899999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc-
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-  200 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-  200 (468)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++   .++|+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG---VVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC---CEEEeccccceecCCCccc
Confidence            9999999999998888899999999999999999999999999999999999998644   499999999987764432 


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      .....++..|+|||.+.+. ++.++|+||||+++|+|++|..||...........+....  .+ .....+++.+.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HP-PLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--CC-CCCCCCCHHHHHHHH
Confidence            2345789999999998764 7889999999999999999999997765444333332221  11 122567899999999


Q ss_pred             HccccCCCCCCCHHHHHhCcCC
Q 012203          280 GMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       280 ~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +||..+|++|||+.+++.|+||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-42  Score=352.12  Aligned_cols=261  Identities=34%  Similarity=0.511  Sum_probs=227.3

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      +..|..++.||-|+||.|.+++..+|+..||.|.+.|..+...+....++.|..||... +++-||+||..|++++.+|+
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEE
Confidence            34689999999999999999999999999999999988777777788899999999988 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec---
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE---  196 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~---  196 (468)
                      ||+|++||++..+|-+-+-|.|..+++|+..+..|+++.|+.|+|||||||+|||||.+|+   |||+||||+..+.   
T Consensus       707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH---IKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc---eeeeeccccccceecc
Confidence            9999999999999999899999999999999999999999999999999999999998766   9999999985432   


Q ss_pred             ------CCC----------------------------------ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHH
Q 012203          197 ------PGQ----------------------------------SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYI  235 (468)
Q Consensus       197 ------~~~----------------------------------~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~e  235 (468)
                            .+.                                  .....+||+.|+|||++.. +|+.-+||||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                  110                                  0012379999999999976 69999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHHhCcCCCCCC
Q 012203          236 LLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSWMGDGI  305 (468)
Q Consensus       236 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~eiL~h~~~~~~~  305 (468)
                      |+.|++||...+.-+....+.+-...+...+...+++++.+||.+++. +++.|+.   ++|+..||||+...
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence            999999998888776666555544444445557899999999998776 6888884   78899999998754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-40  Score=322.51  Aligned_cols=245  Identities=24%  Similarity=0.394  Sum_probs=207.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||++.++ ++..+|+|.+.....    ....+.+|+++++++. ||||+++++++.+.+.+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence            45899999999999999999886 456899998865432    2356788999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+++.++.   +||+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV---VKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe---EEECCCCCccccCCCc
Confidence            9999999999999753 56899999999999999999999999999999999999986554   9999999987654332


Q ss_pred             cc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          200 SL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       200 ~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ..  ....++..|+|||++.+. ++.++|+||||+++|+|++ |+.||...+..+....+........   ....+..+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHH
Confidence            22  223456689999998764 8999999999999999999 9999988887777777766543221   135678999


Q ss_pred             HHHHHccccCCCCCCCHHHHHh
Q 012203          276 DLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +++.+||..||++||+++++++
T Consensus       232 ~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         232 EVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9e-41  Score=329.75  Aligned_cols=257  Identities=28%  Similarity=0.539  Sum_probs=214.2

Q ss_pred             CeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCC-ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~-~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .|++.+.||.|+||.||+|++.   .+|+.||+|++...... .....+.+.+|+++++++.+|+||+++++.++.++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999885   47899999998764322 1223466788999999997799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++   .+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC---CEEEeeCccceeccc
Confidence            99999999999999998888899999999999999999999999999999999999998655   499999999987643


Q ss_pred             CC--ccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccCCCCCCCCC
Q 012203          198 GQ--SLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       198 ~~--~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ..  ......|+..|+|||.+.+   .++.++|+||||+++|+|++|..||.....    .++.+.+......++    .
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~  233 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----Q  233 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----c
Confidence            22  2234578999999999874   367899999999999999999999964322    333333333332222    4


Q ss_pred             CCCHHHHHHHHHccccCCCCCC-----CHHHHHhCcCCCCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRL-----TARQVLDHSWMGDGI  305 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rp-----t~~eiL~h~~~~~~~  305 (468)
                      .++..+.+++.+||+.||++|+     +++++++||||....
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            5788999999999999999997     899999999997643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-40  Score=323.07  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=209.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .+|.+.+.||+|++|.||+|.++.+++.+|+|++..+.    .....+.+|+++++++. ||||+++++++..++.+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEE
Confidence            45999999999999999999999999999999987542    23467888999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.   +||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc---EEeCCCccccccccc
Confidence            9999999999999764  35889999999999999999999999999999999999976554   999999999876543


Q ss_pred             Ccc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          199 QSL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       199 ~~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      ...  ....+++.|+|||.+.+. ++.++|||||||++|+|++ |..||.+.+..+....+....   .......++.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPPKV  234 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHH
Confidence            221  122346679999998764 8899999999999999998 999998888777777665432   112225688999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHh
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+++.+||..||++||++.++++
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-40  Score=327.00  Aligned_cols=249  Identities=23%  Similarity=0.358  Sum_probs=208.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEc----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDK----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      .+|++.+.||+|+||+||+|.+.    .+++.+++|.+....  .......+.+|++++++++ ||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            46899999999999999999853    456889999987532  3344567889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          117 VHLVMELCAGGELFHRLEKF-----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      .|+||||+++++|.+++...                 ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            99999999999999998532                 2377888999999999999999999999999999999998655


Q ss_pred             CCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 012203          180 SSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA  254 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~  254 (468)
                      .   +||+|||+++......   ......++..|+|||++.+. ++.++|+|||||++|||++ |..||.+.....+.+.
T Consensus       162 ~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         162 H---VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             c---EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            4   9999999998764332   12334567789999998764 8999999999999999998 9999988777666666


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +...... +  ....++..+.+++.+||++||.+||++.+++++
T Consensus       239 ~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLL-P--CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6554322 1  225688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.7e-41  Score=336.92  Aligned_cols=263  Identities=29%  Similarity=0.499  Sum_probs=214.4

Q ss_pred             cccCCeEE-EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh-----------hHHHHHHHHHHHHHhcCCCCce
Q 012203           38 NLRERFVL-GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID-----------DERSVKLEIEIMTRLSGHPNVV  105 (468)
Q Consensus        38 ~l~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~-----------~~~~~~~Ei~iL~~L~~HpnIv  105 (468)
                      .+.++|.. .+.||.|+||+||+|.++.+++.||+|++.........           ....+.+|+++++++. ||||+
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv   83 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIM   83 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cccee
Confidence            46778875 57799999999999999999999999998764322110           0124678999999996 99999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEE
Q 012203          106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       106 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                      ++++++...+..++||||+. |+|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~---~k  159 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CK  159 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC---EE
Confidence            99999999999999999996 699999988888999999999999999999999999999999999999986554   99


Q ss_pred             EeecCceeeecC---------------CCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 012203          186 LADFGLATYIEP---------------GQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK  248 (468)
Q Consensus       186 L~DFGla~~~~~---------------~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~  248 (468)
                      |+|||++.....               ........+++.|+|||++.+.  ++.++|+|||||++|+|++|++||...+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999976541               1112234578899999998763  68899999999999999999999988776


Q ss_pred             HHHHHHHHhccCCCCCC------------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          249 SRIFDAVRTADLRFPSN------------------------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       249 ~~~~~~i~~~~~~~~~~------------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      .+.+..+..........                        .....+.++.++|.+||+.||++||+++|++.|+||+..
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            66555443311100000                        012457889999999999999999999999999999765


Q ss_pred             C
Q 012203          305 I  305 (468)
Q Consensus       305 ~  305 (468)
                      .
T Consensus       320 ~  320 (335)
T PTZ00024        320 P  320 (335)
T ss_pred             C
Confidence            4

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=345.38  Aligned_cols=263  Identities=26%  Similarity=0.360  Sum_probs=211.6

Q ss_pred             hhhhcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCcee
Q 012203           27 AETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD  106 (468)
Q Consensus        27 ~~~i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~  106 (468)
                      ....|+..++...++.|.-.+.||+|+||.||+|... +|..||||.+.......   ..+|.+|+++|.+++ |||+|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~  135 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVK  135 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCccc
Confidence            5557889999999999999999999999999999986 45999999876553211   456999999999997 999999


Q ss_pred             eeEEEEeCC-EEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---cEecccCCCcEEEeecCC
Q 012203          107 LKAVYEDED-YVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIG---VVHRDLKPENILLATKAS  180 (468)
Q Consensus       107 l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~g---IiHrDIKp~NILl~~~~~  180 (468)
                      |+|+|.+.+ ..+||+||+++|+|.++|....  .++|....+|+.+++.||+|||+..   ||||||||+|||||.+.+
T Consensus       136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            999999888 5999999999999999997755  8999999999999999999999853   999999999999997776


Q ss_pred             CCCEEEeecCceeeecC-CCccccC-CCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHH-
Q 012203          181 SSPIKLADFGLATYIEP-GQSLLGT-VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFD-  253 (468)
Q Consensus       181 ~~~ikL~DFGla~~~~~-~~~~~~~-~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~-  253 (468)
                         .||+|||+|+.... .....+. .||.+|+|||++.. ..+.|+|||||||++.||++|+.+.....   ...+.+ 
T Consensus       216 ---aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  216 ---AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             ---EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence               99999999976554 3333333 89999999999975 48999999999999999999998886432   111111 


Q ss_pred             ---HHHhcc------CCCCCCCCC--CCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          254 ---AVRTAD------LRFPSNPWD--HISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       254 ---~i~~~~------~~~~~~~~~--~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                         .+....      ..+......  ..-..+..+..+|++.+|.+||++.|+++
T Consensus       293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence               222211      111101101  12233667889999999999999999864

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-41  Score=356.94  Aligned_cols=264  Identities=26%  Similarity=0.343  Sum_probs=197.7

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCC-cEEEEE--------------EeccCcCCChhhHHHHHHHHHHHHHhcCC
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTG-EVFACK--------------SIAKDRLVTIDDERSVKLEIEIMTRLSGH  101 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vavK--------------~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H  101 (468)
                      ..+.++|++++.||+|+||+||+|..+... ...+.|              .+.+...........+.+|+++|+++. |
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence            446788999999999999999999765332 222222              121111112233456789999999995 9


Q ss_pred             CCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEe
Q 012203          102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLA  176 (468)
Q Consensus       102 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~  176 (468)
                      |||+++++++.+.+..|+|+|++ +++|..++...     .......++.++.||+.||.|||++||+||||||+|||++
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            99999999999999999999998 56777776432     2244667888999999999999999999999999999998


Q ss_pred             ecCCCCCEEEeecCceeeecCCCc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC----hH
Q 012203          177 TKASSSPIKLADFGLATYIEPGQS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT----KS  249 (468)
Q Consensus       177 ~~~~~~~ikL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~----~~  249 (468)
                      .++.   +||+|||++..+.....  ..+.+||+.|+|||++.+. ++.++|||||||++|||++|..++....    ..
T Consensus       302 ~~~~---vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        302 CDGK---IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC---EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            6554   99999999987654322  2346899999999999875 8999999999999999999886543321    12


Q ss_pred             HHHHHHHhcc---CCCCCC------------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          250 RIFDAVRTAD---LRFPSN------------------------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       250 ~~~~~i~~~~---~~~~~~------------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      .+.+.+....   ..++..                        ....++.++.++|.+||++||.+|||+.|+|.||||.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            2222221110   111110                        0113566788999999999999999999999999997


Q ss_pred             CCC
Q 012203          303 DGI  305 (468)
Q Consensus       303 ~~~  305 (468)
                      ...
T Consensus       459 ~~~  461 (501)
T PHA03210        459 AEE  461 (501)
T ss_pred             cCC
Confidence            654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=319.84  Aligned_cols=245  Identities=39%  Similarity=0.734  Sum_probs=216.6

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE  128 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  128 (468)
                      ||.|++|.||++.+..+++.+++|++.+...........+..|+++++++. ||||+++++.++.++..++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            689999999999999899999999998775544456678899999999996 9999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-CccccCCCC
Q 012203          129 LFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGS  207 (468)
Q Consensus       129 L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~GT  207 (468)
                      |.+++.....+++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH---IKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc---EEEeecCcceecccCCCcccCCcCC
Confidence            9999988878999999999999999999999999999999999999986554   999999999876543 234456789


Q ss_pred             CCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCC
Q 012203          208 PFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP  286 (468)
Q Consensus       208 ~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP  286 (468)
                      ..|+|||.+.+. ++.++|+||||+++|+|++|..||...+.....+.+......++    ..++..+.+++++||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCH
Confidence            999999998775 78899999999999999999999988777676777666444444    3568899999999999999


Q ss_pred             CCCCCH---HHHHhCcCC
Q 012203          287 SQRLTA---RQVLDHSWM  301 (468)
Q Consensus       287 ~~Rpt~---~eiL~h~~~  301 (468)
                      ++||++   +++++||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.9e-41  Score=331.07  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=216.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++.+.||+|+||.||++.+..+++.|++|.+....   ....+.+.+|+.+++++. ||||+++++.+...+..
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcE
Confidence            34578999999999999999999999899999999986542   233466788999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~---~kL~dfg~~~~~~~  167 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITP  167 (293)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC---EEEccCcceecccc
Confidence            999999999999999876 45889999999999999999999999999999999999976554   99999999876543


Q ss_pred             CC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .. ......|++.|+|||.+.+. ++.++|+|||||++|+|++|+.||...+.......+.... ......+..++..+.
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  246 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR  246 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHH
Confidence            32 22345789999999998764 8899999999999999999999997665543332222211 111122346788999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++|.+||..+|.+||++.+++.|+||+...
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.9e-40  Score=319.69  Aligned_cols=251  Identities=27%  Similarity=0.487  Sum_probs=217.5

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||.|++|.||++.++.+++.+++|.+.+... .......+..|+++++++. |+||+++++++.+....++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence            58999999999999999999999999999999976543 2344567778999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          122 ELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       122 E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||+++++|.+++.+    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.   +||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~---~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc---EEEeeccchhhhcc
Confidence            99999999999866    356899999999999999999999999999999999999987544   99999999987654


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      . ......|++.|+|||.+.+. ++.++|+||||+++|+|++|+.||...+..+....+.....  +... ..++.++.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY--PPIP-PIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCc-hhhCHHHHH
Confidence            4 33446789999999999775 88899999999999999999999988887766666554432  2222 367889999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ++.+||..+|++||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=323.94  Aligned_cols=254  Identities=31%  Similarity=0.452  Sum_probs=209.1

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEEeCCE----
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYEDEDY----  116 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~~~~~----  116 (468)
                      |++.+.||.|++|.||+|+++.+++.||+|++..... .......+.+|+.++++++  +||||+++++++.+.+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7889999999999999999998899999999975532 2222345667888887775  59999999999988776    


Q ss_pred             -EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          117 -VHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       117 -~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                       ++++|||+. ++|.+++....  .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.   +||+|||++.
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~---~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLAR  155 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC---EEEeccCcce
Confidence             999999996 48999887643  5899999999999999999999999999999999999987654   9999999998


Q ss_pred             eecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----C------
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-----R------  261 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~------  261 (468)
                      ............+++.|+|||++.+. ++.++|+|||||++|+|++|++||......+....+.....     .      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            87655444455688999999999875 88999999999999999999999988776665554432110     0      


Q ss_pred             -----CCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          262 -----FPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       262 -----~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                           ++.       .....++..+.++|.+||+.||++||+++|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                 000       0012356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=351.93  Aligned_cols=274  Identities=28%  Similarity=0.457  Sum_probs=231.7

Q ss_pred             cccccccchhhhhcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHH
Q 012203           18 CKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR   97 (468)
Q Consensus        18 ~~~~~~~s~~~~i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~   97 (468)
                      .-+.+-|++++ +|...+-+.+   |.-++.||.|+||.||.|++..+.+.||||.+.-......+....+..|+..|++
T Consensus         7 ~GslKDPeiA~-LF~k~DPEkl---f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~   82 (948)
T KOG0577|consen    7 PGSLKDPEIAD-LFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQ   82 (948)
T ss_pred             CCCCCCchHHH-HHccCCHHHH---HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHh
Confidence            34455566665 3444443333   4446789999999999999999999999999988776677777889999999999


Q ss_pred             hcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEe
Q 012203           98 LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLA  176 (468)
Q Consensus        98 L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~  176 (468)
                      |+ |||++.|.++|-.+...||||||| -|+-.+++.-+ +++.+.++..|+.+.+.||.|||+++.||||||..|||++
T Consensus        83 l~-HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs  160 (948)
T KOG0577|consen   83 LR-HPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS  160 (948)
T ss_pred             cc-CCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec
Confidence            97 999999999999999999999999 56777887543 5799999999999999999999999999999999999998


Q ss_pred             ecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HH
Q 012203          177 TKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGNTKS-RI  251 (468)
Q Consensus       177 ~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~  251 (468)
                      ..+.   |||+|||.|....+   ..+++|||+|||||++.    |.|+-++||||||++..||.-.++|+..++.. .+
T Consensus       161 e~g~---VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL  234 (948)
T KOG0577|consen  161 EPGL---VKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  234 (948)
T ss_pred             CCCe---eeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH
Confidence            6554   99999999987664   45789999999999985    34999999999999999999999998877754 45


Q ss_pred             HHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       252 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      +..-.+..+.++.   ..+++.++.|+..||++-|.+|||.+++|.|+|.....+
T Consensus       235 YHIAQNesPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  235 YHIAQNESPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             HHHHhcCCCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            5555555555655   467889999999999999999999999999999876543

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-41  Score=337.05  Aligned_cols=259  Identities=30%  Similarity=0.470  Sum_probs=218.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-----E
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-----Y  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-----~  116 (468)
                      +|++.+.||.|++|.||+|++..+|+.||+|.+.... ......+.+..|+++++++. ||||+++++++...+     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence            6999999999999999999999899999999987642 12344567888999999996 999999999998775     8


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||++ ++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.   ++|+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~---~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD---LKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEcccCceEeec
Confidence            999999996 589999988778999999999999999999999999999999999999987654   9999999998876


Q ss_pred             CCC----ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC-----
Q 012203          197 PGQ----SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN-----  265 (468)
Q Consensus       197 ~~~----~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-----  265 (468)
                      ...    ......+++.|+|||++.+.  ++.++|+||||+++|+|++|++||...+..+.+..+.......+..     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543    23455789999999998764  7889999999999999999999998887766655554422111110     


Q ss_pred             ----------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          266 ----------------------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       266 ----------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                            ....++..+.++|.+||++||++||++++++.||||++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                                  01246788999999999999999999999999999977554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=319.77  Aligned_cols=243  Identities=27%  Similarity=0.438  Sum_probs=210.6

Q ss_pred             eEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 012203           47 QQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL  123 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~  123 (468)
                      +.||+|+||.||+|.+...   +..|++|++.....  ....+.+..|++++++++ |+||+++++++.+...+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            4699999999999999866   89999999976532  224678889999999997 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          124 CAGGELFHRLEKF---------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       124 ~~ggsL~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +++++|.+++...         ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~---~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc---EEEcccccccc
Confidence            9999999999875         77999999999999999999999999999999999999987655   99999999987


Q ss_pred             ecCCC---ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          195 IEPGQ---SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       195 ~~~~~---~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      .....   ......+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+..+.+..... .+  ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-LP--KPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC--CCcc
Confidence            66432   2334567889999999886 48999999999999999999 6999998888777777765321 11  1246


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++.++.+++.+||..||++||++.|++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            78999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-40  Score=321.21  Aligned_cols=242  Identities=26%  Similarity=0.363  Sum_probs=201.3

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||+|+++.+++.+|+|.+....  ..+....+.+|+++++++. ||||+++++++...+.+++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence            46999999999999999999999999886542  3344567889999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccc---
Q 012203          127 GELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---  202 (468)
Q Consensus       127 gsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~---  202 (468)
                      ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV---LKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc---EEECccccCcccccccccccCC
Confidence            9999999764 35899999999999999999999999999999999999986554   9999999987654321111   


Q ss_pred             cCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHH
Q 012203          203 GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG  280 (468)
Q Consensus       203 ~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  280 (468)
                      ...++..|+|||.+.++ ++.++|+|||||++|+|++ |..||...........+.... ..  ......+..+.+++.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-RL--PCPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CC--CCcccCCHHHHHHHHH
Confidence            11224569999998765 8999999999999999997 999997776666555554431 11  1224678999999999


Q ss_pred             ccccCCCCCCCHHHHHh
Q 012203          281 MLSTDPSQRLTARQVLD  297 (468)
Q Consensus       281 ~L~~dP~~Rpt~~eiL~  297 (468)
                      ||++||++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-40  Score=327.70  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=208.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCC----------------cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTG----------------EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN  103 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g----------------~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn  103 (468)
                      .++|++++.||+|+||.||+|.+...+                ..||+|.+....  .......+.+|++++++++ |||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence            467999999999999999999886544                568999987653  2345677889999999996 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203          104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-----------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus       104 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      |+++++++..++.++++|||+++++|.+++.+..           .+++..++.++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999998765           68999999999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS--GMPPFWGN  246 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt--G~~Pf~~~  246 (468)
                      |+++.++.   ++|+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++  |..||...
T Consensus       161 ili~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         161 CLVGKNYT---IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eeecCCCc---eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            99987644   99999999986543321   123456788999999876 48999999999999999998  78898776


Q ss_pred             ChHHHHHHHHhc----cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          247 TKSRIFDAVRTA----DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       247 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +....++.+...    ...........++.++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            666665555432    111111112356789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-40  Score=336.32  Aligned_cols=263  Identities=27%  Similarity=0.430  Sum_probs=215.7

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .+-.+.++|++.+.||+|++|.||++.+..+|+.||+|++.+.. ........+.+|+++++++. ||||+++++++...
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   86 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPD   86 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCC
Confidence            34558899999999999999999999999999999999986542 22233456788999999996 99999999999765


Q ss_pred             C------EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          115 D------YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       115 ~------~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      .      .+++||||+ |++|..++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   ++|+|
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~---~kl~d  161 (343)
T cd07880          87 LSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE---LKILD  161 (343)
T ss_pred             ccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEee
Confidence            4      468999998 7899888864 57999999999999999999999999999999999999986554   99999


Q ss_pred             cCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---
Q 012203          189 FGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP---  263 (468)
Q Consensus       189 FGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---  263 (468)
                      ||++.....  ......+++.|+|||++.+  .++.++|+|||||++|+|++|+.||...+.......+.......+   
T Consensus       162 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         162 FGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            999986543  2334578999999999876  378899999999999999999999987665444433322211110   


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          264 ------------------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       264 ------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                              ...+..++..+.++|.+||..||.+|||+.+++.||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                                    0112457888999999999999999999999999999977543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3e-40  Score=326.20  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=209.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++++. ||||+++++++.+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSK   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence            35689999999999999999997652     35589999886542  2333456788999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCC
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFG----------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP  183 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~  183 (468)
                      .+..|+||||+++|+|.+++.+.+          .++...+..++.|++.||.|||++||+||||||+|||++.++.   
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~---  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc---
Confidence            999999999999999999997532          2456778899999999999999999999999999999986554   


Q ss_pred             EEEeecCceeeecCCCcc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 012203          184 IKLADFGLATYIEPGQSL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA  258 (468)
Q Consensus       184 ikL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~  258 (468)
                      ++|+|||+++........   ....++..|+|||.+.++ ++.++|+|||||++|||++ |..||.+....+..+.+...
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG  237 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998765432211   122456789999998765 8999999999999999998 89999888877777666544


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh------CcCCCC
Q 012203          259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD------HSWMGD  303 (468)
Q Consensus       259 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~------h~~~~~  303 (468)
                      .....   ....++.+.+++.+||+.||++|||+.++++      ||||..
T Consensus       238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         238 GYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            32111   1356789999999999999999999999987      888865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.2e-40  Score=363.43  Aligned_cols=253  Identities=27%  Similarity=0.387  Sum_probs=206.3

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..+........+.+.+|+++++++. ||||+++++++.+++..|+|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            58999999999999999999999999999999997654333444567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          121 MELCAGGELFHRLEKF-----------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-----------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                      |||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.++.   +||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~---vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC---EEEEec
Confidence            9999999999998642           23456678889999999999999999999999999999987655   999999


Q ss_pred             CceeeecCCC-------------------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 012203          190 GLATYIEPGQ-------------------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS  249 (468)
Q Consensus       190 Gla~~~~~~~-------------------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~  249 (468)
                      |+++......                   .....+||+.|+|||++.+. ++.++|||||||++|||++|+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9998762110                   01124799999999999875 899999999999999999999999775544


Q ss_pred             HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          250 RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .......... .....++..+++.+.+++.+||..||++|++..+.+.+
T Consensus       238 ki~~~~~i~~-P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVILS-PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhccC-hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4332211111 11112335788999999999999999999876665543

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-40  Score=321.61  Aligned_cols=249  Identities=24%  Similarity=0.404  Sum_probs=209.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ++|++.+.||+|+||+||+|.++.+   ...||+|.+....  .......+.+|+.+++++. ||||+++++++.+.+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            5699999999999999999998654   4589999886543  2334567888999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.   ++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~---~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC---EEECccchhhccc
Confidence            9999999999999999764 47899999999999999999999999999999999999986554   9999999998765


Q ss_pred             CCCc-c--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          197 PGQS-L--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       197 ~~~~-~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      .... .  ....+++.|+|||.+.+. ++.++||||||+++|+|++ |..||......+..+.+..... .+.  ...++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR-LPP--PMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-CCC--CCCCC
Confidence            2211 1  123456789999998864 8999999999999999998 9999988887777777665422 221  24678


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.+.+++.+||+.||++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-40  Score=327.61  Aligned_cols=257  Identities=26%  Similarity=0.369  Sum_probs=213.4

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCC-----CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeee
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFT-----GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK  108 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~  108 (468)
                      .+...-.++|++.+.||+|+||.||++.++..     ...+|+|.+....  .......+.+|+++++++.+|+||++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34555667899999999999999999988643     3789999987642  2334567888999999995699999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203          109 AVYEDEDYVHLVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus       109 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      +++..++.++++|||+++|+|.+++...                +.+++..+..++.|++.||.|||++||+||||||+|
T Consensus        83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence            9999999999999999999999999642                458899999999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNT  247 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~  247 (468)
                      ||++.++.   +||+|||+++.+.....   .....++..|+|||++.+. ++.++|||||||++|+|++ |..||....
T Consensus       163 il~~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         163 VLVTEDHV---MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             EEEcCCCe---EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            99976554   99999999987654321   1122356779999998764 8999999999999999997 999998888


Q ss_pred             hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+..+.+..... ..  .....+..+.+|+.+||..||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         240 VEELFKLLKEGYR-ME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHHHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            7777776654432 11  224678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=323.52  Aligned_cols=250  Identities=23%  Similarity=0.312  Sum_probs=209.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCC-----CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFT-----GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      ..++|.+.+.||+|+||.||++.++..     +..||+|.+....  .......+.+|+.+++++. ||||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~   80 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVST   80 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcC
Confidence            356899999999999999999998644     4889999986542  2344567888999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCC
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFG----------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP  183 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~  183 (468)
                      ....++||||+++|+|.+++....          .+++..+..++.|++.||.|||++||+||||||+|||++.++.   
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~---  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT---  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC---
Confidence            999999999999999999996532          3677889999999999999999999999999999999987665   


Q ss_pred             EEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 012203          184 IKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA  258 (468)
Q Consensus       184 ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~  258 (468)
                      +||+|||+++.......   .....++..|+|||.+.+. ++.++|||||||++|||++ |..||...+..+..+.+...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG  237 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence            99999999876543321   2234567889999998764 8999999999999999998 99999888887777777633


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       259 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..  +. ....++..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~--~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 GH--LD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CC--CC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22  11 12456899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.8e-41  Score=338.42  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=202.4

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-  113 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-  113 (468)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|++....  .......+..|+++++++.+|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            3579999999999999999997543     45789999986542  233456678899999999669999999998764 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc---------------------------------------------------------
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF---------------------------------------------------------  136 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------------  136 (468)
                      ...++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            46789999999999999998542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCC
Q 012203          137 ----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPF  209 (468)
Q Consensus       137 ----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~  209 (468)
                          ..+++..+..++.||+.||+|||++||+||||||+|||++.++.   ++|+|||++..+.....   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~---vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc---EEEeccccchhcccCcchhhccCCCCCcc
Confidence                25788899999999999999999999999999999999986554   99999999987643221   122345678


Q ss_pred             CcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCC
Q 012203          210 YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPS  287 (468)
Q Consensus       210 Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~  287 (468)
                      |+|||++.+. ++.++|||||||++|||++ |..||.+....+.+............  ....++++.+++.+||+.+|+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence            9999998765 8999999999999999998 99999775543333222222222211  145788999999999999999


Q ss_pred             CCCCHHHHHhC
Q 012203          288 QRLTARQVLDH  298 (468)
Q Consensus       288 ~Rpt~~eiL~h  298 (468)
                      +||++.|+++|
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.9e-40  Score=320.60  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=208.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.++||+|++|.||+|.+. +++.||+|.+....    ...+.+.+|+.+++++. |+||+++++.+.+.+..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEE
Confidence            457999999999999999999975 56789999886542    23467889999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +|||+++++|.+++.+.  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.   ++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~  155 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM---CKIADFGLARVIED  155 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc---EEECCCccceecCC
Confidence            99999999999999653  46888999999999999999999999999999999999986554   99999999987654


Q ss_pred             CCcc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQSL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ....  ....++..|+|||++.+. ++.++|||||||++|+|++ |+.||...........+.... ..+  ....++.+
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~  232 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RMP--RMENCPDE  232 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCCCHH
Confidence            3221  223456789999998765 8889999999999999998 999998887777776665442 222  23568899


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.+++.+||..||++||+++++++
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         233 LYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-40  Score=344.07  Aligned_cols=252  Identities=26%  Similarity=0.389  Sum_probs=204.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCC-----CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFT-----GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      =.++|++++.||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+++|+++..||||+++++++.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            356799999999999999999987433     3579999986542  233456788999999999669999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc---------------------------------------------------------
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF---------------------------------------------------------  136 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------------  136 (468)
                      .+.+|||||||++|+|.+++.+.                                                         
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            99999999999999999988642                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEee
Q 012203          137 ---------------------------------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLAT  177 (468)
Q Consensus       137 ---------------------------------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~  177 (468)
                                                             ..+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                   13677888999999999999999999999999999999986


Q ss_pred             cCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 012203          178 KASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIF  252 (468)
Q Consensus       178 ~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~  252 (468)
                      ++.   +||+|||+++.......   .....+++.|+|||++.+. ++.++|||||||++|+|++ |..||.........
T Consensus       273 ~~~---~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         273 GKI---VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             CCE---EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            554   99999999987643322   2234577889999998765 8999999999999999997 99999775543333


Q ss_pred             HHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..........+  ....++.++.+++.+||+.||++||++.++.+
T Consensus       350 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         350 YNKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            22222222222  22468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.2e-40  Score=326.39  Aligned_cols=259  Identities=30%  Similarity=0.486  Sum_probs=221.1

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .....+.|++.+.||.|++|.||++.+..+++.+++|++.....    ....+.+|+++++++. |+||+++++.+...+
T Consensus        14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   88 (286)
T cd06614          14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGD   88 (286)
T ss_pred             CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECC
Confidence            34577789999999999999999999998899999999976532    4567888999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      ..|+|+||++|++|.+++.... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.   ++|+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~---~~l~d~~~~~~  165 (286)
T cd06614          89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQ  165 (286)
T ss_pred             EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC---EEECccchhhh
Confidence            9999999999999999998876 8999999999999999999999999999999999999986554   99999999866


Q ss_pred             ecCCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          195 IEPGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       195 ~~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ..... ......+++.|+|||++.+. ++.++|+|||||++|+|++|+.||...........+...... +......++.
T Consensus       166 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  244 (286)
T cd06614         166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSP  244 (286)
T ss_pred             hccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCH
Confidence            54322 22345688899999998765 899999999999999999999999877665555544433221 1112234789


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .+.++|.+||+.+|.+||++.++++|+||.+
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         245 EFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            9999999999999999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-40  Score=329.84  Aligned_cols=257  Identities=29%  Similarity=0.455  Sum_probs=216.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .+.|...+.||+|+||.||++++..+++.+|+|.+........+....+.+|+++++++. |||++++++++.+++..++
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEEE
Confidence            344888999999999999999999999999999997664444455667888999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.   ++|+|||++..... 
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~---~kl~dfg~~~~~~~-  177 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGSASIASP-  177 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC---EEEecCCCccccCC-
Confidence            9999965 77777754 456899999999999999999999999999999999999976554   99999999876443 


Q ss_pred             CccccCCCCCCCcChhhhc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                        .....|++.|+|||++.    +.++.++|+|||||++|+|++|+.||...........+.......  .....+++.+
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  253 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDYF  253 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCccccHHH
Confidence              23457899999999974    237889999999999999999999998776666555554443221  2224678899


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      .+++.+||+.+|.+||++.++++|+|+.....
T Consensus       254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            99999999999999999999999999976544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.3e-40  Score=320.42  Aligned_cols=246  Identities=24%  Similarity=0.374  Sum_probs=207.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|++|+||++.+. .+..+|+|.+.....    ....+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence            46999999999999999999876 355699999875432    2356888999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+.+|+|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.   +||+|||+++......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~---~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC---VKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC---EEECCCccceecCCCc
Confidence            9999999999999764 46899999999999999999999999999999999999986554   9999999988764433


Q ss_pred             cc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          200 SL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       200 ~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ..  ....++..|+|||++.+. ++.++|+|||||++|+|++ |+.||...+..+....+........   ....+..+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence            21  123456779999999864 8999999999999999998 9999988777777777665533222   135688999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +++.+||+.||++||++.+++++
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-40  Score=335.51  Aligned_cols=258  Identities=31%  Similarity=0.473  Sum_probs=208.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE----  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~----  114 (468)
                      +..+|.+.+.||.|+||.||+|.++.+|+.||+|.+.....   ...+.+.+|++++++++ ||||+++++++...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence            56899999999999999999999999999999999866532   34567888999999995 99999999876543    


Q ss_pred             ----------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCE
Q 012203          115 ----------DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       115 ----------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~i  184 (468)
                                ...|+||||++ ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++  ..+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~--~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED--LVL  154 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--ceE
Confidence                      46899999996 589888864 5799999999999999999999999999999999999997533  348


Q ss_pred             EEeecCceeeecCCCc----cccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 012203          185 KLADFGLATYIEPGQS----LLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA  258 (468)
Q Consensus       185 kL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  258 (468)
                      ||+|||++........    .....|+..|+|||++.+  .++.++|||||||++|+|++|+.||...+..+....+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999987643211    123467889999998765  3788999999999999999999999876654443333221


Q ss_pred             c----------------------CCCCCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          259 D----------------------LRFPSN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       259 ~----------------------~~~~~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      .                      ...+..    ....++.++.+||.+||+.||.+|||+.+++.|+||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            0                      000000    013577899999999999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.9e-40  Score=363.12  Aligned_cols=150  Identities=30%  Similarity=0.503  Sum_probs=137.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|.+++.||+|+||+||+|++..+++.||+|++.+...........+..|+.+++.++ ||||+++++++...+.+||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEE
Confidence            367999999999999999999999999999999998765555555678889999999985 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      ||||+.|++|.+++...+.+++..++.++.||+.||.|||.+||+||||||+||||+.++   .+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g---~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG---HIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC---CEEEEeCCCCc
Confidence            999999999999998888899999999999999999999999999999999999998655   49999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.9e-40  Score=329.50  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=209.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcC-------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKF-------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      ..++|.+.+.||+|+||.||++++..       +...+|+|.+....  .......+..|+++++++.+||||+++++++
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34789999999999999999998743       23579999987642  2344567888999999996699999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEE
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL  175 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl  175 (468)
                      ...+..|+||||+++|+|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            99999999999999999999997642                47888999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 012203          176 ATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSR  250 (468)
Q Consensus       176 ~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~  250 (468)
                      +.++.   +||+|||++........   .....+++.|+|||++.+. ++.++|+|||||++|+|++ |..||...+..+
T Consensus       174 ~~~~~---~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         174 TEDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             cCCCc---EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            86554   99999999876543221   1122345689999998775 8999999999999999998 999998888777


Q ss_pred             HHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.+.+..... .  .....++.++.+++.+||..+|++||++.+++++
T Consensus       251 ~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            7776654432 1  1224678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.3e-40  Score=331.76  Aligned_cols=248  Identities=23%  Similarity=0.325  Sum_probs=205.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcE----EEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEV----FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      .+|++.+.||+|+||+||+|.+..+++.    ||+|++...  ......+.+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence            4699999999999999999998766654    899998643  23344567889999999995 99999999999765 5


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~---~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc---EEEccccccccc
Confidence            78999999999999999774 45889999999999999999999999999999999999986554   999999999876


Q ss_pred             cCCCcc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          196 EPGQSL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       196 ~~~~~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      ......   ....++..|+|||++.+. ++.++|||||||++|||++ |+.||.+....++...+.. ...++..  ..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~  236 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQP--PIC  236 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-CCCCCCC--CCC
Confidence            543322   223446789999998764 8999999999999999997 9999988776665544433 3333332  357


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +..+.+++.+||..||++||++.+++.+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4e-40  Score=325.78  Aligned_cols=247  Identities=23%  Similarity=0.391  Sum_probs=207.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .+|.+.+.||+|+||.||+|++.     .++..+++|.+...   .....+.+.+|+++++++. ||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence            46999999999999999999864     34567899987643   2344567889999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          116 YVHLVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      ..++||||+++++|.+++...+                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            9999999999999999997643                378999999999999999999999999999999999998655


Q ss_pred             CCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 012203          180 SSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA  254 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~  254 (468)
                      .   ++|+|||++........   .....+++.|+|||++.+. ++.++|||||||++|+|++ |+.||......+..+.
T Consensus       161 ~---~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         161 L---VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             c---EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            4   99999999976543221   1234568889999998765 8899999999999999998 9999988877777776


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.......   ....++..+.+++.+||++||++||++.++++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            65543322   12457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-40  Score=337.55  Aligned_cols=262  Identities=27%  Similarity=0.459  Sum_probs=216.7

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .+..+.++|++.+.||.|++|.||+|++..+++.||+|++..... .......+.+|+.+++++. ||||+++++++...
T Consensus         9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   86 (343)
T cd07851           9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA   86 (343)
T ss_pred             ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence            345678899999999999999999999999999999999865422 2234456778999999995 99999999988765


Q ss_pred             CE------EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          115 DY------VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       115 ~~------~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      +.      .++|+||+ |++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++|+|
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~---~kL~d  161 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---LKILD  161 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEcc
Confidence            54      99999998 7799998876 57999999999999999999999999999999999999986554   99999


Q ss_pred             cCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---
Q 012203          189 FGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP---  263 (468)
Q Consensus       189 FGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---  263 (468)
                      ||++......  .....+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+.......+   
T Consensus       162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         162 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9999875432  345678999999999865  378899999999999999999999987776655554433211100   


Q ss_pred             -----------------C-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          264 -----------------S-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       264 -----------------~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                       .       ..+..+++.+.++|.+||..||++|||+.+++.||||.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence                             0       00124688999999999999999999999999999998654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.6e-40  Score=328.64  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEc-------CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDK-------FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      -.++|.+++.||+|+||.||+|++.       ..+..+|+|.+....  .......+..|+++++++.+||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3468999999999999999999863       234579999987542  2344567888999999996699999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEE
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL  175 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl  175 (468)
                      .+.+.+|++|||+++|+|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999999763                247888999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 012203          176 ATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSR  250 (468)
Q Consensus       176 ~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~  250 (468)
                      +.++.   +||+|||+++.......   .....+++.|+|||++.+. ++.++|||||||++|+|++ |..||...+..+
T Consensus       168 ~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 TEDNV---MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             cCCCc---EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            86554   99999999986543211   1122345679999998765 8999999999999999999 999998888888


Q ss_pred             HHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .++.+......   .....++.++.+++.+||..||++||++.++++
T Consensus       245 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            77777654321   112467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=324.31  Aligned_cols=253  Identities=33%  Similarity=0.520  Sum_probs=209.5

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |.+.+.||+|++|.||+|....+++.|++|.+..... . .......+|+..++++.+||||+++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            6788999999999999999998999999999876532 1 2233455689999999669999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          123 LCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |+ +|+|.+.+....  .+++..+..++.|++.+|.|||++|++|+||+|.||+++.++.   ++|+|||++........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~---~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC---EEEeecccceeccCCCC
Confidence            99 889999997764  7899999999999999999999999999999999999987554   99999999987765544


Q ss_pred             cccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-----------------
Q 012203          201 LLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR-----------------  261 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  261 (468)
                      .....|+..|+|||++.+  .++.++|+||||+++|+|++|++||......+....+......                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            455678999999998854  3789999999999999999999999776655444333221100                 


Q ss_pred             --CCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          262 --FPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       262 --~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                        ++.       ......+..+.++|.+||+.||++|||++|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence              000       0012336789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-40  Score=320.33  Aligned_cols=248  Identities=24%  Similarity=0.333  Sum_probs=205.2

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE---
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY---  116 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~---  116 (468)
                      |.+++.||+|+||.||.|.+..+   +..||+|++..+.. .......+.+|+++++++. ||||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence            57889999999999999987653   47899999876532 3344567889999999995 9999999998865443   


Q ss_pred             ---EEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          117 ---VHLVMELCAGGELFHRLEKF------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       117 ---~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                         .+++|||+++|+|..++...      ..+++..++.++.|++.||.|||++|++||||||+||+++.++.   +||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---VCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe---EEEC
Confidence               89999999999999988542      35899999999999999999999999999999999999986554   9999


Q ss_pred             ecCceeeecCCCcc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 012203          188 DFGLATYIEPGQSL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       188 DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      |||+++........   ....++..|+|||++.+. ++.++|||||||++|||++ |..||.+....+..+.+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-  234 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99999876533211   123456789999998765 8999999999999999999 99999888777777766654321 


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .  ....++..+.+++.+||+.||++||++.|++++
T Consensus       235 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 K--QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             C--CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1  124688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.1e-40  Score=325.80  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=210.2

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.+.|++.+.||+|++|.||+|.++.+++.||+|.+.+...  ......+..|+.++.++.+||||+++++++.+...+|
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            34669999999999999999999998899999999976532  2234556668877777777999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++|||+ +++|.+++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.   +||+|||++..+.
T Consensus        91 ~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~---~kL~dfg~~~~~~  166 (296)
T cd06618          91 ICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN---VKLCDFGISGRLV  166 (296)
T ss_pred             EEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC---EEECccccchhcc
Confidence            999998 4577777755 4578999999999999999999997 59999999999999986554   9999999998765


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccC-CCCCCCCCC
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-----YNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADL-RFPSNPWDH  269 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-----~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~~~~~~~~  269 (468)
                      .........+++.|+|||.+.+.     ++.++|+||||+++|+|++|+.||..... .+.+..+..... ..+  ....
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  244 (296)
T cd06618         167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP--PNEG  244 (296)
T ss_pred             CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC--CCCC
Confidence            44444445688899999998643     78899999999999999999999965332 233333333221 122  1135


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ++.++.+|+.+||..||.+||++++++.|+||...
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            78899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-40  Score=317.63  Aligned_cols=246  Identities=26%  Similarity=0.358  Sum_probs=207.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      +++|++.+.||+|++|.||+|.+. +++.||+|.+.....    ....+.+|+++++++. ||||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeee
Confidence            467999999999999999999975 467899999875432    2456888999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI---CKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC---EEECCcceEEEccC
Confidence            999999999999997654  6899999999999999999999999999999999999987655   99999999987653


Q ss_pred             CCcc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQSL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ....  ....++..|+|||++.+. ++.++|+||||+++|+|++ |+.||.+.+.......+.... ..+  ....++..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~  232 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMP--CPPGCPKE  232 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC--CCCcCCHH
Confidence            2211  122234579999998764 8999999999999999999 999998887777776665432 222  12467899


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.+++.+||+.||++||+++++++
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.3e-40  Score=328.86  Aligned_cols=256  Identities=28%  Similarity=0.421  Sum_probs=205.3

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-----
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE-----  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~-----  114 (468)
                      .++|++.+.||.|++|.||+|.++.+++.+|+|++...... ......+.+|++++++++ ||||+++++++.+.     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            57899999999999999999999999999999998754321 112345678999999996 99999999987443     


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          115 ---DYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                         ..+++||||+. ++|...+.. ...+++..++.++.|+++||.|||++||+||||||+||+++.++.   ++|+|||
T Consensus        85 ~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECcCc
Confidence               35799999985 477777654 357999999999999999999999999999999999999987655   9999999


Q ss_pred             ceeeecCCCc------------cccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 012203          191 LATYIEPGQS------------LLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR  256 (468)
Q Consensus       191 la~~~~~~~~------------~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  256 (468)
                      ++........            .....|++.|+|||++.+.  ++.++|||||||++|+|++|++||.+.+.....+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9976543221            1223578899999998653  7899999999999999999999998777665555443


Q ss_pred             hccCCCCC--------------------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          257 TADLRFPS--------------------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       257 ~~~~~~~~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ......+.                          ..+..+++.+.++|.+||..||.+|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            22111000                          0012455788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-40  Score=327.86  Aligned_cols=258  Identities=34%  Similarity=0.497  Sum_probs=210.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED--  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~--  115 (468)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|++++++++ ||||+++++++.+..  
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchh
Confidence            456789999999999999999999999999999999876432 2223346678999999996 999999999987654  


Q ss_pred             --------EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEE
Q 012203          116 --------YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKL  186 (468)
Q Consensus       116 --------~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL  186 (468)
                              .+++|+||+++ +|...+... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~---~kl  157 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKL  157 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc---EEe
Confidence                    89999999976 777777653 46899999999999999999999999999999999999986554   999


Q ss_pred             eecCceeeecCCC--ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 012203          187 ADFGLATYIEPGQ--SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       187 ~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      +|||++.......  ......+++.|+|||.+.+.  ++.++|||||||++|+|++|++||...+..+.+..+.......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999998765432  12234568889999988653  7889999999999999999999998766655554444321110


Q ss_pred             CC--------------------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          263 PS--------------------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       263 ~~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ..                          ..+..++..+.+++.+||..||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00                          0123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.2e-40  Score=326.94  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=208.8

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEE-----cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSD-----KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      ..-..++|.+.+.||+|+||.||++.+     ..++..+|+|.+....  .....+.+.+|+++++++.+||||++++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            345567899999999999999999975     2345689999987542  233456788999999999669999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          111 YEDEDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       111 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      +...+.+++||||+++|+|.+++....  .+++..+..++.|++.||.|||+++|+|+||||+|||++.++   .++|+|
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~d  184 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICD  184 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC---eEEECC
Confidence            999999999999999999999997643  389999999999999999999999999999999999997544   499999


Q ss_pred             cCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCC
Q 012203          189 FGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       189 FGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                      ||++........   .....+++.|+|||++.+. ++.++|||||||++|+|++ |..||....................
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  264 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA  264 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC
Confidence            999986543221   1123467889999998765 8999999999999999998 9999987665544434333332222


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                        .....++.+.+++.+||.++|++|||+.|+++
T Consensus       265 --~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         265 --QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence              22457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.5e-40  Score=331.44  Aligned_cols=259  Identities=26%  Similarity=0.409  Sum_probs=209.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCC--CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----CC
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFT--GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED----ED  115 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~--g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~----~~  115 (468)
                      +|++.+.||+|+||.||++++..+  ++.||+|++.... ........+.+|+++++++.+||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  8999999986532 1222345677899999999779999999987532    25


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~---~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC---EEeCcCCCceec
Confidence            6889999984 699999988888999999999999999999999999999999999999986554   999999999875


Q ss_pred             cCCC-----ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--------
Q 012203          196 EPGQ-----SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL--------  260 (468)
Q Consensus       196 ~~~~-----~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------  260 (468)
                      ....     ......||+.|+|||++.+  .++.++|||||||++|+|++|++||...+.......+.....        
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4322     1234578999999998865  378999999999999999999999987664443333221100        


Q ss_pred             ---------------CCC----CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 ---------------RFP----SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 ---------------~~~----~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                     ..+    ...+..++..+.+++.+||+.||.+|||+.+++.|||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                           000    011234678999999999999999999999999999996643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.2e-40  Score=318.66  Aligned_cols=241  Identities=25%  Similarity=0.326  Sum_probs=202.2

Q ss_pred             EEeecCCeEEEEEEE--cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           48 QLGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~--~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      .||+|+||.||+|.+  +.+++.+|+|++.... ......+.+.+|+.+++++. ||||++++++++ .+..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecCC
Confidence            589999999999965  4578899999986543 23344567889999999995 999999999886 456789999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc----c
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS----L  201 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~  201 (468)
                      +++|.+++...+.+++..+..++.|++.||+|||++||+||||||.||+++.++.   +||+|||++........    .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY---AKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe---EEECCCccccccCCCCCeeeec
Confidence            9999999988888999999999999999999999999999999999999986544   99999999987654322    1


Q ss_pred             ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          202 LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ....+++.|+|||.+.+. ++.++|+|||||++|||++ |..||......+..+.+..... .+  ....++.++.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME--CPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC--CCCCCCHHHHHHHH
Confidence            223446789999998764 8889999999999999998 9999988877777777765432 11  12468899999999


Q ss_pred             HccccCCCCCCCHHHHHh
Q 012203          280 GMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       280 ~~L~~dP~~Rpt~~eiL~  297 (468)
                      +||+.||++||++++|..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.5e-40  Score=327.94  Aligned_cols=257  Identities=30%  Similarity=0.473  Sum_probs=214.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..+.|...+.||+|+||.||+|++..+|+.|++|++.............+.+|++++++++ |||++++++++.+.+..|
T Consensus        19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence            3445777889999999999999999999999999997655444455567888999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++.... 
T Consensus        98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~---~kL~dfg~~~~~~-  172 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGSASKSS-  172 (313)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC---EEEeecCCCcccC-
Confidence            9999995 577777755 456899999999999999999999999999999999999976554   9999999986532 


Q ss_pred             CCccccCCCCCCCcChhhhc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                        ......|+..|+|||++.    +.++.++|+|||||++|+|++|..||...+.......+.....  +......++..
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  248 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDS  248 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCHH
Confidence              223567899999999984    2378899999999999999999999987765555544443322  22223467788


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +++|+.+||+++|.+||++.+++.||||+...
T Consensus       249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=351.15  Aligned_cols=254  Identities=22%  Similarity=0.426  Sum_probs=221.0

Q ss_pred             EEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC-ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE--EEEE
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY--VHLV  120 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~-~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~--~~lV  120 (468)
                      +....||+|+|-+||+|.|..+|..||.-.++.+.+. .....+++..|+.+|+.|. ||||+++++.|.+...  +.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeee
Confidence            3456899999999999999999999998766554432 3445688999999999996 9999999999976654  8899


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +|++..|+|..+++++++++...++.|++||++||.|||++.  |||||||-+||||+  |+.+.|||+|+|||......
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence            999999999999999999999999999999999999999985  99999999999997  66778999999999987755


Q ss_pred             CccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ... ..+|||.|||||+....|+..+||||||+++.||+|+..||.. .+..++++++..+...  ...-.--.+++++|
T Consensus       200 ~ak-svIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP--~sl~kV~dPevr~f  276 (632)
T KOG0584|consen  200 HAK-SVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP--AALSKVKDPEVREF  276 (632)
T ss_pred             ccc-eeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH--HHhhccCCHHHHHH
Confidence            443 4899999999999999999999999999999999999999964 6778888888776442  11112336799999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      |.+||.. .++|+|+.|+|+|+||...
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999 8999999999999999875

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-39  Score=320.41  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=205.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCc----EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGE----VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ++|++.+.||+|+||+||+|++..+++    .||+|++....  .......+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~   82 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T   82 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence            569999999999999999999877776    48999986542  3344567888999999995 99999999998754 5


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+++|||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~---~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc---EEECCCCceeec
Confidence            78999999999999999764 56999999999999999999999999999999999999976544   999999999876


Q ss_pred             cCCCcc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          196 EPGQSL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       196 ~~~~~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      ......   ....+++.|+|||.+.+. ++.++|||||||++|||++ |..||.......+...+..... .+.  ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~  236 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-LPQ--PPIC  236 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCC--CccC
Confidence            533221   123456789999998764 8999999999999999998 9999987777666665554322 221  2467


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +..+.+++.+||..||++||++.++++
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2e-40  Score=335.05  Aligned_cols=262  Identities=32%  Similarity=0.489  Sum_probs=212.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--D  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~  115 (468)
                      .+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+... .......+..|+.+++++.+||||+++++++...  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            467889999999999999999999998999999998865321 2233456778999999995599999999998643  4


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+||||++ ++|..++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++...
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~---~kl~d~g~~~~~  157 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR---VKLADFGLARSL  157 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEEeeccchhcc
Confidence            7899999996 5999988775 7889999999999999999999999999999999999987665   999999999866


Q ss_pred             cCCC------ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-------
Q 012203          196 EPGQ------SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-------  260 (468)
Q Consensus       196 ~~~~------~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------  260 (468)
                      ....      ......||+.|+|||++.+  .++.++|+||||+++|+|++|+.||.+....+....+.....       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            4322      2234578999999998765  378899999999999999999999977655444333222110       


Q ss_pred             --------------------CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 --------------------RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 --------------------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                          .........++.++.++|.+||+.||++|||+.++++|+|+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence                                111111234788999999999999999999999999999997753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.4e-40  Score=325.47  Aligned_cols=254  Identities=23%  Similarity=0.354  Sum_probs=211.6

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEc-------CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDK-------FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      ..-.++|.+.+.||+|+||.||+|++.       .++..+|+|.+....  .......+.+|+.+++.+.+||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            345678999999999999999999753       234579999886542  33445778899999999966999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcE
Q 012203          110 VYEDEDYVHLVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENI  173 (468)
Q Consensus       110 ~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NI  173 (468)
                      ++......|+||||+++|+|.+++.+.                ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999999999999764                2467788899999999999999999999999999999


Q ss_pred             EEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 012203          174 LLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTK  248 (468)
Q Consensus       174 Ll~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~  248 (468)
                      +++.++   .+||+|||+++.......   .....+++.|+|||++.+. ++.++||||||+++|+|++ |..||.+.+.
T Consensus       169 li~~~~---~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         169 LVTENN---VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EEcCCC---cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            997654   499999999987653221   1233467789999998765 8999999999999999998 8999988888


Q ss_pred             HHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .++.+.+...... .  ....++..+.+++.+||..+|++||++.|+++.
T Consensus       246 ~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGHRM-D--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            8887777554321 1  124688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-40  Score=333.17  Aligned_cols=262  Identities=28%  Similarity=0.464  Sum_probs=213.2

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .+..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|++++++++ ||||+++++++...
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~   88 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA   88 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeec
Confidence            345678999999999999999999999999999999999876421 2233456778999999996 99999999988643


Q ss_pred             ------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          115 ------DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       115 ------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                            +..|++++++ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kl~d  163 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILD  163 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC---EEEec
Confidence                  4578999987 8899888765 46999999999999999999999999999999999999987654   99999


Q ss_pred             cCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC------
Q 012203          189 FGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL------  260 (468)
Q Consensus       189 FGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------  260 (468)
                      ||++.....  ......|++.|+|||++.+  .++.++|||||||++|+|++|+.||...+.......+.....      
T Consensus       164 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T cd07877         164 FGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  241 (345)
T ss_pred             ccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999876532  3345678999999999876  378899999999999999999999977665444433322111      


Q ss_pred             -----------------CCCC----CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 -----------------RFPS----NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 -----------------~~~~----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                       ..+.    ..+...++++.++|.+||++||.+||++.+++.||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence                             0111    01124578899999999999999999999999999998644

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9e-40  Score=321.47  Aligned_cols=250  Identities=27%  Similarity=0.398  Sum_probs=198.2

Q ss_pred             ccCCe-EEEeEEeecCCeEEEEEE----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERF-VLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y-~i~~~LG~G~fg~Vy~a~----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      |.+|| ++.+.||+|+||+||++.    ...+++.||+|++....  .......+.+|+++++++. ||||+++++++..
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   77 (283)
T cd05080           1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSE   77 (283)
T ss_pred             CChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence            34666 999999999999998865    34578899999987542  2234567788999999995 9999999998865


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          114 --EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       114 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                        ...+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~  153 (283)
T cd05080          78 QGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL---VKIGDFGL  153 (283)
T ss_pred             CCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc---EEEeeccc
Confidence              3468999999999999999976 46999999999999999999999999999999999999986544   99999999


Q ss_pred             eeeecCCCcc----ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH--HHH------------
Q 012203          192 ATYIEPGQSL----LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS--RIF------------  252 (468)
Q Consensus       192 a~~~~~~~~~----~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~--~~~------------  252 (468)
                      +.........    ....++..|+|||.+.+. ++.++||||||+++|+|++|+.||......  +..            
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL  233 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence            9876543221    123456679999998764 899999999999999999999998543211  000            


Q ss_pred             HHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..........+  ....++.++.+++.+||..||++|||++++++
T Consensus       234 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         234 IELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00011111111  12457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5e-40  Score=321.79  Aligned_cols=253  Identities=33%  Similarity=0.540  Sum_probs=210.3

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+..... .......+..|+++++++. |+||+++++++.+.+.+++|||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence            6778899999999999999998999999999876543 2234567888999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-c
Q 012203          123 LCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-S  200 (468)
Q Consensus       123 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~  200 (468)
                      |+++ +|.+.+... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.   ++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc---EEEeeeeeeEecCCCccc
Confidence            9965 888888663 57999999999999999999999999999999999999986554   9999999998776543 2


Q ss_pred             cccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC------------------
Q 012203          201 LLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL------------------  260 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------  260 (468)
                      .....++..|+|||.+.+.  ++.++|+||||+++|+|++|+.||...+..+....+.....                  
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            3345688899999998753  78899999999999999999999987766554433322110                  


Q ss_pred             -CCCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 -RFPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 -~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                       .++.       ..+..++.++.++|.+||.+||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence             0110       0123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.2e-40  Score=319.95  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=203.7

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCc--EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC------
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGE--VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE------  114 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~--~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~------  114 (468)
                      |.+++.||+|+||.||+|++..+++  .+|+|.+.... ........+..|+++++++. ||||+++++++...      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence            3567899999999999999987765  68999887643 23445677888999999995 99999999976422      


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          115 DYVHLVMELCAGGELFHRLEKF------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      ...+++|||+++|+|.+++...      ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC---EEECC
Confidence            3578999999999999887432      34789999999999999999999999999999999999976554   99999


Q ss_pred             cCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCC
Q 012203          189 FGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       189 FGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                      ||+++.......   .....+++.|+|||++.+. ++.++|||||||++|+|++ |+.||......+..+.+...... +
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~  234 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL-K  234 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-C
Confidence            999987653321   1123467789999998875 8999999999999999999 89999888777777777655431 1


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                        ....++..+.++|.+||+.||++|||+++++++
T Consensus       235 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              124678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-40  Score=319.99  Aligned_cols=243  Identities=27%  Similarity=0.378  Sum_probs=199.5

Q ss_pred             eEEeecCCeEEEEEEEcCCCcE--EEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEV--FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~--vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      +.||+|+||.||+|+++.++..  +++|.+...  ........+.+|+++++++.+||||+++++++...+.+++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            3689999999999999888764  577877643  233445678899999999967999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          125 AGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       125 ~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      ++|+|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++.   +||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~---~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe---EEECC
Confidence            9999999997643                4788999999999999999999999999999999999986554   99999


Q ss_pred             cCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          189 FGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       189 FGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      ||++..............+..|+|||++.+. ++.++|+|||||++|||++ |..||...+..+..+.+.... ..  ..
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~--~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RL--EK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CC--CC
Confidence            9998643221111122345679999998764 8899999999999999997 999998877777666654432 11  12


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ...++.++.+++.+||..||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.1e-40  Score=324.50  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=208.2

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +|++.+.||+|+||.||+|.+..     .++.||+|++....  .......+..|+.++.++. ||||+++++++.+.+.
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCc
Confidence            47888999999999999998754     35789999987542  2233466888999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC
Q 012203          117 VHLVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS  180 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~  180 (468)
                      .++++||+++++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence            99999999999999998532                24788889999999999999999999999999999999986544


Q ss_pred             CCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 012203          181 SSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV  255 (468)
Q Consensus       181 ~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i  255 (468)
                         +||+|||+++.......   .....+++.|+|||++.+ .++.++|||||||++|||++ |..||.+....+..+.+
T Consensus       163 ---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         163 ---VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             ---eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence               99999999876543221   123456788999999875 48999999999999999998 89999888888888887


Q ss_pred             HhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          256 RTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       256 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ........   ...++.++.+++.+||++||++||++++|+..
T Consensus       240 ~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            76654321   24688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.9e-40  Score=321.53  Aligned_cols=248  Identities=21%  Similarity=0.362  Sum_probs=207.1

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ..+|.+.++||+|+||.||++...     .++..+|+|.+...   .......+.+|+++++++. |+||+++++++.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   79 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG   79 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC
Confidence            457889999999999999999753     35678999987653   3445567899999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG---------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~---------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      +..+++|||+++++|.+++...+               .+++..+..++.||+.||+|||++|++||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999997653               478899999999999999999999999999999999998654


Q ss_pred             CCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 012203          180 SSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA  254 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~  254 (468)
                         .+||+|||++........   .....+++.|+|||.+.+. ++.++|||||||++|+|++ |++||......+..+.
T Consensus       160 ---~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         160 ---VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             ---CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence               499999999976543221   1223457889999998765 8999999999999999998 9999987777666666


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +......   .....+++.+.+++.+||+.||.+||+++++++
T Consensus       237 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6544321   122468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3e-40  Score=320.20  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=210.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -..+|++++.||.|+||.||+|.++. ++.+++|++....   ......+..|+.++++++ ||||+++++++.+.+.++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeE
Confidence            34569999999999999999999986 8999999987653   223556888999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +||||+++++|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~---~kl~d~g~~~~~~  155 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV---CKVADFGLARLIK  155 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce---EEEccccchhhcC
Confidence            999999999999999763  45899999999999999999999999999999999999986554   9999999997764


Q ss_pred             CCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          197 PGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       197 ~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      .... .....++..|+|||++.+. ++.++|+||||+++|+|++ |+.||......+.+..+... ...+.  ...+++.
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~  232 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPC--PAKCPQE  232 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCC--CCCCCHH
Confidence            3221 1233456789999998764 8899999999999999998 89999888777777776643 22222  2578899


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         233 IYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-39  Score=318.16  Aligned_cols=248  Identities=26%  Similarity=0.450  Sum_probs=208.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCc---EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGE---VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ++|++.+.||+|+||.||+|.++.++.   .+|+|.+....  .......+.+|+.+++++. ||||+++++++.+++.+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence            569999999999999999999875543   79999986543  2334567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |+||||++|++|.+++.+. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~---~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV---CKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe---EEeCCCCcccccc
Confidence            9999999999999999764 46899999999999999999999999999999999999976554   9999999998765


Q ss_pred             CCCcc----ccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          197 PGQSL----LGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       197 ~~~~~----~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .....    ....++..|+|||.+.+ .++.++|+|||||++|++++ |..||......+....+... ...+.  ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPA--PMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCC--CCCC
Confidence            33211    11233567999999986 48999999999999999886 99999888777777766554 22222  2467


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+.+++.+||+++|.+||++.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=345.70  Aligned_cols=237  Identities=27%  Similarity=0.417  Sum_probs=207.0

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      .++-||.|+-|.||+++.+  ++.||||.++.          .-+.+|+.|++|+ ||||+.+.++|...-.+|||||||
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeecc
Confidence            3678999999999999875  78999997642          2245899999997 999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccC
Q 012203          125 AGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT  204 (468)
Q Consensus       125 ~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~  204 (468)
                      +.|.|..+|+..+.+.......+..+|+.|+.|||.+.|||||||.-||||..++.   |||+|||-++..........+
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~---VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV---VKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce---EEeccccchHhhhhhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999987665   999999999988766666789


Q ss_pred             CCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          205 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      +||..|||||++.+. ++.|+|||||||||||||||..||..-+...++=-+-...+.+|.  ...+++.++=|++.||.
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv--PstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV--PSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC--cccCchHHHHHHHHHHh
Confidence            999999999999986 899999999999999999999999766554443222223333332  25789999999999999


Q ss_pred             cCCCCCCCHHHHHhCc
Q 012203          284 TDPSQRLTARQVLDHS  299 (468)
Q Consensus       284 ~dP~~Rpt~~eiL~h~  299 (468)
                      -.|..||++.+||.|-
T Consensus       350 sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  350 SKPRNRPSFRQILLHL  365 (904)
T ss_pred             cCCCCCccHHHHHHHH
Confidence            9999999999999984

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-39  Score=317.78  Aligned_cols=248  Identities=25%  Similarity=0.441  Sum_probs=208.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCc---EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGE---VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+|++.+.||+|+||.||+|.++.+++   .||+|++.+..  .......+..|+.+++++. ||||+++++++.+++.+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence            458999999999999999999987665   69999987542  3445678899999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++   .+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~---~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL---VCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC---cEEECCCccccccc
Confidence            9999999999999999763 5689999999999999999999999999999999999997654   49999999987654


Q ss_pred             CCCcccc---CC---CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          197 PGQSLLG---TV---GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       197 ~~~~~~~---~~---GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      .......   ..   .+..|+|||++.+. ++.++|||||||++|||++ |..||+.....+..+.+... ...+.  ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~--~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPP--PM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCC--cc
Confidence            3322111   11   24579999999764 8999999999999999886 99999988877777766433 22222  24


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .++..+.+++.+||..+|++||++++++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.6e-40  Score=333.31  Aligned_cols=254  Identities=19%  Similarity=0.315  Sum_probs=201.4

Q ss_pred             eEEeec--CCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           47 QQLGWG--QFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        47 ~~LG~G--~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      ..||.|  +||+||+|+++.+|+.||+|++..... .....+.+.+|+.+++.+. ||||++++++|...+.+++||||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence            356666  999999999999999999999876533 2344577888999999885 999999999999999999999999


Q ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-Cc-
Q 012203          125 AGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QS-  200 (468)
Q Consensus       125 ~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~-  200 (468)
                      .+++|.+++.+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   ++++||+.+...... .. 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~---~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL---VSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc---EEEechHHHhhhhccCccc
Confidence            999999999764  34899999999999999999999999999999999999986554   999999865332111 00 


Q ss_pred             ------cccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--------
Q 012203          201 ------LLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP--------  263 (468)
Q Consensus       201 ------~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  263 (468)
                            .....++..|+|||++.+.   ++.++|||||||++|+|++|+.||...................+        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                  0112356679999998753   68899999999999999999999977655443332222111000        


Q ss_pred             -----------------------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          264 -----------------------------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       264 -----------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                                         ......+++.+.+|+++||+.||++|||+.|+++|+||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                               001123567899999999999999999999999999996643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-39  Score=329.21  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=210.4

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCC-------CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFT-------GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-------g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      +-...+|++++.||+|+||.||+|++...       +..||+|.+....  .......+.+|+++++++.+||||+++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            33456799999999999999999986432       2368999886542  33445678899999999966999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcE
Q 012203          110 VYEDEDYVHLVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENI  173 (468)
Q Consensus       110 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NI  173 (468)
                      ++.+.+.++++|||+++|+|.+++.+..                .++...+..++.|++.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            9999999999999999999999997532                367788899999999999999999999999999999


Q ss_pred             EEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 012203          174 LLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTK  248 (468)
Q Consensus       174 Ll~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~  248 (468)
                      |++.++.   +||+|||+++.......   .....++..|+|||++.+. ++.++|||||||++|||++ |..||.+.+.
T Consensus       166 ll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         166 LVTEDNV---MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEcCCCc---EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9986554   99999999987643321   1222345679999999775 8999999999999999998 8999998888


Q ss_pred             HHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      .+..+.+..... .  .....++.++.+++.+||+.+|++||++.|++++-
T Consensus       243 ~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         243 EELFKLLKEGHR-M--DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            887777654422 1  11246788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.3e-40  Score=323.40  Aligned_cols=257  Identities=29%  Similarity=0.519  Sum_probs=211.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCCC-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~~-~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      +|++.+.||+|++|.||++++.   .+++.||+|++.+..... ......+.+|++++.++++||||+++++.+...+.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   467899999987643221 223456788999999998799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++||||+++++|.+.+.....+++..++.++.|++.+|.|||+.|++||||||.||+++.++.   ++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH---VVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEEECcccccccc
Confidence            999999999999999988788999999999999999999999999999999999999986554   99999999877543


Q ss_pred             CCc--cccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccCCCCCCCCC
Q 012203          198 GQS--LLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       198 ~~~--~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ...  .....|++.|+|||.+.+.   ++.++|+||||+++|+|++|..||.....    .++.+.+.......    ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~  233 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----PK  233 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----Cc
Confidence            322  2235689999999998753   68899999999999999999999964322    23333333332222    24


Q ss_pred             CCCHHHHHHHHHccccCCCCCCC---HHHHHhCcCCCCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSWMGDGI  305 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt---~~eiL~h~~~~~~~  305 (468)
                      .++..+.+++.+||+.||++|||   +.++|+|+||+...
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            57889999999999999999998   56789999997643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=314.93  Aligned_cols=241  Identities=24%  Similarity=0.394  Sum_probs=202.2

Q ss_pred             eEEeecCCeEEEEEEEcCCC---cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 012203           47 QQLGWGQFGVIRVCSDKFTG---EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL  123 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g---~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~  123 (468)
                      +.||+|+||.||+|....++   ..+|+|.+......  ...+.+..|+++++++. ||||+++++++. .+.+++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence            47999999999999876554   78999998766432  44567888999999995 999999999876 4568999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccc-
Q 012203          124 CAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-  202 (468)
Q Consensus       124 ~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~-  202 (468)
                      +++++|.+++.+...+++..+..++.|++.||+|||+++++||||||+|||++.++.   +||+|||++.......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~---~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ---AKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc---EEeccccccceeecCCcccc
Confidence            999999999988888999999999999999999999999999999999999987655   9999999998765433211 


Q ss_pred             ---cCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          203 ---GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       203 ---~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                         ...++..|+|||.+.+. ++.++|||||||++|+|++ |..||...+..+....+..... .  .....++..+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-L--PRPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-C--CCCCCCCHHHHHH
Confidence               12234679999998765 8999999999999999998 9999988777777666654432 1  2235678999999


Q ss_pred             HHHccccCCCCCCCHHHHHh
Q 012203          278 VMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~  297 (468)
                      |.+||..||++||++.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-39  Score=316.79  Aligned_cols=245  Identities=28%  Similarity=0.394  Sum_probs=204.1

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.++||+|+||.||+|.+..+ ..||+|++.+...    ....+.+|+++++++. ||||+++++.+.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEE
Confidence            46799999999999999999998755 4699999876432    2356788999999996 9999999998754 56899


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+++++||||||+||+++.++.   ++|+|||++..+..
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~---~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc---EEeccCCceeeccc
Confidence            99999999999999763  35789999999999999999999999999999999999986554   99999999987654


Q ss_pred             CCcc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQSL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ....  ....++..|+|||++.+. ++.++|+|||||++|+|++ |+.||......+..+.+.... ..+.  ...++..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~  231 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPC--PPECPES  231 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCC--ccccCHH
Confidence            3221  234566789999998764 8999999999999999999 899998877777766664432 2221  2468899


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.+++.+||++||++||+++++++
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-40  Score=316.53  Aligned_cols=245  Identities=26%  Similarity=0.412  Sum_probs=205.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +|++.+.||+|++|.||++.++ ++..+|+|++.+...    ....+.+|+++++++. ||||+++++++.+.+..|+||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEE
Confidence            5889999999999999999886 567899999865432    2346778999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          122 ELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       122 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      ||++|++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.   +||+|||+++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV---VKVSDFGLARYVLDDQY  155 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc---EEECCcccceecccccc
Confidence            999999999999764 46899999999999999999999999999999999999986554   99999999987643321


Q ss_pred             c--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          201 L--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       201 ~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      .  ....++..|+|||++.+. ++.++|+||||+++|+|++ |+.||...+..+....+.... ..+  .....+..+.+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~  232 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RLY--RPKLAPTEVYT  232 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cCC--CCCCCCHHHHH
Confidence            1  122334579999998764 8999999999999999999 899998877776666665432 111  12467899999


Q ss_pred             HHHHccccCCCCCCCHHHHHhC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++.+||..+|++|||+.|+++.
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-39  Score=323.26  Aligned_cols=255  Identities=26%  Similarity=0.474  Sum_probs=213.4

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |.....||+|+||.||++.++.+|+.||+|.+...   .......+.+|+.+++++. |+||+++++.+...+..++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEe
Confidence            33346799999999999999999999999988543   2234566888999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-cc
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-SL  201 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~  201 (468)
                      |+++++|.+++.. +.+++..++.++.|++.||+|||++|++||||||+||+++.++.   ++|+|||++....... ..
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~---~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEcccccceecccccccc
Confidence            9999999998754 56899999999999999999999999999999999999987654   9999999987654322 22


Q ss_pred             ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHH
Q 012203          202 LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG  280 (468)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  280 (468)
                      ....|++.|+|||.+.+. ++.++|+||+|+++|+|++|..||...........+...... .......++..+.+++.+
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-ccCCcccCCHHHHHHHHH
Confidence            345789999999998764 789999999999999999999999877666655555433221 111224678899999999


Q ss_pred             ccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          281 MLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       281 ~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ||+.||.+||++.+++.|+||.....
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhccCC
Confidence            99999999999999999999977653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-39  Score=315.86  Aligned_cols=248  Identities=24%  Similarity=0.400  Sum_probs=208.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCc---EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGE---VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ++|...+.||+|++|.||+|.++.+++   .+|+|.+....  .....+.+.+|+++++++. ||||+++.+++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence            468899999999999999999976655   78999886542  2334567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~---~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE---CKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc---EEECCCccceecc
Confidence            9999999999999999764 57899999999999999999999999999999999999986544   9999999998664


Q ss_pred             CCCcc----ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          197 PGQSL----LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       197 ~~~~~----~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .....    .....++.|+|||++.+. ++.++|||||||++|+|++ |+.||+..+..+....+.... ..+.  ...+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~~--~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLPA--PMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCCC--CCCC
Confidence            32211    112234579999998764 8999999999999999997 999998888777777776542 2222  2467


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +..+.+++.+||+.||++||++.++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=376.98  Aligned_cols=261  Identities=34%  Similarity=0.524  Sum_probs=223.7

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ++++.-++.-...||.|.||.||.|.+..+|+..|+|-+...... ......+.+|..++..+. |||+|+++++=.+.+
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHRE 1307 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecHH
Confidence            456777888899999999999999999999999999998765432 344567889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .++|.||||+||+|.++++..+..++...+.+-.|++.|+.|||++|||||||||+||||+.++.   ||++|||.|..+
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~---iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL---IKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc---EEeecccceeEe
Confidence            99999999999999999999878888889999999999999999999999999999999987664   999999999988


Q ss_pred             cCCC-----ccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcc-CCCCC
Q 012203          196 EPGQ-----SLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTAD-LRFPS  264 (468)
Q Consensus       196 ~~~~-----~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~~~  264 (468)
                      .+..     ......|||.|||||++.+    +...++||||||||+.||+||+.||...+. ..+.-.+..+. +.+| 
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P- 1463 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP- 1463 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc-
Confidence            6542     2356789999999999976    367799999999999999999999965442 33433333332 3333 


Q ss_pred             CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       265 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                         ..++.+.++||..||+.||++|.++.|+++|.|-+...
T Consensus      1464 ---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1464 ---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             ---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence               35999999999999999999999999999999975543

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-40  Score=320.27  Aligned_cols=245  Identities=30%  Similarity=0.483  Sum_probs=202.7

Q ss_pred             EEEeEEeecCCeEEEEEEEc----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           44 VLGQQLGWGQFGVIRVCSDK----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      ++.+.||.|.||.||.|...    ..+..|+||.+...  ......+.+.+|+++++++ +||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence            56789999999999999987    45678999999543  2444578899999999999 59999999999998888999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||||++|+|.++|...  ..+++.....++.||+.||.|||+++++|+||++.|||++.++.   +||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~---~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ---VKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE---EEEESTTTGEETTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc
Confidence            99999999999999886  67999999999999999999999999999999999999997665   99999999987632


Q ss_pred             CCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          198 GQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       198 ~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ...   .....+...|+|||.+.+. ++.++||||||+++|||++ |+.||...+..++...+..... .+  ....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LP--IPDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TT--SBTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ce--eccchhH
Confidence            211   2234567789999999876 8999999999999999999 7899988888888877755433 22  1246899


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+.++|.+||..||++||++.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-39  Score=325.56  Aligned_cols=257  Identities=28%  Similarity=0.448  Sum_probs=214.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..+.|...+.||+|++|.||+|+++.+++.+|+|.+.............+.+|+++++++. |+|++++++++...+..+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence            4455888899999999999999999999999999987644334444567788999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||+. |+|.+.+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++   .++|+|||++.....
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC---cEEECCcccceeecC
Confidence            9999996 588777754 45689999999999999999999999999999999999997654   499999999887653


Q ss_pred             CCccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      .   ....|++.|+|||.+.+    .++.++|||||||++|+|++|+.||...+.......+.....  +......++..
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  242 (308)
T cd06634         168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEY  242 (308)
T ss_pred             c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccccHH
Confidence            2   34568899999999752    378899999999999999999999987665554444433322  22222467889


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +.++|.+||.++|++||+++++++|+|+....
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            99999999999999999999999999997754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=322.93  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=203.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCC--------------cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCce
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTG--------------EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVV  105 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g--------------~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv  105 (468)
                      +++|++.+.||+|+||.||+|++..++              ..||+|.+....  .......+.+|+++++++. ||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~   80 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNII   80 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcC
Confidence            357999999999999999999875432              358999987542  3344567889999999996 99999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcE
Q 012203          106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKFG------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENI  173 (468)
Q Consensus       106 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NI  173 (468)
                      ++++++...+..++||||+++++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986532            367888999999999999999999999999999999


Q ss_pred             EEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh--CCCCCCCCC
Q 012203          174 LLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS--GMPPFWGNT  247 (468)
Q Consensus       174 Ll~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt--G~~Pf~~~~  247 (468)
                      +++.++.   +||+|||++........   .....+++.|+|||++.++ ++.++|+|||||++|+|++  |..||...+
T Consensus       161 ll~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         161 LVGNHYT---IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             EEcCCCc---EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            9986544   99999999976543321   1123456789999998764 8999999999999999988  678887766


Q ss_pred             hHHHHHHHHhc----cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          248 KSRIFDAVRTA----DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       248 ~~~~~~~i~~~----~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..+....+...    ...........+++.+.+++.+||+.||++||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            66555443221    111111122457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-39  Score=320.63  Aligned_cols=249  Identities=25%  Similarity=0.349  Sum_probs=208.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .++|++.+.||+|+||.||+|.++.     ++..+|+|++....  .......+.+|+.+++++. ||||+++++++.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence            4579999999999999999998753     67899999987542  2334567888999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG----------------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~----------------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      ..+++||||+++|+|.+++....                      .+++..+..++.|++.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                      36788889999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNT  247 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~  247 (468)
                      ||++.++.   ++|+|||++........   .....+++.|+|||++.+. ++.++|||||||++|+|++ |..||.+..
T Consensus       161 il~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         161 CLVGENMV---VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             eEecCCCc---eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99976554   99999999876543221   1223456779999998764 8999999999999999997 889998888


Q ss_pred             hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..+....+....... .  ...++.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~-~--~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVLS-C--PDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCCC-C--CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            877777766554321 1  1467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=320.31  Aligned_cols=253  Identities=33%  Similarity=0.543  Sum_probs=210.7

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |++.+.||+|++|.||+|++..+++.||+|++.... ........+..|+.+++++. |+||+++++++.+.+.+++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence            677889999999999999999999999999998753 12233456778999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-c
Q 012203          123 LCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-S  200 (468)
Q Consensus       123 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~  200 (468)
                      |++ ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.   ++|+|||++....... .
T Consensus        79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~---~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC---EEEecCCcccccCCCccc
Confidence            997 5999999876 57999999999999999999999999999999999999987554   9999999998765432 2


Q ss_pred             cccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc------------------C
Q 012203          201 LLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD------------------L  260 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------~  260 (468)
                      .....++..|+|||++.+  .++.++|+|||||++|+|++|++||...+..+.+..+....                  .
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            334567888999999865  47889999999999999999999998877655544433211                  0


Q ss_pred             CCCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          261 RFPS-------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       261 ~~~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .++.       .....++..+.++|.+||..||++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0110       1123457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.5e-39  Score=311.89  Aligned_cols=246  Identities=26%  Similarity=0.429  Sum_probs=210.1

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCC----cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTG----EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g----~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +.+.+.||.|+||.||+|.+...+    +.+|+|++....  .......+..|+++++++ +|+||+++++++.+.+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence            356789999999999999998766    899999996553  222567888999999999 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++|||+++++|.+++.....  +++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++....
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~---~~l~dfg~~~~~~  154 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLY  154 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe---EEEcccCCceecc
Confidence            99999999999999976544  999999999999999999999999999999999999987654   9999999998765


Q ss_pred             CCCccc--cCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PGQSLL--GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~~~~--~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ......  ...+++.|+|||.+.+. ++.++|+||||+++|+|++ |++||...+.....+.+........   ...++.
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  231 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP  231 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence            442222  13367899999998664 8999999999999999998 8999988888777777765543221   235889


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+++.+||..||++|||+.|+++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2e-39  Score=327.38  Aligned_cols=263  Identities=31%  Similarity=0.533  Sum_probs=212.9

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-C
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-E  114 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-~  114 (468)
                      +-.+.++|++.+.||.|+||.||+|.++.+|+.||+|++.+... .......+..|+++++++. ||||++++++|.. .
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   82 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPL   82 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCC
Confidence            34578899999999999999999999999999999999876432 2233466778999999996 9999999999865 5


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +..|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||.||+++.++.   ++|+|||++..
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~---~~l~dfg~~~~  157 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD---LKICDFGLARI  157 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC---EEeCccccccc
Confidence            6789999998 6789888765 56889999999999999999999999999999999999986544   99999999976


Q ss_pred             ecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--------------
Q 012203          195 IEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA--------------  258 (468)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------  258 (468)
                      ...  ......+++.|+|||++.+  .++.++|+|||||++|+|++|+.||...........+...              
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            533  2234578899999998765  3889999999999999999999999776543322222110              


Q ss_pred             ----------cC--CCC-CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          259 ----------DL--RFP-SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       259 ----------~~--~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                                ..  ..+ ......+++.+.++|++||+.+|++|||+++++.|+||......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                      00  000 01123567899999999999999999999999999999765443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.7e-39  Score=313.97  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=206.4

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..+.|+++++||+|+||.||+|..+ +++.||+|.+.....    ....+.+|+.+++++. ||||+++++++. .+.++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcE
Confidence            5678999999999999999999875 678899999876532    2456888999999996 999999999875 45689


Q ss_pred             EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.   ++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC---CKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC---EEEccCcceeecC
Confidence            999999999999998653  45889999999999999999999999999999999999986554   9999999998765


Q ss_pred             CCCc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PGQS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ....  .....++..|+|||++.+. ++.++||||||+++|+|++ |++||.+.+..+..+.+.... ..+  .....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~  230 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-RMP--RPDNCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCC--CCCCCCH
Confidence            3221  1233566789999998765 8899999999999999999 999998887777766664432 222  2256788


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+++.+||..||++||+++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=313.20  Aligned_cols=242  Identities=27%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||.|++|.||+|...  |+.||+|.+.....    ..+.+.+|+.+++++. |+||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence            46899999999999999999874  88999999976531    4567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~---~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV---AKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC---EEEcccccccccccc
Confidence            99999999999998765  6899999999999999999999999999999999999986554   999999999876432


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      ..  ...++..|+|||.+.+. ++.++|+||||+++|+|++ |..||...+..++...+.... .  ......+++.+.+
T Consensus       156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~  230 (256)
T cd05039         156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-R--MEAPEGCPPEVYK  230 (256)
T ss_pred             cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-C--CCCccCCCHHHHH
Confidence            22  33456679999998764 8889999999999999997 999998887777766655432 1  1122467899999


Q ss_pred             HHHHccccCCCCCCCHHHHHh
Q 012203          277 LVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +|.+||..+|++||++.++++
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-39  Score=320.50  Aligned_cols=247  Identities=25%  Similarity=0.396  Sum_probs=205.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....  .......+.+|+.+++++. ||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence            47889999999999999998753     23578899886543  2334567889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203          117 VHLVMELCAGGELFHRLEKF------------------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      .+++|||+.+++|.+++...                        ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999998652                        247788899999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNT  247 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~  247 (468)
                      ||++.++   .+||+|||+++.......   .....++..|+|||++.+. ++.++||||||+++|+|++ |..||.+..
T Consensus       158 ill~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVAEGR---KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEcCCC---cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9997654   499999999976543221   1233567789999998765 8999999999999999998 999998888


Q ss_pred             hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..++.+.+.... ..+  ....++.++.+++.+||+.||++||+++++++
T Consensus       235 ~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            777776655432 222  23568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-39  Score=317.78  Aligned_cols=250  Identities=20%  Similarity=0.355  Sum_probs=211.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ++|++.+.||.|+||.||+|+.+.     +.+.+++|.+....  .......+.+|+++++++. ||||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence            679999999999999999999764     34679999886542  2224567889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEE
Q 012203          116 YVHLVMELCAGGELFHRLEKFG---------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKL  186 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~---------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL  186 (468)
                      ..++||||+++|+|.+++....         .+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~---~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE---VKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc---EEE
Confidence            9999999999999999998765         6899999999999999999999999999999999999987654   999


Q ss_pred             eecCceeeecCCC--ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 012203          187 ADFGLATYIEPGQ--SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       187 ~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      +|||++.......  ......+++.|+|||.+.+. ++.++||||||+++|+|++ |..||...........+......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999987543221  22334567789999998764 7889999999999999998 899998777777777766555444


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.  ...++..+.+++.+||+.||.+||++.|+++.
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            33  24688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.5e-40  Score=331.38  Aligned_cols=258  Identities=30%  Similarity=0.477  Sum_probs=209.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE---  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~---  114 (468)
                      .+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++++. ||||+++++++...   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~   89 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSG   89 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheecccccC
Confidence            456799999999999999999999999999999999876432 2223456788999999995 99999999998754   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                         ..+++||||+. .+|..++.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||+
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~---~kL~dfg~  163 (342)
T cd07879          90 DEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE---LKILDFGL  163 (342)
T ss_pred             CCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCCC
Confidence               35799999985 47776653  36899999999999999999999999999999999999987554   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD----------  259 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------  259 (468)
                      ++....  ......+++.|+|||++.+  .++.++|+|||||++|||++|+.||.+.+.......+....          
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            876432  2335578899999999876  37889999999999999999999998876554444333211          


Q ss_pred             -------------CCCCCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          260 -------------LRFPSN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       260 -------------~~~~~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                   ...+..    .+...+..+.+||.+||+.||++||++++++.||||....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                         001111    0234678899999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.8e-39  Score=313.84  Aligned_cols=246  Identities=28%  Similarity=0.396  Sum_probs=205.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|++|.||+|.+. ++..+|+|.+.....    ..+.+.+|+.+++++. |+||+++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCCcE
Confidence            3567999999999999999999876 567799999876532    2356889999999995 999999999885 45689


Q ss_pred             EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++|||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   ++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~---~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV---CKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce---EEeCCceeeeecc
Confidence            999999999999999763  45899999999999999999999999999999999999986544   9999999998765


Q ss_pred             CCCcc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PGQSL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .....  ....++..|+|||++.+. ++.++|+||||+++|+|++ |.+||...+..+..+.+.... ..+  .....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~  230 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RMP--CPQDCPI  230 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC--CCCcCCH
Confidence            43211  223456679999998764 8899999999999999999 999998887777777665432 222  2246788


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+.+++.+||.+||++|||++++.+
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.1e-39  Score=312.79  Aligned_cols=241  Identities=25%  Similarity=0.348  Sum_probs=203.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE-EeCCEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY-EDEDYVHL  119 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~-~~~~~~~l  119 (468)
                      .+|++.+.||+|+||.||++...  |..+|+|.+....     ..+.+.+|+.+++++. |+|++++++++ .+.+..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence            46999999999999999999764  7889999986432     2456888999999995 99999999975 45678999


Q ss_pred             EEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +|||+++++|.+++.+.+  .+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc---EEecCCccceeccc
Confidence            999999999999997654  3789999999999999999999999999999999999986554   99999999886543


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ..  ....++..|+|||++.+. ++.++|||||||++|+|++ |+.||...+..+....+.....   ......+++.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  233456789999998775 8899999999999999997 9999988777777766654422   222357889999


Q ss_pred             HHHHHccccCCCCCCCHHHHHh
Q 012203          276 DLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +++.+||..||++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-39  Score=317.78  Aligned_cols=247  Identities=22%  Similarity=0.315  Sum_probs=201.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcE----EEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEV----FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ++|++.+.||+|+||+||+|.+..+++.    +++|.+....  .......+..|+.+++++. ||||+++++++. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GAS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCc
Confidence            4689999999999999999999877764    6666664321  2223456778888899985 999999999875 455


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.   +||+|||+++..
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~---~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI---VQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc---EEEcCCccceec
Confidence            78999999999999999764 56899999999999999999999999999999999999986554   999999999876


Q ss_pred             cCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          196 EPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       196 ~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .....   .....++..|+|||.+.+. ++.++|||||||++|||++ |+.||.+.......+.+...... +.  ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~  236 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL-AQ--PQIC  236 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-CC--CCCC
Confidence            43321   1234567789999998764 8999999999999999998 99999887776666666544322 21  1346


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +..+.+++.+||..||++|||+.|+++
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-39  Score=330.20  Aligned_cols=251  Identities=26%  Similarity=0.411  Sum_probs=200.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEE-----cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSD-----KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-  113 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-  113 (468)
                      .++|++++.||+|+||+||+|.+     ..+++.||+|++....  .......+.+|+.++.++.+||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            35799999999999999999985     3467899999997543  233456788899999999779999999998754 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc---------------------------------------------------------
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF---------------------------------------------------------  136 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------------  136 (468)
                      ...+++|||||++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45789999999999999998642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc---ccc
Q 012203          137 ----------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLG  203 (468)
Q Consensus       137 ----------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~  203 (468)
                                ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++........   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc---EEEEecccccccccCcchhhcCC
Confidence                      13677788899999999999999999999999999999986554   99999999976533221   112


Q ss_pred             CCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChH-HHHHHHHhccCCCCCCCCCCCCHHHHHHHHH
Q 012203          204 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKS-RIFDAVRTADLRFPSNPWDHISDSAKDLVMG  280 (468)
Q Consensus       204 ~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  280 (468)
                      ..+++.|+|||++.+. ++.++||||||+++|+|++ |..||...... .....+.... ..+..  ...++++.+++.+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~  317 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMRAP--DYTTPEMYQTMLD  317 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-CCCCC--CCCCHHHHHHHHH
Confidence            3456779999998765 8999999999999999997 99999765433 2333333222 22211  3467899999999


Q ss_pred             ccccCCCCCCCHHHHHhC
Q 012203          281 MLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       281 ~L~~dP~~Rpt~~eiL~h  298 (468)
                      ||+.||++||++.|+++|
T Consensus       318 cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         318 CWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3e-39  Score=312.52  Aligned_cols=242  Identities=27%  Similarity=0.391  Sum_probs=204.6

Q ss_pred             eEEeecCCeEEEEEEEcC-CCc--EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 012203           47 QQLGWGQFGVIRVCSDKF-TGE--VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL  123 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~-~g~--~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~  123 (468)
                      +.||+|++|.||+|.+.. +++  .||+|.+......  ...+.+.+|++++++++ ||||+++++.+.+ +.+++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999999865 333  6899999876432  55678889999999996 9999999999988 899999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc-
Q 012203          124 CAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-  200 (468)
Q Consensus       124 ~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-  200 (468)
                      +++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.   +||+|||++..+..... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~---~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE---EEeccccccccccccccc
Confidence            99999999997754  6899999999999999999999999999999999999987654   99999999987654221 


Q ss_pred             ---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          201 ---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       201 ---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                         .....++..|+|||++.+. ++.++|||||||++|+|++ |+.||...+..+....+.......+.  ....+..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence               1124577889999998764 8999999999999999998 99999887777777766653333322  245788999


Q ss_pred             HHHHHccccCCCCCCCHHHHHh
Q 012203          276 DLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +++.+||..+|++||+++++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-39  Score=311.24  Aligned_cols=247  Identities=28%  Similarity=0.409  Sum_probs=208.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|++|.||+|.++ +++.+|+|.+.....    ....+.+|+.+++++. ||||+++++++.+....+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceE
Confidence            4678999999999999999999986 567899999875432    3456888999999996 999999999999989999


Q ss_pred             EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.   +||+|||++....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~---~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV---CKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC---EEECccccceecc
Confidence            9999999999999997643  6899999999999999999999999999999999999987654   9999999998765


Q ss_pred             CCCc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PGQS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ....  .....++..|+|||.+.+. ++.++|+||||+++|+|++ |+.||.+.+.....+.+.... ..+.  ....+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~  231 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMPR--PPNCPE  231 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCH
Confidence            3211  1123356789999999865 8899999999999999998 999998887777777665432 2221  235688


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+++.+||..||++||+++++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-39  Score=314.58  Aligned_cols=252  Identities=28%  Similarity=0.490  Sum_probs=209.0

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC--ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      +|.+.+.||+|+||.||++.+..++..+++|++......  .......+..|+.+++++. ||||+++++++.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            699999999999999999999887777777776543221  1223345667899999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          120 VMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      ||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.    +.++|+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence            9999999999998864    356899999999999999999999999999999999999963    34999999999876


Q ss_pred             cCCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          196 EPGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       196 ~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      .... ......|++.|+|||.+.+. ++.++|+||||+++|+|++|..||...........+.....  +. ....++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT--PS-LPETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC--CC-CcchhcHH
Confidence            5432 23345689999999998764 88899999999999999999999977666555555443321  11 12467889


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      +.++|.+||..||++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6e-39  Score=311.77  Aligned_cols=244  Identities=27%  Similarity=0.389  Sum_probs=202.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+++++++. |||++++++++. .+..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcEEE
Confidence            6799999999999999999988754 4689998865432    2356788999999996 999999999885 4568999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~---~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV---CKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe---EEECCCccceEccCC
Confidence            99999999999997643  4789999999999999999999999999999999999986554   999999999876433


Q ss_pred             Cc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          199 QS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       199 ~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      ..  .....++..|+|||.+.+. ++.++|+|||||++|+|++ |+.||.+....+..+.+... ...+  ....++..+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~  232 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMP--CPQGCPESL  232 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC--CCcccCHHH
Confidence            21  1233466789999998764 8899999999999999999 99999887777766665543 2221  224678999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHh
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+++++||.+||++||+++++++
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         233 HELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-39  Score=324.13  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=197.8

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHHH
Q 012203           53 QFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR  132 (468)
Q Consensus        53 ~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~  132 (468)
                      +++.||+++++.+++.||+|++..... .......+.+|++++++++ ||||+++++++.+++..+++|||+++|+|.++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence            556677777777999999999976532 3445678999999999996 99999999999999999999999999999999


Q ss_pred             HHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc--------cc
Q 012203          133 LEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS--------LL  202 (468)
Q Consensus       133 l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--------~~  202 (468)
                      +.+.  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.   +||+|||.+........        ..
T Consensus        90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~---~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK---VVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc---eEEecCccceeeccccccccccccccc
Confidence            9764  45899999999999999999999999999999999999986554   99999998876532211        12


Q ss_pred             cCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhccCC-------CCC-------
Q 012203          203 GTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIF-DAVRTADLR-------FPS-------  264 (468)
Q Consensus       203 ~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~~-------~~~-------  264 (468)
                      ...++..|+|||++.+   .++.++|+|||||++|+|++|+.||......... +.+. ....       .+.       
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  245 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR-GTVPCLLDKSTYPLYEDSMSQ  245 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCccccccCchhhhcCCcCc
Confidence            3457888999999875   3788999999999999999999999765543322 2221 1100       000       


Q ss_pred             ----------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          265 ----------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       265 ----------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                      .....++.++.+|+.+||..||++|||++++++||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                            00112346789999999999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.3e-39  Score=309.22  Aligned_cols=246  Identities=26%  Similarity=0.418  Sum_probs=207.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .+|++.+.||+|++|.||++.+. ++..+|+|++.....    ....+.+|+++++++. ||||+++++++......++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEE
Confidence            36899999999999999999886 577899999875432    2356788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++   .++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~---~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ---VVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC---eEEECCCcceeecccCc
Confidence            9999999999999764 5689999999999999999999999999999999999997654   49999999998654322


Q ss_pred             c--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          200 S--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       200 ~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .  .....++..|+|||++.++ ++.++|+||||+++|+|++ |+.||......+..+.+......+.   ....++.+.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVY  231 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHH
Confidence            1  1233456789999998864 8889999999999999998 9999988877777777655432221   135688999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +++.+||..+|++|||+.+++++
T Consensus       232 ~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         232 ELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHcccChhhCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-39  Score=335.21  Aligned_cols=253  Identities=24%  Similarity=0.352  Sum_probs=205.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      -.++|.+++.||+|+||.||+|++.     .+++.||+|++....  .....+.+.+|+++|.++..||||+++++++..
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            3456889999999999999999864     356789999997642  223345788999999999669999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC--------------------------------------------------------
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFG--------------------------------------------------------  137 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------------  137 (468)
                      .+.+++|||||++|+|.+++.+.+                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999996532                                                        


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEE
Q 012203          138 ------------------------------------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL  175 (468)
Q Consensus       138 ------------------------------------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl  175 (468)
                                                                .+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                      25667788899999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 012203          176 ATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSR  250 (468)
Q Consensus       176 ~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~  250 (468)
                      +.++   .+||+|||+++.......   .....+++.|+|||.+.+. ++.++|||||||++|||++ |..||......+
T Consensus       273 ~~~~---~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         273 CEGK---LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             eCCC---EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            8644   499999999986543221   2234678899999999765 8899999999999999998 899997765555


Q ss_pred             HHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..........+.+  ....++.++.+++.+||.+||.+||+++||++.
T Consensus       350 ~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 QFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433333333222  224678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=312.94  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=216.1

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      .+.+..||.|..|+|++++.+.+|...|||.+.+..  +.+..+++...+.++....+.|+||+.+++|..+..++|.||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            344667999999999999999999999999998763  455566777788888776678999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          123 LCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       123 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      .| +..++.++++ .++++|.-+-.+...++.||.||.+ +||||||+||+|||+|..++   |||||||.+..+-....
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn---iKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC---EEeecccccceeecccc
Confidence            98 4456666644 4679999999999999999999975 58999999999999987666   99999999999887777


Q ss_pred             cccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccCC-CCCCCCCCCCHHH
Q 012203          201 LLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLR-FPSNPWDHISDSA  274 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~-~~~~~~~~~s~~l  274 (468)
                      .....|-+.|||||.+.-    +|+.++||||||+.++||.||..||.+. +..+++..+.+.... ++.  -..+++.+
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~--~~gFSp~F  325 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG--HMGFSPDF  325 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc--ccCcCHHH
Confidence            777889999999999863    3999999999999999999999999874 345666666664332 222  13489999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++|+..||++|+.+||...++|+|||+....
T Consensus       326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            9999999999999999999999999997654

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.2e-39  Score=318.01  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=201.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcC----------------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKF----------------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN  103 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn  103 (468)
                      +++|++.+.||+|+||.||++.+..                ++..+|+|++....  .......+.+|++++++++ |+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence            4679999999999999999986542                34578999987542  2334567889999999996 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203          104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-----------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus       104 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      |+++++++...+.+++||||+++++|.+++....           .+++..+..++.|++.||+|||++|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999997643           36677899999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS--GMPPFWGN  246 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt--G~~Pf~~~  246 (468)
                      ||++.++.   ++|+|||++..+.....   .....+++.|+|||+..+ .++.++|+|||||++|||++  |..||...
T Consensus       161 ili~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLVGKNYT---IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEEcCCCC---EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99986554   99999999986543321   112344678999998765 48999999999999999998  78999776


Q ss_pred             ChHHHHHHHHh----ccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          247 TKSRIFDAVRT----ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       247 ~~~~~~~~i~~----~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +..+.......    ............+++.+.+|+.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            65555443321    1011111112457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-38  Score=307.26  Aligned_cols=241  Identities=24%  Similarity=0.349  Sum_probs=200.8

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      +.||+|+||.||++... +++.+|+|.+....  .......+.+|+++++++. ||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence            36899999999999865 68899999987542  2333456888999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCcc--cc
Q 012203          127 GELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL--LG  203 (468)
Q Consensus       127 gsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~  203 (468)
                      ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++.........  ..
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~---~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV---LKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe---EEECCCccceeccccccccCCC
Confidence            9999998653 45889999999999999999999999999999999999986554   999999999765433211  12


Q ss_pred             CCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHc
Q 012203          204 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM  281 (468)
Q Consensus       204 ~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~  281 (468)
                      ..+++.|+|||++.+. ++.++|+||||+++|+|++ |..||...........+..... .  .....++..+.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-M--SCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHH
Confidence            2446679999998765 8899999999999999998 9999988777666666554321 1  22246889999999999


Q ss_pred             cccCCCCCCCHHHHHh
Q 012203          282 LSTDPSQRLTARQVLD  297 (468)
Q Consensus       282 L~~dP~~Rpt~~eiL~  297 (468)
                      |..+|++||++.|+++
T Consensus       231 l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         231 WDYKPENRPKFSELQK  246 (250)
T ss_pred             cccCcccCCCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.7e-39  Score=311.17  Aligned_cols=240  Identities=23%  Similarity=0.314  Sum_probs=197.4

Q ss_pred             EEeecCCeEEEEEEEc--CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           48 QLGWGQFGVIRVCSDK--FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~--~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.++++++ ||||++++++++ ...+++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            4899999999999775  445679999986542  2334567889999999995 999999999886 457899999999


Q ss_pred             CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCcc---
Q 012203          126 GGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL---  201 (468)
Q Consensus       126 ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---  201 (468)
                      +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.   +||+|||++.........   
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY---AKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc---EEeccCCccccccCCccceec
Confidence            9999999975 456899999999999999999999999999999999999976544   999999999765433211   


Q ss_pred             -ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          202 -LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       202 -~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                       ....+++.|+|||.+.+. ++.++|||||||++|+|++ |..||......+....+..... .+  .....++++.+++
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-LD--CPAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC--CCCCCCHHHHHHH
Confidence             112235789999998764 8899999999999999996 9999988877777666655432 11  1246789999999


Q ss_pred             HHccccCCCCCCCHHHHHh
Q 012203          279 MGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+||..||++||++.++++
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-39  Score=313.45  Aligned_cols=247  Identities=23%  Similarity=0.339  Sum_probs=207.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCc----EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGE----VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      .+|++.+.||+|+||+||+|.++.+|+    .+|+|.+.+..  .......+.+|+.+++++. ||||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence            569999999999999999999877665    58999886653  2344567889999999995 9999999999987 78


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.   +||+|||+++..
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~---~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH---VKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe---EEECCCcccccc
Confidence            99999999999999999774 46899999999999999999999999999999999999986554   999999999876


Q ss_pred             cCCCccc---cCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          196 EPGQSLL---GTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       196 ~~~~~~~---~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .......   ...++..|+|||.+.. .++.++|+||||+++|||++ |+.||......++.+.+..... ++.  ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~  236 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQ--PPIC  236 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCC--CCCC
Confidence            5433221   1223567999999875 48999999999999999998 9999988887777776665422 222  1357


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +..+.+++.+||..||++||++.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.5e-39  Score=313.45  Aligned_cols=250  Identities=21%  Similarity=0.266  Sum_probs=208.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcC----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKF----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-  113 (468)
                      -+++|++.+.||+|+||.||+|.+..    +++.|++|.+...  ........+.+|+.+++++. ||||+++++++.. 
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIED   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecC
Confidence            35789999999999999999999875    3688999987643  24455677889999999995 9999999998765 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEE
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF--------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                      ....++++||+++++|.+++...        ..+++..+..++.|++.||+|||+++++||||||+||+++.++.   +|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~---~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ---VK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc---EE
Confidence            57889999999999999999764        35889999999999999999999999999999999999986544   99


Q ss_pred             EeecCceeeecCCCcc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 012203          186 LADFGLATYIEPGQSL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       186 L~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                      |+|||+++.+......   ....++..|+|||++.+. ++.++|||||||++|++++ |++||...+..++...+... .
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~  236 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-Y  236 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-C
Confidence            9999999866433221   223466789999998765 8999999999999999998 99999887777766655543 2


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .++  ....+++++.+++.+||..||++|||+.++++
T Consensus       237 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 RLA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            222  22457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-38  Score=311.38  Aligned_cols=249  Identities=26%  Similarity=0.361  Sum_probs=205.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +++|.+.+.||+|+||.||+|.+...   ...+++|.+....  .....+.+.+|+.+++++. ||||+++++++.+ +.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence            46799999999999999999987644   4578999886542  2345567889999999996 9999999999875 45


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~---~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC---VKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC---eEEccCceeeec
Confidence            789999999999999997744 5899999999999999999999999999999999999986554   999999999876


Q ss_pred             cCCCccc--cCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          196 EPGQSLL--GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       196 ~~~~~~~--~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      .......  ...+++.|+|||.+.+. ++.++|+||||+++|+|++ |..||...+..+....+......   .....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence            5432211  22345679999998764 8999999999999999996 99999887777666666544321   1225788


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+.+++.+||..+|++|||+.++++.
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9e-39  Score=311.54  Aligned_cols=252  Identities=28%  Similarity=0.463  Sum_probs=210.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcC-CCcEEEEEEeccCcC-------CChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL-------VTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vavK~i~~~~~-------~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      .|++.+.||+|+||.||++.++. +++.+|+|.+.....       ........+.+|+.++.+..+||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37888999999999999999987 688999998864321       1223345677788888765469999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          114 EDYVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      ++..++||||++|++|.+++..    ...+++..++.++.|++.+|.|||+ .|++|+||||+||+++.++.   ++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~---~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc---EEEec
Confidence            9999999999999999988743    3468999999999999999999996 78999999999999986554   99999


Q ss_pred             cCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          189 FGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       189 FGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      ||++.............|+..|+|||++.+. ++.++|+||||+++|+|++|+.||...........+.......  ...
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~  235 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--LPE  235 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--CCc
Confidence            9999876655444566789999999999875 8999999999999999999999998777666666655544332  122


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+++.+.+++.+||+.||++||++.|+..+
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            4678999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2e-38  Score=308.05  Aligned_cols=246  Identities=25%  Similarity=0.394  Sum_probs=205.2

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|+||.||++.+. .+..+++|.+....    .....+.+|+++++++. |+||+++++.+.+ ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeE
Confidence            4678999999999999999999865 56679999886542    23467888999999996 9999999999987 7789


Q ss_pred             EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++|||+++++|.+++.+.  ..+++..+..++.|++.||.|||++|++||||||+||+++.++   .+||+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC---cEEECCCcceeecc
Confidence            999999999999999763  3578888999999999999999999999999999999997655   49999999998764


Q ss_pred             CCCcc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          197 PGQSL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .....  ....++..|+|||++.++ ++.++|+|||||++|+|++ |+.||...+.......+.... ..+  .....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~  230 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMP--RPENCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCC--CcccCCH
Confidence            33221  223456779999999865 8889999999999999998 999998877776666655432 222  2357889


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+++.+||++||++||++.++++
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=307.76  Aligned_cols=241  Identities=26%  Similarity=0.388  Sum_probs=202.2

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      ++||.|++|.||+|.+.. ++.|++|++.....  ......+.+|+++++++. ||||+++++++.+.+..++||||++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999987 99999999876532  234567889999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCcc---c
Q 012203          127 GELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL---L  202 (468)
Q Consensus       127 gsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---~  202 (468)
                      ++|.+++.+. ..+++..+..++.+++.||.|||+++++||||||+|||++.++.   ++|+|||++.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~---~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV---LKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc---EEEeeccccccccCCcceeccc
Confidence            9999999663 46889999999999999999999999999999999999976554   999999999765422211   1


Q ss_pred             cCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHH
Q 012203          203 GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG  280 (468)
Q Consensus       203 ~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~  280 (468)
                      ...++..|+|||++.++ ++.++|+|||||++|+|++ |..||...........+... ...+  ....++.++.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMP--APQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCC--CCccCCHHHHHHHHH
Confidence            12345679999998764 8999999999999999999 89999887766666665543 2222  225678999999999


Q ss_pred             ccccCCCCCCCHHHHHh
Q 012203          281 MLSTDPSQRLTARQVLD  297 (468)
Q Consensus       281 ~L~~dP~~Rpt~~eiL~  297 (468)
                      ||..+|++|||+.|+++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.3e-39  Score=315.87  Aligned_cols=248  Identities=27%  Similarity=0.406  Sum_probs=199.5

Q ss_pred             CeEEEeEEeecCCeEEEEEEE----cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--C
Q 012203           42 RFVLGQQLGWGQFGVIRVCSD----KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--D  115 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~----~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~  115 (468)
                      -|++++.||+|+||.||+|+.    +.+++.||+|.+....  .......+.+|+++++++. ||||+++++++.+.  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence            368899999999999999974    4578999999986542  2334567889999999995 99999999999775  6


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      ..++||||++|++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~---~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC---EEECCCccccc
Confidence            789999999999999999765 35899999999999999999999999999999999999986554   99999999987


Q ss_pred             ecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHHH
Q 012203          195 IEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT---------------KSRIFDA  254 (468)
Q Consensus       195 ~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~---------------~~~~~~~  254 (468)
                      +.....    .....|+..|+|||++.+. ++.++|||||||++|+|++++.|+....               .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            654322    1234567789999998765 8899999999999999999887653211               0111111


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.. ....+  .+..++..+.+|+.+||+.||++||++++++++
T Consensus       239 ~~~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         239 LEE-GKRLP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHc-CccCC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            111 11222  235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-39  Score=315.23  Aligned_cols=240  Identities=22%  Similarity=0.251  Sum_probs=194.0

Q ss_pred             eEEeecCCeEEEEEEEcCCCc-------EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           47 QQLGWGQFGVIRVCSDKFTGE-------VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~-------~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      +.||.|+||.||+|.++..+.       .+++|.+...   .....+.+..|+.+++.+. ||||+++++++...+..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            369999999999999865544       4888877543   2234467788999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC-----CCEEEeecCcee
Q 012203          120 VMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS-----SPIKLADFGLAT  193 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~-----~~ikL~DFGla~  193 (468)
                      ||||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++..     ..++++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999997654 58999999999999999999999999999999999999865431     237999999987


Q ss_pred             eecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGM-PPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .....   ....+++.|+|||++.+  .++.++|||||||++|+|++|. +||...+....... ......++    ...
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~----~~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLP----APK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCC----CCC
Confidence            65432   23568889999999976  3788999999999999999994 66655444433322 22333333    245


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.++.+++.+||++||++|||++++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            5789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=308.86  Aligned_cols=253  Identities=27%  Similarity=0.393  Sum_probs=208.8

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED---  113 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~---  113 (468)
                      ..-.+||++.+.||+|||+.||++++..+++.||+|.+...   ..++.+...+|++..+++. |||+++++++...   
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEK   92 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhc
Confidence            33568999999999999999999999999999999999765   3567788999999999995 9999999887633   


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCEE
Q 012203          114 --EDYVHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       114 --~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~ik  185 (468)
                        ....||+++|...|+|.+.++..    .-+++.++..|+.+|++||++||+..  ++||||||.|||+...   +.++
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~---~~~v  169 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS---GLPV  169 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC---CceE
Confidence              34599999999999999998653    35899999999999999999999998  9999999999999753   4599


Q ss_pred             EeecCceeeec----CCC------ccccCCCCCCCcChhhhcCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCh--H
Q 012203          186 LADFGLATYIE----PGQ------SLLGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGNTK--S  249 (468)
Q Consensus       186 L~DFGla~~~~----~~~------~~~~~~GT~~Y~APE~l~~~----~~~~sDiwSlGvil~elltG~~Pf~~~~~--~  249 (468)
                      |.|||.+....    ...      .......|..|+|||.+.-+    .+.++|||||||+||+|+.|.-||...-.  .
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg  249 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG  249 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence            99999986543    111      11223568899999998753    68899999999999999999999942111  1


Q ss_pred             HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          250 RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .+.-.+.++.+.+|...  .+++.+.++|+.||+.||.+||++.+++.+
T Consensus       250 SlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11223445566777664  599999999999999999999999999864

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.6e-40  Score=316.16  Aligned_cols=265  Identities=29%  Similarity=0.430  Sum_probs=209.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCC----cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-C
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTG----EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-E  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g----~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-~  114 (468)
                      ...|++...||+|.||.||+|..+.++    +.+|+|.++-+...+ .-....-+|+.+++.|+ ||||+.+..+|-. +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELK-HPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence            345999999999999999999766553    378999987653211 12245667999999997 9999999999976 8


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC-CCCEEEee
Q 012203          115 DYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS-SSPIKLAD  188 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~-~~~ikL~D  188 (468)
                      ..++|++||. .-+|.++|+-+     ..++...++.+++||+.|+.|||++-|+||||||.||||..++. .+.|||+|
T Consensus       101 ~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            8999999998 45999999654     35899999999999999999999999999999999999988754 36799999


Q ss_pred             cCceeeecCCC----ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 012203          189 FGLATYIEPGQ----SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK---------SRIFD  253 (468)
Q Consensus       189 FGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~---------~~~~~  253 (468)
                      ||+++.+...-    .....+-|.+|+|||.+.|.  |+.+.|+|+.|||+.||++-.+.|.+...         .+.++
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999876532    23456789999999999985  99999999999999999999888854321         12233


Q ss_pred             HHHhccCCCCCC---------------------CCC------------CCCHHHHHHHHHccccCCCCCCCHHHHHhCcC
Q 012203          254 AVRTADLRFPSN---------------------PWD------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       254 ~i~~~~~~~~~~---------------------~~~------------~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      +|..........                     .+.            .-++.+.+|+.+||.+||.+|+|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            332221111111                     111            12445889999999999999999999999999


Q ss_pred             CCCCCCC
Q 012203          301 MGDGIQD  307 (468)
Q Consensus       301 ~~~~~~~  307 (468)
                      |+...-.
T Consensus       340 F~~d~lp  346 (438)
T KOG0666|consen  340 FTEDPLP  346 (438)
T ss_pred             cccCCCC
Confidence            9876443

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=324.68  Aligned_cols=266  Identities=30%  Similarity=0.456  Sum_probs=214.8

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-C----Cceee
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-P----NVVDL  107 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-p----nIv~l  107 (468)
                      ....+.+.++|.++..+|+|.||.|-.|.+..++..||+|+++.-.    .-.+..+-|+++|+++..+ |    -+|++
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            3445678999999999999999999999999999999999985321    1223455699999999422 3    38899


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC------
Q 012203          108 KAVYEDEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA------  179 (468)
Q Consensus       108 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~------  179 (468)
                      .+||+-.++.|||+|.+ |-++++.|.++  .+|+...++.+++||++++++||+++++|-||||+|||+.+..      
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence            99999999999999998 77999999775  4699999999999999999999999999999999999985321      


Q ss_pred             -----------CCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 012203          180 -----------SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNT  247 (468)
Q Consensus       180 -----------~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~  247 (468)
                                 ....|+|+|||.|.....  ...+.+.|..|.|||++.+ +++.++||||+||||+||.+|...|+..+
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                       123589999999988553  3467789999999999998 79999999999999999999999999887


Q ss_pred             hHHHHHHHHhccCCCCCC----------------CCC--------------------------CCCHHHHHHHHHccccC
Q 012203          248 KSRIFDAVRTADLRFPSN----------------PWD--------------------------HISDSAKDLVMGMLSTD  285 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~----------------~~~--------------------------~~s~~l~~li~~~L~~d  285 (468)
                      ..+.+..+......+|..                .|+                          ..-.++.||+++||.+|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            666443332221111110                000                          01124789999999999


Q ss_pred             CCCCCCHHHHHhCcCCCCCC
Q 012203          286 PSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       286 P~~Rpt~~eiL~h~~~~~~~  305 (468)
                      |.+|+|+.|+|.||||....
T Consensus       394 P~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  394 PARRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccccHHHHhcCHHhhcCC
Confidence            99999999999999997643

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-38  Score=311.99  Aligned_cols=247  Identities=29%  Similarity=0.425  Sum_probs=197.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEE----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 012203           41 ERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--E  114 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~  114 (468)
                      ++|++.+.||+|+||.||+|.    +..+++.||+|.+...   .....+.+.+|+++++++. ||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence            579999999999999999997    4457899999998654   3345567889999999996 9999999998743  4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 DYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      ..+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~---~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR---VKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe---EEECCCcccc
Confidence            5789999999999999999764 46899999999999999999999999999999999999986554   9999999998


Q ss_pred             eecCCCcc----ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH---------------
Q 012203          194 YIEPGQSL----LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFD---------------  253 (468)
Q Consensus       194 ~~~~~~~~----~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~---------------  253 (468)
                      ........    ....++..|+|||++.+. ++.++|||||||++|||++|..|+..... ...+               
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHH
Confidence            76543221    112234569999999875 88999999999999999999877643221 1111               


Q ss_pred             -HHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          254 -AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       254 -~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                       .+......++  ....++.++.+++.+||..+|++|||++|+++
T Consensus       236 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         236 IELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             1111112222  12467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=337.13  Aligned_cols=252  Identities=26%  Similarity=0.370  Sum_probs=212.4

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +...+...+.+.||+|.||+||+|++..   .||||+++.+.. +.+..+.|++|+..+++-+ |-||+-+.|++.....
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL  462 (678)
T ss_pred             ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce
Confidence            3445567789999999999999999864   499999998865 4558899999999999997 9999999999988877


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                       .||..+|+|-+|+.+++-. .+|.....+.|++||++|+.|||.++|||||||..||||.+++.   |||+|||++...
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k---VkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK---VKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc---EEEecccceeee
Confidence             9999999999999999643 46899999999999999999999999999999999999986554   999999998643


Q ss_pred             ---cCCCccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-CCCCC
Q 012203          196 ---EPGQSLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF-PSNPW  267 (468)
Q Consensus       196 ---~~~~~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~  267 (468)
                         ..........|...|||||+++.    .|+..+||||||+++|||++|..||...+.+.++=.+-.+.... .....
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~  618 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR  618 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence               23344455678889999999974    38999999999999999999999998777766654444442221 12233


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ...++++++|+..||.+++++||.+.+||.
T Consensus       619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            567889999999999999999999999986

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.9e-39  Score=310.94  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=201.4

Q ss_pred             eEEeecCCeEEEEEEEcCCC------cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           47 QQLGWGQFGVIRVCSDKFTG------EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g------~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      +.||+|+||.||+|+++..+      +.+|+|.+.+..  .......+.+|+++++++. ||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence            36899999999999986544      789999886542  2234567888999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC--CCCCEEEeecCc
Q 012203          121 MELCAGGELFHRLEKF-------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA--SSSPIKLADFGL  191 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~--~~~~ikL~DFGl  191 (468)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+++++|+||||+||+++.++  ....++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999999642       3378899999999999999999999999999999999998755  223599999999


Q ss_pred             eeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          192 ATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       192 a~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      +........   .....++..|+|||++.+. ++.++|||||||++|+|++ |+.||...+..+....+.... .+  ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~--~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL--QK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc--CC
Confidence            976543321   1123457789999999865 8999999999999999998 999998777766666554432 11  12


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ...++..+.++|.+||.++|.+||+++++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2467899999999999999999999999975

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-38  Score=306.52  Aligned_cols=240  Identities=28%  Similarity=0.430  Sum_probs=201.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||.||++.  .+++.||+|.+....     ....+.+|+.+++++. ||||+++++++..+. .++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEE
Confidence            459999999999999999986  478899999986432     2356888999999996 999999999987654 7999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.   +||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~---~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV---AKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc---EEECCCccceecccc
Confidence            99999999999997653  4789999999999999999999999999999999999986554   999999999765432


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                        ......+..|+|||++.+. ++.++|+|||||++|+|++ |++||......+....+... ...+  ....++..+.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRME--PPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCC--CCCcCCHHHHH
Confidence              2233446679999998764 8999999999999999997 99999888877776666544 2222  23578899999


Q ss_pred             HHHHccccCCCCCCCHHHHHh
Q 012203          277 LVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+||..+|++||+++++++
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.1e-39  Score=308.38  Aligned_cols=228  Identities=28%  Similarity=0.407  Sum_probs=189.4

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHH
Q 012203           52 GQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFH  131 (468)
Q Consensus        52 G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~  131 (468)
                      |.++.||+|+++.+++.||+|.+.+..        ....|...+... .||||+++++++.+.+.+++||||++||+|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999997642        122344444444 49999999999999999999999999999999


Q ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCc
Q 012203          132 RLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI  211 (468)
Q Consensus       132 ~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~  211 (468)
                      ++.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.   ++|+|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH---IQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC---EEEecccchhccccc--cccCCcCcccc
Confidence            9988788999999999999999999999999999999999999987654   999999988665432  23456778899


Q ss_pred             ChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCC
Q 012203          212 APEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL  290 (468)
Q Consensus       212 APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp  290 (468)
                      |||.+.+. ++.++|+||+|+++|+|++|+.||....... .   .......+    ..+++.+.++|.+||++||++|+
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-~---~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-N---THTTLNIP----EWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-c---cccccCCc----ccCCHHHHHHHHHHccCCHHHhc
Confidence            99998764 8899999999999999999999885432210 0   00111122    35788999999999999999999


Q ss_pred             CH-----HHHHhCcCC
Q 012203          291 TA-----RQVLDHSWM  301 (468)
Q Consensus       291 t~-----~eiL~h~~~  301 (468)
                      ++     +++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            86     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-38  Score=308.42  Aligned_cols=244  Identities=21%  Similarity=0.297  Sum_probs=193.0

Q ss_pred             eEEeecCCeEEEEEEEc--CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           47 QQLGWGQFGVIRVCSDK--FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~--~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      +.||+|+||.||+|...  .++..+|+|.+....  .......+.+|+.++++++ ||||+++++++.+...+++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence            36899999999999864  356789999886553  2233457888999999996 999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          125 AGGELFHRLEKFG-----RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       125 ~ggsL~~~l~~~~-----~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ++|+|.+++....     ..++..++.++.|++.||.|||++|++||||||+||+++.++   .+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~---~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL---TVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC---cEEECCccccccccCcc
Confidence            9999999996532     356677888999999999999999999999999999998654   49999999987543322


Q ss_pred             c---cccCCCCCCCcChhhhcC--------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH-hccCCCCCCC
Q 012203          200 S---LLGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR-TADLRFPSNP  266 (468)
Q Consensus       200 ~---~~~~~GT~~Y~APE~l~~--------~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~-~~~~~~~~~~  266 (468)
                      .   .....|++.|+|||++.+        .++.++|+||||+++|||++ |+.||......+...... ......+...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   123467888999999864        24789999999999999996 999997766555443322 2222222221


Q ss_pred             -CCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          267 -WDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       267 -~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                       ....++.+.+++++|+ .+|++|||++||+.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             1246788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-38  Score=307.51  Aligned_cols=244  Identities=23%  Similarity=0.327  Sum_probs=192.5

Q ss_pred             eEEeecCCeEEEEEEEcC--CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           47 QQLGWGQFGVIRVCSDKF--TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~--~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      +.||+|+||.||+|....  ....+++|.+....  .......+.+|+++++.+. ||||+++++.+.+...+|+||||+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeC
Confidence            369999999999996532  34578888775432  2334567788999999995 999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          125 AGGELFHRLEKFG-----RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       125 ~ggsL~~~l~~~~-----~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ++|+|.+++....     .+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS---VKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc---EEEeccccccccccch
Confidence            9999999997643     2467788899999999999999999999999999999987554   9999999987543221


Q ss_pred             c---cccCCCCCCCcChhhhcC--------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH-HhccCCCCCCC
Q 012203          200 S---LLGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV-RTADLRFPSNP  266 (468)
Q Consensus       200 ~---~~~~~GT~~Y~APE~l~~--------~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~  266 (468)
                      .   .....+++.|+|||++..        .++.++|||||||++|||++ |..||......+....+ ......++...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence            1   123356778999999742        26789999999999999999 88898776655554443 33333333222


Q ss_pred             -CCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          267 -WDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       267 -~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                       ...++..+.+++..|+ .||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence             2467888999999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.2e-38  Score=314.41  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=203.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCc----EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGE----VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ++|++.+.||+|+||.||+|.+..+|+    .+|+|.+....  .......+.+|+.+++++. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence            468899999999999999999987776    46888876542  2233456888999999995 99999999998754 4


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~---~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc---eEEccccccccc
Confidence            679999999999999997654 5899999999999999999999999999999999999976554   999999999876


Q ss_pred             cCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          196 EPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       196 ~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .....   .....++..|+|||++.+. ++.++|||||||++|||++ |..||.+.......+.+... ..++.  ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~  236 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ERLPQ--PPIC  236 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCC--CCCC
Confidence            53322   1233457789999998764 8999999999999999997 99999877766665555433 22222  2457


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +..+.+++.+||..||++||++.++++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.8e-38  Score=305.66  Aligned_cols=243  Identities=23%  Similarity=0.295  Sum_probs=194.3

Q ss_pred             eEEeecCCeEEEEEEEcC---CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-eCCEEEEEEe
Q 012203           47 QQLGWGQFGVIRVCSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE-DEDYVHLVME  122 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~---~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~-~~~~~~lV~E  122 (468)
                      +.||+|+||.||+|.+..   .+..+|+|.+...  ........+..|+.+++.+. ||||+++++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence            468999999999998753   3467999987543  23344567888999999995 999999999765 5667899999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC--
Q 012203          123 LCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--  199 (468)
Q Consensus       123 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--  199 (468)
                      |+.+|+|.+++.+. ..+++..+..++.|++.||.|||+++++||||||+|||++.++.   +||+|||++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~---~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT---VKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc---EEECCccccccccCCcce
Confidence            99999999999764 34677888899999999999999999999999999999986544   9999999997654321  


Q ss_pred             ---ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          200 ---SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       200 ---~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                         ......+++.|+|||.+.+ .++.++|||||||++|||++ |.+||...+..+....+..... .+  ....+++.+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-LL--QPEYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-CC--CCCcCCHHH
Confidence               1123356778999999876 48899999999999999999 5677777666666655544322 11  113578899


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .+++.+||..+|++||++.++++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-38  Score=308.19  Aligned_cols=240  Identities=22%  Similarity=0.222  Sum_probs=192.0

Q ss_pred             eEEeecCCeEEEEEEEcC------------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           47 QQLGWGQFGVIRVCSDKF------------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~------------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      +.||+|+||.||+|+...            ....+++|.+...   .......+..|+.+++.+. ||||+++++++..+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            468999999999998532            2235888887554   2233456788899999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC----CCEEEeec
Q 012203          115 DYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS----SPIKLADF  189 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~----~~ikL~DF  189 (468)
                      ...++||||+++|+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++..    ..++++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999999988753 568999999999999999999999999999999999999865421    23899999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILL-SGMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      |++.....   .....|+..|+|||.+..  .++.++|||||||++|+|+ .|..||......+... .........   
T Consensus       157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~---  229 (262)
T cd05077         157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLV---  229 (262)
T ss_pred             CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCC---
Confidence            99875432   224568889999999863  3889999999999999997 5899987655444332 222222211   


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                       ...++++.+|+.+||+.||++||++.+|+++
T Consensus       230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence             2356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=288.51  Aligned_cols=257  Identities=29%  Similarity=0.507  Sum_probs=216.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|.-.++||+|.||+||+|+++.+++.||+|.+..+.. ....-....+||-+|+.|+ |.|||+++++...++.+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence            46667899999999999999999999999999976532 1222356778999999997 999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-C
Q 012203          122 ELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-Q  199 (468)
Q Consensus       122 E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~  199 (468)
                      ||| ..+|..+... ++.+..+.++.++.|+++||.++|++++.|||+||.|+||+.++.   +||+|||+++.+.-. .
T Consensus        81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge---lkladfglarafgipvr  156 (292)
T KOG0662|consen   81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPVR  156 (292)
T ss_pred             HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc---EEecccchhhhcCCceE
Confidence            999 4588887765 467999999999999999999999999999999999999998776   999999999876422 2


Q ss_pred             ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCC--------
Q 012203          200 SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWD--------  268 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~--------  268 (468)
                      -....+-|.+|.+|.++.|.  |+...|+||.|||+.|+.. |++.|.+.+..+.+..|.........+.|.        
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            23456779999999999985  9999999999999999986 889999999888887776543333222222        


Q ss_pred             -----------------CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          269 -----------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       269 -----------------~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                       .++..-+|+++++|.-+|.+|++++++++||||.+.
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                             233446899999999999999999999999999764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-39  Score=355.31  Aligned_cols=258  Identities=31%  Similarity=0.515  Sum_probs=212.2

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC-
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE-  114 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~-  114 (468)
                      .++...+|+.++.||+||||.||+|+++-+|+.||||.|....  .......+.+|+..|.+|. |||||+|+..|.+. 
T Consensus       474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVEST  550 (1351)
T ss_pred             hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccC
Confidence            3567788999999999999999999999999999999997764  4455678899999999995 99999987553100 


Q ss_pred             --------------------------------------------------------------------------------
Q 012203          115 --------------------------------------------------------------------------------  114 (468)
Q Consensus       115 --------------------------------------------------------------------------------  114 (468)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------CEEEEEEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHH
Q 012203          115 --------------------------------------DYVHLVMELCAGGELFHRLEKFGRF-SEAEARVLFMQLMQVV  155 (468)
Q Consensus       115 --------------------------------------~~~~lV~E~~~ggsL~~~l~~~~~l-~~~~~~~i~~qil~aL  155 (468)
                                                            ..+||=||||+...|.++++.+... ....+++++++|++||
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence                                                  1268889999887777777765433 4788999999999999


Q ss_pred             HHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-------------------CCCccccCCCCCCCcChhhh
Q 012203          156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-------------------PGQSLLGTVGSPFYIAPEVL  216 (468)
Q Consensus       156 ~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-------------------~~~~~~~~~GT~~Y~APE~l  216 (468)
                      .|+|+.|||||||||.|||++.+++   |||+|||+|+...                   +.....+.+||-.|+|||++
T Consensus       711 aYIH~~giIHRDLKP~NIFLd~~~~---VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIHDQGIIHRDLKPRNIFLDSRNS---VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHhCceeeccCCcceeEEcCCCC---eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            9999999999999999999997665   9999999997621                   01123456899999999999


Q ss_pred             cC----CCCCcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC
Q 012203          217 AG----GYNQAADVWSAGVILYILLSGMPPFW-GNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT  291 (468)
Q Consensus       217 ~~----~~~~~sDiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt  291 (468)
                      .+    .|+.|+|+||||||++||+.   ||. .+....++..++.+.+.++...+..--+.-..+|++||+.||++|||
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence            75    39999999999999999995   453 34455667777777666664445556667789999999999999999


Q ss_pred             HHHHHhCcCCC
Q 012203          292 ARQVLDHSWMG  302 (468)
Q Consensus       292 ~~eiL~h~~~~  302 (468)
                      |.|+|++.|+-
T Consensus       865 A~eLL~s~llp  875 (1351)
T KOG1035|consen  865 ATELLNSELLP  875 (1351)
T ss_pred             HHHHhhccCCC
Confidence            99999999996

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-38  Score=310.85  Aligned_cols=239  Identities=26%  Similarity=0.258  Sum_probs=193.0

Q ss_pred             EEeecCCeEEEEEEEcCC------------------------CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC
Q 012203           48 QLGWGQFGVIRVCSDKFT------------------------GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN  103 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~~~------------------------g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn  103 (468)
                      .||+|+||.||++....+                        ...|++|++....   ......+.+|+.+++++. |||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence            599999999999975322                        2358888886442   233456778899999986 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC--
Q 012203          104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS--  180 (468)
Q Consensus       104 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~--  180 (468)
                      |+++++++.++...++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.  
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999999965 467899999999999999999999999999999999999986432  


Q ss_pred             --CCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHH
Q 012203          181 --SSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILL-SGMPPFWGNTKSRIFDAV  255 (468)
Q Consensus       181 --~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i  255 (468)
                        ...+||+|||++......   ....++..|+|||.+.+  .++.++|+|||||++|||+ +|+.||......+....+
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence              234899999998654322   23457888999999875  3789999999999999984 799999877665544333


Q ss_pred             HhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          256 RTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       256 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      . .....+    ...++.+.++|.+||+.+|++||++++++++
T Consensus       235 ~-~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 E-KKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             H-hccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            2 222233    2346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-38  Score=305.16  Aligned_cols=237  Identities=26%  Similarity=0.261  Sum_probs=192.7

Q ss_pred             eEEeecCCeEEEEEEEcCCC----------cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           47 QQLGWGQFGVIRVCSDKFTG----------EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g----------~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +.||+|+||.||++.++.++          ..+++|++....    .....+.+|+.+++++. ||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            46999999999999998776          357778765442    11567888999999995 9999999999987 77


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC----CCCCEEEeecCc
Q 012203          117 VHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA----SSSPIKLADFGL  191 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~----~~~~ikL~DFGl  191 (468)
                      .++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++    ....+||+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            899999999999999998766 789999999999999999999999999999999999998765    112599999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      +.....   .....++..|+|||++.+.   ++.++|+|||||++|+|++ |..||...+..+........ ...+    
T Consensus       155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~----  226 (259)
T cd05037         155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLP----  226 (259)
T ss_pred             cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCC----
Confidence            987543   2234577789999998754   7889999999999999999 68888766544333333211 1112    


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ......+.+++.+||..||.+|||+.++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         227 MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            122378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.4e-38  Score=310.04  Aligned_cols=251  Identities=12%  Similarity=0.164  Sum_probs=190.3

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhH--------HHHHHHHHHHHHhcCCCCce
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDE--------RSVKLEIEIMTRLSGHPNVV  105 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~--------~~~~~Ei~iL~~L~~HpnIv  105 (468)
                      +...++|++.+.||+|+||+||+|.+..+   +..+|+|+............        .....+...+..+ +|+||+
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~   86 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP   86 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence            34567899999999999999999999877   67788886543321110010        0111222334445 499999


Q ss_pred             eeeEEEEeCC----EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC
Q 012203          106 DLKAVYEDED----YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       106 ~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~  181 (468)
                      ++++.+....    ..++++|++ ..++.+.+.....+++..++.++.|++.||.|||+++|+||||||+|||++.++. 
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~-  164 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR-  164 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc-
Confidence            9998765443    457889987 4577777776666789999999999999999999999999999999999976544 


Q ss_pred             CCEEEeecCceeeecCCC--------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 012203          182 SPIKLADFGLATYIEPGQ--------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK-SRI  251 (468)
Q Consensus       182 ~~ikL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~  251 (468)
                        ++|+|||+++.+....        ......||+.|+|||++.+. ++.++|||||||++|||++|+.||.+... ...
T Consensus       165 --~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        165 --GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             --EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence              9999999998764221        11234799999999998875 89999999999999999999999977632 222


Q ss_pred             --------HHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          252 --------FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       252 --------~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                              ...+.....     .....++.+.++++.|+..+|++||+++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                    222222222     12456889999999999999999999999975

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.4e-38  Score=308.15  Aligned_cols=248  Identities=28%  Similarity=0.427  Sum_probs=201.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEc----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--C
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDK----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--E  114 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~  114 (468)
                      +.|++.+.||+|+||.||++...    .+++.+|+|++......  .....+.+|+++++++. ||||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence            46888899999999999999864    34889999999765321  34678899999999995 9999999999877  6


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      ...++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC---EEEccccccc
Confidence            68999999999999999997754 5899999999999999999999999999999999999987654   9999999998


Q ss_pred             eecCCCcc----ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH---------------HHHH
Q 012203          194 YIEPGQSL----LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS---------------RIFD  253 (468)
Q Consensus       194 ~~~~~~~~----~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~---------------~~~~  253 (468)
                      ........    ....++..|+|||.+.+. ++.++|+||||+++|+|++|+.||......               .+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76533221    123445679999998764 889999999999999999999998653221               1222


Q ss_pred             HHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       254 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+. .....+.  ...++.++.+++.+||.+||++|||+.|+++
T Consensus       238 ~~~-~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         238 LLK-EGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHH-cCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222 2222222  2467789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-39  Score=330.15  Aligned_cols=252  Identities=27%  Similarity=0.393  Sum_probs=215.4

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCc---E-EEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGE---V-FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~-vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .++..+.++||+|+||.||+|+.+..+.   . ||+|....+.........++.+|.++|+.+. |||||+++|+...+.
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEE  234 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCC
Confidence            3455667899999999999999875432   3 8999887654456777889999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .++||||+|+||+|.++|++.+. ++..+...++.+.+.||+|||++++|||||-..|+|++.++.   +||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~---vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV---VKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe---EEeCccccccC
Confidence            99999999999999999999874 999999999999999999999999999999999999976443   89999999875


Q ss_pred             ecCCCccccC-CCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          195 IEPGQSLLGT-VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       195 ~~~~~~~~~~-~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      -..-...... --...|+|||.+... |+.++|||||||++||+++ |..||.+....++...+.....+.+..  ...+
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p  389 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTP  389 (474)
T ss_pred             CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCH
Confidence            4311111111 234579999999876 9999999999999999999 899999999999999997766665544  3778


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .++..++.+|+..||++||++.++.+
T Consensus       390 ~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  390 KELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHHhccCChhhccCHHHHHH
Confidence            89999999999999999999999865

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.5e-38  Score=304.67  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=201.6

Q ss_pred             eEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC----
Q 012203           43 FVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED----  115 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~----  115 (468)
                      |.+.+.||+|+||.||+|.++   .+++.+|+|++..+.. .....+.+.+|+++++++. ||||+++++++...+    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            677889999999999999865   3578999999976532 3344667888999999996 999999999886432    


Q ss_pred             --EEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          116 --YVHLVMELCAGGELFHRLEKF------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       116 --~~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                        ..++++||+.+|+|..++...      ..+++..++.++.|++.||+|||++||+||||||+||+++.++.   +||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~---~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT---VCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC---EEEC
Confidence              357899999999998887432      24788999999999999999999999999999999999976554   9999


Q ss_pred             ecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 012203          188 DFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       188 DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      |||+++.......   .....+++.|++||.+.+. ++.++|||||||++|+|++ |++||...+..+....+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL-  234 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence            9999987643321   1223456789999998765 7889999999999999999 99999887777776666544321 


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..  ....++.+.+++.+||..+|++||++.+++.+
T Consensus       235 ~~--~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 KQ--PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11  13577899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6e-37  Score=299.52  Aligned_cols=244  Identities=18%  Similarity=0.243  Sum_probs=190.8

Q ss_pred             eEEeecCCeEEEEEEEcCC--CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           47 QQLGWGQFGVIRVCSDKFT--GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~--g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      +.||+|+||.||++.....  ...+++|.+....  .......+.+|+.+++.+. ||||+++++.+.+....|+||||+
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecC
Confidence            3699999999999976433  2356677665442  2334567889999999995 999999999999999999999999


Q ss_pred             CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          125 AGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       125 ~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      ++|+|.+++.+.    ..+++..++.++.||+.||.|||+++++||||||+|||++.++.   ++|+|||++....... 
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~---~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT---VKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc---EEecccccccccCcchh
Confidence            999999999764    23567778899999999999999999999999999999976554   9999999986432211 


Q ss_pred             --ccccCCCCCCCcChhhhcC--------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc-cCCCCC-CC
Q 012203          200 --SLLGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA-DLRFPS-NP  266 (468)
Q Consensus       200 --~~~~~~GT~~Y~APE~l~~--------~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~-~~  266 (468)
                        .....+|++.|+|||++..        .++.++|||||||++|||++ |..||......+.+..+... ....+. ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence              1234578899999999743        24679999999999999997 57788776666655554333 222221 11


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ...+++.+.+++..|+ .+|++||+++++++
T Consensus       235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            2357889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=330.79  Aligned_cols=257  Identities=26%  Similarity=0.471  Sum_probs=219.4

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----eC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE-----DE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~-----~~  114 (468)
                      .+.|++.+.||.|.+|.||+++++.+++..|+||....    .+..++++.|.+||+.+.+|||++.++++|-     ..
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            45699999999999999999999999999999998654    2345678889999999999999999999984     34


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.+|||||||.||+.-+++++.  .++.|+.+..|++.++.||.+||.+.++|||||-.|||++.++.   |||.|||++
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~---VKLvDFGvS  170 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE---VKLVDFGVS  170 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc---EEEeeeeee
Confidence            6899999999999999999764  57899999999999999999999999999999999999998776   999999999


Q ss_pred             eeecCCC-ccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhccCCCCC
Q 012203          193 TYIEPGQ-SLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-RTADLRFPS  264 (468)
Q Consensus       193 ~~~~~~~-~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i-~~~~~~~~~  264 (468)
                      ..+.... ...+.+|||.|||||++..      .|+.++|+||||++..||--|.+|+..+-+...+=.| .+..++  .
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk--L  248 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK--L  248 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc--c
Confidence            8876543 3457799999999999975      2788999999999999999999999766554333222 222111  1


Q ss_pred             CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       265 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..|..+++++.++|..||.+|-.+||+..++|+|||+++..
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            23567899999999999999999999999999999998543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.5e-38  Score=333.84  Aligned_cols=246  Identities=24%  Similarity=0.431  Sum_probs=212.5

Q ss_pred             CeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+..+.||+|+||+||+|+..     .....||||.++...  .......|++|+++|..|. |||||+|+|++.+++.
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGDP  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCCe
Confidence            3566789999999999999864     345789999987763  3446789999999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC----------C----CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          117 VHLVMELCAGGELFHRLEKFG----------R----FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~----------~----l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      +|||+|||..|+|.++|..+.          .    ++..+...++.||+.|++||-++.++||||-..|.||..+.   
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l---  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL---  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce---
Confidence            999999999999999996542          2    78889999999999999999999999999999999997554   


Q ss_pred             CEEEeecCceeeecCCCccc---cCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 012203          183 PIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT  257 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~~---~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~  257 (468)
                      .|||+|||+++.+.......   ...-...|||||.+.. +|+.++||||+||+|||+++ |+.||.+...+++++.+++
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            49999999998765433221   1223457999998765 69999999999999999997 9999999999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 012203          258 ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL  296 (468)
Q Consensus       258 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL  296 (468)
                      +.. ++..  ..+|.++.+|+..||+.+|.+||++.||-
T Consensus       721 g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  721 GQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            987 4443  68999999999999999999999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.1e-36  Score=285.65  Aligned_cols=242  Identities=48%  Similarity=0.795  Sum_probs=209.1

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHHH
Q 012203           53 QFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR  132 (468)
Q Consensus        53 ~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~  132 (468)
                      +||.||+|.+..+|+.+++|++........  .+.+.+|++.++++ +|+||+++++.+......++++||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            589999999998999999999976543221  57888999999999 599999999999999999999999999999999


Q ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcC
Q 012203          133 LEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA  212 (468)
Q Consensus       133 l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~A  212 (468)
                      +.....+++..+..++.+++.++.+||+.+++|+||+|.||+++.++   .++|+|||.+.............++..|++
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG---HVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC---cEEEccccceeeeccccccccccCCcCCCC
Confidence            98866689999999999999999999999999999999999998764   499999999998776555566788999999


Q ss_pred             hhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCC
Q 012203          213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL  290 (468)
Q Consensus       213 PE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp  290 (468)
                      ||.+.+ .++.++|+|+||+++|+|++|..||.. .......+.+......... .+..++.++.+++.+||..||++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCchhcc
Confidence            999975 488899999999999999999999977 5556666655544443322 1222888999999999999999999


Q ss_pred             CHHHHHhCcCC
Q 012203          291 TARQVLDHSWM  301 (468)
Q Consensus       291 t~~eiL~h~~~  301 (468)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-39  Score=301.66  Aligned_cols=261  Identities=28%  Similarity=0.450  Sum_probs=212.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe------
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED------  113 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~------  113 (468)
                      -..|+-..+||+|.||.||+|+.+.+|+.||+|++-.+.. ....-....+|+.+|+.|+ |+|++.+++.+..      
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTN   93 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcc
Confidence            3457778899999999999999999999999987654321 1112234567999999997 9999999888743      


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          114 --EDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       114 --~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                        ...+|+||.+|+ -+|..++... -+|+..++..++.+++.||.|+|++.|+|||+|++|+||+.++.   +||+|||
T Consensus        94 r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi---lklADFG  169 (376)
T KOG0669|consen   94 RDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI---LKLADFG  169 (376)
T ss_pred             cccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce---EEeeccc
Confidence              345999999995 5898888665 67999999999999999999999999999999999999987655   9999999


Q ss_pred             ceeeecCCCc-----cccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 012203          191 LATYIEPGQS-----LLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       191 la~~~~~~~~-----~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                      +++.+.....     ....+-|.+|++||.+.|.  |+++.|||..|||+.||+++.+-+.+++....+..|......+.
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            9976543221     2234569999999999984  99999999999999999999999999998888887765443333


Q ss_pred             CCCCCC-------------------------------CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          264 SNPWDH-------------------------------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       264 ~~~~~~-------------------------------~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      .+.|+.                               -++++.+|+.+||..||.+|++++++++|.||.....
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            333321                               1347889999999999999999999999999977543

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=326.88  Aligned_cols=245  Identities=31%  Similarity=0.477  Sum_probs=198.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-----
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-----  115 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-----  115 (468)
                      .-+...+.||+|+||.||.++++.+|+.||||.+.+..  .....+..-+|+++|++|. |||||++.++=++..     
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccc
Confidence            34666789999999999999999999999999998764  3445677788999999996 999999999876544     


Q ss_pred             -EEEEEEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC-CCCCEEEeecC
Q 012203          116 -YVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFG  190 (468)
Q Consensus       116 -~~~lV~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~-~~~~ikL~DFG  190 (468)
                       ...+|||||.||+|+.+|++.   ..+++.+.+.++.++..||.|||++||+||||||.||++.... .....||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             567999999999999999653   4599999999999999999999999999999999999996533 22346999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhcc----
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLA--GGYNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTAD----  259 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~~~~----  259 (468)
                      .|+.+..+....+..||+.|++||++.  +.|+..+|.|||||++|+..||..||......     -++..+....    
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            999999988889999999999999998  35899999999999999999999999543222     3333332211    


Q ss_pred             ----------CC----CCCCCCCCCCH----HHHHHHHHccccCCCCCC
Q 012203          260 ----------LR----FPSNPWDHISD----SAKDLVMGMLSTDPSQRL  290 (468)
Q Consensus       260 ----------~~----~~~~~~~~~s~----~l~~li~~~L~~dP~~Rp  290 (468)
                                ..    +|.  ...++.    .+...+..+|.-||.+|.
T Consensus       250 i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                      11    111  112222    345677888889999998

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=314.12  Aligned_cols=264  Identities=29%  Similarity=0.482  Sum_probs=222.8

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhH----HHHHHHHHHHHHhcCCCCceeeeEEEE-
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE----RSVKLEIEIMTRLSGHPNVVDLKAVYE-  112 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~----~~~~~Ei~iL~~L~~HpnIv~l~~~~~-  112 (468)
                      .|.+||-+++.||+|||+.||+|.+...++.||||+-.....+..+..    +...+|.+|-+.| +||.||++|++|. 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSL  538 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeee
Confidence            367899999999999999999999999999999999766543332222    3355689999999 5999999999996 


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--CcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI--GVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      +.+.+|-|+|||+|.+|+-+|+.++.+++.+++.|+.||+.||.||.+.  -|||-||||.||||......+.|||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            5678999999999999999999999999999999999999999999976  59999999999999766556789999999


Q ss_pred             ceeeecCCCc--------cccCCCCCCCcChhhhcC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHH--
Q 012203          191 LATYIEPGQS--------LLGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDA--  254 (468)
Q Consensus       191 la~~~~~~~~--------~~~~~GT~~Y~APE~l~~-----~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~--  254 (468)
                      +++.+.....        .....||.+|++||.+.-     +.+.|+||||.|||+|.-++|+.||..+. ..++++.  
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            9998865432        234579999999998752     26889999999999999999999996543 3344433  


Q ss_pred             -HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          255 -VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       255 -i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                       +.+....||..  ..++.++++||++||.+--+.|....++..||+|.-+
T Consensus       699 IlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  699 ILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence             34556677776  4789999999999999999999999999999998543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.6e-36  Score=325.06  Aligned_cols=257  Identities=22%  Similarity=0.253  Sum_probs=180.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCC----CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFT----GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV----  110 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~----g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~----  110 (468)
                      -.++|++.+.||+|+||.||+|++..+    +..||+|.+.....     .+....|  .+++.. +.+++.+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRAC-PNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhc-hhhHHHHHHhhhcc
Confidence            567899999999999999999999988    99999998754321     1111111  112221 2333332222    


Q ss_pred             --EEeCCEEEEEEeccCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCcEeccc
Q 012203          111 --YEDEDYVHLVMELCAGGELFHRLEKFGR--------------------FSEAEARVLFMQLMQVVLYCHEIGVVHRDL  168 (468)
Q Consensus       111 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------l~~~~~~~i~~qil~aL~~LH~~gIiHrDI  168 (468)
                        ......++|||||+.+++|.+++.....                    .....+..++.||+.||.|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              2456789999999999999999875321                    123346679999999999999999999999


Q ss_pred             CCCcEEEeecCCCCCEEEeecCceeeecCCC--ccccCCCCCCCcChhhhcC-----------------------CCCCc
Q 012203          169 KPENILLATKASSSPIKLADFGLATYIEPGQ--SLLGTVGSPFYIAPEVLAG-----------------------GYNQA  223 (468)
Q Consensus       169 Kp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~-----------------------~~~~~  223 (468)
                      ||+|||++.+  .+.+||+|||+++.+..+.  .....+||+.|+|||.+..                       +++.+
T Consensus       282 KP~NILl~~~--~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        282 KPQNIIFSEG--SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CHHHEEEeCC--CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            9999999753  2349999999998654332  2345689999999997632                       13446


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-------CC----------CCCCCCCHHHHHHHHHccccCC
Q 012203          224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF-------PS----------NPWDHISDSAKDLVMGMLSTDP  286 (468)
Q Consensus       224 sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------~~----------~~~~~~s~~l~~li~~~L~~dP  286 (468)
                      +|||||||++|||+++..|+... .......+......+       +.          ...+.......+||.+||++||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            79999999999999987775321 122222222211110       00          0011223456699999999999


Q ss_pred             CCCCCHHHHHhCcCCCCCCC
Q 012203          287 SQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       287 ~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      .+|||++|+|+||||.....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999977543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=297.85  Aligned_cols=258  Identities=24%  Similarity=0.331  Sum_probs=212.2

Q ss_pred             EEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEec
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL  123 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~  123 (468)
                      +-+..||.|+||+|++-.++.+|+..|||.|.....  ..+..++..|.+...+-.+.||||++++....++..||.||+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            335689999999999999999999999999987643  455678888999888888899999999999999999999999


Q ss_pred             cCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          124 CAGGELFHRLE-----KFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       124 ~~ggsL~~~l~-----~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      | ..+|..+.+     +...++|+-.-.+....+.||.||.+ ..||||||||+||||+..|.   |||||||.+..+..
T Consensus       145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~---vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD---VKLCDFGICGQLVD  220 (361)
T ss_pred             H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC---EeeecccchHhHHH
Confidence            9 567765543     23568999989999999999999975 58999999999999998776   99999999987765


Q ss_pred             CCccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCCCCCCC--CCCCC
Q 012203          198 GQSLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSNP--WDHIS  271 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~--~~~~s  271 (468)
                      .-......|-..|||||.+..   +|+.++|+||||++|||+.||..|+...+. .+.+.++..++.......  ...++
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS  300 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence            444445578888999999964   499999999999999999999999976543 233344444444322111  23578


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                      ..+..+|..||.+|-+.||...+++++||++.....
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence            899999999999999999999999999999876543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=330.72  Aligned_cols=249  Identities=25%  Similarity=0.387  Sum_probs=212.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCC-Cc----EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFT-GE----VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~----~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .....+.+.||+|.||.||.|..... |.    .||+|.+.+.  .+..+...|.+|..+|+++. |||||+++|++-+.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence            45677889999999999999987643 32    3788877655  45677889999999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          115 DYVHLVMELCAGGELFHRLEKF-------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      ...+|++|||.||+|..+|++.       ..++..+...++.||++|+.||+++++|||||-..|+||+..   ..+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~---r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER---RVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc---CcEEEc
Confidence            9999999999999999999886       248899999999999999999999999999999999999865   559999


Q ss_pred             ecCceeeecCCCcc-ccCCC--CCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 012203          188 DFGLATYIEPGQSL-LGTVG--SPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       188 DFGla~~~~~~~~~-~~~~G--T~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      |||+|+.+...+.. ..-.+  ...|||||.+.. .++.|+|||||||++||+++ |..||.+....+++.....+. ++
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence            99999954433221 11112  246999999985 49999999999999999998 999999999988888666655 44


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +..  ..+++.+.+++..||+.+|++||++..|++
T Consensus       924 ~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 DPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            433  689999999999999999999999999997

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.8e-37  Score=285.84  Aligned_cols=254  Identities=24%  Similarity=0.521  Sum_probs=211.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DY  116 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~  116 (468)
                      -.++|++++++|+|-++.|+.|.+..+++.++||+++.-      ..+.+.+|+.||+.|++||||++++++..+.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            356799999999999999999999999999999998543      3578899999999999999999999999765  56


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ..||+||+.+.+...+..   .++...++.++.+++.||.|||+.||+|||+||.|++||....  .++|+|+|+|..+.
T Consensus       110 paLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r--kLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYH  184 (338)
T ss_pred             chhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc--eeeeeecchHhhcC
Confidence            789999998877766554   4888899999999999999999999999999999999986443  49999999999999


Q ss_pred             CCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHH-------------HhccC
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-GNTKSRIFDAV-------------RTADL  260 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~-~~~~~~~~~~i-------------~~~~~  260 (468)
                      ++......+.+..|.-||.+..  .|+..-|+|||||++..|+..+.||. +.+..+.+-.|             .+-.+
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            9888888889999999999976  48999999999999999999999984 33332222222             11111


Q ss_pred             CCC-----------CCCC---------CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          261 RFP-----------SNPW---------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       261 ~~~-----------~~~~---------~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .++           ...|         ...++++.||+.++|.+|-.+|+|++|++.||||..
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence            111           1111         235689999999999999999999999999999954

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=312.58  Aligned_cols=259  Identities=21%  Similarity=0.283  Sum_probs=189.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEc----------------CCCcEEEEEEeccCcCCChh-----------hHHHHHHH
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDK----------------FTGEVFACKSIAKDRLVTID-----------DERSVKLE   91 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~g~~vavK~i~~~~~~~~~-----------~~~~~~~E   91 (468)
                      -.++|++.++||+|+||+||+|.+.                ..++.||||.+.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3668999999999999999999752                34568999998653211100           11223447


Q ss_pred             HHHHHHhcCCCC-----ceeeeEEEEe--------CCEEEEEEeccCCCCHHHHHHHcC---------------------
Q 012203           92 IEIMTRLSGHPN-----VVDLKAVYED--------EDYVHLVMELCAGGELFHRLEKFG---------------------  137 (468)
Q Consensus        92 i~iL~~L~~Hpn-----Iv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~---------------------  137 (468)
                      +.++.+++ |.+     +++++++|..        .+..+|||||+++++|.++++...                     
T Consensus       223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            77788886 444     3667777643        356899999999999999886421                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccC--CCCCCCcC
Q 012203          138 ---RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA  212 (468)
Q Consensus       138 ---~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~--~GT~~Y~A  212 (468)
                         .+++..++.++.|++.+|.|||+++|+||||||+|||++.++.   +||+|||++.....+......  .+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc---EEEEeCcCccccccCCccCccccCCCcceeC
Confidence               2356678889999999999999999999999999999987554   999999999765543333332  34899999


Q ss_pred             hhhhcCC---------------------CC--CcchHHHHHHHHHHHHhCCC-CCCCCChH-----------HHHHHHHh
Q 012203          213 PEVLAGG---------------------YN--QAADVWSAGVILYILLSGMP-PFWGNTKS-----------RIFDAVRT  257 (468)
Q Consensus       213 PE~l~~~---------------------~~--~~sDiwSlGvil~elltG~~-Pf~~~~~~-----------~~~~~i~~  257 (468)
                      ||++...                     |+  .+.|+||+||++|+|++|.. ||......           ...+.+..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            9987531                     11  24799999999999999986 76432110           11112222


Q ss_pred             ccCCCCCCCCCCCCHHHHHHHHHccccCC---CCCCCHHHHHhCcCCCC
Q 012203          258 ADLRFPSNPWDHISDSAKDLVMGMLSTDP---SQRLTARQVLDHSWMGD  303 (468)
Q Consensus       258 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP---~~Rpt~~eiL~h~~~~~  303 (468)
                      ....++  .++..++.++||+.+||.++|   .+|+|++|+|+||||..
T Consensus       459 ~~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        459 QKYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cCCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            233333  467789999999999999876   68999999999999964

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.8e-37  Score=311.45  Aligned_cols=268  Identities=28%  Similarity=0.438  Sum_probs=224.5

Q ss_pred             hhhcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc-----CCC
Q 012203           28 ETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-----GHP  102 (468)
Q Consensus        28 ~~i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-----~Hp  102 (468)
                      +........+.|..+|.+.-..|+|-|++|..|.+..-|+.||||||..+.+    -.+.=..|++||++|.     +--
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~  494 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKF  494 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhh
Confidence            3344555567788999999999999999999999998999999999976532    2344567999999996     234


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       103 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      |+++|+..|...+++|||+|-+ ..+|.++|++.+.   +....++.|+.|++.||..|...||+|.||||.|||++...
T Consensus       495 Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  495 HCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence            8999999999999999999998 6799999998765   88899999999999999999999999999999999997543


Q ss_pred             CCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 012203          180 SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA  258 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  258 (468)
                        ..+||||||.|...... ....+.-+..|.|||++.|- |+...|+||.||+||||.||+..|.+.+..+++......
T Consensus       574 --~iLKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  574 --NILKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             --ceeeeccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence              46899999999876643 34455667789999999984 999999999999999999999999999998888776655


Q ss_pred             cCCCCCCCCC-------------------------------------------------CC-------CHHHHHHHHHcc
Q 012203          259 DLRFPSNPWD-------------------------------------------------HI-------SDSAKDLVMGML  282 (468)
Q Consensus       259 ~~~~~~~~~~-------------------------------------------------~~-------s~~l~~li~~~L  282 (468)
                      ...||.....                                                 .+       -..+++|+.+||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            4444422100                                                 01       124889999999


Q ss_pred             ccCCCCCCCHHHHHhCcCCCC
Q 012203          283 STDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       283 ~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ..||.+|.|..++|.||||+.
T Consensus       731 ~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  731 ILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ccChhhcCCHHHHhcCCcccC
Confidence            999999999999999999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=297.52  Aligned_cols=264  Identities=26%  Similarity=0.448  Sum_probs=201.3

Q ss_pred             cccc-CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-------CCceeee
Q 012203           37 SNLR-ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-------PNVVDLK  108 (468)
Q Consensus        37 ~~l~-~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-------pnIv~l~  108 (468)
                      +.++ .||.+.++||+|-|++||+|+|..+.+.||+|+.+....    -.+....||++|++++.+       .+||+|+
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            4566 899999999999999999999999999999999875532    234567799999998733       2699999


Q ss_pred             EEEEe----CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCC
Q 012203          109 AVYED----EDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       109 ~~~~~----~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~  181 (468)
                      +.|..    ..++|||+|++ |.+|..+|.+.  +.++...++.|++||+.||.|||+ .||||-||||+|||+.....+
T Consensus       149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~  227 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEID  227 (590)
T ss_pred             ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccc
Confidence            99974    46899999998 88999999775  459999999999999999999996 599999999999998432000


Q ss_pred             --------------------------------------------------------------------------------
Q 012203          182 --------------------------------------------------------------------------------  181 (468)
Q Consensus       182 --------------------------------------------------------------------------------  181 (468)
                                                                                                      
T Consensus       228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~  307 (590)
T KOG1290|consen  228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP  307 (590)
T ss_pred             hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 012203          182 --------------------------------------------------------------------------------  181 (468)
Q Consensus       182 --------------------------------------------------------------------------------  181 (468)
                                                                                                      
T Consensus       308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~  387 (590)
T KOG1290|consen  308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP  387 (590)
T ss_pred             CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence                                                                                            


Q ss_pred             ---CCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh------HHH
Q 012203          182 ---SPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK------SRI  251 (468)
Q Consensus       182 ---~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~------~~~  251 (468)
                         -.|||+|||-|.....  .....+.|..|+|||++.| +|+..+||||++|++|||+||...|.....      ++.
T Consensus       388 ~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  388 ECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             ccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence               0145555555554331  2223467889999999998 599999999999999999999999953321      122


Q ss_pred             HHHHHhccCCCC-------------------------CCCCC-------------CCCHHHHHHHHHccccCCCCCCCHH
Q 012203          252 FDAVRTADLRFP-------------------------SNPWD-------------HISDSAKDLVMGMLSTDPSQRLTAR  293 (468)
Q Consensus       252 ~~~i~~~~~~~~-------------------------~~~~~-------------~~s~~l~~li~~~L~~dP~~Rpt~~  293 (468)
                      +..|.......|                         -.+|.             ....++.+|+.-||+.+|++|+||.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence            222211110000                         01111             1234588999999999999999999


Q ss_pred             HHHhCcCCCCCCCC
Q 012203          294 QVLDHSWMGDGIQD  307 (468)
Q Consensus       294 eiL~h~~~~~~~~~  307 (468)
                      ++|+|||+......
T Consensus       546 ~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  546 QCLKHPWLNPVAGP  559 (590)
T ss_pred             HHhcCccccCCCCC
Confidence            99999999876543

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=300.00  Aligned_cols=254  Identities=28%  Similarity=0.433  Sum_probs=210.6

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcC--CC--cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKF--TG--EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~--~g--~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      ...+--++...+.+.||.|.||.||.|....  .|  -.||||.-+.+.  ..++.+.|..|.-+|+++. ||||++++|
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfd-HphIikLIG  458 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFD-HPHIIKLIG  458 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCC-Ccchhheee
Confidence            3444455666667899999999999997532  33  357788776653  4566889999999999995 999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          110 VYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       110 ~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      ++.+. ..|||||+++-|.|.++|+.+ ..++......|+.||..||.|||++.++||||-..|||+.+..-   |||+|
T Consensus       459 v~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C---VKLaD  534 (974)
T KOG4257|consen  459 VCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC---VKLAD  534 (974)
T ss_pred             eeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce---eeecc
Confidence            99754 689999999999999999775 45888999999999999999999999999999999999976554   99999


Q ss_pred             cCceeeecCCCccccCCC--CCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC
Q 012203          189 FGLATYIEPGQSLLGTVG--SPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPS  264 (468)
Q Consensus       189 FGla~~~~~~~~~~~~~G--T~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  264 (468)
                      ||+++.+..........|  ..-|||||-++-. ++.++|||-|||++||++. |..||.+-...+..-.+.+++ ++|.
T Consensus       535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe-RlP~  613 (974)
T KOG4257|consen  535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE-RLPC  613 (974)
T ss_pred             cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC-CCCC
Confidence            999999876654444343  3459999999864 9999999999999999876 999999988777776666664 3333


Q ss_pred             CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       265 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .  +.+|+.+..|..+||.+||.+||++.+|..
T Consensus       614 P--~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  614 P--PNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             C--CCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            2  589999999999999999999999887753

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=287.16  Aligned_cols=255  Identities=27%  Similarity=0.476  Sum_probs=210.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE----  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~----  114 (468)
                      ...||.-++.+|.|.- .|..|-|.-.++.||+|..... .......++..+|...+..+. |+||++++.+|.-.    
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHH
Confidence            4467899999999998 8888889889999999998877 445566778889999999995 99999999999533    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 --DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 --~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                        ..+|+||||+ ..+|.+.+..  .++-..+..++.|++.|++|||+.||+||||||+||++..+..   +||.|||+|
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~---lKi~dfg~a  165 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT---LKILDFGLA  165 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh---eeeccchhh
Confidence              4689999999 5699988874  5778889999999999999999999999999999999976554   999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc------------
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD------------  259 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------  259 (468)
                      +..+..-....++.|..|.|||++.+ +|...+||||+||++.||++|+..|.+.+.-+.+.++....            
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            98776655667899999999999987 59999999999999999999999998776544443331110            


Q ss_pred             ---------------C----CCCCCCCC-------CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          260 ---------------L----RFPSNPWD-------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       260 ---------------~----~~~~~~~~-------~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                                     .    .+|...|.       .-+..+++++.+||..||++|.+++++|.|||++
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                           0    11211111       1234689999999999999999999999999997

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=303.59  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=213.0

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcC-CC--cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKF-TG--EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~-~g--~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++.++||+|.||+|+.+.++. +|  -.||||++..+.+..  ....|.+|+.+|.+|+ |||+++||++..+ ....
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhh
Confidence            35566789999999999998864 33  368999998775432  5678999999999996 9999999999987 6789


Q ss_pred             EEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEK--FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ||||++++|+|.+.|++  ...|.......|+.||+.|+.||..+++|||||-..||||...   ..|||+||||.+.+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp---rtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP---RTVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc---ceeeeecccceeccC
Confidence            99999999999999987  3458888999999999999999999999999999999999763   459999999999887


Q ss_pred             CCCccccCC----CCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          197 PGQSLLGTV----GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       197 ~~~~~~~~~----GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .++......    -...|+|||.++. +++.++|+|++||++|||++ |..||.+-....+++.|.. ..+++..  ..+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~-~erLpRP--k~c  340 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA-GERLPRP--KYC  340 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc-cccCCCC--CCC
Confidence            766554332    2345999999987 59999999999999999998 8999999999999999883 3344433  579


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ++.+.++++.||..+|.+|||+..|.+..++
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            9999999999999999999999999755444

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=306.52  Aligned_cols=248  Identities=25%  Similarity=0.450  Sum_probs=217.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCC---cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTG---EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ...|.+.||.|.||.||.++.+..|   ..||||.++..  ........|..|..||.++. ||||++|.++....+-+.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeE
Confidence            4678899999999999999998666   47899998765  35667789999999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||.|||++|+|+.+|+++ +.|...+..-+++.|+.|++||-+.+++||||-..||||+.+--   +|++|||+++.+..
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv---CKVsDFGLSRvled  783 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLED  783 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE---EEeccccceeeccc
Confidence            999999999999999765 67999999999999999999999999999999999999986554   99999999998754


Q ss_pred             CC-ccccCCC---CCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          198 GQ-SLLGTVG---SPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       198 ~~-~~~~~~G---T~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      +. ...+..|   ...|.|||.+.. +++.++||||+||++||.++ |..|||.++..+.++.|..+ +++|..  .++|
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g-yRLPpP--mDCP  860 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG-YRLPPP--MDCP  860 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc-cCCCCC--CCCc
Confidence            43 2222222   357999999986 59999999999999999665 99999999999999998766 566644  5899


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+..|+..||++|-.+||++.||+.+
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=330.70  Aligned_cols=240  Identities=24%  Similarity=0.287  Sum_probs=185.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ..|...+.||+|+||.||+|+++.+++.||+|.+.....       ....|++++++++ |||||++++++.+.+..|+|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEE
Confidence            456667899999999999999999999999999864321       1134688899995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH---EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH---~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||+++|+|.++++.   +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   .++. ||.......
T Consensus       762 ~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---~~~~-~~~~~~~~~  834 (968)
T PLN00113        762 HEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---PHLR-LSLPGLLCT  834 (968)
T ss_pred             EeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---eEEE-ecccccccc
Confidence            999999999999964   889999999999999999999   669999999999999986554   5554 555443321


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHh--c--------cCCCCC
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK--SRIFDAVRT--A--------DLRFPS  264 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~--~--------~~~~~~  264 (468)
                         .....||+.|+|||++.+. ++.++|||||||++|||++|+.||.....  ..+.+....  .        +.....
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence               1234689999999998875 89999999999999999999999853211  111111100  0        000000


Q ss_pred             C--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          265 N--PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       265 ~--~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .  .......++.+++.+||+.||++|||+.|+++.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0  001122357789999999999999999999864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=292.28  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=209.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -+++..++++||+|.||.|.+|+-. .+..||+|+++...  +.+....|..|+++|.+|+ ||||+.+.++|..++.++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchH
Confidence            3556788999999999999999875 46899999997763  4455688999999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          119 LVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||++.|+|.+++.++.  .........++.||+.|++||.+.+++||||.+.|+|++.+++   +||+|||+++.+.
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~---iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT---IKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc---EEecCcccccccc
Confidence            9999999999999998873  3345556779999999999999999999999999999987766   9999999999766


Q ss_pred             CCCcccc---CCCCCCCcChhhh-cCCCCCcchHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhccCC-----CCCC
Q 012203          197 PGQSLLG---TVGSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS--GMPPFWGNTKSRIFDAVRTADLR-----FPSN  265 (468)
Q Consensus       197 ~~~~~~~---~~GT~~Y~APE~l-~~~~~~~sDiwSlGvil~ellt--G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~  265 (468)
                      .+.....   .+-...|||+|.+ .++++.++|+|+||+++||+++  ...||...+.++..++.......     .+. 
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~-  767 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS-  767 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc-
Confidence            5543321   2345679999976 4679999999999999999765  77899888877777665433211     111 


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      ....++..+.+++.+|+..|-++||+++++  |.+|+
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq  802 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQ  802 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHH
Confidence            125688999999999999999999999999  44443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=307.77  Aligned_cols=260  Identities=30%  Similarity=0.514  Sum_probs=225.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      +=+++|++...+|.|.||.||+|+++.+++..|+|+++.+   ..++...+++|+-+++.++ ||||+.|++.|-..+.+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence            3467899999999999999999999999999999999776   3456778889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+.||||.||+|.+.-+-.+.+++.++...++..+++|+|||+.|-+|||||-.|||++.+++   +|++|||.+..+..
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqita  164 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQITA  164 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhhh
Confidence            999999999999999999999999999999999999999999999999999999999987666   99999999876543


Q ss_pred             C-CccccCCCCCCCcChhhh----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC-CCCCCC
Q 012203          198 G-QSLLGTVGSPFYIAPEVL----AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN-PWDHIS  271 (468)
Q Consensus       198 ~-~~~~~~~GT~~Y~APE~l----~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s  271 (468)
                      . .....++|||.|||||+-    .++|+..+|+|++|+...|+---++|-...-....+-...+-.+..|.. .....+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            2 234568999999999985    3569999999999999999999888876655555555555554444432 235678


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +.+.+|++.+|.++|++||+++.+|.|+|..+.
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            899999999999999999999999999998764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=9e-35  Score=307.53  Aligned_cols=251  Identities=29%  Similarity=0.439  Sum_probs=199.3

Q ss_pred             eEEEeEEeecCCe-EEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           43 FVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        43 y~i~~~LG~G~fg-~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      |.-.+.+|.|+.| .||+|.-  .|+.||||.+..+      ......+|+..|+.-.+|||||+++..-.+..+.||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            4445678999887 6788865  5899999988543      34567889999999889999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC--CCCEEEeecCceeee
Q 012203          122 ELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS--SSPIKLADFGLATYI  195 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~----l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~--~~~ikL~DFGla~~~  195 (468)
                      |+| ..+|.++++..+.    ......+..+.|++.||++||+.+|+||||||.||||+....  ...++|+|||+++.+
T Consensus       583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            999 5699999987411    111445788999999999999999999999999999987422  245899999999998


Q ss_pred             cCCCcc----ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          196 EPGQSL----LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       196 ~~~~~~----~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ..++..    .+..||-+|+|||++... -+.++||+||||++|+.++| .+||...-.  -..+|..+........ ..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~-~~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLE-PL  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeec-cC
Confidence            876543    456799999999999886 67799999999999999886 999954322  2233444433322111 01


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ...++.+||.+||.+||..||+|.++|.||+|....
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence            111899999999999999999999999999997644

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=288.13  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=210.5

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      +.+..+.++||.|.||.||.+.++.-.-.||||.++.+.    -...+|..|..+|+.++ |||+|+|+++|..+-.+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYI  340 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYI  340 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEE
Confidence            345677889999999999999999888899999987653    24678999999999997 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+|||..|+|.++|++..+  ++.-....++.||..|++||..+++|||||-..|.|+..+.   .||++||||++.+..
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh---iVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---IVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc---eEEeeccchhhhhcC
Confidence            9999999999999988654  55566778889999999999999999999999999996544   499999999998875


Q ss_pred             CCcc--ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQSL--LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~~--~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      +...  .+---..-|.|||-+... ++.|+|||+|||+|||+.| |.-||.+-+...++..+.++ +++..  ...+++.
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~~--PeGCPpk  494 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMDG--PEGCPPK  494 (1157)
T ss_pred             CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-ccccC--CCCCCHH
Confidence            4322  112224569999998764 9999999999999999987 99999999999999888765 33333  2689999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHH
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVL  296 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL  296 (468)
                      +.+|+..||+.+|..||++.|+-
T Consensus       495 VYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  495 VYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHHHhcCCcccCccHHHHH
Confidence            99999999999999999998874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=276.50  Aligned_cols=257  Identities=26%  Similarity=0.478  Sum_probs=209.9

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-----E
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-----Y  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-----~  116 (468)
                      +.+-.+.||.|+||+||.+.|..+|+.||+|.+..- ..+....+.+.+|+.+|..++ |.|++..+++.+-.+     .
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHH
Confidence            344467999999999999999999999999987432 233445678889999999997 999999998876543     4


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+++|++ ..+|..+|-....++.+.++.++.||++||+|||+.+|.||||||.|+|+++|--   +||||||+++...
T Consensus       132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv---LKICDFGLARvee  207 (449)
T KOG0664|consen  132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI---LKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce---EEecccccccccc
Confidence            67889998 5688888888888999999999999999999999999999999999999986554   8999999998765


Q ss_pred             CCC--ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--------------
Q 012203          197 PGQ--SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA--------------  258 (468)
Q Consensus       197 ~~~--~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------  258 (468)
                      ..+  .+...+-|-.|.|||++.|.  |+.+.||||.|||+.||+..+..|+..+.-+.++.|...              
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            443  23345678899999999985  999999999999999999999999888776666655322              


Q ss_pred             ---------cCCCCCCC-------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          259 ---------DLRFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       259 ---------~~~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                               ..+.|...       ...-..+..+++.+||..||++|.+.++++.|+++.++
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                     11111111       12334578899999999999999999999999998553

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=293.16  Aligned_cols=200  Identities=33%  Similarity=0.562  Sum_probs=179.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhh-----HHHHHHHHHHHHHhc--CCCCceeeeEEEEeC
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD-----ERSVKLEIEIMTRLS--GHPNVVDLKAVYEDE  114 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~-----~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~~~  114 (468)
                      .|..++.+|.|+||.|++|.++.++..|++|.|.|+++.....     .-.+-.||+||.+|.  .|+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            4999999999999999999999999999999999987643222     234667999999994  399999999999999


Q ss_pred             CEEEEEEeccC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 DYVHLVMELCA-GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~-ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      +++||+||-.. |.+|+++|..+.+++|.++..|++|+..|+++||+.||+|||||-+||.++.+|-   +||+|||.+.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~---~klidfgsaa  718 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF---VKLIDFGSAA  718 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe---EEEeeccchh
Confidence            99999999753 5689999999999999999999999999999999999999999999999997766   9999999998


Q ss_pred             eecCCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCC
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG  245 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~  245 (468)
                      ....+ ....++||..|.|||++.|.  .+..-|||+||++||.++....||+.
T Consensus       719 ~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            87654 46678999999999999985  48899999999999999999999864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1e-33  Score=281.01  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=205.6

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcC---CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      +..+.+.|.++++||.|.|++||++.+..   .++.||+|.+....     .-..+.+|+++|.++.++.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            55677889999999999999999999887   78899999986543     23568999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      .++.+.+||||++..+..++...   ++...++.|++.++.||.++|.+|||||||||.|+|.+..  .+.-.|.|||+|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~--t~rg~LvDFgLA  180 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR--TQRGVLVDFGLA  180 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc--cCCceEEechhH
Confidence            99999999999999888888765   7789999999999999999999999999999999999754  345799999998


Q ss_pred             eeecC-------------------CC--------------------------ccccCCCCCCCcChhhhcC--CCCCcch
Q 012203          193 TYIEP-------------------GQ--------------------------SLLGTVGSPFYIAPEVLAG--GYNQAAD  225 (468)
Q Consensus       193 ~~~~~-------------------~~--------------------------~~~~~~GT~~Y~APE~l~~--~~~~~sD  225 (468)
                      .....                   +.                          ......||++|.|||++..  ..++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            62110                   00                          0011369999999999976  3788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH--------H-----hcc---------------------C---------
Q 012203          226 VWSAGVILYILLSGMPPFWGNTK--SRIFDAV--------R-----TAD---------------------L---------  260 (468)
Q Consensus       226 iwSlGvil~elltG~~Pf~~~~~--~~~~~~i--------~-----~~~---------------------~---------  260 (468)
                      |||.|||+.-+++++.||.....  ..+.+..        .     .+.                     .         
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            99999999999999999943211  1111000        0     000                     0         


Q ss_pred             ---CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          261 ---RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       261 ---~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                         .......+..+..+.+|+.+||..||.+|+|++++|+||||..
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence               0000011234558999999999999999999999999999974

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=253.84  Aligned_cols=208  Identities=26%  Similarity=0.426  Sum_probs=174.6

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      ..-+..||+|++|+|-+.++..+|...|+|.+...  .+.....++.+|+.+..+..++|++|.+++.+.....+||.||
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            44467899999999999999999999999999765  3455567788899999888899999999999999999999999


Q ss_pred             ccCCCCHHHH----HHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          123 LCAGGELFHR----LEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       123 ~~~ggsL~~~----l~~~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      .| ..+|..+    +++.+.++|...-+++..++.||.|||++ .+||||+||+|||++.++.   +|+||||.+..+..
T Consensus       126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq---VKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ---VKICDFGISGYLVD  201 (282)
T ss_pred             Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc---EEEcccccceeehh
Confidence            99 5577654    45567899999999999999999999976 8999999999999988766   99999999988765


Q ss_pred             CCccccCCCCCCCcChhhhcC-----CCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVR  256 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~-----~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~  256 (468)
                      .-...-..|-..|||||.+..     +|+.++||||||+.+.||.+++.||... +..+.+.++.
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV  266 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV  266 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence            433333567778999999864     4899999999999999999999999542 3344444443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-31  Score=289.91  Aligned_cols=251  Identities=25%  Similarity=0.418  Sum_probs=207.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcC-------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKF-------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      ..+...+.+.||+|.||.|++|.-+.       ....||||.++....  ..+.+.+..|+++|+.+..|+||+.+.+++
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            34444667799999999999997531       145789999876643  366788999999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEE
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL  175 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl  175 (468)
                      ...+.+++|+||+..|+|.++++..+                .++......++.||+.|++||++++++||||-..|||+
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI  451 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence            99999999999999999999998765                38888999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCceeeecCCCccc--cCCCC--CCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCC-h
Q 012203          176 ATKASSSPIKLADFGLATYIEPGQSLL--GTVGS--PFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNT-K  248 (468)
Q Consensus       176 ~~~~~~~~ikL~DFGla~~~~~~~~~~--~~~GT--~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~-~  248 (468)
                      ..+.   .+||+|||+|+...+.....  ...|+  ..|||||.+... |+.++|||||||+|||+++ |..||.+.. .
T Consensus       452 ~~~~---~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  452 TKNK---VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             cCCC---EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            8654   49999999999755443322  22222  349999999875 9999999999999999998 889998755 6


Q ss_pred             HHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .++++.+..+.. ...  ...+++++.++++.||..+|++||++.++.+
T Consensus       529 ~~l~~~l~~G~r-~~~--P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  529 EELLEFLKEGNR-MEQ--PEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHhcCCC-CCC--CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            666665555533 222  1567999999999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-32  Score=272.03  Aligned_cols=241  Identities=26%  Similarity=0.360  Sum_probs=190.4

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeCC----EE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDED----YV  117 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-~HpnIv~l~~~~~~~~----~~  117 (468)
                      .++.+.||+|.||.||+|..  +++.||||++..      .+.+.+.+|.+|..... .|+||+++++.-+...    .+
T Consensus       212 l~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            45678899999999999976  469999999853      45678888888876432 5999999999876544    89


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEecccCCCcEEEeecCCCCCEEEee
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI---------GVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~---------gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      +||+||.+.|+|.++|+. ..+++....+++..+++||+|||+-         .|+|||||..||||.+|..   ..|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT---ccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT---CCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc---EEeec
Confidence            999999999999999987 4689999999999999999999962         5999999999999987665   99999


Q ss_pred             cCceeeecCCC---ccccCCCCCCCcChhhhcCC--CC-----CcchHHHHHHHHHHHHhCC------------CCCC--
Q 012203          189 FGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG--YN-----QAADVWSAGVILYILLSGM------------PPFW--  244 (468)
Q Consensus       189 FGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~--~~-----~~sDiwSlGvil~elltG~------------~Pf~--  244 (468)
                      ||||..+.++.   .....+||..|||||++.+.  +.     .+.||||+|.|||||++..            +||.  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            99999987653   34457999999999999885  33     2589999999999999853            3332  


Q ss_pred             ---CCChHHHHHHHHhcc--CCCCCCCCC-CCCHHHHHHHHHccccCCCCCCCHHHH
Q 012203          245 ---GNTKSRIFDAVRTAD--LRFPSNPWD-HISDSAKDLVMGMLSTDPSQRLTARQV  295 (468)
Q Consensus       245 ---~~~~~~~~~~i~~~~--~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rpt~~ei  295 (468)
                         ..+.+++.+.+...+  +.+|..... .-...+++.+..||+.||+-|+|+.=+
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence               223344544444333  334432211 234568999999999999999997644

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=1.1e-30  Score=240.77  Aligned_cols=211  Identities=45%  Similarity=0.741  Sum_probs=185.4

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCC
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE  128 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggs  128 (468)
                      ||.|++|.||++.+..+|+.+++|++.......  ....+.+|++.+++++ |++|+++++++......+++||+++|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999997653211  3467889999999996 9999999999999999999999999999


Q ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-ccccCCC
Q 012203          129 LFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-SLLGTVG  206 (468)
Q Consensus       129 L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~G  206 (468)
                      |.+++... ..++...+..++.+++.+|.+||++|++|+||+|.||+++..  .+.++|+|||.+....... ......+
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence            99999875 468999999999999999999999999999999999999861  2349999999998765432 1334567


Q ss_pred             CCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          207 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       207 T~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      ...|++||.+..  .++.+.|+|++|+++++|                                   ..+.+++.+|+..
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence            888999999876  578899999999999999                                   5889999999999


Q ss_pred             CCCCCCCHHHHHhCc
Q 012203          285 DPSQRLTARQVLDHS  299 (468)
Q Consensus       285 dP~~Rpt~~eiL~h~  299 (468)
                      ||++||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-31  Score=265.38  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=195.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC---
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDE---  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-~HpnIv~l~~~~~~~---  114 (468)
                      +.....+.+.||+|-||.||.|.++  |+.||||++...      +++.+.+|.+|.+..- +|+||+.+++.-..+   
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            5566899999999999999999885  899999999543      4577888888876421 599999999876433   


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecccCCCcEEEeecCCCCCEE
Q 012203          115 -DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI--------GVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       115 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                       ..+|||.+|.+.|+|+++|.+ ..++.+...+++..++.||+|||..        .|.|||||..||||.+++.   +.
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~---C~  356 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CC  356 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc---EE
Confidence             369999999999999999988 6799999999999999999999942        4999999999999988776   99


Q ss_pred             EeecCceeeecCCC-----ccccCCCCCCCcChhhhcCC-----C--CCcchHHHHHHHHHHHHhC----------CCCC
Q 012203          186 LADFGLATYIEPGQ-----SLLGTVGSPFYIAPEVLAGG-----Y--NQAADVWSAGVILYILLSG----------MPPF  243 (468)
Q Consensus       186 L~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~-----~--~~~sDiwSlGvil~elltG----------~~Pf  243 (468)
                      |+|+|||.......     .....+||..|||||++...     +  -..+||||||.|+||+...          ++||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999998876542     23467999999999999763     2  2369999999999999862          5788


Q ss_pred             CCC-----ChHHHHHHHHhccCCCCC-CCCCCC--CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          244 WGN-----TKSRIFDAVRTADLRFPS-NPWDHI--SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       244 ~~~-----~~~~~~~~i~~~~~~~~~-~~~~~~--s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+.     ..+++.+.+.....+... +.|...  -..+-.+++.||..||.-|.|+--|.+
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            542     334555554444444322 233332  234678899999999999999876654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.7e-30  Score=242.25  Aligned_cols=211  Identities=47%  Similarity=0.777  Sum_probs=183.2

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |.+.+.||.|++|.||++.+..+++.+++|.+......  .....+.+|++.++++. |+|++++++++......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence            67889999999999999999988999999999876432  24678888999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC--
Q 012203          123 LCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--  199 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--  199 (468)
                      ++++++|.+++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++   .++|+|||++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~---~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG---LVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeeCceeeEecCcccc
Confidence            9999999999988766 89999999999999999999999999999999999998654   49999999998876543  


Q ss_pred             ccccCCCCCCCcChhhhc-C-CCCCcchHHHHHHHHHHHHhCCCCCCC--CChHHHHHHHHhcc
Q 012203          200 SLLGTVGSPFYIAPEVLA-G-GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVRTAD  259 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~-~-~~~~~sDiwSlGvil~elltG~~Pf~~--~~~~~~~~~i~~~~  259 (468)
                      ......++..|++||++. . .++.++|+|+||+++++|++|+.||..  .+...+.+.+..+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            334567888999999983 3 377899999999999999999999977  44556777776654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=276.96  Aligned_cols=244  Identities=23%  Similarity=0.316  Sum_probs=206.4

Q ss_pred             EEEeEEeecCCeEEEEEEEcCCCc----EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFTGE----VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~g~----~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      +..++||.|+||+||++.+.-.|+    +||+|++....  ......++..|.-+|.+|. |||++++++++..+. +-|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HHH
Confidence            446789999999999998865554    67888887653  3445678899999999995 999999999998776 889


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |++|+++|+|.++++.+ .++.......|..||++|+.|||+++++||||-..||||.+-   .++||+|||+++.+.+.
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP---~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP---NHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC---CeEEEEecchhhccCcc
Confidence            99999999999999765 568899999999999999999999999999999999999754   45999999999988765


Q ss_pred             CccccC-C--CCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          199 QSLLGT-V--GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       199 ~~~~~~-~--GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ...... .  -.+-|||-|.+.. .|+.++|||||||++||++| |..|+.+...+++-+.+..++. ++..  ...+.+
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP--piCtiD  928 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP--PICTID  928 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC--CCccHH
Confidence            443322 2  2345888887776 49999999999999999998 9999999999999888887754 5544  478889


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.-++.+||..|++.||+++++..
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            999999999999999999988764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=248.56  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=204.0

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE-EEeC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV-YEDE  114 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~-~~~~  114 (468)
                      .-.|.+.|.|.+.||+|-||.+.+|+|+.++..+++|.+.+..    ...+.|.+|...--.|+-|.||+.-|++ |+..
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            3457788999999999999999999999999999999998764    3456788888777777789999987655 7888


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+.++|||++-|+|..-+.. ..+.|...+.++.|++.||.|+|+++++|||||.+||||..-+ ...|||||||+.+.
T Consensus        95 d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRK  172 (378)
T ss_pred             ceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccccc
Confidence            999999999999999988866 3488999999999999999999999999999999999996533 33799999999876


Q ss_pred             ecCCCccccCCCCCCCcChhhhcC----C--CCCcchHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhccCCCC
Q 012203          195 IEPGQSLLGTVGSPFYIAPEVLAG----G--YNQAADVWSAGVILYILLSGMPPFWGNTK-----SRIFDAVRTADLRFP  263 (468)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~----~--~~~~sDiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~~  263 (468)
                      ...  .....--+..|.+||+...    .  .++.+|+|.||+++|..++|++||+....     .+..+-........|
T Consensus       173 ~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  173 VGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP  250 (378)
T ss_pred             cCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence            432  2222234556999998753    2  57889999999999999999999963221     122222222222333


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCC---CCHHHHHhCcCCCC
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQR---LTARQVLDHSWMGD  303 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~R---pt~~eiL~h~~~~~  303 (468)
                       ..+..+++.+..+.++-|..++++|   .++++-....|...
T Consensus       251 -~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  251 -KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             -hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence             3356889999999999999999999   55666666667543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.2e-30  Score=290.57  Aligned_cols=196  Identities=19%  Similarity=0.267  Sum_probs=148.2

Q ss_pred             CCceeeeEEE-------EeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcE
Q 012203          102 PNVVDLKAVY-------EDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENI  173 (468)
Q Consensus       102 pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NI  173 (468)
                      +||++++++|       .+...++++||++ +++|.++|... ..+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5777777777       3335678889987 77999999753 4599999999999999999999999999999999999


Q ss_pred             EEeec----------------CCCCCEEEeecCceeeecCC-----------------CccccCCCCCCCcChhhhcCC-
Q 012203          174 LLATK----------------ASSSPIKLADFGLATYIEPG-----------------QSLLGTVGSPFYIAPEVLAGG-  219 (468)
Q Consensus       174 Ll~~~----------------~~~~~ikL~DFGla~~~~~~-----------------~~~~~~~GT~~Y~APE~l~~~-  219 (468)
                      ||+..                .....+||+|||+++.....                 ......+||+.|||||++.+. 
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99642                12345788888888643210                 001124689999999998874 


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       220 ~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      |+.++|||||||+||||++|.+|+....  .....+....  ++... ........+++.+||++||.+||++.|+++||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999999999999999999999875321  2222222211  11111 11234667899999999999999999999999


Q ss_pred             CCCC
Q 012203          300 WMGD  303 (468)
Q Consensus       300 ~~~~  303 (468)
                      ||..
T Consensus       267 ~~~~  270 (793)
T PLN00181        267 FINE  270 (793)
T ss_pred             hhhh
Confidence            9975

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-30  Score=267.41  Aligned_cols=241  Identities=30%  Similarity=0.491  Sum_probs=212.5

Q ss_pred             EeecCCeEEEEEEE---cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           49 LGWGQFGVIRVCSD---KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        49 LG~G~fg~Vy~a~~---~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      +|.|.||.|++++.   .+.|..||+|+..+......... ....|..++..+.+||.+|+++..|+.+..+++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            78999999988754   35688999999988765544333 566788999999889999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCC
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV  205 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~  205 (468)
                      ||.|+..+.+...+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|+   +++.|||+++..-..+..   |
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh---i~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH---IKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc---cccCCchhhhHhHhhhhc---c
Confidence            9999999999889999999999999999999999999999999999999987666   999999999876543332   9


Q ss_pred             CCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccC
Q 012203          206 GSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD  285 (468)
Q Consensus       206 GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~d  285 (468)
                      ||..|||||+++ +....+|+||||+++++|++|..||..    ++...|....+.+|    ..++..+++++..++..+
T Consensus       155 gt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p----~~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  155 GTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP----RELSAEARSLFRQLFKRN  225 (612)
T ss_pred             cchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc----hhhhHHHHHHHHHHHhhC
Confidence            999999999999 778899999999999999999999977    77778888777777    467889999999999999


Q ss_pred             CCCCCC-----HHHHHhCcCCCCCC
Q 012203          286 PSQRLT-----ARQVLDHSWMGDGI  305 (468)
Q Consensus       286 P~~Rpt-----~~eiL~h~~~~~~~  305 (468)
                      |..|..     ..|+++|+||+...
T Consensus       226 p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  226 PENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             HHHHhccCcchhHHHhccchheeee
Confidence            999985     57999999997754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.9e-26  Score=224.18  Aligned_cols=255  Identities=36%  Similarity=0.597  Sum_probs=211.3

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeEEEEeCCEEEEEE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~~~~~~~~~~lV~  121 (468)
                      |.+.+.||.|+|+.||++.+.   ..+++|.+.............+.+|+.+++.+. |+ +|+++.+.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence            788999999999999999987   789999998775444335678889999999997 66 8999999998888899999


Q ss_pred             eccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          122 ELCAGGELFHRLEKFG---RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +++.++++.+++....   .+.+.....++.|++.++.|+|+.+++||||||+||+++..+.  .++++|||.+......
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~  155 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDP  155 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCC
Confidence            9999999998887765   7999999999999999999999999999999999999986552  4899999999866543


Q ss_pred             C-------ccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccCC-C
Q 012203          199 Q-------SLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLR-F  262 (468)
Q Consensus       199 ~-------~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~  262 (468)
                      .       ......||+.|+|||.+.+    .+....|+||+|++++++++|..||.....    ......+...... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            3       2356789999999999986    478899999999999999999999877653    4555555555433 2


Q ss_pred             CCCCCCCC----CHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          263 PSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       263 ~~~~~~~~----s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ........    ...+.+++.+++..+|..|.+..+...+++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            22221222    257999999999999999999999998866544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.1e-27  Score=219.04  Aligned_cols=161  Identities=27%  Similarity=0.361  Sum_probs=127.6

Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCC
Q 012203          127 GELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV  205 (468)
Q Consensus       127 gsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~  205 (468)
                      |+|.+++..+ +.+++..++.++.|++.||.|||+++      ||+|||++.++.   +|+  ||++.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~---~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL---LKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc---eee--ccceEeecccc----CC
Confidence            6899999874 45999999999999999999999998      999999986554   888  99998765432    36


Q ss_pred             CCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCCC-CC--CCCCCCCH--HHHHHH
Q 012203          206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRF-PS--NPWDHISD--SAKDLV  278 (468)
Q Consensus       206 GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-~~--~~~~~~s~--~l~~li  278 (468)
                      ||+.|+|||++.+. ++.++|||||||++|||++|+.||..... ......+....... +.  .....++.  ++.+++
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            89999999999875 89999999999999999999999965432 23333333222211 10  01123333  699999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      .+||..||++||++.|+++|+|+.
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHH
Confidence            999999999999999999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-26  Score=230.57  Aligned_cols=253  Identities=24%  Similarity=0.289  Sum_probs=198.0

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCC-cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc---CCCCceeeeEEE-EeCCE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTG-EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS---GHPNVVDLKAVY-EDEDY  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~---~HpnIv~l~~~~-~~~~~  116 (468)
                      +|.+.+.||+|+||.||+|.+..++ +.+|+|+........   ...+..|+.++..+.   +.+++..+++.+ ..+.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998764 688999876642211   126778999998886   236999999999 58889


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC--CCCEEEeecCce
Q 012203          117 VHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS--SSPIKLADFGLA  192 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~--~~~ikL~DFGla  192 (468)
                      .||||+++ |.+|.++....  +.|+..++..++.|++.+|++||+.|++||||||+|+++.....  ...+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 99999988654  57999999999999999999999999999999999999986542  256999999999


Q ss_pred             e--eecCCC--------c-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 012203          193 T--YIEPGQ--------S-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       193 ~--~~~~~~--------~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                      +  .+....        . .....||..|+++.+..+. .+.+.|+||++.++.+|+.|..||...........+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  321111        1 2235699999999999885 89999999999999999999999976554333333322222


Q ss_pred             CCCCC-CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          261 RFPSN-PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       261 ~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..... .....+.++.++...+-..+...+|....+.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22211 223456778888888877889999988877654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-27  Score=230.79  Aligned_cols=257  Identities=20%  Similarity=0.242  Sum_probs=207.7

Q ss_pred             CccccccccCCeEEEeEEeecCCeEEEEEEEcCC-----CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCcee
Q 012203           32 DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT-----GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD  106 (468)
Q Consensus        32 ~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~  106 (468)
                      ...++.--+.|+++...+-+|.||.||.|.+++.     .+.+.+|.++..  .+.-+...+..|--.+..+. |||+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~  351 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLS  351 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccc
Confidence            3445566778899999999999999999977643     244556655433  23445567778888888887 999999


Q ss_pred             eeEEEE-eCCEEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEee
Q 012203          107 LKAVYE-DEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLAT  177 (468)
Q Consensus       107 l~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~  177 (468)
                      +.++.. +....++++.+..-|+|..++...        +.++..+...++.|++.|++|||++|+||.||-..|.+|+.
T Consensus       352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh
Confidence            999874 556788899999899999999732        23677778889999999999999999999999999999986


Q ss_pred             cCCCCCEEEeecCceeeecCCCcc---ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 012203          178 KASSSPIKLADFGLATYIEPGQSL---LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIF  252 (468)
Q Consensus       178 ~~~~~~ikL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~  252 (468)
                      .-   .+||+|=.+++.+-+....   ...-....||+||.+.+. |+.++|+|||||++|||++ |+.|+..-++.++.
T Consensus       432 ~L---qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~  508 (563)
T KOG1024|consen  432 QL---QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME  508 (563)
T ss_pred             he---eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence            54   4999999999877654332   122234569999999886 9999999999999999998 99999999999998


Q ss_pred             HHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..++.+ .+....  .++|+++..++..||..+|++||+.+|+..
T Consensus       509 ~ylkdG-yRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  509 HYLKDG-YRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHhcc-ceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            887766 333332  589999999999999999999999999864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=9.3e-28  Score=232.10  Aligned_cols=246  Identities=20%  Similarity=0.327  Sum_probs=193.4

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .-.|+|+++||+|+||+++++.+..+|+.||||.-..+     .+...+..|.+..+.|.+.++|..+|.+.++..+-.|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            34599999999999999999999999999999986544     2346788899999999889999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC--CCCEEEeecCceeeec
Q 012203          120 VMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS--SSPIKLADFGLATYIE  196 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~--~~~ikL~DFGla~~~~  196 (468)
                      |||++ |.+|+++..-.+ +|+..++..++.|++.-++|+|++++|+|||||+|+||..-++  ...|.|+|||+|+.+.
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99998 999999998764 5999999999999999999999999999999999999976433  3468999999999875


Q ss_pred             CCC--------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhccCCCCC
Q 012203          197 PGQ--------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSR---IFDAVRTADLRFPS  264 (468)
Q Consensus       197 ~~~--------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~  264 (468)
                      ...        ......||..||+-....|. -+.+.|+-|||-+++++|.|.+||++.....   -++.|-..+..-+.
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            432        23456899999998877775 7889999999999999999999998765443   34444322221111


Q ss_pred             -CCCCCCCHHHHHHHHHccccCCCCCCC
Q 012203          265 -NPWDHISDSAKDLVMGMLSTDPSQRLT  291 (468)
Q Consensus       265 -~~~~~~s~~l~~li~~~L~~dP~~Rpt  291 (468)
                       .....+|.++...+.-.=..+=++-|.
T Consensus       261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PD  288 (449)
T KOG1165|consen  261 EVLCEGFPEEFATYLRYVRRLDFFETPD  288 (449)
T ss_pred             HHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence             112345555555544443333334443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.8e-28  Score=264.32  Aligned_cols=260  Identities=30%  Similarity=0.494  Sum_probs=204.3

Q ss_pred             CCe-EEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccC--cCCCh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERF-VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD--RLVTI-DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~--~~~~~-~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +.| .....+|.|++|.|+.+......+.++.|.+...  ..... .....+..|..+-.+|. |||++.....+.+...
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG  395 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc
Confidence            334 4567899999999999888877777777766532  11111 11223666887788886 9999888777766666


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      .+-+||||++ +|+.++...+.+...++..+++|++.|++|+|+.||.||||||+|++++.++.   +||+|||.+....
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~---lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI---LKIIDFGAASVFR  471 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc---eEEeecCcceeec
Confidence            6666999999 99999998888999999999999999999999999999999999999987664   9999999987765


Q ss_pred             CCC-----ccccCCCCCCCcChhhhcCC-CCC-cchHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhcc---CCCCC
Q 012203          197 PGQ-----SLLGTVGSPFYIAPEVLAGG-YNQ-AADVWSAGVILYILLSGMPPFWGNTKSRIF--DAVRTAD---LRFPS  264 (468)
Q Consensus       197 ~~~-----~~~~~~GT~~Y~APE~l~~~-~~~-~sDiwSlGvil~elltG~~Pf~~~~~~~~~--~~i~~~~---~~~~~  264 (468)
                      ...     ...+.+|+..|+|||++.+. |++ ..||||.|++++.|.+|+.||......+..  +......   ..-+.
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN  551 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence            332     24577999999999999885 765 689999999999999999999665443321  1111111   11222


Q ss_pred             CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       265 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..+..++...+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            33567888999999999999999999999999999997743

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=7.1e-26  Score=230.41  Aligned_cols=173  Identities=23%  Similarity=0.211  Sum_probs=134.9

Q ss_pred             cCccccccccCCeEEEeEEeecCCeEEEEEEEcC-CCcEEEEEEeccCcC--CChhhHHHHHHHHHHHHHhcCCCCcee-
Q 012203           31 LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGHPNVVD-  106 (468)
Q Consensus        31 ~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vavK~i~~~~~--~~~~~~~~~~~Ei~iL~~L~~HpnIv~-  106 (468)
                      +...+...+-++|.+.+.||+|+||+||+|+++. +++.+|||++.....  ........+.+|+++|++|. |+|++. 
T Consensus         8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~   86 (365)
T PRK09188          8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQ   86 (365)
T ss_pred             CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcE
Confidence            3455667788999999999999999999999876 688889998753311  12233567899999999996 999885 


Q ss_pred             eeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeccc-CCCcEEEeecCCCCCEE
Q 012203          107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL-KPENILLATKASSSPIK  185 (468)
Q Consensus       107 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDI-Kp~NILl~~~~~~~~ik  185 (468)
                      ++++    +..||||||++|++|.. +..   ..   ...++.|++++|.|||++||+|||| ||+|||++.++.   +|
T Consensus        87 l~~~----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~---ik  152 (365)
T PRK09188         87 LLAT----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE---AA  152 (365)
T ss_pred             EEEc----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC---EE
Confidence            4432    45799999999999963 211   11   1467899999999999999999999 999999976544   99


Q ss_pred             EeecCceeeecCCC---------ccccCCCCCCCcChhhhcC
Q 012203          186 LADFGLATYIEPGQ---------SLLGTVGSPFYIAPEVLAG  218 (468)
Q Consensus       186 L~DFGla~~~~~~~---------~~~~~~GT~~Y~APE~l~~  218 (468)
                      |+|||+++.+....         ......+++.|.|||++..
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999998765432         1234578889999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-25  Score=208.85  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=200.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..+.|+++++||+|+||.+|+|....+|+.||||+-....-     ...+.-|..+.+.|++-..|..+..++.+..+-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            45679999999999999999999999999999998765422     2356678889999987889999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||++. |.+|++++.-. +.|+..++..++.|++.-++|+|.+++|||||||+|+|..-+.....+.|+|||+|+.+..
T Consensus        88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999998 99999999754 5699999999999999999999999999999999999997666666799999999987654


Q ss_pred             CC--------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCCCCC
Q 012203          198 GQ--------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSN  265 (468)
Q Consensus       198 ~~--------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~  265 (468)
                      ..        ......||..|.+-....+. .+.+.|+-|+|.+|.++..|.+||++...   .+-++.|...+...+.+
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence            32        12345799999998877764 67899999999999999999999987543   44555565554443322


Q ss_pred             -CCCCCCHHHHHHHHHccccCCCCCCC
Q 012203          266 -PWDHISDSAKDLVMGMLSTDPSQRLT  291 (468)
Q Consensus       266 -~~~~~s~~l~~li~~~L~~dP~~Rpt  291 (468)
                       ....+|.++.-.+.-|=..--++-|.
T Consensus       247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  247 VLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             HHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence             23567778888888886655556665

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=1.9e-25  Score=242.09  Aligned_cols=225  Identities=33%  Similarity=0.546  Sum_probs=182.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ....+|+.++.|-.|+||.||+++|+.+.+.+|+ .+++..+.       +++   |+... ++|.+|            
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-------lRn---ilt~a-~npfvv------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-------LRN---ILTFA-GNPFVV------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-------hhc---ccccc-CCccee------------
Confidence            3456799999999999999999999999999999 45554321       111   44333 466666            


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                               |+-...++.-+.++...        +.+++|||+.||+|||+||+|++|+.-+.   +|++|||+++..-.
T Consensus       136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh---iKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKKGLM  195 (1205)
T ss_pred             ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc---ccccchhhhhhhhh
Confidence                     55556666655555543        77899999999999999999999987555   99999999864321


Q ss_pred             C----------------CccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 012203          198 G----------------QSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       198 ~----------------~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                      .                -.....||||.|+|||++.. +|+..+|||++|+|+||.+-|+.||.+.+.++++..+....+
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            1                01134699999999999765 699999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHHhCcCCCCCCCC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRL---TARQVLDHSWMGDGIQD  307 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---t~~eiL~h~~~~~~~~~  307 (468)
                      .++.. ...++.+++++|.++|+.+|..|.   .+-++.+|.||+.....
T Consensus       276 ~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  276 EWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            99987 467899999999999999999997   47788999999875543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=4.3e-23  Score=192.70  Aligned_cols=143  Identities=21%  Similarity=0.218  Sum_probs=112.3

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhh-----------------------HHHHHHHHHHHHHhcCCC
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD-----------------------ERSVKLEIEIMTRLSGHP  102 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~-----------------------~~~~~~Ei~iL~~L~~Hp  102 (468)
                      ...||+|++|.||+|.+. +|+.||+|++..........                       ......|++++.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            457999999999999997 89999999997653211110                       122345999999996 77


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEecccCCCcEEEeecCCC
Q 012203          103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC-HEIGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       103 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~gIiHrDIKp~NILl~~~~~~  181 (468)
                      ++.....+....  .+|||||++|+++...+...+.+++..+..++.|++.+|.+| |+.||+||||||+|||++.    
T Consensus        80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~----  153 (190)
T cd05147          80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD----  153 (190)
T ss_pred             CCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC----
Confidence            765444333222  389999999988776654557899999999999999999999 7999999999999999973    


Q ss_pred             CCEEEeecCceeeec
Q 012203          182 SPIKLADFGLATYIE  196 (468)
Q Consensus       182 ~~ikL~DFGla~~~~  196 (468)
                      +.++|+|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            349999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=4.7e-23  Score=196.42  Aligned_cols=175  Identities=15%  Similarity=0.085  Sum_probs=134.6

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHH------HHHHHHHHHHhcCCCCceeeeEE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS------VKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~------~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      +-+.++|++.+.||.|+||.||++.+  ++..+|+|++.............      +.+|++.+.+|. |++|..+.++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEe
Confidence            34789999999999999999999755  47789999997654333333233      578999999996 9999999998


Q ss_pred             EEeC--------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          111 YEDE--------DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       111 ~~~~--------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      +...        +..+|||||++|.+|.++..    +++    ....+++.+|..||+.|++||||||+||+++.++   
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---  172 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---  172 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---
Confidence            7643        35889999999999987742    333    2456999999999999999999999999997533   


Q ss_pred             CEEEeecCceeeecCCCccccCCCCCCCcChhhh-cCCCCCcchHHHHHHHHHHHH
Q 012203          183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL-AGGYNQAADVWSAGVILYILL  237 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l-~~~~~~~sDiwSlGvil~ell  237 (468)
                       ++|+|||.............           +. ...|+.++|+|+||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHHH
Confidence             99999998876532221111           22 234778999999999877554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=4.5e-23  Score=202.19  Aligned_cols=234  Identities=25%  Similarity=0.350  Sum_probs=154.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcC---------CCCceeeeEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG---------HPNVVDLKAVYE  112 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~---------HpnIv~l~~~~~  112 (468)
                      .+..++.||.|+++.||.+++..||+.+|+|++...........+.+++|.-....+.+         |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            35668899999999999999999999999999987765555567777777655544331         222333333321


Q ss_pred             ---------eC---C-----EEEEEEeccCCCCHHHHHH---HcCCC----CHHHHHHHHHHHHHHHHHHHHcCcEeccc
Q 012203          113 ---------DE---D-----YVHLVMELCAGGELFHRLE---KFGRF----SEAEARVLFMQLMQVVLYCHEIGVVHRDL  168 (468)
Q Consensus       113 ---------~~---~-----~~~lV~E~~~ggsL~~~l~---~~~~l----~~~~~~~i~~qil~aL~~LH~~gIiHrDI  168 (468)
                               ..   +     ..+++|+-+ -++|.+++.   .....    .......+..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     236788887 568887763   22222    12222344589999999999999999999


Q ss_pred             CCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC---------CCCCcchHHHHHHHHHHHHhC
Q 012203          169 KPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG---------GYNQAADVWSAGVILYILLSG  239 (468)
Q Consensus       169 Kp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~---------~~~~~sDiwSlGvil~elltG  239 (468)
                      ||+|+|++.+|.   ++|+||+.......  .......+..|.+||....         .++.+.|.|+||+++|.|.+|
T Consensus       172 ~~~nfll~~~G~---v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGG---VFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS----EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCC---EEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            999999987766   99999998876443  2222345578999998643         268899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCC
Q 012203          240 MPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQR  289 (468)
Q Consensus       240 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R  289 (468)
                      ..||.........+.      .|...  ..+|+.+++||..||+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW------DFSRC--RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence            999975543221110      22222  3789999999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=7.8e-22  Score=184.08  Aligned_cols=144  Identities=22%  Similarity=0.157  Sum_probs=113.5

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh-----------------------hHHHHHHHHHHHHHhcCCC
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID-----------------------DERSVKLEIEIMTRLSGHP  102 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~-----------------------~~~~~~~Ei~iL~~L~~Hp  102 (468)
                      ...||+|++|+||+|.+. +|+.||||++.........                       .......|.+.+.++. |+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            468999999999999987 8999999999875321000                       0123457899999996 88


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCC
Q 012203          103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       103 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~  181 (468)
                      ++.....+....  .+|||||++|+++.........++...+..++.|++.+|.++|. +||+||||||+|||++ ++  
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--
Confidence            876555544333  48999999988665443344678889999999999999999999 9999999999999997 33  


Q ss_pred             CCEEEeecCceeeecC
Q 012203          182 SPIKLADFGLATYIEP  197 (468)
Q Consensus       182 ~~ikL~DFGla~~~~~  197 (468)
                       .++|+|||++.....
T Consensus       155 -~~~liDFG~a~~~~~  169 (190)
T cd05145         155 -KPYIIDVSQAVELDH  169 (190)
T ss_pred             -CEEEEEcccceecCC
Confidence             499999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=8.4e-22  Score=184.54  Aligned_cols=188  Identities=20%  Similarity=0.228  Sum_probs=143.4

Q ss_pred             EEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI-DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~-~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      .+...|++|+||+||++..  .+..++.+.+........ -....+.+|+++|++|.+|+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4567899999999997765  577787777654422111 1123578899999999867899999886    34699999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeccc-CCCcEEEeecCCCCCEEEeecCceeeecCCCcc
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL-KPENILLATKASSSPIKLADFGLATYIEPGQSL  201 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDI-Kp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~  201 (468)
                      |+.|.+|.+.+..      . ...++.|++.+|.++|++||+|||| ||+|||++.++.   ++|+|||++.........
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~---i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS---PAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC---EEEEECCCceecCCcchH
Confidence            9999999765422      1 2357789999999999999999999 799999976554   999999999865543211


Q ss_pred             --------------ccCCCCCCCcChhhhcC--CCC-CcchHHHHHHHHHHHHhCCCCCCCCC
Q 012203          202 --------------LGTVGSPFYIAPEVLAG--GYN-QAADVWSAGVILYILLSGMPPFWGNT  247 (468)
Q Consensus       202 --------------~~~~GT~~Y~APE~l~~--~~~-~~sDiwSlGvil~elltG~~Pf~~~~  247 (468)
                                    .-...++.|++|+...-  ..+ ...++++.|.-+|.++|+..++++.+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                          01236888999987543  233 57899999999999999999987754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2.4e-23  Score=226.04  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=181.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCc-CCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDR-LVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~-~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ...|...+.||.+.|=+|.+|++. .|. |++|++.+.. ........+...|++ .. +-++||.+++.-+-..+..-|
T Consensus        22 ~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t~kAAy   97 (1431)
T KOG1240|consen   22 SVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVTDKAAY   97 (1431)
T ss_pred             ccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHhhHHHH
Confidence            336888999999999999999886 465 8999997754 334444444444555 33 335999999999988889999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee--c
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI--E  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~--~  196 (468)
                      ||-+|.. -+|++++.-+.-+..-+.+.|+.||+.||..+|+.||+|||||.+||||++=.   -+.|+||...+..  .
T Consensus        98 lvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN---W~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen   98 LVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN---WLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec---hhhhhcccccCCccCC
Confidence            9999984 59999998766678888899999999999999999999999999999998633   3899999876532  1


Q ss_pred             CCCc------cccCCCCCCCcChhhhcC-----------C-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 012203          197 PGQS------LLGTVGSPFYIAPEVLAG-----------G-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT  257 (468)
Q Consensus       197 ~~~~------~~~~~GT~~Y~APE~l~~-----------~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~  257 (468)
                      .+..      ..+...-..|+|||.+..           . .+++.||||+||+++||++ |++||   +..+++..-..
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF---~LSQL~aYr~~  250 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF---TLSQLLAYRSG  250 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc---cHHHHHhHhcc
Confidence            1111      112233446999998743           1 3568899999999999988 79998   33333222111


Q ss_pred             ccCCCCCCCC-CCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          258 ADLRFPSNPW-DHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       258 ~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      . -..+.... .--+..++.||..|++.||++|+++++.|+.
T Consensus       251 ~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  251 N-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             C-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1 00000000 0112368999999999999999999999975

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.2e-20  Score=178.71  Aligned_cols=138  Identities=18%  Similarity=0.199  Sum_probs=110.0

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc----CCCCceeeeEEEEeCC---E-E
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS----GHPNVVDLKAVYEDED---Y-V  117 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~----~HpnIv~l~~~~~~~~---~-~  117 (468)
                      .+.||+|+++.||.  ++.++.. +||++....   ....+.+.+|+.++++|.    +||||++++++++++.   . +
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46899999999995  7767666 699887643   224567899999999994    3899999999998873   4 3


Q ss_pred             EEEEec--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHcCcEecccCCCcEEEeecC-CCCCEEEeecCce
Q 012203          118 HLVMEL--CAGGELFHRLEKFGRFSEAEARVLFMQLMQVV-LYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLA  192 (468)
Q Consensus       118 ~lV~E~--~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL-~~LH~~gIiHrDIKp~NILl~~~~-~~~~ikL~DFGla  192 (468)
                      .+||||  +.+++|.+++++ +.+++.  ..++.+++.++ +|||+++|+||||||+|||++.++ ....++|+||+-+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            478999  557999999976 456666  35678888777 999999999999999999998654 2346999995444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.2e-20  Score=208.54  Aligned_cols=200  Identities=21%  Similarity=0.313  Sum_probs=163.7

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEE
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYE  112 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~  112 (468)
                      +..-=.+.|.|.+.||+|+||+||.|.+.. |+.||+|+-.........-..      +++.||+  --+-|+.+...+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHc
Confidence            344455679999999999999999999976 999999987655332211122      2333332  1356777777777


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC----CCCCEEEee
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA----SSSPIKLAD  188 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~----~~~~ikL~D  188 (468)
                      -.+.-+||+||.+.|+|.++++..+.+++..+..+..|++..+++||..+|||+||||+|+||...-    ....++|+|
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            7888899999999999999999888899999999999999999999999999999999999996422    234589999


Q ss_pred             cCceeee---cCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCC
Q 012203          189 FGLATYI---EPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMP  241 (468)
Q Consensus       189 FGla~~~---~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~  241 (468)
                      ||.+..+   ..+......++|-.+-.+|+..|. +++.+|.|.|+.+++-||.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9998654   345566778999999999999996 9999999999999999999864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.2e-19  Score=179.45  Aligned_cols=191  Identities=29%  Similarity=0.467  Sum_probs=143.0

Q ss_pred             cCCCCceeeeEEEEeC---------------------------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHH
Q 012203           99 SGHPNVVDLKAVYEDE---------------------------DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL  151 (468)
Q Consensus        99 ~~HpnIv~l~~~~~~~---------------------------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qi  151 (468)
                      ..|||||++..+|.++                           ..+|+||..+ ..+|..++-. ...+....+.++.|+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-RHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-CCCchHHHHHHHHHH
Confidence            3699999998887432                           3689999987 4599999876 346778888999999


Q ss_pred             HHHHHHHHHcCcEecccCCCcEEEeecCCCC-CEEEeecCceeeecC-C------CccccCCCCCCCcChhhhcCC----
Q 012203          152 MQVVLYCHEIGVVHRDLKPENILLATKASSS-PIKLADFGLATYIEP-G------QSLLGTVGSPFYIAPEVLAGG----  219 (468)
Q Consensus       152 l~aL~~LH~~gIiHrDIKp~NILl~~~~~~~-~ikL~DFGla~~~~~-~------~~~~~~~GT~~Y~APE~l~~~----  219 (468)
                      ++|+.|||++||.|||+|.+||||.-+++.. .+.|+|||.+---.. +      ......-|.-..||||+...-    
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            9999999999999999999999997665432 469999998753221 0      111233577789999998642    


Q ss_pred             --C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHH
Q 012203          220 --Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTAR  293 (468)
Q Consensus       220 --~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~  293 (468)
                        . -.|+|.|+.|.+.||++....||+......+- .-....-++|..+ +.+++.+++++..+|+.||++|+++.
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~r~Yqe~qLPalp-~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-TRTYQESQLPALP-SRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheec-hhhhhhhhCCCCc-ccCChHHHHHHHHHhcCCccccCCcc
Confidence              1 24899999999999999999999874432211 1111112223222 57899999999999999999999854

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=1.4e-19  Score=174.71  Aligned_cols=148  Identities=20%  Similarity=0.114  Sum_probs=114.7

Q ss_pred             cCCeEEEeEEeecCCeEEEEEE-EcCCCcEEEEEEeccCcCCCh-----------------h----hHHHHHHHHHHHHH
Q 012203           40 RERFVLGQQLGWGQFGVIRVCS-DKFTGEVFACKSIAKDRLVTI-----------------D----DERSVKLEIEIMTR   97 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~-~~~~g~~vavK~i~~~~~~~~-----------------~----~~~~~~~Ei~iL~~   97 (468)
                      .--|.+.+.||+|++|.||+|. +..+|+.||+|++........                 .    ....+..|++++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3348999999999999999999 667899999999976432100                 0    11235689999999


Q ss_pred             hcCCCC--ceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC-cEecccCCCcEE
Q 012203           98 LSGHPN--VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG-VVHRDLKPENIL  174 (468)
Q Consensus        98 L~~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~g-IiHrDIKp~NIL  174 (468)
                      +. +.+  +.++++   .. ..++||||++|++|.........+....+..++.|++.+|.+||++| |+||||||+||+
T Consensus       107 L~-~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      107 LY-EAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             HH-hcCCCCCeeeE---ec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            96 432  333333   22 35899999999888776544456677778899999999999999999 999999999999


Q ss_pred             EeecCCCCCEEEeecCceeeec
Q 012203          175 LATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       175 l~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++ ++   .++|+|||.+....
T Consensus       182 i~-~~---~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DG---KVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CC---CEEEEEChhhhccC
Confidence            98 33   49999999987644

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.3e-20  Score=191.19  Aligned_cols=175  Identities=29%  Similarity=0.481  Sum_probs=137.9

Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG---RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      .++||.|++|...+|.++|.+..   ..+......++.|+..|++|   +|.+|||+||.||+...+..   +||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q---~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ---LKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh---hhhhhhhh
Confidence            46899999999999999997543   25667788999999999999   99999999999999976554   99999999


Q ss_pred             eeeecCCC-------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 012203          192 ATYIEPGQ-------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       192 a~~~~~~~-------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      ........       ......||+.||+||.+.+. |+.++|||+||+||+||+. -..+|   .....+..+..+.  +
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~--i  477 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGI--I  477 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCC--C
Confidence            98876555       45567899999999999986 9999999999999999997 33333   2233344444443  3


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      |...+.+.+ .-.+|+++||.+.|.+||++.+.--|.|.
T Consensus       478 p~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  478 PPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ChHHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            333233333 45689999999999999987777767664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=4.6e-21  Score=207.08  Aligned_cols=259  Identities=32%  Similarity=0.501  Sum_probs=209.7

Q ss_pred             CeEEEeEEeecCCeEEEEEEEc-CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDK-FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      .|.+.+.||+|+|+.|-++... .....+|.|.+.... ...........|..+-..+.+|+|++.+++...+.+..+++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4777888999999999888774 344566777766543 12333445556777777776799999999999999999999


Q ss_pred             EeccCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          121 MELCAGGELFHRL-EKFG-RFSEAEARVLFMQLMQVVLYCH-EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       121 ~E~~~ggsL~~~l-~~~~-~l~~~~~~~i~~qil~aL~~LH-~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+.  .++++|||+|..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhccccc
Confidence            9999999999999 5554 6788889999999999999999 999999999999999987662  499999999987655


Q ss_pred             -C---CccccCCC-CCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccCCCCCCCCCC
Q 012203          198 -G---QSLLGTVG-SPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRI-FDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       198 -~---~~~~~~~G-T~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  269 (468)
                       .   ......+| ++.|+|||...+.  .....|+||.|+++.-|++|..|+........ +.........+...+|..
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             2   23345689 9999999999883  57889999999999999999999865443321 111112223345667899


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ++....+++.++|..+|..|.+.+++..++|+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            9999999999999999999999999999999977

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.6e-19  Score=170.90  Aligned_cols=241  Identities=18%  Similarity=0.255  Sum_probs=188.7

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      ..+.-+|.+.-.|..|++++.  |..+++|+++.... +....+.|..|.-.|+-++ ||||+.+++.+.....+.+|..
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence            344567888889999999885  56677888876543 2233456777888888776 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          123 LCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |++-|+|+.+++....  .+..++.+++.++++|+.|||+..  |.---|....+++|.+.. ..+-.+|--++...   
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlt-arismad~kfsfqe---  343 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT-ARISMADTKFSFQE---  343 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh-hheecccceeeeec---
Confidence            9999999999987544  567789999999999999999875  444468888999987653 33555665554331   


Q ss_pred             CccccCCCCCCCcChhhhcCCC----CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGGY----NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~~----~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                         .+..-.|.||+||.++.+.    -.++|+|||.+++|||.|...||......+.--.+.-..++....  ..++..+
T Consensus       344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip--pgis~hm  418 (448)
T KOG0195|consen  344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP--PGISRHM  418 (448)
T ss_pred             ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC--CCccHHH
Confidence               2334578899999998752    347999999999999999999998888777665555554443322  5788999


Q ss_pred             HHHHHHccccCCCCCCCHHHHH
Q 012203          275 KDLVMGMLSTDPSQRLTARQVL  296 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL  296 (468)
                      ..|++-|+..||.+||.++.++
T Consensus       419 ~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999887764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=4.1e-18  Score=160.68  Aligned_cols=137  Identities=26%  Similarity=0.291  Sum_probs=113.5

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh--h---hHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI--D---DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~--~---~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      +.||+|++|.||+|.+  .|..+++|+.........  +   ....+.+|++++..+. |++|.....++.+.+..+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999987  678899998654322111  1   1245778999999996 899888887877788899999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      ||++|++|.+++.....    ....++.+++.+|.++|+.|++|||++|.|||++ ++   .++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~---~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG---KIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC---CEEEEECCcccC
Confidence            99999999999876332    7788999999999999999999999999999998 33   499999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=4e-19  Score=193.49  Aligned_cols=263  Identities=29%  Similarity=0.432  Sum_probs=214.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .+.+.+.+.+-+|.++.++.++...+|...++|+..+.......+.+....+-.++-..+ +|.++....-+......+|
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcch
Confidence            455777889999999999999988888777888766554433334444454544443333 6777665555666778999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec---
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE---  196 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~---  196 (468)
                      +++|..|++|...+++.+..+.+-++.+...+..++++||...+.|||++|.|+|...+++   .+++|||......   
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh---~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH---RPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC---cccCcccccccccccc
Confidence            9999999999999999888999999999999999999999999999999999999976665   8999998432210   


Q ss_pred             ------------------CC-----------CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 012203          197 ------------------PG-----------QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN  246 (468)
Q Consensus       197 ------------------~~-----------~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~  246 (468)
                                        ..           .......||+.|.+||.+.+. .+..+|+|++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                              00           001234799999999999885 899999999999999999999999999


Q ss_pred             ChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHH---HHHhCcCCCCCCCC
Q 012203          247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTAR---QVLDHSWMGDGIQD  307 (468)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~---eiL~h~~~~~~~~~  307 (468)
                      ...++++.+.+.+..++.-+ ...+.++++++..+|..+|.+|..+.   ++..|+||+...+.
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred             chhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence            99999999999998888665 57889999999999999999999988   99999999886643

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=9.8e-18  Score=156.74  Aligned_cols=134  Identities=23%  Similarity=0.259  Sum_probs=106.8

Q ss_pred             EEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           48 QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI-----DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~-----~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      .||+|++|.||++..  +|..+++|..........     .....+.+|++++..+. |+++.....++...+..++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            379999999999984  678899998654322111     12356778999999997 7776665555666777899999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      |++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||+++ ++   .++++|||++...
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~---~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD---KLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC---cEEEEECCCCcCC
Confidence            9999999988765321       7889999999999999999999999999998 33   4999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=6.2e-18  Score=158.56  Aligned_cols=141  Identities=20%  Similarity=0.223  Sum_probs=108.4

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC--h-----------------hhHHHHHHHHHHHHHhcCCC
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT--I-----------------DDERSVKLEIEIMTRLSGHP  102 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~--~-----------------~~~~~~~~Ei~iL~~L~~Hp  102 (468)
                      -|.+.+.||.|+||.||++.++ +|+.||||++.......  .                 ........|+.++.++. |+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence            3888899999999999999886 89999999976543100  0                 01123567899999986 66


Q ss_pred             C--ceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC
Q 012203          103 N--VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS  180 (468)
Q Consensus       103 n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~  180 (468)
                      +  +...++    ....++||||++|++|......      .....++.+++.++.++|+.||+||||||+||+++.++ 
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-  162 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-  162 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-
Confidence            3  444443    2345899999999998765431      34567889999999999999999999999999998654 


Q ss_pred             CCCEEEeecCceeeecC
Q 012203          181 SSPIKLADFGLATYIEP  197 (468)
Q Consensus       181 ~~~ikL~DFGla~~~~~  197 (468)
                        .++|+|||.+.....
T Consensus       163 --~~~liDfg~~~~~~~  177 (198)
T cd05144         163 --KIYIIDWPQMVSTDH  177 (198)
T ss_pred             --cEEEEECCccccCCC
Confidence              499999999966543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=2e-17  Score=178.04  Aligned_cols=148  Identities=20%  Similarity=0.215  Sum_probs=114.7

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC-----hhhHHHHHHHHHHHHHhcCCCCceee
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIEIMTRLSGHPNVVDL  107 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~-----~~~~~~~~~Ei~iL~~L~~HpnIv~l  107 (468)
                      ..........|...+.||+|+||+||++.+..  ..+++|+........     ......+.+|++++++++ |++++..
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p  401 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTP  401 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCee
Confidence            33334445566778999999999999998753  344444432221111     112356788999999996 9999888


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       108 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      ..++.+.+..++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+|||++ ++   .++|+
T Consensus       402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~---~~~li  469 (535)
T PRK09605        402 VIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD---RLYLI  469 (535)
T ss_pred             EEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC---cEEEE
Confidence            877777777899999999999999886        3467899999999999999999999999999993 33   49999


Q ss_pred             ecCceeee
Q 012203          188 DFGLATYI  195 (468)
Q Consensus       188 DFGla~~~  195 (468)
                      |||+++..
T Consensus       470 DFGla~~~  477 (535)
T PRK09605        470 DFGLGKYS  477 (535)
T ss_pred             eCcccccC
Confidence            99999764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.72  E-value=2.9e-17  Score=170.99  Aligned_cols=198  Identities=23%  Similarity=0.330  Sum_probs=154.1

Q ss_pred             HHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCc-EecccCCCcE
Q 012203           96 TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGV-VHRDLKPENI  173 (468)
Q Consensus        96 ~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gI-iHrDIKp~NI  173 (468)
                      +.+. |.|+.++++.+.+....++|.+||.-|+|.+.+.. .-.++..-...++++|+.||.|||...| .|+.++..|.
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4564 99999999999999999999999999999999977 3457777788889999999999998866 9999999999


Q ss_pred             EEeecCCCCCEEEeecCceeeecCC---CccccCCCCCCCcChhhhcCC--------CCCcchHHHHHHHHHHHHhCCCC
Q 012203          174 LLATKASSSPIKLADFGLATYIEPG---QSLLGTVGSPFYIAPEVLAGG--------YNQAADVWSAGVILYILLSGMPP  242 (468)
Q Consensus       174 Ll~~~~~~~~ikL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~--------~~~~sDiwSlGvil~elltG~~P  242 (468)
                      +++....   +||+|||+.......   .......-...|.|||.+.+.        .+.+.|+||+|++++|+++.+.|
T Consensus        81 lvd~~w~---lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LVDSRWV---LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             eeeeeEE---EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9987655   999999998765320   111112234459999999863        36689999999999999999999


Q ss_pred             CCCCC----hHHHHHHHHh-ccCCCCCC-C-CCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          243 FWGNT----KSRIFDAVRT-ADLRFPSN-P-WDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       243 f~~~~----~~~~~~~i~~-~~~~~~~~-~-~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      |....    ..++...+.. ....+... . ....++++..+++.||..+|.+||+++++-.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            96522    2345555555 22111111 1 1256668999999999999999999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=5e-17  Score=150.35  Aligned_cols=141  Identities=24%  Similarity=0.290  Sum_probs=99.7

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHH---------------------HHHHHHHHHHhcCC-CC
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS---------------------VKLEIEIMTRLSGH-PN  103 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~---------------------~~~Ei~iL~~L~~H-pn  103 (468)
                      .+.||+|+||+||+|.+. +|+.||+|++.............                     ...|.+.+.++..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            468999999999999987 89999999987643211111111                     14567777777522 12


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCC
Q 012203          104 VVDLKAVYEDEDYVHLVMELCAGGELFH-RLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       104 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~  181 (468)
                      +.+.++.    ...++||||++|+.+.. .+.... . ...++.++.+++.++.++|. .||+||||||+||+++ ++  
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~--  151 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG--  151 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--
Confidence            4444443    23589999999854321 121111 1 16678899999999999999 9999999999999998 43  


Q ss_pred             CCEEEeecCceeeecC
Q 012203          182 SPIKLADFGLATYIEP  197 (468)
Q Consensus       182 ~~ikL~DFGla~~~~~  197 (468)
                       .++|+|||.+.....
T Consensus       152 -~~~liDfg~a~~~~~  166 (187)
T cd05119         152 -KVYIIDVPQAVEIDH  166 (187)
T ss_pred             -cEEEEECcccccccC
Confidence             499999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=1.2e-15  Score=147.63  Aligned_cols=137  Identities=20%  Similarity=0.277  Sum_probs=103.3

Q ss_pred             eEEe-ecCCeEEEEEEEcCCCcEEEEEEeccCcC----------CChhhHHHHHHHHHHHHHhcCCCCc--eeeeEEEEe
Q 012203           47 QQLG-WGQFGVIRVCSDKFTGEVFACKSIAKDRL----------VTIDDERSVKLEIEIMTRLSGHPNV--VDLKAVYED  113 (468)
Q Consensus        47 ~~LG-~G~fg~Vy~a~~~~~g~~vavK~i~~~~~----------~~~~~~~~~~~Ei~iL~~L~~HpnI--v~l~~~~~~  113 (468)
                      ..|| .||.|+||.+...  +..+++|.+.+..+          ........+.+|++++.+|. |++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence            4576 7888888888663  78899998865322          01123356788999999996 7775  666666433


Q ss_pred             C-CE---EEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          114 E-DY---VHLVMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       114 ~-~~---~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      . ..   .++|||+++| .+|.+++.. ..+++..    +.+++.+|.+||++||+||||||+|||++.++   .++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG---KFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---CEEEEE
Confidence            2 22   3599999997 689888865 4555543    56899999999999999999999999998654   499999


Q ss_pred             cCceee
Q 012203          189 FGLATY  194 (468)
Q Consensus       189 FGla~~  194 (468)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            999875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=8.5e-16  Score=134.87  Aligned_cols=133  Identities=24%  Similarity=0.260  Sum_probs=110.9

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeCCEEEEEEec
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-PNVVDLKAVYEDEDYVHLVMEL  123 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-pnIv~l~~~~~~~~~~~lV~E~  123 (468)
                      +++.||.|.++.||++...  +..+++|.+.....     ...+..|+.+++.++.+ .++++++.++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            4578999999999999985  37899999865421     45688899999999744 6899999999888899999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          124 CAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI---GVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       124 ~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~---gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      ++|+.+..+       +......++.+++.+|.+||..   +++|+|++|.||+++..   +.+++.|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~---~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG---KILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC---cEEEEEecccccC
Confidence            998877644       4556677889999999999985   79999999999999863   3499999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=7.9e-17  Score=167.95  Aligned_cols=260  Identities=23%  Similarity=0.263  Sum_probs=204.0

Q ss_pred             ccccCCeEEEeEEee--cCCeEEEEEEE--cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           37 SNLRERFVLGQQLGW--GQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~--G~fg~Vy~a~~--~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      +.+...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.=+... ........-.+|+...+++..|+|.++.+..++
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccc
Confidence            445667888999999  99999999988  8899999999733221 111222334457777778878999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQ----VVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qil~----aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      ..+..++=+|+| |.+|..+...... ++...++..+.+...    ||.++|..+|+|-|+||.||++..+.  ..++++
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~  265 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLT  265 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecC
Confidence            999999999999 5788777766544 888999999999999    99999999999999999999998773  238999


Q ss_pred             ecCceeeecCCCccc------cCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 012203          188 DFGLATYIEPGQSLL------GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR  261 (468)
Q Consensus       188 DFGla~~~~~~~~~~------~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  261 (468)
                      |||+...+..+....      ...|...|++||.+++-++..+|+|++|.++.+..+|..++........ ..+...  .
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~--~  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQG--Y  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccc--c
Confidence            999998887654222      2257778999999999999999999999999999888776643311111 111111  1


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       262 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .+.+.....+.++...+..|++.+|..|++++.+++|.++..
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            344444566778888999999999999999999999999863

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.53  E-value=3.8e-14  Score=150.90  Aligned_cols=153  Identities=20%  Similarity=0.296  Sum_probs=98.3

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC--------------------------Ch-----hh
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--------------------------TI-----DD   84 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~--------------------------~~-----~~   84 (468)
                      ++.+...|.. +.||+|++|+||.|+.+.+|+.||||++.+....                          ..     +.
T Consensus       115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~  193 (537)
T PRK04750        115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF  193 (537)
T ss_pred             HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence            3445566777 7999999999999999988999999999754210                          00     11


Q ss_pred             HHHHHHHHHH------HHHhc---CCCCceeeeEEEE-eCCEEEEEEeccCCCCHHHH--HHHcC----CCCHHHHHHHH
Q 012203           85 ERSVKLEIEI------MTRLS---GHPNVVDLKAVYE-DEDYVHLVMELCAGGELFHR--LEKFG----RFSEAEARVLF  148 (468)
Q Consensus        85 ~~~~~~Ei~i------L~~L~---~HpnIv~l~~~~~-~~~~~~lV~E~~~ggsL~~~--l~~~~----~l~~~~~~~i~  148 (468)
                      .+.+.+|++.      +.+++   .+.+.+.+-.+|. -....+|||||+.|+.|.++  +...+    .+.+..+..++
T Consensus       194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~  273 (537)
T PRK04750        194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF  273 (537)
T ss_pred             HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence            1223334433      33332   1222222222222 23456799999999999774  33333    13333344444


Q ss_pred             HHHHHHHHHHHHcCcEecccCCCcEEEeecC-CCCCEEEeecCceeeec
Q 012203          149 MQLMQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLATYIE  196 (468)
Q Consensus       149 ~qil~aL~~LH~~gIiHrDIKp~NILl~~~~-~~~~ikL~DFGla~~~~  196 (468)
                      .|+       ...|++|+|+||.||+++.++ ..+.+++.|||++..+.
T Consensus       274 ~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 TQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            444       458999999999999998765 12359999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=7.4e-13  Score=138.95  Aligned_cols=144  Identities=20%  Similarity=0.217  Sum_probs=99.0

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh-------------------------------------hHHHH
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID-------------------------------------DERSV   88 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~-------------------------------------~~~~~   88 (468)
                      .+.||.|++|+||+|+.+ +|+.||||+..........                                     .+-.+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999986 7999999998553210000                                     00023


Q ss_pred             HHHHHHHHHhc----CCCCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 012203           89 KLEIEIMTRLS----GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQ-VVLYCHEIG  162 (468)
Q Consensus        89 ~~Ei~iL~~L~----~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~-aL~~LH~~g  162 (468)
                      .+|...+.+++    +++++.-..-+.......+|||||++|++|.++.... ...   ....++.+++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            44555555553    3454433333333345578999999999998876532 122   23445666666 467899999


Q ss_pred             cEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          163 VVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       163 IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++|+|+||.||+++.++.   ++|+|||++..+.
T Consensus       278 ~~H~D~hPgNilv~~~g~---i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGK---IIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCc---EEEEeCCCeeECC
Confidence            999999999999976554   9999999997754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=6.7e-14  Score=146.22  Aligned_cols=262  Identities=21%  Similarity=0.171  Sum_probs=194.4

Q ss_pred             hhcCccc-cccccCCeEEEeEEeecCCeEEEEEEEc-CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCcee
Q 012203           29 TILDTNQ-ISNLRERFVLGQQLGWGQFGVIRVCSDK-FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD  106 (468)
Q Consensus        29 ~i~~~~~-~~~l~~~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~  106 (468)
                      .|+.... ......+|.++..||.|.|+.|+.+... .++..|++|...+......+++ .-..|+.+...|.-|.+++.
T Consensus       252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCC
Confidence            3555555 7888899999999999999999988755 6788999998876644333332 23346666667767999999


Q ss_pred             eeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEE
Q 012203          107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKL  186 (468)
Q Consensus       107 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL  186 (468)
                      +...|......|+=.|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..++  ...++
T Consensus       331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~  408 (524)
T KOG0601|consen  331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKL  408 (524)
T ss_pred             CCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhc
Confidence            9888888888889999999999877664445688889999999999999999999999999999999998754  45799


Q ss_pred             eecCceeeecCCCccccCCCCCCCc-ChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 012203          187 ADFGLATYIEPGQSLLGTVGSPFYI-APEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       187 ~DFGla~~~~~~~~~~~~~GT~~Y~-APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                      +|||....+.-.  .....++-.+. ..|++...  +..+.|++|||.-+.+.++|..--+....   ...+..+.....
T Consensus       409 ~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~  483 (524)
T KOG0601|consen  409 GDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNL  483 (524)
T ss_pred             ccccccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCC
Confidence            999998653211  11122333344 35666543  78899999999999999998765332221   112222222111


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                          .....+++.+.+.++..++..|+.+.++..|+-|.
T Consensus       484 ----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  484 ----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ----CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                23347889999999999999999999998877653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=8.2e-13  Score=119.79  Aligned_cols=129  Identities=16%  Similarity=0.083  Sum_probs=95.6

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccC
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      ++.|+.|.++.||.++..  ++.|++|+......    ....+..|..+++.+.+...+.+++.+..  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999864  78899999765421    12345779999998873333445555433  33579999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----EecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGV-----VHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       126 ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gI-----iHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      |.++...        ......++.+++++|..||..++     +|+|++|.||+++ ++   .++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~---~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG---RLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC---eEEEEecccccC
Confidence            9887643        01123456799999999999885     9999999999998 33   399999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=4.5e-12  Score=133.97  Aligned_cols=185  Identities=16%  Similarity=0.229  Sum_probs=136.1

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |.+ ...+-++.+..-.+..+.++.+|.+..+....-   .......+-++.|+.|+ ||||++|++.++.++.+|||+|
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTE   89 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTE   89 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEee
Confidence            444 334444444332466677899999998876532   34456777889999997 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc-
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-  200 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH-~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-  200 (468)
                      -+  -.|..++++.   ....+..-+.||+.||.+|| +.+++|++|.-..|+|+..|+   .||++|.++........ 
T Consensus        90 rV--~Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge---WkLggle~v~~~~~~~~~  161 (690)
T KOG1243|consen   90 RV--RPLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE---WKLGGLELVSKASGFNAP  161 (690)
T ss_pred             cc--ccHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc---EEEeeeEEEeccccCCcc
Confidence            87  4788888774   46777888999999999997 568999999999999987665   99999998865432211 


Q ss_pred             cccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCC
Q 012203          201 LLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP  241 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~  241 (468)
                      .....---.|..|+.+... +-..|.|-|||++++++.|..
T Consensus       162 ~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  162 AKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             cccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCccc
Confidence            1111112235556544211 134699999999999999933

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=6.1e-12  Score=117.62  Aligned_cols=143  Identities=14%  Similarity=0.148  Sum_probs=102.6

Q ss_pred             eEEeecCCeEEEEEEEcC------CCcEEEEEEeccCcCC-------------------ChhhHHHHH----HHHHHHHH
Q 012203           47 QQLGWGQFGVIRVCSDKF------TGEVFACKSIAKDRLV-------------------TIDDERSVK----LEIEIMTR   97 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~------~g~~vavK~i~~~~~~-------------------~~~~~~~~~----~Ei~iL~~   97 (468)
                      ..||.|--+.||.|....      .+..+|+|++......                   ..+....+.    .|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653      3579999998542210                   001122333    79999999


Q ss_pred             hcCC-CCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEecccCCCcEEE
Q 012203           98 LSGH-PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC-HEIGVVHRDLKPENILL  175 (468)
Q Consensus        98 L~~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~gIiHrDIKp~NILl  175 (468)
                      +... -++.+++++    +..+|||||+.+..+..-.-+...+++.....+..+++.+|..| |+.||+|+||++.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            9732 356666654    45689999997654432222223456667778889999999998 89999999999999999


Q ss_pred             eecCCCCCEEEeecCceeeecC
Q 012203          176 ATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       176 ~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ..    +.+.|+|||.+.....
T Consensus       159 ~~----~~v~iIDF~qav~~~h  176 (197)
T cd05146         159 HD----GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EC----CcEEEEECCCceeCCC
Confidence            63    3499999999877653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=2.1e-12  Score=125.95  Aligned_cols=199  Identities=17%  Similarity=0.230  Sum_probs=141.8

Q ss_pred             HHHhcCCCCceeeeEEEEeCC-----EEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC--c
Q 012203           95 MTRLSGHPNVVDLKAVYEDED-----YVHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIG--V  163 (468)
Q Consensus        95 L~~L~~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~g--I  163 (468)
                      |-.+. |.|||+++.++.+.+     ...++.||+..|+|.+.|++.    ..+.....++++.||+.||.|||+..  |
T Consensus       121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            44554 999999999986544     588999999999999999764    34778888999999999999999874  9


Q ss_pred             EecccCCCcEEEeecCCCCCEEEeecCceeee---cC--CCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHH
Q 012203          164 VHRDLKPENILLATKASSSPIKLADFGLATYI---EP--GQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILL  237 (468)
Q Consensus       164 iHrDIKp~NILl~~~~~~~~ikL~DFGla~~~---~~--~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ell  237 (468)
                      +|+++...-|++..++   .||++---.....   +.  ........+-++|.+||.=.. +-+.++|||+||+...+|.
T Consensus       200 ihgnlTc~tifiq~ng---LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNG---LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccCCcchhheeecCCc---eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            9999999999997443   3666432211110   00  011112346788999997443 4677999999999999999


Q ss_pred             hCCCCC-CCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          238 SGMPPF-WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       238 tG~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      .|..-- ...........+.+.-+...       ...-++++.+||+-.|..||++.+++-||.+-+.
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            887652 22222233333333222211       1234678999999999999999999999987553

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=5.3e-11  Score=108.22  Aligned_cols=147  Identities=18%  Similarity=0.180  Sum_probs=112.9

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEe-ccC----cCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSI-AKD----RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i-~~~----~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      ....|-+|+-+.|+.+..  .|+.+.||.= .|.    .+...-...+.++|.++|.++. --.|.-..-+|.+.+.-.|
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            566888999999999876  5888888743 222    1111222456778999999997 5577766667777888889


Q ss_pred             EEeccCC-CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          120 VMELCAG-GELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       120 V~E~~~g-gsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +|||++| .++.+++...-  ....+....++++|-+.+.-||.++|+|+||..+||+|..+++...+.++|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999977 47788776542  222333378899999999999999999999999999999888877789999999865

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=4e-10  Score=102.90  Aligned_cols=135  Identities=25%  Similarity=0.281  Sum_probs=99.8

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC--hh---hHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT--ID---DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~--~~---~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      ..+++|+-+.+|.+...  |..+++|.=.++..-.  .+   ....-.+|..++.+++ --.|....-++.+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence            35788999999998653  4456676533322111  11   1235567999999987 456655555666777788999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      ||++|..|.+.+...       ...+++.+-..+.-||..||+|+||.++||++...    .+.++|||++..-
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----~i~~IDfGLg~~s  141 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----RIYFIDFGLGEFS  141 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC----cEEEEECCccccc
Confidence            999999998888774       24567778888889999999999999999999642    3999999999753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.17  E-value=1.2e-09  Score=112.65  Aligned_cols=212  Identities=17%  Similarity=0.225  Sum_probs=158.2

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE----eCCEEEEEEeccCC-C
Q 012203           53 QFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE----DEDYVHLVMELCAG-G  127 (468)
Q Consensus        53 ~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~----~~~~~~lV~E~~~g-g  127 (468)
                      .-.+.|+|....+|..|++|+++-.+......   ...-+++++++. |+|||++.++|.    .+..+++|++|.++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            44688999999999999999996554433321   223467788886 999999999996    45679999999986 5


Q ss_pred             CHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          128 ELFHRLEK---------------FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       128 sL~~~l~~---------------~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +|.++--.               ....+|...+.|+.||..||.++|+.|+.-+-|.|.+||++.+.   +|+|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~---RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM---RIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc---eEEEecccce
Confidence            67665421               12467899999999999999999999999999999999998654   3999999888


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhccCCCCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRI--FDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~  270 (468)
                      ..+..+..             |-+.  --.+-|.--||.+++.|.+|..--+..+...-  .+.|.           ..+
T Consensus       441 Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y  494 (655)
T KOG3741|consen  441 DVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY  494 (655)
T ss_pred             eeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence            77664430             0010  13467999999999999999765333222111  22221           357


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.+++++|..+...++++ -++++++.+
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            789999999999998886 677888754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=2.1e-10  Score=108.16  Aligned_cols=143  Identities=26%  Similarity=0.324  Sum_probs=103.6

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeC---CEEEEEEe
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-PNVVDLKAVYEDE---DYVHLVME  122 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-pnIv~l~~~~~~~---~~~~lV~E  122 (468)
                      +.|+.|..+.||++... +|+.+++|+.......  .....+..|.++++.+..+ .++.+++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            57899999999999875 3689999998654321  1245678899999999732 3456677776554   36789999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE------------------------------------------  160 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------------------  160 (468)
                      |++|.++.+.+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765532 345666666666777777766663                                          


Q ss_pred             --------------cCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          161 --------------IGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       161 --------------~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                                    ..++|+|++|.||+++.+ ....+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                          236999999999999763 123478999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=4.5e-11  Score=126.94  Aligned_cols=153  Identities=22%  Similarity=0.287  Sum_probs=113.1

Q ss_pred             HHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCcc----------ccCCCCCCCcChhhhcC
Q 012203          150 QLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL----------LGTVGSPFYIAPEVLAG  218 (468)
Q Consensus       150 qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~----------~~~~GT~~Y~APE~l~~  218 (468)
                      ++..||.|+|.. ++||++|.|++|.++.++.   +||+.|+++....+....          .-..-...|.|||++.+
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~---wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD---WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcc---eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            444899999975 8999999999999988776   999999998765542110          01124557999999987


Q ss_pred             C-CCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 012203          219 G-YNQAADVWSAGVILYILL-SGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL  296 (468)
Q Consensus       219 ~-~~~~sDiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL  296 (468)
                      . .+.++|++|+||++|.+. .|+.-+........+..-....---....-..++.++++-++++|..++..||++.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            5 688999999999999999 56666655443333222221111111111257899999999999999999999999999


Q ss_pred             hCcCCCCCC
Q 012203          297 DHSWMGDGI  305 (468)
Q Consensus       297 ~h~~~~~~~  305 (468)
                      ..+||.+..
T Consensus       264 ~~~ff~D~~  272 (700)
T KOG2137|consen  264 SIPFFSDPG  272 (700)
T ss_pred             cccccCCch
Confidence            999997743

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.04  E-value=5.8e-09  Score=105.40  Aligned_cols=238  Identities=16%  Similarity=0.176  Sum_probs=162.6

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE-------EeCCEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY-------EDEDYV  117 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~-------~~~~~~  117 (468)
                      ..+.||+|+-+.+|..-..   .-.+.|++.+.....   .   ..-+..|...-+||-+-.=+.|=       ......
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~---~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA---Q---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchH---H---HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            4578999999999975332   234678887753211   1   11234455555566543312221       223347


Q ss_pred             EEEEeccCCCCHHHHH-------HHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          118 HLVMELCAGGELFHRL-------EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l-------~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      .+.|..+.|..--..+       +....+.++...+.++.|+.+...||+.|-+-+|+.++|+|+..++.   |.|.|=.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~---V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK---VVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce---EEEEccc
Confidence            8899998886433333       11234778889999999999999999999999999999999976554   8998877


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhc-C-----CCCCcchHHHHHHHHHHHHhC-CCCCCCCCh-----HHHHHHHHhc
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLA-G-----GYNQAADVWSAGVILYILLSG-MPPFWGNTK-----SRIFDAVRTA  258 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~-~-----~~~~~sDiwSlGvil~elltG-~~Pf~~~~~-----~~~~~~i~~~  258 (468)
                      ....-.++......+|.+.|.+||.-. +     +-+...|.|.|||++++++.| ++||.+-..     .-....|..+
T Consensus       163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            666556666777889999999999866 2     246789999999999999987 999964221     1111122222


Q ss_pred             cC-----------C-CCCCCCCCCCHHHHHHHHHcccc--CCCCCCCHHH
Q 012203          259 DL-----------R-FPSNPWDHISDSAKDLVMGMLST--DPSQRLTARQ  294 (468)
Q Consensus       259 ~~-----------~-~~~~~~~~~s~~l~~li~~~L~~--dP~~Rpt~~e  294 (468)
                      .+           . ....+|..+++.++.|..+|+..  ++.-|||++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            11           1 11235678899999999999875  3567999764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=1.3e-08  Score=100.11  Aligned_cols=143  Identities=16%  Similarity=0.023  Sum_probs=97.9

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCC----C----hhhHHHHHHHHHHHHHhcCCCCc--eeeeEEEEe-----
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV----T----IDDERSVKLEIEIMTRLSGHPNV--VDLKAVYED-----  113 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~----~----~~~~~~~~~Ei~iL~~L~~HpnI--v~l~~~~~~-----  113 (468)
                      +-......|..+..  .|+.|.||........    .    ........+|...+.+|. .-+|  +.+.++.+.     
T Consensus        30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCc
Confidence            33333444555543  5778999976432210    0    001123678999988885 3333  333444443     


Q ss_pred             CCEEEEEEeccCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec----CCCCCEEE
Q 012203          114 EDYVHLVMELCAGG-ELFHRLEK--FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK----ASSSPIKL  186 (468)
Q Consensus       114 ~~~~~lV~E~~~gg-sL~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~----~~~~~ikL  186 (468)
                      ...-+||||++++. +|.+++..  ....+......++.+++..+.-||++||+|+|+++.|||++.+    .....+.|
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence            23578999999886 89998864  2446677788999999999999999999999999999999852    22346999


Q ss_pred             eecCceee
Q 012203          187 ADFGLATY  194 (468)
Q Consensus       187 ~DFGla~~  194 (468)
                      +||+.+..
T Consensus       187 IDl~r~~~  194 (268)
T PRK15123        187 IDLHRAQI  194 (268)
T ss_pred             EECCcccc
Confidence            99998854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=1.5e-08  Score=94.25  Aligned_cols=130  Identities=25%  Similarity=0.240  Sum_probs=83.0

Q ss_pred             EEEEEEEcCCCcEEEEEEeccCcCCC---------------------h--hhHHHHHHHHHHHHHhcCC-CCceeeeEEE
Q 012203           56 VIRVCSDKFTGEVFACKSIAKDRLVT---------------------I--DDERSVKLEIEIMTRLSGH-PNVVDLKAVY  111 (468)
Q Consensus        56 ~Vy~a~~~~~g~~vavK~i~~~~~~~---------------------~--~~~~~~~~Ei~iL~~L~~H-pnIv~l~~~~  111 (468)
                      .||.|... +|+.+|+|+.......-                     .  -.....++|.+.|.++... -++.+++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38888874 68899999986532100                     0  0123567799999999732 1456666443


Q ss_pred             EeCCEEEEEEeccC--CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          112 EDEDYVHLVMELCA--GGELFHRLEKFGRFSEAEARVLFMQLMQVVLY-CHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       112 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~-LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                        .  .+|||||++  |..+..+...  .++......++.+++..+.. +|..||+|+||.+.|||++.+    .+.|+|
T Consensus        80 --~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iID  149 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIID  149 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--
T ss_pred             --C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEe
Confidence              3  369999998  6555443332  12245567788888886655 589999999999999999754    499999


Q ss_pred             cCceeeec
Q 012203          189 FGLATYIE  196 (468)
Q Consensus       189 FGla~~~~  196 (468)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.80  E-value=6e-08  Score=91.72  Aligned_cols=130  Identities=21%  Similarity=0.262  Sum_probs=94.8

Q ss_pred             CCcEEEEEEeccCcCCC----hhhHHHHHHHHHHHHHhcCCCC--ceeeeEEEEeC----CEEEEEEeccCCC-CHHHHH
Q 012203           65 TGEVFACKSIAKDRLVT----IDDERSVKLEIEIMTRLSGHPN--VVDLKAVYEDE----DYVHLVMELCAGG-ELFHRL  133 (468)
Q Consensus        65 ~g~~vavK~i~~~~~~~----~~~~~~~~~Ei~iL~~L~~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l  133 (468)
                      .++.|.+|.........    .-......+|...+.+|. .-+  ..+.+++.+..    ..-+||+|+++|. +|.+++
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~  109 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL  109 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence            45566666543221111    122346777888888776 233  44555555542    2458999999884 799999


Q ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          134 EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       134 ~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      ......+......++.+++..+.-||++||+|+|+++.|||++.++....+.|+||+-+...
T Consensus       110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            87555777888899999999999999999999999999999998764456999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.74  E-value=6.6e-08  Score=93.40  Aligned_cols=139  Identities=24%  Similarity=0.252  Sum_probs=102.6

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC-----------------CCh--hhHHHHHHHHHHHHHhcCC-C
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-----------------VTI--DDERSVKLEIEIMTRLSGH-P  102 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~-----------------~~~--~~~~~~~~Ei~iL~~L~~H-p  102 (468)
                      +.++.+||-|--+.||.|.+. .|.++|+|.=...+.                 .++  -.....++|.++|++|..+ -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567889999999999999986 799999996422111                 011  1123567799999999633 2


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       103 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      .+.+.++    .+...+||||++|-.|...-     +..+.+..++..|++-+..+-..||+|+|+.+-||+++.|+.  
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--  240 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--  240 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence            4555554    45678999999997775322     235566777888888888777999999999999999998766  


Q ss_pred             CEEEeecCceee
Q 012203          183 PIKLADFGLATY  194 (468)
Q Consensus       183 ~ikL~DFGla~~  194 (468)
                       +.++||--+..
T Consensus       241 -~~vIDwPQ~v~  251 (304)
T COG0478         241 -IVVIDWPQAVP  251 (304)
T ss_pred             -EEEEeCccccc
Confidence             99999955443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.64  E-value=4.8e-07  Score=85.65  Aligned_cols=142  Identities=16%  Similarity=0.180  Sum_probs=94.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHH------HHHHHHHHHHHhc--CCCCceeeeEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER------SVKLEIEIMTRLS--GHPNVVDLKAV  110 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~------~~~~Ei~iL~~L~--~HpnIv~l~~~  110 (468)
                      +..+|.+.+.+-......|.+..  .+|+.+++|.........+....      ...+++..+.+++  +-..++.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            66789999999988877776654  46899999987654321111111      1234444455554  12233333333


Q ss_pred             E-----EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEE
Q 012203          111 Y-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       111 ~-----~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                      .     .-....+|+|||++|..|.+...    +.+    .+...+.+++.-||+.|+.|+|.+|.|++++.++    ++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~----i~  174 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG----IR  174 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc----EE
Confidence            2     22345679999999988866542    222    2445677889999999999999999999997432    99


Q ss_pred             EeecCceee
Q 012203          186 LADFGLATY  194 (468)
Q Consensus       186 L~DFGla~~  194 (468)
                      ++||+..+.
T Consensus       175 iID~~~k~~  183 (229)
T PF06176_consen  175 IIDTQGKRM  183 (229)
T ss_pred             EEECccccc
Confidence            999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=3e-07  Score=97.88  Aligned_cols=143  Identities=22%  Similarity=0.268  Sum_probs=96.6

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC---------------------------hhh----HH------HHH
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---------------------------IDD----ER------SVK   89 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~---------------------------~~~----~~------~~~   89 (468)
                      +.|+.++.|+||.|+.+ +|+.||||+....-...                           ..-    .+      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            68999999999999997 59999999985532110                           000    11      123


Q ss_pred             HHHHHHHHhc----CCCCceeeeEEEEeCCEEEEEEeccCCCCHHHHH--HHcCCCCHHHHHHHHHHHHHH-HHHHHHcC
Q 012203           90 LEIEIMTRLS----GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQV-VLYCHEIG  162 (468)
Q Consensus        90 ~Ei~iL~~L~----~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l--~~~~~l~~~~~~~i~~qil~a-L~~LH~~g  162 (468)
                      +|...+.+++    +.+++.--.-+++-.+.-.|+|||+.|-.+.+..  +. ..++.   ..++..++.+ +..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHHHHhcC
Confidence            3444444443    4555555455555556678999999999998874  44 33443   2333344443 23444579


Q ss_pred             cEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       163 IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++|.|.+|.||+++.++.   +.+.|||+...+.+
T Consensus       286 ffHaDpHpGNi~v~~~g~---i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGR---IVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCc---EEEEcCcceecCCH
Confidence            999999999999987755   99999999987654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.52  E-value=5.1e-09  Score=110.46  Aligned_cols=240  Identities=18%  Similarity=0.216  Sum_probs=163.8

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCCEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-VVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn-Iv~l~~~~~~~~~~~lV  120 (468)
                      -|...+.+++|+++++++.+...+.... .+.+...        .....++++|.++. ||| .+.+++-++.+.+.++.
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccccchh
Confidence            3445567889999999998776554443 5555322        45566899999995 999 77888888888999999


Q ss_pred             EeccCCC-CH-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGG-EL-FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~gg-sL-~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |+++.++ +. .......-.+.+.....+.+.-+++|+++|+.--+|||    ||+..+    +..++.||+....+...
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~----~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE----EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc----cccccccccCCcccCcc
Confidence            9999887 22 11111112244444555666777888999988778999    888754    34799999999887766


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--C-CCCCCCCHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP--S-NPWDHISDSA  274 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~-~~~~~~s~~l  274 (468)
                      ....+..+|+.++|||+...+ +....|.|++|+-..+|--|-+|-....  ...-.+-.+...+.  . ..|....  -
T Consensus       385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~--~  460 (829)
T KOG0576|consen  385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVF--H  460 (829)
T ss_pred             cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCccc--c
Confidence            666778999999999988765 8999999999987778877777743210  00000000000000  0 1111111  1


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .++...|+..-|..|++...++.|-+|..
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            24778888899999999888888877755

>PRK09902 hypothetical protein; Provisional

Probab=98.48  E-value=3e-06  Score=79.95  Aligned_cols=141  Identities=13%  Similarity=0.127  Sum_probs=100.4

Q ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC---hhhHHHHHHHHHHHHHhcCCCC--ceeeeEEEE-e----CCEEE
Q 012203           49 LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---IDDERSVKLEIEIMTRLSGHPN--VVDLKAVYE-D----EDYVH  118 (468)
Q Consensus        49 LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~---~~~~~~~~~Ei~iL~~L~~Hpn--Iv~l~~~~~-~----~~~~~  118 (468)
                      -|+||-+-|+....  .|+.+-+|.-......+   ......+.+|+..|.+|. .-+  +.++. ++. .    .-.-+
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~-~~GvPVP~pv-f~~~~k~~~~~rA~  101 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELE-RAGVIVPKIV-FGEAVKIEGEWRAL  101 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHH-HcCCCCCccc-eeeeeccCCceEEE
Confidence            35688888888654  35578888764211111   234678999999999887 222  44444 222 1    12467


Q ss_pred             EEEeccCC-CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          119 LVMELCAG-GELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       119 lV~E~~~g-gsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      ||+|-++| -+|.+++...  .+.+......++.+++.++.-||+.|+.|+|+.+.|||++.++ .-.++++||.-++.
T Consensus       102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            99997754 5888888663  3457777789999999999999999999999999999998554 23599999987654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.46  E-value=1e-06  Score=98.93  Aligned_cols=206  Identities=18%  Similarity=0.258  Sum_probs=145.8

Q ss_pred             HHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE----EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 012203           86 RSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH----LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI  161 (468)
Q Consensus        86 ~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~----lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~  161 (468)
                      .....|++.+.+++ |+|++.++.+..+.....    +..|+|.+.++...+..-+..+....+.+..++++||.|+|+.
T Consensus       227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            34455777788886 999999999986554433    4567999999999999989999999999999999999999998


Q ss_pred             CcEecccCCCcEEEeecCCCCCEEEe--ecCceeeecCCCccccCCCCCCCcChhhhcCCC---CCcchHHHHHHHHHHH
Q 012203          162 GVVHRDLKPENILLATKASSSPIKLA--DFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY---NQAADVWSAGVILYIL  236 (468)
Q Consensus       162 gIiHrDIKp~NILl~~~~~~~~ikL~--DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~sDiwSlGvil~el  236 (468)
                      ...|.-+.-.-..-.....+..+.++  ||+.+.............-+..+.++|....+.   ....|+|.+|..+..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            55544443331111111223345555  888887776555555556677788999887652   3346999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          237 LSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       237 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..|..+-..   ......+.      +    .....+..+++.+|+.-++++|+++.+++.|+|.+...
T Consensus       386 ~~~~~i~~~---~~~~~~~l------~----~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  386 SQGEDISEK---SAVPVSLL------D----VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hhcCccccc---ccchhhhh------c----cccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            887655311   11111110      0    11112678899999999999999999999999986543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.39  E-value=6.1e-06  Score=79.22  Aligned_cols=73  Identities=19%  Similarity=0.148  Sum_probs=55.3

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCCEEEEEEeccC
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-VVDLKAVYEDEDYVHLVMELCA  125 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn-Iv~l~~~~~~~~~~~lV~E~~~  125 (468)
                      .+||.|..+.||+.    .|..+++|......     ....+.+|.++++.+....- +.+.+++.++.+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999984    25567889876432     23456889999999873322 5777888888888999999999


Q ss_pred             CCC
Q 012203          126 GGE  128 (468)
Q Consensus       126 ggs  128 (468)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=8.4e-06  Score=76.96  Aligned_cols=79  Identities=19%  Similarity=0.157  Sum_probs=58.0

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeEEE---EeCCEEEEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKAVY---EDEDYVHLVM  121 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~~~---~~~~~~~lV~  121 (468)
                      ++.|+.|..+.||.+....  ..+++|+....     .....+..|..+++.|..+- .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4689999999999998864  58999986432     34567888999999887442 255666543   3345689999


Q ss_pred             eccCCCCHHH
Q 012203          122 ELCAGGELFH  131 (468)
Q Consensus       122 E~~~ggsL~~  131 (468)
                      ++++|..+..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999988777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.28  E-value=7.9e-06  Score=78.87  Aligned_cols=77  Identities=16%  Similarity=0.086  Sum_probs=56.2

Q ss_pred             EEeecCC-eEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCC
Q 012203           48 QLGWGQF-GVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAG  126 (468)
Q Consensus        48 ~LG~G~f-g~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g  126 (468)
                      .|-.|.. +.||++...  +..+.+|+.....      ...+..|+++++.+.++--+.+++++....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            4455655 789998653  4678888875432      235677999999997665566788888777778999999999


Q ss_pred             CCHHHH
Q 012203          127 GELFHR  132 (468)
Q Consensus       127 gsL~~~  132 (468)
                      .+|...
T Consensus        77 ~~l~~~   82 (244)
T cd05150          77 VPAAAL   82 (244)
T ss_pred             ccHhHh
Confidence            877643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.26  E-value=8.1e-06  Score=78.31  Aligned_cols=158  Identities=21%  Similarity=0.181  Sum_probs=102.2

Q ss_pred             hcCccccccccCCeEEEeEEe---ecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh----------------h-----H
Q 012203           30 ILDTNQISNLRERFVLGQQLG---WGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID----------------D-----E   85 (468)
Q Consensus        30 i~~~~~~~~l~~~y~i~~~LG---~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~----------------~-----~   85 (468)
                      -.+...+..|..+..+....|   .|--+.||+|... ++..+|+|++.........                .     .
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            334455566677777665555   5666799999773 6899999999654221111                0     0


Q ss_pred             HHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEEEEEEeccCCCCH-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cC
Q 012203           86 RSVKLEIEIMTRLSG-HPNVVDLKAVYEDEDYVHLVMELCAGGEL-FHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IG  162 (468)
Q Consensus        86 ~~~~~Ei~iL~~L~~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~g  162 (468)
                      .-...|...|+++.+ +-.+.+.+.+..    -.|||||+....+ .-.|+. -.+...++..+..++++.+.-|-. .+
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~  187 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG  187 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence            123457777777752 233445555442    4699999854311 111111 123333688888999999988865 89


Q ss_pred             cEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       163 IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++|+||..-|||+. ++   .+.|+|||-|....+
T Consensus       188 LVHgDLSEyNiL~~-~~---~p~iID~~QaV~~~h  218 (268)
T COG1718         188 LVHGDLSEYNILVH-DG---EPYIIDVSQAVTIDH  218 (268)
T ss_pred             cccccchhhheEEE-CC---eEEEEECccccccCC
Confidence            99999999999997 33   389999998876553

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.17  E-value=6.1e-05  Score=70.76  Aligned_cols=134  Identities=23%  Similarity=0.230  Sum_probs=95.4

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC-------------CChhhHHHHHHHHHHHHHhc-----CCCCceeee
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-------------VTIDDERSVKLEIEIMTRLS-----GHPNVVDLK  108 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~-------------~~~~~~~~~~~Ei~iL~~L~-----~HpnIv~l~  108 (468)
                      ..||.|+.-.||.-   ......+||+......             ......+...+|+....++.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            57999999999974   3455678999877650             00112345566666655553     377899999


Q ss_pred             EEEEeCCEEEEEEeccCC------CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          109 AVYEDEDYVHLVMELCAG------GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       109 ~~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      |+.+++.-..+|+|.+.+      -+|.+++.. +.+++ .   +...+-+-.+||-+++|+.+|++|.||++..+....
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            999999999999998653      368888855 44555 2   333444445788899999999999999998876654


Q ss_pred             -CEEEee
Q 012203          183 -PIKLAD  188 (468)
Q Consensus       183 -~ikL~D  188 (468)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             566666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.13  E-value=2.9e-05  Score=88.13  Aligned_cols=82  Identities=18%  Similarity=0.259  Sum_probs=58.3

Q ss_pred             EEeEEeecCCeEEEEEEEcCCC--cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCc--eeeeEEEEeC---CEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTG--EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV--VDLKAVYEDE---DYV  117 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g--~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnI--v~l~~~~~~~---~~~  117 (468)
                      .+++|+.|.++.+|+......+  ..+++|+.......  .....+.+|.++|+.|.+|+++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3578899999999998765432  46778876443211  1234678899999999656664  7777777654   467


Q ss_pred             EEEEeccCCCC
Q 012203          118 HLVMELCAGGE  128 (468)
Q Consensus       118 ~lV~E~~~ggs  128 (468)
                      |+||||++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            89999998864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.06  E-value=3.1e-05  Score=82.60  Aligned_cols=144  Identities=20%  Similarity=0.176  Sum_probs=89.2

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC----------------------------hhhHHH------HHHHH
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT----------------------------IDDERS------VKLEI   92 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~----------------------------~~~~~~------~~~Ei   92 (468)
                      +.||.-+.|+||.|+.+. |+.||||+-+..-...                            .+-.+.      +.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            689999999999999985 9999999865431100                            000111      22232


Q ss_pred             HHHHHhc---CCCC------ceeeeEEEEeCCEEEEEEeccCCCCHHHH--HHHcCCCCHHHHHHHHHHHHHHH-HHHHH
Q 012203           93 EIMTRLS---GHPN------VVDLKAVYEDEDYVHLVMELCAGGELFHR--LEKFGRFSEAEARVLFMQLMQVV-LYCHE  160 (468)
Q Consensus        93 ~iL~~L~---~Hpn------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~--l~~~~~l~~~~~~~i~~qil~aL-~~LH~  160 (468)
                      +-..+.+   .|-+      |.+++-  .-.....|+||||+|..+.++  |++. .++...+   +..+.++. +-|=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i---~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDI---LNKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHH---HHHHHHHHHHHHHh
Confidence            2222222   1333      222222  233457899999999877654  3443 3555543   33444442 23345


Q ss_pred             cCcEecccCCCcEEEeecC-CCCCEEEeecCceeeecC
Q 012203          161 IGVVHRDLKPENILLATKA-SSSPIKLADFGLATYIEP  197 (468)
Q Consensus       161 ~gIiHrDIKp~NILl~~~~-~~~~ikL~DFGla~~~~~  197 (468)
                      .|++|.|-+|.||++..+. ....+.+-|||+...+.+
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            6899999999999998643 345699999999876543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.04  E-value=2.2e-05  Score=71.62  Aligned_cols=133  Identities=21%  Similarity=0.273  Sum_probs=91.7

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      -++.+.||+|..|.||++.+.  |..+|+|+-..+     .....++.|.++|..+.+----.+++.+-++    ++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            345678999999999999885  668999986543     3467889999999999744444555555443    24599


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccC-CCcEEEeecCCCCCEEEeecCceeeec
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLK-PENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIK-p~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |+.|-.|...-...   .    +.-...++++-.-|-..||-|+.|. |..++|..+..   +.|+||.-|+...
T Consensus        93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~---~~iIDFd~At~k~  157 (201)
T COG2112          93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRD---VYIIDFDSATFKK  157 (201)
T ss_pred             hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCc---EEEEEccchhhcc
Confidence            99998887665431   1    2233345555445667799999885 44444543333   9999999997533

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.02  E-value=0.00016  Score=67.78  Aligned_cols=129  Identities=20%  Similarity=0.233  Sum_probs=92.6

Q ss_pred             CCeEEEeEEeecCC-eEEEEEEEcCCCcEEEEEEeccCcCCCh------------------hhHHHHHHHHHHHHHhc--
Q 012203           41 ERFVLGQQLGWGQF-GVIRVCSDKFTGEVFACKSIAKDRLVTI------------------DDERSVKLEIEIMTRLS--   99 (468)
Q Consensus        41 ~~y~i~~~LG~G~f-g~Vy~a~~~~~g~~vavK~i~~~~~~~~------------------~~~~~~~~Ei~iL~~L~--   99 (468)
                      ..++.++.||.|.- |.||+++.  .|+.||+|++..-.....                  .....+..|-+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67999999999999 99999976  588999999322110000                  11235778888888887  


Q ss_pred             CCCCc--eeeeEEEEeC------------------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 012203          100 GHPNV--VDLKAVYEDE------------------DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH  159 (468)
Q Consensus       100 ~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH  159 (468)
                      ++.++  |+.++|..-.                  -...||.||.+...         .+..    .-+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence            34455  8999998321                  12458888876643         1222    33457788888999


Q ss_pred             HcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          160 EIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       160 ~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      ..||+-+|+++.|..=        -||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC--------CEEEecccC
Confidence            9999999999999851        399999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.87  E-value=0.00021  Score=68.43  Aligned_cols=76  Identities=18%  Similarity=0.151  Sum_probs=50.8

Q ss_pred             EeEEeecCCeEEEEEEEcC-CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           46 GQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~-~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      ++.|..|-...+|++.... .++.|++|+......    ......+|+.+++.+..+...++++..+.  +  .+||||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4577888888999987643 357889998754321    11233568889998864444555554433  2  4899999


Q ss_pred             CCCCH
Q 012203          125 AGGEL  129 (468)
Q Consensus       125 ~ggsL  129 (468)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            99765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.82  E-value=1.3e-06  Score=99.90  Aligned_cols=207  Identities=14%  Similarity=0.070  Sum_probs=133.3

Q ss_pred             HHHHHHHHHHhcCCCCceeeeEEEE--eCCEEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc
Q 012203           88 VKLEIEIMTRLSGHPNVVDLKAVYE--DEDYVHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEI  161 (468)
Q Consensus        88 ~~~Ei~iL~~L~~HpnIv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~  161 (468)
                      ...|..-++... |+++.....-..  ++...|..++|+.+|.+++.|-+.    .++...-+.....+.+.+..-+|..
T Consensus      1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            334555555565 888877766553  345678999999999999999653    2344444444444546666666653


Q ss_pred             -C----cEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc-cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHH
Q 012203          162 -G----VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILY  234 (468)
Q Consensus       162 -g----IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~  234 (468)
                       +    -+|+++|+-|.+|..+.+   +|++++|+.+...+... .....+++.|++|++.+. .++.++|+|+.|+-+|
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~---v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYN---VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCc---ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence             2    689999999999998776   99999999995444433 334578889999998876 5888899999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          235 ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       235 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ++..|..+|.......+...+.+... +..+.  ..|.++-.....+|-..-..||.-...+..+.+
T Consensus      1432 ~rs~~n~~fi~flq~~Lkgiidn~tf-~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFFLQPALKGIIDNHTF-FSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             HHhcccHHHHHHHHHHHcCccccccc-ccccc--cCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            99999888733222222111222111 11111  112222223333333333568877777766655

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.79  E-value=0.00012  Score=70.38  Aligned_cols=74  Identities=15%  Similarity=0.078  Sum_probs=46.7

Q ss_pred             eEEeecCCe-EEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC--CceeeeEEEEeC---CEEEEE
Q 012203           47 QQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP--NVVDLKAVYEDE---DYVHLV  120 (468)
Q Consensus        47 ~~LG~G~fg-~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp--nIv~l~~~~~~~---~~~~lV  120 (468)
                      +.|+.|+.. .||..     +..+++|+.....     ....+..|.++|+.|.++-  -+.++++.....   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            567777766 58875     2357788754321     2347888999999886431  234444433322   245889


Q ss_pred             EeccCCCCHH
Q 012203          121 MELCAGGELF  130 (468)
Q Consensus       121 ~E~~~ggsL~  130 (468)
                      |++++|.++.
T Consensus        73 ~~~i~G~~l~   82 (235)
T cd05155          73 YRWLEGETAT   82 (235)
T ss_pred             EEeecCCCCC
Confidence            9999997763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.70  E-value=0.00098  Score=69.21  Aligned_cols=81  Identities=19%  Similarity=0.131  Sum_probs=54.9

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC-C-C--hhhHHHHHHHHHHHHHhcCC--CCceeeeEEEEeCCEEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-V-T--IDDERSVKLEIEIMTRLSGH--PNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~-~-~--~~~~~~~~~Ei~iL~~L~~H--pnIv~l~~~~~~~~~~~l  119 (468)
                      .+.||.|.+..||.+.+...++.++||.-..... . .  .-...+...|.+.|+.+..+  .++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4689999999999999864446899998531100 0 0  12345667788888877533  356667666  3455789


Q ss_pred             EEeccCCCC
Q 012203          120 VMELCAGGE  128 (468)
Q Consensus       120 V~E~~~ggs  128 (468)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998744

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.61  E-value=0.00031  Score=69.70  Aligned_cols=138  Identities=18%  Similarity=0.129  Sum_probs=81.6

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeE------EEEeCCEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKA------VYEDEDYVH  118 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~------~~~~~~~~~  118 (468)
                      .+.|..|....+|++..  ++..+++|++...      ....+..|++++..|..+- .+.+++.      +....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            55677788789998865  3457889987541      2345677888888886321 2444433      223456678


Q ss_pred             EEEeccCCCCHHH-----------HH---HHc-CCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 012203          119 LVMELCAGGELFH-----------RL---EKF-GRFSE--------AEAR------------VLFMQLMQVVLYCHE---  160 (468)
Q Consensus       119 lV~E~~~ggsL~~-----------~l---~~~-~~l~~--------~~~~------------~i~~qil~aL~~LH~---  160 (468)
                      +|+++++|..+..           .+   +.. ..+..        ....            .....+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999876421           11   110 00100        0000            011112233444432   


Q ss_pred             ----cCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          161 ----IGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       161 ----~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                          .+++|+|+.|.|||++.+.   .+.|.||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~---~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDE---LSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCc---eEEEeehhhhcC
Confidence                4799999999999998533   368999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.59  E-value=0.00028  Score=68.71  Aligned_cols=134  Identities=18%  Similarity=0.151  Sum_probs=76.5

Q ss_pred             EEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCC
Q 012203           48 QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGG  127 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg  127 (468)
                      .+..|-.+.+|+..  .+++.+++|+.......   ......+|.++++.+..+.-..+++...  .  -++||||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence            34557778899886  35778889976543111   0013467899999887442233444433  2  26899999987


Q ss_pred             CHHH--------------HHH---Hc----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCcEeccc
Q 012203          128 ELFH--------------RLE---KF----GRFSE-AEARVLFMQL---------MQVVLYCHE--------IGVVHRDL  168 (468)
Q Consensus       128 sL~~--------------~l~---~~----~~l~~-~~~~~i~~qi---------l~aL~~LH~--------~gIiHrDI  168 (468)
                      .+..              .+.   ..    .+++. .....+..++         ...++.+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            6532              111   10    01121 1122222222         111222211        24899999


Q ss_pred             CCCcEEEeecCCCCCEEEeecCceee
Q 012203          169 KPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       169 Kp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .|.||+++.++    +.|+||..+..
T Consensus       154 ~~~Nil~~~~~----~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG----LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC----CEEEeccccCc
Confidence            99999997543    78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.50  E-value=0.00044  Score=69.24  Aligned_cols=139  Identities=15%  Similarity=0.118  Sum_probs=79.7

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeEE------EEeCCEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKAV------YEDEDYVH  118 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~~------~~~~~~~~  118 (468)
                      .+.++.|....+|.+...  +..+++|+.....     ....+..|.+++..|.++- .+.+++..      ....+..+
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            566777877899988643  3467889875421     1234566778887775221 13343331      12346688


Q ss_pred             EEEeccCCCCHH-----------HH---HHHc-CCC--------CHHH-----HH----------HHHHHHHHHHHHHH-
Q 012203          119 LVMELCAGGELF-----------HR---LEKF-GRF--------SEAE-----AR----------VLFMQLMQVVLYCH-  159 (468)
Q Consensus       119 lV~E~~~ggsL~-----------~~---l~~~-~~l--------~~~~-----~~----------~i~~qil~aL~~LH-  159 (468)
                      +++||++|..+.           ..   ++.. ..+        ....     ..          .....+...++++. 
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999985431           11   1110 011        0000     00          00112233444443 


Q ss_pred             ------HcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          160 ------EIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       160 ------~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                            ..+++|+|+++.||+++.++   .+.|+||+.+..
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~---~~~vIDfd~~~~  217 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDS---VKGVIDFYFACT  217 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCc---eEEEeecccccC
Confidence                  25899999999999998643   368999998743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.50  E-value=0.00072  Score=67.37  Aligned_cols=77  Identities=12%  Similarity=0.032  Sum_probs=51.1

Q ss_pred             EeEEeecCCeEEEEEEEcC------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKF------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      ++.|..|-...+|++....      .++.+++|+.....    .......+|.+++..+.++--..++++.+. +   .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            3566667778999987643      26889999976542    122346778889988874433445565554 2   36


Q ss_pred             EEeccCCCCHH
Q 012203          120 VMELCAGGELF  130 (468)
Q Consensus       120 V~E~~~ggsL~  130 (468)
                      |+||++|..+.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            89999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.49  E-value=8.6e-05  Score=73.83  Aligned_cols=137  Identities=23%  Similarity=0.239  Sum_probs=96.5

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC-----------------CChhhH--HHHHHHHHHHHHhcCCC
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-----------------VTIDDE--RSVKLEIEIMTRLSGHP  102 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~-----------------~~~~~~--~~~~~Ei~iL~~L~~Hp  102 (468)
                      -+.++++||-|--+-||.+-+. .|++.++|+-...+.                 .+|-..  -....|...|+.|..|-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4778999999999999999885 788899986432221                 111111  12345788888886544


Q ss_pred             C-ceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC
Q 012203          103 N-VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       103 n-Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~  181 (468)
                      . +.+.+    +.+..++|||++.|..|.+.-+-      ..+..+...++..+.-|..+|+||+|..--||+++.++. 
T Consensus       172 fpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-  240 (465)
T KOG2268|consen  172 FPVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-  240 (465)
T ss_pred             CCCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence            3 22333    34568999999999888654422      223445567777778899999999999999999986444 


Q ss_pred             CCEEEeecCce
Q 012203          182 SPIKLADFGLA  192 (468)
Q Consensus       182 ~~ikL~DFGla  192 (468)
                        ++++||--.
T Consensus       241 --i~vIDFPQm  249 (465)
T KOG2268|consen  241 --IVVIDFPQM  249 (465)
T ss_pred             --EEEeechHh
Confidence              999999643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.40  E-value=0.00058  Score=63.68  Aligned_cols=100  Identities=18%  Similarity=0.180  Sum_probs=78.3

Q ss_pred             HHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 012203           89 KLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFH---RLEKFGRFSEAEARVLFMQLMQVVLYCHE---IG  162 (468)
Q Consensus        89 ~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~---~l~~~~~l~~~~~~~i~~qil~aL~~LH~---~g  162 (468)
                      ..|.-+|+.+.+.+++.+++|.+-    .++|.||...+++..   .+......++..+.+++.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            348888999986679999999983    357889997766542   12222346889999999999999999986   34


Q ss_pred             cEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          163 VVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       163 IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      +.-.|++|+|+-++.++.   +|++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~---lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGR---LKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCc---EEEEechhcchh
Confidence            778899999999986555   999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=97.30  E-value=0.0026  Score=63.87  Aligned_cols=76  Identities=9%  Similarity=-0.014  Sum_probs=46.0

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeE------EEEeCCEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKA------VYEDEDYVH  118 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~------~~~~~~~~~  118 (468)
                      .+.|+.|....+|.+...  +..+++|++...      ....+..|+.+++.|..+- .+.+++.      +....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~------~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFERL------TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEeccC------ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            356777887899998753  336889987521      1234445666666664211 1333332      223456789


Q ss_pred             EEEeccCCCCH
Q 012203          119 LVMELCAGGEL  129 (468)
Q Consensus       119 lV~E~~~ggsL  129 (468)
                      +++||++|..+
T Consensus        99 ~l~~~l~G~~~  109 (319)
T PRK05231         99 AIVTFLEGKWP  109 (319)
T ss_pred             EEEEecCCCCC
Confidence            99999998743

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.28  E-value=0.0016  Score=66.04  Aligned_cols=144  Identities=19%  Similarity=0.203  Sum_probs=96.4

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh-------------------hH----HHHHHHHHHHHHhcCCC
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID-------------------DE----RSVKLEIEIMTRLSGHP  102 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~-------------------~~----~~~~~Ei~iL~~L~~Hp  102 (468)
                      .-+|..|--+-||.|... +|..+|||+++..-+.-.+                   ..    --...|++-|.++. ..
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~a  226 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-NA  226 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-hc
Confidence            346778889999999875 7889999998654332111                   01    12345788888885 44


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEecccCCCcEEEeecCCC
Q 012203          103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC-HEIGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       103 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~gIiHrDIKp~NILl~~~~~~  181 (468)
                      .|.-.--+..-  ...|||+++.+..--.=.-+...++...+..+-.+++..+.-| |..+++|.||.--|+|+.    .
T Consensus       227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh----d  300 (520)
T KOG2270|consen  227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH----D  300 (520)
T ss_pred             CCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE----C
Confidence            44332222211  2469999984322111111224578888888888999988877 567999999999999995    4


Q ss_pred             CCEEEeecCceeeecC
Q 012203          182 SPIKLADFGLATYIEP  197 (468)
Q Consensus       182 ~~ikL~DFGla~~~~~  197 (468)
                      +.+.|+|.+-+.....
T Consensus       301 G~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHDH  316 (520)
T ss_pred             CEEEEEEccccccCCC
Confidence            5699999887765443

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.26  E-value=0.00094  Score=70.14  Aligned_cols=166  Identities=19%  Similarity=0.163  Sum_probs=107.9

Q ss_pred             HHHHHHHHHHHhcCCCCceeeeEEEEeC-CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEe
Q 012203           87 SVKLEIEIMTRLSGHPNVVDLKAVYEDE-DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH  165 (468)
Q Consensus        87 ~~~~Ei~iL~~L~~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiH  165 (468)
                      .+.-...+++.+. |+|+..++++-+.. ....+|||++ +.+|++.+..+. +-..       +++       .+++.|
T Consensus        28 ~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~-------s~~-------~~~~~~   90 (725)
T KOG1093|consen   28 QILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDE-------SLL-------AHGVLH   90 (725)
T ss_pred             HHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchh-------hhc-------ccccce
Confidence            3444677888886 99999999988643 4588999999 789999987643 2111       111       112221


Q ss_pred             cccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 012203          166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWG  245 (468)
Q Consensus       166 rDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~  245 (468)
                      -     |+          ++++| -++..   .   ...               .++|+||||+|.++.++.-|...+..
T Consensus        91 ~-----~~----------~~~td-~~~t~---~---~~~---------------~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   91 L-----NI----------IYITD-HFLTK---Y---PSP---------------IGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             e-----hh----------hhccc-ccccc---C---CCC---------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            1     11          34445 11100   0   111               12499999999999999999888766


Q ss_pred             CChHHHHHHHHhccCCCCCC--------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          246 NTKSRIFDAVRTADLRFPSN--------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ....+....+.+-...-...        ....+++...++.++|+-..|..||...++.+++-|.+...
T Consensus       134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~  202 (725)
T KOG1093|consen  134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK  202 (725)
T ss_pred             HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence            66655555554432111000        01235667889999999999999999999999998876543

>PLN02236 choline kinase

Probab=96.95  E-value=0.01  Score=60.69  Aligned_cols=140  Identities=17%  Similarity=0.121  Sum_probs=82.3

Q ss_pred             EEeEEeecCCeEEEEEEEcC----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKF----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      -++.|-.|-...+|++....    .++.|++|+.....   . ..-...+|..+++.+.++.--.++++.+.. .   .|
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v  111 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RV  111 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---C-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence            34566558888999987532    34789999886542   1 112236799999988755445566666633 2   58


Q ss_pred             EeccCCCCHHHH--------------HH---HcC----C-CC-HHHHHHHHHHH-----------------HHHHHHH--
Q 012203          121 MELCAGGELFHR--------------LE---KFG----R-FS-EAEARVLFMQL-----------------MQVVLYC--  158 (468)
Q Consensus       121 ~E~~~ggsL~~~--------------l~---~~~----~-l~-~~~~~~i~~qi-----------------l~aL~~L--  158 (468)
                      +||++|.+|...              +.   .-.    . +. ...+..+..++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            999988666421              11   100    0 11 12222222111                 1111112  


Q ss_pred             --H----HcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          159 --H----EIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       159 --H----~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                        .    ...++|+|+++.|||++.+.  +.+.|+||..+..
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~--~~~~lID~Eya~~  231 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEET--RAITIIDYEYASY  231 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCC--CcEEEEeehhccc
Confidence              1    23589999999999997432  3499999988864

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.92  E-value=0.011  Score=60.53  Aligned_cols=78  Identities=17%  Similarity=0.086  Sum_probs=48.4

Q ss_pred             EEeecCCeEEEEEEEcCCCcEEEEEEeccC-cC---CChhhHHHHHHHHHHHHHhcC-CC-CceeeeEEEEeCCEEEEEE
Q 012203           48 QLGWGQFGVIRVCSDKFTGEVFACKSIAKD-RL---VTIDDERSVKLEIEIMTRLSG-HP-NVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~-~~---~~~~~~~~~~~Ei~iL~~L~~-Hp-nIv~l~~~~~~~~~~~lV~  121 (468)
                      .||.|....||++.+...++.++||.-... +.   ...-...+..-|.+.|+.... -| .+.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999998644478999964321 11   112234455567788876643 23 3444433  3455567999


Q ss_pred             eccCCC
Q 012203          122 ELCAGG  127 (468)
Q Consensus       122 E~~~gg  127 (468)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.81  E-value=0.012  Score=59.79  Aligned_cols=76  Identities=12%  Similarity=0.068  Sum_probs=48.5

Q ss_pred             EeEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           46 GQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      ++.|-.|-...+|++.....   +..|++|+......    ..-...+|..+++.+.++.--.++++++. ++   +|.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence            44555577788998875432   34789998865321    12234568889998874444456666663 32   5899


Q ss_pred             ccCCCCH
Q 012203          123 LCAGGEL  129 (468)
Q Consensus       123 ~~~ggsL  129 (468)
                      |++|..|
T Consensus        91 fi~g~~l   97 (330)
T PLN02421         91 FINARTL   97 (330)
T ss_pred             hhcCCCC
Confidence            9987665

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.78  E-value=0.0096  Score=58.89  Aligned_cols=31  Identities=35%  Similarity=0.461  Sum_probs=24.5

Q ss_pred             CcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          162 GVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       162 gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .++|+|++|.|||++.++  ...-|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~--~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDA--RVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCC--CEEEEECcHhccc
Confidence            489999999999997432  2357999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.69  E-value=0.022  Score=59.25  Aligned_cols=78  Identities=9%  Similarity=0.050  Sum_probs=51.2

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC-CCh---hhHHHHHHHHHHHHHhcC--CCCceeeeEEEEeCCEEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-VTI---DDERSVKLEIEIMTRLSG--HPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~-~~~---~~~~~~~~Ei~iL~~L~~--HpnIv~l~~~~~~~~~~~  118 (468)
                      ..+.||.|....||+..+.  ++.++||.-..... ...   ....+-..|.+.|+.+..  ..++.+++.+.+  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4678999999999998873  45688997542211 111   133444556777766542  246777887776  3457


Q ss_pred             EEEeccCC
Q 012203          119 LVMELCAG  126 (468)
Q Consensus       119 lV~E~~~g  126 (468)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>PRK10593 hypothetical protein; Provisional

Probab=96.51  E-value=0.021  Score=57.05  Aligned_cols=108  Identities=12%  Similarity=0.010  Sum_probs=76.3

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC--CCceeeeEEEEe---CCE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH--PNVVDLKAVYED---EDY  116 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H--pnIv~l~~~~~~---~~~  116 (468)
                      .-.-.+.||.|..+.||..... ++ .+.+|..+..     .....+..|.+.|+.|.++  -.+.++++++..   .+.
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC-CC-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            3444678999999999998653 23 4667774321     1225788899999999754  357888887754   366


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI  161 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~  161 (468)
                      .+||||+++|+++.+.     .........+..+++++|.-||+.
T Consensus        88 ~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         88 DVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             eEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            8999999999887651     123444566677888888889874

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.43  E-value=0.024  Score=58.67  Aligned_cols=79  Identities=15%  Similarity=0.133  Sum_probs=50.9

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccC-cC--CChhhHHHHHHHHHHHHHhcC-CC-CceeeeEEEEeCCEEEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD-RL--VTIDDERSVKLEIEIMTRLSG-HP-NVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~-~~--~~~~~~~~~~~Ei~iL~~L~~-Hp-nIv~l~~~~~~~~~~~lV  120 (468)
                      .+.||.|.-..||++.+...++.++||.-..- +.  ...-..++..-|.++|+.+.. -| .+.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            67899999999999998544678999864321 11  112234566668888877643 24 34445433  45556789


Q ss_pred             EeccCC
Q 012203          121 MELCAG  126 (468)
Q Consensus       121 ~E~~~g  126 (468)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999865

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.24  E-value=0.088  Score=52.39  Aligned_cols=30  Identities=33%  Similarity=0.491  Sum_probs=24.8

Q ss_pred             cCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          161 IGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       161 ~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .+++|+|+++.||+++. +   .+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~---~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N---EVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-C---cEEEEECccccc
Confidence            47899999999999975 2   389999997643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.18  E-value=0.012  Score=55.40  Aligned_cols=56  Identities=18%  Similarity=0.127  Sum_probs=34.0

Q ss_pred             CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCH
Q 012203           66 GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL  129 (468)
Q Consensus        66 g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL  129 (468)
                      ++.|++++.....    ...-....|..+++.+.++-.-.++++.+.+.    +|+||+.|.+|
T Consensus         2 ~~~~~~Ri~g~~t----~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGT----ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCG----CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred             CCEEEEEeCCCCc----ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence            4678888886541    23345677899999887555556666665322    57799877554

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=96.16  E-value=0.051  Score=56.35  Aligned_cols=79  Identities=10%  Similarity=-0.006  Sum_probs=49.2

Q ss_pred             EEEeEEeecCCeEEEEEEEcCC-CcE-----EEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFT-GEV-----FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~-g~~-----vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...+.|..|-...+|++..... +..     |.+++....    ....-...+|+++++.|..+..-.++++.+..    
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----  124 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----  124 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence            3445665588889999975432 222     444433211    11112235689999999866666677777742    


Q ss_pred             EEEEeccCCCCHH
Q 012203          118 HLVMELCAGGELF  130 (468)
Q Consensus       118 ~lV~E~~~ggsL~  130 (468)
                      ++|.||++|.+|.
T Consensus       125 g~l~efIeGr~l~  137 (383)
T PTZ00384        125 FTIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEEeccccCC
Confidence            6999999987764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.10  E-value=0.051  Score=54.14  Aligned_cols=76  Identities=17%  Similarity=0.103  Sum_probs=48.9

Q ss_pred             EEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEEeCCEEEEEE
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .-.+.++.|....+|...  .+++.+.+|+-...      ....+..|.+-|+.|.  .--.+.+++.+...++.-+|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            346789989999999886  57889999986522      2346778888888884  2345778888888777779999


Q ss_pred             eccCCC
Q 012203          122 ELCAGG  127 (468)
Q Consensus       122 E~~~gg  127 (468)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.02  E-value=0.059  Score=54.35  Aligned_cols=148  Identities=16%  Similarity=0.194  Sum_probs=81.0

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeCC--EEEE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-PNVVDLKAVYEDED--YVHL  119 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-pnIv~l~~~~~~~~--~~~l  119 (468)
                      ..+++.+-.|....+|.....  ++.+++. ... ............+|..+|+.+..- --+...++.+.++.  ..+.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            344555544444455555443  7888888 321 122334456777899999888421 12233445554444  6799


Q ss_pred             EEeccCCCCHHH----------HHH--------H-c----------C---CCCHHHHHHHHHHH--------------HH
Q 012203          120 VMELCAGGELFH----------RLE--------K-F----------G---RFSEAEARVLFMQL--------------MQ  153 (468)
Q Consensus       120 V~E~~~ggsL~~----------~l~--------~-~----------~---~l~~~~~~~i~~qi--------------l~  153 (468)
                      ||+|++|..+..          +..        . +          +   .+.......+..+.              ..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            999998832211          111        0 0          0   00111111111111              11


Q ss_pred             HHHHHHHc--------CcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          154 VVLYCHEI--------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       154 aL~~LH~~--------gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ...+|+.+        .++|+|+++.||+++.+..   +-|.||+++..-++
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~---~gVlDwe~~~lGDP  231 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP---TGVLDWELATLGDP  231 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe---eEEEeccccccCCc
Confidence            22445432        4799999999999986554   89999999876443

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.70  E-value=0.22  Score=50.37  Aligned_cols=72  Identities=14%  Similarity=0.123  Sum_probs=45.0

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-Cceee---eE--EEEeCCEEEEEEeccC
Q 012203           52 GQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDL---KA--VYEDEDYVHLVMELCA  125 (468)
Q Consensus        52 G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l---~~--~~~~~~~~~lV~E~~~  125 (468)
                      +.-..||.+... +|+.+++|+.....    .....+..|++.+..|..+- .++..   -+  +...++..+.++++++
T Consensus        36 s~eN~vy~v~~~-~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGDE-DGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEecC-CCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            556678988653 56789999885432    13456677888888776321 12221   11  2334567888999998


Q ss_pred             CCC
Q 012203          126 GGE  128 (468)
Q Consensus       126 ggs  128 (468)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.67  E-value=0.047  Score=55.58  Aligned_cols=116  Identities=17%  Similarity=0.235  Sum_probs=75.0

Q ss_pred             CCCceeeeEEE-EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeec
Q 012203          101 HPNVVDLKAVY-EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATK  178 (468)
Q Consensus       101 HpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~  178 (468)
                      .++..+.+-+- .+..+.|++|++. |++|.. ++   .-..+++..++++.+..+.-+..+ ..-|||+...||||+ +
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~  357 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E  357 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence            44444444443 4556788999985 666542 21   234677888888888887777654 688999999999998 5


Q ss_pred             CCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHH
Q 012203          179 ASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSA  229 (468)
Q Consensus       179 ~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSl  229 (468)
                      |+   |.|+||-+++.-..+.    .+--...--|-.+.|.-+..-+||-+
T Consensus       358 Gn---vtLIDfklsRl~~~q~----~isy~rldhp~lF~G~dd~QFeIYrl  401 (488)
T COG5072         358 GN---VTLIDFKLSRLSYSQG----IISYNRLDHPDLFNGVDDYQFEIYRL  401 (488)
T ss_pred             Cc---eEEEEeeeeecccCCc----eeeccccCchhhhcCccceeeeHHHH
Confidence            66   9999999998422211    11111233444455444556666665

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.40  E-value=0.059  Score=55.65  Aligned_cols=63  Identities=21%  Similarity=0.139  Sum_probs=45.9

Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCcEecccCCCcEEEeecC
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY-CHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~-LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      ...|+-+|..|.++...++.. ..++...+.++.--..||.- |--.+++|.|+.|.||++..+.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            355777899899998888653 34555666666666666543 4456899999999999996544

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.32  E-value=0.23  Score=49.76  Aligned_cols=30  Identities=20%  Similarity=0.279  Sum_probs=25.8

Q ss_pred             CcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          162 GVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       162 gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +++|+|+.+.|||++.++.   +.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~---~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG---GYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC---EEEEEhhhccc
Confidence            7999999999999976544   89999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06148 hypothetical protein; Provisional

Probab=95.28  E-value=0.27  Score=57.36  Aligned_cols=142  Identities=19%  Similarity=0.250  Sum_probs=80.1

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-CCc--eeee--------EEEEe-
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-PNV--VDLK--------AVYED-  113 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-pnI--v~l~--------~~~~~-  113 (468)
                      .+.|+ |..-.+|++... +|+.+++|+.....     ....+..|.+.|..|..+ +.+  .+++        ..... 
T Consensus        30 ~~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~  102 (1013)
T PRK06148         30 ATPLD-GERDLNFRLTTD-DGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDP  102 (1013)
T ss_pred             EeecC-CcCCceEEEEeC-CCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecC
Confidence            35675 556888988753 67789999987542     233445566677666532 222  2221        11111 


Q ss_pred             CC--EEEEEEeccCCCCHHHH-----------------HHH----c------CCCCH-----------------HHHHHH
Q 012203          114 ED--YVHLVMELCAGGELFHR-----------------LEK----F------GRFSE-----------------AEARVL  147 (468)
Q Consensus       114 ~~--~~~lV~E~~~ggsL~~~-----------------l~~----~------~~l~~-----------------~~~~~i  147 (468)
                      ++  +++-+++|++|..|.+.                 ++.    .      ..+.+                 ...+.+
T Consensus       103 ~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~  182 (1013)
T PRK06148        103 DGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRAL  182 (1013)
T ss_pred             CCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHH
Confidence            22  56778999999777541                 110    0      00111                 111223


Q ss_pred             HHHHHHHHHH-----HH--HcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          148 FMQLMQVVLY-----CH--EIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       148 ~~qil~aL~~-----LH--~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+++..+.-     +.  ..++||+|+.+.|||++.+......-|+|||.+..
T Consensus       183 l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        183 VERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3333333321     21  24799999999999998654323345999998754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.64  E-value=0.15  Score=48.72  Aligned_cols=86  Identities=16%  Similarity=0.207  Sum_probs=59.1

Q ss_pred             HHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--cCc
Q 012203           86 RSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE--IGV  163 (468)
Q Consensus        86 ~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~--~gI  163 (468)
                      ..+.++.+++.+..   .|+++..-  +.-.+.+|.|+|-....            . ...++..=+.+|.-.|+  .+.
T Consensus       103 ~~y~nky~v~Armh---GilrL~ND--n~~~yGvIlE~Cy~~~i------------~-~~N~i~agi~~L~~fH~~~~~~  164 (308)
T PF07387_consen  103 ALYFNKYRVFARMH---GILRLKND--NNYKYGVILERCYKIKI------------N-FSNFITAGIKDLMDFHSENQHC  164 (308)
T ss_pred             hhhhhhhhHHHHhh---heeEeecC--CCceeEEEEeeccCccc------------c-hhHHHHHhHHHHHHhhccCCCe
Confidence            45677889998873   78888743  44567899999943211            1 11122222456777884  379


Q ss_pred             EecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          164 VHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       164 iHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +|+|-.|+||+.|+.|.   +||.|=+..
T Consensus       165 lHGD~np~NiM~D~~G~---lKlVDP~~L  190 (308)
T PF07387_consen  165 LHGDCNPDNIMCDKFGY---LKLVDPVCL  190 (308)
T ss_pred             ecCCCChhheeecCCCC---EEecChhhh
Confidence            99999999999998776   999887643

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.22  E-value=0.62  Score=47.35  Aligned_cols=138  Identities=17%  Similarity=0.176  Sum_probs=79.6

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC--cee---eeEEE--EeCC--EE
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN--VVD---LKAVY--EDED--YV  117 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn--Iv~---l~~~~--~~~~--~~  117 (468)
                      ..|.+ .-..||.+... +|+. ++|+....     .....+..|+..|+.|..+.-  .++   +-|-.  .-..  +.
T Consensus        32 ~~l~s-~eN~~f~~~~~-~g~~-iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~  103 (331)
T COG2334          32 RGLNS-EENSNFRVQTE-DGRY-ILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP  103 (331)
T ss_pred             ccccc-ccCceEEEEec-CCCe-EEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence            34554 56678888764 3444 99998765     124566778888888873322  122   11111  1233  78


Q ss_pred             EEEEeccCCCCHHH------------HH---HHc-CC-----------CCHH----HH---------HHHHHHHHHHHHH
Q 012203          118 HLVMELCAGGELFH------------RL---EKF-GR-----------FSEA----EA---------RVLFMQLMQVVLY  157 (468)
Q Consensus       118 ~lV~E~~~ggsL~~------------~l---~~~-~~-----------l~~~----~~---------~~i~~qil~aL~~  157 (468)
                      .-+++|++|..+..            .+   +.. ..           ..+.    ..         .....++...+..
T Consensus       104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~  183 (331)
T COG2334         104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR  183 (331)
T ss_pred             EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence            89999999987772            11   110 00           1111    00         1122233333433


Q ss_pred             HH--------HcC--cEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          158 CH--------EIG--VVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       158 LH--------~~g--IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.        ..+  +||+|+.|.||+++.+..  .+.+.|||-+..
T Consensus       184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~--~~g~iDFdDa~~  228 (331)
T COG2334         184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTD--VSGFIDFDDAGY  228 (331)
T ss_pred             HHhhchhhCCcccceeeecCCCccceeEcCCCC--eeeEEEcccccc
Confidence            33        234  999999999999985442  478999998753

>PTZ00296 choline kinase; Provisional

Probab=93.81  E-value=0.53  Score=49.82  Aligned_cols=77  Identities=17%  Similarity=-0.001  Sum_probs=48.8

Q ss_pred             EEeEEeecCCeEEEEEEEcC--------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           45 LGQQLGWGQFGVIRVCSDKF--------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~--------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      -++.|..|-...+|++....        .++.|.+++.-...-    ..-....|..+++.+..+--=.++++.+.    
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te----~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD----ELYNPISEFEVYKTMSKYRIAPQLLNTFS----  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc----ceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence            45677668888999987542        256899998855321    11234568888888874333345666553    


Q ss_pred             EEEEEeccCCCCH
Q 012203          117 VHLVMELCAGGEL  129 (468)
Q Consensus       117 ~~lV~E~~~ggsL  129 (468)
                      -+.|.||++|.+|
T Consensus       181 gg~I~efi~g~~l  193 (442)
T PTZ00296        181 GGRIEEWLYGDPL  193 (442)
T ss_pred             CCEEEEeeCCccC
Confidence            2467899988644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	468
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-59
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-59
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-59
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-59
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-58
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-57
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-57
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-57
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-57
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-56
3soa_A	444	Full-Length Human Camkii Length = 444		3e-56
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-56
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-56
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-56
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-56
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-56
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-55
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-55
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-55
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-55
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-55
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-55
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-54
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-54
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-54
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-54
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-54
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-53
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-52
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-51
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-51
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-49
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-48
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-48
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-48
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-48
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-48
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-47
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-47
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-47
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-47
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-46
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-46
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-46
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-46
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-46
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-46
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-46
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-46
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-46
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-46
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-46
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-46
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-46
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-46
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-45
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-45
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-45
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-45
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-45
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-45
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-45
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-45
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-45
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-45
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-45
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-45
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-44
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-44
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-43
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-43
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-42
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-42
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-42
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-42
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-42
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-42
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-42
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-42
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-42
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-42
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-42
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-42
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-42
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-42
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-42
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-42
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-41
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-41
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-41
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-41
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-41
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-41
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-41
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-41
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-41
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-41
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-41
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-41
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-41
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-41
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-40
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-40
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-40
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-40
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-40
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-40
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-40
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-40
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-40
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-40
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-40
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-40
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-40
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-40
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-40
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-40
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-40
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-40
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-40
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-40
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-40
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-40
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-40
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-40
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-40
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-40
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-40
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-40
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-40
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-40
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-40
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-40
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-40
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-40
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-40
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-40
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-40
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-39
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-39
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-39
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-39
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-39
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-38
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-38
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-38
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-38
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-38
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-38
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-38
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-38
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-38
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-38
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-38
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-37
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-37
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-37
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-37
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-37
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-37
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-37
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-37
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-37
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-37
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-37
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-37
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-37
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-37
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-37
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-37
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-37
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-37
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-37
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-37
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-37
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-37
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-37
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-37
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-37
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-37
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-37
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-37
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-37
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-37
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-37
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-37
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-37
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-36
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-36
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-36
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-36
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-36
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-36
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-36
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-36
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-36
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-36
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-36
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-36
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-36
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-36
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-36
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-36
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-36
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-36
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-36
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-35
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-35
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-35
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-35
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-35
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-35
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-35
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-35
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-35
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-35
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-35
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-35
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-35
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-35
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-34
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-34
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-34
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-34
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-34
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-34
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-34
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-34
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-34
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-34
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-34
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-34
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-34
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-33
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-33
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-33
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-33
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-33
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-33
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-33
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-33
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-32
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-32
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-31
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-31
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-31
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-31
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-31
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-31
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-31
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-31
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-31
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-31
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-30
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-30
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-30
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-30
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-30
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-30
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-30
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-30
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-30
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-30
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-30
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-30
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-30
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-30
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-29
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-29
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-29
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-29
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-29
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-29
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-29
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-29
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-29
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-29
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-29
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-29
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-29
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-29
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-29
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-29
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-29
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-29
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-29
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-29
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-29
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-29
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-29
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-29
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-28
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-28
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-28
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-28
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-28
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-27
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-27
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-27
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-27
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-27
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-26
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-26
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-26
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-25
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-25
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-25
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-25
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-25
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-25
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-25
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-25
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-25
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-25
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-25
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-25
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-25
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-25
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-25
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-25
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-25
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-25
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-25
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-25
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-25
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-25
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-25
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-25
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-25
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-25
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-25
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-25
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-25
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-25
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-24
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-24
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-24
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-24
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-24
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-23
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-23
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-23
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-23
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-23
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-23
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-23
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-23
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-23
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-23
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-23
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-23
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-23
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-23
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-23
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-23
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-23
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-23
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-23
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-23
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-22
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-22
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-22
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-22
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-22
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-22
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-22
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-22
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-22
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-22
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-22
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-22
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-21
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-21
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-21
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-21
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-21
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-21
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-21
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-21
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-21
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-21
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-21
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-21
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-21
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-21
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-21
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-21
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-20
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-20
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-20
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-20
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-20
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-20
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-19
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-19
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-19
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-19
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-19
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-19
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-19
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-19
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-19
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-19
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-18
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-18
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-18
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-18
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-18
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-18
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-18
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-18
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-18
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-18
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-18
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-18
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-18
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-18
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-18
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-18
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-18
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-18
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-18
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-18
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-18
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-18
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-18
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-18
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-18
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-18
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-18
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-18
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-18
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-18
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-18
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-18
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-18
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-18
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-18
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-18
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-18
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-18
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-18
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-18
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-18
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-18
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-18
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-18
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-18
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-18
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-18
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-18
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-18
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-18
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-18
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-18
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-18
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-18
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-18
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-18
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-18
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-18
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-18
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-18
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-18
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-18
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-18
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-18
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-18
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-18
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-18
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-18
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-18
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-18
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-18
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-18
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-18
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-18
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-18
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-18
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-18
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-18
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-18
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-18
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-18
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-17
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-17
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-17
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-17
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-17
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-17
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-17
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-17
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-17
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-17
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-17
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-17
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-17
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-17
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-17
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-17
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-17
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-16
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-16
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-16
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-16
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-16
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-16
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-16
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-16
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-16
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-16
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-16
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-16
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-16
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-16
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-16
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-16
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-16
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-16
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-16
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-16
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-15
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-15
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-15
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		8e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-15
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-15
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-15
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-15
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-15
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-15
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-15
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		9e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-14
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-14
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-14
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-14
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-14
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-13
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-13
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-13
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-13
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-13
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-13
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		6e-13
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-13
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-13
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-13
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		6e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-13
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		7e-13
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		9e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-12
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-12
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-12
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		9e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-10
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-08
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-08
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-07
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-07
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		4e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-06

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  227 bits (579), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 110/261 (42%), Positives = 163/261 (62%), Gaps = 1/261 (0%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + LG G FG + +C DK TG+  A K I+K ++    D+ S+  E++++ +L  
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 107
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   +ED+ Y +LV E+  GGELF  +    RFSE +A  +  Q++  + Y H+
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             +VHRDLKPEN+LL +K+  + I++ DFGL+T+ E  + +   +G+ +YIAPEVL G Y
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 227
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S+SAKDL+  
Sbjct: 228 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 287
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           ML+  PS R++AR  LDH W+
Sbjct: 288 MLTYVPSMRISARDALDHEWI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  227 bits (579), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 110/261 (42%), Positives = 163/261 (62%), Gaps = 1/261 (0%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + LG G FG + +C DK TG+  A K I+K ++    D+ S+  E++++ +L  
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 108
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   +ED+ Y +LV E+  GGELF  +    RFSE +A  +  Q++  + Y H+
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             +VHRDLKPEN+LL +K+  + I++ DFGL+T+ E  + +   +G+ +YIAPEVL G Y
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 228
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S+SAKDL+  
Sbjct: 229 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 288
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           ML+  PS R++AR  LDH W+
Sbjct: 289 MLTYVPSMRISARDALDHEWI 309

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  227 bits (578), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 110/261 (42%), Positives = 163/261 (62%), Gaps = 1/261 (0%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + LG G FG + +C DK TG+  A K I+K ++    D+ S+  E++++ +L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 84
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   +ED+ Y +LV E+  GGELF  +    RFSE +A  +  Q++  + Y H+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             +VHRDLKPEN+LL +K+  + I++ DFGL+T+ E  + +   +G+ +YIAPEVL G Y
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 204
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S+SAKDL+  
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           ML+  PS R++AR  LDH W+
Sbjct: 265 MLTYVPSMRISARDALDHEWI 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  226 bits (575), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 110/261 (42%), Positives = 163/261 (62%), Gaps = 1/261 (0%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + LG G FG + +C DK TG+  A K I+K ++    D+ S+  E++++ +L  
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 90
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   +ED+ Y +LV E+  GGELF  +    RFSE +A  +  Q++  + Y H+
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             +VHRDLKPEN+LL +K+  + I++ DFGL+T+ E  + +   +G+ +YIAPEVL G Y
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 210
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S+SAKDL+  
Sbjct: 211 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 270
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           ML+  PS R++AR  LDH W+
Sbjct: 271 MLTYVPSMRISARDALDHEWI 291

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  223 bits (567), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 109/261 (41%), Positives = 160/261 (61%), Gaps = 1/261 (0%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + LG G FG + +C DK TG+  A K I+K ++    D+ S+  E++++ +L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 84
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN+  L   +ED+ Y +LV E+  GGELF  +    RFSE +A  +  Q++  + Y H+
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             +VHRDLKPEN+LL +K+  + I++ DFGL+T+ E  +     +G+ +YIAPEVL G Y
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTY 204
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  DVWS GVILYILLSG PPF G  +  I   V      F    W  +S+SAKDL+  
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
            L+  PS R++AR  LDH W+
Sbjct: 265 XLTYVPSXRISARDALDHEWI 285

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  220 bits (560), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 113/261 (43%), Positives = 154/261 (59%), Gaps = 2/261 (0%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+ +   LG G FG +  C D+ T + +A K I K       D  ++  E+E++ +L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLD- 79
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L  + ED    ++V EL  GGELF  + K  RFSE +A  +  Q+   + Y H+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YIAPEVL G Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  DVWSAGVILYILLSG PPF+G  +  I   V T    F    W  ISD AKDL+  
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           ML+  PS R+TA Q L+H W+
Sbjct: 260 MLTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  218 bits (555), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 113/261 (43%), Positives = 154/261 (59%), Gaps = 2/261 (0%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+ +   LG G FG +  C D+ T + +A K I K       D  ++  E+E++ +L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLD- 79
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L  + ED    ++V EL  GGELF  + K  RFSE +A  +  Q+   + Y H+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YIAPEVL G Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  DVWSAGVILYILLSG PPF+G  +  I   V T    F    W  ISD AKDL+  
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           ML+  PS R+TA Q L+H W+
Sbjct: 260 MLTFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  218 bits (555), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 113/261 (43%), Positives = 154/261 (59%), Gaps = 2/261 (0%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+ +   LG G FG +  C D+ T + +A K I K       D  ++  E+E++ +L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLD- 79
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L  + ED    ++V EL  GGELF  + K  RFSE +A  +  Q+   + Y H+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YIAPEVL G Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  DVWSAGVILYILLSG PPF+G  +  I   V T    F    W  ISD AKDL+  
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           ML+  PS R+TA Q L+H W+
Sbjct: 260 MLTFHPSLRITATQCLEHPWI 280

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  217 bits (553), Expect = 9e-57,   Method: Compositional matrix adjust.
 Identities = 111/262 (42%), Positives = 161/262 (61%), Gaps = 6/262 (2%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGH 101
           + L ++LG G F V+R C     G+ +A K I   +L   D +   KLE E  + RL  H
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 80
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           PN+V L     +E + +L+ +L  GGELF  +     +SEA+A     Q+++ VL+CH++
Sbjct: 81  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 140
Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLAGG- 219
           GVVHRDLKPEN+LLA+K   + +KLADFGLA  +E   Q+  G  G+P Y++PEVL    
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           Y +  D+W+ GVILYILL G PPFW   + R++  ++     FPS  WD ++  AKDL+ 
Sbjct: 201 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 260
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            ML+ +PS+R+TA + L H W+
Sbjct: 261 KMLTINPSKRITAAEALKHPWI 282

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  216 bits (550), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 107/270 (39%), Positives = 164/270 (60%), Gaps = 4/270 (1%)
Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
            Q  ++++ F   + LG G F  + +  +K TG++FA K I K  L     E S++ EI 
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKG--KESSIENEIA 72
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           ++ ++  H N+V L+ +YE  ++++LVM+L +GGELF R+ + G ++E +A  L  Q++ 
Sbjct: 73  VLRKIK-HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD 131
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y H +G+VHRDLKPEN+L  ++   S I ++DFGL+     G  +    G+P Y+AP
Sbjct: 132 AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAP 191
Query: 214 EVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           EVLA   Y++A D WS GVI YILL G PPF+    S++F+ +  A+  F S  WD ISD
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISD 251
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           SAKD +  ++  DP++R T  Q   H W+ 
Sbjct: 252 SAKDFIRNLMEKDPNKRYTCEQAARHPWIA 281

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 111/274 (40%), Positives = 164/274 (59%), Gaps = 6/274 (2%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           + T   +   E + L ++LG G F V+R C     G+ +A   I   +L   D +   KL
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KL 57
Query: 91  EIEI-MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           E E  + RL  HPN+V L     +E + +L+ +L  GGELF  +     +SEA+A     
Sbjct: 58  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSP 208
           Q+++ VL+CH++GVVHR+LKPEN+LLA+K   + +KLADFGLA  +E   Q+  G  G+P
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 209 FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
            Y++PEVL    Y +  D+W+ GVILYILL G PPFW   + R++  ++     FPS  W
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237
Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           D ++  AKDL+  ML+ +PS+R+TA + L H W+
Sbjct: 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  216 bits (549), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 158/263 (60%), Gaps = 1/263 (0%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L +R+   ++LG G +G + +C DK TG   A K I K  + T  +  ++  E+ ++ +L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
             HPN++ L   +ED+   +LVME+  GGELF  +    +FSE +A V+  Q++    Y 
Sbjct: 62  D-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG 218
           H+  +VHRDLKPEN+LL +K+  + IK+ DFGL+ + E G  +   +G+ +YIAPEVL  
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 180
Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y++  DVWS GVILYILL G PPF G T   I   V      F    W  +SD AK LV
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
             ML+ +PS+R++A + L+H W+
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWI 263

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  215 bits (547), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 158/263 (60%), Gaps = 1/263 (0%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L +R+   ++LG G +G + +C DK TG   A K I K  + T  +  ++  E+ ++ +L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
             HPN++ L   +ED+   +LVME+  GGELF  +    +FSE +A V+  Q++    Y 
Sbjct: 79  D-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG 218
           H+  +VHRDLKPEN+LL +K+  + IK+ DFGL+ + E G  +   +G+ +YIAPEVL  
Sbjct: 138 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 197
Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y++  DVWS GVILYILL G PPF G T   I   V      F    W  +SD AK LV
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 257
Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
             ML+ +PS+R++A + L+H W+
Sbjct: 258 KLMLTYEPSKRISAEEALNHPWI 280

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  214 bits (545), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 164/270 (60%), Gaps = 4/270 (1%)
Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
            Q  ++R+ +     LG G F  + +  DK T ++ A K IAK+ L     E S++ EI 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEG--KEGSMENEIA 68
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           ++ ++  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  L  Q++ 
Sbjct: 69  VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y H++G+VHRDLKPEN+L  +    S I ++DFGL+   +PG  L    G+P Y+AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 214 EVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           EVLA   Y++A D WS GVI YILL G PPF+    +++F+ +  A+  F S  WD ISD
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           SAKD +  ++  DP +R T  Q L H W+ 
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  214 bits (545), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 164/270 (60%), Gaps = 4/270 (1%)
Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
            Q  ++R+ +     LG G F  + +  DK T ++ A K IAK+ L     E S++ EI 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEG--KEGSMENEIA 68
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           ++ ++  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  L  Q++ 
Sbjct: 69  VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y H++G+VHRDLKPEN+L  +    S I ++DFGL+   +PG  L    G+P Y+AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 214 EVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           EVLA   Y++A D WS GVI YILL G PPF+    +++F+ +  A+  F S  WD ISD
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           SAKD +  ++  DP +R T  Q L H W+ 
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  214 bits (545), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 164/270 (60%), Gaps = 4/270 (1%)
Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
            Q  ++R+ +     LG G F  + +  DK T ++ A K IAK+ L     E S++ EI 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEG--KEGSMENEIA 68
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           ++ ++  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  L  Q++ 
Sbjct: 69  VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y H++G+VHRDLKPEN+L  +    S I ++DFGL+   +PG  L    G+P Y+AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 214 EVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           EVLA   Y++A D WS GVI YILL G PPF+    +++F+ +  A+  F S  WD ISD
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           SAKD +  ++  DP +R T  Q L H W+ 
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  213 bits (543), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 163/270 (60%), Gaps = 4/270 (1%)
Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
            Q  ++R+ +     LG G F  + +  DK T ++ A K IAK  L     E S++ EI 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIA 68
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           ++ ++  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  L  Q++ 
Sbjct: 69  VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y H++G+VHRDLKPEN+L  +    S I ++DFGL+   +PG  L    G+P Y+AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 214 EVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           EVLA   Y++A D WS GVI YILL G PPF+    +++F+ +  A+  F S  WD ISD
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
           SAKD +  ++  DP +R T  Q L H W+ 
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  213 bits (542), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 104/264 (39%), Positives = 152/264 (57%), Gaps = 4/264 (1%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           ++ + + L   +G G +G +++   K T    A K I K     ++D    K EIEIM  
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKS 79
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
           L  HPN++ L   +ED   ++LVMELC GGELF R+     F E++A  +   ++  V Y
Sbjct: 80  LD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 138
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
           CH++ V HRDLKPEN L  T +  SP+KL DFGLA   +PG+ +   VG+P+Y++P+VL 
Sbjct: 139 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 198
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
           G Y    D WSAGV++Y+LL G PPF   T   +   +R     FP   W ++S  A+ L
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 258
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +  +L+  P QR+T+ Q L+H W 
Sbjct: 259 IRRLLTKSPKQRITSLQALEHEWF 282

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 104/264 (39%), Positives = 152/264 (57%), Gaps = 4/264 (1%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           ++ + + L   +G G +G +++   K T    A K I K     ++D    K EIEIM  
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKS 62
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
           L  HPN++ L   +ED   ++LVMELC GGELF R+     F E++A  +   ++  V Y
Sbjct: 63  LD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
           CH++ V HRDLKPEN L  T +  SP+KL DFGLA   +PG+ +   VG+P+Y++P+VL 
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 181
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
           G Y    D WSAGV++Y+LL G PPF   T   +   +R     FP   W ++S  A+ L
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +  +L+  P QR+T+ Q L+H W 
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWF 265

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  212 bits (540), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 109/271 (40%), Positives = 167/271 (61%), Gaps = 7/271 (2%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q +N+R+ F+  + LG G F  + +   + TG++FA K I K        + S++ EI +
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAV 59
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           + ++  H N+V L+ +YE   + +LVM+L +GGELF R+ + G ++E +A ++  Q++  
Sbjct: 60  LKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V Y HE G+VHRDLKPEN+L  T   +S I + DFGL+  +E    +    G+P Y+APE
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPE 177
Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           VLA   Y++A D WS GVI YILL G PPF+  T+S++F+ ++     F S  WD IS+S
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237
Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
           AKD +  +L  DP++R T  + L H W+ DG
Sbjct: 238 AKDFICHLLEKDPNERYTCEKALSHPWI-DG 267

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  211 bits (538), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 109/267 (40%), Positives = 163/267 (61%), Gaps = 6/267 (2%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MT 96
           ++ + + L ++LG G F V+R C    TG+ +A K I   +L   D +   KLE E  + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARIC 57
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           RL  HPN+V L     +E + +LV +L  GGELF  +     +SEA+A     Q+++ V 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEV 215
           +CH  G+VHRDLKPEN+LLA+K+  + +KLADFGLA  ++   Q+  G  G+P Y++PEV
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 216 LAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
           L    Y +  D+W+ GVILYILL G PPFW   + R++  ++     FPS  WD ++  A
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 237
Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWM 301
           KDL+  ML+ +P++R+TA + L H W+
Sbjct: 238 KDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  211 bits (538), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 107/267 (40%), Positives = 162/267 (60%), Gaps = 6/267 (2%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MT 96
           ++ + + L + +G G F V+R C    TG  +A K I   +L   D +   KLE E  + 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARIC 57
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           RL  H N+V L     +E + +LV +L  GGELF  +     +SEA+A     Q+++ VL
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 117
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEV 215
           +CH++GVVHRDLKPEN+LLA+K   + +KLADFGLA  ++   Q+  G  G+P Y++PEV
Sbjct: 118 HCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 216 LAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
           L    Y +  D+W+ GVILYILL G PPFW   + +++  ++     FPS  WD ++  A
Sbjct: 178 LRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEA 237
Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWM 301
           K+L+  ML+ +P++R+TA + L H W+
Sbjct: 238 KNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  210 bits (535), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 113/310 (36%), Positives = 176/310 (56%), Gaps = 8/310 (2%)
Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           N  +   + + + ++LG G F V+R C  K TG  FA K I   +L   D ++ ++ E  
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREAR 80
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I  +L  HPN+V L    ++E + +LV +L  GGELF  +     +SEA+A     Q+++
Sbjct: 81  ICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            + YCH  G+VHR+LKPEN+LLA+KA  + +KLADFGLA  +   ++  G  G+P Y++P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 214 EVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           EVL    Y++  D+W+ GVILYILL G PPFW   + R++  ++     +PS  WD ++ 
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDC-KEWD----LGSG 327
            AK L+  ML+ +P +R+TA Q L   W+ +  +    +      DC K+++    L   
Sbjct: 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGA 319
Query: 328 SFSTQIIPRN 337
             +T I  RN
Sbjct: 320 ILTTMIATRN 329

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 109/267 (40%), Positives = 163/267 (61%), Gaps = 6/267 (2%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MT 96
           ++ + + L ++LG G F V+R C    TG+ +A K I   +L   D +   KLE E  + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARIC 57
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           RL  HPN+V L     +E + +LV +L  GGELF  +     +SEA+A     Q+++ V 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEV 215
           +CH  G+VHRDLKPEN+LLA+K+  + +KLADFGLA  ++   Q+  G  G+P Y++PEV
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 216 LAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
           L    Y +  D+W+ GVILYILL G PPFW   + R++  ++     FPS  WD ++  A
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 237
Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWM 301
           KDL+  ML+ +P++R+TA + L H W+
Sbjct: 238 KDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  208 bits (529), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 160/266 (60%), Gaps = 3/266 (1%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           +   + + + ++LG G F V+R C  K TG  FA K I   +L +  D + ++ E  I  
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 59
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           +L  HPN+V L    ++E + +LV +L  GGELF  +     +SEA+A     Q+++ + 
Sbjct: 60  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 118
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           YCH  G+VHR+LKPEN+LLA+KA  + +KLADFGLA  +   ++  G  G+P Y++PEVL
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               Y++  D+W+ GVILYILL G PPFW   + R++  ++     +PS  WD ++  AK
Sbjct: 179 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
            L+  ML+ +P +R+TA Q L   W+
Sbjct: 239 SLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  208 bits (529), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 160/266 (60%), Gaps = 3/266 (1%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           +   + + + ++LG G F V+R C  K TG  FA K I   +L +  D + ++ E  I  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           +L  HPN+V L    ++E + +LV +L  GGELF  +     +SEA+A     Q+++ + 
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           YCH  G+VHR+LKPEN+LLA+KA  + +KLADFGLA  +   ++  G  G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               Y++  D+W+ GVILYILL G PPFW   + R++  ++     +PS  WD ++  AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
            L+  ML+ +P +R+TA Q L   W+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  208 bits (529), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 160/266 (60%), Gaps = 3/266 (1%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           +   + + + ++LG G F V+R C  K TG  FA K I   +L +  D + ++ E  I  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           +L  HPN+V L    ++E + +LV +L  GGELF  +     +SEA+A     Q+++ + 
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           YCH  G+VHR+LKPEN+LLA+KA  + +KLADFGLA  +   ++  G  G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               Y++  D+W+ GVILYILL G PPFW   + R++  ++     +PS  WD ++  AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
            L+  ML+ +P +R+TA Q L   W+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/297 (37%), Positives = 173/297 (58%), Gaps = 11/297 (3%)
Query: 33  TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI 92
           T++  +L E +   ++LG G +G + +C DK T    A K I K  + T  + + ++ E+
Sbjct: 29  TSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EV 87
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
            ++ +L  HPN++ L   +ED+   +LVME   GGELF  +    +F+E +A V+  Q++
Sbjct: 88  AVL-KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL 146
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
             V Y H+  +VHRDLKPEN+LL +K   + IK+ DFGL+   E  + +   +G+ +YIA
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206
Query: 213 PEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           PEVL   Y++  DVWS GVIL+ILL+G PPF G T   I   V      F S  W ++S+
Sbjct: 207 PEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGD-------GIQDPEKLSGNKIEDCKEW 322
            AKDL+  ML  D  +R++A+Q L+H W+ +       GI+ P     N IE+ +++
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPS--LANAIENMRKF 321

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 105/262 (40%), Positives = 157/262 (59%), Gaps = 6/262 (2%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGH 101
           + L ++LG G F V+R C  K   + +A K I   +L   D +   KLE E  + RL  H
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 89
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           PN+V L     +E + +LV +L  GGELF  +     +SEA+A     Q+++ V + H+ 
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLAGG- 219
            +VHRDLKPEN+LLA+K   + +KLADFGLA  ++   Q+  G  G+P Y++PEVL    
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           Y +  D+W+ GVILYILL G PPFW   + +++  ++     FPS  WD ++  AK+L+ 
Sbjct: 210 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 269
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            ML+ +P++R+TA Q L H W+
Sbjct: 270 QMLTINPAKRITADQALKHPWV 291

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  201 bits (510), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 105/270 (38%), Positives = 151/270 (55%), Gaps = 9/270 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAK---DRLVTIDDERSV-KLEIEIMT 96
           E +   ++LG G +G + +C +K      A K I K   D+    DD +++ K   EI  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 97  RLS-----GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
            +S      HPN++ L  V+ED+ Y +LV E   GGELF ++    +F E +A  +  Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
           +  + Y H+  +VHRD+KPENILL  K S   IK+ DFGL+++      L   +G+ +YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 212 APEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           APEVL   YN+  DVWS GVI+YILL G PPF G     I   V      F  N W +IS
Sbjct: 216 APEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS 275
Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           D AK+L+  ML+ D ++R TA + L+  W+
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  199 bits (505), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 112/274 (40%), Positives = 164/274 (59%), Gaps = 10/274 (3%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           +D +    L + F +  +LG G   ++  C  K T + +A K + K    T+D ++ V+ 
Sbjct: 43  IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK----TVD-KKIVRT 97
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           EI ++ RLS HPN++ LK ++E    + LV+EL  GGELF R+ + G +SE +A     Q
Sbjct: 98  EIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV-GSPF 209
           +++ V Y HE G+VHRDLKPEN+L AT A  +P+K+ADFGL+  +E  Q L+ TV G+P 
Sbjct: 157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPG 215
Query: 210 YIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSR-IFDAVRTADLRFPSNPW 267
           Y APE+L G  Y    D+WS G+I YILL G  PF+     + +F  +   +  F S  W
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275
Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           D +S +AKDLV  ++  DP +RLT  Q L H W+
Sbjct: 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 105/267 (39%), Positives = 150/267 (56%), Gaps = 15/267 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G F + R C  K + + FA K I+K R+     E + + EI  +    GHPN+V L 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK-RM-----EANTQKEITALKLCEGHPNIVKLH 72
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
            V+ D+ +  LVMEL  GGELF R++K   FSE EA  +  +L+  V + H++GVVHRDL
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 169 KPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL-AGGYNQAADV 226
           KPEN+L   +  +  IK+ DFG A    P    L T   +  Y APE+L   GY+++ D+
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDL 192
Query: 227 WSAGVILYILLSGMPPFWGNTKS-------RIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           WS GVILY +LSG  PF  + +S        I   ++  D  F    W ++S  AKDL+ 
Sbjct: 193 WSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQ 252
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQ 306
           G+L+ DP++RL    +  + W+ DG Q
Sbjct: 253 GLLTVDPNKRLKMSGLRYNEWLQDGSQ 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  190 bits (482), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 157/275 (57%), Gaps = 12/275 (4%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIE 93
           LR+ +++ + LG G  G +++  ++ T +  A K I+K +         D   +V+ EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 214 EVLA----GGYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWD 268
           EVL      GYN+A D WS GVIL+I LSG PPF  + T+  + D + +    F    W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +S+ A DLV  +L  DP  R T  + L H W+ D
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  190 bits (482), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 157/275 (57%), Gaps = 12/275 (4%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIE 93
           LR+ +++ + LG G  G +++  ++ T +  A K I+K +         D   +V+ EIE
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q++ 
Sbjct: 67  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 214 EVLA----GGYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWD 268
           EVL      GYN+A D WS GVIL+I LSG PPF  + T+  + D + +    F    W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +S+ A DLV  +L  DP  R T  + L H W+ D
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 157/275 (57%), Gaps = 12/275 (4%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIE 93
           LR+ +++ + LG G  G +++  ++ T +  A K I+K +         D   +V+ EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 214 EVLA----GGYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWD 268
           EVL      GYN+A D WS GVIL+I LSG PPF  + T+  + D + +    F    W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +S+ A DLV  +L  DP  R T  + L H W+ D
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 157/275 (57%), Gaps = 12/275 (4%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIE 93
           LR+ +++ + LG G  G +++  ++ T +  A K I+K +         D   +V+ EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 214 EVLA----GGYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWD 268
           EVL      GYN+A D WS GVIL+I LSG PPF  + T+  + D + +    F    W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +S+ A DLV  +L  DP  R T  + L H W+ D
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 157/275 (57%), Gaps = 12/275 (4%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIE 93
           LR+ +++ + LG G  G +++  ++ T +  A K I+K +         D   +V+ EIE
Sbjct: 14  LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q++ 
Sbjct: 74  ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 214 EVLA----GGYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWD 268
           EVL      GYN+A D WS GVIL+I LSG PPF  + T+  + D + +    F    W 
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 251
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +S+ A DLV  +L  DP  R T  + L H W+ D
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 157/275 (57%), Gaps = 12/275 (4%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIE 93
           LR+ +++ + LG G  G +++  ++ T +  A + I+K +         D   +V+ EIE
Sbjct: 147 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 206
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q++ 
Sbjct: 207 ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 264
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 324
Query: 214 EVLA----GGYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWD 268
           EVL      GYN+A D WS GVIL+I LSG PPF  + T+  + D + +    F    W 
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 384
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +S+ A DLV  +L  DP  R T  + L H W+ D
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 100/275 (36%), Positives = 157/275 (57%), Gaps = 12/275 (4%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIE 93
           LR+ +++ + LG G  G +++  ++ T +  A + I+K +         D   +V+ EIE
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q++ 
Sbjct: 193 ILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 214 EVL----AGGYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWD 268
           EVL      GYN+A D WS GVIL+I LSG PPF  + T+  + D + +    F    W 
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +S+ A DLV  +L  DP  R T  + L H W+ D
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 102/270 (37%), Positives = 161/270 (59%), Gaps = 12/270 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGH 101
           + L + +G G F V+R C ++ TG+ FA K +   +  +     +  L+ E  +  +  H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLY 157
           P++V+L   Y  +  +++V E   G +L   + K       +SEA A     Q+++ + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPE 214
           CH+  ++HRD+KPEN+LLA+K +S+P+KL DFG+A  I+ G+S L   G VG+P ++APE
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFMAPE 203
Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+    Y +  DVW  GVIL+ILLSG  PF+G TK R+F+ +     +     W HIS+S
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISES 262
Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           AKDLV  ML  DP++R+T  + L+H W+ +
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 101/270 (37%), Positives = 151/270 (55%), Gaps = 6/270 (2%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID---DERSVKLEIE 93
           S + + + +G++LG GQF ++R C  K TG+ +A K I K RL +         ++ E+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+  +  HPN++ L  ++E++  V L++EL +GGELF  L +    +E EA     Q++ 
Sbjct: 61  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIA 212
            V Y H   + H DLKPENI+L  K   +P IKL DFG+A  IE G       G+P ++A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 213 PEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PE++        AD+WS GVI YILLSG  PF G TK      +   +  F    + + S
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + AKD +  +L  DP +R+T  Q L+HSW+
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  184 bits (467), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/270 (37%), Positives = 150/270 (55%), Gaps = 6/270 (2%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID---DERSVKLEIE 93
           S + + + +G++LG GQF ++R C  K TG+ +A K I K RL +         ++ E+ 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+  +  HPN++ L  ++E++  V L++EL +GGELF  L +    +E EA     Q++ 
Sbjct: 82  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 140
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIA 212
            V Y H   + H DLKPENI+L  K   +P IKL DFG+A  IE G       G+P ++A
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 213 PEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PE++        AD+WS GVI YILLSG  PF G TK      +   +  F    + + S
Sbjct: 201 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 260
Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + AKD +  +L  DP +R+   Q L+HSW+
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/276 (36%), Positives = 153/276 (55%), Gaps = 6/276 (2%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID---DERS 87
           + T +  ++ + + +G++LG GQF ++R C  K TG+ +A K I K RL +         
Sbjct: 2   MSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE 61
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL 147
           ++ E+ I+  +  HPN++ L  ++E++  V L++EL +GGELF  L +    +E EA   
Sbjct: 62  IEREVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF 120
Query: 148 FMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVG 206
             Q++  V Y H   + H DLKPENI+L  K   +P IKL DFG+A  IE G       G
Sbjct: 121 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 180
Query: 207 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN 265
           +P ++APE++        AD+WS GVI YILLSG  PF G TK      +   +  F   
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE 240
Query: 266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            + + S+ AKD +  +L  DP +R+   Q L+HSW+
Sbjct: 241 YFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  182 bits (463), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPA 182
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  182 bits (462), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 150/275 (54%), Gaps = 18/275 (6%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP 266
           ++APE++   Y      AD+WS GVI YILLSG  PF G+TK      V   +  F    
Sbjct: 183 FVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 150/275 (54%), Gaps = 18/275 (6%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVLAGGYNQ---AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP 266
           ++APE++   Y      AD+WS GVI YILLSG  PF G+TK      V   +  F    
Sbjct: 183 FVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  182 bits (461), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  182 bits (461), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 67  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 181
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  182 bits (461), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  181 bits (460), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 67  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 181
Query: 210 YIAPEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  181 bits (460), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  181 bits (459), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  181 bits (459), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 147/273 (53%), Gaps = 13/273 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + + + +G G + V + C  K T   FA K I K +       R    EIEI+ R   HP
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHP 76
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ LK VY+D  YV++V EL  GGEL  ++ +   FSE EA  +   + + V Y H  G
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 163 VVHRDLKPENILLATKASS-SPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-GG 219
           VVHRDLKP NIL   ++ +   I++ DFG A  +     LL T   +  ++APEVL   G
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196
Query: 220 YNQAADVWSAGVILYILLSGMPPFWG---NTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           Y+ A D+WS GV+LY +L+G  PF     +T   I   + +         W+ +SD+AKD
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           LV  ML  DP QRLTA  VL H W+    Q P+
Sbjct: 257 LVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 144/266 (54%), Gaps = 16/266 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL------EIEIMTRLSGHP 102
           LG G   V+R C  K T + +A K I      +   E   +L      E++I+ ++SGHP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ LK  YE   +  LV +L   GELF  L +    SE E R +   L++V+   H++ 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA----- 217
           +VHRDLKPENILL    +   IKL DFG +  ++PG+ L    G+P Y+APE++      
Sbjct: 145 IVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMND 201
Query: 218 --GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
              GY +  D+WS GVI+Y LL+G PPFW   +  +   + + + +F S  WD  SD+ K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           DLV   L   P +R TA + L H + 
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 105/273 (38%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG G+F V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 148/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L+ EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 144/266 (54%), Gaps = 16/266 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL------EIEIMTRLSGHP 102
           LG G   V+R C  K T + +A K I      +   E   +L      E++I+ ++SGHP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ LK  YE   +  LV +L   GELF  L +    SE E R +   L++V+   H++ 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA----- 217
           +VHRDLKPENILL    +   IKL DFG +  ++PG+ L    G+P Y+APE++      
Sbjct: 145 IVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 218 --GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
              GY +  D+WS GVI+Y LL+G PPFW   +  +   + + + +F S  WD  SD+ K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           DLV   L   P +R TA + L H + 
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 144/266 (54%), Gaps = 16/266 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL------EIEIMTRLSGHP 102
           LG G   V+R C  K T + +A K I      +   E   +L      E++I+ ++SGHP
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ LK  YE   +  LV +L   GELF  L +    SE E R +   L++V+   H++ 
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA----- 217
           +VHRDLKPENILL    +   IKL DFG +  ++PG+ L    G+P Y+APE++      
Sbjct: 132 IVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 218 --GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
              GY +  D+WS GVI+Y LL+G PPFW   +  +   + + + +F S  WD  SD+ K
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           DLV   L   P +R TA + L H + 
Sbjct: 249 DLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 149/273 (54%), Gaps = 13/273 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           +V+ + +G G +   + C  K T   +A K I K +       R    EIEI+ R   HP
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRYGQHP 81
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ LK VY+D  +V+LV EL  GGEL  ++ +   FSE EA  +   + + V Y H  G
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 163 VVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-GG 219
           VVHRDLKP NIL   ++ +   +++ DFG A  +     LL T   +  ++APEVL   G
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 220 YNQAADVWSAGVILYILLSGMPPFWG---NTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           Y++  D+WS G++LY +L+G  PF     +T   I   + +         W+ +S++AKD
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           LV  ML  DP QRLTA+QVL H W+    + P+
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQ 294

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 149/273 (54%), Gaps = 13/273 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           +V+ + +G G +   + C  K T   +A K I K +       R    EIEI+ R   HP
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRYGQHP 81
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ LK VY+D  +V+LV EL  GGEL  ++ +   FSE EA  +   + + V Y H  G
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 163 VVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-GG 219
           VVHRDLKP NIL   ++ +   +++ DFG A  +     LL T   +  ++APEVL   G
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 220 YNQAADVWSAGVILYILLSGMPPFWG---NTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           Y++  D+WS G++LY +L+G  PF     +T   I   + +         W+ +S++AKD
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           LV  ML  DP QRLTA+QVL H W+    + P+
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQ 294

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 155/302 (51%), Gaps = 15/302 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + + + +G G + V + C  K T   FA K I K +       R    EIEI+ R   HP
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLRYGQHP 76
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ LK VY+D  YV++V EL  GGEL  ++ +   FSE EA  +   + + V Y H  G
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 163 VVHRDLKPENILLATKASS-SPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-GG 219
           VVHRDLKP NIL   ++ +   I++ DFG A  +     LL T   +  ++APEVL   G
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQG 196
Query: 220 YNQAADVWSAGVILYILLSGMPPFWG---NTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           Y+ A D+WS GV+LY  L+G  PF     +T   I   + +         W+ +SD+AKD
Sbjct: 197 YDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPR 336
           LV   L  DP QRLTA  VL H W+    Q P+       +D      G+ + +   + R
Sbjct: 257 LVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNR--QDAPHLVKGAXAATYSALNR 314
Query: 337 NQ 338
           NQ
Sbjct: 315 NQ 316

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 158/270 (58%), Gaps = 12/270 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGH 101
           + L + +G G F V+R C ++ TG+ FA K +   +  +     +  L+ E  +  +  H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLY 157
           P++V+L   Y  +  +++V E   G +L   + K       +SEA A     Q+++ + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPE 214
           CH+  ++HRD+KP  +LLA+K +S+P+KL  FG+A  I+ G+S L   G VG+P ++APE
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPE 205
Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+    Y +  DVW  GVIL+ILLSG  PF+G TK R+F+ +     +     W HIS+S
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISES 264
Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           AKDLV  ML  DP++R+T  + L+H W+ +
Sbjct: 265 AKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  178 bits (452), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 105/273 (38%), Positives = 148/273 (54%), Gaps = 14/273 (5%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL------VTIDD-ERSVKL 90
           N+ + +  G++LG G F V++ C +K TG  +A K I K R       V+ +D ER V +
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
             EI      HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q
Sbjct: 68  LKEIQ-----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPF 209
           ++  V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 210 YIAPEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           ++APE++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + S  AKD +  +L  DP +R+T +  L H W+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  178 bits (451), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 145/264 (54%), Gaps = 15/264 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACK--SIAKDRLV--TIDDER-SVKLEIEIMTRLSGHPN 103
           +G G   V+R C  + TG  FA K   +  +RL    +++ R + + E  I+ +++GHP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGV 163
           ++ L   YE   ++ LV +L   GELF  L +    SE E R +   L++ V + H   +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA------ 217
           VHRDLKPENILL        I+L+DFG + ++EPG+ L    G+P Y+APE+L       
Sbjct: 222 VHRDLKPENILLDDNMQ---IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
             GY +  D+W+ GVIL+ LL+G PPFW   +  +   +     +F S  WD  S + KD
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 277 LVMGMLSTDPSQRLTARQVLDHSW 300
           L+  +L  DP  RLTA Q L H +
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPF 362

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  178 bits (451), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 158/270 (58%), Gaps = 12/270 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGH 101
           + L + +G G F V+R C ++ TG+ FA K +   +  +     +  L+ E  +  +  H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLY 157
           P++V+L   Y  +  +++V E   G +L   + K       +SEA A     Q+++ + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPE 214
           CH+  ++HRD+KP  +LLA+K +S+P+KL  FG+A  I+ G+S L   G VG+P ++APE
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPE 203
Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+    Y +  DVW  GVIL+ILLSG  PF+G TK R+F+ +     +     W HIS+S
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISES 262
Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           AKDLV  ML  DP++R+T  + L+H W+ +
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 144/262 (54%), Gaps = 10/262 (3%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            +VLG  LG G FG +++   + TG   A K + + ++ ++D    +K EI+ + +L  H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRH 70
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           P+++ L  V        +VME  +GGELF  + K GR  E EAR LF Q++  V YCH  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYN 221
            VVHRDLKPEN+LL    ++   K+ADFGL+  +  G+ L  + GSP Y APEV++G   
Sbjct: 131 MVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 222 QA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
                D+WS GVILY LL G  PF       +F  +R      P    ++++ S   L+M
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLM 243
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            ML  DP +R T + + +H W 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWF 265

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 144/261 (55%), Gaps = 10/261 (3%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            +VLG  LG G FG +++   + TG   A K + + ++ ++D    +K EI+ + +L  H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRH 70
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           P+++ L  V        +VME  +GGELF  + K GR  E EAR LF Q++  V YCH  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYN 221
            VVHRDLKPEN+LL    ++   K+ADFGL+  +  G+ L  + GSP Y APEV++G   
Sbjct: 131 MVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 222 QA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
                D+WS GVILY LL G  PF       +F  +R      P    ++++ S   L+M
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLM 243
Query: 280 GMLSTDPSQRLTARQVLDHSW 300
            ML  DP +R T + + +H W
Sbjct: 244 HMLQVDPLKRATIKDIREHEW 264

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 152/268 (56%), Gaps = 11/268 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + + + ++LG G FGV+   +++ TG  FA K +         D+ +V+ EI+ M+ L  
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLR- 106
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCH 159
           HP +V+L   +ED++ + ++ E  +GGELF ++ ++  + SE EA     Q+ + + + H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG- 218
           E   VH DLKPENI+  TK S+  +KL DFGL  +++P QS+  T G+  + APEV  G 
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 225
Query: 219 --GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
             GY    D+WS GV+ YILLSG+ PF G         V++ D     + +  IS+  KD
Sbjct: 226 PVGY--YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 283
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            +  +L  DP+ R+T  Q L+H W+  G
Sbjct: 284 FIRKLLLADPNTRMTIHQALEHPWLTPG 311

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 152/268 (56%), Gaps = 11/268 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + + + ++LG G FGV+   +++ TG  FA K +         D+ +V+ EI+ M+ L  
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLR- 212
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCH 159
           HP +V+L   +ED++ + ++ E  +GGELF ++ ++  + SE EA     Q+ + + + H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG- 218
           E   VH DLKPENI+  TK S+  +KL DFGL  +++P QS+  T G+  + APEV  G 
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 219 --GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
             GY    D+WS GV+ YILLSG+ PF G         V++ D     + +  IS+  KD
Sbjct: 332 PVGY--YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            +  +L  DP+ R+T  Q L+H W+  G
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWLTPG 417

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 145/266 (54%), Gaps = 14/266 (5%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD------RLVTIDD-ERSVKLEIEIMTR 97
           +G++LG GQF +++ C +K TG  +A K I K       R V+ ++ ER V +  +++  
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-- 73
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
              H NV+ L  VYE+   V L++EL +GGELF  L +    SE EA     Q++  V Y
Sbjct: 74  ---HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 158 CHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
            H   + H DLKPENI+L  K    P IKL DFGLA  IE G       G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
                   AD+WS GVI YILLSG  PF G+TK      + +    F    + H S+ AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           D +  +L  +  +RLT ++ L H W+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/277 (36%), Positives = 150/277 (54%), Gaps = 8/277 (2%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSV-- 88
           ++T +   + + + +G++LG GQF +++ C +K TG  +A K I K +  +    R V  
Sbjct: 2   METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ--SRASRRGVCR 59
Query: 89  -KLEIEI-MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV 146
            ++E E+ + R   HPN++ L  VYE+   V L++EL +GGELF  L +    SE EA  
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTV 205
              Q++  V Y H   + H DLKPENI+L  K    P IKL DFGLA  IE G       
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 206 GSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
           G+P ++APE++        AD+WS GVI YILLSG  PF G+TK      +      F  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239
Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             +   S+ AKD +  +L  +  +RLT ++ L H W+
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 145/266 (54%), Gaps = 14/266 (5%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD------RLVTIDD-ERSVKLEIEIMTR 97
           +G++LG GQF +++ C +K TG  +A K I K       R V+ ++ ER V +  +++  
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-- 73
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
              H NV+ L  VYE+   V L++EL +GGELF  L +    SE EA     Q++  V Y
Sbjct: 74  ---HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 158 CHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
            H   + H DLKPENI+L  K    P IKL DFGLA  IE G       G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
                   AD+WS GVI YILLSG  PF G+TK      + +    F    + H S+ AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           D +  +L  +  +RLT ++ L H W+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/266 (38%), Positives = 145/266 (54%), Gaps = 14/266 (5%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD------RLVTIDD-ERSVKLEIEIMTR 97
           +G++LG GQF +++ C +K TG  +A K I K       R V+ ++ ER V +  +++  
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-- 73
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
              H NV+ L  VYE+   V L++EL +GGELF  L +    SE EA     Q++  V Y
Sbjct: 74  ---HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 158 CHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
            H   + H DLKPENI+L  K    P IKL DFGLA  IE G       G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
                   AD+WS GVI YILLSG  PF G+TK      + +    F    + H S+ AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           D +  +L  +  +RLT ++ L H W+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 116
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 292
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 350

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 122
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 123 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 182
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 183 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 242
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 243 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 298
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 299 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 356

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 76
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 77  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 136
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 137 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 196
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 197 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 252
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 253 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 310

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 77
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 78  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 137
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 138 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 197
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 198 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 253
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 254 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 311

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 70
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 71  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 130
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 131 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 190
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 246
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 304

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 71
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 72  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 131
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 132 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 191
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 192 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 247
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 248 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 305

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 72
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 192
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 248
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 306

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 78
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 79  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 138
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 139 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 198
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 199 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 254
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 255 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 312

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 72
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 192
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 248
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 306

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 86
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 87  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 146
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 147 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 206
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 207 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 262
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 263 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 320

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 70
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 71  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 130
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 131 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLG 190
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 246
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 304

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 144/261 (55%), Gaps = 10/261 (3%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           ++LG  LG G FG ++V   + TG   A K + + ++ ++D    ++ EI+ + +L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRHP 76
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           +++ L  V      + +VME  +GGELF  + K GR  E E+R LF Q++  V YCH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQ 222
           VVHRDLKPEN+LL    ++   K+ADFGL+  +  G+ L  + GSP Y APEV++G    
Sbjct: 137 VVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 223 A--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
               D+WS+GVILY LL G  PF  +    +F  +       P     +++ S   L+  
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLKH 249
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           ML  DP +R T + + +H W 
Sbjct: 250 MLQVDPMKRATIKDIREHEWF 270

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 71
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    GE++  L+K  +F E        +L   + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 132 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 71
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    GE++  L+K  +F E        +L   + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 132 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRXXLXGTLDYLPPEMIEGRM 187
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 143/266 (53%), Gaps = 14/266 (5%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD------RLVTIDD-ERSVKLEIEIMTR 97
           +G++LG GQF +++ C +K TG  +A K I K       R V+ ++ ER V +  +++  
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-- 73
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
              H NV+ L  VYE+   V L++EL +GGELF  L +    SE EA     Q++  V Y
Sbjct: 74  ---HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 158 CHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
            H   + H DLKPENI+L  K    P IKL DFGLA  IE G       G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
                   AD+WS GVI YILLSG  PF G+TK      +      F    +   S+ AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           D +  +L  +  +RLT ++ L H W+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 143/266 (53%), Gaps = 14/266 (5%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD------RLVTIDD-ERSVKLEIEIMTR 97
           +G++LG GQF +++ C +K TG  +A K I K       R V+ ++ ER V +  +++  
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-- 73
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
              H NV+ L  VYE+   V L++EL +GGELF  L +    SE EA     Q++  V Y
Sbjct: 74  ---HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 158 CHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
            H   + H DLKPENI+L  K    P IKL DFGLA  IE G       G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
                   AD+WS GVI YILLSG  PF G+TK      +      F    +   S+ AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           D +  +L  +  +RLT ++ L H W+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/260 (34%), Positives = 144/260 (55%), Gaps = 10/260 (3%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F +G+ LG G+FG + +  +K    + A K + K +L     E  ++ EIEI + L  HP
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 75
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ +   + D   ++L++E    GEL+  L+K GRF E  +     +L   + YCHE  
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YN 221
           V+HRD+KPEN+L+  K     +K+ADFG + +  P        G+  Y+ PE++ G  ++
Sbjct: 136 VIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTLDYLPPEMIEGKTHD 191
Query: 222 QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
           +  D+W AGV+ Y  L GMPPF   + +     +   DL+FP  P+  +SD +KDL+  +
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PF--LSDGSKDLISKL 247
Query: 282 LSTDPSQRLTARQVLDHSWM 301
           L   P QRL  + V++H W+
Sbjct: 248 LRYHPPQRLPLKGVMEHPWV 267

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 92
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 153 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 208
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 264
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 265 RLLKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 25  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 83
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 143
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 144 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 199
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 200 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 255
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 256 RLLKHNPSQRPMLREVLEHPWITANSSKP 284

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  165 bits (417), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 147/261 (56%), Gaps = 15/261 (5%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG G FGV+  C +K TG VF  K I     +   D+ +VK EI IM +L  HP +++
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLH-HPKLIN 112
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
           L   +ED+  + L++E  +GGELF R+  E + + SEAE      Q  + + + HE  +V
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL----AGGY 220
           H D+KPENI+  TK +SS +K+ DFGLAT + P + +  T  +  + APE++     G Y
Sbjct: 172 HLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 230
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
               D+W+ GV+ Y+LLSG+ PF G         V+  D  F  + +  +S  AKD +  
Sbjct: 231 ---TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           +L  +P +RLT    L+H W+
Sbjct: 288 LLQKEPRKRLTVHDALEHPWL 308

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  165 bits (417), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 102/265 (38%), Positives = 147/265 (55%), Gaps = 12/265 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ L + +G G FGV R+  DK + E+ A K I +   +    + +VK EI I  R   
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREI-INHRSLR 72
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN+V  K V     ++ +VME  +GGELF R+   GRFSE EAR  F QL+  V YCH 
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 161 IGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
           + V HRDLK EN LL    S +P +K+ DFG +           TVG+P YIAPEVL   
Sbjct: 133 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 190
Query: 220 -YN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--RTADLRFPSNPWDHISDSAK 275
            Y+ + ADVWS GV LY++L G  PF    + + F     R  ++++    + HIS   +
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 250
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW 300
            L+  +   DP++R++  ++ +H W
Sbjct: 251 HLISRIFVADPAKRISIPEIRNHEW 275

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  164 bits (416), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 69
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 130 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRM 185
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 71
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 132 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 68
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 129 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRM 184
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 240
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 99/265 (37%), Positives = 145/265 (54%), Gaps = 12/265 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ L + +G G FGV R+  DK + E+ A K I +   +  + +R +     I  R   
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREI-----INHRSLR 73
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN+V  K V     ++ +VME  +GGELF R+   GRFSE EAR  F QL+  V YCH 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 161 IGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
           + V HRDLK EN LL    S +P +K+ DFG +           TVG+P YIAPEVL   
Sbjct: 134 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 220 -YN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--RTADLRFPSNPWDHISDSAK 275
            Y+ + ADVWS GV LY++L G  PF    + + F     R  ++++    + HIS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW 300
            L+  +   DP++R++  ++ +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 92
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 153 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRM 208
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 264
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 265 RLLKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 69
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 130 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 127 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 142/269 (52%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 71
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-G 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE + G  
Sbjct: 132 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEXIEGRX 187
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 244 RLLKHNPSQRPXLREVLEHPWITANSSKP 272

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 71
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 132 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRM 187
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 243
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 128 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 239
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 127 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTELCGTLDYLPPEMIEGRM 182
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 148/282 (52%), Gaps = 11/282 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 128 KRVIHRDIKPENLLL---GSAGELKIADFGWSCHA-PSSRRTTLSGTLDYLPPEMIEGRM 183
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 239
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKE 321
            +L  +PSQR   R+VL+H W+      P   S NK    K+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPSN-SQNKESASKQ 280

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 127 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRM 182
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 127 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 127 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 127 KKVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRM 182
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 154/292 (52%), Gaps = 25/292 (8%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           Q LG G  G +  C  + TG+  A K +         D    + E++   + SG P++V 
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQASGGPHIVC 67
Query: 107 LKAVYEDEDY----VHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHE 160
           +  VYE+  +    + ++ME   GGELF R+++ G   F+E EA  +   +   + + H 
Sbjct: 68  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 127
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-G 218
             + HRD+KPEN+L  +K   + +KL DFG A   E  Q+ L T   +P+Y+APEVL   
Sbjct: 128 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPE 185
Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDA----VRTADLRFPSNPWDHISDSA 274
            Y+++ D+WS GVI+YILL G PPF+ NT   I       +R     FP+  W  +S+ A
Sbjct: 186 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 245
Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI---QDPEKLSGNKIEDCKEWD 323
           K L+  +L TDP++RLT  Q ++H W+   +   Q P   +    ED   WD
Sbjct: 246 KQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWD 297

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 154/292 (52%), Gaps = 25/292 (8%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           Q LG G  G +  C  + TG+  A K +         D    + E++   + SG P++V 
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQASGGPHIVC 86
Query: 107 LKAVYEDEDY----VHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHE 160
           +  VYE+  +    + ++ME   GGELF R+++ G   F+E EA  +   +   + + H 
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-G 218
             + HRD+KPEN+L  +K   + +KL DFG A   E  Q+ L T   +P+Y+APEVL   
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPE 204
Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDA----VRTADLRFPSNPWDHISDSA 274
            Y+++ D+WS GVI+YILL G PPF+ NT   I       +R     FP+  W  +S+ A
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI---QDPEKLSGNKIEDCKEWD 323
           K L+  +L TDP++RLT  Q ++H W+   +   Q P   +    ED   WD
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWD 316

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 144/264 (54%), Gaps = 12/264 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F+  ++LG G FG + +  ++ +G     K+I KDR     ++  ++ EIE++  L  HP
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ--IEAEIEVLKSLD-HP 80
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRL---EKFGR-FSEAEARVLFMQLMQVVLYC 158
           N++ +  V+ED   +++VME C GGEL  R+   +  G+  SE     L  Q+M  + Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG 218
           H   VVH+DLKPENIL    +  SPIK+ DFGLA   +  +      G+  Y+APEV   
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200
Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD--HISDSAKD 276
                 D+WSAGV++Y LL+G  PF G +   +    + A  + P+   +   ++  A D
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV---QQKATYKEPNYAVECRPLTPQAVD 257
Query: 277 LVMGMLSTDPSQRLTARQVLDHSW 300
           L+  ML+ DP +R +A QVL H W
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEW 281

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 146/271 (53%), Gaps = 14/271 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--SLLGTVGSPFYIAPEVLAG 218
             V+HRD+KPEN+LL    S+  +K+ADFG + +    +  +L GT+    Y+ PE++ G
Sbjct: 128 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSRRDTLCGTLD---YLPPEMIEG 181
Query: 219 G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL 237
Query: 278 VMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
           +  +L  +PSQR   R+VL+H W+      P
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 65
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 126 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 237
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 238 RLLKHNPSQRPMLREVLEHPWITANSSKP 266

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 68
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+A+FG + +  P        G+  Y+ PE++ G  
Sbjct: 129 KRVIHRDIKPENLLL---GSAGELKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 184
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 240
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 152/298 (51%), Gaps = 30/298 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K +         D    + E+E+  R S  P+
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVELHWRASQCPH 116
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +V E   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQY 176
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWD 268
              Y+++ D WS GVI YILL G PPF+ N         K+RI    R     FP+  W 
Sbjct: 237 PEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRI----RXGQYEFPNPEWS 292
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
            +S+  K L+  +L T+P+QR T  +  +H W+    + P+  L  +++  ED + W+
Sbjct: 293 EVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTSRVLKEDKERWE 350

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 127 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 70
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 131 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 242
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 243 RLLKHNPSQRPMLREVLEHPWITANSSKP 271

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 127 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRM 182
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 238
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 104/277 (37%), Positives = 144/277 (51%), Gaps = 15/277 (5%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
            I N R    L + +G G F  +++     TG+  A K I K +L +   ++  + E+ I
Sbjct: 12  HIGNYR----LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 66
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           M  L+ HPN+V L  V E E  ++LVME  +GGE+F  L   GR  E EAR  F Q++  
Sbjct: 67  MKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V YCH+  +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 215 VLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           +  G        DVWS GVILY L+SG  PF G     + + V     R P     ++S 
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 238
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             ++L+   L  +PS+R T  Q++   WM  G +D E
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 142/262 (54%), Gaps = 10/262 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 69
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 130 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRM 185
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            +L  +PSQR   R+VL+H W+
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWI 263

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 142/262 (54%), Gaps = 10/262 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 69
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 130 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            +L  +PSQR   R+VL+H W+
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWI 263

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 104/277 (37%), Positives = 144/277 (51%), Gaps = 15/277 (5%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
            I N R    L + +G G F  +++     TG+  A K I K +L +   ++  + E+ I
Sbjct: 12  HIGNYR----LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 66
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           M  L+ HPN+V L  V E E  ++LVME  +GGE+F  L   GR  E EAR  F Q++  
Sbjct: 67  MKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V YCH+  +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 215 VLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           +  G        DVWS GVILY L+SG  PF G     + + V     R P     ++S 
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 238
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             ++L+   L  +PS+R T  Q++   WM  G +D E
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 88/260 (33%), Positives = 143/260 (55%), Gaps = 10/260 (3%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F + + LG G+FG + +  +K    + A K + K +L     E  ++ EIEI + L  HP
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ +   + D   ++L++E    GEL+  L+K GRF E  +     +L   + YCHE  
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YN 221
           V+HRD+KPEN+L+  K     +K+ADFG + +  P        G+  Y+ PE++ G  ++
Sbjct: 135 VIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTLDYLPPEMIEGKTHD 190
Query: 222 QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
           +  D+W AGV+ Y  L GMPPF   + +     +   DL+FP  P+  +SD +KDL+  +
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PF--LSDGSKDLISKL 246
Query: 282 LSTDPSQRLTARQVLDHSWM 301
           L   P QRL  + V++H W+
Sbjct: 247 LRYHPPQRLPLKGVMEHPWV 266

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 144/277 (51%), Gaps = 15/277 (5%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
            I N R    L + +G G F  +++     TG+  A K I K +L +   ++  + E+ I
Sbjct: 12  HIGNYR----LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 66
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           M  L+ HPN+V L  V E E  ++LVME  +GGE+F  L   GR  E EAR  F Q++  
Sbjct: 67  MKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V YCH+  +VHRDLK EN+LL    +   IK+ADFG +     G  L    G+P Y APE
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDAFCGAPPYAAPE 182
Query: 215 VLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           +  G        DVWS GVILY L+SG  PF G     + + V     R P     ++S 
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 238
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             ++L+   L  +PS+R T  Q++   WM  G +D E
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 144/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  ++ +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR- 70
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  RF E        +L   + YCH 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 131 KRVIHRDIKPENLLL---GSNGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L GMPPF  +T    +  +   +  FP    D +++ A+DL+ 
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLIS 242
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  + SQRLT  +VL+H W+      P
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 101/265 (38%), Positives = 146/265 (55%), Gaps = 12/265 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ L + +G G FGV R+  DK + E+ A K I +   +    + +VK EI I  R   
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREI-INHRSLR 73
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN+V  K V     ++ +VME  +GGELF R+   GRFSE EAR  F QL+  V YCH 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 161 IGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
           + V HRDLK EN LL    S +P +K+  FG +           TVG+P YIAPEVL   
Sbjct: 134 MQVCHRDLKLENTLL--DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 220 -YN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--RTADLRFPSNPWDHISDSAK 275
            Y+ + ADVWS GV LY++L G  PF    + + F     R  ++++    + HIS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW 300
            L+  +   DP++R++  ++ +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 69
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+A+FG + +  P        G+  Y+ PE++ G  
Sbjct: 130 KRVIHRDIKPENLLL---GSAGELKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 101/265 (38%), Positives = 146/265 (55%), Gaps = 12/265 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ L + +G G FGV R+  DK + E+ A K I +   +    + +VK EI I  R   
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREI-INHRSLR 73
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN+V  K V     ++ +VME  +GGELF R+   GRFSE EAR  F QL+  V YCH 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 161 IGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
           + V HRDLK EN LL    S +P +K+  FG +           TVG+P YIAPEVL   
Sbjct: 134 MQVCHRDLKLENTLL--DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKK 191
Query: 220 -YN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--RTADLRFPSNPWDHISDSAK 275
            Y+ + ADVWS GV LY++L G  PF    + + F     R  ++++    + HIS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW 300
            L+  +   DP++R++  ++ +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 10/269 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 69
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 130 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 241
Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +L  +PSQR   R+VL+H W+      P
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 144/277 (51%), Gaps = 15/277 (5%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
            I N R    L + +G G F  +++     TG+  A + I K +L +   ++  + E+ I
Sbjct: 12  HIGNYR----LLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRI 66
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           M  L+ HPN+V L  V E E  ++LVME  +GGE+F  L   GR  E EAR  F Q++  
Sbjct: 67  MKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V YCH+  +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 215 VLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           +  G        DVWS GVILY L+SG  PF G     + + V     R P     ++S 
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 238
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             ++L+   L  +PS+R T  Q++   WM  G +D E
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 147/265 (55%), Gaps = 12/265 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ L + +G G FGV R+  DK   E+ A K I  +R   ID+  +VK EI I  R   
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYI--ERGEKIDE--NVKREI-INHRSLR 73
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN+V  K V     ++ +VME  +GGELF R+   GRFSE EAR  F QL+  V Y H 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 161 IGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
           + V HRDLK EN LL    S +P +K+ADFG +            VG+P YIAPEVL   
Sbjct: 134 MQVAHRDLKLENTLL--DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKK 191
Query: 220 -YN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--RTADLRFPSNPWDHISDSAK 275
            Y+ + ADVWS GV LY++L G  PF    + + F     R  ++++    + HIS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW 300
            L+  +   DP++R++  ++ +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 141/262 (53%), Gaps = 10/262 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K    + A K + K +L     E  ++ E+EI + L  
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 124 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 235
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            +L  +PSQR   R+VL+H W+
Sbjct: 236 RLLKHNPSQRPMLREVLEHPWI 257

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 144/277 (51%), Gaps = 15/277 (5%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
            I N R    L + +G G F  +++     TG+  A + I K +L +   ++  + E+ I
Sbjct: 12  HIGNYR----LLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRI 66
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           M  L+ HPN+V L  V E E  ++LVME  +GGE+F  L   GR  E EAR  F Q++  
Sbjct: 67  MKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V YCH+  +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDEFCGSPPYAAPE 182
Query: 215 VLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           +  G        DVWS GVILY L+SG  PF G     + + V     R P     ++S 
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 238
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             ++L+   L  +PS+R T  Q++   WM  G +D E
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 275

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 147/271 (54%), Gaps = 14/271 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  ++ +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR- 70
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  RF E        +L   + YCH 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--SLLGTVGSPFYIAPEVLAG 218
             V+HRD+KPEN+LL    S+  +K+ADFG + +    +  +L GT+    Y+ PE++ G
Sbjct: 131 KRVIHRDIKPENLLL---GSNGELKIADFGWSVHAPSSRRDTLCGTLD---YLPPEMIEG 184
Query: 219 G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             +++  D+WS GV+ Y  L GMPPF  +T    +  +   +  FP    D +++ A+DL
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDL 240
Query: 278 VMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
           +  +L  + SQRLT  +VL+H W+      P
Sbjct: 241 ISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/282 (35%), Positives = 144/282 (51%), Gaps = 32/282 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G    ++ C +  T + +A K I K           V  E+E++ +  GH NV++L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +E+ED  +LV E   GG +   + K   F+E EA V+   +   + + H  G+ HRDL
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 169 KPENILLATKASSSPIKLADFGLATYIE--------PGQSLLGTVGSPFYIAPEVL---- 216
           KPENIL       SP+K+ DFGL + I+            LL   GS  Y+APEV+    
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 217 --AGGYNQAADVWSAGVILYILLSGMPPFWGN---------------TKSRIFDAVRTAD 259
             A  Y++  D+WS GVILYILLSG PPF G                 ++ +F++++   
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             FP   W HIS +AKDL+  +L  D  QRL+A QVL H W+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 143/264 (54%), Gaps = 11/264 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G  LG G F  +       TG   A K I K  +      + V+ E++I  +L  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK- 69
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCH 159
           HP++++L   +ED +YV+LV+E+C  GE+   L+ +   FSE EAR    Q++  +LY H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA- 217
             G++HRDL   N+LL    +   IK+ADFGLAT ++ P +      G+P YI+PE+   
Sbjct: 130 SHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             +   +DVWS G + Y LL G PPF  +T     + V  AD   PS     +S  AKDL
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDL 242
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +  +L  +P+ RL+   VLDH +M
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 146/291 (50%), Gaps = 34/291 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G +  ++       G+ +A K I K           V  E+E + +  G+ N+++L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQ---AGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +ED+   +LV E   GG +   ++K   F+E EA  +   +   + + H  G+ HRDL
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 169 KPENILLATKASSSPIKLADFGLATYIEPGQS--------LLGTVGSPFYIAPEVL---- 216
           KPENIL  +    SP+K+ DF L + ++   S        L    GS  Y+APEV+    
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 217 --AGGYNQAADVWSAGVILYILLSGMPPFWGN---------------TKSRIFDAVRTAD 259
             A  Y++  D+WS GV+LYI+LSG PPF G+                ++++F++++   
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
             FP   W HIS  AKDL+  +L  D  QRL+A QVL H W+    Q PEK
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG--QAPEK 306

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 143/277 (51%), Gaps = 15/277 (5%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
            I N R    L + +G G F  +++     TG+  A K I K +L +   ++  + E+ I
Sbjct: 5   HIGNYR----LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 59
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           M  L+ HPN+V L  V E E  ++LVME  +GGE+F  L   G   E EAR  F Q++  
Sbjct: 60  MKVLN-HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSA 118
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V YCH+  +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE
Sbjct: 119 VQYCHQKFIVHRDLKAENLLLDADMN---IKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 175
Query: 215 VLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           +  G        DVWS GVILY L+SG  PF G     + + V     R P     ++S 
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 231
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             ++L+   L  +PS+R T  Q++   WM  G +D E
Sbjct: 232 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDE 268

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/282 (35%), Positives = 143/282 (50%), Gaps = 32/282 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G    ++ C +  T + +A K I K           V  E+E++ +  GH NV++L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +E+ED  +LV E   GG +   + K   F+E EA V+   +   + + H  G+ HRDL
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 169 KPENILLATKASSSPIKLADFGLATYIE--------PGQSLLGTVGSPFYIAPEVL---- 216
           KPENIL       SP+K+ DF L + I+            LL   GS  Y+APEV+    
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 217 --AGGYNQAADVWSAGVILYILLSGMPPFWGN---------------TKSRIFDAVRTAD 259
             A  Y++  D+WS GVILYILLSG PPF G                 ++ +F++++   
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             FP   W HIS +AKDL+  +L  D  QRL+A QVL H W+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 146/266 (54%), Gaps = 14/266 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G FGV R+  DK T E+ A K I  +R   ID+  +V+ EI I  R   
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE--NVQREI-INHRSLR 74
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN+V  K V     ++ ++ME  +GGEL+ R+   GRFSE EAR  F QL+  V YCH 
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134
Query: 161 IGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAPEV-LAG 218
           + + HRDLK EN LL    S +P +K+ DFG +           TVG+P YIAPEV L  
Sbjct: 135 MQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 219 GYN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--RTADLRFPSNPWD-HISDSA 274
            Y+ + ADVWS GV LY++L G  PF    + R +     R   +++ S P D  IS   
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-SIPDDIRISPEC 251
Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSW 300
             L+  +   DP+ R++  ++  HSW
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSW 277

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 139/269 (51%), Gaps = 11/269 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + L + +G G F  +++     TG   A K I K +L     ++  + E+ IM  L+ HP
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILN-HP 71
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N+V L  V E E  ++L+ME  +GGE+F  L   GR  E EAR  F Q++  V YCH+  
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQ 222
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE+  G    
Sbjct: 132 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 223 A--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
               DVWS GVILY L+SG  PF G     + + V     R P     ++S   ++L+  
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKR 244
Query: 281 MLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
            L  +P +R T  Q++   W+  G ++ E
Sbjct: 245 FLVLNPIKRGTLEQIMKDRWINAGHEEDE 273

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  FA K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 126
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 187 DLKPENLLIDQQGY---IQVTDFGFAKRVKGATWTL--CGTPEYLAPEIILSKGYNKAVD 241
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 297
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWFA 319

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXLA--GTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  FA K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  FA K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--XGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 139/269 (51%), Gaps = 11/269 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + L + +G G F  +++     TG   A K I K +L     ++  + E+ IM  L+ HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILN-HP 74
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N+V L  V E E  ++L+ME  +GGE+F  L   GR  E EAR  F Q++  V YCH+  
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQ 222
           +VHRDLK EN+LL    +   IK+ADFG +     G  L    G+P Y APE+  G    
Sbjct: 135 IVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 223 A--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
               DVWS GVILY L+SG  PF G     + + V     R P     ++S   ++L+  
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKR 247
Query: 281 MLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
            L  +P +R T  Q++   W+  G ++ E
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDE 276

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     IK+ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLMIDQQGY---IKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLPNGVNDIKNHKWFA 298

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 141/260 (54%), Gaps = 16/260 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K TG  +A K + K ++V +        E  I   ++  P +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN-FPFLVKLE 108
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++D   +++V+E   GGE+F  L + GRFSE  AR    Q++    Y H + +++RDL
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 169 KPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAADVW 227
           KPEN+L+  +     IK+ADFG A  ++     L   G+P Y+APE +L+ GYN+A D W
Sbjct: 169 KPENLLIDQQGY---IKVADFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVDWW 223
Query: 228 SAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPS 287
           + GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D +
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLT 279
Query: 288 QRL-----TARQVLDHSWMG 302
           +R          + +H W  
Sbjct: 280 KRFGNLKNGVNDIKNHKWFA 299

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIXNHKWFA 299

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 92
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 152
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 153 DLKPENLLIDEQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 207
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 208 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 263
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 264 LTKRFGNLKNGVNDIKNHKWFA 285

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V + +      E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     IK+ DFGLA  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLMIDQQGY---IKVTDFGLAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 126
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 187 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 241
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 297
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWFA 319

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 98
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 159 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 213
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 269
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWFA 291

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + +G G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     IK+ADFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IKVADFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRF+E  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 85/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWFA 298

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     I++ DFG A  ++     L   G+P Y+APE +++ GYN+A D
Sbjct: 166 DLKPENLIIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIISKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 126
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 187 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 241
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 297
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWFA 319

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 100
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 160
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 161 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 215
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 216 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 271
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 272 LTKRFGNLKNGVNDIKNHKWFA 293

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 143/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V + +      E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     I++ DFGLA  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLMIDQQGY---IQVTDFGLAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/277 (36%), Positives = 139/277 (50%), Gaps = 15/277 (5%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
            I N R    L + +G G F  +++     TG+  A K I K +L +   ++  + E+ I
Sbjct: 12  HIGNYR----LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 66
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
              L+ HPN+V L  V E E  ++LV E  +GGE+F  L   GR  E EAR  F Q++  
Sbjct: 67  XKVLN-HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSA 125
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V YCH+  +VHRDLK EN+LL    +   IK+ADFG +     G  L    G+P Y APE
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADXN---IKIADFGFSNEFTFGNKLDAFCGAPPYAAPE 182
Query: 215 VLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           +  G        DVWS GVILY L+SG  PF G     + + V     R P     + S 
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YXST 238
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             ++L+   L  +PS+R T  Q+    W   G +D E
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIXKDRWXNVGHEDDE 275

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 140/270 (51%), Gaps = 5/270 (1%)
Query: 36  ISNLRERFVL-GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           + N    ++L  ++LG G+F V+R C  K TG+ +A K + K R    D    +  EI +
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAV 81
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLM 152
           +      P V++L  VYE+   + L++E  AGGE+F     E     SE +   L  Q++
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + V Y H+  +VH DLKP+NILL++      IK+ DFG++  I     L   +G+P Y+A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 213 PEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PE+L       A D+W+ G+I Y+LL+   PF G      +  +   ++ +    +  +S
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261
Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             A D +  +L  +P +R TA   L HSW+
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+AP  +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPAIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     IK+ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLMIDQQGY---IKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  151 bits (382), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 98
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 159 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 213
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 269
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWFA 291

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 87/257 (33%), Positives = 142/257 (55%), Gaps = 7/257 (2%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G+FG +  C +  TG   A K I K R   + D+  VK EI +M +L  H N++ L 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAK-IIKTR--GMKDKEEVKNEISVMNQLD-HANLIQLY 152
Query: 109 AVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
             +E ++ + LVME   GGELF R+ ++    +E +  +   Q+ + + + H++ ++H D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 168 LKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY-NQAADV 226
           LKPENIL   +  +  IK+ DFGLA   +P + L    G+P ++APEV+   + +   D+
Sbjct: 213 LKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS GVI Y+LLSG+ PF G+  +   + +           +  IS+ AK+ +  +L  + 
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 287 SQRLTARQVLDHSWMGD 303
           S R++A + L H W+ D
Sbjct: 332 SWRISASEALKHPWLSD 348

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + +G G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GG++F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     IK+ADFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IKVADFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + +G G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GG++F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     IK+ADFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IKVADFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++           + +H W  
Sbjct: 277 LTKAFGNLKNGVNDIKNHKWFA 298

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWFA 298

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 100/277 (36%), Positives = 142/277 (51%), Gaps = 15/277 (5%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
            I N R    L + +G G F  +++     TG   A K I K +L     ++  + E+ I
Sbjct: 13  HIGNYR----LQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRI 67
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           M ++  HPN+V L  V E E  ++LVME  +GGE+F  L   GR  E EAR  F Q++  
Sbjct: 68  M-KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 126
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V YCH+  +VHRDLK EN+LL    +   IK+ADFG +     G  L    GSP Y APE
Sbjct: 127 VQYCHQKYIVHRDLKAENLLLDGDMN---IKIADFGFSNEFTVGNKLDTFCGSPPYAAPE 183
Query: 215 VLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           +  G        DVWS GVILY L+SG  PF G     + + V     R P     ++S 
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 239
Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             ++L+  +L  +P +R +  Q++   WM  G ++ E
Sbjct: 240 DCENLLKKLLVLNPIKRGSLEQIMKDRWMNVGHEEEE 276

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 91
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 151
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 152 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIILSKGYNKAVD 206
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 207 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 262
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 263 LTKRFGNLKDGVNDIKNHKWFA 284

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P  +APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEALAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 98/313 (31%), Positives = 152/313 (48%), Gaps = 52/313 (16%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID--DERSVKLEIEIMT 96
           L++++ L   +G G +GV+RV  +  T  + A K + K+++  I+  D   +K E+ +M 
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GR------------- 138
           +L  HPN+  L  VYEDE Y+ LVMELC GG L  +L  F     G+             
Sbjct: 84  KLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 139 --------------------FSEAEARV--LFMQLMQVVLYCHEIGVVHRDLKPENILLA 176
                               F + E  +  +  Q+   + Y H  G+ HRD+KPEN L +
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 177 TKASSSPIKLADFGLAT---YIEPGQ--SLLGTVGSPFYIAPEVLAG---GYNQAADVWS 228
           T  S   IKL DFGL+     +  G+   +    G+P+++APEVL      Y    D WS
Sbjct: 203 TNKSFE-IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 229 AGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           AGV+L++LL G  PF G   +     V    L F +  ++ +S  A+DL+  +L+ +  +
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 289 RLTARQVLDHSWM 301
           R  A + L H W+
Sbjct: 322 RFDAMRALQHPWI 334

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLMIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     IK+ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLMIDQQGY---IKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLTK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     IK+ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLMIDQQGY---IKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLTK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRFSE  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     IK+ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLMIDQQGY---IKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+L+  +     I++ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 166 DLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 220
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  149 bits (375), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 140/267 (52%), Gaps = 11/267 (4%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           +++ + LG G FG +++ +   T +  A K I++  L   D    V+ EI  + +L  HP
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRHP 69
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           +++ L  V      + +V+E  AGGELF  + +  R +E E R  F Q++  + YCH   
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQ 222
           +VHRDLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y APEV+ G    
Sbjct: 129 IVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 223 A--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
               DVWS G++LY++L G  PF       +F  V +     P    D +S  A+ L+  
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSLIRR 241
Query: 281 MLSTDPSQRLTARQVLDHSWMGDGIQD 307
           M+  DP QR+T +++    W    + D
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLPD 268

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 158/313 (50%), Gaps = 26/313 (8%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD---RLVTIDDERSVKLEIEIMTRLS 99
           F + + LG G FG + +   +  G  +A K + K+   RL  ++     +L + I+T   
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--- 64
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            HP ++ +   ++D   + ++M+   GGELF  L K  RF    A+    ++   + Y H
Sbjct: 65  -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
              +++RDLKPENILL        IK+ DFG A Y+      L   G+P YIAPEV++  
Sbjct: 124 SKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPDVTYXL--CGTPDYIAPEVVSTK 178
Query: 220 -YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            YN++ D WS G+++Y +L+G  PF+ +   + ++ +  A+LRFP       ++  KDL+
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLL 234
Query: 279 MGMLSTDPSQRLTARQ-----VLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQI 333
             +++ D SQRL   Q     V +H W  + +   EKL    IE   E  +  G   T  
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW--EKLLSRNIETPYEPPIQQGQGDTSQ 292
Query: 334 IPR--NQDISFGT 344
             +   +DI++G 
Sbjct: 293 FDKYPEEDINYGV 305

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 16/262 (6%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG + +     TG  +A K + K ++V +        E  I+  ++  P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLTK 106
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L+  ++D   +++VME   GGE+F  L + GRF E  AR    Q++    Y H + +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAAD 225
           DLKPEN+++  +     IK+ DFG A  ++     L   G+P Y+APE +L+ GYN+A D
Sbjct: 167 DLKPENLMIDQQGY---IKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILSKGYNKAVD 221
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 286 PSQRL-----TARQVLDHSWMG 302
            ++R          + +H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/256 (35%), Positives = 135/256 (52%), Gaps = 11/256 (4%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG +++     TG+  A K I K  L   D +  ++ EI  + RL  HP+++ 
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHPHIIK 78
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L  V + +D + +V+E  AG ELF  + +  + SE EAR  F Q++  V YCH   +VHR
Sbjct: 79  LYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHR 137
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQA--A 224
           DLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y APEV++G        
Sbjct: 138 DLKPENLLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 194
Query: 225 DVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
           DVWS GVILY++L    PF   +   +F  +       P      +S  A  L+  ML  
Sbjct: 195 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIV 250
Query: 285 DPSQRLTARQVLDHSW 300
           +P  R++  +++   W
Sbjct: 251 NPLNRISIHEIMQDDW 266

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/256 (35%), Positives = 135/256 (52%), Gaps = 11/256 (4%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG +++     TG+  A K I K  L   D +  ++ EI  + RL  HP+++ 
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHPHIIK 77
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L  V + +D + +V+E  AG ELF  + +  + SE EAR  F Q++  V YCH   +VHR
Sbjct: 78  LYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHR 136
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQA--A 224
           DLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y APEV++G        
Sbjct: 137 DLKPENLLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 193
Query: 225 DVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
           DVWS GVILY++L    PF   +   +F  +       P      +S  A  L+  ML  
Sbjct: 194 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIV 249
Query: 285 DPSQRLTARQVLDHSW 300
           +P  R++  +++   W
Sbjct: 250 NPLNRISIHEIMQDDW 265

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/256 (35%), Positives = 135/256 (52%), Gaps = 11/256 (4%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG +++     TG+  A K I K  L   D +  ++ EI  + RL  HP+++ 
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHPHIIK 68
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L  V + +D + +V+E  AG ELF  + +  + SE EAR  F Q++  V YCH   +VHR
Sbjct: 69  LYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHR 127
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQA--A 224
           DLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y APEV++G        
Sbjct: 128 DLKPENLLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 184
Query: 225 DVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
           DVWS GVILY++L    PF   +   +F  +       P      +S  A  L+  ML  
Sbjct: 185 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIV 240
Query: 285 DPSQRLTARQVLDHSW 300
           +P  R++  +++   W
Sbjct: 241 NPLNRISIHEIMQDDW 256

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/256 (35%), Positives = 135/256 (52%), Gaps = 11/256 (4%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + LG G FG +++     TG+  A K I K  L   D +  ++ EI  + RL  HP+++ 
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHPHIIK 72
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L  V + +D + +V+E  AG ELF  + +  + SE EAR  F Q++  V YCH   +VHR
Sbjct: 73  LYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHR 131
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQA--A 224
           DLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y APEV++G        
Sbjct: 132 DLKPENLLLDEHLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 188
Query: 225 DVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
           DVWS GVILY++L    PF   +   +F  +       P      +S  A  L+  ML  
Sbjct: 189 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIV 244
Query: 285 DPSQRLTARQVLDHSW 300
           +P  R++  +++   W
Sbjct: 245 NPLNRISIHEIMQDDW 260

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 94/297 (31%), Positives = 146/297 (49%), Gaps = 49/297 (16%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 72
Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A                     E   
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------------------ETTG 172
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGN--------TKSRIFDAVRTADLRFPSNPWDH 269
             Y+++ D+WS GVI+YILL G PPF+ N         K+RI    R     FP+  W  
Sbjct: 173 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWSE 228
Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK-LSGNKI--EDCKEWD 323
           +S+  K L+  +L T+P+QR+T  + ++H W+    + P+  L  +++  ED + W+
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 285

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  145 bits (365), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 98/305 (32%), Positives = 152/305 (49%), Gaps = 19/305 (6%)
Query: 7   SNSSSEPSRQPC-----KCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS 61
           S + ++PS +P      K   ++ + + ++D   +    +R++ G+ LG G F      +
Sbjct: 7   SAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTM----KRYMRGRFLGKGGFAKCYEIT 62
Query: 62  DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM 121
           D  T EVFA K + K  L+    +  +  EI I   L  +P+VV     +ED+D+V++V+
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFHGFFEDDDFVYVVL 121
Query: 122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
           E+C    L    ++    +E EAR    Q +Q V Y H   V+HRDLK  N+ L      
Sbjct: 122 EICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 182 SPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLSG 239
             +K+ DFGLAT IE  G+      G+P YIAPEVL   G++   D+WS G ILY LL G
Sbjct: 181 --VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238
Query: 240 MPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            PPF  +     +  ++  +   P     HI+  A  L+  ML  DP+ R +  ++L   
Sbjct: 239 KPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRPSVAELLTDE 294
Query: 300 WMGDG 304
           +   G
Sbjct: 295 FFTSG 299

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 98/305 (32%), Positives = 152/305 (49%), Gaps = 19/305 (6%)
Query: 7   SNSSSEPSRQPC-----KCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS 61
           S + ++PS +P      K   ++ + + ++D   +    +R++ G+ LG G F      +
Sbjct: 7   SAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTM----KRYMRGRFLGKGGFAKCYEIT 62
Query: 62  DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM 121
           D  T EVFA K + K  L+    +  +  EI I   L  +P+VV     +ED+D+V++V+
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFHGFFEDDDFVYVVL 121
Query: 122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
           E+C    L    ++    +E EAR    Q +Q V Y H   V+HRDLK  N+ L      
Sbjct: 122 EICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 182 SPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLSG 239
             +K+ DFGLAT IE  G+      G+P YIAPEVL   G++   D+WS G ILY LL G
Sbjct: 181 --VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238
Query: 240 MPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            PPF  +     +  ++  +   P     HI+  A  L+  ML  DP+ R +  ++L   
Sbjct: 239 KPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRPSVAELLTDE 294
Query: 300 WMGDG 304
           +   G
Sbjct: 295 FFTSG 299

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 98/305 (32%), Positives = 152/305 (49%), Gaps = 19/305 (6%)
Query: 7   SNSSSEPSRQPC-----KCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS 61
           S + ++PS +P      K   ++ + + ++D   +    +R++ G+ LG G F      +
Sbjct: 7   SAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTM----KRYMRGRFLGKGGFAKCYEIT 62
Query: 62  DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM 121
           D  T EVFA K + K  L+    +  +  EI I   L  +P+VV     +ED+D+V++V+
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFHGFFEDDDFVYVVL 121
Query: 122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
           E+C    L    ++    +E EAR    Q +Q V Y H   V+HRDLK  N+ L      
Sbjct: 122 EICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 182 SPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLSG 239
             +K+ DFGLAT IE  G+      G+P YIAPEVL   G++   D+WS G ILY LL G
Sbjct: 181 --VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238
Query: 240 MPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            PPF  +     +  ++  +   P     HI+  A  L+  ML  DP+ R +  ++L   
Sbjct: 239 KPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRPSVAELLTDE 294
Query: 300 WMGDG 304
           +   G
Sbjct: 295 FFTSG 299

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 132 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 287 SQRL-----TARQVLDHSWM 301
            QRL      A++V++H + 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 74
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 75  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 135 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 191
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 192 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 247
Query: 287 SQRL-----TARQVLDHSWM 301
            QRL      A++V++H + 
Sbjct: 248 KQRLGGGPSDAKEVMEHRFF 267

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 132 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 287 SQRL-----TARQVLDHSWM 301
            QRL      A++V++H + 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 132 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 287 SQRL-----TARQVLDHSWM 301
            QRL      A++V++H + 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  144 bits (364), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 132 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 287 SQRL-----TARQVLDHSWM 301
            QRL      A++V++H + 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 132 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 287 SQRL-----TARQVLDHSWM 301
            QRL      A++V++H + 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++   + HP +  LK
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 76
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 77  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 169 KPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 137 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 193
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 194 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 249
Query: 287 SQRL-----TARQVLDHSWM 301
            QRL      A++V++H + 
Sbjct: 250 KQRLGGGPSDAKEVMEHRFF 269

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 146/296 (49%), Gaps = 19/296 (6%)
Query: 11  SEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFA 70
           S+P   P K      + + ++D   +    +R++ G+ LG G F      +D  T EVFA
Sbjct: 5   SDPKSAPLK-----EIPDVLVDPRTM----KRYMRGRFLGKGGFAKCYEITDMDTKEVFA 55
Query: 71  CKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELF 130
            K + K  L+    +  +  EI I   L  +P+VV     +ED+D+V++V+E+C    L 
Sbjct: 56  GKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFHGFFEDDDFVYVVLEICRRRSLL 114
Query: 131 HRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
              ++    +E EAR    Q +Q V Y H   V+HRDLK  N+ L        +K+ DFG
Sbjct: 115 ELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD---VKIGDFG 171
Query: 191 LATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTK 248
           LAT IE  G+      G+P YIAPEVL   G++   D+WS G ILY LL G PPF  +  
Sbjct: 172 LATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 231
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
              +  ++  +   P     HI+  A  L+  ML  DP+ R +  ++L   +   G
Sbjct: 232 KETYIRIKKNEYSVPR----HINPVASALIRRMLHADPTLRPSVAELLTDEFFTSG 283

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 138/260 (53%), Gaps = 10/260 (3%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F +G+ LG G+FG + +  +K +  + A K + K ++     E  ++ EIEI   L  HP
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH-HP 83
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           N++ L   + D   ++L++E    GEL+  L+K   F E     +  +L   ++YCH   
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YN 221
           V+HRD+KPEN+LL  K       +ADFG + +  P        G+  Y+ PE++ G  +N
Sbjct: 144 VIHRDIKPENLLLGLKGELK---IADFGWSVH-APSLRRKTMCGTLDYLPPEMIEGRMHN 199
Query: 222 QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
           +  D+W  GV+ Y LL G PPF   + +  +  +   DL+FP++    +   A+DL+  +
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPAS----VPTGAQDLISKL 255
Query: 282 LSTDPSQRLTARQVLDHSWM 301
           L  +PS+RL   QV  H W+
Sbjct: 256 LRHNPSERLPLAQVSAHPWV 275

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 136/262 (51%), Gaps = 16/262 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ +V  D+      E  ++   S HP +  LK
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 217
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRD 167
             ++  D +  VME   GGELF  L +   FSE  AR    +++  + Y H E  VV+RD
Sbjct: 218 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 277
Query: 168 LKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAAD 225
           LK EN++L        IK+ DFGL    I+ G ++    G+P Y+APEVL    Y +A D
Sbjct: 278 LKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 334
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  GV++Y ++ G  PF+     ++F+ +   ++RFP      +   AK L+ G+L  D
Sbjct: 335 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKD 390
Query: 286 PSQRL-----TARQVLDHSWMG 302
           P QRL      A++++ H +  
Sbjct: 391 PKQRLGGGSEDAKEIMQHRFFA 412

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 136/262 (51%), Gaps = 16/262 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ +V  D+      E  ++   S HP +  LK
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 74
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRD 167
             ++  D +  VME   GGELF  L +   FSE  AR    +++  + Y H E  VV+RD
Sbjct: 75  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 168 LKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAAD 225
           LK EN++L        IK+ DFGL    I+ G ++    G+P Y+APEVL    Y +A D
Sbjct: 135 LKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 191
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  GV++Y ++ G  PF+     ++F+ +   ++RFP      +   AK L+ G+L  D
Sbjct: 192 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKD 247
Query: 286 PSQRL-----TARQVLDHSWMG 302
           P QRL      A++++ H +  
Sbjct: 248 PKQRLGGGSEDAKEIMQHRFFA 269

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 136/262 (51%), Gaps = 16/262 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ +V  D+      E  ++   S HP +  LK
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 76
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRD 167
             ++  D +  VME   GGELF  L +   FSE  AR    +++  + Y H E  VV+RD
Sbjct: 77  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 168 LKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAAD 225
           LK EN++L        IK+ DFGL    I+ G ++    G+P Y+APEVL    Y +A D
Sbjct: 137 LKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 193
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  GV++Y ++ G  PF+     ++F+ +   ++RFP      +   AK L+ G+L  D
Sbjct: 194 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKD 249
Query: 286 PSQRL-----TARQVLDHSWMG 302
           P QRL      A++++ H +  
Sbjct: 250 PKQRLGGGSEDAKEIMQHRFFA 271

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 136/262 (51%), Gaps = 16/262 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ +V  D+      E  ++   S HP +  LK
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 214
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRD 167
             ++  D +  VME   GGELF  L +   FSE  AR    +++  + Y H E  VV+RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 168 LKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAAD 225
           LK EN++L        IK+ DFGL    I+ G ++    G+P Y+APEVL    Y +A D
Sbjct: 275 LKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  GV++Y ++ G  PF+     ++F+ +   ++RFP      +   AK L+ G+L  D
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKD 387
Query: 286 PSQRL-----TARQVLDHSWMG 302
           P QRL      A++++ H +  
Sbjct: 388 PKQRLGGGSEDAKEIMQHRFFA 409

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 136/262 (51%), Gaps = 16/262 (6%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ +V  D+      E  ++   S HP +  LK
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 75
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRD 167
             ++  D +  VME   GGELF  L +   FSE  AR    +++  + Y H E  VV+RD
Sbjct: 76  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 135
Query: 168 LKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGYNQAAD 225
           LK EN++L        IK+ DFGL    I+ G ++    G+P Y+APEVL    Y +A D
Sbjct: 136 LKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 192
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  GV++Y ++ G  PF+     ++F+ +   ++RFP      +   AK L+ G+L  D
Sbjct: 193 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKD 248
Query: 286 PSQRL-----TARQVLDHSWMG 302
           P QRL      A++++ H +  
Sbjct: 249 PKQRLGGGSEDAKEIMQHRFFA 270

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 129/258 (50%), Gaps = 10/258 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G F      SD  T EVFA K + K  L+       + +EI I   L+ H +VV   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 87
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +ED D+V +V+ELC    L    ++    +E EAR    Q++    Y H   V+HRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 169 KPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K  N+ L        +K+ DFGLAT +E  G+      G+P YIAPEVL+  G++   DV
Sbjct: 148 KLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS G I+Y LL G PPF  +     +  ++  +   P     HI+  A  L+  ML TDP
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 260
Query: 287 SQRLTARQVLDHSWMGDG 304
           + R T  ++L+  +   G
Sbjct: 261 TARPTINELLNDEFFTSG 278

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 129/258 (50%), Gaps = 10/258 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G F      SD  T EVFA K + K  L+       + +EI I   L+ H +VV   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +ED D+V +V+ELC    L    ++    +E EAR    Q++    Y H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 169 KPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K  N+ L        +K+ DFGLAT +E  G+      G+P YIAPEVL+  G++   DV
Sbjct: 144 KLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS G I+Y LL G PPF  +     +  ++  +   P     HI+  A  L+  ML TDP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 287 SQRLTARQVLDHSWMGDG 304
           + R T  ++L+  +   G
Sbjct: 257 TARPTINELLNDEFFTSG 274

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 129/258 (50%), Gaps = 10/258 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G F      SD  T EVFA K + K  L+       + +EI I   L+ H +VV   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +ED D+V +V+ELC    L    ++    +E EAR    Q++    Y H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 169 KPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K  N+ L        +K+ DFGLAT +E  G+      G+P YIAPEVL+  G++   DV
Sbjct: 144 KLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS G I+Y LL G PPF  +     +  ++  +   P     HI+  A  L+  ML TDP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 287 SQRLTARQVLDHSWMGDG 304
           + R T  ++L+  +   G
Sbjct: 257 TARPTINELLNDEFFTSG 274

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  141 bits (355), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 129/258 (50%), Gaps = 10/258 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G F      SD  T EVFA K + K  L+       + +EI I   L+ H +VV   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 107
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +ED D+V +V+ELC    L    ++    +E EAR    Q++    Y H   V+HRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 169 KPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K  N+ L        +K+ DFGLAT +E  G+      G+P YIAPEVL+  G++   DV
Sbjct: 168 KLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS G I+Y LL G PPF  +     +  ++  +   P     HI+  A  L+  ML TDP
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 280
Query: 287 SQRLTARQVLDHSWMGDG 304
           + R T  ++L+  +   G
Sbjct: 281 TARPTINELLNDEFFTSG 298

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 129/258 (50%), Gaps = 10/258 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G F      SD  T EVFA K + K  L+       + +EI I   L+ H +VV   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 105
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +ED D+V +V+ELC    L    ++    +E EAR    Q++    Y H   V+HRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 169 KPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K  N+ L        +K+ DFGLAT +E  G+      G+P YIAPEVL+  G++   DV
Sbjct: 166 KLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS G I+Y LL G PPF  +     +  ++  +   P     HI+  A  L+  ML TDP
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 278
Query: 287 SQRLTARQVLDHSWMGDG 304
           + R T  ++L+  +   G
Sbjct: 279 TARPTINELLNDEFFTSG 296

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 96/331 (29%), Positives = 168/331 (50%), Gaps = 29/331 (8%)
Query: 32  DTNQISNLRER-----FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER 86
           D  Q SN  +R     F     LG G FG + +   K T E++A K + KD ++  DD  
Sbjct: 5   DRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVE 64
Query: 87  SVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV 146
              +E  ++  L   P +  L + ++  D ++ VME   GG+L + +++ G+F E +A  
Sbjct: 65  CTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 124
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTV 205
              ++   + + H+ G+++RDLK +N++L ++     IK+ADFG+   ++  G +     
Sbjct: 125 YAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMMDGVTTREFC 181
Query: 206 GSPFYIAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
           G+P YIAPE++A   Y ++ D W+ GV+LY +L+G PPF G  +  +F ++   ++ +P 
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK 241
Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTA-----RQVLDHSWMGDGIQDPEKLSGNKIE-D 318
           +    +S  A  +  G+++  P++RL       R V +H++      D EKL   +I+  
Sbjct: 242 S----LSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFRR--IDWEKLENREIQPP 295
Query: 319 CKEWDLGSGSFSTQIIPRNQDISFGTGSPVF 349
            K    G G+        N D  F  G PV 
Sbjct: 296 FKPKVCGKGA-------ENFDKFFTRGQPVL 319

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 129/258 (50%), Gaps = 10/258 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G F      SD  T EVFA K + K  L+       + +EI I   L+ H +VV   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 81
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             +ED D+V +V+ELC    L    ++    +E EAR    Q++    Y H   V+HRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 169 KPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K  N+ L        +K+ DFGLAT +E  G+      G+P YIAPEVL+  G++   DV
Sbjct: 142 KLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           WS G I+Y LL G PPF  +     +  ++  +   P     HI+  A  L+  ML TDP
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 254
Query: 287 SQRLTARQVLDHSWMGDG 304
           + R T  ++L+  +   G
Sbjct: 255 TARPTINELLNDEFFTSG 272

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/253 (31%), Positives = 134/253 (52%), Gaps = 9/253 (3%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F   + +G G FG + +   K     +A K + K  ++   +E+ +  E  ++ +   HP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L   ++  D ++ V++   GGELF+ L++   F E  AR    ++   + Y H + 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTVGSPFYIAPEVLAGG-Y 220
           +V+RDLKPENILL ++     I L DFGL    IE   +     G+P Y+APEVL    Y
Sbjct: 160 IVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           ++  D W  G +LY +L G+PPF+    + ++D +    L+   N    I++SA+ L+ G
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEG 272
Query: 281 MLSTDPSQRLTAR 293
           +L  D ++RL A+
Sbjct: 273 LLQKDRTKRLGAK 285

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 146/284 (51%), Gaps = 11/284 (3%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L E++++ + LG G+FG++  C +  + + +  K +     V   D+  VK EI I+  +
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILN-I 57
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLY 157
           + H N++ L   +E  + + ++ E  +G ++F R+       +E E      Q+ + + +
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H   + H D++PENI+  T+ SS+ IK+ +FG A  ++PG +      +P Y APEV  
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 218 GGY-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
               + A D+WS G ++Y+LLSG+ PF   T  +I + +  A+  F    +  IS  A D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCK 320
            V  +L  +   R+TA + L H W+   I   E++S   I   K
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKI---ERVSTKVIRTLK 277

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 140/266 (52%), Gaps = 19/266 (7%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           QI    E F+L + LG G FG + +   K T + FA K++ KD ++  DD     +E  +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           ++    HP +  +   ++ ++ +  VME   GG+L + ++   +F  + A     +++  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV------GSP 208
           + + H  G+V+RDLK +NILL        IK+ADFG+       +++LG        G+P
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCK-----ENMLGDAKTNXFCGTP 182
Query: 209 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
            YIAPE+L G  YN + D WS GV+LY +L G  PF G  +  +F ++R  +  +P   W
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W 240
Query: 268 DHISDSAKDLVMGMLSTDPSQRLTAR 293
             +   AKDL++ +   +P +RL  R
Sbjct: 241 --LEKEAKDLLVKLFVREPEKRLGVR 264

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 84/252 (33%), Positives = 136/252 (53%), Gaps = 12/252 (4%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMTRLSGHP 102
           VLG+  G+G+   +R  +   TG++FA K + K  +V    D    K E  I+  +  HP
Sbjct: 24  VLGKG-GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HP 81
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +VDL   ++    ++L++E  +GGELF +LE+ G F E  A     ++   + + H+ G
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGY 220
           +++RDLKPENI+L  +     +KL DFGL    I  G       G+  Y+APE+L   G+
Sbjct: 142 IIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           N+A D WS G ++Y +L+G PPF G  + +  D +    L  P     +++  A+DL+  
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKK 254
Query: 281 MLSTDPSQRLTA 292
           +L  + + RL A
Sbjct: 255 LLKRNAASRLGA 266

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/252 (33%), Positives = 136/252 (53%), Gaps = 12/252 (4%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMTRLSGHP 102
           VLG+  G+G+   +R  +   TG++FA K + K  +V    D    K E  I+  +  HP
Sbjct: 24  VLGKG-GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HP 81
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +VDL   ++    ++L++E  +GGELF +LE+ G F E  A     ++   + + H+ G
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLA-GGY 220
           +++RDLKPENI+L  +     +KL DFGL    I  G       G+  Y+APE+L   G+
Sbjct: 142 IIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           N+A D WS G ++Y +L+G PPF G  + +  D +    L  P     +++  A+DL+  
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKK 254
Query: 281 MLSTDPSQRLTA 292
           +L  + + RL A
Sbjct: 255 LLKRNAASRLGA 266

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 134/252 (53%), Gaps = 9/252 (3%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + F   + LG G FG + +   K TG+++A K + KD ++  DD      E  I++    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP +  L   ++  D +  VME   GG+L   ++K  RF EA AR    +++  +++ H+
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAGG 219
            G+++RDLK +N+LL  +      KLADFG+    I  G +     G+P YIAPE+L   
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHC---KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 220 -YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y  A D W+ GV+LY +L G  PF    +  +F+A+   ++ +P+  W H  + A  ++
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLH--EDATGIL 255
Query: 279 MGMLSTDPSQRL 290
              ++ +P+ RL
Sbjct: 256 KSFMTKNPTMRL 267

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           QI    E F L + LG G FG + +   K T + FA K++ KD ++  DD     +E  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           ++    HP +  +   ++ ++ +  VME   GG+L + ++   +F  + A     +++  
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 131
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV------GSP 208
           + + H  G+V+RDLK +NILL        IK+ADFG+       +++LG        G+P
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCK-----ENMLGDAKTNEFCGTP 183
Query: 209 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
            YIAPE+L G  YN + D WS GV+LY +L G  PF G  +  +F ++R  +  +P   W
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W 241
Query: 268 DHISDSAKDLVMGMLSTDPSQRLTAR 293
             +   AKDL++ +   +P +RL  R
Sbjct: 242 --LEKEAKDLLVKLFVREPEKRLGVR 265

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 142/282 (50%), Gaps = 16/282 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI  + ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEI-CINKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW----MGDGIQDPEKLSG 313
            L+  +L  +PS R+T   +    W    +  G + P   SG
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 280

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 142/282 (50%), Gaps = 16/282 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW----MGDGIQDPEKLSG 313
            L+  +L  +PS R+T   +    W    +  G + P   SG
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 142/282 (50%), Gaps = 16/282 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW----MGDGIQDPEKLSG 313
            L+  +L  +PS R+T   +    W    +  G + P   SG
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 142/282 (50%), Gaps = 16/282 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW----MGDGIQDPEKLSG 313
            L+  +L  +PS R+T   +    W    +  G + P   SG
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 142/282 (50%), Gaps = 16/282 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW----MGDGIQDPEKLSG 313
            L+  +L  +PS R+T   +    W    +  G + P   SG
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEIXI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEIXI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEIXI-NKMLN 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 61
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 122 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKPLK 268

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 136/265 (51%), Gaps = 12/265 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW 300
            L+  +L  +PS R+T   +    W
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 136/265 (51%), Gaps = 12/265 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSW 300
            L+  +L  +PS R+T   +    W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRW 264

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I   L+ 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINAMLN- 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 144/276 (52%), Gaps = 16/276 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K T E++A K + KD ++  DD     +E  ++      P +  L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
           + ++  D ++ VME   GG+L + +++ GRF E  A     ++   + +    G+++RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 169 KPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K +N++L ++     IK+ADFG+    I  G +     G+P YIAPE++A   Y ++ D 
Sbjct: 469 KLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W+ GV+LY +L+G  PF G  +  +F ++   ++ +P +    +S  A  +  G+++  P
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 581
Query: 287 SQRLTA-----RQVLDHSWMGDGIQDPEKLSGNKIE 317
            +RL       R + +H++      D EKL   +I+
Sbjct: 582 GKRLGCGPEGERDIKEHAFF--RYIDWEKLERKEIQ 615

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 137/271 (50%), Gaps = 12/271 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G  G +++  ++ T E  A K +   R   +D   ++K EI I  ++  
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICI-NKMLN 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT   Y    + L    G+  Y+APE+L 
Sbjct: 123 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P W        +     + +   NPW  I  +  
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            L+  +L  +PS R+T   +    W    ++
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 144/276 (52%), Gaps = 16/276 (5%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K T E++A K + KD ++  DD     +E  ++      P +  L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
           + ++  D ++ VME   GG+L + +++ GRF E  A     ++   + +    G+++RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 169 KPENILLATKASSSPIKLADFGLAT-YIEPGQSLLGTVGSPFYIAPEVLA-GGYNQAADV 226
           K +N++L ++     IK+ADFG+    I  G +     G+P YIAPE++A   Y ++ D 
Sbjct: 148 KLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W+ GV+LY +L+G  PF G  +  +F ++   ++ +P +    +S  A  +  G+++  P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 260
Query: 287 SQRLTA-----RQVLDHSWMGDGIQDPEKLSGNKIE 317
            +RL       R + +H++      D EKL   +I+
Sbjct: 261 GKRLGCGPEGERDIKEHAFF--RYIDWEKLERKEIQ 294

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 142/290 (48%), Gaps = 37/290 (12%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--------------------T 81
           ++ L  ++G G +GV+++  ++     +A K ++K +L+                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 82  IDDE---RSVKLEIEIMTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKF 136
           I        V  EI I+ +L  HPNVV L  V +D  ED++++V EL   G +   +   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-EVPTL 131
Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
              SE +AR  F  L++ + Y H   ++HRD+KP N+L+        IK+ADFG++   +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFK 188
Query: 197 PGQSLL-GTVGSPFYIAPEVLAGGYN----QAADVWSAGVILYILLSGMPPFWGNTKSRI 251
              +LL  TVG+P ++APE L+        +A DVW+ GV LY  + G  PF       +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              +++  L FP  P   I++  KDL+  ML  +P  R+   ++  H W+
Sbjct: 249 HSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 132/259 (50%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 91
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP--GQSLLGT-VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P   Q+   + VG+  Y++PE+L 
Sbjct: 152 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 264
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 265 LVEKLLVLDATKRLGCEEM 283

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 88
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 149 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 261
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 262 LVEKLLVLDATKRLGCEEM 280

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 151 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARD 263
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 264 LVEKLLVLDATKRLGCEEM 282

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/259 (32%), Positives = 139/259 (53%), Gaps = 20/259 (7%)
Query: 42  RFVLGQQLGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           +F L + LG G FG   +++  S     +++A K + K  L   D  R+ K+E +I+  +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
           + HP +V L   ++ E  ++L+++   GG+LF RL K   F+E + +    +L   + + 
Sbjct: 84  N-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLAT----YIEPGQSLLGTVGSPFYIAPE 214
           H +G+++RDLKPENILL  +     IKL DFGL+     + +   S  GTV    Y+APE
Sbjct: 143 HSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVE---YMAPE 196
Query: 215 VL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+   G+ Q+AD WS GV+++ +L+G  PF G  +      +  A L  P      +S  
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPE 252
Query: 274 AKDLVMGMLSTDPSQRLTA 292
           A+ L+  +   +P+ RL A
Sbjct: 253 AQSLLRMLFKRNPANRLGA 271

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 138/257 (53%), Gaps = 20/257 (7%)
Query: 42  RFVLGQQLGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
            F L + LG G FG   ++R  +   +G ++A K + K  L   D  R+ K+E +I+  +
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADV 87
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
           + HP VV L   ++ E  ++L+++   GG+LF RL K   F+E + +    +L   + + 
Sbjct: 88  N-HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLAT----YIEPGQSLLGTVGSPFYIAPE 214
           H +G+++RDLKPENILL  +     IKL DFGL+     + +   S  GTV    Y+APE
Sbjct: 147 HSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKEAIDHEKKAYSFCGTVE---YMAPE 200
Query: 215 VL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+   G++ +AD WS GV+++ +L+G  PF G  +      +  A L  P      +S  
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTE 256
Query: 274 AKDLVMGMLSTDPSQRL 290
           A+ L+  +   +P+ RL
Sbjct: 257 AQSLLRALFKRNPANRL 273

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 12/254 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 68
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 69  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 128
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 129 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 241
Query: 277 LVMGMLSTDPSQRL 290
           LV  +L  D ++RL
Sbjct: 242 LVEKLLVLDATKRL 255

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 91
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 152 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 264
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 265 LVEKLLVLDATKRLGCEEM 283

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 151 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 263
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 264 LVEKLLVLDATKRLGCEEM 282

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 67
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 68  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 127
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 128 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 240
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 241 LVEKLLVLDATKRLGCEEM 259

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 151 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 263
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 264 LVEKLLVLDATKRLGCEEM 282

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 88
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 149 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 261
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 262 LVEKLLVLDATKRLGCEEM 280

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 88
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 149 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 261
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 262 LVEKLLVLDATKRLGCEEM 280

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 12/254 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 66
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 127 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 239
Query: 277 LVMGMLSTDPSQRL 290
           LV  +L  D ++RL
Sbjct: 240 LVEKLLVLDATKRL 253

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 95
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 96  HPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 156 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 268
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 269 LVEKLLVLDATKRLGCEEM 287

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 151 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 263
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 264 LVEKLLVLDATKRLGCEEM 282

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 65
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 66  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 125
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 126 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 238
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 239 LVEKLLVLDATKRLGCEEM 257

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 84/259 (32%), Positives = 139/259 (53%), Gaps = 20/259 (7%)
Query: 42  RFVLGQQLGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           +F L + LG G FG   +++  S     +++A K + K  L   D  R+ K+E +I+  +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
           + HP +V L   ++ E  ++L+++   GG+LF RL K   F+E + +    +L   + + 
Sbjct: 84  N-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLAT----YIEPGQSLLGTVGSPFYIAPE 214
           H +G+++RDLKPENILL  +     IKL DFGL+     + +   S  GTV    Y+APE
Sbjct: 143 HSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVE---YMAPE 196
Query: 215 VL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+   G+ Q+AD WS GV+++ +L+G  PF G  +      +  A L  P      +S  
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPE 252
Query: 274 AKDLVMGMLSTDPSQRLTA 292
           A+ L+  +   +P+ RL A
Sbjct: 253 AQSLLRMLFKRNPANRLGA 271

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 132/259 (50%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 87
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP--GQSLLGT-VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P   Q+   + VG+  Y++PE+L 
Sbjct: 148 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 260
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 261 LVEKLLVLDATKRLGCEEM 279

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 151 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARD 263
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 264 LVEKLLVLDATKRLGCEEM 282

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 72
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 73  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 133 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 245
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 246 LVEKLLVLDATKRLGCEEM 264

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 93
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 94  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 154 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP+         A+D
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAA----FFPKARD 266
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 267 LVEKLLVLDATKRLGCEEM 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/259 (32%), Positives = 139/259 (53%), Gaps = 20/259 (7%)
Query: 42  RFVLGQQLGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           +F L + LG G FG   +++  S     +++A K + K  L   D  R+ K+E +I+  +
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 84
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
           + HP +V L   ++ E  ++L+++   GG+LF RL K   F+E + +    +L   + + 
Sbjct: 85  N-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLAT----YIEPGQSLLGTVGSPFYIAPE 214
           H +G+++RDLKPENILL  +     IKL DFGL+     + +   S  GTV    Y+APE
Sbjct: 144 HSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVE---YMAPE 197
Query: 215 VL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+   G+ Q+AD WS GV+++ +L+G  PF G  +      +  A L  P      +S  
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPE 253
Query: 274 AKDLVMGMLSTDPSQRLTA 292
           A+ L+  +   +P+ RL A
Sbjct: 254 AQSLLRMLFKRNPANRLGA 272

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 87
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 148 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 260
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 261 LVEKLLVLDATKRLGCEEM 279

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F    +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 88
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 149 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 261
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 262 LVEKLLVLDATKRLGCEEM 280

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 12/259 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     G L   + K G F E   R    +++  + Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP--GQSLLGT-VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P   Q+   + VG+  Y++PE+L 
Sbjct: 151 KGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
               ++++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 263
Query: 277 LVMGMLSTDPSQRLTARQV 295
           LV  +L  D ++RL   ++
Sbjct: 264 LVEKLLVLDATKRLGCEEM 282

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 142/266 (53%), Gaps = 26/266 (9%)
Query: 41  ERFVLGQQLGWGQFG---VIRVCSDKFTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMT 96
           E F L + LG G +G   ++R  S   TG+++A K + K  +V         + E +++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
            +   P +V L   ++ E  +HL+++   GGELF  L +  RF+E E ++   +++  + 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 173
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGL-----ATYIEPGQSLLGTVGSPFYI 211
           + H++G+++RD+K ENILL    S+  + L DFGL     A   E      GT+    Y+
Sbjct: 174 HLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIE---YM 227
Query: 212 APEVLAG---GYNQAADVWSAGVILYILLSGMPPFW----GNTKSRIFDAVRTADLRFPS 264
           AP+++ G   G+++A D WS GV++Y LL+G  PF      N+++ I   +  ++  +P 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287
Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRL 290
                +S  AKDL+  +L  DP +RL
Sbjct: 288 E----MSALAKDLIQRLLMKDPKKRL 309

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 152/313 (48%), Gaps = 54/313 (17%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL---EIEIM 95
           + E++    ++G G +GV+  C ++ TG++ A K      L + DD    K+   EI ++
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRML 56
Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQV 154
            +L  HPN+V+L  V+  +  +HLV E C    + H L+++ R   E   + +  Q +Q 
Sbjct: 57  KQLK-HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAP 213
           V +CH+   +HRD+KPENIL+      S IKL DFG A  +  P       V + +Y +P
Sbjct: 115 VNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 214 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN------------------------T 247
           E+L G   Y    DVW+ G +   LLSG+P + G                         +
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 248 KSRIFDAVRTAD--------LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            ++ F  V+  D        L+FP+     IS  A  L+ G L  DP++RLT  Q+L H 
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPN-----ISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 300 WMGDGIQDPEKLS 312
           +  + I++ E L+
Sbjct: 287 YF-ENIREIEDLA 298

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 104/341 (30%), Positives = 164/341 (48%), Gaps = 28/341 (8%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  + TG+++ACK + K R+     E     E +I+ +++    VV L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLA 250
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLYCHEIGVVHR 166
             YE +D + LV+ L  GG+L   +   G+    EAR +F   ++   +   H   +V+R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAAD 225
           DLKPENILL        I+++D GLA ++  GQ++ G VG+  Y+APEV+    Y  + D
Sbjct: 311 DLKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ G +LY +++G  PF    K    + V       P    +  S  A+ L   +L  D
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427
Query: 286 PSQRL-----TARQVLDH--------SWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFST- 331
           P++RL     +AR+V +H          +G G+ +P      +   CK+  L    FST 
Sbjct: 428 PAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDV-LDIEQFSTV 486
Query: 332 ---QIIPRNQDI--SFGTGS-PVFSDDESPAFTCRTSFSSF 366
              ++ P +QD    F TGS P+   +E     C    + F
Sbjct: 487 KGVELEPTDQDFYQKFATGSVPIPWQNEMVETECFQELNVF 527

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 104/341 (30%), Positives = 164/341 (48%), Gaps = 28/341 (8%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  + TG+++ACK + K R+     E     E +I+ +++    VV L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLA 250
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLYCHEIGVVHR 166
             YE +D + LV+ L  GG+L   +   G+    EAR +F   ++   +   H   +V+R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAAD 225
           DLKPENILL        I+++D GLA ++  GQ++ G VG+  Y+APEV+    Y  + D
Sbjct: 311 DLKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W+ G +LY +++G  PF    K    + V       P    +  S  A+ L   +L  D
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427
Query: 286 PSQRL-----TARQVLDH--------SWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFST- 331
           P++RL     +AR+V +H          +G G+ +P      +   CK+  L    FST 
Sbjct: 428 PAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDV-LDIEQFSTV 486
Query: 332 ---QIIPRNQDI--SFGTGS-PVFSDDESPAFTCRTSFSSF 366
              ++ P +QD    F TGS P+   +E     C    + F
Sbjct: 487 KGVELEPTDQDFYQKFATGSVPIPWQNEMVETECFQELNVF 527

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 146/277 (52%), Gaps = 36/277 (12%)
Query: 34  NQISNLR---ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           N+I +LR   E + + + +G G FG +++   K T +V+A K ++K  ++   D      
Sbjct: 59  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL------EKFGRFSEAEA 144
           E +IM   +  P VV L   ++D+ Y+++VME   GG+L + +      EK+ RF  AE 
Sbjct: 119 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 177
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLG 203
            VL +  +      H +G +HRD+KP+N+LL     S  +KLADFG    + + G     
Sbjct: 178 -VLALDAI------HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 204 T-VGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFD 253
           T VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+ +    T S+I +
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287
Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
              +  L FP +  + IS  AK+L+   L TD   RL
Sbjct: 288 HKNS--LTFPDD--NDISKEAKNLICAFL-TDREVRL 319

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 145/281 (51%), Gaps = 30/281 (10%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI----DDERSVKLEI 92
           + L  ++++G  LG G +G ++   D    E    +++   +   +    + E +VK EI
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDS---ETLCRRAVKILKKKKLRRIPNGEANVKKEI 57
Query: 93  EIMTRLSGHPNVVDLKAVY--EDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLF 148
           +++ RL  H NV+ L  V   E++  +++VME C  G  E+   + +  RF   +A   F
Sbjct: 58  QLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYF 115
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTV 205
            QL+  + Y H  G+VH+D+KP N+LL T  +   +K++  G+A  + P     +   + 
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQ 172
Query: 206 GSPFYIAPEVLAG-----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL 260
           GSP +  PE+  G     G+    D+WSAGV LY + +G+ PF G+   ++F+ +     
Sbjct: 173 GSPAFQPPEIANGLDTFSGFK--VDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
Query: 261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             P +    +S    DL+ GML  +P++R + RQ+  HSW 
Sbjct: 231 AIPGDCGPPLS----DLLKGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 146/277 (52%), Gaps = 36/277 (12%)
Query: 34  NQISNLR---ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           N+I +LR   E + + + +G G FG +++   K T +V+A K ++K  ++   D      
Sbjct: 64  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL------EKFGRFSEAEA 144
           E +IM   +  P VV L   ++D+ Y+++VME   GG+L + +      EK+ RF  AE 
Sbjct: 124 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 182
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLG 203
            VL +  +      H +G +HRD+KP+N+LL     S  +KLADFG    + + G     
Sbjct: 183 -VLALDAI------HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCD 232
Query: 204 T-VGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFD 253
           T VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+ +    T S+I +
Sbjct: 233 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 292
Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
              +  L FP +  + IS  AK+L+   L TD   RL
Sbjct: 293 HKNS--LTFPDD--NDISKEAKNLICAFL-TDREVRL 324

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 146/277 (52%), Gaps = 36/277 (12%)
Query: 34  NQISNLR---ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           N+I +LR   E + + + +G G FG +++   K T +V+A K ++K  ++   D      
Sbjct: 64  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL------EKFGRFSEAEA 144
           E +IM   +  P VV L   ++D+ Y+++VME   GG+L + +      EK+ RF  AE 
Sbjct: 124 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 182
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLG 203
            VL +  +      H +G +HRD+KP+N+LL     S  +KLADFG    + + G     
Sbjct: 183 -VLALDAI------HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCD 232
Query: 204 T-VGSPFYIAPEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFD 253
           T VG+P YI+PEVL      G Y +  D WS GV LY +L G  PF+ +    T S+I +
Sbjct: 233 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 292
Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRL 290
              +  L FP +  + IS  AK+L+   L TD   RL
Sbjct: 293 HKNS--LTFPDD--NDISKEAKNLICAFL-TDREVRL 324

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 132/259 (50%), Gaps = 18/259 (6%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F L + +G G +  + +   K T  ++A K + K+ +   +D   V+ E  +  + S HP
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L + ++ E  +  V+E   GG+L   +++  +  E  AR    ++   + Y HE G
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GY 220
           +++RDLK +N+LL ++     IKL D+G+    + PG +     G+P YIAPE+L G  Y
Sbjct: 142 IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 198
Query: 221 NQAADVWSAGVILYILLSGMPPF---------WGNTKSRIFDAVRTADLRFPSNPWDHIS 271
             + D W+ GV+++ +++G  PF           NT+  +F  +    +R P +    +S
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----MS 254
Query: 272 DSAKDLVMGMLSTDPSQRL 290
             A  ++   L+ DP +RL
Sbjct: 255 VKAASVLKSFLNKDPKERL 273

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 132/259 (50%), Gaps = 18/259 (6%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F L + +G G +  + +   K T  ++A K + K+ +   +D   V+ E  +  + S HP
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L + ++ E  +  V+E   GG+L   +++  +  E  AR    ++   + Y HE G
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GY 220
           +++RDLK +N+LL ++     IKL D+G+    + PG +     G+P YIAPE+L G  Y
Sbjct: 127 IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 221 NQAADVWSAGVILYILLSGMPPF---------WGNTKSRIFDAVRTADLRFPSNPWDHIS 271
             + D W+ GV+++ +++G  PF           NT+  +F  +    +R P +    +S
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 239
Query: 272 DSAKDLVMGMLSTDPSQRL 290
             A  ++   L+ DP +RL
Sbjct: 240 VKAASVLKSFLNKDPKERL 258

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 132/259 (50%), Gaps = 18/259 (6%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F L + +G G +  + +   K T  ++A K + K+ +   +D   V+ E  +  + S HP
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L + ++ E  +  V+E   GG+L   +++  +  E  AR    ++   + Y HE G
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GY 220
           +++RDLK +N+LL ++     IKL D+G+    + PG +     G+P YIAPE+L G  Y
Sbjct: 131 IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 221 NQAADVWSAGVILYILLSGMPPF---------WGNTKSRIFDAVRTADLRFPSNPWDHIS 271
             + D W+ GV+++ +++G  PF           NT+  +F  +    +R P +    +S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 243
Query: 272 DSAKDLVMGMLSTDPSQRL 290
             A  ++   L+ DP +RL
Sbjct: 244 VKAASVLKSFLNKDPKERL 262

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 132/259 (50%), Gaps = 18/259 (6%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F L + +G G +  + +   K T  ++A + + K+ +   +D   V+ E  +  + S HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L + ++ E  +  V+E   GG+L   +++  +  E  AR    ++   + Y HE G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGTVGSPFYIAPEVLAG-GY 220
           +++RDLK +N+LL ++     IKL D+G+    + PG +     G+P YIAPE+L G  Y
Sbjct: 174 IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 221 NQAADVWSAGVILYILLSGMPPF---------WGNTKSRIFDAVRTADLRFPSNPWDHIS 271
             + D W+ GV+++ +++G  PF           NT+  +F  +    +R P +    +S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 286
Query: 272 DSAKDLVMGMLSTDPSQRL 290
             A  ++   L+ DP +RL
Sbjct: 287 VKAASVLKSFLNKDPKERL 305

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 30  ILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK 89
           + D N+  N  + F + + +G G FG + +     T +++A K + K + V  ++ R+V 
Sbjct: 5   VFDENEDVNF-DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF 63
Query: 90  LEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
            E++IM  L  HP +V+L   ++DE+ + +V++L  GG+L + L++   F E   ++   
Sbjct: 64  KELQIMQGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L+  + Y     ++HRD+KP+NILL        + + DF +A  +     +    G+  
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGH---VHITDFNIAAMLPRETQITTMAGTKP 179
Query: 210 YIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFW---GNTKSRIFDAVRTADLRF 262
           Y+APE+ +     GY+ A D WS GV  Y LL G  P+      +   I     T  + +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY 239
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTA-RQVLDHSWMGD 303
           PS  W   S     L+  +L  +P QR +    V +  +M D
Sbjct: 240 PS-AW---SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 137/271 (50%), Gaps = 14/271 (5%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E++V  Q++G G FG   +      G  +  K I   R+ + + E S + E+ ++  +  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMK- 81
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQVVLYC 158
           HPN+V  +  +E+   +++VM+ C GG+LF R+  +K   F E +    F+Q+   + + 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-GTVGSPFYIAPEVLA 217
           H+  ++HRD+K +NI L    +   ++L DFG+A  +     L    +G+P+Y++PE+  
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198
Query: 218 GG-YNQAADVWSAGVILYILLSGMPPF-WGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
              YN  +D+W+ G +LY L +    F  G+ K+ +   +  +   FP     H S   +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS---FPPVSL-HYSYDLR 254
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            LV  +   +P  R +   +L+  ++   I+
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 94/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 61
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKPEN+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 117 LAFCHSHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 94/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKPEN+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 118 LAFCHSHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 234
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 146/300 (48%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA---------RVLFMQL 151
           HPN+V L  V   E+ ++LV E        H  +   +F +A A         +    QL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFE--------HVDQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +Q + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 211 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF-- 262
            APE+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D     
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 232
Query: 263 ---------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                    PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 145/300 (48%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 61
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA---------RVLFMQL 151
           HPN+V L  V   E+ ++LV E  +            +F +A A         +    QL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLS--------MDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +Q + +CH   V+HRDLKPEN+L+ T+ +   IKLADFGLA  +  P ++    V + +Y
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 211 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF-- 262
            APE+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D     
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 230
Query: 263 ---------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                    PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 145/300 (48%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA---------RVLFMQL 151
           HPN+V L  V   E+ ++LV E  +            +F +A A         +    QL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLS--------MDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +Q + +CH   V+HRDLKPEN+L+ T+ +   IKLADFGLA  +  P ++    V + +Y
Sbjct: 116 LQGLAFCHSHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 211 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF-- 262
            APE+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D     
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 232
Query: 263 ---------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                    PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 147/300 (49%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTR 97
           E++   +++G G +GV+    + + GE FA K I  ++    +DE    +   EI I+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEK----EDEGIPSTTIREISILKE 56
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLM 152
           L  H N+V L  V   +  + LV E      L   L+K      G      A+   +QL+
Sbjct: 57  LK-HSNIVKLYDVIHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYI 211
             + YCH+  V+HRDLKP+N+L+  +     +K+ADFGLA  +  P +     V + +Y 
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYR 167
Query: 212 APEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTADLRFPSN 265
           AP+VL G   Y+   D+WS G I   +++G P F G +++    RIF  + T + +   N
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 266 -----------------PWDH----ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
                            PW+     + +S  DL+  ML  DP+QR+TA+Q L+H++  + 
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 147/300 (49%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTR 97
           E++   +++G G +GV+    + + GE FA K I  ++    +DE    +   EI I+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEK----EDEGIPSTTIREISILKE 56
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLM 152
           L  H N+V L  V   +  + LV E      L   L+K      G      A+   +QL+
Sbjct: 57  LK-HSNIVKLYDVIHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYI 211
             + YCH+  V+HRDLKP+N+L+  +     +K+ADFGLA  +  P +     V + +Y 
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYR 167
Query: 212 APEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTADLRFPSN 265
           AP+VL G   Y+   D+WS G I   +++G P F G +++    RIF  + T + +   N
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 266 -----------------PWDH----ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
                            PW+     + +S  DL+  ML  DP+QR+TA+Q L+H++  + 
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 67
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 122
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 123 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 179
Query: 214 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 239
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 240 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 234
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 235
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 235
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 234
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 61
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 117 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 59
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 171
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 214 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 61
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 117 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 139/291 (47%), Gaps = 20/291 (6%)
Query: 13  PSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACK 72
           P  QP K  R        +  N ++N R    + +++G GQF  +   +    G   A K
Sbjct: 14  PQFQPQKALR------PDMGYNTLANFR----IEKKIGRGQFSEVYRAACLLDGVPVALK 63
Query: 73  SIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR 132
            +    L+          EI+++ +L+ HPNV+   A + +++ +++V+EL   G+L   
Sbjct: 64  KVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRM 122
Query: 133 LEKFGR----FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD 188
           ++ F +      E      F+QL   + + H   V+HRD+KP N+ +    ++  +KL D
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGD 179
Query: 189 FGLATYIEPGQSLLGT-VGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLSGMPPFWGN 246
            GL  +     +   + VG+P+Y++PE +   GYN  +D+WS G +LY + +   PF+G+
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
             +      +     +P  P DH S+  + LV   ++ DP +R     V D
Sbjct: 240 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 59
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 59
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 61
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 117 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 173
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 64
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 176
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 236
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 237 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 59
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 171
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 67
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 122
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 123 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 179
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 239
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 240 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 147/300 (49%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTR 97
           E++   +++G G +GV+    + + GE FA K I  ++    +DE    +   EI I+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEK----EDEGIPSTTIREISILKE 56
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLM 152
           L  H N+V L  V   +  + LV E      L   L+K      G      A+   +QL+
Sbjct: 57  LK-HSNIVKLYDVIHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYI 211
             + YCH+  V+HRDLKP+N+L+  +     +K+ADFGLA  +  P +     + + +Y 
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 212 APEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTADLRFPSN 265
           AP+VL G   Y+   D+WS G I   +++G P F G +++    RIF  + T + +   N
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 266 -----------------PWDH----ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
                            PW+     + +S  DL+  ML  DP+QR+TA+Q L+H++  + 
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 64
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 176
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 236
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 237 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---IDDER--SVKLEIEIMTRLSGHPN 103
           LG G FG +    DK   +    K I K++++    I+D +   V LEI I++R+  H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HAN 90
Query: 104 VVDLKAVYEDEDYVHLVMELCAGG-ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           ++ +  ++E++ +  LVME    G +LF  +++  R  E  A  +F QL+  V Y     
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQ 222
           ++HRD+K ENI++A   +   IKL DFG A Y+E G+      G+  Y APEVL G   +
Sbjct: 151 IIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR 207
Query: 223 AADV--WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
             ++  WS GV LY L+    PF       + + V  A      +P   +S     LV G
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPF-----CELEETVEAA-----IHPPYLVSKELMSLVSG 257
Query: 281 MLSTDPSQRLTARQVLDHSWM 301
           +L   P +R T  +++   W+
Sbjct: 258 LLQPVPERRTTLEKLVTDPWV 278

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 139/267 (52%), Gaps = 33/267 (12%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + + + +G G FG +++   K + +V+A K ++K  ++   D      E +IM   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FAN 133
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL------EKFGRFSEAEARVLFMQLMQV 154
            P VV L   ++D+ Y+++VME   GG+L + +      EK+ +F  AE  VL +  +  
Sbjct: 134 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV-VLALDAI-- 190
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT-VGSPFYIA 212
               H +G++HRD+KP+N+LL        +KLADFG    + E G     T VG+P YI+
Sbjct: 191 ----HSMGLIHRDVKPDNMLLDKHGH---LKLADFGTCMKMDETGMVHCDTAVGTPDYIS 243
Query: 213 PEVLA-----GGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFDAVRTADLRFP 263
           PEVL      G Y +  D WS GV L+ +L G  PF+ +    T S+I D   +  L FP
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS--LCFP 301
Query: 264 SNPWDHISDSAKDLVMGMLSTDPSQRL 290
            +    IS  AK+L+   L TD   RL
Sbjct: 302 EDA--EISKHAKNLICAFL-TDREVRL 325

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 145/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LSFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 145/300 (48%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 59
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA---------RVLFMQL 151
           HPN+V L  V   E+ ++LV E        H  +    F +A A         +    QL
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFE--------HVHQDLKTFMDASALTGIPLPLIKSYLFQL 111
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +Q + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 211 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF-- 262
            APE+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D     
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 263 ---------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                    PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 144/300 (48%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA---------RVLFMQL 151
           HPN+V L  V   E+ ++LV E           +    F +A A         +    QL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH--------QDLKDFMDASALTGIPLPLIKSYLFQL 112
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +Q + +CH   V+HRDLKPEN+L+ T+ +   IKLADFGLA  +  P ++    V + +Y
Sbjct: 113 LQGLAFCHSHRVLHRDLKPENLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 211 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF-- 262
            APE+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D     
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 263 ---------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                    PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 140/297 (47%), Gaps = 41/297 (13%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIM 95
           L E++   +++G G +GV+    D   G + A K I  D     +DE    +   EI ++
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLD----AEDEGIPSTAIREISLL 73
Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
             L  HPN+V L  V   E  + LV E           E      +++ ++   QL++ V
Sbjct: 74  KELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPE 214
            +CH+  ++HRDLKP+N+L+    S   +KLADFGLA  +  P +S    V + +Y AP+
Sbjct: 133 AHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189
Query: 215 VLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTADLR------- 261
           VL G   Y+ + D+WS G I   +++G P F G T      +IF  + T + R       
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 262 -----------FPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                      F   PW  I         DL+  ML  DP++R++AR  ++H +  D
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 140/297 (47%), Gaps = 41/297 (13%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIM 95
           L E++   +++G G +GV+    D   G + A K I  D     +DE    +   EI ++
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLD----AEDEGIPSTAIREISLL 73
Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
             L  HPN+V L  V   E  + LV E           E      +++ ++   QL++ V
Sbjct: 74  KELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPE 214
            +CH+  ++HRDLKP+N+L+    S   +KLADFGLA  +  P +S    V + +Y AP+
Sbjct: 133 AHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189
Query: 215 VLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTADLR------- 261
           VL G   Y+ + D+WS G I   +++G P F G T      +IF  + T + R       
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 262 -----------FPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                      F   PW  I         DL+  ML  DP++R++AR  ++H +  D
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 144/300 (48%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA---------RVLFMQL 151
           HPN+V L  V   E+ ++LV E           +    F +A A         +    QL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLH--------QDLKTFMDASALTGIPLPLIKSYLFQL 115
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +Q + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 211 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF-- 262
            APE+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D     
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 232
Query: 263 ---------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                    PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 92/297 (30%), Positives = 144/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A   I  D         +++ EI ++  L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN- 60
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 92/297 (30%), Positives = 144/297 (48%), Gaps = 44/297 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A   I  D         +++ EI ++  L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN- 59
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA------RVLFMQLMQV 154
           HPN+V L  V   E+ ++LV E      L   L+KF   S          +    QL+Q 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y AP
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 214 EVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           E+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D        
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 263 ------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                 PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 144/300 (48%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 62
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA---------RVLFMQL 151
           HPN+V L  V   E+ ++LV E  +             F +A A         +    QL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLS--------MDLKDFMDASALTGIPLPLIKSYLFQL 114
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +Q + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 211 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF-- 262
            APE+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D     
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 231
Query: 263 ---------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                    PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 144/300 (48%), Gaps = 50/300 (16%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D         +++ EI ++  L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN- 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEA---------RVLFMQL 151
           HPN+V L  V   E+ ++LV E  +             F +A A         +    QL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLS--------MDLKDFMDASALTGIPLPLIKSYLFQL 115
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +Q + +CH   V+HRDLKP+N+L+ T+ +   IKLADFGLA  +  P ++    V + +Y
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 211 IAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF-- 262
            APE+L G   Y+ A D+WS G I   +++    F G+++     RIF  + T D     
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 232
Query: 263 ---------PSNP-WDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                    PS P W           + +  + L+  ML  DP++R++A+  L H +  D
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 133/257 (51%), Gaps = 18/257 (7%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE F + + +G G FG + V   K T  ++A K + K  ++   +    + E +++  ++
Sbjct: 89  REDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL--VN 146
Query: 100 GHPN-VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLY 157
           G    +  L   ++DE++++LVM+   GG+L   L KF  +  E  AR    +++  +  
Sbjct: 147 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 206
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEV 215
            H++  VHRD+KP+N+LL        I+LADFG    +    ++  +  VG+P YI+PE+
Sbjct: 207 IHQLHYVHRDIKPDNVLLDVNGH---IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 216 L------AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR--FPSNPW 267
           L       G Y    D WS GV +Y +L G  PF+  +    +  +   + R  FPS+  
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVT 323
Query: 268 DHISDSAKDLVMGMLST 284
           D +S+ AKDL+  ++ +
Sbjct: 324 D-VSEEAKDLIQRLICS 339

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 133/257 (51%), Gaps = 18/257 (7%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE F + + +G G FG + V   K T  ++A K + K  ++   +    + E +++  ++
Sbjct: 73  REDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL--VN 130
Query: 100 GHPN-VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLY 157
           G    +  L   ++DE++++LVM+   GG+L   L KF  +  E  AR    +++  +  
Sbjct: 131 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 190
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEV 215
            H++  VHRD+KP+N+LL        I+LADFG    +    ++  +  VG+P YI+PE+
Sbjct: 191 IHQLHYVHRDIKPDNVLLDVNGH---IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 216 L------AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR--FPSNPW 267
           L       G Y    D WS GV +Y +L G  PF+  +    +  +   + R  FPS+  
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVT 307
Query: 268 DHISDSAKDLVMGMLST 284
           D +S+ AKDL+  ++ +
Sbjct: 308 D-VSEEAKDLIQRLICS 323

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 145/289 (50%), Gaps = 31/289 (10%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+   RE F + + +G G FG + V   K   +VFA K + K  ++   +    + E ++
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV 127
Query: 95  MTRLSGHPN-VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLM 152
           +  ++G    +  L   ++D++ ++LVM+   GG+L   L KF  R  E  AR    +++
Sbjct: 128 L--VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV 185
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG-LATYIEPG--QSLLGTVGSPF 209
             +   H++  VHRD+KP+NIL+        I+LADFG     +E G  QS +  VG+P 
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVA-VGTPD 241
Query: 210 YIAPEVL------AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR-- 261
           YI+PE+L       G Y    D WS GV +Y +L G  PF+  +    +  +     R  
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301
Query: 262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           FP+   D +S++AKDL+         +RL   +  +H    +GI+D +K
Sbjct: 302 FPTQVTD-VSENAKDLI---------RRLICSR--EHRLGQNGIEDFKK 338

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 135/264 (51%), Gaps = 27/264 (10%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           ++G G  G++ + ++K TG+  A K +   +       R +     ++ R   H NVVD+
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHDNVVDM 107
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
            + Y   D + +VME   GG L   +    R +E +   + + +++ + Y H  GV+HRD
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 168 LKPENILLATKASSSPIKLADFGLATYIE---PGQSLLGTVGSPFYIAPEVLAG-GYNQA 223
           +K ++ILL    S   IKL+DFG    +    P +  L  VG+P+++APEV++   Y   
Sbjct: 167 IKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKXL--VGTPYWMAPEVISRLPYGTE 221
Query: 224 ADVWSAGVILYILLSGMPPFWG----NTKSRIFDAV--RTADLRFPSNPWDHISDSAKDL 277
            D+WS G+++  ++ G PP++         RI D++  R  DL         +S   +  
Sbjct: 222 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLH-------KVSSVLRGF 274
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +  ML  +PSQR TA+++L H ++
Sbjct: 275 LDLMLVREPSQRATAQELLGHPFL 298

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 143/295 (48%), Gaps = 55/295 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+      F  ++     +A  ++  + D+R    E++IM R+  HPNVVDLK
Sbjct: 48  IGNGSFGVV------FQAKLVESDEVAIKKV--LQDKRFKNRELQIM-RIVKHPNVVDLK 98
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEK-FGRFSEAEARVL----FMQLMQVVLY 157
           A +      +DE +++LV+E     E  +R  + + +  +    +L      QL++ + Y
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H IG+ HRD+KP+N+LL     S  +KL DFG A  +  G+  +  + S +Y APE++ 
Sbjct: 157 IHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIF 214
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGN--------------TKSRIFDAVRTAD-- 259
           G   Y    D+WS G ++  L+ G P F G               T SR  + ++T +  
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR--EQIKTMNPN 272
Query: 260 ---LRFPS---NPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
               +FP    +P+  +        A DL+  +L   PS RLTA + L H +  +
Sbjct: 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 98/356 (27%), Positives = 165/356 (46%), Gaps = 61/356 (17%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 113
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 227
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 346
Query: 309 E-KLSGNK----IEDCKEWDLGSG-SFSTQIIPRNQDISFGTGSPVFSDDESPAFT 358
             KL   +    + +    +L S    +T +IP +  I     +P  +   S A T
Sbjct: 347 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANT 402

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 98/356 (27%), Positives = 165/356 (46%), Gaps = 61/356 (17%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 158
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 215 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 272
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 273 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 332
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 333 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 391
Query: 309 E-KLSGNK----IEDCKEWDLGSG-SFSTQIIPRNQDISFGTGSPVFSDDESPAFT 358
             KL   +    + +    +L S    +T +IP +  I     +P  +   S A T
Sbjct: 392 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANT 447

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 98/356 (27%), Positives = 165/356 (46%), Gaps = 61/356 (17%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 113
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 346
Query: 309 E-KLSGNK----IEDCKEWDLGSG-SFSTQIIPRNQDISFGTGSPVFSDDESPAFT 358
             KL   +    + +    +L S    +T +IP +  I     +P  +   S A T
Sbjct: 347 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANT 402

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 98/356 (27%), Positives = 165/356 (46%), Gaps = 61/356 (17%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 107
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 164 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 221
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 222 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 281
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 282 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 340
Query: 309 E-KLSGNK----IEDCKEWDLGSG-SFSTQIIPRNQDISFGTGSPVFSDDESPAFT 358
             KL   +    + +    +L S    +T +IP +  I     +P  +   S A T
Sbjct: 341 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANT 396

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 144/301 (47%), Gaps = 55/301 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 117
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 174 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 231
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 232 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 291
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 292 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 350
Query: 309 E 309
Sbjct: 351 N 351

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 98/356 (27%), Positives = 165/356 (46%), Gaps = 61/356 (17%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 115
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 172 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 229
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 230 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 289
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 290 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 348
Query: 309 E-KLSGNK----IEDCKEWDLGSG-SFSTQIIPRNQDISFGTGSPVFSDDESPAFT 358
             KL   +    + +    +L S    +T +IP +  I     +P  +   S A T
Sbjct: 349 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANT 404

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 98/356 (27%), Positives = 165/356 (46%), Gaps = 61/356 (17%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 84
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 141 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 198
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 258
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 259 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 317
Query: 309 E-KLSGNK----IEDCKEWDLGSG-SFSTQIIPRNQDISFGTGSPVFSDDESPAFT 358
             KL   +    + +    +L S    +T +IP +  I     +P  +   S A T
Sbjct: 318 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANT 373

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 127/273 (46%), Gaps = 31/273 (11%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F + ++LG G +G +     K TG++ A K +  +      D + +  EI IM +   
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDS 83
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCH 159
            P+VV     Y     + +VME C  G +   +    +  +E E   +    ++ + Y H
Sbjct: 84  -PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV-GSPFYIAPEVLAG 218
            +  +HRD+K  NILL T+  +   KLADFG+A  +    +    V G+PF++APEV+  
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHA---KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQE 199
Query: 219 -GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP---------WD 268
            GYN  AD+WS G+    +  G PP+      R       A    P+NP         W 
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------AIFMIPTNPPPTFRKPELW- 251
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             SD+  D V   L   P QR TA Q+L H ++
Sbjct: 252 --SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 91
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 148 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 265
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 266 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 324

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 91
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 148 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 265
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 266 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 324

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 98
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 155 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 212
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 272
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 273 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 331

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 87
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 144 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 201
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 261
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 262 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 320

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 79
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 312

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 83
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 140 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 197
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 257
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 258 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 316

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 92
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 149 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 206
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 266
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 267 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 325

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 80
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 137 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 194
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 254
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 255 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 313

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 79
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 312

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 142/298 (47%), Gaps = 51/298 (17%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 79
Query: 109 AVY----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVVLY 157
             +    E +D V+L + L    E  +R+ +   +S A+        ++   QL + + Y
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE++ 
Sbjct: 138 IHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIF 195
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VRTA 258
           G   Y  + DVWSAG +L  LL G P F G+                T+ +I +      
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 259 DLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
           + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 312

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K +       + D+R    E++IM +L  H N+V L+
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLR 79
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 312

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 11/264 (4%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           ++++   +++G G  G +    D  TG+  A + +    L     +  +  EI +M R +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM-REN 74
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            +PN+V+    Y   D + +VME  AGG L   + +     E +   +  + +Q + + H
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLH 133
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA- 217
              V+HRD+K +NILL    S   +KL DFG    I P QS   T VG+P+++APEV+  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y    D+WS G++   ++ G PP+      R    + T       NP + +S   +D 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 249
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +   L  D  +R +A+++L H ++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 93/324 (28%), Positives = 146/324 (45%), Gaps = 63/324 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS- 99
           +RF + +  G G FG +++  +K TG   A K +       I D R    E++IM  L+ 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQIMQDLAV 75
Query: 100 -GHPNVVDLKAVY-------EDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEA----RV 146
             HPN+V L++ +         + Y+++VME     +  HR    + R   A      +V
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPPILIKV 133
Query: 147 LFMQLMQVV--LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
              QL++ +  L+   + V HRD+KP N+L+    +   +KL DFG A  + P +  +  
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 205 VGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLR 261
           + S +Y APE++ G   Y  A D+WS G I   ++ G P F G N+  ++ + VR   L 
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV--LG 249
Query: 262 FPSN---------------------PW-----DHISDSAK---DLVMGMLSTDPSQRLTA 292
            PS                      PW     DH    AK   DL+  +L   P +R+  
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 293 RQVLDHSWMGDGIQDPE-KLSGNK 315
            + L H +  D + DP  KL  NK
Sbjct: 310 YEALCHPYF-DELHDPATKLPNNK 332

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 132/259 (50%), Gaps = 17/259 (6%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           ++G G  G++ +  +K +G   A K +   +       R +     ++ R   H NVV++
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
              Y   + + ++ME   GG L   + +  R +E +   +   ++Q + Y H  GV+HRD
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 168 LKPENILLATKASSSPIKLADFGLATYIE---PGQSLLGTVGSPFYIAPEVLAGG-YNQA 223
           +K ++ILL        +KL+DFG    I    P +  L  VG+P+++APEV++   Y   
Sbjct: 167 IKSDSILLTLDGR---VKLSDFGFCAQISKDVPKRKXL--VGTPYWMAPEVISRSLYATE 221
Query: 224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH-ISDSAKDLVMGML 282
            D+WS G+++  ++ G PP++ ++  +    +R  D   P     H +S   +D +  ML
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--DSPPPKLKNSHKVSPVLRDFLERML 279
Query: 283 STDPSQRLTARQVLDHSWM 301
             DP +R TA+++LDH ++
Sbjct: 280 VRDPQERATAQELLDHPFL 298

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 127/256 (49%), Gaps = 17/256 (6%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH- 101
           F + + +G G FG +  C    TG+++A K + K R + +    ++ L   IM  L    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 248
Query: 102 --PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
             P +V +   +   D +  +++L  GG+L + L + G FSEA+ R    +++  + + H
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 308
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
              VV+RDLKP NILL        ++++D GLA      +    +VG+  Y+APEVL  G
Sbjct: 309 NRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKG 364
Query: 220 --YNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLRFPSNPWDHISDSA 274
             Y+ +AD +S G +L+ LL G  PF  +    K  I     T  +  P    D  S   
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPEL 420
Query: 275 KDLVMGMLSTDPSQRL 290
           + L+ G+L  D ++RL
Sbjct: 421 RSLLEGLLQRDVNRRL 436

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 127/256 (49%), Gaps = 17/256 (6%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH- 101
           F + + +G G FG +  C    TG+++A K + K R + +    ++ L   IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 102 --PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
             P +V +   +   D +  +++L  GG+L + L + G FSEA+ R    +++  + + H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
              VV+RDLKP NILL        ++++D GLA      +    +VG+  Y+APEVL  G
Sbjct: 310 NRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKG 365
Query: 220 --YNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLRFPSNPWDHISDSA 274
             Y+ +AD +S G +L+ LL G  PF  +    K  I     T  +  P    D  S   
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPEL 421
Query: 275 KDLVMGMLSTDPSQRL 290
           + L+ G+L  D ++RL
Sbjct: 422 RSLLEGLLQRDVNRRL 437

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 122/250 (48%), Gaps = 33/250 (13%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           ++ L ++LG G +G++    D+ TGEV A K I      + D +R+ + EI I+T LSGH
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGH 68
Query: 102 PNVVDLKAVYE-DEDY-VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            N+V+L  V   D D  V+LV +        H + +         + +  QL++V+ Y H
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLA----------------------TYIEP 197
             G++HRD+KP NILL  +     +K+ADFGL+                       + + 
Sbjct: 127 SGGLLHRDMKPSNILLNAECH---VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 198 GQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV 255
              L   V + +Y APE+L G   Y +  D+WS G IL  +L G P F G++     + +
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 256 RTADLRFPSN 265
               + FPSN
Sbjct: 244 -IGVIDFPSN 252

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 127/256 (49%), Gaps = 17/256 (6%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH- 101
           F + + +G G FG +  C    TG+++A K + K R + +    ++ L   IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 102 --PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
             P +V +   +   D +  +++L  GG+L + L + G FSEA+ R    +++  + + H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
              VV+RDLKP NILL        ++++D GLA      +    +VG+  Y+APEVL  G
Sbjct: 310 NRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKG 365
Query: 220 --YNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLRFPSNPWDHISDSA 274
             Y+ +AD +S G +L+ LL G  PF  +    K  I     T  +  P    D  S   
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPEL 421
Query: 275 KDLVMGMLSTDPSQRL 290
           + L+ G+L  D ++RL
Sbjct: 422 RSLLEGLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 127/256 (49%), Gaps = 17/256 (6%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH- 101
           F + + +G G FG +  C    TG+++A K + K R + +    ++ L   IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 102 --PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
             P +V +   +   D +  +++L  GG+L + L + G FSEA+ R    +++  + + H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
              VV+RDLKP NILL        ++++D GLA      +    +VG+  Y+APEVL  G
Sbjct: 310 NRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKG 365
Query: 220 --YNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLRFPSNPWDHISDSA 274
             Y+ +AD +S G +L+ LL G  PF  +    K  I     T  +  P    D  S   
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPEL 421
Query: 275 KDLVMGMLSTDPSQRL 290
           + L+ G+L  D ++RL
Sbjct: 422 RSLLEGLLQRDVNRRL 437

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 146/300 (48%), Gaps = 20/300 (6%)
Query: 11  SEPSRQPCKC--YRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEV 68
           S P R+P +    + R+  + ++D     +  + F+   ++G G  G++ + + + +G++
Sbjct: 2   SSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKL 58
Query: 69  FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE 128
            A K +   +       R +     ++ R   H NVV++   Y   D + +VME   GG 
Sbjct: 59  VAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 114
Query: 129 LFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD 188
           L   +    R +E +   + + ++Q +   H  GV+HRD+K ++ILL        +KL+D
Sbjct: 115 LTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSD 170
Query: 189 FGLATYIE---PGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFW 244
           FG    +    P +  L  VG+P+++APE+++   Y    D+WS G+++  ++ G PP++
Sbjct: 171 FGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 228
Query: 245 GNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
                +    +R  +L         +S S K  +  +L  DP+QR TA ++L H ++   
Sbjct: 229 NEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 287

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 145/298 (48%), Gaps = 20/298 (6%)
Query: 13  PSRQPCKCY--RVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFA 70
           P R+P +    + R+  + ++D     +  + F+   ++G G  G++ + + + +G++ A
Sbjct: 124 PQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVA 180
Query: 71  CKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELF 130
            K +     +     R +     ++ R   H NVV++   Y   D + +VME   GG L 
Sbjct: 181 VKKMD----LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 236
Query: 131 HRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
             +    R +E +   + + ++Q +   H  GV+HRD+K ++ILL        +KL+DFG
Sbjct: 237 D-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFG 292
Query: 191 LATYIE---PGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGN 246
               +    P +  L  VG+P+++APE+++   Y    D+WS G+++  ++ G PP++  
Sbjct: 293 FCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350
Query: 247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
              +    +R  +L         +S S K  +  +L  DP+QR TA ++L H ++   
Sbjct: 351 PPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 11/264 (4%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           ++++   +++G G  G +    D  TG+  A + +    L     +  +  EI +M R +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM-REN 74
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            +PN+V+    Y   D + +VME  AGG L   + +     E +   +  + +Q + + H
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLH 133
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG-TVGSPFYIAPEVLA- 217
              V+HRD+K +NILL    S   +KL DFG    I P QS     VG+P+++APEV+  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR 190
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y    D+WS G++   ++ G PP+      R    + T       NP + +S   +D 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 249
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +   L  D  +R +A+++L H ++
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 11/264 (4%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           ++++   +++G G  G +    D  TG+  A + +    L     +  +  EI +M R +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM-REN 74
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            +PN+V+    Y   D + +VME  AGG L   + +     E +   +  + +Q + + H
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLH 133
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG-TVGSPFYIAPEVLA- 217
              V+HRD+K +NILL    S   +KL DFG    I P QS     VG+P+++APEV+  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR 190
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y    D+WS G++   ++ G PP+      R    + T       NP + +S   +D 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 249
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +   L  D  +R +A+++L H ++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 145/298 (48%), Gaps = 20/298 (6%)
Query: 13  PSRQPCKC--YRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFA 70
           P R+P +    + R+  + ++D     +  + F+   ++G G  G++ + + + +G++ A
Sbjct: 47  PQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVA 103
Query: 71  CKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELF 130
            K +   +       R +     ++ R   H NVV++   Y   D + +VME   GG L 
Sbjct: 104 VKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159
Query: 131 HRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
             +    R +E +   + + ++Q +   H  GV+HRD+K ++ILL        +KL+DFG
Sbjct: 160 D-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFG 215
Query: 191 LATYIE---PGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGN 246
               +    P +  L  VG+P+++APE+++   Y    D+WS G+++  ++ G PP++  
Sbjct: 216 FCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273
Query: 247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
              +    +R  +L         +S S K  +  +L  DP+QR TA ++L H ++   
Sbjct: 274 PPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 145/298 (48%), Gaps = 20/298 (6%)
Query: 13  PSRQPCKC--YRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFA 70
           P R+P +    + R+  + ++D     +  + F+   ++G G  G++ + + + +G++ A
Sbjct: 2   PQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVA 58
Query: 71  CKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELF 130
            K +   +       R +     ++ R   H NVV++   Y   D + +VME   GG L 
Sbjct: 59  VKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 114
Query: 131 HRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
             +    R +E +   + + ++Q +   H  GV+HRD+K ++ILL        +KL+DFG
Sbjct: 115 D-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFG 170
Query: 191 LATYIE---PGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGN 246
               +    P +  L  VG+P+++APE+++   Y    D+WS G+++  ++ G PP++  
Sbjct: 171 FCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 228
Query: 247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
              +    +R  +L         +S S K  +  +L  DP+QR TA ++L H ++   
Sbjct: 229 PPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 285

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 102/212 (48%), Gaps = 13/212 (6%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           + ++LG G FG +     + TGE  A K   +  L   + ER   LEI+IM +L+ HPNV
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQ-CRQELSPKNRERWC-LEIQIMKKLN-HPNV 74
Query: 105 VDLKAVYED------EDYVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLMQVV 155
           V  + V +        D   L ME C GG+L   L +F       E   R L   +   +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y HE  ++HRDLKPENI+L         K+ D G A  ++ G+     VG+  Y+APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
Query: 216 L-AGGYNQAADVWSAGVILYILLSGMPPFWGN 246
           L    Y    D WS G + +  ++G  PF  N
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 102/212 (48%), Gaps = 13/212 (6%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           + ++LG G FG +     + TGE  A K   +  L   + ER   LEI+IM +L+ HPNV
Sbjct: 19  MKERLGTGGFGYVLRWIHQDTGEQVAIKQ-CRQELSPKNRERWC-LEIQIMKKLN-HPNV 75
Query: 105 VDLKAVYED------EDYVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLMQVV 155
           V  + V +        D   L ME C GG+L   L +F       E   R L   +   +
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 135
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y HE  ++HRDLKPENI+L         K+ D G A  ++ G+     VG+  Y+APE+
Sbjct: 136 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 195
Query: 216 L-AGGYNQAADVWSAGVILYILLSGMPPFWGN 246
           L    Y    D WS G + +  ++G  PF  N
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 127/263 (48%), Gaps = 21/263 (7%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL- 107
           +G G +G  +    K  G++   K +    +   + +  V  E+ ++  L  HPN+V   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK-HPNIVRYY 71
Query: 108 -KAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIG 162
            + +      +++VME C GG+L   + K  +      E     +  QL   +  CH   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 163 -----VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
                V+HRDLKP N+ L  K +   +KL DFGLA  +    S   T VG+P+Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               YN+ +D+WS G +LY L + MPPF   ++  +   +R    +F   P+ + SD   
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPYRY-SDELN 245
Query: 276 DLVMGMLSTDPSQRLTARQVLDH 298
           +++  ML+     R +  ++L++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILEN 268

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 129/264 (48%), Gaps = 11/264 (4%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           ++++   +++G G  G +    D  TG+  A + +    L     +  +  EI +M R +
Sbjct: 20  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM-REN 75
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            +PN+V+    Y   D + +VME  AGG L   + +     E +   +  + +Q + + H
Sbjct: 76  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLH 134
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA- 217
              V+HR++K +NILL    S   +KL DFG    I P QS   T VG+P+++APEV+  
Sbjct: 135 SNQVIHRNIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 191
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y    D+WS G++   ++ G PP+      R    + T       NP + +S   +D 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 250
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +   L  D  +R +A++++ H ++
Sbjct: 251 LNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 128/264 (48%), Gaps = 11/264 (4%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           ++++   +++G G  G +    D  TG+  A + +    L     +  +  EI +M R +
Sbjct: 20  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM-REN 75
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            +PN+V+    Y   D + +VME  AGG L   + +     E +   +  + +Q + + H
Sbjct: 76  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLH 134
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG-TVGSPFYIAPEVLA- 217
              V+HRD+K +NILL    S   +KL DFG    I P QS     VG+P+++APEV+  
Sbjct: 135 SNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR 191
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y    D+WS G++   ++ G PP+      R    + T       NP + +S   +D 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 250
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           +   L  D  +R +A++++ H ++
Sbjct: 251 LNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 133/277 (48%), Gaps = 28/277 (10%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLV---TIDDERSVKLEIEIMTRL 98
           + LG  LG G FG +     + T  +  A K I ++R++    + D  +  LE+ ++ ++
Sbjct: 33  YRLGPLLGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 99  S---GHPNVVDLKAVYEDEDYVHLVMEL-CAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
               GHP V+ L   +E ++   LV+E      +LF  + + G   E  +R  F Q++  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI--EPGQSLLGTVGSPFYIA 212
           + +CH  GVVHRD+K ENIL+  +   +  KL DFG    +  EP     GT     Y  
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSGALLHDEPYTDFDGTR---VYSP 206
Query: 213 PEVLAGGYNQA--ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           PE ++     A  A VWS G++LY ++ G  PF  + +      +  A+L FP+    H+
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPA----HV 256
Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD 307
           S     L+   L+  PS R +  ++L   WM    +D
Sbjct: 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 117/237 (49%), Gaps = 15/237 (6%)
Query: 30  ILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK 89
           ++   ++   R+ F + + +G G F  + V   K TG+V+A K + K  ++   +    +
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 90  LEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-ARVLF 148
            E +++        +  L   ++DE+Y++LVME   GG+L   L KFG    AE AR   
Sbjct: 110 EERDVLVN-GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL--LGTVG 206
            +++  +   H +G VHRD+KP+NILL        I+LADFG    +    ++  L  VG
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 207 SPFYIAPEVLAG--------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV 255
           +P Y++PE+L           Y    D W+ GV  Y +  G  PF+ ++ +  +  +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 138/289 (47%), Gaps = 47/289 (16%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK----LEIEIMTRLSGHPNV 104
           +G G +G++  C +K TG + A K     + +  DD++ VK     EI+++ +L  H N+
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLR-HENL 86
Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIG 162
           V+L  V + +   +LV E      +   LE F  G   +   + LF Q++  + +CH   
Sbjct: 87  VNLLEVCKKKKRWYLVFEF-VDHTILDDLELFPNGLDYQVVQKYLF-QIINGIGFCHSHN 144
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAG--G 219
           ++HRD+KPENIL+   + S  +KL DFG A T   PG+     V + +Y APE+L G   
Sbjct: 145 IIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNT------------------------KSRIFDAV 255
           Y +A DVW+ G ++  +  G P F G++                        K+ +F  V
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 256 RTADL--RFP-SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           R  ++  R P    +  +S+   DL    L  DP +R    ++L H + 
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 142/300 (47%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K + + +            E++IM +L  H N+V L+
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLD-HCNIVRLR 79
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             + +FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 312

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 128/251 (50%), Gaps = 10/251 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  K TG+++ACK + K RL      +   +E +I+ ++     +V L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSLA 251
Query: 109 AVYEDEDYVHLVMELCAGGELFHRL----EKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
             +E +  + LVM +  GG++ + +    E    F E  A     Q++  + + H+  ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-LLGTVGSPFYIAPEVLAG-GYNQ 222
           +RDLKPEN+LL    +   ++++D GLA  ++ GQ+   G  G+P ++APE+L G  Y+ 
Sbjct: 312 YRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 223 AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGML 282
           + D ++ GV LY +++   PF    +      ++   L       D  S ++KD    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 283 STDPSQRLTAR 293
             DP +RL  R
Sbjct: 429 QKDPEKRLGFR 439

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 128/251 (50%), Gaps = 10/251 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  K TG+++ACK + K RL      +   +E +I+ ++     +V L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSLA 251
Query: 109 AVYEDEDYVHLVMELCAGGELFHRL----EKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
             +E +  + LVM +  GG++ + +    E    F E  A     Q++  + + H+  ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-LLGTVGSPFYIAPEVLAG-GYNQ 222
           +RDLKPEN+LL    +   ++++D GLA  ++ GQ+   G  G+P ++APE+L G  Y+ 
Sbjct: 312 YRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 223 AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGML 282
           + D ++ GV LY +++   PF    +      ++   L       D  S ++KD    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 283 STDPSQRLTAR 293
             DP +RL  R
Sbjct: 429 QKDPEKRLGFR 439

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 128/251 (50%), Gaps = 10/251 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  K TG+++ACK + K RL      +   +E +I+ ++     +V L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSLA 251
Query: 109 AVYEDEDYVHLVMELCAGGELFHRL----EKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
             +E +  + LVM +  GG++ + +    E    F E  A     Q++  + + H+  ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-LLGTVGSPFYIAPEVLAG-GYNQ 222
           +RDLKPEN+LL    +   ++++D GLA  ++ GQ+   G  G+P ++APE+L G  Y+ 
Sbjct: 312 YRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 223 AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGML 282
           + D ++ GV LY +++   PF    +      ++   L       D  S ++KD    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 283 STDPSQRLTAR 293
             DP +RL  R
Sbjct: 429 QKDPEKRLGFR 439

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 128/251 (50%), Gaps = 10/251 (3%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  K TG+++ACK + K RL      +   +E +I+ ++     +V L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSLA 251
Query: 109 AVYEDEDYVHLVMELCAGGELFHRL----EKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
             +E +  + LVM +  GG++ + +    E    F E  A     Q++  + + H+  ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-LLGTVGSPFYIAPEVLAG-GYNQ 222
           +RDLKPEN+LL    +   ++++D GLA  ++ GQ+   G  G+P ++APE+L G  Y+ 
Sbjct: 312 YRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 223 AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGML 282
           + D ++ GV LY +++   PF    +      ++   L       D  S ++KD    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 283 STDPSQRLTAR 293
             DP +RL  R
Sbjct: 429 QKDPEKRLGFR 439

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 18/273 (6%)
Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           N I++  E F   +++G G FG +    D  T +V A K I  D     D+   ++ EI 
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEIT 73
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           ++++      V      Y     + ++ME   GG     L + G F E +   +  ++++
Sbjct: 74  VLSQCDSS-YVTKYYGSYLKGSKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILK 131
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIA 212
            + Y H    +HRD+K  N+LL+ +     +KLADFG+A  +   Q    T VG+PF++A
Sbjct: 132 GLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMA 188
Query: 213 PEVL-AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PEV+    Y+  AD+WS G+    L  G PP      +     +R   L   +NP   + 
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGEPP------NSDMHPMRVLFLIPKNNPPTLVG 242
Query: 272 D---SAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           D   S K+ +   L+ DPS R TA+++L H ++
Sbjct: 243 DFTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 126/263 (47%), Gaps = 21/263 (7%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL- 107
           +G G +G  +    K  G++   K +    +   + +  V  E+ ++  L  HPN+V   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK-HPNIVRYY 71
Query: 108 -KAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIG 162
            + +      +++VME C GG+L   + K  +      E     +  QL   +  CH   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 163 -----VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
                V+HRDLKP N+ L  K +   +KL DFGLA  +    S     VG+P+Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               YN+ +D+WS G +LY L + MPPF   ++  +   +R    +F   P+ + SD   
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPYRY-SDELN 245
Query: 276 DLVMGMLSTDPSQRLTARQVLDH 298
           +++  ML+     R +  ++L++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILEN 268

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 139/285 (48%), Gaps = 18/285 (6%)
Query: 24  RSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID 83
           R+  + ++D     +  + F+   ++G G  G++ + + + +G++ A K +   +     
Sbjct: 6   RAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----Q 58
Query: 84  DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE 143
             R +     ++ R   H NVV++   Y   D + +VME   GG L   +    R +E +
Sbjct: 59  QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQ 117
Query: 144 ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE---PGQS 200
              + + ++Q +   H  GV+HRD+K ++ILL        +KL+DFG    +    P + 
Sbjct: 118 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRK 174
Query: 201 LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD 259
            L  VG+P+++APE+++   Y    D+WS G+++  ++ G PP++     +    +R  +
Sbjct: 175 XL--VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-N 231
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
           L         +S S K  +  +L  DP+QR TA ++L H ++   
Sbjct: 232 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 33/284 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD--ERSVKLEIEIMTRLSGHPNVVD 106
           LG GQF  +    DK T ++ A K I         D   R+   EI+++  LS HPN++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIG 76
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L   +  +  + LV +           +     + +  +   +  +Q + Y H+  ++HR
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 136
Query: 167 DLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQA 223
           DLKP N+LL     +  +KLADFGLA ++  P ++    V + +Y APE+L G   Y   
Sbjct: 137 DLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVG 193
Query: 224 ADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------ADL----------RFP 263
            D+W+ G IL  LL  +P   G++     +RIF+ + T       D+           FP
Sbjct: 194 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 253
Query: 264 SNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
             P  HI     D   DL+ G+   +P  R+TA Q L   +  +
Sbjct: 254 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 139/285 (48%), Gaps = 18/285 (6%)
Query: 24  RSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID 83
           R+  + ++D     +  + F+   ++G G  G++ + + + +G++ A K +   +     
Sbjct: 10  RAALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----Q 62
Query: 84  DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE 143
             R +     ++ R   H NVV++   Y   D + +VME   GG L   +    R +E +
Sbjct: 63  QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQ 121
Query: 144 ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE---PGQS 200
              + + ++Q +   H  GV+HRD+K ++ILL        +KL+DFG    +    P + 
Sbjct: 122 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRK 178
Query: 201 LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD 259
            L  VG+P+++APE+++   Y    D+WS G+++  ++ G PP++     +    +R  +
Sbjct: 179 XL--VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-N 235
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
           L         +S S K  +  +L  DP+QR TA ++L H ++   
Sbjct: 236 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 280

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 92/314 (29%), Positives = 146/314 (46%), Gaps = 58/314 (18%)
Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAK-DR-LVTIDDERSVKLEIE 93
           + N+   F L   LG G +GV+   + K TGE+ A K I   D+ L  +   R    EI+
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIK 61
Query: 94  IMTRLSGHPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF 148
           I+     H N++ +  +     +E+ + V+++ EL       HR+      S+   +   
Sbjct: 62  ILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFI 118
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI--------EP-GQ 199
            Q ++ V   H   V+HRDLKP N+L+    S+  +K+ DFGLA  I        EP GQ
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 200 S--LLGTVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSR----I 251
              ++  V + +Y APEV+  +  Y++A DVWS G IL  L    P F G         I
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 252 FDAVRTA----DLR----------------FPSNPWD----HISDSAKDLVMGMLSTDPS 287
           F  + T     DLR                +P+ P +     ++    DL+  ML  DP+
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 288 QRLTARQVLDHSWM 301
           +R+TA++ L+H ++
Sbjct: 296 KRITAKEALEHPYL 309

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 141/300 (47%), Gaps = 55/300 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K + + +            E++IM +L  H N+V L+
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLD-HCNIVRLR 79
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-------ARVLFMQLMQVV 155
             +      +DE Y++LV++     E  +R+ +   +S A+        ++   QL + +
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE+
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VR 256
           + G   Y  + DVWSAG +L  LL G P F G+                T+ +I +    
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 257 TADLRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             +  FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP
Sbjct: 254 YTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDP 312

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 92/314 (29%), Positives = 145/314 (46%), Gaps = 58/314 (18%)
Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAK-DR-LVTIDDERSVKLEIE 93
           + N+   F L   LG G +GV+   + K TGE+ A K I   D+ L  +   R    EI+
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIK 61
Query: 94  IMTRLSGHPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF 148
           I+     H N++ +  +     +E+ + V+++ EL       HR+      S+   +   
Sbjct: 62  ILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFI 118
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI--------EP-GQ 199
            Q ++ V   H   V+HRDLKP N+L+    S+  +K+ DFGLA  I        EP GQ
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 200 S--LLGTVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSR----I 251
              +   V + +Y APEV+  +  Y++A DVWS G IL  L    P F G         I
Sbjct: 176 QSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 252 FDAVRTA----DLR----------------FPSNPWD----HISDSAKDLVMGMLSTDPS 287
           F  + T     DLR                +P+ P +     ++    DL+  ML  DP+
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 288 QRLTARQVLDHSWM 301
           +R+TA++ L+H ++
Sbjct: 296 KRITAKEALEHPYL 309

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 21/263 (7%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL- 107
           +G G +G  +    K  G++   K +    +   + +  V  E+ ++  L  HPN+V   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK-HPNIVRYY 71
Query: 108 -KAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIG 162
            + +      +++VME C GG+L   + K  +      E     +  QL   +  CH   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 163 -----VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVL 216
                V+HRDLKP N+ L  K +   +KL DFGLA  +   +      VG+P+Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM 188
Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               YN+ +D+WS G +LY L + MPPF   ++  +   +R    +F   P+ + SD   
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIPYRY-SDELN 245
Query: 276 DLVMGMLSTDPSQRLTARQVLDH 298
           +++  ML+     R +  ++L++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILEN 268

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 92/314 (29%), Positives = 145/314 (46%), Gaps = 58/314 (18%)
Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAK-DR-LVTIDDERSVKLEIE 93
           + N+   F L   LG G +GV+   + K TGE+ A K I   D+ L  +   R    EI+
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIK 61
Query: 94  IMTRLSGHPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF 148
           I+     H N++ +  +     +E+ + V+++ EL       HR+      S+   +   
Sbjct: 62  ILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFI 118
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI--------EP-GQ 199
            Q ++ V   H   V+HRDLKP N+L+    S+  +K+ DFGLA  I        EP GQ
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 200 S--LLGTVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSR----I 251
              +   V + +Y APEV+  +  Y++A DVWS G IL  L    P F G         I
Sbjct: 176 QSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 252 FDAVRTA----DLR----------------FPSNPWD----HISDSAKDLVMGMLSTDPS 287
           F  + T     DLR                +P+ P +     ++    DL+  ML  DP+
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 288 QRLTARQVLDHSWM 301
           +R+TA++ L+H ++
Sbjct: 296 KRITAKEALEHPYL 309

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 19/262 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G FG +    D    EV A K ++     + +  + +  E+  + +L  HPN + 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118
Query: 107 LKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            +  Y  E    LVME C G   +L    +K     E E   +    +Q + Y H   ++
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL----AGGY 220
           HRD+K  NILL+       +KL DFG A+ + P    +GT   P+++APEV+     G Y
Sbjct: 177 HRDVKAGNILLSEPGL---VKLGDFGSASIMAPANXFVGT---PYWMAPEVILAMDEGQY 230
Query: 221 NQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +   DVWS G+    L    PP +  N  S ++   +       S  W   S+  ++ V 
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVD 287
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
             L   P  R T+  +L H ++
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFV 309

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 131/265 (49%), Gaps = 22/265 (8%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    +K TG + A K I       ++D     +EIEI+     HP +V L
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YIVEIEILAT-CDHPYIVKL 81
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
              Y  +  + +++E C GG +   + +  R  +E + +V+  Q+++ + + H   ++HR
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 141
Query: 167 DLKPENILLATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFYIAPEVLA------GG 219
           DLK  N+L+  +     I+LADFG+ A  ++  Q     +G+P+++APEV+         
Sbjct: 142 DLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD---LRFPSNPWDHISDSAKD 276
           Y+  AD+WS G+ L  +    PP       R+   +  +D   L  PS  W   S   +D
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK-W---SVEFRD 254
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
            +   L  +P  R +A Q+L+H ++
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 131/265 (49%), Gaps = 22/265 (8%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    +K TG + A K I       ++D     +EIEI+     HP +V L
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YIVEIEILAT-CDHPYIVKL 73
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
              Y  +  + +++E C GG +   + +  R  +E + +V+  Q+++ + + H   ++HR
Sbjct: 74  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 133
Query: 167 DLKPENILLATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFYIAPEVLA------GG 219
           DLK  N+L+  +     I+LADFG+ A  ++  Q     +G+P+++APEV+         
Sbjct: 134 DLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD---LRFPSNPWDHISDSAKD 276
           Y+  AD+WS G+ L  +    PP       R+   +  +D   L  PS  W   S   +D
Sbjct: 191 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK-W---SVEFRD 246
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
            +   L  +P  R +A Q+L+H ++
Sbjct: 247 FLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 137/298 (45%), Gaps = 49/298 (16%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV+       +GE+ A K + + +            E++IM +L  H N+V L+
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLD-HCNIVRLR 79
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEA----EARVLFMQLMQVVLYC 158
             +      +DE Y++LV++      ++     + R  +       ++   QL + + Y 
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG 218
           H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y APE++ G
Sbjct: 139 HSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 219 G--YNQAADVWSAGVILYILLSGMPPFWGN----------------TKSRIFDA-VRTAD 259
              Y  + DVWSAG +L  LL G P F G+                T+ +I +      +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 260 LRFP---SNPWDHI-----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             FP   ++PW  +        A  L   +L   P+ RLT  +   HS+  D ++DP 
Sbjct: 257 FAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDPN 313

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 137/292 (46%), Gaps = 29/292 (9%)
Query: 31  LDTNQISNLRER---FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS 87
           LD   +S LR+    F L + +G G +G +       TG++ A K +     VT D+E  
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEE 66
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYED------EDYVHLVMELCAGGELFHRLEKFGRFSE 141
           +K EI ++ + S H N+      +        +D + LVME C  G +   ++     + 
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 142 AEARVLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ 199
            E  + ++  ++++ + + H+  V+HRD+K +N+LL   A    +KL DFG++  ++   
Sbjct: 127 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTV 183
Query: 200 SLLGT-VGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSR-I 251
               T +G+P+++APEV+A        Y+  +D+WS G+    +  G PP       R +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           F   R    R  S  W   S   +  +   L  + SQR    Q++ H ++ D
Sbjct: 244 FLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 19/262 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G FG +    D    EV A K ++     + +  + +  E+  + +L  HPN + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79
Query: 107 LKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            +  Y  E    LVME C G   +L    +K     E E   +    +Q + Y H   ++
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL----AGGY 220
           HRD+K  NILL+       +KL DFG A+ + P    +GT   P+++APEV+     G Y
Sbjct: 138 HRDVKAGNILLSEPGL---VKLGDFGSASIMAPANXFVGT---PYWMAPEVILAMDEGQY 191
Query: 221 NQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +   DVWS G+    L    PP +  N  S ++   +       S  W   S+  ++ V 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVD 248
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
             L   P  R T+  +L H ++
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFV 270

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 130/286 (45%), Gaps = 33/286 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSI--AKDRLVTIDDERSV--KLEIEIMTRLSG---- 100
           LG G FG +    +      +A K I   +++L TI  E  +   L  + + R       
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQVVLYC 158
             N V      + +  + + ME C  G L+  +  E   +  +   R LF Q+++ + Y 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR-LFRQILEALSYI 132
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-------------PGQS--LLG 203
           H  G++HRDLKP NI +     S  +K+ DFGLA  +              PG S  L  
Sbjct: 133 HSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 204 TVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR 261
            +G+  Y+A EVL   G YN+  D++S G+I + ++   P   G  +  I   +R+  + 
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIE 247
Query: 262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD 307
           FP +  D+     K ++  ++  DP++R  AR +L+  W+    QD
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 24/268 (8%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSI---AKDRLVTIDDERSVKLEIEIM 95
           + ER+ +  +LG G    + +  D       A K+I    +++  T+   +  + E+   
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL---KRFEREVHNS 65
Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
           ++LS H N+V +  V E++D  +LVME   G  L   +E  G  S   A     Q++  +
Sbjct: 66  SQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-----TYIEPGQSLLGTVGSPFY 210
            + H++ +VHRD+KP+NIL+    S+  +K+ DFG+A     T +     +LGTV    Y
Sbjct: 125 KHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ---Y 178
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD- 268
            +PE   G   ++  D++S G++LY +L G PPF G T   I  A++      P+   D 
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPNVTTDV 236
Query: 269 --HISDSAKDLVMGMLSTDPSQRLTARQ 294
              I  S  ++++     D + R    Q
Sbjct: 237 RKDIPQSLSNVILRATEKDKANRYKTIQ 264

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    +K T  + A K I       ++D     +EI+I+     HPN+V L
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED---YMVEIDILAS-CDHPNIVKL 99
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
              +  E+ + +++E CAGG +   + +  R  +E++ +V+  Q +  + Y H+  ++HR
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 167 DLKPENILLATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFYIAPEVLA------GG 219
           DLK  NIL         IKLADFG+ A      Q     +G+P+++APEV+         
Sbjct: 160 DLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           Y+  ADVWS G+ L  +    PP       R+   +  ++    + P    S + KD + 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSNFKDFLK 275
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
             L  +   R T  Q+L H ++
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    +K T  + A K I       ++D     +EI+I+     HPN+V L
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED---YMVEIDILAS-CDHPNIVKL 99
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
              +  E+ + +++E CAGG +   + +  R  +E++ +V+  Q +  + Y H+  ++HR
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 167 DLKPENILLATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFYIAPEVLA------GG 219
           DLK  NIL         IKLADFG+ A      Q     +G+P+++APEV+         
Sbjct: 160 DLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           Y+  ADVWS G+ L  +    PP       R+   +  ++    + P    S + KD + 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSNFKDFLK 275
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
             L  +   R T  Q+L H ++
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFV 297

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 133/304 (43%), Gaps = 62/304 (20%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER----SVKLEIEIMTRLSGHP 102
           ++LG G +  +    +K TG   A K       V +D E     +   EI +M  L  H 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKELK-HE 63
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFM--------QLM 152
           N+V L  V   E+ + LV E          L+K+   R      R L +        QL+
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYI 211
           Q + +CHE  ++HRDLKP+N+L+  +     +KL DFGLA  +  P  +    V + +Y 
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 212 APEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSR----IFDAVRTA------- 258
           AP+VL G   Y+ + D+WS G IL  +++G P F G         IFD + T        
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 259 -----------------DLRFPSNPW--DHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
                            DLR    P   + +  +  D + G+L  +P  RL+A+Q L H 
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 300 WMGD 303
           W  +
Sbjct: 296 WFAE 299

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 12/264 (4%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            E F   +++G G FG +    D  T +V A K I  D     D+   ++ EI ++++  
Sbjct: 26  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCD 83
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
             P V      Y  +  + ++ME   GG     LE  G   E +   +  ++++ + Y H
Sbjct: 84  S-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLH 141
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA- 217
               +HRD+K  N+LL+       +KLADFG+A  +   Q    T VG+PF++APEV+  
Sbjct: 142 SEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y+  AD+WS G+    L  G PP       ++   +   +   P     + S   K+ 
Sbjct: 199 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEF 255
Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           V   L+ +PS R TA+++L H ++
Sbjct: 256 VEACLNKEPSFRPTAKELLKHKFI 279

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    +K T  + A K I       ++D     +EI+I+     HPN+V L
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED---YMVEIDILAS-CDHPNIVKL 99
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
              +  E+ + +++E CAGG +   + +  R  +E++ +V+  Q +  + Y H+  ++HR
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 167 DLKPENILLATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFYIAPEVLA------GG 219
           DLK  NIL         IKLADFG+ A      Q     +G+P+++APEV+         
Sbjct: 160 DLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           Y+  ADVWS G+ L  +    PP       R+   +  ++    + P    S + KD + 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSNFKDFLK 275
Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
             L  +   R T  Q+L H ++
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFV 297

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 12/263 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G FG +    D  T +V A K I  D     D+   ++ EI ++++   
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P V      Y  +  + ++ME   GG     LE  G   E +   +  ++++ + Y H 
Sbjct: 65  -PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-G 218
              +HRD+K  N+LL+       +KLADFG+A  +   Q    T VG+PF++APEV+   
Sbjct: 123 EKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y+  AD+WS G+    L  G PP       ++   +   +   P     + S   K+ V
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFV 236
Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
              L+ +PS R TA+++L H ++
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFI 259

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 135/294 (45%), Gaps = 50/294 (17%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTRLSGHPN 103
           +++G G +G +    ++ T E+ A K +  D     DDE    S   EI ++  L  H N
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALREICLLKELK-HKN 62
Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYC 158
           +V L  V   +  + LV E C        L+K+     G       +    QL++ + +C
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLA 217
           H   V+HRDLKP+N+L+        +KLA+FGLA  +  P +     V + +Y  P+VL 
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 218 GG--YNQAADVWSAGVILYILL-SGMPPFWGN----TKSRIFDAVRT-ADLRFPS----- 264
           G   Y+ + D+WSAG I   L  +G P F GN       RIF  + T  + ++PS     
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 265 ---------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                          N    ++ + +DL+  +L  +P QR++A + L H +  D
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 134/294 (45%), Gaps = 50/294 (17%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE---RSVKLEIEIMTRLSGHPN 103
           +++G G +G +    ++ T E+ A K +  D     DDE    S   EI ++  L  H N
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALREICLLKELK-HKN 62
Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYC 158
           +V L  V   +  + LV E C        L+K+     G       +    QL++ + +C
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLA 217
           H   V+HRDLKP+N+L+        +KLADFGLA  +  P +     V + +Y  P+VL 
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 218 GG--YNQAADVWSAGVILYILLSGMPP-FWGN----TKSRIFDAVRT-ADLRFPS----- 264
           G   Y+ + D+WSAG I   L +   P F GN       RIF  + T  + ++PS     
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 265 ---------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                          N    ++ + +DL+  +L  +P QR++A + L H +  D
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 129/286 (45%), Gaps = 33/286 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSI--AKDRLVTIDDERSV--KLEIEIMTRLSG---- 100
           LG G FG +    +      +A K I   +++L TI  E  +   L  + + R       
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQVVLYC 158
             N V      + +  + + ME C    L+  +  E   +  +   R LF Q+++ + Y 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR-LFRQILEALSYI 132
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-------------PGQS--LLG 203
           H  G++HRDLKP NI +     S  +K+ DFGLA  +              PG S  L  
Sbjct: 133 HSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 204 TVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR 261
            +G+  Y+A EVL   G YN+  D++S G+I + ++   P   G  +  I   +R+  + 
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIE 247
Query: 262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD 307
           FP +  D+     K ++  ++  DP++R  AR +L+  W+    QD
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 12/270 (4%)
Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           N  ++  E F   +++G G FG +    D  T +V A K I  D     D+   ++ EI 
Sbjct: 15  NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEIT 72
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           ++++    P V      Y  +  + ++ME   GG     LE  G   E +   +  ++++
Sbjct: 73  VLSQCDS-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILK 130
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIA 212
            + Y H    +HRD+K  N+LL+       +KLADFG+A  +   Q      VG+PF++A
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMA 187
Query: 213 PEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PEV+    Y+  AD+WS G+    L  G PP       ++   +   +   P     + S
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYS 244
Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              K+ V   L+ +PS R TA+++L H ++
Sbjct: 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 26/257 (10%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV  VC  K+  +  A K I  +      + ++  +E+  ++R++ HPN+V L 
Sbjct: 17  VGRGAFGV--VCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLY 68
Query: 109 AVYEDEDYVHLVMELCAGGELF---HRLEKFGRFSEAEARVLFMQLMQVVLYCHEI---G 162
               +   V LVME   GG L+   H  E    ++ A A    +Q  Q V Y H +    
Sbjct: 69  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYN 221
           ++HRDLKP N+LL   A  + +K+ DFG A  I+    +    GS  ++APEV  G  Y+
Sbjct: 127 LIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSNYS 182
Query: 222 QAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +  DV+S G+IL+ +++   PF   G    RI  AV     R P     ++    + L+ 
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPLI--KNLPKPIESLMT 239
Query: 280 GMLSTDPSQRLTARQVL 296
              S DPSQR +  +++
Sbjct: 240 RCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 26/257 (10%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FGV  VC  K+  +  A K I  +      + ++  +E+  ++R++ HPN+V L 
Sbjct: 16  VGRGAFGV--VCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLY 67
Query: 109 AVYEDEDYVHLVMELCAGGELF---HRLEKFGRFSEAEARVLFMQLMQVVLYCHEI---G 162
               +   V LVME   GG L+   H  E    ++ A A    +Q  Q V Y H +    
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYN 221
           ++HRDLKP N+LL   A  + +K+ DFG A  I+    +    GS  ++APEV  G  Y+
Sbjct: 126 LIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSNYS 181
Query: 222 QAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +  DV+S G+IL+ +++   PF   G    RI  AV     R P     ++    + L+ 
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPLI--KNLPKPIESLMT 238
Query: 280 GMLSTDPSQRLTARQVL 296
              S DPSQR +  +++
Sbjct: 239 RCWSKDPSQRPSMEEIV 255

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 12/263 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G FG +    D  T +V A K I  D     D+   ++ EI ++++   
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P V      Y  +  + ++ME   GG     LE  G   E +   +  ++++ + Y H 
Sbjct: 65  -PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-G 218
              +HRD+K  N+LL+       +KLADFG+A  +   Q      VG+PF++APEV+   
Sbjct: 123 EKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y+  AD+WS G+    L  G PP       ++   +   +   P     + S   K+ V
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFV 236
Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
              L+ +PS R TA+++L H ++
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFI 259

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 131/296 (44%), Gaps = 45/296 (15%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +G +    D    +  A K +++     I   R+ + E+ ++  L  H NV+ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLK-HENVIGLL 93
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            V+      ED   V+LV  L   G   + + K    S+   + L  QL++ + Y H  G
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GY 220
           ++HRDLKP N+ +      S +++ DFGLA   +  + + G V + +Y APE++     Y
Sbjct: 152 IIHRDLKPSNVAV---NEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 221 NQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAV----------------RTADL 260
           NQ  D+WS G I+  LL G   F G    +   RI + V                RT   
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 261 RFPSNPWDHISDS-------AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             P  P   +S         A DL+  ML  D  QR++A + L H++      DPE
Sbjct: 267 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ-YHDPE 321

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 131/296 (44%), Gaps = 45/296 (15%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +G +    D    +  A K +++     I   R+ + E+ ++  L  H NV+ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLK-HENVIGLL 93
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            V+      ED   V+LV  L   G   + + K    S+   + L  QL++ + Y H  G
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GY 220
           ++HRDLKP N+ +      S +++ DFGLA   +  + + G V + +Y APE++     Y
Sbjct: 152 IIHRDLKPSNVAV---NEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 221 NQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAV----------------RTADL 260
           NQ  D+WS G I+  LL G   F G    +   RI + V                RT   
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 261 RFPSNPWDHISD-------SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             P  P   +S         A DL+  ML  D  QR++A + L H++      DPE
Sbjct: 267 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ-YHDPE 321

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 130/297 (43%), Gaps = 51/297 (17%)
Query: 51  WGQ---FGVIRVCSDKFTGEVFACKSIAKDRLVTID-----DERSVKLEIEIMTRLSGHP 102
           WG    + ++R        EVF   +I  +  V +       +  +K EI+I+  L G P
Sbjct: 33  WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGP 92
Query: 103 NVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           N++ L  + +D       LV E     + F +L  +   ++ + R    ++++ + YCH 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKALDYCHS 149
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
           +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  PE+L    
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 220 -YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL------------- 260
            Y+ + D+WS G +L  ++    PF+    +     RI   + T DL             
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 261 -------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                  R     W+          +S  A D +  +L  D   RLTAR+ ++H + 
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 89/317 (28%), Positives = 145/317 (45%), Gaps = 51/317 (16%)
Query: 32  DTNQIS-NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           D N+ +  L + +V    +G G +G +    DK +GE  A K +++     I  +R+ + 
Sbjct: 14  DVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR- 72
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYV------HLVMELCAGGELFHRLEKFG--RFSEA 142
           E+ ++  +  H NV+ L  V+     +      +LVM           L+K    +FSE 
Sbjct: 73  ELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGLKFSEE 126
Query: 143 EARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL 202
           + + L  Q+++ + Y H  GVVHRDLKP N+ +        +K+ DFGLA + +    + 
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMT 181
Query: 203 GTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIF---- 252
           G V + +Y APEV+     YNQ  D+WS G I+  +L+G   F G    +  ++I     
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241
Query: 253 ------------DAVRTADLRFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTAR 293
                        A ++     P  P       +   S  A DL+  ML  D  +RLTA 
Sbjct: 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301
Query: 294 QVLDHSWMGDGIQDPEK 310
           Q L H +  +  +DPE+
Sbjct: 302 QALTHPFF-EPFRDPEE 317

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 94
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V+LV  L  G +L+ +L K    S         
Sbjct: 95  LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHL-MGADLY-KLLKTQHLSNDHICYFLY 151
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 152 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 269 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 328
Query: 297 DHSWM 301
            H ++
Sbjct: 329 AHPYL 333

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 129/289 (44%), Gaps = 49/289 (16%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--RSVKLEIEIMT 96
           LR R VL +    G F  +    D  +G  +A K     RL++ ++E  R++  E+  M 
Sbjct: 30  LRVRRVLAE----GGFAFVYEAQDVGSGREYALK-----RLLSNEEEKNRAIIQEVCFMK 80
Query: 97  RLSGHPNVVDLKAV----YEDEDYVH----LVMELCAGG--ELFHRLEKFGRFSEAEARV 146
           +LSGHPN+V   +      E+ D       L+ ELC G   E   ++E  G  S      
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 147 LFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLADFGLATYIE--PGQSL- 201
           +F Q  + V + H     ++HRDLK EN+LL+ + +   IKL DFG AT I   P  S  
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPDYSWS 197
Query: 202 ----------LGTVGSPFYIAPEVLAGGYN----QAADVWSAGVILYILLSGMPPFWGNT 247
                     +    +P Y  PE++    N    +  D+W+ G ILY+L     PF    
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
Query: 248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
           K RI +       ++   P D        L+  ML  +P +RL+  +V+
Sbjct: 258 KLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 35/287 (12%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSI--AKDRLVTIDDERSV--KLEIEIMTRLSG---- 100
           LG G FG +    +      +A K I   +++L TI  E  +   L  + + R       
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSEAEARVLFMQLMQVVLYC 158
             N V      + +  + +  E C    L+  +  E   +  +   R LF Q+++ + Y 
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR-LFRQILEALSYI 132
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-------------PGQS--LLG 203
           H  G++HR+LKP NI +     S  +K+ DFGLA  +              PG S  L  
Sbjct: 133 HSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 204 TVGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPF-WGNTKSRIFDAVRTADL 260
            +G+  Y+A EVL   G YN+  D +S G+I +     + PF  G  +  I   +R+  +
Sbjct: 190 AIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTGXERVNILKKLRSVSI 246
Query: 261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD 307
            FP +  D+     K ++  ++  DP++R  AR +L+  W+    QD
Sbjct: 247 EFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 130/296 (43%), Gaps = 45/296 (15%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G +G +    D    +  A K +++     I   R+ + E+ ++  L  H NV+ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLK-HENVIGLL 85
Query: 109 AVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            V+      ED   V+LV  L   G   + + K    S+   + L  QL++ + Y H  G
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GY 220
           ++HRDLKP N+ +        +++ DFGLA   +  + + G V + +Y APE++     Y
Sbjct: 144 IIHRDLKPSNVAVNEDCE---LRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHY 198
Query: 221 NQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAV----------------RTADL 260
           NQ  D+WS G I+  LL G   F G    +   RI + V                RT   
Sbjct: 199 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 258
Query: 261 RFPSNPWDHISDS-------AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             P  P   +S         A DL+  ML  D  QR++A + L H++      DPE
Sbjct: 259 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ-YHDPE 313

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/317 (28%), Positives = 144/317 (45%), Gaps = 51/317 (16%)
Query: 32  DTNQIS-NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           D N+ +  L + +V    +G G +G +    DK +GE  A K +++     I  +R+ + 
Sbjct: 32  DVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR- 90
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYV------HLVMELCAGGELFHRLEKFG--RFSEA 142
           E+ ++  +  H NV+ L  V+     +      +LVM           L+K     FSE 
Sbjct: 91  ELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGMEFSEE 144
Query: 143 EARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL 202
           + + L  Q+++ + Y H  GVVHRDLKP N+ +        +K+ DFGLA + +    + 
Sbjct: 145 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFGLARHADA--EMT 199
Query: 203 GTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIF---- 252
           G V + +Y APEV+     YNQ  D+WS G I+  +L+G   F G    +  ++I     
Sbjct: 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259
Query: 253 ------------DAVRTADLRFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTAR 293
                        A ++     P  P       +   S  A DL+  ML  D  +RLTA 
Sbjct: 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319
Query: 294 QVLDHSWMGDGIQDPEK 310
           Q L H +  +  +DPE+
Sbjct: 320 QALTHPFF-EPFRDPEE 335

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYX-QRTLR-EIKI 78
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 297 DHSWM 301
            H ++
Sbjct: 313 AHPYL 317

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 138/298 (46%), Gaps = 44/298 (14%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEIMTRLSG--HPN 103
           ++G G +G +    D  +G   A KS+   R+   ++   +    E+ ++ RL    HPN
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 104 VVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQVV 155
           VV L  V      + E  V LV E     +L   L+K    G  +E   + L  Q ++ +
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAET-IKDLMRQFLRGL 125
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            + H   +VHRDLKPENIL+ +  +   +KLADFGLA       +L   V + +Y APEV
Sbjct: 126 DFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182
Query: 216 -LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTA-------DLRFP 263
            L   Y    D+WS G I   +    P F GN+++    +IFD +          D+  P
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 264 SNPW------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
              +              + +S   L++ ML+ +P +R++A + L HS++     +PE
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE 300

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 134/286 (46%), Gaps = 34/286 (11%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R+ + L + +G G   V++        E  A K I  ++  T  DE  +  EI+ M++  
Sbjct: 9   RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE--LLKEIQAMSQCH 66
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE--------KFGRFSEAEARVLFMQL 151
            HPN+V     +  +D + LVM+L +GG +   ++        K G   E+    +  ++
Sbjct: 67  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT------V 205
           ++ + Y H+ G +HRD+K  NILL    S   +++ADFG++ ++  G  +         V
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP 263
           G+P ++APEV+    GY+  AD+WS G+    L +G  P+      ++       D   P
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND---P 239
Query: 264 SNPWDHISD---------SAKDLVMGMLSTDPSQRLTARQVLDHSW 300
            +    + D         S + ++   L  DP +R TA ++L H +
Sbjct: 240 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 285

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 134/286 (46%), Gaps = 34/286 (11%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R+ + L + +G G   V++        E  A K I  ++  T  DE  +  EI+ M++  
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE--LLKEIQAMSQCH 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE--------KFGRFSEAEARVLFMQL 151
            HPN+V     +  +D + LVM+L +GG +   ++        K G   E+    +  ++
Sbjct: 72  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT------V 205
           ++ + Y H+ G +HRD+K  NILL    S   +++ADFG++ ++  G  +         V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP 263
           G+P ++APEV+    GY+  AD+WS G+    L +G  P+      ++       D   P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND---P 244
Query: 264 SNPWDHISD---------SAKDLVMGMLSTDPSQRLTARQVLDHSW 300
            +    + D         S + ++   L  DP +R TA ++L H +
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEIMTRLSG--HPN 103
           ++G G +G +    D  +G   A KS+             +    E+ ++ RL    HPN
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 104 VVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVL 156
           VV L  V      + E  V LV E     +L   L+K           + L  Q ++ + 
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV- 215
           + H   +VHRDLKPENIL+ +  +   +KLADFGLA       +L   V + +Y APEV 
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 216 LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTA-------DLRFPS 264
           L   Y    D+WS G I   +    P F GN+++    +IFD +          D+  P 
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR 251
Query: 265 NPW------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             +              + +S   L++ ML+ +P +R++A + L HS++     +PE
Sbjct: 252 GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE 308

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 78
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 297 DHSWM 301
            H ++
Sbjct: 313 AHPYL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 79
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 80  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 136
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 137 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 254 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 313
Query: 297 DHSWM 301
            H ++
Sbjct: 314 AHPYL 318

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 78
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKCQHLSNDHICYFLY 135
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 297 DHSWM 301
            H ++
Sbjct: 313 AHPYL 317

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK----LEIEIMT 96
           +R+    +LG G +G +    D  T E  A K I  +      +E  V      E+ ++ 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-----EEEGVPGTAIREVSLLK 88
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
            L  H N+++LK+V      +HL+ E  A  +L   ++K    S    +    QL+  V 
Sbjct: 89  ELQ-HRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 157 YCHEIGVVHRDLKPENILLA-TKASSSPI-KLADFGLA-TYIEPGQSLLGTVGSPFYIAP 213
           +CH    +HRDLKP+N+LL+ + AS +P+ K+ DFGLA  +  P +     + + +Y  P
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206
Query: 214 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTAD-------L 260
           E+L G   Y+ + D+WS   I   +L   P F G+++     +IF+ +   D        
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266
Query: 261 RFPSNPWDHISDSAKDL--VMG-------------MLSTDPSQRLTARQVLDHSWMGDGI 305
             P           K L  V+G             ML  DP +R++A+  L+H +     
Sbjct: 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326
Query: 306 QDP 308
            DP
Sbjct: 327 FDP 329

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 79
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 80  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 136
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 137 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 254 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 313
Query: 297 DHSWM 301
            H ++
Sbjct: 314 AHPYL 318

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 23  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 80
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 81  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 137
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 138 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 254
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 255 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 314
Query: 297 DHSWM 301
            H ++
Sbjct: 315 AHPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 14  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 71
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 72  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 128
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 129 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 245
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 246 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 305
Query: 297 DHSWM 301
            H ++
Sbjct: 306 AHPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 78
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 297 DHSWM 301
            H ++
Sbjct: 313 AHPYL 317

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 72
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 73  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 129
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 130 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 246
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 247 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 306
Query: 297 DHSWM 301
            H ++
Sbjct: 307 AHPYL 311

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 78
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 297 DHSWM 301
            H ++
Sbjct: 313 AHPYL 317

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 72
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 73  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 129
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 130 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPE 246
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 247 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 306
Query: 297 DHSWM 301
            H ++
Sbjct: 307 AHPYL 311

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 138/298 (46%), Gaps = 44/298 (14%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEIMTRLSG--HPN 103
           ++G G +G +    D  +G   A KS+   R+   ++   +    E+ ++ RL    HPN
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 104 VVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQVV 155
           VV L  V      + E  V LV E     +L   L+K    G  +E   + L  Q ++ +
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAET-IKDLMRQFLRGL 125
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            + H   +VHRDLKPENIL+ +  +   +KLADFGLA       +L   V + +Y APEV
Sbjct: 126 DFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182
Query: 216 -LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTA-------DLRFP 263
            L   Y    D+WS G I   +    P F GN+++    +IFD +          D+  P
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 264 SNPW------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
              +              + +S   L++ ML+ +P +R++A + L HS++     +PE
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE 300

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/325 (26%), Positives = 149/325 (45%), Gaps = 54/325 (16%)
Query: 21  YRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV 80
           YR + LA+TI +      + ER+     +G G +G +    D  TG   A K +++    
Sbjct: 5   YR-QELAKTIWE------VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 57
Query: 81  TIDDERSVKLEIEIMTRLSGHPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLE 134
            I  +R+ + E+ ++  +  H NV+ L  V+      E+ + V+LV  L  G +L + + 
Sbjct: 58  IIHAKRTYR-ELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIV 113
Query: 135 KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY 194
           K  + ++   + L  Q+++ + Y H   ++HRDLKP N+ +        +K+ DFGLA +
Sbjct: 114 KCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARH 170
Query: 195 IEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWG------- 245
            +    + G V + +Y APE++     YNQ  D+WS G I+  LL+G   F G       
Sbjct: 171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 228
Query: 246 ---------------------NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
                                + ++ I    +   + F +N +   +  A DL+  ML  
Sbjct: 229 KLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVL 287
Query: 285 DPSQRLTARQVLDHSWMGDGIQDPE 309
           D  +R+TA Q L H++      DP+
Sbjct: 288 DSDKRITAAQALAHAYFAQ-YHDPD 311

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +      S +K+ DFGLA + +    + G V + +Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLARHTD--DEMTGYVATRWYRAPE 194
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 255 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 312
Query: 305 IQDPE 309
             DP+
Sbjct: 313 YHDPD 317

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 76
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 77  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 133
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 134 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 251 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 297 DHSWM 301
            H ++
Sbjct: 311 AHPYL 315

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 25  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 82
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 83  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 139
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T      +K+ DFGLA   +P     G     V
Sbjct: 140 QILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYV 196
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 256
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 257 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 316
Query: 297 DHSWM 301
            H ++
Sbjct: 317 AHPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 74
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T      +K+ DFGLA   +P     G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYV 188
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 297 DHSWM 301
            H ++
Sbjct: 309 AHPYL 313

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 85
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +      S +K+ DFGLA + +    + G V + +Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLARHTD--DEMTGYVATRWYRAPE 198
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 259 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 316
Query: 305 IQDPE 309
             DP+
Sbjct: 317 YHDPD 321

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 99
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMXGXVATRWYRAPE 212
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 273 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 330
Query: 305 IQDPE 309
             DP+
Sbjct: 331 YHDPD 335

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 12/222 (5%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E++++     HPNV+      +D  + ++ +ELCA     +  +K       E   L  Q
Sbjct: 67  EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQ 126
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK--LADFGLATYIEPGQSLL----GT 204
               + + H + +VHRDLKP NIL++   +   IK  ++DFGL   +  G+       G 
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 205 VGSPFYIAPEVLAGGYNQ----AADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTAD 259
            G+  +IAPE+L+    +      D++SAG + Y ++S G  PF G +  R  + +  A 
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQANILLGAC 245
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                +P  H    A++L+  M++ DP +R +A+ VL H + 
Sbjct: 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 74
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 297 DHSWM 301
            H ++
Sbjct: 309 AHPYL 313

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VL--AGGYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++  A  YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 94
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 95  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 151
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T      +K+ DFGLA   +P     G     V
Sbjct: 152 QILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYV 208
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 269 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 328
Query: 297 DHSWM 301
            H ++
Sbjct: 329 AHPYL 333

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 74
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 297 DHSWM 301
            H ++
Sbjct: 309 AHPYL 313

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 99
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 212
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 273 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 330
Query: 305 IQDPE 309
             DP+
Sbjct: 331 YHDPD 335

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 74
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 249 QEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 297 DHSWM 301
            H ++
Sbjct: 309 AHPYL 313

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 14/272 (5%)
Query: 34  NQISNL--RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           NQ S +   E F    ++G G FG +    D  T EV A K I  D     D+   ++ E
Sbjct: 10  NQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQE 67
Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
           I ++++    P +      Y     + ++ME   GG     L K G   E     +  ++
Sbjct: 68  ITVLSQCDS-PYITRYFGSYLKSTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREI 125
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFY 210
           ++ + Y H    +HRD+K  N+LL+ +     +KLADFG+A  +   Q      VG+PF+
Sbjct: 126 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNXFVGTPFW 182
Query: 211 IAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
           +APEV+    Y+  AD+WS G+    L  G PP   N+       +       P      
Sbjct: 183 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPP---NSDLHPMRVLFLIPKNSPPTLEGQ 239
Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            S   K+ V   L+ DP  R TA+++L H ++
Sbjct: 240 HSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 271

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 98
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 211
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 271
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 272 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 329
Query: 305 IQDPE 309
             DP+
Sbjct: 330 YHDPD 334

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 74
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 75  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 131
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 132 QILRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 249 QEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 297 DHSWM 301
            H ++
Sbjct: 309 AHPYL 313

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A + I+     T   +R+++ EI+I
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYC-QRTLR-EIKI 78
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 135
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 297 DHSWM 301
            H ++
Sbjct: 313 AHPYL 317

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K ++K     I  +R+ + E+ ++  +  
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMK- 91
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 204
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 265 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 322
Query: 305 IQDPE 309
             DP+
Sbjct: 323 YHDPD 327

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 46/298 (15%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           R+   Q +G G +G++    D       A K I+     T   +R+++ EI+I+ R   H
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYC-QRTLR-EIQILLRFR-H 100
Query: 102 PNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
            NV+ ++ +      E    V++V +L       ++L K  + S         Q+++ + 
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETD--LYKLLKSQQLSNDHICYFLYQILRGLK 158
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TVGSPFYIA 212
           Y H   V+HRDLKP N+L+ T      +K+ DFGLA   +P     G     V + +Y A
Sbjct: 159 YIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 213 PEVL--AGGYNQAADVWSAGVILYILLSGMPPFWG-------NTKSRIFDAVRTADLR-- 261
           PE++  + GY ++ D+WS G IL  +LS  P F G       N    I  +    DL   
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 262 -----------FPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                       PS     W  +   SDS A DL+  ML+ +P++R+T  + L H ++
Sbjct: 276 INMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 138/298 (46%), Gaps = 44/298 (14%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEIMTRLSG--HPN 103
           ++G G +G +    D  +G   A KS+   R+   ++   +    E+ ++ RL    HPN
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 104 VVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQVV 155
           VV L  V      + E  V LV E     +L   L+K    G  +E   + L  Q ++ +
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAET-IKDLMRQFLRGL 125
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            + H   +VHRDLKPENIL+ +  +   +KLADFGLA       +L   V + +Y APEV
Sbjct: 126 DFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 216 -LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTA-------DLRFP 263
            L   Y    D+WS G I   +    P F GN+++    +IFD +          D+  P
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 264 SNPW------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
              +              + +S   L++ ML+ +P +R++A + L HS++     +PE
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE 300

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 75
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 188
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 249 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 306
Query: 305 IQDPE 309
             DP+
Sbjct: 307 YHDPD 311

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 89
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 147
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 202
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 262
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 263 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 320
Query: 305 IQDPE 309
             DP+
Sbjct: 321 YHDPD 325

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 46/306 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 76
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +     H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 77  LLAFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 133
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +S +K+ DFGLA   +P     G     V
Sbjct: 134 QILRGLKYIHSANVLHRDLKPSNLLLNT---TSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 251 QEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 297 DHSWMG 302
            H ++ 
Sbjct: 311 AHPYLA 316

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 22  NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 76
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 77  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 133
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 134 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 191
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 192 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 232 ILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  +    + ++F   R             +S   + L+   L+  PS 
Sbjct: 246 LLYDMVCGDIPFEHDEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSD 292
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 293 RPTFEEIQNHPWMQD 307

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 7   NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 61
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 62  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 118
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 119 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 176
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 177 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 232 ILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  +    + ++F   R             +S   + L+   L+  PS 
Sbjct: 231 LLYDMVCGDIPFEHDEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSD 277
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 278 RPTFEEIQNHPWMQD 292

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 90/340 (26%), Positives = 156/340 (45%), Gaps = 58/340 (17%)
Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
           QSN+S E   +P   YR + L +TI +      + ER+     +G G +G +    D  T
Sbjct: 21  QSNASQE---RPT-FYR-QELNKTIWE------VPERYQNLSPVGSGAYGSVCAAFDTKT 69
Query: 66  GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY------EDEDYVHL 119
           G   A K +++     I  +R+ + E+ ++  +  H NV+ L  V+      E+ + V+L
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYL 127
Query: 120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA 179
           V  L  G +L + + K  + ++   + L  Q+++ + Y H   ++HRDLKP N+ +    
Sbjct: 128 VTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 185
Query: 180 SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILL 237
               +K+ DFGLA + +    + G V + +Y APE++     YNQ  D+WS G I+  LL
Sbjct: 186 E---LKILDFGLARHTD--DEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 238 SGMPPFWG----------------------------NTKSRIFDAVRTADLRFPSNPWDH 269
           +G   F G                            + ++ I    +   + F +N +  
Sbjct: 241 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIG 299
Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
            +  A DL+  ML  D  +R+TA Q L H++      DP+
Sbjct: 300 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ-YHDPD 338

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 17/264 (6%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S+L +R+ LG+ LG+G    + +  D       A K +  D  +  D    ++   E   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQN 65
Query: 97  RLS-GHPNVVDLKAVYEDEDYV----HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
             +  HP +V + A  E E       ++VME   G  L   +   G  +   A  +    
Sbjct: 66  AAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT---VGS 207
            Q + + H+ G++HRD+KP NI++   ++++ +K+ DFG+A  I + G S+  T   +G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 208 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSN 265
             Y++PE   G   +  +DV+S G +LY +L+G PPF G++  S  +  VR  D   PS 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPPSA 241
Query: 266 PWDHISDSAKDLVMGMLSTDPSQR 289
             + +S     +V+  L+ +P  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 134/284 (47%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 61
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVME-LCAGGELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E +    +LF  + + G   E  AR  F 
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFW 121
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 122 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 173
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 230
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 231 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 85
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 198
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 259 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 316
Query: 305 IQDPE 309
             DP+
Sbjct: 317 YHDPD 321

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 75
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMAGFVATRWYRAPE 188
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 249 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 306
Query: 305 IQDPE 309
             DP+
Sbjct: 307 YHDPD 311

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 27  NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 81
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 82  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 138
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 139 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 196
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 197 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 250
Query: 232 ILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  +    + ++F   R             +S   + L+   L+  PS 
Sbjct: 251 LLYDMVCGDIPFEHDEEIIRGQVFFRQR-------------VSXECQHLIRWCLALRPSD 297
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 298 RPTFEEIQNHPWMQD 312

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 124/261 (47%), Gaps = 26/261 (9%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGHPNVVDL 107
           LG G +G++    D       A K I +      D   S  L  EI + +   H N+V  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM--QLMQVVLYCHEIGVV 164
              + +  ++ + ME   GG L   L  K+G   + E  + F   Q+++ + Y H+  +V
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATY---IEP-GQSLLGTVGSPFYIAPEVLAGG- 219
           HRD+K +N+L+ T   S  +K++DFG +     I P  ++  GT+    Y+APE++  G 
Sbjct: 145 HRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQ---YMAPEIIDKGP 199
Query: 220 --YNQAADVWSAGVILYILLSGMPPFW--GNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
             Y +AAD+WS G  +  + +G PPF+  G  ++ +F   +    +      + +S  AK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPESMSAEAK 256
Query: 276 DLVMGMLSTDPSQRLTARQVL 296
             ++     DP +R  A  +L
Sbjct: 257 AFILKCFEPDPDKRACANDLL 277

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMAGFVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMAGFVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 22  NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 76
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 77  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 133
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 134 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 191
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 192 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 232 ILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  +    + ++F   R             +S   + L+   L+  PS 
Sbjct: 246 LLYDMVCGDIPFEHDEEIIRGQVFFRQR-------------VSXECQHLIRWCLALRPSD 292
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 293 RPTFEEIQNHPWMQD 307

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 76
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 77  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 136
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 137 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 188
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 245
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 246 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 77
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 189
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 246
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 247 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 84
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARHTD--DEMTGYVATRWYRAPE 197
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 258 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 315
Query: 305 IQDPE 309
             DP+
Sbjct: 316 YHDPD 320

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 76
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 77  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 136
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 137 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 188
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 245
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 246 ----------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 98
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 211
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 271
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 272 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 329
Query: 305 IQDPE 309
             DP+
Sbjct: 330 YHDPD 334

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 77
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 189
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 246
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 247 ----------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 96
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 97  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 208
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 265
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 266 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGXVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 7   NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 61
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 62  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 118
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 119 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 176
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 177 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 232 ILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  + +    ++F   R             +S   + L+   L+  PS 
Sbjct: 231 LLYDMVCGDIPFEHDEEIIGGQVFFRQR-------------VSSECQHLIRWCLALRPSD 277
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 278 RPTFEEIQNHPWMQD 292

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 8   NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 62
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 63  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 119
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 120 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 177
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 178 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 232 ILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  + +    ++F   R             +S   + L+   L+  PS 
Sbjct: 232 LLYDMVCGDIPFEHDEEIIGGQVFFRQR-------------VSSECQHLIRWCLALRPSD 278
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 279 RPTFEEIQNHPWMQD 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 8   NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 62
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 63  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 119
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 120 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 177
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 178 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 232 ILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  + +    ++F   R             +S   + L+   L+  PS 
Sbjct: 232 LLYDMVCGDIPFEHDEEIIGGQVFFRQR-------------VSSECQHLIRWCLALRPSD 278
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 279 RPTFEEIQNHPWMQD 293

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/331 (25%), Positives = 141/331 (42%), Gaps = 82/331 (24%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +++ LG+ LG G FG++    D  +G+ FA K +       + D R    E++IM  L  
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLD- 58
Query: 101 HPNVVDLKAVYE---DED-----------------------------------YVHLVME 122
           H N++ L   +    DE+                                   Y++++ME
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 123 LCAGGELFHR-LEKFGRFSEAEAR----VLFMQLMQVVLYCHEIGVVHRDLKPENILLAT 177
                +  H+ L+ F R   +       +   QL + V + H +G+ HRD+KP+N+L+ +
Sbjct: 119 YVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 178 KASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYI 235
           K ++  +KL DFG A  + P +  +  + S FY APE++ G   Y  + D+WS G +   
Sbjct: 177 KDNT--LKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 236 LLSGMPPFWGNTK----SRIFDAVRT-------------ADLRFPS---NPWDHI----- 270
           L+ G P F G T      RI   + T              ++RFP+     W  I     
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294
Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              A DL+  +L  +P  R+   + + H + 
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 7   NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 61
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 62  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 118
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 119 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 176
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 177 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 232 ILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  + +    ++F   R             +S   + L+   L+  PS 
Sbjct: 231 LLYDMVCGDIPFEHDEEIIGGQVFFRQR-------------VSSECQHLIRWCLALRPSD 277
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 278 RPTFEEIQNHPWMQD 292

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 62
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 174
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 231
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 232 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 194
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 255 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 312
Query: 305 IQDPE 309
             DP+
Sbjct: 313 YHDPD 317

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 194
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 255 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 312
Query: 305 IQDPE 309
             DP+
Sbjct: 313 YHDPD 317

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 99
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 212
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 273 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 330
Query: 305 IQDPE 309
             DP+
Sbjct: 331 YHDPD 335

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 91
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 204
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 265 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 322
Query: 305 IQDPE 309
             DP+
Sbjct: 323 YHDPD 327

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 194
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 255 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 312
Query: 305 IQDPE 309
             DP+
Sbjct: 313 YHDPD 317

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 86
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 199
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 260 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 317
Query: 305 IQDPE 309
             DP+
Sbjct: 318 YHDPD 322

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 91
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 204
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 265 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 322
Query: 305 IQDPE 309
             DP+
Sbjct: 323 YHDPD 327

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +      S +K+ DFGL  + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLCRHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 138/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 86
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA +      + G V + +Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHT--ADEMTGYVATRWYRAPE 199
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 260 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 317
Query: 305 IQDPE 309
             DP+
Sbjct: 318 YHDPD 322

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 8   NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 62
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 63  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 119
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 120 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 177
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 178 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 232 ILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  + +    ++F   R             +S   + L+   L+  PS 
Sbjct: 232 LLYDMVCGDIPFEHDEEIIGGQVFFRQR-------------VSXECQHLIRWCLALRPSD 278
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 279 RPTFEEIQNHPWMQD 293

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 90
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 149 LKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARHTD--DEMTGYVATRWYRAPE 203
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 263
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 264 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 321
Query: 305 IQDPE 309
             DP+
Sbjct: 322 YHDPD 326

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 8   NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 62
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 63  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 119
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 120 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 177
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 178 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 232 ILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  + +    ++F   R             +S   + L+   L+  PS 
Sbjct: 232 LLYDMVCGDIPFEHDEEIIGGQVFFRQR-------------VSXECQHLIRWCLALRPSD 278
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 279 RPTFEEIQNHPWMQD 293

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 61
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 121
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 122 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 173
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 230
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 231 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 84
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARHTD--DEMTGYVATRWYRAPE 197
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 258 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 315
Query: 305 IQDPE 309
             DP+
Sbjct: 316 YHDPD 320

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 77
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 135
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 190
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 250
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 251 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 308
Query: 305 IQDPE 309
             DP+
Sbjct: 309 YHDPD 313

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 138/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 86
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA +      + G V + +Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHT--ADEMTGYVATRWYRAPE 199
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 260 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 317
Query: 305 IQDPE 309
             DP+
Sbjct: 318 YHDPD 322

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 102
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 215
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 275
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 276 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 333
Query: 305 IQDPE 309
             DP+
Sbjct: 334 YHDPD 338

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 76
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 134
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 189
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 249
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 250 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 307
Query: 305 IQDPE 309
             DP+
Sbjct: 308 YHDPD 312

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 84
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 197
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 258 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 315
Query: 305 IQDPE 309
             DP+
Sbjct: 316 YHDPD 320

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 76
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 134
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 189
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 249
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 250 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 307
Query: 305 IQDPE 309
             DP+
Sbjct: 308 YHDPD 312

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 62
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 174
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 231
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 232 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 85
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 198
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 259 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 316
Query: 305 IQDPE 309
             DP+
Sbjct: 317 YHDPD 321

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 84
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 197
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 258 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 315
Query: 305 IQDPE 309
             DP+
Sbjct: 316 YHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 78
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 136
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 191
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 251
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 252 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 309
Query: 305 IQDPE 309
             DP+
Sbjct: 310 YHDPD 314

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 90
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 203
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 263
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 264 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 321
Query: 305 IQDPE 309
             DP+
Sbjct: 322 YHDPD 326

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 141/315 (44%), Gaps = 48/315 (15%)
Query: 8   NSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGV----IRVCSDK 63
           NS +     PC       LA       +   L  ++ +G  LG G FG     IRV SD 
Sbjct: 7   NSLAHLRAAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDN 61
Query: 64  FTGEVFACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHL 119
                 A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L
Sbjct: 62  LP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 118
Query: 120 VMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK 178
           ++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+   
Sbjct: 119 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D 176
Query: 179 ASSSPIKLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGV 231
            +   +KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G+
Sbjct: 177 LNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 232 ILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           +LY ++ G  PF  + +    ++F   R             +S   + L+   L+  PS 
Sbjct: 231 LLYDMVCGDIPFEHDEEIIGGQVFFRQR-------------VSXECQHLIRWCLALRPSD 277
Query: 289 RLTARQVLDHSWMGD 303
           R T  ++ +H WM D
Sbjct: 278 RPTFEEIQNHPWMQD 292

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 62
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 174
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 231
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 232 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 124/261 (47%), Gaps = 26/261 (9%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGHPNVVDL 107
           LG G +G++    D       A K I +      D   S  L  EI + +   H N+V  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM--QLMQVVLYCHEIGVV 164
              + +  ++ + ME   GG L   L  K+G   + E  + F   Q+++ + Y H+  +V
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATY---IEP-GQSLLGTVGSPFYIAPEVLAGG- 219
           HRD+K +N+L+ T   S  +K++DFG +     I P  ++  GT+    Y+APE++  G 
Sbjct: 131 HRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQ---YMAPEIIDKGP 185
Query: 220 --YNQAADVWSAGVILYILLSGMPPFW--GNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
             Y +AAD+WS G  +  + +G PPF+  G  ++ +F   +    +      + +S  AK
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPESMSAEAK 242
Query: 276 DLVMGMLSTDPSQRLTARQVL 296
             ++     DP +R  A  +L
Sbjct: 243 AFILKCFEPDPDKRACANDLL 263

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 138/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 86
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA +      + G V + +Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHT--ADEMTGYVATRWYRAPE 199
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 260 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 317
Query: 305 IQDPE 309
             DP+
Sbjct: 318 YHDPD 322

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S+L +R+ LG+ LG+G    + +  D       A K +  D  +  D    ++   E   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQN 65
Query: 97  RLS-GHPNVVDLKAVYEDEDYV----HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
             +  HP +V +    E E       ++VME   G  L   +   G  +   A  +    
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT---VGS 207
            Q + + H+ G++HRD+KP NIL+   ++++ +K+ DFG+A  I + G S+  T   +G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILI---SATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 208 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSN 265
             Y++PE   G   +  +DV+S G +LY +L+G PPF G++  S  +  VR  D   PS 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPPSA 241
Query: 266 PWDHISDSAKDLVMGMLSTDPSQR 289
             + +S     +V+  L+ +P  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 85
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 198
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 259 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 316
Query: 305 IQDPE 309
             DP+
Sbjct: 317 YHDPD 321

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 75
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 188
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 249 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 306
Query: 305 IQDPE 309
             DP+
Sbjct: 307 YHDPD 311

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 57
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 169
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 226
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 227 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 60
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 61  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 120
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 121 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 172
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 173 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 229
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 230 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 263

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 84
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 85  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 144
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 145 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 196
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 197 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 253
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 254 ----------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 287

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S+L +R+ LG+ LG+G    + +  D       A K +  D  +  D    ++   E   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQN 65
Query: 97  RLS-GHPNVVDLKAVYEDEDYV----HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
             +  HP +V +    E E       ++VME   G  L   +   G  +   A  +    
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT---VGS 207
            Q + + H+ G++HRD+KP NI++   ++++ +K+ DFG+A  I + G S+  T   +G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 208 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRI-FDAVRTADLRFPSN 265
             Y++PE   G   +  +DV+S G +LY +L+G PPF G++   + +  VR  D   PS 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVRE-DPIPPSA 241
Query: 266 PWDHISDSAKDLVMGMLSTDPSQR 289
             + +S     +V+  L+ +P  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 40  RERFVLGQQLGWGQFGVIR---VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RER  LG+ +G GQFG +      S +      A K+       T D  R   L+  +  
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTM 65
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQV 154
           R   HP++V L  V   E+ V ++MELC  GEL  F ++ KF     A   +   QL   
Sbjct: 66  RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTA 123
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIA 212
           + Y      VHRD+   N+L++   S+  +KL DFGL+ Y+E       + G  P  ++A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMA 180
Query: 213 PEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           PE +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  + 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NC 237
Query: 271 SDSAKDLVMGMLSTDPSQR 289
             +   L+    + DPS+R
Sbjct: 238 PPTLYSLMTKCWAYDPSRR 256

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 57
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 118 QVLEAVRHCHNXGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 169
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 226
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 227 ----------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 135/306 (44%), Gaps = 46/306 (15%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+     T   +R+++ EI+I
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLR-EIKI 76
Query: 95  MTRLSGHPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +     H N++ +  +      E    V++V +L       ++L K    S         
Sbjct: 77  LLAFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQHLSNDHICYFLY 133
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG----TV 205
           Q+++ + Y H   V+HRDLKP N+LL T   +  +K+ DFGLA   +P     G     V
Sbjct: 134 QILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 206 GSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------- 255
            + +Y APE++  + GY ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 256 ------------RTADLRFPSN---PWDHI---SDS-AKDLVMGMLSTDPSQRLTARQVL 296
                       R   L  P     PW+ +   +DS A DL+  ML+ +P +R+   Q L
Sbjct: 251 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 297 DHSWMG 302
            H ++ 
Sbjct: 311 AHPYLA 316

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 77
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 189
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  +    + ++F   R   
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR--- 246
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  P  R T  ++ +H WM D
Sbjct: 247 ----------VSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQD 280

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ D+GLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDYGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S+L +R+ LG+ LG+G    + +  D       A K +  D  +  D    ++   E   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQN 65
Query: 97  RLS-GHPNVVDLKAVYEDEDYV----HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
             +  HP +V +    E E       ++VME   G  L   +   G  +   A  +    
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT---VGS 207
            Q + + H+ G++HRD+KP NI++   ++++ +K+ DFG+A  I + G S+  T   +G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 208 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSN 265
             Y++PE   G   +  +DV+S G +LY +L+G PPF G++  S  +  VR  D   PS 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPPSA 241
Query: 266 PWDHISDSAKDLVMGMLSTDPSQR 289
             + +S     +V+  L+ +P  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 39  LRERFVLGQQLGWGQFGV----IRVCSDKFTGEVFACKSIAKDRLV---TIDDERSVKLE 91
           L  ++ +G  LG G FG     IRV SD       A K + KDR+     + +   V +E
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRV-SDNLP---VAIKHVEKDRISDWGELPNGTRVPME 57
Query: 92  IEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFM 149
           + ++ ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F 
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---- 205
           Q+++ V +CH  GV+HRD+K ENIL+    +   +KL DFG       G  L  TV    
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG------SGALLKDTVYTDF 169
Query: 206 -GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK---SRIFDAVRTAD 259
            G+  Y  PE +     + ++A VWS G++LY ++ G  PF  + +    ++F   R   
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR--- 226
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +S   + L+   L+  PS R T  ++ +H WM D
Sbjct: 227 ----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S+L +R+ LG+ LG+G    + +  D       A K +  D  +  D    ++   E   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQN 65
Query: 97  RLS-GHPNVVDLKAVYEDEDYV----HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
             +  HP +V +    E E       ++VME   G  L   +   G  +   A  +    
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT---VGS 207
            Q + + H+ G++HRD+KP NI++   ++++ +K+ DFG+A  I + G S+  T   +G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 208 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSN 265
             Y++PE   G   +  +DV+S G +LY +L+G PPF G++  S  +  VR  D   PS 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPPSA 241
Query: 266 PWDHISDSAKDLVMGMLSTDPSQR 289
             + +S     +V+  L+ +P  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 113/253 (44%), Gaps = 17/253 (6%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G +G +     K  G ++A K          D  R +  E+    ++  HP  V L
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQHPCCVRL 122
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           +  +E+   ++L  ELC G  L    E +G    EA+        +  + + H  G+VH 
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV--GSPFYIAPEVLAGGYNQAA 224
           D+KP NI L  +      KL DFGL   +E G +  G V  G P Y+APE+L G Y  AA
Sbjct: 182 DVKPANIFLGPRGR---CKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAA 236
Query: 225 DVWSAGV-ILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS 283
           DV+S G+ IL +  +   P  G    ++           P      +S   + +++ ML 
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELRSVLVMMLE 290
Query: 284 TDPSQRLTARQVL 296
            DP  R TA  +L
Sbjct: 291 PDPKLRATAEALL 303

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 40  RERFVLGQQLGWGQFGVIR---VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RER  LG+ +G GQFG +      S +      A K+       T D  R   L+  +  
Sbjct: 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTM 445
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQV 154
           R   HP++V L  V   E+ V ++MELC  GEL  F ++ KF     A   +   QL   
Sbjct: 446 RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTA 503
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIA 212
           + Y      VHRD+   N+L+   +S+  +KL DFGL+ Y+E       + G  P  ++A
Sbjct: 504 LAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 213 PEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           PE +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  + 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NC 617
Query: 271 SDSAKDLVMGMLSTDPSQR 289
             +   L+    + DPS+R
Sbjct: 618 PPTLYSLMTKCWAYDPSRR 636

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 40  RERFVLGQQLGWGQFGVIR---VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RER  LG+ +G GQFG +      S +      A K+       T D  R   L+  +  
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTM 65
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQV 154
           R   HP++V L  V   E+ V ++MELC  GEL  F ++ KF     A   +   QL   
Sbjct: 66  RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTA 123
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIA 212
           + Y      VHRD+   N+L+   +++  +KL DFGL+ Y+E       + G  P  ++A
Sbjct: 124 LAYLESKRFVHRDIAARNVLV---SATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 213 PEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           PE +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  + 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NC 237
Query: 271 SDSAKDLVMGMLSTDPSQR 289
             +   L+    + DPS+R
Sbjct: 238 PPTLYSLMTKCWAYDPSRR 256

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DF LA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFYLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 131/260 (50%), Gaps = 27/260 (10%)
Query: 47  QQLGWGQFGVI---RVCSDKFTGEVFACKSI----AKDRLVTIDDERSVKLEIEIMTRLS 99
           +Q+G G FG++   R+  DK    V A KS+    ++     I+  +  + E+ IM+ L+
Sbjct: 25  KQIGKGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYC 158
            HPN+V L  +  +     +VME    G+L+HRL +K      +    L + +   + Y 
Sbjct: 82  -HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 159 HEIG--VVHRDLKPENILLATKASSSPI--KLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
                 +VHRDL+  NI L +   ++P+  K+ADFGL+   +   S+ G +G+  ++APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPE 196
Query: 215 VLAG---GYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDH 269
            +      Y + AD +S  +ILY +L+G  PF  +   K +  + +R   LR P+ P D 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-PTIPED- 254
Query: 270 ISDSAKDLVMGMLSTDPSQR 289
                ++++    S DP +R
Sbjct: 255 CPPRLRNVIELCWSGDPKKR 274

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S+L +R+ LG+ LG+G    + +  D       A K +  D  +  D    ++   E   
Sbjct: 25  SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQN 82
Query: 97  RLS-GHPNVVDLKAVYEDEDYV----HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
             +  HP +V +    E E       ++VME   G  L   +   G  +   A  +    
Sbjct: 83  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 142
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGT---VGS 207
            Q + + H+ G++HRD+KP NI++   ++++ +K+ DFG+A  I + G S+  T   +G+
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 208 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRI-FDAVRTADLRFPSN 265
             Y++PE   G   +  +DV+S G +LY +L+G PPF G++   + +  VR  D   PS 
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPPSA 258
Query: 266 PWDHISDSAKDLVMGMLSTDPSQR 289
             + +S     +V+  L+ +P  R
Sbjct: 259 RHEGLSADLDAVVLKALAKNPENR 282

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 40  RERFVLGQQLGWGQFGVIR---VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RER  LG+ +G GQFG +      S +      A K+       T D  R   L+  +  
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTM 65
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQV 154
           R   HP++V L  V   E+ V ++MELC  GEL  F ++ K+     A   +   QL   
Sbjct: 66  RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 123
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIA 212
           + Y      VHRD+   N+L++   S+  +KL DFGL+ Y+E       + G  P  ++A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 213 PEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           PE +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  + 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NC 237
Query: 271 SDSAKDLVMGMLSTDPSQR 289
             +   L+    + DPS+R
Sbjct: 238 PPTLYSLMTKCWAYDPSRR 256

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 138/304 (45%), Gaps = 45/304 (14%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  +G   A K +++     I  +R+ + E+ ++  +  
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 108
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 166
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 167 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLARHTD--DEMTGYVATRWYRAPE 221
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAVRTADL----RFPS 264
           ++     YN   D+WS G I+  LL+G   F G    N   +I     T       R PS
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPS 281
Query: 265 N------------PWDHISDS-------AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI 305
           +            P  + +D        A DL+  ML  D  +R+TA + L H +     
Sbjct: 282 HEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ-Y 340
Query: 306 QDPE 309
            DP+
Sbjct: 341 HDPD 344

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 120/256 (46%), Gaps = 14/256 (5%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RER  LG+ +G GQFG +               +I   +  T D  R   L+  +  R  
Sbjct: 37  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 96
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            HP++V L  V   E+ V ++MELC  GEL  F ++ K+     A   +   QL   + Y
Sbjct: 97  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 154
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAPEV 215
                 VHRD+   N+L++   S+  +KL DFGL+ Y+E       + G  P  ++APE 
Sbjct: 155 LESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 211
Query: 216 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 212 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 268
Query: 274 AKDLVMGMLSTDPSQR 289
              L+    + DPS+R
Sbjct: 269 LYSLMTKCWAYDPSRR 284

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 120/256 (46%), Gaps = 14/256 (5%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RER  LG+ +G GQFG +               +I   +  T D  R   L+  +  R  
Sbjct: 12  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            HP++V L  V   E+ V ++MELC  GEL  F ++ K+     A   +   QL   + Y
Sbjct: 72  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAPEV 215
                 VHRD+   N+L++   S+  +KL DFGL+ Y+E       + G  P  ++APE 
Sbjct: 130 LESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 216 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 187 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 243
Query: 274 AKDLVMGMLSTDPSQR 289
              L+    + DPS+R
Sbjct: 244 LYSLMTKCWAYDPSRR 259

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 40  RERFVLGQQLGWGQFGVIR---VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RER  LG+ +G GQFG +      S +      A K+       T D  R   L+  +  
Sbjct: 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTM 445
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQV 154
           R   HP++V L  V   E+ V ++MELC  GEL  F ++ KF     A   +   QL   
Sbjct: 446 RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTA 503
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIA 212
           + Y      VHRD+   N+L+   +++  +KL DFGL+ Y+E       + G  P  ++A
Sbjct: 504 LAYLESKRFVHRDIAARNVLV---SATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 213 PEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           PE +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  + 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NC 617
Query: 271 SDSAKDLVMGMLSTDPSQR 289
             +   L+    + DPS+R
Sbjct: 618 PPTLYSLMTKCWAYDPSRR 636

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 120/256 (46%), Gaps = 14/256 (5%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RER  LG+ +G GQFG +               +I   +  T D  R   L+  +  R  
Sbjct: 11  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 70
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            HP++V L  V   E+ V ++MELC  GEL  F ++ K+     A   +   QL   + Y
Sbjct: 71  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 128
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAPEV 215
                 VHRD+   N+L++   S+  +KL DFGL+ Y+E       + G  P  ++APE 
Sbjct: 129 LESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 216 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 186 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 242
Query: 274 AKDLVMGMLSTDPSQR 289
              L+    + DPS+R
Sbjct: 243 LYSLMTKCWAYDPSRR 258

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 120/256 (46%), Gaps = 14/256 (5%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RER  LG+ +G GQFG +               +I   +  T D  R   L+  +  R  
Sbjct: 14  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 73
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            HP++V L  V   E+ V ++MELC  GEL  F ++ K+     A   +   QL   + Y
Sbjct: 74  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 131
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAPEV 215
                 VHRD+   N+L++   S+  +KL DFGL+ Y+E       + G  P  ++APE 
Sbjct: 132 LESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188
Query: 216 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 245
Query: 274 AKDLVMGMLSTDPSQR 289
              L+    + DPS+R
Sbjct: 246 LYSLMTKCWAYDPSRR 261

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 120/256 (46%), Gaps = 14/256 (5%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RER  LG+ +G GQFG +               +I   +  T D  R   L+  +  R  
Sbjct: 6   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            HP++V L  V   E+ V ++MELC  GEL  F ++ K+     A   +   QL   + Y
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 123
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAPEV 215
                 VHRD+   N+L++   S+  +KL DFGL+ Y+E       + G  P  ++APE 
Sbjct: 124 LESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 216 LA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  +   +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NCPPT 237
Query: 274 AKDLVMGMLSTDPSQR 289
              L+    + DPS+R
Sbjct: 238 LYSLMTKCWAYDPSRR 253

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 40  RERFVLGQQLGWGQFGVIR---VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RER  LG+ +G GQFG +      S +      A K+       T D  R   L+  +  
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTM 65
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQV 154
           R   HP++V L  V   E+ V ++MELC  GEL  F ++ K+     A   +   QL   
Sbjct: 66  RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 123
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIA 212
           + Y      VHRD+   N+L++   S+  +KL DFGL+ Y+E       + G  P  ++A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 213 PEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           PE +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P  P  + 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPP--NC 237
Query: 271 SDSAKDLVMGMLSTDPSQR 289
             +   L+    + DPS+R
Sbjct: 238 PPTLYSLMTKCWAYDPSRR 256

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+  FGLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILGFGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 137/310 (44%), Gaps = 52/310 (16%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD-ERSVKLEIEIMTRLSGHPN-- 103
           + L  G+F  I +C      + +A K   K  L    D  +S   +I I ++     N  
Sbjct: 37  RTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 104 --VVDLKAVY--------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
             + D+K  Y         + D V+++ E      +    E F    +     + +Q+++
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 154 VVL--------YCH-EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
            ++        Y H E  + HRD+KP NIL+     +  +KL+DFG + Y+   + + G+
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYM-VDKKIKGS 210
Query: 205 VGSPFYIAPEVLAG--GYNQA-ADVWSAGVILYILLSGMPPF-WGNTKSRIFDAVRTADL 260
            G+  ++ PE  +    YN A  D+WS G+ LY++   + PF    +   +F+ +RT ++
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 261 RFP-----------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
            +P                 SN +  +S+   D +   L  +P++R+T+   L H W+ D
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNF--LSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328
Query: 304 -GIQDPEKLS 312
             I+D  + S
Sbjct: 329 TNIEDLREFS 338

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 50/297 (16%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L+   V  + LG+G  G + V    F G   A K +       ID      +EI+++T  
Sbjct: 13  LKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRML------IDFCDIALMEIKLLTES 65
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--------LFMQ 150
             HPNV+        + ++++ +ELC        L +    S+   ++        L  Q
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATK----------ASSSPIKLADFGLATYIEPGQS 200
           +   V + H + ++HRDLKP+NIL++T           A +  I ++DFGL   ++ GQS
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 201 LLGT-----VGSPFYIAPEVLAGGYN--------QAADVWSAGVILYILLS-GMPPFWGN 246
              T      G+  + APE+L    N        ++ D++S G + Y +LS G  PF G+
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-GD 242
Query: 247 TKSRIFDAVRTADLRFPSNPWDHISD-----SAKDLVMGMLSTDPSQRLTARQVLDH 298
             SR  + +R     F  +    + D      A DL+  M+  DP +R TA +VL H
Sbjct: 243 KYSRESNIIRGI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ D GLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDAGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGH 101
           +L Q    G   V +V ++K   +++A K +  +     T+D  R+   EI  + +L  H
Sbjct: 60  ILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQH 114
Query: 102 PNVVDLKAVYEDED-YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            + +     YE  D Y+++VME C   +L   L+K       E +  +  +++ V   H+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G+VH DLKP N L+        +KL DFG+A  ++P  + +     VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 218 G------------GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVR-TADLRF 262
                          +  +DVWS G ILY +  G  PF    N  S++   +    ++ F
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  P        +D++   L  DP QR++  ++L H ++
Sbjct: 290 PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 115/256 (44%), Gaps = 43/256 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQDPEKLS 312
           +H +    ++D  ++S
Sbjct: 320 EHPYFYTVVKDQARMS 335

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 36/249 (14%)
Query: 70  ACKSIAKDRLV---TIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDYVHLVMELCA 125
           A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D   L++E   
Sbjct: 80  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 139
Query: 126 G-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPI 184
              +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+    +   +
Sbjct: 140 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGEL 197
Query: 185 KLADFGLATYIEPGQSLLGTV-----GSPFYIAPEVLAGG--YNQAADVWSAGVILYILL 237
           KL DFG       G  L  TV     G+  Y  PE +     + ++A VWS G++LY ++
Sbjct: 198 KLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 238 SGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQ 294
            G  PF  +    + ++F   R             +S   + L+   L+  PS R T  +
Sbjct: 252 CGDIPFEHDEEIIRGQVFFRQR-------------VSSECQHLIRWCLALRPSDRPTFEE 298
Query: 295 VLDHSWMGD 303
           + +H WM D
Sbjct: 299 IQNHPWMQD 307

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGH 101
           +L Q    G   V +V ++K   +++A K +  +     T+D  R+   EI  + +L  H
Sbjct: 13  ILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQH 67
Query: 102 PNVVDLKAVYEDED-YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            + +     YE  D Y+++VME C   +L   L+K       E +  +  +++ V   H+
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G+VH DLKP N L+        +KL DFG+A  ++P  + +     VG+  Y+ PE + 
Sbjct: 127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 218 G------------GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVR-TADLRF 262
                          +  +DVWS G ILY +  G  PF    N  S++   +    ++ F
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  P        +D++   L  DP QR++  ++L H ++
Sbjct: 243 PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGH 101
           +L Q    G   V +V ++K   +++A K +  +     T+D  R+   EI  + +L  H
Sbjct: 60  ILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQH 114
Query: 102 PNVVDLKAVYEDED-YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            + +     YE  D Y+++VME C   +L   L+K       E +  +  +++ V   H+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G+VH DLKP N L+        +KL DFG+A  ++P  + +     VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 218 G------------GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVR-TADLRF 262
                          +  +DVWS G ILY +  G  PF    N  S++   +    ++ F
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  P        +D++   L  DP QR++  ++L H ++
Sbjct: 290 PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGH 101
           +L Q    G   V +V ++K   +++A K +  +     T+D  R+   EI  + +L  H
Sbjct: 60  ILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQH 114
Query: 102 PNVVDLKAVYEDED-YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            + +     YE  D Y+++VME C   +L   L+K       E +  +  +++ V   H+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G+VH DLKP N L+        +KL DFG+A  ++P  + +     VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 218 G------------GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVR-TADLRF 262
                          +  +DVWS G ILY +  G  PF    N  S++   +    ++ F
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  P        +D++   L  DP QR++  ++L H ++
Sbjct: 290 PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ D GLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDRGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 130/260 (50%), Gaps = 27/260 (10%)
Query: 47  QQLGWGQFGVI---RVCSDKFTGEVFACKSI----AKDRLVTIDDERSVKLEIEIMTRLS 99
           +Q+G G FG++   R+  DK    V A KS+    ++     I+  +  + E+ IM+ L+
Sbjct: 25  KQIGKGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYC 158
            HPN+V L  +  +     +VME    G+L+HRL +K      +    L + +   + Y 
Sbjct: 82  -HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 159 HEIG--VVHRDLKPENILLATKASSSPI--KLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
                 +VHRDL+  NI L +   ++P+  K+ADFG  T  +   S+ G +G+  ++APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--TSQQSVHSVSGLLGNFQWMAPE 196
Query: 215 VLAG---GYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDH 269
            +      Y + AD +S  +ILY +L+G  PF  +   K +  + +R   LR P+ P D 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-PTIPED- 254
Query: 270 ISDSAKDLVMGMLSTDPSQR 289
                ++++    S DP +R
Sbjct: 255 CPPRLRNVIELCWSGDPKKR 274

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 136/305 (44%), Gaps = 47/305 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V+      E+ + V+LV  L   G   + + K  + ++   + L  Q+++ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ D GLA + +    + G V + +Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCE---LKILDGGLARHTD--DEMTGYVATRWYRAPE 192
Query: 215 VLAG--GYNQAADVWSAGVILYILLSGMPPFWG--------------------------- 245
           ++     YNQ  D+WS G I+  LL+G   F G                           
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 246 -NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            + ++ I    +   + F +N +   +  A DL+  ML  D  +R+TA Q L H++    
Sbjct: 253 ESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 310
Query: 305 IQDPE 309
             DP+
Sbjct: 311 YHDPD 315

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGH 101
           +L Q    G   V +V ++K   +++A K +  +     T+D  R+   EI  + +L  H
Sbjct: 32  ILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQH 86
Query: 102 PNVVDLKAVYEDED-YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            + +     YE  D Y+++VME C   +L   L+K       E +  +  +++ V   H+
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G+VH DLKP N L+        +KL DFG+A  ++P  + +     VG+  Y+ PE + 
Sbjct: 146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 218 G------------GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVR-TADLRF 262
                          +  +DVWS G ILY +  G  PF    N  S++   +    ++ F
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  P        +D++   L  DP QR++  ++L H ++
Sbjct: 262 PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/221 (34%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 40  RERFVLGQQLGWGQFG-VIRVCSDKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RE  VL + LG G FG V         GE    A K+  KD   T+D++     E  IM 
Sbjct: 23  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 80
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-MQLMQVV 155
            L  HP++V L  + E+E    ++MEL   GEL H LE+     +    VL+ +Q+ + +
Sbjct: 81  NLD-HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 138
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAP 213
            Y   I  VHRD+   NIL+   AS   +KL DFGL+ YIE       +V   P  +++P
Sbjct: 139 AYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 195
Query: 214 EVLA-GGYNQAADVWSAGVILYILLS--GMPPFWGNTKSRI 251
           E +    +  A+DVW   V ++ +LS    P FW   K  I
Sbjct: 196 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 236

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 52/292 (17%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTRLSGHPNVV 105
           Q LG G FGV+    +K     +A K I   RL   +  R  V  E++ + +L  HP +V
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKLE-HPGIV 66
Query: 106 DLKAVYEDED------------YVHLVMELCAGGELFHRLEKFGRFSEAEARV---LFMQ 150
                + +++            Y+++ M+LC    L   +       E E  V   +F+Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI---EPGQSLL----- 202
           + + V + H  G++HRDLKP NI          +K+ DFGL T +   E  Q++L     
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 203 -----GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR 256
                G VG+  Y++PE + G  Y+   D++S G+IL+ LL    PF      R+     
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF-STQMERVRTLTD 239
Query: 257 TADLRFP-----SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
             +L+FP       P +++      +V  MLS  P +R  A  +++++   D
Sbjct: 240 VRNLKFPPLFTQKYPCEYV------MVQDMLSPSPMERPEAINIIENAVFED 285

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGH 101
           +L Q    G   V +V ++K   +++A K +  +     T+D  R+   EI  + +L  H
Sbjct: 32  ILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQH 86
Query: 102 PNVVDLKAVYEDED-YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            + +     YE  D Y+++VME C   +L   L+K       E +  +  +++ V   H+
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G+VH DLKP N L+        +KL DFG+A  ++P    +     VG+  Y+ PE + 
Sbjct: 146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201
Query: 218 G------------GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVR-TADLRF 262
                          +  +DVWS G ILY +  G  PF    N  S++   +    ++ F
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  P        +D++   L  DP QR++  ++L H ++
Sbjct: 262 PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+L+  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVLIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQDPEKL 311
           +H +    ++D  ++
Sbjct: 320 EHPYFYTVVKDQARM 334

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/221 (34%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 40  RERFVLGQQLGWGQFG-VIRVCSDKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RE  VL + LG G FG V         GE    A K+  KD   T+D++     E  IM 
Sbjct: 7   REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 64
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-MQLMQVV 155
            L  HP++V L  + E+E    ++MEL   GEL H LE+     +    VL+ +Q+ + +
Sbjct: 65  NLD-HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 122
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAP 213
            Y   I  VHRD+   NIL+   AS   +KL DFGL+ YIE       +V   P  +++P
Sbjct: 123 AYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 179
Query: 214 EVLA-GGYNQAADVWSAGVILYILLS--GMPPFWGNTKSRI 251
           E +    +  A+DVW   V ++ +LS    P FW   K  I
Sbjct: 180 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGH 101
           +L Q    G   V +V ++K   +++A K +  +     T+D  R+   EI  + +L  H
Sbjct: 16  ILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQH 70
Query: 102 PNVVDLKAVYEDED-YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            + +     YE  D Y+++VME C   +L   L+K       E +  +  +++ V   H+
Sbjct: 71  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G+VH DLKP N L+        +KL DFG+A  ++P  + +     VG+  Y+ PE + 
Sbjct: 130 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185
Query: 218 G------------GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVR-TADLRF 262
                          +  +DVWS G ILY +  G  PF    N  S++   +    ++ F
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 245
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  P        +D++   L  DP QR++  ++L H ++
Sbjct: 246 PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL--VTIDDERSVKLEIEIMTRLSGH 101
           +L Q    G   V +V ++K   +++A K +  +     T+D  R+   EI  + +L  H
Sbjct: 12  ILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQH 66
Query: 102 PNVVDLKAVYEDED-YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            + +     YE  D Y+++VME C   +L   L+K       E +  +  +++ V   H+
Sbjct: 67  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
            G+VH DLKP N L+        +KL DFG+A  ++P  + +     VG+  Y+ PE + 
Sbjct: 126 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 218 G------------GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVR-TADLRF 262
                          +  +DVWS G ILY +  G  PF    N  S++   +    ++ F
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 241
Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P  P        +D++   L  DP QR++  ++L H ++
Sbjct: 242 PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/221 (34%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 40  RERFVLGQQLGWGQFG-VIRVCSDKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMT 96
           RE  VL + LG G FG V         GE    A K+  KD   T+D++     E  IM 
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 68
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-MQLMQVV 155
            L  HP++V L  + E+E    ++MEL   GEL H LE+     +    VL+ +Q+ + +
Sbjct: 69  NLD-HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAP 213
            Y   I  VHRD+   NIL+   AS   +KL DFGL+ YIE       +V   P  +++P
Sbjct: 127 AYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183
Query: 214 EVLA-GGYNQAADVWSAGVILYILLS--GMPPFWGNTKSRI 251
           E +    +  A+DVW   V ++ +LS    P FW   K  I
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 27/260 (10%)
Query: 47  QQLGWGQFGVI---RVCSDKFTGEVFACKSI----AKDRLVTIDDERSVKLEIEIMTRLS 99
           +Q+G G FG++   R+  DK    V A KS+    ++     I+  +  + E+ IM+ L+
Sbjct: 25  KQIGKGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYC 158
            HPN+V L  +  +     +VME    G+L+HRL +K      +    L + +   + Y 
Sbjct: 82  -HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 159 HEIG--VVHRDLKPENILLATKASSSPI--KLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
                 +VHRDL+  NI L +   ++P+  K+ADF L+   +   S+ G +G+  ++APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAPE 196
Query: 215 VLAG---GYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDH 269
            +      Y + AD +S  +ILY +L+G  PF  +   K +  + +R   LR P+ P D 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-PTIPED- 254
Query: 270 ISDSAKDLVMGMLSTDPSQR 289
                ++++    S DP +R
Sbjct: 255 CPPRLRNVIELCWSGDPKKR 274

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQDPEKL 311
           +H +    ++D  ++
Sbjct: 320 EHPYFYTVVKDQARM 334

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQDPEKL 311
           +H +    ++D  ++
Sbjct: 320 EHPYFYTVVKDQARM 334

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 13/212 (6%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLS 99
           E ++   +LG G +  +     K T  + A K I   RL   +      + E+ ++  L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYC 158
            H N+V L  +   E  + LV E     +L   L+  G         LF+ QL++ + YC
Sbjct: 59  -HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQSLLGTVGSPFYIAPEVLA 217
           H   V+HRDLKP+N+L+  +     +KLADFGLA     P ++    V + +Y  P++L 
Sbjct: 117 HRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNT 247
           G   Y+   D+W  G I Y + +G P F G+T
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 135/312 (43%), Gaps = 59/312 (18%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL----EIEIMTRLSG--H 101
           ++G G +G +    D   G  F    +A  R+     E  + L    E+ ++  L    H
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 102 PNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQ 153
           PNVV L  V      + E  + LV E     +L   L+K    G  +E    ++F QL++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMF-QLLR 131
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            + + H   VVHRDLKP+NIL+    SS  IKLADFGLA       +L   V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 214 EV-LAGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTA-------DLR 261
           EV L   Y    D+WS G I   +    P F G++      +I D +          D+ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 262 FPSNPWD------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
            P   +              I +  KDL++  L+ +P++R++A   L H +  D      
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD------ 302
Query: 310 KLSGNKIEDCKE 321
                 +E CKE
Sbjct: 303 ------LERCKE 308

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 133/297 (44%), Gaps = 50/297 (16%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L+   V  + LG+G  G + V    F G   A K +       ID      +EI+++T  
Sbjct: 13  LKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTES 65
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--------LFMQ 150
             HPNV+        + ++++ +ELC        L +    S+   ++        L  Q
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATK----------ASSSPIKLADFGLATYIEPGQ- 199
           +   V + H + ++HRDLKP+NIL++T           A +  I ++DFGL   ++ GQ 
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 183
Query: 200 ----SLLGTVGSPFYIAPEVLAGGYN--------QAADVWSAGVILYILLS-GMPPFWGN 246
               +L    G+  + APE+L    N        ++ D++S G + Y +LS G  PF G+
Sbjct: 184 XFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-GD 242
Query: 247 TKSRIFDAVRTADLRFPSNPWDHISD-----SAKDLVMGMLSTDPSQRLTARQVLDH 298
             SR  + +R     F  +    + D      A DL+  M+  DP +R TA +VL H
Sbjct: 243 KYSRESNIIRGI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQDPEKL 311
           +H +    ++D  ++
Sbjct: 320 EHPYFYTVVKDQARM 334

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 84  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 140
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318
Query: 297 DHSWMGDGIQDPEKL 311
           +H +    ++D  ++
Sbjct: 319 EHPYFYTVVKDQARM 333

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQDPEKL 311
           +H +    ++D  ++
Sbjct: 320 EHPYFYTVVKDQARM 334

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 90  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 146
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 147 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 204
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 205 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 264
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 265 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 324
Query: 297 DHSWMGDGIQDPEKL 311
           +H +    ++D  ++
Sbjct: 325 EHPYFYTVVKDQARM 339

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 132/293 (45%), Gaps = 46/293 (15%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L+   V  + LG+G  G + V    F G   A K +       ID      +EI+++T  
Sbjct: 31  LKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTES 83
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--------LFMQ 150
             HPNV+        + ++++ +ELC        L +    S+   ++        L  Q
Sbjct: 84  DDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQ 141
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATK----------ASSSPIKLADFGLATYIEPGQ- 199
           +   V + H + ++HRDLKP+NIL++T           A +  I ++DFGL   ++ GQ 
Sbjct: 142 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 201
Query: 200 ----SLLGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLS-GMPPFWGNTKSR 250
               +L    G+  + APE+L         ++ D++S G + Y +LS G  PF G+  SR
Sbjct: 202 XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF-GDKYSR 260
Query: 251 IFDAVRTADLRFPSNPWDHISD-----SAKDLVMGMLSTDPSQRLTARQVLDH 298
             + +R     F  +    + D      A DL+  M+  DP +R TA +VL H
Sbjct: 261 ESNIIRGI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L +    ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQ--TLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQDPEKL 311
           +H +    ++D  ++
Sbjct: 320 EHPYFYTVVKDQARM 334

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 132/293 (45%), Gaps = 46/293 (15%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L+   V  + LG+G  G + V    F G   A K +       ID      +EI+++T  
Sbjct: 31  LKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTES 83
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--------LFMQ 150
             HPNV+        + ++++ +ELC        L +    S+   ++        L  Q
Sbjct: 84  DDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQ 141
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATK----------ASSSPIKLADFGLATYIEPGQ- 199
           +   V + H + ++HRDLKP+NIL++T           A +  I ++DFGL   ++ GQ 
Sbjct: 142 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 201
Query: 200 ----SLLGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLS-GMPPFWGNTKSR 250
               +L    G+  + APE+L         ++ D++S G + Y +LS G  PF G+  SR
Sbjct: 202 XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF-GDKYSR 260
Query: 251 IFDAVRTADLRFPSNPWDHISD-----SAKDLVMGMLSTDPSQRLTARQVLDH 298
             + +R     F  +    + D      A DL+  M+  DP +R TA +VL H
Sbjct: 261 ESNIIRGI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 135/308 (43%), Gaps = 57/308 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D   G   A K +++        +R+ + E+ ++ +   
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-EL-VLLKCVN 79
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLM 152
           H N++ L  V+      E+   V+LVMEL      ++ H      R S      L  Q++
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQML 134
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
             + + H  G++HRDLKP NI++ +  +   +K+ DFGLA        +   V + +Y A
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTASTNFMMTPYVVTRYYRA 191
Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRF----- 262
           PEV+ G GY +  D+WS G I+  L+ G   F G       +++ + + T    F     
Sbjct: 192 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQ 251
Query: 263 ----------PSNP----------WDHISDS---------AKDLVMGMLSTDPSQRLTAR 293
                     P+ P          W   S+S         A+DL+  ML  DP +R++  
Sbjct: 252 PTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVD 311
Query: 294 QVLDHSWM 301
           + L H ++
Sbjct: 312 EALRHPYI 319

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 43/251 (17%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 84  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 140
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318
Query: 297 DHSWMGDGIQD 307
           +H +    ++D
Sbjct: 319 EHPYFYTVVKD 329

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 135/312 (43%), Gaps = 59/312 (18%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL----EIEIMTRLSG--H 101
           ++G G +G +    D   G  F    +A  R+     E  + L    E+ ++  L    H
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 102 PNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQ 153
           PNVV L  V      + E  + LV E     +L   L+K    G  +E    ++F QL++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMF-QLLR 131
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            + + H   VVHRDLKP+NIL+    SS  IKLADFGLA       +L   V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 214 EV-LAGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTA-------DLR 261
           EV L   Y    D+WS G I   +    P F G++      +I D +          D+ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 262 FPSNPWD------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
            P   +              I +  KDL++  L+ +P++R++A   L H +  D      
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD------ 302
Query: 310 KLSGNKIEDCKE 321
                 +E CKE
Sbjct: 303 ------LERCKE 308

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 43/251 (17%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQD 307
           +H +    ++D
Sbjct: 320 EHPYFYTVVKD 330

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 43/251 (17%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWMGDGIQD 307
           +H +    ++D
Sbjct: 320 EHPYFYTVVKD 330

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 87/347 (25%), Positives = 145/347 (41%), Gaps = 89/347 (25%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + +++   +G G +G + +  DK T +  A K + +     ID +R ++ EI I+ RL  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKS 84
Query: 101 HPNVVDLKAVYEDE----DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
              +     +  D+    D +++V+E+ A  +L    +     +E   + +   L+    
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI----------------EPG-- 198
           + HE G++HRDLKP N LL    S   +K+ DFGLA  I                EPG  
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCS---VKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 199 -----QSLLGTVGSPFYIAPE--VLAGGYNQAADVWSAGVILYILLSGM----------- 240
                + L   V + +Y APE  +L   Y ++ D+WS G I   LL+ +           
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 241 PPFWG----------NTK-----------SRIFDAVRTA---DLRFPSNP---------- 266
           P F G          N+K           + IF+ + T    DL+  + P          
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320
Query: 267 ----------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     +  ISD   +L+  ML  +P++R+T  Q LDH ++ D
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 43/251 (17%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 83  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 139
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 140 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
Query: 297 DHSWMGDGIQD 307
           +H +    ++D
Sbjct: 318 EHPYFYTVVKD 328

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 138/320 (43%), Gaps = 74/320 (23%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK---LEIEI 94
           +L  R++  + LG G  G++    D    +  A K I       + D +SVK    EI+I
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------VLTDPQSVKHALREIKI 61
Query: 95  MTRLSGHPNVV---------------------DLKAVYEDEDYVHLVMELCAGGELFHRL 133
           + RL  H N+V                     +L +VY  ++Y+          +L + L
Sbjct: 62  IRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--------TDLANVL 112
Query: 134 EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT 193
           E+ G   E  AR+   QL++ + Y H   V+HRDLKP N+ + T+     +K+ DFGLA 
Sbjct: 113 EQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE--DLVLKIGDFGLAR 169
Query: 194 YIEPGQSLLGTVG----SPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNT 247
            ++P  S  G +     + +Y +P +L     Y +A D+W+AG I   +L+G   F G  
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 248 K----SRIFDAVRTA------------------DLRFPSNPWDH----ISDSAKDLVMGM 281
           +      I +++                     D+  P  P       IS  A D +  +
Sbjct: 230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI 289
Query: 282 LSTDPSQRLTARQVLDHSWM 301
           L+  P  RLTA + L H +M
Sbjct: 290 LTFSPMDRLTAEEALSHPYM 309

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 109/245 (44%), Gaps = 43/245 (17%)
Query: 95  MTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN++ L  + +D       LV E     + F +L  +   ++ + R    +++
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEIL 141
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 213 PEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +L  ++    PF+    +     RI   + T DL     
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 261 ---------------RFPSNPWDH---------ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R     W+          +S  A D +  +L  D   RLTAR+ +
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 297 DHSWM 301
           +H + 
Sbjct: 320 EHPYF 324

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 129/292 (44%), Gaps = 47/292 (16%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL----EIEIMTRLSG--H 101
           ++G G +G +    D   G  F    +A  R+     E  + L    E+ ++  L    H
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 102 PNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFMQLMQ 153
           PNVV L  V      + E  + LV E     +L   L+K    G  +E    ++F QL++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMF-QLLR 131
Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            + + H   VVHRDLKP+NIL+    SS  IKLADFGLA       +L   V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 214 EV-LAGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTA-------DLR 261
           EV L   Y    D+WS G I   +    P F G++      +I D +          D+ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 262 FPSNPWD------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            P   +              I +  KDL++  L+ +P++R++A   L H + 
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 102/241 (42%), Gaps = 41/241 (17%)
Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+SN+   F +  ++G G F  + + + +   +V   + IA   L+       +  E++ 
Sbjct: 18  QLSNV---FKIEDKIGEGTFSSVYLATAQL--QVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           +T   G  NV+ +K  +   D+V + M           L+     S  E R   + L + 
Sbjct: 73  LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESF---LDILNSLSFQEVREYMLNLFKA 129
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-----TYIE------------- 196
           +   H+ G+VHRD+KP N L   +       L DFGLA     T IE             
Sbjct: 130 LKRIHQFGIVHRDVKPSNFLYNRRLKK--YALVDFGLAQGTHDTKIELLKFVQSEAQQER 187
Query: 197 -----------PGQSLLGTVGSPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPF 243
                        Q +    G+P + APEVL    NQ  A D+WSAGVI   LLSG  PF
Sbjct: 188 CSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247
Query: 244 W 244
           +
Sbjct: 248 Y 248

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 41/296 (13%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           Q +G G +G +    D  TG   A K + +     +  +R+ + E+ ++  +  H NV+ 
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR-HENVIG 88
Query: 107 LKAVYE-DE---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           L  V+  DE   D+    + +   G    +L K  +  E   + L  Q+++ + Y H  G
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GY 220
           ++HRDLKP N+ +        +K+ DFGLA   +    + G V + +Y APEV+     Y
Sbjct: 149 IIHRDLKPGNLAV---NEDCELKILDFGLAR--QADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI-SDSAKDLVM 279
            Q  D+WS G I+  +++G   F G+        +       P+     + SD AK+ + 
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 280 G--------------------------MLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           G                          ML  D  QR+TA + L H +  + + D E
Sbjct: 264 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-ESLHDTE 318

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 139/311 (44%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M ++  
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KVVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V++VMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++ + A+   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT---LKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SR 250
            APEV+ G GY +  D+WS GVI+  ++ G   F G                       +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 251 IFDAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLT 291
           +   VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 292 ARQVLDHSWMG 302
             + L H ++ 
Sbjct: 312 VDEALQHPYIN 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 132/308 (42%), Gaps = 57/308 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D   G   A K +++        +R+ + E+ ++ +   
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-EL-VLLKCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLM 152
           H N++ L  V+      E+   V+LVMEL      ++ H      R S      L  Q++
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
             + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + +Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 193
Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGN--------------TKSRIFDAVRT 257
           PEV+ G GY    D+WS G I+  L+ G   F G               T S  F A   
Sbjct: 194 PEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQ 253
Query: 258 ADLR----------------------FPS-NPWDHISDS-AKDLVMGMLSTDPSQRLTAR 293
             +R                      FPS +  D I  S A+DL+  ML  DP +R++  
Sbjct: 254 PTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVD 313
Query: 294 QVLDHSWM 301
           + L H ++
Sbjct: 314 EALRHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 139/311 (44%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M ++  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KVVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V++VMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++ + A+   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT---LKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SR 250
            APEV+ G GY +  D+WS GVI+  ++ G   F G                       +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 251 IFDAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLT 291
           +   VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 292 ARQVLDHSWMG 302
             + L H ++ 
Sbjct: 312 VDEALQHPYIN 322

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 135/310 (43%), Gaps = 49/310 (15%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + + + + +G G +GV+     + TG+  A K I     V  + +R+++ E++I+     
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFK- 112
Query: 101 HPNVVDLKAV------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ +K +      Y +   V++V++L    +L   +      +    R    QL++ 
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI--EPGQS---LLGTVGSPF 209
           + Y H   V+HRDLKP N+L+        +K+ DFG+A  +   P +    +   V + +
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLVNENCE---LKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNT-------------------- 247
           Y APE++     Y QA D+WS G I   +L+    F G                      
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 288
Query: 248 ----KSRIFDAVRTADLRFPSNPWDHISDSAK----DLVMGMLSTDPSQRLTARQVLDHS 299
                 R+   +++   R P  PW+ +   A      L+  ML  +PS R++A   L H 
Sbjct: 289 QAVGAERVRAYIQSLPPRQPV-PWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 347
Query: 300 WMGDGIQDPE 309
           ++     DP+
Sbjct: 348 FLAK-YHDPD 356

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE-RSVKLEIEIMTRLSGH 101
             L + +G G FG  +V    + G+  A K+   D    I     +V+ E ++   L  H
Sbjct: 9   LTLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-H 65
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE- 160
           PN++ L+ V   E  + LVME   GG L +R+    R          +Q+ + + Y H+ 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 161 --IGVVHRDLKPENILLATKA-----SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
             + ++HRDLK  NIL+  K      S+  +K+ DFGLA       + +   G+  ++AP
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAP 183
Query: 214 EVL-AGGYNQAADVWSAGVILYILLSGMPPFWG 245
           EV+ A  +++ +DVWS GV+L+ LL+G  PF G
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 119
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 176
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 231
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSG-----------------MPPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 352 DALQHPYIN 360

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 141/298 (47%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 28  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 86
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + +++E C  G L   L     +F  + EA   +   F
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF 146
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIE 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y +
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKD 203
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 204 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 263
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 264 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 312

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G+FG +  C  +  G ++A K   K    ++D++ +++ E+     L  H +VV 
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVR 71
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIG 162
             + + ++D++ +  E C GG L   + +  R    F EAE + L +Q+ + + Y H + 
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 131
Query: 163 VVHRDLKPENILLATKA--------------SSSPI--KLADFGLATYIEPGQSLLGTVG 206
           +VH D+KP NI ++  +              +S+ +  K+ D G  T I   Q      G
Sbjct: 132 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---EEG 188
Query: 207 SPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
              ++A EVL   Y     AD+++  + + +  +G  P   N     +  +R    R P 
Sbjct: 189 DSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQ--WHEIRQG--RLPR 243
Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            P   +S    +L+  M+  DP +R +A  ++ HS
Sbjct: 244 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 277

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    DK TG  F C ++ K RL     E     E+     LS  P +V L
Sbjct: 79  RLGRGSFGEVHRMKDKQTG--FQC-AVKKVRLEVFRVE-----ELVACAGLSS-PRIVPL 129
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
                +  +V++ MEL  GG L   +++ G   E  A     Q ++ + Y H   ++H D
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 189
Query: 168 LKPENILLATKASSSPIKLADFGLATYIEP---GQSLLG---TVGSPFYIAPEVLAGGYN 221
           +K +N+LL++  S +   L DFG A  ++P   G+SLL      G+  ++APEV+ G   
Sbjct: 190 VKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 222 QA-ADVWSAGVILYILLSGMPPF 243
            A  D+WS+  ++  +L+G  P+
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G+FG +  C  +  G ++A K   K    ++D++ +++ E+     L  H +VV 
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVR 73
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIG 162
             + + ++D++ +  E C GG L   + +  R    F EAE + L +Q+ + + Y H + 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 163 VVHRDLKPENILLATKA--------------SSSPI--KLADFGLATYIEPGQSLLGTVG 206
           +VH D+KP NI ++  +              +S+ +  K+ D G  T I   Q      G
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---EEG 190
Query: 207 SPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
              ++A EVL   Y     AD+++  + + +  +G  P   N     +  +R    R P 
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQ--WHEIRQG--RLPR 245
Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            P   +S    +L+  M+  DP +R +A  ++ HS
Sbjct: 246 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 279

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 132/304 (43%), Gaps = 49/304 (16%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           + +G G +GV+     + TG+  A K I     V  + +R+++ E++I+     H N++ 
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFK-HDNIIA 117
Query: 107 LKAV------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           +K +      Y +   V++V++L    +L   +      +    R    QL++ + Y H 
Sbjct: 118 IKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYI--EPGQS---LLGTVGSPFYIAPEV 215
             V+HRDLKP N+L+        +K+ DFG+A  +   P +    +   V + +Y APE+
Sbjct: 177 AQVIHRDLKPSNLLVNENCE---LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 216 LAG--GYNQAADVWSAGVILYILLSGMPPFWGNT------------------------KS 249
           +     Y QA D+WS G I   +L+    F G                            
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 293
Query: 250 RIFDAVRTADLRFPSNPWDHISDSAK----DLVMGMLSTDPSQRLTARQVLDHSWMGDGI 305
           R+   +++   R P  PW+ +   A      L+  ML  +PS R++A   L H ++    
Sbjct: 294 RVRAYIQSLPPRQPV-PWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK-Y 351
Query: 306 QDPE 309
            DP+
Sbjct: 352 HDPD 355

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 135/311 (43%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M  ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVN- 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V+LVMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++    S   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGN 246
            APEV+ G GY +  D+WS G I+       IL  G                  P F   
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 247 TKSRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLT 291
            +  + + V    + A L FP    D +           +  A+DL+  ML  DP++R++
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 292 ARQVLDHSWMG 302
               L H ++ 
Sbjct: 312 VDDALQHPYIN 322

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G+FG +  C  +  G ++A K   K    ++D++ +++ E+     L  H +VV 
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVR 73
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIG 162
             + + ++D++ +  E C GG L   + +  R    F EAE + L +Q+ + + Y H + 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 163 VVHRDLKPENILLATKA--------------SSSPI--KLADFGLATYIEPGQSLLGTVG 206
           +VH D+KP NI ++  +              +S+ +  K+ D G  T I   Q      G
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---EEG 190
Query: 207 SPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
              ++A EVL   Y     AD+++  + + +  +G  P   N     +  +R    R P 
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQ--WHEIRQG--RLPR 245
Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            P   +S    +L+  M+  DP +R +A  ++ HS
Sbjct: 246 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 279

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 35/206 (16%)
Query: 116 YVHLVMELCAGGELFHRLEKFGRFSEAEARV---LFMQLMQVVLYCHEIGVVHRDLKPEN 172
           Y+++ M+LC    L   + +     + E  V   +F+Q+ + V + H  G++HRDLKP N
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSN 194
Query: 173 ILLATKASSSPIKLADFGLATYI---EPGQSLL----------GTVGSPFYIAPEVLAG- 218
           I          +K+ DFGL T +   E  Q++L          G VG+  Y++PE + G 
Sbjct: 195 IFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN 251
Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP-----SNPWDHISDS 273
            Y+   D++S G+IL+ LL          + RI   VR  +L+FP       P +H+   
Sbjct: 252 NYSHKVDIFSLGLILFELLYSFST--QMERVRIITDVR--NLKFPLLFTQKYPQEHM--- 304
Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHS 299
              +V  MLS  P++R  A  +++++
Sbjct: 305 ---MVQDMLSPSPTERPEATDIIENA 327

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 134/311 (43%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V+LVMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++    S   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGN 246
            APEV+ G GY +  D+WS G I+       IL  G                  P F   
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 247 TKSRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLT 291
            +  + + V    + A L FP    D +           +  A+DL+  ML  DP++R++
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 292 ARQVLDHSWMG 302
               L H ++ 
Sbjct: 312 VDDALQHPYIN 322

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +++G G+FG +  C  +  G ++A K   K    ++D++ +++ E+     L  H +VV 
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVR 75
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIG 162
             + + ++D++ +  E C GG L   + +  R    F EAE + L +Q+ + + Y H + 
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 163 VVHRDLKPENILLATKA--------------SSSPI--KLADFGLATYIEPGQSLLGTVG 206
           +VH D+KP NI ++  +              +S+ +  K+ D G  T I   Q      G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---EEG 192
Query: 207 SPFYIAPEVLAGGYNQ--AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
              ++A EVL   Y     AD+++  + + +  +G  P   N     +  +R    R P 
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQ--WHEIRQG--RLPR 247
Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            P   +S    +L+  M+  DP +R +A  ++ HS
Sbjct: 248 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    DK TG  F C ++ K RL     E     E+     L+  P +V L
Sbjct: 100 RLGRGSFGEVHRMEDKQTG--FQC-AVKKVRLEVFRAE-----ELMACAGLTS-PRIVPL 150
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
                +  +V++ MEL  GG L   +++ G   E  A     Q ++ + Y H   ++H D
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 210
Query: 168 LKPENILLATKASSSPIKLADFGLATYIEP---GQSLLG---TVGSPFYIAPEVLAG-GY 220
           +K +N+LL++  S +   L DFG A  ++P   G+SLL      G+  ++APEV+ G   
Sbjct: 211 VKADNVLLSSDGSHA--ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 221 NQAADVWSAGVILYILLSGMPPF 243
           +   DVWS+  ++  +L+G  P+
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 134/311 (43%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 74
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V+LVMEL         L +  +      R+  L  Q++
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQML 129
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++    S   +K+ DFGLA     G S + T  V + +Y
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 211 IAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGN 246
            APEV+ G GY +  D+WS G I+       IL  G                  P F   
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 247 TKSRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLT 291
            +  + + V    + A L FP    D +           +  A+DL+  ML  DP++R++
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 292 ARQVLDHSWMG 302
               L H ++ 
Sbjct: 305 VDDALQHPYIN 315

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 119
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 176
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 231
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 352 DALQHPYIN 360

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 107/245 (43%), Gaps = 17/245 (6%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           R+ + + +G G FG +    D    +  A K +  ++       R    EI I+  L   
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQ 153
Query: 102 P-----NVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQV 154
                 NV+ +   +   +++ +  EL +    EL  +  KF  FS    R     ++Q 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK-NKFQGFSLPLVRKFAHSILQC 212
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           +   H+  ++H DLKPENILL  +  S  IK+ DFG + Y    Q +   + S FY APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEH--QRVYTXIQSRFYRAPE 269
Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+ G  Y    D+WS G IL  LL+G P   G  +     A     L  PS      S  
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL-ACMIELLGMPSQKLLDASKR 328
Query: 274 AKDLV 278
           AK+ V
Sbjct: 329 AKNFV 333

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           ++L   LG G    +     K TG++FA K       +   D +    E E++ +L+ H 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKKLN-HK 67
Query: 103 NVVDLKAVYEDEDYVH--LVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVL 156
           N+V L A+ E+    H  L+ME C  G L+  LE+    +G   E+E  ++   ++  + 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMN 126
Query: 157 YCHEIGVVHRDLKPENIL-LATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
           +  E G+VHR++KP NI+ +  +   S  KL DFG A  +E  +  +   G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 216 LAGG---------YNQAADVWSAGVILYILLSGMPPF 243
                        Y    D+WS GV  Y   +G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 107/245 (43%), Gaps = 17/245 (6%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           R+ + + +G G FG +    D    +  A K +  ++       R    EI I+  L   
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQ 153
Query: 102 P-----NVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQV 154
                 NV+ +   +   +++ +  EL +    EL  +  KF  FS    R     ++Q 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK-NKFQGFSLPLVRKFAHSILQC 212
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           +   H+  ++H DLKPENILL  +  S  IK+ DFG + Y    Q +   + S FY APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEH--QRVYTXIQSRFYRAPE 269
Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+ G  Y    D+WS G IL  LL+G P   G  +     A     L  PS      S  
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL-ACMIELLGMPSQKLLDASKR 328
Query: 274 AKDLV 278
           AK+ V
Sbjct: 329 AKNFV 333

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 135/311 (43%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M  ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVN- 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V+LVMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++    S   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGN 246
            APEV+ G GY +  D+WS G I+       IL  G                  P F   
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 247 TKSRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLT 291
            +  + + V    + A L FP    D +           +  A+DL+  ML  DP++R++
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 292 ARQVLDHSWMG 302
               L H ++ 
Sbjct: 312 VDDALQHPYIN 322

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           ++G G FG +    DK TG  F C ++ K RL     E     E+     LS  P +V L
Sbjct: 65  RVGRGSFGEVHRMKDKQTG--FQC-AVKKVRLEVFRVE-----ELVACAGLSS-PRIVPL 115
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
                +  +V++ MEL  GG L   +++ G   E  A     Q ++ + Y H   ++H D
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 168 LKPENILLATKASSSPIKLADFGLATYIEP---GQSLLG---TVGSPFYIAPEVLAGGYN 221
           +K +N+LL++  S +   L DFG A  ++P   G+SLL      G+  ++APEV+ G   
Sbjct: 176 VKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 222 QA-ADVWSAGVILYILLSGMPPF 243
            A  D+WS+  ++  +L+G  P+
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGH 101
           ++L   LG G    +     K TG++FA K       +   D   V++ E E++ +L+ H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD---VQMREFEVLKKLN-H 66
Query: 102 PNVVDLKAVYEDEDYVH--LVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVV 155
            N+V L A+ E+    H  L+ME C  G L+  LE+    +G   E+E  ++   ++  +
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGM 125
Query: 156 LYCHEIGVVHRDLKPENIL-LATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
            +  E G+VHR++KP NI+ +  +   S  KL DFG A  +E  +  +   G+  Y+ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 215 VLAGG---------YNQAADVWSAGVILYILLSGMPPF 243
           +             Y    D+WS GV  Y   +G  PF
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 138
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 314 DALQHPYIN 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 82
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 139
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 194
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 314
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 315 DALQHPYIN 323

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           R+ + + +G G FG +    D    +  A K +  ++       R    EI I+  L   
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQ 153
Query: 102 P-----NVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQV 154
                 NV+ +   +   +++ +  EL +    EL  +  KF  FS    R     ++Q 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK-NKFQGFSLPLVRKFAHSILQC 212
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           +   H+  ++H DLKPENILL  +  S  IK+ DFG + Y    Q +   + S FY APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCYEH--QRVYXXIQSRFYRAPE 269
Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMP 241
           V+ G  Y    D+WS G IL  LL+G P
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 138/311 (44%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M ++  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KVVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V++VMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++ + A+   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT---LKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SR 250
            APEV+ G GY +  D+WS G I+  ++ G   F G                       +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 251 IFDAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLT 291
           +   VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 292 ARQVLDHSWMG 302
             + L H ++ 
Sbjct: 312 VDEALQHPYIN 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 80
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 137
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 138 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 192
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 252
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 253 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 312
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 313 DALQHPYIN 321

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 82
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 139
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 194
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 314
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 315 DALQHPYIN 323

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 138
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 314 DALQHPYIN 322

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 31/273 (11%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD--ERSVKLEIEIMTRLSGHPNVV 105
           ++G G +G +     K +G++ A K I      T+D+  ++ + ++++++ R S  P +V
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRS----TVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRF----------SEAEARVLFMQLMQVV 155
                   E    + MEL +        +KF ++           E   ++    +  + 
Sbjct: 85  QFYGALFREGDCWICMELMSTS-----FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
                + ++HRD+KP NILL     S  IKL DFG++  +    +     G   Y+APE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 196
Query: 216 L-----AGGYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWD 268
           +       GY+  +DVWS G+ LY L +G  P+  W +   ++   V+    +  ++   
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256
Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             S S  + V   L+ D S+R   +++L H ++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           ++G G FG +    DK TG  F C ++ K RL     E     E+     LS  P +V L
Sbjct: 81  RVGRGSFGEVHRMKDKQTG--FQC-AVKKVRLEVFRVE-----ELVACAGLSS-PRIVPL 131
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
                +  +V++ MEL  GG L   +++ G   E  A     Q ++ + Y H   ++H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 191
Query: 168 LKPENILLATKASSSPIKLADFGLATYIEP---GQSLLG---TVGSPFYIAPEVLAGGYN 221
           +K +N+LL++  S +   L DFG A  ++P   G+SLL      G+  ++APEV+ G   
Sbjct: 192 VKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 222 QA-ADVWSAGVILYILLSGMPPF 243
            A  D+WS+  ++  +L+G  P+
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ +   +G G FG +    D+   E  A K I K++   ++     ++E+ ++  ++ 
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLN---QAQIEVRLLELMNK 90
Query: 101 HPN-----VVDLKAVYEDEDYVHLVMELCAGGEL-FHRLEKFGRFSEAEARVLFMQLMQV 154
           H       +V LK  +   +++ LV E+ +       R   F   S    R    Q+   
Sbjct: 91  HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 150
Query: 155 VLYCH--EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           +L+    E+ ++H DLKPENILL     S+ IK+ DFG +  +  GQ +   + S FY +
Sbjct: 151 LLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL--GQRIYQXIQSRFYRS 207
Query: 213 PEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG 245
           PEVL G  Y+ A D+WS G IL  + +G P F G
Sbjct: 208 PEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 241

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 75
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 132
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 187
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 307
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 308 DALQHPYIN 316

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M  ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVN- 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 138
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++    S   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 314 DALQHPYIN 322

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 75
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 132
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 187
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 307
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 308 DALQHPYIN 316

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 138/311 (44%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M ++  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KVVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V++VMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++ + A+   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDAT---LKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SR 250
            APEV+ G GY +  D+WS G I+  ++ G   F G                       +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 251 IFDAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLT 291
           +   VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 292 ARQVLDHSWMG 302
             + L H ++ 
Sbjct: 312 VDEALQHPYIN 322

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 74
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V+LVMEL     L   ++            L  Q++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 131
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 186
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTK 248
           PEV+ G GY +  D+WS G I+       IL  G                  P F    +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 249 SRIFDAV----RTADLRFPSNPWDHI-----------SDSAKDLVMGMLSTDPSQRLTAR 293
             + + V    + A L FP    D +           +  A+DL+  ML  DP++R++  
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 294 QVLDHSWMG 302
             L H ++ 
Sbjct: 307 DALQHPYIN 315

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 43/234 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ +   +G G +G +    DK    V A K I +     ID +R ++ EI I+ RL+ 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLN- 110
Query: 101 HPNVVDLKAVY-----EDEDYVHLVMELCAGGELFHRLEKFGRF-SEAEARVLFMQLMQV 154
           H +VV +  +      E  D +++V+E+      F +L +   + +E   + L   L+  
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQS----------- 200
           V Y H  G++HRDLKP N L+    S   +K+ DFGLA    Y E G S           
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCS---VKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 201 --------------LLGTVGSPFYIAPE--VLAGGYNQAADVWSAGVILYILLS 238
                         L G V + +Y APE  +L   Y +A DVWS G I   LL+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 16/221 (7%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G + V   K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 31  RTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 86
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   ++V E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 87  -HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEY 145
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 146 LEKKNFIHRDLAARNCLV---GENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPE 201
Query: 215 VLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA   ++  +DVW+ GV+L+ I   GM P+ G   S+++D
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYD 242

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ +   +G G FG +    D+   E  A K I   +      +  V+L +E+M +   
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRL-LELMNKHDT 112
Query: 101 HPN--VVDLKAVYEDEDYVHLVMELCAGGEL-FHRLEKFGRFSEAEARVLFMQLMQVVLY 157
                +V LK  +   +++ LV E+ +       R   F   S    R    Q+   +L+
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 158 CH--EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
               E+ ++H DLKPENILL     S+ IK+ DFG +  +  GQ +   + S FY +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL--GQRIYQXIQSRFYRSPEV 229
Query: 216 LAGG-YNQAADVWSAGVILYILLSGMPPFWG 245
           L G  Y+ A D+WS G IL  + +G P F G
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G FG +    DK TG  F C ++ K RL     E     E+     L+  P +V L
Sbjct: 81  RLGRGSFGEVHRMEDKQTG--FQC-AVKKVRLEVFRAE-----ELMACAGLTS-PRIVPL 131
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
                +  +V++ MEL  GG L   +++ G   E  A     Q ++ + Y H   ++H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 191
Query: 168 LKPENILLATKASSSPIKLADFGLATYIEP---GQSLLG---TVGSPFYIAPEVLAG-GY 220
           +K +N+LL++  S +   L DFG A  ++P   G+ LL      G+  ++APEV+ G   
Sbjct: 192 VKADNVLLSSDGSHA--ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 221 NQAADVWSAGVILYILLSGMPPF 243
           +   DVWS+  ++  +L+G  P+
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQFG +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 10  RTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 65
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 66  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 125 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPE 180
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 181 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 126/258 (48%), Gaps = 11/258 (4%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 88
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 89  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 148
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAAD 225
           D+KP NIL+ ++     IKL DFG++  +    +    VG+  Y++PE L G  Y+  +D
Sbjct: 149 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 204
Query: 226 VWSAGVILYILLSGMPPFW-GNTKSRIFDAV-RTADLRFPSNPWDHISDSAKDLVMGMLS 283
           +WS G+ L  +  G  P   G+    IF+ +    +   P  P    S   +D V   L 
Sbjct: 205 IWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 264
Query: 284 TDPSQRLTARQVLDHSWM 301
            +P++R   +Q++ H+++
Sbjct: 265 KNPAERADLKQLMVHAFI 282

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V++VMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++ + A+   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDAT---LKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SR 250
            APEV+ G GY +  D+WS G I+  ++ G   F G                       +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 251 IFDAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLT 291
           +   VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 292 ARQVLDHSWMG 302
             + L H ++ 
Sbjct: 312 VDEALQHPYIN 322

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 38/199 (19%)
Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
            ++ + R    +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  P 
Sbjct: 129 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFYHPA 186
Query: 199 QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RI 251
           Q     V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +     RI
Sbjct: 187 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRI 246
Query: 252 FDAVRTADL--------------------RFPSNPWDH---------ISDSAKDLVMGML 282
              + T +L                    +     W++         +S  A DL+  +L
Sbjct: 247 AKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLL 306
Query: 283 STDPSQRLTARQVLDHSWM 301
             D  QRLTA++ ++H + 
Sbjct: 307 RYDHQQRLTAKEAMEHPYF 325

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 140/298 (46%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 26  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + +++E C  G L   L     +F  +  A   +   F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIE 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKD 201
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 262 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 310

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 38/199 (19%)
Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
            ++ + R    +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  P 
Sbjct: 134 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFYHPA 191
Query: 199 QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-----RI 251
           Q     V S ++  PE+L     Y+ + D+WS G +L  ++    PF+    +     RI
Sbjct: 192 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRI 251
Query: 252 FDAVRTADL--------------------RFPSNPWDH---------ISDSAKDLVMGML 282
              + T +L                    +     W++         +S  A DL+  +L
Sbjct: 252 AKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLL 311
Query: 283 STDPSQRLTARQVLDHSWM 301
             D  QRLTA++ ++H + 
Sbjct: 312 RYDHQQRLTAKEAMEHPYF 330

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 10  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 65
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   ++++E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 66  -HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 125 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPE 180
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 181 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 89/326 (27%), Positives = 126/326 (38%), Gaps = 68/326 (20%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L  R+ +   LG G FG +  C D   G       I K+     +  RS   EI+++  L
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHL 68
Query: 99  -SGHPN----VVDLKAVYEDEDYVHLVMELCAGGEL-FHRLEKFGRFSEAEARVLFMQLM 152
            +  PN     V +   +E   ++ +V EL       F +   F  F     R +  Q+ 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 153 QVVLYCHEIGVVHRDLKPENILLA----TKASSSP------------IKLADFGLATYIE 196
           + V + H   + H DLKPENIL      T+A +              IK+ DFG ATY +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 197 PGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVIL--YIL-------------LSGM 240
              S L  V +  Y APEV LA G++Q  DVWS G IL  Y L             L+ M
Sbjct: 189 EHHSTL--VSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246
Query: 241 PPFWGNTKSRIFDAVRTAD-LRFPSNPWDHISDSAK------------------------ 275
               G     +    R           WD  S + +                        
Sbjct: 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           DL+  ML  DP++R+T R+ L H + 
Sbjct: 307 DLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 140/298 (46%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 26  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + +++E C  G L   L     +F  +  A   +   F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIE 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKD 201
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 262 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 310

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 130/265 (49%), Gaps = 19/265 (7%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 69
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAA 224
           D+KP NIL+ ++     IKL DFG++  +    S+  + VG+  Y++PE L G  Y+  +
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 225 DVWSAGVILYILLSG---MPPFWGNTKSR----IFDAV-RTADLRFPSNPWDHISDSAKD 276
           D+WS G+ L  +  G   +PP      SR    IF+ +    +   P  P    S   +D
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 244
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
            V   L  +P++R   +Q++ H+++
Sbjct: 245 FVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 10  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 65
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 66  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 125 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPE 180
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 181 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 67
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   ++++E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 68  -HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 127 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 182
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 183 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 140/298 (46%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 63  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 121
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + +++E C  G L   L     +F  +  A   +   F
Sbjct: 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 181
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIE 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y +
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKD 238
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 239 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 299 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 347

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 67
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   ++++E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 68  -HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 127 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 182
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 183 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 139/298 (46%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 17  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + ++ E C  G L   L     +F  +  A   +   F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIE 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y +
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKD 192
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 253 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 301

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 17/229 (7%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVVDL 107
           +G G+FG +     K  G+  +C +I   +    + +R   L E  IM +   HPN++ L
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE-HPNIIRL 82
Query: 108 KAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           + V  +   V ++ E    G L  F RL   G+F+  +   +   +   + Y  E+  VH
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLND-GQFTVIQLVGMLRGIASGMRYLAEMSYVH 141
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQ------SLLGTVGSPFYIAPEVLA-G 218
           RDL   NIL+    S+   K++DFGL+ ++E         S LG      + APE +A  
Sbjct: 142 RDLAARNILV---NSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 219 GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP 266
            +  A+D WS G++++ ++S G  P+W  +   + +A+   D R P  P
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-DYRLPPPP 246

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 10/211 (4%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+ +   +G G FG +    D+   E  A K I   +      +  V+L +E+M +   
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRL-LELMNKHDT 112
Query: 101 HPN--VVDLKAVYEDEDYVHLVMELCAGGEL-FHRLEKFGRFSEAEARVLFMQLMQVVLY 157
                +V LK  +   +++ LV E+ +       R   F   S    R    Q+   +L+
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 158 CH--EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
               E+ ++H DLKPENILL      + IK+ DFG +  +  GQ +   + S FY +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRXA-IKIVDFGSSCQL--GQRIYQXIQSRFYRSPEV 229
Query: 216 LAGG-YNQAADVWSAGVILYILLSGMPPFWG 245
           L G  Y+ A D+WS G IL  + +G P F G
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 139/298 (46%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 17  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + ++ E C  G L   L     +F  +  A   +   F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIE 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y +
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKD 192
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 253 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 301

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 17  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 72
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 73  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 131
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 187
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 188 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 67
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 68  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 127 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 182
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 183 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 123/258 (47%), Gaps = 15/258 (5%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 72
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 73  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 132
Query: 167 DLKPENILLATKASSSPIKLADFGLATYI--EPGQSLLGTVGSPFYIAPEVLAG-GYNQA 223
           D+KP NIL+ ++     IKL DFG++  +  E     +GT     Y++PE L G  Y+  
Sbjct: 133 DVKPSNILVNSRGE---IKLCDFGVSGQLIDEMANEFVGTRS---YMSPERLQGTHYSVQ 186
Query: 224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS 283
           +D+WS G+ L  +  G  P        + D +   +   P  P    S   +D V   L 
Sbjct: 187 SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYI--VNEPPPKLPSAVFSLEFQDFVNKCLI 244
Query: 284 TDPSQRLTARQVLDHSWM 301
            +P++R   +Q++ H+++
Sbjct: 245 KNPAERADLKQLMVHAFI 262

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 274
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 275 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HR+L   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 334 LEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 389
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 390 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 17/229 (7%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVVDL 107
           +G G+FG +     K  G+  +C +I   +    + +R   L E  IM +   HPN++ L
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE-HPNIIRL 80
Query: 108 KAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           + V  +   V ++ E    G L  F RL   G+F+  +   +   +   + Y  E+  VH
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLND-GQFTVIQLVGMLRGIASGMRYLAEMSYVH 139
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQ------SLLGTVGSPFYIAPEVLA-G 218
           RDL   NIL+    S+   K++DFGL+ ++E         S LG      + APE +A  
Sbjct: 140 RDLAARNILV---NSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 219 GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP 266
            +  A+D WS G++++ ++S G  P+W  +   + +A+   D R P  P
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-DYRLPPPP 244

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 67
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R   +   +L+M  Q+   + Y
Sbjct: 68  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 127 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 182
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 183 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 132/307 (42%), Gaps = 53/307 (17%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 83
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 140
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA        ++  V + +Y APE
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTAGTSFMMVPFVVTRYYRAPE 197
Query: 215 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SRIFDA 254
           V+ G GY +  D+WS G I+  ++ G   F G                       ++   
Sbjct: 198 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 257
Query: 255 VRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLTARQV 295
           VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++  + 
Sbjct: 258 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 296 LDHSWMG 302
           L H ++ 
Sbjct: 318 LQHPYIN 324

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 138
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPEVVTRYYRA 193
Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SRIF 252
           PEV+ G GY +  D+WS G I+  ++ G   F G                       ++ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 253 DAVRT-----------------ADLRFPSNPWDHI--SDSAKDLVMGMLSTDPSQRLTAR 293
             VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++  
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVD 313
Query: 294 QVLDHSWMG 302
           + L H ++ 
Sbjct: 314 EALQHPYIN 322

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 89/326 (27%), Positives = 125/326 (38%), Gaps = 68/326 (20%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L  R+ +   LG G FG +  C D   G       I K+     +  RS   EI+++  L
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHL 68
Query: 99  -SGHPN----VVDLKAVYEDEDYVHLVMELCAGGEL-FHRLEKFGRFSEAEARVLFMQLM 152
            +  PN     V +   +E   ++ +V EL       F +   F  F     R +  Q+ 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 153 QVVLYCHEIGVVHRDLKPENILLA----TKASSSP------------IKLADFGLATYIE 196
           + V + H   + H DLKPENIL      T+A +              IK+ DFG ATY +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 197 PGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVIL--YIL-------------LSGM 240
              S L  V    Y APEV LA G++Q  DVWS G IL  Y L             L+ M
Sbjct: 189 EHHSTL--VXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246
Query: 241 PPFWGNTKSRIFDAVRTAD-LRFPSNPWDHISDSAK------------------------ 275
               G     +    R           WD  S + +                        
Sbjct: 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           DL+  ML  DP++R+T R+ L H + 
Sbjct: 307 DLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 17  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 72
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   ++++E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 73  -HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 187
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 188 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 13  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 68
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   ++++E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 69  -HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 127
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 128 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPE 183
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 184 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 136/311 (43%), Gaps = 61/311 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--LFMQLM 152
           H N++ L  V+      E+   V++VMEL         L +  +      R+  L  Q++
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMSYLLYQML 136
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFY 210
             + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SR 250
            APEV+ G GY +  D+WS G I+  ++ G   F G                       +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 251 IFDAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLT 291
           +   VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 292 ARQVLDHSWMG 302
             + L H ++ 
Sbjct: 312 VDEALQHPYIN 322

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 82
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 139
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 194
Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SRIF 252
           PEV+ G GY +  D+WS G I+  ++ G   F G                       ++ 
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 253 DAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLTAR 293
             VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++  
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 294 QVLDHSWMG 302
           + L H ++ 
Sbjct: 315 EALQHPYIN 323

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 140/298 (46%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 26  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + +++E C  G L   L     +F  +  A   +   F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLATYI--E 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA  I  +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIXKD 201
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 262 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 310

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 10  DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 64
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 65  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 123
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 124 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 179
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 180 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 8   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 62
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 63  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 121
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 122 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 177
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 178 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 6   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 60
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 61  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 119
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 175
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 176 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 34  DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 88
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 89  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 147
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 203
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 140/298 (46%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 17  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + +++E C  G L   L     +F  +  A   +   F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLATYI--E 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA  I  +
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIXKD 192
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 253 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 301

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 47  QQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           QQLG G FG + +C        TGEV A K +      T +  R  + EIEI+  L  H 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 70
Query: 103 NVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCH 159
           N+V  K V        + L+ME    G L   L+K   R    +      Q+ + + Y  
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP-----FYIAPE 214
               +HRDL   NIL+    + + +K+ DFGL T + P       V  P     F+ APE
Sbjct: 131 TKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 215 VLA-GGYNQAADVWSAGVILYILLS 238
            L    ++ A+DVWS GV+LY L +
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 17  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 72
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 73  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 187
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 188 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 3   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 58  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEFFK 172
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 3   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 58  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 172
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 138
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SRIF 252
           PEV+ G GY +  D+WS G I+  ++ G   F G                       ++ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 253 DAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLTAR 293
             VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++  
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 294 QVLDHSWMG 302
           + L H ++ 
Sbjct: 314 EALQHPYIN 322

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 22/220 (10%)
Query: 33  TNQISNLRERFV-LGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           ++ ++   ER +   QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 75
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 76  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 135 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 190
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 191 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 22/220 (10%)
Query: 33  TNQISNLRERFV-LGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           ++ ++   ER +   QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 75
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 76  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 135 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 190
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 191 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 9   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 63
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 64  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 122
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 123 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 178
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 179 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 47  QQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           QQLG G FG + +C        TGEV A K +      T +  R  + EIEI+  L  H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 71
Query: 103 NVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCH 159
           N+V  K V        + L+ME    G L   L+K   R    +      Q+ + + Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP-----FYIAPE 214
               +HRDL   NIL+    + + +K+ DFGL T + P       V  P     F+ APE
Sbjct: 132 TKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 215 VLA-GGYNQAADVWSAGVILYILLS 238
            L    ++ A+DVWS GV+LY L +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 134/309 (43%), Gaps = 57/309 (18%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 138
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK-------------------SRIF 252
           PEV+ G GY +  D+WS G I+  ++ G   F G                       ++ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 253 DAVRT-----------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLTAR 293
             VRT                  D+ FP++   +   +  A+DL+  ML  D S+R++  
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 294 QVLDHSWMG 302
           + L H ++ 
Sbjct: 314 EALQHPYIN 322

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 7   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 61
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 62  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 120
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 121 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 176
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 177 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 1   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 55
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 56  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 114
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 115 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 170
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 171 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 139/297 (46%), Gaps = 43/297 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 27  RDRLNLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 85
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL-FM 149
             +  H NVV+L  A  +    + +++E C  G L   L     +F  +   E     F+
Sbjct: 86  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFL 145
Query: 150 QLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLATYI--EP 197
            L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA  I  +P
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIXKDP 202
Query: 198 GQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTKS 249
                G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G         
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 250 RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
           R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 263 RLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 310

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--RSVKLEIEIMTRLSG 100
            + G+ LG G FG     + + TGEV   K      L+  D+E  R+   E+++M R   
Sbjct: 12  LIHGEVLGKGCFGQAIKVTHRETGEVMVMKE-----LIRFDEETQRTFLKEVKVM-RCLE 65
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ-LMQVVLYCH 159
           HPNV+    V   +  ++ + E   GG L   ++          RV F + +   + Y H
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLA-------TYIEPGQSL--------LGT 204
            + ++HRDL   N L+    +   + +ADFGLA       T  E  +SL           
Sbjct: 126 SMNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 205 VGSPFYIAPEVLAG-GYNQAADVWSAGVIL 233
           VG+P+++APE++ G  Y++  DV+S G++L
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 13  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 68
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 69  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 127
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 128 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPE 183
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 184 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 17  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 72
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 73  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 187
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 188 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 139/298 (46%), Gaps = 44/298 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRL---VTIDDERSVKLEIEIM 95
           R+R  LG+ LG G FG + + +D F   +   C+++A   L    T  + R++  E++I+
Sbjct: 17  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 96  TRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVL--F 148
             +  H NVV+L  A  +    + ++ E C  G L   L     +F  +  A   +   F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLATYI--E 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA  I  +
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIXKD 192
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 253 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 301

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 14  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 69
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 70  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 129 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 184
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 185 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 14  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 69
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 70  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 129 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPE 184
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 185 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 72  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 130
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 131 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 186
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 187 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 14  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 69
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 70  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 129 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 184
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 185 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 17  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 72
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 73  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 132 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPE 187
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 188 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 25  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 80
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 81  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 139
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 140 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 195
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 196 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 236

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 258 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 313
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 314 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 372
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HR+L   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 373 LEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 428
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 429 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 469

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++VME  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 72  -HEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 130 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 242
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 67
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 68  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 127 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 182
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 183 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 47  QQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           +QLG G FG + +C        TGEV A K +      T +  R  + EIEI+  L  H 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 74
Query: 103 NVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCH 159
           N+V  K V        + L+ME    G L   L+K   R    +      Q+ + + Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP-----FYIAPE 214
               +HRDL   NIL+    + + +K+ DFGL T + P       V  P     F+ APE
Sbjct: 135 TKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 215 VLA-GGYNQAADVWSAGVILYILLS 238
            L    ++ A+DVWS GV+LY L +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D   T++ E  +K E  +M  + 
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKEIK 67
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R       +L+M  Q+   + Y
Sbjct: 68  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F   + APE
Sbjct: 127 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 182
Query: 215 VLAGGYNQ---AADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            LA  YN+    +DVW+ GV+L+ I   GM P+ G   S++++
Sbjct: 183 SLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V+E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 72  -HEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 130 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNEX-TARQGAKFPIKWTAPE 185
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 242
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 13  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVL-RKTRH 67
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  + + Y H 
Sbjct: 68  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L      + +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 127 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADL 260
              +  Y+  +DV++ G++LY L++G  P+   N + +I + V    L
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 231

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V+E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 72  -HEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 130 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 242
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 25  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVL-RKTRH 79
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  + + Y H 
Sbjct: 80  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L      + +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 139 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADL 260
              +  Y+  +DV++ G++LY L++G  P+   N + +I + V    L
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 43/245 (17%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYV--HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN+V L  +  D+      L+ E     + F  L  +   ++ + R    +L+
Sbjct: 81  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 137
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S ++  
Sbjct: 138 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 195
Query: 213 PEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L     
Sbjct: 196 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLN 255
Query: 261 ---------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R    PW         H +S  A D +  +L  D  +RLTA + +
Sbjct: 256 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 315
Query: 297 DHSWM 301
            H + 
Sbjct: 316 THPYF 320

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 80/335 (23%), Positives = 130/335 (38%), Gaps = 72/335 (21%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L+ER+ +   LG G FG +  C D   G       I K+       + + +LEI ++ ++
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKN---VEKYKEAARLEINVLEKI 87
Query: 99  S-GHPNVVDLKAVYEDEDYVHLVMELCAGGEL-------FHRLEKFGRFSEAEARVLFMQ 150
           +   P+  +L    +  D+      +C   EL       F +   +  +   + R +  Q
Sbjct: 88  NEKDPDNKNL--CVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLAT----------------KASSSPIKLADFGLATY 194
           L Q V + H+  + H DLKPENIL                      S+ +++ DFG AT+
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF 205
Query: 195 IEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSGMPPF---------- 243
                S +  V +  Y APEV L  G++Q  DVWS G I++    G   F          
Sbjct: 206 DHEHHSTI--VSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLA 263
Query: 244 -----WGNTKSRIFDAVRTADLRFPSN-PWD-------HISDSAK--------------- 275
                 G   SR+    R     +     WD       ++ ++ K               
Sbjct: 264 MMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQ 323
Query: 276 --DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             DL+  ML  +P++RLT  + L H +      +P
Sbjct: 324 LFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEP 358

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 21/230 (9%)
Query: 47  QQLGWGQFGVIRVCSD--KFTG--EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           Q +G G+FG   VCS   K  G  E+F      K    T    R    E  IM +   HP
Sbjct: 39  QVIGAGEFG--EVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFD-HP 94
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEI 161
           NV+ L+ V      V ++ E    G L   L +  G+F+  +   +   +   + Y  ++
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS------LLGTVGSPFYIAPEV 215
             VHRDL   NIL+    S+   K++DFGL+ ++E   S       LG      + APE 
Sbjct: 155 NYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 216 LA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
           +    +  A+DVWS G++++ ++S G  P+W  T   + +A+   D R P
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLP 260

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +  L G PN+V L  +  D+   H     L+ E     + F  L  +   ++ + R    
Sbjct: 80  LQNLXGGPNIVKLLDIVRDQ---HSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIY 133
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S +
Sbjct: 134 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL-- 260
           +  PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L  
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 251
Query: 261 ------------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTAR 293
                             R    PW         H +S  A D +  +L  D  +RLTA 
Sbjct: 252 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 311
Query: 294 QVLDHSWM 301
           + + H + 
Sbjct: 312 EAMTHPYF 319

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +  L G PN+V L  +  D+   H     L+ E     + F  L  +   ++ + R    
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQ---HSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIY 132
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S +
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL-- 260
           +  PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 261 ------------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTAR 293
                             R    PW         H +S  A D +  +L  D  +RLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 294 QVLDHSWM 301
           + + H + 
Sbjct: 311 EAMTHPYF 318

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 138
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA        +   V + +Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTAGTSFMMEPEVVTRYYRAPE 195
Query: 215 VLAG-GYNQAADVWSAGVIL------YILLSGM-----------------PPFWGNTKSR 250
           V+ G GY +  D+WS G I+       IL  G                  P F    +  
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPT 255
Query: 251 IFDAVRT-------------ADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRLTARQV 295
           + + V                D+ FP++   +   +  A+DL+  ML  D S+R++  + 
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 296 LDHSWMG 302
           L H ++ 
Sbjct: 316 LQHPYIN 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +  L G PN+V L  +  D+   H     L+ E     + F  L  +   ++ + R    
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQ---HSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIY 132
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S +
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL-- 260
           +  PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 261 ------------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTAR 293
                             R    PW         H +S  A D +  +L  D  +RLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 294 QVLDHSWM 301
           + + H + 
Sbjct: 311 EAMTHPYF 318

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +  L G PN+V L  +  D+   H     L+ E     + F  L  +   ++ + R    
Sbjct: 79  LQNLCGGPNIVKLLDIVRDQ---HSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIY 132
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S +
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL-- 260
           +  PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 261 ------------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTAR 293
                             R    PW         H +S  A D +  +L  D  +RLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 294 QVLDHSWM 301
           + + H + 
Sbjct: 311 EAMTHPYF 318

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +  L G PN+V L  +  D+   H     L+ E     + F  L  +   ++ + R    
Sbjct: 80  LQNLCGGPNIVKLLDIVRDQ---HSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIY 133
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S +
Sbjct: 134 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL-- 260
           +  PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L  
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 251
Query: 261 ------------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTAR 293
                             R    PW         H +S  A D +  +L  D  +RLTA 
Sbjct: 252 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 311
Query: 294 QVLDHSWM 301
           + + H + 
Sbjct: 312 EAMTHPYF 319

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +  L G PN+V L  +  D+   H     L+ E     + F  L  +   ++ + R    
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQ---HSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIY 132
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S +
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL-- 260
           +  PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 261 ------------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTAR 293
                             R    PW         H +S  A D +  +L  D  +RLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 294 QVLDHSWM 301
           + + H + 
Sbjct: 311 EAMTHPYF 318

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 43/245 (17%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYV--HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           +  L G PN+V L  +  D+      L+ E     + F  L  +   ++ + R    +L+
Sbjct: 100 LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELL 156
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S ++  
Sbjct: 157 KALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKG 214
Query: 213 PEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL----- 260
           PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L     
Sbjct: 215 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLN 274
Query: 261 ---------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                          R    PW         H +S  A D +  +L  D  +RLTA + +
Sbjct: 275 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 334
Query: 297 DHSWM 301
            H + 
Sbjct: 335 THPYF 339

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 137/296 (46%), Gaps = 44/296 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF------TGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R+R  LG+ LG G FG + + +D F      T    A K + +    T  + R++  E++
Sbjct: 26  RDRLNLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELK 82
Query: 94  IMTRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQ 150
           I+  +  H NVV+L  A  +    + +++E C  G L  + R ++       +    F+ 
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 151 LMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIEPG 198
           L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y +P 
Sbjct: 143 LEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEK---NVVKIXDFGLARDIYKDPD 199
Query: 199 QSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTKSR 250
               G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G         R
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRR 259
Query: 251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
           + +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 260 LKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 306

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 4   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 58
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+K   R    + 
Sbjct: 59  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 117
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HR+L   NIL+    + + +K+ DFGL T + P       
Sbjct: 118 LQYTSQICKGMEYLGTKRYIHRNLATRNILVE---NENRVKIGDFGL-TKVLPQDKEYYK 173
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 174 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +  L G PN+V L  +  D+   H     L+ E     + F  L  +   ++ + R    
Sbjct: 79  LQNLCGGPNIVKLLDIVRDQ---HSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIY 132
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S +
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL-- 260
           +  PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 261 ------------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTAR 293
                             R    PW         H +S  A D +  +L  D  +RLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 294 QVLDHSWM 301
           + + H + 
Sbjct: 311 EAMTHPYF 318

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 95  MTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +  L G PN+V L  +  D+   H     L+ E     + F  L  +   ++ + R    
Sbjct: 79  LQNLMGGPNIVKLLDIVRDQ---HSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIY 132
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           +L++ + YCH  G++HRD+KP N+++  +     ++L D+GLA +  PG+     V S +
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 210 YIAPEVLAG--GYNQAADVWSAGVILY-ILLSGMPPFWGNTKS----RIFDAVRTADL-- 260
           +  PE+L     Y+ + D+WS G +   ++    P F+G+       +I   + T  L  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 261 ------------------RFPSNPW--------DH-ISDSAKDLVMGMLSTDPSQRLTAR 293
                             R    PW         H +S  A D +  +L  D  +RLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 294 QVLDHSWM 301
           + + H + 
Sbjct: 311 EAMTHPYF 318

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 33/198 (16%)
Query: 91  EIEIMTRLSGHPNVVDLKAVY--EDEDYVHLVMELCAGGELFHRLEKFGRFSEAE----- 143
           EI ++  L  HPNV+ L+ V+    +  V L+ +  A  +L+H + KF R S+A      
Sbjct: 68  EIALLRELK-HPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHII-KFHRASKANKKPVQ 124
Query: 144 -----ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLATY--- 194
                 + L  Q++  + Y H   V+HRDLKP NIL+  +      +K+AD G A     
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 195 -IEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRI 251
            ++P   L   V + +Y APE+L G   Y +A D+W+ G I   LL+  P F        
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-------- 236
Query: 252 FDAVRTADLRFPSNPWDH 269
               R  D++  SNP+ H
Sbjct: 237 --HCRQEDIK-TSNPYHH 251

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 6   RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 60
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 61  -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 119 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 174
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 231
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 232 SLHDLMCQCWRKDPEERPT 250

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 116/267 (43%), Gaps = 38/267 (14%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +     +  G+ +  K       V  ++E++ + E++ + +L  H N+V   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKR------VKYNNEKAER-EVKALAKLD-HVNIVHYN 70
Query: 109 AVYEDEDY----------------VHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQ 150
             ++  DY                + + ME C  G L   +EK    +  +  A  LF Q
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFY 210
           + + V Y H   +++RDLKP NI L     +  +K+ DFGL T ++       + G+  Y
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
           ++PE ++   Y +  D+++ G+IL  LL      +    S+ F  +R   +       D 
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGIIS------DI 239
Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVL 296
                K L+  +LS  P  R    ++L
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERS 87
           D  Q      +F+  QQLG G FG + +C        TGEV A K +      T +  R 
Sbjct: 6   DPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 60
Query: 88  VKLEIEIMTRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEA 144
            + EIEI+  L  H N+V  K V        + L+ME    G L   L+    R    + 
Sbjct: 61  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL 119
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
                Q+ + + Y      +HRDL   NIL+    + + +K+ DFGL T + P       
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL-TKVLPQDKEXXK 175
Query: 205 VGSP-----FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           V  P     F+ APE L    ++ A+DVWS GV+LY L +
Sbjct: 176 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 49  LGWGQFGVIRVCSD--KFTGEVFACKSIAKDRL-VTIDDERSVKLEIEIMTRLSGHPNVV 105
           +G G+FG   VCS   K  G+     +I   ++  T    R    E  IM +   HPNVV
Sbjct: 51  IGAGEFG--EVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFD-HPNVV 107
Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            L+ V      V +V+E    G L   L K  G+F+  +   +   +   + Y  ++G V
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPF---YIAPEVLA-GG 219
           HRDL   NIL+    S+   K++DFGL+  IE   +++  T G      + APE +    
Sbjct: 168 HRDLAARNILV---NSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 220 YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPS 264
           +  A+DVWS G++++ ++S G  P+W  +   +  A+     R P+
Sbjct: 225 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLPA 269

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF------TGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R+R  LG+ LG G FG + + +D F      T    A K + +    T  + R++  E++
Sbjct: 28  RDRLKLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELK 84
Query: 94  IMTRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVLF 148
           I+  +  H NVV+L  A  +    + +++E C  G L   L     +F  +   +    F
Sbjct: 85  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF 144
Query: 149 MQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLATYI--E 196
           + L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA  I  +
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEK---NVVKICDFGLARDIXKD 201
Query: 197 PGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTK 248
           P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G        
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
            R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 262 RRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 310

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 8   RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 62
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 63  -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 121 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 176
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 233
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 234 SLHDLMCQCWRKDPEERPT 252

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 72  -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 130 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 242
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 72  -HEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 130 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 242
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 67/314 (21%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 86
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 143
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 198
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSG-------------------------- 239
           PEV+ G GY +  D+WS G I+       IL  G                          
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 258
Query: 240 ---------MPPFWGNTKSRIFDAVRTADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQ 288
                     P + G +  ++F      D+ FP++   +   +  A+DL+  ML  D S+
Sbjct: 259 PTVRTYVENRPKYAGYSFEKLF-----PDVLFPADSEHNKLKASQARDLLSKMLVIDASK 313
Query: 289 RLTARQVLDHSWMG 302
           R++  + L H ++ 
Sbjct: 314 RISVDEALQHPYIN 327

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 86/359 (23%), Positives = 138/359 (38%), Gaps = 98/359 (27%)
Query: 36  ISNLR--ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           I N++  + + +   +G G +G + +  DK   +  A K + +     ID +R ++ EI 
Sbjct: 21  IKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILR-EIT 79
Query: 94  IMTRLSG------HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL 147
           I+ RL        H  ++    +  DE Y+  V+E+ A  +L    +     +E   + +
Sbjct: 80  ILNRLKSDYIIRLHDLIIPEDLLKFDELYI--VLEI-ADSDLKKLFKTPIFLTEQHVKTI 136
Query: 148 FMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE----------- 196
              L+    + HE G++HRDLKP N LL    S   +K+ DFGLA  I            
Sbjct: 137 LYNLLLGEKFIHESGIIHRDLKPANCLLNQDCS---VKICDFGLARTINSDKDIHIVNDL 193
Query: 197 --------PG-------QSLLGTVGSPFYIAPE--VLAGGYNQAADVWSAGVILYILLSG 239
                   PG       + L   V + +Y APE  +L   Y  + D+WS G I   LL+ 
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNM 253
Query: 240 MPPFWGNTKSR--------------------------------IFDAVRT---ADLR--- 261
           M     N  +R                                IF+ + T    DL+   
Sbjct: 254 MKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCIT 313
Query: 262 ----------FP-------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                     FP       S  +  IS    DL+  ML  +  +R+T  + L H ++ D
Sbjct: 314 KQEVIKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKD 372

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 36  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVL-RKTRH 90
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 91  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 149
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 150 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 37  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVL-RKTRH 91
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 92  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 25  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVL-RKTRH 79
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y     + +V + C G  L+H L     +F   +   +  Q  + + Y H 
Sbjct: 80  VNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L      + +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 139 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADL 260
              +  Y+  +DV++ G++LY L++G  P+   N + +I + V    L
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 48  QLGWGQFGVIRVCS-DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           QLG G FG + +C  D       A  ++ + +    D +R  + EI+I+  L       D
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-----D 71
Query: 107 LKAVYEDEDY------VHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYCH 159
               Y    Y      + LVME    G L   L++     +A   +L+  Q+ + + Y  
Sbjct: 72  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYI----------EPGQSLLGTVGSPF 209
               VHRDL   NIL+ ++A    +K+ADFGLA  +          EPGQS +      F
Sbjct: 132 SRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDYYVVREPGQSPI------F 182
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLS 238
           + APE L+   +++ +DVWS GV+LY L +
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 137/296 (46%), Gaps = 44/296 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF------TGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R+R  LG+ LG G FG + + +D F      T    A K + +    T  + R++  E++
Sbjct: 26  RDRLNLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELK 82
Query: 94  IMTRLSGHPNVVDL-KAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQ 150
           I+  +  H NVV+L  A  +    + +++E C  G L  + R ++       +    F+ 
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 151 LMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYIEPG 198
           L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y +P 
Sbjct: 143 LEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPD 199
Query: 199 QSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NTKSR 250
               G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G         R
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 259
Query: 251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
           + +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 260 LKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 306

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 37  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVL-RKTRH 91
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 92  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 134/314 (42%), Gaps = 67/314 (21%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 75
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 132
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIA 212
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA     G S + T  V + +Y A
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLAR--TAGTSFMMTPYVVTRYYRA 187
Query: 213 PEVLAG-GYNQAADVWSAGVIL------YILLSG-------------------------- 239
           PEV+ G GY +  D+WS G I+       IL  G                          
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 240 ---------MPPFWGNTKSRIFDAVRTADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQ 288
                     P + G +  ++F      D+ FP++   +   +  A+DL+  ML  D S+
Sbjct: 248 PTVRTYVENRPKYAGYSFEKLF-----PDVLFPADSEHNKLKASQARDLLSKMLVIDASK 302
Query: 289 RLTARQVLDHSWMG 302
           R++  + L H ++ 
Sbjct: 303 RISVDEALQHPYIN 316

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 48  QLGWGQFGVIRVCS-DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           QLG G FG + +C  D       A  ++ + +    D +R  + EI+I+  L       D
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-----D 72
Query: 107 LKAVYEDEDY------VHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYCH 159
               Y    Y      + LVME    G L   L++     +A   +L+  Q+ + + Y  
Sbjct: 73  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYI----------EPGQSLLGTVGSPF 209
               VHRDL   NIL+ ++A    +K+ADFGLA  +          EPGQS +      F
Sbjct: 133 SRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDYYVVREPGQSPI------F 183
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLS 238
           + APE L+   +++ +DVWS GV+LY L +
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 14  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVTA-PTPQQLQAFKNEVGVL-RKTRH 68
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 69  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 128 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 29  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVT-APTPQQLQAFKNEVGVL-RKTRH 83
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 84  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 142
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 143 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 11  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVTA-PTPQQLQAFKNEVGVL-RKTRH 65
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 66  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 124
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 125 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 101 HPNVVDLKAVYEDED-----YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
           HP++V +    E  D       ++VME   G  L  +  K  +   AEA    ++++  +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEILPAL 195
Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y H IG+V+ DLKPENI+L    +   +KL D G  + I     L GT   P + APE+
Sbjct: 196 SYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINSFGYLYGT---PGFQAPEI 248
Query: 216 LAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
           +  G   A D+++ G  L  L   +P        R  D +   D      P     DS  
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLP----TRNGRYVDGLPEDD------PVLKTYDSYG 298
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMG 302
            L+   +  DP QR T  + +     G
Sbjct: 299 RLLRRAIDPDPRQRFTTAEEMSAQLTG 325

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 14  QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVTA-PTPQQLQAFKNEVGVL-RKTRH 68
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 69  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 128 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 48  QLGWGQFGVIRVCS-DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           QLG G FG + +C  D       A  ++ + +    D +R  + EI+I+  L       D
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-----D 84
Query: 107 LKAVYEDEDY------VHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYCH 159
               Y    Y      + LVME    G L   L++     +A   +L+  Q+ + + Y  
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYI----------EPGQSLLGTVGSPF 209
               VHRDL   NIL+ ++A    +K+ADFGLA  +          EPGQS +      F
Sbjct: 145 SRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDYYVVREPGQSPI------F 195
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLS 238
           + APE L+   +++ +DVWS GV+LY L +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/329 (23%), Positives = 119/329 (36%), Gaps = 72/329 (21%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTR 97
           L+ER+ +   LG G FG +  C D   G+      +A   +  +   R + +LEI ++ +
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGK----SQVALKIIRNVGKYREAARLEINVLKK 104
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL-------FHRLEKFGRFSEAEARVLFMQ 150
           +           V    D+ +    +C   EL       F +   F  +     R +  Q
Sbjct: 105 IKEKDKENKFLCVLMS-DWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ 163
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLAT----------------KASSSPIKLADFGLATY 194
           L   + + HE  + H DLKPENIL                      ++ I++ADFG AT+
Sbjct: 164 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 223
Query: 195 IEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSG-------------- 239
                + +  V +  Y  PEV L  G+ Q  DVWS G IL+    G              
Sbjct: 224 DHEHHTTI--VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 281
Query: 240 -MPPFWGNTKSRIFDAVRTADLRFPSN-PWDHISDSAK---------------------- 275
            M    G   S +    R     +     WD  S   +                      
Sbjct: 282 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 341
Query: 276 --DLVMGMLSTDPSQRLTARQVLDHSWMG 302
             DL+  ML  DP+QR+T  + L H +  
Sbjct: 342 LFDLMRRMLEFDPAQRITLAEALLHPFFA 370

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 48  QLGWGQFGVIRVCS-DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           QLG G FG + +C  D       A  ++ + +    D +R  + EI+I+  L       D
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-----D 68
Query: 107 LKAVYEDEDY------VHLVMELCAGGELFHRLEKFGRFSEAEARVLFM-QLMQVVLYCH 159
               Y    Y      + LVME    G L   L++     +A   +L+  Q+ + + Y  
Sbjct: 69  FIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYI----------EPGQSLLGTVGSPF 209
               VHRDL   NIL+ ++A    +K+ADFGLA  +          EPGQS +      F
Sbjct: 129 SRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDXXVVREPGQSPI------F 179
Query: 210 YIAPEVLAGG-YNQAADVWSAGVILYILLS 238
           + APE L+   +++ +DVWS GV+LY L +
Sbjct: 180 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M ++ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKIR 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 72  -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 130 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 242
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/329 (23%), Positives = 122/329 (37%), Gaps = 72/329 (21%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTR 97
           L+ER+ +   LG G FG +  C D   G+      +A   +  +   R + +LEI ++ +
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGK----SQVALKIIRNVGKYREAARLEINVLKK 81
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL-------FHRLEKFGRFSEAEARVLFMQ 150
           +           V    D+ +    +C   EL       F +   F  +     R +  Q
Sbjct: 82  IKEKDKENKFLCVLMS-DWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ 140
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLAT----------------KASSSPIKLADFGLATY 194
           L   + + HE  + H DLKPENIL                      ++ I++ADFG AT+
Sbjct: 141 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 200
Query: 195 IEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSG-------------- 239
                + +  V +  Y  PEV L  G+ Q  DVWS G IL+    G              
Sbjct: 201 DHEHHTTI--VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 258
Query: 240 -MPPFWGNTKSRIFDAVRTADLRFPSN-PWD-------HISDSAK--------------- 275
            M    G   S +    R     +     WD       ++ ++ K               
Sbjct: 259 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 318
Query: 276 --DLVMGMLSTDPSQRLTARQVLDHSWMG 302
             DL+  ML  DP+QR+T  + L H +  
Sbjct: 319 LFDLMRRMLEFDPAQRITLAEALLHPFFA 347

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 116/259 (44%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++    +       +   E ++M +L 
Sbjct: 184 RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGNM----SPEAFLQEAQVMKKLR 238
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 239 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 296
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGL   IE  +      G+ F   + APE
Sbjct: 297 VERMNYVHRDLRAANILVGENLV---CKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPE 352
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 409
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 410 SLHDLMCQCWRKDPEERPT 428

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 320
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 321 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 379 VERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 434
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 491
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 492 SLHDLMCQCWRKEPEERPT 510

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 17/225 (7%)
Query: 49  LGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVV 105
           +G G+FG   VCS   K  G+   C +I   +    D +R   L E  IM +   HPN++
Sbjct: 37  IGVGEFG--EVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNII 93
Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            L+ V      V ++ E    G L   L K  GRF+  +   +   +   + Y  ++  V
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAV 153
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPF---YIAPEVLA-GG 219
           HRDL   NIL+    S+   K++DFG++  +E   ++   T G      + APE +A   
Sbjct: 154 HRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 220 YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
           +  A+DVWS G++++ ++S G  P+W  +   +  A+     R P
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 254

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 9   QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVTA-PTPQQLQAFKNEVGVL-RKTRH 63
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 64  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 49  LGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVV 105
           +G G+FG   VCS   K  G+     +I   ++   + +R   L E  IM +   HPN++
Sbjct: 30  IGAGEFG--EVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 86
Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            L+ V      V +V E    G L   L+K  G+F+  +   +   +   + Y  ++G V
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPF---YIAPEVLA-GG 219
           HRDL   NIL+    S+   K++DFGL+  +E   ++   T G      + APE +A   
Sbjct: 147 HRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 220 YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPS 264
           +  A+DVWS G++++ ++S G  P+W  T   +  AV     R PS
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEG-YRLPS 248

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 24/264 (9%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           + +++G G FG +     ++ G   A K I  ++    +       E+ IM RL  HPN+
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSDVAVK-ILMEQDFHAERVNEFLREVAIMKRLR-HPNI 96
Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFM--QLMQVVLYCHEI 161
           V           + +V E  + G L+  L K G R    E R L M   + + + Y H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 162 G--VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG--TVGSPFYIAPEVLA 217
              +VHRDLK  N+L+  K +   +K+ DFGL+  ++    L      G+P ++APEVL 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLR 212
Query: 218 G-GYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAV--RTADLRFPSNPWDHISDS 273
               N+ +DV+S GVIL+ L +   P WGN   +++  AV  +   L  P N    ++  
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKCKRLEIPRN----LNPQ 267
Query: 274 AKDLVMGMLSTDPSQRLTARQVLD 297
              ++ G  + +P +R +   ++D
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 72  -HEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 130 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 242
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 71
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 72  -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL   NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 130 VERMNYVHRDLAAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 242
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      DP +R T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/329 (23%), Positives = 122/329 (37%), Gaps = 72/329 (21%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTR 97
           L+ER+ +   LG G FG +  C D   G+      +A   +  +   R + +LEI ++ +
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGK----SQVALKIIRNVGKYREAARLEINVLKK 72
Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL-------FHRLEKFGRFSEAEARVLFMQ 150
           +           V    D+ +    +C   EL       F +   F  +     R +  Q
Sbjct: 73  IKEKDKENKFLCVLMS-DWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLAT----------------KASSSPIKLADFGLATY 194
           L   + + HE  + H DLKPENIL                      ++ I++ADFG AT+
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 195 IEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLSG-------------- 239
                + +  V +  Y  PEV L  G+ Q  DVWS G IL+    G              
Sbjct: 192 DHEHHTTI--VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 240 -MPPFWGNTKSRIFDAVRTADLRFPSN-PWD-------HISDSAK--------------- 275
            M    G   S +    R     +     WD       ++ ++ K               
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309
Query: 276 --DLVMGMLSTDPSQRLTARQVLDHSWMG 302
             DL+  ML  DP+QR+T  + L H +  
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFA 338

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 17/225 (7%)
Query: 49  LGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVV 105
           +G G+FG   VCS   K  G+   C +I   +    D +R   L E  IM +   HPN++
Sbjct: 22  IGVGEFG--EVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNII 78
Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            L+ V      V ++ E    G L   L K  GRF+  +   +   +   + Y  ++  V
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 138
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPF---YIAPEVLA-GG 219
           HRDL   NIL+    S+   K++DFG++  +E   ++   T G      + APE +A   
Sbjct: 139 HRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 220 YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
           +  A+DVWS G++++ ++S G  P+W  +   +  A+     R P
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 239

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 34  NQISNLRER--FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD-ERSVKL 90
           N  +N  ER   V G ++G G FGV  V          A K +A    +T ++ ++    
Sbjct: 22  NVTNNFDERPISVGGNKMGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEA--EARVLF 148
           EI++M +   H N+V+L     D D + LV      G L  RL             R   
Sbjct: 80  EIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 149 MQ-LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT-- 204
            Q     + + HE   +HRD+K  NILL    ++   K++DFGLA   E   Q+++ +  
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQTVMXSRI 195
Query: 205 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 241
           VG+  Y+APE L G     +D++S GV+L  +++G+P
Sbjct: 196 VGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 9   QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVTA-PTPQQLQAFKNEVGVL-RKTRH 63
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y  +  + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 64  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLAT---YIEPGQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPF 243
                 Y+  +DV++ G++LY L++G  P+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 30/267 (11%)
Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           + +++G G FG +     ++ G   A K I  ++    +       E+ IM RL  HPN+
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSDVAVK-ILMEQDFHAERVNEFLREVAIMKRLR-HPNI 96
Query: 105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFM--QLMQVVLYCHEI 161
           V           + +V E  + G L+  L K G R    E R L M   + + + Y H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 162 G--VVHRDLKPENILLATKASSSPIKLADFGL-----ATYIEPGQSLLGTVGSPFYIAPE 214
              +VHR+LK  N+L+  K +   +K+ DFGL     +T++    S     G+P ++APE
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFL----SSKSAAGTPEWMAPE 209
Query: 215 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAV--RTADLRFPSNPWDHI 270
           VL     N+ +DV+S GVIL+ L +   P WGN   +++  AV  +   L  P N    +
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKCKRLEIPRN----L 264
Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLD 297
           +     ++ G  + +P +R +   ++D
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 237
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 238 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 296 VERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 408
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 17/225 (7%)
Query: 49  LGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSGHPNVV 105
           +G G+FG   VCS   K  G+   C +I   +    D +R   L E  IM +   HPN++
Sbjct: 16  IGVGEFG--EVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPNII 72
Query: 106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVV 164
            L+ V      V ++ E    G L   L K  GRF+  +   +   +   + Y  ++  V
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 132
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPF---YIAPEVLA-GG 219
           HRDL   NIL+    S+   K++DFG++  +E   ++   T G      + APE +A   
Sbjct: 133 HRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 220 YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
           +  A+DVWS G++++ ++S G  P+W  +   +  A+     R P
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 233

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/312 (23%), Positives = 131/312 (41%), Gaps = 63/312 (20%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M +   
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLM-KCVN 81
Query: 101 HPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V+      E+   V++VMEL     L   ++            L  Q++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCG 138
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + + H  G++HRDLKP NI++ +  +   +K+ DFGLA        +   V + +Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTAGTSFMMEPEVVTRYYRAPE 195
Query: 215 VLAG-GYNQAADVWSAGVIL------YILLSG---------------------------- 239
           V+ G GY +  D+WS G I+       IL  G                            
Sbjct: 196 VILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 240 -------MPPFWGNTKSRIFDAVRTADLRFPSNPWDH--ISDSAKDLVMGMLSTDPSQRL 290
                   P + G +  ++F      D+ FP++   +   +  A+DL+  ML  D S+R+
Sbjct: 256 VRTYVENRPKYAGYSFEKLF-----PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 291 TARQVLDHSWMG 302
           +  + L H ++ 
Sbjct: 311 SVDEALQHPYIN 322

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 237
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 238 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 296 VERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 408
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 23/231 (9%)
Query: 47  QQLGWGQFGVIRVCSD--KFTG--EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           Q +G G+FG   VCS   K  G  E+F      K    T    R    E  IM +   HP
Sbjct: 13  QVIGAGEFG--EVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFD-HP 68
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           NV+ L+ V      V ++ E    G L  F R +  G+F+  +   +   +   + Y  +
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLAD 127
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS------LLGTVGSPFYIAPE 214
           +  VHR L   NIL+    S+   K++DFGL+ ++E   S       LG      + APE
Sbjct: 128 MNYVHRALAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 215 VLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
            +    +  A+DVWS G++++ ++S G  P+W  T   + +A+   D R P
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLP 234

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 116/280 (41%), Gaps = 51/280 (18%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +     +  G+ +        R V  ++E++ + E++ + +L  H N+V   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVI------RRVKYNNEKAER-EVKALAKLD-HVNIVHYN 71
Query: 109 AVYEDEDY-----------------------------VHLVMELCAGGELFHRLEKFG-- 137
             ++  DY                             + + ME C  G L   +EK    
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 138 RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +  +  A  LF Q+ + V Y H   ++HRDLKP NI L     +  +K+ DFGL T ++ 
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL---VDTKQVKIGDFGLVTSLKN 188
Query: 198 GQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR 256
                 + G+  Y++PE ++   Y +  D+++ G+IL  LL      +    S+ F  +R
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 246
Query: 257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
              +       D      K L+  +LS  P  R    ++L
Sbjct: 247 DGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 119/268 (44%), Gaps = 24/268 (8%)
Query: 48  QLGWGQFGVIRVCSD-KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++G G F  +    D + T EV  C+   +DR +T  + +  K E E +  L  HPN+V 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCE--LQDRKLTKSERQRFKEEAEXLKGLQ-HPNIVR 89
Query: 107 LKAVYED----EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
               +E     +  + LV EL   G L   L++F        R    Q+++ + + H   
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 163 --VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGY 220
             ++HRDLK +NI +     S  +K+ D GLAT ++        +G+P + APE     Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGS--VKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKY 206
Query: 221 NQAADVWSAGVILYILLSGMPPF-----WGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
           +++ DV++ G       +   P+           R+   V+ A     + P        K
Sbjct: 207 DESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP------EVK 260
Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           +++ G +  +  +R + + +L+H++  +
Sbjct: 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           + N + NL E       +G G  G +     + TG V A K +   R    ++ + + ++
Sbjct: 23  EINDLENLGE-------MGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMD 73
Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL---CAGGELFHRLEKFGRFSEAEARVLF 148
           ++++ +    P +V     +     V + MEL   CA  +L  R++  G   E     + 
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE-KLKKRMQ--GPIPERILGKMT 130
Query: 149 MQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS 207
           + +++ + Y  E  GV+HRD+KP NILL  +     IKL DFG++  +   ++   + G 
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGC 187
Query: 208 PFYIAPEVL------AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR 261
             Y+APE +         Y+  ADVWS G+ L  L +G  P+  N K+      +     
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY-KNCKTDFEVLTKVLQEE 246
Query: 262 FPSNPWDH-ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            P  P     S   +  V   L+ D  +R    ++L+HS++
Sbjct: 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 15/217 (6%)
Query: 34  NQISNLRER--FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD-ERSVKL 90
           N  +N  ER   V G ++G G FGV  V          A K +A    +T ++ ++    
Sbjct: 22  NVTNNFDERPISVGGNKMGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEA--EARVLF 148
           EI++M +   H N+V+L     D D + LV      G L  RL             R   
Sbjct: 80  EIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 149 MQ-LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT-- 204
            Q     + + HE   +HRD+K  NILL    ++   K++DFGLA   E   Q+++    
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQTVMXXRI 195
Query: 205 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 241
           VG+  Y+APE L G     +D++S GV+L  +++G+P
Sbjct: 196 VGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 18/217 (8%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ R + H
Sbjct: 9   QITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVTA-PTPQQLQAFKNEVGVL-RKTRH 63
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L   Y     + +V + C G  L+H L     +F   +   +  Q  Q + Y H 
Sbjct: 64  VNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL- 216
             ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 217 ---AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSR 250
                 Y+  +DV++ G++LY L++G  P+  N  +R
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNR 215

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGLA  +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLARVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           +L  ++G G FG   V   K+ G+V A K I K    T +  ++ + E+ ++ R + H N
Sbjct: 39  MLSTRIGSGSFGT--VYKGKWHGDV-AVK-ILKVVDPTPEQFQAFRNEVAVL-RKTRHVN 93
Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVLFMQLMQVVLYCH 159
           ++ L   Y  +D + +V + C G  L+  L     KF  F   +   +  Q  Q + Y H
Sbjct: 94  IL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLID---IARQTAQGMDYLH 149
Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP---GQSLLGTVGSPFYIAPEVL 216
              ++HRD+K  NI L    +   +K+ DFGLAT        Q +    GS  ++APEV+
Sbjct: 150 AKNIIHRDMKSNNIFLHEGLT---VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 217 AGGYNQ----AADVWSAGVILYILLSGMPPF 243
               N      +DV+S G++LY L++G  P+
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 46/236 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID--------DERSVKLEI 92
           E  VLG+Q+G G FG           EVF+ +  A + LV +         D ++  L+ 
Sbjct: 114 EDLVLGEQIGRGNFG-----------EVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQE 162
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
             + +   HPN+V L  V   +  +++VMEL  GG+    L   G      AR+    L+
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLL 216
Query: 153 QVV-------LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV 205
           Q+V        Y      +HRDL   N L+  K   + +K++DFG++   E    +    
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMSR--EEADGVYAAS 271
Query: 206 GS----PF-YIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPF--WGNTKSRIF 252
           G     P  + APE L  G Y+  +DVWS G++L+   S G  P+    N ++R F
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 46/236 (19%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID--------DERSVKLEI 92
           E  VLG+Q+G G FG           EVF+ +  A + LV +         D ++  L+ 
Sbjct: 114 EDLVLGEQIGRGNFG-----------EVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQE 162
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
             + +   HPN+V L  V   +  +++VMEL  GG+    L   G      AR+    L+
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLL 216
Query: 153 QVV-------LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV 205
           Q+V        Y      +HRDL   N L+  K   + +K++DFG++   E    +    
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMSR--EEADGVXAAS 271
Query: 206 GS----PF-YIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPF--WGNTKSRIF 252
           G     P  + APE L  G Y+  +DVWS G++L+   S G  P+    N ++R F
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/329 (23%), Positives = 141/329 (42%), Gaps = 72/329 (21%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           R++L ++LGWG F  + +  D       A K +  D++ T     + + EI+++ R++  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 75
Query: 102 PNVVD--------LKAV----YEDEDYVHLVMELCAGGE----LFHRLEKFGRFSEAEAR 145
            N  +        LK +    ++  + VH+VM     GE    L  + E  G       +
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYVK 134
Query: 146 VLFMQLMQVVLYCH-EIGVVHRDLKPENILLATKASSS---PIKLADFGLATYIEPGQSL 201
            +  QL+  + Y H   G++H D+KPEN+L+    S      IK+AD G A + +  +  
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 202 LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG---MPPFWGNTKSRIFDAV-- 255
             ++ +  Y +PEVL G  +   AD+WS   +++ L++G     P  G++ ++  D +  
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 256 -------------------RT-----------ADLRF------PSNPWDHISDSAK---D 276
                              RT           + L+F       +  +    D AK   D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI 305
            +  ML  DP +R  A  +++H W+ D +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTL 341

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/329 (23%), Positives = 141/329 (42%), Gaps = 72/329 (21%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           R++L ++LGWG F  + +  D       A K +  D++ T     + + EI+++ R++  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 75
Query: 102 PNVVD--------LKAV----YEDEDYVHLVMELCAGGE----LFHRLEKFGRFSEAEAR 145
            N  +        LK +    ++  + VH+VM     GE    L  + E  G       +
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYVK 134
Query: 146 VLFMQLMQVVLYCH-EIGVVHRDLKPENILLATKASSS---PIKLADFGLATYIEPGQSL 201
            +  QL+  + Y H   G++H D+KPEN+L+    S      IK+AD G A + +  +  
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 202 LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG---MPPFWGNTKSRIFDAV-- 255
             ++ +  Y +PEVL G  +   AD+WS   +++ L++G     P  G++ ++  D +  
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 256 -------------------RT-----------ADLRF------PSNPWDHISDSAK---D 276
                              RT           + L+F       +  +    D AK   D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI 305
            +  ML  DP +R  A  +++H W+ D +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTL 341

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 237
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 238 -HEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 296 VERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 408
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 16/218 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           Q++G GQFG++ +       +  A K+I +  +     E     E E+M +LS HP +V 
Sbjct: 13  QEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQ 66
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V  ++  + LV E    G L   L  + G F+      + + + + + Y  E  V+H
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIH 126
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV +   Y+
Sbjct: 127 RDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRYS 182
Query: 222 QAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA 258
             +DVWS GV+++ + S G  P+   + S + + + T 
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 220

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 10  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 64
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 65  -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 123 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 178
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 235
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 236 SLHDLMCQCWRKEPEERPT 254

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 47  QQLGWGQFGVIRV----CSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           Q++G GQFG++ +      DK   +     S+++D  +          E E+M +LS HP
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE---------EAEVMMKLS-HP 82
Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEI 161
            +V L  V  ++  + LV E    G L   L  + G F+      + + + + + Y  E 
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA- 217
            V+HRDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV + 
Sbjct: 143 CVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSF 198
Query: 218 GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA 258
             Y+  +DVWS GV+++ + S G  P+   + S + + + T 
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 240

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 15/217 (6%)
Query: 34  NQISNLRER--FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD-ERSVKL 90
           N  +N  ER   V G ++G G FGV  V          A K +A    +T ++ ++    
Sbjct: 16  NVTNNFDERPISVGGNKMGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 73
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEA--EARVLF 148
           EI++M +   H N+V+L     D D + LV      G L  RL             R   
Sbjct: 74  EIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 132
Query: 149 MQ-LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT-- 204
            Q     + + HE   +HRD+K  NILL    ++   K++DFGLA   E   Q ++    
Sbjct: 133 AQGAANGINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQXVMXXRI 189
Query: 205 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 241
           VG+  Y+APE L G     +D++S GV+L  +++G+P
Sbjct: 190 VGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           Q++G GQFG++ +       +  A K+I +  +     E     E E+M +LS HP +V 
Sbjct: 11  QEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQ 64
Query: 107 LKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
           L  V  ++  + LV E    G L  + R ++ G F+      + + + + + Y  E  V+
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGY 220
           HRDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV +   Y
Sbjct: 124 HRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRY 179
Query: 221 NQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA 258
           +  +DVWS GV+++ + S G  P+   + S + + + T 
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 16/218 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           Q++G GQFG++ +       +  A K+I +  +     E     E E+M +LS HP +V 
Sbjct: 16  QEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQ 69
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V  ++  + LV E    G L   L  + G F+      + + + + + Y  E  V+H
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 129
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV +   Y+
Sbjct: 130 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRYS 185
Query: 222 QAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA 258
             +DVWS GV+++ + S G  P+   + S + + + T 
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 223

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 16/218 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           Q++G GQFG++ +       +  A K+I +  +     E     E E+M +LS HP +V 
Sbjct: 13  QEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQ 66
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V  ++  + LV E    G L   L  + G F+      + + + + + Y  E  V+H
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 126
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV +   Y+
Sbjct: 127 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRYS 182
Query: 222 QAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA 258
             +DVWS GV+++ + S G  P+   + S + + + T 
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 220

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 32/270 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +     K  G              + DD R    E+E++ +L  HPN+++L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEK---------FGRFSEAEARVLFMQLMQVVL--- 156
              E   Y++L +E    G L   L K         F   +   + +   QL+       
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 157 ----YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA----TYIEPGQSLLGTVGSP 208
               Y  +   +HRDL   NIL+     +   K+ADFGL+     Y+   +  +G +   
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRGQEVYV---KKTMGRLPVR 206
Query: 209 FYIAPEVLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV-RTADLRFPSNP 266
           +     +    Y   +DVWS GV+L+ ++S G  P+ G T + +++ + +   L  P N 
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN- 265
Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
                D   DL+       P +R +  Q+L
Sbjct: 266 ---CDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 32/270 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +     K  G              + DD R    E+E++ +L  HPN+++L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEK---------FGRFSEAEARVLFMQLMQVVL--- 156
              E   Y++L +E    G L   L K         F   +   + +   QL+       
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 157 ----YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA----TYIEPGQSLLGTVGSP 208
               Y  +   +HRDL   NIL+     +   K+ADFGL+     Y+   +  +G +   
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRGQEVYV---KKTMGRLPVR 196
Query: 209 FYIAPEVLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV-RTADLRFPSNP 266
           +     +    Y   +DVWS GV+L+ ++S G  P+ G T + +++ + +   L  P N 
Sbjct: 197 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN- 255
Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
                D   DL+       P +R +  Q+L
Sbjct: 256 ---CDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 13  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 63
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 64  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 124/263 (47%), Gaps = 19/263 (7%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFGV+++   K+ G+      + K+  ++ D+      E + M +LS
Sbjct: 7   REEITLLKELGSGQFGVVKL--GKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLS 61
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSE-AEARVLFMQLMQVVLYC 158
            HP +V    V   E  +++V E  + G L + L   G+  E ++   +   + + + + 
Sbjct: 62  -HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEV 215
                +HRDL   N L+        +K++DFG+  Y+   Q  + +VG+ F   + APEV
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEV 176
Query: 216 LAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
                Y+  +DVW+ G++++ + S G  P+   T S +   V      +  +     SD+
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL---ASDT 233
Query: 274 AKDLVMGMLSTDPSQRLTARQVL 296
              ++       P +R T +Q+L
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLL 256

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 131
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 132 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 191
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAA 224
           D+KP NIL+ ++     IKL DFG++  +    S+  + VG+  Y++PE L G  Y+  +
Sbjct: 192 DVKPSNILVNSRGE---IKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 246
Query: 225 DVWSAGVILYILLSGMPPF 243
           D+WS G+ L  +  G  P 
Sbjct: 247 DIWSMGLSLVEMAVGRYPI 265

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 27/228 (11%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + +     + +V A K++    +      ++   E  +M  L 
Sbjct: 12  RESIKLVKRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSV----QAFLEEANLMKTLQ 66
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-------MQLM 152
            H  +V L AV   E+ ++++ E  A G L   L+     S+   +VL         Q+ 
Sbjct: 67  -HDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIA 120
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF--- 209
           + + Y      +HRDL+  N+L++    S   K+ADFGLA  IE  +      G+ F   
Sbjct: 121 EGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIK 176
Query: 210 YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAV 255
           + APE +  G +   +DVWS G++LY I+  G  P+ G T + +  A+
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 13  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 63
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 64  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 16/218 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           Q++G GQFG++ +       +  A K+I +  +     E     E E+M +LS HP +V 
Sbjct: 14  QEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQ 67
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V  ++  + LV E    G L   L  + G F+      + + + + + Y  E  V+H
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+     +  IK++DFG+  ++   Q    T G+ F   + +PEV +   Y+
Sbjct: 128 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFSRYS 183
Query: 222 QAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTA 258
             +DVWS GV+++ + S G  P+   + S + + + T 
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 30  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 80
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 81  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 139
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 196
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 197 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 251

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 44/264 (16%)
Query: 86  RSVKLEIEIMTRLSGHPNVVDLKAVYE--DEDYVH---LVMELCAG--GELFHRLEKFGR 138
           + V  EI ++     HPN++ L+ ++   +E  +H   LV EL      ++ H  ++   
Sbjct: 74  KRVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH--DQRIV 130
Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
            S    +     ++  +   HE GVVHRDL P NILL   A ++ I + DF LA      
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTAD 187
Query: 199 QSLLGTVGSPFYIAPEVLA--GGYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIF 252
            +    V   +Y APE++    G+ +  D+WSAG ++  + +    F G    N  ++I 
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 253 DAVRTADL--------------------RFPSNPWDHISDSAK----DLVMGMLSTDPSQ 288
           + V T  +                      P+  W  +  +A     DL+  ML  +P +
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 289 RLTARQVLDHSWMGDGIQDPEKLS 312
           R++  Q L H +  + + DP  L+
Sbjct: 308 RISTEQALRHPYF-ESLFDPLDLT 330

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 7   RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 61
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  + +V E  + G L   L+ + G++      V +  Q+   + Y
Sbjct: 62  -HEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 120 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNEX-TARQGAKFPIKWTAPE 175
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 232
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 233 SLHDLMCQCWRKEPEERPT 251

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 14  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 68
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E    G L   L+ + G++      V +  Q+   + Y
Sbjct: 69  -HEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 127 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 182
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 239
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 240 SLHDLMCQCWRKEPEERPT 258

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 14  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 68
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARV-LFMQLMQVVLY 157
            H  +V L AV  +E  +++V E    G L   L+ + G++      V +  Q+   + Y
Sbjct: 69  -HEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
              +  VHRDL+  NIL+         K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 127 VERMNYVHRDLRAANILVGENLVC---KVADFGLARLIEDNE-WTARQGAKFPIKWTAPE 182
Query: 215 -VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
             L G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPP--ECPE 239
Query: 273 SAKDLVMGMLSTDPSQRLT 291
           S  DL+      +P +R T
Sbjct: 240 SLHDLMCQCWRKEPEERPT 258

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 44/264 (16%)
Query: 86  RSVKLEIEIMTRLSGHPNVVDLKAVYE--DEDYVH---LVMELCAG--GELFHRLEKFGR 138
           + V  EI ++     HPN++ L+ ++   +E  +H   LV EL      ++ H  ++   
Sbjct: 74  KRVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH--DQRIV 130
Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
            S    +     ++  +   HE GVVHRDL P NILL   A ++ I + DF LA      
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTAD 187
Query: 199 QSLLGTVGSPFYIAPEVLA--GGYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIF 252
            +    V   +Y APE++    G+ +  D+WSAG ++  + +    F G    N  ++I 
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 253 DAVRTADL--------------------RFPSNPWDHISDSAK----DLVMGMLSTDPSQ 288
           + V T  +                      P+  W  +  +A     DL+  ML  +P +
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 289 RLTARQVLDHSWMGDGIQDPEKLS 312
           R++  Q L H +  + + DP  L+
Sbjct: 308 RISTEQALRHPYF-ESLFDPLDLT 330

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 47  QQLGWGQFGVIRV-CSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + LG G FG + + C D     TGE+ A K++  D           K EI+I+  L  H 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLY-HE 76
Query: 103 NVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           +++  K   ED  E  + LVME    G L   L +      A+  +   Q+ + + Y H 
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHS 135
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---GSP-FYIAPEVL 216
              +HR+L   N+LL    +   +K+ DFGLA  +  G           SP F+ APE L
Sbjct: 136 QHYIHRNLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 217 AG-GYNQAADVWSAGVILYILLS 238
               +  A+DVWS GV LY LL+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 116/264 (43%), Gaps = 19/264 (7%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G +GV+       +G++ A K I     V   +++ + ++++I  R    P  V  
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 108 KAVYEDEDYVHLVMELCAGG-ELFHR--LEKFGRFSEAEARVLFMQLMQVVLYCH-EIGV 163
                 E  V + MEL     + F++  ++K     E     + + +++ + + H ++ V
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL-----AG 218
           +HRD+KP N+L+        +K+ DFG++ Y+    +     G   Y+APE +       
Sbjct: 176 IHRDVKPSNVLINALGQ---VKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 219 GYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           GY+  +D+WS G+ +  L     P+  WG    ++   V       P  P D  S    D
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS---PQLPADKFSAEFVD 289
Query: 277 LVMGMLSTDPSQRLTARQVLDHSW 300
                L  +  +R T  +++ H +
Sbjct: 290 FTSQCLKKNSKERPTYPELMQHPF 313

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 40  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 90
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 91  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 149
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL+  +E   ++   T 
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTR 206
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 207 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 261

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 27/228 (11%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + +     + +V A K++    +      ++   E  +M  L 
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSV----QAFLEEANLMKTLQ 65
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-------MQLM 152
            H  +V L AV   E+ ++++ E  A G L   L+     S+   +VL         Q+ 
Sbjct: 66  -HDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIA 119
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF--- 209
           + + Y      +HRDL+  N+L+   + S   K+ADFGLA  IE  +      G+ F   
Sbjct: 120 EGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIK 175
Query: 210 YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAV 255
           + APE +  G +   ++VWS G++LY I+  G  P+ G T + +  A+
Sbjct: 176 WTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 106/235 (45%), Gaps = 23/235 (9%)
Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERS 87
           LD   IS       + + +G G+FG   VCS +         S+A   L    T    R 
Sbjct: 42  LDATNIS-------IDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARV 146
              E  IM +   HPN++ L+ V      V +V E    G L   L K   +F+  +   
Sbjct: 93  FLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTV 205
           +   +   + Y  ++G VHRDL   NIL+    S+   K++DFGL   +E   ++   T 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 206 GSPF---YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
           G      + +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 47  QQLGWGQFGVIRV-CSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + LG G FG + + C D     TGE+ A K++  D           K EI+I+  L  H 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLY-HE 76
Query: 103 NVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           +++  K   ED  E  + LVME    G L   L +      A+  +   Q+ + + Y H 
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHA 135
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---GSP-FYIAPEVL 216
              +HR+L   N+LL    +   +K+ DFGLA  +  G           SP F+ APE L
Sbjct: 136 QHYIHRNLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 217 AG-GYNQAADVWSAGVILYILLS 238
               +  A+DVWS GV LY LL+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-----SVKLEIEIMTRLSGHP 102
           ++G G FG +     + TG+  A K       V +++E+     +   EI+I+ +L  H 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKK------VLMENEKEGFPITALREIKIL-QLLKHE 77
Query: 103 NVVDLKAVYEDE--------DYVHLVMELCA---GGELFHRLEKFGRFSEAEARVLFMQL 151
           NVV+L  +   +          ++LV + C     G L + L KF   + +E + +   L
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF---TLSEIKRVMQML 134
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-----LLGTVG 206
           +  + Y H   ++HRD+K  N+L+        +KLADFGLA      ++         V 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 207 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
           + +Y  PE+L G   Y    D+W AG I+  + +  P   GNT+      +         
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 265 NPWDHISD----------------------------SAKDLVMGMLSTDPSQRLTARQVL 296
             W ++ +                             A DL+  +L  DP+QR+ +   L
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 297 DHSW 300
           +H +
Sbjct: 312 NHDF 315

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 37  SNLRERFVLG-QQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           ++  +RF+   + LG G FG + +C        TGE  A KS+  +     +    +K E
Sbjct: 16  THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKE 73
Query: 92  IEIMTRLSGHPNVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF- 148
           IEI+  L  H N+V  K +  ++  + + L+ME    G L   L K       + ++ + 
Sbjct: 74  IEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ---SLLGTV 205
           +Q+ + + Y      VHRDL   N+L+    S   +K+ DFGL   IE  +   ++    
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEXXTVKDDR 189
Query: 206 GSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
            SP F+ APE L    +  A+DVWS GV L+ LL+
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMT 96
           R     G+ LG G FG +   +    G+  A   +A   L +    D++ ++  E++IM+
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRF-----------SEAEAR 145
            L  H N+V+L         V ++ E C  G+L + L +  R            S A  R
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 146 VLFM---QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-------TYI 195
            L     Q+ Q + +      +HRD+   N+LL     +   K+ DFGLA        YI
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMNDSNYI 221
Query: 196 EPGQSLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG---NTK-- 248
             G + L       ++APE +    Y   +DVWS G++L+ + S G+ P+ G   N+K  
Sbjct: 222 VKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 249 SRIFDAVRTADLRF-PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
             + D  + A   F P N +         ++    + +P+ R T +Q+
Sbjct: 278 KLVKDGYQMAQPAFAPKNIY--------SIMQACWALEPTHRPTFQQI 317

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 96
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAA 224
           D+KP NIL+ ++     IKL DFG++  +    S+  + VG+  Y++PE L G  Y+  +
Sbjct: 157 DVKPSNILVNSRGE---IKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 211
Query: 225 DVWSAGVILYILLSGMPPF 243
           D+WS G+ L  +  G  P 
Sbjct: 212 DIWSMGLSLVEMAVGRYPI 230

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 69
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAA 224
           D+KP NIL+ ++     IKL DFG++  +    S+  + VG+  Y++PE L G  Y+  +
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 225 DVWSAGVILYILLSGMPPF 243
           D+WS G+ L  +  G  P 
Sbjct: 185 DIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 69
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAA 224
           D+KP NIL+ ++     IKL DFG++  +    S+  + VG+  Y++PE L G  Y+  +
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 225 DVWSAGVILYILLSGMPPF 243
           D+WS G+ L  +  G  P 
Sbjct: 185 DIWSMGLSLVEMAVGRYPI 203

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 37  SNLRERFVLG-QQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           ++  +RF+   + LG G FG + +C        TGE  A KS+  +     +    +K E
Sbjct: 4   THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKE 61
Query: 92  IEIMTRLSGHPNVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF- 148
           IEI+  L  H N+V  K +  ++  + + L+ME    G L   L K       + ++ + 
Sbjct: 62  IEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 120
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ---SLLGTV 205
           +Q+ + + Y      VHRDL   N+L+    S   +K+ DFGL   IE  +   ++    
Sbjct: 121 VQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEXXTVKDDR 177
Query: 206 GSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
            SP F+ APE L    +  A+DVWS GV L+ LL+
Sbjct: 178 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 111/270 (41%), Gaps = 32/270 (11%)
Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G FG +     K  G              + DD R    E+E++ +L  HPN+++L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEK---------FGRFSEAEARVLFMQLMQVVL--- 156
              E   Y++L +E    G L   L K         F   +   + +   QL+       
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 157 ----YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA----TYIEPGQSLLGTVGSP 208
               Y  +   +HR+L   NIL+     +   K+ADFGL+     Y+   +  +G +   
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILVGENYVA---KIADFGLSRGQEVYV---KKTMGRLPVR 203
Query: 209 FYIAPEVLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV-RTADLRFPSNP 266
           +     +    Y   +DVWS GV+L+ ++S G  P+ G T + +++ + +   L  P N 
Sbjct: 204 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN- 262
Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
                D   DL+       P +R +  Q+L
Sbjct: 263 ---CDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-----SVKLEIEIMTRLSGHP 102
           ++G G FG +     + TG+  A K       V +++E+     +   EI+I+ +L  H 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKK------VLMENEKEGFPITALREIKIL-QLLKHE 77
Query: 103 NVVDLKAVYEDE--------DYVHLVMELCA---GGELFHRLEKFGRFSEAEARVLFMQL 151
           NVV+L  +   +          ++LV + C     G L + L KF   + +E + +   L
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF---TLSEIKRVMQML 134
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-----LLGTVG 206
           +  + Y H   ++HRD+K  N+L+        +KLADFGLA      ++         V 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 207 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
           + +Y  PE+L G   Y    D+W AG I+  + +  P   GNT+      +         
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 265 NPWDHISD----------------------------SAKDLVMGMLSTDPSQRLTARQVL 296
             W ++ +                             A DL+  +L  DP+QR+ +   L
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 297 DHSW 300
           +H +
Sbjct: 312 NHDF 315

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-----SVKLEIEIMTRLSGHP 102
           ++G G FG +     + TG+  A K       V +++E+     +   EI+I+ +L  H 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKK------VLMENEKEGFPITALREIKIL-QLLKHE 77
Query: 103 NVVDLKAVYEDEDY--------VHLVMELCA---GGELFHRLEKFGRFSEAEARVLFMQL 151
           NVV+L  +   +          ++LV + C     G L + L KF   + +E + +   L
Sbjct: 78  NVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKF---TLSEIKRVMQML 134
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-----LLGTVG 206
           +  + Y H   ++HRD+K  N+L+        +KLADFGLA      ++         V 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 207 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
           + +Y  PE+L G   Y    D+W AG I+  + +  P   GNT+      +         
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 265 NPWDHISD----------------------------SAKDLVMGMLSTDPSQRLTARQVL 296
             W ++ +                             A DL+  +L  DP+QR+ +   L
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 297 DHSW 300
           +H +
Sbjct: 312 NHDF 315

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 69
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAAD 225
           D+KP NIL+ ++     IKL DFG++  +    +    VG+  Y++PE L G  Y+  +D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 226 VWSAGVILYILLSGMPPF 243
           +WS G+ L  +  G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+   S K +G V A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 69
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHR 166
              +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  E   ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAAD 225
           D+KP NIL+ ++     IKL DFG++  +    +    VG+  Y++PE L G  Y+  +D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 226 VWSAGVILYILLSGMPPF 243
           +WS G+ L  +  G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 47  QQLGWGQFGVIRV-CSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           + LG G FG + + C D     TGE+ A K++  D           K EI+I+  L  H 
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HE 93
Query: 103 NVVDLKAVYEDEDY--VHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLYC 158
           +++  K   ED     + LVME    G L   L    R S   A++L    Q+ + + Y 
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYL 150
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---GSP-FYIAPE 214
           H    +HRDL   N+LL    +   +K+ DFGLA  +  G           SP F+ APE
Sbjct: 151 HAQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 215 VLAG-GYNQAADVWSAGVILYILLS 238
            L    +  A+DVWS GV LY LL+
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-----SVKLEIEIMTRLSGHP 102
           ++G G FG +     + TG+  A K       V +++E+     +   EI+I+ +L  H 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKK------VLMENEKEGFPITALREIKIL-QLLKHE 76
Query: 103 NVVDLKAVYEDE--------DYVHLVMELCA---GGELFHRLEKFGRFSEAEARVLFMQL 151
           NVV+L  +   +          ++LV + C     G L + L KF   + +E + +   L
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF---TLSEIKRVMQML 133
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS-----LLGTVG 206
           +  + Y H   ++HRD+K  N+L+        +KLADFGLA      ++         V 
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 207 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS 264
           + +Y  PE+L G   Y    D+W AG I+  + +  P   GNT+      +         
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 265 NPWDHISD----------------------------SAKDLVMGMLSTDPSQRLTARQVL 296
             W ++ +                             A DL+  +L  DP+QR+ +   L
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310
Query: 297 DHSW 300
           +H +
Sbjct: 311 NHDF 314

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 47/288 (16%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMT 96
           R     G+ LG G FG +   +    G+  A   +A   L +    D++ ++  E++IM+
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE-----------AR 145
            L  H N+V+L         V ++ E C  G+L + L +  R  E +            R
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 146 VLFM---QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-------TYI 195
            L     Q+ Q + +      +HRD+   N+LL     +   K+ DFGLA        YI
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMNDSNYI 221
Query: 196 EPGQSLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG---NTK-- 248
             G + L       ++APE +    Y   +DVWS G++L+ + S G+ P+ G   N+K  
Sbjct: 222 VKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 249 SRIFDAVRTADLRF-PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
             + D  + A   F P N +         ++    + +P+ R T +Q+
Sbjct: 278 KLVKDGYQMAQPAFAPKNIY--------SIMQACWALEPTHRPTFQQI 317

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 122/265 (46%), Gaps = 33/265 (12%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + + +     +V A K++      T+  E  ++ E +IM +L 
Sbjct: 8   RESLQLIKRLGNGQFGEVWMGTWNGNTKV-AIKTLKPG---TMSPESFLE-EAQIMKKLK 62
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--------QL 151
            H  +V L AV  +E  +++V E    G L   L+      + E R L +        Q+
Sbjct: 63  -HDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLK------DGEGRALKLPNLVDMAAQV 114
Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF-- 209
              + Y   +  +HRDL+  NIL+         K+ADFGLA  IE  +      G+ F  
Sbjct: 115 AAGMAYIERMNYIHRDLRSANILVGNGLIC---KIADFGLARLIEDNEX-TARQGAKFPI 170
Query: 210 -YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP 266
            + APE  L G +   +DVWS G++L  L++ G  P+ G     + + V     R P  P
Sbjct: 171 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPC-P 228
Query: 267 WDHISDSAKDLVMGMLSTDPSQRLT 291
            D    S  +L++     DP +R T
Sbjct: 229 QD-CPISLHELMIHCWKKDPEERPT 252

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 116/264 (43%), Gaps = 19/264 (7%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G +GV+       +G++ A K I     V   +++ + ++++I  R    P  V  
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 108 KAVYEDEDYVHLVMELCAGG-ELFHR--LEKFGRFSEAEARVLFMQLMQVVLYCH-EIGV 163
                 E  V + MEL     + F++  ++K     E     + + +++ + + H ++ V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL-----AG 218
           +HRD+KP N+L+        +K+ DFG++ Y+    +     G   Y+APE +       
Sbjct: 132 IHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 219 GYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           GY+  +D+WS G+ +  L     P+  WG    ++   V       P  P D  S    D
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS---PQLPADKFSAEFVD 245
Query: 277 LVMGMLSTDPSQRLTARQVLDHSW 300
                L  +  +R T  +++ H +
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPF 269

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 124/284 (43%), Gaps = 43/284 (15%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMT 96
           R     G+ LG G FG +   +    G+  A   +A   L +    D++ ++  E++IM+
Sbjct: 37  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF---------GRFSEAEARVL 147
            L  H N+V+L         V ++ E C  G+L + L +          GR  E    + 
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 148 F-MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-------TYIEPGQ 199
           F  Q+ Q + +      +HRD+   N+LL     +   K+ DFGLA        YI  G 
Sbjct: 157 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMNDSNYIVKGN 213
Query: 200 SLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG---NTK--SRIF 252
           + L       ++APE +    Y   +DVWS G++L+ + S G+ P+ G   N+K    + 
Sbjct: 214 ARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 269
Query: 253 DAVRTADLRF-PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
           D  + A   F P N +         ++    + +P+ R T +Q+
Sbjct: 270 DGYQMAQPAFAPKNIY--------SIMQACWALEPTHRPTFQQI 305

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 124/284 (43%), Gaps = 43/284 (15%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMT 96
           R     G+ LG G FG +   +    G+  A   +A   L +    D++ ++  E++IM+
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFM----- 149
            L  H N+V+L         V ++ E C  G+L  F R +      + + R L +     
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 150 ---QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-------TYIEPGQ 199
              Q+ Q + +      +HRD+   N+LL     +   K+ DFGLA        YI  G 
Sbjct: 165 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMNDSNYIVKGN 221
Query: 200 SLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG---NTK--SRIF 252
           + L       ++APE +    Y   +DVWS G++L+ + S G+ P+ G   N+K    + 
Sbjct: 222 ARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 277
Query: 253 DAVRTADLRF-PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
           D  + A   F P N +         ++    + +P+ R T +Q+
Sbjct: 278 DGYQMAQPAFAPKNIY--------SIMQACWALEPTHRPTFQQI 313

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T +D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEEDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 105/230 (45%), Gaps = 36/230 (15%)
Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L   F++ +++G G FG + +C      + +A K +   +  T    RS K+E +I+ ++
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKIEADILKKI 88
Query: 99  SGHPNVVDLKAVYEDE----DYVHLVMELCAGGELFHRLEK--FGRFSEAEARVLFMQLM 152
                  +    Y  +    D++ L+ E   G  L+  + +  +  F   + ++  ++++
Sbjct: 89  QNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 153 QVVLYCHEIGVVHRDLKPENILL----------------------ATKASSSPIKLADFG 190
           + + Y  ++ + H DLKPENILL                        +  S+ IKL DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 191 LATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSG 239
            AT+          + +  Y APEV+   G++ ++D+WS G +L  L +G
Sbjct: 208 CATFKSDYHG--SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 84
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-------KFG-------- 137
           E+M  +  H N+++L      +  +++++E  + G L   L+       +F         
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPE 144
Query: 138 -RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 201
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 262 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 49  LGWGQFGVIRV-CSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           LG G FG + + C D     TGE+ A K++ +            + EIEI+  L  H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREIEILRTLY-HEHI 73
Query: 105 VDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           V  K   ED  E  V LVME    G L   L +      A+  +   Q+ + + Y H   
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQH 132
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---GSP-FYIAPEVLA- 217
            +HR L   N+LL    +   +K+ DFGLA  +  G           SP F+ APE L  
Sbjct: 133 YIHRALAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 218 GGYNQAADVWSAGVILYILLS 238
             +  A+DVWS GV LY LL+
Sbjct: 190 CKFYYASDVWSFGVTLYELLT 210

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 34  NQISNLRER--FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD-ERSVKL 90
           N  +N  ER   V G + G G FGV  V          A K +A    +T ++ ++    
Sbjct: 13  NVTNNFDERPISVGGNKXGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 70
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEA--EARVLF 148
           EI++  +   H N+V+L     D D + LV      G L  RL             R   
Sbjct: 71  EIKVXAKCQ-HENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKI 129
Query: 149 MQ-LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQSLLGT-- 204
            Q     + + HE   +HRD+K  NILL    ++   K++DFGLA   E   Q +  +  
Sbjct: 130 AQGAANGINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQXVXXSRI 186
Query: 205 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP 241
           VG+  Y APE L G     +D++S GV+L  +++G+P
Sbjct: 187 VGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD--ERSVKL-EIEIMT 96
           RE    G+ LG G FG +   +     +      +A   L    D  ER   + E+++MT
Sbjct: 44  RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 103
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL----EKFG---------RFSEAE 143
           +L  H N+V+L         ++L+ E C  G+L + L    EKF          +  E E
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 144 ARVLFMQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLAT 193
             +  +    ++ + +++            VHRDL   N+L+        +K+ DFGLA 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 220
Query: 194 YI--EPGQSLLGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWG 245
            I  +    + G    P  ++APE L  G Y   +DVWS G++L+ + S G+ P+ G
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 49  LGWGQFGVIRV-CSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
           LG G FG + + C D     TGE+ A K++ +            + EIEI+  L  H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREIEILRTLY-HEHI 72
Query: 105 VDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
           V  K   ED  E  V LVME    G L   L +      A+  +   Q+ + + Y H   
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQH 131
Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV---GSP-FYIAPEVLA- 217
            +HR L   N+LL    +   +K+ DFGLA  +  G           SP F+ APE L  
Sbjct: 132 YIHRALAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 218 GGYNQAADVWSAGVILYILLS 238
             +  A+DVWS GV LY LL+
Sbjct: 189 CKFYYASDVWSFGVTLYELLT 209

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 16  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 73
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF---------------- 136
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 74  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 133
Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 190
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 250
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 251 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 19  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 76
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG--------------- 137
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 77  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 136
Query: 138 -RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 193
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 253
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 254 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 84
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG--------------- 137
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 144
Query: 138 -RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 201
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 262 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 80  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 138
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 255
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 316 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 14/182 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLF 148
           E  IM +   HPN++ L+ V        +V E    G L  F R    G+F+  +   + 
Sbjct: 100 EASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGML 157
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE--PGQSLLGTVG 206
             +   + Y  ++G VHRDL   N+L+    S+   K++DFGL+  +E  P  +   T G
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 207 S-PF-YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRF 262
             P  + APE +A   ++ A+DVWS GV+++ +L  G  P+W  T   +  +V     R 
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRL 273
Query: 263 PS 264
           P+
Sbjct: 274 PA 275

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 23  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 81
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 82  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 141
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 142 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 198
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 199 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 258
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 259 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 14/182 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLF 148
           E  IM +   HPN++ L+ V        +V E    G L  F R    G+F+  +   + 
Sbjct: 100 EASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGML 157
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE--PGQSLLGTVG 206
             +   + Y  ++G VHRDL   N+L+    S+   K++DFGL+  +E  P  +   T G
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAXTTTGG 214
Query: 207 S-PF-YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRF 262
             P  + APE +A   ++ A+DVWS GV+++ +L  G  P+W  T   +  +V     R 
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRL 273
Query: 263 PS 264
           P+
Sbjct: 274 PA 275

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 84
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF---------------- 136
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPE 144
Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 201
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 262 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 68  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 125
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF---------------- 136
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 242
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 303 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 69
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG--------------- 137
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 129
Query: 138 -RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 186
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 247 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 26  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 84
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 85  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 144
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 145 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 201
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 202 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 261
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 262 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + + +     +V A K++    +       +   E  +M  L 
Sbjct: 187 RESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSV----EAFLAEANVMKTLQ 241
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            H  +V L AV   E  ++++ E  A G L   L+      +   +++    Q+ + + +
Sbjct: 242 -HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL+  NIL+   ++S   K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 300 IEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 355
Query: 215 VLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
            +  G +   +DVWS G++L  I+  G  P+ G +   +  A+     R P    ++  +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRP--ENCPE 412
Query: 273 SAKDLVMGMLSTDPSQRLT 291
              +++M      P +R T
Sbjct: 413 ELYNIMMRCWKNRPEERPT 431

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 21  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 79
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 80  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 139
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 140 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLV---TENNVMKIADFGLARDINN 196
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 197 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 256
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 257 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 20  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 77
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF---------------- 136
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 78  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 137
Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 194
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 254
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 255 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG       I +  DK       A K +  D   T  D   +  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 84
Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF---------------- 136
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 144
Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+      + +K+ADFGLA  I 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 201
Query: 197 PGQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
                  T        ++APE L    Y   +DVWS GV+L+ I   G  P+ G     +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
           F  ++        +  D  S+   +L M M       PSQR T +Q+++
Sbjct: 262 FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N++ L      +  +++++E  + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N++ L      +  +++++E  + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++E  + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +++ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMRIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 30/271 (11%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + ++  Q+LG G F  + +      G  +A K I    L     +R        M RL  
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI----LCHEQQDREEAQREADMHRLFN 84
Query: 101 HPNVVDLKAVYEDE----DYVHLVMELCAGGELFHRLEKF---GRF-SEAEARVLFMQLM 152
           HPN++ L A    E        L++     G L++ +E+    G F +E +   L + + 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLL------GTV 205
           + +   H  G  HRDLKP NILL  +     + L     A  ++E  +  L         
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 206 GSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA--- 258
            +  Y APE+ +       ++  DVWS G +LY ++ G  P+  +   +  D+V  A   
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY--DMVFQKGDSVALAVQN 262
Query: 259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQR 289
            L  P +P    S +   L+  M++ DP QR
Sbjct: 263 QLSIPQSPRH--SSALWQLLNSMMTVDPHQR 291

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G  GV+     + +G + A K I  +    I ++  +  E++++   +  P +V  
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNS-PYIVGF 79
Query: 108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG-VVHR 166
              +  +  + + ME   GG L   L++  R  E     + + +++ + Y  E   ++HR
Sbjct: 80  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 139
Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAA 224
           D+KP NIL+ ++     IKL DFG++  +    S+  + VG+  Y+APE L G  Y+  +
Sbjct: 140 DVKPSNILVNSRGE---IKLCDFGVSGQLI--DSMANSFVGTRSYMAPERLQGTHYSVQS 194
Query: 225 DVWSAGVILYILLSGMPPF 243
           D+WS G+ L  L  G  P 
Sbjct: 195 DIWSMGLSLVELAVGRYPI 213

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 20  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 73
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 74  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 131
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 132 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEX-TAREGAKFPIKWTAP 187
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 227

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + + +     +V A K++    +       +   E  +M  L 
Sbjct: 14  RESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSV----EAFLAEANVMKTLQ 68
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            H  +V L AV   E  ++++ E  A G L   L+      +   +++    Q+ + + +
Sbjct: 69  -HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 126
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL+  NIL+   ++S   K+ADFGLA  IE  +      G+ F   + APE
Sbjct: 127 IEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 182
Query: 215 VLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
            +  G +   +DVWS G++L  I+  G  P+ G +   +  A+     R P    ++  +
Sbjct: 183 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRP--ENCPE 239
Query: 273 SAKDLVMGMLSTDPSQRLT 291
              +++M      P +R T
Sbjct: 240 ELYNIMMRCWKNRPEERPT 258

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 18  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 71
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 72  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEX-TAREGAKFPIKWTAP 185
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 225

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 17  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 70
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 71  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 128
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 129 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNE-YTAREGAKFPIKWTAP 184
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 185 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 224

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 67  EVFACKSIAKDRLV-------TIDDERSVKLEIEIMTRLSGH---PNVVDLKAVYEDEDY 116
           +V+  +   ++R+V       T+  +   +   +   R +G    P+VV +    E +  
Sbjct: 49  DVYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQ 108
Query: 117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLA 176
           +++   L  G +L   L + G  +   A  +  Q+   +   H  G  HRD+KPENIL++
Sbjct: 109 LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 177 TKASSSPIKLADFGL--ATYIEPGQSLLGTVGSPFYIAPEVLAGGY-NQAADVWSAGVIL 233
               +    L DFG+  AT  E    L  TVG+ +Y APE  +  +    AD+++   +L
Sbjct: 169 ADDFA---YLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVL 225
Query: 234 YILLSGMPPFWGNTKS 249
           Y  L+G PP+ G+  S
Sbjct: 226 YECLTGSPPYQGDQLS 241

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 18  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 71
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 72  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNE-YTAREGAKFPIKWTAP 185
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 225

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 12  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 65
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 66  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEX-TAREGAKFPIKWTAP 179
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 22  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 75
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 76  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 133
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 134 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNE-YTAREGAKFPIKWTAP 189
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 190 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 229

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 12  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 65
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 66  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEX-TAREGAKFPIKWTAP 179
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 21  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 74
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 75  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 132
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 133 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEX-TAREGAKFPIKWTAP 188
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 228

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 130/301 (43%), Gaps = 51/301 (16%)
Query: 27  AETILDTNQISNLRERFVLGQQLGWGQFG-VIRVCSDKFTGE----VFACKSIAKDRLVT 81
           A  IL+  +    R+  VLG+ LG G+FG V++  +    G       A K + ++   +
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--AS 66
Query: 82  IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL---FHRLEKFG- 137
             + R +  E  ++ +++ HP+V+ L      +  + L++E    G L        K G 
Sbjct: 67  PSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 138 ------------RFSEAEARVLFM--------QLMQVVLYCHEIGVVHRDLKPENILLAT 177
                            + R L M        Q+ Q + Y  E+ +VHRDL   NIL+  
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-- 183
Query: 178 KASSSPIKLADFGLA-------TYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAG 230
            A    +K++DFGL+       +Y++  Q   G +   +     +    Y   +DVWS G
Sbjct: 184 -AEGRKMKISDFGLSRDVYEEDSYVKRSQ---GRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 231 VILY-ILLSGMPPFWGNTKSRIFDAVRTAD-LRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
           V+L+ I+  G  P+ G    R+F+ ++T   +  P    D+ S+    L++     +P +
Sbjct: 240 VLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERP----DNCSEEMYRLMLQCWKQEPDK 295
Query: 289 R 289
           R
Sbjct: 296 R 296

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 14  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 67
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 68  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 125
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 126 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEX-TAREGAKFPIKWTAP 181
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 221

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 13  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 66
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 67  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 124
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 125 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEX-TAREGAKFPIKWTAP 180
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 220

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 119/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++   + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 7   RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 60
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 61  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 118
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 119 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNE-YTAREGAKFPIKWTAP 174
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 175 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 214

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 12  RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 65
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 66  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNE-YTAREGAKFPIKWTAP 179
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 128/298 (42%), Gaps = 45/298 (15%)
Query: 27  AETILDTNQISNLRERFVLGQQLGWGQFG-VIRVCSDKFTGE----VFACKSIAKDRLVT 81
           A  IL+  +    R+  VLG+ LG G+FG V++  +    G       A K + ++   +
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--AS 66
Query: 82  IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL---FHRLEKFG- 137
             + R +  E  ++ +++ HP+V+ L      +  + L++E    G L        K G 
Sbjct: 67  PSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 138 ------------RFSEAEARVLFM--------QLMQVVLYCHEIGVVHRDLKPENILLAT 177
                            + R L M        Q+ Q + Y  E+ +VHRDL   NIL+  
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILV-- 183
Query: 178 KASSSPIKLADFGLATYIEPGQSLL----GTVGSPFYIAPEVLAGGYNQAADVWSAGVIL 233
            A    +K++DFGL+  +    S +    G +   +     +    Y   +DVWS GV+L
Sbjct: 184 -AEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 234 Y-ILLSGMPPFWGNTKSRIFDAVRTAD-LRFPSNPWDHISDSAKDLVMGMLSTDPSQR 289
           + I+  G  P+ G    R+F+ ++T   +  P    D+ S+    L++     +P +R
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNLLKTGHRMERP----DNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 49/290 (16%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMT 96
           R     G+ LG G FG +   +    G+  A   +A   L +    D++ ++  E++IM+
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG----------------RFS 140
            L  H N+V+L         V ++ E C  G+L + L +                  + S
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 141 EAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-------T 193
             +      Q+ Q + +      +HRD+   N+LL     +   K+ DFGLA        
Sbjct: 165 SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMNDSN 221
Query: 194 YIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG---NTK 248
           YI  G + L       ++APE +    Y   +DVWS G++L+ + S G+ P+ G   N+K
Sbjct: 222 YIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 277
Query: 249 --SRIFDAVRTADLRF-PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
               + D  + A   F P N +         ++    + +P+ R T +Q+
Sbjct: 278 FYKLVKDGYQMAQPAFAPKNIY--------SIMQACWALEPTHRPTFQQI 319

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 128/298 (42%), Gaps = 45/298 (15%)
Query: 27  AETILDTNQISNLRERFVLGQQLGWGQFG-VIRVCSDKFTGE----VFACKSIAKDRLVT 81
           A  IL+  +    R+  VLG+ LG G+FG V++  +    G       A K + ++   +
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--AS 66
Query: 82  IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL---FHRLEKFG- 137
             + R +  E  ++ +++ HP+V+ L      +  + L++E    G L        K G 
Sbjct: 67  PSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 138 ------------RFSEAEARVLFM--------QLMQVVLYCHEIGVVHRDLKPENILLAT 177
                            + R L M        Q+ Q + Y  E+ +VHRDL   NIL+  
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-- 183
Query: 178 KASSSPIKLADFGLATYIEPGQSLL----GTVGSPFYIAPEVLAGGYNQAADVWSAGVIL 233
            A    +K++DFGL+  +    S +    G +   +     +    Y   +DVWS GV+L
Sbjct: 184 -AEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 234 Y-ILLSGMPPFWGNTKSRIFDAVRTAD-LRFPSNPWDHISDSAKDLVMGMLSTDPSQR 289
           + I+  G  P+ G    R+F+ ++T   +  P    D+ S+    L++     +P +R
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNLLKTGHRMERP----DNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 119/288 (41%), Gaps = 40/288 (13%)
Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R++  LG+ LG G FG       + +  DK    V     + KD   T  D   +  E+E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEME 92
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-----------KFGRFSEA 142
           +M  +  H N+++L      +  +++++   + G L   L               R  E 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 EARVLFM-----QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
           +     +     QL + + Y      +HRDL   N+L+     ++ +K+ADFGLA  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINN 209
Query: 198 GQSLLGTVGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
                 T        ++APE L    Y   +DVWS GV+++ I   G  P+ G     +F
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGM---LSTDPSQRLTARQVLD 297
             ++        +  D  ++   +L M M       PSQR T +Q+++
Sbjct: 270 KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 56/297 (18%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMT 96
           R     G+ LG G FG +   +    G+  A   +A   L +    D++ ++  E++IM+
Sbjct: 30  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 89
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-------------------- 136
            L  H N+V+L         V ++ E C  G+L + L +                     
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 137 --GRFSEAEARVLFM-QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA- 192
             GR  E    + F  Q+ Q + +      +HRD+   N+LL     +   K+ DFGLA 
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLAR 206
Query: 193 ------TYIEPGQSLLGTVGSPFYIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFW 244
                  YI  G + L       ++APE +    Y   +DVWS G++L+ + S G+ P+ 
Sbjct: 207 DIMNDSNYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 262
Query: 245 G---NTK--SRIFDAVRTADLRF-PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
           G   N+K    + D  + A   F P N +         ++    + +P+ R T +Q+
Sbjct: 263 GILVNSKFYKLVKDGYQMAQPAFAPKNIY--------SIMQACWALEPTHRPTFQQI 311

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG GQFGV++    K+ G+      + K+  ++ D+      E ++M  LS H  +V 
Sbjct: 30  KELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLS-HEKLVQ 83
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V   +  + ++ E  A G L + L E   RF   +   +   + + + Y      +H
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+  +     +K++DFGL+ Y+   +    +VGS F   +  PEVL    ++
Sbjct: 144 RDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEE-TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 222 QAADVWSAGVILYILLS-GMPPF 243
             +D+W+ GV+++ + S G  P+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 117/283 (41%), Gaps = 31/283 (10%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERSVKLEIEIMT 96
           R R   G+ LG G FG +   +     +  A  ++A   L     + +  ++  E+++++
Sbjct: 45  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 104
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM------ 149
            L  H N+V+L           ++ E C  G+L + L  K   F  ++     M      
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 150 -----------QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
                      Q+ + + +      +HRDL   NILL     +   K+ DFGLA +I+  
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARHIKND 221
Query: 199 QSLL--GTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD 253
            + +  G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F 
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 281
Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
            +     R  S   +H      D++      DP +R T +Q++
Sbjct: 282 KMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG GQFGV++    K+ G+      + K+  ++ D+      E ++M  LS H  +V 
Sbjct: 30  KELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLS-HEKLVQ 83
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V   +  + ++ E  A G L + L E   RF   +   +   + + + Y      +H
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+  +     +K++DFGL+ Y+   +    +VGS F   +  PEVL    ++
Sbjct: 144 RDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 222 QAADVWSAGVILYILLS-GMPPF 243
             +D+W+ GV+++ + S G  P+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG GQFGV++    K+ G+      + K+  ++ D+      E ++M  LS H  +V 
Sbjct: 14  KELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLS-HEKLVQ 67
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V   +  + ++ E  A G L + L E   RF   +   +   + + + Y      +H
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 127
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+  +     +K++DFGL+ Y+   +    +VGS F   +  PEVL    ++
Sbjct: 128 RDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 222 QAADVWSAGVILYILLS-GMPPF 243
             +D+W+ GV+++ + S G  P+
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 8   RETLKLVERLGAGQFG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 61
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 62  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HR+L+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 120 FIEERNYIHRNLRAANILVSDTLSC---KIADFGLARLIEDNE-YTAREGAKFPIKWTAP 175
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRI 251
           E +  G +   +DVWS G++L  I+  G  P+ G T   +
Sbjct: 176 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 31/259 (11%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + + +     +V A K++    +       +   E  +M  L 
Sbjct: 181 RESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSV----EAFLAEANVMKTLQ 235
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVLY 157
            H  +V L AV   E  ++++ E  A G L   L+      +   +++    Q+ + + +
Sbjct: 236 -HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 293
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPE 214
             +   +HRDL+  NIL+   ++S   K+ADFGLA            VG+ F   + APE
Sbjct: 294 IEQRNYIHRDLRAANILV---SASLVCKIADFGLA-----------RVGAKFPIKWTAPE 339
Query: 215 VLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
            +  G +   +DVWS G++L  I+  G  P+ G +   +  A+     R P    ++  +
Sbjct: 340 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRP--ENCPE 396
Query: 273 SAKDLVMGMLSTDPSQRLT 291
              +++M      P +R T
Sbjct: 397 ELYNIMMRCWKNRPEERPT 415

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG GQFGV++    K+ G+      + K+  ++ D+      E ++M  LS H  +V 
Sbjct: 21  KELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLS-HEKLVQ 74
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V   +  + ++ E  A G L + L E   RF   +   +   + + + Y      +H
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 134
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+  +     +K++DFGL+ Y+   +    +VGS F   +  PEVL    ++
Sbjct: 135 RDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 222 QAADVWSAGVILYILLS-GMPPF 243
             +D+W+ GV+++ + S G  P+
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG GQFGV++    K+ G+      + K+  ++ D+      E ++M  LS H  +V 
Sbjct: 10  KELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLS-HEKLVQ 63
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V   +  + ++ E  A G L + L E   RF   +   +   + + + Y      +H
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+  +     +K++DFGL+ Y+   +    +VGS F   +  PEVL    ++
Sbjct: 124 RDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 222 QAADVWSAGVILYILLS-GMPPFWGNTKS 249
             +D+W+ GV+++ + S G  P+   T S
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNS 208

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG GQFGV++    K+ G+      + K+  ++ D+      E ++M  LS H  +V 
Sbjct: 15  KELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLS-HEKLVQ 68
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V   +  + ++ E  A G L + L E   RF   +   +   + + + Y      +H
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+  +     +K++DFGL+ Y+   +    +VGS F   +  PEVL    ++
Sbjct: 129 RDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 222 QAADVWSAGVILYILLS-GMPPF 243
             +D+W+ GV+++ + S G  P+
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFM 149
           E  IM + S H N++ L+ V      + ++ E    G L   L EK G FS  +   +  
Sbjct: 96  EAGIMGQFSHH-NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSP 208
            +   + Y   +  VHRDL   NIL+    S+   K++DFGL+  +E   ++   T G  
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 209 F---YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFP 263
               + APE ++   +  A+DVWS G++++ ++  G  P+W  +   +  A+     R P
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLP 270
Query: 264 S 264
           +
Sbjct: 271 T 271

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 45  LGQQLGWGQFGVIRVCS-DKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           L ++LG G FGV+R    D  +G+    A K +  D L   +       E+  M  L  H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 74
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L  V      + +V EL   G L  RL K  G F         +Q+ + + Y   
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPF-YIAPEVL 216
              +HRDL   N+LLAT+     +K+ DFGL   +        +      PF + APE L
Sbjct: 134 KRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 217 AG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
               ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQ G   V    + G    A KS+ +  +       +   E  +M +L
Sbjct: 12  RETLKLVERLGAGQAG--EVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL 65
Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM--QLMQVVL 156
             H  +V L AV   E  ++++ E    G L   L+          ++L M  Q+ + + 
Sbjct: 66  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAP 213
           +  E   +HRDL+  NIL++   S    K+ADFGLA  IE  +      G+ F   + AP
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDAEX-TAREGAKFPIKWTAP 179
Query: 214 EVL-AGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIF 252
           E +  G +   +DVWS G++L  I+  G  P+ G T   + 
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 31/283 (10%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERSVKLEIEIMT 96
           R R   G+ LG G FG +   +     +  A  ++A   L     + +  ++  E+++++
Sbjct: 38  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 97
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM------ 149
            L  H N+V+L           ++ E C  G+L + L  K   F  ++     M      
Sbjct: 98  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 157
Query: 150 -----------QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
                      Q+ + + +      +HRDL   NILL         K+ DFGLA  I+  
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKND 214
Query: 199 QSLL--GTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD 253
            + +  G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F 
Sbjct: 215 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 274
Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
            +     R  S   +H      D++      DP +R T +Q++
Sbjct: 275 KMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 45  LGQQLGWGQFGVIRVCS-DKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           L ++LG G FGV+R    D  +G+    A K +  D L   +       E+  M  L  H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 80
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L  V      + +V EL   G L  RL K  G F         +Q+ + + Y   
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPF-YIAPEVL 216
              +HRDL   N+LLAT+     +K+ DFGL   +        +      PF + APE L
Sbjct: 140 KRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 217 AG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
               ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 45  LGQQLGWGQFGVIRVCS-DKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           L ++LG G FGV+R    D  +G+    A K +  D L   +       E+  M  L  H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 80
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L  V      + +V EL   G L  RL K  G F         +Q+ + + Y   
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPF-YIAPEVL 216
              +HRDL   N+LLAT+     +K+ DFGL   +        +      PF + APE L
Sbjct: 140 KRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 217 AG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
               ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERSVKLEIEIMT 96
           R R   G+ LG G FG +   +     +  A  ++A   L     + +  ++  E+++++
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM------ 149
            L  H N+V+L           ++ E C  G+L + L  K   F  ++     M      
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 150 -----------QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
                      Q+ + + +      +HRDL   NILL     +   K+ DFGLA  I+  
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKND 198
Query: 199 QSLL--GTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD 253
            + +  G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F 
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
            +     R  S   +H      D++      DP +R T +Q++
Sbjct: 259 KMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 45  LGQQLGWGQFGVIRVCS-DKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           L ++LG G FGV+R    D  +G+    A K +  D L   +       E+  M  L  H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 74
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L  V      + +V EL   G L  RL K  G F         +Q+ + + Y   
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPF-YIAPEVL 216
              +HRDL   N+LLAT+     +K+ DFGL   +        +      PF + APE L
Sbjct: 134 KRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 217 AG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
               ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERSVKLEIEIMT 96
           R R   G+ LG G FG +   +     +  A  ++A   L     + +  ++  E+++++
Sbjct: 45  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 104
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM------ 149
            L  H N+V+L           ++ E C  G+L + L  K   F  ++     M      
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 150 -----------QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
                      Q+ + + +      +HRDL   NILL     +   K+ DFGLA  I+  
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKND 221
Query: 199 QSLL--GTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD 253
            + +  G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F 
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 281
Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
            +     R  S   +H      D++      DP +R T +Q++
Sbjct: 282 KMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 45  LGQQLGWGQFGVIRVCS-DKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           L ++LG G FGV+R    D  +G+    A K +  D L   +       E+  M  L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L  V      + +V EL   G L  RL K  G F         +Q+ + + Y   
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPF-YIAPEVL 216
              +HRDL   N+LLAT+     +K+ DFGL   +        +      PF + APE L
Sbjct: 130 KRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 217 AG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
               ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 45  LGQQLGWGQFGVIRVCS-DKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           L ++LG G FGV+R    D  +G+    A K +  D L   +       E+  M  L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L  V      + +V EL   G L  RL K  G F         +Q+ + + Y   
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPF-YIAPEVL 216
              +HRDL   N+LLAT+     +K+ DFGL   +        +      PF + APE L
Sbjct: 130 KRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 217 AG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
               ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERSVKLEIEIMT 96
           R R   G+ LG G FG +   +     +  A  ++A   L     + +  ++  E+++++
Sbjct: 40  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 99
Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFM------ 149
            L  H N+V+L           ++ E C  G+L + L  K   F  ++     M      
Sbjct: 100 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 159
Query: 150 -----------QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
                      Q+ + + +      +HRDL   NILL     +   K+ DFGLA  I+  
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKND 216
Query: 199 QSLL--GTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD 253
            + +  G    P  ++APE +    Y   +DVWS G+ L+ L S G  P+ G      F 
Sbjct: 217 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 276
Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
            +     R  S   +H      D++      DP +R T +Q++
Sbjct: 277 KMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE------ 93
           RE+  L ++LG G FG++   + +   ++   ++  +  + T+++  S++  IE      
Sbjct: 16  REKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEAR 145
           +M   + H +VV L  V        +VMEL A G+L   L           GR       
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 146 VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL-------ATYIE 196
           ++ M  ++   + Y +    VHRDL   N ++A   +   +K+ DFG+       A Y +
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETAYYRK 188
Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
            G+ LL       ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   
Sbjct: 189 GGKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 244
Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           V   D  +   P D+  +   DL+      +P  R T  ++++
Sbjct: 245 V--MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 45  LGQQLGWGQFGVIRVCS-DKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           L ++LG G FGV+R    D  +G+    A K +  D L   +       E+  M  L  H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHE 160
            N++ L  V      + +V EL   G L  RL K  G F         +Q+ + + Y   
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPF-YIAPEVL 216
              +HRDL   N+LLAT+     +K+ DFGL   +        +      PF + APE L
Sbjct: 130 KRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 217 AG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
               ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 47  QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           ++LG GQFGV++    K+ G+      + K+  ++ D+      E ++M  LS H  +V 
Sbjct: 15  KELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLS-HEKLVQ 68
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVH 165
           L  V   +  + ++ E  A G L + L E   RF   +   +   + + + Y      +H
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 166 RDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---YIAPEVLA-GGYN 221
           RDL   N L+  +     +K++DFGL+ Y+   +    + GS F   +  PEVL    ++
Sbjct: 129 RDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 222 QAADVWSAGVILYILLS-GMPPF 243
             +D+W+ GV+++ + S G  P+
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTRLSG 100
           R+ LG+++G G FG I + +D   GE  A K      L  +  +   + +E +I   + G
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKHPQLHIESKIYKMMQG 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
              +  ++    + DY  +VMEL      +LF+   +  +FS     +L  Q++  + Y 
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYI 121
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLA 192
           H    +HRD+KP+N L+      + + + DFGLA
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 12/89 (13%)
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEV 215
           H+  + HRD K +N+LL +  ++    LADFGLA   EPG+      G VG+  Y+APEV
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAV---LADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 216 LAGGYN------QAADVWSAGVILYILLS 238
           L G  N         D+++ G++L+ L+S
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTRLS 99
            R+ LG+++G G FG I + +D   GE  A K      L  +  +   + +E +I   + 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKHPQLHIESKIYKMMQ 60
Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
           G   +  ++    + DY  +VMEL      +LF+   +  +FS     +L  Q++  + Y
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEY 118
Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLA 192
            H    +HRD+KP+N L+      + + + DFGLA
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 44/286 (15%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---------TIDDERSVKL 90
           R   VL ++LG G FG +      F  E +   S  KD+++         T+   +  + 
Sbjct: 14  RRDIVLKRELGEGAFGKV------FLAECYNL-SPTKDKMLVAVKALKDPTLAARKDFQR 66
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG---------RFSE 141
           E E++T L  H ++V    V  D D + +V E    G+L   L   G         +  +
Sbjct: 67  EAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 142 AEARVLFMQLMQV-------VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-- 192
           A+  +   Q++ +       ++Y      VHRDL   N L+    ++  +K+ DFG++  
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRD 182
Query: 193 TYIEPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILY-ILLSGMPPFWGNTKS 249
            Y      + G    P  ++ PE ++   +   +DVWS GVIL+ I   G  P++  + +
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
Query: 250 RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
            + + +     R    P         D+++G    +P QRL  +++
Sbjct: 243 EVIECITQG--RVLERP-RVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 111/265 (41%), Gaps = 19/265 (7%)
Query: 48  QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDL 107
           +LG G +GV+       +G++ A K I     V   +++ +  +++I  R    P  V  
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 108 KAVYEDEDYVHLVMELCAGG-ELFHR--LEKFGRFSEAEARVLFMQLMQVVLYCH-EIGV 163
                 E  V +  EL     + F++  ++K     E     + + +++ + + H ++ V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG-----SPFYIAPEVLAG 218
           +HRD+KP N+L+        +K  DFG++ Y+    +     G     +P  I PE+   
Sbjct: 159 IHRDVKPSNVLINALGQ---VKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQK 215
Query: 219 GYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           GY+  +D+WS G+    L     P+  WG    ++   V       P  P D  S    D
Sbjct: 216 GYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPS---PQLPADKFSAEFVD 272
Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
                L  +  +R T  ++  H + 
Sbjct: 273 FTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 117 VHLVMELCAGGELF-HRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL 175
           V LV +L   G L  H  E  GR    +     MQ+ + + Y  ++ +VHRDL   N+L+
Sbjct: 93  VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLV 152
Query: 176 ATKASSSPIKLADFGLATYIEPGQSLL----GTVGSPFYIAPEVLAGGYNQAADVWSAGV 231
               S + +K+ DFGLA  ++  ++      G V   +     +L   +   +DVWS GV
Sbjct: 153 ---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGV 209
Query: 232 ILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP 266
            ++ L++ G  P+ G     I D +   + R P  P
Sbjct: 210 TVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQPP 244

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTRLSG 100
           +F LG+++G G FG I + ++  T E  A K      L  +  +    L E +I   L G
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKIYRILQG 61
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
              + +++    + DY  LVM+L      +LF+   +  + S     +L  Q++  V + 
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 119
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE--------PGQSLLGTVGSPFY 210
           H    +HRD+KP+N L+     ++ + + DFGLA            P +      G+  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWG---NTKSRIFDAV 255
            +     G   ++  D+ S G +L   L G  P+ G    TK + ++ +
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 127/283 (44%), Gaps = 39/283 (13%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE------ 93
           RE+  L ++LG G FG++   + +   ++   ++  +  + T+++  S++  IE      
Sbjct: 16  REKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEAR 145
           +M   + H +VV L  V        +VMEL A G+L   L           GR       
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 146 VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT-------YIE 196
           ++ M  ++   + Y +    VHRDL   N ++A   +   +K+ DFG+         Y +
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRK 188
Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
            G+ LL       ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   
Sbjct: 189 GGKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 244
Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           V   D  +   P D+  +   DL+      +P  R T  ++++
Sbjct: 245 V--MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 127/283 (44%), Gaps = 39/283 (13%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE------ 93
           RE+  L ++LG G FG++   + +   ++   ++  +  + T+++  S++  IE      
Sbjct: 15  REKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEAR 145
           +M   + H +VV L  V        +VMEL A G+L   L           GR       
Sbjct: 72  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 146 VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT-------YIE 196
           ++ M  ++   + Y +    VHRDL   N ++A   +   +K+ DFG+         Y +
Sbjct: 131 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRK 187
Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
            G+ LL       ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   
Sbjct: 188 GGKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 243
Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           V   D  +   P D+  +   DL+      +P  R T  ++++
Sbjct: 244 V--MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 283

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 25/188 (13%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEAR----- 145
           E  +  RL  HPNVV L  V   +  + ++   C+ G+L   L      S+  +      
Sbjct: 62  EAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 146 -----------VLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL--A 192
                       L  Q+   + Y     VVH+DL   N+L+  K +   +K++D GL   
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLFRE 177
Query: 193 TYIEPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKS 249
            Y      LLG    P  ++APE ++ G ++  +D+WS GV+L+ + S G+ P+ G +  
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237
Query: 250 RIFDAVRT 257
            + + +R 
Sbjct: 238 DVVEMIRN 245

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE------ 93
           RE+  L ++LG G FG++   + +   ++   ++  +  + T+++  S++  IE      
Sbjct: 16  REKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEAR 145
           +M   + H +VV L  V        +VMEL A G+L   L           GR       
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 146 VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-------E 196
           ++ M  ++   + Y +    VHRDL   N ++A   +   +K+ DFG+   I       +
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRK 188
Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
            G+ LL       ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   
Sbjct: 189 GGKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 244
Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           V   D  +   P D+  +   DL+      +P+ R T  ++++
Sbjct: 245 V--MDGGYLDQP-DNCPERVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 25/188 (13%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEAR----- 145
           E  +  RL  HPNVV L  V   +  + ++   C+ G+L   L      S+  +      
Sbjct: 79  EAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 146 -----------VLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL--A 192
                       L  Q+   + Y     VVH+DL   N+L+  K +   +K++D GL   
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLFRE 194
Query: 193 TYIEPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWGNTKS 249
            Y      LLG    P  ++APE ++ G ++  +D+WS GV+L+ + S G+ P+ G +  
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254
Query: 250 RIFDAVRT 257
            + + +R 
Sbjct: 255 DVVEMIRN 262

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 118/296 (39%), Gaps = 37/296 (12%)
Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVF---ACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           ++F LG+ LG G+FG +R    K     F   A K +  D + + D E  ++ E   M  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 98  LSGHPNVVDLKAVYEDED------YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
              HP+V  L  V              +++     G+L H      R  E    +    L
Sbjct: 82  FD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL-HAFLLASRIGENPFNLPLQTL 139
Query: 152 MQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
           ++ ++       Y      +HRDL   N +LA   +   + +ADFGL+  I  G      
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT---VCVADFGLSRKIYSGDYYRQG 196
Query: 205 VGSPF---YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTAD 259
             S     ++A E LA   Y   +DVW+ GV ++ I+  G  P+ G   + I++ +   +
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQ-------RLTARQVLDHSWMGDGIQDP 308
            R    P     +   DL+    S DP Q       R+    +L H  +    QDP
Sbjct: 257 -RLKQPP--ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 127/283 (44%), Gaps = 39/283 (13%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE------ 93
           RE+  L ++LG G FG++   + +   ++   ++  +  + T+++  S++  IE      
Sbjct: 13  REKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEAR 145
           +M   + H +VV L  V        +VMEL A G+L   L           GR       
Sbjct: 70  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 128
Query: 146 VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-------E 196
           ++ M  ++   + Y +    VHRDL   N ++A   +   +K+ DFG+   I       +
Sbjct: 129 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRK 185
Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
            G+ LL       ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   
Sbjct: 186 GGKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 241
Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           V   D  +   P D+  +   DL+      +P  R T  ++++
Sbjct: 242 V--MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 281

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 127/283 (44%), Gaps = 39/283 (13%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE------ 93
           RE+  L ++LG G FG++   + +   ++   ++  +  + T+++  S++  IE      
Sbjct: 16  REKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEAR 145
           +M   + H +VV L  V        +VMEL A G+L   L           GR       
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 146 VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-------E 196
           ++ M  ++   + Y +    VHRDL   N ++A   +   +K+ DFG+   I       +
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRK 188
Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
            G+ LL       ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   
Sbjct: 189 GGKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 244
Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           V   D  +   P D+  +   DL+      +P  R T  ++++
Sbjct: 245 V--MDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE------ 93
           RE+  L ++LG G FG++   + +   ++   ++  +  + T+++  S++  IE      
Sbjct: 16  REKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEAR 145
           +M   + H +VV L  V        +VMEL A G+L   L           GR       
Sbjct: 73  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 146 VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT-------YIE 196
           ++ M  ++   + Y +    VHR+L   N ++A   +   +K+ DFG+         Y +
Sbjct: 132 MIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRK 188
Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
            G+ LL       ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   
Sbjct: 189 GGKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 244
Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           V   D  +   P D+  +   DL+      +P+ R T  ++++
Sbjct: 245 V--MDGGYLDQP-DNCPERVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE------ 93
           RE+  L ++LG G FG++   + +   ++   ++  +  + T+++  S++  IE      
Sbjct: 17  REKITLLRELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF--------GRFSEAEAR 145
           +M   + H +VV L  V        +VMEL A G+L   L           GR       
Sbjct: 74  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 132
Query: 146 VLFM--QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT-------YIE 196
           ++ M  ++   + Y +    VHR+L   N ++A   +   +K+ DFG+         Y +
Sbjct: 133 MIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRK 189
Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
            G+ LL       ++APE L  G +  ++D+WS GV+L+ + S    P+ G +  ++   
Sbjct: 190 GGKGLLPVR----WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 245
Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
           V   D  +   P D+  +   DL+      +P+ R T  ++++
Sbjct: 246 V--MDGGYLDQP-DNCPERVTDLMRMCWQFNPNMRPTFLEIVN 285

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 47  QQLGWGQFGVIR-----VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           ++LG G FG ++     +     T  V   K+ A D    + DE  +  E  +M +L  +
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDE--LLAEANVMQQLD-N 429
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           P +V +  + E E ++ LVME+   G L   L++     +     L  Q+   + Y  E 
Sbjct: 430 PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 488
Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG--TVGS-PF-YIAPEVLA 217
             VHRDL   N+LL T+  +   K++DFGL+  +   ++     T G  P  + APE + 
Sbjct: 489 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 545
Query: 218 -GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 47  QQLGWGQFGVIR-----VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           ++LG G FG ++     +     T  V   K+ A D    + DE  +  E  +M +L  +
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDE--LLAEANVMQQLD-N 430
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           P +V +  + E E ++ LVME+   G L   L++     +     L  Q+   + Y  E 
Sbjct: 431 PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 489
Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG--TVGS-PF-YIAPEVLA 217
             VHRDL   N+LL T+  +   K++DFGL+  +   ++     T G  P  + APE + 
Sbjct: 490 NFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 546
Query: 218 -GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 582

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           N++E  +L Q +G G+FG + +    + G   A K I  D        ++   E  +MT+
Sbjct: 10  NMKELKLL-QTIGKGEFGDVML--GDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQ 61
Query: 98  LSGHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL--MQV 154
           L  H N+V L  V  E++  +++V E  A G L   L   GR       +L   L   + 
Sbjct: 62  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 120
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF-YIAP 213
           + Y      VHRDL   N+L++     +  K++DFGL       Q    T   P  + AP
Sbjct: 121 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAP 174
Query: 214 EVL-AGGYNQAADVWSAGVILYILLS-GMPPF 243
           E L    ++  +DVWS G++L+ + S G  P+
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 48  QLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +LG G FG +R    +    ++     + K      D E  ++ E +IM +L  +P +V 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQLD-NPYIVR 74
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL---YCHEIGV 163
           L  V + E  + LVME+  GG L   L   G+  E     +   L QV +   Y  E   
Sbjct: 75  LIGVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS---PF-YIAPEVLA-G 218
           VHRDL   N+LL  +  +   K++DFGL+  +    S      +   P  + APE +   
Sbjct: 132 VHRDLAARNVLLVNRHYA---KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 219 GYNQAADVWSAGVILYILLS-GMPPF 243
            ++  +DVWS GV ++  LS G  P+
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTRLSG 100
           ++ LG+++G G FG I + ++  +GE  A K      L  +  +   + +E +    + G
Sbjct: 10  KYRLGRKIGSGSFGDIYLGANIASGEEVAIK------LECVKTKHPQLHIESKFYKMMQG 63
Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
              +  +K    + DY  +VMEL      +LF+   +  +FS     +L  Q++  + Y 
Sbjct: 64  GVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYI 121
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLA 192
           H    +HRD+KP+N L+      + + + DFGLA
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 27/270 (10%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           N++E  +L Q +G G+FG + +    + G   A K I  D        ++   E  +MT+
Sbjct: 191 NMKELKLL-QTIGKGEFGDVML--GDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQ 242
Query: 98  LSGHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL--MQV 154
           L  H N+V L  V  E++  +++V E  A G L   L   GR       +L   L   + 
Sbjct: 243 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF-YIAP 213
           + Y      VHRDL   N+L++     +  K++DFGL    +   S   T   P  + AP
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAP 355
Query: 214 EVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           E L    ++  +DVWS G++L+ + S G  P+    +  + D V   +  +  +  D   
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPY---PRIPLKDVVPRVEKGYKMDAPDGCP 412
Query: 272 DSAKDLVMGMLSTDPSQR---LTARQVLDH 298
            +  D++      D + R   L  R+ L+H
Sbjct: 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEH 442

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 19  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 71
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++L+ H N+V    V        +++EL AGG+L   L +  
Sbjct: 72  -VCSEQDELDFLMEALIISKLN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 190 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 247 YPSKSNQEVLEFVTSG 262

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 33  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++L+ H N+V    V        +++EL AGG+L   L +  
Sbjct: 86  -VCSEQDELDFLMEALIISKLN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 204 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 261 YPSKSNQEVLEFVTSG 276

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 33  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        ++MEL AGG+L   L +  
Sbjct: 86  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 143
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 204 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 261 YPSKSNQEVLEFVTSG 276

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 12/89 (13%)
Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEV 215
           H+  + HRD+K +N+LL    ++    +ADFGLA   E G+S     G VG+  Y+APEV
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTAC---IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 216 LAGGYN------QAADVWSAGVILYILLS 238
           L G  N         D+++ G++L+ L S
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 48  QLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD 106
           +LG G FG +R    +    ++     + K      D E  ++ E +IM +L  +P +V 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQLD-NPYIVR 400
Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL---YCHEIGV 163
           L  V + E  + LVME+  GG L   L   G+  E     +   L QV +   Y  E   
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 164 VHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS---PF-YIAPEVLA-G 218
           VHR+L   N+LL  +  +   K++DFGL+  +    S      +   P  + APE +   
Sbjct: 458 VHRNLAARNVLLVNRHYA---KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 219 GYNQAADVWSAGVILYILLS-GMPPF 243
            ++  +DVWS GV ++  LS G  P+
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 18  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 70
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        ++MEL AGG+L   L +  
Sbjct: 71  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 128
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 246 YPSKSNQEVLEFVTSG 261

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           N++E  +L Q +G G+FG + +    + G   A K I  D        ++   E  +MT+
Sbjct: 19  NMKELKLL-QTIGKGEFGDVML--GDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQ 70
Query: 98  LSGHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL--MQV 154
           L  H N+V L  V  E++  +++V E  A G L   L   GR       +L   L   + 
Sbjct: 71  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF-YIAP 213
           + Y      VHRDL   N+L++     +  K++DFGL    +   S   T   P  + AP
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAP 183
Query: 214 EVL-AGGYNQAADVWSAGVILYILLS-GMPPF 243
           E L    ++  +DVWS G++L+ + S G  P+
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  +M +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q
Sbjct: 76  EANVMQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 133
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
           +   + Y  E   VHRDL   N+LL T+  +   K++DFGL+  +   ++       G  
Sbjct: 134 VSMGMKYLEESNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKW 190
Query: 206 GSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              +Y APE +    ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 191 PVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 237

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  +M +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q
Sbjct: 78  EANVMQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
           +   + Y  E   VHRDL   N+LL T+  +   K++DFGL+  +   ++       G  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKW 192
Query: 206 GSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              +Y APE +    ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 193 PVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  +M +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q
Sbjct: 78  EANVMQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
           +   + Y  E   VHRDL   N+LL T+  +   K++DFGL+  +   ++       G  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKW 192
Query: 206 GSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              +Y APE +    ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 193 PVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 8/116 (6%)
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP--GQSLLGTVG 206
           +Q+ + + Y  E G+VHR+L   N+LL    S S +++ADFG+A  + P   Q L     
Sbjct: 140 VQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAK 196
Query: 207 SPF-YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTAD 259
           +P  ++A E +  G Y   +DVWS GV ++ L++ G  P+ G   + + D +   +
Sbjct: 197 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 252

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  +M +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q
Sbjct: 56  EANVMQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 113
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
           +   + Y  E   VHRDL   N+LL T+  +   K++DFGL+  +   ++       G  
Sbjct: 114 VSMGMKYLEESNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKW 170
Query: 206 GSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              +Y APE +    ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 171 PVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 217

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  +M +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q
Sbjct: 62  EANVMQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
           +   + Y  E   VHRDL   N+LL T+  +   K++DFGL+  +   ++       G  
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKW 176
Query: 206 GSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              +Y APE +    ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 177 PVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           N++E  +L Q +G G+FG + +    + G   A K I  D        ++   E  +MT+
Sbjct: 4   NMKELKLL-QTIGKGEFGDVML--GDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQ 55
Query: 98  LSGHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL--MQV 154
           L  H N+V L  V  E++  +++V E  A G L   L   GR       +L   L   + 
Sbjct: 56  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF-YIAP 213
           + Y      VHRDL   N+L++     +  K++DFGL    +   S   T   P  + AP
Sbjct: 115 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAP 168
Query: 214 EVL-AGGYNQAADVWSAGVILYILLS-GMPPF 243
           E L    ++  +DVWS G++L+ + S G  P+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  +M +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q
Sbjct: 58  EANVMQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
           +   + Y  E   VHRDL   N+LL T+  +   K++DFGL+  +   ++       G  
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKW 172
Query: 206 GSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              +Y APE +    ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 173 PVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  +M +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q
Sbjct: 68  EANVMQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
           +   + Y  E   VHRDL   N+LL T+  +   K++DFGL+  +   ++       G  
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKW 182
Query: 206 GSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              +Y APE +    ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 183 PVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  +M +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q
Sbjct: 62  EANVMQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
           +   + Y  E   VHRDL   N+LL T+  +   K++DFGL+  +   ++       G  
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENXYKAQTHGKW 176
Query: 206 GSPFYIAPEVL-AGGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              +Y APE +    ++  +DVWS GV+++   S G  P+ G   S +
Sbjct: 177 PVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 8/116 (6%)
Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP--GQSLLGTVG 206
           +Q+ + + Y  E G+VHR+L   N+LL    S S +++ADFG+A  + P   Q L     
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
Query: 207 SPF-YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTAD 259
           +P  ++A E +  G Y   +DVWS GV ++ L++ G  P+ G   + + D +   +
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 148 FMQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYI 195
           F+ L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y 
Sbjct: 187 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYK 243
Query: 196 EPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NT 247
           +P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G       
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 303
Query: 248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
             R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 304 CRRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 353

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 148 FMQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYI 195
           F+ L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y 
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYK 245
Query: 196 EPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NT 247
           +P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G       
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
             R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 306 CRRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 148 FMQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYI 195
           F+ L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y 
Sbjct: 196 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYK 252
Query: 196 EPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NT 247
           +P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G       
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 312
Query: 248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
             R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 313 CRRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 362

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 148 FMQLMQVVLYCHEIG----------VVHRDLKPENILLATKASSSPIKLADFGLA--TYI 195
           F+ L  ++ Y  ++            +HRDL   NILL+ K   + +K+ DFGLA   Y 
Sbjct: 194 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYK 250
Query: 196 EPGQSLLGTVGSPF-YIAPE-VLAGGYNQAADVWSAGVILYILLS-GMPPFWG-----NT 247
           +P     G    P  ++APE +    Y   +DVWS GV+L+ + S G  P+ G       
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 310
Query: 248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
             R+ +  R   +R P    D+ +      ++     +PSQR T  ++++H  +G+ +Q
Sbjct: 311 CRRLKEGTR---MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 360

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 19  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 71
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 72  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 190 MAQDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 247 YPSKSNQEVLEFVTSG 262

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACK-SIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           F +G+++G G FG +R+  + +T E  A K    K R         + LE     +LS  
Sbjct: 6   FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSR------APQLHLEYRFYKQLSAT 59
Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
             V  +        Y  +V+EL      +LF   ++   F+     ++ +QL+  + Y H
Sbjct: 60  EGVPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCDR--TFTLKTVLMIAIQLITRMEYVH 117
Query: 160 EIGVVHRDLKPENILLATKASS--SPIKLADFGLAT-YIEP 197
              +++RD+KPEN L+    +     I + DFGLA  YI+P
Sbjct: 118 TKSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDP 158

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 19  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 71
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 72  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 190 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 247 YPSKSNQEVLEFVTSG 262

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 25  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 77
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 78  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 135
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 136 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 195
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 196 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 252
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 253 YPSKSNQEVLEFVTSG 268

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 10  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 62
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 63  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 120
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 121 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 180
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 181 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 237
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 238 YPSKSNQEVLEFVTSG 253

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 42/253 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 45  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 97
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 98  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 155
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 156 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 215
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE    G +    D WS GV+L+ + S G  P
Sbjct: 216 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 272
Query: 243 FWGNTKSRIFDAV 255
           +   +   + + V
Sbjct: 273 YPSKSNQEVLEFV 285

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 35  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 87
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 88  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 145
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 146 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 205
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 206 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 262
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 263 YPSKSNQEVLEFVTSG 278

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 18  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 70
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 71  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 128
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 246 YPSKSNQEVLEFVTSG 261

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 33  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 86  -VYSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 191 L------ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPP 242
           +      A+Y   G   +  V    ++ PE    G +    D WS GV+L+ + S G  P
Sbjct: 204 MARDIYRASYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 261 YPSKSNQEVLEFVTSG 276

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-M 95
           S +    VL + +G G+FG   V   K+ GE  A K      + +  +ERS   E EI  
Sbjct: 5   STIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVK------IFSSREERSWFREAEIYQ 56
Query: 96  TRLSGHPNVVDLKAVYEDED----YVHLVMELCAGGELFHRLEKFG-------RFSEAEA 144
           T +  H N++   A    ++     + LV +    G LF  L ++        + + + A
Sbjct: 57  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA 116
Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
             L    M++V    +  + HRDLK +NIL+    +     +AD GLA   +     +  
Sbjct: 117 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC---IADLGLAVRHDSATDTIDI 173
Query: 205 -----VGSPFYIAPEVLAGGYN-------QAADVWSAGVILY 234
                VG+  Y+APEVL    N       + AD+++ G++ +
Sbjct: 174 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 59  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 111
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 112 -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 169
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 170 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 191 LAT------YIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +A       Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 287 YPSKSNQEVLEFVTSG 302

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 42/256 (16%)
Query: 33  TNQISNLRE----RFVLGQQLGWGQFGVIRVCSDKFTGEV-----------FACKSIAKD 77
           T+ IS+L+E       L + LG G FG +      + G+V            A K++ + 
Sbjct: 36  TSSISDLKEVPRKNITLIRGLGHGAFGEV------YEGQVSGMPNDPSPLQVAVKTLPE- 88
Query: 78  RLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
            + +  DE    +E  I+++ + H N+V    V        +++EL AGG+L   L +  
Sbjct: 89  -VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 146
Query: 138 RFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                 + +  + L+ V         Y  E   +HRD+   N LL         K+ DFG
Sbjct: 147 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 206
Query: 191 LAT------YIEPGQSLLGTVGSPFYIAPEV-LAGGYNQAADVWSAGVILYILLS-GMPP 242
           +A       Y   G   +  V    ++ PE  + G +    D WS GV+L+ + S G  P
Sbjct: 207 MARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 263
Query: 243 FWGNTKSRIFDAVRTA 258
           +   +   + + V + 
Sbjct: 264 YPSKSNQEVLEFVTSG 279

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGH 101
            VL + +G G+FG   V   K+ GE  A K      + +  +ERS   E EI  T +  H
Sbjct: 44  IVLQESIGKGRFG--EVWRGKWRGEEVAVK------IFSSREERSWFREAEIYQTVMLRH 95
Query: 102 PNVVDLKAVYEDED----YVHLVMELCAGGELFHRLEKFG-------RFSEAEARVLFMQ 150
            N++   A    ++     + LV +    G LF  L ++        + + + A  L   
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 155
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-----V 205
            M++V    +  + HRDLK +NIL+    +     +AD GLA   +     +       V
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC---IADLGLAVRHDSATDTIDIAPNHRV 212
Query: 206 GSPFYIAPEVLAGGYN-------QAADVWSAGVILY 234
           G+  Y+APEVL    N       + AD+++ G++ +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI-MTRLSGH 101
            VL + +G G+FG   V   K+ GE  A K      + +  +ERS   E EI  T +  H
Sbjct: 31  IVLQESIGKGRFG--EVWRGKWRGEEVAVK------IFSSREERSWFREAEIYQTVMLRH 82
Query: 102 PNVVDLKAVYEDED----YVHLVMELCAGGELFHRLEKFG-------RFSEAEARVLFMQ 150
            N++   A    ++     + LV +    G LF  L ++        + + + A  L   
Sbjct: 83  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 142
Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-----V 205
            M++V    +  + HRDLK +NIL+    +     +AD GLA   +     +       V
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC---IADLGLAVRHDSATDTIDIAPNHRV 199
Query: 206 GSPFYIAPEVLAGGYN-------QAADVWSAGVILY 234
           G+  Y+APEVL    N       + AD+++ G++ +
Sbjct: 200 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 110/253 (43%), Gaps = 50/253 (19%)
Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDR------LVTIDDERSVKLEIE 93
           RE+  + ++LG G FG++      + G     K + KD       + T+++  S++  IE
Sbjct: 24  REKITMSRELGQGSFGMV------YEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 94  ------IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL 147
                 +M   + H +VV L  V        ++MEL   G+L   L    R + A   VL
Sbjct: 75  FLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVL 132
Query: 148 ----FMQLMQV-------VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT--- 193
                 +++Q+       + Y +    VHRDL   N ++A   +   +K+ DFG+     
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIY 189
Query: 194 ----YIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNT 247
               Y + G+ LL       +++PE L  G +   +DVWS GV+L+ I      P+ G +
Sbjct: 190 ETDYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 248 KSRIFDAVRTADL 260
             ++   V    L
Sbjct: 246 NEQVLRFVMEGGL 258
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	468
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-154
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-153
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-152
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-152
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-151
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-150
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-150
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-148
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-148
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-148
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-147
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-146
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-146
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-146
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-145
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-144
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-144
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-142
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-142
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-142
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-141
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-140
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-140
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-138
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-136
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-136
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-135
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-134
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-133
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-132
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-130
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-128
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-128
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-105
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-102
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-101
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-101
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-99
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-95
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-91
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-91
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-91
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-91
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-90
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-90
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-89
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-89
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-88
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-88
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-88
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-87
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-87
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-86
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-86
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-86
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-85
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-80
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-80
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-78
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-77
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-75
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-74
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-72
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-71
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-69
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-68
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-68
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-67
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-67
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-65
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-63
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-62
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-62
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-61
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-61
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-61
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-61
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-60
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-60
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-60
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-60
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-60
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-60
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-60
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-59
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-59
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-58
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-58
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-58
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-58
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-57
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-57
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-53
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-51
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-50
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-50
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-50
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-50
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-50
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-50
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-49
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-49
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-48
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-48
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-48
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-48
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-47
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-46
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-46
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-46
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-45
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-45
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-45
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-45
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-45
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-45
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-45
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-44
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-44
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-44
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-44
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-44
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-43
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-42
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-41
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-40
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-38
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-37
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-37
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-37
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-36
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-36
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-36
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-35
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-35
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-35
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-35
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-34
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-34
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-32
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-32
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-31
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-31
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-30
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-26
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-23
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-22
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-21
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-21
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-21
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-18
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-18
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	2e-05

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  438 bits (1128), Expect = e-154
 Identities = 106/284 (37%), Positives = 165/284 (58%), Gaps = 3/284 (1%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           +   + + + ++LG G F V+R C  K TG  FA K I   +L   D ++ ++ E  I  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICR 60

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           +L  HPN+V L    ++E + +LV +L  GGELF  +     +SEA+A     Q+++ + 
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           YCH  G+VHR+LKPEN+LLA+KA  + +KLADFGLA  +   ++  G  G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               Y++  D+W+ GVILYILL G PPFW   + R++  ++     +PS  WD ++  AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDC 319
            L+  ML+ +P +R+TA Q L   W+ +  +    +      DC
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 283

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  439 bits (1131), Expect = e-153
 Identities = 97/312 (31%), Positives = 154/312 (49%), Gaps = 15/312 (4%)

Query: 2   AAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS 61
            A  +  + ++P       ++     + + D        +++     +G G   V+R C 
Sbjct: 55  LAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV 114

Query: 62  DKFTGEVFACKSIAKDRLVTI-----DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY 116
            + TG  FA K +             +   + + E  I+ +++GHP+++ L   YE   +
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174

Query: 117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLA 176
           + LV +L   GELF  L +    SE E R +   L++ V + H   +VHRDLKPENILL 
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL- 233

Query: 177 TKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-------GYNQAADVWSA 229
               +  I+L+DFG + ++EPG+ L    G+P Y+APE+L         GY +  D+W+ 
Sbjct: 234 --DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291

Query: 230 GVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQR 289
           GVIL+ LL+G PPFW   +  +   +     +F S  WD  S + KDL+  +L  DP  R
Sbjct: 292 GVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEAR 351

Query: 290 LTARQVLDHSWM 301
           LTA Q L H + 
Sbjct: 352 LTAEQALQHPFF 363

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  433 bits (1117), Expect = e-152
 Identities = 105/274 (38%), Positives = 155/274 (56%), Gaps = 4/274 (1%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
            ++ + + L   +G G +G +++   K T    A K I K  +   +D    K EIEIM 
Sbjct: 5   GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMK 61

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
            L  HPN++ L   +ED   ++LVMELC GGELF R+     F E++A  +   ++  V 
Sbjct: 62  SLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           YCH++ V HRDLKPEN L  T +  SP+KL DFGLA   +PG+ +   VG+P+Y++P+VL
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180

Query: 217 AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
            G Y    D WSAGV++Y+LL G PPF   T S +   +R     FP   W ++S  A+ 
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           L+  +L+  P QR+T+ Q L+H W    +    +
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  433 bits (1117), Expect = e-152
 Identities = 113/265 (42%), Positives = 153/265 (57%), Gaps = 2/265 (0%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
               ER+ +   LG G FG +  C D+ T + +A K I K      D    +  E+E++ 
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLK 76

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           +L  HPN++ L  + ED    ++V EL  GGELF  + K  RFSE +A  +  Q+   + 
Sbjct: 77  KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           Y H+  +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YIAPEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195

Query: 217 AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
            G Y++  DVWSAGVILYILLSG PPF+G  +  I   V T    F    W  ISD AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
           L+  ML+  PS R+TA Q L+H W+
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWI 280

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  434 bits (1118), Expect = e-151
 Identities = 107/288 (37%), Positives = 166/288 (57%), Gaps = 3/288 (1%)

Query: 33  TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI 92
            N  +   + + + ++LG G F V+R C  K TG  FA K I   +L   D ++ ++ E 
Sbjct: 21  MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREA 79

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
            I  +L  HPN+V L    ++E + +LV +L  GGELF  +     +SEA+A     Q++
Sbjct: 80  RICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 138

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
           + + YCH  G+VHR+LKPEN+LLA+KA  + +KLADFGLA  +   ++  G  G+P Y++
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 198

Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PEVL    Y++  D+W+ GVILYILL G PPFW   + R++  ++     +PS  WD ++
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDC 319
             AK L+  ML+ +P +R+TA Q L   W+ +  +    +      DC
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 306

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  427 bits (1101), Expect = e-150
 Identities = 98/296 (33%), Positives = 151/296 (51%), Gaps = 16/296 (5%)

Query: 28  ETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI----- 82
             +  ++      E +   + LG G   V+R C  K T + +A K I      +      
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 83  -DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSE 141
            +   +   E++I+ ++SGHPN++ LK  YE   +  LV +L   GELF  L +    SE
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 142 AEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
            E R +   L++V+   H++ +VHRDLKPENILL        IKL DFG +  ++PG+ L
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKL 180

Query: 202 LGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDA 254
               G+P Y+APE++         GY +  D+WS GVI+Y LL+G PPFW   +  +   
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240

Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           + + + +F S  WD  SD+ KDLV   L   P +R TA + L H +    + +  +
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  433 bits (1115), Expect = e-150
 Identities = 109/292 (37%), Positives = 165/292 (56%), Gaps = 4/292 (1%)

Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           + T   +   E + L ++LG G F V+R C     G+ +A   I   +L   D ++ ++ 
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LER 59

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           E  I   L  HPN+V L     +E + +L+ +L  GGELF  +     +SEA+A     Q
Sbjct: 60  EARICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 118

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPF 209
           +++ VL+CH++GVVHR+LKPEN+LLA+K   + +KLADFGLA  +E  Q       G+P 
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178

Query: 210 YIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD 268
           Y++PEVL    Y +  D+W+ GVILYILL G PPFW   + R++  ++     FPS  WD
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238

Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCK 320
            ++  AKDL+  ML+ +PS+R+TA + L H W+         +   +  DC 
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL 290

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  425 bits (1095), Expect = e-148
 Identities = 89/288 (30%), Positives = 143/288 (49%), Gaps = 5/288 (1%)

Query: 25  SLAETILDTNQISNLRERFVL-GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID 83
            L    L    + N    ++L  ++LG G+F V+R C  K TG+ +A K + K R    D
Sbjct: 12  DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-D 70

Query: 84  DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL--EKFGRFSE 141
               +  EI ++      P V++L  VYE+   + L++E  AGGE+F     E     SE
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE 130

Query: 142 AEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
            +   L  Q+++ V Y H+  +VH DLKP+NILL++      IK+ DFG++  I     L
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190

Query: 202 LGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL 260
              +G+P Y+APE+L       A D+W+ G+I Y+LL+   PF G      +  +   ++
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250

Query: 261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            +    +  +S  A D +  +L  +P +R TA   L HSW+     + 
Sbjct: 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  431 bits (1109), Expect = e-148
 Identities = 114/285 (40%), Positives = 157/285 (55%), Gaps = 2/285 (0%)

Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           +        ER+ +   LG G FG +  C D+ T + +A K I K      D    +  E
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILRE 71

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
           +E++ +L  HPN++ L  + ED    ++V EL  GGELF  + K  RFSE +A  +  Q+
Sbjct: 72  VELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
              + Y H+  +VHRDLKPENILL +K     IK+ DFGL+T  +    +   +G+ +YI
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 212 APEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           APEVL G Y++  DVWSAGVILYILLSG PPF+G  +  I   V T    F    W  IS
Sbjct: 191 APEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKI 316
           D AKDL+  ML+  PS R+TA Q L+H W+     +   +S    
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPS 295

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  422 bits (1088), Expect = e-148
 Identities = 91/272 (33%), Positives = 138/272 (50%), Gaps = 8/272 (2%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
             + + F+  ++LG G FG + +  ++ +G     K+I KDR         ++ EIE++ 
Sbjct: 18  GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLK 75

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL----EKFGRFSEAEARVLFMQLM 152
            L  HPN++ +  V+ED   +++VME C GGEL  R+     +    SE     L  Q+M
Sbjct: 76  SLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
             + Y H   VVH+DLKPENIL    +  SPIK+ DFGLA   +  +      G+  Y+A
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194

Query: 213 PEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           PEV         D+WSAGV++Y LL+G  PF G +   +       +  +       ++ 
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTP 253

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG 304
            A DL+  ML+ DP +R +A QVL H W    
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  427 bits (1099), Expect = e-147
 Identities = 111/293 (37%), Positives = 169/293 (57%), Gaps = 1/293 (0%)

Query: 17  PCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAK 76
           P            +   +  +   +R+   + LG G FG + +C DK TG+  A K I+K
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61

Query: 77  DRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF 136
            ++    D+ S+  E++++ +L  HPN++ L   +ED+ Y +LV E+  GGELF  +   
Sbjct: 62  RQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120

Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            RFSE +A  +  Q++  + Y H+  +VHRDLKPEN+LL +K+  + I++ DFGL+T+ E
Sbjct: 121 KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 197 PGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR 256
             + +   +G+ +YIAPEVL G Y++  DVWS GVILYILLSG PPF G  +  I   V 
Sbjct: 181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240

Query: 257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
                F    W  +S+SAKDL+  ML+  PS R++AR  LDH W+    ++  
Sbjct: 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  418 bits (1078), Expect = e-146
 Identities = 101/270 (37%), Positives = 151/270 (55%), Gaps = 6/270 (2%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID---DERSVKLEIE 93
           S + + + +G++LG GQF ++R C  K TG+ +A K I K RL +         ++ E+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           I+  +  HPN++ L  ++E++  V L++EL +GGELF  L +    +E EA     Q++ 
Sbjct: 61  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119

Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIA 212
            V Y H   + H DLKPENI+L  K   +P IKL DFG+A  IE G       G+P ++A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179

Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PE++        AD+WS GVI YILLSG  PF G TK      +   +  F    + + S
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           + AKD +  +L  DP +R+T  Q L+HSW+
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  426 bits (1098), Expect = e-146
 Identities = 107/302 (35%), Positives = 164/302 (54%), Gaps = 2/302 (0%)

Query: 9   SSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEV 68
                 R+             +  T++  +L E +   ++LG G +G + +C DK T   
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64

Query: 69  FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE 128
            A K I K  + T  + + +  E+ ++  L  HPN++ L   +ED+   +LVME   GGE
Sbjct: 65  RAIKIIRKTSVSTSSNSK-LLEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGE 122

Query: 129 LFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD 188
           LF  +    +F+E +A V+  Q++  V Y H+  +VHRDLKPEN+LL +K   + IK+ D
Sbjct: 123 LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVD 182

Query: 189 FGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTK 248
           FGL+   E  + +   +G+ +YIAPEVL   Y++  DVWS GVIL+ILL+G PPF G T 
Sbjct: 183 FGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242

Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
             I   V      F S  W ++S+ AKDL+  ML  D  +R++A+Q L+H W+ +     
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302

Query: 309 EK 310
           E 
Sbjct: 303 ES 304

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  420 bits (1082), Expect = e-146
 Identities = 103/298 (34%), Positives = 162/298 (54%), Gaps = 11/298 (3%)

Query: 22  RVRSLAETILD-TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV 80
            +      ILD  +      + + L + +G G F V+R C ++ TG+ FA K +   +  
Sbjct: 4   GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63

Query: 81  TID--DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR 138
           +        +K E  I   L  HP++V+L   Y  +  +++V E   G +L   + K   
Sbjct: 64  SSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122

Query: 139 ----FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY 194
               +SEA A     Q+++ + YCH+  ++HRD+KP  +LLA+K +S+P+KL  FG+A  
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 195 I-EPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIF 252
           + E G    G VG+P ++APEV+    Y +  DVW  GVIL+ILLSG  PF+G TK R+F
Sbjct: 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLF 241

Query: 253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           + +     +     W HIS+SAKDLV  ML  DP++R+T  + L+H W+ +  +   K
Sbjct: 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYK 299

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  424 bits (1091), Expect = e-145
 Identities = 103/315 (32%), Positives = 155/315 (49%), Gaps = 12/315 (3%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
             +      R+      +       +   +   + E +   ++LG G +G + +C +K  
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKE-GKIGESYFKVRKLGSGAYGEVLLCKEKNG 60

Query: 66  GEVFACKSIAKDRLVTID----------DERSVKLEIEIMTRLSGHPNVVDLKAVYEDED 115
               A K I K +                   +  EI ++  L  HPN++ L  V+ED+ 
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKK 119

Query: 116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL 175
           Y +LV E   GGELF ++    +F E +A  +  Q++  + Y H+  +VHRD+KPENILL
Sbjct: 120 YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILL 179

Query: 176 ATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYI 235
             K S   IK+ DFGL+++      L   +G+ +YIAPEVL   YN+  DVWS GVI+YI
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYI 239

Query: 236 LLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQV 295
           LL G PPF G     I   V      F  N W +ISD AK+L+  ML+ D ++R TA + 
Sbjct: 240 LLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

Query: 296 LDHSWMGDGIQDPEK 310
           L+  W+     +  K
Sbjct: 300 LNSRWIKKYANNINK 314

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  415 bits (1068), Expect = e-144
 Identities = 109/312 (34%), Positives = 156/312 (50%), Gaps = 17/312 (5%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
               + + + + +G G + V + C  K T   FA K I K +            EIEI+ 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILL 70

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           R   HPN++ LK VY+D  YV++V EL  GGEL  ++ +   FSE EA  +   + + V 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130

Query: 157 YCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPE 214
           Y H  GVVHRDLKP NIL   ++ +   I++ DFG A  +     LL T   +  ++APE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 215 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHI 270
           VL   GY+ A D+WS GV+LY +L+G  PF      T   I   + +         W+ +
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250

Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFS 330
           SD+AKDLV  ML  DP QRLTA  VL H W    I   ++L   ++       L  G+ +
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPW----IVHWDQLPQYQLNRQDAPHLVKGAMA 306

Query: 331 TQIIPRNQDISF 342
                 N++ S 
Sbjct: 307 ATYSALNRNQSP 318

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  413 bits (1065), Expect = e-144
 Identities = 103/289 (35%), Positives = 152/289 (52%), Gaps = 15/289 (5%)

Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           +  +      +  +  + LG G F + R C  K + + FA K I+K          + + 
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQK 54

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
           EI  +    GHPN+V L  V+ D+ +  LVMEL  GGELF R++K   FSE EA  +  +
Sbjct: 55  EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPF 209
           L+  V + H++GVVHRDLKPEN+L   +  +  IK+ DFG A    P    L T   +  
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174

Query: 210 YIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKS-------RIFDAVRTADLR 261
           Y APE+L   GY+++ D+WS GVILY +LSG  PF  + +S        I   ++  D  
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234

Query: 262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           F    W ++S  AKDL+ G+L+ DP++RL    +  + W+ DG Q    
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  409 bits (1054), Expect = e-142
 Identities = 107/290 (36%), Positives = 170/290 (58%), Gaps = 6/290 (2%)

Query: 33  TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI 92
           + Q +N+R+ F+  + LG G F  + +   + TG++FA K I K        + S++ EI
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEI 57

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
            ++ ++  H N+V L+ +YE   + +LVM+L +GGELF R+ + G ++E +A ++  Q++
Sbjct: 58  AVLKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL 116

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
             V Y HE G+VHRDLKPEN+L  T   +S I + DFGL+   + G  +    G+P Y+A
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVA 175

Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PEVLA   Y++A D WS GVI YILL G PPF+  T+S++F+ ++     F S  WD IS
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKE 321
           +SAKD +  +L  DP++R T  + L H W+         +  +     ++
Sbjct: 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQK 285

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  410 bits (1056), Expect = e-142
 Identities = 113/298 (37%), Positives = 166/298 (55%), Gaps = 11/298 (3%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
           QS SS   S  P        + +  +D +    L + F +  +LG G   ++  C  K T
Sbjct: 21  QSMSSVTASAAPGT---ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 66  GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA 125
            + +A K + K       D++ V+ EI ++ RLS HPN++ LK ++E    + LV+EL  
Sbjct: 78  QKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVT 131

Query: 126 GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK 185
           GGELF R+ + G +SE +A     Q+++ V Y HE G+VHRDLKPEN+L AT A  +P+K
Sbjct: 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLK 191

Query: 186 LADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFW 244
           +ADFGL+  +E    +    G+P Y APE+L G  Y    D+WS G+I YILL G  PF+
Sbjct: 192 IADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251

Query: 245 GNTKSR-IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                + +F  +   +  F S  WD +S +AKDLV  ++  DP +RLT  Q L H W+
Sbjct: 252 DERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  408 bits (1051), Expect = e-142
 Identities = 102/295 (34%), Positives = 146/295 (49%), Gaps = 33/295 (11%)

Query: 37  SNLRERFVLGQQ-LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
               + + L +  LG G    ++ C +  T + +A K I K           V  E+E++
Sbjct: 8   GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR---VFREVEML 64

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
            +  GH NV++L   +E+ED  +LV E   GG +   + K   F+E EA V+   +   +
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG--------QSLLGTVGS 207
            + H  G+ HRDLKPENIL       SP+K+ DF L + I+            LL   GS
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 208 PFYIAPEVL------AGGYNQAADVWSAGVILYILLSGMPPFWGNTKS------------ 249
             Y+APEV+      A  Y++  D+WS GVILYILLSG PPF G   S            
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244

Query: 250 ---RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
               +F++++     FP   W HIS +AKDL+  +L  D  QRL+A QVL H W+
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  406 bits (1045), Expect = e-141
 Identities = 101/276 (36%), Positives = 147/276 (53%), Gaps = 6/276 (2%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---IDDERSVKLEIEI 94
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R  +         ++ E+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           +  +  HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q++  
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
           V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P ++AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186

Query: 214 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           E++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
            AKD +  +L  DP +R+T +  L H W+       
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  404 bits (1041), Expect = e-140
 Identities = 101/285 (35%), Positives = 157/285 (55%), Gaps = 12/285 (4%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEI 92
            LR+ +++ + LG G  G +++  ++ T +  A K I+K +         D   +V+ EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           EI+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q++
Sbjct: 67  EILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
             V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 213 PEVLAG----GYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPW 267
           PEVL      GYN+A D WS GVIL+I LSG PPF    T+  + D + +    F    W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLS 312
             +S+ A DLV  +L  DP  R T  + L H W+ D     +   
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  406 bits (1044), Expect = e-140
 Identities = 96/295 (32%), Positives = 153/295 (51%), Gaps = 19/295 (6%)

Query: 27  AETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER 86
            ++ L   + + + +  V  Q LG G  G +    +K T E FA K +         D  
Sbjct: 48  VKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCP 99

Query: 87  SVKLEIEIMTRLSGHPNVVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFS 140
             + E+E+  R S  P++V +  VYE+       + +VME   GGELF R++  G   F+
Sbjct: 100 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 159

Query: 141 EAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS 200
           E EA  +   + + + Y H I + HRD+KPEN+L  +K  ++ +KL DFG A       S
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

Query: 201 LLGTVGSPFYIAPEVLA-GGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFDAV 255
           L     +P+Y+APEVL    Y+++ D+WS GVI+YILL G PPF+ N        +   +
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279

Query: 256 RTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           R     FP+  W  +S+  K L+  +L T+P+QR+T  + ++H W+    + P+ 
Sbjct: 280 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  400 bits (1030), Expect = e-138
 Identities = 99/288 (34%), Positives = 149/288 (51%), Gaps = 6/288 (2%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---IDDERSVKLEIEI 94
            + + + +G++LG GQF +++ C +K TG  +A K I K +            ++ E+ I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           + ++  H NV+ L  VYE+   V L++EL +GGELF  L +    SE EA     Q++  
Sbjct: 69  LRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
           V Y H   + H DLKPENI+L  K    P IKL DFGLA  IE G       G+P ++AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 214 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           E++        AD+WS GVI YILLSG  PF G+TK      + +    F    + H S+
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCK 320
            AKD +  +L  +  +RLT ++ L H W+         +    + + +
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  394 bits (1014), Expect = e-136
 Identities = 92/286 (32%), Positives = 149/286 (52%), Gaps = 21/286 (7%)

Query: 37  SNLRERFVLGQQ-LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
             + + + L +Q LG G  G +  C  + TG+  A K +              + E++  
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA--------RQEVDHH 75

Query: 96  TRLSGHPNVVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFM 149
            + SG P++V +  VYE+    +  + ++ME   GGELF R+++ G   F+E EA  +  
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
            +   + + H   + HRD+KPEN+L  +K   + +KL DFG A        L     +P+
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPY 194

Query: 210 YIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSR----IFDAVRTADLRFPS 264
           Y+APEVL    Y+++ D+WS GVI+YILL G PPF+ NT       +   +R     FP+
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254

Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
             W  +S+ AK L+  +L TDP++RLT  Q ++H W+   +  P+ 
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 300

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  394 bits (1014), Expect = e-136
 Identities = 99/286 (34%), Positives = 149/286 (52%), Gaps = 6/286 (2%)

Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID---DERS 87
           ++T +   + + + +G++LG GQF +++ C +K TG  +A K I K +            
Sbjct: 2   METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61

Query: 88  VKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVL 147
           ++ E+ I+ ++  HPN++ L  VYE+   V L++EL +GGELF  L +    SE EA   
Sbjct: 62  IEREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120

Query: 148 FMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVG 206
             Q++  V Y H   + H DLKPENI+L  K    P IKL DFGLA  IE G       G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 207 SPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN 265
           +P ++APE++        AD+WS GVI YILLSG  PF G+TK      +      F   
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240

Query: 266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKL 311
            +   S+ AKD +  +L  +  +RLT ++ L H W+         +
Sbjct: 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMV 286

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  395 bits (1016), Expect = e-135
 Identities = 100/277 (36%), Positives = 156/277 (56%), Gaps = 12/277 (4%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLE 91
             LR+ +++ + LG G  G +++  ++ T +  A + I+K +         D   +V+ E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
           IEI+ +L+ HP ++ +K  ++ EDY ++V+EL  GGELF ++    R  EA  ++ F Q+
Sbjct: 191 IEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
           +  V Y HE G++HRDLKPEN+LL+++     IK+ DFG +  +     +    G+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308

Query: 212 APEVLAG----GYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNP 266
           APEVL      GYN+A D WS GVIL+I LSG PPF    T+  + D + +    F    
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368

Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
           W  +S+ A DLV  +L  DP  R T  + L H W+ D
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  387 bits (997), Expect = e-134
 Identities = 77/266 (28%), Positives = 134/266 (50%), Gaps = 8/266 (3%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
            L E++++ + LG G+FG++  C +  + + +  K +         D+  VK EI I+  
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNI 57

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR-LEKFGRFSEAEARVLFMQLMQVVL 156
              H N++ L   +E  + + ++ E  +G ++F R        +E E      Q+ + + 
Sbjct: 58  A-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           + H   + H D++PENI+  T+  SS IK+ +FG A  ++PG +      +P Y APEV 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
                + A D+WS G ++Y+LLSG+ PF   T  +I + +  A+  F    +  IS  A 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           D V  +L  +   R+TA + L H W+
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWL 261

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  388 bits (997), Expect = e-133
 Identities = 96/345 (27%), Positives = 148/345 (42%), Gaps = 52/345 (15%)

Query: 18  CKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD 77
              +              +  L++++ L   +G G +GV+RV  +  T  + A K + K+
Sbjct: 3   HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62

Query: 78  RL--VTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEK 135
           ++  +   D   +K E+ +M +L  HPN+  L  VYEDE Y+ LVMELC GG L  +L  
Sbjct: 63  KIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121

Query: 136 FGR----------------------------------------FSEAEARVLFMQLMQVV 155
           F                                            E     +  Q+   +
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-----GQSLLGTVGSPFY 210
            Y H  G+ HRD+KPEN L +T   S  IKL DFGL+             +    G+P++
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240

Query: 211 IAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
           +APEVL      Y    D WSAGV+L++LL G  PF G   +     V    L F +  +
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300

Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLS 312
           + +S  A+DL+  +L+ +  +R  A + L H W+        K+S
Sbjct: 301 NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  383 bits (986), Expect = e-132
 Identities = 88/294 (29%), Positives = 142/294 (48%), Gaps = 38/294 (12%)

Query: 27  AETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER 86
            ++ L   + + + +  V  Q LG G  G +    +K T E FA K +         D  
Sbjct: 4   VKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCP 55

Query: 87  SVKLEIEIMTRLSGHPNVVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFS 140
             + E+E+  R S  P++V +  VYE+       + +VME   GGELF R++  G   F+
Sbjct: 56  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 115

Query: 141 EAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS 200
           E EA  +   + + + Y H I + HRD+KPEN+L  +K  ++ +KL DFG          
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------- 166

Query: 201 LLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFDAVR 256
                      A E     Y+++ D+WS GVI+YILL G PPF+ N        +   +R
Sbjct: 167 -----------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215

Query: 257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
                FP+  W  +S+  K L+  +L T+P+QR+T  + ++H W+    + P+ 
Sbjct: 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  382 bits (983), Expect = e-130
 Identities = 94/287 (32%), Positives = 156/287 (54%), Gaps = 8/287 (2%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           ++ + + + ++LG G FGV+  C +K TG VF  K I     +   D+ +VK EI IM +
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQ 104

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVL 156
           L  HP +++L   +ED+  + L++E  +GGELF R+  +  + SEAE      Q  + + 
Sbjct: 105 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           + HE  +VH D+KPENI+  TK  +S +K+ DFGLAT + P + +  T  +  + APE++
Sbjct: 164 HMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222

Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
                    D+W+ GV+ Y+LLSG+ PF G         V+  D  F  + +  +S  AK
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM-GDGIQDPEKLSGNKIEDCKE 321
           D +  +L  +P +RLT    L+H W+ GD      ++  ++    ++
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  376 bits (967), Expect = e-128
 Identities = 86/283 (30%), Positives = 145/283 (51%), Gaps = 9/283 (3%)

Query: 37  SNLRERFVLGQQ--LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
             +   + + +   LG G+FG +  C +  TG   A K I    +    D+  VK EI +
Sbjct: 83  GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISV 139

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR-LEKFGRFSEAEARVLFMQLMQ 153
           M +L  H N++ L   +E ++ + LVME   GGELF R +++    +E +  +   Q+ +
Sbjct: 140 MNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE 198

Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            + + H++ ++H DLKPENIL   +  +  IK+ DFGLA   +P + L    G+P ++AP
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257

Query: 214 EVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           EV+     +   D+WS GVI Y+LLSG+ PF G+  +   + +           +  IS+
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNK 315
            AK+ +  +L  + S R++A + L H W+ D        +  K
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  381 bits (981), Expect = e-128
 Identities = 93/298 (31%), Positives = 154/298 (51%), Gaps = 7/298 (2%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
                +  S      + +           +  ++ + + + ++LG G FGV+   +++ T
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181

Query: 66  GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA 125
           G  FA K +        +    V+ EI+ M+ L  HP +V+L   +ED++ + ++ E  +
Sbjct: 182 GNNFAAKFVMTPHESDKET---VRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMS 237

Query: 126 GGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPI 184
           GGELF ++ ++  + SE EA     Q+ + + + HE   VH DLKPENI+  TK S+  +
Sbjct: 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-L 296

Query: 185 KLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPF 243
           KL DFGL  +++P QS+  T G+  + APEV  G       D+WS GV+ YILLSG+ PF
Sbjct: 297 KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

Query: 244 WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            G         V++ D     + +  IS+  KD +  +L  DP+ R+T  Q L+H W+
Sbjct: 357 GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  317 bits (815), Expect = e-105
 Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 25/291 (8%)

Query: 32  DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           +T+ +   +  F     LG G  G I V    F     A K I  +             E
Sbjct: 15  ETSVVIVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECF------SFADRE 67

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQ 150
           ++++     HPNV+      +D  + ++ +ELC    L   +E+        E   L  Q
Sbjct: 68  VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQ 126

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP--IKLADFGLATYIEPGQSLL----GT 204
               + + H + +VHRDLKP NIL++   +       ++DFGL   +  G+       G 
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 205 VGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTAD 259
            G+  +IAPE+L+           D++SAG + Y ++S G  PF  + + +    +    
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246

Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           L     P  H    A++L+  M++ DP +R +A+ VL H +        EK
Sbjct: 247 LDCLH-PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF----FWSLEK 292

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  311 bits (799), Expect = e-102
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 46/311 (14%)

Query: 33  TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI 92
            N   +L+   V  + LG+G  G + V    F G   A K +  D            +EI
Sbjct: 7   PNFEQSLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDF------CDIALMEI 59

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFS-------EAEAR 145
           +++T    HPNV+        + ++++ +ELC    L   +E             E    
Sbjct: 60  KLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118

Query: 146 VLFMQLMQVVLYCHEIGVVHRDLKPENILLATK----------ASSSPIKLADFGLATYI 195
            L  Q+   V + H + ++HRDLKP+NIL++T           A +  I ++DFGL   +
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 196 EPGQSLLGT-----VGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMP 241
           + GQS   T      G+  + APE+L             ++ D++S G + Y +LS G  
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 242 PFWGN--TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
           PF      +S I   + + D          +   A DL+  M+  DP +R TA +VL H 
Sbjct: 239 PFGDKYSRESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

Query: 300 WMGDGIQDPEK 310
                     K
Sbjct: 298 L----FWPKSK 304

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  306 bits (785), Expect = e-101
 Identities = 101/331 (30%), Positives = 148/331 (44%), Gaps = 11/331 (3%)

Query: 2   AAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS 61
            A      +  P             A+ I +       R R+V G+ LG G F      S
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61

Query: 62  DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM 121
           D  T EVFA K + K  L+       + +EI I   L+ H +VV     +ED D+V +V+
Sbjct: 62  DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVL 120

Query: 122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
           ELC    L    ++    +E EAR    Q++    Y H   V+HRDLK  N+ L      
Sbjct: 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE- 179

Query: 182 SPIKLADFGLATYIEPGQSLLGTV-GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSG 239
             +K+ DFGLAT +E        + G+P YIAPEVL+  G++   DVWS G I+Y LL G
Sbjct: 180 --VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237

Query: 240 MPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
            PPF  +     +  ++  +   P     HI+  A  L+  ML TDP+ R T  ++L+  
Sbjct: 238 KPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTINELLNDE 293

Query: 300 WMGDGIQDPEKLSGNKIEDCKEWDLGSGSFS 330
           +   G   P +L    +     + +   S  
Sbjct: 294 FFTSGY-IPARLPITCLTIPPRFSIAPSSLD 323

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  304 bits (780), Expect = e-101
 Identities = 97/288 (33%), Positives = 141/288 (48%), Gaps = 15/288 (5%)

Query: 26  LAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE 85
           + E ++D         R+V G+ LG G F      SD  T EVFA K + K  L+     
Sbjct: 4   IPEVLVDPRSR----RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR 59

Query: 86  RSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEAR 145
             + +EI I   L+ H +VV     +ED D+V +V+ELC    L    ++    +E EAR
Sbjct: 60  EKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 118

Query: 146 VLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV 205
               Q++    Y H   V+HRDLK  N+ L        +K+ DFGLAT +E        +
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVL 175

Query: 206 -GSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP 263
            G+P YIAPEVL+  G++   DVWS G I+Y LL G PPF  +     +  ++  +   P
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP 235

Query: 264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKL 311
                HI+  A  L+  ML TDP+ R T  ++L+  +   G   P +L
Sbjct: 236 K----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY-IPARL 278

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  298 bits (765), Expect = 2e-99
 Identities = 100/284 (35%), Positives = 145/284 (51%), Gaps = 11/284 (3%)

Query: 33  TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI 92
              I    E F +G  LG G F  +       TG   A K I K  +      + V+ E+
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQL 151
           +I  +L  HP++++L   +ED +YV+LV+E+C  GE+   L  +   FSE EAR    Q+
Sbjct: 63  KIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV-GSPFY 210
           +  +LY H  G++HRDL   N+LL    +   IK+ADFGLAT ++       T+ G+P Y
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNY 178

Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
           I+PE+     +   +DVWS G + Y LL G PPF  +T     + V  AD   PS     
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----F 234

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSG 313
           +S  AKDL+  +L  +P+ RL+   VLDH +M        K  G
Sbjct: 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  294 bits (754), Expect = 1e-97
 Identities = 85/274 (31%), Positives = 142/274 (51%), Gaps = 12/274 (4%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV-GSPFYIAPEVLAG- 218
             V+HRD+KPEN+LL +      +K+ADFG + +     S    + G+  Y+ PE++ G 
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAP--SSRRTDLCGTLDYLPPEMIEGR 182

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP      +++ A+DL+
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLI 238

Query: 279 MGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLS 312
             +L  +PSQR   R+VL+H W+      P    
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 272

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  293 bits (752), Expect = 8e-97
 Identities = 68/305 (22%), Positives = 113/305 (37%), Gaps = 43/305 (14%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S     ++L   LG G    +     K TG++FA K         +        E E++ 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLK 62

Query: 97  RLSGHPNVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQL 151
           +L+ H N+V L A+ E+    +  L+ME C  G L+  LE+        E+E  ++   +
Sbjct: 63  KLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLATYIEPGQSLLGTVGSPFY 210
           +  + +  E G+VHR++KP NI+        S  KL DFG A  +E  +  +   G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 211 IAPEVLAG---------GYNQAADVWSAGVILYILLSGMPPFWGNTKSR----IFDAVRT 257
           + P++             Y    D+WS GV  Y   +G  PF      R    +   + T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 258 A-----------------DLRFPSNPWDHISDSAKDLV----MGMLSTDPSQRLTARQVL 296
                             D          +S   + L+      +L  D  +     Q  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 297 DHSWM 301
             +  
Sbjct: 302 AETSD 306

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  289 bits (741), Expect = 1e-95
 Identities = 88/263 (33%), Positives = 144/263 (54%), Gaps = 12/263 (4%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + F +G+ LG G+FG + +  +K    + A K + K +L     E  ++ EIEI + L  
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ +   + D   ++L++E    GEL+  L+K GRF E  +     +L   + YCHE
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV-GSPFYIAPEVLAG- 218
             V+HRD+KPEN+L+  K     +K+ADFG + +         T+ G+  Y+ PE++ G 
Sbjct: 133 RKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAP--SLRRRTMCGTLDYLPPEMIEGK 187

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            +++  D+W AGV+ Y  L GMPPF   + +     +   DL+FP      +SD +KDL+
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLI 243

Query: 279 MGMLSTDPSQRLTARQVLDHSWM 301
             +L   P QRL  + V++H W+
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWV 266

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  286 bits (733), Expect = 4e-94
 Identities = 73/303 (24%), Positives = 125/303 (41%), Gaps = 41/303 (13%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
                 F     LG G FG +    +      +A K I        +   ++  E+ ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLA 57

Query: 97  RLSGHPNVVDLKAVYEDED-------------YVHLVMELCAGGELFHRLEKFGRF-SEA 142
            L+ H  VV   A + +                + + ME C  G L+  +          
Sbjct: 58  SLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 143 EARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE------ 196
           E   LF Q+++ + Y H  G++HRDLKP NI +     S  +K+ DFGLA  +       
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDIL 173

Query: 197 ---------PGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWG 245
                       +L   +G+  Y+A EVL G   YN+  D++S G+I + ++   P   G
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTG 231

Query: 246 NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI 305
             +  I   +R+  + FP +  D+     K ++  ++  DP++R  AR +L+  W+    
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

Query: 306 QDP 308
           QD 
Sbjct: 292 QDE 294

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  282 bits (724), Expect = 1e-91
 Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 43/304 (14%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S     ++L   LG G    +     K TG++FA K         +        E E++ 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLK 62

Query: 97  RLSGHPNVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQL 151
           +L+ H N+V L A+ E+    +  L+ME C  G L+  LE+        E+E  ++   +
Sbjct: 63  KLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLATYIEPGQSLLGTVGSPFY 210
           +  + +  E G+VHR++KP NI+        S  KL DFG A  +E  +  +   G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 211 IAPEVLAG---------GYNQAADVWSAGVILYILLSGMPPFWGNTKSR----IFDAVRT 257
           + P++             Y    D+WS GV  Y   +G  PF      R    +   + T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 258 A-----------------DLRFPSNPWDHISDSAKDLV----MGMLSTDPSQRLTARQVL 296
                             D          +S   + L+      +L  D  +     Q  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 297 DHSW 300
             + 
Sbjct: 302 AETS 305

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  278 bits (713), Expect = 1e-91
 Identities = 86/267 (32%), Positives = 136/267 (50%), Gaps = 14/267 (5%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I   L+ 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN- 63

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS--LLGT-VGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT         LL    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 218 G-GYN-QAADVWSAGVILYILLSGMPPF-WGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
              ++ +  DVWS G++L  +L+G  P+   +   + +   +         PW  I  + 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAP 238

Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWM 301
             L+  +L  +PS R+T   +    W 
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWY 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  279 bits (716), Expect = 2e-91
 Identities = 67/301 (22%), Positives = 125/301 (41%), Gaps = 24/301 (7%)

Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
             +S     + + +Q+G G    +    ++   +++A K +  +         S + EI 
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIA 78

Query: 94  IMTRLSGH-PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
            + +L  H   ++ L      + Y+++VME C   +L   L+K       E +  +  ++
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML 137

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS--LLGT-VGSPF 209
           + V   H+ G+VH DLKP N L+        +KL DFG+A  ++P  +  +  + VG+  
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193

Query: 210 YIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT 257
           Y+ PE +                +  +DVWS G ILY +  G  PF       I      
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAI 252

Query: 258 ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIE 317
            D        D      +D++   L  DP QR++  ++L H ++        +++    E
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 312

Query: 318 D 318
           +
Sbjct: 313 E 313

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  278 bits (714), Expect = 5e-91
 Identities = 97/270 (35%), Positives = 141/270 (52%), Gaps = 11/270 (4%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            + L + +G G F  +++     TG   A K I K +L     ++ +  E+ IM  L+ H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILN-H 73

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           PN+V L  V E E  ++L+ME  +GGE+F  L   GR  E EAR  F Q++  V YCH+ 
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GY 220
            +VHRDLK EN+LL    +   IK+ADFG +     G  L    G+P Y APE+  G  Y
Sbjct: 134 RIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

Query: 221 N-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +    DVWS GVILY L+SG  PF G     + + V     R P     ++S   ++L+ 
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLK 246

Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
             L  +P +R T  Q++   W+  G ++ E
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  278 bits (714), Expect = 5e-91
 Identities = 88/277 (31%), Positives = 138/277 (49%), Gaps = 16/277 (5%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I   L+ 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN- 63

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS--LLGT-VGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL  + +   +K++DFGLAT         LL    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 218 G-GYN-QAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
              ++ +  DVWS G++L  +L+G  P+    ++     D            PW  I  +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLN--PWKKIDSA 237

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
              L+  +L  +PS R+T   +    W    ++   K
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  276 bits (708), Expect = 7e-91
 Identities = 99/262 (37%), Positives = 141/262 (53%), Gaps = 10/262 (3%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            +VLG  LG G FG +++   + TG   A K + + ++ ++D    +K EI+ +     H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-H 70

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           P+++ L  V        +VME  +GGELF  + K GR  E EAR LF Q++  V YCH  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GY 220
            VVHRDLKPEN+LL    +    K+ADFGL+  +  G+ L  + GSP Y APEV++G  Y
Sbjct: 131 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 221 N-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
                D+WS GVILY LL G  PF       +F  +R      P     +++ S   L+M
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLM 243

Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            ML  DP +R T + + +H W 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWF 265

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  278 bits (712), Expect = 3e-90
 Identities = 95/267 (35%), Positives = 138/267 (51%), Gaps = 14/267 (5%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G FGV R+  DK T E+ A K I +   +    + +V+ EI     L  
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLR- 74

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN+V  K V     ++ ++ME  +GGEL+ R+   GRFSE EAR  F QL+  V YCH 
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-G 219
           + + HRDLK EN LL    +   +K+ DFG +           TVG+P YIAPEVL    
Sbjct: 135 MQICHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193

Query: 220 YN-QAADVWSAGVILYILLSGMPPFWGNTKSRIF----DAVRTADLRFPSNPWDHISDSA 274
           Y+ + ADVWS GV LY++L G  PF    + R +      + +     P +    IS   
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPEC 251

Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWM 301
             L+  +   DP+ R++  ++  HSW 
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWF 278

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  276 bits (709), Expect = 5e-90
 Identities = 66/298 (22%), Positives = 125/298 (41%), Gaps = 26/298 (8%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
             + + +Q+G G    +    ++   +++A K +  +         S + EI  + +L  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQ 66

Query: 101 H-PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
           H   ++ L      + Y+++VME C   +L   L+K       E +  +  +++ V   H
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS--LLGT-VGSPFYIAPEVL 216
           + G+VH DLKP N L+        +KL DFG+A  ++P  +  +  + VG+  Y+ PE +
Sbjct: 126 QHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 217 AG------------GYNQAADVWSAGVILYILLSGMPPFWGNTKS-RIFDAVRTADLRFP 263
                           +  +DVWS G ILY +  G  PF           A+   +    
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241

Query: 264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKE 321
               D      +D++   L  DP QR++  ++L H ++        +++    E+ K 
Sbjct: 242 F--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 297

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  274 bits (703), Expect = 3e-89
 Identities = 90/271 (33%), Positives = 141/271 (52%), Gaps = 11/271 (4%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            +++ + LG G FG +++ +   T +  A K I++  L   D    V+ EI  + +L  H
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRH 68

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           P+++ L  V      + +V+E  AGGELF  + +  R +E E R  F Q++  + YCH  
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GY 220
            +VHRDLKPEN+LL    +   +K+ADFGL+  +  G  L  + GSP Y APEV+ G  Y
Sbjct: 128 KIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184

Query: 221 N-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
                DVWS G++LY++L G  PF       +F  V +     P      +S  A+ L+ 
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD----FLSPGAQSLIR 240

Query: 280 GMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
            M+  DP QR+T +++    W    + D  +
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLR 271

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  272 bits (697), Expect = 2e-88
 Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 22/287 (7%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS-----VKLEIEIMT 96
           ++     LG G FG +    DK   +    K I K++++            V LEI I++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMEL-CAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
           R+  H N++ +  ++E++ +  LVME   +G +LF  +++  R  E  A  +F QL+  V
Sbjct: 85  RVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            Y     ++HRD+K ENI++A   +   IKL DFG A Y+E G+      G+  Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 216 LAG-GYN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           L G  Y     ++WS GV LY L+    PF         +    A +  P      +S  
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY----LVSKE 250

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCK 320
              LV G+L   P +R T  +++   W+   +   +          K
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNK 297

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  271 bits (695), Expect = 3e-88
 Identities = 78/282 (27%), Positives = 128/282 (45%), Gaps = 22/282 (7%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---IDDERSVKLEIE 93
                 + LG  LG G FG +            A K I ++R++    + D  +  LE+ 
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86

Query: 94  IMTRLS---GHPNVVDLKAVYEDEDYVHLVMEL-CAGGELFHRLEKFGRFSEAEARVLFM 149
           ++ ++    GHP V+ L   +E ++   LV+E      +LF  + + G   E  +R  F 
Sbjct: 87  LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
           Q++  + +CH  GVVHRD+K ENIL+  +      KL DFG    +          G+  
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGSGALLHDEP-YTDFDGTRV 203

Query: 210 YIAPEVLAG-GYN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
           Y  PE ++   Y+   A VWS G++LY ++ G  PF  + +      +  A+L FP+   
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPA--- 254

Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
            H+S     L+   L+  PS R +  ++L   WM    +D  
Sbjct: 255 -HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP 295

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  281 bits (721), Expect = 4e-88
 Identities = 97/442 (21%), Positives = 158/442 (35%), Gaps = 59/442 (13%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            + + ++LG G FG +     + TGE  A K   ++      +     LEI+IM +L+ H
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLN-H 71

Query: 102 PNVVDLKAVYEDEDYVH------LVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLM 152
           PNVV  + V +    +       L ME C GG+L   L +F       E   R L   + 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIA 212
             + Y HE  ++HRDLKPENI+L         K+ D G A  ++ G+     VG+  Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191

Query: 213 PEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           PE+L    Y    D WS G + +  ++G  PF  N +   +              +D ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251

Query: 272 DS--------------------AKDLVMGMLSTDPSQRLTARQVLDHSW--MGDGIQDPE 309
            +                     +  +  ML     QR T  Q  +       D I   +
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311

Query: 310 KLSGNKIEDCKEWDLGSG------------SFSTQIIPRNQDISFGTGSPVFSDDESPAF 357
            LS   +   +                      T I    Q++   +G  +  +   P  
Sbjct: 312 LLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLAL--NSAQPLT 369

Query: 358 TCRTSFSSFLQEPSTST-GFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVAQVFTTVDG 416
                 +            F F +       +    LP+ P         V+ V      
Sbjct: 370 QYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQI--SLPAHPES-------VSIVLQDPKR 420

Query: 417 SISISRVDAVPGEKWSSIIQLK 438
            ++ + +  V G+ W +I  LK
Sbjct: 421 PLTYTHLRRVWGQIWQTIRALK 442

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  273 bits (699), Expect = 7e-88
 Identities = 69/305 (22%), Positives = 126/305 (41%), Gaps = 24/305 (7%)

Query: 33  TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEI 92
              IS     + + +Q+G G    +    ++   +++A K +  +         S + EI
Sbjct: 48  NECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEI 105

Query: 93  EIMTRLSGH-PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
             + +L  H   ++ L      + Y+++VME C   +L   L+K       E +  +  +
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNM 164

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS--LLGT-VGSP 208
           ++ V   H+ G+VH DLKP N L+        +KL DFG+A  ++P  +  +  + VG+ 
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 209 FYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR 256
            Y+ PE +                +  +DVWS G ILY +  G  PF       I     
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHA 279

Query: 257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKI 316
             D        D      +D++   L  DP QR++  ++L H ++        +++    
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339

Query: 317 EDCKE 321
           E+ K 
Sbjct: 340 EEMKY 344

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  268 bits (688), Expect = 2e-87
 Identities = 82/290 (28%), Positives = 140/290 (48%), Gaps = 37/290 (12%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--------------------- 80
           ++ L  ++G G +GV+++  ++     +A K ++K +L+                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 81  --TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKF 136
                    V  EI I+ +L  HPNVV L  V +D  ED++++V EL   G +       
Sbjct: 74  IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL- 131

Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
              SE +AR  F  L++ + Y H   ++HRD+KP N+L+        IK+ADFG++   +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFK 188

Query: 197 PGQSLLGT-VGSPFYIAPEVLAG---GYN-QAADVWSAGVILYILLSGMPPFWGNTKSRI 251
              +LL   VG+P ++APE L+     ++ +A DVW+ GV LY  + G  PF       +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248

Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              +++  L FP      I++  KDL+  ML  +P  R+   ++  H W+
Sbjct: 249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  274 bits (703), Expect = 2e-87
 Identities = 96/262 (36%), Positives = 144/262 (54%), Gaps = 10/262 (3%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            ++LG  LG G FG ++V   + TG   A K + + ++ ++D    ++ EI+ + +L  H
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRH 75

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
           P+++ L  V      + +VME  +GGELF  + K GR  E E+R LF Q++  V YCH  
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GY 220
            VVHRDLKPEN+LL    +    K+ADFGL+  +  G+ L  + GSP Y APEV++G  Y
Sbjct: 136 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192

Query: 221 N-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
                D+WS+GVILY LL G  PF  +    +F  +       P     +++ S   L+ 
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLK 248

Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            ML  DP +R T + + +H W 
Sbjct: 249 HMLQVDPMKRATIKDIREHEWF 270

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  266 bits (683), Expect = 2e-86
 Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 14/299 (4%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILD-TNQISNLRERFVLGQQLGWGQFGVIRVCSDKF 64
           QS    +P R   +     +L     D +   S  ++ F    +LG G +G +     K 
Sbjct: 21  QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKE 80

Query: 65  TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC 124
            G ++A K          D  R +  E+    ++  HP  V L+  +E+   ++L  ELC
Sbjct: 81  DGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139

Query: 125 AGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP 183
            G  L    E +G    EA+        +  + + H  G+VH D+KP NI L  +     
Sbjct: 140 -GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--- 195

Query: 184 IKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMP-P 242
            KL DFGL   +    +     G P Y+APE+L G Y  AADV+S G+ +  +   M  P
Sbjct: 196 CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELP 255

Query: 243 FWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             G    ++           P      +S   + +++ ML  DP  R TA  +L    +
Sbjct: 256 HGGEGWQQLR------QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  266 bits (683), Expect = 2e-86
 Identities = 81/317 (25%), Positives = 139/317 (43%), Gaps = 23/317 (7%)

Query: 2   AAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQ-ISNLRERFVLGQQLGWGQFGVIRVC 60
           ++    + SS    +         L  T L   +    L  ++ +G  LG G FG +   
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 61  SDKFTGEVFACKSIAKDRLVT---IDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDEDY 116
                    A K + KDR+     + +   V +E+ ++ ++S G   V+ L   +E  D 
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122

Query: 117 VHLVMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL 175
             L++E      +LF  + + G   E  AR  F Q+++ V +CH  GV+HRD+K ENIL+
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 182

Query: 176 ATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYN-QAADVWSAGVI 232
                   +KL DFG    ++    +     G+  Y  PE +    Y+ ++A VWS G++
Sbjct: 183 DLNRGE--LKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238

Query: 233 LYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTA 292
           LY ++ G  PF  + +      +    + F       +S   + L+   L+  PS R T 
Sbjct: 239 LYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTF 288

Query: 293 RQVLDHSWMGDGIQDPE 309
            ++ +H WM D +   E
Sbjct: 289 EEIQNHPWMQDVLLPQE 305

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  267 bits (684), Expect = 3e-86
 Identities = 61/312 (19%), Positives = 125/312 (40%), Gaps = 49/312 (15%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--------------TIDDER 86
             + + + L  G+F  I +C  +   + +A K   K  L                     
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 87  SVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG--------R 138
             K E++I+T +  +   +  + +  + D V+++ E      +    E F          
Sbjct: 89  DFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 139 FSEAEARVLFMQLMQVVLYCH-EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP 197
                 + +   ++    Y H E  + HRD+KP NIL+        +KL+DFG + Y+  
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLSDFGESEYM-V 203

Query: 198 GQSLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFD 253
            + + G+ G+  ++ PE  +          D+WS G+ LY++   + PF    +   +F+
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263

Query: 254 AVRTADLRFPSNP---------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
            +RT ++ +P +                 + +S+   D +   L  +P++R+T+   L H
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323

Query: 299 SWMGDGIQDPEK 310
            W+ D   +  +
Sbjct: 324 EWLADTNIEDLR 335

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  262 bits (672), Expect = 5e-85
 Identities = 87/279 (31%), Positives = 141/279 (50%), Gaps = 20/279 (7%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI-DDERSVKLEIEIMTRLSG 100
           ++++G  LG G +G ++   D  T    A K + K +L  I + E +VK EI+++ RL  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64

Query: 101 HPNVVDLKAVYEDE--DYVHLVMELCAGG--ELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           H NV+ L  V  +E    +++VME C  G  E+   + +  RF   +A   F QL+  + 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--SLLGTV-GSPFYIAP 213
           Y H  G+VH+D+KP N+LL T  +   +K++  G+A  + P        T  GSP +  P
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 214 EVLAG--GYN-QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           E+  G   ++    D+WSAGV LY + +G+ PF G+   ++F+ +       P       
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----GDC 236

Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
                DL+ GML  +P++R + RQ+  HSW        E
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  252 bits (645), Expect = 2e-80
 Identities = 68/270 (25%), Positives = 131/270 (48%), Gaps = 12/270 (4%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E++V  Q++G G FG   +      G  +  K I   R+ +  +    + E+ ++  +  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK- 81

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE--KFGRFSEAEARVLFMQLMQVVLYC 158
           HPN+V  +  +E+   +++VM+ C GG+LF R+   K   F E +    F+Q+   + + 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA 217
           H+  ++HRD+K +NI L    +   ++L DFG+A  +     L    +G+P+Y++PE+  
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 218 G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
              YN  +D+W+ G +LY L +    F   +   +   + +    FP     H S   + 
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--FPPVS-LHYSYDLRS 255

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
           LV  +   +P  R +   +L+  ++   I+
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  249 bits (638), Expect = 3e-80
 Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 21/280 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + +   +G G +G  +    K  G++   K +    + T  +++ +  E+ ++  L  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK- 63

Query: 101 HPNVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQV 154
           HPN+V       D     +++VME C GG+L   + K  +      E     +  QL   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 155 VLYCHE-----IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSP 208
           +  CH        V+HRDLKP N+ L  K +   +KL DFGLA  +    S   T VG+P
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 209 FYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
           +Y++PE +    YN+ +D+WS G +LY L + MPPF   ++  +   +R    +F   P 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KFRRIP- 237

Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD 307
              SD   +++  ML+     R +  ++L++  + +    
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  245 bits (627), Expect = 3e-78
 Identities = 76/302 (25%), Positives = 136/302 (45%), Gaps = 17/302 (5%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
           QS     P              +  L  +   N    F + +++G GQF  +   +    
Sbjct: 4   QSQGMQGPPVPQ-------FQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLD 56

Query: 66  GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCA 125
           G   A K +    L+          EI+++ +L+ HPNV+   A + +++ +++V+EL  
Sbjct: 57  GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELAD 115

Query: 126 GGELFHRLEKFGR----FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
            G+L   ++ F +      E      F+QL   + + H   V+HRD+KP N+ + T    
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI-TATGV 174

Query: 182 SPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSG 239
             +KL D GL  +     +   + VG+P+Y++PE +   GYN  +D+WS G +LY + + 
Sbjct: 175 --VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232

Query: 240 MPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
             PF+G+  +      +     +P  P DH S+  + LV   ++ DP +R     V D +
Sbjct: 233 QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292

Query: 300 WM 301
             
Sbjct: 293 KR 294

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  244 bits (625), Expect = 3e-77
 Identities = 50/335 (14%), Positives = 90/335 (26%), Gaps = 53/335 (15%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
              + +           V SL          S    +  L + L  G   V+ +  D   
Sbjct: 36  MVEAVTATVWPQNAETTVDSLL---------SQGERKLKLVEPLRVGDRSVVFLVRDVER 86

Query: 66  GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL-----------------------SGHP 102
            E FA K        +  +   +        RL                          P
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 103 NVVDLKAVYEDEDYVH--LVMELCAG-----GELFHRLEKFGRFSEAEARVLFM-QLMQV 154
               L    +D    +  L+M   +            +  F       A  +   QL+++
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
                  G+VH    P+N+ +        + L D       + G     +     Y   E
Sbjct: 207 AANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALW--KVGTRGPASSVPVTYAPRE 261

Query: 215 VLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD--- 268
            L      +  A + W  G+ +Y +     PF   T        R +     ++      
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321

Query: 269 --HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              + D  K L+   L+ D  +RL   + ++    
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  236 bits (604), Expect = 4e-75
 Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 40/294 (13%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
                 F   + +G G FG +     +  G+ +  K +  +           + E++ + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59

Query: 97  RLSGHPNVVDLKAVYEDED----------------YVHLVMELCAGGELFHRLEK--FGR 138
           +L  H N+V     ++  D                 + + ME C  G L   +EK    +
Sbjct: 60  KLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 139 FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG 198
             +  A  LF Q+ + V Y H   +++RDLKP NI L        +K+ DFGL T ++  
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKND 175

Query: 199 QSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT 257
                + G+  Y++PE ++   Y +  D+++ G+IL  LL              F+  + 
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--------FETSKF 227

Query: 258 -ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
             DLR      D      K L+  +LS  P  R    ++L    +     +  +
Sbjct: 228 FTDLRDGIIS-DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  237 bits (605), Expect = 4e-74
 Identities = 44/304 (14%), Positives = 86/304 (28%), Gaps = 58/304 (19%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL--- 98
             V G  LG          +D+ TGE F             +  + +K E+  +  L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 99  ---------------------SGHPNVVDLKAVYEDED--YVHLVMELCA------GGEL 129
                                     ++ ++    D        +           G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 130 FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF 189
                            L +Q+++++   H  G+VH  L+P +I+L        + L  F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGF 250

Query: 190 GLATYIEPGQSLLGTVGSPFYIAPEVLA------------GGYNQAADVWSAGVILYILL 237
                     + + +  S  +  PE+ A                 + D W+ G+++Y + 
Sbjct: 251 EHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 238 SGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
               P   +      + +     R       +I    + L+ G L      RL   Q ++
Sbjct: 308 CADLPITKDAALGGSEWI----FRSC----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359

Query: 298 HSWM 301
               
Sbjct: 360 TPEY 363

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  229 bits (587), Expect = 3e-72
 Identities = 77/268 (28%), Positives = 129/268 (48%), Gaps = 18/268 (6%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  HP
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
             V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLAG- 218
           ++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L   
Sbjct: 151 IIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
              +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+DLV
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV 263

Query: 279 MGMLSTDPSQRLT------ARQVLDHSW 300
             +L  D ++RL          +  H +
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  227 bits (580), Expect = 4e-71
 Identities = 68/292 (23%), Positives = 109/292 (37%), Gaps = 35/292 (11%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            + ++  Q+LG G F  + +      G  +A K I         D    + E ++  RL 
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMH-RLF 83

Query: 100 GHPNVVDLKAVYEDED----YVHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQL 151
            HPN++ L A    E        L++     G L++ +E+        +E +   L + +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG----------QSL 201
            + +   H  G  HRDLKP NILL  +       L D G                  Q  
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 202 LGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVR 256
                +  Y APE+ +       ++  DVWS G +LY ++ G  P+     K        
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260

Query: 257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
              L  P +P    S +   L+  M++ DP QR     +L        +Q P
Sbjct: 261 QNQLSIPQSP--RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA---LQPP 307

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  220 bits (562), Expect = 8e-69
 Identities = 67/288 (23%), Positives = 123/288 (42%), Gaps = 34/288 (11%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S     F   +++G G+FG +  C  +  G ++A K   K    ++D++ +++ E+    
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHA 65

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLM 152
            L  H +VV   + + ++D++ +  E C GG L   + +  R    F EAE + L +Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 153 QVVLYCHEIGVVHRDLKPENILL----------------ATKASSSPIKLADFGLATYIE 196
           + + Y H + +VH D+KP NI +                   ++    K+ D G  T I 
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 197 PGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFW-GNTKSRIFD 253
             Q      G   ++A EVL     +   AD+++  + +       P    G+    I  
Sbjct: 186 SPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242

Query: 254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                  R P  P   +S    +L+  M+  DP +R +A  ++ HS +
Sbjct: 243 G------RLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  221 bits (564), Expect = 3e-68
 Identities = 85/265 (32%), Positives = 143/265 (53%), Gaps = 18/265 (6%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F   + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++  P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPFYIAPEVLAG-GY 220
           +++RDLKPEN+L+  +     I++ DFG A  ++    +L GT   P  +APE++   GY
Sbjct: 162 LIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWTLCGT---PEALAPEIILSKGY 215

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           N+A D W+ GV++Y + +G PPF+ +   +I++ + +  +RFPS    H S   KDL+  
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRN 271

Query: 281 MLSTDPSQRL-----TARQVLDHSW 300
           +L  D ++R          + +H W
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKW 296

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  218 bits (558), Expect = 5e-68
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 41/300 (13%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
             F   Q LG G FGV+    +K     +A K I             V  E++ + +L  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE- 61

Query: 101 HPNVVDLKAVYEDED------------YVHLVMELCAGGELFHRLEK---FGRFSEAEAR 145
           HP +V     + +++            Y+++ M+LC    L   +           +   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 146 VLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT- 204
            +F+Q+ + V + H  G++HRDLKP NI          +K+ DFGL T ++  +      
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 205 ------------VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRI 251
                       VG+  Y++PE + G  Y+   D++S G+IL+ LL   P      + R 
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRT 236

Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKL 311
              VR  +L+FP             +V  MLS  P +R  A  +++++   D    P K 
Sbjct: 237 LTDVR--NLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL-DFPGKT 292

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  217 bits (555), Expect = 2e-67
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 18/265 (6%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F + + LG G FG + +   +  G  +A K + K+ +V +        E  +++ ++ HP
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            ++ +   ++D   + ++M+   GGELF  L K  RF    A+    ++   + Y H   
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSLLGTVGSPFYIAPEVLAG-GY 220
           +++RDLKPENILL        IK+ DFG A Y+     +L GT   P YIAPEV++   Y
Sbjct: 127 IIYRDLKPENILLDKNGH---IKITDFGFAKYVPDVTYTLCGT---PDYIAPEVVSTKPY 180

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           N++ D WS G+++Y +L+G  PF+ +   + ++ +  A+LRFP       ++  KDL+  
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSR 236

Query: 281 MLSTDPSQRL-----TARQVLDHSW 300
           +++ D SQRL         V +H W
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHPW 261

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  218 bits (557), Expect = 7e-67
 Identities = 75/269 (27%), Positives = 131/269 (48%), Gaps = 16/269 (5%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F + + +G G FG + +     T +++A K + K + V  ++ R+V  E++IM  L  HP
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HP 75

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V+L   ++DE+ + +V++L  GG+L + L++   F E   ++   +L+  + Y     
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR 135

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA----G 218
           ++HRD+KP+NILL        + + DF +A  +     +    G+  Y+APE+ +     
Sbjct: 136 IIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWG---NTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
           GY+ A D WS GV  Y LL G  P+      +   I     T  + +PS      S    
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMV 248

Query: 276 DLVMGMLSTDPSQRL-TARQVLDHSWMGD 303
            L+  +L  +P QR      V +  +M D
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  213 bits (545), Expect = 1e-65
 Identities = 82/325 (25%), Positives = 129/325 (39%), Gaps = 43/325 (13%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
             R  + + L  G F  +    D  +G  +A K +  +     +  R++  E+  M +LS
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLS 83

Query: 100 GHPNVVDL-------KAVYEDEDYVHLVMELCAGGELFHRLEKF---GRFSEAEARVLFM 149
           GHPN+V         K   +      L++     G+L   L+K    G  S      +F 
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 150 QLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLADFGLATYIEPG--------- 198
           Q  + V + H     ++HRDLK EN+LL+ + +   IKL DFG AT I            
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPDYSWSAQR 200

Query: 199 ----QSLLGTVGSPFYIAPEV--LAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSR 250
               +  +    +P Y  PE+  L       +  D+W+ G ILY+L     PF    K R
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260

Query: 251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK 310
           I +         P  P D        L+  ML  +P +RL+  +V+         ++   
Sbjct: 261 IVNG----KYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314

Query: 311 LSGNKIEDCKEWDLGSGSFSTQIIP 335
            S   I +  E + G GS +    P
Sbjct: 315 KS--PITELLEQNGGYGSATLSRGP 337

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  215 bits (548), Expect = 9e-63
 Identities = 78/264 (29%), Positives = 130/264 (49%), Gaps = 20/264 (7%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG--HPNVVD 106
           +G G FG +  C    TG+++A K + K R+     E     E  +++ +S    P +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           +   +   D +  +++L  GG+L + L + G FSEA+ R    +++  + + H   VV+R
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAA 224
           DLKP NILL        ++++D GLA      +    +VG+  Y+APEVL     Y+ +A
Sbjct: 317 DLKPANILLDEHGH---VRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSA 372

Query: 225 DVWSAGVILYILLSGMPPFWG-NTKSR--IFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
           D +S G +L+ LL G  PF    TK +  I     T  +  P    D  S   + L+ G+
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGL 428

Query: 282 LSTDPSQRL-----TARQVLDHSW 300
           L  D ++RL      A++V +  +
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPF 452

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  203 bits (520), Expect = 4e-62
 Identities = 86/270 (31%), Positives = 140/270 (51%), Gaps = 29/270 (10%)

Query: 44  VLGQQLGWGQFG-VI--RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           VLGQ    G FG V   +  S     +++A K + K  L   D  R+ K+E +I+  ++ 
Sbjct: 31  VLGQ----GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN- 84

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP +V L   ++ E  ++L+++   GG+LF RL K   F+E + +    +L   + + H 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQ---SLLGTVGSPFYIAPEVL 216
           +G+++RDLKPENILL  +     IKL DFGL+   I+  +   S  GT     Y+APEV+
Sbjct: 145 LGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGT---VEYMAPEVV 198

Query: 217 AG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
              G+ Q+AD WS GV+++ +L+G  PF G  +      +  A L  P      +S  A+
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ 254

Query: 276 DLVMGMLSTDPSQRL-----TARQVLDHSW 300
            L+  +   +P+ RL        ++  HS+
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  203 bits (519), Expect = 6e-62
 Identities = 87/271 (32%), Positives = 140/271 (51%), Gaps = 29/271 (10%)

Query: 44  VLGQQLGWGQFG-VI--RVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTRLS 99
           VLG+    G +G V   R  +   TG++FA K + K  +V    +    K E  I+  + 
Sbjct: 24  VLGK----GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            HP +VDL   ++    ++L++E  +GGELF +LE+ G F E  A     ++   + + H
Sbjct: 80  -HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQ---SLLGTVGSPFYIAPEV 215
           + G+++RDLKPENI+L  +     +KL DFGL    I  G    +  GT     Y+APE+
Sbjct: 139 QKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCGT---IEYMAPEI 192

Query: 216 LAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
           L   G+N+A D WS G ++Y +L+G PPF G  + +  D +    L  P     +++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEA 248

Query: 275 KDLVMGMLSTDPSQRL-----TARQVLDHSW 300
           +DL+  +L  + + RL      A +V  H +
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  203 bits (518), Expect = 2e-61
 Identities = 82/278 (29%), Positives = 143/278 (51%), Gaps = 35/278 (12%)

Query: 44  VLGQQLGWGQFG-VI--RVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKLEIEIMTRLS 99
           VLG     G +G V   R  S   TG+++A K + K  +V         + E +++  + 
Sbjct: 61  VLGT----GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
             P +V L   ++ E  +HL+++   GGELF  L +  RF+E E ++   +++  + + H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLA-----TYIEPGQSLLGTVGSPFYIAPE 214
           ++G+++RD+K ENILL    S+  + L DFGL+        E      GT     Y+AP+
Sbjct: 177 KLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGT---IEYMAPD 230

Query: 215 VLAG---GYNQAADVWSAGVILYILLSGMPPFWG----NTKSRIFDAVRTADLRFPSNPW 267
           ++ G   G+++A D WS GV++Y LL+G  PF      N+++ I   +  ++  +P    
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--- 287

Query: 268 DHISDSAKDLVMGMLSTDPSQRL-----TARQVLDHSW 300
             +S  AKDL+  +L  DP +RL      A ++ +H +
Sbjct: 288 -EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  208 bits (531), Expect = 3e-61
 Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 20/264 (7%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  + TG+++ACK + K R+     E     E +I+ +++    VV L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLA 250

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHR 166
             YE +D + LV+ L  GG+L   +   G+  F EA A     ++   +   H   +V+R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310

Query: 167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAAD 225
           DLKPENILL        I+++D GLA ++  GQ++ G VG+  Y+APEV+    Y  + D
Sbjct: 311 DLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367

Query: 226 VWSAGVILYILLSGMPPFWG----NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGM 281
            W+ G +LY +++G  PF        +  +   V+     +     +  S  A+ L   +
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQL 423

Query: 282 LSTDPSQRL-----TARQVLDHSW 300
           L  DP++RL     +AR+V +H  
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHPL 447

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  204 bits (520), Expect = 3e-61
 Identities = 87/283 (30%), Positives = 140/283 (49%), Gaps = 23/283 (8%)

Query: 33  TNQISNLR---ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVK 89
            N+I +LR   E + + + +G G FG +++   K T +V+A K ++K  ++   D     
Sbjct: 58  INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 117

Query: 90  LEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
            E +IM   +  P VV L   ++D+ Y+++VME   GG+L + +       E  AR    
Sbjct: 118 EERDIMAFAN-SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTA 175

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGS 207
           +++  +   H +G +HRD+KP+N+LL     S  +KLADFG    +     +     VG+
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232

Query: 208 PFYIAPEVL-----AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--RTADL 260
           P YI+PEVL      G Y +  D WS GV LY +L G  PF+ ++    +  +      L
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292

Query: 261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSW 300
            FP +    IS  AK+L+   L TD   RL      ++  H +
Sbjct: 293 TFPDDND--ISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLF 332

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  201 bits (514), Expect = 8e-61
 Identities = 76/268 (28%), Positives = 137/268 (51%), Gaps = 20/268 (7%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F     LG G FG + +   K T E++A K + KD ++  DD     +E  ++      P
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +  L + ++  D ++ VME   GG+L + +++ GRF E  A     ++   + +    G
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQ---SLLGTVGSPFYIAPEVLAG 218
           +++RDLK +N++L ++     IK+ADFG+    I  G    +  GT   P YIAPE++A 
Sbjct: 142 IIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFCGT---PDYIAPEIIAY 195

Query: 219 -GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
             Y ++ D W+ GV+LY +L+G  PF G  +  +F ++   ++ +P      +S  A  +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI 251

Query: 278 VMGMLSTDPSQRL-----TARQVLDHSW 300
             G+++  P +RL       R + +H++
Sbjct: 252 CKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  200 bits (512), Expect = 1e-60
 Identities = 79/261 (30%), Positives = 134/261 (51%), Gaps = 10/261 (3%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F+L + LG G FG + +   K T + FA K++ KD ++  DD     +E  +++    HP
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +  +   ++ ++ +  VME   GG+L + ++   +F  + A     +++  + + H  G
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAG-GY 220
           +V+RDLK +NILL        IK+ADFG+    +          G+P YIAPE+L G  Y
Sbjct: 139 IVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 195

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
           N + D WS GV+LY +L G  PF G  +  +F ++R  +  +P      +   AKDL++ 
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVK 251

Query: 281 MLSTDPSQRLTARQ-VLDHSW 300
           +   +P +RL  R  +  H  
Sbjct: 252 LFVREPEKRLGVRGDIRQHPL 272

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  200 bits (512), Expect = 1e-60
 Identities = 80/263 (30%), Positives = 134/263 (50%), Gaps = 21/263 (7%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +   K TG+++A K + KD ++  DD      E  I++    HP +  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GG+L   ++K  RF EA AR    +++  +++ H+ G+++RDL
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150

Query: 169 KPENILLATKASSSPIKLADFGLA-TYIEPGQ---SLLGTVGSPFYIAPEVLAG-GYNQA 223
           K +N+LL  +      KLADFG+    I  G    +  GT   P YIAPE+L    Y  A
Sbjct: 151 KLDNVLLDHEGH---CKLADFGMCKEGICNGVTTATFCGT---PDYIAPEILQEMLYGPA 204

Query: 224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS 283
            D W+ GV+LY +L G  PF    +  +F+A+   ++ +P+     + + A  ++   ++
Sbjct: 205 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMT 260

Query: 284 TDPSQRL------TARQVLDHSW 300
            +P+ RL          +L H +
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPF 283

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  201 bits (513), Expect = 2e-60
 Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 23/266 (8%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V+G+    G FG + +   K     +A K + K  ++   +E+ +  E  ++ +   HP 
Sbjct: 45  VIGK----GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100

Query: 104 VVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGV 163
           +V L   ++  D ++ V++   GGELF+ L++   F E  AR    ++   + Y H + +
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160

Query: 164 VHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQ---SLLGTVGSPFYIAPEVLAG- 218
           V+RDLKPENILL    S   I L DFGL    IE      +  GT   P Y+APEVL   
Sbjct: 161 VYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGT---PEYLAPEVLHKQ 214

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y++  D W  G +LY +L G+PPF+    + ++D +    L+       +I++SA+ L+
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLL 270

Query: 279 MGMLSTDPSQRL----TARQVLDHSW 300
            G+L  D ++RL       ++  H +
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVF 296

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  199 bits (508), Expect = 4e-60
 Identities = 86/259 (33%), Positives = 135/259 (52%), Gaps = 15/259 (5%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++     HP +  LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALK 71

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDL 168
             ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H   VV+RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131

Query: 169 KPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADV 226
           K EN++L        IK+ DFGL    I  G ++    G+P Y+APEVL    Y +A D 
Sbjct: 132 KLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188

Query: 227 WSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDP 286
           W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+ G+L  DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244

Query: 287 SQRL-----TARQVLDHSW 300
            QRL      A++V++H +
Sbjct: 245 KQRLGGGPSDAKEVMEHRF 263

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  205 bits (522), Expect = 4e-60
 Identities = 73/267 (27%), Positives = 130/267 (48%), Gaps = 23/267 (8%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG +  C  K TG+++ACK + K RL      +   +E +I+ ++     +V L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLA 251

Query: 109 AVYEDEDYVHLVMELCAGGELFHRL----EKFGRFSEAEARVLFMQLMQVVLYCHEIGVV 164
             +E +  + LVM +  GG++ + +    E    F E  A     Q++  + + H+  ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311

Query: 165 HRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQ 222
           +RDLKPEN+LL    +   ++++D GLA  ++ GQ+      G+P ++APE+L G  Y+ 
Sbjct: 312 YRDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368

Query: 223 AADVWSAGVILYILLSGMPPFWG----NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
           + D ++ GV LY +++   PF           +   V    + +P    D  S ++KD  
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFC 424

Query: 279 MGMLSTDPSQRL-----TARQVLDHSW 300
             +L  DP +RL     +   +  H  
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  201 bits (511), Expect = 7e-60
 Identities = 47/300 (15%), Positives = 86/300 (28%), Gaps = 51/300 (17%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL--- 98
             V G  LG          +D+ TGE F             +  + +K E+  +  L   
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 99  ---------------------SGHPNVVDLKAVYEDEDYVH--LVMELCAG------GEL 129
                                     ++ ++    D   +    +              L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 130 FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF 189
                            L +Q+++++   H  G+VH  L+P +I+L  +     + L  F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG---VFLTGF 255

Query: 190 GLATYI-EPGQSLLGT-VGSPFYIAPEVLAGG------YNQAADVWSAGVILYILLSGMP 241
                      S +G     P   A  +L  G         A D W+ G+ +Y +     
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 242 PFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           P   +      + +      F S    +I    + L+ G L      RL   Q ++    
Sbjct: 316 PNTDDAALGGSEWI------FRSCK--NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 367

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  200 bits (511), Expect = 8e-60
 Identities = 75/268 (27%), Positives = 124/268 (46%), Gaps = 22/268 (8%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           +G G F  + V   K TG+V+A K + K  ++   +    + E +++        +  L 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLH 127

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
             ++DE+Y++LVME   GG+L   L KFG R     AR    +++  +   H +G VHRD
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187

Query: 168 LKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEVL--------A 217
           +KP+NILL        I+LADFG    +    ++     VG+P Y++PE+L         
Sbjct: 188 IKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244

Query: 218 GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--RTADLRFPSNPWDHISDSAK 275
           G Y    D W+ GV  Y +  G  PF+ ++ +  +  +      L  P    + + + A+
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD-EGVPEEAR 303

Query: 276 DLVMGMLSTDPSQRLT---ARQVLDHSW 300
           D +  +L   P  RL    A     H +
Sbjct: 304 DFIQRLL-CPPETRLGRGGAGDFRTHPF 330

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  200 bits (510), Expect = 2e-59
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 18/274 (6%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE F + + +G G FG + V   K   +VFA K + K  ++   +    + E +++    
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYC 158
               +  L   ++D++ ++LVM+   GG+L   L KF  R  E  AR    +++  +   
Sbjct: 133 -SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATY-IEPGQSLLGT-VGSPFYIAPEVL 216
           H++  VHRD+KP+NIL+     +  I+LADFG     +E G       VG+P YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 217 ------AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW-DH 269
                  G Y    D WS GV +Y +L G  PF+  +    +  +     RF        
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308

Query: 270 ISDSAKDLVMGMLSTDPSQRLT---ARQVLDHSW 300
           +S++AKDL+  ++      RL          H +
Sbjct: 309 VSENAKDLIRRLI-CSREHRLGQNGIEDFKKHPF 341

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  198 bits (504), Expect = 2e-59
 Identities = 43/300 (14%), Positives = 90/300 (30%), Gaps = 38/300 (12%)

Query: 41  ERFVLGQQLGWGQFGVI-----RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           +   +   LG G F  +        +D    + F  K            E  +  ++   
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP----WEFYIGTQLMER 120

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-----FSEAEARVLFMQ 150
            + S     +   + +  ++   LV EL + G L + +  +         +       M+
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSP--------IKLADFGLA---TYIEPGQ 199
           ++ ++   H+  ++H D+KP+N +L                + L D G +        G 
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 200 SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA 258
                  +  +   E+L+   +N   D +     +Y +L G      N            
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE---- 296

Query: 259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIED 318
                        D   +    ML+      L +  +L         +  ++   NKI  
Sbjct: 297 --GLFRRLPH--LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK----KVFQQHYTNKIRA 348

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  194 bits (496), Expect = 2e-58
 Identities = 71/330 (21%), Positives = 129/330 (39%), Gaps = 28/330 (8%)

Query: 7   SNSSSEPSRQPCKCYRVRSLAETILDTNQISNLR-------ERFVLGQQLGWGQFGVIRV 59
           + + S  S +  +        E +L T ++  +               ++G G FG +  
Sbjct: 17  AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHR 76

Query: 60  CSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL 119
             DK TG   A K +   RL     E     E+     LS  P +V L     +  +V++
Sbjct: 77  MKDKQTGFQCAVKKV---RLEVFRVE-----ELVACAGLS-SPRIVPLYGAVREGPWVNI 127

Query: 120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA 179
            MEL  GG L   +++ G   E  A     Q ++ + Y H   ++H D+K +N+LL++  
Sbjct: 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD- 186

Query: 180 SSSPIKLADFGLATYIEPGQSLLGT------VGSPFYIAPEVLAG-GYNQAADVWSAGVI 232
             S   L DFG A  ++P              G+  ++APEV+ G   +   D+WS+  +
Sbjct: 187 -GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245

Query: 233 LYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTA 292
           +  +L+G  P+    +  +   + +        P    +      +   L  +P  R +A
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQAIQEGLRKEPVHRASA 304

Query: 293 RQVLDHSWMGDGIQDPEKLSGNKIEDCKEW 322
            ++         +Q+   L      + KE 
Sbjct: 305 MELRRKVGK--ALQEVGGLKSPWKGEYKEP 332

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  202 bits (516), Expect = 2e-58
 Identities = 75/265 (28%), Positives = 137/265 (51%), Gaps = 14/265 (5%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F     LG G FG + +   K T E++A K + KD ++  DD     +E  ++      P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +  L + ++  D ++ VME   GG+L + +++ GRF E  A     ++   + +    G
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAG-GY 220
           +++RDLK +N++L ++     IK+ADFG+    I  G +     G+P YIAPE++A   Y
Sbjct: 463 IIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519

Query: 221 NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMG 280
            ++ D W+ GV+LY +L+G  PF G  +  +F ++   ++ +P      +S  A  +  G
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKG 575

Query: 281 MLSTDPSQRL-----TARQVLDHSW 300
           +++  P +RL       R + +H++
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAF 600

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  195 bits (497), Expect = 2e-58
 Identities = 74/275 (26%), Positives = 134/275 (48%), Gaps = 24/275 (8%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F L + +G G +  + +   K T  ++A K + K+ +   +D   V+ E  +  + S HP
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L + ++ E  +  V+E   GG+L   +++  +  E  AR    ++   + Y HE G
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAG-GY 220
           +++RDLK +N+LL ++     IKL D+G+    + PG +     G+P YIAPE+L G  Y
Sbjct: 131 IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 187

Query: 221 NQAADVWSAGVILYILLSGMPPFW---------GNTKSRIFDAVRTADLRFPSNPWDHIS 271
             + D W+ GV+++ +++G  PF           NT+  +F  +    +R P      +S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS 243

Query: 272 DSAKDLVMGMLSTDPSQRL------TARQVLDHSW 300
             A  ++   L+ DP +RL          +  H +
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  196 bits (501), Expect = 6e-58
 Identities = 88/260 (33%), Positives = 136/260 (52%), Gaps = 16/260 (6%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK 108
           LG G FG + +  +K TG  +A K + K+ +V  D+      E  ++   S HP +  LK
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 214

Query: 109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRD 167
             ++  D +  VME   GGELF  L +   FSE  AR    +++  + Y H E  VV+RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274

Query: 168 LKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAAD 225
           LK EN++L        IK+ DFGL    I+ G ++    G+P Y+APEVL    Y +A D
Sbjct: 275 LKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTD 285
            W  GV++Y ++ G  PF+     ++F+ +   ++RFP      +   AK L+ G+L  D
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKD 387

Query: 286 PSQRL-----TARQVLDHSW 300
           P QRL      A++++ H +
Sbjct: 388 PKQRLGGGSEDAKEIMQHRF 407

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  194 bits (494), Expect = 2e-57
 Identities = 73/262 (27%), Positives = 131/262 (50%), Gaps = 24/262 (9%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP 102
           F L + +G G +  + +   K T  ++A + + K+ +   +D   V+ E  +  + S HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG 162
            +V L + ++ E  +  V+E   GG+L   +++  +  E  AR    ++   + Y HE G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173

Query: 163 VVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQ---SLLGTVGSPFYIAPEVLAG 218
           +++RDLK +N+LL ++     IKL D+G+    + PG    +  GT   P YIAPE+L G
Sbjct: 174 IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGT---PNYIAPEILRG 227

Query: 219 -GYNQAADVWSAGVILYILLSGMPPFW---------GNTKSRIFDAVRTADLRFPSNPWD 268
             Y  + D W+ GV+++ +++G  PF           NT+  +F  +    +R P     
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 283

Query: 269 HISDSAKDLVMGMLSTDPSQRL 290
            +S  A  ++   L+ DP +RL
Sbjct: 284 SLSVKAASVLKSFLNKDPKERL 305

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  189 bits (482), Expect = 6e-57
 Identities = 71/284 (25%), Positives = 125/284 (44%), Gaps = 18/284 (6%)

Query: 27  AETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER 86
            +   D  +     +       LG G +G++    D       A K I           +
Sbjct: 8   GDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQ 64

Query: 87  SVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEA- 144
            +  EI +   L  H N+V     + +  ++ + ME   GG L   L  K+G   + E  
Sbjct: 65  PLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123

Query: 145 -RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG 203
                 Q+++ + Y H+  +VHRD+K +N+L+ T   S  +K++DFG +  +        
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTE 181

Query: 204 T-VGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFW--GNTKSRIFDAVRT 257
           T  G+  Y+APE++     GY +AAD+WS G  +  + +G PPF+  G  ++ +F  V  
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGM 240

Query: 258 ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             +  P  P + +S  AK  ++     DP +R  A  +L   ++
Sbjct: 241 FKVH-PEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  178 bits (454), Expect = 8e-53
 Identities = 61/264 (23%), Positives = 123/264 (46%), Gaps = 14/264 (5%)

Query: 45  LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV 104
              ++G G F  +    D  T    A   + +DR +T  + +  K E E++  L  HPN+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQ-HPNI 87

Query: 105 VDLKAVYED----EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           V     +E     +  + LV EL   G L   L++F        R    Q+++ + + H 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 161 IG--VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG 218
               ++HRDLK +NI +     S  +K+ D GLAT ++        +G+P ++APE+   
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE 204

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDSAKDL 277
            Y+++ DV++ G+ +  + +   P+      ++I+  V +     P++         K++
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEI 262

Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           + G +  +  +R + + +L+H++ 
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFF 286

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  173 bits (442), Expect = 8e-51
 Identities = 91/306 (29%), Positives = 148/306 (48%), Gaps = 44/306 (14%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--RSVKL-EIEIMTR 97
           E++    ++G G +GV+  C ++ TG++ A K   +      DD   + + L EI ++ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE----DDPVIKKIALREIRMLKQ 58

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVL 156
           L  HPN+V+L  V+  +  +HLV E C    + H L+++ R   E   + +  Q +Q V 
Sbjct: 59  LK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFYIAPEV 215
           +CH+   +HRD+KPENIL+      S IKL DFG A     P       V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 216 LAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------------ 257
           L G   Y    DVW+ G +   LLSG+P + G +       I   +              
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233

Query: 258 ---ADLRFP----SNPWD----HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ 306
              + ++ P      P +    +IS  A  L+ G L  DP++RLT  Q+L H +  + I+
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF-ENIR 292

Query: 307 DPEKLS 312
           + E L+
Sbjct: 293 EIEDLA 298

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  175 bits (446), Expect = 2e-50
 Identities = 94/349 (26%), Positives = 151/349 (43%), Gaps = 61/349 (17%)

Query: 1   MAAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVC 60
           M+    +     P   P K  +V +      +  +I      +   + +G G FGV  V 
Sbjct: 5   MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREI-----AYTNCKVIGNGSFGV--VF 57

Query: 61  S--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY------E 112
                 + EV A K + +D+       R    E++IM  +  HPNVVDLKA +      +
Sbjct: 58  QAKLVESDEV-AIKKVLQDKRFKN---R----ELQIMRIVK-HPNVVDLKAFFYSNGDKK 108

Query: 113 DEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
           DE +++LV+E     E  +R  +              ++   QL++ + Y H IG+ HRD
Sbjct: 109 DEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166

Query: 168 LKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAAD 225
           +KP+N+LL     S  +KL DFG A  +  G+  +  + S +Y APE++ G   Y    D
Sbjct: 167 IKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNID 224

Query: 226 VWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT-------------ADLRFP---SN 265
           +WS G ++  L+ G P F G +       I   + T              + +FP    +
Sbjct: 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPH 284

Query: 266 PWD-----HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           P+           A DL+  +L   PS RLTA + L H +  D ++  E
Sbjct: 285 PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF-DELRTGE 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  173 bits (440), Expect = 2e-50
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 26/250 (10%)

Query: 69  FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGE 128
           +         L +     +  ++I  M   S   N V        + Y+++ M+LC    
Sbjct: 89  WLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQMQLCRKEN 147

Query: 129 LFHRLEKFGRFSEAE---ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK 185
           L   + +     + E      +F+Q+ + V + H  G++HRDLKP NI          +K
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK 204

Query: 186 LADFGLATYIE-------------PGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGV 231
           + DFGL T ++                +  G VG+  Y++PE + G  Y+   D++S G+
Sbjct: 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGL 264

Query: 232 ILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT 291
           IL+ LL          + RI   VR  +L+FP   +         +V  MLS  P++R  
Sbjct: 265 ILFELL--YSFSTQMERVRIITDVR--NLKFPL-LFTQKYPQEHMMVQDMLSPSPTERPE 319

Query: 292 ARQVLDHSWM 301
           A  +++++  
Sbjct: 320 ATDIIENAIF 329

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  173 bits (440), Expect = 2e-50
 Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 48/298 (16%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE-------RSVKLEIE 93
           +R+    +LG G +G +    D  T E  A K I   RL   ++E       R    E+ 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI---RLEH-EEEGVPGTAIR----EVS 85

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           ++  L  H N+++LK+V      +HL+ E     +L   ++K    S    +    QL+ 
Sbjct: 86  LLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN 143

Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSP--IKLADFGLA-TYIEPGQSLLGTVGSPFY 210
            V +CH    +HRDLKP+N+LL+   +S    +K+ DFGLA  +  P +     + + +Y
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203

Query: 211 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------- 257
             PE+L G   Y+ + D+WS   I   +L   P F G+++     +IF+ +         
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263

Query: 258 -------ADLRFPSNP--------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                      FP              + D   DL+  ML  DP +R++A+  L+H +
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  173 bits (440), Expect = 4e-50
 Identities = 83/297 (27%), Positives = 132/297 (44%), Gaps = 49/297 (16%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKL----EIEIM 95
           +R+     LG GQF  +    DK T ++ A K I   +L    + +  +      EI+++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLL 66

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQ 150
             LS HPN++ L   +  +  + LV +          LE          + +  +   + 
Sbjct: 67  QELS-HPNIIGLLDAFGHKSNISLVFDFME-----TDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPF 209
            +Q + Y H+  ++HRDLKP N+LL        +KLADFGLA ++  P ++    V + +
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRW 177

Query: 210 YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------ 257
           Y APE+L G   Y    D+W+ G IL  LL  +P   G++     +RIF+ + T      
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237

Query: 258 ---ADL-------RFPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                L        FP  P  HI     D   DL+ G+   +P  R+TA Q L   +
Sbjct: 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  172 bits (437), Expect = 6e-50
 Identities = 72/298 (24%), Positives = 121/298 (40%), Gaps = 53/298 (17%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL----EIEIMT 96
           E ++   +LG G +  +     K T  + A K I   RL   + E         E+ ++ 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RL---EHEEGAPCTAIREVSLLK 55

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQL 151
            L  H N+V L  +   E  + LV E          L+++        +    ++   QL
Sbjct: 56  DLK-HANIVTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           ++ + YCH   V+HRDLKP+N+L+  +     +KLADFGLA     P ++    V + +Y
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWY 166

Query: 211 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------- 257
             P++L G   Y+   D+W  G I Y + +G P F G+T       IF  + T       
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 258 --------ADLRFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                       +P             +     DL+  +L  +   R++A   + H +
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  172 bits (439), Expect = 3e-49
 Identities = 85/310 (27%), Positives = 139/310 (44%), Gaps = 57/310 (18%)

Query: 41  ERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKL-EIEIMTR 97
             +   + +G G FGV  V       +GE+ A K + +D+          K  E++IM +
Sbjct: 54  VSYTDTKVIGNGSFGV--VYQAKLCDSGELVAIKKVLQDK------RF--KNRELQIMRK 103

Query: 98  LSGHPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARV 146
           L  H N+V L+  +      +DE Y++LV++     E  +R+ +              ++
Sbjct: 104 LD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL 160

Query: 147 LFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG 206
              QL + + Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + 
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218

Query: 207 SPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT--- 257
           S +Y APE++ G   Y  + DVWSAG +L  LL G P F G++       I   + T   
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278

Query: 258 ----------ADLRFPS---NPWD-----HISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
                      + +FP    +PW           A  L   +L   P+ RLT  +   HS
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338

Query: 300 WMGDGIQDPE 309
           +  D ++DP 
Sbjct: 339 FF-DELRDPN 347

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  168 bits (429), Expect = 4e-49
 Identities = 89/298 (29%), Positives = 139/298 (46%), Gaps = 54/298 (18%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER----SVKL-EIEIM 95
           E++   +++G G +GV+    +   GE FA K I   RL   + E     S  + EI I+
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI---RL---EKEDEGIPSTTIREISIL 54

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQ 150
             L  H N+V L  V   +  + LV E          L+K      G      A+   +Q
Sbjct: 55  KELK-HSNIVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPF 209
           L+  + YCH+  V+HRDLKP+N+L+  +     +K+ADFGLA  +  P +     + + +
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLW 165

Query: 210 YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------ 257
           Y AP+VL G   Y+   D+WS G I   +++G P F G ++     RIF  + T      
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225

Query: 258 --------ADLRFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                    D  F              + +S  DL+  ML  DP+QR+TA+Q L+H++
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  168 bits (427), Expect = 2e-48
 Identities = 78/299 (26%), Positives = 130/299 (43%), Gaps = 53/299 (17%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL----EIEIMT 96
           E++     +G G +G++  C +K TG + A K   +      DD++ VK     EI+++ 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES-----DDDKMVKKIAMREIKLLK 79

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQL 151
           +L  H N+V+L  V + +   +LV E        H +                +    Q+
Sbjct: 80  QLR-HENLVNLLEVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQI 133

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPFY 210
           +  + +CH   ++HRD+KPENIL++       +KL DFG A T   PG+     V + +Y
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWY 190

Query: 211 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------- 257
            APE+L G   Y +A DVW+ G ++  +  G P F G++       I   +         
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250

Query: 258 --------ADLRFP----SNPWD----HISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                   A +R P      P +     +S+   DL    L  DP +R    ++L H +
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  167 bits (426), Expect = 2e-48
 Identities = 86/311 (27%), Positives = 133/311 (42%), Gaps = 70/311 (22%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE--------RSVKLEI 92
            +F   ++LG G +  +    +K TG   A K +   +L   D E        R    EI
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KL---DSEEGTPSTAIR----EI 54

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF----------GRFSEA 142
            +M  L  H N+V L  V   E+ + LV E        + L+K+                
Sbjct: 55  SLMKELK-HENIVRLYDVIHTENKLTLVFEFMD-----NDLKKYMDSRTVGNTPRGLELN 108

Query: 143 EARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSL 201
             +    QL+Q + +CHE  ++HRDLKP+N+L+  +     +KL DFGLA  +  P  + 
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTF 165

Query: 202 LGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAV 255
              V + +Y AP+VL G   Y+ + D+WS G IL  +++G P F G         IFD +
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225

Query: 256 RT------------------------ADLR--FPSNPWDHISDSAKDLVMGMLSTDPSQR 289
            T                         DLR     +  + +  +  D + G+L  +P  R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285

Query: 290 LTARQVLDHSW 300
           L+A+Q L H W
Sbjct: 286 LSAKQALHHPW 296

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  167 bits (425), Expect = 2e-48
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 59/301 (19%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE-------RSVKLEIE 93
           E++   +++G G +GV+    D   G + A K I  D     +DE       R    EI 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA----EDEGIPSTAIR----EIS 71

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLF 148
           ++  L  HPN+V L  V   E  + LV E          L+K          +++ ++  
Sbjct: 72  LLKELH-HPNIVSLIDVIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYL 125

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGS 207
            QL++ V +CH+  ++HRDLKP+N+L+ +  +   +KLADFGLA  +  P +S    V +
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVT 182

Query: 208 PFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTAD-- 259
            +Y AP+VL G   Y+ + D+WS G I   +++G P F G T      +IF  + T +  
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242

Query: 260 -------------LRFPSNP-------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
                          F                    DL+  ML  DP++R++AR  ++H 
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302

Query: 300 W 300
           +
Sbjct: 303 Y 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  166 bits (422), Expect = 4e-48
 Identities = 84/299 (28%), Positives = 137/299 (45%), Gaps = 54/299 (18%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER----SVKL-EIEIM 95
           +++   +++G G +G +    ++ T E+ A K +   RL   DD+     S  L EI ++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RL---DDDDEGVPSSALREICLL 55

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEAEARVLFMQ 150
             L  H N+V L  V   +  + LV E C        L+K+     G       +    Q
Sbjct: 56  KELK-HKNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA-TYIEPGQSLLGTVGSPF 209
           L++ + +CH   V+HRDLKP+N+L+        +KLA+FGLA  +  P +     V + +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 210 YIAPEVLAGG--YNQAADVWSAGVILYILLS-GMPPFWGNTK----SRIFDAVRT----- 257
           Y  P+VL G   Y+ + D+WSAG I   L + G P F GN       RIF  + T     
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 258 ----ADLR----FPSNP--------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                 L     +P  P           ++ + +DL+  +L  +P QR++A + L H +
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  165 bits (420), Expect = 1e-47
 Identities = 78/289 (26%), Positives = 131/289 (45%), Gaps = 21/289 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G FG +    D  T +V A K I  +     D+   ++ EI ++++   
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD- 78

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P V      Y  +  + ++ME   GG     L + G   E +   +  ++++ + Y H 
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHS 137

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA-G 218
              +HRD+K  N+LL+       +KLADFG+A  +   Q    T VG+PF++APEV+   
Sbjct: 138 EKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194

Query: 219 GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP----WDHISDSA 274
            Y+  AD+WS G+    L  G PP            ++      P N       + S   
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSE------LHPMK-VLFLIPKNNPPTLEGNYSKPL 247

Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWD 323
           K+ V   L+ +PS R TA+++L H ++    +    L+   I+  K W 
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLT-ELIDRYKRWK 295

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  161 bits (410), Expect = 3e-46
 Identities = 82/312 (26%), Positives = 126/312 (40%), Gaps = 55/312 (17%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL------EIEI 94
            R+    ++G G +G +    D  +G   A KS+               L      E+ +
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN----GGGGGGGLPISTVREVAL 64

Query: 95  MTRLSG--HPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF------GRFSE 141
           + RL    HPNVV L  V      + E  V LV E          L  +           
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-----QDLRTYLDKAPPPGLPA 119

Query: 142 AEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
              + L  Q ++ + + H   +VHRDLKPENIL+ +  +   +KLADFGLA       +L
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMAL 176

Query: 202 LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVR 256
              V + +Y APEVL    Y    D+WS G I   +    P F GN++     +IFD + 
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236

Query: 257 TAD---------------LRFPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLD 297
                                   P   +     +S   L++ ML+ +P +R++A + L 
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296

Query: 298 HSWMGDGIQDPE 309
           HS++     +PE
Sbjct: 297 HSYLHKDEGNPE 308

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  161 bits (410), Expect = 5e-46
 Identities = 73/287 (25%), Positives = 131/287 (45%), Gaps = 26/287 (9%)

Query: 31  LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL 90
           +D + + +    F L + +G G +G +       TG++ A K +     VT D+E  +K 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQ 69

Query: 91  EIEIMTRLSGHPNVVDLKAVY------EDEDYVHLVMELCAGGEL--FHRLEKFGRFSEA 142
           EI ++ + S H N+      +        +D + LVME C  G +    +  K     E 
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 143 EARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL 202
               +  ++++ + + H+  V+HRD+K +N+LL   A    +KL DFG++  ++      
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRR 186

Query: 203 GT-VGSPFYIAPEVLA------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSR-IFDA 254
            T +G+P+++APEV+A        Y+  +D+WS G+    +  G PP       R +F  
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246

Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            R    R  S  W   S   +  +   L  + SQR    Q++ H ++
Sbjct: 247 PRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  160 bits (407), Expect = 2e-45
 Identities = 70/308 (22%), Positives = 132/308 (42%), Gaps = 52/308 (16%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + + L ++LG G++  +    +    E    K +   + V    ++ +K EI+I+  L G
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPV---KKKKIKREIKILENLRG 89

Query: 101 HPNVVDLKAVYEDE---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            PN++ L  + +D        +   +      F +L  +   ++ + R    ++++ + Y
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHV--NNTDFKQL--YQTLTDYDIRFYMYEILKALDY 145

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
           CH +G++HRD+KP N+++        ++L D+GLA +  PGQ     V S ++  PE+L 
Sbjct: 146 CHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203

Query: 218 GG--YNQAADVWSAGVILYILLSGMPP-FWGNTK----SRIFDAVRTADL---------- 260
               Y+ + D+WS G +L  ++    P F G+       RI   + T DL          
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263

Query: 261 ----------RFPSNPWDHI---------SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                     R     W+           S  A D +  +L  D   RLTAR+ ++H + 
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

Query: 302 GDGIQDPE 309
              +   +
Sbjct: 324 -YTVVKDQ 330

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  159 bits (405), Expect = 2e-45
 Identities = 60/270 (22%), Positives = 114/270 (42%), Gaps = 16/270 (5%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
                  ++G G  G +     + TG V A K + +      ++ + + ++++++ +   
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHD 82

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P +V     +     V + MEL        +    G   E     + + +++ + Y  E
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 161 I-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA-- 217
             GV+HRD+KP NILL  +     IKL DFG++  +   ++   + G   Y+APE +   
Sbjct: 143 KHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199

Query: 218 ----GGYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWDHIS 271
                 Y+  ADVWS G+ L  L +G  P+         +   ++      P +     S
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH--MGFS 257

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              +  V   L+ D  +R    ++L+HS++
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  159 bits (405), Expect = 2e-45
 Identities = 63/273 (23%), Positives = 122/273 (44%), Gaps = 17/273 (6%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E      ++G G +G +     K +G++ A K I     V   +++ + ++++++ R S 
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSD 79

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGG--ELFHRLEKF--GRFSEAEARVLFMQLMQVVL 156
            P +V        E    + MEL +    + +  +         E     + +  ++ + 
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 157 YCHEIG-VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
           +  E   ++HRD+KP NILL    +   IKL DFG++  +    +     G   Y+APE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 196

Query: 216 LAG-----GYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPWD 268
           +       GY+  +DVWS G+ LY L +G  P+  W +   ++   V+    +  ++   
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256

Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             S S  + V   L+ D S+R   +++L H ++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  159 bits (405), Expect = 6e-45
 Identities = 81/319 (25%), Positives = 134/319 (42%), Gaps = 66/319 (20%)

Query: 41  ERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           +RF + +  G G FG   V    +K TG   A K +       I D R    E++IM  L
Sbjct: 23  DRFQVERMAGQGTFGT--VQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQIMQDL 73

Query: 99  S--GHPNVVDLKAVY-------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARV--- 146
           +   HPN+V L++ +         + Y+++VME     +  HR  +   +   +      
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCR--NYYRRQVAPPPI 129

Query: 147 ---LFM-QLMQVVLYCHE--IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS 200
              +F+ QL++ +   H   + V HRD+KP N+L+    +   +KL DFG A  + P + 
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEP 187

Query: 201 LLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDA 254
            +  + S +Y APE++ G   Y  A D+WS G I   ++ G P F G+        I   
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

Query: 255 VRT-------------ADLRFPS---NPWD--------HISDSAKDLVMGMLSTDPSQRL 290
           +                D+   +    PW           +  A DL+  +L   P +R+
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307

Query: 291 TARQVLDHSWMGDGIQDPE 309
              + L H +  D + DP 
Sbjct: 308 KPYEALCHPYF-DELHDPA 325

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  157 bits (400), Expect = 7e-45
 Identities = 69/299 (23%), Positives = 132/299 (44%), Gaps = 34/299 (11%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            E + +  +LG G FG +    +K TG + A K I      + ++     +EIEI+    
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCD 74

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYC 158
            HP +V L   Y  +  + +++E C GG +   + +     +E + +V+  Q+++ + + 
Sbjct: 75  -HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA 217
           H   ++HRDLK  N+L+  +     I+LADFG++           + +G+P+++APEV+ 
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 218 ------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP----- 266
                   Y+  AD+WS G+ L  +    PP          + +R   L+   +      
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMR-VLLKIAKSDPPTLL 243

Query: 267 -WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNK--IEDCKEW 322
                S   +D +   L  +P  R +A Q+L+H +    +         +  + + K  
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF----VSSITSNKALRELVAEAKAE 298

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  159 bits (403), Expect = 8e-45
 Identities = 79/332 (23%), Positives = 130/332 (39%), Gaps = 33/332 (9%)

Query: 2   AAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS 61
               Q      P+       +   +AE         +  + F   +++G G FG +    
Sbjct: 19  NLYFQGAMDPMPAGGRAGSLKDPDVAELFFK----DDPEKLFSDLREIGHGSFGAVYFAR 74

Query: 62  DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM 121
           D    EV A K ++     + +  + +  E+  + +L  HPN +  +  Y  E    LVM
Sbjct: 75  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVM 133

Query: 122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS 181
           E C G              E E   +    +Q + Y H   ++HRD+K  NILL+     
Sbjct: 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL- 192

Query: 182 SPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILL 237
             +KL DFG A+ + P  S +GT   P+++APEV+     G Y+   DVWS G+    L 
Sbjct: 193 --VKLGDFGSASIMAPANSFVGT---PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

Query: 238 SGMPPFWGNTKSRIFDAVRTADLRFPSNP-----WDHISDSAKDLVMGMLSTDPSQRLTA 292
              PP +        +A+  A      N        H S+  ++ V   L   P  R T+
Sbjct: 248 ERKPPLFN------MNAMS-ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTS 300

Query: 293 RQVLDHSWMGDGIQDPEKLSG--NKIEDCKEW 322
             +L H +    +      +   + I+  K+ 
Sbjct: 301 EVLLKHRF----VLRERPPTVIMDLIQRTKDA 328

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  157 bits (399), Expect = 8e-45
 Identities = 58/274 (21%), Positives = 115/274 (41%), Gaps = 23/274 (8%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +      +LG G +GV+       +G++ A K I     V   +++ + ++++I  R   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVD 64

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGG---ELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            P  V        E  V + MEL            ++K     E     + + +++ + +
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 158 CH-EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPE 214
            H ++ V+HRD+KP N+L+        +K+ DFG++ Y+     +      G   Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLV--DDVAKDIDAGCKPYMAPE 179

Query: 215 VLAG-----GYNQAADVWSAGVILYILLSGMPPF--WGNTKSRIFDAVRTADLRFPSNPW 267
            +       GY+  +D+WS G+ +  L     P+  WG    ++   V     + P++ +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239

Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
              S    D     L  +  +R T  +++ H + 
Sbjct: 240 ---SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  156 bits (397), Expect = 4e-44
 Identities = 79/328 (24%), Positives = 145/328 (44%), Gaps = 28/328 (8%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQI---SNLRERFVLGQQLGWGQFGVIRVCSD 62
            S+     +        V +  +       +    + R       ++G G  G++ +  +
Sbjct: 7   HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66

Query: 63  KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME 122
           K +G   A K +    L        +  E+ IM R   H NVV++   Y   + + ++ME
Sbjct: 67  KHSGRQVAVKMM---DLRKQQRRELLFNEVVIM-RDYQHFNVVEMYKSYLVGEELWVLME 122

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
              GG L   +    R +E +   +   ++Q + Y H  GV+HRD+K ++ILL       
Sbjct: 123 FLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-- 179

Query: 183 PIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGM 240
            +KL+DFG    I        + VG+P+++APEV++   Y    D+WS G+++  ++ G 
Sbjct: 180 -VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

Query: 241 PPFWGNTKSRIFDAVRTADLRFPSNP------WDHISDSAKDLVMGMLSTDPSQRLTARQ 294
           PP++ ++  +       A  R   +P         +S   +D +  ML  DP +R TA++
Sbjct: 239 PPYFSDSPVQ-------AMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291

Query: 295 VLDHSWMGDGIQDPEKLSGNKIEDCKEW 322
           +LDH ++      PE L    I+  ++ 
Sbjct: 292 LLDHPFLLQT-GLPECLV-PLIQLYRKQ 317

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  157 bits (399), Expect = 4e-44
 Identities = 71/341 (20%), Positives = 127/341 (37%), Gaps = 76/341 (22%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDER-SVKL----EIEIM 95
            ++    ++G G FG +     + TG+  A K +    +   ++E+    +    EI+I+
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LM---ENEKEGFPITALREIKIL 70

Query: 96  TRLSGHPNVVDLKAV--------YEDEDYVHLVMELCAGGELFHRLEKF-----GRFSEA 142
             L  H NVV+L  +           +  ++LV + C      H L         +F+ +
Sbjct: 71  QLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-----HDLAGLLSNVLVKFTLS 124

Query: 143 EARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL 202
           E + +   L+  + Y H   ++HRD+K  N+L+        +KLADFGLA          
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLA---K 178

Query: 203 GTVGSPF--------YIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK---- 248
            +  + +        Y  PE+L G   Y    D+W AG I+  + +  P   GNT+    
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query: 249 SRIFDAVRT---------------ADLRFPSN---------PWDHISDSAKDLVMGMLST 284
           + I     +                 L                      A DL+  +L  
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query: 285 DPSQRLTARQVLDHSWMGDG--IQDPEKLSGNKIEDCKEWD 323
           DP+QR+ +   L+H +        D + +    +    E+ 
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 339

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  155 bits (395), Expect = 7e-44
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 59/304 (19%)

Query: 41  ERFVLGQQLGWGQFGVI-RVCSDKFTGEVFACKSIAKDRLVTIDDER------SVKLEIE 93
           +++    ++G G +G + +    K  G   A K +   R+             +++ E+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RV---QTGEEGMPLSTIR-EVA 63

Query: 94  IMTRLSG--HPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKF------GRFS 140
           ++  L    HPNVV L  V      + E  + LV E          L  +          
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVP 118

Query: 141 EAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS 200
               + +  QL++ + + H   VVHRDLKP+NIL+ +      IKLADFGLA       +
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMA 175

Query: 201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAV 255
           L   V + +Y APEVL    Y    D+WS G I   +    P F G++      +I D +
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

Query: 256 RTAD---------------LRFPSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVL 296
                                  + P +       +  KDL++  L+ +P++R++A   L
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295

Query: 297 DHSW 300
            H +
Sbjct: 296 SHPY 299

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  155 bits (394), Expect = 8e-44
 Identities = 85/296 (28%), Positives = 135/296 (45%), Gaps = 31/296 (10%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            E F + ++LG G +G +     K TG++ A K +  +      D + +  EI IM +  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCD 82

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYC 158
             P+VV     Y     + +VME C  G +   +       +E E   +    ++ + Y 
Sbjct: 83  -SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLA 217
           H +  +HRD+K  NILL T+      KLADFG+A  +    +   T +G+PF++APEV+ 
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGH---AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198

Query: 218 -GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP------WDHI 270
             GYN  AD+WS G+    +  G PP+      R       A    P+NP       +  
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------AIFMIPTNPPPTFRKPELW 251

Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSG--NKIEDCKEWDL 324
           SD+  D V   L   P QR TA Q+L H +    ++  + +S   + I +  +  L
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPF----VRSAKGVSILRDLINEAMDVKL 303

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  157 bits (398), Expect = 9e-44
 Identities = 81/341 (23%), Positives = 138/341 (40%), Gaps = 87/341 (25%)

Query: 41  ERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           +++ LG+ LG G FG+  VC   D  +G+ FA K + +D        R    E++IM  L
Sbjct: 7   KKYSLGKTLGTGSFGI--VCEVFDIESGKRFALKKVLQDPRYKN---R----ELDIMKVL 57

Query: 99  SGHPNVVDLKAVY--------------------------------------EDEDYVHLV 120
             H N++ L   +                                          Y++++
Sbjct: 58  D-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 121 MELCAGGELFHRLEKFG-----RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL 175
           ME     +  H++ K               +   QL + V + H +G+ HRD+KP+N+L+
Sbjct: 117 MEYV--PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174

Query: 176 ATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVIL 233
              +  + +KL DFG A  + P +  +  + S FY APE++ G   Y  + D+WS G + 
Sbjct: 175 --NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 234 YILLSGMPPFWGNTK----SRIFDAVRT-------------ADLRFPS---NPWDHI--- 270
             L+ G P F G T      RI   + T              ++RFP+     W  I   
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292

Query: 271 --SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
                A DL+  +L  +P  R+   + + H +  D +++  
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF-DHLRNSY 332

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  153 bits (388), Expect = 4e-43
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 25/291 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           ++++   +++G G  G +    D  TG+  A + +    L     +  +  EI +M R +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM-REN 74

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
            +PN+V+    Y   D + +VME  AGG L   +       E +   +  + +Q + + H
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAG 218
              V+HRD+K +NILL    S   +KL DFG    I P QS   T VG+P+++APEV+  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 219 -GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP------WDHIS 271
             Y    D+WS G++   ++ G PP+      R       A     +N        + +S
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNGTPELQNPEKLS 243

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEW 322
              +D +   L  D  +R +A+++L H ++    +    L+   I   KE 
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA-KPLSSLT-PLIAAAKEA 292

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  151 bits (383), Expect = 3e-42
 Identities = 72/287 (25%), Positives = 127/287 (44%), Gaps = 28/287 (9%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S  R+ + L + +G G   V++        E  A K I  ++         +  EI+ M 
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAM- 67

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFH--------RLEKFGRFSEAEARVLF 148
               HPN+V     +  +D + LVM+L +GG +             K G   E+    + 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---- 204
            ++++ + Y H+ G +HRD+K  NILL    S   +++ADFG++ ++  G  +       
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRNKVRK 184

Query: 205 --VGSPFYIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD- 259
             VG+P ++APEV+    GY+  AD+WS G+    L +G  P+      ++       D 
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244

Query: 260 --LRFPSNPWDHI---SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
             L       + +     S + ++   L  DP +R TA ++L H + 
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  149 bits (379), Expect = 8e-42
 Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 26/267 (9%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +   + + +G G FGV  VC  K+  +  A K I  +      + ++  +E+  ++R++ 
Sbjct: 8   KEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVN- 59

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV---VLY 157
           HPN+V L     +     LVME   GG L++ L          A       +Q    V Y
Sbjct: 60  HPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 158 CHEI---GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
            H +    ++HRDLKP N+LL    +   +K+ DFG A  I+    +    GS  ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQ--THMTNNKGSAAWMAPE 173

Query: 215 VLAG-GYNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVRTADLRFPSNPWDHIS 271
           V  G  Y++  DV+S G+IL+ +++   PF        RI  AV     R P     ++ 
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTR-PPLI-KNLP 230

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDH 298
              + L+    S DPSQR +  +++  
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  151 bits (382), Expect = 1e-41
 Identities = 70/324 (21%), Positives = 130/324 (40%), Gaps = 52/324 (16%)

Query: 22  RVRSLAETILDTNQISNLR-ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV 80
           + + L   +    ++  L+ + F    +LG G  GV+   S K +G V A K I  +  +
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--I 70

Query: 81  TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFS 140
                  +  E++++   +  P +V     +  +  + + ME   GG L   L+K GR  
Sbjct: 71  KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 129

Query: 141 EAEARVLFMQLMQVVLYCHEIG-VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ 199
           E     + + +++ + Y  E   ++HRD+KP NIL+ ++     IKL DFG++  +    
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI--D 184

Query: 200 SLLGT-VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT 257
           S+  + VG+  Y++PE L G  Y+  +D+WS G+ L  +  G  P        +      
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244

Query: 258 ADLRF----------------------------------------PSNPWDHISDSAKDL 277
                                                        P  P    S   +D 
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 304

Query: 278 VMGMLSTDPSQRLTARQVLDHSWM 301
           V   L  +P++R   +Q++ H+++
Sbjct: 305 VNKCLIKNPAERADLKQLMVHAFI 328

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  149 bits (378), Expect = 1e-41
 Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 16/265 (6%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
               + +++G G FG   V   ++ G   A K + +      +       E+ IM RL  
Sbjct: 37  CDLNIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR- 92

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL---Y 157
           HPN+V           + +V E  + G L+  L K G   + + R        V     Y
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152

Query: 158 CHEIG--VVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPE 214
            H     +VHR+LK  N+L+  K +   +K+ DFGL+        S     G+P ++APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209

Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           VL     N+ +DV+S GVIL+ L +   P+     +++  AV     R    P  +++  
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIP-RNLNPQ 267

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDH 298
              ++ G  + +P +R +   ++D 
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDL 292

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  148 bits (376), Expect = 1e-41
 Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 25/274 (9%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSI----AKDRLVTIDDERSVKLEIEIMT 96
                 +Q+G G FG++          V A KS+    ++     I+  +  + E+ IM+
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV-- 154
            L+ HPN+V L  +  +     +VME    G+L+HRL       +   ++  M  + +  
Sbjct: 79  NLN-HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM--LDIAL 133

Query: 155 -VLYCHEIG--VVHRDLKPENILLATKASSSP--IKLADFGLATYIEPGQSLLGTVGSPF 209
            + Y       +VHRDL+  NI L +   ++P   K+ADFGL+   +   S+ G +G+  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 210 YIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWG--NTKSRIFDAVRTADLRFPS 264
           ++APE +      Y + AD +S  +ILY +L+G  PF      K +  + +R   LR P+
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-PT 250

Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
            P +      ++++    S DP +R     ++  
Sbjct: 251 IP-EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  149 bits (378), Expect = 2e-41
 Identities = 58/276 (21%), Positives = 120/276 (43%), Gaps = 28/276 (10%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            E+  +G+ +G G+FG  +V   ++ GEV A + I  +R    D  ++ K E+    +  
Sbjct: 32  FEQLEIGELIGKGRFG--QVYHGRWHGEV-AIRLIDIERD-NEDQLKAFKREVMAYRQTR 87

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYC 158
            H NVV          ++ ++  LC G  L+  + +        + R +  ++++ + Y 
Sbjct: 88  -HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS------LLGTVGSPFYIA 212
           H  G++H+DLK +N+          + + DFGL +     Q+      L    G   ++A
Sbjct: 147 HAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 213 PEVLAGG----------YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF 262
           PE++             +++ +DV++ G I Y L +   PF       I   + T  ++ 
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT-GMK- 260

Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
           P+     +     D+++   + +  +R T  +++D 
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  148 bits (376), Expect = 2e-40
 Identities = 73/321 (22%), Positives = 120/321 (37%), Gaps = 72/321 (22%)

Query: 44  VLGQQLGWGQFG-VIR-VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
             G ++G G +G V +    D    + +A K I            S   EI ++  L  H
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRELK-H 77

Query: 102 PNVVDLKAVYED--EDYVHLVME--------LCAGGELFHRLEKFGRFSEAEARVLFMQL 151
           PNV+ L+ V+    +  V L+ +        +          +K  +      + L  Q+
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSS-PIKLADFGLA-TYIEPGQSLLGTVGSP- 208
           +  + Y H   V+HRDLKP NIL+  +      +K+AD G A  +  P + L      P 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL--ADLDPV 195

Query: 209 ----FYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK-------------S 249
               +Y APE+L G   Y +A D+W+ G I   LL+  P F    +              
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255

Query: 250 RIFDAVRTAD-----------------LRFPSNPWDH-------------ISDSAKDLVM 279
           RIF+ +                       F  N + +                 A  L+ 
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315

Query: 280 GMLSTDPSQRLTARQVLDHSW 300
            +L+ DP +R+T+ Q +   +
Sbjct: 316 KLLTMDPIKRITSEQAMQDPY 336

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  144 bits (366), Expect = 3e-40
 Identities = 74/272 (27%), Positives = 118/272 (43%), Gaps = 23/272 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD-ERSVKLEIEIMTRL 98
                L + +G G FG  +V    + G+  A K+   D    I     +V+ E ++   L
Sbjct: 6   FAELTLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV---V 155
             HPN++ L+ V   E  + LVME   GG L   L            +L    +Q+   +
Sbjct: 64  K-HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGM 118

Query: 156 LYCHEIG---VVHRDLKPENILLATKASSSP-----IKLADFGLATYIEPGQSLLGTVGS 207
            Y H+     ++HRDLK  NIL+  K  +       +K+ DFGLA       + +   G+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGA 177

Query: 208 PFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP 266
             ++APEV+    +++ +DVWS GV+L+ LL+G  PF G     +   V    L     P
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA-LPIP 236

Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
                +    L+    + DP  R +   +LD 
Sbjct: 237 -STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  144 bits (365), Expect = 1e-39
 Identities = 80/320 (25%), Positives = 134/320 (41%), Gaps = 59/320 (18%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           +L  R++  + LG G  G+  V S  D    +  A K I          + +++ EI+I+
Sbjct: 8   DLGSRYMDLKPLGCGGNGL--VFSAVDNDCDKRVAIKKIVLTDP--QSVKHALR-EIKII 62

Query: 96  TRLSGHPNVVDLKAV--------------YEDEDYVHLVMELCAGGELFHRLEKFGRFSE 141
            RL  H N+V +  +                + + V++V E     +L   + + G   E
Sbjct: 63  RRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDL-ANVLEQGPLLE 119

Query: 142 AEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
             AR+   QL++ + Y H   V+HRDLKP N+ +        +K+ DFGLA  ++P  S 
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMDPHYSH 177

Query: 202 LGT----VGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRI 251
            G     + + +Y +P +L     Y +A D+W+AG I   +L+G   F G  +      I
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 252 FDAVRT---ADLRF---------------PSNPWDHI----SDSAKDLVMGMLSTDPSQR 289
            +++      D +                P  P   +    S  A D +  +L+  P  R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297

Query: 290 LTARQVLDHSWMGDGIQDPE 309
           LTA + L H +M      P 
Sbjct: 298 LTAEEALSHPYM-SIYSFPM 316

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  141 bits (357), Expect = 7e-39
 Identities = 66/270 (24%), Positives = 114/270 (42%), Gaps = 21/270 (7%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
             +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ +  
Sbjct: 23  DGQITVGQRIGSGSFG--TVYKGKWHGDV-AVKMLNVTAP-TPQQLQAFKNEVGVLRKTR 78

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF-MQLMQVVLYC 158
            H N++             +V + C G  L+H L       E +  +    Q  + + Y 
Sbjct: 79  -HVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI---EPGQSLLGTVGSPFYIAPEV 215
           H   ++HRDLK  NI L    +   +K+ DFGLAT               GS  ++APEV
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNT---VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193

Query: 216 LAGG----YNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLR--FPSNPWD 268
           +       Y+  +DV++ G++LY L++G  P+   N + +I + V    L          
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR-S 252

Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
           +     K L+   L     +R +  ++L  
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  138 bits (349), Expect = 8e-38
 Identities = 48/266 (18%), Positives = 100/266 (37%), Gaps = 25/266 (9%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
               +L     G   +   ++ G     K + K R  +    R    E   +   S HPN
Sbjct: 13  NFLTKLNENHSG--ELWKGRWQGNDIVVK-VLKVRDWSTRKSRDFNEECPRLRIFS-HPN 68

Query: 104 VVDLKAVYEDEDYVHL--VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV-----L 156
           V+ +    +     H   +      G L++ L +   F   +++ +    + +      L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-ALDMARGMAFL 127

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           +  E  +    L   ++++    +    +++   +    +      G + +P ++APE L
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSP----GRMYAPAWVAPEAL 180

Query: 217 AGG----YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
                    ++AD+WS  V+L+ L++   PF   +   I   V    LR P+ P   IS 
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-PTIP-PGISP 238

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDH 298
               L+   ++ DP++R     ++  
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPI 264

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  139 bits (353), Expect = 2e-37
 Identities = 81/304 (26%), Positives = 136/304 (44%), Gaps = 45/304 (14%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK- 86

Query: 101 HPNVVDLKAV------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V       E+ + V+LV  L  G +L + + K  + ++   + L  Q+++ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQILRG 144

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H   ++HRDLKP N+ +        +K+ DFGLA +      + G V + +Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTAD--EMTGYVATRWYRAPE 199

Query: 215 VL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT---ADLRF--- 262
           ++     YNQ  D+WS G I+  LL+G   F G         I   V T     L+    
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 263 -------------PSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI 305
                        P   + ++    +  A DL+  ML  D  +R+TA Q L H++     
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF-AQY 318

Query: 306 QDPE 309
            DP+
Sbjct: 319 HDPD 322

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  138 bits (350), Expect = 4e-37
 Identities = 83/336 (24%), Positives = 137/336 (40%), Gaps = 54/336 (16%)

Query: 9   SSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEV 68
           SS  P+R       V               +R  +   Q +G G +G +    D  TG  
Sbjct: 2   SSPPPARSGFYRQEVT---------KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAK 52

Query: 69  FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV------YEDEDYVHLVME 122
            A K + +     +  +R+ + E+ ++  +  H NV+ L  V       +D    +LVM 
Sbjct: 53  VAIKKLYRPFQSELFAKRAYR-ELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMP 110

Query: 123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS 182
              G +L  +L K  +  E   + L  Q+++ + Y H  G++HRDLKP N+ +       
Sbjct: 111 F-MGTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDC 165

Query: 183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGM 240
            +K+ DFGLA   +    + G V + +Y APEV+     Y Q  D+WS G I+  +++G 
Sbjct: 166 ELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

Query: 241 PPFWGNTK----SRIFDAVRT---ADLRF----------------PSNPWDHI----SDS 273
             F G+        I     T     ++                     +  I    S  
Sbjct: 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 283

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           A +L+  ML  D  QR+TA + L H +  + + D E
Sbjct: 284 AVNLLEKMLVLDAEQRVTAGEALAHPYF-ESLHDTE 318

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  138 bits (349), Expect = 4e-37
 Identities = 83/304 (27%), Positives = 137/304 (45%), Gaps = 46/304 (15%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + +V    +G G +G +    DK +GE  A K +++     I  +R+ + E+ ++  +  
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ- 81

Query: 101 HPNVVDLKAV------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H NV+ L  V        +    +LVM      +L  ++    +FSE + + L  Q+++ 
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDL-QKIMG-LKFSEEKIQYLVYQMLKG 138

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + Y H  GVVHRDLKP N+ +        +K+ DFGLA + +    + G V + +Y APE
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPE 193

Query: 215 VL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT---ADLRF--- 262
           V+     YNQ  D+WS G I+  +L+G   F G       ++I           ++    
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253

Query: 263 -------------PSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI 305
                        P   +  +    S  A DL+  ML  D  +RLTA Q L H +  +  
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF-EPF 312

Query: 306 QDPE 309
           +DPE
Sbjct: 313 RDPE 316

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  136 bits (344), Expect = 7e-37
 Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 32/254 (12%)

Query: 66  GEVFACKSIAKDRLVTI--------DDERSV---KLEIEIMTRLSGHPNVVDLKAVY--- 111
             V+  +    +  V I        + E ++   + E+   ++LS H N+V   ++    
Sbjct: 25  STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIV---SMIDVD 80

Query: 112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPE 171
           E++D  +LVME   G  L   +E  G  S   A     Q++  + + H++ +VHRD+KP+
Sbjct: 81  EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ 140

Query: 172 NILLATKASSSPIKLADFGLA-----TYIEPGQSLLGTVGSPFYIAPEVLAGGY-NQAAD 225
           NIL+ +  +   +K+ DFG+A     T +     +LGTV    Y +PE   G   ++  D
Sbjct: 141 NILIDSNKT---LKIFDFGIAKALSETSLTQTNHVLGTVQ---YFSPEQAKGEATDECTD 194

Query: 226 VWSAGVILYILLSGMPPFWGNTKSRI-FDAVRTADLRFPSNPWDHISDSAKDLVMGMLST 284
           ++S G++LY +L G PPF G T   I    ++ +     ++    I  S  ++++     
Sbjct: 195 IYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEK 254

Query: 285 DPSQR-LTARQVLD 297
           D + R  T +++ D
Sbjct: 255 DKANRYKTIQEMKD 268

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  138 bits (349), Expect = 8e-37
 Identities = 57/339 (16%), Positives = 112/339 (33%), Gaps = 62/339 (18%)

Query: 41  ERFVLGQQLGWGQ--FGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
             + L   +G G      + +   K TGE    + I  +     +    ++ E+ +    
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFH--RLEKFGRFSEAEARVLFMQLMQVVL 156
           + HPN+V  +A +  ++ + +V    A G              +E     +   +++ + 
Sbjct: 84  N-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--------VGSP 208
           Y H +G VHR +K  +IL++       + L+       +                 V   
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 209 FYIAPEVLA---GGYNQAADVWSAGVILYILLSGMPPF---------------------- 243
            +++PEVL     GY+  +D++S G+    L +G  PF                      
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259

Query: 244 -------------------WGNTKSRIFDAVRTADLRFPSNPWDHI-SDSAKDLVMGMLS 283
                               G + S      R ++   PS+P+    S      V   L 
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319

Query: 284 TDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEW 322
            +P  R +A  +L+HS+     +   +     +      
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPI 358

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  135 bits (342), Expect = 2e-36
 Identities = 58/241 (24%), Positives = 107/241 (44%), Gaps = 25/241 (10%)

Query: 66  GEVFACKSIAKDRLVTI--------DDERSV---KLEIEIMTRLSGHPNVVDLKAVY--- 111
           G+V+  +   ++R+V +         D       + E     RL   P+VV    ++   
Sbjct: 48  GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVV---PIHDFG 103

Query: 112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPE 171
           E +  +++ M L  G +L   L + G  +   A  +  Q+   +   H  G  HRD+KPE
Sbjct: 104 EIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE 163

Query: 172 NILLATKASSSPIKLADFGLATYI-EPGQSLLGTV-GSPFYIAPEVLAGGY-NQAADVWS 228
           NIL++         L DFG+A+   +   + LG   G+ +Y+APE  +  +    AD+++
Sbjct: 164 NILVSADDF---AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYA 220

Query: 229 AGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQ 288
              +LY  L+G PP+ G+  S +   +    +  PS     I  +   ++   ++ +P  
Sbjct: 221 LTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPED 279

Query: 289 R 289
           R
Sbjct: 280 R 280

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  141 bits (357), Expect = 2e-36
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 32/216 (14%)

Query: 91  EIEIMTRLSGHPNVVDLKAVY---EDEDY-----VHLVMELCAGGELFHRLEKFGRFSEA 142
           E + +  +  HP++V    ++   E  D       ++VME   G  L        +   A
Sbjct: 129 ERQFLAEVV-HPSIV---QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVA 182

Query: 143 EARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL 202
           EA    ++++  + Y H IG+V+ DLKPENI+L    +   +KL D G  + I     L 
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINSFGYLY 238

Query: 203 GTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF 262
           GT G   + APE++  G   A D+++ G  L  L   +P   G       D +   D   
Sbjct: 239 GTPG---FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV----DGLPEDDPVL 291

Query: 263 PSNPWDHISDSAKDLVMGMLSTDPSQR-LTARQVLD 297
                    DS   L+   +  DP QR  TA ++  
Sbjct: 292 K------TYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  136 bits (345), Expect = 3e-36
 Identities = 74/324 (22%), Positives = 133/324 (41%), Gaps = 59/324 (18%)

Query: 34  NQISNLRERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLV---------TI 82
            ++  ++  + + + +  G +G   VC+  D   G   A K +               + 
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGA--VCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSF 71

Query: 83  DDERSVKLEIEIMTRLSGHPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFG 137
             +R ++ EI ++     HPN++ L+ +           ++LV EL    +L  ++    
Sbjct: 72  LCKRVLR-EIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDL-AQVIHDQ 127

Query: 138 R--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI 195
           R   S    +     ++  +   HE GVVHRDL P NILL   A ++ I + DF LA   
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLARED 184

Query: 196 EPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK----S 249
               +    V   +Y APE++    G+ +  D+WSAG ++  + +    F G+T     +
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244

Query: 250 RIFDAVRT---ADLRF-----------------PSNPWDHI----SDSAKDLVMGMLSTD 285
           +I + V T    D+                   P+  W  +       A DL+  ML  +
Sbjct: 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304

Query: 286 PSQRLTARQVLDHSWMGDGIQDPE 309
           P +R++  Q L H +  + + DP 
Sbjct: 305 PQRRISTEQALRHPYF-ESLFDPL 327

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  135 bits (343), Expect = 5e-36
 Identities = 70/314 (22%), Positives = 132/314 (42%), Gaps = 54/314 (17%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M  +  
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCV-N 82

Query: 101 HPNVVDLKAV------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V       E+   V++VMEL     L  ++ +           L  Q++  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANL-CQVIQ-MELDHERMSYLLYQMLCG 139

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + +Y APE
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196

Query: 215 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT---ADLRF---- 262
           V+ G GY +  D+WS G I+  ++ G   F G       +++ + + T     ++     
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256

Query: 263 -----------PSNPWDHI----------------SDSAKDLVMGMLSTDPSQRLTARQV 295
                          ++ +                +  A+DL+  ML  D S+R++  + 
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 296 LDHSWMGDGIQDPE 309
           L H ++ +   DP 
Sbjct: 317 LQHPYI-NVWYDPS 329

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  136 bits (344), Expect = 1e-35
 Identities = 70/314 (22%), Positives = 130/314 (41%), Gaps = 54/314 (17%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +R+   + +G G  G++    D       A K +++        +R+ + E+ +M  +  
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCV-N 119

Query: 101 HPNVVDLKAV------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           H N++ L  V       E+   V+LVMEL     L  ++ +           L  Q++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANL-CQVIQ-MELDHERMSYLLYQMLCG 176

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + +Y APE
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233

Query: 215 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT---ADLRF---- 262
           V+ G GY +  D+WS G I+  ++     F G       +++ + + T     ++     
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293

Query: 263 -----------PSNPWDHI----------------SDSAKDLVMGMLSTDPSQRLTARQV 295
                          +  +                +  A+DL+  ML  DP++R++    
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353

Query: 296 LDHSWMGDGIQDPE 309
           L H ++ +   DP 
Sbjct: 354 LQHPYI-NVWYDPA 366

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  133 bits (338), Expect = 2e-35
 Identities = 79/308 (25%), Positives = 134/308 (43%), Gaps = 49/308 (15%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSI-AKDRLVTIDDERSVKLEIEIMTRLS 99
            R+     +G G +G++    D       A K I   +       +R+++ EI+I+ R  
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLR-EIKILLRFR 83

Query: 100 GHPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
            H N++ +  +      E    V++V +L    +L ++L K    S         Q+++ 
Sbjct: 84  -HENIIGINDIIRAPTIEQMKDVYIVQDL-METDL-YKLLKTQHLSNDHICYFLYQILRG 140

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT----VGSPFY 210
           + Y H   V+HRDLKP N+LL    ++  +K+ DFGLA   +P     G     V + +Y
Sbjct: 141 LKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 211 IAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT---ADLR 261
            APE++  + GY ++ D+WS G IL  +LS  P F G       + I   + +    DL 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 262 F----------------PSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                               PW+ +       A DL+  ML+ +P +R+   Q L H ++
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

Query: 302 GDGIQDPE 309
            +   DP 
Sbjct: 318 -EQYYDPS 324

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  134 bits (338), Expect = 2e-35
 Identities = 73/352 (20%), Positives = 137/352 (38%), Gaps = 78/352 (22%)

Query: 42  RFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS- 99
           R++L ++LGWG F  V     D       A K +  D++ T     + + EI+++ R++ 
Sbjct: 20  RYILVRKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVND 74

Query: 100 ---------GHPNVVDLKA--VYEDEDYVH--LVMELCAGGELFHRLEK--FGRFSEAEA 144
                    G  +++ L     ++  + VH  +V E+  G  L   ++K           
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133

Query: 145 RVLFMQLMQVVLYCH-EIGVVHRDLKPENILLATKASS---SPIKLADFGLATYIEPGQS 200
           + +  QL+  + Y H   G++H D+KPEN+L+    S      IK+AD G A + +  + 
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EH 191

Query: 201 LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNT------------ 247
              ++ +  Y +PEVL G  +   AD+WS   +++ L++G   F  +             
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251

Query: 248 -------------------KSRIFD---------AVRTADLRFPSNPWDHISDSA----K 275
                                  F+          ++   L          S        
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSG 327
           D +  ML  DP +R  A  +++H W    ++D   +   ++ D + +  GS 
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPW----LKDTLGMEEIRVPDRELYGSGSD 359

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  132 bits (333), Expect = 4e-35
 Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 39/274 (14%)

Query: 40  RERFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
               + G+ LG G FG  I+V + + TGEV   K + +      + +R+   E+++M  L
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKV-THRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCL 64

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL-- 156
             HPNV+    V   +  ++ + E   GG L   ++        +++  + Q +      
Sbjct: 65  E-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS------MDSQYPWSQRVSFAKDI 117

Query: 157 -----YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE--------------- 196
                Y H + ++HRDL   N L+     +  + +ADFGLA  +                
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV 255
             +     VG+P+++APE++ G  Y++  DV+S G++L  ++  +          +   +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234

Query: 256 RTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQR 289
                     P  +   S   + +     DP +R
Sbjct: 235 NVRGFLDRYCP-PNCPPSFFPITVRCCDLDPEKR 267

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  131 bits (333), Expect = 4e-35
 Identities = 66/253 (26%), Positives = 110/253 (43%), Gaps = 42/253 (16%)

Query: 66  GEVFACKSIAKDRLVTI--------DDERSV---KLEIEIMTRLSGHPNVVDLKAVY--- 111
            EV   + +   R V +         D       + E +    L+ HP +V   AVY   
Sbjct: 26  SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIV---AVYDTG 81

Query: 112 EDED----YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
           E E       ++VME   G  L   +   G  +   A  +     Q + + H+ G++HRD
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 141

Query: 168 LKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTV-GSPFYIAPEVLAGGY-NQ 222
           +KP NI+++   +   +K+ DFG+A  I    + +     V G+  Y++PE   G   + 
Sbjct: 142 VKPANIMISATNA---VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 198

Query: 223 AADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA------DLRFPSNPWDHISDSAKD 276
            +DV+S G +LY +L+G PPF G++       V  A      D   PS   + +S     
Sbjct: 199 RSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPPSARHEGLSADLDA 252

Query: 277 LVMGMLSTDPSQR 289
           +V+  L+ +P  R
Sbjct: 253 VVLKALAKNPENR 265

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  132 bits (335), Expect = 8e-35
 Identities = 86/343 (25%), Positives = 145/343 (42%), Gaps = 80/343 (23%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           ++  ++ L ++LG G +G+  V    D+ TGEV A K I      + D +R+ + EI I+
Sbjct: 6   HVLRKYELVKKLGKGAYGI--VWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMIL 62

Query: 96  TRLSGHPNVVDLKAVYEDEDY--VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           T LSGH N+V+L  V   ++   V+LV +     +L H + +         + +  QL++
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL-HAVIRANILEPVHKQYVVYQLIK 120

Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF---- 209
           V+ Y H  G++HRD+KP NILL    +   +K+ADFGL+      + +   +        
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 210 ------------------YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTK- 248
                             Y APE+L G   Y +  D+WS G IL  +L G P F G++  
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237

Query: 249 ---SRIFDAVRT---ADLRFPSN------------------------------------P 266
               RI   +      D+    +                                    P
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297

Query: 267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
               ++ A DL+  +L  +P++R++A   L H ++     +P 
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRISANDALKHPFV-SIFHNPN 339

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  131 bits (331), Expect = 2e-34
 Identities = 91/321 (28%), Positives = 142/321 (44%), Gaps = 61/321 (19%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSI-AKDRLVTIDDERSVKLEIEI 94
           N+   F L   LG G +GV  VCS   K TGE+ A K I   D+   +   R+++ EI+I
Sbjct: 8   NISSDFQLKSLLGEGAYGV--VCSATHKPTGEIVAIKKIEPFDKP--LFALRTLR-EIKI 62

Query: 95  MTRLSGHPNVVDLKAV-----YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           +     H N++ +  +     +E+ + V+++ EL    +L HR+      S+   +    
Sbjct: 63  LKHFK-HENIITIFNIQRPDSFENFNEVYIIQEL-MQTDL-HRVISTQMLSDDHIQYFIY 119

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA--TYIEPGQSLLGTVGS 207
           Q ++ V   H   V+HRDLKP N+L+    S+  +K+ DFGLA         +   T   
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 208 PF---------YIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFWGNTK----SRIF 252
                      Y APEV+  +  Y++A DVWS G IL  L    P F G         IF
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236

Query: 253 DAVRT----ADLRFPSN----------------PWDHI----SDSAKDLVMGMLSTDPSQ 288
             + T     DLR   +                P + +    +    DL+  ML  DP++
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296

Query: 289 RLTARQVLDHSWMGDGIQDPE 309
           R+TA++ L+H ++     DP 
Sbjct: 297 RITAKEALEHPYL-QTYHDPN 316

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  130 bits (329), Expect = 3e-34
 Identities = 69/337 (20%), Positives = 127/337 (37%), Gaps = 82/337 (24%)

Query: 38  NLRERFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSI-AKDRLVTIDDERSVKLEIEIM 95
            L   F++ +++G G FG V+  C      + +A K +    +       RS K+E +I+
Sbjct: 32  LLNNAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYT-----RSAKIEADIL 85

Query: 96  TRLSGHP----NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFM 149
            ++        N+V     +   D++ L+ E   G  L+  + +     F   + ++  +
Sbjct: 86  KKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCI 144

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILL----------------------ATKASSSPIKLA 187
           ++++ + Y  ++ + H DLKPENILL                        +  S+ IKL 
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 188 DFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSG------- 239
           DFG AT+          + +  Y APEV+   G++ ++D+WS G +L  L +G       
Sbjct: 205 DFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 240 --------------MPPFW-----GNTKSRIFDAVRTADLRFPSNPW------------- 267
                           P         T    +       L +P N               
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 268 --DHISDSA-KDLVMGMLSTDPSQRLTARQVLDHSWM 301
               I      D +  +L  DP+ R +  ++L H ++
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  127 bits (322), Expect = 1e-32
 Identities = 78/326 (23%), Positives = 119/326 (36%), Gaps = 73/326 (22%)

Query: 39  LRERFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           +  R+ + + +G G FG V++   D    +  A K +  ++       R    EI I+  
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEH 149

Query: 98  LSGHP-----NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEK--FGRFSEAEARVLFMQ 150
           L         NV+ +   +   +++ +  EL     L+  ++K  F  FS    R     
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFY 210
           ++Q +   H+  ++H DLKPENILL  +   S IK+ DFG + Y    Q +   + S FY
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265

Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSG---------------------MPPFW---- 244
            APEV+ G  Y    D+WS G IL  LL+G                     MP       
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325

Query: 245 GNTKSRIFD------------------------AVRTADLRFP-SNPWDHISDSA----- 274
                                            + R      P S  W +          
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385

Query: 275 KDLVMGMLSTDPSQRLTARQVLDHSW 300
            D +   L  DP+ R+T  Q L H W
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPW 411

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  126 bits (319), Expect = 3e-32
 Identities = 83/403 (20%), Positives = 142/403 (35%), Gaps = 104/403 (25%)

Query: 2   AAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS 61
           +    + S S+   Q  K +       ++   +    + +R+ +   +G G +G   VC 
Sbjct: 14  SGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH--VCE 71

Query: 62  --DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY--- 116
             DK    V A K I +     ID +R ++ EI I+ RL+ H +VV +  +   +D    
Sbjct: 72  AYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLN-HDHVVKVLDIVIPKDVEKF 129

Query: 117 --VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENIL 174
             +++V+E+ A  +           +E   + L   L+  V Y H  G++HRDLKP N L
Sbjct: 130 DELYVVLEI-ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL 188

Query: 175 LATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF------------------------- 209
           +    S   +K+ DFGLA  ++  ++    +                             
Sbjct: 189 VNQDCS---VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245

Query: 210 ---YIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSR-------------- 250
              Y APE++     Y +A DVWS G I   LL+ +         R              
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSP 305

Query: 251 ---------------------IFDAVRT---ADLRF----------------PSNPWDHI 270
                                IF+ + T    D+                          
Sbjct: 306 DQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365

Query: 271 ----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
               S  A  L+  ML  +P++R+T  + L H +    ++  E
Sbjct: 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFF-KEVRIAE 407

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  123 bits (311), Expect = 1e-31
 Identities = 77/334 (23%), Positives = 125/334 (37%), Gaps = 82/334 (24%)

Query: 39  LRERFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSI-AKDRLVTIDDERSVKLEIEIMT 96
             +R+ +   +G G FG V++   D+   E  A K I  K   +        ++E+ ++ 
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFL-----NQAQIEVRLLE 105

Query: 97  RLSGHP-----NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFM 149
            ++ H       +V LK  +   +++ LV E+     L+  L        S    R    
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164

Query: 150 QLMQVVLYCH--EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS 207
           Q+   +L+    E+ ++H DLKPENILL      S IK+ DFG +  +  GQ +   + S
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQL--GQRIYQYIQS 221

Query: 208 PFYIAPEVLAG-GYNQAADVWSAGVILYILLSG---------------------MPPFW- 244
            FY +PEVL G  Y+ A D+WS G IL  + +G                     +PP   
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281

Query: 245 ---GNTKSRIFDAVRTADLRF-------------PSNPWDHISDSA-------------- 274
                   + F+ +                     +    +I                  
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341

Query: 275 --------KDLVMGMLSTDPSQRLTARQVLDHSW 300
                   KDL++ ML  DP  R+     L HS+
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  122 bits (308), Expect = 3e-31
 Identities = 77/330 (23%), Positives = 119/330 (36%), Gaps = 76/330 (23%)

Query: 38  NLRERFVLGQQLGWGQFG-VIRVCSDKFTG-EVFACKSI-AKDRLVTIDDERSVKLEIEI 94
            L+ER+ +   LG G FG V+  C D   G    A K I    +        + +LEI +
Sbjct: 16  WLQERYEIVGNLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYR-----EAARLEINV 69

Query: 95  MTRL-----SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEK--FGRFSEAEARVL 147
           + ++           V +   +    ++ +  EL  G   F  L++  F  +     R +
Sbjct: 70  LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHM 128

Query: 148 FMQLMQVVLYCHEIGVVHRDLKPENILLAT----------------KASSSPIKLADFGL 191
             QL   + + HE  + H DLKPENIL                      ++ I++ADFG 
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 192 ATYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNT--- 247
           AT+    +     V +  Y  PEV+   G+ Q  DVWS G IL+    G   F  +    
Sbjct: 189 ATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

Query: 248 ------------------KSRIFDAVRTADLRFPSNPWDHIS------------------ 271
                             ++R         L +  N  D                     
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306

Query: 272 -DSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
                DL+  ML  DP+QR+T  + L H +
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPF 336

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  121 bits (306), Expect = 4e-31
 Identities = 79/329 (24%), Positives = 120/329 (36%), Gaps = 74/329 (22%)

Query: 38  NLRERFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSI-AKDRLVTIDDERSVKLEIEIM 95
            L  R+ +   LG G FG V+     K  G   A K +   DR        + + EI+++
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-----EAARSEIQVL 65

Query: 96  TRL-----SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLF 148
             L     +     V +   +E   ++ +V EL  G   +  +++ G   F     R + 
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILL----------------ATKASSSPIKLADFGLA 192
            Q+ + V + H   + H DLKPENIL                      +  IK+ DFG A
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 193 TYIEPGQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNT---- 247
           TY    +     V +  Y APEV+   G++Q  DVWS G IL     G   F  +     
Sbjct: 185 TYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242

Query: 248 --------------------KSRIFDAVR----------------TADLRFPSNPWDHIS 271
                               K + F   R                   L+      D   
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
           +   DL+  ML  DP++R+T R+ L H +
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPF 331

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  117 bits (295), Expect = 7e-30
 Identities = 62/298 (20%), Positives = 110/298 (36%), Gaps = 57/298 (19%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM-TRLSGHP 102
            L + +G G++G   V    + GE  A K        +  DE+S   E E+  T +  H 
Sbjct: 11  TLLECVGKGRYG--EVWRGSWQGENVAVKIF------SSRDEKSWFRETELYNTVMLRHE 62

Query: 103 NVV-----DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
           N++     D+ + +       L+      G L+  L+            + + +   + +
Sbjct: 63  NILGFIASDMTSRHSSTQLW-LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAH 120

Query: 158 CHE--------IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GT 204
            H           + HRDLK +NIL+          +AD GLA       + L       
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ---CCIADLGLAVMHSQSTNQLDVGNNPR 177

Query: 205 VGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSG----------MPPFWG-- 245
           VG+  Y+APEVL            +  D+W+ G++L+ +              PPF+   
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237

Query: 246 ---NTKSRIFDAVRTADLR--FPSNPWDHISDSA-KDLVMGMLSTDPSQRLTARQVLD 297
               +   +   V     R   P+  +   + ++   L+      +PS RLTA ++  
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  117 bits (296), Expect = 3e-29
 Identities = 76/360 (21%), Positives = 135/360 (37%), Gaps = 98/360 (27%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCS--DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           ++ + +++   +G G +G   V    DK T +  A K + +     ID +R ++ EI I+
Sbjct: 23  HVPDNYIIKHLIGRGSYGY--VYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITIL 79

Query: 96  TRLSGHPNVVDLKAVYEDEDY-----VHLVMELCAGGELFHRLEKFG-RFSEAEARVLFM 149
            RL     ++ L  +   +D      +++V+E+ A  +L  +L K     +E   + +  
Sbjct: 80  NRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDL-KKLFKTPIFLTEEHIKTILY 136

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPF 209
            L+    + HE G++HRDLKP N LL        +K+ DFGLA  I   +          
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 210 -----------------------YIAPEVL--AGGYNQAADVWSAGVILYILLSGMPPFW 244
                                  Y APE++     Y ++ D+WS G I   LL+ +    
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 245 GNTKSR--------------------------------IFDAVRT---ADLRF------- 262
            +  +R                                IF+ + T    DL+        
Sbjct: 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVI 313

Query: 263 ---------PSNPWDHI----SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
                                SD   +L+  ML  +P++R+T  Q LDH ++   ++  +
Sbjct: 314 KYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL-KDVRKKK 372

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  115 bits (289), Expect = 9e-29
 Identities = 65/297 (21%), Positives = 111/297 (37%), Gaps = 55/297 (18%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM-TRLSGHP 102
           VL + +G G+FG   V   K+ GE  A K  +        +ERS   E EI  T +  H 
Sbjct: 45  VLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHE 96

Query: 103 NVVDLKAVYEDEDYVH----LVMELCAGGELFHRLEKFGRFSEAEARVLFMQL------- 151
           N++   A    ++       LV +    G LF  L +    +      L +         
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHL 155

Query: 152 -MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
            M++V    +  + HRDLK +NIL+    +     +AD GLA   +     +       V
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 206 GSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSG----------MPPFWGNTK 248
           G+  Y+APEVL            + AD+++ G++ + +               P++    
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272

Query: 249 SR-----IFDAVRTADLR--FPSNPWDHISDSA-KDLVMGMLSTDPSQRLTARQVLD 297
           S      +   V    LR   P+      +      ++      + + RLTA ++  
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  113 bits (285), Expect = 5e-28
 Identities = 74/306 (24%), Positives = 122/306 (39%), Gaps = 38/306 (12%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
            S       +     +R     + +L+        E  VLG+Q+G G FG   V S +  
Sbjct: 86  LSTQQPLTKKSGVVLHRAVPKDKWVLN-------HEDLVLGEQIGRGNFGE--VFSGRLR 136

Query: 66  GEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMEL 123
            +    A KS  +   +  D +     E  I+ + S HPN+V L  V   +  +++VMEL
Sbjct: 137 ADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMEL 193

Query: 124 CAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLA 176
             GG+    L   G       R+    L+Q+V        Y      +HRDL   N L+ 
Sbjct: 194 VQGGDFLTFLRTEGA------RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV- 246

Query: 177 TKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---APEVLAGG-YNQAADVWSAGVI 232
                + +K++DFG++     G            +   APE L  G Y+  +DVWS G++
Sbjct: 247 --TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304

Query: 233 LY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT 291
           L+     G  P+   +  +  + V     R P  P +   D+   L+    + +P QR +
Sbjct: 305 LWETFSLGASPYPNLSNQQTREFVE-KGGRLPC-P-ELCPDAVFRLMEQCWAYEPGQRPS 361

Query: 292 ARQVLD 297
              +  
Sbjct: 362 FSTIYQ 367

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  112 bits (281), Expect = 1e-27
 Identities = 65/297 (21%), Positives = 104/297 (35%), Gaps = 55/297 (18%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM-TRLSGHP 102
            + +Q+G G++G   V   K+ GE  A K           +E S   E EI  T L  H 
Sbjct: 40  QMVKQIGKGRYG--EVWMGKWRGEKVAVKVF------FTTEEASWFRETEIYQTVLMRHE 91

Query: 103 NVVDLKAVYEDEDYVH----LVMELCAGGELFHRLEKFGRFSEAEARVLFMQL------- 151
           N++   A             L+ +    G L+  L K           L           
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHL 150

Query: 152 -MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTV 205
             ++     +  + HRDLK +NIL+    +     +AD GLA       + +       V
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 206 GSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSG----------MPPFWG--- 245
           G+  Y+ PEVL              AD++S G+IL+ +               P+     
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 246 --NTKSRIFDAVRTADLR--FPSNPWDHISDSA-KDLVMGMLSTDPSQRLTARQVLD 297
              +   + + V    LR  FP+             L+    + +P+ RLTA +V  
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  109 bits (276), Expect = 1e-27
 Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 36/233 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVF-ACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFGV  V   K+ G+   A K I +    ++ ++   + E + M +L
Sbjct: 7   REEITLLKELGSGQFGV--VKLGKWKGQYDVAVKMIKEG---SMSEDEFFQ-EAQTMMKL 60

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
           S HP +V    V   E  +++V E  + G L + L   G+          ++  Q++  C
Sbjct: 61  S-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---------GLEPSQLLEMC 110

Query: 159 HEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP 208
           +++            +HRDL   N L+        +K++DFG+  Y+      + +VG+ 
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVL-DDQYVSSVGTK 166

Query: 209 FYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
           F +   APEV     Y+  +DVW+ G++++ + S G  P+   T S +   V 
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  110 bits (276), Expect = 2e-27
 Identities = 39/257 (15%), Positives = 62/257 (24%), Gaps = 40/257 (15%)

Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
              R+ L    G           D       A   +    ++  D  +        ++R+
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 99  SGHPNVVDLKAVY---EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
              P V     V           +V E   GG L    +     S   A      L    
Sbjct: 89  D-KPGVA---RVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAA 142

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
              H  GV      P  + ++       + LA                       +    
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSI---DGDVVLAYPA-------------------TMPDA- 179

Query: 216 LAGGYNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDAVRTADLRF--PSNPWDHISD 272
                N   D+   G  LY LL    P      +S +  A R    +   P++    I  
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 273 SAKDLVMGMLSTDPSQR 289
               +    +  D   R
Sbjct: 235 QISAVAARSVQGDGGIR 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  110 bits (277), Expect = 2e-27
 Identities = 66/317 (20%), Positives = 111/317 (35%), Gaps = 66/317 (20%)

Query: 25  SLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD 84
                   +  +        L +    G+FG   V   +   E  A K      +  I D
Sbjct: 15  GTENLYFQSMPLQ-------LLEVKARGRFGC--VWKAQLLNEYVAVK------IFPIQD 59

Query: 85  ERS--VKLEIEIMTRLSGHPNVV-----DLKAVYEDEDYVHLVMELCAGGELFHRLEKFG 137
           ++S   + E+  +  +  H N++     + +    D D   L+      G L   L K  
Sbjct: 60  KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVDLW-LITAFHEKGSLSDFL-KAN 116

Query: 138 RFSEAEARVLFMQLMQVVLYCHE----------IGVVHRDLKPENILLATKASSSPIKLA 187
             S  E   +   + + + Y HE            + HRD+K +N+LL  K + +   +A
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLTA-CIA 173

Query: 188 DFGLATYIEPGQSLLGT---VGSPFYIAPEVLAGG------YNQAADVWSAGVILYILLS 238
           DFGLA   E G+S   T   VG+  Y+APEVL G            D+++ G++L+ L S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

Query: 239 GMPPFWGN----------------TKSRIFDAV--RTADLRFPSNPWDHISDSA-KDLVM 279
                 G                 +   + + V  +            H   +   + + 
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293

Query: 280 GMLSTDPSQRLTARQVL 296
                D   RL+A  V 
Sbjct: 294 ECWDHDAEARLSAGCVG 310

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  109 bits (274), Expect = 4e-27
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 22/227 (9%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           R    +  +LG GQ+G   V    +       A K++ +D   T++ E  +K E  +M  
Sbjct: 12  RTDITMKHKLGGGQYGE--VYEGVWKKYSLTVAVKTLKED---TMEVEEFLK-EAAVMKE 65

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL- 156
           +  HPN+V L  V   E   +++ E    G L   L +  R   +   +L+M   Q+   
Sbjct: 66  IK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSA 123

Query: 157 --YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI--- 211
             Y  +   +HRDL   N L+     +  +K+ADFGL+  +  G +     G+ F I   
Sbjct: 124 MEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT 179

Query: 212 APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
           APE LA   ++  +DVW+ GV+L+ + + GM P+ G   S++++ + 
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  107 bits (269), Expect = 1e-26
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 30/230 (13%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVF-ACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
                  Q++G GQFG+  V    +  +   A K+I +     + +E  ++ E E+M +L
Sbjct: 7   PSELTFVQEIGSGQFGL--VHLGYWLNKDKVAIKTIREG---AMSEEDFIE-EAEVMMKL 60

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL-- 156
           S HP +V L  V  ++  + LV E    G L   L                 L+ + L  
Sbjct: 61  S-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDV 113

Query: 157 -----YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
                Y  E  V+HRDL   N L+     +  IK++DFG+  ++        + G+ F +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPV 169

Query: 212 ---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
              +PEV +   Y+  +DVWS GV+++ + S G  P+   + S + + + 
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  107 bits (270), Expect = 1e-26
 Identities = 64/253 (25%), Positives = 110/253 (43%), Gaps = 32/253 (12%)

Query: 17  PCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVF-ACKSIA 75
           P       S A     + +I    +     ++LG GQFGV  V   K+ G+   A K I 
Sbjct: 2   PLGSKNAPSTAGLGYGSWEID--PKDLTFLKELGTGQFGV--VKYGKWRGQYDVAIKMIK 57

Query: 76  KDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEK 135
           +    ++ ++  ++ E ++M  LS H  +V L  V   +  + ++ E  A G L + L  
Sbjct: 58  EG---SMSEDEFIE-EAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR- 111

Query: 136 FGRFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLAD 188
                E   R    QL+++         Y      +HRDL   N L+        +K++D
Sbjct: 112 -----EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSD 163

Query: 189 FGLATYIEPGQSLLGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPF 243
           FGL+ Y+        +VGS F +    PEVL    ++  +D+W+ GV+++ + S G  P+
Sbjct: 164 FGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

Query: 244 WGNTKSRIFDAVR 256
              T S   + + 
Sbjct: 223 ERFTNSETAEHIA 235

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  106 bits (267), Expect = 3e-26
 Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 40/233 (17%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            +   L Q +G G+FG   V    + G   A K I  D        ++   E  +MT+L 
Sbjct: 20  MKELKLLQTIGKGEFGD--VMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLR 72

Query: 100 GHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
            H N+V L  V  E++  +++V E  A G L   L   GR          +    ++ + 
Sbjct: 73  -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--------SVLGGDCLLKFS 123

Query: 159 HEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP 208
            ++            VHRDL   N+L+   +  +  K++DFGL       Q         
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD-----TGK 175

Query: 209 FYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
             +   APE L    ++  +DVWS G++L+ + S G  P+       +   V 
Sbjct: 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  109 bits (275), Expect = 3e-26
 Identities = 60/226 (26%), Positives = 92/226 (40%), Gaps = 26/226 (11%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            +   L Q +G G+FG   V    + G   A K I  D        ++   E  +MT+L 
Sbjct: 192 MKELKLLQTIGKGEFGD--VMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLR 244

Query: 100 GHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV--- 155
            H N+V L  V  E++  +++V E  A G L   L   GR       +L    + V    
Sbjct: 245 -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAM 302

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---A 212
            Y      VHRDL   N+L+   +  +  K++DFGL       Q           +   A
Sbjct: 303 EYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTA 354

Query: 213 PEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
           PE L    ++  +DVWS G++L+ + S G  P+       +   V 
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  106 bits (267), Expect = 4e-26
 Identities = 62/239 (25%), Positives = 89/239 (37%), Gaps = 25/239 (10%)

Query: 40  RERFVLGQQLGWGQFGVIRVC------SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
            +   L ++LG G FGV  V           T  V A K +  D L   +       E+ 
Sbjct: 17  EKDLRLLEKLGDGSFGV--VRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVN 73

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
            M  L  H N++ L  V      + +V EL   G L  RL K            +    Q
Sbjct: 74  AMHSLD-HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--Q 129

Query: 154 VVL---YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL-LGTVGSPF 209
           V     Y      +HRDL   N+LL   A+   +K+ DFGL   +       +       
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 210 YI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
                APE L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (268), Expect = 6e-26
 Identities = 67/299 (22%), Positives = 107/299 (35%), Gaps = 56/299 (18%)

Query: 40  RERFVLGQQLGWGQFGVIRVC-------SDKFTGEVFACKSIAKDRLVTIDDERSVKL-E 91
              F   + LG G FG   V         +K    V A K + +    T        L E
Sbjct: 14  ETEFKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPV-AIKELREA---TSPKANKEILDE 67

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQ 150
             +M  +  +P+V  L  +      V L+ +L   G L   + +                
Sbjct: 68  AYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG---------- 115

Query: 151 LMQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS 200
              ++ +C +I           +VHRDL   N+L+ T      +K+ DFGLA  +   + 
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEK 172

Query: 201 LLGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
                G    I   A E +    Y   +DVWS GV ++ L++ G  P+ G   S I   +
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

Query: 256 RTADLRFPSNPWDHISDSAKDLVMGML---STDPSQRLTARQVLDHSWMGDGIQDPEKL 311
              + R P  P         D+ M M      D   R   R+++         +DP++ 
Sbjct: 233 EKGE-RLPQ-P----PICTIDVYMIMRKCWMIDADSRPKFRELIIE--FSKMARDPQRY 283

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  109 bits (273), Expect = 7e-26
 Identities = 63/251 (25%), Positives = 114/251 (45%), Gaps = 22/251 (8%)

Query: 15  RQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVF--ACK 72
             P       ++     + ++    R    +  +LG GQ+G   V    +       A K
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGE--VYEGVWKKYSLTVAVK 251

Query: 73  SIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR 132
           ++ +D   T++ E  +K E  +M  +  HPN+V L  V   E   +++ E    G L   
Sbjct: 252 TLKED---TMEVEEFLK-EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 306

Query: 133 LEKFGRFSEAEARVLFMQLMQVV---LYCHEIGVVHRDLKPENILLATKASSSPIKLADF 189
           L +  R   +   +L+M   Q+     Y  +   +HR+L   N L+     +  +K+ADF
Sbjct: 307 LRECNRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADF 362

Query: 190 GLATYIEPGQSLLGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFW 244
           GL+  +  G +     G+ F I   APE LA   ++  +DVW+ GV+L+ + + GM P+ 
Sbjct: 363 GLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421

Query: 245 GNTKSRIFDAV 255
           G   S++++ +
Sbjct: 422 GIDLSQVYELL 432

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  107 bits (268), Expect = 1e-25
 Identities = 72/377 (19%), Positives = 117/377 (31%), Gaps = 128/377 (33%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFA---CKSIAKDRLVTIDDERSVKLEIEI 94
               R+ + ++LGWG F  + +  D    +  A    KS             +   EI +
Sbjct: 34  LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-------ETALDEIRL 86

Query: 95  MTRLS-------GHPNVVDLKAVYEDEDY-----VH--LVMELCAGGELFHRLEKF--GR 138
           +  +            VV L    +D         H  +V E+  G  L   + K     
Sbjct: 87  LKSVRNSDPNDPNREMVVQL---LDDFKISGVNGTHICMVFEV-LGHHLLKWIIKSNYQG 142

Query: 139 FSEAEARVLFMQLMQVVLYCH-EIGVVHRDLKPENILLA--------------------- 176
                 + +  Q++Q + Y H +  ++H D+KPENILL+                     
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202

Query: 177 -------------------------TKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
                                      A    +K+AD G A +    +     + +  Y 
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYR 260

Query: 212 APEVLAG-GYNQAADVWSAGVILYILLSG----------------------------MPP 242
           + EVL G GYN  AD+WS   + + L +G                            +P 
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR 320

Query: 243 FW---GNTKSRIFDAVRTADLRFPSN--PWDHIS-------------DSAKDLVMGMLST 284
                G      F   +  DL+  +   PW                     D ++ ML  
Sbjct: 321 KLIVAGKYSKEFFT--KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378

Query: 285 DPSQRLTARQVLDHSWM 301
            P +R TA + L H W+
Sbjct: 379 IPEKRATAAECLRHPWL 395

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  104 bits (261), Expect = 2e-25
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 22/226 (9%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVF-ACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    + G    A KS+ +    ++  +  +  E  +M +L
Sbjct: 12  RETLKLVERLGAGQFGE--VWMGYYNGHTKVAVKSLKQG---SMSPDAFLA-EANLMKQL 65

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV--- 155
             H  +V L AV   E  ++++ E    G L   L+          ++L M   Q+    
Sbjct: 66  Q-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAEGM 122

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---A 212
            +  E   +HRDL+  NIL+   + +   K+ADFGLA  IE         G+ F I   A
Sbjct: 123 AFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTA 178

Query: 213 PEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
           PE +  G +   +DVWS G++L  +++ G  P+ G T   +   + 
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  107 bits (268), Expect = 2e-25
 Identities = 68/251 (27%), Positives = 109/251 (43%), Gaps = 21/251 (8%)

Query: 13  PSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACK 72
                C   + ++      D  +I   RE   L  +LG G FG + + +   T  V A K
Sbjct: 159 RLTTVCPTSKPQTQGLA-KDAWEIP--RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIK 214

Query: 73  SIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHR 132
           ++      T+  E  ++ E ++M +L  H  +V L AV   E+ +++V E  + G L   
Sbjct: 215 TLKPG---TMSPEAFLQ-EAQVMKKLR-HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDF 268

Query: 133 LEKFGRFSEAEARVLFMQLMQVV---LYCHEIGVVHRDLKPENILLATKASSSPIKLADF 189
           L+          +++ M   Q+     Y   +  VHRDL+  NIL+     +   K+ADF
Sbjct: 269 LKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADF 324

Query: 190 GLATYIEPGQSLLGTVGS-PF-YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWG 245
           GLA  IE  +         P  + APE    G +   +DVWS G++L  L + G  P+ G
Sbjct: 325 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384

Query: 246 NTKSRIFDAVR 256
                + D V 
Sbjct: 385 MVNREVLDQVE 395

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  102 bits (257), Expect = 1e-24
 Identities = 79/299 (26%), Positives = 122/299 (40%), Gaps = 55/299 (18%)

Query: 40  RERFVLGQQLGWGQFGVIRVC------SDKFTGEVFACKSIAKDRLVTIDDERSVKL-EI 92
             R  + + +G G  G   VC        +    V A K++        + +R   L E 
Sbjct: 48  ASRIHIEKIIGSGDSGE--VCYGRLRVPGQRDVPV-AIKALKAG---YTERQRRDFLSEA 101

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQL 151
            IM +   HPN++ L+ V        +V E    G L   L    G+F+          +
Sbjct: 102 SIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT----------I 150

Query: 152 MQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
           MQ+V     +          G VHRDL   N+L+    S+   K++DFGL+  +E     
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDA 207

Query: 202 -LGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
              T G    I   APE +A   ++ A+DVWS GV+++ +L+ G  P+W  T   +  +V
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

Query: 256 RTADLRFPSNPWDHISDSAKDLVMGMLST---DPSQRLTARQVLDHSWMGDGIQDPEKL 311
                R P+ P      +   L   ML     D +QR    Q+   S +   I+ PE L
Sbjct: 268 -EEGYRLPA-P-MGCPHALHQL---MLDCWHKDRAQRPRFSQI--VSVLDALIRSPESL 318

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  102 bits (257), Expect = 1e-24
 Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 43/240 (17%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVF------ACKSIAKDRLVTIDDERSVKL-EI 92
                  + +G G+FG   V                A K++        + +R   L E 
Sbjct: 43  PSCVTRQKVIGAGEFGE--VYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEA 97

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQL 151
            IM + S H N++ L+ V      + ++ E    G L   L +  G FS          +
Sbjct: 98  GIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS----------V 146

Query: 152 MQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
           +Q+V     I            VHRDL   NIL+    S+   K++DFGL+  +E     
Sbjct: 147 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEA 203

Query: 202 L-GTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
              T G    I   APE ++   +  A+DVWS G++++ +++ G  P+W  +   +  A+
Sbjct: 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  102 bits (257), Expect = 2e-24
 Identities = 63/260 (24%), Positives = 106/260 (40%), Gaps = 34/260 (13%)

Query: 20  CYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKS 73
            Y       +I D  ++   R+   L + LG G FG      V  + +D    +V A K+
Sbjct: 11  NYCFAGKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKT 67

Query: 74  IAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL 133
           + +    +  DE    +E  I+++ + H N+V    V        ++MEL AGG+L   L
Sbjct: 68  LPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL 124

Query: 134 EKFGRFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKL 186
            +        + +  + L+ V         Y  E   +HRD+   N LL         K+
Sbjct: 125 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184

Query: 187 ADFGLA-------TYIEPGQSLLGTVGSPF-YIAPEVLA-GGYNQAADVWSAGVILYILL 237
            DFG+A        Y + G ++L     P  ++ PE    G +    D WS GV+L+ + 
Sbjct: 185 GDFGMARDIYRASYYRKGGCAML-----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

Query: 238 S-GMPPFWGNTKSRIFDAVR 256
           S G  P+   +   + + V 
Sbjct: 240 SLGYMPYPSKSNQEVLEFVT 259

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (255), Expect = 2e-24
 Identities = 65/251 (25%), Positives = 96/251 (38%), Gaps = 47/251 (18%)

Query: 40  RERFVLGQQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
                  QQLG G FG + +C        TGEV A K +      T +  R  + EIEI+
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEIL 65

Query: 96  TRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
             L  H N+V  K V        + L+ME    G L   L+K       + R+  ++L+Q
Sbjct: 66  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------HKERIDHIKLLQ 118

Query: 154 VVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL-LGTV 205
                     Y      +HRDL   NIL+  +     +K+ DFGL   +   +       
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEFFKVKE 175

Query: 206 GSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS----------------GMPPFWG 245
                I   APE L    ++ A+DVWS GV+LY L +                G      
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235

Query: 246 NTKSRIFDAVR 256
                + + ++
Sbjct: 236 MIVFHLIELLK 246

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  102 bits (256), Expect = 2e-24
 Identities = 61/327 (18%), Positives = 104/327 (31%), Gaps = 75/327 (22%)

Query: 25  SLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD 84
           + +E  LD + +        L + +G G++G   V          A K      + +  +
Sbjct: 4   AASEPSLDLDNLK-------LLELIGRGRYG--AVYKGSLDERPVAVK------VFSFAN 48

Query: 85  ERSVKLEIEIM-TRLSGHPNVV-----DLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR 138
            ++   E  I    L  H N+      D +   +      LVME    G L   L     
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HT 107

Query: 139 FSEAEARVLFMQLMQVVLYCHE---------IGVVHRDLKPENILLATKASSSPIKLADF 189
                +  L   + + + Y H            + HRDL   N+L+    +     ++DF
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT---CVISDF 164

Query: 190 GLATYIEPGQSLL---------GTVGSPFYIAPEVLAGGYN--------QAADVWSAGVI 232
           GL+  +   + +            VG+  Y+APEVL G  N        +  D+++ G+I
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224

Query: 233 LYILLSG-------------MPPFWGN-----TKSRIFDAVRTADLRFPSNPWDHISDSA 274
            + +                   F        T   +   V     R P  P     +S 
Sbjct: 225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR-PKFPEAWKENSL 283

Query: 275 KDLVMGML-----STDPSQRLTARQVL 296
               +          D   RLTA+   
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAE 310

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  101 bits (254), Expect = 2e-24
 Identities = 48/248 (19%), Positives = 80/248 (32%), Gaps = 53/248 (21%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVF-------ACKSIAKDRLVTIDDERSVKLEI 92
            E  +  + LG G F  I     +  G+           K + K      +   S     
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAA 63

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
            +M++LS H ++V    V    D   LV E    G L   L+K             + ++
Sbjct: 64  SMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---------CINIL 113

Query: 153 QVVLYCHEI----------GVVHRDLKPENILLATKASSSP-----IKLADFGLATYIEP 197
             +    ++           ++H ++  +NILL  +          IKL+D G++  + P
Sbjct: 114 WKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173

Query: 198 GQSLLGTVGSPFY------IAPEVLA--GGYNQAADVWSAGVILYILLS-GMPPFWGNTK 248
                              + PE +      N A D WS G  L+ + S G  P      
Sbjct: 174 KD---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224

Query: 249 SRIFDAVR 256
            R      
Sbjct: 225 QRKLQFYE 232

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  104 bits (262), Expect = 3e-24
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 18/224 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++      T+  E  ++ E ++M +L 
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG---TMSPEAFLQ-EAQVMKKLR 320

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV---L 156
            H  +V L AV   E+ +++V E  + G L   L+          +++ M   Q+     
Sbjct: 321 -HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMA 377

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGS-PF-YIAPE 214
           Y   +  VHRDL+  NIL+     +   K+ADFGLA  IE  +         P  + APE
Sbjct: 378 YVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434

Query: 215 VLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
               G +   +DVWS G++L  L + G  P+ G     + D V 
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (255), Expect = 3e-24
 Identities = 65/251 (25%), Positives = 96/251 (38%), Gaps = 47/251 (18%)

Query: 40  RERFVLGQQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
                  QQLG G FG + +C        TGEV A K +      T +  R  + EIEI+
Sbjct: 40  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEIL 96

Query: 96  TRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
             L  H N+V  K V        + L+ME    G L   L+K       + R+  ++L+Q
Sbjct: 97  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------HKERIDHIKLLQ 149

Query: 154 VVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL-LGTV 205
                     Y      +HRDL   NIL+  +     +K+ DFGL   +   +       
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEYYKVKE 206

Query: 206 GSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS----------------GMPPFWG 245
                I   APE L    ++ A+DVWS GV+LY L +                G      
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266

Query: 246 NTKSRIFDAVR 256
                + + ++
Sbjct: 267 MIVFHLIELLK 277

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  104 bits (260), Expect = 3e-24
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 22/226 (9%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVF-ACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           RE   L ++LG GQFG   V    +      A K++      ++  E  +  E  +M  L
Sbjct: 187 RESLKLEKKLGAGQFGE--VWMATYNKHTKVAVKTMKPG---SMSVEAFLA-EANVMKTL 240

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV--- 155
             H  +V L AV   ++ ++++ E  A G L   L+      +   +++     Q+    
Sbjct: 241 Q-HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGM 297

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---A 212
            +  +   +HRDL+  NIL+   ++S   K+ADFGLA  IE         G+ F I   A
Sbjct: 298 AFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTA 353

Query: 213 PEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
           PE +  G +   +DVWS G++L  +++ G  P+ G +   +  A+ 
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  102 bits (256), Expect = 4e-24
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 44/241 (18%)

Query: 40  RERFVLGQQLGWGQFGVIRVCS------DKFTGEVFACKSIAKDRLVTIDDERSVKL-EI 92
                + + +G G+FG   VCS       K    V A K++        + +R   L E 
Sbjct: 44  ATNISIDKVVGAGEFGE--VCSGRLKLPSKKEISV-AIKTLKVG---YTEKQRRDFLGEA 97

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQL 151
            IM +   HPN++ L+ V      V +V E    G L   L K   +F+          +
Sbjct: 98  SIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT----------V 146

Query: 152 MQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
           +Q+V     I          G VHRDL   NIL+    S+   K++DFGL   +E     
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEA 203

Query: 202 -LGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
              T G    I   +PE +A   +  A+DVWS G++L+ ++S G  P+W  +   +  AV
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

Query: 256 R 256
            
Sbjct: 264 D 264

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  101 bits (253), Expect = 6e-24
 Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 32/228 (14%)

Query: 40  RERFVLGQQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
                   QLG G FG + +C        TG + A K +        D +R  + EI+I+
Sbjct: 22  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQIL 78

Query: 96  TRLSGHPNVVDLKAV--YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
             L     +V  + V        + LVME    G L   L++        AR+   +L+ 
Sbjct: 79  KALH-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRLLL 131

Query: 154 VVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS--LLGT 204
                     Y      VHRDL   NIL+ ++A    +K+ADFGLA  +   +   ++  
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKDYYVVRE 188

Query: 205 VG-SP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTK 248
            G SP F+ APE L+   +++ +DVWS GV+LY L +        + +
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  100 bits (251), Expect = 6e-24
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 29/233 (12%)

Query: 40  RERFVL-GQQLGWGQFGVIRVCSDKFTGEVF----ACKSIAKDRLVTIDDERSVKL--EI 92
           R+   L  ++LG G FG   V    +  +      A K +  +     D     +L  E 
Sbjct: 15  RKLLTLEDKELGSGNFGT--VKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEA 69

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
            +M +L  +P +V +  + E E    LVME+   G L   L++     +     +   + 
Sbjct: 70  NVMQQLD-NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVH 124

Query: 153 QVVL---YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL-LGTVGSP 208
           QV +   Y  E   VHRDL   N+LL T+      K++DFGL+  +   ++         
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGK 181

Query: 209 FYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
           + +   APE +    ++  +DVWS GV+++   S G  P+ G   S +   + 
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  100 bits (251), Expect = 9e-24
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 25/231 (10%)

Query: 40  RERFVLGQQLGWGQFG-----VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
                  + LG G FG     V     +     V   K I +D+      +      +  
Sbjct: 12  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPV-CIKVI-EDKSGRQSFQAVTD-HMLA 68

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQ 153
           +  L  H ++V L  +      + LV +    G L   + +  G       ++L    +Q
Sbjct: 69  IGSLD-HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALG---PQLLLNWGVQ 123

Query: 154 VVL---YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFY 210
           +     Y  E G+VHR+L   N+LL    S S +++ADFG+A  + P    L    +   
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 211 I---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
           I   A E +  G Y   +DVWS GV ++ L++ G  P+ G   + + D + 
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 70/238 (29%), Positives = 104/238 (43%), Gaps = 41/238 (17%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVF-----ACKSIAKDRLVTIDDERSVKL-EIE 93
           RE  VL + LG G FG   V    +T         A K+  KD      D +   + E  
Sbjct: 11  REDVVLNRILGEGFFGE--VYEGVYTNHKGEKINVAVKTCKKD---CTLDNKEKFMSEAV 65

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           IM  L  HP++V L  + E+E    ++MEL   GEL H LE+             ++++ 
Sbjct: 66  IMKNLD-HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKN---------SLKVLT 114

Query: 154 VVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG 203
           +VLY  +I            VHRD+   NIL+   AS   +KL DFGL+ YIE  +    
Sbjct: 115 LVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYIE-DEDYYK 170

Query: 204 TVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
              +   I   +PE +    +  A+DVW   V ++ +LS G  PF+      +   + 
Sbjct: 171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 66/291 (22%), Positives = 108/291 (37%), Gaps = 40/291 (13%)

Query: 40  RERFVLGQQLGWGQFGVIRVC-------SDKFTGEVFACKSIAKDRLVTIDDERSVKL-E 91
              F   + LG G FG   V         +K    V A K + +    T        L E
Sbjct: 14  ETEFKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPV-AIKELREA---TSPKANKEILDE 67

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
             +M  +  +P+V  L  +      V L+ +L   G L   + +      ++  + +   
Sbjct: 68  AYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV- 124

Query: 152 MQVVL---YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP 208
            Q+     Y  +  +VHRDL   N+L+    +   +K+ DFGLA  +   +      G  
Sbjct: 125 -QIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180

Query: 209 FYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP 263
             I   A E +    Y   +DVWS GV ++ L++ G  P+ G   S I   +     R P
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLP 239

Query: 264 SNPWDHISDSAKDLVMGML---STDPSQRLTARQVLDHSWMGDGIQDPEKL 311
             P         D+ M M+     D   R   R++          +DP++ 
Sbjct: 240 QPP-----ICTIDVYMIMVKCWMIDADSRPKFREL--IIEFSKMARDPQRY 283

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 63/244 (25%), Positives = 107/244 (43%), Gaps = 37/244 (15%)

Query: 40  RERFVLGQQLGWGQFGVI---RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
                    +G G FG +   R+  D    +  A K + +    + DD R    E+E++ 
Sbjct: 24  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEY--ASKDDHRDFAGELEVLC 80

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHR----LEKFGRFSEAEARVLFMQ 150
           +L  HPN+++L    E   Y++L +E    G L  F R    LE    F+ A +    + 
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 151 LMQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLA----TYIE 196
             Q++ +  ++            +HRDL   NIL+     +   K+ADFGL+     Y++
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVK 197

Query: 197 PGQSLLGTVGSPF-YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
                L     P  ++A E L    Y   +DVWS GV+L+ I+  G  P+ G T + +++
Sbjct: 198 KTMGRL-----PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252

Query: 254 AVRT 257
            +  
Sbjct: 253 KLPQ 256

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  100 bits (250), Expect = 2e-23
 Identities = 61/262 (23%), Positives = 101/262 (38%), Gaps = 40/262 (15%)

Query: 21  YRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV 80
           Y       +I D  ++   R+   L + LG G FG   V      G+V    +      V
Sbjct: 53  YCFAGKTSSISDLKEVP--RKNITLIRGLGHGAFG--EVYE----GQVSGMPNDPSPLQV 104

Query: 81  ---------TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFH 131
                    +  DE    +E  I+++ + H N+V    V        +++EL AGG+L  
Sbjct: 105 AVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKS 163

Query: 132 RLEKFGRFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPI 184
            L +        + +  + L+ V         Y  E   +HRD+   N LL         
Sbjct: 164 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223

Query: 185 KLADFGLA-------TYIEPGQSLLGTVGSPF-YIAPEVLA-GGYNQAADVWSAGVILYI 235
           K+ DFG+A        Y + G ++L     P  ++ PE    G +    D WS GV+L+ 
Sbjct: 224 KIGDFGMARDIYRAGYYRKGGCAML-----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278

Query: 236 LLS-GMPPFWGNTKSRIFDAVR 256
           + S G  P+   +   + + V 
Sbjct: 279 IFSLGYMPYPSKSNQEVLEFVT 300

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 66/236 (27%), Positives = 98/236 (41%), Gaps = 37/236 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVC------SDKFTGEVFACKSIAKDRLVTIDDERSVKL-EI 92
           RER  LG+ +G GQFG   V        +     V A K+       T D  R   L E 
Sbjct: 14  RERIELGRCIGEGQFGD--VHQGIYMSPENPALAV-AIKTCKNC---TSDSVREKFLQEA 67

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
             M +   HP++V L  V  +   V ++MELC  GEL   L+           +    L+
Sbjct: 68  LTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKY------SLDLASLI 119

Query: 153 QVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTV 205
                      Y      VHRD+   N+L+   +S+  +KL DFGL+ Y+E   +     
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYME-DSTYYKAS 175

Query: 206 GSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
                I   APE +    +  A+DVW  GV ++ +L  G+ PF G   + +   + 
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 18/177 (10%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
            R+ LG+++G G FG I + +D   GE  A K               + +E +I   + G
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQG 63

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCH 159
              +  ++    + DY  +VMEL  G  L        R FS     +L  Q++  + Y H
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLAT-YIEP----------GQSLLGTV 205
               +HRD+KP+N L+      + + + DFGLA  Y +            ++L GT 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 47/261 (18%)

Query: 29  TILDTNQISNLRERFVLGQQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDRLVTIDD 84
           T +D       +      + LG G FG + +C        TGE  A KS+  +     + 
Sbjct: 11  TEVDPTHFE--KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNH 66

Query: 85  ERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY--VHLVMELCAGGELFHRLEKFGRFSEA 142
              +K EIEI+  L  H N+V  K +  ++    + L+ME    G L   L K       
Sbjct: 67  IADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK------N 119

Query: 143 EARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI 195
           + ++   Q ++  +       Y      VHRDL   N+L+ ++     +K+ DFGL   I
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAI 176

Query: 196 EPGQSL-LGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS------------ 238
           E  +            +   APE L    +  A+DVWS GV L+ LL+            
Sbjct: 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236

Query: 239 ---GMPPFWGNTKSRIFDAVR 256
                P     T +R+ + ++
Sbjct: 237 LKMIGPTHGQMTVTRLVNTLK 257

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 27/232 (11%)

Query: 40  RERFVLGQ-QLGWGQFGVIRVC-----SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R+  ++   +LG G FG   V        K   +V A K + +       D   +  E +
Sbjct: 8   RDNLLIADIELGCGNFGS--VRQGVYRMRKKQIDV-AIKVLKQG--TEKADTEEMMREAQ 62

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           IM +L  +P +V L  V + E  + LVME+  GG L   L               +   Q
Sbjct: 63  IMHQLD-NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH--Q 118

Query: 154 VVL---YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL-LGTVGSPF 209
           V +   Y  E   VHRDL   N+LL  +      K++DFGL+  +    S         +
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKW 175

Query: 210 YI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
            +   APE +    ++  +DVWS GV ++  LS G  P+       +   + 
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.2 bits (245), Expect = 5e-23
 Identities = 65/234 (27%), Positives = 95/234 (40%), Gaps = 34/234 (14%)

Query: 23  VRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVC----SDKFTGEVFACKSIAKDR 78
           +  L +   D       +      + LG G FG + +     ++  TGE+ A K++  D 
Sbjct: 15  LEVLFQGPGDPTVFH--KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD- 71

Query: 79  LVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY--VHLVMELCAGGELFHRLEKF 136
                     K EI+I+  L  H +++  K   ED     + LVME    G L   L + 
Sbjct: 72  -AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR- 128

Query: 137 GRFSEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADF 189
                    +   QL+           Y H    +HRDL   N+LL        +K+ DF
Sbjct: 129 -------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDF 178

Query: 190 GLATYIEPGQS---LLGTVGSP-FYIAPEVLA-GGYNQAADVWSAGVILYILLS 238
           GLA  +  G     +     SP F+ APE L    +  A+DVWS GV LY LL+
Sbjct: 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  101 bits (252), Expect = 5e-23
 Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 43/239 (17%)

Query: 40  RERFVLGQQLGWGQFGVIRVC------SDKFTGEVFACKSIAKDRLVTIDDERSVKL-EI 92
           RER  LG+ +G GQFG   V        +     V A K+       T D  R   L E 
Sbjct: 389 RERIELGRCIGEGQFGD--VHQGIYMSPENPAMAV-AIKTCKNC---TSDSVREKFLQEA 442

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQL 151
             M +   HP++V L  V  +   V ++MELC  GEL   L+                 L
Sbjct: 443 LTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLD----------L 490

Query: 152 MQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
             ++LY +++            VHRD+   N+L+++      +KL DFGL+ Y+E     
Sbjct: 491 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYY 547

Query: 202 LGTVG-SPF-YIAPEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
             + G  P  ++APE +    +  A+DVW  GV ++ +L  G+ PF G   + +   + 
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 57/239 (23%), Positives = 93/239 (38%), Gaps = 27/239 (11%)

Query: 40  RERFVLGQQLGWGQFG-VIR-VCSDKFTGEVF-ACKSIAKDRLVTIDDERSVKLEIEIMT 96
            ++F LG+ LG G+FG V       +    V  A K + K  ++   D      E   M 
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMK 80

Query: 97  RLSGHPNVVDLKAV------YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQ 150
               HP+V  L  V              +++     G+L   L    R  E    +    
Sbjct: 81  EFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-SRIGENPFNLPLQT 138

Query: 151 LMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG 203
           L++ ++       Y      +HRDL   N +L   A    + +ADFGL+  I  G     
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQ 195

Query: 204 TVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT 257
              S   +   A E LA   Y   +DVW+ GV ++ +++ G  P+ G   + I++ +  
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 45/252 (17%)

Query: 40  RERFVLGQQLGWGQFGV--------IRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           R++  LG+ LG G FG         I     K    V A K +  D   T  D   +  E
Sbjct: 80  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDD--ATEKDLSDLVSE 136

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHR------LEKFGRFSEAE 143
           +E+M  +  H N+++L      +  +++++E  + G L  + R      +E     +   
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 144 ARVL-FMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA--- 192
              + F  L+           Y      +HRDL   N+L+     ++ +K+ADFGLA   
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDI 253

Query: 193 ----TYIEPGQSLLGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWG 245
                Y +     L     P  ++APE L    Y   +DVWS GV+++ I   G  P+ G
Sbjct: 254 NNIDYYKKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 246 NTKSRIFDAVRT 257
                +F  ++ 
Sbjct: 309 IPVEELFKLLKE 320

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 62/252 (24%), Positives = 101/252 (40%), Gaps = 45/252 (17%)

Query: 40  RERFVLGQQLGWGQFGV--------IRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           R++  LG+ LG G FG         I     K    V A K +  D   T  D   +  E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDD--ATEKDLSDLVSE 90

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHR-------LEKFGRFSEA 142
           +E+M  +  H N+++L      +  +++++E  + G L  + R          +      
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 143 EARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA--- 192
           E ++ F  L+           Y      +HRDL   N+L+        +K+ADFGLA   
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDI 207

Query: 193 ----TYIEPGQSLLGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWG 245
                Y +     L     P  ++APE L    Y   +DVWS GV+++ I   G  P+ G
Sbjct: 208 NNIDYYKKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 246 NTKSRIFDAVRT 257
                +F  ++ 
Sbjct: 263 IPVEELFKLLKE 274

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 20/179 (11%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
             + +G+++G G FGVI   ++    +  A K   +       D   ++ E      L+G
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 64

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCH 159
              + ++    ++  +  LV++L  G  L   L+  GR FS     +   Q++  V   H
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 160 EIGVVHRDLKPENILL--ATKASSSPIKLADFGLAT-YIEP----------GQSLLGTV 205
           E  +V+RD+KP+N L+      +++ I + DFG+   Y +P           ++L GT 
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.1 bits (244), Expect = 5e-22
 Identities = 57/238 (23%), Positives = 94/238 (39%), Gaps = 41/238 (17%)

Query: 40  RERFVLGQ-QLGWGQFGVIRVC-----SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R+  ++   +LG G FG   V        K   +V A K + +       D   +  E +
Sbjct: 334 RDNLLIADIELGCGNFGS--VRQGVYRMRKKQIDV-AIKVLKQG--TEKADTEEMMREAQ 388

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           IM +L  +P +V L  V + E  + LVME+  GG L   L               + +  
Sbjct: 389 IMHQLD-NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---------IPVSN 437

Query: 154 VVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL-L 202
           V    H++            VHR+L   N+LL  +      K++DFGL+  +    S   
Sbjct: 438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADDSYYT 494

Query: 203 GTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAV 255
                 + +   APE +    ++  +DVWS GV ++  LS G  P+       +   +
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 57/239 (23%), Positives = 87/239 (36%), Gaps = 36/239 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVC------SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
                  + +G G FG   V       +D       A KS+ +     I +      E  
Sbjct: 24  SLIVHFNEVIGRGHFG--CVYHGTLLDNDGKKIHC-AVKSLNRI--TDIGEVSQFLTEGI 78

Query: 94  IMTRLSGHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           IM   S HPNV+ L  +    E    +V+     G+L + +                 L+
Sbjct: 79  IMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLI 131

Query: 153 QVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--SLLG 203
              L       Y      VHRDL   N +L        +K+ADFGLA  +   +  S+  
Sbjct: 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEYYSVHN 188

Query: 204 TVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT 257
             G+   +   A E L    +   +DVWS GV+L+ L++ G PP+       I   +  
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 94.6 bits (236), Expect = 9e-22
 Identities = 47/226 (20%), Positives = 79/226 (34%), Gaps = 40/226 (17%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---------TIDDERSVKL 90
           R R   G+ LG G FG  +V         +          V          + +  ++  
Sbjct: 22  RNRLSFGKTLGAGAFG--KV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL-----------FHRLEKFGRF 139
           E+++++ L  H N+V+L           ++ E C  G+L                     
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 140 SEAEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA 192
            + E  +    L+           +      +HRDL   NILL         K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI---TKICDFGLA 192

Query: 193 TYIEPGQSLLGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILY 234
             I+   + +    +   +   APE +    Y   +DVWS G+ L+
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 94.7 bits (236), Expect = 9e-22
 Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 32/241 (13%)

Query: 40  RERFVLGQQLGWGQFGVIRVC------SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           R   +LG+ LG G+FG   V        D  + +V A K++ K    +  +      E  
Sbjct: 33  RNLLILGKILGEGEFG--SVMEGNLKQEDGTSLKV-AVKTM-KLDNSSQREIEEFLSEAA 88

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVH-----LVMELCAGGELFHRLEKFGRFSEAEARVLF 148
            M   S HPNV+ L  V  +          +++     G+L   L  + R       +  
Sbjct: 89  CMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPL 146

Query: 149 MQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL 201
             L++ ++       Y      +HRDL   N +L        + +ADFGL+  I  G   
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYY 203

Query: 202 LGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR 256
                +   +   A E LA   Y   +DVW+ GV ++ + + GM P+ G     ++D + 
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263

Query: 257 T 257
            
Sbjct: 264 H 264

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 62/252 (24%), Positives = 100/252 (39%), Gaps = 45/252 (17%)

Query: 40  RERFVLGQQLGWGQFGV--------IRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE 91
           R+R VLG+ LG G FG         +         +V A K +  D   T  D   +  E
Sbjct: 68  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV-AVKMLKSD--ATEKDLSDLISE 124

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL---------EKFGRFSEA 142
           +E+M  +  H N+++L      +  +++++E  + G L   L           +      
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 143 EARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA--- 192
           E ++    L+           Y      +HRDL   N+L+        +K+ADFGLA   
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLARDI 241

Query: 193 ----TYIEPGQSLLGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWG 245
                Y +     L     P  ++APE L    Y   +DVWS GV+L+ I   G  P+ G
Sbjct: 242 HHIDYYKKTTNGRL-----PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 246 NTKSRIFDAVRT 257
                +F  ++ 
Sbjct: 297 VPVEELFKLLKE 308

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 96.6 bits (240), Expect = 1e-21
 Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 18/177 (10%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
            +F LG+++G G FG I + ++  T E  A K               +  E +I   L G
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKIYRILQG 61

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCH 159
              + +++    + DY  LVM+L  G  L        R  S     +L  Q++  V + H
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLAT-YIEP----------GQSLLGTV 205
               +HRD+KP+N L+     ++ + + DFGLA  Y +            ++L GT 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 46/229 (20%), Positives = 86/229 (37%), Gaps = 38/229 (16%)

Query: 6   QSNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFT 65
             +SS          ++     E  +  +   N   ++VLG+++G G FG+I +      
Sbjct: 5   HHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGN---QWVLGKKIGSGGFGLIYLAFPTNK 61

Query: 66  GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA---------------- 109
            E  A   +  +      +   +  E++   R++    +                     
Sbjct: 62  PEKDARHVVKVEY----QENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117

Query: 110 --VYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRD 167
              ++   Y  +VME   G +L     + G F ++    L ++++ V+ Y HE   VH D
Sbjct: 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGD 176

Query: 168 LKPENILLATKASSSPIKLADFGLAT-YIEPGQ----------SLLGTV 205
           +K  N+LL  K +   + LAD+GL+  Y   G              GT+
Sbjct: 177 IKAANLLLGYK-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI 224

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 20/178 (11%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
            F +G+++G G FG +R+  + +T E  A K +   +         + LE     +L   
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQLGSG 64

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHE 160
             +  +        Y  +V+EL  G  L    +   R FS     ++ +QL+  + Y H 
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 161 IGVVHRDLKPENILLATKASSSP--IKLADFGLAT-YIEP----------GQSLLGTV 205
             +++RD+KPEN L+    + +   I + DF LA  YI+P           +SL GT 
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 37/234 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---------TIDDERSVKL 90
           R     G+ LG G FG  +V         F          V           D++ ++  
Sbjct: 45  RNNLQFGKTLGAGAFG--KV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHR-----LEKFGRFSEAE 143
           E++IM+ L  H N+V+L         V ++ E C  G+L  F R     LE    F+ A 
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 144 ARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
           +      L+           +      +HRD+   N+LL    +    K+ DFGLA  I 
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIM 215

Query: 197 PGQSLLGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWG 245
              + +    +   +   APE +    Y   +DVWS G++L+ I   G+ P+ G
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 60/297 (20%), Positives = 105/297 (35%), Gaps = 63/297 (21%)

Query: 2   AAVGQSNSSSEPSRQPCKCYRVRSLAETILDTNQISNL------RERFVLGQQLGWGQFG 55
            A+G  +S S    +             I +    S+       R   VL  +LG G FG
Sbjct: 1   GAMGSGSSLSPTEGKGSGLQ-----GHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFG 55

Query: 56  VIRVCSDKFTGEVFACKSIAKDRLV--------TIDDERSVKLEIEIMTRLSGHPNVVDL 107
             +V       E           LV        +    +  + E E++T L  H ++V  
Sbjct: 56  --KVFL----AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRF 108

Query: 108 KAVYEDEDYVHLVMELCAGGEL-----FHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI- 161
             V  +   + +V E    G+L      H  +        +     + L Q++    ++ 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 162 ---------GVVHRDLKPENILLATKASSSPIKLADFGLA-------TYIEPGQSLLGTV 205
                      VHRDL   N L+        +K+ DFG++        Y   G+++L   
Sbjct: 169 AGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--- 222

Query: 206 GSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT 257
             P  I    PE +    +   +DVWS GV+L+ + + G  P++  + +   D +  
Sbjct: 223 --P--IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 58/244 (23%), Positives = 96/244 (39%), Gaps = 38/244 (15%)

Query: 40  RERFVLGQQLGWGQFG------VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           RE+  + ++LG G FG         V  D+    V A K++ +    ++ +      E  
Sbjct: 24  REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEA--ASMRERIEFLNEAS 80

Query: 94  IMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           +M       +VV L  V        ++MEL   G+L   L            +    L +
Sbjct: 81  VMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 154 VVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLA-------TYIE 196
           ++    EI            VHRDL   N ++   A    +K+ DFG+         Y +
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 197 PGQSLLGTVGSPF-YIAPEVLA-GGYNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFD 253
            G+ LL     P  +++PE L  G +   +DVWS GV+L+ I      P+ G +  ++  
Sbjct: 197 GGKGLL-----PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251

Query: 254 AVRT 257
            V  
Sbjct: 252 FVME 255

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 50/242 (20%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---------TIDDERSVKL 90
           R+R  LG+ LG G FG  +V       + F     A  R V         T  + R++  
Sbjct: 26  RDRLKLGKPLGRGAFG--QV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDY-VHLVMELCAGGELFHRL------EKFGRFSEAE 143
           E++I+  +  H NVV+L          + +++E C  G L   L          + +  +
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 144 ARVLFMQLMQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIKLADFGLA- 192
               F+ L  ++ Y  ++            +HRDL   NILL   +  + +K+ DFGLA 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLAR 196

Query: 193 ------TYIEPGQSLLGTVGSPF-YIAPEVLAGG-YNQAADVWSAGVILY-ILLSGMPPF 243
                  Y+  G + L     P  ++APE +    Y   +DVWS GV+L+ I   G  P+
Sbjct: 197 DIYKDPDYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

Query: 244 WG 245
            G
Sbjct: 252 PG 253

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 91.6 bits (228), Expect = 9e-21
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 32/237 (13%)

Query: 40  RERFVLGQQLGWGQFG-VIR---VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           R      + +G G FG V     +   +   +  A KS+++     +    +   E  +M
Sbjct: 20  RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRI--TEMQQVEAFLREGLLM 76

Query: 96  TRLSGHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
             L+ HPNV+ L  +    E   H+++     G+L   +    R            L+  
Sbjct: 77  RGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR------NPTVKDLISF 129

Query: 155 VL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--SLLGTV 205
            L       Y  E   VHRDL   N +L     S  +K+ADFGLA  I   +  S+    
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHR 186

Query: 206 GSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT 257
            +   +   A E L    +   +DVWS GV+L+ LL+ G PP+       +   +  
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 54/246 (21%), Positives = 98/246 (39%), Gaps = 39/246 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--------TIDDERSVKLE 91
           R   VL ++LG G FG +      F  E +         LV        T+   +  + E
Sbjct: 14  RRDIVLKRELGEGAFGKV------FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQRE 67

Query: 92  IEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL---------FHRLEKFGRFSEA 142
            E++T L  H ++V    V  D D + +V E    G+L            +   G+  +A
Sbjct: 68  AELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126

Query: 143 EARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI 195
           +  +   Q++ +         Y      VHRDL   N L+    ++  +K+ DFG++  +
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDV 183

Query: 196 EPGQSLLGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSR 250
                      +   I    PE +    +   +DVWS GVIL+ + + G  P++  + + 
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243

Query: 251 IFDAVR 256
           + + + 
Sbjct: 244 VIECIT 249

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 54/248 (21%), Positives = 96/248 (38%), Gaps = 40/248 (16%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI--------DDERSVKL- 90
                  ++LG  +FG  +V      G +F      + + V I           R     
Sbjct: 8   LSAVRFMEELGEDRFG--KVYK----GHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL---------FHRLEKFGRFSE 141
           E  +  RL  HPNVV L  V   +  + ++   C+ G+L            +        
Sbjct: 62  EAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 142 AEARVLFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY 194
            ++ +     + +V        Y     VVH+DL   N+L+  K +   +K++D GL   
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLFRE 177

Query: 195 IEPGQSLLGTVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKS 249
           +           S   I   APE +  G ++  +D+WS GV+L+ + S G+ P+ G +  
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237

Query: 250 RIFDAVRT 257
            + + +R 
Sbjct: 238 DVVEMIRN 245

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 63/260 (24%), Positives = 108/260 (41%), Gaps = 58/260 (22%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---------TIDDERSVKL 90
           R+  VLG+ LG G+FG  +V         F  K  A    V         +  + R +  
Sbjct: 22  RKNLVLGKTLGEGEFG--KV----VKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--F---HRLEKFGRFSEAEAR 145
           E  ++ ++  HP+V+ L      +  + L++E    G L  F    R    G      +R
Sbjct: 76  EFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 146 VLF---------MQLMQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIKL 186
                       + +  ++ +  +I           +VHRDL   NIL+A       +K+
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKI 191

Query: 187 ADFGLA-------TYIEPGQSLLGTVGSPF-YIAPEVLA-GGYNQAADVWSAGVILY-IL 236
           +DFGL+       +Y++  Q  +     P  ++A E L    Y   +DVWS GV+L+ I+
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRI-----PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

Query: 237 LSGMPPFWGNTKSRIFDAVR 256
             G  P+ G    R+F+ ++
Sbjct: 247 TLGGNPYPGIPPERLFNLLK 266

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 56/239 (23%), Positives = 86/239 (35%), Gaps = 36/239 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVC------SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
                  + +G G FG   V       +D       A KS+ +     I +      E  
Sbjct: 88  SLIVHFNEVIGRGHFG--CVYHGTLLDNDGKKIHC-AVKSLNRI--TDIGEVSQFLTEGI 142

Query: 94  IMTRLSGHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           IM   S HPNV+ L  +    E    +V+     G+L + +                 L+
Sbjct: 143 IMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLI 195

Query: 153 QVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG--QSLLG 203
              L       +      VHRDL   N +L        +K+ADFGLA  +      S+  
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSVHN 252

Query: 204 TVGSPFYI---APEVLA-GGYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRT 257
             G+   +   A E L    +   +DVWS GV+L+ L++ G PP+       I   +  
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 58/243 (23%), Positives = 93/243 (38%), Gaps = 46/243 (18%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---------TIDDERSVKL 90
           RE    G+ LG G FG  +V         +          V            +  ++  
Sbjct: 44  RENLEFGKVLGSGAFG--KV----MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS 97

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL---------------FHRLEK 135
           E+++MT+L  H N+V+L         ++L+ E C  G+L                    +
Sbjct: 98  ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157

Query: 136 FGRFSEAEARVL-FMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLA 187
                E +  VL F  L+           +      VHRDL   N+L+        +K+ 
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV---VKIC 214

Query: 188 DFGLATYIEPGQSLLGTVGSPFYI---APEVLAGG-YNQAADVWSAGVILYILLS-GMPP 242
           DFGLA  I    + +    +   +   APE L  G Y   +DVWS G++L+ + S G+ P
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

Query: 243 FWG 245
           + G
Sbjct: 275 YPG 277

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 57/260 (21%), Positives = 91/260 (35%), Gaps = 58/260 (22%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV---------TIDDERSVKL 90
           R      + +G G FG  RV    F              +V         + D +   + 
Sbjct: 46  RNNIEYVRDIGEGAFG--RV----FQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 99

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGEL--F---HRLEKFGRFSEAEAR 145
           E  +M     +PN+V L  V      + L+ E  A G+L  F            S ++  
Sbjct: 100 EAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 146 VL------------FMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKL 186
                           + + +         Y  E   VHRDL   N L+        +K+
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKI 215

Query: 187 ADFGLA-------TYIEPGQSLLGTVGSPF-YIAPEVLA-GGYNQAADVWSAGVILYILL 237
           ADFGL+        Y   G   +     P  ++ PE +    Y   +DVW+ GV+L+ + 
Sbjct: 216 ADFGLSRNIYSADYYKADGNDAI-----PIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

Query: 238 S-GMPPFWGNTKSRIFDAVR 256
           S G+ P++G     +   VR
Sbjct: 271 SYGLQPYYGMAHEEVIYYVR 290

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 35/224 (15%), Positives = 72/224 (32%), Gaps = 37/224 (16%)

Query: 14  SRQPCKCYRVRSLAETILDTNQISNLR-ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACK 72
             +      + +  E +     +++    ++ L         G++   +   T     C 
Sbjct: 14  GTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLT---CD 70

Query: 73  SIAKDRLVTIDDERS---VKLEIEIMTRLSGHPNVVDLKAVY---------------EDE 114
           S  + +  ++  +     +  E     R +    V   K +Y                 +
Sbjct: 71  SGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQD 130

Query: 115 DYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN 172
            Y  LV+    G  L   L+   +   SE     +  +L+  + + HE   VH ++  EN
Sbjct: 131 KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189

Query: 173 ILLATKASSSPIKLADFGLAT-YIEPGQ----------SLLGTV 205
           I +  +   S + LA +G A  Y   G+             G +
Sbjct: 190 IFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDL 232

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 43/231 (18%), Positives = 83/231 (35%), Gaps = 45/231 (19%)

Query: 9   SSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEV 68
           ++    +   K +     A   + T+  +     + +G  +G G FG I      +  ++
Sbjct: 6   AAQAGRQSSAKRHLAEQFAVGEIITDMAAA---AWKVGLPIGQGGFGCI------YLADM 56

Query: 69  FACKSIAKDRLVTIDDERS----VKLEIEIMTRLSGHPNVVDLKAV-------------- 110
            + +S+  D    +  E S    +  E++   R +    +                    
Sbjct: 57  NSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116

Query: 111 ----YEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVH 165
                  + Y  ++M+   G +L    E   + FS      L ++++ ++ Y HE   VH
Sbjct: 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVH 175

Query: 166 RDLKPENILLATKASSSPIKLADFGLAT-YIEPGQ----------SLLGTV 205
            D+K  N+LL  K +   + L D+GLA  Y   G              GT+
Sbjct: 176 GDIKASNLLLNYK-NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI 225

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 32/170 (18%)

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEA----EARV 146
           EI++M +   H N+V+L     D D + LV      G L  RL               R 
Sbjct: 80  EIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMR- 135

Query: 147 LFMQLMQVVL-------YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ 199
                 ++         + HE   +HRD+K  NILL    ++   K++DFGLA   E   
Sbjct: 136 -----CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFA 187

Query: 200 S------LLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPF 243
                  ++GT     Y+APE L G     +D++S GV+L  +++G+P  
Sbjct: 188 QTVMTSRIVGTTA---YMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 66/250 (26%), Positives = 109/250 (43%), Gaps = 36/250 (14%)

Query: 7   SNSSSEPSRQPCKCYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFG-VIR-VCSDKF 64
           +++ S     P + YRV  L +    TN   N   +F++G     G FG V + V  D  
Sbjct: 13  NDALSSSYLVPFESYRV-PLVDLEEATN---NFDHKFLIGH----GVFGKVYKGVLRD-- 62

Query: 65  TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC 124
            G   A K    +           + EIE ++    HP++V L    ++ + + L+ +  
Sbjct: 63  -GAKVALKRRTPESS---QGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYM 117

Query: 125 AGGELFHRLEKFGRFSEAEARVL-FMQLMQVVL-------YCHEIGVVHRDLKPENILLA 176
             G L   L  +G  S+     + + Q +++ +       Y H   ++HRD+K  NILL 
Sbjct: 118 ENGNLKRHL--YG--SDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD 173

Query: 177 TKASSSPIKLADFGLA-TYIEPGQSLLGTV--GSPFYIAPEVLAGGY-NQAADVWSAGVI 232
                   K+ DFG++    E  Q+ L TV  G+  YI PE    G   + +DV+S GV+
Sbjct: 174 ENFVP---KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230

Query: 233 LYILLSGMPP 242
           L+ +L     
Sbjct: 231 LFEVLCARSA 240

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 40/176 (22%)

Query: 91  EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAE------- 143
           E+E+++    H N++ L+          LV    A G +   L    R            
Sbjct: 77  EVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKR 133

Query: 144 -------ARVLFMQLMQVVLYCHE---IGVVHRDLKPENILLATKASSSPIKLADFGLAT 193
                  AR L         Y H+     ++HRD+K  NILL  +  +    + DFGLA 
Sbjct: 134 QRIALGSARGL--------AYLHDHCDPKIIHRDVKAANILLDEEFEA---VVGDFGLAK 182

Query: 194 YIEPGQS-----LLGTVGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLSGMPPF 243
            ++   +     + GT+G   +IAPE L+ G  ++  DV+  GV+L  L++G   F
Sbjct: 183 LMDYKDTHVTTAVRGTIG---HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.7 bits (146), Expect = 2e-10
 Identities = 42/246 (17%), Positives = 75/246 (30%), Gaps = 60/246 (24%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE-----RSVKLEIEI 94
            E+    +++G G FG   V          A K IA +    ++         +  EI I
Sbjct: 19  TEKLQRCEKIGEGVFGE--VFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 95  MTRLSG--------HPNVVDLKAVY------------------------------EDEDY 116
              LS             + L +V+                                +D 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENIL- 174
           + +V+E   GG    ++      S A A+ +  QL   +      +   HRDL   N+L 
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 175 -------LATKASSSPIKLADFGL-ATYIEPGQSLLGTVGSPFY----IAPEVLAGGYNQ 222
                  L    +     +   GL  + I+   S L   G   +    +  ++  G  + 
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDY 255

Query: 223 AADVWS 228
             D++ 
Sbjct: 256 QFDIYR 261

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 34/149 (22%), Positives = 58/149 (38%), Gaps = 12/149 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           R+R  LG+ LG G FG +            T    A K + +    T  + R++  E++I
Sbjct: 21  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKI 78

Query: 95  MTRLSGHPNVVDLKAVYEDEDY-VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           +  +  H NVV+L          + +++E C  G L   L    R    E      +  +
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGAR 134

Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSS 182
                  +G +  DLK     + +  SS+
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSA 163

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 8/94 (8%)

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI---AP 213
           +      +HRDL   NILL   +  + +K+ DFGLA  I      +    +   +   AP
Sbjct: 208 FLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264

Query: 214 EVLAGG-YNQAADVWSAGVILY-ILLSGMPPFWG 245
           E +    Y   +DVWS GV+L+ I   G  P+ G
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 2e-07
 Identities = 59/458 (12%), Positives = 120/458 (26%), Gaps = 170/458 (37%)

Query: 62  DKFTGEV-FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV 120
           D  TGE  +  K I         D    K +++ M +           ++   E+  H++
Sbjct: 8   DFETGEHQYQYKDILSVFEDAFVDNFDCK-DVQDMPK-----------SILSKEEIDHII 55

Query: 121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS 180
           M           +             LF  L+                K E ++      
Sbjct: 56  MSK-------DAVSG--------TLRLFWTLLS---------------KQEEMV------ 79

Query: 181 SSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAAD-VWSAGVIL------ 233
                   F +   +      L +        P ++   Y +  D +++   +       
Sbjct: 80  ------QKF-VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132

Query: 234 -------------------YILLSGMPPFWGNTKSR-IFDAVRTADL--RFPSNP-WDHI 270
                               +L+ G+    G+ K+    D   +  +  +      W ++
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVL---GSGKTWVALDVCLSYKVQCKMDFKIFWLNL 189

Query: 271 S-DSAKDLVMGMLST-------------DPSQRLTARQ---------------------V 295
              ++ + V+ ML               D S  +  R                      V
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249

Query: 296 LDHSWMGDGIQDPEKLSGNKIEDCKEWDLGSGSFSTQIIPRNQDI----SFGTGSPVFSD 351
           L +        + +  +   +  CK            +  R + +    S  T + +  D
Sbjct: 250 LLNVQ------NAKAWNAFNLS-CK----------ILLTTRFKQVTDFLSAATTTHISLD 292

Query: 352 DESPAFTCRTS---FSSFLQEPSTSTGFSFCSPGDSDASEFMSPLPSMPSFSFFSPGSVA 408
             S   T          +L           C P D         LP        +P  ++
Sbjct: 293 HHSMTLTPDEVKSLLLKYLD----------CRPQD---------LP--REVLTTNPRRLS 331

Query: 409 QVFTTV-DGSISISRVDAVPGEKWSSIIQLKLEEQEEP 445
            +  ++ DG  +      V  +K ++II+  L   E  
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 45/336 (13%), Positives = 94/336 (27%), Gaps = 103/336 (30%)

Query: 16  QPCKCYRVRSLAETILDTNQISNLRERFV---LGQQLGWGQFGVIRVCSDK-FTGEVFAC 71
                     L  T+L       + ++FV   L     +    +            ++  
Sbjct: 57  SKDAVSGTLRLFWTLLSKQ--EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY-- 112

Query: 72  KSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK-AVYE--DEDYV--H-------- 118
               +DRL   D++   K  +   +RL      + L+ A+ E      V           
Sbjct: 113 -IEQRDRLYN-DNQVFAKYNV---SRL---QPYLKLRQALLELRPAKNVLIDGVLGSGKT 164

Query: 119 -LVMELCAGGELFHRLE------KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPE 171
            + +++C   ++  +++           +  E  +  +Q +      ++I        P 
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL-----LYQI-------DPN 212

Query: 172 NILLATKASSSPIKLAD--------FGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQA 223
               +  +S+  +++               Y      LL            VL       
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN---CLL------------VLL------ 251

Query: 224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS 283
            +V +A             F  N   +I   + T   +        ++D         +S
Sbjct: 252 -NVQNAKAW--------NAF--NLSCKIL--LTTRFKQ--------VTDFLSAATTTHIS 290

Query: 284 TDPSQR-LTARQVLD--HSWMGDGIQD--PEKLSGN 314
            D     LT  +V      ++    QD   E L+ N
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 45.1 bits (106), Expect = 2e-05
 Identities = 24/113 (21%), Positives = 35/113 (30%), Gaps = 19/113 (16%)

Query: 91  EIEIMTRLSGH----PNVVDLKAVYEDEDYVHLVMELCAGGELFHR--LEKFGRFSEAEA 144
           E   + R        P              V L+ME     EL     +E      E + 
Sbjct: 120 EFRNLERAKEAGVSVPQPYTYM------KNV-LLMEFIGEDELPAPTLVELGRELKELDV 172

Query: 145 RVLFMQLM-QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
             +F  ++  V     E  +VH DL   NI+   K     +   D G A  + 
Sbjct: 173 EGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMGQAVTLR 220

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	468
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.08
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.88
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.62
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.56
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.54
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.37
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.36
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.29
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.27
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.11
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.96
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.91
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.76
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.08
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.19
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.95
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.92

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.1e-64  Score=502.11  Aligned_cols=257  Identities=30%  Similarity=0.575  Sum_probs=235.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+..+......+.+.+|+++|++|. |||||+++++|++++.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence            56999999999999999999999999999999998765544455678999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.   +||+|||+|+.+.... 
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~---vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC---EEEEEcCCceecCCCCC
Confidence            999999999999999999999999999999999999999999999999999999987655   9999999999875432 


Q ss_pred             --ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          200 --SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       200 --~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                        ...+.+||+.|||||++.+. |+.++|||||||++|+|++|++||.+.+..++++.+....+.+|    ..+++++++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d  263 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARD  263 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHHH
Confidence              34567999999999999875 99999999999999999999999999999999999999888776    468999999


Q ss_pred             HHHHccccCCCCCCCHHH------HHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQ------VLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~e------iL~h~~~~~~~  305 (468)
                      ||.+||++||++|||++|      |++||||++..
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            999999999999999987      68999997643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.7e-63  Score=488.03  Aligned_cols=255  Identities=35%  Similarity=0.634  Sum_probs=216.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++|++|+ |||||+++++|++++.+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999998876655566778999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |||| +|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~---vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN---VKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC---EEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC---EEEeecCCCeecCCCCc
Confidence            9999 7899999999999999999999999999999999999999999999999987655   99999999988776666


Q ss_pred             cccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      ..+.+||+.|||||++.+. | +.++|||||||++|+|++|++||.+.+..++++.+......+|    ..+++++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            6778999999999999875 4 6799999999999999999999999999999999988877665    46899999999


Q ss_pred             HHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      .+||++||++|||++|+++||||+..
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHHcCcccccC
Confidence            99999999999999999999999754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-62  Score=494.75  Aligned_cols=258  Identities=26%  Similarity=0.472  Sum_probs=230.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.+.|++.++||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+++|++|. |||||+++++|++++.+|
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            35679999999999999999999999999999999976543   23456788999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||||+||+|.+++.+ +++++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+|+.+...
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~~  223 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKE  223 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC---EEEecCcCceecCCC
Confidence            99999999999999976 67999999999999999999999999999999999999987665   999999999987544


Q ss_pred             -CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 -QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                       ....+.+||+.|||||++.+. |+.++|||||||++|||++|++||.+.+..+.+..+..... .....+..+++++++
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  302 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  302 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHH
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHH
Confidence             345678999999999999875 99999999999999999999999999998888888876532 233345689999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ||.+||++||++|||++|+|+||||++..
T Consensus       303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          303 FLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999999999999999997654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-62  Score=496.20  Aligned_cols=256  Identities=25%  Similarity=0.518  Sum_probs=224.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|+ |||||+++++|++++.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999987754 3445678999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||+||+|.++|...  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+|+.+...
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC---EEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC---EEEcccccceeecCC
Confidence            9999999999999764  35799999999999999999999999999999999999987655   999999999876543


Q ss_pred             C-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      . ...+.+||+.|||||++.+. |+.++|||||||++|||++|++||.+.+..+++..+.......   .+..+++++++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHH
Confidence            2 23456899999999999885 9999999999999999999999999999999998888776532   23578999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ||.+||++||++|||++|+|+||||++.
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.5e-61  Score=496.00  Aligned_cols=258  Identities=26%  Similarity=0.472  Sum_probs=231.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -++.|+++++||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+++|++|. |||||+++++|++++.+|
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEE
Confidence            35679999999999999999999999999999999986643   23456889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||||+||+|.++++. +++++..++.++.||+.||+|||++|||||||||+||||+.++.   +||+|||+|+.+...
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~---vKl~DFGla~~~~~~  300 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC---EEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---EEEecCccceECCCC
Confidence            99999999999999976 67999999999999999999999999999999999999987665   999999999987544


Q ss_pred             -CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 -QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                       ....+.+||+.|||||++.+. |+.++|||||||++|||++|++||.+.+..+.+..+..... .....+..+++++++
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHH
Confidence             345678999999999999875 99999999999999999999999999998888888876532 223345789999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ||.+||++||++|||++|+|+||||++..
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999999997644

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-60  Score=473.06  Aligned_cols=257  Identities=24%  Similarity=0.424  Sum_probs=221.7

Q ss_pred             cCCe-EEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----C
Q 012203           40 RERF-VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED----E  114 (468)
Q Consensus        40 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~----~  114 (468)
                      ..+| ++.++||+|+||+||+|.++.+++.||+|++.+... .....+.+.+|+++|++|+ |||||+++++|++    +
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCC
Confidence            3455 788899999999999999999999999999987654 3445678999999999996 9999999999975    4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+||||+.+  ++.+||+|||+|
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~--~g~vKl~DFGla  179 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST--TSCEEECCTTGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC--CCCEEEEeCcCC
Confidence            578999999999999999999999999999999999999999999998  9999999999999742  234999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccCCCCCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      +... .....+.+|||.|||||++.++|+.++|||||||++|||++|++||.+.. ...+...+.....  +...+..++
T Consensus       180 ~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~  256 (290)
T 3fpq_A          180 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI  256 (290)
T ss_dssp             GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred             EeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCC
Confidence            7543 33456789999999999999899999999999999999999999997644 4555555554422  222335678


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +++++||.+||++||++|||++|+|+||||++
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-61  Score=483.26  Aligned_cols=255  Identities=31%  Similarity=0.539  Sum_probs=223.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++.+..... .....+.+|+++|++|. |||||+++++|++++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            56999999999999999999984   468899999998764322 23346788999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC---EEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC---EEecccccceeccC
Confidence            999999999999999999999999999999999999999999999999999999999987665   99999999987543


Q ss_pred             -CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 -GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 -~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                       .....+.+||+.|||||++.+. |+.++|||||||++|||++|++||.+.+..+++..+......+|    ..++++++
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  254 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ  254 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHH
Confidence             3345578999999999999875 99999999999999999999999999999999999998877665    46899999


Q ss_pred             HHHHHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      +||.+||++||++|||     ++|+++||||++.
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999999998     5899999999763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.7e-60  Score=475.09  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=221.5

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .+.|++.++||+|+||+||+|+++.+|+.||||++.++...        .+|+.+|++|+ |||||+++++|++++.+||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            45699999999999999999999999999999999876432        35999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||||+||+|.++|++.+.+++..++.++.||+.||.|||++|||||||||+||||+.++.  .+||+|||+|+.+....
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS--RAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC--CEEECCCTTCEEC----
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC--EEEEeeCCCCeEccCCC
Confidence            9999999999999999899999999999999999999999999999999999999986542  49999999999875432


Q ss_pred             c------cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          200 S------LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       200 ~------~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .      ....+||+.|||||++.+. |+.++|||||||++|||++|++||.+.+..++...+......+. ..+..+++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCH
Confidence            1      2345899999999999885 99999999999999999999999998888777777777654332 22367999


Q ss_pred             HHHHHHHHccccCCCCCCCHHHH-------------HhCcCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQV-------------LDHSWMGDG  304 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~ei-------------L~h~~~~~~  304 (468)
                      ++.+||.+||++||++|||+.|+             |+|||+.+.
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            99999999999999999999998             468998653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-58  Score=472.39  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=226.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED----  113 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~----  113 (468)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|+ |||||++++++..    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence            356789999999999999999999999999999999976543 3445677889999999996 9999999999764    


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          114 --EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       114 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                        .+.+|||||||. |+|.+++.+.+.+++..++.+++||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~---~Ki~DFGl  204 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE---LKIGDFGM  204 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---EEECCCTT
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC---EEEeecce
Confidence              368999999995 689999998899999999999999999999999999999999999999987655   99999999


Q ss_pred             eeeecCC-----CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 012203          192 ATYIEPG-----QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS  264 (468)
Q Consensus       192 a~~~~~~-----~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  264 (468)
                      |+.+...     ....+.+||+.|||||++.+.  |+.++||||+||++|||++|++||.+.+..+.+..|......++.
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876432     234567999999999998763  799999999999999999999999999988888887654333221


Q ss_pred             CC---------------------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          265 NP---------------------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       265 ~~---------------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..                           +..+++++++||.+||++||++|||++|+|+||||++..
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            11                           235789999999999999999999999999999998753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.1e-57  Score=461.20  Aligned_cols=259  Identities=29%  Similarity=0.472  Sum_probs=214.0

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      .+..+.++|++++.||+|+||+||+|+++   .+++.||+|++.+..     ....+.+|+++|+++.+|||||+++++|
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~   89 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCF   89 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            34567889999999999999999999985   467899999986542     3456788999999997799999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      ++++++|||||||+||+|.++++   .+++.+++.+++||+.||+|||++||+||||||+|||++.+.  +.+||+|||+
T Consensus        90 ~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~--~~~kl~DFGl  164 (361)
T 4f9c_A           90 RKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL--KKYALVDFGL  164 (361)
T ss_dssp             EETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTT
T ss_pred             EECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC--CeEEECcCCC
Confidence            99999999999999999999984   599999999999999999999999999999999999998642  3599999999


Q ss_pred             eeeecCCC-----------------------------ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCC
Q 012203          192 ATYIEPGQ-----------------------------SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGM  240 (468)
Q Consensus       192 a~~~~~~~-----------------------------~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~  240 (468)
                      |+......                             ...+.+||+.|+|||++.+.  |+.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            98654321                             12346899999999999763  899999999999999999999


Q ss_pred             CCCCCC-ChHHHHHHHHhc--------------------------------------cCC------------CCCCCCCC
Q 012203          241 PPFWGN-TKSRIFDAVRTA--------------------------------------DLR------------FPSNPWDH  269 (468)
Q Consensus       241 ~Pf~~~-~~~~~~~~i~~~--------------------------------------~~~------------~~~~~~~~  269 (468)
                      .||... +..+.+..|...                                      ...            .....|..
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            999643 333333333210                                      000            11123567


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ++++++|||++||++||++|+|++|+|+||||++
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            8999999999999999999999999999999976

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.6e-57  Score=486.29  Aligned_cols=263  Identities=36%  Similarity=0.641  Sum_probs=242.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++.+.   ...+.+.+.+|+++|++|+ |||||+++++|++++.+|
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence            457899999999999999999999999999999999765   3445678889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||||||+||+|.++|.+ .+.+++..++.+++||+.||.|||++||+||||||+|||++.+. .+.+||+|||+|+.+..
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~-~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCSSCEECCT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC-CCCEEEeeccceeEccC
Confidence            99999999999999964 46799999999999999999999999999999999999997542 34699999999999887


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      .......+||+.|||||++.+. |+.++|||||||++|||++|++||.+.+..+++..+......++...+..+++++++
T Consensus       310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred             CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            7777788999999999999885 999999999999999999999999999999999999999888888888899999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ||.+||++||.+|||++|+|+||||+....
T Consensus       390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            999999999999999999999999987543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-56  Score=484.25  Aligned_cols=256  Identities=30%  Similarity=0.477  Sum_probs=222.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHH---HHHhcCCCCceeeeEEEEeCCEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI---MTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~i---L~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+..+........+.+|..+   ++.+ +|||||+++++|++.+.+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence            579999999999999999999999999999999987654333334445555444   4445 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||||||+||+|.++|.+.+.|++..++.|+.||+.||+|||++|||||||||+||||+.++.   +||+|||+|+.+..
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~---vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC---EEecccceeeecCC
Confidence            999999999999999999999999999999999999999999999999999999999987665   99999999988764


Q ss_pred             CCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      . ...+.||||.|||||++.+  +|+.++|||||||++|||++|++||.+.   +..++...+......+|    ..+++
T Consensus       345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~  419 (689)
T 3v5w_A          345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSP  419 (689)
T ss_dssp             C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCH
Confidence            3 3467899999999999964  4999999999999999999999999764   34456666666666555    57899


Q ss_pred             HHHHHHHHccccCCCCCCC-----HHHHHhCcCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLT-----ARQVLDHSWMGDGI  305 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt-----~~eiL~h~~~~~~~  305 (468)
                      ++++||.+||++||.+|++     ++||++||||++..
T Consensus       420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            9999999999999999998     79999999998743

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4e-57  Score=449.88  Aligned_cols=253  Identities=29%  Similarity=0.501  Sum_probs=200.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-----
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-----  115 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-----  115 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+++|++|+ |||||+++++|.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            45999999999999999999999999999999997653  3444567899999999996 999999999997544     


Q ss_pred             -------EEEEEEeccCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEE
Q 012203          116 -------YVHLVMELCAGGELFHRLEKFGRF---SEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       116 -------~~~lV~E~~~ggsL~~~l~~~~~l---~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                             ++|||||||+||+|.+++...+.+   .+..++.++.||+.||.|||++||+||||||+||||+.++.   +|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~---vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc---EE
Confidence                   479999999999999999876554   45668899999999999999999999999999999987655   99


Q ss_pred             EeecCceeeecCCCc-------------cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 012203          186 LADFGLATYIEPGQS-------------LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK-SR  250 (468)
Q Consensus       186 L~DFGla~~~~~~~~-------------~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~  250 (468)
                      |+|||+|+.+.....             ..+.+||+.|||||++.+. |+.++|||||||++|||++   ||..... ..
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999987654321             2346899999999999875 9999999999999999996   7754321 12


Q ss_pred             HHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ....+..  ..+|. .+...++.+.+||++||++||++|||+.|+++||||++..
T Consensus       236 ~~~~~~~--~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          236 TLTDVRN--LKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHT--TCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHhc--CCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            2222222  23332 2245567889999999999999999999999999997643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.8e-56  Score=440.91  Aligned_cols=251  Identities=21%  Similarity=0.364  Sum_probs=216.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      +++|.+.+.||+|+||+||+|++.     .+++.||||++...   .....+.+.+|+++|++|+ |||||++++++.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence            367999999999999999999875     36889999999754   4455678999999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC
Q 012203          115 DYVHLVMELCAGGELFHRLEKF-------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~-------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~  181 (468)
                      +.+|||||||+||+|.++|++.             ..+++..+..++.||+.||.|||+++|+||||||+||||+.++. 
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~-  166 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-  166 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc-
Confidence            9999999999999999999764             35999999999999999999999999999999999999987665 


Q ss_pred             CCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 012203          182 SPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVR  256 (468)
Q Consensus       182 ~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~  256 (468)
                        +||+|||+|+.......   ....+||+.|||||++.+. |+.++|||||||++|||+| |+.||.+.+..++...+.
T Consensus       167 --~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          167 --VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             --EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             --EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence              99999999986543322   2234699999999999864 9999999999999999998 999999999999988888


Q ss_pred             hccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       257 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      .+....   .+..+++++.+|+.+||+.||++|||++|++  +|++
T Consensus       245 ~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~  285 (299)
T 4asz_A          245 QGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ  285 (299)
T ss_dssp             HTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred             cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence            765321   1257899999999999999999999999994  4553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.9e-55  Score=441.06  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=210.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .++|.+.++||+|+||+||+|+++     .+++.||||++...   .....+.+.+|+++|++|+ |||||++++++.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence            367999999999999999999865     36889999999754   4455678999999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          115 DYVHLVMELCAGGELFHRLEKF---------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~---------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      +.+|||||||+||+|.+++++.               +++++..+..++.||+.||.|||+++|+||||||+||||+.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            9999999999999999999764               3589999999999999999999999999999999999998765


Q ss_pred             CCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 012203          180 SSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA  254 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~  254 (468)
                      .   +||+|||+++.......   ....+||+.|||||++.+. |+.++|||||||++|||+| |+.||.+.+..++...
T Consensus       196 ~---~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          196 V---VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             E---EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             c---EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            5   99999999987654322   2346899999999999875 9999999999999999998 9999999998888888


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +..+.. .+  .+..+++++.+|+.+||++||++|||++||+++
T Consensus       273 i~~g~~-~~--~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGRE-LE--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTCC-CC--CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCCC-CC--CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            876532 11  225789999999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6e-55  Score=443.86  Aligned_cols=258  Identities=31%  Similarity=0.577  Sum_probs=229.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+..|+++++++.+||||+++++++++.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            36799999999999999999999999999999999876444445567788999999998779999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~  198 (468)
                      |||||+||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++... ..
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~---ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC---EEEccccceeecccCC
Confidence            9999999999999999899999999999999999999999999999999999999987655   9999999998643 23


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ......+||+.|+|||++.+. |+.++|||||||++|||++|+.||.+.+..++++.+......+|    ..+++++.+|
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  254 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGI  254 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            344567899999999999875 99999999999999999999999999999999999999887776    3589999999


Q ss_pred             HHHccccCCCCCCCH------HHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRLTA------RQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~------~eiL~h~~~~~~  304 (468)
                      |++||++||.+||++      +|+++||||++.
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999999998      899999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-55  Score=435.60  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=206.5

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .+++++.++||+|+||+||+|+++   ..||||+++... ......+.+.+|+++|++|+ |||||++++++.+ +.+||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEE
Confidence            467899999999999999999865   359999987543 24455678999999999996 9999999998864 56899


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||||+||+|.++|... +++++..+..++.||+.||.|||+++||||||||+||||+.++.   +||+|||+|+.....
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~---~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT---VKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE---EEECCCSSCBC----
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc---EEEeeccCceecccC
Confidence            99999999999999764 57999999999999999999999999999999999999987655   999999999875432


Q ss_pred             ---CccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--CCCCCC
Q 012203          199 ---QSLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP--SNPWDH  269 (468)
Q Consensus       199 ---~~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~  269 (468)
                         ......+||+.|||||++.+    .|+.++|||||||++|||++|+.||.+.+.......+.......|  ...+..
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence               23345789999999999964    389999999999999999999999988665554444444333333  223467


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +++++.+|+.+||++||++|||+.|++++
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999988654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-54  Score=433.41  Aligned_cols=249  Identities=23%  Similarity=0.359  Sum_probs=215.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ..+++.++||+|+||+||+|+..     .+++.||||++....  .....+.+.+|+.+|++|+ |||||++++++.+++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence            46889999999999999999863     467899999997543  2334578999999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          116 YVHLVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      .++||||||++|+|.++|...                ..+++..+..++.||+.||.|||+++||||||||+||||+.++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence            999999999999999999653                3589999999999999999999999999999999999998766


Q ss_pred             CCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 012203          180 SSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA  254 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~  254 (468)
                      .   +||+|||+++......   .....+||+.|||||++.++ |+.++|||||||++|||+| |+.||.+.+..++...
T Consensus       183 ~---~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          183 N---VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             C---EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             C---EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            5   9999999998764332   23356899999999998764 9999999999999999998 8999999999998888


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +..+... +  ....+++++.+|+.+||+.||++|||+.||+++
T Consensus       260 i~~~~~~-~--~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVL-P--CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCC-C--CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8766432 2  225789999999999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.1e-54  Score=432.46  Aligned_cols=256  Identities=34%  Similarity=0.603  Sum_probs=232.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++|+++. ||||+++++++++.+.+|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999998754333345677889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CCC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~  199 (468)
                      |||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC---EEEeeccchhhcccCCC
Confidence            999999999999998889999999999999999999999999999999999999987654   9999999998643 334


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      .....+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+...+.+.+......+|    ..+++++++||
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  236 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            45677899999999999875 89999999999999999999999999999999999888877766    46899999999


Q ss_pred             HHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      .+||++||.+||     +++|+++||||...
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            999999999999     89999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.2e-54  Score=442.51  Aligned_cols=258  Identities=28%  Similarity=0.540  Sum_probs=227.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++.++.+||||++++++|++.+.+||
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            45799999999999999999999999999999999887655555556788999999988679999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee-ecCC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY-IEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~-~~~~  198 (468)
                      ||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++. ....
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~---ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC---EEEeecceeeecccCC
Confidence            9999999999999999899999999999999999999999999999999999999987655   99999999986 3344


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhccCCCCCCCCC
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN---------TKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ....+.+||+.|+|||++.+. ++.++|||||||++|||++|++||...         ....+.+.+......+|    .
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~  283 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R  283 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----T
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----C
Confidence            556678999999999999875 899999999999999999999999632         33456677777777666    4


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCH------HHHHhCcCCCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTA------RQVLDHSWMGDG  304 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~------~eiL~h~~~~~~  304 (468)
                      .++.++++||++||++||.+||++      +|+++||||++.
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            689999999999999999999985      799999999764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.6e-53  Score=432.08  Aligned_cols=267  Identities=36%  Similarity=0.617  Sum_probs=242.9

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||+|++.+......   .....+.+|+.+|+++. ||||++++++|++
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~   86 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN   86 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence            4678899999999999999999999999999999999987654221   13567899999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC-CCCEEEeecCce
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS-SSPIKLADFGLA  192 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~-~~~ikL~DFGla  192 (468)
                      .+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            9999999999999999999988888999999999999999999999999999999999999976542 225999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ............+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++...|..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence            988776666778999999999999874 8999999999999999999999999999999999999888888777778899


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +++++||.+||.+||.+|||+.|+++||||+..
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999999999753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.6e-54  Score=435.89  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=212.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCC-----CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFT-----GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-  113 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-  113 (468)
                      .++|++++.||+|+||+||+|+++.+     ++.||+|.+....  .....+.+.+|+++|.++..|||||+++++|.+ 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            47899999999999999999998654     4689999987653  344567899999999999756999999999865 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEee
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLAT  177 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~  177 (468)
                      ++.+|||||||++|+|.++|++.                ..+++..+..++.||+.||.|||+++||||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            46799999999999999999763                24899999999999999999999999999999999999987


Q ss_pred             cCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHH-H
Q 012203          178 KASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSR-I  251 (468)
Q Consensus       178 ~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~-~  251 (468)
                      ++.   +||+|||+|+.+.....   ....+||+.|||||++.+. |+.++|||||||++|||+| |+.||.+....+ +
T Consensus       221 ~~~---vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          221 KNV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             GGC---EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             CCC---EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            665   99999999987654332   2345799999999999865 9999999999999999998 999998866444 4


Q ss_pred             HHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       252 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ...+..+ .+++.  ...+++++.+++.+||+.||++|||+.||++|
T Consensus       298 ~~~i~~g-~~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKEG-TRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcC-CCCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4444443 33222  25689999999999999999999999999987

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-53  Score=431.11  Aligned_cols=261  Identities=31%  Similarity=0.534  Sum_probs=233.3

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .-.++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+..|..++.++.+||||+++++++++.+.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999999999999999998764333345567888999999885699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++....
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENML  170 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC---EEEeEChhhhhccc
Confidence            999999999999999998889999999999999999999999999999999999999987654   99999999986432


Q ss_pred             -CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 -GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 -~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                       .......+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+..++++.+......++    ..++++++
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  246 (345)
T 1xjd_A          171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAK  246 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHH
Confidence             2345567999999999999875 89999999999999999999999999999999999988876665    46899999


Q ss_pred             HHHHHccccCCCCCCCHH-HHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTAR-QVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~-eiL~h~~~~~~~  305 (468)
                      +||.+||..||++||++. ++++||||+...
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            999999999999999998 999999997643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.5e-53  Score=431.10  Aligned_cols=267  Identities=39%  Similarity=0.758  Sum_probs=245.9

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ....+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|++++++|. ||||+++++++.+.
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~  100 (362)
T 2bdw_A           23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE  100 (362)
T ss_dssp             -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence            345577889999999999999999999999999999999987654 3445678899999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +..|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++..
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999999999998888899999999999999999999999999999999999998776666799999999988


Q ss_pred             ecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          195 IEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ..........+||+.|+|||++.+. ++.++|||||||++|+|++|++||.+.+..++...+......++...|..++++
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            7766666678999999999999875 899999999999999999999999999999999999999888888888899999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +++||.+||.+||++|||+.|+|+||||..
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999999965

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-52  Score=421.53  Aligned_cols=260  Identities=37%  Similarity=0.608  Sum_probs=237.2

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ....++|++++.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+++|+++. ||||+++++++.+.+.
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCE
Confidence            3456789999999999999999999999999999999987643 3455677889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~  165 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNEFT  165 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSTTCCGGGS
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC---EEEeeccCceecC
Confidence            9999999999999999998899999999999999999999999999999999999999987655   9999999998777


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .+......+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.+..++.+.+......+|    ..+++++
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  241 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDC  241 (328)
T ss_dssp             SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence            66667788999999999999875 4 4799999999999999999999999999999999988877766    3689999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+||++||..||.+|||++|+++||||+...
T Consensus       242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999997654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-52  Score=425.97  Aligned_cols=258  Identities=29%  Similarity=0.534  Sum_probs=230.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++++.+||||+++++++++.+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            35799999999999999999999999999999999987666666677889999999998669999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~  198 (468)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++... ..
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCGGGCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC---EEEEeccccccccCCC
Confidence            9999999999999998889999999999999999999999999999999999999986654   9999999998643 33


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCC---------CChHHHHHHHHhccCCCCCCCCC
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG---------NTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ......+||+.|+|||++.+. ++.++|||||||++|||++|+.||..         .....+.+.+......+|    .
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~  240 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R  240 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----T
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----C
Confidence            445667999999999999875 89999999999999999999999965         334456667777766665    4


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCH------HHHHhCcCCCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTA------RQVLDHSWMGDG  304 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~------~eiL~h~~~~~~  304 (468)
                      .++.++.+||.+||++||.+||++      +|+++||||++.
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            689999999999999999999995      899999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.1e-53  Score=437.01  Aligned_cols=269  Identities=28%  Similarity=0.458  Sum_probs=232.9

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ..++....++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.+. ||||++++++|+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~  139 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE
Confidence            3445556789999999999999999999999999999999997643322223345788999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.+.+|||||||+||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~---ikL~DFG~a  215 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTC  215 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC---EEEecccee
Confidence            99999999999999999999976 57999999999999999999999999999999999999987655   999999999


Q ss_pred             eeecCCCc--cccCCCCCCCcChhhhcCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 012203          193 TYIEPGQS--LLGTVGSPFYIAPEVLAGG-----YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN  265 (468)
Q Consensus       193 ~~~~~~~~--~~~~~GT~~Y~APE~l~~~-----~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  265 (468)
                      +.......  ..+.+||+.|+|||++.+.     ++.++|||||||++|||++|++||.+.+..+.+..+......+...
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence            88765432  3467899999999999752     6789999999999999999999999999999988887654333333


Q ss_pred             CCCCCCHHHHHHHHHccccCCCC--CCCHHHHHhCcCCCCCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQ--RLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~--Rpt~~eiL~h~~~~~~~~  306 (468)
                      .+..+++++++||++||..+|.+  |++++||++||||++...
T Consensus       296 ~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          296 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            34579999999999999999988  999999999999987543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=437.74  Aligned_cols=266  Identities=40%  Similarity=0.770  Sum_probs=242.5

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ...+.++|++++.||+|+||+||+|.++.+|+.||+|++.+... .......+.+|+++++++. ||||+++++++.+.+
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~   83 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEG   83 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSS
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECC
Confidence            45678899999999999999999999999999999999987654 3345667889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++...
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999999999999999899999999999999999999999999999999999999987656677999999999876


Q ss_pred             cCCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          196 EPGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       196 ~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      .... .....+||+.|+|||++.+. ++.++|||||||++|+|++|++||.+.+..++...+......++...|..++++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  243 (444)
T 3soa_A          164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE  243 (444)
T ss_dssp             CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence            5433 33567899999999999875 999999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +++||.+||+.||++|||+.|+|+||||++
T Consensus       244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            999999999999999999999999999965

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.5e-53  Score=428.07  Aligned_cols=259  Identities=29%  Similarity=0.535  Sum_probs=233.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+..|..++..+.+||||+++++++++.+.+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34679999999999999999999999999999999987644333456778889999988867999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-C
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-P  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~  197 (468)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++... .
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc---EEEEeCCcccccccC
Confidence            99999999999999998889999999999999999999999999999999999999987654   9999999998643 3


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      .......+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+..++++.+......+|    ..+++++.+
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  250 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVA  250 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence            3345677999999999999875 89999999999999999999999999999999999998877776    468999999


Q ss_pred             HHHHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          277 LVMGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       277 li~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      ||.+||.+||.+||+     ++++++||||+..
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            999999999999994     6999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-52  Score=436.70  Aligned_cols=269  Identities=27%  Similarity=0.477  Sum_probs=232.4

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ..++....++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++.++. ||||++++++|+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~  144 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEE
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe
Confidence            3445566789999999999999999999999999999999997643222223344788999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          113 DEDYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      +.+.+|||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~---vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC---EEEcchhh
Confidence            99999999999999999999987 478999999999999999999999999999999999999987665   99999999


Q ss_pred             eeeecCCCc--cccCCCCCCCcChhhhc-----C-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--CC
Q 012203          192 ATYIEPGQS--LLGTVGSPFYIAPEVLA-----G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD--LR  261 (468)
Q Consensus       192 a~~~~~~~~--~~~~~GT~~Y~APE~l~-----~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~  261 (468)
                      ++.......  ....+||+.|+|||++.     . .|+.++|||||||++|||++|+.||.+.+..+.+..+....  ..
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ  301 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence            987654433  23468999999999986     2 38999999999999999999999999999888888886543  34


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCCCC--CCCHHHHHhCcCCCCCCC
Q 012203          262 FPSNPWDHISDSAKDLVMGMLSTDPSQ--RLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       262 ~~~~~~~~~s~~l~~li~~~L~~dP~~--Rpt~~eiL~h~~~~~~~~  306 (468)
                      +|.. +..+++++++||++||..+|++  |++++|+++||||++...
T Consensus       302 ~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          302 FPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             CCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             CCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence            4432 3568999999999999999988  999999999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-51  Score=402.26  Aligned_cols=267  Identities=39%  Similarity=0.756  Sum_probs=246.6

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +.+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++++. ||||+++++++.+.+.
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESF   79 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCE
Confidence            3578999999999999999999999999999999999987653 4445677889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      .++||||++|++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999999999999888899999999999999999999999999999999999999887766779999999998877


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .........||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+.......+......++...+..+++++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence            66666678899999999999875 89999999999999999999999999999999999999888888887889999999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +||.+||+.||++|||++|+++||||++..
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            999999999999999999999999997654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-52  Score=418.84  Aligned_cols=262  Identities=30%  Similarity=0.564  Sum_probs=238.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|++...    ......+.+|+++++++. ||||+++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence            5788999999999999999999999999999999998754    234567889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~-~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC-CCCEEEEECCCCeECC
Confidence            9999999999999999765 3699999999999999999999999999999999999998632 3569999999999887


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .+......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+......++...|..+++++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            76666677899999999999886 79999999999999999999999999999999999998888877766778999999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +||.+||..||.+|||+.|+|+||||++..
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            999999999999999999999999997643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-52  Score=415.52  Aligned_cols=267  Identities=37%  Similarity=0.660  Sum_probs=240.4

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+......   .....+.+|+.+|+++. ||||+++++++.+
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            4577889999999999999999999999999999999987643221   13577889999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC-CCCCEEEeecCce
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA-SSSPIKLADFGLA  192 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~-~~~~ikL~DFGla  192 (468)
                      .+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998888899999999999999999999999999999999999998765 2335999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ............+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+......++...+..++
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            988766666677899999999999864 8999999999999999999999999999888888888877777665567889


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ..+.+||.+||..||++|||+.|+|+||||+..
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            999999999999999999999999999999764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5e-52  Score=425.52  Aligned_cols=258  Identities=30%  Similarity=0.550  Sum_probs=222.1

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHH-HHhcCCCCceeeeEEEEeCCEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM-TRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL-~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+..|..++ +.+ +||||++++++|++.+.+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEE
Confidence            446799999999999999999999999999999999887665555566677787774 455 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-  196 (468)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++... 
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCBCGGGBC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC---EEEeeCcccccccc
Confidence            999999999999999998889999999999999999999999999999999999999987654   9999999998633 


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ........+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+..++++.+......++    ..++.+++
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~  267 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSAR  267 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Confidence            33345577999999999999875 89999999999999999999999999999999999988876665    46899999


Q ss_pred             HHHHHccccCCCCCCCH----HHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTA----RQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~----~eiL~h~~~~~~  304 (468)
                      +||.+||++||.+||++    .++++|+||+..
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            99999999999999986    699999999764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-51  Score=437.88  Aligned_cols=274  Identities=37%  Similarity=0.638  Sum_probs=245.4

Q ss_pred             CccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh----------hhHHHHHHHHHHHHHhcCC
Q 012203           32 DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI----------DDERSVKLEIEIMTRLSGH  101 (468)
Q Consensus        32 ~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~----------~~~~~~~~Ei~iL~~L~~H  101 (468)
                      -......+.++|++++.||+|+||+||+|+++.+++.||+|++.+......          ...+.+.+|+.+|+++. |
T Consensus        27 ~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h  105 (504)
T 3q5i_A           27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-H  105 (504)
T ss_dssp             CCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-C
T ss_pred             eeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-C
Confidence            344456788999999999999999999999999999999999987643221          23567889999999996 9


Q ss_pred             CCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC
Q 012203          102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS  181 (468)
Q Consensus       102 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~  181 (468)
                      |||+++++++.+.+.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..
T Consensus       106 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCC
T ss_pred             CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCC
Confidence            99999999999999999999999999999999888899999999999999999999999999999999999999877655


Q ss_pred             CCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 012203          182 SPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR  261 (468)
Q Consensus       182 ~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  261 (468)
                      ..+||+|||++............+||+.|+|||++.+.++.++|||||||++|+|++|++||.+.+..++...+......
T Consensus       186 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  265 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY  265 (504)
T ss_dssp             SSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             ccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            57999999999988776666778999999999999988999999999999999999999999999999999999998888


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       262 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ++...|..+++++++||.+||++||.+|||++|+|+||||+....
T Consensus       266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            777777889999999999999999999999999999999977554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-51  Score=411.79  Aligned_cols=254  Identities=31%  Similarity=0.630  Sum_probs=231.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++++.+.+|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEE
Confidence            56999999999999999999999999999999998754333344667888999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++....  .
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~Dfg~a~~~~~--~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPD--V  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC---EEECCCSSCEECSS--C
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC---EEEeecCcceecCC--c
Confidence            999999999999999889999999999999999999999999999999999999986654   99999999987643  3


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ..+.+||+.|+|||++.+. ++.++|||||||++|||++|+.||...+..+.+..+......++    ..+++++.++|.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  235 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  235 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence            4467899999999999875 89999999999999999999999999999899999988877766    468999999999


Q ss_pred             HccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          280 GMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       280 ~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      +||..||.+||     +++|+++||||++.
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            99999999999     99999999999764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.7e-52  Score=456.17  Aligned_cols=258  Identities=29%  Similarity=0.540  Sum_probs=234.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+...........+..|..+|..+.+||+|++++++|++.+.+||
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46799999999999999999999999999999999876443344556788899999988779999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-CC
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-PG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-~~  198 (468)
                      ||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.   +||+|||+++... .+
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~---ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC---EEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc---EEEeecceeeccccCC
Confidence            9999999999999999899999999999999999999999999999999999999987665   9999999998743 33


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ....+.+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.+..++++.+......+|    ..+++++.+|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  572 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  572 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence            445678999999999999874 99999999999999999999999999999999999998887777    4689999999


Q ss_pred             HHHccccCCCCCCCH-----HHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRLTA-----RQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~-----~eiL~h~~~~~~  304 (468)
                      |++||++||++||++     +||++||||+..
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999997     999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.9e-51  Score=415.39  Aligned_cols=271  Identities=39%  Similarity=0.698  Sum_probs=223.4

Q ss_pred             cCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           31 LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        31 ~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      +.......+.++|++.+.||+|+||.||+|+++.+++.||+|++....     ..+.+.+|+++++++. ||||++++++
T Consensus        43 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~  116 (349)
T 2w4o_A           43 IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEI  116 (349)
T ss_dssp             CCSSBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEE
T ss_pred             ccCcccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeee
Confidence            345566778899999999999999999999999999999999997642     3456788999999996 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          111 YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       111 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      +.+.+.+++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.....+.+||+|||
T Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             EecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            99999999999999999999999888889999999999999999999999999999999999999864445679999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccCCCCCCCCC
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSR-IFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~  268 (468)
                      ++............+||+.|+|||++.+. ++.++|||||||++|+|++|+.||....... ....+......++...+.
T Consensus       197 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (349)
T 2w4o_A          197 LSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWD  276 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTT
T ss_pred             cccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhh
Confidence            99877655555667899999999999875 8999999999999999999999997765544 677777777777766778


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD  307 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~~  307 (468)
                      .++.++.+||.+||+.||++|||+.|+++||||.+....
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             hCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            899999999999999999999999999999999876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=425.97  Aligned_cols=267  Identities=29%  Similarity=0.523  Sum_probs=229.6

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ..+.....++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.++.++. ||||++++++|+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~  131 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEE
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEe
Confidence            3455666789999999999999999999999999999999997653323333456788999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      +.+.+||||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~---vkL~DFGl  208 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH---IRLADFGS  208 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC---EEEeechh
Confidence            9999999999999999999998754 7999999999999999999999999999999999999987655   99999999


Q ss_pred             eeeecCCCc--cccCCCCCCCcChhhhc--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--
Q 012203          192 ATYIEPGQS--LLGTVGSPFYIAPEVLA--------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD--  259 (468)
Q Consensus       192 a~~~~~~~~--~~~~~GT~~Y~APE~l~--------~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--  259 (468)
                      ++.......  ....+||+.|+|||++.        +.|+.++|||||||++|||++|+.||.+.+..+.+..+....  
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            988765433  23468999999999987        238999999999999999999999999999888888887543  


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHccccCCCCC---CCHHHHHhCcCCCCCC
Q 012203          260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQR---LTARQVLDHSWMGDGI  305 (468)
Q Consensus       260 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---pt~~eiL~h~~~~~~~  305 (468)
                      ..+|. ....+++++++||++||. +|.+|   ++++|+++||||+...
T Consensus       289 ~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          289 LSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             CCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             cCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence            33332 125789999999999999 99998   5899999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.3e-51  Score=434.85  Aligned_cols=269  Identities=39%  Similarity=0.683  Sum_probs=243.0

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ......+.++|++++.||+|+||+||+|+++.+++.||+|++.+.... ......+.+|+.+++++. ||||++++++|.
T Consensus        29 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~  106 (494)
T 3lij_A           29 TSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLD-HPNIMKLYDFFE  106 (494)
T ss_dssp             CCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             ecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCC-CCCCCeEEEEEE
Confidence            344566888999999999999999999999999999999999876432 223567889999999996 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.+.+|+|||||+||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            99999999999999999999988889999999999999999999999999999999999999987666677999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ............+||+.|+|||++.+.|+.++|||||||++|+|++|++||.+.+..++...+......++...|..+++
T Consensus       187 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  266 (494)
T 3lij_A          187 AVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE  266 (494)
T ss_dssp             EECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred             eECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence            98877666677899999999999988899999999999999999999999999999999999999988888888889999


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .+++||.+||+.||.+|||+.|+|+||||++
T Consensus       267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            9999999999999999999999999999965

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.2e-52  Score=437.10  Aligned_cols=269  Identities=41%  Similarity=0.732  Sum_probs=248.4

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ...+.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+++++++. ||||+++++++.+.+
T Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   99 (484)
T 3nyv_A           21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKG   99 (484)
T ss_dssp             CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred             CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            3457789999999999999999999999999999999998776555556788999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++...
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999999999999889999999999999999999999999999999999999976555667999999999887


Q ss_pred             cCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .........+||+.|+|||++.+.++.++|||||||++|+|++|++||.+.+..++...+......++...|..++++++
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence            76666667789999999999999999999999999999999999999999999999999999988888777889999999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +||.+||++||.+|||+.|+|+||||+...
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            999999999999999999999999997543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.3e-52  Score=419.16  Aligned_cols=264  Identities=36%  Similarity=0.690  Sum_probs=231.4

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC--hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT--IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~--~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+.....  ....+.+.+|+.+++++. ||||+++++++.+++
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG   99 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            46778999999999999999999999999999999997543211  123567899999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          116 YVHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      .+|+|||||+|++|.+.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999998888543    3589999999999999999999999999999999999998877667799999999


Q ss_pred             eeeecCCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          192 ATYIEPGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       192 a~~~~~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      +........ ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+. ..+....+......++...|..
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence            988765433 3457899999999999875 899999999999999999999999874 4566777777766666555678


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +++++++||.+||..||++|||+.|+++||||++
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            9999999999999999999999999999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-51  Score=399.26  Aligned_cols=265  Identities=40%  Similarity=0.756  Sum_probs=241.5

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+.++|++.+.||+|+||.||+|.++.+++.+|+|++.+...   ...+.+.+|+++++++. ||||+++++++.+.+.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTD   80 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCe
Confidence            3567889999999999999999999999999999999976532   33567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      .++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+..++..+.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999888899999999999999999999999999999999999999655555679999999999887


Q ss_pred             CCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|+.||...+..+....+......++...+..+++.+.+
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence            77666778899999999999888999999999999999999999999999998999888888877776656688999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +|.+||+.||.+|||+.|+++||||++..
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999996543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-51  Score=416.56  Aligned_cols=258  Identities=31%  Similarity=0.618  Sum_probs=234.0

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ....++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+++|+++. ||||+++++++.+.+.
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence            345578999999999999999999999999999999997764433345677889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++...
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~DFg~a~~~~  192 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVK  192 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECS
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC---EEEcccccceecc
Confidence            9999999999999999998889999999999999999999999999999999999999986654   9999999998765


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ..  ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..++++.+......+|    ..+++++.
T Consensus       193 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  266 (350)
T 1rdq_E          193 GR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLK  266 (350)
T ss_dssp             SC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHH
T ss_pred             CC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            43  3467899999999999875 89999999999999999999999999999999999988877766    46899999


Q ss_pred             HHHHHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      ++|.+||+.||.+||+     ++|+++||||...
T Consensus       267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            9999999999999998     9999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-51  Score=435.85  Aligned_cols=267  Identities=42%  Similarity=0.729  Sum_probs=242.5

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++++.||+|+||+||+|+++.+|+.||+|++.+.... ......+.+|+++|+++. ||||+++++++.+.+.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEE
Confidence            4667899999999999999999999999999999999764322 234577889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+|||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999998888999999999999999999999999999999999999998766667799999999987766


Q ss_pred             CCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      .......+||+.|+|||++.+.|+.++|||||||++|+|++|++||.+.+..++...+......++...|..+++++++|
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  256 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence            66666788999999999999999999999999999999999999999999999999999998888877788999999999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      |.+||+.||.+|||+.|+|+||||+....
T Consensus       257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          257 IRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             HHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            99999999999999999999999976543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-51  Score=414.41  Aligned_cols=260  Identities=38%  Similarity=0.679  Sum_probs=232.9

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+...       ...+|++++.++.+||||+++++++++.+.
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            4578899999999999999999999999999999999977642       134688899888679999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec-CCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK-ASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~-~~~~~ikL~DFGla~~~  195 (468)
                      +|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +....+||+|||++...
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999999999999988899999999999999999999999999999999999998543 33345999999999876


Q ss_pred             cCC-CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhccCCCCCCCCCCC
Q 012203          196 EPG-QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG---NTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       196 ~~~-~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      ... ....+.+||+.|+|||++.+. |+.++|||||||++|+|++|+.||..   .+..++...+......++...|..+
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            543 334567899999999999875 89999999999999999999999975   4567788888888888888888899


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ++++++||.+||..||++|||+.|+++||||.+
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            999999999999999999999999999999965

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-50  Score=416.07  Aligned_cols=264  Identities=35%  Similarity=0.607  Sum_probs=238.7

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+.++|++++.||+|+||+||+|.++.+|+.||+|++...   .......+.+|+++|+++. ||||+++++++.+.+.
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE  122 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCE
Confidence            45678999999999999999999999999999999999765   2344567889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      +++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+.+||+|||++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCC-CCceEEEecccceec
Confidence            99999999999999999765 3699999999999999999999999999999999999997532 345999999999988


Q ss_pred             cCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .........+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+......++...+..+++++
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            766555667899999999999875 8999999999999999999999999998888888888888888777778899999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+||.+||..||.+|||+.|+++||||+...
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-50  Score=399.89  Aligned_cols=261  Identities=26%  Similarity=0.451  Sum_probs=227.2

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      +....++|++.+.||+|+||+||+|.+..+|+.||+|++.....   ...+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGD   90 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence            44577899999999999999999999999999999999976532   23466888999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+||||++||+|.+++.+. .+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~~  166 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQI  166 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEEC
T ss_pred             EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC---EEEeeCCCceec
Confidence            999999999999999999874 6999999999999999999999999999999999999987655   999999999876


Q ss_pred             cCCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          196 EPGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       196 ~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      .... .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+.......+........ .....+++.
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  245 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAI  245 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCHH
T ss_pred             CCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCHH
Confidence            5443 33456899999999999875 89999999999999999999999988887666655544432211 223578999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +.+||.+||+.||++|||++|+++||||+...
T Consensus       246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            99999999999999999999999999997643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-50  Score=396.94  Aligned_cols=262  Identities=35%  Similarity=0.625  Sum_probs=226.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++.+.||+|+||.||+|+++.+++.+|+|++.+...  ....+.+.+|+++++++. ||||+++++++.+.+..
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeE
Confidence            466789999999999999999999999999999999987642  234577889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          118 HLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      ++||||++||+|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999999988543    679999999999999999999999999999999999999765556679999999998


Q ss_pred             eecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ............||+.|+|||++.+.++.++|||||||++|+|++|+.||.+....+....+......+.... ..++++
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  254 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTPQ  254 (285)
T ss_dssp             C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred             ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcCCHH
Confidence            7766555567789999999999988899999999999999999999999999888888777776655544332 458899


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +.+||.+||+.||++|||+.|+++||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-50  Score=403.10  Aligned_cols=269  Identities=36%  Similarity=0.610  Sum_probs=239.3

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ...+.++|++.+.||+|+||.||+|+++.+|+.||+|++.+......   .....+.+|+.+++++. ||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   85 (321)
T 2a2a_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYE   85 (321)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEe
Confidence            35577889999999999999999999999999999999987643221   13567899999999996 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC-CCEEEeecCc
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS-SPIKLADFGL  191 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~-~~ikL~DFGl  191 (468)
                      +.+.+++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.. ..+||+|||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999999999988889999999999999999999999999999999999999865521 2599999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      +.............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+......++...+..+
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence            9987766556677899999999999875 899999999999999999999999999988888888877666655445678


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++.+.+||.+||..||++|||+.|+++||||....
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            99999999999999999999999999999997643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.6e-51  Score=403.30  Aligned_cols=266  Identities=38%  Similarity=0.652  Sum_probs=226.0

Q ss_pred             ccccCCeEEE-eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           37 SNLRERFVLG-QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        37 ~~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ..+.++|++. +.||+|+||.||+|+++.+|+.||+|++.+..   ......+.+|++++.++.+||||+++++++.+.+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3577889995 78999999999999999999999999997653   2345678899999999767999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999998889999999999999999999999999999999999999987766567999999998765


Q ss_pred             cCC--------CccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCC--------------
Q 012203          196 EPG--------QSLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNT--------------  247 (468)
Q Consensus       196 ~~~--------~~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~--------------  247 (468)
                      ...        ......+||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+..              
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            421        12234579999999999874      37899999999999999999999997654              


Q ss_pred             -hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          248 -KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       248 -~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                       ...+.+.+......++...+..+++++++||.+||+.||.+|||++|+++||||++..
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence             2446677777777766555567899999999999999999999999999999997643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.3e-51  Score=405.10  Aligned_cols=248  Identities=23%  Similarity=0.273  Sum_probs=193.4

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC----
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED----  115 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~----  115 (468)
                      ..+|.+.++||+|+||+||+|++  +|+.||||++....    ......+.|+..+.+++ |||||++++++.+++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence            35699999999999999999987  58999999986542    12223344566666775 999999999997654    


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecccCCCcEEEeecCCCCCEEEe
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI--------GVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      .+|||||||+||+|.++++. ..++++.+..++.|++.||.|||++        +|+||||||+||||+.++.   +||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~---~Ki~  150 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC---EEEC
T ss_pred             EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC---EEEE
Confidence            68999999999999999987 5689999999999999999999987        9999999999999987665   9999


Q ss_pred             ecCceeeecCCCcc-----ccCCCCCCCcChhhhcCC-------CCCcchHHHHHHHHHHHHhCCCCCCCC---------
Q 012203          188 DFGLATYIEPGQSL-----LGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSGMPPFWGN---------  246 (468)
Q Consensus       188 DFGla~~~~~~~~~-----~~~~GT~~Y~APE~l~~~-------~~~~sDiwSlGvil~elltG~~Pf~~~---------  246 (468)
                      |||+|+........     ...+||+.|||||++.+.       |+.++|||||||++|||++|++||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            99999887654322     245899999999999753       567899999999999999998765321         


Q ss_pred             ------ChHHHHHHHHhccCCC--CCCC-CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          247 ------TKSRIFDAVRTADLRF--PSNP-WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       247 ------~~~~~~~~i~~~~~~~--~~~~-~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                            ....+...+.....+.  |... ....++.+.+|+.+||+.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                  1233344443333322  2111 11234578999999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-50  Score=417.32  Aligned_cols=260  Identities=35%  Similarity=0.650  Sum_probs=220.3

Q ss_pred             cccCCeEEE-eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 012203           38 NLRERFVLG-QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED---  113 (468)
Q Consensus        38 ~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~---  113 (468)
                      .+.++|.+. +.||+|+||+||+|.++.+|+.||||++...        ..+.+|++++.++.+||||++++++|..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            455678876 7999999999999999999999999998642        3567889988777679999999999976   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          114 -EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       114 -~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                       .+.+|||||||+||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             678999999999999999998753  59999999999999999999999999999999999999875556679999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhccCCCCCC
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTADLRFPSN  265 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~  265 (468)
                      +++...........+||+.|+|||++.+. |+.++|||||||++|+|++|+.||......    .....+......++..
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            99987655556678999999999999764 899999999999999999999999765532    2566777777888877


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .|..+++++.+||.+||..||++|||+.|+++||||.+..
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            7889999999999999999999999999999999997644

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.4e-51  Score=409.90  Aligned_cols=262  Identities=39%  Similarity=0.690  Sum_probs=212.3

Q ss_pred             cccCCeEEE---eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           38 NLRERFVLG---QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        38 ~l~~~y~i~---~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .+.++|++.   +.||+|+||+||+|.++.+|+.||+|++.+.      ....+.+|+.+++++.+||||+++++++.+.
T Consensus         5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~   78 (325)
T 3kn6_A            5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ   78 (325)
T ss_dssp             HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            355678885   7899999999999999999999999999654      3456778999999997899999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999999999999988999999999999999999999999999999999999998766555699999999987


Q ss_pred             ecCC-CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhccCCCCCC
Q 012203          195 IEPG-QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT-------KSRIFDAVRTADLRFPSN  265 (468)
Q Consensus       195 ~~~~-~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~  265 (468)
                      .... ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+       ..++.+.+......++..
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            6543 234567899999999999875 8999999999999999999999997643       356777777777777766


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .|..+++++++||.+||..||.+|||++|+++||||++..
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            6678999999999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.4e-50  Score=404.27  Aligned_cols=271  Identities=32%  Similarity=0.569  Sum_probs=237.3

Q ss_pred             cccccccCCeEEE-eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           34 NQISNLRERFVLG-QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        34 ~~~~~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ...+.+.++|.+. +.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++++.+||||+++++++.
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            3345678889998 899999999999999999999999999987543 23346778899999999987899999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      +.+.+++||||++||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.....+.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            999999999999999999998543  679999999999999999999999999999999999999874445569999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ++............+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+....+......++...+..
T Consensus       180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  259 (327)
T 3lm5_A          180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS  259 (327)
T ss_dssp             GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred             cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence            99987766555667899999999999875 89999999999999999999999999999888888888888888777788


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            999999999999999999999999999999997644

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-50  Score=414.73  Aligned_cols=259  Identities=29%  Similarity=0.518  Sum_probs=230.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+++|+++. ||||++++++|.+.+.+|
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEE
Confidence            3477999999999999999999999999999999998765434445678889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH---VHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC---EEEeccceeeeccCC
Confidence            99999999999999999889999999999999999999999999999999999999986654   999999999988776


Q ss_pred             CccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          199 QSLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGN---TKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ....+.+||+.|+|||++.+    .|+.++|||||||++|+|++|+.||...   ....+...+......++    ..++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s  244 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWS  244 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCC
Confidence            66778899999999999963    3899999999999999999999999743   34555666666655555    4689


Q ss_pred             HHHHHHHHHccccCCCCCCC-HHHHHhCcCCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLT-ARQVLDHSWMGDGI  305 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt-~~eiL~h~~~~~~~  305 (468)
                      +.+.+||.+||.+||.+||+ ++++++||||.+..
T Consensus       245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            99999999999999999998 99999999997643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-51  Score=415.75  Aligned_cols=259  Identities=34%  Similarity=0.622  Sum_probs=225.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|++++++++ ||||+++++++.+.+.+
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence            45578999999999999999999999999999999997653322233457889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTD  160 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC---EEECCSSCTBTTTT
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC---EEEEEeccceeccC
Confidence            9999999 7899999988889999999999999999999999999999999999999986655   99999999988776


Q ss_pred             CCccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      +......+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.....+...+......+|    ..+++++.
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  236 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQ  236 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHH
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHH
Confidence            6666778999999999999875 4 7899999999999999999999987665544433333333333    46899999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +||.+||..||.+|||++|+++||||+...
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence            999999999999999999999999997643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6e-50  Score=396.84  Aligned_cols=266  Identities=30%  Similarity=0.426  Sum_probs=218.3

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC--hhhHHHHHHHHHHHHHhc--CCCCceeeeEEEE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT--IDDERSVKLEIEIMTRLS--GHPNVVDLKAVYE  112 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~--~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~  112 (468)
                      +.+.++|++++.||+|+||+||+|+++.+|+.||+|++.......  ......+.+|+++++++.  +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            346789999999999999999999999999999999997543211  112245667888877775  4999999999998


Q ss_pred             eCC-----EEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEE
Q 012203          113 DED-----YVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       113 ~~~-----~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                      ...     .+++||||+. ++|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++.   +|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~---~k  160 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VK  160 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC---EE
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC---EE
Confidence            765     6899999996 699999987654  999999999999999999999999999999999999986654   99


Q ss_pred             EeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 012203          186 LADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS  264 (468)
Q Consensus       186 L~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  264 (468)
                      |+|||++............+||+.|+|||++.+. ++.++|||||||++|+|++|++||.+.+..+....+.......+.
T Consensus       161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9999999877655556677899999999999764 899999999999999999999999998888777776553322222


Q ss_pred             CC-----------------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          265 NP-----------------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       265 ~~-----------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ..                       ...+++.+.+||.+||+.||++|||+.|+|+||||++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            21                       1357899999999999999999999999999999987544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.2e-50  Score=398.24  Aligned_cols=266  Identities=29%  Similarity=0.478  Sum_probs=219.0

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ....+.+.++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+++++++. ||||+++++++.
T Consensus        13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~   89 (311)
T 3niz_A           13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIH   89 (311)
T ss_dssp             --CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             ceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEc
Confidence            3456678999999999999999999999996 599999999976532 2233467889999999996 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      +.+.+++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~  165 (311)
T 3niz_A           90 SERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGL  165 (311)
T ss_dssp             CSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTT
T ss_pred             cCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC---EEEccCcC
Confidence            99999999999975 888888664 45999999999999999999999999999999999999987655   99999999


Q ss_pred             eeeecCC-CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC--
Q 012203          192 ATYIEPG-QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP--  266 (468)
Q Consensus       192 a~~~~~~-~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--  266 (468)
                      +...... ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+...........  
T Consensus       166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            9876533 33445689999999999976  389999999999999999999999988777666665543221111111  


Q ss_pred             ------------------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          267 ------------------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       267 ------------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                              ...+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                    124678999999999999999999999999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-49  Score=391.95  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=217.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|++++++++ ||||+++++++.+++.+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence            579999999999999999999999999999999987643 3344567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-
Q 012203          121 MELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-  198 (468)
                      |||+.+ +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecccceecCCcc
Confidence            999976 5555554 4678999999999999999999999999999999999999987655   999999999876533 


Q ss_pred             CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhccCCCCCC----------
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPP-FWGNTKSRIFDAVRTADLRFPSN----------  265 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~----------  265 (468)
                      ......+||+.|+|||++.+.  ++.++|||||||++|+|++|..| |.+.+..+....+.......+..          
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            334456899999999999764  79999999999999999988777 55566666666654422211111          


Q ss_pred             ---------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          266 ---------------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       266 ---------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                     ....+++++++||.+||+.||++|||++|+++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                           123578999999999999999999999999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-50  Score=422.45  Aligned_cols=258  Identities=33%  Similarity=0.592  Sum_probs=222.1

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEE
Confidence            4567999999999999999999999999999999998764444445567788999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeec-
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIE-  196 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~-  196 (468)
                      |||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.++.   +||+|||+++... 
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKEGIK  301 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC---EEECCCCCCCTTCC
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC---EEEccCCCceeccC
Confidence            999999999999999988899999999999999999999998 99999999999999987654   9999999997633 


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ........+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+...+.+.+......++    ..+++++.
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  377 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAK  377 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence            23344567899999999999875 99999999999999999999999999999999999988877766    46899999


Q ss_pred             HHHHHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      +||.+||++||.+||     +++|+++||||.+.
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999999     99999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.7e-49  Score=388.30  Aligned_cols=267  Identities=37%  Similarity=0.673  Sum_probs=238.6

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC------hhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT------IDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~------~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      ...+.++|++.+.||+|+||.||+|.++.+|+.||+|++.......      ....+.+.+|+++++++.+||||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            4567899999999999999999999999999999999997653211      1224567889999999977999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          110 VYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       110 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                      ++.+.+..++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~df  168 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDF  168 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCC
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc---EEEecc
Confidence            99999999999999999999999998889999999999999999999999999999999999999986655   999999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhc-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLA-------GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~-------~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      |++.............||+.|+|||++.       ..++.++||||||+++|+|++|+.||...+.......+......+
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            9999887666666778999999999985       237889999999999999999999999988888888888888877


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +...+..+++.+.++|.+||..||.+|||+.|+++||||++..
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            7777778999999999999999999999999999999998654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-49  Score=399.56  Aligned_cols=258  Identities=33%  Similarity=0.544  Sum_probs=218.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCCC-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~~-~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ..++|++.+.||+|+||.||+|++.   .+|+.||+|++.+..... ......+.+|+++|+++. ||||+++++++.+.
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence            4567999999999999999999985   689999999998764322 233456788999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~~~  170 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKE  170 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC---EEECCCSCC--
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc---EEEEeCCcccc
Confidence            999999999999999999998889999999999999999999999999999999999999986554   99999999976


Q ss_pred             ecC-CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          195 IEP-GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       195 ~~~-~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ... .......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+..+.+......++    ..+++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~  246 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQ  246 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCH
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCH
Confidence            433 2334567899999999999775 89999999999999999999999999998888888888776665    46899


Q ss_pred             HHHHHHHHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      ++.+||.+||..||.+||     ++.|+++||||+..
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            999999999999999999     89999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-49  Score=406.29  Aligned_cols=263  Identities=36%  Similarity=0.679  Sum_probs=235.4

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC-Ch----hhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV-TI----DDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~-~~----~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      ..+.++|++.+.||+|+||.||+|+++.+|+.||||++...... ..    ...+.+.+|+.+++++.+||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            44667899999999999999999999999999999999765321 11    12456788999999996699999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      ...+..|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~---ikl~DfG~  246 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ---IRLSDFGF  246 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEEEecCc
Confidence            999999999999999999999998888999999999999999999999999999999999999986554   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcC-------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS  264 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  264 (468)
                      +..+.........+||+.|+|||++.+       .++.++|||||||++|+|++|+.||...........+......++.
T Consensus       247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  326 (365)
T 2y7j_A          247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS  326 (365)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            998877666677899999999999863       3788999999999999999999999998888888888887777665


Q ss_pred             CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       265 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      ..|..++..+.++|.+||..||++|||+.|+++||||+
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            55678899999999999999999999999999999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-50  Score=423.67  Aligned_cols=260  Identities=37%  Similarity=0.661  Sum_probs=235.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|.+++.||+|+||+||+|+++.+|+.||+|++.+......+....+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            35578999999999999999999999999999999997654333334567899999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~---vkL~DFG~a~~~~~  168 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSD  168 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC---EEECCCSSCEECCT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC---eEEEeccchhhccc
Confidence            999999999999999988888999999999999999999999999999999999999987655   99999999998876


Q ss_pred             CCccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      +....+.+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.+...+...+.......+    ..+++++.
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  244 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVI  244 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHH
Confidence            6666778999999999999875 3 6799999999999999999999999888888888887765544    46889999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +||.+||+.||.+|||++|+++||||++..
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            999999999999999999999999997654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-49  Score=403.48  Aligned_cols=260  Identities=36%  Similarity=0.615  Sum_probs=212.8

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++++.||+|+||+||+|+++.+|+.||+|++.+....    ...+.+|+.++++++ ||||+++++++.+.+.+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLR-HPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEE
Confidence            4567899999999999999999999999999999999765322    256788999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+||||++||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++....
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-SCCEEECCCCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CceEEEeecCccccccc
Confidence            99999999999999998888999999999999999999999999999999999999997543 24599999999986554


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCc-chHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccCCCCCCCCCCCC
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQA-ADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~-sDiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      .......+||+.|+|||++.+. ++.+ +|||||||++|+|++|+.||.+...    ......+......++.  ...++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s  248 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRIS  248 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCC
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCC
Confidence            4455567899999999999775 5544 8999999999999999999976443    3445555555554443  24689


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +++.+||.+||++||.+|||+.|+++||||....
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            9999999999999999999999999999996643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.5e-49  Score=397.03  Aligned_cols=261  Identities=36%  Similarity=0.566  Sum_probs=235.2

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ....++|.+++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCe
Confidence            346778999999999999999999999999999999998776556666778899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg~~~~~~  192 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVE  192 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC---EEEeeccCceecc
Confidence            9999999999999999998889999999999999999999999999999999999999986554   9999999998765


Q ss_pred             CC-CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          197 PG-QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       197 ~~-~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .. .......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+....+......++    ..+++.+
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~  268 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVA  268 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHH
Confidence            32 334456899999999999875 88999999999999999999999998888888888777766555    4688999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+||.+||+.||++|||++|+++|+||....
T Consensus       269 ~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          269 ASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999997654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-49  Score=393.14  Aligned_cols=265  Identities=40%  Similarity=0.737  Sum_probs=234.0

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ...+.++|++.+.||+|+||.||+|+++.+|+.||+|++.....   .....+.+|+.+++++. ||||+++++++.+.+
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIK-HENIVTLEDIYESTT   79 (304)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCC-CCCeeehhhhcccCC
Confidence            34577899999999999999999999999999999999986532   23456889999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+..++..+.+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999999999999988889999999999999999999999999999999999999954444566999999998764


Q ss_pred             cCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      ... .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+.....+.+......++...+..+++++
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          160 QNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            432 23345799999999999875 8999999999999999999999999999889999998888777777778899999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .++|.+||..||++|||++|+++||||....
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999997643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.7e-49  Score=387.93  Aligned_cols=264  Identities=38%  Similarity=0.680  Sum_probs=230.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      +.++|++.+.||+|+||.||+|+++.+|+.||+|++.+......   ...+.+.+|+.+++++. ||||+++++++.+.+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence            56789999999999999999999999999999999987644322   13577899999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC-CCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS-SSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~-~~~ikL~DFGla~~  194 (468)
                      ..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++. ...+||+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            99999999999999999988888999999999999999999999999999999999999987552 23599999999988


Q ss_pred             ecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          195 IEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       195 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ...........||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+....+......++...+..+++.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            7665555667899999999999865 899999999999999999999999998888888888777666655445678999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +.++|.+||..||++|||+.|+++||||+.
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            999999999999999999999999999965

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-49  Score=388.77  Aligned_cols=258  Identities=33%  Similarity=0.634  Sum_probs=227.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEE
Confidence            4567999999999999999999999999999999997654333334567889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~---~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC---EEECSCCEESCC---
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC---EEEEeccccccCCcc
Confidence            99999999999999998889999999999999999999999999999999999999986655   999999998654432


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                       ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+....+......++    ..+++.+.+|
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  237 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL  237 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence             23456899999999999875 78999999999999999999999999998888888887776665    4688999999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      |.+||+.||.+|||+.|+++||||+...
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCc
Confidence            9999999999999999999999997644

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-49  Score=398.78  Aligned_cols=260  Identities=33%  Similarity=0.566  Sum_probs=220.3

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++++.||+|+||+||+|+++.+++.||+|++.....  ....+.+.+|+.+++++. ||||+++++++.+.+..
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeE
Confidence            366889999999999999999999999999999999976532  223456889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..+..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRY  157 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCEECEE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC---EEEEEeeccceecc
Confidence            999999999999999988888999999999999999999999999999999999999986655   99999999987543


Q ss_pred             CC---ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccCCCCCCCCCCCC
Q 012203          198 GQ---SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-RIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       198 ~~---~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ..   .....+||+.|+|||++.+.  ++.++|||||||++|+|++|+.||...... ...........  ....+..++
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKID  235 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSC
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCC
Confidence            22   23457899999999999875  477899999999999999999999765543 33333333222  223357899


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +.+.+||.+||+.||++|||++|+++||||++..
T Consensus       236 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999999999997643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-49  Score=391.16  Aligned_cols=266  Identities=42%  Similarity=0.736  Sum_probs=240.0

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+.++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+++++++. ||||+++++++.+.+.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCe
Confidence            4466789999999999999999999999999999999976543 2334677889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +++||||+++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888899999999999999999999999999999999999999876666679999999998766


Q ss_pred             CCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|+.||.+.+..+....+......++...+..+++++.+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            55545556789999999999988999999999999999999999999999988888888888777666666789999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +|.+||..||++|||+.|+++||||++.
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=406.85  Aligned_cols=261  Identities=33%  Similarity=0.605  Sum_probs=228.5

Q ss_pred             ccCCeEE--EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           39 LRERFVL--GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        39 l~~~y~i--~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +...|.+  .+.||+|+||.||+|+++.+|+.||+|++....   ....+.+.+|+++|+++. ||||+++++++.+.+.
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND  160 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            4455666  678999999999999999999999999997653   345678899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      ++|||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+|||++...
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD-AKQIKIIDFGLARRY  239 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-TTEEEECCCSSCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-CCcEEEEeCCCceec
Confidence            99999999999999988654 4699999999999999999999999999999999999996432 345999999999988


Q ss_pred             cCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .........+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......++...+..+++++
T Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence            766666677899999999999875 8899999999999999999999999999888888888887777766677899999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ++||.+||++||.+|||++|+++||||++.
T Consensus       320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          320 KEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999999653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.8e-49  Score=388.61  Aligned_cols=256  Identities=31%  Similarity=0.505  Sum_probs=213.1

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|++ .+|+.||+|++..... .......+.+|++++++++ ||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence            5799999999999999999999 5899999999976532 2223467788999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-  198 (468)
                      |||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEEeECccccccCccc
Confidence            999975 999998764 67999999999999999999999999999999999999986655   999999999765432 


Q ss_pred             CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC------------
Q 012203          199 QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS------------  264 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------  264 (468)
                      ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.......+.            
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            23345689999999999976  3899999999999999999999999988877666655432111000            


Q ss_pred             -------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          265 -------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       265 -------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                                   .....+++++.+||.+||+.||++|||++|+++||||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                         012357899999999999999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=392.34  Aligned_cols=256  Identities=32%  Similarity=0.602  Sum_probs=218.4

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh-----------------------hhHHHHHHHHHHHH
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI-----------------------DDERSVKLEIEIMT   96 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~-----------------------~~~~~~~~Ei~iL~   96 (468)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+......                       ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4679999999999999999999999999999999977643211                       12356889999999


Q ss_pred             HhcCCCCceeeeEEEEe--CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEE
Q 012203           97 RLSGHPNVVDLKAVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENIL  174 (468)
Q Consensus        97 ~L~~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NIL  174 (468)
                      ++. ||||+++++++.+  .+.+|+||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        92 ~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           92 KLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             TCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            996 9999999999986  678999999999999987654 357999999999999999999999999999999999999


Q ss_pred             EeecCCCCCEEEeecCceeeecCCC-ccccCCCCCCCcChhhhcCC----CCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 012203          175 LATKASSSPIKLADFGLATYIEPGQ-SLLGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGNTKS  249 (468)
Q Consensus       175 l~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~----~~~~sDiwSlGvil~elltG~~Pf~~~~~~  249 (468)
                      ++.++.   +||+|||++....... ......||+.|+|||++.+.    ++.++|||||||++|+|++|+.||......
T Consensus       170 ~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          170 VGEDGH---IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             ECTTSC---EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ECCCCC---EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            986654   9999999998875433 33456899999999999764    367899999999999999999999988888


Q ss_pred             HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          250 RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      .....+......++..  ..+++++.+||.+||+.||++|||+.|+++||||+
T Consensus       247 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 CLHSKIKSQALEFPDQ--PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHCCCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHhcccCCCCCc--cccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            8777777766655543  57899999999999999999999999999999984

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5e-49  Score=398.65  Aligned_cols=276  Identities=24%  Similarity=0.396  Sum_probs=228.5

Q ss_pred             cccccchhhhhcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc
Q 012203           20 CYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS   99 (468)
Q Consensus        20 ~~~~~s~~~~i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~   99 (468)
                      ..--..-...-+...+...+.++|++++.||+|+||+||+|++..+++.||+|++...    .........|+++++++.
T Consensus        14 ~~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~   89 (360)
T 3llt_A           14 LYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQ   89 (360)
T ss_dssp             ------CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTC
T ss_pred             eeeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhc
Confidence            3334444445566777788999999999999999999999999999999999999643    234566788999999996


Q ss_pred             ----CCCCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcE
Q 012203          100 ----GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENI  173 (468)
Q Consensus       100 ----~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NI  173 (468)
                          +||||+++++++...+.+++||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||
T Consensus        90 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  168 (360)
T 3llt_A           90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENI  168 (360)
T ss_dssp             CCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             ccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccE
Confidence                5999999999999999999999999 999999998754  499999999999999999999999999999999999


Q ss_pred             EEeecC----------------------CCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHH
Q 012203          174 LLATKA----------------------SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAG  230 (468)
Q Consensus       174 Ll~~~~----------------------~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlG  230 (468)
                      |++.+.                      ..+.+||+|||++.....  .....+||+.|+|||++.+. ++.++||||||
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  246 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG  246 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence            997421                      245699999999987443  33467899999999999875 99999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC---------------------C---------------------C
Q 012203          231 VILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP---------------------W---------------------D  268 (468)
Q Consensus       231 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------~---------------------~  268 (468)
                      |++|+|++|+.||...+..+....+......++...                     |                     .
T Consensus       247 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  326 (360)
T 3llt_A          247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI  326 (360)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred             HHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence            999999999999998888777776655433222100                     0                     0


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      ..++.+.+||.+||+.||++|||++|+|+||||+
T Consensus       327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             chHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            1236788999999999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.2e-49  Score=385.46  Aligned_cols=260  Identities=36%  Similarity=0.568  Sum_probs=234.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+.+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEE
Confidence            46678999999999999999999999999999999998776555666778899999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~  167 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEY  167 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC---EEEEeccCceeccc
Confidence            999999999999999998889999999999999999999999999999999999999986554   99999999987653


Q ss_pred             C-CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 G-QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~-~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      . .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+......++    ..+++.+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  243 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAA  243 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHH
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHH
Confidence            2 334456899999999999875 88999999999999999999999999888888777777665554    46889999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++|.+||+.||++|||++|+++|+||.+..
T Consensus       244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          244 SLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            999999999999999999999999997654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.6e-49  Score=396.98  Aligned_cols=266  Identities=26%  Similarity=0.443  Sum_probs=214.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+++++++. ||||+++++++.+++.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEE
Confidence            355679999999999999999999999999999999976542 2233456778999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC--CCCEEEeecCceeee
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS--SSPIKLADFGLATYI  195 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~--~~~ikL~DFGla~~~  195 (468)
                      ++||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  ...+||+|||++...
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99999997 599999999889999999999999999999999999999999999999965432  345999999999765


Q ss_pred             cCC-CccccCCCCCCCcChhhhcC-C-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC-----
Q 012203          196 EPG-QSLLGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW-----  267 (468)
Q Consensus       196 ~~~-~~~~~~~GT~~Y~APE~l~~-~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-----  267 (468)
                      ... ......+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+....+....+.......+...|     
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            432 23345688999999999976 3 799999999999999999999999988877766666543221111111     


Q ss_pred             ---------------------CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          268 ---------------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       268 ---------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                           ..+++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                                 116789999999999999999999999999999987553

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.1e-50  Score=402.35  Aligned_cols=270  Identities=35%  Similarity=0.624  Sum_probs=230.9

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC--ChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--TIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~--~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      ..+..+.++|++.+.||+|+||+||+|.++.+++.||+|++.+....  .....+.+.+|++++++++ ||||+++++++
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~   97 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY   97 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence            33456788999999999999999999999999999999999765321  2345678899999999996 99999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHc----------------------------------------CCCCHHHHHHHHHHH
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKF----------------------------------------GRFSEAEARVLFMQL  151 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~----------------------------------------~~l~~~~~~~i~~qi  151 (468)
                      .+.+..++|||||+||+|.+++...                                        ..+++..++.++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            9999999999999999999988421                                        123677888999999


Q ss_pred             HHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-----ccccCCCCCCCcChhhhcC---CCCCc
Q 012203          152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-----SLLGTVGSPFYIAPEVLAG---GYNQA  223 (468)
Q Consensus       152 l~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~---~~~~~  223 (468)
                      +.||.|||++||+||||||+|||++.++ ...+||+|||++..+....     ......||+.|+|||++.+   .++.+
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            9999999999999999999999997654 2359999999998764321     2345689999999999974   48899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       224 sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +|||||||++|+|++|+.||.+.+..+....+......++...+..+++++.+||.+||..||.+||++.|+++||||++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            99999999999999999999999988888888888877777666779999999999999999999999999999999977


Q ss_pred             CC
Q 012203          304 GI  305 (468)
Q Consensus       304 ~~  305 (468)
                      ..
T Consensus       337 ~~  338 (345)
T 3hko_A          337 FS  338 (345)
T ss_dssp             TS
T ss_pred             Ch
Confidence            54

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.7e-49  Score=425.05  Aligned_cols=259  Identities=32%  Similarity=0.545  Sum_probs=229.7

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+++|+++. ||||+++++++++.+.+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEE
Confidence            34577999999999999999999999999999999997764433344567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          118 HLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      |+||||++||+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++..
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~---vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH---IRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC---eEEEecccceec
Confidence            999999999999999987544  999999999999999999999999999999999999986554   999999999988


Q ss_pred             cCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhccCCCCCCCCCCC
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT----KSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .........+||+.|+|||++.+. |+.++|||||||++|||++|+.||....    ...+.+.+......++    ..+
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~  412 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERF  412 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred             ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccC
Confidence            766666678999999999999875 8999999999999999999999998753    3556666666555554    578


Q ss_pred             CHHHHHHHHHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          271 SDSAKDLVMGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      ++++++||.+||++||.+||     +++|+++||||+..
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999999999999     79999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-49  Score=393.94  Aligned_cols=259  Identities=29%  Similarity=0.477  Sum_probs=207.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++....  .......+.+|+++++++. ||||+++++++.+++.+|+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEE
Confidence            467999999999999999999999999999999997653  2223456788999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          120 VMELCAGGELFHRLEKF------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      ||||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLAR  156 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCSSCE
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC---EEECcCccce
Confidence            999997 5999998764      35899999999999999999999999999999999999987655   9999999998


Q ss_pred             eecCC-CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC-----
Q 012203          194 YIEPG-QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN-----  265 (468)
Q Consensus       194 ~~~~~-~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-----  265 (468)
                      ..... ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.......+..     
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            76533 23345689999999999976  38999999999999999999999999988877777665421111100     


Q ss_pred             -------------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          266 -------------------------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       266 -------------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                               ....++.++.+||.+||+.||++|||++|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                                     1125788999999999999999999999999999997644

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.2e-50  Score=416.94  Aligned_cols=265  Identities=36%  Similarity=0.691  Sum_probs=220.5

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC-----hhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----IDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~-----~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      ..+.++|.+.+.||+|+||+||+|.++.+++.||+|++.+.....     ......+.+|+++|+++. ||||+++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  209 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF  209 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            346789999999999999999999999999999999998754321     112235788999999995 99999999998


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      .. +.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            64 55899999999999999998888999999999999999999999999999999999999998766666799999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCCCCCCC
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~  266 (468)
                      ++...........+||+.|+|||++.+    .++.++|||||||++|+|++|+.||..... ..+.+.+......+....
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            988766555567889999999999853    478899999999999999999999976443 345566666666665555


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      |..+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            6778999999999999999999999999999999965

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-49  Score=405.45  Aligned_cols=261  Identities=33%  Similarity=0.527  Sum_probs=212.3

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED--  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~--  115 (468)
                      .+.++|++++.||+|+||+||+|.++.+|+.||+|++.+.. ........+.+|+.+++++.+||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            45678999999999999999999999999999999986542 345556778899999999977999999999997554  


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+|+|||||. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.+
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~  159 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH---VKVADFGLSRSF  159 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEES
T ss_pred             EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC---EEecCCcccccc
Confidence            7999999996 689999976 57999999999999999999999999999999999999987654   999999999875


Q ss_pred             cC----------------------CCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 012203          196 EP----------------------GQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRI  251 (468)
Q Consensus       196 ~~----------------------~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~  251 (468)
                      ..                      .......+||+.|+|||++.+  .++.++|||||||++|||++|++||.+.+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            32                      112334689999999999976  489999999999999999999999999888777


Q ss_pred             HHHHHhccCCCCC--------------------------------------------CCCCCCCHHHHHHHHHccccCCC
Q 012203          252 FDAVRTADLRFPS--------------------------------------------NPWDHISDSAKDLVMGMLSTDPS  287 (468)
Q Consensus       252 ~~~i~~~~~~~~~--------------------------------------------~~~~~~s~~l~~li~~~L~~dP~  287 (468)
                      +..+.... ..|.                                            .++..+++++.+||.+||+.||+
T Consensus       240 ~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          240 LERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            76664321 1111                                            01126788999999999999999


Q ss_pred             CCCCHHHHHhCcCCCCCC
Q 012203          288 QRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       288 ~Rpt~~eiL~h~~~~~~~  305 (468)
                      +|||++|+|+||||+...
T Consensus       319 ~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFH  336 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTC
T ss_pred             cCCCHHHHhCCHHHHHhc
Confidence            999999999999997643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=391.24  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=213.3

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++.++||+|+||+||+|+++.+|+.||||++..... ..........|+..+.++.+||||+++++++.+.+.+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            355789999999999999999999999999999999876533 3334455566777777775699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kl~DFG~a~~~~  208 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELG  208 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC---EEECCCTTCEECC
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC---EEEccceeeeecc
Confidence            9999999 77999888665 45999999999999999999999999999999999999987665   9999999998876


Q ss_pred             CCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      .........||+.|+|||++.+.++.++|||||||++|||++|..||...   .....+....  .+...+..+++++.+
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~l~~  283 (311)
T 3p1a_A          209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGY--LPPEFTAGLSSELRS  283 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTC--CCHHHHTTSCHHHHH
T ss_pred             cCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccC--CCcccccCCCHHHHH
Confidence            65555667899999999999988999999999999999999997776543   2233333322  222223568999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +|.+||+.||++|||++|+++||||++
T Consensus       284 li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          284 VLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.4e-49  Score=388.09  Aligned_cols=262  Identities=31%  Similarity=0.518  Sum_probs=217.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+++++++. ||||+++++++.+.+..+
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEE
Confidence            35789999999999999999999999999999999876532 3334567888999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGP  155 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC--
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC---EEEeeCCCchhccCc
Confidence            99999999999999988888999999999999999999999999999999999999986554   999999999876533


Q ss_pred             -CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---------------
Q 012203          199 -QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL---------------  260 (468)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------  260 (468)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.....               
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence             23345689999999999976  379999999999999999999999998887766655543211               


Q ss_pred             ----CCCCC--------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 ----RFPSN--------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 ----~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                          ..+..        .+..+++++.+||.+||..||.+|||++|+++||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence                11110        0246788999999999999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.7e-49  Score=401.48  Aligned_cols=262  Identities=19%  Similarity=0.283  Sum_probs=217.3

Q ss_pred             ccCCeEEEeEEeec--CCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           39 LRERFVLGQQLGWG--QFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        39 l~~~y~i~~~LG~G--~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      -.++|++++.||+|  +||.||+|+++.+|+.||+|++..... .......+.+|+.+++++. ||||+++++++.+.+.
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNE  100 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCE
Confidence            44679999999999  999999999999999999999987643 3455677889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          117 VHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +|+|||||++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~---~kl~dfg~~~~  177 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLS  177 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCGGGCEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEccccccee
Confidence            99999999999999999876  67999999999999999999999999999999999999986654   99999999865


Q ss_pred             ecCCC--------ccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--
Q 012203          195 IEPGQ--------SLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR--  261 (468)
Q Consensus       195 ~~~~~--------~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--  261 (468)
                      .....        .....+||+.|+|||++.+   .++.++|||||||++|+|++|+.||.+.+.......+......  
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            43211        1223479999999999986   3899999999999999999999999876654444332221110  


Q ss_pred             ----------------------------------------CCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          262 ----------------------------------------FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       262 ----------------------------------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                                                              .....+..+++.+.+||.+||+.||++|||++|+|+||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence                                                    0011234678899999999999999999999999999999


Q ss_pred             CCCC
Q 012203          302 GDGI  305 (468)
Q Consensus       302 ~~~~  305 (468)
                      ++..
T Consensus       338 ~~~~  341 (389)
T 3gni_B          338 KQIK  341 (389)
T ss_dssp             GGC-
T ss_pred             HHHh
Confidence            7643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.5e-49  Score=384.21  Aligned_cols=261  Identities=38%  Similarity=0.682  Sum_probs=222.5

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ....++|++++.||+|+||.||+|.++.+|+.||+|++.............+.+|+++++++. ||||+++++++.+.+.
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTD   85 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCe
Confidence            345678999999999999999999999999999999997653322334567889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~dfg~~~~~~  162 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMMS  162 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC---EEECCCCGGGCCC
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC---EEEeecccccccC
Confidence            9999999999999999998889999999999999999999999999999999999999986554   9999999998776


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .........||+.|+|||++.+. + +.++||||||+++|+|++|+.||.........+.+......++    ..++..+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l  238 (276)
T 2h6d_A          163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSV  238 (276)
T ss_dssp             C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHH
Confidence            55555567899999999999875 3 6799999999999999999999998888888888877665544    4678999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .++|.+||+.||.+|||+.|+++||||++..
T Consensus       239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence            9999999999999999999999999997654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2e-49  Score=395.88  Aligned_cols=264  Identities=38%  Similarity=0.706  Sum_probs=223.7

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC-----ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV-----TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~-----~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      .+.++|++.+.||+|+||.||+|+++.+++.||+|++.+....     .......+.+|+++++++. ||||+++++++.
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEc
Confidence            4667899999999999999999999999999999999765431     1122345788999999995 999999999997


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      .++ +|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            765 8999999999999999988888999999999999999999999999999999999999987766667999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~  267 (468)
                      .............||+.|+|||++.    ..++.++|||||||++|+|++|+.||..... ..+...+......+....+
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            8876554445668999999999974    2488999999999999999999999976543 2455556555555444444


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ..+++.+.+||.+||..||++|||+.++++||||++
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            678999999999999999999999999999999965

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.9e-49  Score=415.18  Aligned_cols=260  Identities=25%  Similarity=0.400  Sum_probs=212.5

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE---  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~---  114 (468)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+++. ||||+++++++...   
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence            45689999999999999999999999999999999997653 24455678889999999995 99999999999654   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                         ..+||||||+.+ +|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~---~kl~DFG~  210 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL  210 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCC
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC---EEEEEEEe
Confidence               468999999965 57777653  5999999999999999999999999999999999999987655   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF--------  262 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------  262 (468)
                      ++...........+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.+..+.+..+.......        
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            9987766566678999999999999875 9999999999999999999999999988777666654421110        


Q ss_pred             --------------CCCCC-----C-----------CCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          263 --------------PSNPW-----D-----------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       263 --------------~~~~~-----~-----------~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                    ....+     .           ..++++++||.+||+.||++|||++|+|+||||....
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                          00000     0           0156799999999999999999999999999997643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-49  Score=413.78  Aligned_cols=264  Identities=29%  Similarity=0.455  Sum_probs=202.5

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE----
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE----  112 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~----  112 (468)
                      -.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+++|+++. ||||+++++++.    
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred             CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCc
Confidence            346789999999999999999999999999999999997642 34455678899999999995 999999999994    


Q ss_pred             -eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          113 -DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       113 -~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                       ..+.+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~---~kl~DFGl  202 (458)
T 3rp9_A          127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS---VKVCDFGL  202 (458)
T ss_dssp             TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---EEECCCTT
T ss_pred             ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC---Eeeccccc
Confidence             336799999998 6799999998888999999999999999999999999999999999999987655   99999999


Q ss_pred             eeeecCCC----------------------------ccccCCCCCCCcChhhhc-C-CCCCcchHHHHHHHHHHHHh---
Q 012203          192 ATYIEPGQ----------------------------SLLGTVGSPFYIAPEVLA-G-GYNQAADVWSAGVILYILLS---  238 (468)
Q Consensus       192 a~~~~~~~----------------------------~~~~~~GT~~Y~APE~l~-~-~~~~~sDiwSlGvil~ellt---  238 (468)
                      ++......                            .....+||+.|+|||++. + .|+.++|||||||++|||++   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            98754221                            234568999999999874 3 49999999999999999999   


Q ss_pred             --------CCCCCCCCCh--------------------HHHHHHHHhcc--------------------CCCC-------
Q 012203          239 --------GMPPFWGNTK--------------------SRIFDAVRTAD--------------------LRFP-------  263 (468)
Q Consensus       239 --------G~~Pf~~~~~--------------------~~~~~~i~~~~--------------------~~~~-------  263 (468)
                              |+++|.+...                    .+.+..+....                    ..++       
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    7777765431                    11112111100                    0001       


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ...+..+++++.+||.+||..||++|||++|+|+||||++...
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            1123456899999999999999999999999999999987543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6e-49  Score=383.32  Aligned_cols=259  Identities=37%  Similarity=0.598  Sum_probs=200.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEE
Confidence            3467999999999999999999999999999999997653322233567889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++.....
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~  164 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKM  164 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC---EEECCCTTCEECC-
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEEEeecceeeccC
Confidence            999999999999999875 57999999999999999999999999999999999999986654   99999999987653


Q ss_pred             C-CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 G-QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~-~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      . .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+.......+    ..++.++.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  240 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEAK  240 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHHH
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHHH
Confidence            2 233456899999999999875 88999999999999999999999987766555554443333333    46889999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++|.+||+.||++|||++++++||||.+..
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            999999999999999999999999997644

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.5e-48  Score=382.06  Aligned_cols=257  Identities=34%  Similarity=0.643  Sum_probs=229.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+++++++. ||||+++++++.+.+.++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEE
Confidence            4467999999999999999999999999999999997653322233567889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++......
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC---EEECCCTTCEECSSS
T ss_pred             EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC---EEEecccccccCccc
Confidence            99999999999999998889999999999999999999999999999999999999986554   999999999775432


Q ss_pred             CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          199 QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                       ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+......++    ..++..+.++
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  242 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDL  242 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHH
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHH
Confidence             33456899999999999875 89999999999999999999999998888888888877766555    4688999999


Q ss_pred             HHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          278 VMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      |.+||..||.+||+++|+++||||+..
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            999999999999999999999999653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-48  Score=417.33  Aligned_cols=258  Identities=29%  Similarity=0.514  Sum_probs=227.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++|+++. ||||++++++|++.+.+|
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEE
Confidence            3478999999999999999999999999999999998764433344567889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          119 LVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +||||++||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~---vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC---EEEeecceeee
Confidence            999999999999999764    36999999999999999999999999999999999999987655   99999999998


Q ss_pred             ecCCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhccCCCCCCCCC
Q 012203          195 IEPGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       195 ~~~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      +..... ....+||+.|+|||++.+. |+.++|||||||++|||++|+.||.+.    ...++.+.+......++    .
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~  414 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----D  414 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----T
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----c
Confidence            765443 3456999999999999875 899999999999999999999999775    34567777777666655    4


Q ss_pred             CCCHHHHHHHHHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      .+++++++||.+||++||.+||+     ++++++||||+..
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            78999999999999999999996     5899999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-49  Score=394.51  Aligned_cols=264  Identities=25%  Similarity=0.404  Sum_probs=223.9

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ...+.++|++.+.||+|+||.||+|+++.+++.||+|++.............+.+|+++++++. ||||+++++++....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAET   85 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEE
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccC
Confidence            3457889999999999999999999999999999999998765555555678899999999995 999999999987654


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          116 ----YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       116 ----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                          ..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~  162 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGI  162 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC---EEECCCSC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC---EEEeeccC
Confidence                45999999999999999998889999999999999999999999999999999999999987665   99999999


Q ss_pred             eeeecCCC----ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          192 ATYIEPGQ----SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       192 a~~~~~~~----~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      +.......    .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........+.......+...
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            98765432    22345799999999999875 89999999999999999999999999888777766666655444434


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +..+++++.++|.+||..||.+||++.+++.|+|++.
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            4578999999999999999999999999999999854

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.6e-48  Score=383.99  Aligned_cols=256  Identities=25%  Similarity=0.489  Sum_probs=216.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDY  116 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~~~  116 (468)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++...      ....+.+|+++++++.+||||+++++++.+  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            457899999999999999999999999999999998643      246788999999999779999999999987  678


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      .++||||+.+++|.+++..   +++..++.++.||+.||.|||++||+||||||+|||++.++.  .+||+|||++....
T Consensus       108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECC
T ss_pred             eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC--EEEEEeCCCceEcC
Confidence            9999999999999998854   899999999999999999999999999999999999986542  49999999999887


Q ss_pred             CCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHH-------------HHhccC
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDA-------------VRTADL  260 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~-------------i~~~~~  260 (468)
                      ........+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.... ..+....             +.....
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            6666667789999999999876  38999999999999999999999995432 2222221             111111


Q ss_pred             CC--------------------CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          261 RF--------------------PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       261 ~~--------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..                    .......+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            11                    1111233799999999999999999999999999999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.2e-49  Score=392.99  Aligned_cols=259  Identities=26%  Similarity=0.465  Sum_probs=212.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.....  ......+.+|+++++++. ||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence            579999999999999999999999999999999975431  111123456999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-
Q 012203          121 MELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-  198 (468)
                      |||+. |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... 
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC---EEECSSSEEECC----
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC---EEEccCcccccccCCc
Confidence            99996 59999887754 5999999999999999999999999999999999999987655   999999999865432 


Q ss_pred             CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC---------
Q 012203          199 QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW---------  267 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---------  267 (468)
                      ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.......+...|         
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            23345688999999999876  3899999999999999999999999998888877776553322222111         


Q ss_pred             -----------------CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          268 -----------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       268 -----------------~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                       ..+++++.+||.+||+.||.+|||++|+|+||||.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                             246889999999999999999999999999999976543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.1e-48  Score=393.04  Aligned_cols=260  Identities=26%  Similarity=0.439  Sum_probs=221.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe------
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED------  113 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~------  113 (468)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+++++++. ||||+++++++.+      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence            46799999999999999999999999999999999766432 223456778999999996 9999999999987      


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          114 --EDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       114 --~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                        .+.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg  169 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFG  169 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCT
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC---EEEccch
Confidence              4579999999965 777777654 57999999999999999999999999999999999999987654   9999999


Q ss_pred             ceeeecCC-----CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 012203          191 LATYIEPG-----QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       191 la~~~~~~-----~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                      ++..+...     ......+||+.|+|||++.+.  ++.++|||||||++|+|++|++||.+.+.......+......++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99876522     223456899999999999763  79999999999999999999999999988888887776555554


Q ss_pred             CCCCCCC----------------------------CHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          264 SNPWDHI----------------------------SDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       264 ~~~~~~~----------------------------s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ...|...                            ++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            4433332                            67899999999999999999999999999997644

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.1e-48  Score=386.22  Aligned_cols=254  Identities=27%  Similarity=0.495  Sum_probs=222.8

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      .|...+.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            4888999999999999999999999999999997653   234567889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-c
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-S  200 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~  200 (468)
                      ||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++....... .
T Consensus       122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSSSCC
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc---EEEeeeeeeeecccCccc
Confidence            99999999998865 57999999999999999999999999999999999999986654   9999999998765432 3


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...........+........ .....+++.+.++|.
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  276 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFLE  276 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHHH
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHHH
Confidence            3466899999999999875 89999999999999999999999998888777777665533221 123468899999999


Q ss_pred             HccccCCCCCCCHHHHHhCcCCCCC
Q 012203          280 GMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       280 ~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +||+.||++|||++|+++||||.+.
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HHccCChhhCcCHHHHhcChhhccC
Confidence            9999999999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.4e-48  Score=376.26  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=216.1

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+.++|++.+.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.++.++.+||||+++++++.+.+.
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            4467889999999999999999999999999999999987543 233456788899999999569999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC-------------
Q 012203          117 VHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA-------------  179 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~-------------  179 (468)
                      +++||||++|++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++             
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999999765    6799999999999999999999999999999999999998654             


Q ss_pred             ---CCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 012203          180 ---SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDA  254 (468)
Q Consensus       180 ---~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~  254 (468)
                         ....+||+|||++......   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+|+....   ....
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH
T ss_pred             ccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH
Confidence               3456999999999876543   235699999999999875  5579999999999999999998875432   2334


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +......   .....+++++.++|.+||..||++|||+.|+++||||.+.
T Consensus       240 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          240 IRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            4433321   1225789999999999999999999999999999999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.5e-48  Score=388.48  Aligned_cols=255  Identities=27%  Similarity=0.487  Sum_probs=209.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED--  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~--  115 (468)
                      .+.++|++++.||+|+||.||+|+++.+|+.||+|++....  .....+.+.+|+++|++++ ||||++++++|.+.+  
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSC
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccc
Confidence            45678999999999999999999999999999999997653  3345678899999999996 999999999986543  


Q ss_pred             -------------------------------------------------------EEEEEEeccCCCCHHHHHHHcCC--
Q 012203          116 -------------------------------------------------------YVHLVMELCAGGELFHRLEKFGR--  138 (468)
Q Consensus       116 -------------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~--  138 (468)
                                                                             .+++|||||+|++|.+++.....  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  159 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE  159 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence                                                                   48999999999999999987644  


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-------------ccccC
Q 012203          139 -FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-------------SLLGT  204 (468)
Q Consensus       139 -l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-------------~~~~~  204 (468)
                       ..+..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......             .....
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEECSCC--------------CCCSC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC---EEEeecCcccccccchhhcccccccccccccccc
Confidence             456678999999999999999999999999999999986554   9999999998876532             22345


Q ss_pred             CCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccc
Q 012203          205 VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLS  283 (468)
Q Consensus       205 ~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~  283 (468)
                      +||+.|+|||++.+. ++.++|||||||++|+|++|..|+..  .......+...  .++. .+...++.+.+||.+||+
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~-~~~~~~~~~~~li~~~l~  311 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFPL-LFTQKYPQEHMMVQDMLS  311 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCH-HHHHHCHHHHHHHHHHHC
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCc-ccccCChhHHHHHHHHcc
Confidence            799999999999875 89999999999999999999877521  12222222222  2221 124567789999999999


Q ss_pred             cCCCCCCCHHHHHhCcCCCC
Q 012203          284 TDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       284 ~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .||++|||++|+++||||++
T Consensus       312 ~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          312 PSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SSGGGSCCHHHHHHSTTCCC
T ss_pred             CCCCcCCCHHHHhhchhhhc
Confidence            99999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-47  Score=399.62  Aligned_cols=263  Identities=29%  Similarity=0.482  Sum_probs=212.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC---
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE---  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~---  114 (468)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+++|++++ ||||+++++++...   
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCC
Confidence            36789999999999999999999999999999999997642 34455678899999999996 99999999999766   


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 --DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 --~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                        +.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus       101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---~kL~DFGla  176 (432)
T 3n9x_A          101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS---VKVCDFGLA  176 (432)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTC
T ss_pred             cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC---EEEccCCCc
Confidence              67999999985 699999998888999999999999999999999999999999999999987655   999999999


Q ss_pred             eeecCCC-----------------------ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhC--------
Q 012203          193 TYIEPGQ-----------------------SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSG--------  239 (468)
Q Consensus       193 ~~~~~~~-----------------------~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG--------  239 (468)
                      +......                       .....+||+.|+|||++..  .|+.++|||||||++|||++|        
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence            8765432                       2356789999999998643  489999999999999999984        


Q ss_pred             ---CCCCCCCCh-----------------HHHHHHH------------------------HhccCCCCCC---CCCCCCH
Q 012203          240 ---MPPFWGNTK-----------------SRIFDAV------------------------RTADLRFPSN---PWDHISD  272 (468)
Q Consensus       240 ---~~Pf~~~~~-----------------~~~~~~i------------------------~~~~~~~~~~---~~~~~s~  272 (468)
                         +++|.+.+.                 .+.+..+                        .......+..   .+..+++
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence               444444321                 1111111                        1111111110   1246899


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ++.+||.+||+.||++|||++|+|+||||++...
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            9999999999999999999999999999987543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.8e-49  Score=394.65  Aligned_cols=254  Identities=32%  Similarity=0.549  Sum_probs=220.4

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI-----DDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~-----~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      .+.++|++.+.||+|+||.||+|+++.+|+.||+|++.+......     .....+.+|+++++++. ||||+++++++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~   99 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE   99 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            467889999999999999999999999999999999987653222     12345677999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          113 DEDYVHLVMELCAGG-ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       113 ~~~~~~lV~E~~~gg-sL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      +.+.+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~  176 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGS  176 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTT
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc---EEEeeccc
Confidence            999999999999776 99999999889999999999999999999999999999999999999986554   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      +............+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.....      ....    .......
T Consensus       177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~----~~~~~~~  246 (335)
T 3dls_A          177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA----AIHPPYL  246 (335)
T ss_dssp             CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT----CCCCSSC
T ss_pred             ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh----ccCCCcc
Confidence            9988776666677899999999999875 4 7899999999999999999999965321      1111    1122246


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +++++.+||.+||+.||++|||++|+++||||++..
T Consensus       247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            899999999999999999999999999999997643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-48  Score=396.34  Aligned_cols=258  Identities=30%  Similarity=0.549  Sum_probs=218.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCC-ChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~-~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .++|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .......+.+|+++|+++.+||||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            378999999999999999999984   58999999999764321 11223456679999999977999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEESCSSEEEEC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc---EEEeeCCCCeec
Confidence            99999999999999999998889999999999999999999999999999999999999986654   999999999876


Q ss_pred             cCCC--ccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhccCCCCCCC
Q 012203          196 EPGQ--SLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNT----KSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       196 ~~~~--~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~  266 (468)
                      ....  .....+||+.|+|||++.+   .++.++|||||||++|+|++|+.||....    ...+...+......++   
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  286 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---  286 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC---
Confidence            4322  2334689999999999985   27889999999999999999999996533    3444455544444333   


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                       ..++..+.+||.+||.+||.+||     +++|+++|+||+..
T Consensus       287 -~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          287 -QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             -cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence             57889999999999999999999     99999999999763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.4e-48  Score=380.05  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=218.2

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+.++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++. ||||+++++++.+.+.
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSSE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCCe
Confidence            457789999999999999999999999999999999997765555566778999999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKALS  162 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCSSSTTC-
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEEeCCCccccc
Confidence            9999999999999999999889999999999999999999999999999999999999986654   9999999997654


Q ss_pred             CCC--ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-CCCCCCCCCCCH
Q 012203          197 PGQ--SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL-RFPSNPWDHISD  272 (468)
Q Consensus       197 ~~~--~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~  272 (468)
                      ...  .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+............. ..+......+++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            332  22346799999999999875 88999999999999999999999988877665444433322 111223457899


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .+.++|.+||.+||.+||+..+.+.+.|.
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            99999999999999999965555555553

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-47  Score=375.67  Aligned_cols=261  Identities=23%  Similarity=0.406  Sum_probs=220.6

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED---  113 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~---  113 (468)
                      ..-...|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++++. ||||+++++++..   
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccC
Confidence            4455669999999999999999999999999999999986644 3455678899999999996 9999999999875   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          114 -EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       114 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                       ...+++||||+++++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++.  ..+.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCC
Confidence             4679999999999999999998889999999999999999999999999  999999999999972  23349999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCCCCCCCCCC
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ++..... .......||+.|+|||++.+.++.++|||||||++|+|++|+.||..... ......+.....  +......
T Consensus       178 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~  254 (290)
T 1t4h_A          178 LATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKV  254 (290)
T ss_dssp             GGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGC
T ss_pred             Ccccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCCC
Confidence            9975443 23345689999999999998899999999999999999999999987443 444444433321  2222346


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      .++++.++|.+||+.||.+|||++|+++||||++.
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            77899999999999999999999999999999763

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-48  Score=392.67  Aligned_cols=260  Identities=27%  Similarity=0.418  Sum_probs=216.9

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--  114 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--  114 (468)
                      -.+.++|++++.||+|+||.||+|.++.+|+.||+|++.... ........+.+|+++|++++ ||||+++++++...  
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDET   98 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSS
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCc
Confidence            446789999999999999999999999999999999996643 23445677889999999996 99999999999765  


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          115 ----DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       115 ----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                          ..+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg  173 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFG  173 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCT
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC---EEEEeee
Confidence                3569999999 8899999977 67999999999999999999999999999999999999987655   9999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC------
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF------  262 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------  262 (468)
                      +++....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+.+..+.......      
T Consensus       174 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          174 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9987543  3456789999999999876  48999999999999999999999999888777666654322111      


Q ss_pred             -----------------CC----CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          263 -----------------PS----NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       263 -----------------~~----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                       +.    ..+..+++.+.+||.+||+.||.+|||++|+|+||||.+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                             11    11246789999999999999999999999999999997654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.1e-48  Score=390.72  Aligned_cols=259  Identities=35%  Similarity=0.676  Sum_probs=192.6

Q ss_pred             cccCCeEEEe-EEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 012203           38 NLRERFVLGQ-QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED---  113 (468)
Q Consensus        38 ~l~~~y~i~~-~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~---  113 (468)
                      .+.++|++.+ .||+|+||+||+|+++.+|+.||+|++...        .....|+..+.++.+||||+++++++..   
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            3677899965 699999999999999999999999998653        1223344444344469999999999976   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          114 -EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       114 -~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                       ...+++||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             556999999999999999998764  69999999999999999999999999999999999999876666779999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhccCCCCCC
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRI----FDAVRTADLRFPSN  265 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~  265 (468)
                      ++..... ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||........    ...+......++..
T Consensus       177 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          177 FAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             cceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            9987653 234456899999999999765 88999999999999999999999977655443    33344455556666


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+..+++++.+||.+||+.||.+|||++|+++||||++..
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            6778999999999999999999999999999999997643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-48  Score=390.26  Aligned_cols=265  Identities=27%  Similarity=0.421  Sum_probs=214.0

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh--hHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID--DERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~--~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      +....++|++++.||+|+||.||+|+++.+|+.||+|++.........  ..+.+.+|+++++++. ||||+++++++.+
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   83 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGH   83 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECC
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEee
Confidence            455678899999999999999999999999999999999764322111  1246778999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      .+.+++||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a  159 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLA  159 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCCGGG
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC---EEEEecccc
Confidence            9999999999975 898888764 46899999999999999999999999999999999999986654   999999999


Q ss_pred             eeecCC-CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC---
Q 012203          193 TYIEPG-QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP---  266 (468)
Q Consensus       193 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---  266 (468)
                      ...... ......+||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+.+..+.+..+...........   
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            876432 234457899999999999753  78999999999999999999999999888777776654322211111   


Q ss_pred             ---------------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          267 ---------------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       267 ---------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                           +..+++++.+||.+||..||.+|||++|+++||||.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                                 145678999999999999999999999999999997643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-47  Score=388.74  Aligned_cols=257  Identities=28%  Similarity=0.448  Sum_probs=222.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++...........+.+.+|++++++++ ||||+++++++.+++..+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeEE
Confidence            4567999999999999999999999999999999998765444455577889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||+. |+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus       131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAP  206 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE---EEECCCTTCBSSSS
T ss_pred             EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEeeccCceecCC
Confidence            9999996 68888775 4567999999999999999999999999999999999999986654   99999999976543


Q ss_pred             CCccccCCCCCCCcChhhhc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLA----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~----~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                         ....+||+.|+|||++.    +.++.++|||||||++|||++|+.||...+.......+......  ......+++.
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  281 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEY  281 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCCCTTSCHH
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCCCCCCHH
Confidence               33568999999999985    34899999999999999999999999888776666655554332  2223578999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +.+||.+||+.||++|||++++++|||+....
T Consensus       282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            99999999999999999999999999997654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-47  Score=393.23  Aligned_cols=258  Identities=24%  Similarity=0.398  Sum_probs=215.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeCCEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG-HPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~-HpnIv~l~~~~~~~~~~  117 (468)
                      ...+|++++.||+|+||+||+|.+.. ++.||||++.+... .......+.+|+++|++|.. ||||+++++++...+.+
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            34569999999999999999999874 99999999987643 34456788999999999973 69999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ +   +.+||+|||+++.+..
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~---~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D---GMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S---SCEEECCCSSSCCC--
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C---CeEEEEecCccccccC
Confidence            99999 56899999999988999999999999999999999999999999999999995 2   4599999999987654


Q ss_pred             CC---ccccCCCCCCCcChhhhcC------------CCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccCC
Q 012203          198 GQ---SLLGTVGSPFYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDAVRTADLR  261 (468)
Q Consensus       198 ~~---~~~~~~GT~~Y~APE~l~~------------~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~  261 (468)
                      ..   .....+||+.|+|||++.+            .++.++|||||||++|+|++|+.||.... ....+..+......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            32   2345689999999999865            48889999999999999999999997653 33444444444333


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++..  ...+.++.+||.+||..||.+|||+.|+++||||+...
T Consensus       287 ~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          287 IEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            3222  34578999999999999999999999999999997644

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.2e-47  Score=396.55  Aligned_cols=262  Identities=27%  Similarity=0.391  Sum_probs=218.3

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc-----CCCCceeeeEEE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-----GHPNVVDLKAVY  111 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-----~HpnIv~l~~~~  111 (468)
                      ..+..+|++++.||+|+||+||+|.+..+++.||||++...    ......+.+|+++++.++     +|+||+++++++
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            45778899999999999999999999999999999999754    234567788999998885     477999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                      ...+.+++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.++. ..+||+||
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~DF  246 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDF  246 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEECCC
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEeec
Confidence            99999999999995 69999997754  4999999999999999999999999999999999999986542 34999999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-----
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP-----  263 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----  263 (468)
                      |++.....  ...+.+||+.|+|||++.+. ++.++|||||||++|||++|++||.+.+..+.+..+.......+     
T Consensus       247 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          247 GSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            99976543  34467899999999999874 99999999999999999999999998887776665543211000     


Q ss_pred             ---------------------------------------------CCC-----CCCCCHHHHHHHHHccccCCCCCCCHH
Q 012203          264 ---------------------------------------------SNP-----WDHISDSAKDLVMGMLSTDPSQRLTAR  293 (468)
Q Consensus       264 ---------------------------------------------~~~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~  293 (468)
                                                                   ...     ....++.+.+||.+||+.||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                                                         000     012378899999999999999999999


Q ss_pred             HHHhCcCCCCCCC
Q 012203          294 QVLDHSWMGDGIQ  306 (468)
Q Consensus       294 eiL~h~~~~~~~~  306 (468)
                      |+|+||||++...
T Consensus       405 e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          405 QALRHPWLRRRLP  417 (429)
T ss_dssp             HHHTSTTTC----
T ss_pred             HHhCChhhccCCC
Confidence            9999999987543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-47  Score=391.51  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=207.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED--  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~--  115 (468)
                      .+.++|++++.||+|+||.||+|.++.+|+.||+|++.... ........+.+|+.+++++. ||||+++++++...+  
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence            35688999999999999999999999999999999997653 23445677889999999995 999999999997665  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          116 ----YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       116 ----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                          .+|+||||++ ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       100 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~  173 (371)
T 2xrw_A          100 EEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL  173 (371)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCCCC
T ss_pred             ccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---EEEEEeec
Confidence                8999999996 57888886  46999999999999999999999999999999999999986654   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR---------  261 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------  261 (468)
                      +............+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......         
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            9877655455567899999999999875 899999999999999999999999988877766665432111         


Q ss_pred             -------------CCCCC----------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          262 -------------FPSNP----------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       262 -------------~~~~~----------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                   +....                ....+.++++||.+||+.||++|||++|+|+||||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                         00000                00125689999999999999999999999999999654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-47  Score=372.49  Aligned_cols=259  Identities=34%  Similarity=0.576  Sum_probs=221.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +.++|++.+.||+|+||.||+|.++.+|+.||+|++.....  ....+.+.+|+.+++++. ||||+++++++.+.+..|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence            45679999999999999999999999999999999976542  234577889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC---EEEeeCCCccccCCC
Confidence            99999999999999987778999999999999999999999999999999999999986554   999999999875432


Q ss_pred             C---ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccCCCCCCCCCCCCH
Q 012203          199 Q---SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKS-RIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       199 ~---~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .   .....+||+.|+|||++.+.  ++.++||||||+++|+|++|+.||...... .....+.......  ..+..+++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--CchhhcCH
Confidence            2   23456899999999999864  367899999999999999999999775543 3333333332222  23467899


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+.++|.+||..||++|||++|+++||||++..
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            999999999999999999999999999997654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=381.98  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=216.3

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-  115 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-  115 (468)
                      ..+.++|++.+.||+|+||+||+|+++.+|+.||+|++.....  ....+.+.+|++++++++ ||||+++++++.+.+ 
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT   81 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCC
Confidence            4567899999999999999999999999999999999976532  233567789999999996 999999999998765 


Q ss_pred             -EEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec-CCCCCEEEeecC
Q 012203          116 -YVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK-ASSSPIKLADFG  190 (468)
Q Consensus       116 -~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~-~~~~~ikL~DFG  190 (468)
                       .+++||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+..+ .....+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence             88999999999999999976543   9999999999999999999999999999999999998322 223459999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhc---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHh
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLA---------GGYNQAADVWSAGVILYILLSGMPPFWGNT----KSRIFDAVRT  257 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~---------~~~~~~sDiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~  257 (468)
                      +++............||+.|+|||++.         ..++.++|||||||++|||++|+.||....    ..+....+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            999887766666788999999999985         348899999999999999999999996432    2344444443


Q ss_pred             ccCC-------------------CC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcC
Q 012203          258 ADLR-------------------FP--SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       258 ~~~~-------------------~~--~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      ....                   ++  ......+++.+.++|.+||+.||++|||++|+|+||-
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            3221                   11  1112345678999999999999999999999999873

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=383.74  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=214.0

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-CCceeeeEEEEeC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-PNVVDLKAVYEDE  114 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-pnIv~l~~~~~~~  114 (468)
                      ++...++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+++|+++..| |||+++++++.+.
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD   81 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence            4556788999999999999999999985 689999999976543 344557789999999999732 9999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +.+|+|||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ +   +.+||+|||++..
T Consensus        82 ~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~---~~~kl~DFG~a~~  156 (343)
T 3dbq_A           82 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D---GMLKLIDFGIANQ  156 (343)
T ss_dssp             SEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T---TEEEECCCSSSCC
T ss_pred             CEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-C---CcEEEeecccccc
Confidence            999999995 5889999999988999999999999999999999999999999999999996 2   3499999999987


Q ss_pred             ecCCCc---cccCCCCCCCcChhhhcC------------CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhc
Q 012203          195 IEPGQS---LLGTVGSPFYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRTA  258 (468)
Q Consensus       195 ~~~~~~---~~~~~GT~~Y~APE~l~~------------~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~  258 (468)
                      ......   ....+||+.|+|||++.+            .++.++|||||||++|+|++|+.||..... ......+...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            654322   235689999999999853            478899999999999999999999976433 2333333322


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       259 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ...  .......+.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       237 ~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          237 NHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             TSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             Ccc--cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            222  222245678999999999999999999999999999997543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.1e-47  Score=378.45  Aligned_cols=268  Identities=28%  Similarity=0.420  Sum_probs=221.6

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEc-CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDK-FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKA  109 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~  109 (468)
                      ...+..+.++|++.+.||+|+||.||+|++. .+|+.||+|++...... ......+.+|+.+++++.  +||||+++++
T Consensus         3 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~   81 (326)
T 1blx_A            3 KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFD   81 (326)
T ss_dssp             --CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             CccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeee
Confidence            3456677889999999999999999999995 67899999999765321 112234567888877774  5999999999


Q ss_pred             EEE-----eCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          110 VYE-----DEDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       110 ~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      ++.     ....+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--  158 (326)
T 1blx_A           82 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--  158 (326)
T ss_dssp             EEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--
T ss_pred             eeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--
Confidence            997     5678999999997 69999998754  4999999999999999999999999999999999999986654  


Q ss_pred             CEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 012203          183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR  261 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  261 (468)
                       +||+|||++.............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........+......
T Consensus       159 -~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          159 -IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             -EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             -EEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence             999999999876654455567899999999999875 899999999999999999999999988877766666532110


Q ss_pred             -----CC------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 -----FP------------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 -----~~------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                           ++                  ...+..++..+.+||.+||..||.+|||+.|+++||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                 00                  011346889999999999999999999999999999997643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-47  Score=391.17  Aligned_cols=257  Identities=28%  Similarity=0.515  Sum_probs=212.8

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE---
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE---  112 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~---  112 (468)
                      ++...++|++++.||+|+||+||+|++..+|+.||+|++..+...       ..+|+++|+++. ||||++++++|.   
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~   73 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTG   73 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC-
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecC
Confidence            345678999999999999999999999999999999998765321       236999999995 999999999984   


Q ss_pred             -----------------------------------eCCEEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHH
Q 012203          113 -----------------------------------DEDYVHLVMELCAGGELFHRLE----KFGRFSEAEARVLFMQLMQ  153 (468)
Q Consensus       113 -----------------------------------~~~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qil~  153 (468)
                                                         +..++++||||++ |+|.+.+.    ....+++..++.++.||+.
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~  152 (383)
T 3eb0_A           74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR  152 (383)
T ss_dssp             ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence                                               3445899999997 57777664    3467999999999999999


Q ss_pred             HHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHH
Q 012203          154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGV  231 (468)
Q Consensus       154 aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGv  231 (468)
                      ||.|||++||+||||||+|||++.+  .+.+||+|||+++...........+||+.|+|||++.+  .++.++|||||||
T Consensus       153 aL~~LH~~gi~H~Dikp~Nil~~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          153 AVGFIHSLGICHRDIKPQNLLVNSK--DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHHHHHTTTEECSCCCGGGEEEETT--TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHHHHHCcCccCccCHHHEEEcCC--CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            9999999999999999999999732  23499999999998877666777899999999999876  3899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhcc-----------------CCCCCC--------CCCCCCHHHHHHHHHccccCC
Q 012203          232 ILYILLSGMPPFWGNTKSRIFDAVRTAD-----------------LRFPSN--------PWDHISDSAKDLVMGMLSTDP  286 (468)
Q Consensus       232 il~elltG~~Pf~~~~~~~~~~~i~~~~-----------------~~~~~~--------~~~~~s~~l~~li~~~L~~dP  286 (468)
                      ++|+|++|++||.+.+..+.+..+....                 ..++..        ....+++++.+||.+||+.||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999999888777666654321                 111111        113478899999999999999


Q ss_pred             CCCCCHHHHHhCcCCCC
Q 012203          287 SQRLTARQVLDHSWMGD  303 (468)
Q Consensus       287 ~~Rpt~~eiL~h~~~~~  303 (468)
                      .+|||+.|+++||||++
T Consensus       311 ~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          311 DLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             GGSCCHHHHHTSGGGHH
T ss_pred             hhCCCHHHHhcCHHHHH
Confidence            99999999999999965

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.8e-47  Score=386.54  Aligned_cols=265  Identities=27%  Similarity=0.445  Sum_probs=222.0

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ..++-.+.++|++++.||+|+||.||+|++..+++.||+|++....  .......+.+|+++++++. ||||+++++++.
T Consensus        19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~   95 (364)
T 3qyz_A           19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIR   95 (364)
T ss_dssp             C-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEEC
T ss_pred             ccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEe
Confidence            3445567789999999999999999999999999999999997532  3444577889999999996 999999999997


Q ss_pred             eC-----CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          113 DE-----DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       113 ~~-----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      ..     ..+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+
T Consensus        96 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~  170 (364)
T 3qyz_A           96 APTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKIC  170 (364)
T ss_dssp             CSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEEC
T ss_pred             cCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC---EEEE
Confidence            55     47999999996 599999976 57999999999999999999999999999999999999986655   9999


Q ss_pred             ecCceeeecCCCc----cccCCCCCCCcChhhhcC-C-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 012203          188 DFGLATYIEPGQS----LLGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR  261 (468)
Q Consensus       188 DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~-~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  261 (468)
                      |||++........    ....+||+.|+|||++.+ . ++.++|||||||++|+|++|++||.+.+..+....+......
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  250 (364)
T 3qyz_A          171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  250 (364)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred             eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999987654322    234689999999998764 3 899999999999999999999999988777666665432111


Q ss_pred             C--------------------CCC-------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 F--------------------PSN-------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 ~--------------------~~~-------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .                    +..       ....+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence            1                    000       0245788999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-48  Score=393.80  Aligned_cols=260  Identities=28%  Similarity=0.450  Sum_probs=203.2

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--  114 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--  114 (468)
                      -.+.++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+++|+++. ||||+++++++...  
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS  102 (367)
T ss_dssp             EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred             cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCc
Confidence            446689999999999999999999999999999999997643 24445677889999999996 99999999999654  


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          115 ----DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       115 ----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                          +.+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kL~DFG  177 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFG  177 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECC--
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC---EEEeecc
Confidence                6689999999 7899999876 67999999999999999999999999999999999999986654   9999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-------
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR-------  261 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  261 (468)
                      +++....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+......       
T Consensus       178 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          178 LARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9987543  2445789999999999976  4899999999999999999999999988877666665432111       


Q ss_pred             ----------------CCCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 ----------------FPSNP----WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 ----------------~~~~~----~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                      .+...    +...++.+.+||.+||+.||++|||+.|+|+||||.+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                            11111    235688999999999999999999999999999998644

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-47  Score=377.22  Aligned_cols=266  Identities=25%  Similarity=0.440  Sum_probs=220.6

Q ss_pred             cCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           31 LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        31 ~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      ++..++....++|++++.||+|+||.||+|++..+|+.||+|++....    .....+.+|+.+++++.+||||++++++
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence            345667778999999999999999999999999999999999997543    2346788999999999669999999999


Q ss_pred             EEe------CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          111 YED------EDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       111 ~~~------~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      +..      .+.+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--  167 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--  167 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--
Confidence            987      56899999999999999999864  56999999999999999999999999999999999999986554  


Q ss_pred             CEEEeecCceeeecCCC-ccccCCCCCCCcChhhhc-----C-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 012203          183 PIKLADFGLATYIEPGQ-SLLGTVGSPFYIAPEVLA-----G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV  255 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~-----~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i  255 (468)
                       +||+|||++....... ......||+.|+|||++.     + .++.++|||||||++|+|++|+.||...........+
T Consensus       168 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          168 -VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             -EEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             -EEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence             9999999988764322 234567999999999986     2 3889999999999999999999999887776665555


Q ss_pred             HhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          256 RTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       256 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .....  +......+++.+.+||.+||..||.+||++.++++||||++..
T Consensus       247 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          247 PRNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             HHSCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             hcCcc--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            44432  2222357899999999999999999999999999999997654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.3e-48  Score=386.28  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=217.4

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+++++++. ||||+++++++.+.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   99 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRW   99 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEE
Confidence            345679999999999999999999999999999999876532 3344566788999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAA  176 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCTTC-----
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc---EEEEeCCCceeecC
Confidence            999999999999998887788999999999999999999999999999999999999986654   99999999987644


Q ss_pred             C-CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--------------
Q 012203          198 G-QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL--------------  260 (468)
Q Consensus       198 ~-~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------  260 (468)
                      . ......+||+.|+|||++.+.  ++.++|||||||++|+|++|+.||.+.+..+....+.....              
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            3 334456899999999999873  78999999999999999999999988877665554432111              


Q ss_pred             -----CCCCC--------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          261 -----RFPSN--------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       261 -----~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                           ..+..        .+..+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                 11110        12357899999999999999999999999999999965

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.9e-47  Score=386.02  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=220.4

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ....++|++.+.||+|+||.||+|+++.+|+.||+|++....  .......+.+|+.+++++. ||||+++++++.+.+.
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCE
Confidence            345678999999999999999999999999999999997652  3445678899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      +++||||++|++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.   +||+|||++...
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~  182 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL  182 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC---EEECCCCCCHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC---EEEEECCCCccc
Confidence            999999999999999999988999999999999999999999996 9999999999999987655   999999998654


Q ss_pred             cCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------------
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV-------------------  255 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i-------------------  255 (468)
                      ... ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+....+                   
T Consensus       183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            321 23456899999999999875 899999999999999999999999876655433221                   


Q ss_pred             -----------------------HhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          256 -----------------------RTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       256 -----------------------~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                             ...  ..+..+...++.++.+||.+||+.||++|||++|+++||||++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ------------CCCHHHHHHHHHHS--CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhcc--CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                   111  11222234578999999999999999999999999999999653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-46  Score=377.81  Aligned_cols=264  Identities=28%  Similarity=0.449  Sum_probs=219.4

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      .....+.++|++.+.||+|+||.||+|+++.+|+.||+|++...  ........+.+|++++++++ ||||+++++++..
T Consensus         4 ~~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   80 (353)
T 2b9h_A            4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRP   80 (353)
T ss_dssp             TCCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC
T ss_pred             ccccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecc
Confidence            34566889999999999999999999999999999999999653  23445567889999999996 9999999999865


Q ss_pred             C-----CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          114 E-----DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       114 ~-----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      .     ...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|
T Consensus        81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~D  155 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCD  155 (353)
T ss_dssp             SCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECC
T ss_pred             cccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc---EEEEe
Confidence            4     78999999996 699999876 57999999999999999999999999999999999999986554   99999


Q ss_pred             cCceeeecCCC-----------ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 012203          189 FGLATYIEPGQ-----------SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV  255 (468)
Q Consensus       189 FGla~~~~~~~-----------~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i  255 (468)
                      ||++.......           .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  235 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI  235 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            99998765321           1224579999999998864  4889999999999999999999999988766655544


Q ss_pred             HhccCC------------------------CCCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          256 RTADLR------------------------FPSN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       256 ~~~~~~------------------------~~~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ......                        .+..    .+..+++++.+||.+||..||++|||++|+++||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            321111                        1111    1246889999999999999999999999999999997654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.2e-47  Score=370.60  Aligned_cols=257  Identities=22%  Similarity=0.339  Sum_probs=198.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHH-HHHHhcCCCCceeeeEEEEeCCE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE-IMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~-iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ...++|++++.||+|+||+||+|+++.+|+.||+|++....  ..........|.. .++.+ +||||+++++++.+.+.
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSS
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCC
Confidence            35678999999999999999999999999999999997653  2223333344444 45555 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          117 VHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      .++||||++ |+|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.   +||+|||+
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~  156 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGI  156 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC---EEBCCC--
T ss_pred             EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC---EEEeecCC
Confidence            999999996 588777653    46799999999999999999999998 9999999999999986554   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhc----C-CCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccCCCCCC
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLA----G-GYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSN  265 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~----~-~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~  265 (468)
                      +.............||+.|+|||++.    + .++.++|||||||++|+|++|+.||... ..............  +..
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~  234 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQL  234 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCC
T ss_pred             cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCc
Confidence            98876655555668999999999973    2 3788999999999999999999999753 33333333332221  222


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ....+++++.++|.+||+.||++|||++|+++||||+.
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            23578999999999999999999999999999999965

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-46  Score=373.99  Aligned_cols=260  Identities=28%  Similarity=0.417  Sum_probs=218.5

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEE-cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC------Cceeee
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSD-KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP------NVVDLK  108 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~-~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp------nIv~l~  108 (468)
                      .+.+.++|++.+.||+|+||.||+|.+ +.+|+.||+|++...    ......+.+|+++++++. |+      +|++++
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~   83 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQML   83 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEeee
Confidence            345788999999999999999999998 568999999998643    234567888999999986 55      499999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC------
Q 012203          109 AVYEDEDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS------  180 (468)
Q Consensus       109 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~------  180 (468)
                      +++.+.+.+++||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++.      
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 899999998765  6899999999999999999999999999999999999976331      


Q ss_pred             ----------CCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 012203          181 ----------SSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS  249 (468)
Q Consensus       181 ----------~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~  249 (468)
                                ...+||+|||++.....  .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                      34599999999987443  33466899999999999874 899999999999999999999999988877


Q ss_pred             HHHHHHHhccCCCCCC----------------------------------------CCCCCCHHHHHHHHHccccCCCCC
Q 012203          250 RIFDAVRTADLRFPSN----------------------------------------PWDHISDSAKDLVMGMLSTDPSQR  289 (468)
Q Consensus       250 ~~~~~i~~~~~~~~~~----------------------------------------~~~~~s~~l~~li~~~L~~dP~~R  289 (468)
                      +....+......++..                                        .....++++.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            6665554332222110                                        011235678999999999999999


Q ss_pred             CCHHHHHhCcCCCC
Q 012203          290 LTARQVLDHSWMGD  303 (468)
Q Consensus       290 pt~~eiL~h~~~~~  303 (468)
                      ||++|+++||||+.
T Consensus       321 pt~~ell~hp~f~~  334 (339)
T 1z57_A          321 ITLREALKHPFFDL  334 (339)
T ss_dssp             CCHHHHTTSGGGGG
T ss_pred             cCHHHHhcCHHHHH
Confidence            99999999999965

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-46  Score=385.50  Aligned_cols=264  Identities=28%  Similarity=0.437  Sum_probs=218.7

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC-----ceeee
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-----VVDLK  108 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn-----Iv~l~  108 (468)
                      ...+.+.++|++.+.||+|+||+||+|+++.+++.||||++...    ......+..|+.+++.+..|++     |++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            44566789999999999999999999999999999999999753    2345677889999998875664     99999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HcCcEecccCCCcEEEeecCCCCCE
Q 012203          109 AVYEDEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCH--EIGVVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       109 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH--~~gIiHrDIKp~NILl~~~~~~~~i  184 (468)
                      +++...+.+|+||||+. ++|.+++...  +.+++..++.++.|++.||.|||  +.||+||||||+|||++.+. .+.+
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~-~~~~  200 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAI  200 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT-SCCE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC-CCcE
Confidence            99999999999999995 5999999875  45999999999999999999999  57999999999999996432 3459


Q ss_pred             EEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 012203          185 KLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       185 kL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                      ||+|||++.....  .....+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+..+.+..+.......+
T Consensus       201 kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          201 KIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             EECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999999987643  34467899999999999875 89999999999999999999999998888777766654211110


Q ss_pred             ------------------CCCC-----------------CC-------------------------CCHHHHHHHHHccc
Q 012203          264 ------------------SNPW-----------------DH-------------------------ISDSAKDLVMGMLS  283 (468)
Q Consensus       264 ------------------~~~~-----------------~~-------------------------~s~~l~~li~~~L~  283 (468)
                                        ...|                 ..                         ..+++.+||.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence                              0000                 00                         01478999999999


Q ss_pred             cCCCCCCCHHHHHhCcCCCCCC
Q 012203          284 TDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       284 ~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .||++|||++|+|+||||++..
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC--
T ss_pred             CChhhCCCHHHHhcCcccccCC
Confidence            9999999999999999997654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.9e-46  Score=373.62  Aligned_cols=265  Identities=25%  Similarity=0.391  Sum_probs=214.1

Q ss_pred             hcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           30 ILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        30 i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      .++....+...++|++.+.||+|+||+||+|++  +|+.||+|++..... .......+.+|++++++++ ||||+++++
T Consensus        26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~  101 (309)
T 3p86_A           26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMG  101 (309)
T ss_dssp             ------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred             CCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence            445566667788999999999999999999987  588999999976643 3445677889999999996 999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCE
Q 012203          110 VYEDEDYVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       110 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~i  184 (468)
                      ++.+.+.+++||||++||+|.+++.+.+.   +++..++.++.||+.||.|||++|  |+||||||+|||++.++.   +
T Consensus       102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~---~  178 (309)
T 3p86_A          102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---V  178 (309)
T ss_dssp             EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC---E
T ss_pred             EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc---E
Confidence            99999999999999999999999987553   999999999999999999999999  999999999999986554   9


Q ss_pred             EEeecCceeeecCCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 012203          185 KLADFGLATYIEPGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       185 kL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      ||+|||+++...... ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+....+.......
T Consensus       179 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  258 (309)
T 3p86_A          179 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL  258 (309)
T ss_dssp             EECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             EECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            999999997654332 23456899999999999875 8999999999999999999999999988887777765443333


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh--CcCCCC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD--HSWMGD  303 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~--h~~~~~  303 (468)
                      ..  ...+++++.+||.+||..||.+|||++++++  .++++.
T Consensus       259 ~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          259 EI--PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CC--CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            22  2578999999999999999999999999987  455443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.5e-48  Score=397.22  Aligned_cols=249  Identities=18%  Similarity=0.210  Sum_probs=205.1

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeee-------EE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLK-------AV  110 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~-------~~  110 (468)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++++.++  +||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            578999999999999999999999999999999998765555566788999996555443  599999998       77


Q ss_pred             EEeCCE-----------------EEEEEeccCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHcCcEec
Q 012203          111 YEDEDY-----------------VHLVMELCAGGELFHRLEKFGRFSE-------AEARVLFMQLMQVVLYCHEIGVVHR  166 (468)
Q Consensus       111 ~~~~~~-----------------~~lV~E~~~ggsL~~~l~~~~~l~~-------~~~~~i~~qil~aL~~LH~~gIiHr  166 (468)
                      +++.+.                 .||||||+ +|+|.+++...+.+++       ..+..++.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776643                 89999999 6899999987665666       7778899999999999999999999


Q ss_pred             ccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC------------CCCcchHHHHHHHHH
Q 012203          167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG------------YNQAADVWSAGVILY  234 (468)
Q Consensus       167 DIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~------------~~~~sDiwSlGvil~  234 (468)
                      ||||+|||++.++.   +||+|||+++...  ......+| +.|+|||++.+.            ++.++|||||||++|
T Consensus       231 Dikp~NIll~~~~~---~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVLDQRGG---VFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEECTTCC---EEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCC---EEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            99999999986654   9999999998643  34456778 999999998753            899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          235 ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       235 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ||++|+.||.+.........+.        ..+..+++++.+||.+||+.||++|||+.|+++||||++
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            9999999997655433222221        122578999999999999999999999999999999964

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-46  Score=390.84  Aligned_cols=257  Identities=29%  Similarity=0.497  Sum_probs=212.4

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED----  113 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~----  113 (468)
                      ....+|++.+.||+|+||+||+|+++.+|+.||||++.....       ...+|+++|++|+ ||||++++++|..    
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETT
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCC
Confidence            345579999999999999999999999999999999876432       1236999999996 9999999999843    


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          114 --EDYVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       114 --~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                        ..++++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+||||+.++  ..+||+
T Consensus       123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--~~~kl~  199 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLC  199 (420)
T ss_dssp             TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT--TEEEEC
T ss_pred             CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC--CeEEec
Confidence              2347799999975 67666543    46799999999999999999999999999999999999998543  248999


Q ss_pred             ecCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------
Q 012203          188 DFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTA-------  258 (468)
Q Consensus       188 DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------  258 (468)
                      |||+++.+.........+||+.|+|||++.+  .++.++|||||||++|||++|++||.+.+..+.+..+...       
T Consensus       200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999998776666667899999999999876  4899999999999999999999999988766655544331       


Q ss_pred             ----------cCCCCCC---C-----CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          259 ----------DLRFPSN---P-----WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       259 ----------~~~~~~~---~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                ...++..   +     ...+++++.+||.+||++||.+|||+.|+++||||.+..
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                      1112211   1     135689999999999999999999999999999996643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8.3e-47  Score=372.21  Aligned_cols=260  Identities=27%  Similarity=0.442  Sum_probs=218.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++....   ......+.+|+++++++. ||||+++++++.+.+.+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-CE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCeE
Confidence            46788999999999999999999999999999999987652   334577889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKNL  168 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC---EEECCCHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC---EEEEECCCCcccc
Confidence            999999999999999876 467999999999999999999999999999999999999986655   9999999875432


Q ss_pred             CC-CccccCCCCCCCcChhhhc-----C-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          197 PG-QSLLGTVGSPFYIAPEVLA-----G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       197 ~~-~~~~~~~GT~~Y~APE~l~-----~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      .. .......||+.|+|||++.     + .++.++||||||+++|+|++|+.||...+.......+........ .....
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~  247 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSK  247 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGG
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCccc
Confidence            11 1223457999999999983     3 488999999999999999999999998887777666655543221 12256


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++..+.++|.+||..||.+|||+.++++||||++..
T Consensus       248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            889999999999999999999999999999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=375.26  Aligned_cols=259  Identities=33%  Similarity=0.580  Sum_probs=220.6

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC-hhhHHHHHHHHHHHHHhcCCCCceeeeEEE--EeC
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRLSGHPNVVDLKAVY--EDE  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~-~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~--~~~  114 (468)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|++.+..... ......+.+|++++++++ ||||+++++++  .+.
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEK   80 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC--
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCC
Confidence            46688999999999999999999999999999999997653211 234567899999999996 99999999998  455


Q ss_pred             CEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYVHLVMELCAGGELFHRLEK--FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.+++||||+.++ |.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc---EEeeccccc
Confidence            6899999999876 7777765  356999999999999999999999999999999999999986654   999999999


Q ss_pred             eeecCC---CccccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          193 TYIEPG---QSLLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       193 ~~~~~~---~~~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      ......   .......||+.|+|||++.+.   ++.++||||||+++|+|++|+.||...+..+..+.+......++   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---  233 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP---  233 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC---
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC---
Confidence            876532   223456799999999999763   47799999999999999999999999888888888887766554   


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                       ..+++.+.++|.+||..||.+|||+.|+++||||++..
T Consensus       234 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          234 -GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             -SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             -CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence             46889999999999999999999999999999997644

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=393.56  Aligned_cols=265  Identities=26%  Similarity=0.455  Sum_probs=201.0

Q ss_pred             cccccccCCeEE-EeEEeecCCeEEEEEEEc--CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           34 NQISNLRERFVL-GQQLGWGQFGVIRVCSDK--FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        34 ~~~~~l~~~y~i-~~~LG~G~fg~Vy~a~~~--~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      .+...+.+.|++ +++||+|+||+||+|+++  .+++.||+|++.....     ...+.+|+++|++|+ ||||++++++
T Consensus        13 ~~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~   86 (405)
T 3rgf_A           13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKV   86 (405)
T ss_dssp             HHCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEE
T ss_pred             hhhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeE
Confidence            345667788988 568999999999999976  5689999999976532     245778999999996 9999999999


Q ss_pred             EE--eCCEEEEEEeccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec-
Q 012203          111 YE--DEDYVHLVMELCAGGELFHRLEKF---------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK-  178 (468)
Q Consensus       111 ~~--~~~~~~lV~E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~-  178 (468)
                      +.  ....+|+||||+. ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||||..+ 
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~  165 (405)
T 3rgf_A           87 FLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG  165 (405)
T ss_dssp             EEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS
T ss_pred             EecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC
Confidence            95  4779999999995 5888888532         249999999999999999999999999999999999999543 


Q ss_pred             CCCCCEEEeecCceeeecCC----CccccCCCCCCCcChhhhcC-C-CCCcchHHHHHHHHHHHHhCCCCCCCCChH---
Q 012203          179 ASSSPIKLADFGLATYIEPG----QSLLGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGMPPFWGNTKS---  249 (468)
Q Consensus       179 ~~~~~ikL~DFGla~~~~~~----~~~~~~~GT~~Y~APE~l~~-~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~---  249 (468)
                      ...+.+||+|||+++.....    ......+||+.|+|||++.+ . ++.++|||||||++|+|++|++||.+....   
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  245 (405)
T 3rgf_A          166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  245 (405)
T ss_dssp             TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence            23456999999999876532    23345789999999999986 3 899999999999999999999999765432   


Q ss_pred             ------HHHHHHHhccCCCCCCCCCC----------------------------------CCHHHHHHHHHccccCCCCC
Q 012203          250 ------RIFDAVRTADLRFPSNPWDH----------------------------------ISDSAKDLVMGMLSTDPSQR  289 (468)
Q Consensus       250 ------~~~~~i~~~~~~~~~~~~~~----------------------------------~s~~l~~li~~~L~~dP~~R  289 (468)
                            +.+..+.......+...|..                                  .++.+.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                  33333333222222222222                                  26789999999999999999


Q ss_pred             CCHHHHHhCcCCCCCC
Q 012203          290 LTARQVLDHSWMGDGI  305 (468)
Q Consensus       290 pt~~eiL~h~~~~~~~  305 (468)
                      ||++|+|+||||.+..
T Consensus       326 ~ta~e~L~hp~f~~~~  341 (405)
T 3rgf_A          326 ITSEQAMQDPYFLEDP  341 (405)
T ss_dssp             CCHHHHHTSGGGTSSS
T ss_pred             CCHHHHhcChhhccCC
Confidence            9999999999997754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-46  Score=369.62  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=226.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++.....  ....+.+.+|+.+++++. ||||+++++++.+.+.+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeE
Confidence            456779999999999999999999999999999999976542  234678899999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++.....
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTD  171 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECBT
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC---EEEeecccceecCc
Confidence            999999999999999865 67999999999999999999999999999999999999986554   99999999987654


Q ss_pred             CC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .. ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+......   .....++..+.
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  248 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLK  248 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHH
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHH
Confidence            33 23456899999999999875 899999999999999999999999888877766666554322   22357899999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +||.+||..||.+|||+.|+++|+||....
T Consensus       249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          249 EFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            999999999999999999999999996644

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.5e-47  Score=386.34  Aligned_cols=260  Identities=24%  Similarity=0.391  Sum_probs=211.0

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc-------CCCCceeeeE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-------GHPNVVDLKA  109 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-------~HpnIv~l~~  109 (468)
                      +.+.++|++.+.||+|+||+||+|++..+|+.||+|++...    ......+.+|++++++++       +|+||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            34678999999999999999999999999999999999753    334567889999999996       2788999999


Q ss_pred             EEE----eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecC---
Q 012203          110 VYE----DEDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKA---  179 (468)
Q Consensus       110 ~~~----~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~---  179 (468)
                      ++.    +...+|+||||+ +++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++   
T Consensus       109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            997    566899999999 66777777554  4699999999999999999999998 999999999999998654   


Q ss_pred             -------------------------------------------CCCCEEEeecCceeeecCCCccccCCCCCCCcChhhh
Q 012203          180 -------------------------------------------SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL  216 (468)
Q Consensus       180 -------------------------------------------~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l  216 (468)
                                                                 ....+||+|||++.....  .....+||+.|+|||++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhh
Confidence                                                       112599999999987653  34456899999999999


Q ss_pred             cCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhccCCCCC-------------------------
Q 012203          217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTK------SRIFDAVRTADLRFPS-------------------------  264 (468)
Q Consensus       217 ~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~-------------------------  264 (468)
                      .+. ++.++|||||||++|+|++|+.||...+.      ......+.......+.                         
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            875 89999999999999999999999976542      2222222211111000                         


Q ss_pred             -------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          265 -------------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       265 -------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                                   ......+..+.+||.+||+.||++|||++|+|+||||++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                         001234567899999999999999999999999999963

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.4e-47  Score=388.93  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=210.5

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-  115 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-  115 (468)
                      .....+|++.+.||+|+||+||+|++..+++ +|+|++......       ..+|+++|+++. ||||++++++|...+ 
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEESS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEecCC
Confidence            4466789999999999999999999987666 888877654321       235999999996 999999999995433 


Q ss_pred             -----EEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEe-ecCCCCCEE
Q 012203          116 -----YVHLVMELCAGGELFHRLE----KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLA-TKASSSPIK  185 (468)
Q Consensus       116 -----~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~-~~~~~~~ik  185 (468)
                           .+++||||++++ +.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++ .++   .+|
T Consensus       107 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~~k  182 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG---VLK  182 (394)
T ss_dssp             SSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT---EEE
T ss_pred             CCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC---cEE
Confidence                 489999999764 444332    346799999999999999999999999999999999999998 444   499


Q ss_pred             EeecCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----
Q 012203          186 LADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD----  259 (468)
Q Consensus       186 L~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----  259 (468)
                      |+|||+++....+......+||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+.+..+....    
T Consensus       183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999998876666677899999999999976  38999999999999999999999999888766665554321    


Q ss_pred             -------------CCCCCC--------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          260 -------------LRFPSN--------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       260 -------------~~~~~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                   ..++..        ....+++++.+||.+||++||.+|||+.|+++||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence                         111111        1234789999999999999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8e-47  Score=368.13  Aligned_cols=259  Identities=28%  Similarity=0.478  Sum_probs=222.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE--eCCE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE--DEDY  116 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~--~~~~  116 (468)
                      ..++|++.+.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|++++++++ ||||+++++++.  ..+.
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCce
Confidence            35689999999999999999999999999999999987643 3445678899999999996 999999999884  4678


Q ss_pred             EEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----cEecccCCCcEEEeecCCCCCEEEe
Q 012203          117 VHLVMELCAGGELFHRLEKF----GRFSEAEARVLFMQLMQVVLYCHEIG-----VVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~g-----IiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      +++||||++|++|.+++...    ..+++..++.++.|++.||.|||++|     |+||||||+|||++.++.   +||+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~---~kl~  158 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLG  158 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC---EEEC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC---EEEe
Confidence            99999999999999999754    34999999999999999999999999     999999999999986654   9999


Q ss_pred             ecCceeeecCCCc-cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 012203          188 DFGLATYIEPGQS-LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN  265 (468)
Q Consensus       188 DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  265 (468)
                      |||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..++...+........  
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--  236 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--  236 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC--
Confidence            9999976654322 2345799999999999875 89999999999999999999999999888888877776654211  


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                       ...+++++.++|.+||..||.+||+++|+++|+|+.+..
T Consensus       237 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 -PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence             246899999999999999999999999999999997643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=370.84  Aligned_cols=260  Identities=30%  Similarity=0.452  Sum_probs=216.3

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .....++|++.+.||+|+||.||+|.++.+|+.||+|++....     ....+.+|+.+++++. ||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   97 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCC
Confidence            4567889999999999999999999999999999999997642     2356888999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .+++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH---AKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC---EEEeecccchh
Confidence            9999999999999999997 4567999999999999999999999999999999999999986654   99999999987


Q ss_pred             ecCCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          195 IEPGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       195 ~~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ..... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+...... .......+++
T Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  253 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSD  253 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCH
T ss_pred             hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCH
Confidence            65432 23456899999999999875 899999999999999999999999887766555444433221 1112246789


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .+.+||.+||..||.+|||+.++++||||+...
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999999999997643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-46  Score=381.94  Aligned_cols=258  Identities=30%  Similarity=0.456  Sum_probs=215.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.... ........+.+|+.+++++. ||||+++++++...+..
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSS
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCc
Confidence            47789999999999999999999999999999999997653 23444677889999999996 99999999999877654


Q ss_pred             ------EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          118 ------HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       118 ------~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                            |+||||+. ++|.+++.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       117 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kL~Dfg~  190 (371)
T 4exu_A          117 RNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFGL  190 (371)
T ss_dssp             TTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECSTTC
T ss_pred             ccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC---EEEEecCc
Confidence                  99999996 68888774  35999999999999999999999999999999999999986655   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF-------  262 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------  262 (468)
                      +.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.......       
T Consensus       191 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          191 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            986543  3446789999999999986  48999999999999999999999999888776666654321110       


Q ss_pred             ----------------CCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          263 ----------------PSN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       263 ----------------~~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                      +..    .+..+++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                            000    1235789999999999999999999999999999997643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.1e-46  Score=367.93  Aligned_cols=256  Identities=27%  Similarity=0.522  Sum_probs=213.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-----  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-----  113 (468)
                      +.++|++++.||+|+||.||+|+++.+|+.||+|++...    ......+.+|+.+++++. ||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            567899999999999999999999999999999999643    344577889999999996 9999999999865     


Q ss_pred             --------CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCE
Q 012203          114 --------EDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       114 --------~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~i  184 (468)
                              .+.+|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.   +
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~---~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---V  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---E
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC---E
Confidence                    467899999999999999998643 5788999999999999999999999999999999999986554   9


Q ss_pred             EEeecCceeeecCC---------------CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCC-C
Q 012203          185 KLADFGLATYIEPG---------------QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWG-N  246 (468)
Q Consensus       185 kL~DFGla~~~~~~---------------~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~-~  246 (468)
                      ||+|||++......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||.. .
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999999765421               12235679999999999975  38999999999999999998   5542 3


Q ss_pred             ChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          247 TKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ........+......++.......++.+.++|.+||+.||.+|||+.++++||||+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            34455666666666666666677889999999999999999999999999999997643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.8e-46  Score=380.88  Aligned_cols=253  Identities=24%  Similarity=0.367  Sum_probs=217.8

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEc-------CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDK-------FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      ...++|++++.||+|+||.||+|++.       .++..||+|++....  .......+.+|+++|+++.+||||++++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            34578999999999999999999975       345689999997652  345567899999999999559999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEE
Q 012203          111 YEDEDYVHLVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENIL  174 (468)
Q Consensus       111 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NIL  174 (468)
                      +.+.+.+|+||||++||+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence            999999999999999999999998753                4789999999999999999999999999999999999


Q ss_pred             EeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 012203          175 LATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKS  249 (468)
Q Consensus       175 l~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~  249 (468)
                      ++.++.   +||+|||+++.......   .....||+.|+|||++.+. ++.++|||||||++|||++ |+.||.+....
T Consensus       236 l~~~~~---~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          236 VTENNV---MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             ECTTCC---EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             ECCCCC---EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            986654   99999999987654322   2334678899999999875 8999999999999999999 99999998888


Q ss_pred             HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          250 RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++...+......   .....+++++.++|.+||+.||.+|||+.|++++
T Consensus       313 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            887777665321   1225789999999999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.8e-47  Score=388.40  Aligned_cols=258  Identities=16%  Similarity=0.172  Sum_probs=198.5

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc-CCCCceeee-------EEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-GHPNVVDLK-------AVY  111 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-~HpnIv~l~-------~~~  111 (468)
                      ...|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++++.|+ +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999999876545556677888877666665 499988755       555


Q ss_pred             EeC-----------------CEEEEEEeccCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHHcCcEecc
Q 012203          112 EDE-----------------DYVHLVMELCAGGELFHRLEKF-GRFSEAEA------RVLFMQLMQVVLYCHEIGVVHRD  167 (468)
Q Consensus       112 ~~~-----------------~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~------~~i~~qil~aL~~LH~~gIiHrD  167 (468)
                      ...                 ..+|||||||+ |+|.+++... ..+.+...      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            543                 34899999998 8999999764 33444444      56779999999999999999999


Q ss_pred             cCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCC
Q 012203          168 LKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFW  244 (468)
Q Consensus       168 IKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~  244 (468)
                      |||+|||++.++.   +||+|||+++....  ......||+.|+|||++.+   .++.++|||||||++|+|++|+.||.
T Consensus       220 ikp~NIll~~~~~---~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIMPDGR---LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEECTTSC---EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEECCCCC---EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999987654   99999999987543  2225567799999999986   38999999999999999999999997


Q ss_pred             CCChHHH--HHH---HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          245 GNTKSRI--FDA---VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       245 ~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .......  +..   .......+....+..+++.+.+||.+||+.||++|||+.|+++||||++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            7643211  000   0111112222334578999999999999999999999999999999965

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-46  Score=380.20  Aligned_cols=257  Identities=26%  Similarity=0.380  Sum_probs=214.3

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEE-----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCS-----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      ..+...++|++++.||+|+||.||+|+     +..+++.||+|++....  .....+.+.+|+++++++.+||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            345567889999999999999999999     55677999999997652  34456778999999999977999999999


Q ss_pred             EEEeCC-EEEEEEeccCCCCHHHHHHHcCC--------------------------------------------------
Q 012203          110 VYEDED-YVHLVMELCAGGELFHRLEKFGR--------------------------------------------------  138 (468)
Q Consensus       110 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------  138 (468)
                      ++.+.+ .+++|||||+||+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998754 49999999999999999977543                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC---
Q 012203          139 ----------------FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ---  199 (468)
Q Consensus       139 ----------------l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---  199 (468)
                                      +++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......   
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCGGGSCTTSCTTCE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc---EEEEeccceeeecccccch
Confidence                            899999999999999999999999999999999999987665   9999999998654332   


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDL  277 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l  277 (468)
                      ......||+.|+|||++.+. ++.++|||||||++|+|++ |+.||.+....+............+.  ...+++++.++
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l  328 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQT  328 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHH
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHH
Confidence            22345789999999998764 8999999999999999998 99999887654444333333222221  25688999999


Q ss_pred             HHHccccCCCCCCCHHHHHhC
Q 012203          278 VMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       278 i~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.+||..||.+|||+.|+++|
T Consensus       329 i~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          329 MLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.8e-46  Score=372.35  Aligned_cols=263  Identities=27%  Similarity=0.391  Sum_probs=217.0

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCC-cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC------ceee
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTG-EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN------VVDL  107 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn------Iv~l  107 (468)
                      ..+.+.++|++.+.||+|+||+||+|.++.++ +.||+|++...    ......+.+|+++++++. |++      ++.+
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~   87 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCVLM   87 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCE
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEEEe
Confidence            34557889999999999999999999998776 68999999643    234567888999999997 555      9999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec-------
Q 012203          108 KAVYEDEDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK-------  178 (468)
Q Consensus       108 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~-------  178 (468)
                      ++++...+.+++||||+ +++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+|||++.+       
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            99999999999999999 677877776653  69999999999999999999999999999999999999432       


Q ss_pred             ---------CCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 012203          179 ---------ASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK  248 (468)
Q Consensus       179 ---------~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~  248 (468)
                               .....+||+|||++.....  .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+.
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                     1245699999999987443  33456899999999999874 89999999999999999999999998887


Q ss_pred             HHHHHHHHhccCCCCCC----------------------------------------CCCCCCHHHHHHHHHccccCCCC
Q 012203          249 SRIFDAVRTADLRFPSN----------------------------------------PWDHISDSAKDLVMGMLSTDPSQ  288 (468)
Q Consensus       249 ~~~~~~i~~~~~~~~~~----------------------------------------~~~~~s~~l~~li~~~L~~dP~~  288 (468)
                      .+....+.......|..                                        .....+.++.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            76665554432222210                                        00122457899999999999999


Q ss_pred             CCCHHHHHhCcCCCCCC
Q 012203          289 RLTARQVLDHSWMGDGI  305 (468)
Q Consensus       289 Rpt~~eiL~h~~~~~~~  305 (468)
                      |||+.|+++||||++..
T Consensus       325 Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLT  341 (355)
T ss_dssp             SCCHHHHTTSGGGGGCC
T ss_pred             CcCHHHHhcChhhcCCC
Confidence            99999999999997643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-46  Score=380.50  Aligned_cols=267  Identities=24%  Similarity=0.379  Sum_probs=212.6

Q ss_pred             ccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC--------ChhhHHHHHHHHHHHHHhcCCCCc
Q 012203           33 TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV--------TIDDERSVKLEIEIMTRLSGHPNV  104 (468)
Q Consensus        33 ~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~--------~~~~~~~~~~Ei~iL~~L~~HpnI  104 (468)
                      ..++..+.++|++++.||+|+||.||+|.+. +|+.||+|++......        .....+.+.+|+++++++. ||||
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i   91 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNI   91 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTB
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCc
Confidence            4567789999999999999999999999986 4999999998654321        1223477899999999996 9999


Q ss_pred             eeeeEEEEe-----CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec
Q 012203          105 VDLKAVYED-----EDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK  178 (468)
Q Consensus       105 v~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~  178 (468)
                      +++++++..     ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  170 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN  170 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC
Confidence            999999943     347999999996 6888888654 469999999999999999999999999999999999999866


Q ss_pred             CCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 012203          179 ASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR  256 (468)
Q Consensus       179 ~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  256 (468)
                      +.   +||+|||++............+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus       171 ~~---~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          171 ND---ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             CC---EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CC---EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            55   99999999987665555566789999999999876  38999999999999999999999999888777666654


Q ss_pred             hccC------------------------CCCCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          257 TADL------------------------RFPSNP----WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       257 ~~~~------------------------~~~~~~----~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ....                        ..+...    ...+++.+.+||.+||+.||.+|||+.|+++||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            3211                        111111    135688999999999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=384.35  Aligned_cols=259  Identities=21%  Similarity=0.301  Sum_probs=222.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEE-----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCS-----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ...++|++++.||+|+||+||+|+     +..+++.||+|++...  ........+.+|+.+++++. ||||+++++++.
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  144 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSL  144 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence            346789999999999999999999     4557889999999654  24455667889999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEE
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFG-------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                      +.+..++|||||+||+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999998753       489999999999999999999999999999999999999777667799


Q ss_pred             EeecCceeeecCC---CccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 012203          186 LADFGLATYIEPG---QSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       186 L~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                      |+|||+++.....   .......||+.|+|||++.+. ++.++|||||||++|||++ |..||......++.+.+.....
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999999754321   222345789999999998764 8999999999999999998 9999999998888888776653


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      ..+   ...++..+.+|+.+||+.||.+|||+.+++++.+..
T Consensus       305 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          305 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            222   257889999999999999999999999999988753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7e-47  Score=380.48  Aligned_cols=261  Identities=24%  Similarity=0.492  Sum_probs=225.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhh--------------HHHHHHHHHHHHHhcCCCC
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD--------------ERSVKLEIEIMTRLSGHPN  103 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~--------------~~~~~~Ei~iL~~L~~Hpn  103 (468)
                      ...++|++.+.||+|+||.||+|.+  +|+.||+|++..........              ...+.+|++++++++ |||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~  104 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY  104 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence            3567999999999999999999999  89999999997653322111              277899999999996 999


Q ss_pred             ceeeeEEEEeCCEEEEEEeccCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEE
Q 012203          104 VVDLKAVYEDEDYVHLVMELCAGGELFHR------LEK--FGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENIL  174 (468)
Q Consensus       104 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~--~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NIL  174 (468)
                      |+++++++.+.+.+++||||++|++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999998      655  5679999999999999999999999 99999999999999


Q ss_pred             EeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC--CCC-cchHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 012203          175 LATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQ-AADVWSAGVILYILLSGMPPFWGNTK-SR  250 (468)
Q Consensus       175 l~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~-~sDiwSlGvil~elltG~~Pf~~~~~-~~  250 (468)
                      ++.++.   +||+|||++...... ......||+.|+|||++.+.  ++. ++|||||||++|+|++|+.||..... .+
T Consensus       185 ~~~~~~---~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGR---VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSC---EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCc---EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            986654   999999999886543 44567899999999999875  555 99999999999999999999988776 77


Q ss_pred             HHHHHHhccCCCCCCC---------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          251 IFDAVRTADLRFPSNP---------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       251 ~~~~i~~~~~~~~~~~---------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ..+.+......++...               ...++.++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            7777777766555321               146899999999999999999999999999999997643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3e-46  Score=372.34  Aligned_cols=267  Identities=24%  Similarity=0.346  Sum_probs=201.0

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCc---EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGE---VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      .+.....++|++++.||+|+||.||+|+++.+++   .||+|++..... .....+.+.+|+++++++. ||||++++++
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   93 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGV   93 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhce
Confidence            3445567789999999999999999999987765   899999976543 3345678899999999995 9999999999


Q ss_pred             EEeCCEE------EEEEeccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec
Q 012203          111 YEDEDYV------HLVMELCAGGELFHRLEKFG------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK  178 (468)
Q Consensus       111 ~~~~~~~------~lV~E~~~ggsL~~~l~~~~------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~  178 (468)
                      +...+..      ++||||+.+|+|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence            9877665      99999999999999996543      59999999999999999999999999999999999999866


Q ss_pred             CCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 012203          179 ASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFD  253 (468)
Q Consensus       179 ~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~  253 (468)
                      +.   +||+|||++........   .....+++.|+|||++.+. ++.++|||||||++|+|++ |+.||.+.+..+...
T Consensus       174 ~~---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          174 MT---VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             SC---EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             CC---EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            54   99999999987654332   2234578889999999875 8999999999999999999 999999988888877


Q ss_pred             HHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCC-------HHHHHhCcCCCCCCCCC
Q 012203          254 AVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLT-------ARQVLDHSWMGDGIQDP  308 (468)
Q Consensus       254 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-------~~eiL~h~~~~~~~~~~  308 (468)
                      .+.......   ....+++++.+||.+||+.||.+|||       ++++++|+|+....+++
T Consensus       251 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          251 YLIGGNRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             HHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred             HHhcCCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence            776654221   12578899999999999999999999       78888999997765443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.2e-46  Score=378.60  Aligned_cols=261  Identities=26%  Similarity=0.429  Sum_probs=204.2

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-  115 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-  115 (468)
                      ....++|++.+.||+|+||+||+|+++.+|+.||+|++......    ......|++.+..+. ||||++++++|...+ 
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLH-HPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHC-CTTBCCEEEEEEEECS
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcC-CCCcccHHHhhhcccc
Confidence            34457899999999999999999999999999999998665322    234556777888885 999999999996543 


Q ss_pred             ------EEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--HcCcEecccCCCcEEEee-cCCCC
Q 012203          116 ------YVHLVMELCAGGELFHRLE----KFGRFSEAEARVLFMQLMQVVLYCH--EIGVVHRDLKPENILLAT-KASSS  182 (468)
Q Consensus       116 ------~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH--~~gIiHrDIKp~NILl~~-~~~~~  182 (468)
                            .+++||||+++ +|...+.    ....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++   
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG---  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT---
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC---
Confidence                  38999999976 5554443    4567899999999999999999999  999999999999999985 44   


Q ss_pred             CEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 012203          183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                      .+||+|||++.............||+.|+|||++.+.  ++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            4999999999987766666677899999999998653  89999999999999999999999999887777766654211


Q ss_pred             CCC--------------------C--------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          261 RFP--------------------S--------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       261 ~~~--------------------~--------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      ..+                    .        ......++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            100                    0        011235788999999999999999999999999999977543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.1e-47  Score=372.09  Aligned_cols=262  Identities=26%  Similarity=0.453  Sum_probs=198.4

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++++. ||||+++++++...+..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSCE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCc
Confidence            356789999999999999999999998999999999876532  233567888999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          118 HLVMELCAGGELFHRLEK--------FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~--------~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                      ++||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC---EEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC---EEEEec
Confidence            999999999999999974        356999999999999999999999999999999999999986654   999999


Q ss_pred             CceeeecCCC------ccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 012203          190 GLATYIEPGQ------SLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR  261 (468)
Q Consensus       190 Gla~~~~~~~------~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  261 (468)
                      |++.......      ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||..................
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            9987654321      1234579999999999875  4899999999999999999999999887766555444333221


Q ss_pred             C-C-----CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 F-P-----SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 ~-~-----~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      . .     ...+..+++++.++|.+||..||.+|||+.|+++||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            1 1     112356889999999999999999999999999999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=372.55  Aligned_cols=261  Identities=30%  Similarity=0.449  Sum_probs=212.8

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE----
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE----  112 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~----  112 (468)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||+|++...   .....+.+.+|+++++++. ||||+++++++.    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGS   82 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSC
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccc
Confidence            45788999999999999999999999999999999998754   3455678889999999996 999999999883    


Q ss_pred             ----------eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          113 ----------DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       113 ----------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                                +.+.+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++  .
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~  158 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED--L  158 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--T
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--C
Confidence                      4578999999997 699999865 6799999999999999999999999999999999999997432  3


Q ss_pred             CEEEeecCceeeecCC----CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 012203          183 PIKLADFGLATYIEPG----QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR  256 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~----~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  256 (468)
                      .+||+|||++......    .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            4999999999876432    12234568999999999865  48999999999999999999999999888766666554


Q ss_pred             hccCC----------------------CCCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          257 TADLR----------------------FPSN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       257 ~~~~~----------------------~~~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .....                      .+..    .+..++.++.+||.+||+.||.+|||++|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            33211                      0111    1245789999999999999999999999999999997643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.9e-46  Score=371.92  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=214.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCc---EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGE---VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ...++|++.+.||+|+||.||+|+++.+++   .||+|++....  .....+.+.+|+++++++. ||||+++++++.+.
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  122 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRG  122 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGG
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence            356789999999999999999999986555   59999997542  3455678899999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 DYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      +.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~  199 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV---CKVSDFGLSR  199 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCSSCE
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC---EEECCCCccc
Confidence            9999999999999999999764 57999999999999999999999999999999999999986554   9999999998


Q ss_pred             eecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          194 YIEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       194 ~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      .......    .....+|+.|+|||++.+. ++.++|||||||++|+|++ |..||......+....+..... .+  ..
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~  276 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR-LP--AP  276 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-CC--CC
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-CC--CC
Confidence            7654321    2234568889999999865 8999999999999999999 9999999988888887766532 22  22


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..+++.+.++|.+||..||++|||+.++++
T Consensus       277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            578999999999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5e-46  Score=372.80  Aligned_cols=253  Identities=19%  Similarity=0.285  Sum_probs=212.1

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++.+.||+|+||.||+|+++.+|+.||+|++.....     ...+.+|++++++|.+||||+++++++.+.+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            356889999999999999999999999999999999876532     235778999999996699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC--CCEEEeecCceee
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS--SPIKLADFGLATY  194 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~--~~ikL~DFGla~~  194 (468)
                      ++||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++..  ..+||+|||+++.
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 99999999874 679999999999999999999999999999999999999876532  2399999999987


Q ss_pred             ecCCCc--------cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccCCC
Q 012203          195 IEPGQS--------LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLRF  262 (468)
Q Consensus       195 ~~~~~~--------~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~  262 (468)
                      ......        ....+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+..   ..+.+..+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            654322        2456899999999999875 8999999999999999999999998744   334445544433333


Q ss_pred             CCCC-CCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          263 PSNP-WDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       263 ~~~~-~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +... ...++ ++.+++.+||..||.+||+++++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            3211 12344 9999999999999999999999876

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.6e-46  Score=367.42  Aligned_cols=260  Identities=25%  Similarity=0.385  Sum_probs=222.0

Q ss_pred             hcCccccccccCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCc
Q 012203           30 ILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV  104 (468)
Q Consensus        30 i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnI  104 (468)
                      +++....+...++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+++++++. ||||
T Consensus        12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~i   88 (314)
T 2ivs_A           12 ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHV   88 (314)
T ss_dssp             --CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTB
T ss_pred             ccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCce
Confidence            3344455666789999999999999999999983     456899999997552  4455678899999999995 9999


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHH
Q 012203          105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR------------------------FSEAEARVLFMQLMQVVLYCHE  160 (468)
Q Consensus       105 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------l~~~~~~~i~~qil~aL~~LH~  160 (468)
                      +++++++.+.+.+++||||++|++|.+++.....                        +++..++.++.||+.||.|||+
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  168 (314)
T 2ivs_A           89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE  168 (314)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999987543                        8999999999999999999999


Q ss_pred             cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHH
Q 012203          161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYIL  236 (468)
Q Consensus       161 ~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~el  236 (468)
                      +||+||||||+|||++.++.   +||+|||++........   .....+|+.|+|||++.+. ++.++|||||||++|+|
T Consensus       169 ~~ivH~dikp~NIli~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  245 (314)
T 2ivs_A          169 MKLVHRDLAARNILVAEGRK---MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI  245 (314)
T ss_dssp             TTEECCCCSGGGEEEETTTE---EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred             CCCcccccchheEEEcCCCC---EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHH
Confidence            99999999999999986554   99999999987654332   2334678899999999875 89999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          237 LS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       237 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++ |..||.+.....+.+.+......   .....+++++.++|.+||+.||++||++.|++++
T Consensus       246 ~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          246 VTLGGNPYPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhCCCCCCCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99 99999998888887777655322   2225789999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-45  Score=356.25  Aligned_cols=251  Identities=26%  Similarity=0.382  Sum_probs=217.7

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      .-..++|++.+.||+|+||.||+|.++ ++..||+|++.....    ....+.+|+++++++. ||||+++++++.+.+.
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCc
Confidence            345678999999999999999999886 677899999976532    2456889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      +++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~l~Dfg~~~~~  154 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRYV  154 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC---EEECCTTCEEEC
T ss_pred             eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC---EEEccCccceec
Confidence            999999999999999997754 4999999999999999999999999999999999999986654   999999999876


Q ss_pred             cCCCc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          196 EPGQS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       196 ~~~~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      .....  .....+|+.|+|||++.+. ++.++||||||+++|+|++ |+.||...........+.........   ...+
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  231 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLAS  231 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSC
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcCh
Confidence            54432  2345677889999999874 8999999999999999999 99999988888877777665433322   4678


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      +.+.+++.+||+.||.+|||+.|++++-
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          232 DTIYQIMYSCWHELPEKRPTFQQLLSSI  259 (268)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=371.49  Aligned_cols=245  Identities=23%  Similarity=0.395  Sum_probs=207.4

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||+||+|.++.+++.||+|++...   .....+.+.+|+++++++. ||||+++++++.+++..++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEE
Confidence            46799999999999999999999999999999998543   4456678999999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDE  161 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC---EEECCCTTCEECC--
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC---EEEeecccceecccc
Confidence            9999999999999987 567999999999999999999999999999999999999986555   999999999876433


Q ss_pred             Ccc---------------ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHh
Q 012203          199 QSL---------------LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSR-----IFDAVRT  257 (468)
Q Consensus       199 ~~~---------------~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~~  257 (468)
                      ...               ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.......     .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            221               156899999999999875 8999999999999999999999986532211     0011111


Q ss_pred             ccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          258 ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       258 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .  ..+    ..+++.+.+++.+||+.||++|||+.++++
T Consensus       242 ~--~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          242 R--YCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             H--TCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c--cCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1  111    467789999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-46  Score=374.97  Aligned_cols=263  Identities=28%  Similarity=0.477  Sum_probs=218.2

Q ss_pred             hcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh---hhHHHHHHHHHHHHHhc-CCCCce
Q 012203           30 ILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMTRLS-GHPNVV  105 (468)
Q Consensus        30 i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~-~HpnIv  105 (468)
                      +....+.+.+.++|++.+.||+|+||.||+|+++.+|+.||+|++........   .....+.+|+.+++++. +||||+
T Consensus        32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            44566778899999999999999999999999999999999999987643321   12245667999999997 379999


Q ss_pred             eeeEEEEeCCEEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCE
Q 012203          106 DLKAVYEDEDYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       106 ~l~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~i  184 (468)
                      ++++++.+.+.+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+  .+.+
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~--~~~~  189 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGEL  189 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TTEE
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC--CCCE
Confidence            999999999999999999976 8999999988899999999999999999999999999999999999999832  2349


Q ss_pred             EEeecCceeeecCCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 012203          185 KLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       185 kL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      ||+|||++...... ......||+.|+|||++.+.  ++.++|||||||++|+|++|+.||....      .+......+
T Consensus       190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~  262 (320)
T 3a99_A          190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF  262 (320)
T ss_dssp             EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC
T ss_pred             EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc
Confidence            99999999876543 34456899999999998764  4678999999999999999999996432      222333333


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +    ..+++++.+||.+||..||++|||++|+++||||++..
T Consensus       263 ~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          263 R----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             S----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             c----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            2    46899999999999999999999999999999997754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-46  Score=373.58  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=219.1

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      .....++|++++.||+|+||.||+|+++     .+++.||+|++....  .......+.+|+++++++. ||||++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~  118 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGV  118 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEE
Confidence            4556789999999999999999999997     456899999997653  3445678899999999995 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEec
Q 012203          111 YEDEDYVHLVMELCAGGELFHRLEKF------------------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHR  166 (468)
Q Consensus       111 ~~~~~~~~lV~E~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHr  166 (468)
                      +.+.+.+++||||+++|+|.+++...                        ..+++..++.++.||+.||.|||++||+||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999999999999999774                        568999999999999999999999999999


Q ss_pred             ccCCCcEEEeecCCCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCC
Q 012203          167 DLKPENILLATKASSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMP  241 (468)
Q Consensus       167 DIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~  241 (468)
                      ||||+|||++.++.   +||+|||++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..
T Consensus       199 Dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          199 DLATRNCLVGENMV---VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSGGGEEECGGGC---EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCcceEEECCCCe---EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            99999999987665   9999999997654321   2234568899999999876 48999999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          242 PFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       242 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ||.+.+..+....+........   ...+++++.++|.+||..||++||++.+++++
T Consensus       276 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          276 PYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9999888888887776644221   25788999999999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-45  Score=361.89  Aligned_cols=256  Identities=18%  Similarity=0.252  Sum_probs=215.3

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+.++|++.+.||+|+||.||+|++..+|+.||+|++.....     ...+.+|+.+++++.+|+|++++++++.+...
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            4577889999999999999999999999999999999865432     23577899999999779999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC--CCCEEEeecCcee
Q 012203          117 VHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS--SSPIKLADFGLAT  193 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~--~~~ikL~DFGla~  193 (468)
                      .++||||+ |++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.  ...+||+|||++.
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 999999998754 5999999999999999999999999999999999999986542  3459999999998


Q ss_pred             eecCCCc--------cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccCC
Q 012203          194 YIEPGQS--------LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLR  261 (468)
Q Consensus       194 ~~~~~~~--------~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~  261 (468)
                      .......        .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..   .......+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            7754322        3456799999999999875 8999999999999999999999998743   34444444333222


Q ss_pred             CC-CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          262 FP-SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       262 ~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .+ ......+++++.+++.+||..||++||+++++++.
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11 11124688999999999999999999999999763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=369.89  Aligned_cols=258  Identities=30%  Similarity=0.523  Sum_probs=206.5

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh---hhHHHHHHHHHHHHHhc---CCCCceee
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMTRLS---GHPNVVDL  107 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~---~HpnIv~l  107 (468)
                      ...+.+.++|++.+.||+|+||.||+|+++.+|+.||+|++........   .....+.+|+.++.++.   +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            4556788999999999999999999999999999999999977643221   12334567999999983   49999999


Q ss_pred             eEEEEeCCEEEEEEec-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEe-ecCCCCCEE
Q 012203          108 KAVYEDEDYVHLVMEL-CAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLA-TKASSSPIK  185 (468)
Q Consensus       108 ~~~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~-~~~~~~~ik  185 (468)
                      ++++.+.+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++   .+|
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~k  180 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG---CAK  180 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT---EEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC---eEE
Confidence            9999999999999999 78999999999888899999999999999999999999999999999999998 444   499


Q ss_pred             EeecCceeeecCCCccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 012203          186 LADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       186 L~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                      |+|||++...... ......||+.|+|||++.+. + +.++|||||||++|+|++|+.||....      .+......++
T Consensus       181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~  253 (312)
T 2iwi_A          181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP  253 (312)
T ss_dssp             ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC
T ss_pred             EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc
Confidence            9999999877543 34566799999999998764 4 458999999999999999999996431      2233333333


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                          ..++..+.++|.+||..||++|||++|+++|+||+...
T Consensus       254 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          254 ----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                46889999999999999999999999999999997654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-45  Score=365.02  Aligned_cols=265  Identities=24%  Similarity=0.385  Sum_probs=215.4

Q ss_pred             CccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcC-CCCceeeeEE
Q 012203           32 DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG-HPNVVDLKAV  110 (468)
Q Consensus        32 ~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~-HpnIv~l~~~  110 (468)
                      ....+....++|++++.||+|+||.||+|.+. +++.||+|++..... .......+.+|+++++++.. ||||++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            34445667788999999999999999999986 589999999976543 34456788999999999973 6999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          111 YEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       111 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      +.+.+.+++||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.    +.+||+|||
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~Dfg  171 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFG  171 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCS
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEeecc
Confidence            999999999999 568899999999889999999999999999999999999999999999999962    459999999


Q ss_pred             ceeeecCCCc---cccCCCCCCCcChhhhcC------------CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 012203          191 LATYIEPGQS---LLGTVGSPFYIAPEVLAG------------GYNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDA  254 (468)
Q Consensus       191 la~~~~~~~~---~~~~~GT~~Y~APE~l~~------------~~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~  254 (468)
                      ++........   .....||+.|+|||++.+            .++.++|||||||++|+|++|+.||..... ......
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  251 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence            9987654322   234579999999999875            478899999999999999999999976543 233333


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +........  .....++++.++|.+||..||.+||++.|+++||||+...
T Consensus       252 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          252 IIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             HHhcccccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            333322222  2245688999999999999999999999999999997654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-45  Score=357.42  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=215.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|++++++++ ||||+++++++.+.+..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEE
Confidence            367999999999999999999997 578899999976532    2356889999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC---EEECCTTGGGGBCCH
T ss_pred             EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC---EEecccccccccccc
Confidence            99999999999999764 45899999999999999999999999999999999999987655   999999999865433


Q ss_pred             C--ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          199 Q--SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       199 ~--~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .  ......||+.|+|||++.+ .++.++||||||+++|+|++ |+.||......+....+........   ...+++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  236 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  236 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHH
Confidence            2  2234567888999999985 48999999999999999999 9999999888888887776533222   24678999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .+++.+||+.||.+|||+.++++|
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999976

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=374.87  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=220.3

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcC-------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKF-------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      +...++|++++.||+|+||.||+|++..       ++..||+|++....  .......+.+|+++++++.+||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            4456789999999999999999999753       33589999997652  44556788999999999966999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcE
Q 012203          110 VYEDEDYVHLVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENI  173 (468)
Q Consensus       110 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NI  173 (468)
                      ++.+.+.+++||||++||+|.+++....                .+++..++.++.||+.||.|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998754                499999999999999999999999999999999999


Q ss_pred             EEeecCCCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 012203          174 LLATKASSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTK  248 (468)
Q Consensus       174 Ll~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~  248 (468)
                      |++.++.   +||+|||+++......   ......||+.|+|||++.+. ++.++|||||||++|+|++ |..||.+.+.
T Consensus       223 ll~~~~~---~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          223 LVTEDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             EECTTCC---EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEcCCCc---EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9986654   9999999998765432   22345678899999999875 8999999999999999999 9999999888


Q ss_pred             HHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      .++.+.+.......   ....+++++.+||.+||+.||++|||++|++++-
T Consensus       300 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          300 EELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             HHHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            88887776654221   2257899999999999999999999999999753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.8e-45  Score=373.24  Aligned_cols=260  Identities=25%  Similarity=0.455  Sum_probs=209.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc----------CCCCceeee
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS----------GHPNVVDLK  108 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~----------~HpnIv~l~  108 (468)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++...    ......+.+|+.+++++.          +||||++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            356899999999999999999999999999999999754    234567788999999885          278999999


Q ss_pred             EEEEeCC----EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecC--
Q 012203          109 AVYEDED----YVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKA--  179 (468)
Q Consensus       109 ~~~~~~~----~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~--  179 (468)
                      +++...+    .+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++  
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            9998654    899999999 99999999874  4599999999999999999999998 999999999999997653  


Q ss_pred             -CCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh------HHH
Q 012203          180 -SSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK------SRI  251 (468)
Q Consensus       180 -~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~------~~~  251 (468)
                       ....+||+|||++.....  .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.....      ...
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence             223599999999987643  33456899999999999875 89999999999999999999999976542      222


Q ss_pred             HHHHHhccCCCCC--------------------------------------CCCCCCCHHHHHHHHHccccCCCCCCCHH
Q 012203          252 FDAVRTADLRFPS--------------------------------------NPWDHISDSAKDLVMGMLSTDPSQRLTAR  293 (468)
Q Consensus       252 ~~~i~~~~~~~~~--------------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~  293 (468)
                      ...+.......|.                                      .....+++++.+||.+||+.||++|||++
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            2222211111110                                      01124567899999999999999999999


Q ss_pred             HHHhCcCCCCCC
Q 012203          294 QVLDHSWMGDGI  305 (468)
Q Consensus       294 eiL~h~~~~~~~  305 (468)
                      |+|+||||++..
T Consensus       330 ell~hp~f~~~~  341 (373)
T 1q8y_A          330 GLVNHPWLKDTL  341 (373)
T ss_dssp             HHHTCGGGTTCT
T ss_pred             HHhhChhhhccc
Confidence            999999998754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=371.43  Aligned_cols=258  Identities=30%  Similarity=0.463  Sum_probs=214.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE-
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY-  116 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~-  116 (468)
                      .+.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++++. ||||+++++++...+. 
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence            46789999999999999999999999999999999997653 23444567889999999996 9999999999987654 


Q ss_pred             -----EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          117 -----VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       117 -----~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                           +|+||||+. ++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg~  172 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFGL  172 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC---EEECSTTC
T ss_pred             ccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc---EEEeeccc
Confidence                 599999996 688887753  5999999999999999999999999999999999999986654   99999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--------
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR--------  261 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------  261 (468)
                      +.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+......        
T Consensus       173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            976543  2345689999999999876  4899999999999999999999999988876666555432100        


Q ss_pred             ---------------CC----CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 ---------------FP----SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 ---------------~~----~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                     .+    ...+..+++++.+||.+||..||++|||++|+++||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                           00    112346789999999999999999999999999999997643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-45  Score=364.75  Aligned_cols=256  Identities=24%  Similarity=0.351  Sum_probs=208.9

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ....++|++.+.||+|+||.||+|+++.+++.||+|++.............+.+|+.+++++. ||||+++++++.+++.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCe
Confidence            345678999999999999999999999999999999998765444445578899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~~~~~~  185 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF---AYLVDFGIASATT  185 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSCCC-----
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC---EEEecCccCcccc
Confidence            9999999999999999998889999999999999999999999999999999999999986654   9999999997765


Q ss_pred             CCC--ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          197 PGQ--SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       197 ~~~--~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ...  ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.......+...+. .....+......++++
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCTH
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCHH
Confidence            432  22356799999999999875 8999999999999999999999998776654444333 3333333344678999


Q ss_pred             HHHHHHHccccCCCCCC-CHHHHHh
Q 012203          274 AKDLVMGMLSTDPSQRL-TARQVLD  297 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rp-t~~eiL~  297 (468)
                      +.++|.+||..||++|| +++++++
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999999 8888875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=361.17  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=207.7

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      |.....||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++++. ||||+++++++.+.+.+++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence            333458999999999999999999999999997652   234567889999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          123 LCAGGELFHRLEKFG---RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |+++++|.+++....   .+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCCC
Confidence            999999999998752   46788999999999999999999999999999999999862  2349999999998765432


Q ss_pred             -ccccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccCCCCCCCCCCCCHHH
Q 012203          200 -SLLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTKSRI-FDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       200 -~~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                       ......||+.|+|||++.+.   ++.++||||||+++|+|++|+.||........ .......  .........+++++
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEA  255 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHHH
Confidence             23456899999999998753   78899999999999999999999976443221 1111111  11222235789999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      .++|.+||..||++||++.|+++|+||+...
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999999997643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-45  Score=355.60  Aligned_cols=253  Identities=28%  Similarity=0.434  Sum_probs=204.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~-~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      -.++|++.+.||+|+||.||+|.+.  |+.||+|++....... ....+.+.+|++++++++ ||||+++++++.+.+..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--C
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCce
Confidence            3578999999999999999999974  8899999987653322 233567889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---cEecccCCCcEEEeecCC-----CCCEEEeec
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG---VVHRDLKPENILLATKAS-----SSPIKLADF  189 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~g---IiHrDIKp~NILl~~~~~-----~~~ikL~DF  189 (468)
                      ++||||++|++|.+++.. +.+++..++.++.|++.||.|||++|   |+||||||+|||++.+..     .+.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999998854 67999999999999999999999999   999999999999986332     456999999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      |++....... .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+.......+.......+.  ..
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  237 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PS  237 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CT
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Cc
Confidence            9998765432 2356799999999999875 899999999999999999999999988877777666655544332  25


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .+++.+.+++.+||..||.+|||+.|++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            789999999999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.5e-45  Score=363.11  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=216.3

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEE-----cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSD-----KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      .....++|++.+.||+|+||.||+|++     ..+++.||+|++....  .....+.+.+|+.+++++.+||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            344567899999999999999999985     4578899999997653  344567889999999999569999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203          111 YEDEDYVHLVMELCAGGELFHRLEKFG------------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus       111 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      +.+.+..++||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999998754                  38999999999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNT  247 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~  247 (468)
                      ||++.++.   +||+|||++........   .....||+.|+|||++.+. ++.++|||||||++|+|++ |+.||.+..
T Consensus       176 il~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          176 ILLTHGRI---TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             EEEETTTE---EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             EEEcCCCC---EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99986554   99999999987654332   2234678899999998764 8999999999999999998 999998876


Q ss_pred             hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .................  ...+++.+.++|.+||..||.+|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          253 VDSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            55544444433333222  25789999999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.7e-45  Score=359.75  Aligned_cols=257  Identities=27%  Similarity=0.505  Sum_probs=206.0

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++. ||||+++++++.+.+
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDN  105 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence            3445678999999999999999999999999999999998765555566778899999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          116 YVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      .+++||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~---~kl~Dfg~  182 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGL  182 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCC--
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC---EEEEeccc
Confidence            99999999999999999864    456999999999999999999999999999999999999986554   99999999


Q ss_pred             eeeecCCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhccCCCCCCCC
Q 012203          192 ATYIEPGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT--KSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       192 a~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~  267 (468)
                      +....... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+..  .......+....  ++....
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  260 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPS  260 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCT
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcc
Confidence            98765432 23356799999999999875 8999999999999999999999997643  234444444433  333334


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+++++.++|.+||..||.+|||+.+++++
T Consensus       261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            6789999999999999999999999999863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.9e-45  Score=358.48  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=205.5

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      +.+...++|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.+++++. ||||+++++++
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~   85 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVI   85 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEE
Confidence            3455678999999999999999999998654   4579999986542  3445677889999999995 99999999998


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      . ++..|+||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg  161 (281)
T 1mp8_A           86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFG  161 (281)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECC--
T ss_pred             c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC---EEECccc
Confidence            5 566899999999999999998654 6999999999999999999999999999999999999997665   9999999


Q ss_pred             ceeeecCCCc--cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          191 LATYIEPGQS--LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       191 la~~~~~~~~--~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      ++........  .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+......   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~  238 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PM  238 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CC
T ss_pred             cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CC
Confidence            9987654332  223457889999999976 48999999999999999996 99999988888877777655322   12


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ...+++.+.+++.+||..||++|||+.|++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            25789999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.2e-45  Score=357.91  Aligned_cols=249  Identities=23%  Similarity=0.355  Sum_probs=213.2

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.++|++++.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+++++++. ||||+++++++.+.+.++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeE
Confidence            4567999999999999999999886 678899999976532    2356889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLD  172 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC---EEECSTTGGGGBCC
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC---EEEccccccccccc
Confidence            99999999999999976 467999999999999999999999999999999999999986554   99999999976543


Q ss_pred             CC--ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQ--SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~--~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ..  ......+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||...+..+....+........   ....++.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  249 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEK  249 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHH
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCHH
Confidence            32  1234567888999999985 48999999999999999998 9999999888888877776543322   2467899


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      +.++|.+||+.||.+|||++++++|-
T Consensus       250 l~~li~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          250 VYTIMYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHHH
Confidence            99999999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-45  Score=367.20  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=211.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEE--EEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVF--ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v--avK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ++|++.+.||+|+||.||+|+++.+|+.+  |+|.+....  .....+.+.+|+++++++.+||||+++++++.+.+.+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            56999999999999999999999888866  999886532  33345678899999999956999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          119 LVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      +||||+++|+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.++.  
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--  180 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--  180 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--
Confidence            9999999999999998754                6999999999999999999999999999999999999987655  


Q ss_pred             CEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 012203          183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                       +||+|||++.............+++.|+|||++.+. ++.++|||||||++|+|++ |+.||.+.+..+..+.+.....
T Consensus       181 -~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          181 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             -EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence             999999999754322223345678899999999875 8999999999999999998 9999999888887777655421


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                         ......+++.+.+||.+||..||.+|||++|++++-
T Consensus       260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence               122257899999999999999999999999999753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-45  Score=369.40  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=213.3

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      +.-.++|++.+.||+|+||.||+|++.     .+++.||+|++....  .......+.+|+.+++++.+||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345678999999999999999999973     456789999997542  2234567889999999995599999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeccc
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFG-----------------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDL  168 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDI  168 (468)
                      .+.+.+++||||++||+|.+++....                       .+++..++.++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999997653                       2789999999999999999999999999999


Q ss_pred             CCCcEEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCC
Q 012203          169 KPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPF  243 (468)
Q Consensus       169 Kp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf  243 (468)
                      ||+|||++.++.   +||+|||++........   .....||+.|+|||++.+. ++.++|||||||++|+|++ |..||
T Consensus       199 kp~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          199 AARNVLVTHGKV---VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             SGGGEEEETTTE---EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ChhhEEEcCCCc---EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999986654   99999999987643322   2344678899999998764 8999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcC
Q 012203          244 WGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      .+.........+.......+.  ...+++++.+||.+||..||.+|||+.++++|..
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            887765555444444333332  2468999999999999999999999999998753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-44  Score=363.50  Aligned_cols=253  Identities=24%  Similarity=0.361  Sum_probs=217.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEc-------CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDK-------FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      ...++|++.+.||+|+||.||+|++.       .+++.||+|++....  .......+.+|+++++++.+||||++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            34578999999999999999999985       467889999997653  345567889999999999569999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEE
Q 012203          111 YEDEDYVHLVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENIL  174 (468)
Q Consensus       111 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NIL  174 (468)
                      +.+.+.+++||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence            999999999999999999999998654                3899999999999999999999999999999999999


Q ss_pred             EeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 012203          175 LATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKS  249 (468)
Q Consensus       175 l~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~  249 (468)
                      ++.++.   +||+|||++........   .....+|+.|+|||++.+. ++.++|||||||++|+|++ |..||.+....
T Consensus       190 l~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          190 VTENNV---MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             ECTTCC---EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EcCCCC---EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            986554   99999999987764332   2334678899999998765 8999999999999999999 99999998888


Q ss_pred             HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          250 RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++...+.......   ....++.++.++|.+||..||.+|||+.|++++
T Consensus       267 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          267 ELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8887776654221   225789999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-44  Score=354.51  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=210.7

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhH----HHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDE----RSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~----~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...........    +.+.+|+++++++. ||||+++++++.+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecC
Confidence            355789999999999999999999999999999999976543322221    67889999999996 9999999999977


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCC--CCCEEEee
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKAS--SSPIKLAD  188 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~--~~~ikL~D  188 (468)
                      ..  ++||||+++|+|.+.+... ..+++..++.++.|++.||.|||++|  |+||||||+|||++.++.  ...+||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            66  6999999999999888654 46999999999999999999999999  999999999999976543  22489999


Q ss_pred             cCceeeecCCCccccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhccCCCC
Q 012203          189 FGLATYIEPGQSLLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRI--FDAVRTADLRFP  263 (468)
Q Consensus       189 FGla~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~  263 (468)
                      ||++.....  ......||+.|+|||++.+   .++.++|||||||++|+|++|+.||........  ...+.....  .
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~  248 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--R  248 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--C
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--C
Confidence            999975433  3456789999999999843   278899999999999999999999987654443  333333332  2


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ......+++++.++|.+||+.||.+|||++|+++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            2233678999999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.5e-45  Score=375.49  Aligned_cols=250  Identities=27%  Similarity=0.399  Sum_probs=214.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.++|++.+.||+|+||.||+|+++.+++.||+|++...  ........+.+|+++|+++. ||||+++++++.+.+.+|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcE
Confidence            456899999999999999999999999999999998754  23344557888999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||+++....
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~---~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEAD  265 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCGGGCEECTT
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc---EEECcCCCceecCC
Confidence            9999999999999997654 5999999999999999999999999999999999999986554   99999999987544


Q ss_pred             CCccc---cCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          198 GQSLL---GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       198 ~~~~~---~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .....   ...+++.|+|||++.++ ++.++|||||||++|||++ |..||.+....+..+.+.... ..+.  ...+++
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~  342 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLPC--PELCPD  342 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCCC--CTTCCH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCH
Confidence            32211   12356789999999865 8999999999999999998 999999888877777666543 2222  246889


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+|+.+||+.||++|||++++++
T Consensus       343 ~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.9e-45  Score=363.80  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=221.9

Q ss_pred             cCccccccccCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCce
Q 012203           31 LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVV  105 (468)
Q Consensus        31 ~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv  105 (468)
                      +...+.....++|++.+.||+|+||.||+|.++     .+++.||+|++....  .......+.+|+++++++. ||||+
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~   91 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVV   91 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBC
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEe
Confidence            445566778899999999999999999999887     467899999997542  3445567889999999996 99999


Q ss_pred             eeeEEEEeCCEEEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEE
Q 012203          106 DLKAVYEDEDYVHLVMELCAGGELFHRLEKF----------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL  175 (468)
Q Consensus       106 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl  175 (468)
                      ++++++.+.+..++||||++||+|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV  171 (322)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred             eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence            9999999999999999999999999999753          357899999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 012203          176 ATKASSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSR  250 (468)
Q Consensus       176 ~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~  250 (468)
                      +.++.   +||+|||++.......   ......||+.|+|||++.+. ++.++|||||||++|+|++ |..||.+.+..+
T Consensus       172 ~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          172 AEDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             CTTCC---EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             cCCCe---EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            86554   9999999997654322   12234678999999998764 8999999999999999999 899999988888


Q ss_pred             HHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ....+........   ...+++.+.++|.+||..||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          249 VLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8877766543221   25789999999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5e-45  Score=358.97  Aligned_cols=251  Identities=28%  Similarity=0.406  Sum_probs=204.1

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEE----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      .-..++|++++.||+|+||+||+|+    +..+++.||+|++...   .....+.+.+|++++++++ ||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            3456789999999999999999998    5678999999998754   3455678899999999996 999999999985


Q ss_pred             e--CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          113 D--EDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       113 ~--~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                      .  ...+++||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+||
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~kl~Df  158 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDF  158 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe---EEEccC
Confidence            4  456899999999999999998754 4999999999999999999999999999999999999987665   999999


Q ss_pred             CceeeecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH---------------
Q 012203          190 GLATYIEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS---------------  249 (468)
Q Consensus       190 Gla~~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~---------------  249 (468)
                      |++........    .....|++.|+|||++.+. ++.++||||||+++|+|++|..||......               
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            99987654321    2234577889999999864 899999999999999999999998543211               


Q ss_pred             -HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          250 -RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       250 -~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                       ...+.+... ...+  ....+++++.++|.+||..||++|||+.|+++
T Consensus       239 ~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 FHLIELLKNN-GRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHTT-CCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcc-CcCC--CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             111222211 1222  23578999999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.8e-45  Score=366.56  Aligned_cols=259  Identities=22%  Similarity=0.301  Sum_probs=217.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEE-----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCS-----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      ...++|++++.||+|+||.||+|+     +..+++.||+|++...  ........+.+|+.+++++. ||||+++++++.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  103 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSL  103 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEc
Confidence            356789999999999999999999     5567899999999644  23455667889999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEE
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFG-------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                      +.+..|+||||++|++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998753       489999999999999999999999999999999999999776667799


Q ss_pred             EeecCceeeecCCC---ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 012203          186 LADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       186 L~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~  260 (468)
                      |+|||++.......   ......||+.|+|||++.+. ++.++|||||||++|+|++ |+.||......+..+.+.....
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  263 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  263 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence            99999987553322   22345689999999998764 8999999999999999998 9999998888888777766543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      ..   ....++..+.++|.+||..||.+||++.+++++.|..
T Consensus       264 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          264 MD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            22   2257899999999999999999999999999998763

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.4e-45  Score=366.76  Aligned_cols=263  Identities=23%  Similarity=0.337  Sum_probs=193.2

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ...-.++|++++.||+|+||.||+|.++.+|+.||+|++....  .......+..|+..+.+..+||||+++++++.+.+
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            3445678999999999999999999999999999999997653  23344556666664444336999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          116 YVHLVMELCAGGELFHRLEK-----FGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                      ..++||||+.+ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.   +||+||
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~---~kl~Df  170 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDF  170 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE---EEECCC
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC---EEEccC
Confidence            99999999975 88888764     56799999999999999999999999 9999999999999987655   999999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhc----C-CCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc-cCCC
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLA----G-GYNQAADVWSAGVILYILLSGMPPFWGNTKS-RIFDAVRTA-DLRF  262 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~----~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~-~~~~  262 (468)
                      |++.............||+.|+|||++.    + .++.++|||||||++|+|++|+.||...... +....+... ...+
T Consensus       171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            9998766544444558999999999983    3 3899999999999999999999999764321 111111111 1122


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +...+..+++.+.+||.+||..||++|||+.|+++||||...
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            333345689999999999999999999999999999999653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=358.51  Aligned_cols=260  Identities=24%  Similarity=0.349  Sum_probs=196.9

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHH-HHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS-VKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~-~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .....++|++++.||+|+||.||+|+++.+|+.||+|++.....  ...... +..+..+++.+ +||||+++++++.+.
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSH-DCPYIVQCFGTFITN   96 (318)
T ss_dssp             EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECS
T ss_pred             hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC
Confidence            33445779999999999999999999999999999999976532  222333 33444456666 599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEI-GVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~-gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.+++||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.   +||+|||++
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~  172 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGIS  172 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC---EEECCCTTC
T ss_pred             CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC---EEEEECCCc
Confidence            9999999999 6666666544 46799999999999999999999995 9999999999999986554   999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhc-----C-CCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLA-----G-GYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSN  265 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~-----~-~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~  265 (468)
                      .............||+.|+|||++.     + .++.++|||||||++|+|++|+.||... ...+....+........ .
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~  251 (318)
T 2dyl_A          173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-P  251 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-C
T ss_pred             hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-C
Confidence            8776555555678999999999984     2 3788999999999999999999999763 44455555554433221 1


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ....+++++.++|.+||..||.+||+++|+++||||++
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            22468999999999999999999999999999999965

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-45  Score=359.60  Aligned_cols=249  Identities=22%  Similarity=0.256  Sum_probs=207.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCC-------cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTG-------EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-------~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      ..++|++.+.||+|+||+||+|+++.++       ..||+|++...   .....+.+.+|++++++++ ||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   81 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLS-HKHLVLNYGVC   81 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence            4578999999999999999999998877       47999998654   2345677899999999996 99999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCC-----CCEE
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASS-----SPIK  185 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~-----~~ik  185 (468)
                      .+.+..++||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++..     ..+|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 9999999999999999999999999999999999999876542     1289


Q ss_pred             EeecCceeeecCCCccccCCCCCCCcChhhhcC-C-CCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhccCCC
Q 012203          186 LADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-G-YNQAADVWSAGVILYILLSGM-PPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       186 L~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~-~~~~sDiwSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      |+|||++.....   .....||+.|+|||++.+ . ++.++|||||||++|+|++|. +||.......... .......+
T Consensus       162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~~  237 (289)
T 4fvq_A          162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQL  237 (289)
T ss_dssp             ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCCC
T ss_pred             eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCCC
Confidence            999999865432   223468899999999986 3 899999999999999999955 5554444444333 33333333


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      +    ...++++.+++.+||+.||++|||+.|+++|-
T Consensus       238 ~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  270 (289)
T 4fvq_A          238 P----APKAAELANLINNCMDYEPDHRPSFRAIIRDL  270 (289)
T ss_dssp             C----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             C----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            3    34577899999999999999999999999753

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.3e-46  Score=372.37  Aligned_cols=263  Identities=20%  Similarity=0.255  Sum_probs=213.6

Q ss_pred             hhcCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeee
Q 012203           29 TILDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK  108 (468)
Q Consensus        29 ~i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~  108 (468)
                      ..+...++....++|++.+.||+|+||.||+|+++ +|+.||+|++....   ....+.+.+|++++++++ ||||++++
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~  101 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLI  101 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEE
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEE
Confidence            44566778889999999999999999999999975 78999999987652   334677899999999996 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCE
Q 012203          109 AVYEDEDYVHLVMELCAGGELFHRLEKFG----RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       109 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~i  184 (468)
                      +++.+.+..++||||++||+|.+++....    .+++..++.++.|++.||.|||++||+||||||+|||++.++.   +
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~  178 (321)
T 2qkw_B          102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV---P  178 (321)
T ss_dssp             EECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC---E
T ss_pred             EEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC---E
Confidence            99999999999999999999999986543    5899999999999999999999999999999999999986554   9


Q ss_pred             EEeecCceeeecCCC---ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH------
Q 012203          185 KLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDA------  254 (468)
Q Consensus       185 kL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~------  254 (468)
                      ||+|||++.......   ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+....      
T Consensus       179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  258 (321)
T 2qkw_B          179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE  258 (321)
T ss_dssp             EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred             EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence            999999998754321   22345689999999998764 89999999999999999999999976543221111      


Q ss_pred             -HHhccC------CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          255 -VRTADL------RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       255 -i~~~~~------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                       ......      ..........+..+.+++.+||+.||++|||+.|++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence             111111      111111234567799999999999999999999999865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.2e-45  Score=361.95  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=213.9

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEE-----cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSD-----KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      ......++|++.+.||+|+||.||+|++     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            3345678899999999999999999985     4577899999997653  34455678899999999976999999999


Q ss_pred             EEEeCC-EEEEEEeccCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203          110 VYEDED-YVHLVMELCAGGELFHRLEKFGR----------------FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus       110 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~----------------l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      ++...+ .+++||||++||+|.+++.....                +++..++.++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            987654 59999999999999999987654                8999999999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNT  247 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~  247 (468)
                      ||++.++.   +||+|||++........   .....||+.|+|||++.+. ++.++|||||||++|+|++ |+.||.+..
T Consensus       179 il~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          179 ILLSEKNV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             EEECGGGC---EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEECCCCC---EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99987655   99999999987643322   2345678999999998764 8999999999999999998 999998766


Q ss_pred             hHH-HHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          248 KSR-IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       248 ~~~-~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      ... ....+.... ..+.  ...+++.+.++|.+||+.||.+|||+.|+++|.
T Consensus       256 ~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          256 IDEEFCRRLKEGT-RMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             CSHHHHHHHHHTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhHHHHHHhccCc-cCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            443 334443332 2221  246889999999999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.7e-45  Score=364.18  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=205.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEE----EEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVF----ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v----avK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .++|++.+.||+|+||+||+|++..+++.+    |+|.+....  .......+.+|+.+++++. ||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            467999999999999999999998887765    666665432  2344577899999999996 999999999998765


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                       .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC---EEEccCcceeE
Confidence             78999999999999999774 56999999999999999999999999999999999999988665   99999999987


Q ss_pred             ecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          195 IEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       195 ~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ......   .....||+.|+|||++.+. ++.++|||||||++|+|++ |+.||.+.....+...+..... .+.  ...
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~  243 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQ--PPI  243 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCC--CTT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-CCC--Ccc
Confidence            654332   2234678899999998865 8999999999999999999 9999998888777776665532 221  256


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++..+.+++.+||+.||.+||++.|++++
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            88999999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-44  Score=353.73  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=207.6

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeCCE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-VVDLKAVYEDEDY  116 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn-Iv~l~~~~~~~~~  116 (468)
                      .+.++|++.+.||+|+||.||+|+++.+|+.||+|++.....     ...+.+|+.+++++. |++ +..+..++.+.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhh-cCCCCCccccccCCCCc
Confidence            467899999999999999999999999999999999876532     235788999999997 555 5555555578889


Q ss_pred             EEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 9999999974 457999999999999999999999999999999999999964334456999999999887


Q ss_pred             cCCCc--------cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccCCCC
Q 012203          196 EPGQS--------LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT---KSRIFDAVRTADLRFP  263 (468)
Q Consensus       196 ~~~~~--------~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~  263 (468)
                      .....        .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||....   ..+.+..+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            65432        2456899999999999875 8999999999999999999999997633   2233344433332222


Q ss_pred             C-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          264 S-NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       264 ~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      . .....+++++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1 112467899999999999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.6e-45  Score=355.25  Aligned_cols=248  Identities=25%  Similarity=0.437  Sum_probs=213.3

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED---  113 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~---  113 (468)
                      +.+.++|++++.||+|+||.||+|++..+|+.||+|++....       ..+.+|+++++++. ||||+++++++..   
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEecccc
Confidence            346778999999999999999999999999999999997642       24568999999996 9999999999865   


Q ss_pred             -------------CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec
Q 012203          114 -------------EDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK  178 (468)
Q Consensus       114 -------------~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~  178 (468)
                                   ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence                         45689999999999999999764  579999999999999999999999999999999999999876


Q ss_pred             CCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 012203          179 ASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRT  257 (468)
Q Consensus       179 ~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~  257 (468)
                      +.   +||+|||++.............||+.|+|||++.+. ++.++||||||+++|+|++|..||..  .......+..
T Consensus       159 ~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~  233 (284)
T 2a19_B          159 KQ---VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRD  233 (284)
T ss_dssp             TE---EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHT
T ss_pred             CC---EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhc
Confidence            65   999999999987766555667899999999999875 89999999999999999999999742  2233333333


Q ss_pred             ccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          258 ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       258 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ..  .    ...++..+.++|.+||..||.+|||+.|+++|.+...
T Consensus       234 ~~--~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 GI--I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TC--C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cc--c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            22  1    1467899999999999999999999999999987643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.2e-44  Score=354.04  Aligned_cols=257  Identities=23%  Similarity=0.296  Sum_probs=214.6

Q ss_pred             CccccccccCCeEEEe-EEeecCCeEEEEEEE--cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeee
Q 012203           32 DTNQISNLRERFVLGQ-QLGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK  108 (468)
Q Consensus        32 ~~~~~~~l~~~y~i~~-~LG~G~fg~Vy~a~~--~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~  108 (468)
                      .+.++..-.++|++.+ .||+|+||.||+|.+  +.+++.||+|++..... .....+.+.+|+++++++. ||||++++
T Consensus         7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~   84 (291)
T 1xbb_A            7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMI   84 (291)
T ss_dssp             ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEE
T ss_pred             CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEE
Confidence            3455556678899998 999999999999954  56789999999976532 2334577899999999995 99999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEee
Q 012203          109 AVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLAD  188 (468)
Q Consensus       109 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~D  188 (468)
                      +++ +.+.+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|
T Consensus        85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~---~kl~D  160 (291)
T 1xbb_A           85 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISD  160 (291)
T ss_dssp             EEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECC
T ss_pred             EEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc---EEEcc
Confidence            999 56678999999999999999999888999999999999999999999999999999999999997665   99999


Q ss_pred             cCceeeecCCCcc----ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 012203          189 FGLATYIEPGQSL----LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRF  262 (468)
Q Consensus       189 FGla~~~~~~~~~----~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  262 (468)
                      ||++.........    ....||+.|+|||++.+. ++.++||||||+++|+|++ |+.||...+..+....+...... 
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-  239 (291)
T 1xbb_A          161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-  239 (291)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-
T ss_pred             CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            9999887544321    223567889999999765 8899999999999999999 99999998888877777665321 


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          263 PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       263 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                        .....+++.+.++|.+||..||.+||++.++++
T Consensus       240 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              122578999999999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7e-45  Score=356.00  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=218.8

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ..+...++|++.+.||+|+||.||+|.++.+++.||+|++....    ...+.+.+|++++++++ ||||+++++++.+.
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE   81 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence            33456778999999999999999999999999999999997542    34567889999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.+++||||++|++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~l~Dfg~~  158 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLS  158 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC---EEECCCCGG
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC---EEEccCccc
Confidence            9999999999999999999874  34999999999999999999999999999999999999987665   999999999


Q ss_pred             eeecCCC--ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          193 TYIEPGQ--SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       193 ~~~~~~~--~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      .......  ......+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...+.....+.+......   ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  235 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE  235 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCC
Confidence            8665432  2234567889999999986 48999999999999999999 99999988887777776654221   2235


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+++.+.+|+.+||..||.+|||++++++
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            78999999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=377.14  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=212.9

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-  115 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-  115 (468)
                      +.+.++|++.+.||+|+||+||+|+++.+|+.||+|++.....  ....+.+.+|++++++++ ||||+++++++.+.+ 
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT   81 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCC
Confidence            4567899999999999999999999999999999999976532  233567788999999996 999999999998765 


Q ss_pred             -EEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeec-CCCCCEEEeecC
Q 012203          116 -YVHLVMELCAGGELFHRLEKFGR---FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATK-ASSSPIKLADFG  190 (468)
Q Consensus       116 -~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~-~~~~~ikL~DFG  190 (468)
                       ..++|||||+||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+..+ .....+||+|||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence             78999999999999999976433   9999999999999999999999999999999999998332 223459999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcC---------CCCCcchHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHh
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAG---------GYNQAADVWSAGVILYILLSGMPPFWGN----TKSRIFDAVRT  257 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~---------~~~~~sDiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~  257 (468)
                      +++...........+||+.|+|||++.+         .++.++|||||||++|+|++|+.||...    ...+....+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            9998876666667889999999999863         3678999999999999999999999642    23344444444


Q ss_pred             ccCC-------------------CC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          258 ADLR-------------------FP--SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       258 ~~~~-------------------~~--~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ....                   ++  ......++..+.++|.+||..||++||+++|++++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            3221                   01  01113456678999999999999999999999764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-44  Score=361.65  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=216.3

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCCCc-----EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeE
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGE-----VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKA  109 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~  109 (468)
                      ......++|++.+.||+|+||.||+|.+..+++     .||+|++....  .......+.+|+.+++++.+||||+++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            345567889999999999999999999976664     79999997653  34456778999999999955999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEE
Q 012203          110 VYEDEDYVHLVMELCAGGELFHRLEKF--------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILL  175 (468)
Q Consensus       110 ~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl  175 (468)
                      ++.+.+.+++||||+++|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL  197 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence            999999999999999999999999753              357999999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 012203          176 ATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSR  250 (468)
Q Consensus       176 ~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~  250 (468)
                      +.++.   +||+|||++........   .....||+.|+|||++.+. ++.++|||||||++|+|++ |..||.+.....
T Consensus       198 ~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          198 TNGHV---AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             EGGGE---EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             CCCCe---EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            87665   99999999986543322   2234578899999998764 8999999999999999998 999998876655


Q ss_pred             HHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          251 IFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ....+.......+.  ....++.+.++|.+||+.||.+|||+.|++++
T Consensus       275 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          275 KFYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            55544444333322  24678999999999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-44  Score=354.30  Aligned_cols=250  Identities=27%  Similarity=0.390  Sum_probs=204.9

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEE----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ..++|++++.||+|+||.||+|+    +..+++.||+|++....  .......+.+|++++++++ ||||+++++++.+.
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTED   95 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC
Confidence            35669999999999999999999    56789999999997653  2334577899999999996 99999999999876


Q ss_pred             --CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          115 --DYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       115 --~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                        +.+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~  172 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGL  172 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC---EEECcccc
Confidence              679999999999999999954 457999999999999999999999999999999999999987665   99999999


Q ss_pred             eeeecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC--------------C-hHHH
Q 012203          192 ATYIEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN--------------T-KSRI  251 (468)
Q Consensus       192 a~~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~--------------~-~~~~  251 (468)
                      +........    .....||+.|+|||++.+. ++.++||||||+++|+|++|..|+...              . ....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            988765432    2345788899999999775 889999999999999999999986321              1 1112


Q ss_pred             HHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       252 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ...+... ...  .....+++.+.+||.+||..||.+|||+.++++
T Consensus       253 ~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 VNTLKEG-KRL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTT-CCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcc-CCC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2222222 222  223578999999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-44  Score=348.33  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=214.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+++++++. ||||+++++++.+.+.+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEE
Confidence            467999999999999999999997 678999999976532    2367889999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||++......
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC---EEECCTTGGGGBCCH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC---EEEcccccccccccc
Confidence            99999999999999875 56899999999999999999999999999999999999987665   999999999765432


Q ss_pred             C--ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHH
Q 012203          199 Q--SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       199 ~--~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l  274 (468)
                      .  ......||+.|+|||++.+ .++.++||||||+++|+|++ |+.||......+....+........   ...++..+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHH
Confidence            2  1234567889999999985 48999999999999999999 9999998888888877766533222   24678999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .+++.+||..||++||++.+++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-44  Score=349.26  Aligned_cols=246  Identities=17%  Similarity=0.238  Sum_probs=212.0

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC--CE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE--DY  116 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~--~~  116 (468)
                      -.++|++.+.||+|+||.||+|++.  |+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.  +.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCC
Confidence            4467999999999999999999985  88999999987643 3445677899999999995 99999999999877  78


Q ss_pred             EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          117 VHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +++||||++||+|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.   ++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~---~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC---EEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc---eeEEeccce
Confidence            999999999999999998765  4899999999999999999999999  999999999999986554   899999987


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC-CC---CcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG-YN---QAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~---~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ....    .....||+.|+|||++.+. ++   .++|||||||++|+|++|+.||...........+........  ...
T Consensus       161 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  234 (271)
T 3kmu_A          161 FSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPP  234 (271)
T ss_dssp             CTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCT
T ss_pred             eeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCC
Confidence            5432    2346789999999999874 33   379999999999999999999998888777766665544332  235


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+++++.++|.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            78999999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.1e-44  Score=350.88  Aligned_cols=253  Identities=30%  Similarity=0.400  Sum_probs=211.6

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcC---CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      .....++|++.+.||+|+||+||+|++..   ++..||+|++.+..  .....+.+.+|+.+++++. ||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   83 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIE   83 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEEC
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEc
Confidence            34456789999999999999999998753   34569999997653  3455678899999999996 999999999987


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      ++ ..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~  159 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGL  159 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE---EEECCCCG
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc---EEeCccCC
Confidence            54 568999999999999999765 45999999999999999999999999999999999999987665   99999999


Q ss_pred             eeeecCCCc--cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          192 ATYIEPGQS--LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       192 a~~~~~~~~--~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      +........  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||......+....+...... +  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-~--~~  236 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-P--KP  236 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-C--CC
T ss_pred             CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-C--CC
Confidence            986654321  234567889999999976 48999999999999999998 99999887777777766655322 1  12


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+++.+.++|.+||..||++|||+.|++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            4688999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4e-45  Score=365.70  Aligned_cols=249  Identities=21%  Similarity=0.302  Sum_probs=207.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcE----EEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEV----FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .++|++++.||+|+||+||+|+++.+++.    ||+|.+....  .......+.+|+.+++++. ||||+++++++. .+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence            56799999999999999999999888876    6677664432  1222345677999999995 999999999986 45


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      ..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC---EEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe---EEECCCCcccc
Confidence            689999999999999999774 57999999999999999999999999999999999999986655   99999999987


Q ss_pred             ecCCCc---cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          195 IEPGQS---LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       195 ~~~~~~---~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ......   .....||+.|+|||++.+ .++.++|||||||++|+|++ |+.||.+....+..+.+........   ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  241 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQI  241 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CTT
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CCc
Confidence            654322   234568889999999986 48999999999999999999 9999998888888777766543222   135


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++.++.+++.+||..||.+||++.+++++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77889999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.1e-45  Score=369.34  Aligned_cols=254  Identities=19%  Similarity=0.211  Sum_probs=196.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCC-----CcEEEEEEeccCcCCChhhH--------HHHHHHHHHHHHhcCCCCc
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFT-----GEVFACKSIAKDRLVTIDDE--------RSVKLEIEIMTRLSGHPNV  104 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vavK~i~~~~~~~~~~~--------~~~~~Ei~iL~~L~~HpnI  104 (468)
                      ...++|++++.||+|+||.||+|.++.+     ++.||+|++...........        .....|+..+..+. ||||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence            4667999999999999999999999764     58899999876531000000        11223344445553 9999


Q ss_pred             eeeeEEEEeC----CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC
Q 012203          105 VDLKAVYEDE----DYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA  179 (468)
Q Consensus       105 v~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~  179 (468)
                      +++++++...    ...||||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+.
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            9999998764    5689999999 99999999876 6799999999999999999999999999999999999998322


Q ss_pred             CCCCEEEeecCceeeecCCCc--------cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 012203          180 SSSPIKLADFGLATYIEPGQS--------LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSR  250 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~  250 (468)
                       .+.+||+|||+++.+.....        ....+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.....
T Consensus       190 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          190 -PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             -TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             -CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence             34599999999987653221        1334699999999999875 8999999999999999999999997543322


Q ss_pred             HHHHHHhcc----------CCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          251 IFDAVRTAD----------LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       251 ~~~~i~~~~----------~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .........          ..++   ...+++++.+++..||..||.+||+++++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            221111100          0111   1467899999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-44  Score=374.96  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=202.1

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+      ..+.+.+|+++|+++.+||||+++++++.+.+.
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            4577788889999999999998754 458999999998653      235677899999988669999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCC-------HHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC----------
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFS-------EAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA----------  179 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~-------~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~----------  179 (468)
                      +|||||||. |+|.+++.......       +..++.++.||+.||.|||++||+||||||+|||++.++          
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence            999999995 69999998754332       234567999999999999999999999999999998642          


Q ss_pred             CCCCEEEeecCceeeecCCCc-----cccCCCCCCCcChhhhcC--------CCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 012203          180 SSSPIKLADFGLATYIEPGQS-----LLGTVGSPFYIAPEVLAG--------GYNQAADVWSAGVILYILLS-GMPPFWG  245 (468)
Q Consensus       180 ~~~~ikL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~--------~~~~~sDiwSlGvil~ellt-G~~Pf~~  245 (468)
                      ....+||+|||+++.......     ....+||+.|+|||++.+        .++.++|||||||++|||++ |+.||..
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            234699999999998765432     234589999999999964        37899999999999999999 9999976


Q ss_pred             CChHHHHHHHHhccCCCCCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          246 NTKSRIFDAVRTADLRFPSN---PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .....  ..+.......+..   ....+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            54433  2333333333221   12345688999999999999999999999999999964

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-44  Score=370.55  Aligned_cols=250  Identities=25%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEc---CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDK---FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ..++|++.+.||+|+||.||+|+++   .++..||+|++....  .....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  119 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCC
Confidence            3468999999999999999999987   467789999997642  3445678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .+++||||++||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  196 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLGRV  196 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC-----
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC---EEECcCccccc
Confidence            9999999999999999998754 6999999999999999999999999999999999999986554   99999999987


Q ss_pred             ecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          195 IEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       195 ~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ......    .....+|+.|+|||++.+. ++.++|||||||++|||++ |+.||......++.+.+..... .+.  ..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~-~~~--~~  273 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-LPP--PM  273 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE-CCC--CT
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCC--Cc
Confidence            654321    1223457889999999864 8999999999999999998 9999999888888777765432 222  24


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .++..+.+++.+||+.||.+||++.++++
T Consensus       274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            78899999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.9e-44  Score=350.07  Aligned_cols=254  Identities=21%  Similarity=0.287  Sum_probs=201.5

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++.+.||+|+||.||+|++..+++.||+|++.....     ...+.+|+++++++..|+++..+..++.+.+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            467899999999999999999999999999999998765432     234778999999997444455555556888999


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++....
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999999 9999999985 4579999999999999999999999999999999999999433344559999999998875


Q ss_pred             CCCc--------cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCCCC
Q 012203          197 PGQS--------LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK---SRIFDAVRTADLRFPS  264 (468)
Q Consensus       197 ~~~~--------~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~  264 (468)
                      ....        .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+...   ......+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            4322        2356899999999999875 89999999999999999999999976432   2233333333222221


Q ss_pred             -CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          265 -NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       265 -~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                       .....+++++.++|.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence             112467899999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.1e-44  Score=360.28  Aligned_cols=247  Identities=24%  Similarity=0.299  Sum_probs=199.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC----
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED----  115 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~----  115 (468)
                      .++|++++.||+|+||+||+|++.  ++.||+|++....    ........|+.++++++ ||||+++++++.+..    
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence            456999999999999999999875  7999999996542    23445566888899996 999999999998743    


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc----------CcEecccCCCcEEEeecCCCCCEE
Q 012203          116 YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI----------GVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~----------gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                      .+++||||+++|+|.++++. ..+++..++.++.|++.||.|||++          ||+||||||+|||++.++.   +|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~---~k  171 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT---AC  171 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC---EE
T ss_pred             eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe---EE
Confidence            57999999999999999977 5699999999999999999999999          9999999999999986554   99


Q ss_pred             EeecCceeeecCCCc---cccCCCCCCCcChhhhcCC------CCCcchHHHHHHHHHHHHhCCCCCCCCC---------
Q 012203          186 LADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG------YNQAADVWSAGVILYILLSGMPPFWGNT---------  247 (468)
Q Consensus       186 L~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~------~~~~sDiwSlGvil~elltG~~Pf~~~~---------  247 (468)
                      |+|||+++.......   ....+||+.|+|||++.+.      ++.++|||||||++|||++|+.||.+..         
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999988764432   3346899999999999862      4568899999999999999999996532         


Q ss_pred             -------hHHHHHHHHhccCCCCCCC-C--CCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          248 -------KSRIFDAVRTADLRFPSNP-W--DHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       248 -------~~~~~~~i~~~~~~~~~~~-~--~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                             ...+...+........... +  ...++++.+||.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                   2222333322222211110 1  123456999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-44  Score=349.32  Aligned_cols=254  Identities=24%  Similarity=0.305  Sum_probs=215.5

Q ss_pred             ccccCCeEEEe-EEeecCCeEEEEEEEc--CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           37 SNLRERFVLGQ-QLGWGQFGVIRVCSDK--FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        37 ~~l~~~y~i~~-~LG~G~fg~Vy~a~~~--~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      ..-.++|.+.+ .||+|+||.||+|.++  .+++.||+|++....  .....+.+.+|+++++++. ||||+++++++ .
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~   80 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-Q   80 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-E
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-c
Confidence            33456788877 9999999999999864  468889999997652  3455678899999999995 99999999999 4


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      .+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~Dfg~~  157 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLS  157 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE---EEECCCTTC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC---EEECcccce
Confidence            56699999999999999999654 56999999999999999999999999999999999999987665   999999999


Q ss_pred             eeecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          193 TYIEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       193 ~~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      ........    .....||+.|+|||++.+. ++.++||||||+++|+|++ |+.||......+....+......   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~  234 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---EC  234 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CC
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CC
Confidence            88754332    1234578999999999864 8999999999999999998 99999988888877777665321   12


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      ...+++++.++|.+||..||.+||++.+++++.+
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            2578999999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.9e-44  Score=357.59  Aligned_cols=249  Identities=26%  Similarity=0.396  Sum_probs=208.7

Q ss_pred             cCCeEEEeEEeecCCeEEEEEE----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE--e
Q 012203           40 RERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE--D  113 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~--~  113 (468)
                      .++|++++.||+|+||.||+|+    +..+++.||+|++...   .....+.+.+|+++++++. ||||+++++++.  +
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence            3579999999999999999999    5678999999999765   3455677899999999995 999999999986  5


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          114 EDYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      .+.+++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~~  174 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLA  174 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCGGGC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC---EEEcccccc
Confidence            6779999999999999999977 356999999999999999999999999999999999999988665   999999999


Q ss_pred             eeecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH---------------HHH
Q 012203          193 TYIEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS---------------RIF  252 (468)
Q Consensus       193 ~~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~---------------~~~  252 (468)
                      ........    .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||......               ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            88754332    2234688899999999875 889999999999999999999998543321               122


Q ss_pred             HHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +.+... ...  .....+++.+.+||.+||+.||.+|||+.|++++
T Consensus       255 ~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          255 ELLEEG-QRL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHTT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcc-cCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222222 222  2235789999999999999999999999999764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-44  Score=352.22  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcC-CCc--EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKF-TGE--VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~--~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ..++|++.+.||+|+||+||+|++.. +++  .||+|++...........+.+.+|+++++++. ||||+++++++.+.+
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC
Confidence            45679999999999999999998643 333  68999998765444456678899999999996 999999999998765


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                       .++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~~  170 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRA  170 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTCEE
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC---EEEcccccccc
Confidence             89999999999999999764 56999999999999999999999999999999999999987665   99999999988


Q ss_pred             ecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          195 IEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       195 ~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ......    .....+|+.|+|||++.+. ++.++||||||+++|+|++ |+.||...+..+....+.......+..  .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~  248 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--E  248 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC--T
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC--c
Confidence            754332    1234678899999999875 8899999999999999999 999999998888888887665544432  5


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .+++++.++|.+||..||.+|||+.+++++
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            789999999999999999999999999873

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.8e-44  Score=356.56  Aligned_cols=240  Identities=35%  Similarity=0.641  Sum_probs=197.2

Q ss_pred             cccCCeEEE-eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe---
Q 012203           38 NLRERFVLG-QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED---  113 (468)
Q Consensus        38 ~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~---  113 (468)
                      .+.++|.+. +.||+|+||.||+|.++.+|+.||+|++...        ....+|++++.++.+||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            456678887 7899999999999999999999999998643        3567889998666679999999999987   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          114 -EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       114 -~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                       .+.+++||||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             778999999999999999998764  69999999999999999999999999999999999999875545679999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhccCCCCCCC
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV----RTADLRFPSNP  266 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i----~~~~~~~~~~~  266 (468)
                      ++.....                    ..++.++|||||||++|+|++|+.||...........+    ......++...
T Consensus       166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            9976432                    22678999999999999999999999766543322111    11112222222


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +..+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            356899999999999999999999999999999997643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=358.13  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=205.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEE----EEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVF----ACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v----avK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      ..++|++++.||+|+||.||+|+++.+++.+    |+|.+....  .......+.+|+.+++++. ||||+++++++.+.
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS   89 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESS
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecC
Confidence            3578999999999999999999998888766    555554332  3345678899999999996 99999999999876


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 DYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      + .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kL~DfG~a~  165 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAK  165 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCTTC--
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC---EEEccCccee
Confidence            5 78999999999999999774 56999999999999999999999999999999999999987665   9999999998


Q ss_pred             eecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          194 YIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       194 ~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      .......   .....||+.|+|||++.+. ++.++|||||||++|+|++ |+.||.+....++...+..... .+.  ..
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~  242 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQ--PP  242 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCC--CT
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCC--Cc
Confidence            7644322   2334678899999999875 8999999999999999999 9999999888887777665532 221  25


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .++.++.++|.+||..||.+||++.|+++
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            68999999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6e-44  Score=354.16  Aligned_cols=259  Identities=24%  Similarity=0.307  Sum_probs=207.6

Q ss_pred             CccccccccCCeEEEeEEeecCCeEEEEEEEcC---CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeee
Q 012203           32 DTNQISNLRERFVLGQQLGWGQFGVIRVCSDKF---TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK  108 (468)
Q Consensus        32 ~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~  108 (468)
                      ...++....++|.+.+.||+|+||.||+|.+..   +++.||+|++..... .....+.+.+|+.++++++ ||||++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~  102 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLL  102 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCC
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeee
Confidence            334445566889999999999999999998865   556899999976543 3445677889999999996 99999999


Q ss_pred             EEEEeCC-----EEEEEEeccCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEee
Q 012203          109 AVYEDED-----YVHLVMELCAGGELFHRLEK------FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLAT  177 (468)
Q Consensus       109 ~~~~~~~-----~~~lV~E~~~ggsL~~~l~~------~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~  177 (468)
                      +++.+.+     ..++||||+++|+|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence            9997655     45999999999999999953      356999999999999999999999999999999999999986


Q ss_pred             cCCCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 012203          178 KASSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIF  252 (468)
Q Consensus       178 ~~~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~  252 (468)
                      ++.   +||+|||++.......   ......+++.|+|||++.+. ++.++||||||+++|+|++ |..||.........
T Consensus       183 ~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  259 (313)
T 3brb_A          183 DMT---VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY  259 (313)
T ss_dssp             TSC---EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             CCc---EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            554   9999999998765432   12234678899999999875 8999999999999999999 99999988888777


Q ss_pred             HHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+......   .....+++.+.++|.+||..||.+|||+.+++++
T Consensus       260 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          260 DYLLHGHRL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHHTTCCC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            777655322   1225788999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=356.70  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=208.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCC----cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTG----EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g----~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      ...++|.+.+.||+|+||+||+|.++.++    ..||+|++....  .......+.+|+++++++. ||||+++++++.+
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  117 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISK  117 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEec
Confidence            35678999999999999999999987553    459999997542  3445567889999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      .+.+++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~~  194 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLS  194 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC-
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc---EEECCCCcc
Confidence            99999999999999999999765 57999999999999999999999999999999999999986554   999999999


Q ss_pred             eeecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          193 TYIEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       193 ~~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      ........    .....+|+.|+|||++.+. ++.++|||||||++|+|++ |+.||......++...+.... ..+.  
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~--  271 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLPT--  271 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCC--
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-cCCC--
Confidence            87654321    1233568889999999864 8999999999999999999 999999888888877776552 2222  


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ...+++.+.+++.+||+.||.+||++.+++++
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            24789999999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=358.87  Aligned_cols=252  Identities=30%  Similarity=0.488  Sum_probs=190.9

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE---
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE---  112 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~---  112 (468)
                      ++....+|++.+.||+|+||.||+|+++.+|+.||+|++...   .......+.+|+.+++++.+||||+++++++.   
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            344456899999999999999999999999999999998654   34556778899999999977999999999993   


Q ss_pred             -----eCCEEEEEEeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCC
Q 012203          113 -----DEDYVHLVMELCAGGELFHRLEK---FGRFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSS  182 (468)
Q Consensus       113 -----~~~~~~lV~E~~~ggsL~~~l~~---~~~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~  182 (468)
                           ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.  
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--  176 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--  176 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--
Confidence                 4456899999995 799988865   467999999999999999999999999  999999999999986554  


Q ss_pred             CEEEeecCceeeecCCCcc-------------ccCCCCCCCcChhhhc---C-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 012203          183 PIKLADFGLATYIEPGQSL-------------LGTVGSPFYIAPEVLA---G-GYNQAADVWSAGVILYILLSGMPPFWG  245 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~-------------~~~~GT~~Y~APE~l~---~-~~~~~sDiwSlGvil~elltG~~Pf~~  245 (468)
                       +||+|||++.........             ...+||+.|+|||++.   + .++.++|||||||++|+|++|+.||..
T Consensus       177 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          177 -IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             -EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             -EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence             999999999876543211             1456999999999983   3 378899999999999999999999976


Q ss_pred             CChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcC
Q 012203          246 NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW  300 (468)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~  300 (468)
                      ........    .....+  .....+..+.+||.+||+.||.+|||+.|++++.+
T Consensus       256 ~~~~~~~~----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          256 GAKLRIVN----GKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             --------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hhHHHhhc----CcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            54433222    222222  23567788999999999999999999999998754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-43  Score=370.70  Aligned_cols=245  Identities=25%  Similarity=0.345  Sum_probs=209.4

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC-
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED-  115 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~-  115 (468)
                      ..-.++|++.+.||+|+||.||+|.++  |+.||||++....     ..+.+.+|+++|++++ ||||+++++++.+.+ 
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTS
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCC
Confidence            344578999999999999999999875  7899999997653     3467889999999996 999999999987655 


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          116 YVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      .+||||||+++|+|.+++.+.+.  +++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~  337 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTK  337 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC---EEECCCTTCE
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC---EEEeeCCCcc
Confidence            79999999999999999987654  799999999999999999999999999999999999986554   9999999998


Q ss_pred             eecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      .....  .....+++.|+|||++.+. ++.++|||||||++|||++ |+.||...+..+....+..+. +.+  ....++
T Consensus       338 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~--~p~~~~  412 (450)
T 1k9a_A          338 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMD--APDGCP  412 (450)
T ss_dssp             ECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-CCC--CCTTCC
T ss_pred             ccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCcCC
Confidence            65432  2234678999999999875 8999999999999999998 999999888777777776542 222  225789


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.+.++|.+||..||.+|||+.++++
T Consensus       413 ~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          413 PAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-43  Score=345.01  Aligned_cols=248  Identities=25%  Similarity=0.353  Sum_probs=212.1

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ....++|++++.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+++++++. ||||+++++++.+ +.
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CC
Confidence            445678999999999999999999986 677899999976532    3467889999999996 9999999999874 45


Q ss_pred             EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          117 VHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .++||||++|++|.+++....  .+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~  158 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARL  158 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEE
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC---EEECCCccccc
Confidence            899999999999999996543  6999999999999999999999999999999999999986554   99999999988


Q ss_pred             ecCCCc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          195 IEPGQS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       195 ~~~~~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      ......  .....+++.|+|||++.+. ++.++||||||+++|+|++ |+.||.+.+..+....+......   .....+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNC  235 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTC
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCcccc
Confidence            754332  2344678899999999865 8999999999999999999 99999988888877777654321   122578


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++++.+++.+||..||++|||++++++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.6e-44  Score=349.37  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=199.6

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .+-..++|++.+.||+|+||+||+|++.   ..+|+|++..... .....+.+.+|+++++++. ||||++++++. ..+
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAP   92 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSS
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCC
Confidence            3456788999999999999999999764   3599999976542 4455678899999999996 99999999965 556


Q ss_pred             EEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      ..++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~  169 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT---VKIGDFGLATE  169 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE---EEECCCC----
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC---EEEccceeccc
Confidence            68999999999999999954 356999999999999999999999999999999999999987654   99999999976


Q ss_pred             ecC---CCccccCCCCCCCcChhhhc---C-CCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccCCCC-CC
Q 012203          195 IEP---GQSLLGTVGSPFYIAPEVLA---G-GYNQAADVWSAGVILYILLSGMPPFWGNTKS-RIFDAVRTADLRFP-SN  265 (468)
Q Consensus       195 ~~~---~~~~~~~~GT~~Y~APE~l~---~-~~~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~-~~  265 (468)
                      ...   ........||+.|+|||++.   + .++.++||||||+++|+|++|+.||...... ...+.+........ ..
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            543   22234567999999999986   2 3788999999999999999999999875544 44444444433322 22


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ....+++.+.+||.+||..||.+|||+.++++
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            23578899999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=364.65  Aligned_cols=258  Identities=20%  Similarity=0.221  Sum_probs=202.3

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcC---CCcEEEEEEeccCcCCChh--------hHHHHHHHHHHHHHhcCCCCcee
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKF---TGEVFACKSIAKDRLVTID--------DERSVKLEIEIMTRLSGHPNVVD  106 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vavK~i~~~~~~~~~--------~~~~~~~Ei~iL~~L~~HpnIv~  106 (468)
                      ...++|++.+.||+|+||.||+|+++.   ++..+|+|++.........        ....+.+|+.+++.+. ||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcce
Confidence            356789999999999999999999987   7899999999765321111        1123556778888885 999999


Q ss_pred             eeEEEEe----CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          107 LKAVYED----EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       107 l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      +++++.+    ...+|+||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. .
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP-D  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST-T
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC-C
Confidence            9999988    78999999999 9999999988778999999999999999999999999999999999999987652 3


Q ss_pred             CEEEeecCceeeecCCC--------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCC--ChHHH
Q 012203          183 PIKLADFGLATYIEPGQ--------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGN--TKSRI  251 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~--~~~~~  251 (468)
                      .+||+|||+++.+....        ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...  .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            59999999998764321        12456899999999999886 899999999999999999999999652  22222


Q ss_pred             HHHHHhccCCCCCC-----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          252 FDAVRTADLRFPSN-----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       252 ~~~i~~~~~~~~~~-----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ...........+..     +...+++++.++|.+||..||++||+++++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            22222221122210     112788999999999999999999999999863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-43  Score=376.47  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=217.4

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ..-.++|++.+.||+|+||.||+|.++.+++.||||++.....    ..+.+.+|+++|++++ ||||+++++++.+.+.
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP  290 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCCc
Confidence            3456789999999999999999999998899999999976532    3567899999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          117 VHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +||||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~  367 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL---VKVADFGLSRL  367 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC---EEECCTTCEEC
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc---EEEeeccccee
Confidence            99999999999999999874  45899999999999999999999999999999999999987655   99999999987


Q ss_pred             ecCCCc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          195 IEPGQS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       195 ~~~~~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      ......  .....+++.|+|||++.+. ++.++|||||||++|||++ |..||.+.+..++.+.+.... ..+  ....+
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~  444 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RME--RPEGC  444 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCC--CCTTC
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCC
Confidence            654322  2234567889999999865 8999999999999999999 999999988887777765542 222  23578


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+.+||.+||+.||++|||+.++++
T Consensus       445 ~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          445 PEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            999999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=356.27  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=204.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE----eC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE----DE  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~----~~  114 (468)
                      ..++|++.+.||+|+||.||+|+++.+|+.||+|++...   .....+.+.+|+++++++. ||||+++++++.    ..
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCC
Confidence            356799999999999999999999999999999998654   3455678899999999995 999999999996    34


Q ss_pred             CEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          115 DYVHLVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      +..++||||+.+|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~dfg  179 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLG  179 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCS
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC---EEEEecC
Confidence            589999999999999999976    467999999999999999999999999999999999999986554   9999999


Q ss_pred             ceeeecCCC----------ccccCCCCCCCcChhhhcCC----CCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHH
Q 012203          191 LATYIEPGQ----------SLLGTVGSPFYIAPEVLAGG----YNQAADVWSAGVILYILLSGMPPFWGNT--KSRIFDA  254 (468)
Q Consensus       191 la~~~~~~~----------~~~~~~GT~~Y~APE~l~~~----~~~~sDiwSlGvil~elltG~~Pf~~~~--~~~~~~~  254 (468)
                      ++.......          ......||+.|+|||++.+.    ++.++|||||||++|+|++|+.||....  .......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            987643211          01234689999999998753    6889999999999999999999994311  1112222


Q ss_pred             HHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       255 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      +. ....++.  ...++.++.++|.+||+.||.+|||+.+++++-
T Consensus       260 ~~-~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          260 VQ-NQLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HH-CC--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hh-ccCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            22 2233332  257899999999999999999999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-44  Score=360.99  Aligned_cols=264  Identities=22%  Similarity=0.288  Sum_probs=211.5

Q ss_pred             cCccccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEE
Q 012203           31 LDTNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAV  110 (468)
Q Consensus        31 ~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~  110 (468)
                      ++..++....++|++.+.||+|+||.||+|+++ +|+.||+|++......  .....+.+|+++++++. ||||++++++
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~   95 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAV-HRNLLRLRGF   95 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEE
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhcc-CCCccceEEE
Confidence            456677788899999999999999999999865 6899999999765321  22236889999999996 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CcEecccCCCcEEEeecCCCCC
Q 012203          111 YEDEDYVHLVMELCAGGELFHRLEKFG----RFSEAEARVLFMQLMQVVLYCHEI---GVVHRDLKPENILLATKASSSP  183 (468)
Q Consensus       111 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~---gIiHrDIKp~NILl~~~~~~~~  183 (468)
                      +.+.+..++||||+.+|+|.+++....    .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.   
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~---  172 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---  172 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC---
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC---
Confidence            999999999999999999999998653    399999999999999999999999   9999999999999986554   


Q ss_pred             EEEeecCceeeecCCC--ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCC-----CChHHHHHHH
Q 012203          184 IKLADFGLATYIEPGQ--SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWG-----NTKSRIFDAV  255 (468)
Q Consensus       184 ikL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~-----~~~~~~~~~i  255 (468)
                      +||+|||++.......  ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||..     .......+.+
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999998765332  23445699999999999765 89999999999999999999999942     1111111111


Q ss_pred             HhccC----------CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          256 RTADL----------RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       256 ~~~~~----------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      .....          ..........+..+.+++.+||+.||.+|||+.|+++|..-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            11100          01111122345789999999999999999999999998753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=374.99  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=200.7

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      ..+|++.+.||+|+||+||. ....+|+.||||++.....      ..+.+|+++|+++.+||||+++++++.+.+.+||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            34699999999999999764 4446899999999976432      2245799999999669999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC--CCCEEEeecCceeeec
Q 012203          120 VMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS--SSPIKLADFGLATYIE  196 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~--~~~ikL~DFGla~~~~  196 (468)
                      |||||. |+|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.++.  ...+||+|||+++...
T Consensus        96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            999995 69999997653 4566677899999999999999999999999999999965432  2357899999998765


Q ss_pred             CCC----ccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          197 PGQ----SLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       197 ~~~----~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      ...    .....+||+.|+|||++.+    .++.++|||||||++|||++ |..||...........+........ .+.
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  253 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL-HPE  253 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS-CTT
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc-Ccc
Confidence            432    2345689999999999974    36789999999999999999 9999966554443322222221111 122


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ...+..+.+||.+||+.||.+|||++|+++||||..
T Consensus       254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            345667899999999999999999999999999965

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-43  Score=348.92  Aligned_cols=248  Identities=26%  Similarity=0.364  Sum_probs=198.8

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHH--hcCCCCceeeeEEEEe-
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR--LSGHPNVVDLKAVYED-  113 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~--L~~HpnIv~l~~~~~~-  113 (468)
                      ..+.++|++.+.||+|+||+||+|++  +|+.||+|++...      ....+..|.+++..  + +||||+++++++.+ 
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence            34678899999999999999999987  6899999998643      34556667777776  5 59999999998654 


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEecccCCCcEEEeecCCCC
Q 012203          114 ---EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH--------EIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       114 ---~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH--------~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                         ...+++||||+++|+|.++++. ..+++..+..++.|++.||.|||        ++||+||||||+|||++.++.  
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--  151 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--  151 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--
Confidence               3568999999999999999965 57999999999999999999999        999999999999999986554  


Q ss_pred             CEEEeecCceeeecCCCcc-----ccCCCCCCCcChhhhcCC-------CCCcchHHHHHHHHHHHHhC----------C
Q 012203          183 PIKLADFGLATYIEPGQSL-----LGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSG----------M  240 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~-----~~~~GT~~Y~APE~l~~~-------~~~~sDiwSlGvil~elltG----------~  240 (468)
                       +||+|||++.........     ...+||+.|+|||++.+.       ++.++|||||||++|||++|          .
T Consensus       152 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          152 -CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             -EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             -EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence             999999999876544322     234899999999999864       23689999999999999999          8


Q ss_pred             CCCCCCCh----HHHHHHHHhccCCCCCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          241 PPFWGNTK----SRIFDAVRTADLRFPSNP----WDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       241 ~Pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .||.....    ..............+..+    ....++++.+|+.+||+.||.+|||+.|+++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            89865321    222222222222222111    1235678999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.9e-44  Score=354.51  Aligned_cols=254  Identities=28%  Similarity=0.383  Sum_probs=207.1

Q ss_pred             cccccccCCe-EEEeEEeecCCeEEEEEEE----cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeee
Q 012203           34 NQISNLRERF-VLGQQLGWGQFGVIRVCSD----KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLK  108 (468)
Q Consensus        34 ~~~~~l~~~y-~i~~~LG~G~fg~Vy~a~~----~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~  108 (468)
                      .+...+.++| ++++.||+|+||+||++..    ..+|+.||+|++....  .......+.+|+++++++. ||||++++
T Consensus        23 g~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~   99 (318)
T 3lxp_A           23 GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYK   99 (318)
T ss_dssp             -CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred             CCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEE
Confidence            3344566777 9999999999999988753    4578999999997652  3455678899999999996 99999999


Q ss_pred             EEEEe--CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEE
Q 012203          109 AVYED--EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKL  186 (468)
Q Consensus       109 ~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL  186 (468)
                      +++.+  ...+++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~---~kl  175 (318)
T 3lxp_A          100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKI  175 (318)
T ss_dssp             EEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEE
T ss_pred             EEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC---EEE
Confidence            99987  47899999999999999999764 5999999999999999999999999999999999999986554   999


Q ss_pred             eecCceeeecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH------------
Q 012203          187 ADFGLATYIEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS------------  249 (468)
Q Consensus       187 ~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~------------  249 (468)
                      +|||++........    .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||......            
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  255 (318)
T 3lxp_A          176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM  255 (318)
T ss_dssp             CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred             CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence            99999988765432    2345688899999999875 889999999999999999999999653221            


Q ss_pred             ---HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          250 ---RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       250 ---~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                         ...+.+... ..  ......+++++.+||.+||+.||.+|||++|+++
T Consensus       256 ~~~~~~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          256 TVLRLTELLERG-ER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHHTT-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhcc-cC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               111112211 12  2223578999999999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-43  Score=347.82  Aligned_cols=253  Identities=23%  Similarity=0.283  Sum_probs=209.2

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE-
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY-  111 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~-  111 (468)
                      +..-..+|++.+.||+|+||+||+|++..+   +..+|+|.+...  ........+.+|+.+++++. ||||+++++++ 
T Consensus        20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   96 (298)
T 3f66_A           20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICL   96 (298)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEC
T ss_pred             cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEE
Confidence            344556799999999999999999997643   346899988754  24455678899999999996 99999999985 


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      ..++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg  173 (298)
T 3f66_A           97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFG  173 (298)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECSCG
T ss_pred             cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC---EEECccc
Confidence            5567889999999999999999764 45899999999999999999999999999999999999986554   9999999


Q ss_pred             ceeeecCCC-----ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCC
Q 012203          191 LATYIEPGQ-----SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFP  263 (468)
Q Consensus       191 la~~~~~~~-----~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  263 (468)
                      ++.......     ......||+.|+|||++.+. ++.++||||||+++|+|++ |.+||...+..+....+........
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  253 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC
Confidence            998764332     12345678899999999764 8999999999999999999 6778877777666666665543332


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .   ..+++.+.+++.+||..||.+|||+.|+++
T Consensus       254 ~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          254 P---EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C---ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2   467899999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=360.12  Aligned_cols=247  Identities=19%  Similarity=0.241  Sum_probs=203.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcC--------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCcee-----
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKF--------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVD-----  106 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~--------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~-----  106 (468)
                      .++|++.+.||+|+||.||+|+++.        +++.||+|++...        ..+.+|++++++++ ||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            5799999999999999999999987        4899999998754        35778999999996 999887     


Q ss_pred             ----------eeEEEEe-CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcE
Q 012203          107 ----------LKAVYED-EDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENI  173 (468)
Q Consensus       107 ----------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NI  173 (468)
                                +++++.. ++.+|+||||+ |++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777765 78999999999 99999999886  7799999999999999999999999999999999999


Q ss_pred             EEeecCCCCCEEEeecCceeeecCCC--------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCC
Q 012203          174 LLATKASSSPIKLADFGLATYIEPGQ--------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFW  244 (468)
Q Consensus       174 Ll~~~~~~~~ikL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~  244 (468)
                      |++.++. ..+||+|||+++.+....        ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.
T Consensus       191 l~~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          191 FVDPEDQ-SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEETTEE-EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEcCCCC-ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9986541 149999999998764322        11345899999999999874 8999999999999999999999997


Q ss_pred             CCC--hHHHHHHHHh---ccCCC--CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          245 GNT--KSRIFDAVRT---ADLRF--PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       245 ~~~--~~~~~~~i~~---~~~~~--~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ...  ...+......   ....+  ....+..+++++.+||.+||..||++||+++++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            653  3333333321   11111  11223467999999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-43  Score=344.32  Aligned_cols=251  Identities=24%  Similarity=0.303  Sum_probs=208.5

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCc---EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGE---VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .-.-.|++.+.||+|+||+||+|.+..+++   .+|+|++...  ......+.+.+|+.+++++. ||||+++++++.+.
T Consensus        18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   94 (298)
T 3pls_A           18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPP   94 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCS
T ss_pred             ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecC
Confidence            334467888999999999999999765544   7999998754  34455678889999999995 99999999999766


Q ss_pred             CEE-EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYV-HLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~-~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.. ++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~  171 (298)
T 3pls_A           95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT---VKVADFGLA  171 (298)
T ss_dssp             SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECCTTSS
T ss_pred             CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc---EEeCcCCCc
Confidence            654 999999999999999977 356899999999999999999999999999999999999986554   999999999


Q ss_pred             eeecCCC-----ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 012203          193 TYIEPGQ-----SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSN  265 (468)
Q Consensus       193 ~~~~~~~-----~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  265 (468)
                      .......     ......||+.|+|||.+.+. ++.++|||||||++|+|++ |.+||...+..+....+...... +  
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~--  248 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-P--  248 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-C--
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-C--
Confidence            7654321     22345788999999999875 8999999999999999999 55566666666666666555422 2  


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ....+++.+.+++.+||..||.+|||+.++++
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            12568899999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-43  Score=371.64  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=214.6

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      .......++|++.+.||+|+||.||+|.++ ++..||||++....    ...+.+.+|+++|++++ ||||+++++++. 
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-  253 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-  253 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-
Confidence            344556788999999999999999999986 57889999997653    23577899999999996 999999999986 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      .+.+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DFG~  330 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV---CKIADFGL  330 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC---EEECSTTG
T ss_pred             CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc---EEEeeCCC
Confidence            56789999999999999999754  36899999999999999999999999999999999999986554   99999999


Q ss_pred             eeeecCCCc--cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          192 ATYIEPGQS--LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       192 a~~~~~~~~--~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      ++.......  .....+|+.|+|||++.+ .++.++|||||||++|||++ |+.||.+.+..++...+.... ..+.  .
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~--~  407 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMPR--P  407 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCC--C
T ss_pred             ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--C
Confidence            987643221  223456788999999985 48999999999999999999 999999988888887776552 2222  2


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..+++++.++|.+||..||++|||++++++
T Consensus       408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            578999999999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-43  Score=344.23  Aligned_cols=243  Identities=24%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CCEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-EDYV  117 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-~~~~  117 (468)
                      ..++|++.+.||+|+||.||+|.+.  |+.||+|++....     ..+.+.+|++++++++ ||||+++++++.+ .+.+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCce
Confidence            3567999999999999999999874  8899999987542     3467889999999996 9999999999754 4579


Q ss_pred             EEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          118 HLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      ++||||+++++|.+++...+.  +++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~Dfg~~~~~  167 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEA  167 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC---EEECCCCC----
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc---EEEeeccccccc
Confidence            999999999999999976543  899999999999999999999999999999999999986554   999999999765


Q ss_pred             cCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          196 EPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       196 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ...  .....+++.|+|||++.+. ++.++||||||+++|+|++ |+.||...+..+....+.....   ......+++.
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  242 (278)
T 1byg_A          168 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPA  242 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHH
T ss_pred             ccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHH
Confidence            432  2344688999999999764 8999999999999999998 9999998887777776655422   2223578999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.++|.+||..||.+|||+.|+++
T Consensus       243 l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          243 VYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCChhhCCCHHHHHH
Confidence            999999999999999999999985

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-43  Score=350.59  Aligned_cols=250  Identities=25%  Similarity=0.325  Sum_probs=203.9

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC-CChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-VTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~-~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      |...+.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.++++++ ||||+++++++.+.+..++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEE
Confidence            33448999999999999986  688999999976432 22344678899999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          122 ELCAGGELFHRLEK---FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       122 E~~~ggsL~~~l~~---~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||++|++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT---AKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc---EEEeecccccccccc
Confidence            99999999999974   346999999999999999999999999999999999999986554   999999999876542


Q ss_pred             Cc---cccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhccCC-------CCC
Q 012203          199 QS---LLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKS----RIFDAVRTADLR-------FPS  264 (468)
Q Consensus       199 ~~---~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~-------~~~  264 (468)
                      ..   .....||+.|+|||++.+.++.++||||||+++|+|++|+.||......    .+.+.+......       ...
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence            21   2345799999999999888999999999999999999999999765432    222222221110       011


Q ss_pred             CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       265 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ......++.+.+++.+||+.||.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1123456789999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=359.54  Aligned_cols=252  Identities=17%  Similarity=0.216  Sum_probs=201.1

Q ss_pred             CccccccccCCeEEEeEEeecCCeEEEEE-----EEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcC--CCCc
Q 012203           32 DTNQISNLRERFVLGQQLGWGQFGVIRVC-----SDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG--HPNV  104 (468)
Q Consensus        32 ~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a-----~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~--HpnI  104 (468)
                      ...++....++|++.+.||+|+||+||+|     .+..+++.||+|++...      ....+..|+++++++..  |+||
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~i  129 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMF  129 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGB
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhh
Confidence            33455566788999999999999999999     46778999999998654      23567778888887752  8999


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEee--
Q 012203          105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEK-----FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLAT--  177 (468)
Q Consensus       105 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~--  177 (468)
                      +++++++...+..|||||||+||+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+||||+.  
T Consensus       130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred             hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence            9999999999999999999999999999974     456999999999999999999999999999999999999986  


Q ss_pred             ------cCCCCCEEEeecCceeeec---CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 012203          178 ------KASSSPIKLADFGLATYIE---PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT  247 (468)
Q Consensus       178 ------~~~~~~ikL~DFGla~~~~---~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~  247 (468)
                            +...+.+||+|||+++.+.   ........+||+.|+|||++.+. ++.++|||||||++|||++|+.||....
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence                  1224559999999997654   23345567899999999999886 8999999999999999999999996433


Q ss_pred             hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ....     .....+..   ...++.+.+++..||..+|.+|++..+.+.
T Consensus       290 ~~~~-----~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          290 GGEC-----KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             TTEE-----EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             CCce-----eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            2110     01111111   134678999999999999999965444433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.1e-43  Score=370.23  Aligned_cols=254  Identities=21%  Similarity=0.267  Sum_probs=210.6

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++++.||+|+||.||+|++..+++.||||++......     ..+..|+++++.|..|++|..+..++.+.+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4678999999999999999999999999999999998765321     34778999999998667888888888899999


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.+...+.+||+|||+++.+.
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 9999999985 4679999999999999999999999999999999999999543345569999999998876


Q ss_pred             CCCc--------cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCCC-
Q 012203          197 PGQS--------LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK---SRIFDAVRTADLRFP-  263 (468)
Q Consensus       197 ~~~~--------~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~-  263 (468)
                      ....        ....+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+...   ...+..+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            4332        1256899999999999875 89999999999999999999999977443   333443333222111 


Q ss_pred             CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          264 SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       264 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ......+++++.+||.+||..||++||++++|++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1111467899999999999999999999998775

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-43  Score=347.03  Aligned_cols=242  Identities=30%  Similarity=0.490  Sum_probs=195.4

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||+||+|++.  ++.||+|++...     ...+.+.+|+++++++. ||||+++++++.+  ..++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEE
Confidence            357999999999999999999874  789999998643     34567889999999996 9999999998874  4789


Q ss_pred             EEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---cCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          120 VMELCAGGELFHRLEKFG---RFSEAEARVLFMQLMQVVLYCHE---IGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~---~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      ||||++||+|.+++....   .+++..+..++.|++.||.|||+   +||+||||||+|||++.++.  .+||+|||++.
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~~kl~Dfg~~~  154 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--VLKICDFGTAC  154 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--EEEECCCCC--
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--EEEEccccccc
Confidence            999999999999998764   37899999999999999999999   89999999999999986443  37999999997


Q ss_pred             eecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhccCCCCCCCCCCC
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS--RIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      .....  .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||......  .....+....   .......+
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  229 (307)
T 2eva_A          155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNL  229 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTC
T ss_pred             ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCccccc
Confidence            65432  2345799999999999875 899999999999999999999999754332  2332332221   11223578


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++.+.+++.+||..||++|||+++++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=349.38  Aligned_cols=268  Identities=27%  Similarity=0.396  Sum_probs=207.2

Q ss_pred             cccccchhhhhcCccccccccCCeEEEeEEeecCCeEEEEEE----EcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHH
Q 012203           20 CYRVRSLAETILDTNQISNLRERFVLGQQLGWGQFGVIRVCS----DKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM   95 (468)
Q Consensus        20 ~~~~~s~~~~i~~~~~~~~l~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL   95 (468)
                      +|-.+.+...+...+......++|++++.||+|+||.||+|+    +..+|+.||+|++...   .....+.+.+|++++
T Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l   96 (326)
T 2w1i_A           20 LYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEIL   96 (326)
T ss_dssp             -----------------CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHH
Confidence            333333444444444555567789999999999999999998    4668999999999764   334567889999999


Q ss_pred             HHhcCCCCceeeeEEEEeCC--EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203           96 TRLSGHPNVVDLKAVYEDED--YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus        96 ~~L~~HpnIv~l~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      ++++ ||||+++++++...+  .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus        97 ~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N  175 (326)
T 2w1i_A           97 KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN  175 (326)
T ss_dssp             HTCC-CTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             HhCC-CCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence            9996 999999999986543  789999999999999999876 459999999999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNT  247 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~  247 (468)
                      ||++.++.   +||+|||++........    .....+++.|+|||++.+. ++.++|||||||++|+|++|..||....
T Consensus       176 Ili~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  252 (326)
T 2w1i_A          176 ILVENENR---VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP  252 (326)
T ss_dssp             EEEEETTE---EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH
T ss_pred             EEEcCCCc---EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH
Confidence            99987665   99999999988754432    1234678889999999875 8899999999999999999999985321


Q ss_pred             hH----------------HHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          248 KS----------------RIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       248 ~~----------------~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ..                .+.+.+.. ....+  ....+++++.++|.+||..||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          253 AEFMRMIGNDKQGQMIVFHLIELLKN-NGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHCTTCCTHHHHHHHHHHHHT-TCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhccccchhhhHHHHHHHhhc-CCCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            10                11122221 11222  23578999999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8e-43  Score=365.61  Aligned_cols=249  Identities=27%  Similarity=0.366  Sum_probs=207.9

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .+.-.++|++.+.||+|+||.||+|.++. +..||+|++.....    ..+.+.+|+++|++++ ||||+++++++.+ +
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E  251 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence            34456789999999999999999999974 56799999976532    2467889999999996 9999999999976 6


Q ss_pred             EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          116 YVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      .+++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~  328 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLAR  328 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCTTC
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC---EEECCCccce
Confidence            789999999999999999643  56999999999999999999999999999999999999987655   9999999998


Q ss_pred             eecCCC--ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          194 YIEPGQ--SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       194 ~~~~~~--~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ......  ......+++.|+|||++.+ .++.++|||||||++|||++ |+.||.+....+..+.+.... ..+.  ...
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~--~~~  405 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPC--PPE  405 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCC--CTT
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCC
Confidence            765332  1234467889999999875 48999999999999999999 999999988888887776542 2222  257


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +++.+.++|.+||..||++|||++++++
T Consensus       406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          406 CPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.8e-43  Score=379.78  Aligned_cols=247  Identities=24%  Similarity=0.300  Sum_probs=207.9

Q ss_pred             CeEEE-eEEeecCCeEEEEEEE--cCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           42 RFVLG-QQLGWGQFGVIRVCSD--KFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        42 ~y~i~-~~LG~G~fg~Vy~a~~--~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      .+.+. +.||+|+||.||+|.+  +.+++.||||++..... .....+.+.+|+++|++|+ |||||++++++++ +.++
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~  445 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWM  445 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEE
Confidence            34443 5899999999999955  45678999999976532 3344678999999999996 9999999999975 4588


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      +|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++.+...
T Consensus       446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~---~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRAD  522 (635)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCTTHHHHTTC-
T ss_pred             EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC---EEEEEcCCccccccC
Confidence            99999999999999998888999999999999999999999999999999999999997665   999999999876543


Q ss_pred             Cc----cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          199 QS----LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       199 ~~----~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ..    .....||+.|+|||++.+ .++.++|||||||++|||++ |+.||.+.+..++.+.+.......   ....+++
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~  599 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPR  599 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCH
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCH
Confidence            22    223457889999999987 49999999999999999998 999999999888888877664321   1257899


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHh
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+||.+||..||++||+++++++
T Consensus       600 ~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          600 EMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=347.04  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=196.8

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc-CCCCceeeeEEEEeC-
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-GHPNVVDLKAVYEDE-  114 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~-~HpnIv~l~~~~~~~-  114 (468)
                      ..+.++|++.+.||+|+||.||+|++.  |+.||+|++...      .......|.+++..+. +||||+++++++.+. 
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            446678999999999999999999875  899999998543      2344455666665442 599999999999887 


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecccCCCcEEEeecCCCCC
Q 012203          115 ---DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI--------GVVHRDLKPENILLATKASSSP  183 (468)
Q Consensus       115 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------gIiHrDIKp~NILl~~~~~~~~  183 (468)
                         +.+++||||+++|+|.++++. ..+++..++.++.|++.||.|||++        ||+||||||+|||++.++.   
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~---  180 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT---  180 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC---
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC---
Confidence               789999999999999999976 4799999999999999999999998        9999999999999986554   


Q ss_pred             EEEeecCceeeecCCCcc-----ccCCCCCCCcChhhhcCC-CCCc------chHHHHHHHHHHHHhC----------CC
Q 012203          184 IKLADFGLATYIEPGQSL-----LGTVGSPFYIAPEVLAGG-YNQA------ADVWSAGVILYILLSG----------MP  241 (468)
Q Consensus       184 ikL~DFGla~~~~~~~~~-----~~~~GT~~Y~APE~l~~~-~~~~------sDiwSlGvil~elltG----------~~  241 (468)
                      +||+|||++.........     ...+||+.|+|||++.+. ++.+      +|||||||++|||++|          ..
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            999999999876543221     245899999999999875 4443      8999999999999999          77


Q ss_pred             CCCCCC-----hHHHHHHHHhccCCCCCCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          242 PFWGNT-----KSRIFDAVRTADLRFPSNP---WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       242 Pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ||....     .......+...........   ...+++++.++|.+||+.||.+|||+.|+++|
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            775432     1222222222222111110   12466789999999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=360.24  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=200.3

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCC---cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-eC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTG---EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE-DE  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~-~~  114 (468)
                      -...|++.+.||+|+||+||+|++..++   ..||+|.+...  ........+.+|+.++++++ ||||+++++++. .+
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  163 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSE  163 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCS
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCC
Confidence            3446899999999999999999986433   46899988653  23455678899999999996 999999999864 45


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 DYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      +..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kL~DFG~a~  240 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLAR  240 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC----
T ss_pred             CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC---EEEeeccccc
Confidence            6889999999999999999765 45889999999999999999999999999999999999986554   9999999998


Q ss_pred             eecCCC-----ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          194 YIEPGQ-----SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       194 ~~~~~~-----~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      ......     ......+|+.|+|||++.+. ++.++|||||||++|||++ |.+||...+..+....+........   
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---  317 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---  317 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            664322     12345678899999999764 8999999999999999999 7888887776666666655433222   


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ...+++.+.+++.+||..||++|||+.|++++
T Consensus       318 p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            24688999999999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=376.60  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=207.1

Q ss_pred             ccCCeEEEe-EEeecCCeEEEEEEEc--CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           39 LRERFVLGQ-QLGWGQFGVIRVCSDK--FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        39 l~~~y~i~~-~LG~G~fg~Vy~a~~~--~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ..+++.+.+ .||+|+||.||+|.++  .++..||||++....  .....+.+.+|+++|++++ ||||+++++++.+ +
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-E  408 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-S
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-C
Confidence            445667766 8999999999999876  356779999997652  3345678999999999995 9999999999976 5


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          116 YVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      .++||||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++.
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkL~DFGla~~  485 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKA  485 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCSTTTT
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc---EEEeeccCccc
Confidence            699999999999999999654 45999999999999999999999999999999999999997665   99999999986


Q ss_pred             ecCCCcc----ccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          195 IEPGQSL----LGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       195 ~~~~~~~----~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      .......    ....+|+.|+|||++.+ .++.++|||||||++|||++ |+.||.+.+..++.+.+..+.. .+  ...
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-~~--~p~  562 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-ME--CPP  562 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-CC--CCT
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--CCC
Confidence            6433221    22346789999999975 59999999999999999998 9999999888888888776542 11  124


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          269 HISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      .+++++.+||.+||..||++||++.++++
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            68999999999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.8e-42  Score=344.79  Aligned_cols=249  Identities=24%  Similarity=0.320  Sum_probs=203.8

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHh-cCCCCceeeeEEEEeCC-
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL-SGHPNVVDLKAVYEDED-  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L-~~HpnIv~l~~~~~~~~-  115 (468)
                      .+.++|++.+.||+|+||.||+|++  +|+.||+|++...      ....+.+|++++..+ .+||||+++++++...+ 
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            3567899999999999999999988  5899999998643      345677899999873 25999999999998876 


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEecccCCCcEEEeecCCCCCE
Q 012203          116 ---YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH--------EIGVVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       116 ---~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH--------~~gIiHrDIKp~NILl~~~~~~~~i  184 (468)
                         .+++||||+++|+|.+++.+ ..+++..++.++.|++.||.|||        ++||+||||||+|||++.++.   +
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~---~  186 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---C  186 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC---E
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC---E
Confidence               89999999999999999976 56999999999999999999999        899999999999999987654   9


Q ss_pred             EEeecCceeeecCCCc-----cccCCCCCCCcChhhhcCCC-------CCcchHHHHHHHHHHHHhC----------CCC
Q 012203          185 KLADFGLATYIEPGQS-----LLGTVGSPFYIAPEVLAGGY-------NQAADVWSAGVILYILLSG----------MPP  242 (468)
Q Consensus       185 kL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~-------~~~sDiwSlGvil~elltG----------~~P  242 (468)
                      ||+|||++........     .....||+.|+|||++.+..       +.++|||||||++|+|++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            9999999988765432     24568999999999998752       2589999999999999999          789


Q ss_pred             CCCCC-----hHHHHHHHHhccCCCCCCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          243 FWGNT-----KSRIFDAVRTADLRFPSNP---WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       243 f~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      |....     ...+...+...........   ....++.+.+|+.+||+.||++|||+.|+++|
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            86642     2344444433322211110   12345689999999999999999999999976

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=370.01  Aligned_cols=250  Identities=26%  Similarity=0.365  Sum_probs=213.1

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      .+...++|++.+.||+|+||.||+|.++. +..||||++.....    ..+.+.+|+++|++|+ ||||+++++++.+ +
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E  334 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-c
Confidence            34456789999999999999999999974 56799999976532    2467889999999996 9999999999976 6


Q ss_pred             EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          116 YVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      .+||||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~  411 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLAR  411 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCTTSTT
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc---EEEcccccce
Confidence            789999999999999999643  56999999999999999999999999999999999999987655   9999999997


Q ss_pred             eecCCC--ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          194 YIEPGQ--SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       194 ~~~~~~--~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ......  ......+++.|+|||++.+ .++.++|||||||++|||++ |+.||.+....++.+.+.... +.+.  ...
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~--~~~  488 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPC--PPE  488 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCCC--CTT
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCC
Confidence            654322  1223457788999999876 48999999999999999999 999999988888887776542 2222  257


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +++.+.+||.+||..||++|||+++|++.
T Consensus       489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          489 CPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            89999999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.4e-43  Score=349.90  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=191.4

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHH--HHhcCCCCceeeeEEEE----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM--TRLSGHPNVVDLKAVYE----  112 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL--~~L~~HpnIv~l~~~~~----  112 (468)
                      -.++|++++.||+|+||.||+|++  +++.||+|++....      ...+..|.+++  ..+ +||||+++++.+.    
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECT
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheeccccccc
Confidence            457899999999999999999976  68999999986542      23344444444  346 5999999998654    


Q ss_pred             -eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEecccCCCcEEEeecCCCC
Q 012203          113 -DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI---------GVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       113 -~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~---------gIiHrDIKp~NILl~~~~~~~  182 (468)
                       ....+++||||+++|+|.+++... ..++..+..++.||+.||.|||++         ||+||||||+|||++.++.  
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--  158 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--  158 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--
Confidence             234689999999999999999774 468999999999999999999999         9999999999999986554  


Q ss_pred             CEEEeecCceeeecCCC---------ccccCCCCCCCcChhhhcCC--------CCCcchHHHHHHHHHHHHhCCCCCCC
Q 012203          183 PIKLADFGLATYIEPGQ---------SLLGTVGSPFYIAPEVLAGG--------YNQAADVWSAGVILYILLSGMPPFWG  245 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~---------~~~~~~GT~~Y~APE~l~~~--------~~~~sDiwSlGvil~elltG~~Pf~~  245 (468)
                       +||+|||++..+....         .....+||+.|+|||++.+.        ++.++|||||||++|||++|..||..
T Consensus       159 -~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          159 -CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             -EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             -EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence             9999999998765321         22345799999999999862        56689999999999999999777643


Q ss_pred             CCh------------------HHHHHHHHhcc--CCCCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHh------
Q 012203          246 NTK------------------SRIFDAVRTAD--LRFPSN--PWDHISDSAKDLVMGMLSTDPSQRLTARQVLD------  297 (468)
Q Consensus       246 ~~~------------------~~~~~~i~~~~--~~~~~~--~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~------  297 (468)
                      ...                  ......+....  ..++..  ....+++++.+||.+||..||++|||++|+++      
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            211                  11111111111  111211  11235568999999999999999999999954      


Q ss_pred             CcCCCCC
Q 012203          298 HSWMGDG  304 (468)
Q Consensus       298 h~~~~~~  304 (468)
                      ++|-++.
T Consensus       318 ~~~~~~~  324 (336)
T 3g2f_A          318 MIWERNK  324 (336)
T ss_dssp             HCCCC--
T ss_pred             HHHHhcc
Confidence            5666554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=348.02  Aligned_cols=254  Identities=20%  Similarity=0.282  Sum_probs=209.9

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      .+.....++|++.+.||+|+||.||+|.++.   .+|+|++..... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~  100 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMS  100 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEEC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence            3344456889999999999999999998863   499999976532 2223345678999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      .+.+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ +   +.+||+|||++
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~---~~~~l~Dfg~~  176 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N---GKVVITDFGLF  176 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCC
T ss_pred             CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C---CCEEEeecCCc
Confidence            999999999999999999997754 699999999999999999999999999999999999997 3   34999999998


Q ss_pred             eeecC------CCccccCCCCCCCcChhhhcC----------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 012203          193 TYIEP------GQSLLGTVGSPFYIAPEVLAG----------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVR  256 (468)
Q Consensus       193 ~~~~~------~~~~~~~~GT~~Y~APE~l~~----------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  256 (468)
                      .....      ........||+.|+|||++.+          .++.++|||||||++|+|++|+.||...........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            65431      122234568999999999864          26889999999999999999999999888888777766


Q ss_pred             hccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          257 TADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       257 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ......  .....++.++.+++.+||..||++|||+.++++.
T Consensus       257 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          257 TGMKPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             TTCCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             cCCCCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            553322  2224678899999999999999999999999873

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-43  Score=355.55  Aligned_cols=251  Identities=19%  Similarity=0.212  Sum_probs=198.7

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCC-----ChhhHHHHHHHHHHHHHhc--------CCCCcee
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLV-----TIDDERSVKLEIEIMTRLS--------GHPNVVD  106 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~-----~~~~~~~~~~Ei~iL~~L~--------~HpnIv~  106 (468)
                      .++|++++.||+|+||+||+|++  +|+.||+|++.+....     .....+.+.+|+.++++++        +||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  6899999999876432     2233477889999999996        4777777


Q ss_pred             eeEEEE------------------------------eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 012203          107 LKAVYE------------------------------DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL  156 (468)
Q Consensus       107 l~~~~~------------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~  156 (468)
                      +.+++.                              +.+.+|||||||++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            777642                              27889999999999977666644 67899999999999999999


Q ss_pred             HHH-HcCcEecccCCCcEEEeecCC-----------------CCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcC
Q 012203          157 YCH-EIGVVHRDLKPENILLATKAS-----------------SSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG  218 (468)
Q Consensus       157 ~LH-~~gIiHrDIKp~NILl~~~~~-----------------~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~  218 (468)
                      ||| ++||+||||||+|||++.++.                 ...+||+|||+++.....    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 999999999999999998651                 125999999999887643    3489999999999998


Q ss_pred             CCCCcchHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhc-cCC--CCCCCCCCCCHHHHHHHHHccccCCCCCCCHH
Q 012203          219 GYNQAADVWSAGVI-LYILLSGMPPFWGNTK-SRIFDAVRTA-DLR--FPSNPWDHISDSAKDLVMGMLSTDPSQRLTAR  293 (468)
Q Consensus       219 ~~~~~sDiwSlGvi-l~elltG~~Pf~~~~~-~~~~~~i~~~-~~~--~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~  293 (468)
                      ..+.++||||||++ .++++.|..||..... ....+.+... ...  .+...+..+++++++||++||++|     |++
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            77889999998776 7789999999833211 1122222211 111  111113457889999999999987     999


Q ss_pred             HHH-hCcCCC
Q 012203          294 QVL-DHSWMG  302 (468)
Q Consensus       294 eiL-~h~~~~  302 (468)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-43  Score=385.79  Aligned_cols=262  Identities=30%  Similarity=0.469  Sum_probs=213.5

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-----  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-----  113 (468)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++...  ........+.+|+++++++. ||||+++++++..     
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccccccc
Confidence            347899999999999999999999999999999998764  24455677899999999995 9999999999765     


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeec
Q 012203          114 -EDYVHLVMELCAGGELFHRLEKFG---RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       114 -~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                       .+..++|||||+||+|.+++....   .+++..++.++.|++.||.|||++||+||||||+|||++.++....+||+||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence             678899999999999999998754   5899999999999999999999999999999999999997766566899999


Q ss_pred             CceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH---------HHH----
Q 012203          190 GLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIF---------DAV----  255 (468)
Q Consensus       190 Gla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~---------~~i----  255 (468)
                      |++.............||+.|+|||++.+. ++.++|||||||++|+|++|..||.........         ..+    
T Consensus       169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            999987766656677899999999999864 899999999999999999999999764322110         000    


Q ss_pred             -HhccCCC------CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          256 -RTADLRF------PSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       256 -~~~~~~~------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                       ..+...+      +......+++.+.++|.+||..||++|||+.|+++||||..
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence             0011111      11223447789999999999999999999999999999865

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.3e-41  Score=370.18  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=212.6

Q ss_pred             ccccccCCeEEEeEEeecCCeEEEEEEEcCC---CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Q 012203           35 QISNLRERFVLGQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVY  111 (468)
Q Consensus        35 ~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~  111 (468)
                      ......++|++.+.||+|+||.||+|.++.+   +..||+|++...  ......+.+.+|+.+++++. ||||+++++++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  460 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVI  460 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence            4455678899999999999999999998643   467999988654  23445577889999999996 99999999998


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          112 EDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       112 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      . ++.+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~---vkL~DFG  536 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFG  536 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCC
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC---EEEEecC
Confidence            5 456899999999999999998654 6899999999999999999999999999999999999997665   9999999


Q ss_pred             ceeeecCCCc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 012203          191 LATYIEPGQS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNP  266 (468)
Q Consensus       191 la~~~~~~~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  266 (468)
                      +++.......  .....||+.|+|||++.+. ++.++|||||||++|||++ |..||.+....+....+...... +  .
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-~--~  613 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-P--M  613 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-C--C
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-C--C
Confidence            9987654322  2234578899999999764 8999999999999999997 99999998888888777765422 1  1


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ...+++.+.++|.+||..||.+|||+.++++.
T Consensus       614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            25789999999999999999999999999863

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-42  Score=358.48  Aligned_cols=247  Identities=19%  Similarity=0.187  Sum_probs=193.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-CCce---------e----
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-PNVV---------D----  106 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-pnIv---------~----  106 (468)
                      ..|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.+. | +|..         .    
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchhh
Confidence            45889999999999999999999999999999998554444444677889999999886 5 3211         1    


Q ss_pred             --------eeEEEEe-----CCEEEEEEeccCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEec
Q 012203          107 --------LKAVYED-----EDYVHLVMELCAGGELFHRLEK-------FGRFSEAEARVLFMQLMQVVLYCHEIGVVHR  166 (468)
Q Consensus       107 --------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~-------~~~l~~~~~~~i~~qil~aL~~LH~~gIiHr  166 (468)
                              +..++..     ...++++|+++ +++|.++++.       .+.+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                    1111111     22467888876 7899998852       2347778889999999999999999999999


Q ss_pred             ccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhh----------cCC-CCCcchHHHHHHHHHH
Q 012203          167 DLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL----------AGG-YNQAADVWSAGVILYI  235 (468)
Q Consensus       167 DIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l----------~~~-~~~~sDiwSlGvil~e  235 (468)
                      ||||+||||+.++.   +||+|||+++....  .....+| +.|+|||++          .+. ++.++|||||||++|+
T Consensus       236 DiKp~NILl~~~~~---~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRGG---VFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTCC---EEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCe---EEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999987665   99999999987543  3556788 999999998          332 7889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          236 LLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       236 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      |++|+.||...+..+..+.+.        ..+..+++++.+||.+||..||++||++.++++||||++
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            999999997765443322221        122468899999999999999999999999999999965

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-41  Score=335.65  Aligned_cols=229  Identities=17%  Similarity=0.077  Sum_probs=190.3

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .+.++|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.++.++. ||||+++++++.+++..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence            46788999999999999999999999999999999998776555556678899999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |+||||++|++|.++++. + ....++..++.||+.||.|||++||+||||||+|||++.++.   +||+++        
T Consensus       107 ~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~---~kl~~~--------  173 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD---VVLAYP--------  173 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC---EEECSC--------
T ss_pred             EEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC---EEEEec--------
Confidence            999999999999999954 3 466678899999999999999999999999999999987655   888744        


Q ss_pred             CCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhccCCCCCCCCCCCCHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFD---AVRTADLRFPSNPWDHISDSA  274 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~l  274 (468)
                                 .|++|      ++.++|||||||++|+|++|+.||.+.+......   .........+......+++++
T Consensus       174 -----------~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          174 -----------ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             -----------CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             -----------cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                       34443      6889999999999999999999998765432110   000111111111235689999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHhC
Q 012203          275 KDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       275 ~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      .++|.+||++||++| |+.|+++.
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999 99999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-41  Score=373.54  Aligned_cols=243  Identities=25%  Similarity=0.379  Sum_probs=203.8

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcC-CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKF-TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      +.+.++|++.+.||+|+||+||+|.++. +|+.||||++....  .......+.+|+++++++. ||||+++++++.+.+
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTD  152 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEEC
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecC
Confidence            4567899999999999999999999976 79999999987542  3445567889999999996 999999999998766


Q ss_pred             E-----EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecC
Q 012203          116 Y-----VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG  190 (468)
Q Consensus       116 ~-----~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFG  190 (468)
                      .     .||||||++|++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.+    .+||+|||
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~DFG  226 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLG  226 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEECCCT
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEEecc
Confidence            5     7999999999999988765  79999999999999999999999999999999999999753    49999999


Q ss_pred             ceeeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          191 LATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       191 la~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      +++.....   ...+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.....         . ....+....
T Consensus       227 ~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~-~~~~~~~~~  293 (681)
T 2pzi_A          227 AVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------L-PEDDPVLKT  293 (681)
T ss_dssp             TCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------C-CTTCHHHHH
T ss_pred             cchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc---------c-ccccccccc
Confidence            99876543   4568999999999998888899999999999999999999986422110         0 011111234


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ++.+.++|.+||++||.+||+..+.+.|+|+
T Consensus       294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            6789999999999999999999999988886

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.3e-34  Score=311.70  Aligned_cols=189  Identities=21%  Similarity=0.155  Sum_probs=138.7

Q ss_pred             EEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC-------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           48 QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-------IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        48 ~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~-------~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ..+.|+.|.+..++....|+.|++|++.+.....       ....+++.+|+++|+++..|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4567778888888888899999999998764322       123457899999999998899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-C
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-Q  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~  199 (468)
                      |||++|++|.++|.+.+++++.   .|+.||+.||+|||++|||||||||+||||+.++.   +||+|||+|+..... .
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~---vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH---ARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC---EEECCCTTEESCC---C
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC---EEEeecccCeeCCCCCc
Confidence            9999999999999998888765   47899999999999999999999999999987655   999999999876543 3


Q ss_pred             ccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 012203          200 SLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPP  242 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~P  242 (468)
                      ...+.+||+.|||||++.+.+..++|+||+|+++++|.++..+
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             cccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            3456789999999999999888899999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=9.8e-29  Score=264.44  Aligned_cols=185  Identities=16%  Similarity=0.153  Sum_probs=146.2

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh-----hHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID-----DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~-----~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      +...+.||+|+||+||+|.  ..++.+++|...........     ..+.+.+|+++|++++ ||||+++..++...+..
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~  414 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNK  414 (540)
T ss_dssp             ----------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTT
T ss_pred             CCCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCcc
Confidence            3456799999999999993  46788999987654332221     1345789999999996 99999766666677778


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||||||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.     .+||+|||+++....
T Consensus       415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~  481 (540)
T 3en9_A          415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCC
T ss_pred             EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCC
Confidence            999999999999999875        5689999999999999999999999999999975     599999999998765


Q ss_pred             CCc--------cccCCCCCCCcChhhhcC---CCCCcchHHHHHHHHHHHHhCCCCC
Q 012203          198 GQS--------LLGTVGSPFYIAPEVLAG---GYNQAADVWSAGVILYILLSGMPPF  243 (468)
Q Consensus       198 ~~~--------~~~~~GT~~Y~APE~l~~---~~~~~sDiwSlGvil~elltG~~Pf  243 (468)
                      ...        ....+||+.|||||++.+   +|+..+|+|+..+-..+.+.++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            322        135689999999999976   3888899999999888888887776

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=6.2e-25  Score=216.07  Aligned_cols=161  Identities=20%  Similarity=0.202  Sum_probs=124.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh---------------hhHHHHHHHHHHHHHhcCCCCc
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---------------DDERSVKLEIEIMTRLSGHPNV  104 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~---------------~~~~~~~~Ei~iL~~L~~HpnI  104 (468)
                      ...|.+++.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+++|+++. |   
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---  163 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---  163 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---
Confidence            34455669999999999999999 7899999999965422111               13456889999999996 4   


Q ss_pred             eeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCE
Q 012203          105 VDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPI  184 (468)
Q Consensus       105 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~i  184 (468)
                      +++.+++.. +..|+||||++|++|.+ +.      ......++.|++.||.|||++||+||||||+|||++ ++.   +
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~---v  231 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG---I  231 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE---E
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc---E
Confidence            556665544 45699999999999987 42      133557999999999999999999999999999998 554   9


Q ss_pred             EEeecCceeeecCCCccccCCCCCCCcChhhhcC-----------CCCCcchHHHH
Q 012203          185 KLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-----------GYNQAADVWSA  229 (468)
Q Consensus       185 kL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~~~sDiwSl  229 (468)
                      ||+|||++..            +..|+|||++..           .|+..+|+|.+
T Consensus       232 kl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          232 WIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             EECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             EEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            9999999974            345899998753           24556666643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.5e-21  Score=186.53  Aligned_cols=142  Identities=18%  Similarity=0.153  Sum_probs=109.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcE--EEEEEeccCcCCCh---------------------hhHHHHHHHHHHHHHh
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEV--FACKSIAKDRLVTI---------------------DDERSVKLEIEIMTRL   98 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vavK~i~~~~~~~~---------------------~~~~~~~~Ei~iL~~L   98 (468)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||++........                     .....+.+|+.+|.+|
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            488999999999999999999778999  99999765421100                     1123678899999999


Q ss_pred             cCCCCc--eeeeEEEEeCCEEEEEEeccCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEecccCC
Q 012203           99 SGHPNV--VDLKAVYEDEDYVHLVMELCAG-G----ELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH-EIGVVHRDLKP  170 (468)
Q Consensus        99 ~~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH-~~gIiHrDIKp  170 (468)
                      . |+++  ..+++.    +..+|||||+.+ |    +|.++...   .++..+..++.|++.+|.||| ++||+||||||
T Consensus       128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            7 7764  333332    246899999942 3    67665432   235567889999999999999 99999999999


Q ss_pred             CcEEEeecCCCCCEEEeecCceeeec
Q 012203          171 ENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       171 ~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +|||++.     .++|+|||+|....
T Consensus       200 ~NILl~~-----~~~liDFG~a~~~~  220 (258)
T 1zth_A          200 YNIMYID-----KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TSEEESS-----SEEECCCTTCEETT
T ss_pred             HHEEEcC-----cEEEEECcccccCC
Confidence            9999974     49999999997643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.6e-17  Score=169.56  Aligned_cols=145  Identities=17%  Similarity=0.241  Sum_probs=104.1

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC-----------hhhH--------HHHHHHHHHHHHhcCCC
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT-----------IDDE--------RSVKLEIEIMTRLSGHP  102 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~-----------~~~~--------~~~~~Ei~iL~~L~~Hp  102 (468)
                      -|+++++||.|++|.||+|.+. +|+.||||++.......           ....        .....|...|.+|. +.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            4999999999999999999985 79999999986432110           0000        11235777888885 44


Q ss_pred             CceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          103 NVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       103 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      ++....-+....  .+|||||++|++|.++.      ..+.+..++.||+.+|.+||++|||||||||.|||++.++...
T Consensus       174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             TCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            443222222222  37999999998886543      2234567889999999999999999999999999998776321


Q ss_pred             -------CEEEeecCceeeec
Q 012203          183 -------PIKLADFGLATYIE  196 (468)
Q Consensus       183 -------~ikL~DFGla~~~~  196 (468)
                             .+.|+||+-+....
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccceEEEEeCCcccCC
Confidence                   27899999776543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=6.2e-13  Score=127.77  Aligned_cols=142  Identities=15%  Similarity=0.131  Sum_probs=112.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      -+.|++...++.|+.+.||++...  ++.+++|+......   .....+.+|+++++.|.++..+.++++++.+.+..|+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            356999999999999999998753  68999999865321   1123578899999999767788899999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 012203          120 VMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE---------------------------------------  160 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~---------------------------------------  160 (468)
                      ||||++|.+|.+.+.     +......++.++..+|..||+                                       
T Consensus        88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999876531     122345678899999999998                                       


Q ss_pred             --------------------cCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          161 --------------------IGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       161 --------------------~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                                          ..++|+|++|.|||++.+   ..+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC---cEEEEEEchhccc
Confidence                                458999999999999642   2357999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=9.4e-12  Score=118.41  Aligned_cols=141  Identities=13%  Similarity=0.036  Sum_probs=102.2

Q ss_pred             cccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCC-ceeeeEEEEeC
Q 012203           36 ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN-VVDLKAVYEDE  114 (468)
Q Consensus        36 ~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hpn-Iv~l~~~~~~~  114 (468)
                      +......|.+....+.|..+.||++.. .+|+.+++|+.....      ...+..|+.+++.+..+.- +.+++++..+.
T Consensus        15 l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           15 WVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             GTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             HHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            444556677755444566799999965 467889999975431      2356789999999975522 56688888888


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG--------------------------------  162 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~g--------------------------------  162 (468)
                      +..++||||++|.+|.  .   ....   ...++.+++..|..||+..                                
T Consensus        88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            8899999999998884  2   1122   2245667777777777643                                


Q ss_pred             --------------------------cEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          163 --------------------------VVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       163 --------------------------IiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                                                ++|+|++|.|||++.+   ..+.|+|||.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~liD~~~a~~  214 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG---RFSGFIDCGRLGV  214 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC---cEEEEEcchhccc
Confidence                                      9999999999999643   2356999999865

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=1.7e-10  Score=116.22  Aligned_cols=145  Identities=21%  Similarity=0.359  Sum_probs=106.9

Q ss_pred             EEEeEEeecCCeEEEEEEEcCCCcEEEEEEec--cCcCCChhhHHHHHHHHHHHHHhcC-CCCceeeeEEEEeC---CEE
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIA--KDRLVTIDDERSVKLEIEIMTRLSG-HPNVVDLKAVYEDE---DYV  117 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~--~~~~~~~~~~~~~~~Ei~iL~~L~~-HpnIv~l~~~~~~~---~~~  117 (468)
                      ..++.|+.|.++.||++...  +..+++|+..  ....  ......+.+|..+++.|.. +..+.+++.++.+.   +..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            34678999999999998764  4678899875  3321  1223467889999999973 34578888888766   458


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-------------------------------------  160 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------  160 (468)
                      |+||||++|..+.+..  ...++......++.+++.+|..||+                                     
T Consensus       117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999999998874311  1346788888899999999999997                                     


Q ss_pred             ---------------------cCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          161 ---------------------IGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       161 ---------------------~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                                           ..++|+|++|.|||++.++. ..+.|+||+.+..-
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECccccccC
Confidence                                 35899999999999986442 33689999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=2.3e-10  Score=112.54  Aligned_cols=185  Identities=16%  Similarity=0.177  Sum_probs=125.2

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCc--eeeeEEEEeCC---EEEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV--VDLKAVYEDED---YVHLV  120 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnI--v~l~~~~~~~~---~~~lV  120 (468)
                      ++.++.|....||.+.     ..+++|+....     .....+.+|.++|+.+..+..+  .+++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            3569999999999863     46889985422     3456788999999998644433  34444433333   35899


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE----------------------------------------  160 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------------------  160 (468)
                      ||+++|.+|.....  ..++..+...++.+++..|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999998875433  247777888888888888888885                                        


Q ss_pred             ------------------cCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhc---CC
Q 012203          161 ------------------IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA---GG  219 (468)
Q Consensus       161 ------------------~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~  219 (468)
                                        ..++|+|++|.||+++.+. ...+.|+||+.+..-.+............-..|+...   ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                              1369999999999998631 2347899999987754332221111110113444322   12


Q ss_pred             CCC------------cchHHHHHHHHHHHHhCCCCC
Q 012203          220 YNQ------------AADVWSAGVILYILLSGMPPF  243 (468)
Q Consensus       220 ~~~------------~sDiwSlGvil~elltG~~Pf  243 (468)
                      |..            ..+.|++|.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            222            258999999999999999887

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=5.3e-07  Score=88.78  Aligned_cols=139  Identities=17%  Similarity=0.209  Sum_probs=95.1

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC--CceeeeEEEE-eCCEEEEEEe
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP--NVVDLKAVYE-DEDYVHLVME  122 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp--nIv~l~~~~~-~~~~~~lV~E  122 (468)
                      ++.++.|....||..     |..+++|+-.     .......+..|.++|+.|..+-  .+.+++.+.. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456888999999987     5678899842     2234567889999999997432  2556666664 4566789999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI-----------------------------------------  161 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-----------------------------------------  161 (468)
                      +++|..|....-  ..++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988876321  1234444455555555555555532                                         


Q ss_pred             -------------------CcEecccCCCcEEEeecCCCCCE-EEeecCceeeec
Q 012203          162 -------------------GVVHRDLKPENILLATKASSSPI-KLADFGLATYIE  196 (468)
Q Consensus       162 -------------------gIiHrDIKp~NILl~~~~~~~~i-kL~DFGla~~~~  196 (468)
                                         .++|+|++|.|||++.++..+.+ .|+||+.+..-.
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                               35999999999999753222334 899999887644

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.61  E-value=7.8e-07  Score=85.17  Aligned_cols=138  Identities=19%  Similarity=0.178  Sum_probs=98.7

Q ss_pred             eEEEeEEeecCCe-EEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEE
Q 012203           43 FVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        43 y~i~~~LG~G~fg-~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~  121 (468)
                      |+.. .+..|..+ .||.......+..+++|+-..      .....+..|..+|+.|..+--+.+++.++++.+..++||
T Consensus        27 ~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm   99 (272)
T 4gkh_A           27 YRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT   99 (272)
T ss_dssp             CEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             CeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence            4443 44445544 789988877788899998643      234568889999999975545778899999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------
Q 012203          122 ELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI----------------------------------------  161 (468)
Q Consensus       122 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~----------------------------------------  161 (468)
                      |+++|.++.+.....    ......+..++...|..||..                                        
T Consensus       100 e~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          100 TAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             ECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             EeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            999998887765431    122234445555555555531                                        


Q ss_pred             ------------------CcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          162 ------------------GVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       162 ------------------gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                                        .++|+|+++.|||++.+   +.+-|+||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~---~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG---KLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC---eEEEEEECccccc
Confidence                              15899999999999743   2357999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=2.5e-06  Score=86.74  Aligned_cols=81  Identities=19%  Similarity=0.135  Sum_probs=51.1

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC-CCh---hhHHHHHHHHHHHHHhcCC-CCce-eeeEEEEeCCEEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-VTI---DDERSVKLEIEIMTRLSGH-PNVV-DLKAVYEDEDYVH  118 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~-~~~---~~~~~~~~Ei~iL~~L~~H-pnIv-~l~~~~~~~~~~~  118 (468)
                      ..+.||.|..+.||++....+++.+++|....... ...   .....+..|.++|+.+..+ +..+ +++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35689999999999998766678999998653211 000   1234567799999888643 3433 45543  344568


Q ss_pred             EEEeccCCC
Q 012203          119 LVMELCAGG  127 (468)
Q Consensus       119 lV~E~~~gg  127 (468)
                      +|||+++|.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=1.2e-06  Score=87.56  Aligned_cols=88  Identities=7%  Similarity=0.033  Sum_probs=57.8

Q ss_pred             eEEEeEE-eecCCeEEEEEEEc--C----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC--CCceeeeEEEEe
Q 012203           43 FVLGQQL-GWGQFGVIRVCSDK--F----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH--PNVVDLKAVYED  113 (468)
Q Consensus        43 y~i~~~L-G~G~fg~Vy~a~~~--~----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H--pnIv~l~~~~~~  113 (468)
                      ....+.| +.|..+.+|++...  .    +++.+++|+..............+..|..+|+.|..+  -.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3445778 88888999988653  1    2678899986543200000113467789999888754  246677777765


Q ss_pred             C---CEEEEEEeccCCCCHH
Q 012203          114 E---DYVHLVMELCAGGELF  130 (468)
Q Consensus       114 ~---~~~~lV~E~~~ggsL~  130 (468)
                      .   +..++|||+++|..+.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            5   3568999999986643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.08  E-value=3.3e-05  Score=75.93  Aligned_cols=75  Identities=13%  Similarity=0.165  Sum_probs=44.5

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC-CCceeeeE------EEEeCCEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH-PNVVDLKA------VYEDEDYVH  118 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H-pnIv~l~~------~~~~~~~~~  118 (468)
                      .+.|+.|..+.||++...  +..+++|+....       ...+..|..+++.|..+ -.+.+++.      +....+..+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            456776778899998763  345899998642       13344566666666421 12333332      224567889


Q ss_pred             EEEeccCCCCH
Q 012203          119 LVMELCAGGEL  129 (468)
Q Consensus       119 lV~E~~~ggsL  129 (468)
                      ++|||++|..+
T Consensus       108 ~l~~~i~G~~~  118 (346)
T 2q83_A          108 VVYDWIEGRPF  118 (346)
T ss_dssp             EEEECCCCBCC
T ss_pred             EEEEeecCccC
Confidence            99999998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.88  E-value=7.7e-05  Score=76.44  Aligned_cols=78  Identities=6%  Similarity=-0.010  Sum_probs=46.0

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcC-CCh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL-VTI-----DDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~-~~~-----~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      -.+.||.|..+.||++..  +++.+++|....... ...     .....++.|+..+..-.....+.+++.+.  .+..+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            356899999999999954  567899994322110 010     02223333443332222234566666665  56678


Q ss_pred             EEEecc-CC
Q 012203          119 LVMELC-AG  126 (468)
Q Consensus       119 lV~E~~-~g  126 (468)
                      +||||+ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.70  E-value=0.00028  Score=69.62  Aligned_cols=78  Identities=14%  Similarity=0.092  Sum_probs=62.2

Q ss_pred             EEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC--CCceeeeEEEEeCCEEEEEE
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH--PNVVDLKAVYEDEDYVHLVM  121 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H--pnIv~l~~~~~~~~~~~lV~  121 (468)
                      .-.+.|+.|....+|+...  ++..+++|+....      ....+..|.+.|+.|..+  ..+.+++.+....+..++||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm  110 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL  110 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence            3467899999999999875  4678899987532      246678899999988643  56888888888888999999


Q ss_pred             eccCCCCH
Q 012203          122 ELCAGGEL  129 (468)
Q Consensus       122 E~~~ggsL  129 (468)
                      ||++|..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99999764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=7.2e-05  Score=73.32  Aligned_cols=140  Identities=16%  Similarity=0.106  Sum_probs=78.6

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeE------EEEeCCEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKA------VYEDEDYV  117 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~------~~~~~~~~  117 (468)
                      -.+.|+.|....+|++... +| .+++|+.....     ....+..|..+++.|..+. .+.+++.      +....+..
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            3567888888999998764 33 68899986531     1234566888888776331 1233332      12335678


Q ss_pred             EEEEeccCCCCHHH--------------HHHHc-CCC--------CHHHHHHH---------------HHHHHHHHHHHH
Q 012203          118 HLVMELCAGGELFH--------------RLEKF-GRF--------SEAEARVL---------------FMQLMQVVLYCH  159 (468)
Q Consensus       118 ~lV~E~~~ggsL~~--------------~l~~~-~~l--------~~~~~~~i---------------~~qil~aL~~LH  159 (468)
                      +++|+|++|..+..              .++.. ..+        ........               -..+...++.++
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            99999999865310              11111 111        11100000               011333445554


Q ss_pred             H-------cCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          160 E-------IGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       160 ~-------~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                      +       .+++|+|+++.|||++.+   ..+.|+||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~---~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGD---ELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCC---ceEEEecchhccC
Confidence            2       369999999999999743   2247999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.62  E-value=0.00015  Score=70.55  Aligned_cols=72  Identities=7%  Similarity=-0.119  Sum_probs=46.4

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc-
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC-  124 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~-  124 (468)
                      .+.|+.|....+|++      +.+++|+......    .......|..+++.+..+.-..+++...  .+.-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            678988999999998      5688998764311    0112346888888886443334555543  33347899999 


Q ss_pred             CCCCH
Q 012203          125 AGGEL  129 (468)
Q Consensus       125 ~ggsL  129 (468)
                      +|.+|
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.56  E-value=0.00052  Score=63.91  Aligned_cols=122  Identities=19%  Similarity=0.151  Sum_probs=80.9

Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH-HHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCccccC
Q 012203          127 GELFHRLEKF-GRFSEAEARVLFMQLMQVVLYC-HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT  204 (468)
Q Consensus       127 gsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~L-H~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~  204 (468)
                      -+|.++|+.. .++++++++.++.|.+.+|.-+ +.+.-..+=+.|..|++..+|+   |...+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~---V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA---VTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC---EEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc---eeccc-cccc-----------
Confidence            4789999764 6799999999999999998776 3222223445578899987776   55443 1110           


Q ss_pred             CCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHcccc
Q 012203          205 VGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLST  284 (468)
Q Consensus       205 ~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~  284 (468)
                      .....+.|||......+.+.=|||||+++|.-+--                     ..+...-..+++.+..||..|..-
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDy---------------------gL~e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDY---------------------GLKENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTT---------------------TCCTTEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhc---------------------CCCcccchhhCHHHHHHHHHHHhc
Confidence            11224678888765567788999999999987742                     233333357999999999999865

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.54  E-value=0.0013  Score=63.40  Aligned_cols=81  Identities=14%  Similarity=0.037  Sum_probs=56.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC--CceeeeEEEEeCCEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP--NVVDLKAVYEDEDYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp--nIv~l~~~~~~~~~~~  118 (468)
                      .+..-++.+|.|..+.||+++.. +|+.|.+|+......   .....+..|...|+.|....  -+.+++.+  +.  -+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence            45667889999999999999874 789999998654321   11245778999999886432  23444443  23  36


Q ss_pred             EEEeccCCCCH
Q 012203          119 LVMELCAGGEL  129 (468)
Q Consensus       119 lV~E~~~ggsL  129 (468)
                      +||||+.++..
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            89999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.37  E-value=0.00061  Score=70.13  Aligned_cols=75  Identities=15%  Similarity=0.060  Sum_probs=52.0

Q ss_pred             EEeEEeecCCeEEEEEEEcC-------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKF-------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~-------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      -++.|+.|....+|++....       +++.+++|+.....  .   ...+..|..+++.|..+.-..++++.+.  +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            45688889899999998652       35789999984321  1   1344579999998875544466776654  2  


Q ss_pred             EEEEeccCCCC
Q 012203          118 HLVMELCAGGE  128 (468)
Q Consensus       118 ~lV~E~~~ggs  128 (468)
                      .+||||++|.+
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            38999998744

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.36  E-value=0.00065  Score=66.58  Aligned_cols=76  Identities=14%  Similarity=0.151  Sum_probs=49.9

Q ss_pred             eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeEE-----EEeCCEEEEE
Q 012203           47 QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKAV-----YEDEDYVHLV  120 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~~-----~~~~~~~~lV  120 (468)
                      ..|+ |....||.+... +|+.+++|+......    ....+..|..+++.|..+. .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 888899987653 567899999864321    2345677888888886331 13444432     2345677899


Q ss_pred             EeccCCCC
Q 012203          121 MELCAGGE  128 (468)
Q Consensus       121 ~E~~~ggs  128 (468)
                      ||+++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998854

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.29  E-value=0.00063  Score=67.03  Aligned_cols=143  Identities=12%  Similarity=0.078  Sum_probs=74.1

Q ss_pred             EeEEeecCCeE-EEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeEEEEeCCEEEEEEec
Q 012203           46 GQQLGWGQFGV-IRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKAVYEDEDYVHLVMEL  123 (468)
Q Consensus        46 ~~~LG~G~fg~-Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~~~~~~~~~~lV~E~  123 (468)
                      .+.|+.|+... +|.... .+|+.+++|......      ...+..|+.+++.|..+. .+.+++.+..+.+  +++||+
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~   93 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED   93 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence            44676665554 556643 236778887654321      023455778888776442 2455666533333  689999


Q ss_pred             cCCCCHHHHHHHc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHH
Q 012203          124 CAGGELFHRLEKF--------------------------GRFSEAEAR-------V-LF------------MQLMQVVLY  157 (468)
Q Consensus       124 ~~ggsL~~~l~~~--------------------------~~l~~~~~~-------~-i~------------~qil~aL~~  157 (468)
                      +.|..+.+.+...                          ..+......       . +.            ..+...+..
T Consensus        94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  173 (333)
T 3csv_A           94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ  173 (333)
T ss_dssp             CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred             CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            9776665444221                          012221110       0 00            011112222


Q ss_pred             H------HHcCcEecccCCCcEEEeecCC-CCCEEEeecCceeeecC
Q 012203          158 C------HEIGVVHRDLKPENILLATKAS-SSPIKLADFGLATYIEP  197 (468)
Q Consensus       158 L------H~~gIiHrDIKp~NILl~~~~~-~~~ikL~DFGla~~~~~  197 (468)
                      +      +...++|||+.+.|||++.+.. ...+.|+||+.+..-..
T Consensus       174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            2      2346999999999999975311 13589999999876443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.27  E-value=0.00046  Score=69.95  Aligned_cols=141  Identities=15%  Similarity=0.152  Sum_probs=83.6

Q ss_pred             EeEEeecCCeEEEEEEEcC-------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKF-------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~-------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ++.|..|-...+|++....       +++.|++|+....    ......+.+|.++++.|..+.-..++++.+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            3567778888999998742       3578999986331    12244566899999998855555667766543    3


Q ss_pred             EEEeccCCCCHH--------------HHHH---Hc-----CCCC--HHHHHHHHHHHHH-------------------HH
Q 012203          119 LVMELCAGGELF--------------HRLE---KF-----GRFS--EAEARVLFMQLMQ-------------------VV  155 (468)
Q Consensus       119 lV~E~~~ggsL~--------------~~l~---~~-----~~l~--~~~~~~i~~qil~-------------------aL  155 (468)
                      +||||++|.+|.              +.|.   .-     +...  ...+..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            999999985542              1111   11     0111  2444545544322                   22


Q ss_pred             HHHH----H----cCcEecccCCCcEEEeecC-CCCCEEEeecCceee
Q 012203          156 LYCH----E----IGVVHRDLKPENILLATKA-SSSPIKLADFGLATY  194 (468)
Q Consensus       156 ~~LH----~----~gIiHrDIKp~NILl~~~~-~~~~ikL~DFGla~~  194 (468)
                      ..|.    .    ..++|+|+.+.|||++.+. ..+.+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    2    2589999999999998651 124599999998865

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.11  E-value=0.001  Score=66.62  Aligned_cols=77  Identities=16%  Similarity=0.038  Sum_probs=47.1

Q ss_pred             EEeEEeecCCeEEEEEEEcC--------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           45 LGQQLGWGQFGVIRVCSDKF--------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~--------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      -.+.|+.|....+|++....        .++.+++|+.....    ........|.++++.|..+.-..++++.+  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            35678888889999998653        13688999875431    11112357888888887443344666554  33 


Q ss_pred             EEEEEeccCCCCH
Q 012203          117 VHLVMELCAGGEL  129 (468)
Q Consensus       117 ~~lV~E~~~ggsL  129 (468)
                       ++||||++|..+
T Consensus       110 -~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 -GRIEEWLYGDPL  121 (369)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -cEEEEEecCCcC
Confidence             689999988543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.96  E-value=0.0068  Score=62.86  Aligned_cols=77  Identities=13%  Similarity=0.047  Sum_probs=50.4

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      -++.|+.|-...+|++.....++.+++|+...... ..   -....|..+++.|..+.-..++++.+.  +  .+||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            35678889899999998764457899998854311 11   112579999999975444456777663  3  2599999


Q ss_pred             CCCCH
Q 012203          125 AGGEL  129 (468)
Q Consensus       125 ~ggsL  129 (468)
                      +|.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            88544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.91  E-value=0.0064  Score=60.25  Aligned_cols=73  Identities=7%  Similarity=0.003  Sum_probs=46.3

Q ss_pred             EeEE--eecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcC--CCCceeeeEE------EEeCC
Q 012203           46 GQQL--GWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG--HPNVVDLKAV------YEDED  115 (468)
Q Consensus        46 ~~~L--G~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~--HpnIv~l~~~------~~~~~  115 (468)
                      .+.+  |.|....||++... +| .+++|+......         ..|+.+++.|..  -|++++++..      ....+
T Consensus        26 ~~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g   94 (339)
T 3i1a_A           26 AQFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKH   94 (339)
T ss_dssp             EEEETTTSCSSCEEEEEECS-SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSS
T ss_pred             eEEeeccCccccceEEEEeC-CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECC
Confidence            3445  33446899998754 45 899998765431         346666766652  2334444432      24467


Q ss_pred             EEEEEEeccCCCCH
Q 012203          116 YVHLVMELCAGGEL  129 (468)
Q Consensus       116 ~~~lV~E~~~ggsL  129 (468)
                      ..+++|+|++|..+
T Consensus        95 ~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           95 FKIIAYPFIHAPNG  108 (339)
T ss_dssp             EEEEEEECCCCCBT
T ss_pred             EEEEEEeccCCCcC
Confidence            88999999998765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.08  E-value=0.022  Score=58.48  Aligned_cols=77  Identities=17%  Similarity=0.084  Sum_probs=51.2

Q ss_pred             EEeEEeecCCeEEEEEEEcCC-------CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKFT-------GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~-------g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      -++.|..|-...+|++.....       ++.|++++.....    ...-...+|..+++.|..+.-..++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            356777788889999987521       5789999875431    11112356888888887554455666543  33  


Q ss_pred             EEEEeccCCCCH
Q 012203          118 HLVMELCAGGEL  129 (468)
Q Consensus       118 ~lV~E~~~ggsL  129 (468)
                      ++||||++|.+|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.19  E-value=0.078  Score=53.62  Aligned_cols=32  Identities=31%  Similarity=0.523  Sum_probs=25.6

Q ss_pred             cEecccCCCcEEEeec---CCCCCEEEeecCceee
Q 012203          163 VVHRDLKPENILLATK---ASSSPIKLADFGLATY  194 (468)
Q Consensus       163 IiHrDIKp~NILl~~~---~~~~~ikL~DFGla~~  194 (468)
                      ++|+|+.+.|||+..+   .....+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999542   2345699999999865

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.95  E-value=2.4  Score=38.97  Aligned_cols=122  Identities=11%  Similarity=0.172  Sum_probs=81.9

Q ss_pred             HHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCC
Q 012203           91 EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKP  170 (468)
Q Consensus        91 Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp  170 (468)
                      |+.+|..  .||+++.. .+-++++.+.+.++.-+.+.=+..++   .++....++++.+|+....++  ..-+|--|.|
T Consensus        36 el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P  107 (215)
T 4ann_A           36 LMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAP  107 (215)
T ss_dssp             GGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSG
T ss_pred             HHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEec
Confidence            4555543  48999987 56677778888887754333233343   378888899999988877444  3457888999


Q ss_pred             CcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 012203          171 ENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPF  243 (468)
Q Consensus       171 ~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf  243 (468)
                      +||+++.++.   +++.-.|+-..+.                |.-    .+...=+-.+=+++..++.++..|
T Consensus       108 ~NL~f~~~~~---p~i~~RGik~~l~----------------P~~----~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          108 DELFFTRDGL---PIAKTRGLQNVVD----------------PLP----VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             GGEEECTTSC---EEESCCEETTTBS----------------CCC----CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             ceEEEcCCCC---EEEEEccCccCCC----------------CCC----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999987665   8888777643222                110    122223445668888999998887

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.92  E-value=3.1  Score=38.31  Aligned_cols=121  Identities=15%  Similarity=0.197  Sum_probs=80.9

Q ss_pred             HHHHHHHhcCCCCceeeeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHHcCcEecccC
Q 012203           91 EIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL-YCHEIGVVHRDLK  169 (468)
Q Consensus        91 Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~-~LH~~gIiHrDIK  169 (468)
                      |..+|..  .||++  -..+-.+++.+.+.++.-+++.=+..++   .++....++++.+|+.... ++  ..-+|--|.
T Consensus        41 e~~lL~~--~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~  111 (219)
T 4ano_A           41 ELEVLKE--VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVC  111 (219)
T ss_dssp             GGGGGGG--SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCC
T ss_pred             HHHHHhc--cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEe
Confidence            3444433  48888  5555578888888888765555555554   4788888988888888665 44  456788899


Q ss_pred             CCcEEEeecCCCCCEEEeecCceeeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 012203          170 PENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPF  243 (468)
Q Consensus       170 p~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf  243 (468)
                      |+||+++.++.   +++.-.|+-..+                +|.-    .+...=+-.+=+++..++.++..|
T Consensus       112 P~NL~f~~~~~---p~i~hRGi~~~l----------------pP~e----~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          112 PENLMFNRALE---PFFLHVGVKESL----------------PPDE----WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GGGEEECTTCC---EEESCCEETTTB----------------SSCS----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CceEEEeCCCc---EEEEEcCCcccC----------------CCCC----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999987666   888887764322                2211    111222335567788888888776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	468
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-88
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-87
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-87
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-86
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-86
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-84
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-81
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-80
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-80
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-79
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-79
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-79
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-77
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-75
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-75
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-73
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-71
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-70
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-70
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-69
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-68
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-66
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-65
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-63
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-63
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-61
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-61
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-61
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-61
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-60
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-60
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-60
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-59
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-57
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-55
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-54
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-49
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-47
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-43
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-20

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  271 bits (693), Expect = 1e-88
 Identities = 109/268 (40%), Positives = 163/268 (60%), Gaps = 4/268 (1%)

Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q  ++R+ +     LG G F  + +  DK T ++ A K IAK  L     E S++ EI +
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAV 60

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           + ++  HPN+V L  +YE   +++L+M+L +GGELF R+ + G ++E +A  L  Q++  
Sbjct: 61  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           V Y H++G+VHRDLKPEN+L  +    S I ++DFGL+   +PG  L    G+P Y+APE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 215 VLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           VLA   Y++A D WS GVI YILL G PPF+    +++F+ +  A+  F S  WD ISDS
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           AKD +  ++  DP +R T  Q L H W+
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  267 bits (683), Expect = 1e-87
 Identities = 100/274 (36%), Positives = 146/274 (53%), Gaps = 16/274 (5%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL------EIEI 94
           E +   + LG G   V+R C  K T + +A K I      +   E   +L      E++I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           + ++SGHPN++ LK  YE   +  LV +L   GELF  L +    SE E R +   L++V
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           +   H++ +VHRDLKPENILL        IKL DFG +  ++PG+ L    G+P Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179

Query: 215 VLAG-------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
           ++         GY +  D+WS GVI+Y LL+G PPFW   +  +   + + + +F S  W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239

Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           D  SD+ KDLV   L   P +R TA + L H + 
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  268 bits (687), Expect = 3e-87
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 7/266 (2%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + + + ++LG G FGV+   +++ TG  FA K +         D+ +V+ EI+ M+ L  
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLR- 81

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVVLYCH 159
           HP +V+L   +ED++ + ++ E  +GGELF ++ ++  + SE EA     Q+ + + + H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG 219
           E   VH DLKPENI+  TK S+  +KL DFGL  +++P QS+  T G+  + APEV  G 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 220 -YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
                 D+WS GV+ YILLSG+ PF G         V++ D     + +  IS+  KD +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260

Query: 279 MGMLSTDPSQRLTARQVLDHSWMGDG 304
             +L  DP+ R+T  Q L+H W+  G
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPG 286

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  266 bits (681), Expect = 3e-86
 Identities = 93/266 (34%), Positives = 147/266 (55%), Gaps = 7/266 (2%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           ++ + + + ++LG G FGV+  C +K TG VF  K I         D+ +VK EI IM +
Sbjct: 26  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQ 82

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVL 156
           L  HP +++L   +ED+  + L++E  +GGELF R+     + SEAE      Q  + + 
Sbjct: 83  LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           + HE  +VH D+KPENI+  TK +SS +K+ DFGLAT + P + +  T  +  + APE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 217 AGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
                    D+W+ GV+ Y+LLSG+ PF G         V+  D  F  + +  +S  AK
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
           D +  +L  +P +RLT    L+H W+
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWL 286

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  262 bits (670), Expect = 9e-86
 Identities = 86/262 (32%), Positives = 142/262 (54%), Gaps = 10/262 (3%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F +G+ LG G+FG + +  +K +  + A K + K +L     E  ++ E+EI + L  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HPN++ L   + D   V+L++E    G ++  L+K  +F E        +L   + YCH 
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             V+HRD+KPEN+LL    S+  +K+ADFG + +  P        G+  Y+ PE++ G  
Sbjct: 125 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           +++  D+WS GV+ Y  L G PPF  NT    +  +   +  FP    D +++ A+DL+ 
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 236

Query: 280 GMLSTDPSQRLTARQVLDHSWM 301
            +L  +PSQR   R+VL+H W+
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWI 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (664), Expect = 4e-84
 Identities = 82/285 (28%), Positives = 142/285 (49%), Gaps = 11/285 (3%)

Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRL 98
           L E++++ + LG G+FG++  C +  + + +  K +         D+  VK EI I+   
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA 58

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLY 157
             H N++ L   +E  + + ++ E  +G ++F R+       +E E      Q+ + + +
Sbjct: 59  R-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H   + H D++PENI+  T+  SS IK+ +FG A  ++PG +      +P Y APEV  
Sbjct: 118 LHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 218 GG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
               + A D+WS G ++Y+LLSG+ PF   T  +I + +  A+  F    +  IS  A D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKE 321
            V  +L  +   R+TA + L H W+    Q  E++S   I   K 
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWL---KQKIERVSTKVIRTLKH 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (645), Expect = 4e-81
 Identities = 101/310 (32%), Positives = 156/310 (50%), Gaps = 22/310 (7%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPN 103
           V  Q LG G  G +    +K T E FA K         + D    + E+E+  R S  P+
Sbjct: 15  VTSQVLGLGINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPH 66

Query: 104 VVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
           +V +  VYE+       + +VME   GGELF R++  G   F+E EA  +   + + + Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H I + HRD+KPEN+L  +K  ++ +KL DFG A       SL     +P+Y+APEVL 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 218 G-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDA----VRTADLRFPSNPWDHISD 272
              Y+++ D+WS GVI+YILL G PPF+ N    I       +R     FP+  W  +S+
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEK---LSGNKIEDCKEWDLGSGSF 329
             K L+  +L T+P+QR+T  + ++H W+    + P+     S    ED + W+      
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEM 306

Query: 330 STQIIPRNQD 339
           ++ +     D
Sbjct: 307 TSALATMRVD 316

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 1e-80
 Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 12/265 (4%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F  G+ LG G F  + +  +  T   +A K + K  ++  +    V  E ++M+RL  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 66

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP  V L   ++D++ ++  +     GEL   + K G F E   R    +++  + Y H 
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT---VGSPFYIAPEVLA 217
            G++HRDLKPENILL        I++ DFG A  + P          VG+  Y++PE+L 
Sbjct: 127 KGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 218 GG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
                +++D+W+ G I+Y L++G+PPF    +  IF  +   +  FP    +     A+D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 239

Query: 277 LVMGMLSTDPSQRLTARQVLDHSWM 301
           LV  +L  D ++RL   ++  +  +
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (632), Expect = 7e-80
 Identities = 73/272 (26%), Positives = 129/272 (47%), Gaps = 16/272 (5%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           N  + + +  +LG G FG +    +K T  + A K I      + ++     +EI+I+  
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 65

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR-FSEAEARVLFMQLMQVVL 156
              HPN+V L   +  E+ + +++E CAGG +   + +  R  +E++ +V+  Q +  + 
Sbjct: 66  CD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEV 215
           Y H+  ++HRDLK  NIL         IKLADFG++           + +G+P+++APEV
Sbjct: 125 YLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181

Query: 216 LAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
           +         Y+  ADVWS G+ L  +    PP       R+   +  ++    + P   
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            S + KD +   L  +   R T  Q+L H ++
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  247 bits (633), Expect = 1e-79
 Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 13/268 (4%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
           +  + F   +++G G FG +    D    EV A K ++     + +  + +  E+  + +
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 98  LSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLY 157
           L  HPN +  +  Y  E    LVME C G              E E   +    +Q + Y
Sbjct: 72  LR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLA 217
            H   ++HRD+K  NILL   +    +KL DFG A+ + P  S    VG+P+++APEV+ 
Sbjct: 131 LHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 184

Query: 218 ----GGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
               G Y+   DVWS G+    L    PP +          +   +   P+    H S+ 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEY 242

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            ++ V   L   P  R T+  +L H ++
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (630), Expect = 2e-79
 Identities = 102/269 (37%), Positives = 147/269 (54%), Gaps = 6/269 (2%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL---EIEI 94
           N+ + +  G++LG GQF V++ C +K TG  +A K I K R  +     S +    E+ I
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQV 154
           +  +  HPNV+ L  VYE++  V L++EL AGGELF  L +    +E EA     Q++  
Sbjct: 67  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 155 VLYCHEIGVVHRDLKPENILLATKASSSP-IKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
           V Y H + + H DLKPENI+L  +    P IK+ DFGLA  I+ G       G+P ++AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 214 EVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD 272
           E++        AD+WS GVI YILLSG  PF G+TK      V   +  F    + + S 
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245

Query: 273 SAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            AKD +  +L  DP +R+T +  L H W+
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (625), Expect = 5e-79
 Identities = 87/266 (32%), Positives = 133/266 (50%), Gaps = 12/266 (4%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + L Q LG G +G +++  ++ T E  A K +   R   +D   ++K EI I   L+ 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN- 61

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H NVV       + +  +L +E C+GGELF R+E      E +A+  F QLM  V+Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLA 217
           IG+ HRD+KPEN+LL        +K++DFGLAT          L    G+  Y+APE+L 
Sbjct: 122 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 218 GG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
               + +  DVWS G++L  +L+G  P+   + S    +       +  NPW  I  +  
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDSAPL 237

Query: 276 DLVMGMLSTDPSQRLTARQVLDHSWM 301
            L+  +L  +PS R+T   +    W 
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWY 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 3e-77
 Identities = 71/268 (26%), Positives = 128/268 (47%), Gaps = 11/268 (4%)

Query: 36  ISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIM 95
           + + ++++   +++G G  G +    D  TG+  A + +   +      +  +  EI +M
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVM 71

Query: 96  TRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
                +PN+V+    Y   D + +VME  AGG L   + +     E +   +  + +Q +
Sbjct: 72  RENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQAL 129

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPE 214
            + H   V+HRD+K +NILL        +KL DFG    I P QS   T VG+P+++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 215 VLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           V+    Y    D+WS G++   ++ G PP+      R    + T       NP + +S  
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAI 245

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            +D +   L  D  +R +A+++L H ++
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (601), Expect = 2e-75
 Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 21/273 (7%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E + +   +G G +G  +    K  G++   K +    +   + +  +  E+ ++  L  
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELK- 61

Query: 101 HPNVVDLKAVYEDE--DYVHLVMELCAGGELFHRLEKFGR----FSEAEARVLFMQLMQV 154
           HPN+V       D     +++VME C GG+L   + K  +      E     +  QL   
Sbjct: 62  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 155 VLYCHEIG-----VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVG-SP 208
           +  CH        V+HRDLKP N+ L        +KL DFGLA  +    S       +P
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 209 FYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW 267
           +Y++PE +    YN+ +D+WS G +LY L + MPPF   ++  +   +R    R      
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP 235

Query: 268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSW 300
              SD   +++  ML+     R +  ++L++  
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 4e-75
 Identities = 92/323 (28%), Positives = 159/323 (49%), Gaps = 18/323 (5%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F+L + LG G FG + +   K T + FA K++ KD ++  DD     +E  +++    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP +  +   ++ ++ +  VME   GG+L + ++   +F  + A     +++  + + H 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYIAPEVLAGG 219
            G+V+RDLK +NIL         IK+ADFG+      G +   T  G+P YIAPE+L G 
Sbjct: 122 KGIVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 220 -YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            YN + D WS GV+LY +L G  PF G  +  +F ++R  +  +P      +   AKDL+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLL 234

Query: 279 MGMLSTDPSQRLTAR-QVLDHSWMGDGIQDPEKLSGNKIE-----DCKEWDLGSGSFSTQ 332
           + +   +P +RL  R  +  H      I + E+L   +I+       K     S +F  +
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLF-REI-NWEELERKEIDPPFRPKVKSPFDCS-NFDKE 291

Query: 333 IIPRNQDISFGTGSPVFSDDESP 355
            +     +SF   + + S D++ 
Sbjct: 292 FLNEKPRLSFADRALINSMDQNM 314

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 3e-74
 Identities = 61/268 (22%), Positives = 123/268 (45%), Gaps = 15/268 (5%)

Query: 42  RFV-LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           RF+    ++G G F  +    D  T    A   +   +L T  + +  K E E++  L  
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ- 66

Query: 101 HPNVVDLKAVYED----EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           HPN+V     +E     +  + LV EL   G L   L++F        R    Q+++ + 
Sbjct: 67  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126

Query: 157 YCHEIG--VVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPE 214
           + H     ++HRDLK +NI +     +  +K+ D GLAT ++        +G+P ++APE
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPE 183

Query: 215 VLAGGYNQAADVWSAGVILYILLSGMPPFWG-NTKSRIFDAVRTADLRFPSNPWDHISDS 273
           +    Y+++ DV++ G+ +  + +   P+      ++I+  V       P++        
Sbjct: 184 MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPASFDKVAIPE 241

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDHSWM 301
            K+++ G +  +  +R + + +L+H++ 
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 9e-73
 Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 49/304 (16%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            + F    +LG G  GV+   S K +G V A K I  +  +       +  E++++   +
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECN 62

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
             P +V     +  +  + + ME   GG L   L+K GR  E     + + +++ + Y  
Sbjct: 63  -SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 160 EI-GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG 218
           E   ++HRD+KP NIL+    S   IKL DFG++  +    +    VG+  Y++PE L G
Sbjct: 122 EKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQG 177

Query: 219 G-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV---------------------- 255
             Y+  +D+WS G+ L  +  G  P        +                          
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 256 ------------------RTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD 297
                                +   P  P    S   +D V   L  +P++R   +Q++ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 298 HSWM 301
           H+++
Sbjct: 298 HAFI 301

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 2e-71
 Identities = 74/281 (26%), Positives = 130/281 (46%), Gaps = 21/281 (7%)

Query: 39  LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---IDDERSVKLEIEIM 95
           L  ++ +G  LG G FG +            A K + KDR+     + +   V +E+ ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 96  TRLS-GHPNVVDLKAVYEDEDYVHLVMELCAGG-ELFHRLEKFGRFSEAEARVLFMQLMQ 153
            ++S G   V+ L   +E  D   L++E      +LF  + + G   E  AR  F Q+++
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            V +CH  GV+HRD+K ENIL+    +   +KL DFG    ++         G+  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPP 178

Query: 214 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           E +     + ++A VWS G++LY ++ G  PF  + +      +    + F       +S
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVS 228

Query: 272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLS 312
              + L+   L+  PS R T  ++ +H WM   +  P++ +
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWM-QDVLLPQETA 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  223 bits (569), Expect = 1e-70
 Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 7/271 (2%)

Query: 37  SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           S+L +R+ LG+ LG+G    + +  D       A K +  D           + E +   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 97  RLSGHPNVVDLKAVYEDED----YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
            L+ HP +V +    E E       ++VME   G  L   +   G  +   A  +     
Sbjct: 63  ALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT-VGSPFYI 211
           Q + + H+ G++HRD+KP NI+++   +   +               +     +G+  Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 212 APEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           +PE   G   +  +DV+S G +LY +L+G PPF G++   +       D   PS   + +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
           S     +V+  L+ +P  R      +    +
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  226 bits (576), Expect = 2e-70
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 14/270 (5%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS- 99
             F + + +G G FG +  C    TG+++A K + K R+     E     E  +++ +S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 100 -GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYC 158
              P +V +   +   D +  +++L  GG+L + L + G FSEA+ R    +++  + + 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG 218
           H   VV+RDLKP NILL        ++++D GLA      +    +VG+  Y+APEVL  
Sbjct: 124 HNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQK 179

Query: 219 G--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD 276
           G  Y+ +AD +S G +L+ LL G  PF  +      +  R   L       D  S   + 
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFSPELRS 238

Query: 277 LVMGMLSTDPSQRLT-----ARQVLDHSWM 301
           L+ G+L  D ++RL      A++V +  + 
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  221 bits (563), Expect = 3e-69
 Identities = 85/283 (30%), Positives = 145/283 (51%), Gaps = 18/283 (6%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           + F + + LG G FG + +   +  G  +A K + K+ +V +        E  +++ ++ 
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 62

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP ++ +   ++D   + ++M+   GGELF  L K  RF    A+    ++   + Y H 
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG- 219
             +++RDLKPENILL     +  IK+ DFG A Y+          G+P YIAPEV++   
Sbjct: 123 KDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKP 177

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           YN++ D WS G+++Y +L+G  PF+ +   + ++ +  A+LRFP       ++  KDL+ 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 233

Query: 280 GMLSTDPSQRL-----TARQVLDHSWMGDGIQDPEKLSGNKIE 317
            +++ D SQRL         V +H W    +   EKL    IE
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWF-KEV-VWEKLLSRNIE 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 7e-68
 Identities = 88/284 (30%), Positives = 142/284 (50%), Gaps = 17/284 (5%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
             F   + LG G FG + +  +K TG  +A K + K+ ++  D+      E  ++     
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           HP +  LK  ++  D +  VME   GGELF  L +   F+E  AR    +++  + Y H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPEVLAGG 219
             VV+RD+K EN++L        IK+ DFGL       G ++    G+P Y+APEVL   
Sbjct: 124 RDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 220 -YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV 278
            Y +A D W  GV++Y ++ G  PF+     R+F+ +   ++RFP      +S  AK L+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL 236

Query: 279 MGMLSTDPSQRL-----TARQVLDHSWMGDGIQDPEKLSGNKIE 317
            G+L  DP QRL      A++V++H +    I + + +   K+ 
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFF-LSI-NWQDVVQKKLL 278

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 1e-66
 Identities = 67/269 (24%), Positives = 112/269 (41%), Gaps = 19/269 (7%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
             +  +GQ++G G FG   V   K+ G+V A K +      T    ++ K E+ ++ +  
Sbjct: 7   DGQITVGQRIGSGSFGT--VYKGKWHGDV-AVKMLNVTAP-TPQQLQAFKNEVGVLRKTR 62

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYC 158
            H N++     Y     + +V + C G  L+H L     +F   +   +  Q  Q + Y 
Sbjct: 63  -HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG---QSLLGTVGSPFYIAPEV 215
           H   ++HRDLK  NI L        +K+ DFGLAT               GS  ++APEV
Sbjct: 121 HAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 216 L----AGGYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP--SNPWDH 269
           +       Y+  +DV++ G++LY L++G  P+           +       P  S    +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
              + K L+   L     +R    Q+L  
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 7e-65
 Identities = 82/291 (28%), Positives = 148/291 (50%), Gaps = 19/291 (6%)

Query: 41  ERFVLGQQLGWGQFGVI---RVCSDKFTGEVFACKSIAKDRLV-TIDDERSVKLEIEIMT 96
           E F L + LG G +G +   R  S   TG+++A K + K  +V         + E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
            +   P +V L   ++ E  +HL+++   GGELF  L +  RF+E E ++   +++  + 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP--GQSLLGTVGSPFYIAPE 214
           + H++G+++RD+K ENILL    S+  + L DFGL+        +      G+  Y+AP+
Sbjct: 144 HLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 215 VLAG---GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS 271
           ++ G   G+++A D WS GV++Y LL+G  PF  + +      +    L+        +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 272 DSAKDLVMGMLSTDPSQRL-----TARQVLDHSWMGDGIQDPEKLSGNKIE 317
             AKDL+  +L  DP +RL      A ++ +H +    I + + L+  K+ 
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF-QKI-NWDDLAAKKVP 309

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  207 bits (527), Expect = 1e-63
 Identities = 65/308 (21%), Positives = 130/308 (42%), Gaps = 49/308 (15%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
             ++ + L ++LG G++  +    +    E    K +          ++ +K EI+I+  
Sbjct: 32  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILEN 85

Query: 98  LSGHPNVVDLKAVYEDED--YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVV 155
           L G PN++ L  + +D       LV E     +           ++ + R    ++++ +
Sbjct: 86  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 142

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEV 215
            YCH +G++HRD+KP N+++  +     ++L D+GLA +  PGQ     V S ++  PE+
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDHE--HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200

Query: 216 LAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSR--------------IFDAVRTAD 259
           L     Y+ + D+WS G +L  ++    PF+    +               ++D +   +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 260 LR--------------------FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHS 299
           +                       S     +S  A D +  +L  D   RLTAR+ ++H 
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320

Query: 300 WMGDGIQD 307
           +    ++D
Sbjct: 321 YFYTVVKD 328

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 1e-63
 Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 33/282 (11%)

Query: 49  LGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD--ERSVKLEIEIMTRLSGHPNVVD 106
           LG GQF  +    DK T ++ A K I         D   R+   EI+++  LS HPN++ 
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIG 64

Query: 107 LKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHR 166
           L   +  +  + LV +           +     + +  +   +  +Q + Y H+  ++HR
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124

Query: 167 DLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPEVLAG--GYNQA 223
           DLKP N+LL     +  +KLADFGLA     P ++    V + +Y APE+L G   Y   
Sbjct: 125 DLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 224 ADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD--------------- 268
            D+W+ G IL  LL  +P   G++       +           W                
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 269 ---------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                       D   DL+ G+   +P  R+TA Q L   + 
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (519), Expect = 2e-62
 Identities = 86/283 (30%), Positives = 148/283 (52%), Gaps = 18/283 (6%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           ++F   + LG G FG + +   K +G  +A K + K ++V +        E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
            P +V L+  ++D   +++VME  AGGE+F  L + GRFSE  AR    Q++    Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAG-G 219
           + +++RDLKPEN+L+  +     I++ DFG A  ++     L   G+P  +APE++   G
Sbjct: 160 LDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTL--CGTPEALAPEIILSKG 214

Query: 220 YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM 279
           YN+A D W+ GV++Y + +G PPF+ +   +I++ + +  +RFP     H S   KDL+ 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270

Query: 280 GMLSTDPSQRL-----TARQVLDHSWMGDGIQDPEKLSGNKIE 317
            +L  D ++R          + +H W      D   +   K+E
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT--TDWIAIYQRKVE 311

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 4e-61
 Identities = 58/290 (20%), Positives = 109/290 (37%), Gaps = 36/290 (12%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERSVKLEIEIMT 96
           RE    G+ LG G FG +   +     +      +A   L       +  ++  E+++MT
Sbjct: 36  RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEK--------------------- 135
           +L  H N+V+L         ++L+ E C  G+L + L                       
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 136 --FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT 193
                 +  +      Q+ + + +      VHRDL   N+L+        +K+ DFGLA 
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLAR 212

Query: 194 YIEPGQSLL---GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTK 248
            I    + +          ++APE L  G Y   +DVWS G++L+ + S G+ P+ G   
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272

Query: 249 SRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
              F  +     +       + ++    ++    + D  +R +   +   
Sbjct: 273 DANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 4e-61
 Identities = 86/338 (25%), Positives = 142/338 (42%), Gaps = 53/338 (15%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
              +   + +G G FGV+       +GE+ A K + +D       +R    E++IM +L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLD 71

Query: 100 GHPNVVDLKAVY------EDEDYVHLVMELCAGG---ELFHRLEKFGRFSEAEARVLFMQ 150
            H N+V L+  +      +DE Y++LV++           H             ++   Q
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 151 LMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFY 210
           L + + Y H  G+ HRD+KP+N+LL     ++ +KL DFG A  +  G+  +  + S +Y
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188

Query: 211 IAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK----SRIFDAVRT------- 257
            APE++ G   Y  + DVWSAG +L  LL G P F G++       I   + T       
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 258 ------ADLRFPSNP--------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD 303
                  + +FP                  A  L   +L   P+ RLT  +   HS+  D
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-D 307

Query: 304 GIQDPEKLSGNKIEDCKEWDLGSGSFS------TQIIP 335
            ++DP     N  +    ++  +   S      T +IP
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIP 345

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 5e-61
 Identities = 66/303 (21%), Positives = 119/303 (39%), Gaps = 48/303 (15%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
            ++    ++G G FG +     + TG+  A K +  +         +++ EI+I+  L  
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLK- 67

Query: 101 HPNVVDLKAVYED--------EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLM 152
           H NVV+L  +           +  ++LV + C             +F+ +E + +   L+
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127

Query: 153 QVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL-----GTVGS 207
             + Y H   ++HRD+K  N+L+        +KLADFGLA      ++         V +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 208 PFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN 265
            +Y  PE+L G   Y    D+W AG I+  + +  P   GNT+      +          
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 266 PWDHI----------------------------SDSAKDLVMGMLSTDPSQRLTARQVLD 297
            W ++                               A DL+  +L  DP+QR+ +   L+
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

Query: 298 HSW 300
           H +
Sbjct: 305 HDF 307

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (504), Expect = 9e-61
 Identities = 57/292 (19%), Positives = 105/292 (35%), Gaps = 21/292 (7%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH 101
           R+ LG+++G G FG I + +D   GE  A K               + +E +I   + G 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGG 62

Query: 102 PNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEI 161
             +  ++    + DY  +VMEL              +FS     +L  Q++  + Y H  
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122

Query: 162 GVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--------VGSPFYIAP 213
             +HRD+KP+N L+      + + + DFGLA      ++             G+  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 214 EVLAGG-YNQAADVWSAGVILYILLSGMPPF---WGNTKSRIFDAVRTADLRFPSNP-WD 268
               G   ++  D+ S G +L     G  P+      TK + ++ +    +  P      
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242

Query: 269 HISDSAKDLVMGMLSTDPSQRLTA---RQVLDHSWMGDGIQDPEKLSGNKIE 317
                    +    S     +      RQ+  + +   G         N ++
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 1e-60
 Identities = 74/307 (24%), Positives = 126/307 (41%), Gaps = 45/307 (14%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
            +R  +   Q +G G +G +    D  TG   A K + +     +  +R    E+ ++  
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKH 73

Query: 98  LSGHPNVVDLKAVYEDED------YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
           +  H NV+ L  V+  ++        +LVM     G    +L K  +  E   + L  Q+
Sbjct: 74  MR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
           ++ + Y H  G++HRDLKP N+ +        +K+ DFGLA   +    + G V + +Y 
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--QADSEMTGYVVTRWYR 185

Query: 212 APEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD- 268
           APEV+     Y Q  D+WS G I+  +++G   F G+        +       P+     
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 269 --------------------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMG 302
                                     + S  A +L+  ML  D  QR+TA + L H +  
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF- 304

Query: 303 DGIQDPE 309
           + + D E
Sbjct: 305 ESLHDTE 311

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  197 bits (502), Expect = 1e-60
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 34/289 (11%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E++   +++G G +GV+    +   GE FA K I  ++        +++ EI I+  L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-EISILKELK- 58

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H N+V L  V   +  + LV E              G      A+   +QL+  + YCH+
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPEVLAG- 218
             V+HRDLKP+N+L+        +K+ADFGLA     P +     + + +Y AP+VL G 
Sbjct: 119 RRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 219 -GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD--------- 268
             Y+   D+WS G I   +++G P F G +++     +        S  W          
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 269 ----------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                            + +S  DL+  ML  DP+QR+TA+Q L+H++ 
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-60
 Identities = 72/305 (23%), Positives = 121/305 (39%), Gaps = 46/305 (15%)

Query: 35  QISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           Q+ ++  R+     +G G +G++    D       A K I+          +    EI+I
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKI 59

Query: 95  MTRLSGHPNVVDLKAVYEDED-----YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFM 149
           + R   H N++ +  +           V+LV  L  G +L+  L K    S         
Sbjct: 60  LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL-KTQHLSNDHICYFLY 116

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT----V 205
           Q+++ + Y H   V+HRDLKP N+LL    ++  +K+ DFGLA   +P     G     V
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYV 173

Query: 206 GSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP 263
            + +Y APE++     Y ++ D+WS G IL  +LS  P F G       + +        
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233

Query: 264 SNPWD---------------------------HISDSAKDLVMGMLSTDPSQRLTARQVL 296
               +                           +    A DL+  ML+ +P +R+   Q L
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

Query: 297 DHSWM 301
            H ++
Sbjct: 294 AHPYL 298

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-60
 Identities = 63/277 (22%), Positives = 105/277 (37%), Gaps = 24/277 (8%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
                    +G G FG +     K  G              + DD R    E+E++ +L 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKF----------------GRFSEAE 143
            HPN+++L    E   Y++L +E    G L   L K                    S  +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 144 ARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLG 203
                  + + + Y  +   +HRDL   NIL+     +   K+ADFGL+   E       
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTM 185

Query: 204 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLR 261
                 ++A E L    Y   +DVWS GV+L+ ++S G  P+ G T + +++ +      
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--- 242

Query: 262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
           +      +  D   DL+       P +R +  Q+L  
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 6e-60
 Identities = 80/314 (25%), Positives = 121/314 (38%), Gaps = 49/314 (15%)

Query: 41  ERFVLGQQLGWGQFG-VIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           +++    ++G G +G V +    K  G   A K +            S   E+ ++  L 
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLE 65

Query: 100 G--HPNVVDLKAVY-----EDEDYVHLVMELCAGGEL-FHRLEKFGRFSEAEARVLFMQL 151
              HPNVV L  V      + E  + LV E        +              + +  QL
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
           ++ + + H   VVHRDLKP+NIL+    SS  IKLADFGLA       +L   V + +Y 
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 182

Query: 212 APEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW--- 267
           APEVL    Y    D+WS G I   +    P F G++       +           W   
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 268 --------------------DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQD 307
                                 I +  KDL++  L+ +P++R++A   L H +  D    
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD---- 298

Query: 308 PEKLSGNKIEDCKE 321
                   +E CKE
Sbjct: 299 --------LERCKE 304

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (497), Expect = 1e-59
 Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 19/282 (6%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAK-DRLVTIDDERSVKLEIEIMTRL 98
                + Q +G G+FG +     K  G+     +I       T    R    E  IM + 
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELF-HRLEKFGRFSEAEARVLFMQLMQVVLY 157
             HPNV+ L+ V      V ++ E    G L     +  G+F+  +   +   +   + Y
Sbjct: 85  D-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL------LGTVGSPFYI 211
             ++  VHRDL   NIL+    S+   K++DFGL+ ++E   S       LG      + 
Sbjct: 144 LADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 212 APEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
           APE +    +  A+DVWS G++++ ++S G  P+W  T   + +A+   D R P  P   
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLP--PPMD 257

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKL 311
              +   L++     D + R    Q+++   +   I++P  L
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIRNPNSL 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 3e-59
 Identities = 62/264 (23%), Positives = 105/264 (39%), Gaps = 21/264 (7%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            +   L Q +G G+FG   V    + G   A K I  D        ++   E  +MT+L 
Sbjct: 6   MKELKLLQTIGKGEFGD--VMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR 58

Query: 100 GHPNVVDLKAV-YEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVL 156
            H N+V L  V  E++  +++V E  A G L   L   GR            + + + + 
Sbjct: 59  -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVL 216
           Y      VHRDL   N+L++        K++DFGL       Q          + APE L
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL 172

Query: 217 AGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
               ++  +DVWS G++L+ + S G  P+       +   V      +  +  D    + 
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAV 229

Query: 275 KDLVMGMLSTDPSQRLTARQVLDH 298
            +++      D + R +  Q+ + 
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQ 253

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-58
 Identities = 81/297 (27%), Positives = 130/297 (43%), Gaps = 35/297 (11%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           E F   +++G G +GV+    +K TGEV A K I  D   T     +   EI ++  L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN- 59

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCA-GGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCH 159
           HPN+V L  V   E+ ++LV E      + F              +    QL+Q + +CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 160 EIGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPEVLAG 218
              V+HRDLKP+N+L+    +   IKLADFGLA     P ++    V + +Y APE+L G
Sbjct: 120 SHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 219 G--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD-------- 268
              Y+ A D+WS G I   +++    F G+++      +           W         
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 269 -----------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDP 308
                             + +  + L+  ML  DP++R++A+  L H +    +  P
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKP 292

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-58
 Identities = 60/264 (22%), Positives = 112/264 (42%), Gaps = 17/264 (6%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
            +     ++LG GQFGV++    +      A K I +  +     E     E ++M  LS
Sbjct: 3   PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS 57

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYC 158
            H  +V L  V   +  + ++ E  A G L + L     RF   +   +   + + + Y 
Sbjct: 58  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ--SLLGTVGSPFYIAPEVL 216
                +HRDL   N L+  +     +K++DFGL+ Y+   +  S +G+     +  PEVL
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 217 AGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
               ++  +D+W+ GV+++ + S G  P+   T S   + +    LR         S+  
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLY--RPHLASEKV 230

Query: 275 KDLVMGMLSTDPSQRLTARQVLDH 298
             ++         +R T + +L +
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 5e-58
 Identities = 64/264 (24%), Positives = 113/264 (42%), Gaps = 17/264 (6%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
                  Q++G GQFG++ +       +  A K+I +  +     E     E E+M +LS
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS 58

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELF-HRLEKFGRFSEAEARVLFMQLMQVVLYC 158
            HP +V L  V  ++  + LV E    G L  +   + G F+      + + + + + Y 
Sbjct: 59  -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 159 HEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGSPFYIAPEVL 216
            E  V+HRDL   N L+     +  IK++DFG+  ++   Q     GT     + +PEV 
Sbjct: 118 EEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 217 AGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSA 274
           +   Y+  +DVWS GV+++ + S G  P+   + S + + + T    F        S   
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHV 231

Query: 275 KDLVMGMLSTDPSQRLTARQVLDH 298
             ++       P  R    ++L  
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (481), Expect = 2e-57
 Identities = 62/264 (23%), Positives = 112/264 (42%), Gaps = 17/264 (6%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           R    +  +LG GQ+G +     K      A K++ +D +    +      E  +M  + 
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK 71

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR--FSEAEARVLFMQLMQVVLY 157
            HPN+V L  V   E   +++ E    G L   L +  R   S      +  Q+   + Y
Sbjct: 72  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGSPFYIAPEV 215
             +   +HRDL   N L+     +  +K+ADFGL+  +         G      + APE 
Sbjct: 131 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 216 LAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           LA   ++  +DVW+ GV+L+ + + GM P+ G   S++++ +   D R      +   + 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRME--RPEGCPEK 244

Query: 274 AKDLVMGMLSTDPSQRLTARQVLD 297
             +L+      +PS R +  ++  
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQ 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 63/264 (23%), Positives = 111/264 (42%), Gaps = 19/264 (7%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L ++LG GQFG + +          A KS+ +  +       +   E  +M +L 
Sbjct: 12  RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 66

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLY 157
            H  +V L AV   E  ++++ E    G L   L+     + +  +   +  Q+ + + +
Sbjct: 67  -HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGSPFYIAPEV 215
             E   +HRDL+  NIL+   + +   K+ADFGLA  IE  +     G      + APE 
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 216 LAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           +  G +   +DVWS G++L  +++ G  P+ G T   +   +      +     D+  + 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEE 238

Query: 274 AKDLVMGMLSTDPSQRLTARQVLD 297
              L+       P  R T   +  
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRS 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 4e-57
 Identities = 70/265 (26%), Positives = 114/265 (43%), Gaps = 14/265 (5%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERS-VKLEIEIMTRL 98
           RER  LG+ +G GQFG +               +I   +  T D  R     E   M + 
Sbjct: 6   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65

Query: 99  SGHPNVVDLKAVYEDEDYVHLVMELCAGGELF-HRLEKFGRFSEAEARVLFMQLMQVVLY 157
             HP++V L  V  + + V ++MELC  GEL      +      A   +   QL   + Y
Sbjct: 66  D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT--VGSPFYIAPEV 215
                 VHRD+   N+L+   +S+  +KL DFGL+ Y+E       +       ++APE 
Sbjct: 124 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 216 LAGG-YNQAADVWSAGVILY-ILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
           +    +  A+DVW  GV ++ IL+ G+ PF G   + +   +   + R P     +   +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLP--MPPNCPPT 237

Query: 274 AKDLVMGMLSTDPSQRLTARQVLDH 298
              L+    + DPS+R    ++   
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 5e-57
 Identities = 71/290 (24%), Positives = 121/290 (41%), Gaps = 34/290 (11%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
           +++   +++G G +G +    ++ T E+ A K +  D         S   EI ++  L  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK- 59

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           H N+V L  V   +  + LV E C      +     G       +    QL++ + +CH 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYI-EPGQSLLGTVGSPFYIAPEVLAGG 219
             V+HRDLKP+N+L+     +  +KLA+FGLA     P +     V + +Y  P+VL G 
Sbjct: 120 RNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 220 --YNQAADVWSAGVILYILLSG-MPPFWGNTKSRIFDAVRTADLRFPSNPWD-------- 268
             Y+ + D+WSAG I   L +   P F GN        +           W         
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 269 -----------------HISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                             ++ + +DL+  +L  +P QR++A + L H + 
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 9e-57
 Identities = 65/269 (24%), Positives = 103/269 (38%), Gaps = 17/269 (6%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFT---GEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
            +   L ++LG G FGV+R              A K +  D L   +       E+  M 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVV 155
            L  H N++ L  V        +V EL   G L  RL +  G F         +Q+ + +
Sbjct: 67  SLD-HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT----VGSPFYI 211
            Y      +HRDL   N+LLAT+     +K+ DFGL   +                  + 
Sbjct: 125 GYLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 212 APEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH 269
           APE L    ++ A+D W  GV L+ + + G  P+ G   S+I   +     R P    + 
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 239

Query: 270 ISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
                 ++++   +  P  R T   + D 
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 1e-56
 Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 21/270 (7%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS 99
           RE   L  +LG G FG + + +   T  V A K++    +       +   E ++M +L 
Sbjct: 16  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLR 70

Query: 100 GHPNVVDLKAVYEDEDYVHLVMELCAGGEL--FHRLEKFGRFSEAEARVLFMQLMQVVLY 157
            H  +V L AV  +E   ++V E  + G L  F + E        +   +  Q+   + Y
Sbjct: 71  -HEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 158 CHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL--GTVGSPFYIAPEV 215
              +  VHRDL+  NIL+         K+ADFGLA  IE  +     G      + APE 
Sbjct: 129 VERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 216 LAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS 273
              G +   +DVWS G++L  L + G  P+ G     + D V     R P  P     +S
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPP--ECPES 242

Query: 274 AKDLVMGMLSTDPSQRLTARQVLD--HSWM 301
             DL+      +P +R T   +      + 
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 3e-56
 Identities = 62/277 (22%), Positives = 110/277 (39%), Gaps = 20/277 (7%)

Query: 40  RERFVLGQ-QLGWGQFGVIR--VCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           R+   L   +LG G FG ++      K   +  A K + K+       +  +  E  +M 
Sbjct: 5   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQ 63

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVL 156
           +L  +P +V +  + E E ++ LVME+   G L   L++     +     L  Q+   + 
Sbjct: 64  QLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121

Query: 157 YCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT----VGSPFYIA 212
           Y  E   VHRDL   N+LL    +    K++DFGL+  +   ++             + A
Sbjct: 122 YLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 213 PEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI 270
           PE +    ++  +DVWS GV+++   S G  P+ G   S +   +   +           
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGC 235

Query: 271 SDSAKDLVMGMLSTDPSQRLTARQVLD--HSWMGDGI 305
                DL+    + D   R     V     ++  D +
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 2e-55
 Identities = 61/285 (21%), Positives = 105/285 (36%), Gaps = 35/285 (12%)

Query: 40  RERFVLGQQLGWGQFGVI-----RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           R R   G+ LG G FG +                 A K +       + +  ++  E+++
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKV 79

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFG----------------- 137
           ++ L  H N+V+L           ++ E C  G+L + L +                   
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 138 -RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
                 +      Q+ + + +      +HRDL   NILL         K+ DFGLA  I+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIK 196

Query: 197 PGQSLLGT---VGSPFYIAPEVLAGGY-NQAADVWSAGVILYILLS-GMPPFWGNTKSRI 251
              + +          ++APE +        +DVWS G+ L+ L S G  P+ G      
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
           F  +     R  S   +H      D++      DP +R T +Q++
Sbjct: 257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  183 bits (465), Expect = 5e-55
 Identities = 46/299 (15%), Positives = 102/299 (34%), Gaps = 26/299 (8%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
             + +G+++G G FGVI   ++    +  A K   +       D   ++ E      L+G
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 59

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
              + ++    ++  +  LV++L              +FS     +   Q++  V   HE
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 161 IGVVHRDLKPENILLA--TKASSSPIKLADFGLATYIEPGQS--------LLGTVGSPFY 210
             +V+RD+KP+N L+      +++ I + DFG+  +     +             G+  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 211 IAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP--- 266
           ++     G   ++  D+ + G +    L G  P+ G   +           +  S P   
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 267 -WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLSGNKIEDCKEWDL 324
                 +     +    +           +              +      ++  +W+L
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL------FSKVLERLNTTEDENFDWNL 292

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-54
 Identities = 63/276 (22%), Positives = 102/276 (36%), Gaps = 25/276 (9%)

Query: 40  RERFVLGQ-QLGWGQFGVIRVCSDKFTGE--VFACKSIAKDRLVTIDDERSVKLEIEIMT 96
           R+  ++   +LG G FG +R    +   +    A K + +       D   +  E +IM 
Sbjct: 7   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMH 64

Query: 97  RLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRL-EKFGRFSEAEARVLFMQLMQVV 155
           +L  +P +V L  V + E    LVME+  GG L   L  K      +    L  Q+   +
Sbjct: 65  QLD-NPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 156 LYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL----GTVGSPFYI 211
            Y  E   VHRDL   N+LL    +    K++DFGL+  +    S             + 
Sbjct: 123 KYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 212 APEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTAD-LRFPSNPWD 268
           APE +    ++  +DVWS GV ++  LS G  P+       +   +     +  P     
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP----P 235

Query: 269 HISDSAKDLVMGMLSTDPSQRLTARQV---LDHSWM 301
                   L+          R     V   +   + 
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (458), Expect = 6e-54
 Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 43/291 (14%)

Query: 40  RERFVLGQQLGWGQFGVI-----RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           R      + +G G FG +               + A K + ++   + D +   + E  +
Sbjct: 12  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAAL 69

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGR---------------- 138
           M     +PN+V L  V      + L+ E  A G+L   L                     
Sbjct: 70  MAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 139 --------FSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFG 190
                    S AE   +  Q+   + Y  E   VHRDL   N L+     +  +K+ADFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFG 185

Query: 191 LATYIEPGQSLLGT---VGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWG 245
           L+  I                 ++ PE +    Y   +DVW+ GV+L+ + S G+ P++G
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245

Query: 246 NTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVL 296
                +   VR  ++       ++      +L+    S  P+ R +   + 
Sbjct: 246 MAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-53
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 40/297 (13%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
            + ER+     +G G +G +    D  TG   A K +++     I  +R+ + E+ ++  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 73

Query: 98  LSGHPNVVDLKAVYEDE----DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQ 153
           +  H NV+ L  V+       ++  + +     G   + + K  + ++   + L  Q+++
Sbjct: 74  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 154 VVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYIAP 213
            + Y H   ++HRDLKP N+          +K+ DFGLA + +   +  G V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARHTDDEMT--GYVATRWYRAP 187

Query: 214 EVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP-------- 263
           E++     YNQ  D+WS G I+  LL+G   F G         +                
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 264 -------------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM 301
                              +N +   +  A DL+  ML  D  +R+TA Q L H++ 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 58/284 (20%), Positives = 110/284 (38%), Gaps = 30/284 (10%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGE-------VFACKSIAKDRLVTIDDERSVKLEI 92
           R+R VLG+ LG G FG + +       +         A K +  D   T  D   +  E+
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEM 69

Query: 93  EIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLE----------------KF 136
           E+M  +  H N+++L      +  +++++E  + G L   L+                  
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 137 GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE 196
            + S  +      Q+ + + Y      +HRDL   N+L+                  +I+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDA 254
             +          ++APE L    Y   +DVWS GV+L+ + + G  P+ G     +F  
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
           ++    R       + ++    ++       PSQR T +Q+++ 
Sbjct: 250 LK-EGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-52
 Identities = 57/277 (20%), Positives = 103/277 (37%), Gaps = 18/277 (6%)

Query: 43  FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAK--DRLVTIDDERSVKLEIEIMTRLSG 100
           F   + LG G FG +        GE        K      +    + +  E  +M  +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69

Query: 101 HPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE 160
           +P+V  L  +        +   +  G  L +  E              +Q+ + + Y  +
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 161 IGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLL---GTVGSPFYIAPEVLA 217
             +VHRDL   N+L+    +   +K+ DFGLA  +   +      G      ++A E + 
Sbjct: 130 RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 218 GG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK 275
              Y   +DVWS GV ++ L++ G  P+ G   S I   +     R P       +    
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLP--QPPICTIDVY 243

Query: 276 DLVMGMLSTDPSQRLTARQVLDH-SWMGDGIQDPEKL 311
            +++     D   R   R+++   S M    +DP++ 
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKM---ARDPQRY 277

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-50
 Identities = 63/291 (21%), Positives = 117/291 (40%), Gaps = 24/291 (8%)

Query: 33  TNQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGE----VFACKSIAKDRLVTIDDERSV 88
           T +I          + +G G+FG +     K +        A K++      T       
Sbjct: 1   TTEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDF 56

Query: 89  KLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGG-ELFHRLEKFGRFSEAEARVL 147
             E  IM + S H N++ L+ V      + ++ E    G       EK G FS  +   +
Sbjct: 57  LGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 115

Query: 148 FMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ----SLLG 203
              +   + Y   +  VHRDL   NIL+ +       K++DFGL+  +E       +  G
Sbjct: 116 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSG 172

Query: 204 TVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLR 261
                 + APE ++   +  A+DVWS G++++ +++ G  P+W  +   +  A+     R
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFR 231

Query: 262 FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQDPEKLS 312
            P+        +   L+M     + ++R     ++  S +   I+ P+ L 
Sbjct: 232 LPT--PMDCPSAIYQLMMQCWQQERARRPKFADIV--SILDKLIRAPDSLK 278

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-49
 Identities = 61/298 (20%), Positives = 108/298 (36%), Gaps = 51/298 (17%)

Query: 41  ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSG 100
              VL + +G G+FG   V   K+ GE  A K  +     +   E     EI     L  
Sbjct: 3   RTIVLQESIGKGRFGE--VWRGKWRGEEVAVKIFSSREERSWFREA----EIYQTVMLR- 55

Query: 101 HPNVVDLKAVYEDED----YVHLVMELCAGGELFHRLEKFG-------RFSEAEARVLFM 149
           H N++   A    ++     + LV +    G LF  L ++        + + + A  L  
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAH 115

Query: 150 QLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT----- 204
             M++V    +  + HRDLK +NIL+    +     +AD GLA   +     +       
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPNHR 172

Query: 205 VGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSGMPPFWGN----------- 246
           VG+  Y+APEVL            + AD+++ G++ + +         +           
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232

Query: 247 ----TKSRIFDAVRTADLR--FPSNPWDH-ISDSAKDLVMGMLSTDPSQRLTARQVLD 297
               +   +   V    LR   P+             ++      + + RLTA ++  
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-49
 Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 30/284 (10%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRL---VTIDDERSVKLEIEIMT 96
           R+R  LG+ LG G FG +         +   C+++A   L    T  + R++  E++I+ 
Sbjct: 12  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 71

Query: 97  RLSGHPNVVDLK-AVYEDEDYVHLVMELCAGGELFHRLEKFGR----------------F 139
            +  H NVV+L  A  +    + +++E C  G L   L                      
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 140 SEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ 199
           +         Q+ + + +      +HRDL   NILL   +  + +K+ DFGLA  I    
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDP 188

Query: 200 SLLGT---VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGM-PPFWGNTKSRIFDA 254
             +          ++APE +    Y   +DVWS GV+L+ + S    P+ G      F  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 255 VRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
                 R      D+ +      ++     +PSQR T  ++++H
Sbjct: 249 RLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-49
 Identities = 73/320 (22%), Positives = 127/320 (39%), Gaps = 54/320 (16%)

Query: 38  NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTR 97
            + +R+   + +G G  G++    D       A K +++         +    E+ +M  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 72

Query: 98  LSGHPNVVDLKAVY------EDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQL 151
           ++ H N++ L  V+      E+   V+LVMEL                       L  Q+
Sbjct: 73  VN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 128

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSPFYI 211
           +  + + H  G++HRDLKP NI++    S   +K+ DFGLA        +   V + +Y 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185

Query: 212 APEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--------------- 255
           APEV+ G GY +  D+WS G I+  ++     F G      ++ V               
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 256 ------------RTADLRFP-----------SNPWDHISDSAKDLVMGMLSTDPSQRLTA 292
                       + A L FP           S      +  A+DL+  ML  DP++R++ 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 293 RQVLDHSWMGDGIQDPEKLS 312
              L H ++ +   DP ++ 
Sbjct: 306 DDALQHPYI-NVWYDPAEVE 324

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-47
 Identities = 56/279 (20%), Positives = 110/279 (39%), Gaps = 29/279 (10%)

Query: 40  RERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEI 94
           RE+  + ++LG G FG++     K           A K++ +    ++ +      E  +
Sbjct: 19  REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASV 76

Query: 95  MTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRF----------SEAEA 144
           M   +   +VV L  V        ++MEL   G+L   L                S ++ 
Sbjct: 77  MKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 145 RVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGT 204
             +  ++   + Y +    VHRDL   N ++A   +   +K+ DFG+   I         
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYRKG 192

Query: 205 ---VGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGM-PPFWGNTKSRIFDAVRTAD 259
              +    +++PE L  G +   +DVWS GV+L+ + +    P+ G +  ++   V    
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252

Query: 260 LRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
           L    +  D+  D   +L+      +P  R +  +++  
Sbjct: 253 LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-47
 Identities = 60/274 (21%), Positives = 109/274 (39%), Gaps = 23/274 (8%)

Query: 37  SNLRERFVLGQQLGWGQFGVI---RVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIE 93
           S+L   F   + +G G FG +    +  +       A KS+  +R+  I +      E  
Sbjct: 25  SSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGI 80

Query: 94  IMTRLSGHPNVVDLKAV-YEDEDYVHLVMELCAGGELF-HRLEKFGRFSEAEARVLFMQL 151
           IM   S HPNV+ L  +    E    +V+     G+L      +    +  +     +Q+
Sbjct: 81  IMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139

Query: 152 MQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-----SLLGTVG 206
            + + +      VHRDL   N +L        +K+ADFGLA  +   +     +  G   
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 207 SPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPS 264
              ++A E L    +   +DVWS GV+L+ L++ G PP+       I   +     R   
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RRLL 254

Query: 265 NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH 298
            P ++  D   ++++         R +  +++  
Sbjct: 255 QP-EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (389), Expect = 2e-43
 Identities = 67/332 (20%), Positives = 125/332 (37%), Gaps = 70/332 (21%)

Query: 42  RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS-- 99
           R++L ++LGWG F  + +  D       A K +  D++ T   E     EI+++ R++  
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDA 69

Query: 100 --------GHPNVVDLKAVYED--EDYVHLVMELCAGG---ELFHRLEKFGRFSEAEARV 146
                   G  +++ L   +     + VH+VM     G       +  +         + 
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 147 LFMQLMQVVLYC-HEIGVVHRDLKPENILLATK---ASSSPIKLADFGLATYIEPGQSLL 202
           +  QL+  + Y     G++H D+KPEN+L+       +   IK+AD G A + +   +  
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-- 187

Query: 203 GTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK------------- 248
            ++ +  Y +PEVL G  +   AD+WS   +++ L++G   F  +               
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 249 --------SRIFDAVRTADLRFPSNP-----------------------WDHISDSAKDL 277
                   S +    +     F S                             +    D 
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 278 VMGMLSTDPSQRLTARQVLDHSWMGDGIQDPE 309
           +  ML  DP +R  A  +++H W+ D +   E
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE 339

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.6 bits (211), Expect = 4e-20
 Identities = 36/214 (16%), Positives = 66/214 (30%), Gaps = 47/214 (21%)

Query: 44  VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD---------------ERSV 88
            +G+ +G G+   +  C  +        K                            RS 
Sbjct: 3   AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 89  KLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLF 148
           + E   + +L     V  + A   +     ++MEL    EL+    +           + 
Sbjct: 62  RNEFRALQKLQ-GLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDE-------VL 109

Query: 149 MQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSLLGTVGSP 208
             +++ V   +  G+VH DL   N+L+    S   I + DF  +  +          G  
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGE-------EGWR 158

Query: 209 FYIAPEV------LAGGYNQAADVWSAGVILYIL 236
             +  +V       +  Y    D+ S   I  IL
Sbjct: 159 EILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	468
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.6
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.2
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.39
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.07
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.91

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-62  Score=483.10  Aligned_cols=269  Identities=41%  Similarity=0.748  Sum_probs=227.2

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      .+.+.++++|++++.||+|+||+||+|+++.+|+.||||++.+....  .....+.+|+++|+++. |||||++++++++
T Consensus         2 ~~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~   78 (307)
T d1a06a_           2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYES   78 (307)
T ss_dssp             EECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred             CCCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence            34567889999999999999999999999999999999999876542  23456788999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      ++.+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+.....++.+||+|||+++
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            99999999999999999999998899999999999999999999999999999999999999865556779999999999


Q ss_pred             eecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .........+.+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+....++...+......++...+..+++
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  238 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD  238 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence            87766666778999999999999875 99999999999999999999999999999999999999888888777789999


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++++||.+||++||++|||++|+++||||++..
T Consensus       239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999999999997643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-61  Score=469.86  Aligned_cols=254  Identities=33%  Similarity=0.648  Sum_probs=232.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++|+++. |||||++++++.+++.+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999998765434445677899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|+..... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCSCSCCCCC-C
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC---EeecccceeeecCCC-c
Confidence            999999999999999899999999999999999999999999999999999999987655   999999999876543 3


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ....+||+.|+|||++.+. |+.++|||||||++|||++|+.||.+.+..+++..+......+|    ..+++++++||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence            4467899999999999986 89999999999999999999999999999999999988877666    468999999999


Q ss_pred             HccccCCCCCCCHHHHHhCcCCCC
Q 012203          280 GMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       280 ~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      +||++||++|||++|+|+||||+.
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=469.55  Aligned_cols=267  Identities=37%  Similarity=0.658  Sum_probs=243.4

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCCh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTI---DDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~---~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      .++.++|++++.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+++|++|. |||||+++++|++
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~   84 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   84 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence            3477899999999999999999999999999999999987654322   23578899999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCC-CCCEEEeecCce
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKAS-SSPIKLADFGLA  192 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~-~~~ikL~DFGla  192 (468)
                      ++.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ...+||+|||++
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            9999999999999999999998889999999999999999999999999999999999999987653 335999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      .....+....+..||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.+..+.+..+......++...+..++
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            998777777788999999999999875 8999999999999999999999999999999999999888877766667899


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +++++||++||++||++|||++|+|+||||+..
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-60  Score=477.95  Aligned_cols=256  Identities=34%  Similarity=0.603  Sum_probs=235.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+++. ||||++++++|++++.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence            46999999999999999999999999999999998765444455678899999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC-CC
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP-GQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~  199 (468)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+|+.... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~---vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC---EEEeecccccccccCCc
Confidence            999999999999999999999999999999999999999999999999999999987655   99999999987643 34


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      .....+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.+..++++.+......+|    ..+++++++||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence            45678999999999999875 99999999999999999999999999999999999999887776    46899999999


Q ss_pred             HHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      ++||++||.+|++     ++|+++||||++.
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccC
Confidence            9999999999994     9999999999764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=466.56  Aligned_cols=259  Identities=34%  Similarity=0.579  Sum_probs=220.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +-++|++++.||+|+||+||+|+++.+|+.||||++.+...  .+..+.+.+|+++|++++ |||||++++++.+++.+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeE
Confidence            45679999999999999999999999999999999987643  223456889999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|+.....
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~---~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC---EEEccchhheeeccC
Confidence            99999999999999988888999999999999999999999999999999999999987655   999999999876533


Q ss_pred             C---ccccCCCCCCCcChhhhcCC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccCCCCCCCCCCCCH
Q 012203          199 Q---SLLGTVGSPFYIAPEVLAGG-Y-NQAADVWSAGVILYILLSGMPPFWGNTKS-RIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       199 ~---~~~~~~GT~~Y~APE~l~~~-~-~~~sDiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      .   .....+||+.|||||++.+. + +.++|||||||++|||++|++||...... ..+..+.....  ...++..+++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~  234 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS  234 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCH
Confidence            2   23467899999999999875 4 67899999999999999999999765543 33333333222  2234578999


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ++++||.+||++||++|||++|+|+||||++..
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         235 APLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            999999999999999999999999999997643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-60  Score=467.60  Aligned_cols=256  Identities=30%  Similarity=0.576  Sum_probs=229.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+++. ||||++++++|++++.+|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999998765444455678999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      ||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||+|+.+.... 
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~---vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce---EEecccccceecccCCc
Confidence            999999999999999999999999999999999999999999999999999999987655   9999999998875332 


Q ss_pred             --ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          200 --SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       200 --~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                        ...+.+||+.|+|||++.+. |+.++|||||||++|||++|+.||.+.+..++++.+......+|    ..+++++++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  239 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD  239 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence              23456899999999999875 89999999999999999999999999999999999988877766    468999999


Q ss_pred             HHHHccccCCCCCCCHHH------HHhCcCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQ------VLDHSWMGDG  304 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~e------iL~h~~~~~~  304 (468)
                      ||++||++||++|||++|      +++||||++.
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999999987      5889999664

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-59  Score=474.75  Aligned_cols=262  Identities=36%  Similarity=0.645  Sum_probs=240.2

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +-++|++++.||+|+||+||+|+++.+|+.||||++.+.   .....+.+.+|+++|++|+ |||||+++++|++++.+|
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            456899999999999999999999999999999999765   3445678899999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||||||+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+|||+++.+..
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~-~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-SCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC-CCeEEEeecchheeccc
Confidence            9999999999999995 446799999999999999999999999999999999999997543 35699999999999887


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      .....+.+||+.|||||++.+. |+.++|||||||++|+|++|+.||.+.+..+++..+......++...+..+++++++
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            7777778999999999999885 899999999999999999999999999999999999998888887777789999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ||.+||++||++|||++|+|+||||++..
T Consensus       259 li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999998654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=462.71  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=226.1

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++.+...   ...+.+.+|+++|+++. |||||+++++|.+++.+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence            35689999999999999999999999999999999986543   23567899999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          119 LVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.+...
T Consensus        94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCST
T ss_pred             EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc---Eeeccchhheeeccc
Confidence            99999999999998876 57999999999999999999999999999999999999986654   999999999987544


Q ss_pred             C-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          199 Q-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       199 ~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      . .....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..+....+...... ....+..+++++++
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  248 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD  248 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence            3 44567899999999999875 899999999999999999999999988877766665544322 12233678999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      ||.+||++||++|||++|+|+||||+.
T Consensus       249 li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         249 FLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999999964

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6e-59  Score=455.87  Aligned_cols=262  Identities=37%  Similarity=0.688  Sum_probs=239.7

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh------hHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID------DERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~------~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++.+.......      ..+.+.+|+.+|++|..||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            468999999999999999999999999999999999876543321      23457889999999977999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +++.+|||||||+||+|.++++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~---~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC---eEEccchhe
Confidence            99999999999999999999999899999999999999999999999999999999999999986555   999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcC-------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAG-------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSN  265 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  265 (468)
                      +.+.........+||+.|+|||++.+       .++.++||||+||++|+|++|+.||.+.+.....+.+......++..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            98877666677899999999999863       26889999999999999999999999999999999999888888877


Q ss_pred             CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          266 PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       266 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                      .+..+|+++++||++||++||++|||++|+|+||||++
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            77899999999999999999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.8e-59  Score=472.25  Aligned_cols=262  Identities=35%  Similarity=0.610  Sum_probs=240.2

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++.+..   ..+...+.+|+++|++|. |||||+++++|++++.+|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            5578999999999999999999999999999999997653   345567889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||||||+||+|.+++... .++++.+++.++.||+.||.|||++||+||||||+||||+.+. .+.+||+|||+|..+..
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~-~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccC-CCeEEEeecccceecCC
Confidence            999999999999887654 4699999999999999999999999999999999999997432 34699999999999887


Q ss_pred             CCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      .......+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+..+.+..+......++...+..+++++++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            7777778999999999999875 899999999999999999999999999999999999999888888888899999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ||.+||++||++|||++|+|+||||+...
T Consensus       262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            99999999999999999999999998643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=468.27  Aligned_cols=257  Identities=32%  Similarity=0.564  Sum_probs=230.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.++..........+..|+.++.+..+|||||++++++++++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999999999999999998764433445566777888776533599999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-C
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-Q  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~  199 (468)
                      ||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++..... .
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~---~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc---eeccccchhhhcccccc
Confidence            999999999999999999999999999999999999999999999999999999987655   999999999876543 3


Q ss_pred             ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          200 SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                      .....+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++...+....+.+|    ..+++++++||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  234 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLL  234 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHH
Confidence            34457899999999999885 99999999999999999999999999999999999988877665    46899999999


Q ss_pred             HHccccCCCCCCCHH-HHHhCcCCCCC
Q 012203          279 MGMLSTDPSQRLTAR-QVLDHSWMGDG  304 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~-eiL~h~~~~~~  304 (468)
                      ++||++||++|||+. |+++||||++.
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHhcccCCCCCcCHHHHHHhCchhccC
Confidence            999999999999995 89999999763

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-59  Score=457.64  Aligned_cols=256  Identities=28%  Similarity=0.439  Sum_probs=225.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      +.|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+++|++|. |||||++++++.+++.+|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEEE
Confidence            56999999999999999999999999999999997653   344567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-
Q 012203          121 MELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-  198 (468)
                      ||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|+..... 
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~---~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTI  164 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECHHHH
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC---EEEEechhhhccCCCc
Confidence            999999999999765 456999999999999999999999999999999999999987665   999999999875432 


Q ss_pred             CccccCCCCCCCcChhhhcC------CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCH
Q 012203          199 QSLLGTVGSPFYIAPEVLAG------GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISD  272 (468)
Q Consensus       199 ~~~~~~~GT~~Y~APE~l~~------~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  272 (468)
                      ....+.+||+.|+|||++.+      .|+.++|||||||++|||++|++||.+.+..+.+..+........ ..+..+++
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~  243 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSS  243 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSCH
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCCH
Confidence            23346789999999999842      378999999999999999999999999888888888777654322 22357899


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          273 SAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       273 ~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ++++||.+||++||++|||++|+|+||||+..
T Consensus       244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-59  Score=466.37  Aligned_cols=261  Identities=30%  Similarity=0.573  Sum_probs=240.0

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      .|.++|++++.||+|+||+||+|.++.+|+.||+|++.+..    .+...+.+|+++|++++ |||||+++++|++++.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            57899999999999999999999999999999999997653    33456889999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |||||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-ceEEEEcccchhhccc
Confidence            99999999999999998765 799999999999999999999999999999999999997643 3469999999999887


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      ........+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+..+++..+......++...+..++++++
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            76666778899999999999876 89999999999999999999999999999999999999988888777778999999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      +||.+||.+||++|||++|+++||||++.
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-58  Score=449.09  Aligned_cols=256  Identities=24%  Similarity=0.422  Sum_probs=220.5

Q ss_pred             cCCe-EEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----C
Q 012203           40 RERF-VLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED----E  114 (468)
Q Consensus        40 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~----~  114 (468)
                      ..+| ++.++||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+++|++++ |||||+++++|++    +
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSC
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccC
Confidence            3455 788899999999999999999999999999987654 3445678899999999996 9999999999975    4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          115 DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIG--VVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~g--IiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      +.+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+  .+.+||+|||++
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~--~~~~Kl~DFGla  162 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--TSCEEECCTTGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC--CCCEEEeecCcc
Confidence            578999999999999999999899999999999999999999999998  9999999999999642  234999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccCCCCCCCCCCCC
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGGYNQAADVWSAGVILYILLSGMPPFWGNT-KSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~sDiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      +.... ....+.+||+.|+|||++.++|+.++|||||||++|||++|+.||.+.. ...+.+.+.....  +.......+
T Consensus       163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~  239 (270)
T d1t4ha_         163 TLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI  239 (270)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred             eeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCC
Confidence            76443 3345679999999999999999999999999999999999999997654 4555555554322  222335678


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMG  302 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~  302 (468)
                      +++++||.+||++||++|||++|+|+||||+
T Consensus       240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999999999995

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=451.79  Aligned_cols=253  Identities=28%  Similarity=0.504  Sum_probs=213.7

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~~~~~  118 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+... .....+.+.+|+++|+++. |||||++++++.+  ++.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            579999999999999999999999999999999987754 3445677899999999996 9999999999864  56789


Q ss_pred             EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----cEecccCCCcEEEeecCCCCCEEEeec
Q 012203          119 LVMELCAGGELFHRLEK----FGRFSEAEARVLFMQLMQVVLYCHEIG-----VVHRDLKPENILLATKASSSPIKLADF  189 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~g-----IiHrDIKp~NILl~~~~~~~~ikL~DF  189 (468)
                      ||||||+||+|.+++.+    .+.+++..++.++.||+.||.|||++|     |+||||||+||||+.++.   +||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~---vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC---EEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc---EEEeec
Confidence            99999999999999864    357999999999999999999999976     999999999999987655   999999


Q ss_pred             CceeeecCCC-ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          190 GLATYIEPGQ-SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       190 Gla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      |+++.+.... ...+.+||+.|+|||++.+. |+.++|||||||++|||++|+.||.+.+..++...+........   +
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            9998765433 34567899999999999875 99999999999999999999999999999998888887765422   2


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWM  301 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~  301 (468)
                      ..+++++.+||.+||+.||++|||++|+++|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            5789999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-58  Score=459.92  Aligned_cols=254  Identities=31%  Similarity=0.630  Sum_probs=232.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ |||||++++++.+++.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence            45999999999999999999999999999999998764434445678899999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      ||||.||+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+|+....  .
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~---vkL~DFG~a~~~~~--~  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPD--V  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC---EEECCCSSCEECSS--C
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC---EEEecCccceEecc--c
Confidence            999999999999999999999999999999999999999999999999999999987655   99999999988654  3


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ..+.+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+.+..++...+......+|    ..++++++++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            4467999999999999875 89999999999999999999999999999999999988877665    468999999999


Q ss_pred             HccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          280 GMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       280 ~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      +||.+||.+|+     |++|+++||||++.
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999996     89999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-58  Score=459.98  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=228.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++|+ |||||++++++.+++.+|||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999998876555556678999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      ||||.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+|.....   
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAP---  167 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE---EEECCCTTCBSSSS---
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC---EEEeecccccccCC---
Confidence            999999999888888889999999999999999999999999999999999999987655   99999999986543   


Q ss_pred             cccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKD  276 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~  276 (468)
                      ....+||+.|+|||++.+    .|+.++|||||||++|||++|+.||.+.+..+....+........  ....+++++++
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~  245 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRN  245 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSCHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCCHHHHH
Confidence            345789999999999864    389999999999999999999999998888777777666544322  23578999999


Q ss_pred             HHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          277 LVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       277 li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      ||.+||++||++|||++|+|+||||....
T Consensus       246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999999999997643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=462.81  Aligned_cols=259  Identities=26%  Similarity=0.374  Sum_probs=218.3

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      -..++|++++.||+|+||+||+|+++.+|+.||+|++.++.  .......+.+|+.+|++++ |||||+++++|.+++.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            34678999999999999999999999999999999997653  2344567899999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.++.   +||+|||+|+...
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~---vkl~DFGla~~~~  156 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI  156 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC---EEECCCCCCHHHH
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC---EEEeeCCCccccC
Confidence            9999999999999999998999999999999999999999997 59999999999999987655   9999999998764


Q ss_pred             CCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------------------
Q 012203          197 PGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV--------------------  255 (468)
Q Consensus       197 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i--------------------  255 (468)
                      .. ...+.+||+.|+|||++.+. |+.++|||||||++|||++|+.||.+.+........                    
T Consensus       157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence            32 23467999999999999985 999999999999999999999999775543221100                    


Q ss_pred             -------------------Hh-ccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          256 -------------------RT-ADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       256 -------------------~~-~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                                         .. .....+..+...++.++++||.+||++||++|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                               00 0001111122357899999999999999999999999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-57  Score=461.45  Aligned_cols=254  Identities=32%  Similarity=0.631  Sum_probs=232.9

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+++. |||||+++++|.+.+.+++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence            68999999999999999999999999999999998765444445677899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCc
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQS  200 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~  200 (468)
                      |||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+|+.+...  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~---ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC---EEeeeceeeeecccc--
Confidence            999999999999999899999999999999999999999999999999999999987654   999999999987643  


Q ss_pred             cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHH
Q 012203          201 LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVM  279 (468)
Q Consensus       201 ~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~  279 (468)
                      ..+.+||+.|||||++.+. |+.++|||||||++|||++|++||.+.+...++..+......++    ..+++++.+||+
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHH
Confidence            3467899999999999885 89999999999999999999999999999999999988877665    478999999999


Q ss_pred             HccccCCCCCC-----CHHHHHhCcCCCCC
Q 012203          280 GMLSTDPSQRL-----TARQVLDHSWMGDG  304 (468)
Q Consensus       280 ~~L~~dP~~Rp-----t~~eiL~h~~~~~~  304 (468)
                      +||++||.+|+     |++|+++||||++.
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCC
Confidence            99999999995     99999999999764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-58  Score=463.29  Aligned_cols=260  Identities=35%  Similarity=0.642  Sum_probs=226.1

Q ss_pred             ccCCeEEEe-EEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe----
Q 012203           39 LRERFVLGQ-QLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED----  113 (468)
Q Consensus        39 l~~~y~i~~-~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~----  113 (468)
                      +-++|++.. .||+|+||+||+|+++.+|+.||||++.+.        ..+.+|++++.++.+|||||+++++|++    
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            556899875 599999999999999999999999998643        4567899998877679999999999976    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                      ++.+|||||||+||+|.++|.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++..+.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            46799999999999999999875  3699999999999999999999999999999999999999877677899999999


Q ss_pred             eeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhccCCCCCCC
Q 012203          192 ATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFD----AVRTADLRFPSNP  266 (468)
Q Consensus       192 a~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~~~~~  266 (468)
                      |+...........+||+.|+|||++.+. |+.++|||||||++|+|++|++||.+.+......    .+......+|...
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  240 (335)
T d2ozaa1         161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  240 (335)
T ss_dssp             CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred             eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence            9988777777788999999999999875 9999999999999999999999998766544433    3344455566655


Q ss_pred             CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          267 WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       267 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                      +..+++++++||++||++||++|||+.|+++||||.+...
T Consensus       241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence            6679999999999999999999999999999999976543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-56  Score=455.71  Aligned_cols=258  Identities=29%  Similarity=0.471  Sum_probs=219.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHH---HHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLE---IEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~E---i~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|   +++++.+ +|||||+++++|++++.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence            469999999999999999999999999999999976544333333444555   4455555 499999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|+.+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~---iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC---EEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc---EEEeeeceeeecCC
Confidence            999999999999999999899999999999999999999999999999999999999987655   99999999997764


Q ss_pred             CCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      . .....+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+............ ....+...+..++++++
T Consensus       160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPELR  237 (364)
T ss_dssp             S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCCCCCCSSSCHHHH
T ss_pred             C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cccCCCCCCCCCCHHHH
Confidence            3 3456789999999999964  389999999999999999999999987655443333322 22333334468999999


Q ss_pred             HHHHHccccCCCCCCC-----HHHHHhCcCCCCC
Q 012203          276 DLVMGMLSTDPSQRLT-----ARQVLDHSWMGDG  304 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt-----~~eiL~h~~~~~~  304 (468)
                      +||.+||++||++|||     ++|+++||||++.
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999999     7999999999764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=440.90  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=215.0

Q ss_pred             EEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChh--hHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEe
Q 012203           45 LGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTID--DERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVME  122 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~--~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E  122 (468)
                      .++.||+|+||+||+|+++.+|+.||||++.+.......  ..+.+.+|+++|+++. |||||++++++.+++.+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            467899999999999999999999999999766432221  1346889999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC-Ccc
Q 012203          123 LCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG-QSL  201 (468)
Q Consensus       123 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~  201 (468)
                      ||.|+.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++..... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~---~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc---cccccCccccccCCCcccc
Confidence            9999888877777778999999999999999999999999999999999999986655   999999999876543 334


Q ss_pred             ccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC-------------
Q 012203          202 LGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP-------------  266 (468)
Q Consensus       202 ~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------  266 (468)
                      ...+||+.|+|||++.+.  |+.++|||||||++|||++|++||.+.+..+.+..+...........             
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            567899999999998753  79999999999999999999999999888887777654321111100             


Q ss_pred             -----------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          267 -----------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       267 -----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                 +..+++++++||.+||++||++|||++|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                       135688999999999999999999999999999998643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-56  Score=433.08  Aligned_cols=254  Identities=29%  Similarity=0.500  Sum_probs=219.2

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhh---HHHHHHHHHHHHHhc-CCCCceeeeEEEEeC
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDD---ERSVKLEIEIMTRLS-GHPNVVDLKAVYEDE  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~---~~~~~~Ei~iL~~L~-~HpnIv~l~~~~~~~  114 (468)
                      |.++|++++.||+|+||+||+|+++.+|+.||||++.+........   ...+.+|+.+|+++. +|||||+++++|+++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            6789999999999999999999999999999999998765433221   234668999999996 489999999999999


Q ss_pred             CEEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 DYVHLVMELCAG-GELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 ~~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                      +.+|+||||+.+ +++.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+.  +.+||+|||+|+
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~--~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC--CeEEECccccce
Confidence            999999999976 68889998888999999999999999999999999999999999999998542  349999999998


Q ss_pred             eecCCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      .... ....+.+||+.|+|||++.+.  ++.++|||||||++|||++|+.||...      +.+......++    ..+|
T Consensus       160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~~s  228 (273)
T d1xwsa_         160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVS  228 (273)
T ss_dssp             ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SCCC
T ss_pred             eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CCCC
Confidence            7543 344567899999999999764  467899999999999999999999653      23444555444    4789


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                      +++++||++||++||++|||++|+++||||++..
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999999999997643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-55  Score=432.08  Aligned_cols=259  Identities=26%  Similarity=0.422  Sum_probs=222.9

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED--  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~--  115 (468)
                      .|.++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+++. ||||+++++++...+  
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            47889999999999999999999999999999999998876655666678999999999995 999999999997654  


Q ss_pred             --EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          116 --YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       116 --~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                        .+|||||||+|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.   ++|+|||++.
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~---~~l~d~~~~~  159 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIAR  159 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC---EEECCCTTCE
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc---ceeehhhhhh
Confidence              48999999999999999999899999999999999999999999999999999999999987665   9999999987


Q ss_pred             eecCCC----ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCC
Q 012203          194 YIEPGQ----SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWD  268 (468)
Q Consensus       194 ~~~~~~----~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  268 (468)
                      ......    .....+||+.|+|||++.+. ++.++|||||||++|+|++|++||.+.+..+....+.......+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence            654332    33456899999999999875 8999999999999999999999999998888888888777776666678


Q ss_pred             CCCHHHHHHHHHccccCCCCCC-CHHHHHhCcCC
Q 012203          269 HISDSAKDLVMGMLSTDPSQRL-TARQVLDHSWM  301 (468)
Q Consensus       269 ~~s~~l~~li~~~L~~dP~~Rp-t~~eiL~h~~~  301 (468)
                      .+|+++.+||.+||++||++|| |+++++ |+|.
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~  272 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMR-ADLV  272 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence            8999999999999999999999 555554 5553

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=429.05  Aligned_cols=259  Identities=31%  Similarity=0.476  Sum_probs=214.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|+++++||+|+||+||+|+++.+|+.||||++..... .......+.+|+++|+++. |||||+++++|++++.+|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence            579999999999999999999999999999999976532 2233567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          121 MELCAGGELFHRLEK--FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      ||||.+ .+.+.+..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+|+.....
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~---~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSTTHHHHHCCC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc---ceeccCCcceeccCC
Confidence            999965 44444433  356999999999999999999999999999999999999986554   999999999876543


Q ss_pred             -CccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC---------
Q 012203          199 -QSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNP---------  266 (468)
Q Consensus       199 -~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------  266 (468)
                       ......+||+.|+|||++...  ++.++|||||||++|+|++|+.||.+.+..+....+...........         
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             344556899999999998764  68899999999999999999999998887776665543211111110         


Q ss_pred             ----------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          267 ----------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       267 ----------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                      ...+++++++||++||++||++|||++|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence                            125678999999999999999999999999999997654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-55  Score=430.49  Aligned_cols=264  Identities=27%  Similarity=0.362  Sum_probs=218.5

Q ss_pred             ccccCCeEEEeEEeecCCeEEEEEEEcCC-CcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc--CCCCceeeeEEEEe
Q 012203           37 SNLRERFVLGQQLGWGQFGVIRVCSDKFT-GEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS--GHPNVVDLKAVYED  113 (468)
Q Consensus        37 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~--~HpnIv~l~~~~~~  113 (468)
                      ....++|++++.||+|+||+||+|+++.+ ++.||||++.+.... ......+.+|+.+|+.|+  +||||++++++|..
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            34568999999999999999999999765 677999999765332 222334567888887774  59999999999853


Q ss_pred             -----CCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          114 -----EDYVHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       114 -----~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                           ...++++|||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.   +||+
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~---~kl~  158 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLA  158 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEEC
T ss_pred             cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC---eeec
Confidence                 3578999999988777554433 356999999999999999999999999999999999999986555   9999


Q ss_pred             ecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---
Q 012203          188 DFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP---  263 (468)
Q Consensus       188 DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---  263 (468)
                      |||+++...........+||+.|+|||++.+. |+.++|||||||++|||++|++||.+.+..+.+..+........   
T Consensus       159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             chhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            99999877666666788999999999999775 99999999999999999999999999888877777654211100   


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          264 --------------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       264 --------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                          ...+..+++++++||.+||++||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                                01234678999999999999999999999999999999764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.9e-54  Score=423.34  Aligned_cols=257  Identities=30%  Similarity=0.464  Sum_probs=216.8

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|+++++||+|+||+||+|+++ +|+.||||++.+... .......+.+|+.+|++++ ||||++++++|.+++..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence            68999999999999999999996 889999999977643 2333567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      |||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~---~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC---EEecccccceecccCcc
Confidence            999988877777777788999999999999999999999999999999999999987665   9999999998765432 


Q ss_pred             ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--------------
Q 012203          200 SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP--------------  263 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------  263 (468)
                      ......|++.|+|||++.+.  ++.++|||||||++|||++|+.||.+.+..+....+........              
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            23456799999999999763  79999999999999999999999998887777666543211111              


Q ss_pred             -----------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCC
Q 012203          264 -----------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGD  303 (468)
Q Consensus       264 -----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~  303 (468)
                                 ......+++++.+||++||++||++|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                       0112457889999999999999999999999999999964

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=422.11  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=216.8

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe------
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED------  113 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~------  113 (468)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.++.. .......+.+|+++|++++ ||||+++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence            3679999999999999999999999999999999977643 2334567889999999996 9999999999854      


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCc
Q 012203          114 --EDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGL  191 (468)
Q Consensus       114 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGl  191 (468)
                        ++.+|+|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~---~kl~dfg~  163 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGL  163 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTT
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc---EEeeecce
Confidence              4568999999988777766666678999999999999999999999999999999999999987665   99999999


Q ss_pred             eeeecCC-----CccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 012203          192 ATYIEPG-----QSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPS  264 (468)
Q Consensus       192 a~~~~~~-----~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  264 (468)
                      +..+...     ....+.+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+.+.......+......++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876532     22345689999999999876  3899999999999999999999999998888877777665444333


Q ss_pred             CCCCC----------------------------CCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          265 NPWDH----------------------------ISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       265 ~~~~~----------------------------~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                      ..+..                            .++++.+||.+||++||++|||++|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            22211                            26788999999999999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-54  Score=428.33  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=212.6

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCc-----EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGE-----VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED  115 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~  115 (468)
                      ++|++++.||+|+||+||+|+++.+++     .||+|.+....  .......+.+|+.+|.++.+|||||++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            679999999999999999999876554     69999987653  23345678899999999966999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCc
Q 012203          116 YVHLVMELCAGGELFHRLEKFG-----------------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPEN  172 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~N  172 (468)
                      .+|||||||+||+|.++|+...                       .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            9999999999999999997642                       48899999999999999999999999999999999


Q ss_pred             EEEeecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 012203          173 ILLATKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNT  247 (468)
Q Consensus       173 ILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~  247 (468)
                      ||++.++.   +||+|||+|+.......   ..+..||+.|||||++.+ .|+.++|||||||++|||++ |++||.+.+
T Consensus       195 ill~~~~~---~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         195 VLVTHGKV---VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             EEEETTTE---EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cccccCCe---EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99987665   99999999987654332   234578999999999876 49999999999999999997 899998877


Q ss_pred             hHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          248 KSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+.+..+.....+++.  +..+++++++||.+||+.||++|||++||++|
T Consensus       272 ~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66665555555444433  25789999999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=426.35  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=214.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC---
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED---  115 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~---  115 (468)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+++. |||||+++++|...+   
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcccc
Confidence            78999999999999999999999999999999999976533 4455678899999999996 999999999997654   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          116 ---YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       116 ---~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                         .+||||||| |.+|..+++. +++++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~---~kl~Dfg~a  168 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFGLA  168 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTC
T ss_pred             ccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc---cccccccce
Confidence               579999999 6677777654 68999999999999999999999999999999999999987665   999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--------
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRF--------  262 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------  262 (468)
                      +....  .....+||+.|+|||++.+.  ++.++|||||||++|+|++|++||.+.+....+..+.......        
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            87653  34567899999999998763  7899999999999999999999998887766655544322111        


Q ss_pred             ---------------CCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          263 ---------------PSN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       263 ---------------~~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                     ...    ....+++++.+||.+||++||++|||++|+|+||||++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                           111    1245789999999999999999999999999999998754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.9e-53  Score=420.57  Aligned_cols=255  Identities=25%  Similarity=0.487  Sum_probs=215.3

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe--CCEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED--EDYV  117 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~--~~~~  117 (468)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+.      ..+.+.+|+++|+++.+||||++++++|..  .+.+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            46899999999999999999999999999999998654      246788999999999779999999999974  4679


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          118 HLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ++|||||.+++|..+.   +.+++..++.++.||+.||.|||++||+||||||+|||++.++.  .+||+|||+|.....
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~--~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC--eeeecccccceeccC
Confidence            9999999999997764   46999999999999999999999999999999999999986443  489999999998887


Q ss_pred             CCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHh-------------ccCC
Q 012203          198 GQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTK-SRIFDAVRT-------------ADLR  261 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~-------------~~~~  261 (468)
                      .......+||+.|+|||++.+.  ++.++||||+||++|+|++|+.||..... ......+..             ....
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            7777788999999999998763  79999999999999999999999975442 222221111             0000


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 --------------------FPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 --------------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                          .....+..+++++.+||++||++||++|||++|+|+||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                11122345789999999999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-53  Score=418.91  Aligned_cols=250  Identities=27%  Similarity=0.456  Sum_probs=205.2

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCc---EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGE---VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      .++|++.+.||+|+||+||+|+++.+|+   .||||.+....  .....+.+.+|+++|++|+ |||||++++++.+++.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence            4679999999999999999999987765   58888876542  3455678999999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      +|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++.+
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~---~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc---EEECCcccceEc
Confidence            99999999999999988774 56999999999999999999999999999999999999987655   999999999876


Q ss_pred             cCCCcc------ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 012203          196 EPGQSL------LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPW  267 (468)
Q Consensus       196 ~~~~~~------~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  267 (468)
                      ......      ....||+.|+|||++.++ ++.++|||||||++|||++ |++||.+.+..++...+.... +.+  ..
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~--~~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY-RLP--PP  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCC--CC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CC
Confidence            543222      234689999999999875 8999999999999999998 899999999888888876653 222  22


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          268 DHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       268 ~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+++++.+|+.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5789999999999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-53  Score=424.54  Aligned_cols=253  Identities=29%  Similarity=0.472  Sum_probs=212.9

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe------CC
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED------ED  115 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~------~~  115 (468)
                      +|+.+++||+|+||+||+|+++.+|+.||||++.++...       ..+|+++|++|+ ||||++++++|..      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence            699999999999999999999999999999999765421       236999999995 9999999999853      34


Q ss_pred             EEEEEEeccCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          116 YVHLVMELCAGGELFHRL---EKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       116 ~~~lV~E~~~ggsL~~~l---~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      ++|||||||+++.+..+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||++
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~--~~kl~DFG~a  170 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLCDFGSA  170 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC--CEEECCCTTC
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC--ceeEecccch
Confidence            689999999766433332   34567999999999999999999999999999999999999986542  4999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----------
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTAD-----------  259 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------  259 (468)
                      ..........+.+||+.|+|||++.+  .|+.++|||||||++|||++|++||...+..+.+..+....           
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            98877777778899999999999875  48999999999999999999999999888777666554311           


Q ss_pred             ------CCCCC--------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          260 ------LRFPS--------NPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       260 ------~~~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                            ..++.        .....+++++.+||.+||++||++|||++|+|+||||++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                  11111        1124578999999999999999999999999999999764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=409.56  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=205.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++ +++.||||++.+...    ..+.+.+|++++++++ |||||++++++.+++.+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence            46999999999999999999986 678899999976532    3467899999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      ||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.   +||+|||+++......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~---~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC---EEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC---eEecccchheeccCCC
Confidence            9999999999998765 56899999999999999999999999999999999999998765   9999999998765433


Q ss_pred             c--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          200 S--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       200 ~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .  .....||+.|+|||++.+. |+.++|||||||++|||++ |++||...+..++.+.+.......   ....+++++.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---CCTTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHH
Confidence            2  2346799999999999875 9999999999999999999 677787778878888877653322   1256789999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +|+.+||++||++|||++|+++|
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=416.10  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=206.6

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||+||+|+.+   ..||||++..... .....+.+.+|+++|++++ |||||++++++. ++.++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccEEEE
Confidence            467999999999999999999754   3599999976643 3445678999999999996 999999999875 456899


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.   +||+|||+|+.....
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~---~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS---EEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC---EEEccccceeecccc
Confidence            99999999999999764 56999999999999999999999999999999999999987655   999999999776432


Q ss_pred             C---ccccCCCCCCCcChhhhcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--CCCCCC
Q 012203          199 Q---SLLGTVGSPFYIAPEVLAG----GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP--SNPWDH  269 (468)
Q Consensus       199 ~---~~~~~~GT~~Y~APE~l~~----~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~  269 (468)
                      .   ...+..||+.|||||++.+    .|+.++|||||||++|||++|+.||.+.+.......+.......|  ......
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence            2   2345689999999999864    378899999999999999999999988665544444433333222  123457


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      +++++.+|+.+||..||++|||++|++++-
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            899999999999999999999999999863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-53  Score=417.02  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=212.7

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.++..    ..+.+.+|+++|++|+ |||||++++++.+++.+||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEE
Confidence            4679999999999999999999999999999999976532    3567899999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||||++|+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~---~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc---EEEccccceeecCC
Confidence            99999999999999764  56899999999999999999999999999999999999987765   99999999987654


Q ss_pred             CCc--cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQS--LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPP-FWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~--~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ...  .....||+.|+|||++.+ .|+.++|||||||++|||++|..| |.+.+...+.+.+... ...  ..+..++++
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~--~~~~~~~~~  244 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM--ERPEGCPEK  244 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC--CCCTTCCHH
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC--CCCccchHH
Confidence            322  234468999999999876 499999999999999999996555 5556666666665543 222  223578999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.+||.+||+.||++|||++|+++
T Consensus       245 l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         245 VYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999999976

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-53  Score=411.81  Aligned_cols=246  Identities=24%  Similarity=0.313  Sum_probs=208.0

Q ss_pred             eEEeecCCeEEEEEEEc--CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEEEecc
Q 012203           47 QQLGWGQFGVIRVCSDK--FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLVMELC  124 (468)
Q Consensus        47 ~~LG~G~fg~Vy~a~~~--~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV~E~~  124 (468)
                      ++||+|+||+||+|.++  .+++.||||++..... .....+.+.+|+++|++++ |||||+++++++++ ..+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence            57999999999999864  4567899999976532 3344578999999999996 99999999999755 578999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCCcc---
Q 012203          125 AGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQSL---  201 (468)
Q Consensus       125 ~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---  201 (468)
                      ++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++.+......   
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~---~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc---ccccchhhhhhcccccccccc
Confidence            99999999999899999999999999999999999999999999999999998765   999999999887544322   


Q ss_pred             -ccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHH
Q 012203          202 -LGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLV  278 (468)
Q Consensus       202 -~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li  278 (468)
                       ....||+.|+|||++.+. ++.++|||||||++|||++ |++||.+.+..++...+..+.. .+  ....+++++.+||
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-~~--~p~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-MG--CPAGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCcccCHHHHHHH
Confidence             235799999999999765 8999999999999999998 8999999988888888876532 11  1257899999999


Q ss_pred             HHccccCCCCCCCHHHHH---hCcCC
Q 012203          279 MGMLSTDPSQRLTARQVL---DHSWM  301 (468)
Q Consensus       279 ~~~L~~dP~~Rpt~~eiL---~h~~~  301 (468)
                      .+||+.||++|||+++|+   +|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999984   55553

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=408.86  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=213.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++.+.||+|+||+||+|+++ +++.||||++.....    ..+.+.+|+++|++++ |||||++++++.+ +.+||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEE
Confidence            468999999999999999999986 678899999976532    3467899999999996 9999999998865 55799


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKF--GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||||++|+|.+++...  .++++..+..++.||+.||.|||+++|+||||||+||||+.++.   +||+|||+|+....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~---~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc---eeeccccceEEccC
Confidence            99999999999977433  36999999999999999999999999999999999999987655   99999999998765


Q ss_pred             CCc--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQS--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ...  .....||+.|+|||++.++ ++.++|||||||++|||++ |++||...+..++.+.+...... +  ....++++
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-~--~p~~~~~~  238 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-V--RPDNCPEE  238 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-C--CCTTCCHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-C--CcccChHH
Confidence            432  2356799999999999865 8999999999999999999 56667777777777777655322 1  22578999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh--CcCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD--HSWMG  302 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~--h~~~~  302 (468)
                      +.+|+.+||+.||++|||++|+++  |+||.
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999999999999998  67764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=422.50  Aligned_cols=260  Identities=29%  Similarity=0.522  Sum_probs=222.0

Q ss_pred             CCeEEEeEEeecCCeEEEEEEE---cCCCcEEEEEEeccCcCCC-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSD---KFTGEVFACKSIAKDRLVT-IDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~---~~~g~~vavK~i~~~~~~~-~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++.+..... ....+.+.+|+++|++++.||||+++++++++.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6699999999999999999987   4478999999998754322 22345678899999999855899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          117 VHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++++|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC---EEEeeccchhhhc
Confidence            9999999999999999999999999999999999999999999999999999999999987654   9999999998765


Q ss_pred             CCC--ccccCCCCCCCcChhhhcCC---CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          197 PGQ--SLLGTVGSPFYIAPEVLAGG---YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       197 ~~~--~~~~~~GT~~Y~APE~l~~~---~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ...  ...+..|++.|+|||.+.+.   ++.++|||||||++|+|++|+.||.+.+.......+..............++
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            332  33467899999999999753   6889999999999999999999998766555555554443333333335799


Q ss_pred             HHHHHHHHHccccCCCCCC-----CHHHHHhCcCCCC
Q 012203          272 DSAKDLVMGMLSTDPSQRL-----TARQVLDHSWMGD  303 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rp-----t~~eiL~h~~~~~  303 (468)
                      +++.+||.+||++||++||     |++|+++||||++
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            9999999999999999999     5899999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=406.91  Aligned_cols=259  Identities=27%  Similarity=0.423  Sum_probs=222.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++ ||||+++++++.+.+..++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence            589999999999999999999999999999999976643 3445678899999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC-
Q 012203          121 MELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ-  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-  199 (468)
                      ||++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.   +||+|||.++...... 
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~---~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc---eeeeecchhhcccCCCc
Confidence            999999999999998899999999999999999999999999999999999999987655   9999999998876433 


Q ss_pred             ccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhccCCCC-------------
Q 012203          200 SLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPF-WGNTKSRIFDAVRTADLRFP-------------  263 (468)
Q Consensus       200 ~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~~-------------  263 (468)
                      ......+++.|+|||++.+.  ++.++|||||||++|||++|+.|| .+.+..+....+........             
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            33455788999999998764  689999999999999999999885 45555666655543221111             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCC
Q 012203          264 ------------SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDG  304 (468)
Q Consensus       264 ------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~  304 (468)
                                  ......+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                        11224578899999999999999999999999999999763

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=410.59  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=214.7

Q ss_pred             cCCeEEEe-EEeecCCeEEEEEEEcC--CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           40 RERFVLGQ-QLGWGQFGVIRVCSDKF--TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        40 ~~~y~i~~-~LG~G~fg~Vy~a~~~~--~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +++|.+.+ +||+|+||+||+|.++.  ++..||||++.+..  .....+.+.+|+++|++++ |||||+++++++++ .
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~   82 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-A   82 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-e
Confidence            35688888 49999999999998764  35579999997652  4455678999999999996 99999999999754 5


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      +|||||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++.+
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~---~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE---EEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc---eeeccchhhhcc
Confidence            89999999999999998654 57999999999999999999999999999999999999998765   999999999987


Q ss_pred             cCCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          196 EPGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       196 ~~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      .....    .....||+.|+|||++.++ ++.++|||||||++|||++ |+.||.+.+..++...+..+... +  ....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~-~--~p~~  236 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-E--CPPE  236 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-C--CCTT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCc
Confidence            64432    2245789999999999865 8999999999999999998 99999998888888887765421 1  2257


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHH---HhCcCC
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQV---LDHSWM  301 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~ei---L~h~~~  301 (468)
                      +++++.+||.+||+.||++|||+.+|   |+|+|+
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            89999999999999999999999888   566765

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=418.18  Aligned_cols=261  Identities=28%  Similarity=0.463  Sum_probs=213.2

Q ss_pred             cccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCC--
Q 012203           38 NLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDED--  115 (468)
Q Consensus        38 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~--  115 (468)
                      ++.++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+++|++|. ||||+++++++....  
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence            46689999999999999999999999999999999997643  3445567889999999995 999999999997553  


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          116 ---YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       116 ---~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                         .+|++| |+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++
T Consensus        82 ~~~~~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~---~kl~DfG~a  156 (345)
T d1pmea_          82 QMKDVYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLA  156 (345)
T ss_dssp             TCCCEEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTC
T ss_pred             ccceEEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC---EEEcccCce
Confidence               355555 5569999999976 57999999999999999999999999999999999999986554   999999999


Q ss_pred             eeecCCCc----cccCCCCCCCcChhhhcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-----
Q 012203          193 TYIEPGQS----LLGTVGSPFYIAPEVLAG--GYNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR-----  261 (468)
Q Consensus       193 ~~~~~~~~----~~~~~GT~~Y~APE~l~~--~~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----  261 (468)
                      ........    ....+||+.|+|||++..  .++.++||||+||++|+|++|+.||.+.+..+...........     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            87654322    345689999999999865  3788999999999999999999999887765555443221110     


Q ss_pred             ---------------CCCC-------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCCC
Q 012203          262 ---------------FPSN-------PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGIQ  306 (468)
Q Consensus       262 ---------------~~~~-------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~~  306 (468)
                                     .+..       .+..++.++++||.+||++||.+|||++|+|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                           1110       13467889999999999999999999999999999986543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=404.54  Aligned_cols=246  Identities=23%  Similarity=0.354  Sum_probs=216.4

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHLV  120 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~lV  120 (468)
                      ++|+++++||+|+||+||+|+++ +++.||||++.+...    ..+.+.+|++++++++ ||||+++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence            46889999999999999999985 788999999987643    2457899999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCCC
Q 012203          121 MELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPGQ  199 (468)
Q Consensus       121 ~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~~  199 (468)
                      |||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.   +||+|||+++......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~---~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC---EEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc---EEECcchhheeccCCC
Confidence            999999999999754 467999999999999999999999999999999999999986554   9999999998765433


Q ss_pred             c--cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          200 S--LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       200 ~--~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                      .  .....||+.|+|||++.+. ++.++|||||||++|||++ |+.||.+.+..++...+...... +  .+...++++.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-~--~p~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-Y--RPHLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-C--CCTTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-C--CcccccHHHH
Confidence            2  2346799999999999864 8999999999999999998 89999999999988888765332 2  2257889999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +||.+||+.||++|||++++++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=400.68  Aligned_cols=249  Identities=27%  Similarity=0.371  Sum_probs=204.0

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCC---cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTG---EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +++|++++.||+|+||+||+|++..++   ..||+|.+...  ......+.+.+|+++|++++ |||||++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence            578999999999999999999987543   46888887543  24455678999999999995 999999999996 467


Q ss_pred             EEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEK-FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      +|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||+++..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~---~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc---EEEccchhheec
Confidence            8999999999999998765 456999999999999999999999999999999999999998766   999999999876


Q ss_pred             cCCCc--cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          196 EPGQS--LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       196 ~~~~~--~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      .....  .....||+.|+|||++.+ .|+.++|||||||++|||++ |.+||.+.+..++...+......   ..+..++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            54322  234578999999999986 48999999999999999998 89999999988888888765432   2236789


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +++.+||.+||..||++|||++||++|
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=416.48  Aligned_cols=259  Identities=25%  Similarity=0.391  Sum_probs=204.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE------
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE------  112 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~------  112 (468)
                      +.++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+++. ||||++++++|.      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccc
Confidence            56789999999999999999999999999999999987643 4555677899999999995 999999999995      


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCce
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLA  192 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla  192 (468)
                      ..+.+|+|||||.++ +.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +|++|||++
T Consensus        93 ~~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~---~kl~df~~~  166 (355)
T d2b1pa1          93 EFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLA  166 (355)
T ss_dssp             TCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC-
T ss_pred             cCceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc---eeeechhhh
Confidence            347899999999664 545443  57999999999999999999999999999999999999987655   999999999


Q ss_pred             eeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC----------
Q 012203          193 TYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLR----------  261 (468)
Q Consensus       193 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------  261 (468)
                      +...........+||+.|+|||++.+. ++.++||||+||++|+|++|++||.+.+.......+......          
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            887766666777899999999999875 899999999999999999999999888766655554321111          


Q ss_pred             ------------CCCCC----------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          262 ------------FPSNP----------------WDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       262 ------------~~~~~----------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                  .....                ....++++.+||++||.+||++|||++|+|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                        10000                012466899999999999999999999999999998643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-52  Score=416.45  Aligned_cols=259  Identities=26%  Similarity=0.408  Sum_probs=215.8

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC----
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE----  114 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~----  114 (468)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|. |||||++++++...    
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccc
Confidence            46789999999999999999999999999999999987643 4445667889999999996 99999999999633    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCcee
Q 012203          115 -DYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLAT  193 (468)
Q Consensus       115 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~  193 (468)
                       ...+++|+|+.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.   +|++|||++.
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~---~kl~dfg~a~  169 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLAR  169 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCC----
T ss_pred             cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc---ccccccchhc
Confidence             334566677789999999865 57999999999999999999999999999999999999987655   9999999997


Q ss_pred             eecCCCccccCCCCCCCcChhhhcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--------
Q 012203          194 YIEPGQSLLGTVGSPFYIAPEVLAGG--YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAVRTADLRFP--------  263 (468)
Q Consensus       194 ~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  263 (468)
                      ...  ....+..||+.|+|||++.+.  ++.++|||||||++|+|++|++||.+.+.......+.......+        
T Consensus       170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            643  345567899999999997763  68899999999999999999999998887777766654322211        


Q ss_pred             ---------------CC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHhCcCCCCCC
Q 012203          264 ---------------SN----PWDHISDSAKDLVMGMLSTDPSQRLTARQVLDHSWMGDGI  305 (468)
Q Consensus       264 ---------------~~----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h~~~~~~~  305 (468)
                                     ..    .+..+++++++||.+||++||.+|||++|+|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                           11    1235789999999999999999999999999999998743

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-51  Score=398.69  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=204.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCC----cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTG----EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDY  116 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g----~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~  116 (468)
                      +.|++.+.||+|+||.||+|.++.++    ..||||++....  .......+.+|+++|++|+ |||||++++++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            56999999999999999999987654    479999997543  3445567889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeee
Q 012203          117 VHLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYI  195 (468)
Q Consensus       117 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~  195 (468)
                      .++|||||.+++|.+++... +.+++..+..++.||+.||.|||+++|+||||||+||||+.++.   +||+|||+++.+
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~---~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe---EEEcccchhhcc
Confidence            99999999999999988665 57999999999999999999999999999999999999987655   999999999876


Q ss_pred             cCCC----ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccCCCCCCCCCC
Q 012203          196 EPGQ----SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGNTKSRIFDAVRTADLRFPSNPWDH  269 (468)
Q Consensus       196 ~~~~----~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (468)
                      ....    ......||+.|+|||++.++ ++.++|||||||++|||++| .+||...+..++++.+..+. +.+.  ...
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~~~--~~~  237 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLPT--PMD  237 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCC--CTT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CCCC--chh
Confidence            5432    22345789999999999875 89999999999999999995 55566667777777766542 2222  257


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          270 ISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       270 ~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +++++.+||.+||+.||++|||+.||++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            8999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=407.94  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=211.5

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcE--EEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEV--FACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      ++|++.++||+|+||+||+|+++.+|..  ||||.+...  ...+..+.+.+|+++|+++.+|||||++++++.+++.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            5699999999999999999999988875  566666433  233445678999999999966999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCC
Q 012203          119 LVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSS  182 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~  182 (468)
                      +|||||+||+|.++|.+.                ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.  
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--  165 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--  165 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--
Confidence            999999999999999754                56899999999999999999999999999999999999987765  


Q ss_pred             CEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhccC
Q 012203          183 PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGM-PPFWGNTKSRIFDAVRTADL  260 (468)
Q Consensus       183 ~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~~~  260 (468)
                       +||+|||+++............||+.|+|||.+.++ |+.++|||||||++|||++|. +||.+.+..++.+.+.... 
T Consensus       166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-  243 (309)
T d1fvra_         166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  243 (309)
T ss_dssp             -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred             -eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-
Confidence             999999999866544444566799999999999875 899999999999999999965 6788888888888776542 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          261 RFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       261 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ++  ..+..+++++.+||.+||++||++|||++||++|
T Consensus       244 ~~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            22  2235789999999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-51  Score=402.76  Aligned_cols=252  Identities=26%  Similarity=0.367  Sum_probs=201.5

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-  113 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-  113 (468)
                      .++|++++.||+|+||.||+|+++.     +++.||+|++....  .....+.+.+|..++.++.+|+||+.+++++.+ 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            4679999999999999999999754     45789999987543  344566788899999998779999999999865 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEee
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF----------------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLAT  177 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~  177 (468)
                      ++.+++|||||+||+|.+++...                ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence            45789999999999999999753                24889999999999999999999999999999999999987


Q ss_pred             cCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHH
Q 012203          178 KASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGNTKSRIF  252 (468)
Q Consensus       178 ~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~  252 (468)
                      ++.   +||+|||+|+.......   .....||+.|+|||++.++ ++.++|||||||++|||++| .+||.+....+.+
T Consensus       170 ~~~---~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         170 KNV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             GGC---EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCc---EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            665   99999999987654322   2346799999999999875 89999999999999999986 5678776554444


Q ss_pred             HHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          253 DAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ..+......++  ....+++++.+||.+||+.||++|||++|+++|
T Consensus       247 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33333333322  225789999999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=398.58  Aligned_cols=252  Identities=26%  Similarity=0.371  Sum_probs=207.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~l  119 (468)
                      .++|++++.||+|+||+||+|+++. ++.||||++.....    ..+.+.+|+.+|++++ |||||++++++.+ +.+++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEE
Confidence            3679999999999999999999974 46799999976532    3467899999999996 9999999999965 45789


Q ss_pred             EEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEK--FGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      |||||++|+|..++..  .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~---~kl~DfGla~~~~~  165 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIED  165 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCTTC----
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc---EEEcccchhhhccC
Confidence            9999999999988854  357999999999999999999999999999999999999987765   99999999987654


Q ss_pred             CC--ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHH
Q 012203          198 GQ--SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDS  273 (468)
Q Consensus       198 ~~--~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  273 (468)
                      ..  ......||+.|+|||++.++ ++.++|||||||++|||++| ++|+......+++..+.... +.+  ....++++
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~  242 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP--CPPECPES  242 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCC--CCTTSCHH
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CCC--CCcccCHH
Confidence            33  22346799999999999764 89999999999999999995 55566666777777776543 222  23578999


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHh--CcCCCCC
Q 012203          274 AKDLVMGMLSTDPSQRLTARQVLD--HSWMGDG  304 (468)
Q Consensus       274 l~~li~~~L~~dP~~Rpt~~eiL~--h~~~~~~  304 (468)
                      +++||.+||+.||++||++++|++  ++||...
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999999999999988  8888654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-51  Score=398.11  Aligned_cols=250  Identities=27%  Similarity=0.394  Sum_probs=205.3

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcC-CC--cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKF-TG--EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~-~g--~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      ++|++.+.||+|+||.||+|+... ++  ..||||++.+.........+.+.+|+++|++++ ||||+++++++.+ +.+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence            569999999999999999998653 33  368999998776555556678999999999995 9999999999975 467


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      ++|||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~---vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc---eeeccchhhhhcc
Confidence            8999999999999887654 56999999999999999999999999999999999999998765   9999999999875


Q ss_pred             CCCc----cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCC
Q 012203          197 PGQS----LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHI  270 (468)
Q Consensus       197 ~~~~----~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (468)
                      ....    .....|++.|+|||++.+. ++.++|||||||++|||++ |++||.+.+..+....+......++.  +..+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence            4432    1234678899999999876 8999999999999999998 89999999999998888777665543  3578


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          271 SDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       271 s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++++.+||.+||.+||++|||++||++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999974

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=402.61  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=206.9

Q ss_pred             CeEEEeEEeecCCeEEEEEEEcCCCc----EEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           42 RFVLGQQLGWGQFGVIRVCSDKFTGE----VFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        42 ~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      +|++++.||+|+||+||+|+++.+|+    .||+|.+....  .....+.+.+|+++|++++ |||||++++++.+++ .
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~-~   85 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-V   85 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESSS-E
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC-e
Confidence            59999999999999999999988877    47777775432  3344678999999999996 999999999998654 6


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeec
Q 012203          118 HLVMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIE  196 (468)
Q Consensus       118 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~  196 (468)
                      +++|||+.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||+++...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~---~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC---eEeeccccceecc
Confidence            7888999999999888664 57999999999999999999999999999999999999998765   9999999998765


Q ss_pred             CCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          197 PGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       197 ~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ....   .....||+.|+|||++.++ |+.++|||||||++|||+| |.+||.+.+..++...+..+.. .+.  ...++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~--p~~~~  239 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQ--PPICT  239 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-CCC--CTTBC
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCC--CcccC
Confidence            4332   2334689999999998765 8999999999999999998 8999999888888887776542 221  25789


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhCc
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDHS  299 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h~  299 (468)
                      +++.+|+.+||..||++|||+.|+++|.
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-50  Score=398.46  Aligned_cols=250  Identities=24%  Similarity=0.313  Sum_probs=215.4

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      =+++|++.+.||+|+||+||+|+++     .+++.||||++....  .....+.+.+|+++|++++ ||||+++++++.+
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAV   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeecc
Confidence            3567999999999999999999975     356899999987653  3445678999999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccC
Q 012203          114 EDYVHLVMELCAGGELFHRLEKFG------------------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLK  169 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~~------------------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIK  169 (468)
                      .+..++||||+++|+|.+++....                        .+++..+..++.||+.||+|||+++|+|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            999999999999999999996532                        38899999999999999999999999999999


Q ss_pred             CCcEEEeecCCCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCC-CCCC
Q 012203          170 PENILLATKASSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGM-PPFW  244 (468)
Q Consensus       170 p~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~-~Pf~  244 (468)
                      |+||||+.++.   +||+|||+++......   ...+..||+.|+|||++.+. |+.++|||||||++|||++|. +||.
T Consensus       168 p~NILld~~~~---~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         168 TRNCLVGENMV---VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             GGGEEECGGGC---EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ccceEECCCCc---EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            99999987665   9999999998654332   22346789999999999874 999999999999999999985 7899


Q ss_pred             CCChHHHHHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          245 GNTKSRIFDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +.+..++...+.......   .+..+++++.+||.+||+.||++|||+.||++
T Consensus       245 ~~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         245 GMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999889888887765321   22578999999999999999999999999965

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=397.06  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=211.9

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCC-------cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTG-------EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE  112 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g-------~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~  112 (468)
                      .++|++++.||+|+||.||+|++..++       ..||+|++.++.  .......+.+|...+.++.+|||||++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            468999999999999999999986554       479999997653  34556788899999999967999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEe
Q 012203          113 DEDYVHLVMELCAGGELFHRLEKFG----------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLA  176 (468)
Q Consensus       113 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~  176 (468)
                      +++.+++|||||++|+|.++|....                .+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence            9999999999999999999997543                489999999999999999999999999999999999998


Q ss_pred             ecCCCCCEEEeecCceeeecCCC---ccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 012203          177 TKASSSPIKLADFGLATYIEPGQ---SLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRI  251 (468)
Q Consensus       177 ~~~~~~~ikL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~  251 (468)
                      .++.   +||+|||+++......   ......||+.|+|||++.+ .|+.++|||||||++|||++ |.+||.+.+...+
T Consensus       170 ~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         170 EDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             TTCC---EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             CCCC---eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            7665   9999999998765432   2334679999999999876 49999999999999999998 7999999888888


Q ss_pred             HHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       252 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      ++.+..+. .++.  ...+++++.+||.+||++||++|||+.|+++
T Consensus       247 ~~~i~~~~-~~~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKEGH-RMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTTC-CCCC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCC-CCCC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            88776643 2222  2578999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=389.90  Aligned_cols=242  Identities=24%  Similarity=0.338  Sum_probs=201.2

Q ss_pred             CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-eCCEEEE
Q 012203           41 ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYE-DEDYVHL  119 (468)
Q Consensus        41 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~-~~~~~~l  119 (468)
                      ++|++++.||+|+||.||+|+++  |+.||||++.++.     ..+.+.+|++++++++ ||||+++++++. +++.+||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEE
Confidence            46999999999999999999984  7899999997542     3467889999999996 999999999985 4567899


Q ss_pred             EEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          120 VMELCAGGELFHRLEKFG--RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      ||||+++|+|.+++.+.+  .+++..++.++.||+.||.|||+++|+||||||+|||++.++.   +||+|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~---~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC---EEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC---EeecccccceecCC
Confidence            999999999999996643  4899999999999999999999999999999999999987665   99999999987543


Q ss_pred             CCccccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCCCCCHHHH
Q 012203          198 GQSLLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLS-GMPPFWGNTKSRIFDAVRTADLRFPSNPWDHISDSAK  275 (468)
Q Consensus       198 ~~~~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~  275 (468)
                        ......+|+.|+|||++.+ .++.++|||||||++|||++ |++||...+..++...+..... .+  ....+++++.
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~~~  230 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MD--APDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-CC--CCTTCCHHHH
T ss_pred             --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--CCccCCHHHH
Confidence              2345578999999999976 49999999999999999998 7999999888888888765422 22  1256889999


Q ss_pred             HHHHHccccCCCCCCCHHHHHhC
Q 012203          276 DLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       276 ~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +||++||++||++|||+.+++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=395.23  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=214.3

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEc-----CCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeC
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDK-----FTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDE  114 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~  114 (468)
                      .++|++++.||+|+||.||+|+++     .+++.||||++.+..  .......+.+|+.+++++.+|||||++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            468999999999999999999863     467899999997653  3455667899999999997799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEe
Q 012203          115 DYVHLVMELCAGGELFHRLEKFG------------------RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLA  176 (468)
Q Consensus       115 ~~~~lV~E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~  176 (468)
                      +.+|||||||++|+|.+++.+..                  .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            99999999999999999997643                  589999999999999999999999999999999999998


Q ss_pred             ecCCCCCEEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 012203          177 TKASSSPIKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLS-GMPPFWGNTKSRI  251 (468)
Q Consensus       177 ~~~~~~~ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~ellt-G~~Pf~~~~~~~~  251 (468)
                      .++.   +||+|||+++.......   ....+||+.|+|||++.+. ++.++|||||||++|||++ |.+||...+..+.
T Consensus       180 ~~~~---~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         180 HGRI---TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             TTTE---EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ccCc---ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            7665   99999999987654322   2345789999999999864 8999999999999999998 6777777666565


Q ss_pred             HHHHHhccCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          252 FDAVRTADLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       252 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                      +..+.....+...  ...+++++.+||.+||+.||++|||++||++
T Consensus       257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5555444443332  2568999999999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-49  Score=387.14  Aligned_cols=260  Identities=22%  Similarity=0.283  Sum_probs=208.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +.++|+++++||+|+||+||+|+++.+|+.||||++..+..     ...+..|+++++++..|++|+.+.+++.+.+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            45789999999999999999999999999999999876532     2347789999999975556777778888999999


Q ss_pred             EEEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecC
Q 012203          119 LVMELCAGGELFHRLE-KFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEP  197 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~  197 (468)
                      +||||+ +++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++..+....+||+|||+|+.+..
T Consensus        80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            999999 566666654 456799999999999999999999999999999999999998766667799999999998754


Q ss_pred             CC--------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhccCCCC-C
Q 012203          198 GQ--------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKSRIFDAV---RTADLRFP-S  264 (468)
Q Consensus       198 ~~--------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~-~  264 (468)
                      ..        .....+||+.|+|||++.+. ++.++|||||||++|||++|+.||...........+   .......+ .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            32        22356899999999999885 899999999999999999999999776544333222   11111111 1


Q ss_pred             CCCCCCCHHHHHHHHHccccCCCCCCCHH---HHHhCcCCCCC
Q 012203          265 NPWDHISDSAKDLVMGMLSTDPSQRLTAR---QVLDHSWMGDG  304 (468)
Q Consensus       265 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~---eiL~h~~~~~~  304 (468)
                      .....+|+++.+++.+||..||++||+++   ++|+|+|.+..
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            12357899999999999999999999987   45677775443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=388.97  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=215.6

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcC-----CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKF-----TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      -.++|++++.||+|+||+||+|.++.     ++..||||++.+..  .......+.+|+++++++. ||||+++++++..
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEec
Confidence            35789999999999999999998853     35789999997542  4455567899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCC
Q 012203          114 EDYVHLVMELCAGGELFHRLEKF----------GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSP  183 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~  183 (468)
                      ++..++|||||++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.   
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~---  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC---
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce---
Confidence            99999999999999999998643          24688999999999999999999999999999999999987655   


Q ss_pred             EEEeecCceeeecCCCc---cccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhc
Q 012203          184 IKLADFGLATYIEPGQS---LLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSG-MPPFWGNTKSRIFDAVRTA  258 (468)
Q Consensus       184 ikL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~  258 (468)
                      +||+|||+++.......   .....||+.|+|||.+.+. ++.++|||||||++|||++| .+||.+.+..+.++.+..+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            99999999986643322   2344789999999999875 88999999999999999998 5889888888888888765


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          259 DLRFPSNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       259 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      ....   ....+++.+.++|.+||+.||++|||++|++++
T Consensus       252 ~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         252 GLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4321   125789999999999999999999999999973

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=379.15  Aligned_cols=246  Identities=22%  Similarity=0.258  Sum_probs=200.9

Q ss_pred             EEEeEEeecCCeEEEEEEEcCCC---cEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe-CCEEEE
Q 012203           44 VLGQQLGWGQFGVIRVCSDKFTG---EVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED-EDYVHL  119 (468)
Q Consensus        44 ~i~~~LG~G~fg~Vy~a~~~~~g---~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~-~~~~~l  119 (468)
                      ...++||+|+||+||+|++..++   ..||||++.+.  ........+.+|+++|++|+ ||||+++++++.+ ++.+++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence            34678999999999999987543   36899998653  35556688999999999996 9999999999765 568999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEeecCceeeecCC
Q 012203          120 VMELCAGGELFHRLEKF-GRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLADFGLATYIEPG  198 (468)
Q Consensus       120 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~~~~~  198 (468)
                      |||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||||+.++.   +||+|||+++.....
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~---~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDK  183 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECSSGGGCCTTTT
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC---EEEecccchhhcccc
Confidence            99999999999998754 45778889999999999999999999999999999999986554   999999999876543


Q ss_pred             Cc-----cccCCCCCCCcChhhhcC-CCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccCCCCCCCCCCCC
Q 012203          199 QS-----LLGTVGSPFYIAPEVLAG-GYNQAADVWSAGVILYILLSGMPPFWGN-TKSRIFDAVRTADLRFPSNPWDHIS  271 (468)
Q Consensus       199 ~~-----~~~~~GT~~Y~APE~l~~-~~~~~sDiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s  271 (468)
                      ..     .....||+.|+|||++.+ .++.++||||||+++|||++|..||... +..++...+..+.. .+.  ...++
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~~~--p~~~~  260 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQ--PEYCP  260 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-CCC--CTTCC
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCC--cccCc
Confidence            22     223578999999999876 5999999999999999999977777543 34445555554432 221  25688


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          272 DSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       272 ~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                      +++.+||.+||++||++||++.||++|
T Consensus       261 ~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         261 DPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-47  Score=375.98  Aligned_cols=253  Identities=18%  Similarity=0.254  Sum_probs=209.4

Q ss_pred             ccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEEE
Q 012203           39 LRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYVH  118 (468)
Q Consensus        39 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~~  118 (468)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.....     ...+.+|+++++.|.+|+|++.+++++.+....+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            56789999999999999999999999999999999865432     2346789999999986799999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecC--CCCCEEEeecCceeee
Q 012203          119 LVMELCAGGELFHRLEKFG-RFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKA--SSSPIKLADFGLATYI  195 (468)
Q Consensus       119 lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~--~~~~ikL~DFGla~~~  195 (468)
                      +||||+ |++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.+.  ..+.+||+|||+|+..
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999 789999997754 699999999999999999999999999999999999997643  2456999999999886


Q ss_pred             cCCC--------ccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCCC
Q 012203          196 EPGQ--------SLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTK---SRIFDAVRTADLRFP  263 (468)
Q Consensus       196 ~~~~--------~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~  263 (468)
                      ....        .....+||+.|||||++.+. ++.++|||||||++|||++|+.||.+...   ......+.......+
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            5321        23356899999999999886 99999999999999999999999975443   233333332221111


Q ss_pred             -CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHh
Q 012203          264 -SNPWDHISDSAKDLVMGMLSTDPSQRLTARQVLD  297 (468)
Q Consensus       264 -~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~  297 (468)
                       ......+|+++.+++..|+..+|++||+++.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence             1112468899999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=371.22  Aligned_cols=246  Identities=24%  Similarity=0.286  Sum_probs=191.7

Q ss_pred             cCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHH--HHHHHHHhcCCCCceeeeEEEEeCC--
Q 012203           40 RERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKL--EIEIMTRLSGHPNVVDLKAVYEDED--  115 (468)
Q Consensus        40 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~--Ei~iL~~L~~HpnIv~l~~~~~~~~--  115 (468)
                      .++|.+.+.||+|+||+||+|++  +|+.||||++..+      .......  |+..+.+++ ||||+++++++.+++  
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence            45799999999999999999986  6899999998643      2233333  444455665 999999999997654  


Q ss_pred             --EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------cCcEecccCCCcEEEeecCCCCCEE
Q 012203          116 --YVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHE--------IGVVHRDLKPENILLATKASSSPIK  185 (468)
Q Consensus       116 --~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~--------~gIiHrDIKp~NILl~~~~~~~~ik  185 (468)
                        .+|+|||||++|+|.+++++ ..+++..+..++.|++.||.|||+        +||+||||||+||||+.++.   +|
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~---~K  148 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC---EE
T ss_pred             ceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC---eE
Confidence              68999999999999999987 468999999999999999999996        59999999999999987655   99


Q ss_pred             EeecCceeeecCCCc-----cccCCCCCCCcChhhhcCC-------CCCcchHHHHHHHHHHHHhCCCCCCCC-------
Q 012203          186 LADFGLATYIEPGQS-----LLGTVGSPFYIAPEVLAGG-------YNQAADVWSAGVILYILLSGMPPFWGN-------  246 (468)
Q Consensus       186 L~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~-------~~~~sDiwSlGvil~elltG~~Pf~~~-------  246 (468)
                      |+|||+++.......     ....+||+.|+|||++.+.       ++.++|||||||++|||++|..||...       
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            999999998765432     2346899999999998753       466899999999999999999887321       


Q ss_pred             --------ChHHHHHHHHhccCCC--CCCC-CCCCCHHHHHHHHHccccCCCCCCCHHHHHhC
Q 012203          247 --------TKSRIFDAVRTADLRF--PSNP-WDHISDSAKDLVMGMLSTDPSQRLTARQVLDH  298 (468)
Q Consensus       247 --------~~~~~~~~i~~~~~~~--~~~~-~~~~s~~l~~li~~~L~~dP~~Rpt~~eiL~h  298 (468)
                              ......+.+.....+.  +... .......+.+|+.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                    2223333333322221  1110 01233568999999999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-44  Score=363.64  Aligned_cols=262  Identities=25%  Similarity=0.443  Sum_probs=200.5

Q ss_pred             ccc-CCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhc----------CCCCcee
Q 012203           38 NLR-ERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLS----------GHPNVVD  106 (468)
Q Consensus        38 ~l~-~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~----------~HpnIv~  106 (468)
                      .|. +||++++.||+|+||+||+|+++.+|+.||||++.++.    ...+.+.+|+++++++.          +|+||++
T Consensus         9 ~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~   84 (362)
T d1q8ya_           9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   84 (362)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence            344 46999999999999999999999999999999997653    23456778999988875          2688999


Q ss_pred             eeEEEEe--CCEEEEEEeccCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecccCCCcEEEeecCC
Q 012203          107 LKAVYED--EDYVHLVMELCAGGELFHRL---EKFGRFSEAEARVLFMQLMQVVLYCHE-IGVVHRDLKPENILLATKAS  180 (468)
Q Consensus       107 l~~~~~~--~~~~~lV~E~~~ggsL~~~l---~~~~~l~~~~~~~i~~qil~aL~~LH~-~gIiHrDIKp~NILl~~~~~  180 (468)
                      +++++..  ....+++|+++..+......   .....+++..++.++.||+.||+|||+ .||+||||||+||||+.++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             EEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence            9998854  46777777777665443333   223568999999999999999999998 89999999999999987654


Q ss_pred             CC---CEEEeecCceeeecCCCccccCCCCCCCcChhhhcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCChH------H
Q 012203          181 SS---PIKLADFGLATYIEPGQSLLGTVGSPFYIAPEVLAGG-YNQAADVWSAGVILYILLSGMPPFWGNTKS------R  250 (468)
Q Consensus       181 ~~---~ikL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~sDiwSlGvil~elltG~~Pf~~~~~~------~  250 (468)
                      ..   .++|+|||.+.....  .....+||+.|+|||++.+. ++.++|+||+||++++|++|+.||......      .
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence            22   389999999986543  34567899999999998874 999999999999999999999999654321      1


Q ss_pred             HHHHHHhc-c-----------------------CCC--------------CCCCCCCCCHHHHHHHHHccccCCCCCCCH
Q 012203          251 IFDAVRTA-D-----------------------LRF--------------PSNPWDHISDSAKDLVMGMLSTDPSQRLTA  292 (468)
Q Consensus       251 ~~~~i~~~-~-----------------------~~~--------------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~  292 (468)
                      ........ .                       ...              ....+...++++.+||.+||++||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            11111000 0                       000              000112356789999999999999999999


Q ss_pred             HHHHhCcCCCCCC
Q 012203          293 RQVLDHSWMGDGI  305 (468)
Q Consensus       293 ~eiL~h~~~~~~~  305 (468)
                      +|+|+||||++..
T Consensus       323 ~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         323 GGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHTCGGGTTCT
T ss_pred             HHHhcCcccCCCC
Confidence            9999999998543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=2.8e-25  Score=203.53  Aligned_cols=166  Identities=19%  Similarity=0.176  Sum_probs=122.9

Q ss_pred             eEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCC---------------hhhHHHHHHHHHHHHHhcCCCCceee
Q 012203           43 FVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVT---------------IDDERSVKLEIEIMTRLSGHPNVVDL  107 (468)
Q Consensus        43 y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~---------------~~~~~~~~~Ei~iL~~L~~HpnIv~l  107 (468)
                      |.++++||+|+||+||+|++. +|+.||||++.......               .........|...+.++. |.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            568999999999999999985 79999999875422110               011234456888999996 9999988


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecccCCCcEEEeecCCCCCEEEe
Q 012203          108 KAVYEDEDYVHLVMELCAGGELFHRLEKFGRFSEAEARVLFMQLMQVVLYCHEIGVVHRDLKPENILLATKASSSPIKLA  187 (468)
Q Consensus       108 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~gIiHrDIKp~NILl~~~~~~~~ikL~  187 (468)
                      +++..    .+++|||+++..+.       .++...+..++.|++.+|.|||++||+||||||+|||++.+    .++|+
T Consensus        80 ~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~----~~~li  144 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE----GIWII  144 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT----EEEEC
T ss_pred             EEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC----CEEEE
Confidence            76532    27999999886653       35566678899999999999999999999999999999843    28999


Q ss_pred             ecCceeeecCCCccccCCCCCCCcC------hhhhcCCCCCcchHHHHHHH
Q 012203          188 DFGLATYIEPGQSLLGTVGSPFYIA------PEVLAGGYNQAADVWSAGVI  232 (468)
Q Consensus       188 DFGla~~~~~~~~~~~~~GT~~Y~A------PE~l~~~~~~~sDiwSlGvi  232 (468)
                      |||.|.........       .|..      .+.+...|+.++|+||+.--
T Consensus       145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            99999875433211       1221      12233458999999998543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.60  E-value=8.5e-08  Score=89.18  Aligned_cols=94  Identities=14%  Similarity=0.046  Sum_probs=69.1

Q ss_pred             cccccccCCeEEEeEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEe
Q 012203           34 NQISNLRERFVLGQQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYED  113 (468)
Q Consensus        34 ~~~~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~  113 (468)
                      .++..+-+.|++.+..+.++.+.||...  .+++.+++|+.......   ....+..|...++.|..+--+.+++.+.++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~   81 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence            4556666788888776656667999875  35677889987654221   223467789999888755456788888888


Q ss_pred             CCEEEEEEeccCCCCHHHH
Q 012203          114 EDYVHLVMELCAGGELFHR  132 (468)
Q Consensus       114 ~~~~~lV~E~~~ggsL~~~  132 (468)
                      ++..++||++++|.++.+.
T Consensus        82 ~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          82 DGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHH
T ss_pred             CCceEEEEEeccccccccc
Confidence            9999999999999877543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.20  E-value=3.1e-06  Score=83.93  Aligned_cols=82  Identities=18%  Similarity=0.152  Sum_probs=50.3

Q ss_pred             EeEEeecCCeEEEEEEEcCCCcEEEEEEeccC-cCCC---hhhHHHHHHHHHHHHHhcCC-C-CceeeeEEEEeCCEEEE
Q 012203           46 GQQLGWGQFGVIRVCSDKFTGEVFACKSIAKD-RLVT---IDDERSVKLEIEIMTRLSGH-P-NVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        46 ~~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~-~~~~---~~~~~~~~~Ei~iL~~L~~H-p-nIv~l~~~~~~~~~~~l  119 (468)
                      .+.||.|....||++.+..+++.+++|.-... +...   .....+...|.+.|+.+..+ | .+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            55799999999999998777889999964321 1100   11223455688888877644 2 34445443  4445678


Q ss_pred             EEeccCCCCH
Q 012203          120 VMELCAGGEL  129 (468)
Q Consensus       120 V~E~~~ggsL  129 (468)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=1e-05  Score=74.17  Aligned_cols=80  Identities=14%  Similarity=0.072  Sum_probs=55.5

Q ss_pred             CeEEEeEEeecC-CeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCC-CceeeeEEEEeCCEEEE
Q 012203           42 RFVLGQQLGWGQ-FGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHP-NVVDLKAVYEDEDYVHL  119 (468)
Q Consensus        42 ~y~i~~~LG~G~-fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~Hp-nIv~l~~~~~~~~~~~l  119 (468)
                      .+... .+..|. .+.||+.... .+..+.+|......      ...+..|...|+.|..+. .+.+++.+..+.+..++
T Consensus        12 g~~~~-~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~   83 (255)
T d1nd4a_          12 GYDWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   83 (255)
T ss_dssp             TCEEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCceE-EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence            34543 445554 4688988764 57778899865442      234677888888776432 25667888888889999


Q ss_pred             EEeccCCCCH
Q 012203          120 VMELCAGGEL  129 (468)
Q Consensus       120 V~E~~~ggsL  129 (468)
                      ||++++|.++
T Consensus        84 v~~~i~G~~~   93 (255)
T d1nd4a_          84 LLGEVPGQDL   93 (255)
T ss_dssp             EEECCSSEET
T ss_pred             EEEeeecccc
Confidence            9999988665

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.39  E-value=0.00032  Score=68.81  Aligned_cols=76  Identities=14%  Similarity=0.066  Sum_probs=53.5

Q ss_pred             EEeEEeecCCeEEEEEEEcC-------CCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCceeeeEEEEeCCEE
Q 012203           45 LGQQLGWGQFGVIRVCSDKF-------TGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNVVDLKAVYEDEDYV  117 (468)
Q Consensus        45 i~~~LG~G~fg~Vy~a~~~~-------~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnIv~l~~~~~~~~~~  117 (468)
                      -+++|+.|-.-.+|++....       ..+.|.+++.-...     ......+|..+++.+..+.-..++++++.+    
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            34688889999999998753       34678888875321     123456799999999866555677777643    


Q ss_pred             EEEEeccCCCCH
Q 012203          118 HLVMELCAGGEL  129 (468)
Q Consensus       118 ~lV~E~~~ggsL  129 (468)
                      .+||||++|..|
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            689999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.07  E-value=0.00037  Score=65.77  Aligned_cols=154  Identities=14%  Similarity=0.158  Sum_probs=82.1

Q ss_pred             cCccccccccCCeEEE-----eEEeecCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCC----
Q 012203           31 LDTNQISNLRERFVLG-----QQLGWGQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGH----  101 (468)
Q Consensus        31 ~~~~~~~~l~~~y~i~-----~~LG~G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~H----  101 (468)
                      ++..++..+-..|.++     +.|..|--.+.|+++.. + ..|++|++....     ....+..|+++|..|.++    
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~-g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pv   75 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSC   75 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-S-CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-C-CcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccc
Confidence            4556666666777663     34456666889998764 3 458999986532     123455677777777622    


Q ss_pred             CCceee---eEEEEeCCEEEEEEeccCCCCHHH--------------HHHHcC---------CCCH--------------
Q 012203          102 PNVVDL---KAVYEDEDYVHLVMELCAGGELFH--------------RLEKFG---------RFSE--------------  141 (468)
Q Consensus       102 pnIv~l---~~~~~~~~~~~lV~E~~~ggsL~~--------------~l~~~~---------~l~~--------------  141 (468)
                      |..+..   ..+..-......++.+..|.....              .++...         ....              
T Consensus        76 p~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (316)
T d2ppqa1          76 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  155 (316)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             cccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhh
Confidence            111111   011233456677777776643211              011000         0000              


Q ss_pred             ----HHHHHHHHHHHHHHHHHH----HcCcEecccCCCcEEEeecCCCCCEEEeecCceee
Q 012203          142 ----AEARVLFMQLMQVVLYCH----EIGVVHRDLKPENILLATKASSSPIKLADFGLATY  194 (468)
Q Consensus       142 ----~~~~~i~~qil~aL~~LH----~~gIiHrDIKp~NILl~~~~~~~~ikL~DFGla~~  194 (468)
                          ......+..+...+...+    ..|+||+|+.+.||+++.+.   ..-|.||+.+..
T Consensus       156 ~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~---v~gvIDF~~~~~  213 (316)
T d2ppqa1         156 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDE---LSGLIDFYFACN  213 (316)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTE---EEEECCCTTCEE
T ss_pred             hhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhccccc---ceeEeccccccc
Confidence                111222223333333332    24799999999999998543   358999999864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.91  E-value=0.0016  Score=61.78  Aligned_cols=71  Identities=13%  Similarity=0.146  Sum_probs=48.3

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEeccCcCCChhhHHHHHHHHHHHHHhcCCCCc--eee-----eEEEEeCCEEEEEEecc
Q 012203           52 GQFGVIRVCSDKFTGEVFACKSIAKDRLVTIDDERSVKLEIEIMTRLSGHPNV--VDL-----KAVYEDEDYVHLVMELC  124 (468)
Q Consensus        52 G~fg~Vy~a~~~~~g~~vavK~i~~~~~~~~~~~~~~~~Ei~iL~~L~~HpnI--v~l-----~~~~~~~~~~~lV~E~~  124 (468)
                      +.-..||.+... +|+.|++|+.....    .....+..|...+..|.++ .|  +..     -..+...+..+.+++++
T Consensus        33 s~EN~vy~v~~~-dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~  106 (325)
T d1zyla1          33 SYENRVYQFQDE-DRRRFVVKFYRPER----WTADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSV  106 (325)
T ss_dssp             CSSSEEEEECCT-TCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             cccceeEEEEcC-CCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence            445799999874 78999999986542    2345677899998888732 22  111     12335677899999999


Q ss_pred             CCCC
Q 012203          125 AGGE  128 (468)
Q Consensus       125 ~ggs  128 (468)
                      +|..
T Consensus       107 ~G~~  110 (325)
T d1zyla1         107 GGRQ  110 (325)
T ss_dssp             CCEE
T ss_pred             CCcC
Confidence            8743